Citrus Sinensis ID: 042486

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-----
Protein Sequence
MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccEEEcccccccccHHHHHHHHcccHHHHHHHcccccccccccccEEEEEEEcccccccccEEEEEEEEccccccHHHHHHccccHHHHHHHHccccccccccccEEEccccccccccccccccccEEEEEEccccccHHHHHHHHcccHHHHHHHccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHcccccccccccccccHHHHHHccccccccHHHHHHHHccccccccccccEEEEEEccEEEEEEEccccHHHHHHHHHHccccccccEEEEEEEccEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccEcccccccccEEEEEEcccccccHHHHHHHHcccHHHHHHHcccccccccccccEEEEEEEcccccccccccEEEEEEccccHHHHHHHHHccccHHHHHHHHcccccccccccEEEEEEEcccccccccccccEEEEEEEccccccHHHHHHHccccHHHEEcccccccccccccccccEEccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccHccccccEEcHHHHHHHHccccHHHccccEEEEEEEcccEEHHHHcHHHHHHHHHHHHHHHHHcHEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHcHEEEccccccEEccccHHHEccccccccEEEEEEEcccccccHHHHHccccccHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccccccHHHHccHHccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHcccHccccccccccc
Coil and Loop (DISEMBL)
MGFLPCISVFILFTLSFISSiqaqqpyiglattacssfdttnsalgyscnglnrSCLAFLIfrskppfntVASISTLlaskpsqlskinsvsetatfetnqmvivpvncscsgkhyqanttyfvqNGDTYFLIANNTFQGLSTCQALQdqhgnvsnfgvgtrllaplrcacptknqtdsGVHYLLSYLVKggntvygiskrfgvdtdrtleanglsegapniypfttllvplenppsssqtteqrplppssppppnsssnkgakktWIYVVIGVLAGIALTLIFGMIIFYMFFRISYkkefdstiVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQaatddfnpscwikgsvyrgkiGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWindkggkfLDWAQRIQIALDVATglnylhsftnpphvhkdikcsnvllDTDFRAKIANFALarpaerqegefaltshivgtkgymapeylenglvstklDVYAFGVLMLEMlsgkeapalyseENMLLVDVLnpvlhkedgeeslrhlmdpsmqgnyppVTAILVIRLIESClkkdpsgrpamDKIAQSISRFLNASLAWELSKNISEL
Flexible Loop (DISEMBL)
MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTllaskpsqlSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEAnglsegapnIYPFTTLLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQaatddfnpscwIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAlarpaerqegeFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL
Low Complexity Region (SEG)
MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLppssppppnsssnKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL
Disordered region (IsUnstruct)
**FLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLA*************ETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVP*********************************KTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSS********************LESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH******************NYPPVTAILVIRLIESCLK***************ISRFLNASLAWE********
Disordered Region (DISOPRED)
****PCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPL*************************************VVIGVLAGIALTLIFGMIIFYMFF*********************************************LKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP*****ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF****************
Disordered Region (DISEMBL)
MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLE****************************GAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL
Disordered Region (DISPRO)
MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN*******************************TWIYVVIGVLAGIALTLIFGMIIFYMFFRISY**************************************AQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN**************
Transmembrane Helix (TMHMM)
oooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	635	2.2.26 [Sep-21-2011]
O64825	612	LysM domain receptor-like	yes	no	0.930	0.965	0.459	1e-143
O22808	664	Protein LYK5 OS=Arabidops	no	no	0.963	0.921	0.398	1e-118
A8R7E6	617	Chitin elicitor receptor	no	no	0.792	0.815	0.305	1e-57
Q9SGI7	654	Protein LYK2 OS=Arabidops	no	no	0.826	0.802	0.270	4e-57
D7UPN3	605	Chitin elicitor receptor	no	no	0.755	0.793	0.307	2e-52
F4IB81	651	LysM domain receptor-like	no	no	0.448	0.437	0.388	5e-51
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.538	0.506	0.323	8e-44
Q8RWW0	744	Receptor-like serine/thre	no	no	0.440	0.376	0.350	3e-43
Q9SX31	708	Proline-rich receptor-lik	no	no	0.592	0.531	0.298	8e-42
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.574	0.535	0.271	2e-40

>sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1

 Score =  508 bits (1309), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 290/631 (45%), Positives = 401/631 (63%), Gaps = 40/631 (6%)

Query: 9   VFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPF 68
           VFIL +LS  ++  AQQPY+G++TT CS  D T S  GYSCNGLN++C A++IFRS P F
Sbjct: 10  VFILLSLSSFAT--AQQPYVGISTTDCSVSDNTTSVFGYSCNGLNKTCQAYVIFRSTPSF 67

Query: 69  NTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGD 128
           +TV SIS+L +  PS +S +N  S + +F + Q VI+P+ CSC+G   Q+N TY +Q  D
Sbjct: 68  STVTSISSLFSVDPSLVSSLNDASPSTSFPSGQQVIIPLTCSCTGDDSQSNITYTIQPND 127

Query: 129 TYFLIANNTFQGLSTCQALQDQHGNVSNFGV--GTRLLAPLRCACPTKNQ-TDSGVHYLL 185
           +YF IAN+T QGLSTCQAL  Q+ NVS+  +  G R++ P+RCACPT  Q  + GV YL+
Sbjct: 128 SYFAIANDTLQGLSTCQALAKQN-NVSSQSLFPGMRIVVPIRCACPTAKQINEDGVKYLM 186

Query: 186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQT---- 241
           SY V   +T+  IS RFGV+T +TL+AN +S     ++PFTT+L+PL NPP+++ +    
Sbjct: 187 SYTVVFEDTIAIISDRFGVETSKTLKANEMSFENSEVFPFTTILIPLVNPPANTNSLIPP 246

Query: 242 TEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEF 301
               P    SPPP +    K  KKTW+Y + GVL G  +  + G  IF +  + +  +  
Sbjct: 247 PPPPPPQSVSPPPLSPDGRKSKKKTWVYALAGVLGGALVLSVIGAAIFCLSKKKTKTQTQ 306

Query: 302 DSTIVSSSFEACEKASNKKLDEESRDFLESISD-IAQSLKVYTFEELQAATDDFNPSCWI 360
           + T    SF          + ++  D L+ +S  + +SLKVY F ELQ+AT DF  S  I
Sbjct: 307 EETGNLDSF----MGKKPPMSDQEFDPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSI 362

Query: 361 KGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN 420
            GS Y GKI GD   IKK+ G+AS+++ LL+K+NH ++IRL G CF+ G+WYLVYE+A N
Sbjct: 363 GGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFHEGDWYLVYEHASN 422

Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSLS WI+      L   Q++QIALD+ATGLNYLH+F +PP+VH+D+  +NV LD +FRA
Sbjct: 423 GSLSEWIHTTKS-LLSLTQKLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLDLEFRA 481

Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           KI +   AR       +F LT H+ GT+GY+APEYLE+GLVSTKLDVYAFGV++LE+++G
Sbjct: 482 KIGSLGSARSTTE---DFVLTKHVEGTRGYLAPEYLEHGLVSTKLDVYAFGVVLLEIVTG 538

Query: 541 KEAPALYSE--ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESC 598
           KEA  L  E  E   + ++L   +H     E L   ++                RL+  C
Sbjct: 539 KEASELKKEIDEGKAIDEIL---IHGRLLPEGLTSFVE----------------RLVVDC 579

Query: 599 LKKDPSGRPAMDKIAQSISRFLNASLAWELS 629
           LKKD   RP+MD+   S+S+ L A+  WE S
Sbjct: 580 LKKDHLNRPSMDENVMSLSKILAATQNWEES 610

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1

 Score =  424 bits (1090), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 266/668 (39%), Positives = 396/668 (59%), Gaps = 56/668 (8%)

Query: 4   LPCISVFILFTLSF-ISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIF 62
           L  +SV +   L F +S  +AQQPY+     AC      N   G++CNG   SC ++L F
Sbjct: 6   LHALSVTLFLLLFFAVSPAKAQQPYVNNHQLACEVRVYDNITNGFTCNG-PPSCRSYLTF 64

Query: 63  RSKPPFNTVASISTLLASKPSQLSKINSV-SETATFETNQMVIVPVNCSCSGKH---YQA 118
            S+PP+NT  SI+ LL    +++  IN++ + T    T ++V++P NCSCS      YQ 
Sbjct: 65  WSQPPYNTADSIAKLLNVSAAEIQSINNLPTATTRIPTRELVVIPANCSCSSSSGGFYQH 124

Query: 119 NTTYFV---QNGDTYFLIANNTFQGLSTCQAL--QDQHGNVSNFGVGTRLLAPLRCACPT 173
           N TY +   +  +TYF +AN+T+Q LSTCQA+  Q+++G       G  LL PLRCACPT
Sbjct: 125 NATYNLSGNRGDETYFSVANDTYQALSTCQAMMSQNRYGE-RQLTPGLNLLVPLRCACPT 183

Query: 174 KNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLE 233
             QT +G  YLL+YLV  G+++ GI++ F   +    E N L+  + NI+ FT +LVPL 
Sbjct: 184 AKQTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNELT--SDNIFFFTPVLVPLT 241

Query: 234 NPPSS------------SQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALT 281
             P+               T  Q P+ P    P +SSS+K     WIY+ IG+ AG+ L 
Sbjct: 242 TEPTKIVISPSPPPPPVVATPPQTPVDP----PGSSSSHK-----WIYIGIGIGAGLLLL 292

Query: 282 LIFGMIIFYMFFRISYKKEFDSTIVSSS--FEACEKAS---------NKKLDEESRDFLE 330
           L    + FY   R S KK   S++   +  F++  K S         +  L   S  F  
Sbjct: 293 LSILALCFYK--RRSKKKSLPSSLPEENKLFDSSTKQSIPTTTTTQWSIDLSNSSEAF-- 348

Query: 331 SISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGD-ASDQIKL 389
            +    +SL +Y F +LQ+AT +F+    IKGSVYR  I GD  A+K + GD +S +I L
Sbjct: 349 GLKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINL 408

Query: 390 LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           L K+NHS++IRL G C   G  YLV+E + NGS+S W++  G K L W QR++IA DVA 
Sbjct: 409 LKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHSSGKKSLTWKQRVEIARDVAE 468

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
            L+YLH++  PPH+HK+++ +N+LLD++FRAKIANF +AR  +  + +  LT H+ GT+G
Sbjct: 469 ALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQG 528

Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY-----SEENMLLVDVLNPVLHK 564
           Y+APEY+ENG++++KLDV+AFGV +LE+LSG+EA  ++      EE  +L  V+N VL  
Sbjct: 529 YLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLCKVINSVLGG 588

Query: 565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
           E+  E L+  MDPS+   YP   A  + +L +SC+  D + RP++ ++  ++S  +++S+
Sbjct: 589 ENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVSSSI 648

Query: 625 AWELSKNI 632
            WE S ++
Sbjct: 649 DWEPSDDL 656

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  224 bits (572), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 174/569 (30%), Positives = 290/569 (50%), Gaps = 66/569 (11%)

Query: 89  NSVSETATFETNQMVIVPVNCSCS-GKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQAL 147
           +++ +    +    V+VP  C C  G     N +Y V+  DTY  +A + +  L+T ++L
Sbjct: 71  SNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESL 130

Query: 148 QDQHG-NVSNFGVGTRLLAPLRCACPTKN-QTDSGVHYLLSYLVKGGNTVYGISKRFGVD 205
           Q ++    +N  +   L   + C+C  ++   D G+   ++Y ++  +++  I++  GV 
Sbjct: 131 QARNPFPATNIPLSATLNVLVNCSCGDESVSKDFGL--FVTYPLRPEDSLSSIARSSGVS 188

Query: 206 TDRTLEAN-GLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAK 264
            D     N G++  + N      + VP  +P  +              PP  SS   G  
Sbjct: 189 ADILQRYNPGVNFNSGN----GIVYVPGRDPNGAF-------------PPFKSSKQDGVG 231

Query: 265 KTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKK--EFDSTIVSSSFEACEKASNKKLD 322
                V+ G++ G+ + L+  + I Y  +R +  K   F S+I  S+          K D
Sbjct: 232 AG---VIAGIVIGVIVALLLILFIVYYAYRKNKSKGDSFSSSIPLST----------KAD 278

Query: 323 EESRDFLES-----------ISDIAQSLKV-YTFEELQAATDDFNPSCWIK----GSVYR 366
             S   L+S           I+ I+    V ++ EEL  ATD+FN S  I     G+VY 
Sbjct: 279 HASSTSLQSGGLGGAGVSPGIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYY 338

Query: 367 GKIGGDFVAIKKVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
            ++ G+  AIKK+  +AS Q    +K+L +++H +L+RL+G C  G + +LVYE   NG+
Sbjct: 339 AELRGEKAAIKKMDMEASKQFLAELKVLTRVHHVNLVRLIGYCVEG-SLFLVYEYVENGN 397

Query: 423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKI 482
           L   ++  G + L W +R+QIALD A GL Y+H  T P +VH+DIK +N+L+D  FRAK+
Sbjct: 398 LGQHLHGSGREPLPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKV 457

Query: 483 ANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
           A+F L +  E      + T   +GT GYMAPE +  G VS K+DVYAFGV++ E++S K 
Sbjct: 458 ADFGLTKLTEVGG---SATRGAMGTFGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKG 513

Query: 543 APALYSE---ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           A    +E   E   LV V      + D EE+LR ++DP +  +YP  +   +  L ++C 
Sbjct: 514 AVVKMTEAVGEFRGLVGVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACT 573

Query: 600 KKDPSGRPAMDKIAQSISRFLNASLAWEL 628
           +++   RP+M  I  ++S   +++  W++
Sbjct: 574 QENAQLRPSMRYIVVALSTLFSSTGNWDV 602

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGI7|LYK2_ARATH Protein LYK2 OS=Arabidopsis thaliana GN=LYK2 PE=2 SV=1

 Score =  223 bits (568), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 170/629 (27%), Positives = 297/629 (47%), Gaps = 104/629 (16%)

Query: 43  SALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQM 102
           S+ GY C+   + C  F I R+KPPF +++ +S  L             ++       Q+
Sbjct: 44  SSFGYVCHSNLQKCHTFAILRAKPPFYSLSDLSRHLGLD----------ADDEYVPKGQL 93

Query: 103 VIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVS--NFGVG 160
           +++P+ C C+G  Y+A+       GDT F   + + QGL+TC ++++++ ++S    G  
Sbjct: 94  LLIPIECRCNGSIYEASLIKNCVKGDT-FRSVSQSLQGLTTCLSIREKNPHISEDKLGDN 152

Query: 161 TRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAP 220
            +L   +RC+CP +  +++   +L++Y V   ++V  ++ RF    D  + AN  S    
Sbjct: 153 IKLRLAIRCSCPQEGVSNAS--FLVTYPVGVRDSVSSLAVRFNTTEDAIVSANNKS---- 206

Query: 221 NIYPFTTLLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIAL 280
            + P    L+PL++ P    + ++ P           S  K +K   +  V   +AG+  
Sbjct: 207 GVVPLKPALIPLDHKPEKQGSRKRNP-----------SKKKRSKMKLMIAVSSAIAGVC- 254

Query: 281 TLIFGMIIFYMFFRISYKKEFDSTIVSSSF------------EACEKASNKKLD-EESRD 327
               G++   +F  + +KKE      +  +             +    S+KK+  E S+D
Sbjct: 255 ----GLVTLMVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSDKKISFEGSQD 310

Query: 328 --FLESISDIAQS------LKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKV 379
              L+S + +  +      L++Y FEEL+ AT++F+ S  IKGSVY G + G  +AIK+V
Sbjct: 311 GSILDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQV 370

Query: 380 YGDASDQIK--LLNKINH---SSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDKGG 432
             D   +    LLN  +H    ++IR+LG CF     + YLV+E A NGSL  WI +K  
Sbjct: 371 NADEMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLA 430

Query: 433 K----------FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKI 482
                      FL W QRI+I  DVA  L Y+H      +VH +IK  N+ L+ D R K+
Sbjct: 431 IKNQFIESCYCFLAWKQRIKICHDVAIALKYMHRIN---YVHGNIKSRNIFLNEDLRGKV 487

Query: 483 ANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK- 541
            NF +++                 T      E L    +S   D++A+G++++E+LSG+ 
Sbjct: 488 GNFGMSKCV---------------TNELATEENLIESSLSPASDIFAYGIIVMEVLSGQT 532

Query: 542 ----------EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
                     E  +L ++E    V   + +      +E LR +MD ++  +Y   +A  +
Sbjct: 533 PDMLLGLQEVETTSLGTQET--FVSEWSRLRRLLGDKEKLREVMDSTLGESYSVDSAFEI 590

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +   C  ++   RP+  +IA+ +SR +
Sbjct: 591 ASIARDCTAEEAESRPSAVEIAERVSRLV 619

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  207 bits (527), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 169/550 (30%), Positives = 266/550 (48%), Gaps = 70/550 (12%)

Query: 99  TNQMVIVPVNCSCSGKHYQANTTYFVQ-----------NGDTYFLIANNTFQGLSTCQAL 147
           T   V+VP  CSC G      +T+               GDTY  +A N +  L+T   L
Sbjct: 77  TGDRVLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAAN-YADLTTAAWL 135

Query: 148 QDQH----GNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFG 203
           +  +    G +   G   R+   + C+C    +        L+Y +  G T+  ++ ++G
Sbjct: 136 EATNAYPPGRIP--GGDGRVNVTINCSC-GDERVSPRYGLFLTYPLWDGETLESVAAQYG 192

Query: 204 VDTDRTLE-ANGLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKG 262
             +   +E     + G   +     + +P+++P  S                P  S   G
Sbjct: 193 FSSPAEMELIRRYNPGMGGVSGKGIVFIPVKDPNGSYH--------------PLKSGGMG 238

Query: 263 AKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLD 322
              +   +   V+A IA+  I  + +  MF+R               ++   KA+++   
Sbjct: 239 NSLSGGAIAGIVIACIAI-FIVAIWLIIMFYR---------------WQKFRKATSRPSP 282

Query: 323 EESRDFLESISDIAQSLKV-----YTFEELQAATDDFNPSCWIK----GSVYRGKIGGDF 373
           EE+   L+  S  A+ +KV     +++EE+  AT  F+    I     GSVY  ++ G+ 
Sbjct: 283 EET-SHLDDASQ-AEGIKVERSIEFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEK 340

Query: 374 VAIKKVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND 429
            AIKK+   A+ +    +K+L  ++H +L+RL+G C      +LVYE   NG+LS  +  
Sbjct: 341 TAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVEN-CLFLVYEFIDNGNLSQHLQR 399

Query: 430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
            G   L WA R+QIALD A GL YLH    P +VH+DIK +N+LLD DFRAKIA+F LA+
Sbjct: 400 TGYAPLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAK 459

Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
             E      +L++ + GT GYM PE    G VS K+DVYAFGV++ E+LS K+A    SE
Sbjct: 460 LTEVGSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSE 518

Query: 550 ENML---LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                  LV +    L   +  E+L  L+DPS+QG+YP  +A+ +  L +SC  ++P  R
Sbjct: 519 SVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMR 578

Query: 607 PAMDKIAQSI 616
           P M  +  ++
Sbjct: 579 PTMRSVVVAL 588

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  202 bits (515), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 120/309 (38%), Positives = 181/309 (58%), Gaps = 24/309 (7%)

Query: 341 VYTFEELQAATDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGDASDQ----IKLLNK 392
           V+T+EE++AATD+F+ S  +     GSVY G +    VA+K++    + +    +K+L K
Sbjct: 328 VFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCK 387

Query: 393 INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND---KGGKFLDWAQRIQIALDVAT 449
           ++HS+L+ L+G        ++VYE    G L   ++D   KG   L W  R QIALD A 
Sbjct: 388 VHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIALDAAR 447

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHIVGTK 508
           GL Y+H  T   +VH+DIK SN+LLD  FRAKI++F LA+  E+  EGE ++T  +VGT 
Sbjct: 448 GLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTK-VVGTY 506

Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE-------ENMLLVDVLNPV 561
           GY+APEYL +GL ++K D+YAFGV++ E++SG+EA  + +E       E   L  ++  V
Sbjct: 507 GYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREA-VIRTEAIGTKNPERRPLASIMLAV 565

Query: 562 LHKEDGE---ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
           L          SL+  +DP+M   YP      +  L + C+  DP  RP M ++  S+S+
Sbjct: 566 LKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQ 625

Query: 619 FLNASLAWE 627
            L +S+ WE
Sbjct: 626 ILLSSIEWE 634

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  179 bits (453), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 124/383 (32%), Positives = 201/383 (52%), Gaps = 41/383 (10%)

Query: 251 SPPPPNSSSNKGAKKTWIYVVIGVLAGIAL-TLIFGMIIFYMFFRISYKKEFDSTIVSSS 309
           + PP N  S KG  K    +V  +   +++  L+ G + + +  R               
Sbjct: 266 TAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR--------------- 310

Query: 310 FEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVY 365
                   N KL  E+ D  E      ++L+ + F  ++AAT+ F+ S  +     G VY
Sbjct: 311 -------RNNKLSAETEDLDEDGITSTETLQ-FQFSAIEAATNKFSESNKLGHGGFGEVY 362

Query: 366 RGK-IGGDFVAIKKVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           +G+ I G+ VAIK++   ++       +++ ++ K+ H +L +LLG C +G    LVYE 
Sbjct: 363 KGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEF 422

Query: 418 AVNGSLSVWIND-KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT 476
             N SL  ++ D +  + LDW +R +I   +A G+ YLH  +    +H+D+K SN+LLD 
Sbjct: 423 VPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDA 482

Query: 477 DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLE 536
           D   KI++F +AR     + + A T  IVGT GYM+PEY  +G  S K DVY+FGVL+LE
Sbjct: 483 DMHPKISDFGMARIFGVDQTQ-ANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLE 541

Query: 537 MLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIE 596
           +++GK+  + Y E+   L D++  V  K   E S   L+D +M+GN+     I  I +  
Sbjct: 542 LITGKKNSSFYEEDG--LGDLVTYVW-KLWVENSPLELVDEAMRGNFQTNEVIRCIHIAL 598

Query: 597 SCLKKDPSGRPAMDKIAQSISRF 619
            C+++D S RP+MD I   ++ F
Sbjct: 599 LCVQEDSSERPSMDDILVMMNSF 621

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  177 bits (448), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 107/305 (35%), Positives = 173/305 (56%), Gaps = 25/305 (8%)

Query: 332 ISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKVYGDASD- 385
           ++  A S+K +T  EL+ ATD F+    +     G VY+G +  G  VA+K +  D  + 
Sbjct: 327 MATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNR 386

Query: 386 ------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQ 439
                 ++++L++++H +L++L+GIC  G    L+YE   NGS+   +++     LDW  
Sbjct: 387 DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGT---LDWDA 443

Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           R++IAL  A GL YLH  +NP  +H+D K SNVLL+ DF  K+++F LAR  E  EG   
Sbjct: 444 RLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQH 501

Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS---EENMLLVD 556
           +++ ++GT GY+APEY   G +  K DVY++GV++LE+L+G+    +     EEN  LV 
Sbjct: 502 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEEN--LVT 559

Query: 557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
              P+L   +G   L  L+DP++ G Y       V  +   C+ ++ S RP M ++ Q++
Sbjct: 560 WARPLLANREG---LEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616

Query: 617 SRFLN 621
               N
Sbjct: 617 KLIYN 621

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  172 bits (436), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 124/415 (29%), Positives = 210/415 (50%), Gaps = 39/415 (9%)

Query: 228 LLVPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMI 287
           +LVP  N PS +  T + PL       PNS++N G        V+G+   +AL +     
Sbjct: 246 ILVPGSNNPSQNNPTLRPPLDA-----PNSTNNSG---IGTGAVVGISVAVALVVFTLFG 297

Query: 288 IFYMFFRISYKK------------EFDSTIVS-SSFEACEKASNKKLDEESRDFLESISD 334
           IF    R   K+               ST  S S+F   + ++     + S  +      
Sbjct: 298 IFVWCLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGG 357

Query: 335 IAQSLKVYTFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIK--KVYGDASD-- 385
           +  S  ++++EEL  AT+ F+    +     G VY+G +  G  VA+K  K+ G   D  
Sbjct: 358 LGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDRE 417

Query: 386 ---QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
              +++ L++I+H  L+ ++G C +G    L+Y+   N  L   ++ +    LDWA R++
Sbjct: 418 FKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK-SVLDWATRVK 476

Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
           IA   A GL YLH   +P  +H+DIK SN+LL+ +F A++++F LAR A   +    +T+
Sbjct: 477 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLA--LDCNTHITT 534

Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE--NMLLVDVLNP 560
            ++GT GYMAPEY  +G ++ K DV++FGV++LE+++G++ P   S+   +  LV+   P
Sbjct: 535 RVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK-PVDTSQPLGDESLVEWARP 593

Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
           ++      E    L DP + GNY       +I    +C++   + RP M +I ++
Sbjct: 594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRA 648

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  167 bits (424), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 109/402 (27%), Positives = 203/402 (50%), Gaps = 37/402 (9%)

Query: 255 PNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSS----- 309
           P+SS  K    T   V IGV+ G+    +F M +++   R   K++   T V  +     
Sbjct: 224 PSSSPGKSEVGTGGIVAIGVIVGLVFLSLFVMGVWFTRKR---KRKDPGTFVGYTMPPSA 280

Query: 310 -----------FEACEKASNKKLDEESRDFLESISD---IAQSLKVYTFEELQAATDDFN 355
                      F +   A  K       D++ + SD   ++     ++++EL   T  F+
Sbjct: 281 YSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFS 340

Query: 356 PSCWIK----GSVYRGKIG-GDFVAIK--KVYGDASD-----QIKLLNKINHSSLIRLLG 403
               +     G VY+G +  G  VA+K  K+ G   +     +++++++++H  L+ L+G
Sbjct: 341 EKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVG 400

Query: 404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV 463
            C +  +  LVY+   N +L   ++  G   + W  R+++A   A G+ YLH   +P  +
Sbjct: 401 YCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRII 460

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           H+DIK SN+LLD  F A +A+F LA+ A+  +    +++ ++GT GYMAPEY  +G +S 
Sbjct: 461 HRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSE 520

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEE--NMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           K DVY++GV++LE+++G++ P   S+   +  LV+   P+L +    E    L+DP +  
Sbjct: 521 KADVYSYGVILLELITGRK-PVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGK 579

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           N+ P     ++    +C++   + RP M ++ +++     A+
Sbjct: 580 NFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEAT 621

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	635
224096894	643	predicted protein [Populus trichocarpa]	0.992	0.979	0.656	0.0
255585146	647	BRASSINOSTEROID INSENSITIVE 1-associated	0.981	0.962	0.641	0.0
225430870	638	PREDICTED: wall-associated receptor kina	0.987	0.982	0.661	0.0
224133922	630	predicted protein [Populus trichocarpa]	0.963	0.971	0.662	0.0
297735221	1305	unnamed protein product [Vitis vinifera]	0.952	0.463	0.650	0.0
134032232	630	LysM-domain containing receptor-like kin	0.984	0.992	0.590	0.0
356496806	633	PREDICTED: probable receptor-like protei	0.979	0.982	0.560	0.0
356540724	634	PREDICTED: probable receptor-like protei	0.981	0.982	0.568	0.0
449448550	639	PREDICTED: probable receptor protein kin	0.971	0.965	0.546	0.0
356502197	660	PREDICTED: probable receptor-like protei	0.982	0.945	0.567	0.0

>gi|224096894|ref|XP_002310777.1| predicted protein [Populus trichocarpa] gi|222853680|gb|EEE91227.1| predicted protein [Populus trichocarpa]

 Score =  819 bits (2116), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/640 (65%), Positives = 493/640 (77%), Gaps = 10/640 (1%)

Query: 1   MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFL 60
           M F   +S F LF L   S IQAQQPY+G  TT CS  +T NSALGYSCNGLN+SC A+L
Sbjct: 1   MSFRSVVSPFALFILYCCSLIQAQQPYVGKGTTKCS--NTENSALGYSCNGLNKSCQAYL 58

Query: 61  IFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANT 120
           IFRS+PP++TVASISTLL S PSQLS+INSVSET +F TNQ+V+VPVNCSCSG ++QAN 
Sbjct: 59  IFRSQPPYSTVASISTLLGSDPSQLSQINSVSETTSFPTNQLVLVPVNCSCSGDYFQANA 118

Query: 121 TYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVS-NFGVGTRLLAPLRCACPTKNQTDS 179
           +Y VQ+G+T FLIANNT+QGLSTCQA++++ G  + N   G  L  PLRCACPTKNQ+D 
Sbjct: 119 SYIVQSGNTPFLIANNTYQGLSTCQAIRNEKGTRTVNIFAGETLTVPLRCACPTKNQSDL 178

Query: 180 GVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSS 239
           G+ YLLSYLV  G+TV     RFG D  R LEAN +SE  P IYPFTTLL+PL+NPP+SS
Sbjct: 179 GIRYLLSYLVTWGDTVSIAGVRFGADIGRALEANEISEKNPTIYPFTTLLIPLKNPPTSS 238

Query: 240 QTT---EQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRIS 296
           QT         P  SPP P+ +S+K A KTWIYV +G + GI LTL+ G IIF+M FR S
Sbjct: 239 QTVVPPPPPASPSPSPPSPSPNSDKSANKTWIYVFVGAVGGIVLTLVIGTIIFFMLFRKS 298

Query: 297 YKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNP 356
            KK+    IVS SFEA EK  N+KLDEE +D LES+  IAQS+KVY +E+L+AATD+F+P
Sbjct: 299 -KKQPGPIIVSQSFEAHEKPLNRKLDEEPQDLLESVYSIAQSIKVYNYEDLKAATDNFSP 357

Query: 357 SCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           S WIKGSV+RG I GDF AIKK+ GD S +I LLNKINHS+LIRL G+CFN G+WYLVYE
Sbjct: 358 SFWIKGSVFRGLINGDFAAIKKMNGDVSKEIDLLNKINHSNLIRLSGVCFNDGHWYLVYE 417

Query: 417 NAVNGSLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            A NG LS WI  +   GKFL W QRIQIA DVATGLNYLHSFTN PHVHKDIK SN+LL
Sbjct: 418 YAANGPLSDWIYVSSNEGKFLKWTQRIQIATDVATGLNYLHSFTNYPHVHKDIKSSNILL 477

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
           D D RAKIANF+LAR  +  EGEFALT HIVGTKGYMAPEYLENG++ TKLDVYAFG+L 
Sbjct: 478 DKDLRAKIANFSLARSTDGPEGEFALTRHIVGTKGYMAPEYLENGIICTKLDVYAFGILT 537

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-EESLRHLMDPSMQGNYPPVTAILVIR 593
           LE+++GKE  ALY EEN  L DVLN VL +E G EESL  L+DPSMQGNYP   A+L++R
Sbjct: 538 LEIMTGKEVAALYREENRELSDVLNGVLSEEGGLEESLSQLIDPSMQGNYPSGLAVLMVR 597

Query: 594 LIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
           LI+SCL K+P+GRPAMD+I QS+S  L  SLAWELS N S
Sbjct: 598 LIDSCLNKNPAGRPAMDEIVQSLSGILITSLAWELSNNTS 637

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585146|ref|XP_002533278.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223526903|gb|EEF29110.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  815 bits (2106), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/641 (64%), Positives = 499/641 (77%), Gaps = 18/641 (2%)

Query: 1   MGFLPCISVFILFTLSFISS-----IQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRS 55
           MGF   IS F LF LS   +     I AQQPY+  ATT C+  +T +SALGYSCNGLN S
Sbjct: 1   MGF---ISAFSLFFLSIFLAFCCLLIHAQQPYVAKATTNCT--NTADSALGYSCNGLNTS 55

Query: 56  CLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKH 115
           C  +L FRS+PP+  V SISTLL S PSQLS INSVSETATF+TN++VIVPVNCSCSG +
Sbjct: 56  CQTYLTFRSQPPYTNVTSISTLLNSDPSQLSAINSVSETATFDTNKLVIVPVNCSCSGDY 115

Query: 116 YQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVS-NFGVGTRLLAPLRCACPTK 174
           YQANT+Y VQ  D  F IANNTFQGLSTCQA+ DQ+   + +      L  PLRCACPTK
Sbjct: 116 YQANTSYVVQAKDAPFFIANNTFQGLSTCQAINDQNRRQTVDIFPNEILHIPLRCACPTK 175

Query: 175 NQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN 234
           NQTD+G+ YLLSYLV  G+TV  +S +FG +T R+LEANGLSE  P IYPFTTLL+PLEN
Sbjct: 176 NQTDAGIKYLLSYLVTWGDTVSAVSVKFGGNTGRSLEANGLSEQTPTIYPFTTLLIPLEN 235

Query: 235 PPSSSQT---TEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYM 291
           PP+S+QT          P  PP  ++ +N  + K W+YV++GVLAGI  TL    IIFY 
Sbjct: 236 PPTSNQTISPPPPPASSPPPPPSTDTPNNGSSSKKWVYVLVGVLAGIVFTLGLVTIIFYA 295

Query: 292 FFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAAT 351
            FR S K++ +  IVS SFEA EK+ NKKLDEES+DFL+SIS IAQS+KVY F+EL+AAT
Sbjct: 296 LFRRS-KRKPEPIIVSESFEAQEKSLNKKLDEESQDFLDSISSIAQSIKVYKFKELEAAT 354

Query: 352 DDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNW 411
           D+F+PSCWIKGSVYRG I GD+ AIKKV GD S +I+LLNK+NH +LIRL G+CF+GG+W
Sbjct: 355 DNFSPSCWIKGSVYRGYISGDYAAIKKVNGDVSKEIELLNKVNHFNLIRLSGVCFSGGHW 414

Query: 412 YLVYENAVNGSLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           YLVYE A NG+LS WI  ++  G FL W QR+QIALDVATGLNYLHSFT+PPH+HKDIK 
Sbjct: 415 YLVYEYAANGALSDWIYYSNNEGNFLSWTQRVQIALDVATGLNYLHSFTSPPHIHKDIKS 474

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           SNVL+D+DFRAKIAN A+AR  E Q+GEFALT HIVGTKGYMAPEYLENGLVSTKLDVYA
Sbjct: 475 SNVLIDSDFRAKIANLAMARSTEGQDGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 534

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP-PVTA 588
           FG+LMLEM++GKE  ALY+EEN+ L D+LN VL KEDG++SL+  +DPSM+ N+P  ++ 
Sbjct: 535 FGILMLEMVTGKEVAALYTEENLNLSDILNDVLSKEDGQQSLKQFVDPSMEENFPSEISL 594

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELS 629
            +++R+I+SCL K+P+ RPAMD+I+QS+SR L  SL+WE S
Sbjct: 595 FMMVRMIDSCLNKNPADRPAMDEISQSLSRILTDSLSWESS 635

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225430870|ref|XP_002269408.1| PREDICTED: wall-associated receptor kinase-like 4-like [Vitis vinifera]

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/638 (66%), Positives = 496/638 (77%), Gaps = 11/638 (1%)

Query: 1   MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFL 60
           M +L  ISVF L  +SF SSI AQQ Y+G  TT C + + T S LGY+CNG+N SC AFL
Sbjct: 1   MAWLSFISVFTLSLISFSSSILAQQSYVGKGTTDCDNNNLT-SVLGYACNGVNASCQAFL 59

Query: 61  IFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANT 120
           IFRS+PP+N V+SIS LL S PSQL++INSV ETATFET + VIVPVNCSCSG+  QANT
Sbjct: 60  IFRSEPPYNDVSSISDLLGSDPSQLAQINSVDETATFETKKEVIVPVNCSCSGEFSQANT 119

Query: 121 TYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVS-NFGVGTRLLAPLRCACPTKNQTDS 179
           +Y VQ+GDTY LIANNTF+GLSTCQAL+ Q  +++ N   GT+L  PLRCACPTKNQ+D 
Sbjct: 120 SYVVQHGDTYLLIANNTFEGLSTCQALRSQRTSLTTNIYTGTKLTVPLRCACPTKNQSDV 179

Query: 180 GVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSS 239
           GV YL+SYLV  G+ V  IS RFGVDT  TLEAN LSE  PNIYPFTTLL+PL+N PSSS
Sbjct: 180 GVKYLMSYLVASGDYVSSISVRFGVDTGMTLEANELSEQNPNIYPFTTLLIPLQNLPSSS 239

Query: 240 QT--TEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISY 297
           QT      P P   PP   SS +K  KKTW+YVV+GV+AG AL L+FG +IF+ FFR + 
Sbjct: 240 QTIVPPPPPPPSPPPPTAVSSPSKSLKKTWVYVVVGVVAGSALVLLFGSVIFFKFFRKTR 299

Query: 298 KKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPS 357
           KK  D   +S SFEACEK     L EE  +FLESIS IAQSLKVY FEELQ+ATD+F+P+
Sbjct: 300 KKT-DPIAISESFEACEKP----LKEEQHEFLESISSIAQSLKVYKFEELQSATDNFSPN 354

Query: 358 CWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           C IKGSVYRG I GD  AIKK+ G+ S++I LLNKINH ++IRL GICFN G+WYLV+E 
Sbjct: 355 CRIKGSVYRGTIKGDLAAIKKMDGEVSNEIALLNKINHFNVIRLSGICFNDGHWYLVHEY 414

Query: 418 AVNGSLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           AVNG L+ WI  N+   +FL W QRIQIALDVATGLNYLHS+T+PP+VHKDIK  NVLLD
Sbjct: 415 AVNGPLTDWIYNNNDDSRFLVWMQRIQIALDVATGLNYLHSYTSPPYVHKDIKSGNVLLD 474

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
           +DFRAKIANF LAR AE QEG+FALT HI+GT+GYMAPEYLENGLVSTKLDVYAFGVLML
Sbjct: 475 SDFRAKIANFGLARSAEGQEGQFALTRHIIGTRGYMAPEYLENGLVSTKLDVYAFGVLML 534

Query: 536 EMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
           EML+GKE  ALY  ENM L DVL  VLH+ DG+E LR+ +DPS+ GNYP   AI++IRLI
Sbjct: 535 EMLTGKEVAALYEGENMHLPDVLVAVLHEGDGKEKLRNFIDPSLSGNYPLELAIVMIRLI 594

Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
           +SCLKK P+ RP M +I Q++SR L  S+AWELS N+S
Sbjct: 595 DSCLKKSPASRPDMVEIVQALSRTLTTSVAWELSNNVS 632

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133922|ref|XP_002327712.1| predicted protein [Populus trichocarpa] gi|222836797|gb|EEE75190.1| predicted protein [Populus trichocarpa]

 Score =  790 bits (2039), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/620 (66%), Positives = 488/620 (78%), Gaps = 8/620 (1%)

Query: 19  SSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLL 78
           S IQAQQPY+G ATT CS  +T NSALGYSCN LN+SC A+LIFRS+PP+NTVASISTLL
Sbjct: 8   SLIQAQQPYVGKATTNCS--NTENSALGYSCNALNKSCQAYLIFRSQPPYNTVASISTLL 65

Query: 79  ASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTF 138
            S PSQLS++NSVSET +F +NQ+VIVPVNCSCSG++ QAN +Y VQ  DT FLIANNT+
Sbjct: 66  GSDPSQLSEVNSVSETTSFPSNQLVIVPVNCSCSGEYSQANASYIVQPNDTLFLIANNTY 125

Query: 139 QGLSTCQALQDQHG-NVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYG 197
           QGLSTCQALQ+Q      +   G  L  PLRCACPTKNQ+D G+ YLLSYLV  G+ V  
Sbjct: 126 QGLSTCQALQNQKTTRTDDILSGETLTVPLRCACPTKNQSDLGIRYLLSYLVTPGDDVPA 185

Query: 198 ISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQT-TEQRPLPPSSPPPPN 256
           IS++FG  T RTLEANGL E  P I+PFTTLL+PL++ P+SSQT     P   SSPP P+
Sbjct: 186 ISEQFGAATGRTLEANGLPEQNPTIFPFTTLLIPLQSTPTSSQTVVPPPPPASSSPPSPS 245

Query: 257 SSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKA 316
            +  K +KKTW+YVV+GV+ GIALT++ G IIF+M  R S KK+    I S SFEA EK 
Sbjct: 246 PNPEKSSKKTWLYVVVGVVGGIALTIVIGTIIFFMLSRKS-KKQPGPVIESQSFEAHEKP 304

Query: 317 SNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAI 376
            NKKLDEES++F ESIS IAQS+KVY FE+L+AATD+F+PSCWIKGSVYRG I GDF AI
Sbjct: 305 LNKKLDEESQEFFESISAIAQSIKVYKFEDLKAATDNFSPSCWIKGSVYRGLINGDFAAI 364

Query: 377 KKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG--GKF 434
           KK+ GD S +I+LLNKINHS+LIRL G+CFN G+WYLVYE A +G LS WI D+   GKF
Sbjct: 365 KKMNGDVSKEIELLNKINHSNLIRLSGVCFNDGHWYLVYEYAASGQLSDWIYDRSNEGKF 424

Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           L+W +RIQIA DVATGLNYLHSFTN PHVHKDIK SN+LLD+D RAKIANF+LAR    Q
Sbjct: 425 LNWTKRIQIASDVATGLNYLHSFTNYPHVHKDIKSSNILLDSDLRAKIANFSLARSTGDQ 484

Query: 495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
           + EF LT HIVGTKGYMAPEYLENG+VS+KLDVYAFG+L LE+++GKE  AL+SEE+  L
Sbjct: 485 DDEFVLTRHIVGTKGYMAPEYLENGVVSSKLDVYAFGILTLEIITGKEVAALHSEESRNL 544

Query: 555 VDVLNPVLHKEDG-EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA 613
            DVLN  L + DG EESL+ L+DPS+  NYP   A+LV+RLI+SCL K+P  RP MD+I 
Sbjct: 545 SDVLNGALSEVDGQEESLKQLIDPSLHENYPSGLAVLVVRLIDSCLNKNPGDRPTMDEIV 604

Query: 614 QSISRFLNASLAWELSKNIS 633
           QS+SR L  SLAWELS N+S
Sbjct: 605 QSLSRILTTSLAWELSSNVS 624

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735221|emb|CBI17583.3| unnamed protein product [Vitis vinifera]

 Score =  788 bits (2034), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/636 (65%), Positives = 487/636 (76%), Gaps = 31/636 (4%)

Query: 1   MGFLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFL 60
           M +L  ISVF L  +SF SSI AQQ Y+G  TT C + + T S LGY+CNG+N SC AFL
Sbjct: 21  MAWLSFISVFTLSLISFSSSILAQQSYVGKGTTDCDNNNLT-SVLGYACNGVNASCQAFL 79

Query: 61  IFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANT 120
           IFRS+PP+N V+SIS LL S PSQL++INSV ETATFET + VIVPVNCSCSG+  QANT
Sbjct: 80  IFRSEPPYNDVSSISDLLGSDPSQLAQINSVDETATFETKKEVIVPVNCSCSGEFSQANT 139

Query: 121 TYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVS-NFGVGTRLLAPLRCACPTKNQTDS 179
           +Y VQ+GDTY LIANNTF+GLSTCQAL+ Q  +++ N   GT+L  PLRCACPTKNQ+D 
Sbjct: 140 SYVVQHGDTYLLIANNTFEGLSTCQALRSQRTSLTTNIYTGTKLTVPLRCACPTKNQSDV 199

Query: 180 GVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSS 239
           GV YL+SYLV  G+ V  IS RFGVDT  TLEAN LSE  PNIYPFTTLL+PL+N PSSS
Sbjct: 200 GVKYLMSYLVASGDYVSSISVRFGVDTGMTLEANELSEQNPNIYPFTTLLIPLQNLPSSS 259

Query: 240 QTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKK 299
           QT                       KTW+YVV+GV+AG AL L+FG +IF+ FFR + KK
Sbjct: 260 QTI----------------------KTWVYVVVGVVAGSALVLLFGSVIFFKFFRKTRKK 297

Query: 300 EFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCW 359
             D   +S SFEACEK     L EE  +FLESIS IAQSLKVY FEELQ+ATD+F+P+C 
Sbjct: 298 T-DPIAISESFEACEKP----LKEEQHEFLESISSIAQSLKVYKFEELQSATDNFSPNCR 352

Query: 360 IKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV 419
           IKGSVYRG I GD  AIKK+ G+ S++I LLNKINH ++IRL GICFN G+WYLV+E AV
Sbjct: 353 IKGSVYRGTIKGDLAAIKKMDGEVSNEIALLNKINHFNVIRLSGICFNDGHWYLVHEYAV 412

Query: 420 NGSLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           NG L+ WI  N+   +FL W QRIQIALDVATGLNYLHS+T+PP+VHKDIK  NVLLD+D
Sbjct: 413 NGPLTDWIYNNNDDSRFLVWMQRIQIALDVATGLNYLHSYTSPPYVHKDIKSGNVLLDSD 472

Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
           FRAKIANF LAR AE QEG+FALT HI+GT+GYMAPEYLENGLVSTKLDVYAFGVLMLEM
Sbjct: 473 FRAKIANFGLARSAEGQEGQFALTRHIIGTRGYMAPEYLENGLVSTKLDVYAFGVLMLEM 532

Query: 538 LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIES 597
           L+GKE  ALY  ENM L DVL  VLH+ DG+E LR+ +DPS+ GNYP   AI++IRLI+S
Sbjct: 533 LTGKEVAALYEGENMHLPDVLVAVLHEGDGKEKLRNFIDPSLSGNYPLELAIVMIRLIDS 592

Query: 598 CLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
           CLKK P+ RP M +I Q++SR L  S+AWELS N+S
Sbjct: 593 CLKKSPASRPDMVEIVQALSRTLTTSVAWELSNNVS 628

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|134032232|gb|ABN50364.2| LysM-domain containing receptor-like kinase [Sesbania rostrata]

 Score =  702 bits (1811), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/637 (59%), Positives = 473/637 (74%), Gaps = 12/637 (1%)

Query: 1   MGFLPCISVFILFTL--SFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLA 58
           M   P I+VFI FTL  S    IQ QQPYIGLAT AC     +NS  GY CNGLN +C A
Sbjct: 1   MPLFPFITVFI-FTLLISHFFVIQGQQPYIGLATVACPRRGDSNSIRGYICNGLNPTCQA 59

Query: 59  FLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQA 118
           +L FRS+P +++V +IS LL S PSQL++INSVS   TF+TN++V+VPVNCSC+G++YQA
Sbjct: 60  YLTFRSQPIYSSVHTISALLGSDPSQLAEINSVSLNDTFDTNKLVLVPVNCSCAGQYYQA 119

Query: 119 NTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTD 178
           NT+Y  QN DTY LIANNTF+GLSTCQAL  ++ N  +   G +L+ PLRCACPTKNQT+
Sbjct: 120 NTSYVFQNTDTYLLIANNTFEGLSTCQALMHENHNPGDIYPGRKLMVPLRCACPTKNQTE 179

Query: 179 SGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSS 238
            G+ YLLSYLV  G++V  IS RFGV T  TLEAN LS  +  IYPFTTLLVPL + PSS
Sbjct: 180 KGIKYLLSYLVDWGDSVSFISNRFGVKTKTTLEANTLSLTSI-IYPFTTLLVPLHDKPSS 238

Query: 239 SQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIAL-TLIFGMIIFYMFFRISY 297
           SQ        PSSP   +SS+++ + KTW+YVV+GVL G+   TLI   ++F+  +  S 
Sbjct: 239 SQIVSPPQPSPSSPS--SSSTDQSSNKTWVYVVVGVLGGVLALTLILSAVMFFTRYNKSK 296

Query: 298 KKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPS 357
           KK+ DS IVS SFEA EK   +  ++E+    E IS IAQS KVY FEEL+ ATD+F+PS
Sbjct: 297 KKD-DSMIVSKSFEAVEKPPPQ--EKENEKLQEIISGIAQSFKVYGFEELKLATDNFSPS 353

Query: 358 CWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           CWIKGSV+RG I GD  AIKK  GD S +I++LNK+NHS++IRL G+ FN G WYLVYE 
Sbjct: 354 CWIKGSVFRGVINGDLAAIKKTEGDVSKEIQILNKVNHSNVIRLSGVSFNQGQWYLVYEY 413

Query: 418 AVNGSLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           A NG+LS WI  N+  GKFL W QRIQIA DVATG++YLHSFT+PPH+HKD+K SN+LLD
Sbjct: 414 AANGALSDWIYFNNVDGKFLSWTQRIQIAFDVATGVDYLHSFTSPPHIHKDLKNSNILLD 473

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
           +DFRAK+AN +LAR  E  + +F  T HIVGT+GYMAPEYLENGLVSTKLDVYAFGV+ML
Sbjct: 474 SDFRAKVANLSLARSVEGVDDQFLATRHIVGTRGYMAPEYLENGLVSTKLDVYAFGVMML 533

Query: 536 EMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
           E+L+GKE  A+ +EEN  L DVL+ +L ++ G++ L+  MDPS+QGNYP   A+ V+ +I
Sbjct: 534 EILTGKEVAAILTEENPNLEDVLSAILGEKGGQQRLKEFMDPSLQGNYPLELAMFVVEMI 593

Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNI 632
           ++C+KKDP+ RPAM +I  S+S  LN+SL+WE S  I
Sbjct: 594 DNCIKKDPTSRPAMHEIVPSLSITLNSSLSWEKSVKI 630

Source: Sesbania rostrata

Species: Sesbania rostrata

Genus: Sesbania

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496806|ref|XP_003517256.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max] gi|148362072|gb|ABQ59612.1| LYK4 [Glycine max]

 Score =  684 bits (1764), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/633 (56%), Positives = 451/633 (71%), Gaps = 11/633 (1%)

Query: 3   FLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIF 62
           F+P I +F L   +F S I  QQPYIGL T AC      NS  GY+CNG N SC ++L F
Sbjct: 6   FIPII-IFTLLIHNF-SLILGQQPYIGLGTVACPRRGNKNSIRGYTCNGANHSCQSYLTF 63

Query: 63  RSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTY 122
           RS+P +N+V +ISTLL S PSQL+KINSVS   TFETN++VIVPVNCSC+G++YQ NT+Y
Sbjct: 64  RSQPIYNSVKTISTLLGSDPSQLAKINSVSMNDTFETNKLVIVPVNCSCAGEYYQTNTSY 123

Query: 123 FVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVH 182
              N +TYFLIANNTF+GL+TCQAL++Q+ N +N   G RLL PLRCACPTKNQT+ G+ 
Sbjct: 124 EFHNSETYFLIANNTFEGLTTCQALENQNHNPANIYPGRRLLVPLRCACPTKNQTEKGIR 183

Query: 183 YLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTT 242
           YLLSYLV  G++V  IS++FGV+   TLEAN L+     IYPFTT+LVPL + PSSSQT 
Sbjct: 184 YLLSYLVNWGDSVSFISEKFGVNFMTTLEANTLTLTQATIYPFTTILVPLHDKPSSSQTV 243

Query: 243 EQRPLPPSSPPPPNSSSNKGAKKTW-IYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEF 301
                 P        SS+  + KTW   VV  V+  IAL  +   +IF+  +R + KK+ 
Sbjct: 244 SPTRRTPPP---SPPSSDHSSNKTWVYVVVGVVVGAIALISVLCAVIFFTRYRKNRKKDD 300

Query: 302 DSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK 361
              + S SFEA E+    K++E+     E IS IAQS KVY FEELQ ATD+F+PS WIK
Sbjct: 301 SVVVGSKSFEAIEEKPEVKVNEK---LSEIISGIAQSFKVYNFEELQRATDNFSPSSWIK 357

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG 421
           GSVYRG I GD  AIK++ GD S +I++LNKINHS++IRL G+ F+ G WYLVYE A NG
Sbjct: 358 GSVYRGVINGDLAAIKRIEGDVSKEIEILNKINHSNVIRLSGVSFHEGGWYLVYEYAANG 417

Query: 422 SLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
            LS WI  ++  GKFL W QR+QIALDVATGL+YLHSFT+PPH+HKDI  SN+LLD DFR
Sbjct: 418 DLSEWIYFHNVNGKFLSWTQRMQIALDVATGLDYLHSFTSPPHIHKDINSSNILLDGDFR 477

Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            K+ N +LAR  E  + +   T HIVGT+GYMAPEYLENGLVSTKLDVYAFGVLMLEM++
Sbjct: 478 GKVTNLSLARCLEGGDDQLPATRHIVGTRGYMAPEYLENGLVSTKLDVYAFGVLMLEMVT 537

Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           GKE  A+ +E+   L  VL+ +L +E G+E L+  +DPS+  N P   A+ VI +I++C+
Sbjct: 538 GKEVAAILTEDETKLSHVLSGILGEESGKEMLKEFVDPSLGENCPLELAMFVIEMIDNCI 597

Query: 600 KKDPSGRPAMDKIAQSISRFLNASLAWELSKNI 632
           K DP+ RP++ +I QS+SR L +SL+WE S N+
Sbjct: 598 KTDPASRPSVHEIVQSMSRTLKSSLSWERSMNV 630

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356540724|ref|XP_003538835.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/633 (56%), Positives = 453/633 (71%), Gaps = 10/633 (1%)

Query: 3   FLPCISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIF 62
           F+P I +F L   +F S I  QQPYIGL T AC      NS  GY+CNG N SC ++L F
Sbjct: 6   FIPII-IFTLLIHNF-SLILGQQPYIGLGTVACPRRGNKNSIRGYTCNGANHSCQSYLTF 63

Query: 63  RSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTY 122
           RS+P +N+V +ISTLL S PSQL+KINSVS   TFETN++VIVPVNCSCSG++YQ NT+Y
Sbjct: 64  RSQPIYNSVKTISTLLGSDPSQLAKINSVSMNDTFETNKLVIVPVNCSCSGEYYQTNTSY 123

Query: 123 FVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSNFGVGTRLLAPLRCACPTKNQTDSGVH 182
             QN +TY LIANNTF+GL+TCQAL++Q+ N +N   G RLL PLRCACPTKNQT  G+ 
Sbjct: 124 VFQNSETYLLIANNTFEGLTTCQALENQNHNPANIYPGRRLLVPLRCACPTKNQTKKGIR 183

Query: 183 YLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTT 242
           YLLSYLV  G++V  IS++FGV+   TLEAN L+     IYPFTT+LVPL + PSSSQT 
Sbjct: 184 YLLSYLVNWGDSVSFISEKFGVNFMSTLEANTLTLTQAMIYPFTTILVPLHDKPSSSQTV 243

Query: 243 EQRPLPPSSPPPPNSSSNKGAKKTW-IYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEF 301
              P    SPPP   SS+  + KTW   VV  V+  IALT +   +IF+  +R +  K+ 
Sbjct: 244 S--PTQRISPPPSPPSSDHSSNKTWVYVVVGVVVGAIALTSVLCAVIFFKRYRKNRNKDD 301

Query: 302 DSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK 361
               V  SFEA E+    K++E+     E+IS IAQS KVY FEELQ ATD+F+PS WIK
Sbjct: 302 SLVAVPKSFEAIEEKPQVKVNEK---LSENISGIAQSFKVYNFEELQRATDNFSPSSWIK 358

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG 421
           GSVYRG I GD  AIKK+ GD S +I++LNKINH+++IRL G+ F+ G WYLVY  A NG
Sbjct: 359 GSVYRGVINGDLAAIKKIEGDVSKEIEILNKINHTNVIRLSGVSFHEGRWYLVYVYATNG 418

Query: 422 SLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
            LS WI  N+  GKFL W QR+QIALDVATGL+YLHSFT+PPH+HKDI  SN+LLD DFR
Sbjct: 419 DLSEWIYFNNVDGKFLSWTQRMQIALDVATGLDYLHSFTSPPHIHKDINSSNILLDGDFR 478

Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            K+AN +LAR  E  + +F  T HIVGT+GYMAPEYLENGLVSTKLDVYAFGVLMLEM++
Sbjct: 479 GKVANLSLARCLEGGDDQFPTTRHIVGTRGYMAPEYLENGLVSTKLDVYAFGVLMLEMVT 538

Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           GKE  A+ +E+   L  VL+ +  +  G+E L+  +DPS+  N P   A+ VI +I+ C+
Sbjct: 539 GKEVAAILTEDETKLSHVLSGIPGERSGKEWLKEFVDPSLGENCPLELAMFVIEMIDDCI 598

Query: 600 KKDPSGRPAMDKIAQSISRFLNASLAWELSKNI 632
           K DP+ RP++ +I QS+SR +N+SL+WE S N+
Sbjct: 599 KTDPASRPSVHEIVQSLSRTVNSSLSWERSMNV 631

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448550|ref|XP_004142029.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus]

 Score =  668 bits (1724), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/631 (54%), Positives = 451/631 (71%), Gaps = 14/631 (2%)

Query: 10  FILFTLS---FISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKP 66
           F  FT S   F S I +QQPY G  T  C+    +   LGY CN  NR+C +FL FRS+ 
Sbjct: 6   FHFFTASLFCFFSFIVSQQPYAGSTTADCAVTHRSTGNLGYFCNTPNRNCHSFLTFRSRS 65

Query: 67  PFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQN 126
           PFN+V+SI+TLL S PS+LS++NSV+ +ATF  +++V+VP  CSCSG+ +Q+N ++  + 
Sbjct: 66  PFNSVSSIATLLGSDPSELSRVNSVNASATFPPDKLVLVPTTCSCSGQFFQSNVSFTTRT 125

Query: 127 GDTYFLIANNTFQGLSTCQALQDQHGNVSNFGV--GTRLLAPLRCACPTKNQTDSGVHYL 184
           GD+YF+IAN T QGLSTCQ+L  Q+ NVS   +  G R+L PLRCACPTKNQTD G +YL
Sbjct: 126 GDSYFVIANETLQGLSTCQSLISQNPNVSVTSIKGGERILVPLRCACPTKNQTDMGFNYL 185

Query: 185 LSYLVKGGNTVYGISK---RFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQT 241
           LSYLV  G+TV+ I++    FG D    L+AN L +G+  + PFTTLL+PL+  PSS+  
Sbjct: 186 LSYLVVFGDTVFDIAQIFESFGADMGIILDANEL-QGSSFVNPFTTLLIPLKTEPSSTGM 244

Query: 242 TEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEF 301
            E R   P  PP   +S +  +K+TW+Y+++ V+ G+ L  + G ++F+   R   KK  
Sbjct: 245 KE-RNSSPPPPPSLPTSPSPASKRTWVYILVAVVGGVVLAAVIGAVVFFACVRKRKKKTE 303

Query: 302 DSTIVSSSFEACEKASNKKLDEESRDF-LESISDIAQSLKVYTFEELQAATDDFNPSCWI 360
            + I   SFE+ EK S KKLD +S    L+SIS + QS+K YTF+ELQ ATD+F+ +  I
Sbjct: 304 HTPIEIDSFESTEKTSEKKLDGDSSSITLDSISSVVQSVKAYTFKELQDATDNFSSTHLI 363

Query: 361 KGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN 420
           KGSVY G I GD  AIKK+ GD S QI LLNK NH++LIRL G+CF  G+WYLV+E A  
Sbjct: 364 KGSVYHGTINGDSAAIKKMNGDVSKQINLLNKTNHTNLIRLSGVCFEEGHWYLVFEYAAK 423

Query: 421 GSLSVWINDKGG---KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           G LS WI+  G    +FL W QRIQIA+DVATGLNYLHSFTNPPHVHKD+K  N+LLD D
Sbjct: 424 GVLSDWIDSNGSNNDRFLTWTQRIQIAVDVATGLNYLHSFTNPPHVHKDLKMDNILLDDD 483

Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
           FR KI+NF+LAR A  +EGEF LT HIVGT+GYMAPEYLENGLVSTKLDVY+FG+L++EM
Sbjct: 484 FRGKISNFSLARSAGWEEGEFTLTMHIVGTRGYMAPEYLENGLVSTKLDVYSFGILIIEM 543

Query: 538 LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIES 597
           L+GKE   L+ +EN+ L D+L  VL ++DG+E L HLMDPS++GN+P   A+LV+ + + 
Sbjct: 544 LTGKEVSELHRKENLQLTDLLEKVLDQKDGKEYLNHLMDPSLEGNFPTELAVLVMNIAKL 603

Query: 598 CLKKDPSGRPAMDKIAQSISRFLNASLAWEL 628
           C+ KDPS RP+MD I QS+ R L++SL+WEL
Sbjct: 604 CMNKDPSQRPSMDDIVQSLCRILSSSLSWEL 634

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356502197|ref|XP_003519907.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max]

 Score =  653 bits (1685), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/652 (56%), Positives = 468/652 (71%), Gaps = 28/652 (4%)

Query: 1   MGFLPCIS-----VFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRS 55
           M   P I+     + +L ++S +  +Q +QPY+GLATTAC     +NS  GY+CNG+N S
Sbjct: 1   MNLFPMITTTIFTLIMLCSMSVVVHVQGKQPYVGLATTACGQTGNSNSMRGYTCNGVNPS 60

Query: 56  CLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKH 115
           C A+L FR++P +NTV SIS LL S  SQLS  NSVSE  TFETN++VIVP+NCSCSG +
Sbjct: 61  CQAYLTFRAQPLYNTVPSISALLGSDSSQLSVANSVSEDGTFETNKLVIVPINCSCSGNN 120

Query: 116 YQAN----TTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNV--SNFGVGTRLLAPLRC 169
                   T+Y V+ GD+YF+IANNTF+GLSTCQALQDQ+ N+   +   G  L+ PLRC
Sbjct: 121 NNQYYQFNTSYEVERGDSYFVIANNTFEGLSTCQALQDQN-NIPEGDLMPGNELIVPLRC 179

Query: 170 ACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLL 229
           ACP+KNQT+ GV YLLSYLV   + V+ I +RFGV ++  +EAN LS   P I+PFTTLL
Sbjct: 180 ACPSKNQTEQGVKYLLSYLVASNHIVWLIGERFGVSSETIVEANTLSSQQPIIHPFTTLL 239

Query: 230 VPLENPPSSSQTTEQRPLPPSSPPPPNSSSNKGAKKTWIYVVIGVLAGIALTLIFGMIIF 289
           VPL++ PSS+QT+E  P P + PPPP SSS+  + KTW+Y V+GV+  IAL      ++ 
Sbjct: 240 VPLQDEPSSNQTSEPSPPPSTPPPPPLSSSSGRSSKTWVYAVVGVVGAIAL---ISSVLC 296

Query: 290 YMFFRISY-----KKEFDSTIVSSSFEACE---KASNKKLDEESRDFLESISDIAQSLKV 341
            + FR  Y     K++ DS IVS SF A         K  +EES +  E IS I++S KV
Sbjct: 297 AIVFRTRYLKGGNKRKDDSLIVSDSFVAVAIEKPQEKKLEEEESENLAEIISGISESFKV 356

Query: 342 YTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRL 401
           Y +EELQ+AT+ F+PSC IKGSVYRG I GD  AIKK+ GD S +I+LL+K+NHS++IRL
Sbjct: 357 YRYEELQSATNGFSPSCCIKGSVYRGFINGDLAAIKKIDGDVSKEIELLSKVNHSNVIRL 416

Query: 402 LGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
            G+CFNGG WYLVYE A NG LS WIN K GKFL W QRIQIALDVATGL+YLHSFT+PP
Sbjct: 417 SGVCFNGGYWYLVYEYAANGYLSDWINIK-GKFLSWTQRIQIALDVATGLDYLHSFTSPP 475

Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE---FALTSHIVGTKGYMAPEYLEN 518
           HVHKD+K  N+LLD+DFRAKI+NF LAR  ER+  E   + +T HIVGT+GYMAPEYLEN
Sbjct: 476 HVHKDLKSGNILLDSDFRAKISNFRLARSVEREGSEGDQYVMTRHIVGTRGYMAPEYLEN 535

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML-LVDVLNPVLHKEDGEESLRHLMDP 577
           GLVSTKLDVYAFGVLMLEML+GK+   +Y+E N+  L DVL+ VL +E     L   MDP
Sbjct: 536 GLVSTKLDVYAFGVLMLEMLTGKDVADVYAEGNIANLFDVLSAVLDEEGEHLRLSEFMDP 595

Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELS 629
           S++GNYP   A+ V R+IE+C+KKDP+ RP M +I  S+S+ L++SL WE S
Sbjct: 596 SLKGNYPMELAVFVARMIETCIKKDPASRPDMHEIVSSLSKALDSSLRWETS 647

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	635
TAIR|locus:2049029	612	LYK4 "LysM-containing receptor	0.834	0.866	0.479	6.5e-138
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.973	0.930	0.383	9.7e-112
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.450	0.439	0.389	1.4e-62
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.807	0.831	0.309	1.1e-55
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.866	0.909	0.301	8e-53
TAIR|locus:2082359	654	LYK2 "LysM-containing receptor	0.842	0.818	0.260	6.4e-44
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.467	0.44	0.361	6.6e-42
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.451	0.385	0.352	2e-41
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.418	0.519	0.351	2.9e-41
TAIR|locus:2017572	882	AT1G51790 [Arabidopsis thalian	0.475	0.342	0.327	1.1e-40

TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1281 (456.0 bits), Expect = 6.5e-138, Sum P(2) = 6.5e-138
 Identities = 263/549 (47%), Positives = 361/549 (65%)

Query:     9 VFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPF 68
             VFIL +LS  ++  AQQPY+G++TT CS  D T S  GYSCNGLN++C A++IFRS P F
Sbjct:    10 VFILLSLSSFAT--AQQPYVGISTTDCSVSDNTTSVFGYSCNGLNKTCQAYVIFRSTPSF 67

Query:    69 NTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGD 128
             +TV SIS+L +  PS +S +N  S + +F + Q VI+P+ CSC+G   Q+N TY +Q  D
Sbjct:    68 STVTSISSLFSVDPSLVSSLNDASPSTSFPSGQQVIIPLTCSCTGDDSQSNITYTIQPND 127

Query:   129 TYFLIANNTFQGLSTCQALQDQHGNVSNFGV--GTRLLAPLRCACPTKNQ-TDSGVHYLL 185
             +YF IAN+T QGLSTCQAL  Q+ NVS+  +  G R++ P+RCACPT  Q  + GV YL+
Sbjct:   128 SYFAIANDTLQGLSTCQALAKQN-NVSSQSLFPGMRIVVPIRCACPTAKQINEDGVKYLM 186

Query:   186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTT--- 242
             SY V   +T+  IS RFGV+T +TL+AN +S     ++PFTT+L+PL NPP+++ +    
Sbjct:   187 SYTVVFEDTIAIISDRFGVETSKTLKANEMSFENSEVFPFTTILIPLVNPPANTNSLIPP 246

Query:   243 -EQRPLXXXXXXXXXXXXXKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEF 301
                 P              K  KKTW+Y + GVL G  +  + G  IF +  + +  +  
Sbjct:   247 PPPPPPQSVSPPPLSPDGRKSKKKTWVYALAGVLGGALVLSVIGAAIFCLSKKKTKTQTQ 306

Query:   302 DSTIVSSSFEACEKASNKKLDEESRDFLESISD-IAQSLKVYTFEELQAATDDFNPSCWI 360
             + T    SF          + ++  D L+ +S  + +SLKVY F ELQ+AT DF  S  I
Sbjct:   307 EETGNLDSF----MGKKPPMSDQEFDPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSI 362

Query:   361 KGSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN 420
              GS Y GKI GD   IKK+ G+AS+++ LL+K+NH ++IRL G CF+ G+WYLVYE+A N
Sbjct:   363 GGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFHEGDWYLVYEHASN 422

Query:   421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
             GSLS WI+      L   Q++QIALD+ATGLNYLH+F +PP+VH+D+  +NV LD +FRA
Sbjct:   423 GSLSEWIHTTKS-LLSLTQKLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLDLEFRA 481

Query:   481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             KI +   AR       +F LT H+ GT+GY+APEYLE+GLVSTKLDVYAFGV++LE+++G
Sbjct:   482 KIGSLGSARSTTE---DFVLTKHVEGTRGYLAPEYLEHGLVSTKLDVYAFGVVLLEIVTG 538

Query:   541 KEAPALYSE 549
             KEA  L  E
Sbjct:   539 KEASELKKE 547

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
 Identities = 251/654 (38%), Positives = 381/654 (58%)

Query:     7 ISVFILFTLSFISSIQAQQPYIGLATTACSSFDTTNSALGYSCNGLN--RSCLAFLIFRS 64
             +++F+L   + +S  +AQQPY+     AC      N   G++CNG    RS L F     
Sbjct:    11 VTLFLLLFFA-VSPAKAQQPYVNNHQLACEVRVYDNITNGFTCNGPPSCRSYLTFWSQPP 69

Query:    65 KPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCS---GKHYQANTT 121
                 +++A +  + A++   ++  N  + T    T ++V++P NCSCS   G  YQ N T
Sbjct:    70 YNTADSIAKLLNVSAAEIQSIN--NLPTATTRIPTRELVVIPANCSCSSSSGGFYQHNAT 127

Query:   122 YFVQN--GD-TYFLIANNTFQGLSTCQAL--QDQHGNVSNFGVGTRLLAPLRCACPTKNQ 176
             Y +    GD TYF +AN+T+Q LSTCQA+  Q+++G       G  LL PLRCACPT  Q
Sbjct:   128 YNLSGNRGDETYFSVANDTYQALSTCQAMMSQNRYGE-RQLTPGLNLLVPLRCACPTAKQ 186

Query:   177 TDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPP 236
             T +G  YLL+YLV  G+++ GI++ F   +    E N L+  + NI+ FT +LVPL   P
Sbjct:   187 TTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNELT--SDNIFFFTPVLVPLTTEP 244

Query:   237 SS---SQTTEQRPLXXXXXXXXXXXXXKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFF 293
             +    S +    P+               +   WIY+ IG+ AG+ L L    + FY   
Sbjct:   245 TKIVISPSPPPPPVVATPPQTPVDPPGSSSSHKWIYIGIGIGAGLLLLLSILALCFYK-- 302

Query:   294 RISYKKEFDSTIVSSS--FEACEKAS--NKKLDEESRDFLES-----ISDIAQSLKVYTF 344
             R S KK   S++   +  F++  K S       + S D   S     +    +SL +Y F
Sbjct:   303 RRSKKKSLPSSLPEENKLFDSSTKQSIPTTTTTQWSIDLSNSSEAFGLKSAIESLTLYRF 362

Query:   345 EELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGD-ASDQIKLLNKINHSSLIRLLG 403
              +LQ+AT +F+    IKGSVYR  I GD  A+K + GD +S +I LL K+NHS++IRL G
Sbjct:   363 NDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINLLKKLNHSNIIRLSG 422

Query:   404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV 463
              C   G  YLV+E + NGS+S W++  G K L W QR++IA DVA  L+YLH++  PPH+
Sbjct:   423 FCIREGTSYLVFEYSENGSISDWLHSSGKKSLTWKQRVEIARDVAEALDYLHNYITPPHI 482

Query:   464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
             HK+++ +N+LLD++FRAKIANF +AR  +  + +  LT H+ GT+GY+APEY+ENG++++
Sbjct:   483 HKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQGYLAPEYVENGVITS 542

Query:   524 KLDVYAFGVLMLEMLSGKEAPALYS-----EENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
             KLDV+AFGV +LE+LSG+EA  ++      EE  +L  V+N VL  E+  E L+  MDPS
Sbjct:   543 KLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLCKVINSVLGGENVREKLKEFMDPS 602

Query:   579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNI 632
             +   YP   A  + +L +SC+  D + RP++ ++  ++S  +++S+ WE S ++
Sbjct:   603 LGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVSSSIDWEPSDDL 656

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
 Identities = 120/308 (38%), Positives = 183/308 (59%)

Query:   341 VYTFEELQAATDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYG----DASDQIKLLNK 392
             V+T+EE++AATD+F+ S  +     GSVY G +    VA+K++      + + ++K+L K
Sbjct:   328 VFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCK 387

Query:   393 INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND---KGGKFLDWAQRIQIALDVAT 449
             ++HS+L+ L+G        ++VYE    G L   ++D   KG   L W  R QIALD A 
Sbjct:   388 VHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIALDAAR 447

Query:   450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHIVGTK 508
             GL Y+H  T   +VH+DIK SN+LLD  FRAKI++F LA+  E+  EGE ++T  +VGT 
Sbjct:   448 GLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTK-VVGTY 506

Query:   509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA----PALYSE--ENMLLVDVLNPVL 562
             GY+APEYL +GL ++K D+YAFGV++ E++SG+EA     A+ ++  E   L  ++  VL
Sbjct:   507 GYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRPLASIMLAVL 566

Query:   563 HKEDGE---ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
                       SL+  +DP+M   YP      +  L + C+  DP  RP M ++  S+S+ 
Sbjct:   567 KNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQI 626

Query:   620 LNASLAWE 627
             L +S+ WE
Sbjct:   627 LLSSIEWE 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
 Identities = 173/559 (30%), Positives = 290/559 (51%)

Query:    89 NSVSETATFETNQMVIVPVNCSCS-GKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQAL 147
             +++ +    +    V+VP  C C  G     N +Y V+  DTY  +A + +  L+T ++L
Sbjct:    71 SNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESL 130

Query:   148 QDQHG-NVSNFGVGTRLLAPLRCACPTKNQT-DSGVHYLLSYLVKGGNTVYGISKRFGVD 205
             Q ++    +N  +   L   + C+C  ++ + D G+   ++Y ++  +++  I++  GV 
Sbjct:   131 QARNPFPATNIPLSATLNVLVNCSCGDESVSKDFGL--FVTYPLRPEDSLSSIARSSGVS 188

Query:   206 TDRTLEAN-GLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLXXXXXXXXXXXXXKGAK 264
              D     N G++  + N      + VP  +P  +       P               G  
Sbjct:   189 ADILQRYNPGVNFNSGN----GIVYVPGRDPNGAFP-----PFKSSKQDGVGAGVIAG-- 237

Query:   265 KTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEE 324
                  +VIGV+  +AL LI   I++Y + +   K +  S+ +  S +A + AS+  L   
Sbjct:   238 -----IVIGVI--VALLLIL-FIVYYAYRKNKSKGDSFSSSIPLSTKA-DHASSTSLQSG 288

Query:   325 S---RDFLESISDIAQSLKV-YTFEELQAATDDFNPSCWIK----GSVYRGKIGGDFVAI 376
                       I+ I+    V ++ EEL  ATD+FN S  I     G+VY  ++ G+  AI
Sbjct:   289 GLGGAGVSPGIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAI 348

Query:   377 KKVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
             KK+  +AS Q    +K+L +++H +L+RL+G C  G + +LVYE   NG+L   ++  G 
Sbjct:   349 KKMDMEASKQFLAELKVLTRVHHVNLVRLIGYCVEG-SLFLVYEYVENGNLGQHLHGSGR 407

Query:   433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
             + L W +R+QIALD A GL Y+H  T P +VH+DIK +N+L+D  FRAK+A+F L +  E
Sbjct:   408 EPLPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTE 467

Query:   493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE--- 549
                G  A T   +GT GYMAPE +  G VS K+DVYAFGV++ E++S K A    +E   
Sbjct:   468 --VGGSA-TRGAMGTFGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVG 523

Query:   550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM 609
             E   LV V      + D EE+LR ++DP +  +YP  +   +  L ++C +++   RP+M
Sbjct:   524 EFRGLVGVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSM 583

Query:   610 DKIAQSISRFLNASLAWEL 628
               I  ++S   +++  W++
Sbjct:   584 RYIVVALSTLFSSTGNWDV 602

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 547 (197.6 bits), Expect = 8.0e-53, P = 8.0e-53
 Identities = 184/611 (30%), Positives = 297/611 (48%)

Query:    34 ACSSFDTTNSALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKIN-SVS 92
             AC+      +A G  C       +A   F        +A+I  +       L   N +++
Sbjct:    11 ACAFAAAAVAASGDGCRAGCSLAIAAYYFSEGSNLTFIATIFAIGGGGYQALLPYNPAIT 70

Query:    93 ETATFETNQMVIVPVNCSCSGKHYQANTTYFVQ-----------NGDTYFLIANNTFQGL 141
                   T   V+VP  CSC G      +T+               GDTY  +A N +  L
Sbjct:    71 NPDYVVTGDRVLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAAN-YADL 129

Query:   142 STCQALQDQH----GNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYG 197
             +T   L+  +    G +   G G R+   + C+C  + +        L+Y +  G T+  
Sbjct:   130 TTAAWLEATNAYPPGRIPG-GDG-RVNVTINCSCGDE-RVSPRYGLFLTYPLWDGETLES 186

Query:   198 ISKRFGVDTDRTLEA-NGLSEGAPNIYPFTTLLVPLENPPSSSQTTEQRPLXXXXXXXXX 256
             ++ ++G  +   +E     + G   +     + +P+++P  S       PL         
Sbjct:   187 VAAQYGFSSPAEMELIRRYNPGMGGVSGKGIVFIPVKDPNGS-----YHPLKSGGMGNSL 241

Query:   257 XXXXKGAKKTWIYVVIGVLAGIALTLIFGMIIFYMFFRISYKKEFDSTIVSSSFEACEKA 316
                  GA      +VI  +A I +  I+ +I+FY + +  ++K       ++S  + E+ 
Sbjct:   242 SG---GAIAG---IVIACIA-IFIVAIWLIIMFYRWQK--FRK-------ATSRPSPEET 285

Query:   317 SNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVYRGKIGGD 372
             S+  LD+ S+   E I  + +S++ +++EE+  AT  F+    I     GSVY  ++ G+
Sbjct:   286 SH--LDDASQ--AEGIK-VERSIE-FSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGE 339

Query:   373 FVAIKKVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
               AIKK+   A+ +    +K+L  ++H +L+RL+G C      +LVYE   NG+LS  + 
Sbjct:   340 KTAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVENC-LFLVYEFIDNGNLSQHLQ 398

Query:   429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
               G   L WA R+QIALD A GL YLH    P +VH+DIK +N+LLD DFRAKIA+F LA
Sbjct:   399 RTGYAPLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLA 458

Query:   489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
             +  E      +L++ + GT GYM PE    G VS K+DVYAFGV++ E+LS K+A    S
Sbjct:   459 KLTEVGSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSS 517

Query:   549 E---ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG 605
             E   E+  LV +    L   +  E+L  L+DPS+QG+YP  +A+ +  L +SC  ++P  
Sbjct:   518 ESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGM 577

Query:   606 RPAMDKIAQSI 616
             RP M  +  ++
Sbjct:   578 RPTMRSVVVAL 588

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2082359 LYK2 "LysM-containing receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 463 (168.0 bits), Expect = 6.4e-44, P = 6.4e-44
 Identities = 162/621 (26%), Positives = 296/621 (47%)

Query:    43 SALGYSCNGLNRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQM 102
             S+ GY C+   + C  F I R+KPPF +++ +S  L         +++  E       Q+
Sbjct:    44 SSFGYVCHSNLQKCHTFAILRAKPPFYSLSDLSRHLG--------LDADDEYVP--KGQL 93

Query:   103 VIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHGNVSN--FGVG 160
             +++P+ C C+G  Y+A+       GDT F   + + QGL+TC ++++++ ++S    G  
Sbjct:    94 LLIPIECRCNGSIYEASLIKNCVKGDT-FRSVSQSLQGLTTCLSIREKNPHISEDKLGDN 152

Query:   161 TRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAP 220
              +L   +RC+CP +  +++   +L++Y V   ++V  ++ RF    D  + AN  S    
Sbjct:   153 IKLRLAIRCSCPQEGVSNAS--FLVTYPVGVRDSVSSLAVRFNTTEDAIVSANNKS---- 206

Query:   221 NIYPFTTLLVPLENPPSSSQTTEQRPLXXXXXXXXXXXXXKGAKKTWIYVVIGVLAGIAL 280
              + P    L+PL++ P    + ++ P                A       + GV  G+  
Sbjct:   207 GVVPLKPALIPLDHKPEKQGSRKRNPSKKKRSKMKLMIAVSSA-------IAGV-CGLVT 258

Query:   281 TLIFGMIIFYMFFRISYK-------KEFDSTIVSSSFEACEKASNKKLD-EESRD--FLE 330
              ++FG + +    +I  +       K+ ++  +S S       S+KK+  E S+D   L+
Sbjct:   259 LMVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRT---TSDKKISFEGSQDGSILD 315

Query:   331 SISDIAQS------LKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDAS 384
             S + +  +      L++Y FEEL+ AT++F+ S  IKGSVY G + G  +AIK+V  D  
Sbjct:   316 SHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNADEM 375

Query:   385 DQIK--LLNKINH---SSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDK---GGKF 434
              +    LLN  +H    ++IR+LG CF     + YLV+E A NGSL  WI +K     +F
Sbjct:   376 KRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIKNQF 435

Query:   435 LD-----WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
             ++      A + +I +     +  L       +VH +IK  N+ L+ D R K+ NF +++
Sbjct:   436 IESCYCFLAWKQRIKICHDVAIA-LKYMHRINYVHGNIKSRNIFLNEDLRGKVGNFGMSK 494

Query:   490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS- 548
                    E A   +++           E+ L S   D++A+G++++E+LSG+    L   
Sbjct:   495 CVTN---ELATEENLI-----------ESSL-SPASDIFAYGIIVMEVLSGQTPDMLLGL 539

Query:   549 ---EENML-----LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
                E   L      V   + +      +E LR +MD ++  +Y   +A  +  +   C  
Sbjct:   540 QEVETTSLGTQETFVSEWSRLRRLLGDKEKLREVMDSTLGESYSVDSAFEIASIARDCTA 599

Query:   601 KDPSGRPAMDKIAQSISRFLN 621
             ++   RP+  +IA+ +SR ++
Sbjct:   600 EEAESRPSAVEIAERVSRLVD 620

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 443 (161.0 bits), Expect = 6.6e-42, Sum P(2) = 6.6e-42
 Identities = 114/315 (36%), Positives = 179/315 (56%)

Query:   318 NKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVYRGK-IGGD 372
             N KL  E+ D  E      ++L+ + F  ++AAT+ F+ S  +     G VY+G+ I G+
Sbjct:   312 NNKLSAETEDLDEDGITSTETLQ-FQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGE 370

Query:   373 FVAIKKV-YGDAS------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
              VAIK++  G         +++ ++ K+ H +L +LLG C +G    LVYE   N SL  
Sbjct:   371 TVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDY 430

Query:   426 WIND-KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
             ++ D +  + LDW +R +I   +A G+ YLH  +    +H+D+K SN+LLD D   KI++
Sbjct:   431 FLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISD 490

Query:   485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
             F +AR     + + A T  IVGT GYM+PEY  +G  S K DVY+FGVL+LE+++GK+  
Sbjct:   491 FGMARIFGVDQTQ-ANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNS 549

Query:   545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             + Y E+   L D++  V  K   E S   L+D +M+GN+     I  I +   C+++D S
Sbjct:   550 SFYEEDG--LGDLVTYVW-KLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSS 606

Query:   605 GRPAMDKIAQSISRF 619
              RP+MD I   ++ F
Sbjct:   607 ERPSMDDILVMMNSF 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 453 (164.5 bits), Expect = 2.0e-41, P = 2.0e-41
 Identities = 110/312 (35%), Positives = 177/312 (56%)

Query:   325 SRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKV 379
             S   + S++  A S+K +T  EL+ ATD F+    +     G VY+G +  G  VA+K +
Sbjct:   320 SDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL 379

Query:   380 YGDASD-------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
               D  +       ++++L++++H +L++L+GIC  G    L+YE   NGS+   +++  G
Sbjct:   380 TRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHE--G 437

Query:   433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
               LDW  R++IAL  A GL YLH  +NP  +H+D K SNVLL+ DF  K+++F LAR  E
Sbjct:   438 T-LDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAR--E 494

Query:   493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS---E 549
               EG   +++ ++GT GY+APEY   G +  K DVY++GV++LE+L+G+    +     E
Sbjct:   495 ATEGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGE 554

Query:   550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM 609
             EN  LV    P+L   +G   L  L+DP++ G Y       V  +   C+ ++ S RP M
Sbjct:   555 EN--LVTWARPLLANREG---LEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFM 609

Query:   610 DKIAQSISRFLN 621
              ++ Q++    N
Sbjct:   610 GEVVQALKLIYN 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 416 (151.5 bits), Expect = 2.9e-41, Sum P(2) = 2.9e-41
 Identities = 103/293 (35%), Positives = 162/293 (55%)

Query:   342 YTFEELQAATDDFNPSCWIK----GSVYRGK-IGGDFVAIKKVY---GDASDQIKL---- 389
             +T  +LQ AT+ F     I     G VY+G+ I G+ VA+KK+    G A  + ++    
Sbjct:   178 FTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEA 237

Query:   390 LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK--FLDWAQRIQIALDV 447
             +  + H +L+RLLG C  G N  LVYE   +G+L  W++   GK   L W  R++I +  
Sbjct:   238 IGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGT 297

Query:   448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
             A  L YLH    P  VH+DIK SN+L+D DF AK+++F LA+  +   GE  +T+ ++GT
Sbjct:   298 AQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLD--SGESHITTRVMGT 355

Query:   508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE--ENMLLVDVLNPVLHKE 565
              GY+APEY   GL++ K D+Y+FGVL+LE ++G++ P  Y      + LV+ L  ++   
Sbjct:   356 FGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRD-PVDYERPANEVNLVEWLKMMVGTR 414

Query:   566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIES--CLKKDPSGRPAMDKIAQSI 616
               EE +   ++P      PP T  L   L+ +  C+  +   RP M ++ + +
Sbjct:   415 RAEEVVDSRIEP------PPATRALKRALLVALRCVDPEAQKRPKMSQVVRML 461

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2017572 AT1G51790 [Arabidopsis thaliana (taxid:3702)]

 Score = 445 (161.7 bits), Expect = 1.1e-40, Sum P(2) = 1.1e-40
 Identities = 105/321 (32%), Positives = 172/321 (53%)

Query:   319 KKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKG--SVYRGKIGGDFVAI 376
             KK D    +      D+  S + +T+ E+   T+ F+      G    Y GK+ G  V +
Sbjct:   544 KKQDYGGNETAVDAFDLEPSNRKFTYAEIVNITNGFDRDQGKVGFGRNYLGKLDGKEVTV 603

Query:   377 KKV-------YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND 429
             K V       Y     ++K L +I+H +LI +LG C  G    ++YE   NG+L   I++
Sbjct:   604 KLVSSLSSQGYKQLRAEVKHLFRIHHKNLITMLGYCNEGDKMAVIYEYMANGNLKQHISE 663

Query:   430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                    W  R+ IA+DVA GL YLH+   PP +H+++KC+NV LD  F AK+  F L+R
Sbjct:   664 NSTTVFSWEDRLGIAVDVAQGLEYLHTGCKPPIIHRNVKCTNVFLDESFNAKLGGFGLSR 723

Query:   490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
               +  EG   L + I GT GY+ PEY  + +++ K DVY+FGV++LE+++ K A  + +E
Sbjct:   724 AFDAAEGSH-LNTAIAGTPGYVDPEYYTSNMLTEKSDVYSFGVVLLEIVTAKPA-IIKNE 781

Query:   550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM 609
             E M +   +  +L +E+  E    ++DPS+ G+Y P +A   + +  +C+ ++   RP M
Sbjct:   782 ERMHISQWVESLLSRENIVE----ILDPSLCGDYDPNSAFKTVEIAVACVCRNSGDRPGM 837

Query:   610 DKIAQSISRFLNASLAWELSK 630
              ++  +    L  SLA E+ +
Sbjct:   838 SQVVTA----LKESLAVEVER 854

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O64825	LYK4_ARATH	2, ., 7, ., 1, 1, ., 1	0.4595	0.9307	0.9656	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	635
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-30
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
pfam01476	43	pfam01476, LysM, LysM domain	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
smart00257	44	smart00257, LysM, Lysin motif	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (388), Expect = 2e-42
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 43/272 (15%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G VY+G + G        VA+K +  DAS+Q         +++ K++H ++++LLG+C  
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
                +V E    G L  ++     K L  +  +  AL +A G+ YL S      +H+D+
Sbjct: 73  EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDL 129

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLVSTK 524
              N L+  +   KI++F L+R     +        + G K    +MAPE L+ G  ++K
Sbjct: 130 AARNCLVGENLVVKISDFGLSRDLYDDD-----YYKVKGGKLPIRWMAPESLKEGKFTSK 184

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            DV++FGVL+ E+ +  E P  Y    M   +VL    + + G       +        P
Sbjct: 185 SDVWSFGVLLWEIFTLGEEP--Y--PGMSNAEVLE---YLKKGY-----RLPK------P 226

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           P     + +L+  C  +DP  RP   ++ + +
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  149 bits (379), Expect = 5e-41
 Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 44/272 (16%)

Query: 362 GSVYRGKI------GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G VY+GK+          VA+K +  DAS+Q         +++ K++H ++++LLG+C  
Sbjct: 13  GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
               Y+V E    G L  ++     K L  +  +  AL +A G+ YL S      +H+D+
Sbjct: 73  EEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLES---KNFIHRDL 128

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLVSTK 524
              N L+  +   KI++F L+R     +          G K    +MAPE L+ G  ++K
Sbjct: 129 AARNCLVGENLVVKISDFGLSRDLYDDD-----YYRKRGGKLPIRWMAPESLKEGKFTSK 183

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            DV++FGVL+ E+ +  E P  Y    M   +VL    + ++G       +        P
Sbjct: 184 SDVWSFGVLLWEIFTLGEQP--Y--PGMSNEEVLE---YLKNGY-----RLPQ------P 225

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           P     +  L+  C  +DP  RP   ++ + +
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  145 bits (369), Expect = 4e-40
 Identities = 61/188 (32%), Positives = 98/188 (52%), Gaps = 19/188 (10%)

Query: 362 GSVYRGKIGGD--FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G+VY  +       VAIK +  + S          I++L K+NH ++++L G+  +  + 
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YLV E    GSL   + +  GK L   + ++I L +  GL YLHS      +H+D+K  N
Sbjct: 67  YLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHRDLKPEN 122

Query: 472 VLLD-TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYA 529
           +LLD  + + K+A+F L++     +        IVGT  YMAPE L   G  S K D+++
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 530 FGVLMLEM 537
            GV++ E+
Sbjct: 180 LGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (362), Expect = 1e-38
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 42/275 (15%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNG 408
           G VY+GK+ G       VA+K +  DAS++         +++ K+ H +++RLLG+C   
Sbjct: 9   GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68

Query: 409 GNWYLVYENAVNGSL-------SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
              YLV E    G L                  L     +  A+ +A G+ YL S     
Sbjct: 69  EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KK 125

Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+   N L+  D   KI++F L+R     +     T   +  + +MAPE L++G+ 
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIF 184

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           ++K DV++FGVL+ E+ +    P  Y    +   +VL  +     G      L  P    
Sbjct: 185 TSKSDVWSFGVLLWEIFTLGATP--Y--PGLSNEEVLEYL---RKG----YRLPKPE--- 230

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
             P      +  L+ SC + DP  RP   ++ + +
Sbjct: 231 YCPD----ELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  142 bits (359), Expect = 3e-38
 Identities = 80/267 (29%), Positives = 135/267 (50%), Gaps = 41/267 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           G+VY+   K  G  VA+K +   +           +I++L +++H +++RL+    +  +
Sbjct: 13  GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            YLV E    G L  +++  G   L   +  +IAL +  GL YLHS     +  +H+D+K
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHS-----NGIIHRDLK 125

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLDV 527
             N+LLD +   KIA+F LA+   +     +  +  VGT  YMAPE  L       K+DV
Sbjct: 126 PENILLDENGVVKIADFGLAK---KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
           ++ GV++ E+L+GK     +S EN+L            D  + +R ++ P ++ + P  +
Sbjct: 183 WSLGVILYELLTGK---PPFSGENIL------------DQLQLIRRILGPPLEFDEPKWS 227

Query: 588 AIL--VIRLIESCLKKDPSGRPAMDKI 612
           +       LI+ CL KDPS RP  ++I
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  139 bits (352), Expect = 2e-37
 Identities = 71/260 (27%), Positives = 104/260 (40%), Gaps = 43/260 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY    K  G  VAIK +      +        IK+L K+ H +++RL  +  +    
Sbjct: 13  GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKL 72

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
           YLV E    G L   +  +G   L   +       + + L YLHS        VH+D+K 
Sbjct: 73  YLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEYLHS-----KGIVHRDLKP 125

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+LLD D   K+A+F LAR    Q       +  VGT  YMAPE L        +D+++
Sbjct: 126 ENILLDEDGHVKLADFGLAR----QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM--DPSMQGNYPPVT 587
            GV++ E+L+GK                  P    +   E  + +    P        ++
Sbjct: 182 LGVILYELLTGK-----------------PPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224

Query: 588 AILVIRLIESCLKKDPSGRP 607
                 LI   L KDP  R 
Sbjct: 225 P-EAKDLIRKLLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (350), Expect = 5e-37
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 51/276 (18%)

Query: 362 GSVYRGKIGGDF------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G VY+G + GD       VA+K +   AS++          ++ K++H +++RLLG+C  
Sbjct: 13  GEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQ 72

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHK 465
           G   Y+V E    G L  ++   G K L     +Q+AL +A G+ YL S  F     VH+
Sbjct: 73  GEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESKNF-----VHR 126

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY-----MAPEYLENGL 520
           D+   N L+  +   KI++F L+R     +       +     G      MAPE L++G 
Sbjct: 127 DLAARNCLVTENLVVKISDFGLSRDIYEDD------YYRKRGGGKLPIKWMAPESLKDGK 180

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            ++K DV++FGVL+ E+ +  E P  Y    M   +VL      EDG     + +     
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQP--YPG--MSNEEVLE---LLEDG-----YRLPR--- 225

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
              P      +  L+  C   DP  RP   ++ + +
Sbjct: 226 ---PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  122 bits (308), Expect = 3e-31
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 42/262 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFN--G 408
           GSVY    K  G+ +A+K V      +         I++L+ + H +++R  G   +   
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI-ALDVATGLNYLHSFTNPPH--VHK 465
               +  E    GSLS  +  K GK  +    I+     +  GL YLHS     +  VH+
Sbjct: 74  NTLNIFLEYVSGGSLSSLLK-KFGKLPE--PVIRKYTRQILEGLAYLHS-----NGIVHR 125

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           DIK +N+L+D+D   K+A+F  A+     E     T  + GT  +MAPE +         
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEG-TGSVRGTPYWMAPEVIRGEEYGRAA 184

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           D+++ G  ++EM +GK  P      N   +  L  +    +  E   HL   S +     
Sbjct: 185 DIWSLGCTVIEMATGK--PPWSELGN--PMAALYKIGSSGEPPEIPEHL---SEEA---- 233

Query: 586 VTAILVIRLIESCLKKDPSGRP 607
                    +  CL++DP  RP
Sbjct: 234 ------KDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 3e-30
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 37/266 (13%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDAS------DQIKLLNKINHSSLIRLLGICFNGGNWYLVY 415
           G V  G   G  VA+K +  D++       +  ++  + H +L++LLG+   G   Y+V 
Sbjct: 20  GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E    GSL  ++  +G   +  AQ++  ALDV  G+ YL        VH+D+   NVL+ 
Sbjct: 80  EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVS 136

Query: 476 TDFRAKIANFALARPAERQE--GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 533
            D  AK+++F LA+ A + +  G+  +         + APE L     STK DV++FG+L
Sbjct: 137 EDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKFSTKSDVWSFGIL 188

Query: 534 MLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR 593
           + E+ S    P  Y    + L DV+    H E G     + M+   +G  P      V +
Sbjct: 189 LWEIYSFGRVP--YPR--IPLKDVVP---HVEKG-----YRMEAP-EGCPPE-----VYK 230

Query: 594 LIESCLKKDPSGRPAMDKIAQSISRF 619
           +++ C + DP+ RP   ++ + ++  
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  115 bits (290), Expect = 5e-29
 Identities = 78/262 (29%), Positives = 136/262 (51%), Gaps = 33/262 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           G+V +G+  G  VA+K +  D +     ++  ++ K++H +L+RLLG+  + G  Y+V E
Sbjct: 20  GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME 78

Query: 417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT 476
               G+L  ++  +G   +   Q +Q +LDVA G+ YL S      VH+D+   N+L+  
Sbjct: 79  LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSE 135

Query: 477 DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLE 536
           D  AK+++F LAR          + +  +  K + APE L++   S+K DV+++GVL+ E
Sbjct: 136 DGVAKVSDFGLARVGSM-----GVDNSKLPVK-WTAPEALKHKKFSSKSDVWSYGVLLWE 189

Query: 537 MLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIE 596
           + S   AP  Y +  M L +V      KE  E+  R  M+P  +G    V  ++      
Sbjct: 190 VFSYGRAP--YPK--MSLKEV------KECVEKGYR--MEPP-EGCPADVYVLM-----T 231

Query: 597 SCLKKDPSGRPAMDKIAQSISR 618
           SC + +P  RP+  K+ + + +
Sbjct: 232 SCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 4e-27
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 60/280 (21%)

Query: 362 GSVY--RGKIGGDFVAIKKVY---------GDASDQIKLLNKINHSSLIRLLGICFN-GG 409
           G VY  R K  G    +K++           DA +++K+L K+NH ++I+     F   G
Sbjct: 14  GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE-SFEEKG 72

Query: 410 NWYLVYENAVNGSLSVWIND---KGGKF-----LDWAQRIQIALDVATGLNYLHSFTNPP 461
              +V E A  G LS  I     +G  F     LDW   +Q+ L     L YLHS     
Sbjct: 73  KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL----ALKYLHS----R 122

Query: 462 HV-HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
            + H+DIK  N+ L ++   K+ +F +++       + A T  +VGT  Y++PE  +N  
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKT--VVGTPYYLSPELCQNKP 179

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            + K D+++ G ++ E+ + K                           E+L  L    ++
Sbjct: 180 YNYKSDIWSLGCVLYELCTLK--HPFEG--------------------ENLLELALKILK 217

Query: 581 GNYPPVTAIL---VIRLIESCLKKDPSGRPAMDKIAQSIS 617
           G YPP+ +     +  L+ S L+KDP  RP++ +I QS  
Sbjct: 218 GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 3e-24
 Identities = 75/267 (28%), Positives = 114/267 (42%), Gaps = 58/267 (21%)

Query: 362 GSVYRG--KIGGDFVAIKKV--YGDASDQ-------IKLLNKINHSSLIRLLGICFNGGN 410
           G VY+G     GDFVAIK++       +        I LL  + H ++++ +G      +
Sbjct: 14  GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA---TGLNYLHSFTNPPHVHKDI 467
            Y++ E A NGSL   I  K G F        +A+ V     GL YLH       +H+DI
Sbjct: 74  LYIILEYAENGSLRQIIK-KFGPF----PESLVAVYVYQVLQGLAYLH---EQGVIHRDI 125

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           K +N+L   D   K+A+F +A        + A    +VGT  +MAPE +E    ST  D+
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEMSGASTASDI 182

Query: 528 YAFGVLMLEMLSGK-------EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
           ++ G  ++E+L+G           AL+      +V   +P L +    E    LM     
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFR-----IVQDDHPPLPEGISPELKDFLM----- 232

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRP 607
                            C +KDP+ RP
Sbjct: 233 ----------------QCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 98.0 bits (245), Expect = 6e-23
 Identities = 65/268 (24%), Positives = 111/268 (41%), Gaps = 60/268 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+   K  G  VAIK +  ++ ++       I++L K  H ++++  G        +
Sbjct: 14  GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW 73

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIA---LDVATGLNYLHSFTNPPH-VHKDIK 468
           +V E    GSL   +              QIA    ++  GL YLHS       +H+DIK
Sbjct: 74  IVMEFCSGGSLKDLLKSTNQTL----TESQIAYVCKELLKGLEYLHSN----GIIHRDIK 125

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALT---SHIVGTKGYMAPEYLENGLVSTKL 525
            +N+LL +D   K+ +F L+        + + T   + +VGT  +MAPE +       K 
Sbjct: 126 AANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEEN----MLLVDVLNPV--LHKEDGEESLRHLMDPSM 579
           D+++ G+  +E+  GK  P  YSE      +  +    P    + E   +  +       
Sbjct: 179 DIWSLGITAIELAEGK-PP--YSELPPMKALFKIATNGPPGLRNPEKWSDEFKD------ 229

Query: 580 QGNYPPVTAILVIRLIESCLKKDPSGRP 607
                          ++ CL+K+P  RP
Sbjct: 230 --------------FLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 31/199 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN--G 408
           G VY+   K  G+ VA+KK+  +         A  +IKLL K+ H +++RL  I  +   
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
           G+ Y+V+E   +  L+  ++    KF + +Q       +  GL YLHS     +  +H+D
Sbjct: 73  GSIYMVFEYMDH-DLTGLLDSPEVKFTE-SQIKCYMKQLLEGLQYLHS-----NGILHRD 125

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST--- 523
           IK SN+L++ D   K+A+F LARP  +       T+ ++ T  Y  PE L   L +T   
Sbjct: 126 IKGSNILINNDGVLKLADFGLARPYTK-RNSADYTNRVI-TLWYRPPELL---LGATRYG 180

Query: 524 -KLDVYAFGVLMLEMLSGK 541
            ++D+++ G ++ E+  GK
Sbjct: 181 PEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 71/233 (30%), Positives = 108/233 (46%), Gaps = 39/233 (16%)

Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLD----W 437
           +A D+ ++L K++ S +IR      + G   +V E A NG L   +  + G+ L     W
Sbjct: 45  EAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW 104

Query: 438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE 497
              IQI L    GL +LHS      +H+DIK  N+ LD     KI +  +A+        
Sbjct: 105 RFFIQILL----GLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156

Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           FA T  IVGT  Y++PE  E+   + K DV+A GV++ E  +GK                
Sbjct: 157 FANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK---------------- 198

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL---VIRLIESCLKKDPSGRP 607
                H  D   +   L+   ++G +PPV+ +    + +LI+ CL KD   RP
Sbjct: 199 -----HPFDA-NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 84/282 (29%), Positives = 123/282 (43%), Gaps = 58/282 (20%)

Query: 362 GSVYRGKI--------GGDFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGIC 405
           G VY G          G   VA+K +   A+DQ K        L++  NH ++++LLG+C
Sbjct: 9   GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68

Query: 406 FNGGNWYLVYENAVNGSLSVWINDK-----GGKFLDWAQRIQIALDVATGLNYLHSFTNP 460
                 Y++ E    G L  ++ D      G   L   + + I LDVA G  YL      
Sbjct: 69  LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-- 126

Query: 461 PHVHKDIKCSNVLL-----DTDFRAKIANFALARPAE-----RQEGEFALTSHIVGTKGY 510
             +H+D+   N L+     D D   KI +F LAR        R+EGE  L         +
Sbjct: 127 -FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR------W 179

Query: 511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES 570
           MAPE L +G  +T+ DV++FGVLM E+L+  + P  Y   N    +VL  V     G   
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPALNNQ--EVLQHV--TAGGR-- 231

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
               +        P      + +L+ +C  +DPS RP  D+I
Sbjct: 232 ----LQK------PENCPDKIYQLMTNCWAQDPSERPTFDRI 263

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 7e-22
 Identities = 58/191 (30%), Positives = 91/191 (47%), Gaps = 14/191 (7%)

Query: 362 GSVYRGKIGGDF-VAIK-------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G V+ G       VAIK           D   +++ L ++ H  LI L  +C  G   Y+
Sbjct: 20  GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    GSL  ++    G+ L  A  I +A  VA G+ YL        +H+D+   N+L
Sbjct: 80  ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNIL 136

Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 533
           +  D   K+A+F LAR    +E  +  +   +  K + APE   +G  STK DV++FG+L
Sbjct: 137 VGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYK-WTAPEAASHGTFSTKSDVWSFGIL 193

Query: 534 MLEMLSGKEAP 544
           + EM +  + P
Sbjct: 194 LYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 77/267 (28%), Positives = 118/267 (44%), Gaps = 54/267 (20%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICFN 407
           GSVY G     GDF A+K+V      Q            I LL+K+ H ++++ LG    
Sbjct: 14  GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVH 464
             N Y+  E    GSL+  +  K G F +      I L    +  GL YLH   +   VH
Sbjct: 74  EDNLYIFLELVPGGSLAK-LLKKYGSFPE----PVIRLYTRQILLGLEYLH---DRNTVH 125

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL-ENGLVST 523
           +DIK +N+L+DT+   K+A+F +A    +Q  EF+      G+  +MAPE + + G    
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMA----KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
             D+++ G  +LEM +GK                  P   + +G  ++  +         
Sbjct: 182 AADIWSLGCTVLEMATGK------------------PPWSQLEGVAAVFKI---GRSKEL 220

Query: 584 PPVTAILVIRL---IESCLKKDPSGRP 607
           PP+   L       I  CL++DPS RP
Sbjct: 221 PPIPDHLSDEAKDFILKCLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 50/279 (17%)

Query: 362 GSVYRG--KIGGD---FVAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICFNG 408
           G V RG  K+ G     VAIK +   +SD+ +L        + + +H ++IRL G+    
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
               ++ E   NGSL  ++ +  GKF    Q + +   +A+G+ YL   +   +VH+D+ 
Sbjct: 78  RPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGMKYL---SEMNYVHRDLA 133

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVS 522
             N+L++++   K+++F L+R  E  E  +        TKG      + APE +     +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYT-------TKGGKIPIRWTAPEAIAYRKFT 186

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQG 581
           +  DV++FG++M E++S  E P  Y   +M   DV+  V   EDG   L   MD PS   
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP--Y--WDMSNQDVIKAV---EDGYR-LPPPMDCPS--- 235

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                    + +L+  C +KD + RP   +I  ++ + +
Sbjct: 236 --------ALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 94.4 bits (233), Expect = 9e-21
 Identities = 70/265 (26%), Positives = 110/265 (41%), Gaps = 30/265 (11%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDAS----------DQIKLLNKINHSSLI-RLLGICFNGGN 410
           G VY  +     VA+K +                +I++L  +NH   I +L     + G+
Sbjct: 14  GEVYLARDRKL-VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS 72

Query: 411 WYLVYENAVNGSLSVWINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
            YLV E    GSL   +   G    L  ++ + I   + + L YLHS      +H+DIK 
Sbjct: 73  LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI---IHRDIKP 129

Query: 470 SNVLLDTD-FRAKIANFALARPAERQEGEF---ALTSHIVGTKGYMAPEYLE---NGLVS 522
            N+LLD D    K+ +F LA+            AL S  VGT GYMAPE L        S
Sbjct: 130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYAS 189

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
           +  D+++ G+ + E+L+G   P    E+N         ++ +              +  +
Sbjct: 190 SSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLA-----SPLSPS 242

Query: 583 YPPVTAILVIRLIESCLKKDPSGRP 607
            P + +     L++  L KDP  R 
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 75/261 (28%), Positives = 121/261 (46%), Gaps = 33/261 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQI-----KLLNKINHSSLIRLLG-ICFNGGNWYLVY 415
           G V  G   G+ VA+K +  DA+ Q       ++ ++ HS+L++LLG I    G  Y+V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E    GSL  ++  +G   L     ++ +LDV   + YL +      VH+D+   NVL+ 
Sbjct: 80  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVS 136

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
            D  AK+++F L + A   +    L         + APE L     STK DV++FG+L+ 
Sbjct: 137 EDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLW 190

Query: 536 EMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
           E+ S    P       + L DV+  V   E G     + MD       PPV    V  ++
Sbjct: 191 EIYSFGRVPY----PRIPLKDVVPRV---EKG-----YKMDAP--DGCPPV----VYDVM 232

Query: 596 ESCLKKDPSGRPAMDKIAQSI 616
           + C   D + RP+  ++ + +
Sbjct: 233 KQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 68/262 (25%), Positives = 109/262 (41%), Gaps = 44/262 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+   K  G   A+KK++ D           ++K L       +++  G  +  G  
Sbjct: 15  GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDIKC 469
            +V E    GSL+  +   G       + +   IA  +  GL+YLH+  +   +H+DIK 
Sbjct: 75  SIVLEYMDGGSLADLLKKVGK----IPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKP 128

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           SN+L+++    KIA+F +++  E         +  VGT  YM+PE ++    S   D+++
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTL---DQCNTFVGTVTYMSPERIQGESYSYAADIWS 185

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            G+ +LE   GK                  P L       S   LM     G  P + A 
Sbjct: 186 LGLTLLECALGK-----------------FPFLPPGQP--SFFELMQAICDGPPPSLPAE 226

Query: 590 LV----IRLIESCLKKDPSGRP 607
                    I +CL+KDP  RP
Sbjct: 227 EFSPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 53/274 (19%)

Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG+C   G  Y+V E A +G+
Sbjct: 45  VAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGN 102

Query: 423 L--------------SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L              S        + L     +  A  VA G+ +L S      +H+D+ 
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLA 159

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK-WMAPEALFDRVYTHQSDVW 218

Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FGVL+ E+  L G   P +  EE   L  +L     KE       + M+       P  
Sbjct: 219 SFGVLLWEIFTLGGSPYPGIPVEE---LFKLL-----KEG------YRMEK------PQN 258

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               +  L+  C  + PS RP   ++ + + R L
Sbjct: 259 CTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 66/268 (24%), Positives = 121/268 (45%), Gaps = 40/268 (14%)

Query: 362 GSVYRGKI-GGDFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWY 412
           G VY+G + G   VA+K         +K        +L + +H ++++L+G+C      Y
Sbjct: 9   GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY 68

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V E    GSL  ++  K  + L   + +Q++LD A G+ YL S      +H+D+   N 
Sbjct: 69  IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNC---IHRDLAARNC 124

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK----GYMAPEYLENGLVSTKLDVY 528
           L+  +   KI++F ++R  E + G + ++    G K     + APE L  G  +++ DV+
Sbjct: 125 LVGENNVLKISDFGMSR--EEEGGIYTVSD---GLKQIPIKWTAPEALNYGRYTSESDVW 179

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           ++G+L+ E  S  + P  Y    M                +  R  ++   +   P +  
Sbjct: 180 SYGILLWETFSLGDTP--YP--GM--------------SNQQTRERIESGYRMPAPQLCP 221

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSI 616
             + RL+  C   DP  RP+  +I   +
Sbjct: 222 EEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 65/290 (22%)

Query: 362 GSVYRG-----KIGGDF--VAIKKVYGDAS--DQIKLLN------KINHSSLIRLLGICF 406
           G VY G       G     VAIK V  +AS  ++I+ LN      + N   ++RLLG+  
Sbjct: 20  GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79

Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E    G L  ++        N+ G       + IQ+A ++A G+ YL +  
Sbjct: 80  TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK 139

Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  D   KI +F + R     +       +  G KG     +MAP
Sbjct: 140 ---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMAP 190

Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLV---DVLNPVLHKEDGE 568
           E L++G+ +TK DV++FGV++ EM +  E P   L +EE +  V     L+     E+  
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL---PENCP 247

Query: 569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
           + L  LM                      C + +P  RP   +I  S+  
Sbjct: 248 DKLLELM--------------------RMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 49/271 (18%)

Query: 362 GSVYRGK-IGGDFVAIKKVY------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ GK  G   VAIK +        D  ++ K++ K++H +L++L G+C      ++V
Sbjct: 18  GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSNV 472
            E   NG L  ++ ++ GK       + +  DV   + YL  + F     +H+D+   N 
Sbjct: 78  TEYMANGCLLNYLRERKGKL-GTEWLLDMCSDVCEAMEYLESNGF-----IHRDLAARNC 131

Query: 473 LLDTDFRAKIANFALARPAERQEGEFAL----TSHIVGTK---GYMAPEYLENGLVSTKL 525
           L+  D   K+++F LAR        + L    TS   GTK    +  PE  +    S+K 
Sbjct: 132 LVGEDNVVKVSDFGLAR--------YVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           DV++FGVLM E+ S  + P     E     +V+      E      R L  P +      
Sbjct: 183 DVWSFGVLMWEVFSEGKMPY----ERFSNSEVV------ESVSAGYR-LYRPKLAP--TE 229

Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           V  I+      SC  + P  RPA  K+   +
Sbjct: 230 VYTIM-----YSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 45/260 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           GSVY+   K  G  VAIK V  +   Q     I +L + +   +++  G  F   + ++V
Sbjct: 17  GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GS+S  +     K L   +   I      GL YLHS      +H+DIK  N+LL
Sbjct: 77  MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKK---IHRDIKAGNILL 132

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
           + + +AK+A+F +   + +     A  + ++GT  +MAPE ++    + K D+++ G+  
Sbjct: 133 NEEGQAKLADFGV---SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITA 189

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT------- 587
           +EM  GK  P  YS+        ++P+          R +    M  N PP T       
Sbjct: 190 IEMAEGK-PP--YSD--------IHPM----------RAIF---MIPNKPPPTLSDPEKW 225

Query: 588 AILVIRLIESCLKKDPSGRP 607
           +      ++ CL KDP  RP
Sbjct: 226 SPEFNDFVKKCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 63/246 (25%), Positives = 94/246 (38%), Gaps = 45/246 (18%)

Query: 390 LNKIN-HSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           L ++N H  +I+L    F +  N Y V E A NG L  +I   G       +    A ++
Sbjct: 55  LTRLNGHPGIIKLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR--FYAAEI 111

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP----------------- 490
              L YLHS      +H+D+K  N+LLD D   KI +F  A+                  
Sbjct: 112 LLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
             + E      +  VGT  Y++PE L         D++A G ++ +ML+GK  P   S E
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK-PPFRGSNE 227

Query: 551 NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD 610
            +    +L         E S      P                LIE  L  DP  R  ++
Sbjct: 228 YLTFQKILK-------LEYSFPPNFPP------------DAKDLIEKLLVLDPQDRLGVN 268

Query: 611 KIAQSI 616
           +    +
Sbjct: 269 EGYDEL 274

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.3 bits (207), Expect = 6e-18
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 34/220 (15%)

Query: 390 LNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L++INH  +++L    F      YLV E A  G L   ++ K G+F +   R   A ++ 
Sbjct: 47  LSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAA-EIV 103

Query: 449 TGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
             L YLHS        +++D+K  N+LLD D   K+ +F LA+       E + T+   G
Sbjct: 104 LALEYLHS-----LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS---EGSRTNTFCG 155

Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L        +D ++ GVL+ EML+GK  P  Y+E+   + +        +D
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPFYAEDRKEIYE-----KILKD 208

Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                  L  P  +             LI   L+KDP+ R
Sbjct: 209 PLRFPEFL-SPEARD------------LISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 46/270 (17%)

Query: 362 GSVYRGKIGGD--FVAIKKV---------YGDASDQIKLLNKINHSSLIRLLGICFNGGN 410
           GSVY+ K   D  F A+K+V           DA ++I++L  +NH ++I       +G  
Sbjct: 14  GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73

Query: 411 WYLVYENAVNGSLSVWI-NDKGGKFLDWAQRI-QIALDVATGLNYLHSFTNPPHVHKDIK 468
             +V E A  G LS  I   K  + L   Q I +I + +  GL  LH       +H+D+K
Sbjct: 74  LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI---LHRDLK 130

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
            +N+LL  +   KI +  +++  +      A T   +GT  YMAPE  +    S K D++
Sbjct: 131 SANILLVANDLVKIGDLGISKVLK---KNMAKTQ--IGTPHYMAPEVWKGRPYSYKSDIW 185

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           + G L+ EM +                    P       ++ LR+ +    +G YPP+  
Sbjct: 186 SLGCLLYEMATFA------------------PPFEARSMQD-LRYKV---QRGKYPPIPP 223

Query: 589 IL---VIRLIESCLKKDPSGRPAMDKIAQS 615
           I    +   I S L+  P  RP  DKI  S
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 24/194 (12%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VAIKK+      +         IKLL ++NH ++I+LL +  + G+
Sbjct: 13  GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD 72

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            YLV+E  ++  L   I D+  + L  +        +  GL + HS     H  +H+D+K
Sbjct: 73  LYLVFE-FMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS-----HGILHRDLK 125

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDV 527
             N+L++T+   K+A+F LAR            +H V T+ Y APE L      ST +D+
Sbjct: 126 PENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182

Query: 528 YAFGVLMLEMLSGK 541
           ++ G +  E+LS +
Sbjct: 183 WSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 43/262 (16%)

Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G+  VA+K +  G  S     ++ +++ K+ H  L++L  +  +    Y+V
Sbjct: 20  GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIV 78

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++ D  G+ L     + +A  VA G+ Y+       ++H+D++ +N+L+
Sbjct: 79  TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILV 135

Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
                 KIA+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 136 GDGLVCKIADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 187

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+++    P  Y   N           ++E  E+  R    P  Q     +  
Sbjct: 188 SFGILLTELVTKGRVP--YPGMN-----------NREVLEQVERGYRMPCPQDCPISLHE 234

Query: 589 ILVIRLIESCLKKDPSGRPAMD 610
           +++      C KKDP  RP  +
Sbjct: 235 LML-----QCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 52/239 (21%), Positives = 106/239 (44%), Gaps = 29/239 (12%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-------SVWINDKGGKFLDWA 438
           ++ +  K++H +++RLLG+C      Y++ E    G L                  L   
Sbjct: 58  ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117

Query: 439 QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
           Q++ +   +A G+++L   +N   VH+D+   N L+ +    K++  +L++     E  +
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YY 173

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL 558
            L + ++  + ++APE ++    STK DV++FGVLM E+ +  E P  +   +       
Sbjct: 174 KLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLS------- 223

Query: 559 NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                    EE L  L    ++   P      + +L+  C   +P  RP+  ++  ++ 
Sbjct: 224 --------DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 37/266 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 20  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 80  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 136

Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R           T+H  G K    + APE L     S K DV+AF
Sbjct: 137 VGENHLVKVADFGLSRLMT----GDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 191

Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 192 GVLLWEI-------ATYGMSPYPGIDLSQ-----------VYELLEKGYRMERPEGCPPK 233

Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI 616
           V  L+ +C + +PS RP+  +I Q+ 
Sbjct: 234 VYELMRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 47/278 (16%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           G V   R K  G+ VAIKK      D         ++K+L ++ H +++ L       G 
Sbjct: 15  GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            YLV+E      L +     GG   D  +     L     + Y HS     H  +H+DIK
Sbjct: 75  LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHS-----HNIIHRDIK 127

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK---- 524
             N+L+      K+ +F  AR   R      LT + V T+ Y APE L   +  T     
Sbjct: 128 PENILVSESGVLKLCDFGFARAL-RARPASPLTDY-VATRWYRAPELL---VGDTNYGKP 182

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN-----MLLVDVLNPVL--HKEDGEESLRH---- 573
           +DV+A G +M E+L G+    L+  ++      L+   L P+   H+E    + R     
Sbjct: 183 VDVWAIGCIMAELLDGE---PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 574 LMDP----SMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
             +P    S++  YP   +   +  +++CL+ DP  R 
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 7/166 (4%)

Query: 378 KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +V      +I+L+ ++NH  +IR+LG      ++ L  E    GS+S  ++  G      
Sbjct: 45  EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKE 102

Query: 438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANF-ALARPAERQE 495
           A  I     +  GL+YLH       +H+D+K +N+L+D T  R +IA+F A AR A +  
Sbjct: 103 AVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159

Query: 496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           G       ++GT  +MAPE L         DV++ G +++EM + K
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 70/262 (26%), Positives = 107/262 (40%), Gaps = 48/262 (18%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+   +  G  VAIKK+      Q        I ++    H +++        G   
Sbjct: 33  GEVYKATDRATGKEVAIKKM--RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIKCS 470
           ++V E    GSL+  I  +    ++  Q   +  +V  GL YLHS     +V H+DIK  
Sbjct: 91  WVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSD 145

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           N+LL  D   K+A+F  A  A+  + +    S +VGT  +MAPE ++      K+D+++ 
Sbjct: 146 NILLSKDGSVKLADFGFA--AQLTKEKSKRNS-VVGTPYWMAPEVIKRKDYGPKVDIWSL 202

Query: 531 GVLMLEMLSGKEAPALYSEENML-----LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           G++ +EM  G E P  Y  E  L     +     P L      E                
Sbjct: 203 GIMCIEMAEG-EPP--YLREPPLRALFLITTKGIPPL---KNPEKWSPEF---------- 246

Query: 586 VTAILVIRLIESCLKKDPSGRP 607
                    +  CL KDP  RP
Sbjct: 247 ------KDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 36/259 (13%)

Query: 362 GSVYRGKIGGDF-VAIKKVY------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VA+K +            + +++ K+ H  L++L  +C      Y+V
Sbjct: 20  GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++    GK L   Q + +A  +A G+ YL S     ++H+D+   N+L+
Sbjct: 80  TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILV 136

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
             +   KIA+F LAR  E  E     T+   G K    + APE    G  + K DV++FG
Sbjct: 137 GENLVCKIADFGLARLIEDDE----YTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFG 191

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           +L+ E+++    P  Y    M   +VL  V      E   R  M P        +  +++
Sbjct: 192 ILLTEIVTYGRVP--Y--PGMTNREVLEQV------ERGYR--M-PRPPNCPEELYDLML 238

Query: 592 IRLIESCLKKDPSGRPAMD 610
                 C  KDP  RP  +
Sbjct: 239 -----QCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 43/269 (15%)

Query: 362 GSVYRGK-IGGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G  +    VAIK +        D  ++ +++ K++H  L++L G+C       LV
Sbjct: 18  GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
           +E   +G LS ++  + GKF      + + LDV  G+ YL S      +H+D+   N L+
Sbjct: 78  FEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMAYLESSN---VIHRDLAARNCLV 133

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVY 528
             +   K+++F + R        F L      + G      + +PE       S+K DV+
Sbjct: 134 GENQVVKVSDFGMTR--------FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FGVLM E+ S  + P   +  N  +V+ +N       G    +           P + +
Sbjct: 186 SFGVLMWEVFSEGKTP-YENRSNSEVVETINA------GFRLYK-----------PRLAS 227

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
             V  L++ C K+ P  RP+   +   ++
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 19/196 (9%)

Query: 360 IKGSVYRGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           +K  +Y+ K     VA+K +  D +D         +  ++ ++++  ++R++GIC    +
Sbjct: 11  VKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAES 69

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIK 468
           W LV E A  G L+ ++     K +      ++   V+ G+ YL   +F     VH+D+ 
Sbjct: 70  WMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNF-----VHRDLA 122

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVLL T   AKI++F L++     E  +   +H      + APE +     S+K DV+
Sbjct: 123 ARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVW 182

Query: 529 AFGVLMLEMLSGKEAP 544
           +FGVLM E  S  + P
Sbjct: 183 SFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 46/216 (21%)

Query: 362 GSVYRGKI-----GGDF--VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICF 406
           G V+ G+        D   VA+K +   AS+  +        LL    H ++++  G+C 
Sbjct: 19  GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT 78

Query: 407 NGGNWYLVYENAVNGSLSVWI--NDKGGKFLDW----------AQRIQIALDVATGLNYL 454
            G    +V+E   +G L+ ++  +     FL            +Q +QIA+ +A+G+ YL
Sbjct: 79  EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL 138

Query: 455 HS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA-----ERQEGEFALTSHIVGT 507
            S  F     VH+D+   N L+  D   KI +F ++R        R  G   L       
Sbjct: 139 ASQHF-----VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR---- 189

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKE 542
             +M PE +     +T+ DV++FGV++ E+ + GK+
Sbjct: 190 --WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 40/261 (15%)

Query: 364 VYRGKIGGDFVAIK---------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           +YR       V  K         K   DA ++I +L+ + H ++I       +     + 
Sbjct: 18  LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E A  G+L   I  + G+  +    +     + + ++Y+H       +H+DIK  N+ L
Sbjct: 78  MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI---LHRDIKTLNIFL 134

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
                 K+ +F +++       E+++   +VGT  YM+PE  +    + K D++A G ++
Sbjct: 135 TKAGLIKLGDFGISK---ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL---V 591
            E+L+ K              D  NP+           +L+   +QGNY PV ++    +
Sbjct: 192 YELLTLKRT-----------FDATNPL-----------NLVVKIVQGNYTPVVSVYSSEL 229

Query: 592 IRLIESCLKKDPSGRPAMDKI 612
           I L+ S L++DP  RP  D++
Sbjct: 230 ISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 69/258 (26%), Positives = 120/258 (46%), Gaps = 38/258 (14%)

Query: 374 VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAI  +    SD+ +         L + +HS+++RL G+   G    +V E   NG+L  
Sbjct: 36  VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95

Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++    G+ L   Q + +   +A+G+ YL   +   +VHK +    VL+++D   KI+ F
Sbjct: 96  FLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF 151

Query: 486 ALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
              R  +  + E   T+  +  K    + APE ++    S+  DV++FG++M E++S  E
Sbjct: 152 ---RRLQEDKSEAIYTT--MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206

Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P      +M   DV+  V   EDG      L  P    N P     L+ +L+  C +K+
Sbjct: 207 RPYW----DMSGQDVIKAV---EDG----FRLPAPR---NCPN----LLHQLMLDCWQKE 248

Query: 603 PSGRPAMDKIAQSISRFL 620
              RP   +I   +S+ +
Sbjct: 249 RGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 58/295 (19%)

Query: 360 IKGSVYR--GKIGGDFVAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGICFNGG 409
           +K + +R  G+ G   VA+K +  +AS         +  LL ++NH  +I+L G C   G
Sbjct: 17  VKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76

Query: 410 NWYLVYENAVNGSL----------------------SVWINDKGGKFLDWAQRIQIALDV 447
              L+ E A  GSL                      S ++++   + L     I  A  +
Sbjct: 77  PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           + G+ YL        VH+D+   NVL+    + KI++F L+R    ++     +   +  
Sbjct: 137 SRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV 193

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKE 565
           K +MA E L + + +T+ DV++FGVL+ E+  L G   P +                   
Sbjct: 194 K-WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI------------------- 233

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              E L +L+    +   P   +  +  L+ +C K++P  RP    I++ + + +
Sbjct: 234 -APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 75/277 (27%), Positives = 118/277 (42%), Gaps = 52/277 (18%)

Query: 360 IKGSVYRGKIGGDF-VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGN 410
           +KG VY  K G +  VA+K +  +     K        ++ +++H  ++RL+G+C  G  
Sbjct: 12  VKG-VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEP 69

Query: 411 WYLVYENAVNGSLSVWINDKGG----KFLDWAQRIQIALDVATGLNYLHS--FTNPPHVH 464
             LV E A  G L  ++  +         + A        VA G+ YL S  F     VH
Sbjct: 70  LMLVMELAPLGPLLKYLKKRREIPVSDLKELA------HQVAMGMAYLESKHF-----VH 118

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG---TKGYMAPEYLENGLV 521
           +D+   NVLL    +AKI++F ++R        +  T+   G    K Y APE +  G  
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA--GRWPLKWY-APECINYGKF 175

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           S+K DV+++GV + E  S    P  Y E  M   +V+  +   E GE   R         
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKP--YGE--MKGAEVIAML---ESGERLPR--------- 219

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
             P      +  ++ SC K  P  RP   ++  +  R
Sbjct: 220 --PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 48/206 (23%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           G VY+   K  G+ VA+KK+  D  +         +I LL ++ H ++++LL +      
Sbjct: 13  GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72

Query: 411 WYLVYENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDI 467
            YLV+E   +  L  +++ + G    +  + I   L    GL Y HS     H  +H+D+
Sbjct: 73  LYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQL--LRGLAYCHS-----HRILHRDL 124

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEF-----ALTSHIVGTKGYMAPE-------Y 515
           K  N+L++ D   K+A+F LAR        F       T  +V T  Y APE       Y
Sbjct: 125 KPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176

Query: 516 LENGLVSTKLDVYAFGVLMLEMLSGK 541
                 ST +D+++ G +  EM++GK
Sbjct: 177 ------STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 36/256 (14%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G       VA+K +     D      + +++ K+ H  LI+L  +C      Y+V
Sbjct: 20  GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++    G+ L   Q I +A  VA+G+ YL +     ++H+D+   NVL+
Sbjct: 80  TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLV 136

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
             +   K+A+F LAR  +    E        G K    + APE       S K DV++FG
Sbjct: 137 GENNICKVADFGLARVIKEDIYEAR-----EGAKFPIKWTAPEAALYNRFSIKSDVWSFG 191

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           +L+ E+++    P  Y    M   +VL  V      ++  R  M        PP     +
Sbjct: 192 ILLTEIVTYGRMP--YP--GMTNAEVLQQV------DQGYR--MPC------PPGCPKEL 233

Query: 592 IRLIESCLKKDPSGRP 607
             ++  C K+DP  RP
Sbjct: 234 YDIMLDCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 39/266 (14%)

Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S     ++ K++ K++H  L++L G+C      Y+V
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +  GK    +Q +++  DV  G+ YL S      +H+D+   N L+
Sbjct: 78  TEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLV 133

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           D     K+++F L+R     E     TS  VG+K    +  PE L     S+K DV+AFG
Sbjct: 134 DDQGCVKVSDFGLSRYVLDDE----YTSS-VGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188

Query: 532 VLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           VLM E+ S GK     ++            V     G    R           P + +  
Sbjct: 189 VLMWEVYSLGKMPYERFNNSET--------VEKVSQGLRLYR-----------PHLASEK 229

Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI 616
           V  ++ SC  +    RP   ++  SI
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 46/269 (17%)

Query: 373 FVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
            VA+K +  D +         +IK+++++ + ++IRLLG+C +     ++ E   NG L+
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 425 VWINDKG--GKF--------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            +++ +     F        +  A  + +A+ +A+G+ YL S      VH+D+   N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLV 162

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
              +  KIA+F ++R     +  + +    V    +MA E +  G  +T  DV+AFGV +
Sbjct: 163 GNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Query: 535 LEMLS-GKEAP-ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG-----NYPPVT 587
            EM +  KE P +L S+E ++           E+  E  R+      QG     +  P+ 
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVI-----------ENTGEFFRN------QGRQIYLSQTPLC 264

Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSI 616
              V +L+  C  +D   RP  +KI   +
Sbjct: 265 PSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 54/282 (19%)

Query: 362 GSVYRG---------KIGGDFVAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGI 404
           G+VY+G         KI    VAIK +  + S        D+  ++  ++H  ++RLLGI
Sbjct: 21  GTVYKGVWIPEGEKVKIP---VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77

Query: 405 CFNGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTN 459
           C       L+ +    G L  ++ +          L+W  +I      A G++YL     
Sbjct: 78  CL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE---E 127

Query: 460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
              VH+D+   NVL+ T    KI +F LA+  +  E E+      V  K +MA E + + 
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK-WMALESILHR 186

Query: 520 LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM 579
           + + K DV+++GV + E+++    P  Y  E +  V++ +     E GE   +       
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP--Y--EGIPAVEIPD---LLEKGERLPQ------- 232

Query: 580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
               PP+  I V  ++  C   D   RP   ++    S+   
Sbjct: 233 ----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 74/279 (26%), Positives = 120/279 (43%), Gaps = 59/279 (21%)

Query: 366 RGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           + K  G  VAIKK      D         +I++L ++ H +L+ L+ +       YLV+E
Sbjct: 21  KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80

Query: 417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCSNVLL 474
              +  L        G  LD ++  +    +  G+ + HS     H  +H+DIK  N+L+
Sbjct: 81  FVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHS-----HNIIHRDIKPENILV 133

Query: 475 DTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK----LD 526
                 K+ +F  AR    P E        T + V T+ Y APE L   +  TK    +D
Sbjct: 134 SQSGVVKLCDFGFARTLAAPGE------VYTDY-VATRWYRAPELL---VGDTKYGRAVD 183

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH--LMD-------- 576
           ++A G L+ EML+G+  P    + +   +D L  ++ K  G    RH  +          
Sbjct: 184 IWAVGCLVTEMLTGE--PLFPGDSD---IDQLYHII-KCLGNLIPRHQEIFQKNPLFAGM 237

Query: 577 --PSMQGNYP-----PVTAILVIRLIESCLKKDPSGRPA 608
             P ++   P     P  + LV+ L + CL+ DP  RP+
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 53/280 (18%)

Query: 362 GSVYRG--KIGGDFVAIKKV----YGDASD--------QIKLLNKINHSSLIRLLGICFN 407
             VY+   K  G  VAIKK+      +A D        +IKLL ++ H ++I LL +  +
Sbjct: 14  AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHK 465
             N  LV+E      L   I DK       A      L    GL YLHS     +  +H+
Sbjct: 74  KSNINLVFEFM-ETDLEKVIKDKSIVLTP-ADIKSYMLMTLRGLEYLHS-----NWILHR 126

Query: 466 DIKCSNVLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENG-L 520
           D+K +N+L+ +D   K+A+F LAR    P  +      +T  +V T+ Y APE L     
Sbjct: 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNRK------MTHQVV-TRWYRAPELLFGARH 179

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK-----EDGEESLRHLM 575
               +D+++ G +  E+L     P L  + +   +D L  +        E+    +  L 
Sbjct: 180 YGVGVDMWSVGCIFAELLLRV--PFLPGDSD---IDQLGKIFEALGTPTEENWPGVTSLP 234

Query: 576 DPSMQGNYP--PVTAIL------VIRLIESCLKKDPSGRP 607
           D      +P  P+  I        + L++  L  +P+ R 
Sbjct: 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI 274

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 68/267 (25%), Positives = 128/267 (47%), Gaps = 40/267 (14%)

Query: 371 GDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+    ++        I++L  + H ++++  G+C++ G  N  LV E    G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + LD  + +  A  +  G+ YL S     +VH+D+   N+L++++ R K
Sbjct: 93  SLRDYL-QKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148

Query: 482 IANFALAR--PAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 533
           I +F L +  P +      R+ GE    S I     + APE L     S   DV++FGV+
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGE----SPIF----WYAPESLTESKFSVASDVWSFGVV 200

Query: 534 MLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY----PPVTAI 589
           + E+ +  +       E M ++       + + G+  + HL++  ++ N     PP    
Sbjct: 201 LYELFTYSDKSCSPPAEFMRMMG------NDKQGQMIVYHLIE-LLKNNGRLPAPPGCPA 253

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSI 616
            +  +++ C   DPS RP+  ++A  +
Sbjct: 254 EIYAIMKECWNNDPSQRPSFSELALQV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 18/200 (9%)

Query: 388 KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++L ++NH  L+ L     +  N YLV +  + G L   +  +  KF +   +  I  ++
Sbjct: 52  RILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EI 109

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
              L YLHS      +H+DIK  N+LLD      I +F +A           LT+   GT
Sbjct: 110 VLALEYLHSKGI---IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGT 162

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK---EAPALYSEENMLLV----DVLNP 560
            GYMAPE L     S  +D ++ GV   E L GK      +    + +       DVL P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222

Query: 561 VLHKEDGEESLRHL--MDPS 578
                +  +++  L   DP 
Sbjct: 223 ATWSTEAIDAINKLLERDPQ 242

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 39/268 (14%)

Query: 362 GSVYRGKIGGD--FVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNW 411
           G V+ G++  D   VA+K         +K        +L + +H +++RL+G+C      
Sbjct: 9   GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 68

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH-VHKDIKCS 470
           Y+V E    G    ++  +G + L   + IQ+  + A G+ YL S     H +H+D+   
Sbjct: 69  YIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLES----KHCIHRDLAAR 123

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHI--VGTKGYMAPEYLENGLVSTKLDVY 528
           N L+      KI++F ++R  E ++G +A T  +  +  K + APE L  G  S++ DV+
Sbjct: 124 NCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVK-WTAPEALNYGRYSSESDVW 180

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E  S                  L  V +     +  R  ++  ++   P +  
Sbjct: 181 SFGILLWEAFS------------------LGAVPYANLSNQQTREAIEQGVRLPCPELCP 222

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSI 616
             V RL+E C + DP  RP+   + Q +
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 51/263 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKV-YGDASDQIKLLNK-IN-----HSSLI-RLLGICFNGGNW 411
           G VY+   K     VAIK +   +A D+I+ + + I       S  I +  G    G   
Sbjct: 15  GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +++ E    GS    +  K GK  D      I  +V  GL YLH       +H+DIK +N
Sbjct: 75  WIIMEYCGGGSCLDLL--KPGKL-DETYIAFILREVLLGLEYLHE---EGKIHRDIKAAN 128

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSH----IVGTKGYMAPEYLENGLVSTKLDV 527
           +LL  +   K+A+F ++       G+   T       VGT  +MAPE ++      K D+
Sbjct: 129 ILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 528 YAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN-YP 584
           ++ G+  +E+  G E P   L+    + L+   NP                PS++GN + 
Sbjct: 182 WSLGITAIELAKG-EPPLSDLHPMRVLFLIPKNNP----------------PSLEGNKFS 224

Query: 585 PVTAILVIRLIESCLKKDPSGRP 607
                     +  CL KDP  RP
Sbjct: 225 K----PFKDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 36/234 (15%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
            + +++ K+ H  L+ L  +  +    Y+V E    GSL  ++ +  GK+L   Q + +A
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEF 498
             +A G+ Y+       ++H+D++ +N+L+  +   KIA+F LAR  E      RQ  +F
Sbjct: 109 AQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF 165

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL 558
            +         + APE    G  + K DV++FG+L+ E+++    P              
Sbjct: 166 PIK--------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-------------Y 204

Query: 559 NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
             ++++E  E+  R    P  QG    +       L++ C KKDP  RP  + I
Sbjct: 205 PGMVNREVLEQVERGYRMPCPQGCPESLH-----ELMKLCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 54/277 (19%)

Query: 362 GSVYRG--------KIGGDFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGIC 405
           G VY+G        KI    VA+K      S  ++        ++ + +H  +++L+G+ 
Sbjct: 20  GDVYQGVYMSPENEKIA---VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76

Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
                W +V E A  G L  ++       LD A  I  +  ++T L YL S      VH+
Sbjct: 77  TENPVW-IVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES-KR--FVHR 131

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGL 520
           DI   NVL+ +    K+ +F L+R  E +       S+   +KG     +MAPE +    
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDE-------SYYKASKGKLPIKWMAPESINFRR 184

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            ++  DV+ FGV M E+L     P    + N    DV+      E+GE          M 
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIG---RIENGER-------LPMP 230

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            N PP     +  L+  C   DPS RP   ++   +S
Sbjct: 231 PNCPPT----LYSLMTKCWAYDPSKRPRFTELKAQLS 263

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 55/283 (19%)

Query: 362 GSVYRGK---IGGDFVAIKKV-----------------YGDASDQIKLLNK-INHSSLIR 400
           G VY+ +    G + +A+K++                  GD   ++ ++ + + H +++R
Sbjct: 14  GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVR 73

Query: 401 LLGICFNGGNWYLVY---ENAVNGSLSVWINDKGGKFLD---WAQRIQIALDVATGLNYL 454
                      Y+V    E A  G     + +K  +F +   W   +Q+ L     L YL
Sbjct: 74  YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL----ALRYL 129

Query: 455 HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
           H       VH+D+  +N++L  D +  I +F LA+    Q+   +  + +VGT  Y  PE
Sbjct: 130 HK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTILYSCPE 183

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
            ++N     K DV+AFG ++ +M + +  P  YS  NML +             + +  +
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQ--PPFYS-TNMLSL-----------ATKIVEAV 229

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            +P  +G Y    +  V  +I SCL  D   RP + +++  IS
Sbjct: 230 YEPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 61/289 (21%)

Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  +A+D+           +KL+ K  H ++I LLG+C   G  Y++ E A  G+
Sbjct: 47  VAVKMLKDNATDKDLADLISEMELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGN 104

Query: 423 LSVWINDKGGKFLDWA--------------QRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +     D+                 +  A  VA G+ YL S      +H+D+ 
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLA 161

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR        +  TS+      +MAPE L + + + + DV+
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220

Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FG+LM E+  L G   P +  EE   L+        +E       H MD       P  
Sbjct: 221 SFGILMWEIFTLGGSPYPGIPVEELFKLL--------REG------HRMDK------PSN 260

Query: 587 TAILVIRLIESCLKKDPSGRP-------AMDKIAQSIS-RFLNASLAWE 627
               +  L+  C    P+ RP       A+DK+  ++S  +L+ S+ +E
Sbjct: 261 CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFE 309

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 4e-15
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 26/195 (13%)

Query: 362 GSVYRGKI--GGDFVAIKKV---YGDASDQIKL-----LNKIN-HSSLIRLLGICFNGGN 410
           GSVY  +    G+ VAIKK+   +    + + L     L K+N H ++++L  +      
Sbjct: 13  GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE 72

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS---FTNPPHVHKDI 467
            Y V+E  + G+L   + D+ GK    +    I   +  GL ++H    F      H+D+
Sbjct: 73  LYFVFEY-MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF------HRDL 125

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLD 526
           K  N+L+      KIA+F LAR    +      T + V T+ Y APE  L +   S+ +D
Sbjct: 126 KPENLLVSGPEVVKIADFGLAREIRSRP---PYTDY-VSTRWYRAPEILLRSTSYSSPVD 181

Query: 527 VYAFGVLMLEMLSGK 541
           ++A G +M E+ + +
Sbjct: 182 IWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 21/198 (10%)

Query: 362 GSVYRGK---IGGDF--VAIK-----KVYGDASDQIK---LLNKINHSSLIRLLGICFNG 408
           G V RG+    GG    VA+K     K+     D +K   +++ ++H +LIRL G+    
Sbjct: 9   GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH 68

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHKD 466
               +V E A  GSL   +          +     A+ +A G+ YL S  F     +H+D
Sbjct: 69  -PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF-----IHRD 122

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLD 526
           +   N+LL +D + KI +F L R   + E  + +  H+     + APE L     S   D
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182

Query: 527 VYAFGVLMLEMLSGKEAP 544
           V+ FGV + EM +  E P
Sbjct: 183 VWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 62/258 (24%), Positives = 115/258 (44%), Gaps = 46/258 (17%)

Query: 374 VAIKKVY------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI 427
           VAIK +        D  ++ K++ K++H  L++L G+C      Y+V E   NG L  ++
Sbjct: 31  VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90

Query: 428 NDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
             + GK       + +  DV  G+ YL  +SF     +H+D+   N L+ +    K+++F
Sbjct: 91  RQRQGKL-SKDMLLSMCQDVCEGMEYLERNSF-----IHRDLAARNCLVSSTGVVKVSDF 144

Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        + L      + G      +  PE       S+K DV++FGVLM E+ +
Sbjct: 145 GMTR--------YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P    + N  +V++++       G    R           P + ++ V  ++ SC 
Sbjct: 197 EGKMP-FEKKSNYEVVEMIS------RGFRLYR-----------PKLASMTVYEVMYSCW 238

Query: 600 KKDPSGRPAMDKIAQSIS 617
            + P GRP   ++ ++I+
Sbjct: 239 HEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 35/213 (16%)

Query: 359 WIKG---------SVYRG--KIGGDFVAIKKVYGDASD----------------QIKLLN 391
           WIKG         SVY G     G+ +A+K+V   +                  +I LL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 392 KINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGL 451
           ++ H ++++ LG   +  +  +  E    GS++  +N+ G    +          +  GL
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGL 119

Query: 452 NYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH---IVGTK 508
           NYLH   N   +H+DIK +N+L+D     KI++F +++  E              + G+ 
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            +MAPE ++    + K D+++ G L++EML+GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 75/269 (27%), Positives = 117/269 (43%), Gaps = 58/269 (21%)

Query: 382 DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL-------------SVWI 427
           D + ++++L K+ +H ++I LLG C N G  Y+  E A  G+L               + 
Sbjct: 48  DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107

Query: 428 NDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA 486
            + G    L   Q +Q A DVATG+ YL   +    +H+D+   NVL+  +  +KIA+F 
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG 164

Query: 487 LARPAERQEGEFALTSHIVG--TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS----- 539
           L+R      GE       +G     +MA E L   + +TK DV++FGVL+ E++S     
Sbjct: 165 LSR------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Query: 540 --GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIES 597
             G     LY +            L +    E  R+  D              V  L+  
Sbjct: 219 YCGMTCAELYEK------------LPQGYRMEKPRNCDDE-------------VYELMRQ 253

Query: 598 CLKKDPSGRPAMDKIAQSISRFLNASLAW 626
           C +  P  RP   +I+  +SR L A  A+
Sbjct: 254 CWRDRPYERPPFAQISVQLSRMLEARKAY 282

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 53/277 (19%)

Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+D+           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGN 104

Query: 423 LSVWINDKGGKFLDWA--------------QRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    +D++                +  A  VA G+ YL S      +H+D+ 
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVW 220

Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FGVL+ E+  L G   P +  EE   L+        KE       H MD       P  
Sbjct: 221 SFGVLLWEIFTLGGSPYPGIPVEELFKLL--------KEG------HRMDK------PAN 260

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
               +  ++  C    PS RP   ++ + + R L  +
Sbjct: 261 CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 65/274 (23%), Positives = 128/274 (46%), Gaps = 37/274 (13%)

Query: 362 GSVYRG--KIGG---DFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           G V RG  K+ G    FVAIK +    +++ +        ++ + +H ++I L G+    
Sbjct: 18  GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
               ++ E   NG+L  ++    G+F    Q + +   +A G+ YL       +VH+D+ 
Sbjct: 78  RPVMIITEFMENGALDSFLRQNDGQF-TVIQLVGMLRGIAAGMKYLSEMN---YVHRDLA 133

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG--YMAPEYLENGLVSTKLD 526
             N+L++++   K+++F L+R  E    +   TS + G     + APE +     ++  D
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASD 193

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           V+++G++M E++S  E P      +M   DV+N +      E+  R  + P      P  
Sbjct: 194 VWSYGIVMWEVMSYGERPYW----DMSNQDVINAI------EQDYR--LPP------PMD 235

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               + +L+  C +KD + RP   +I  ++ + +
Sbjct: 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 43/262 (16%)

Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 20  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 78

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 79  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 135

Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 136 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 187

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R    P      PP   
Sbjct: 188 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM---PC-----PPECP 229

Query: 589 ILVIRLIESCLKKDPSGRPAMD 610
             +  L+  C +K+P  RP  +
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 57/275 (20%)

Query: 374 VAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VA+K +  DASD        ++K+L++++  ++ RLLG+C       ++ E   NG L+ 
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 426 WINDK---------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT 476
           ++              K L ++  + +A  +A+G+ YL S      VH+D+   N L+  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165

Query: 477 DFRAKIANFALARPA-----ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           ++  KIA+F ++R        R +G   L         +MA E +  G  +TK DV+AFG
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESVLLGKFTTKSDVWAFG 219

Query: 532 VLMLEMLS-GKEAPALYSE-------ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
           V + E+L+  +E P  Y         EN            ++DG +   +L         
Sbjct: 220 VTLWEILTLCREQP--YEHLTDQQVIENAGH-------FFRDDGRQ--IYL-------PR 261

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
           PP     +  L+  C ++D   RP   +I   + R
Sbjct: 262 PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 39/185 (21%)

Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD  Q   I  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A      
Sbjct: 98  LDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA------ 148

Query: 495 EGEFALT----SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYS 548
            G+   T    +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   L+ 
Sbjct: 149 -GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPHSELHP 206

Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP-PVTAILVIRLIESCLKKDPSGRP 607
            + + L+   NP                P+++GNY  P+        +E+CL K+PS RP
Sbjct: 207 MKVLFLIPKNNP----------------PTLEGNYSKPLK-----EFVEACLNKEPSFRP 245

Query: 608 AMDKI 612
              ++
Sbjct: 246 TAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 53/266 (19%), Positives = 117/266 (43%), Gaps = 34/266 (12%)

Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVN 420
           G+ VA+K +     +Q        I++L  ++H ++++  G+C   G  +  L+ E   +
Sbjct: 33  GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92

Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++     + ++  + +  +  +  G++YL    +  ++H+D+   N+L++++   
Sbjct: 93  GSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLV 148

Query: 481 KIANFALARPAE--------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 532
           KI++F LA+           ++ GE  +         + APE L     S+  DV++FGV
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIF--------WYAPECLRTSKFSSASDVWSFGV 200

Query: 533 LMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI 592
            + E+ +  +     S+        +  +   +     L  L+    +   PP     V 
Sbjct: 201 TLYELFTYGDP----SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY 256

Query: 593 RLIESCLKKDPSGRPAMDKIAQSISR 618
            L++ C + +P  RP+   +   + R
Sbjct: 257 DLMKLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 53/277 (19%)

Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 423 LSVWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    +++                 +  A  VA G+ YL S      +H+D+ 
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLA 167

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVW 226

Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FGVL+ E+  L G   P +  EE   L+        KE       H MD       P  
Sbjct: 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLL--------KEG------HRMDK------PSN 266

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
               +  ++  C    PS RP   ++ + + R L  +
Sbjct: 267 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 67/279 (24%)

Query: 362 GSVY--RGKIGGDFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGG 409
           G+VY  R     + VAIKK+          + D   +++ L ++ H + I   G      
Sbjct: 29  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88

Query: 410 NWYLVYENAVNGSLS--VWINDKGGKFLDWAQRIQIA---LDVATGLNYLHSFTNPPHVH 464
             +LV E  + GS S  + ++ K        Q ++IA        GL YLHS      +H
Sbjct: 89  TAWLVMEYCL-GSASDILEVHKKP------LQEVEIAAICHGALQGLAYLHSHER---IH 138

Query: 465 KDIKCSNVLLDTDFRAKIANF---ALARPAERQEGEFALTSHIVGTKGYMAPEY---LEN 518
           +DIK  N+LL      K+A+F   +L  PA          +  VGT  +MAPE    ++ 
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPA----------NSFVGTPYWMAPEVILAMDE 188

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-- 576
           G    K+DV++ G+  +E+   K  P L++   M                 +L H+    
Sbjct: 189 GQYDGKVDVWSLGITCIELAERK--PPLFNMNAM----------------SALYHIAQND 230

Query: 577 -PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
            P++  N     +      ++SCL+K P  RP+ +++ +
Sbjct: 231 SPTLSSND---WSDYFRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 57/284 (20%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G   G         VA+K +    S+Q +         ++K NH +++RL+G+ F
Sbjct: 20  GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     +  A DVA G  YL       
Sbjct: 80  ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--- 136

Query: 462 HVHKDIKCSNVLLDT---DFRAKIANFALARPAERQE----GEFALTSHIVGTKGYMAPE 514
            +H+DI   N LL        AKIA+F +AR   R      G  A+    +  K +M PE
Sbjct: 137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM----LPIK-WMPPE 191

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESLR 572
              +G+ ++K DV++FGVL+ E+ S    P     ++E M  V           G     
Sbjct: 192 AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV--------TGGGR---- 239

Query: 573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
             +DP      P      V R++  C +  P  RP    I + I
Sbjct: 240 --LDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 9e-15
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 31/197 (15%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQ---------IKLLNKI---NHSSLIRLLGIC-- 405
           G+VY+ +    G FVA+KKV    S++         I LL ++    H +++RLL +C  
Sbjct: 13  GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG 72

Query: 406 ---FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                     LV+E+ V+  L+ +++      L       +   +  G+++LHS     H
Sbjct: 73  PRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-----H 126

Query: 463 --VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
             VH+D+K  N+L+ +D + KIA+F LAR       E ALTS +V T  Y APE L    
Sbjct: 127 RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTS-VVVTLWYRAPEVLLQSS 182

Query: 521 VSTKLDVYAFGVLMLEM 537
            +T +D+++ G +  E+
Sbjct: 183 YATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 67/264 (25%), Positives = 118/264 (44%), Gaps = 48/264 (18%)

Query: 374 VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK V   AS  ++I+ LN+       N   ++RLLG+   G    ++ E    G L  
Sbjct: 39  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98

Query: 426 WI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           ++        N+         + IQ+A ++A G+ YL++      VH+D+   N ++  D
Sbjct: 99  YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 155

Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGV 532
           F  KI +F + R     +       +  G KG     +M+PE L++G+ +T  DV++FGV
Sbjct: 156 FTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209

Query: 533 LMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI 592
           ++ E+ +  E P                       E+ LR +M+  +  + P     ++ 
Sbjct: 210 VLWEIATLAEQP-----------------YQGMSNEQVLRFVMEGGLL-DKPDNCPDMLF 251

Query: 593 RLIESCLKKDPSGRPAMDKIAQSI 616
            L+  C + +P  RP+  +I  SI
Sbjct: 252 ELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 38/255 (14%)

Query: 374 VAIKKV--------YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK++          +   +++ +++ NH ++++       G   +LV      GSL  
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88

Query: 426 WINDK-GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
            +        LD A    +  +V  GL YLHS      +H+DIK  N+LL  D   KIA+
Sbjct: 89  IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIAD 145

Query: 485 F----ALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST-KLDVYAFGVLMLEMLS 539
           F    +LA   +R        +  VGT  +MAPE +E       K D+++FG+  +E+ +
Sbjct: 146 FGVSASLADGGDRTRK--VRKT-FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202

Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN--YPPVTAILVIRLIES 597
           G    + Y    +L++ + N                 PS++    Y   +     ++I  
Sbjct: 203 GAAPYSKYPPMKVLMLTLQND---------------PPSLETGADYKKYSKSFR-KMISL 246

Query: 598 CLKKDPSGRPAMDKI 612
           CL+KDPS RP  +++
Sbjct: 247 CLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 62/273 (22%), Positives = 118/273 (43%), Gaps = 45/273 (16%)

Query: 362 GSVY--RGKIGGDFVAIKKV-YGDASDQIK--------LLNKINHSSLIRLLGICFNGGN 410
           G+V   R K  G  +  K++ YG+ +++ K        +L ++ H +++R      +  N
Sbjct: 14  GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73

Query: 411 --WYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV--H 464
              Y+V E    G L+  I    K  K+++     +I   +   L   H+ ++P +   H
Sbjct: 74  QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K +N+ LD +   K+ +F LA+        FA T   VGT  YM+PE L +     K
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKT--YVGTPYYMSPEQLNHMSYDEK 190

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            D+++ G L+ E+ +    P   +   + L                ++       +G + 
Sbjct: 191 SDIWSLGCLIYELCALS--PPFTARNQLQLA-------------SKIK-------EGKFR 228

Query: 585 PVTAIL---VIRLIESCLKKDPSGRPAMDKIAQ 614
            +       +  +I+S L  DP  RP+ +++ Q
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 27/193 (13%)

Query: 362 GSVY--RGKIGGDFVAIK---KVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           GSVY  + +  GD+ AIK   K    A +Q+         ++ +     + +L     + 
Sbjct: 10  GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK 69

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
              YLV E    G  +  I   GG   DWA+  Q   +V  G+  LH       +H+DIK
Sbjct: 70  DYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGIIHRDIK 124

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DV 527
             N+L+D     K+ +F L+R               VGT  Y+APE +  G+   K+ D 
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGL-------ENKKFVGTPDYLAPETI-LGVGDDKMSDW 176

Query: 528 YAFGVLMLEMLSG 540
           ++ G ++ E L G
Sbjct: 177 WSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 44/275 (16%)

Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 20  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79

Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 80  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 137

Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +MAP
Sbjct: 138 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAP 190

Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESL 571
           E L++G+ +T  D+++FGV++ E+ S  E P   L +E+ +  V     +   ++  E +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERV 250

Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKD--PS 604
             LM   M   + P      + ++   LK D  PS
Sbjct: 251 TDLM--RMCWQFNPKMRPTFLEIVN-LLKDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 36/199 (18%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
           + V E    G L   I  + G+F D  +    A ++  GL +LH         +++D+K 
Sbjct: 72  FFVMEYVNGGDLMFHIQ-RSGRF-DEPRARFYAAEIVLGLQFLHE-----RGIIYRDLKL 124

Query: 470 SNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
            NVLLD++   KIA+F + +     EG      TS   GT  Y+APE L        +D 
Sbjct: 125 DNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
           +A GVL+ EML+G ++P                    +D +E  + +++  ++  YP   
Sbjct: 180 WALGVLLYEMLAG-QSP-----------------FEGDDEDELFQSILEDEVR--YPRWL 219

Query: 588 AILVIRLIESCLKKDPSGR 606
           +     +++S L K+P  R
Sbjct: 220 SKEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 47/206 (22%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  +  D         +I LL ++NH +++RLL +  +   
Sbjct: 13  GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK 72

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA--------TGLNYLHSFTNPPH 462
            YLV+E         +++    K++D +    +   +          G+ Y HS     H
Sbjct: 73  LYLVFE---------FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-----H 118

Query: 463 --VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYL 516
             +H+D+K  N+L+D +   K+A+F LAR        F +     +H V T  Y APE L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARA-------FGVPVRTYTHEVVTLWYRAPEIL 171

Query: 517 ENG-LVSTKLDVYAFGVLMLEMLSGK 541
                 ST +D+++ G +  EM++ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 44/180 (24%)

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--A 499
           +IA  V  GL+YLHS      +H+DIK SN+LL    + K+ +F ++       GE   +
Sbjct: 109 KIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVS-------GELVNS 158

Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG-------KEAPALYSEENM 552
           L     GT  YMAPE ++    S   DV++ G+ +LE+           E P    E   
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218

Query: 553 LLVDVLNPVLHKEDGE-----ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
            +V++ NP L  E G      E  +                      I+ CL+KDP+ RP
Sbjct: 219 YIVNMPNPELKDEPGNGIKWSEEFKD--------------------FIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 10/161 (6%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI- 443
           ++I L + + H ++++ LG     G + +  E    GSLS  +  K G   D  Q I   
Sbjct: 54  EEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTS 502
              +  GL YLH   +   VH+DIK  NVL++T     KI++F  ++   R  G    T 
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK---RLAGINPCTE 167

Query: 503 HIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGK 541
              GT  YMAPE ++ G        D+++ G  ++EM +GK
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 47/206 (22%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 14  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA--------TGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L +          GL + HS     H
Sbjct: 74  LYLVFE---------FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-----H 119

Query: 463 --VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPE-Y 515
             +H+D+K  N+L++T+   K+A+F LAR        F +     +H V T  Y APE  
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARA-------FGVPVRTYTHEVVTLWYRAPEIL 172

Query: 516 LENGLVSTKLDVYAFGVLMLEMLSGK 541
           L     ST +D+++ G +  EM++ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 47/270 (17%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
           G+VY    +  G   A+K +YG+  D        +I++L  +NH ++++   +  + G  
Sbjct: 88  GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH-VHKDIKCS 470
            ++ E    GSL      +G    D      +A  + +G+ YLH      H VH+DIK S
Sbjct: 148 QVLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHR----RHIVHRDIKPS 197

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA- 529
           N+L+++    KIA+F ++R    Q  +   +S  VGT  YM+PE +   L     D YA 
Sbjct: 198 NLLINSAKNVKIADFGVSRILA-QTMDPCNSS--VGTIAYMSPERINTDLNHGAYDGYAG 254

Query: 530 ----FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
                GV +LE   G+                    + ++    SL   +  S Q    P
Sbjct: 255 DIWSLGVSILEFYLGRFPFG----------------VGRQGDWASLMCAICMS-QPPEAP 297

Query: 586 VTAILVIR-LIESCLKKDPSGRPAMDKIAQ 614
            TA    R  I  CL+++P+ R +  ++ Q
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 63/279 (22%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASD--------QIKLLNKINHS---SLIRLLGICFNG 408
           G+VYRGK    G  VA+K +  D  D        ++ LL+++  S   ++ +  G    G
Sbjct: 15  GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ------IALDVATGLNYLHSFTNPPH 462
              +++ E A  GS+         + L  A  I       I  +V   L Y+H       
Sbjct: 75  PRLWIIMEYAEGGSV---------RTLMKAGPIAEKYISVIIREVLVALKYIHK---VGV 122

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LV 521
           +H+DIK +N+L+      K+ +F +A  A   +     ++  VGT  +MAPE +  G   
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRST-FVGTPYWMAPEVITEGKYY 179

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEEN-----MLLVDVLNPVLHKEDGEESLRHLMD 576
            TK D+++ G+ + EM +G   P  YS+ +     ML+     P L      + LR    
Sbjct: 180 DTKADIWSLGITIYEMATG-NPP--YSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE--- 233

Query: 577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
                             + +CL ++P  R + +++ +S
Sbjct: 234 -----------------FVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 53/274 (19%)

Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 107

Query: 423 LSVWINDKGGKFLDWAQRIQIALD--------------VATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    ++++  I    D              VA G+ YL S      +H+D+ 
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLA 164

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVW 223

Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FGVLM E+  L G   P +  EE   L+        KE       H MD       P  
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLL--------KEG------HRMDK------PAN 263

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               +  ++  C    PS RP   ++ + + R L
Sbjct: 264 CTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 50/273 (18%)

Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VA+K +  +AS  ++        L+ + +H ++++LLG+C  G    L++E    G L+ 
Sbjct: 38  VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97

Query: 426 WINDKGGKF--------------------LDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
           ++  +  +                     L   +++ IA  VA G+ YL   +    VH+
Sbjct: 98  FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHR 154

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           D+   N L+  +   KIA+F L+R     +   A  +  +  + +M PE +     +T+ 
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTES 213

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           DV+A+GV++ E+ S    P  Y   +                EE + ++ D ++  + P 
Sbjct: 214 DVWAYGVVLWEIFSYGMQP-YYGMAH----------------EEVIYYVRDGNVL-SCPD 255

Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
              + +  L+  C  K PS RP+   I + + R
Sbjct: 256 NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 64/273 (23%)

Query: 375 AIKKVYGDASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSL---------- 423
           A K  + D + ++++L K+  H ++I LLG C + G  YL  E A +G+L          
Sbjct: 46  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 105

Query: 424 ----SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
               +  I +     L   Q +  A DVA G++YL   +    +H+D+   N+L+  ++ 
Sbjct: 106 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 162

Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLM 534
           AKIA+F L+R  E          ++  T G     +MA E L   + +T  DV+++GVL+
Sbjct: 163 AKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213

Query: 535 LEMLS-------GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
            E++S       G     LY  E +     L   L+ +D                     
Sbjct: 214 WEIVSLGGTPYCGMTCAELY--EKLPQGYRLEKPLNCDDE-------------------- 251

Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              V  L+  C ++ P  RP+  +I  S++R L
Sbjct: 252 ---VYDLMRQCWREKPYERPSFAQILVSLNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 25/194 (12%)

Query: 362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G V++ K    G+ VA+KKV            A  +IK L    H  +++LL +  +G  
Sbjct: 14  GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
           + LV E  +   LS  + D+     + AQ       +  G+ Y+H+      +H+D+K +
Sbjct: 74  FVLVME-YMPSDLSEVLRDEERPLPE-AQVKSYMRMLLKGVAYMHANGI---MHRDLKPA 128

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK----LD 526
           N+L+  D   KIA+F LAR     E E  L SH V T+ Y APE L     + K    +D
Sbjct: 129 NLLISADGVLKIADFGLARLFS--EEEPRLYSHQVATRWYRAPELL---YGARKYDPGVD 183

Query: 527 VYAFGVLMLEMLSG 540
           ++A G +  E+L+G
Sbjct: 184 LWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 53/197 (26%), Positives = 102/197 (51%), Gaps = 19/197 (9%)

Query: 362 GSVYRG--KIGGD---FVAIK--------KVYGDASDQIKLLNKINHSSLIRLLGICFNG 408
           G V+RG  K+ G     VAIK        K   D   +  ++ + +H ++IRL G+    
Sbjct: 19  GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
               ++ E   NG+L  ++ D  G+F  + Q + +   +A G+ YL   ++  +VH+D+ 
Sbjct: 79  KPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL---SDMNYVHRDLA 134

Query: 469 CSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
             N+L++++   K+++F L+R  E   EG +  +   +  + + APE +     ++  DV
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR-WTAPEAIAYRKFTSASDV 193

Query: 528 YAFGVLMLEMLSGKEAP 544
           ++FG++M E++S  E P
Sbjct: 194 WSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 13/175 (7%)

Query: 374 VAIK--KVYGDASDQIKLLNKI-------NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K  K    +S++  L++++       NH +++ LLG C  GG   ++ E    G L 
Sbjct: 68  VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127

Query: 425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
            ++  K   FL     +  +  VA G+ +L S      +H+D+   NVLL      KI +
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICD 184

Query: 485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           F LAR            +  +  K +MAPE + N + + + DV+++G+L+ E+ S
Sbjct: 185 FGLARDIMNDSNYVVKGNARLPVK-WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 20/196 (10%)

Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L +L   CF   +        VNG   ++   K  +F D A+    A ++ + L +
Sbjct: 54  NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEITSALMF 111

Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSHIVGTKGYM 511
           LH       +++D+K  NVLLD +   K+A+F + +     EG F    TS   GT  Y+
Sbjct: 112 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYI 163

Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN-----PVLHKED 566
           APE L+  L    +D +A GVL+ EML G  AP     E+ L   +LN     P    +D
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG-HAPFEAENEDDLFEAILNDEVVYPTWLSQD 222

Query: 567 GEESLRHLM--DPSMQ 580
             + L+  M  +P+M+
Sbjct: 223 AVDILKAFMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 56/276 (20%)

Query: 363 SVYRG--KIGGDFVAIKKVY----------GDASDQIKLLNKINHSSLIRLLGICFNGGN 410
            VY+    + G  VA+KKV            D   +I LL +++H ++I+ L        
Sbjct: 17  VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76

Query: 411 WYLVYENAVNGSLSVWIND--KGGKFLD----WAQRIQIALDVATGLNYLHSFTNPPHVH 464
             +V E A  G LS  I    K  + +     W   +Q+     + L ++HS      +H
Sbjct: 77  LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSKRI---MH 129

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH-IVGTKGYMAPEYL-ENGLVS 522
           +DIK +NV +      K+ +  L R    +       +H +VGT  YM+PE + ENG  +
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGY-N 184

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            K D+++ G L+ EM +  ++P  +  + M L  +   +                  + +
Sbjct: 185 FKSDIWSLGCLLYEM-AALQSP--FYGDKMNLYSLCKKI-----------------EKCD 224

Query: 583 YPPVTAILV---IR-LIESCLKKDPSGRPAMDKIAQ 614
           YPP+ A      +R L+  C+  DP  RP +  + Q
Sbjct: 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 51/267 (19%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQI--------KLLNKINHSSLIRLLGICFNGGNW 411
           G V     +  G  +A+K +  + ++ I         +L+K N   ++   G  +N G+ 
Sbjct: 15  GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQ-RI------QIALDVATGLNYLHSFTNPPHVH 464
            +  E    GSL         K L   Q RI      +IA+ V  GL YLH       +H
Sbjct: 75  SICMEYMDGGSLD--------KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI--IH 124

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K SN+L+++  + K+ +F ++    +     A T   VGT  YMAPE ++    S K
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTF--VGTSSYMAPERIQGNDYSVK 179

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN---MLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
            D+++ G+ ++E+ +G   P  Y  EN     + ++L  ++  E           P  Q 
Sbjct: 180 SDIWSLGLSLIELATG-RFP--YPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ- 234

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPA 608
                        +  CL KDP  RP+
Sbjct: 235 -----------DFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 56/271 (20%)

Query: 362 GSVYRG--KIGGDFVAIK---------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY       G+ +A+K         K   + +D++K+L  + H +L++  G+  +   
Sbjct: 14  GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            Y+  E    G+L   +  + G+ LD        L +  GL YLHS     H  VH+DIK
Sbjct: 74  VYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHS-----HGIVHRDIK 126

Query: 469 CSNVLLDTDFRAKIANFA----LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
            +N+ LD +   K+ +F     L         E      + GT  YMAPE +  G     
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ---SLAGTPAYMAPEVITGGKGKGH 183

Query: 525 L---DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
               D+++ G ++LEM +GK                      + D E     +M     G
Sbjct: 184 GRAADIWSLGCVVLEMATGK------------------RPWSELDNEFQ---IMFHVGAG 222

Query: 582 NYPPVTAIL-----VIRLIESCLKKDPSGRP 607
           + PP+   L         ++ CL+ DP  RP
Sbjct: 223 HKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 68/282 (24%)

Query: 362 GSVYRGKI--GGDFVAIKKVYGDASD-------QIKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+ +    G+ VAIK +  +  D       +I +L +  H +++   G        +
Sbjct: 17  GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIKC 469
           +V E    GSL        G        +QIA    +   GL YLH       +H+DIK 
Sbjct: 77  IVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAYLHETGK---IHRDIKG 129

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHI------VGTKGYMAPEYLE---NGL 520
           +N+LL  D   K+A+F ++  A+       LT+ I      +GT  +MAPE       G 
Sbjct: 130 ANILLTEDGDVKLADFGVS--AQ-------LTATIAKRKSFIGTPYWMAPEVAAVERKGG 180

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-MDPSM 579
              K D++A G+  +E+   +  P ++              LH       +R L +    
Sbjct: 181 YDGKCDIWALGITAIELAELQ--PPMFD-------------LH------PMRALFLISKS 219

Query: 580 QGNYPPVT-------AILVIRLIESCLKKDPSGRPAMDKIAQ 614
             N+PP         + +    I+ CL KDP  RP   K+ Q
Sbjct: 220 --NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 47/214 (21%)

Query: 362 GSVYRGKIGGDF-------VAIK--------KVYGDASDQIKLLNKINHSSLIRLLGICF 406
           G VY+G++ G         VAIK        KV  +   + +L++ + H +++ LLG+C 
Sbjct: 19  GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78

Query: 407 NGGNWYLVYENAVNGSLSVWI--------------NDKGGKFLDWAQRIQIALDVATGLN 452
                 +++E   +G L  ++              ++     LD +  + IA+ +A G+ 
Sbjct: 79  KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGME 138

Query: 453 YL--HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE-----RQEGEFALTSHIV 505
           YL  H F     VH+D+   N L+      KI++F L+R        R + +  L     
Sbjct: 139 YLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-- 191

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
               +M PE +  G  +T+ D+++FGV++ E+ S
Sbjct: 192 ----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 21/174 (12%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF-LDWAQ--RI 441
           ++ ++L  I H  L+ L G   +  N YLV E    G L   +  K G+F    A+    
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVARFYAA 108

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA-RPAERQEGEFAL 500
           Q+ L     L YLHS      V++D+K  N+LLD+D   KI +F  A R   R       
Sbjct: 109 QVVL----ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------- 154

Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
           T  + GT  Y+APE + +      +D +A G+L+ EML+G   P  + +  + +
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG--YPPFFDDNPIQI 206

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 43/240 (17%)

Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG------KFL 435
           ++  ++ +L+ + H ++++        GN Y+V +    G L   IN + G      + L
Sbjct: 45  ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104

Query: 436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
           DW   +QI L     L ++H   +   +H+DIK  N+ L  D   K+ +F +AR      
Sbjct: 105 DWF--VQICL----ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNST 154

Query: 496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV 555
            E A T   +GT  Y++PE  EN   + K D++A G ++ EM + K A   +   NM   
Sbjct: 155 VELARTC--IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA---FEAGNM--- 206

Query: 556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT---AILVIRLIESCLKKDPSGRPAMDKI 612
                           ++L+   ++G+YPPV+   +  +  L+    K++P  RP+++ I
Sbjct: 207 ----------------KNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 40/237 (16%)

Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   +I +L++ +   + +  G    G   +++ E    GS    +  + G F D  Q  
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPF-DEFQIA 104

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
            +  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A       G+   T
Sbjct: 105 TMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA-------GQLTDT 154

Query: 502 ----SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA--LYSEENMLLV 555
               +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   ++    + L+
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-EPPNSDMHPMRVLFLI 213

Query: 556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
              NP                P++ G +           I++CL KDPS RP   ++
Sbjct: 214 PKNNP----------------PTLTGEFSKPFK----EFIDACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 49/175 (28%), Positives = 89/175 (50%), Gaps = 32/175 (18%)

Query: 442 QIALDVATGLNYLHSFTNPPH-VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-- 498
           +IA+ V  GL YL+   N    +H+DIK SN+L+++  + K+ +F ++       GE   
Sbjct: 107 KIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-------GELIN 156

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK------EAPALYSEENM 552
           ++    VGT  YM+PE ++ G  + K DV++ G+ ++E+  GK             ++ M
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216

Query: 553 LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
            ++D+L  ++     E   R    PS   ++P      +   +++CL KDP+ RP
Sbjct: 217 GILDLLQQIVQ----EPPPRL---PS--SDFPED----LRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 46/167 (27%), Positives = 85/167 (50%), Gaps = 19/167 (11%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI-NDKGGKFLDWAQRIQI 443
           ++  L+  + H  L+RL  +       Y++ E    GSL  ++ +D+GGK L   + I  
Sbjct: 50  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDF 108

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGE 497
           +  +A G+ Y+       ++H+D++ +NVL+      KIA+F LAR  E      R+  +
Sbjct: 109 SAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165

Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           F +         + APE +  G  + K DV++FG+L+ E+++  + P
Sbjct: 166 FPIK--------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 32/200 (16%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGIC----- 405
           G V+  R K     VA+KKV  +         A  +IK+L  + H +++ L+ IC     
Sbjct: 26  GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85

Query: 406 -FNG--GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
            +N   G++YLV+E   +  L+  +++K  KF   ++  ++   +  GL Y+H   N   
Sbjct: 86  PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF-TLSEIKKVMKMLLNGLYYIHR--NKI- 140

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEFALTSHIVGTKGYMAPEYLEN--- 518
           +H+D+K +N+L+  D   K+A+F LAR  +  +  +    ++ V T  Y  PE L     
Sbjct: 141 LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD 200

Query: 519 -GLVSTKLDVYAFGVLMLEM 537
            G     +D++  G +M EM
Sbjct: 201 YG---PPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 72/261 (27%), Positives = 115/261 (44%), Gaps = 48/261 (18%)

Query: 362 GSVYRG--KIGGDFVAIKKV--------YGDASDQIKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+G      + VAIK +          D   +I +L++ +   + R  G    G   
Sbjct: 18  GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +++ E    GS    +  K G  L+      I  ++  GL+YLHS      +H+DIK +N
Sbjct: 78  WIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLHS---ERKIHRDIKAAN 131

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYLENGLVSTKLDV 527
           VLL      K+A+F +A       G+   T    +  VGT  +MAPE ++      K D+
Sbjct: 132 VLLSEQGDVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP-PV 586
           ++ G+  +E+  G E P   S+ + + V  L P       + S      P+++G Y  P 
Sbjct: 185 WSLGITAIELAKG-EPP--NSDLHPMRVLFLIP-------KNS-----PPTLEGQYSKPF 229

Query: 587 TAILVIRLIESCLKKDPSGRP 607
                   +E+CL KDP  RP
Sbjct: 230 K-----EFVEACLNKDPRFRP 245

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 25/196 (12%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +   +        +  L+ ++ H  L+RL  +       Y++
Sbjct: 20  GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYII 78

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NGSL  ++    G  L   + I +A  +A G+ ++       ++H+D++ +N+L+
Sbjct: 79  TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILV 135

Query: 475 DTDFRAKIANFALARPAER-----QEG-EFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
                 KIA+F LAR  E      +EG +F +         + APE +  G  + K DV+
Sbjct: 136 SETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------WTAPEAINYGTFTIKSDVW 187

Query: 529 AFGVLMLEMLSGKEAP 544
           +FG+L+ E+++    P
Sbjct: 188 SFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 32/197 (16%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y V E    G L   I  + GKF +    +  A ++A GL +LHS      +++D+K  N
Sbjct: 77  YFVMEYVNGGDLMYHIQ-QVGKFKE-PHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDN 131

Query: 472 VLLDTDFRAKIANFALARPAERQEGEF--ALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           V+LD +   KIA+F + +     E  F    T    GT  Y+APE +        +D +A
Sbjct: 132 VMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FGVL+ EML+G+                  P    ED +E  + +M+ ++  +YP   + 
Sbjct: 187 FGVLLYEMLAGQ------------------PPFDGEDEDELFQSIMEHNV--SYPKSLSK 226

Query: 590 LVIRLIESCLKKDPSGR 606
             + + +  L K P+ R
Sbjct: 227 EAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.0 bits (174), Expect = 1e-12
 Identities = 67/273 (24%), Positives = 125/273 (45%), Gaps = 30/273 (10%)

Query: 361 KGSVYRGKI---GGDFVA--IKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY 415
           KG+ Y+GK    G  FV   I  V    S +I  + K+ H ++++L+G+C +    YL++
Sbjct: 703 KGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E     +LS  + +     L W +R +IA+ +A  L +LH   +P  V  ++    +++D
Sbjct: 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
                 +    L+ P     G     +    +  Y+APE  E   ++ K D+Y FG++++
Sbjct: 818 GKDEPHLR---LSLP-----GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILI 869

Query: 536 EMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL---MDPSMQGNYP--PVTAIL 590
           E+L+GK         +  +V+             S  HL   +DPS++G+        + 
Sbjct: 870 ELLTGKSPADAEFGVHGSIVEWARYCY-------SDCHLDMWIDPSIRGDVSVNQNEIVE 922

Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           V+ L   C   DP+ RP  + + +++     +S
Sbjct: 923 VMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 63/255 (24%), Positives = 108/255 (42%), Gaps = 26/255 (10%)

Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVN 420
           G+ VA+K +  +   Q        I +L  + H ++++  G C   G     L+ E    
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++       L+ AQ +  A  +  G+ YLHS     ++H+D+   NVLLD D   
Sbjct: 93  GSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLV 146

Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS- 539
           KI +F LA+        + +         + A E L+    S   DV++FGV + E+L+ 
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206

Query: 540 --GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIES 597
              K++P    EE +        V+        L  L++  M+   P      V  L+++
Sbjct: 207 CDSKQSPPKKFEEMIGPKQGQMTVV-------RLIELLERGMRLPCPKNCPQEVYILMKN 259

Query: 598 CLKKDPSGRPAMDKI 612
           C + +   RP    +
Sbjct: 260 CWETEAKFRPTFRSL 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 64/256 (25%), Positives = 113/256 (44%), Gaps = 44/256 (17%)

Query: 382 DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL-------------SVWI 427
           D + ++++L K+ +H ++I LLG C + G  YL  E A +G+L               + 
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100

Query: 428 NDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA 486
                   L   Q +  A DVA G++YL   +    +H+D+   N+L+  ++ AKIA+F 
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 157

Query: 487 LARPAERQEGEFALTSHIVG--TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           L+R      G+       +G     +MA E L   + +T  DV+++GVL+ E++S    P
Sbjct: 158 LSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
                  M   ++   +      E+   +  D              V  L+  C ++ P 
Sbjct: 212 YC----GMTCAELYEKLPQGYRLEKP-LNCDDE-------------VYDLMRQCWREKPY 253

Query: 605 GRPAMDKIAQSISRFL 620
            RP+  +I  S++R L
Sbjct: 254 ERPSFAQILVSLNRML 269

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 61/258 (23%), Positives = 120/258 (46%), Gaps = 36/258 (13%)

Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK +    +++ +        ++ + +H ++I L G+        +V E   NGSL  
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94

Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++    G+F    Q + +   +A+G+ YL       +VH+D+   N+L++++   K+++F
Sbjct: 95  FLRKHDGQF-TVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDF 150

Query: 486 ALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
            L+R  E  + E A T+   G K    + APE +     ++  DV+++G++M E++S  E
Sbjct: 151 GLSRVLE-DDPEAAYTTR--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207

Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P       M   DV+  +      EE  R  +   M           + +L+  C +KD
Sbjct: 208 RPYW----EMSNQDVIKAI------EEGYR--LPAPMD------CPAALHQLMLDCWQKD 249

Query: 603 PSGRPAMDKIAQSISRFL 620
            + RP  ++I   + + +
Sbjct: 250 RNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           + + V E    G L   I   G +F D A+    A ++  GL +LH       +++D+K 
Sbjct: 70  HLFFVMEYLNGGDLMFHIQSSG-RF-DEARARFYAAEIICGLQFLHKKGI---IYRDLKL 124

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            NVLLD D   KIA+F + +  E   GE    S   GT  Y+APE L+    +  +D ++
Sbjct: 125 DNVLLDKDGHIKIADFGMCK--ENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWS 181

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           FGVL+ EML G ++P    +E+ L   +LN   H
Sbjct: 182 FGVLLYEMLIG-QSPFHGEDEDELFDSILNDRPH 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 34/235 (14%)

Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           A  + +LL+++ H +++      + G +   Y+V      G L   + ++ GK L   Q 
Sbjct: 46  AEQEAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV 104

Query: 441 IQIALDVATGLNYLHSFTNPPHV-HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           ++  + +A  L YLH      H+ H+D+K  NV L      K+ +  +AR  E Q     
Sbjct: 105 VEWFVQIAMALQYLHE----KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---CD 157

Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDV 557
           + S ++GT  YM+PE   N   + K DV+A G  + EM + K A   ++ ++M  L+  +
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA---FNAKDMNSLVYRI 214

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           +   L              P M  +Y P        LI + L K P  RP++  I
Sbjct: 215 IEGKL--------------PPMPKDYSPELG----ELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 14/184 (7%)

Query: 366 RGKIGGDFVAIKKV--------YGDASDQIKLLNKINHSSLIRLLGICFNGGN--WYLVY 415
            G   G+ VA+K +          D   +I++L  + H ++++  GIC   G     L+ 
Sbjct: 28  EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E   +GSL  ++     K ++  Q+++ A+ +  G++YL S     +VH+D+   NVL++
Sbjct: 88  EFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVE 143

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
           ++ + KI +F L +  E  +  + +   +     + APE L         DV++FGV + 
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 536 EMLS 539
           E+L+
Sbjct: 204 ELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 44/197 (22%)

Query: 371 GDFVAIKKVY---GDASD------QIKLLNKI-NHSSLIRLLGI--CFNGGNWYLVYE-- 416
            + VA+KK++    +A+D      +I  L ++ +H ++++LL +    N  + YLV+E  
Sbjct: 32  KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91

Query: 417 ----NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIKCSN 471
               +AV       I  +     D   +  I   +   L Y+HS     +V H+D+K SN
Sbjct: 92  ETDLHAV-------I--RANILED-VHKRYIMYQLLKALKYIHS----GNVIHRDLKPSN 137

Query: 472 VLLDTDFRAKIANFALARP-AERQEGEF--ALTSHIVGTKGYMAPEYLENGLVSTK---- 524
           +LL++D R K+A+F LAR  +E +E      LT + V T+ Y APE L   L ST+    
Sbjct: 138 ILLNSDCRVKLADFGLARSLSELEENPENPVLTDY-VATRWYRAPEIL---LGSTRYTKG 193

Query: 525 LDVYAFGVLMLEMLSGK 541
           +D+++ G ++ EML GK
Sbjct: 194 VDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 352 DDFNPSCWIK----GSVY--RGKIGGDFVAIKKVYGDASDQIKL------------LNKI 393
           DD      +     G V+  R +I   + A+K +     + I+L            L ++
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEV 58

Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           +H  +IRL     +    Y++ E    G L  ++ + G +F +       A ++   L Y
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLF-YASEIVCALEY 116

Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
           LHS      V++D+K  N+LLD +   K+ +F  A+    +      T  + GT  Y+AP
Sbjct: 117 LHSKEI---VYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPEYLAP 167

Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           E +++   +  +D +A G+L+ EML G 
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.9 bits (167), Expect = 3e-12
 Identities = 84/277 (30%), Positives = 128/277 (46%), Gaps = 60/277 (21%)

Query: 371 GDFVAIKK---VYGDASD------QIKLLNKINHSSLIRLLGI-------CFNGGNWYLV 414
           G  VAIKK   V+ D  D      +IKLL  + H ++I LL I        FN  + Y+V
Sbjct: 25  GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN--DVYIV 82

Query: 415 YENAVNGS-LSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHV-HKDIKCSN 471
            E  +  + L   I  K  + L     IQ     +  GL YLHS     +V H+D+K SN
Sbjct: 83  TE--LMETDLHKVI--KSPQPLT-DDHIQYFLYQILRGLKYLHS----ANVIHRDLKPSN 133

Query: 472 VLLDTDFRAKIANFALARPAERQEGEF-ALTSHIVGTKGYMAPEYLENGLVSTK----LD 526
           +L++++   KI +F LAR  +  E E   LT ++V T+ Y APE L   L S++    +D
Sbjct: 134 ILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELL---LSSSRYTKAID 189

Query: 527 VYAFGVLMLEMLSGKEAPALY---SEENML--LVDVLNPVLHKED-----GEESLRHL-M 575
           +++ G +  E+L+ K    L+      + L  +V+VL     +ED      E++  +L  
Sbjct: 190 IWSVGCIFAELLTRK---PLFPGRDYIDQLNLIVEVL-GTPSEEDLKFITSEKARNYLKS 245

Query: 576 DPSMQGN-----YPPVTAILVIRLIESCLKKDPSGRP 607
            P          +P  +    I L+E  L  DP  R 
Sbjct: 246 LPKKPKKPLSKLFPGASP-EAIDLLEKMLVFDPKKRI 281

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 61/282 (21%)

Query: 373 FVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
            VA+K +  DA+         ++K+L+++   ++IRLLG+C +     ++ E   NG L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 425 VWIN-----DKGGKFLD------------WAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
            +++     DK     D            ++  + +AL +A+G+ YL S      VH+D+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164

Query: 468 KCSNVLLDTDFRAKIANFALAR-----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
              N L+  +   KIA+F ++R        R +G   L         +MA E +  G  +
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR------WMAWECILMGKFT 218

Query: 523 TKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           T  DV+AFGV + E+L   KE P  Y E            L  E   E+         + 
Sbjct: 219 TASDVWAFGVTLWEILMLCKEQP--YGE------------LTDEQVIENAGEFFRDQGRQ 264

Query: 582 NY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
            Y   PP     +  L+  C  +D   RP+       I  FL
Sbjct: 265 VYLFRPPPCPQGLYELMLQCWSRDCRERPSF----SDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 35/204 (17%)

Query: 362 GSVYRGKIGGDF------VAIKKVYGDASD-QIKLLNK-------INHSSLIRLLGICFN 407
           G ++ G +  +       V +K V   AS+ Q+ LL +       ++H +++ +L +C  
Sbjct: 20  GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79

Query: 408 GGNWYLVYENAVN-GSLSVWIND------KGGKFLDWAQRIQIALDVATGLNYLHSFTNP 460
            G    V    +N G+L +++           + L   Q + +A+ +A G++YLH     
Sbjct: 80  DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-- 137

Query: 461 PHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY-----MAPEY 515
             +HKDI   N ++D + + KI + AL+R        F +  H +G         MA E 
Sbjct: 138 -VIHKDIAARNCVIDEELQVKITDNALSRDL------FPMDYHCLGDNENRPVKWMALES 190

Query: 516 LENGLVSTKLDVYAFGVLMLEMLS 539
           L N   S+  DV++FGVL+ E+++
Sbjct: 191 LVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 24/197 (12%)

Query: 362 GSVY--RGKIGGDFVAIKKV------YGDASDQIK----LLNKINHSSLIRLLGICFNG- 408
           G V+  + K  GD  AIK +        +  DQ+     +L++     +++L    F G 
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGK 65

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
            N YLV E    G L+  + + G    D A RI IA ++   L YLHS      +H+D+K
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVA-RIYIA-EIVLALEYLHSNG---IIHRDLK 120

Query: 469 CSNVLLDTDFRAKIANFALARPA--ERQEGEFALTSH---IVGTKGYMAPEYLENGLVST 523
             N+L+D++   K+ +F L++     RQ            IVGT  Y+APE +     S 
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 524 KLDVYAFGVLMLEMLSG 540
            +D ++ G ++ E L G
Sbjct: 181 TVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 42/110 (38%), Positives = 62/110 (56%), Gaps = 6/110 (5%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL +LHS      V++D+K  N+LLDTD   KIA+F + +  E   G+ A T  
Sbjct: 102 AAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGD-AKTCT 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
             GT  Y+APE L     +T +D ++FGVL+ EML G+     + EE + 
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 23/191 (12%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICFNGGNWY 412
           G V++G +     VA+K    D   ++K+        L + +H ++++L+G+C      Y
Sbjct: 9   GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIY 68

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V E    G    ++  K  + L   Q ++ ALD A G+ YL S      +H+D+   N 
Sbjct: 69  IVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNC---IHRDLAARNC 124

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK----GYMAPEYLENGLVSTKLDVY 528
           L+  +   KI++F ++R    QE +   +S   G K     + APE L  G  S++ DV+
Sbjct: 125 LVGENNVLKISDFGMSR----QEDDGIYSSS--GLKQIPIKWTAPEALNYGRYSSESDVW 178

Query: 529 AFGVLMLEMLS 539
           ++G+L+ E  S
Sbjct: 179 SYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)

Query: 391 NKINHSSLIRLLGICFNGGNW-YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           N   H  L+ L   CF   +    V E A  G L + I+          + +  A  V  
Sbjct: 57  NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVL 112

Query: 450 GLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           GL YLH      +  V++D+K  N+LLDT+   KIA+F L +      G    TS   GT
Sbjct: 113 GLQYLHE-----NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGT 164

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG 567
             ++APE L     +  +D +  GVL+ EML G E+P    +E     +V + ++     
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG-ESPFPGDDEE----EVFDSIV----- 214

Query: 568 EESLRHLMDPSMQGNYP---PVTAILVIRLIESCLKKDPSGR 606
                     + +  YP      AI ++R +   L+++P  R
Sbjct: 215 ----------NDEVRYPRFLSREAISIMRRL---LRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 55/234 (23%), Positives = 102/234 (43%), Gaps = 33/234 (14%)

Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           A ++ ++L  ++H ++I             +V E A  G+L+ +I  +    LD    + 
Sbjct: 46  AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH 105

Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALT 501
             + +   L+++H       +H+D+K  N+LLD      KI +F +++         +  
Sbjct: 106 FFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISK----ILSSKSKA 158

Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
             +VGT  Y++PE  E    + K D++A G ++ E+ S K A   +   N          
Sbjct: 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA---FEAAN---------- 205

Query: 562 LHKEDGEESLRHLMDPSMQGNYPPVT---AILVIRLIESCLKKDPSGRPAMDKI 612
                    L  L+   M G + P++   +  + +LI S L  DPS RP + +I
Sbjct: 206 ---------LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 51/273 (18%)

Query: 362 GSVY--RGKIGGDFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGG 409
           G+VY  R     + VAIKK+          + D   ++K L +I H + I   G      
Sbjct: 39  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             +LV E  + GS S  + +   K L   +   I      GL YLHS      +H+DIK 
Sbjct: 99  TAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKA 153

Query: 470 SNVLLDTDFRAKIANF---ALARPAERQEGEFALTSHIVGTKGYMAPEY---LENGLVST 523
            N+LL    + K+A+F   ++A PA          +  VGT  +MAPE    ++ G    
Sbjct: 154 GNILLTEPGQVKLADFGSASIASPA----------NSFVGTPYWMAPEVILAMDEGQYDG 203

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
           K+DV++ G+  +E+   K  P L+   NM  +  L  +   E           P++Q N 
Sbjct: 204 KVDVWSLGITCIELAERK--PPLF---NMNAMSALYHIAQNE----------SPTLQSNE 248

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
               +      ++SCL+K P  RP  +++ + +
Sbjct: 249 ---WSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 31/203 (15%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG-- 408
           G VY  R K  G+ VA+KKV  D         A  +IK+L ++NH +++ L  I  +   
Sbjct: 21  GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80

Query: 409 --------GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTN 459
                   G +YLV+E  ++  L   +      F +    I+     +  GLNY H    
Sbjct: 81  ALDFKKDKGAFYLVFE-YMDHDLMGLLESGLVHFSE--DHIKSFMKQLLEGLNYCH---K 134

Query: 460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLEN 518
              +H+DIKCSN+LL+   + K+A+F LAR    +E      ++ V T  Y  PE  L  
Sbjct: 135 KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR--PYTNKVITLWYRPPELLLGE 192

Query: 519 GLVSTKLDVYAFGVLMLEMLSGK 541
                 +DV++ G ++ E+ + K
Sbjct: 193 ERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 64/262 (24%), Positives = 122/262 (46%), Gaps = 41/262 (15%)

Query: 373 FVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
            VA+K +  DA+         +IK+++++   ++IRLL +C       ++ E   NG L+
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 425 VWIN---------DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
            +++               + ++  I +A  +A+G+ YL S      VH+D+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
            ++  KIA+F ++R     +  + +    V    +M+ E +  G  +T  DV+AFGV + 
Sbjct: 165 KNYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223

Query: 536 EMLS-GKEAP-ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY---PPVTAIL 590
           E+L+  KE P +  S+E ++           E+  E  R   D   Q  Y   P +    
Sbjct: 224 EILTLCKEQPYSQLSDEQVI-----------ENTGEFFR---DQGRQ-VYLPKPALCPDS 268

Query: 591 VIRLIESCLKKDPSGRPAMDKI 612
           + +L+ SC +++   RP+  +I
Sbjct: 269 LYKLMLSCWRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 65/283 (22%)

Query: 362 GSVY--RGKIGGDFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGG 409
           G+VY  R     + VAIKK+          + D   +++ L K+ H + I+  G      
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 410 NWYLVYENAVNGSLS--VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
             +LV E  + GS S  + ++ K  + ++ A     AL    GL YLHS      +H+D+
Sbjct: 89  TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLHSHN---MIHRDV 141

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY---LENGLVSTK 524
           K  N+LL      K+ +F  A          A  +  VGT  +MAPE    ++ G    K
Sbjct: 142 KAGNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL-------NPVLHKEDGEESLRHLMDP 577
           +DV++ G+  +E+   +  P L+   NM  +  L       +P L      E  R+ +D 
Sbjct: 195 VDVWSLGITCIEL--AERKPPLF---NMNAMSALYHIAQNESPALQSGHWSEYFRNFVD- 248

Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                              SCL+K P  RP  + + +   RF+
Sbjct: 249 -------------------SCLQKIPQDRPTSEVLLK--HRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 41/159 (25%), Positives = 79/159 (49%), Gaps = 8/159 (5%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
            +I+ L  ++H ++++ LG       +  ++   V G          G+F +   R    
Sbjct: 57  SEIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFT 114

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V  GL YLHS      +H+D+K  N+L+D D   KI++F +++ ++         S +
Sbjct: 115 EQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-M 170

Query: 505 VGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGK 541
            G+  +MAPE + +     S K+D+++ G ++LEM +G+
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 28/195 (14%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           + V E    G L   I DKG +F D  +    A ++  GL +LHS      +++D+K  N
Sbjct: 72  FFVMEFLNGGDLMFHIQDKG-RF-DLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDN 126

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           V+LD D   KIA+F + +  E   G+    S   GT  Y+APE L+    +  +D ++FG
Sbjct: 127 VMLDRDGHIKIADFGMCK--ENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFG 183

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           VL+ EML G ++P    +E+ L               ES+R  +D     +YP       
Sbjct: 184 VLLYEMLIG-QSPFHGDDEDELF--------------ESIR--VDTP---HYPRWITKES 223

Query: 592 IRLIESCLKKDPSGR 606
             ++E   ++DP+ R
Sbjct: 224 KDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 45/133 (33%), Positives = 69/133 (51%), Gaps = 23/133 (17%)

Query: 444 ALDVATGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFA 499
           A +V   L +LH      H  +++D+K  N+LLD +   K+A+F + +     EG     
Sbjct: 102 AAEVTLALMFLHR-----HGVIYRDLKLDNILLDAEGHCKLADFGMCK-----EGILNGV 151

Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE------ENML 553
            T+   GT  Y+APE L+       +D +A GVLM EM++G+  P   ++      E++L
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ--PPFEADNEDDLFESIL 209

Query: 554 LVDVLNPV-LHKE 565
             DVL PV L KE
Sbjct: 210 HDDVLYPVWLSKE 222

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 36/242 (14%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGG----KFLDWAQRIQI 443
           ++   +H +++ LLGIC  + G+  +V     +G L  +I  +      K L     I  
Sbjct: 49  IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGF 103

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
            L VA G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +
Sbjct: 104 GLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHN 158

Query: 504 IVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP 560
             G K    +MA E L+    +TK DV++FGVL+ E+++    P  Y + +    D+   
Sbjct: 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVDSF--DITVY 214

Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           +L    G    R L+ P     Y P     +  ++ SC    P  RP   ++   I +  
Sbjct: 215 LL---QG----RRLLQPE----YCPDP---LYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260

Query: 621 NA 622
           + 
Sbjct: 261 ST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 7/121 (5%)

Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           G L   I + G      A+ I  A  +  GL +LH       V++D+K  NVLLD     
Sbjct: 78  GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNV 134

Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           +I++  LA   E + G+        GT GYMAPE L+  +    +D +A G  + EM++G
Sbjct: 135 RISDLGLA--VELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190

Query: 541 K 541
           +
Sbjct: 191 R 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 70/248 (28%), Positives = 113/248 (45%), Gaps = 43/248 (17%)

Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRG--KIGGDFVAIK 377
           DEE  + L +I  +    K YT FE++ Q A+          G+VY       G  VAIK
Sbjct: 1   DEEILEKLRTIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAIDVATGQEVAIK 50

Query: 378 KVYGDASDQIK---LLNKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
           ++  +   Q K   ++N+I       H +++  L     G   ++V E    GSL+  + 
Sbjct: 51  QM--NLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108

Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--- 485
           +     +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F   
Sbjct: 109 ETC---MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA 545
           A   P + +       S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P 
Sbjct: 163 AQITPEQSKR------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-EPP- 214

Query: 546 LYSEENML 553
            Y  EN L
Sbjct: 215 -YLNENPL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 75/275 (27%), Positives = 115/275 (41%), Gaps = 48/275 (17%)

Query: 362 GSVYRGK--IGGDFVAIK--KVYGDASDQIK----LLNKINHSSLIRLLGICFNGGN--- 410
           G VY+G+    G   AIK   V GD  ++IK    +L K +H   I      F   N   
Sbjct: 20  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79

Query: 411 ----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
                +LV E    GS++  I +  G  L       I  ++  GL++LH       +H+D
Sbjct: 80  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRD 136

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---EN--GLV 521
           IK  NVLL  +   K+ +F ++   +R  G     +  +GT  +MAPE +   EN     
Sbjct: 137 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDATY 193

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNPVLHKEDGEESLRHLMDPSM 579
             K D+++ G+  +EM  G  AP L     M  L +   NP    +  + S +       
Sbjct: 194 DFKSDLWSLGITAIEMAEG--APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ----- 246

Query: 580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                          IESCL K+ S RP  +++ +
Sbjct: 247 -------------SFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 28/200 (14%)

Query: 362 GSVYRG---KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICF 406
           G V++    K GG FVA+K+V     ++            ++ L    H +++RL  +C 
Sbjct: 15  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74

Query: 407 -----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                      LV+E+ V+  L+ +++      +       +   +  GL++LHS     
Sbjct: 75  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV-- 131

Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+K  N+L+ +  + K+A+F LAR    Q       + +V T  Y APE L     
Sbjct: 132 -VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSY 186

Query: 522 STKLDVYAFGVLMLEMLSGK 541
           +T +D+++ G +  EM   K
Sbjct: 187 ATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 18/177 (10%)

Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF------- 434
           D   + +LL  + H  +++  G+C +G    +V+E   +G L+ ++   G          
Sbjct: 53  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112

Query: 435 -------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL 487
                  L  +Q + IA  +A+G+ YL S      VH+D+   N L+  +   KI +F +
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGM 169

Query: 488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           +R     +  + +  H +    +M PE +     +T+ DV++FGV++ E+ +  + P
Sbjct: 170 SRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 69/285 (24%), Positives = 109/285 (38%), Gaps = 65/285 (22%)

Query: 362 GSVYRGKI--GGDFVAIK--KVYGDASDQIKL----LNKI-NHSSLIRLLGICF------ 406
           G VY+ +    G  VAIK   +  D  ++IK     L K  NH ++    G         
Sbjct: 20  GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI---QIAL---DVATGLNYLHSFTNP 460
           N    +LV E    GS++  +           +R+    IA    +   GL YLH     
Sbjct: 80  NDDQLWLVMELCGGGSVTDLVK----GLRKKGKRLKEEWIAYILRETLRGLAYLHE---- 131

Query: 461 PHV-HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL--- 516
             V H+DIK  N+LL  +   K+ +F ++   +   G     +  +GT  +MAPE +   
Sbjct: 132 NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR---RNTFIGTPYWMAPEVIACD 188

Query: 517 ENGLVS--TKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNP---VLHKEDGEE 569
           E    S   + DV++ G+  +E+  GK  P L     M  L     NP   +   E+  +
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGK--PPLCDMHPMRALFKIPRNPPPTLKSPENWSK 246

Query: 570 SLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                                    I  CL K+   RP M+++ +
Sbjct: 247 KFND--------------------FISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 55/255 (21%), Positives = 104/255 (40%), Gaps = 45/255 (17%)

Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG--GKFLD--- 436
           D   + +LL  + H  ++R  G+C  G    +V+E   +G L+ ++   G   K L    
Sbjct: 53  DFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGE 112

Query: 437 --------WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                     Q + IA  +A+G+ YL S      VH+D+   N L+      KI +F ++
Sbjct: 113 DVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 169

Query: 489 RPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           R        ++   + VG +      +M PE +     +T+ D+++FGV++ E+ +  + 
Sbjct: 170 RDI------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Query: 544 PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP 603
           P  Y   N   ++ +        G E  R    P             V  +++ C +++P
Sbjct: 224 P-WYQLSNTEAIECIT------QGRELERPRTCPPE-----------VYAIMQGCWQREP 265

Query: 604 SGRPAMDKIAQSISR 618
             R  +  I   +  
Sbjct: 266 QQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 37/160 (23%), Positives = 76/160 (47%), Gaps = 6/160 (3%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
            +  ++  + H  L++L  +       Y++ E    GSL  ++    G      + I  +
Sbjct: 50  AEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 108

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             +A G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+      
Sbjct: 109 AQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGA 163

Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                + APE +  G  + K DV++FG+L++E+++    P
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 28/195 (14%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y V E    G L   I  + GKF +  Q +  A +++ GL +LH       +++D+K  N
Sbjct: 77  YFVMEYVNGGDLMYHIQ-QVGKFKE-PQAVFYAAEISVGLFFLH---RRGIIYRDLKLDN 131

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           V+LD++   KIA+F + +     +G    T    GT  Y+APE +        +D +A+G
Sbjct: 132 VMLDSEGHIKIADFGMCK-EHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYG 188

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           VL+ EML+G+                  P    ED +E  + +M+ ++  +YP   +   
Sbjct: 189 VLLYEMLAGQ------------------PPFDGEDEDELFQSIMEHNV--SYPKSLSKEA 228

Query: 592 IRLIESCLKKDPSGR 606
           + + +  + K PS R
Sbjct: 229 VSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.6 bits (154), Expect = 6e-11
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 33/243 (13%)

Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAIK
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAIDIATGQEVAIK 50

Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 51  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 110

Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L++LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 111 ---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164

Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 165 ITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-EPP--YLNE 218

Query: 551 NML 553
           N L
Sbjct: 219 NPL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 43/270 (15%)

Query: 362 GSVYRGKIG-GDFVAIKKVYGDASDQ-------------IKLLNKINHSSLIRLLGICFN 407
           G+VY G    G  +A+K+V  D S+              + LL  + H ++++ LG C +
Sbjct: 14  GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
                +  E    GS+S  +N + G   +     +    +  G+ YLH   N   VH+DI
Sbjct: 74  DNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLH---NNCVVHRDI 128

Query: 468 KCSNVLLDTDFRAKIANFALARP-----AERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           K +NV+L  +   K+ +F  AR                + H  GT  +MAPE +      
Sbjct: 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH--GTPYWMAPEVINESGYG 186

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            K D+++ G  + EM +GK  P L S      +D L  + +       L   +  S    
Sbjct: 187 RKSDIWSIGCTVFEMATGK--PPLAS------MDRLAAMFYIGAH-RGLMPRLPDSFSAA 237

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
                    I  + SCL +D   RP+  ++
Sbjct: 238 --------AIDFVTSCLTRDQHERPSALQL 259

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 33/243 (13%)

Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51

Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111

Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 112 ---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165

Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 166 ITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 219

Query: 551 NML 553
           N L
Sbjct: 220 NPL 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 46/269 (17%)

Query: 374 VAIKKVY-------GDASDQIKLLNKINHSSLIRLLGICFNGGN--------------WY 412
           VA+KK+          A  +IK++ +++H +++++  +    G+               Y
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V E  +   L+  +    G   +   R+     +  GL Y+HS  N   +H+D+K +NV
Sbjct: 93  IVQE-YMETDLANVLEQ--GPLSEEHARL-FMYQLLRGLKYIHS-ANV--LHRDLKPANV 145

Query: 473 LLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDVYAF 530
            ++T D   KI +F LAR  +         S  + TK Y +P  L +    TK +D++A 
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205

Query: 531 GVLMLEMLSGKE--APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY----- 583
           G +  EML+GK   A A   E+  L+++ + PV+ +ED  E L   + PS   N      
Sbjct: 206 GCIFAEMLTGKPLFAGAHELEQMQLILESV-PVVREEDRNELLN--VIPSFVRNDGGEPR 262

Query: 584 PPVTAIL------VIRLIESCLKKDPSGR 606
            P+  +L       +  +E  L  +P  R
Sbjct: 263 RPLRDLLPGVNPEALDFLEQILTFNPMDR 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 9/155 (5%)

Query: 388 KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALD 446
           ++L K+N S  I  L   F       +  + +NG  L   I + G + L+  + I  +  
Sbjct: 45  EILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ 103

Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G+ +LHS      V++D+K  NVLLD     ++++  LA   E ++G+    +   G
Sbjct: 104 ITCGILHLHSMDI---VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGK--TITQRAG 156

Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T GYMAPE L+    S  +D +A G  + EM++G+
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 24/191 (12%)

Query: 373 FVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
            VA+K +  DASD        + +LL  + H  +++  G+C  G    +V+E   +G L+
Sbjct: 37  LVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 425 VWINDKGGKF-----------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
            ++   G              L  +Q + IA  +A G+ YL S      VH+D+   N L
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCL 152

Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 533
           +  +   KI +F ++R     +  + +  H +    +M PE +     +T+ DV++ GV+
Sbjct: 153 VGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211

Query: 534 MLEMLSGKEAP 544
           + E+ +  + P
Sbjct: 212 LWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 38/242 (15%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQ 439
           D+  ++  ++H  L+RLLG+C +     LV +   +G L  ++++          L+W  
Sbjct: 58  DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC- 115

Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+ YL        VH+D+   NVL+ +    KI +F LAR  E  E E+ 
Sbjct: 116 -----VQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167

Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENMLLVDV 557
                +  K +MA E +     + + DV+++GV + E+++  GK    + + E   + D+
Sbjct: 168 ADGGKMPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL 223

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           L      E GE   +           PP+  I V  ++  C   D   RP   ++A   S
Sbjct: 224 L------EKGERLPQ-----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266

Query: 618 RF 619
           R 
Sbjct: 267 RM 268

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 48/284 (16%)

Query: 362 GSVYRGKIGGD-----FVAIK--KVYGDASDQIK-------LLNKINHSSLIRLLGICFN 407
           GSV  G++  D      VA+K  K+      +I+        +   +H ++++L+G+CF 
Sbjct: 13  GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72

Query: 408 GGNWYLVYENAV------NGSLSVWI----NDKGGKFLDWAQRIQIALDVATGLNYLHSF 457
             +   + +  V      +G L  ++         + L     ++  +D+A G+ YL   
Sbjct: 73  ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--- 129

Query: 458 TNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK-GYMAPEYL 516
           +N   +H+D+   N +L  D    +A+F L++      G++     I      ++A E L
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVKWIAIESL 187

Query: 517 ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD 576
            + + ++K DV+AFGV M E+ +  + P               P +   +  + LRH   
Sbjct: 188 ADRVYTSKSDVWAFGVTMWEIATRGQTPY--------------PGVENHEIYDYLRH--- 230

Query: 577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              +   P      +  L+ SC + DP  RP   K+ + +   L
Sbjct: 231 -GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 40/165 (24%), Positives = 84/165 (50%), Gaps = 11/165 (6%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           +++ ++   +H +++ +      G   ++V E    G+L+  +       ++  Q   + 
Sbjct: 68  NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVC 124

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
           L V   L+YLH   N   +H+DIK  ++LL +D R K+++F       +   E      +
Sbjct: 125 LSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK---EVPKRKSL 178

Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
           VGT  +MAPE +      T++D+++ G++++EM+ G+  P  ++E
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE--PPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 6/95 (6%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++A  L++LHS      +++D+K  N+LLD +   K+ +F L++ +   E +        
Sbjct: 106 ELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFC 159

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  YMAPE +     +   D ++FGVLM EML+G
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 33/243 (13%)

Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L +I  I    K YT +E++ Q A+          G+V+       G  VAIK
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGAS----------GTVFTAIDVATGQEVAIK 50

Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ ++ + +++  L     G   ++V E    GSL+  + + 
Sbjct: 51  QINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET 110

Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D AQ   +  +    L +LH+      +H+DIK  NVLL  D   K+ +F     
Sbjct: 111 ---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164

Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 165 ITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-EPP--YLNE 218

Query: 551 NML 553
           N L
Sbjct: 219 NPL 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 43/250 (17%)

Query: 372 DFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG 421
           + VA+KK+          + D   ++K L ++ H + I   G        +LV E  + G
Sbjct: 47  EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105

Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           S S  + +   K L   +   I      GL YLHS      +H+DIK  N+LL    + K
Sbjct: 106 SASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVK 161

Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEY---LENGLVSTKLDVYAFGVLMLEML 538
           +A+F  A  +       +  +  VGT  +MAPE    ++ G    K+DV++ G+  +E+ 
Sbjct: 162 LADFGSASKS-------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214

Query: 539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESC 598
             K  P L+   NM  +  L  +   +           P++Q N    +       ++ C
Sbjct: 215 ERK--PPLF---NMNAMSALYHIAQND----------SPTLQSNEWTDS---FRGFVDYC 256

Query: 599 LKKDPSGRPA 608
           L+K P  RPA
Sbjct: 257 LQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 32/188 (17%)

Query: 371 GDFVAIKKVY---------GDASDQIKLLNKINHSSLIRLLGI-----CFNG-GNWYLVY 415
           G+ VAIKK+            A  ++ LL  + H ++I LL +       +   ++YLV 
Sbjct: 40  GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
                    +     G    +   ++Q +   +  GL Y+HS      +H+D+K  N+ +
Sbjct: 100 PYMQTDLQKI----MGHPLSE--DKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAV 150

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVL 533
           + D   KI +F LAR A+ +     +T ++V T+ Y APE + N +   + +D+++ G +
Sbjct: 151 NEDCELKILDFGLARHADAE-----MTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCI 204

Query: 534 MLEMLSGK 541
           M EML+GK
Sbjct: 205 MAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 61/247 (24%), Positives = 113/247 (45%), Gaps = 34/247 (13%)

Query: 377 KKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG---- 432
           ++ + + +D +  +  ++H+ ++RLLGIC  G +  LV + +  GSL   +         
Sbjct: 50  RQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP 108

Query: 433 -KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
            + L+W       + +A G+ YL        VH+++   N+LL +D   +IA+F +A   
Sbjct: 109 QRLLNWC------VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159

Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN 551
              + ++  + H    K +MA E +  G  + + DV+++GV + EM+S    P  Y+   
Sbjct: 160 YPDDKKYFYSEHKTPIK-WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP--YA--G 214

Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDK 611
           M   +V  P L  E GE   +           P +  I V  ++  C   D + RP   +
Sbjct: 215 MRPHEV--PDL-LEKGERLAQ-----------PQICTIDVYMVMVKCWMIDENVRPTFKE 260

Query: 612 IAQSISR 618
           +A   +R
Sbjct: 261 LANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 51/252 (20%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI---- 441
           ++K+L++ N   ++   G  ++ G   +  E+   GSL         + L  A RI    
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKKAGRIPENI 100

Query: 442 --QIALDVATGLNYL---HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +I++ V  GL YL   H       +H+D+K SN+L+++    K+ +F ++       G
Sbjct: 101 LGKISIAVLRGLTYLREKHKI-----MHRDVKPSNILVNSRGEIKLCDFGVS-------G 148

Query: 497 EF--ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK---EAPALYSEEN 551
           +   ++ +  VGT+ YM+PE L+    + + D+++ G+ ++EM  G+     P     E 
Sbjct: 149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208

Query: 552 MLLVDVLNPVLHKEDGEESLRHLMD--PSMQ--------GNYPP------VTAILVIRLI 595
           M    V +    KE       H  D    M          N PP        +      +
Sbjct: 209 MFGRPV-SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFV 267

Query: 596 ESCLKKDPSGRP 607
           + CLKK+P  R 
Sbjct: 268 DKCLKKNPKERA 279

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 32/234 (13%)

Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           +  ++ LL K+ H +++         G  ++V E    G L   IN + G      Q + 
Sbjct: 46  SKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS 105

Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR-AKIANFALARPAERQEGEFALT 501
             + ++ GL ++H   +   +H+DIK  N+ L  +   AK+ +F +AR       E A T
Sbjct: 106 WFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYT 161

Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
              VGT  Y++PE  +N   + K D+++ G ++ E+ + K                    
Sbjct: 162 C--VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK-------------------- 199

Query: 562 LHKEDGEESLRHLMDPSMQGNYPPVTAIL---VIRLIESCLKKDPSGRPAMDKI 612
            H  +G  +L  L+    QG + P++      +  LI    K  P  RP++  I
Sbjct: 200 -HPFEG-NNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 73/266 (27%), Positives = 109/266 (40%), Gaps = 45/266 (16%)

Query: 374 VAIKKVYG---------DASDQIKLLNKI-NHSSLIRL--LGICFNGG-NWYLVYENAVN 420
           VAIKK+            A  ++KLL     H ++  L  + I F G  N   +YE  + 
Sbjct: 30  VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME 89

Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
             L   I  + G+ L  A        +  GL Y+HS      +H+D+K  N+L++ D   
Sbjct: 90  ADLHQII--RSGQPLTDAHFQSFIYQILCGLKYIHSANV---LHRDLKPGNLLVNADCEL 144

Query: 481 KIANFALARPAERQEGEFALTSHI---VGTKGYMAPE-YLENGLVSTKLDVYAFGVLMLE 536
           KI +F LAR     E        +   V T+ Y APE  L     +  +DV++ G ++ E
Sbjct: 145 KICDFGLARGF--SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE 202

Query: 537 MLSGKEAPALYSEENMLLVDVLNPVLHK--EDGEESLRHLMDPSMQ------GNYPPV-- 586
           +L  K  P    ++    VD LN +L       EE+L  +  P  Q       N P    
Sbjct: 203 LLGRK--PVFKGKD---YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF 257

Query: 587 ------TAILVIRLIESCLKKDPSGR 606
                    L + L+E  L  DP+ R
Sbjct: 258 ESIFPNANPLALDLLEKLLAFDPTKR 283

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 4/93 (4%)

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS  N   +H+D+K SN+LL+T+   KI +F LAR A+ +       +  V T+ 
Sbjct: 118 GLKYIHS-ANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 510 YMAPE-YLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y APE  L +   +  +D+++ G ++ EMLS +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 35/195 (17%)

Query: 430 KGGKFLDWAQRI-----QIAL---DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           +GG   D   +      QIA     V   L YLHS      +H+DIK  ++LL  D R K
Sbjct: 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVK 157

Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +++F       +   +      +VGT  +MAPE +      T++D+++ G++++EM+ G+
Sbjct: 158 LSDFGFCAQISK---DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Query: 542 EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD--PSMQGNYPPVTAILVIRLIESCL 599
             P  +S+         +PV       ++++ L D  P    N   ++ +L    +E  L
Sbjct: 215 --PPYFSD---------SPV-------QAMKRLRDSPPPKLKNAHKISPVLR-DFLERML 255

Query: 600 KKDPSGRPAMDKIAQ 614
            ++P  R    ++  
Sbjct: 256 TREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 10/139 (7%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++A+ L YLHS      V++D+K  N+LLD+     + +F L +      G    TS 
Sbjct: 102 AAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TST 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD-VLN-PV 561
             GT  Y+APE L        +D +  G ++ EML G   P  YS     + D +LN P+
Sbjct: 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYDNILNKPL 213

Query: 562 LHKEDGEESLRHLMDPSMQ 580
             K +   S RHL++  +Q
Sbjct: 214 QLKPNITNSARHLLEGLLQ 232

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 59/258 (22%), Positives = 114/258 (44%), Gaps = 45/258 (17%)

Query: 368 KIGGDFVAIKKVYGDASDQIK---LLNKI------NHSSLIRLLGICFNGGNWYLVYENA 418
           K  G  VA+KK+  D   Q +   L N++       H +++ +      G   ++V E  
Sbjct: 42  KSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99

Query: 419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF 478
             G+L+  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D 
Sbjct: 100 EGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDG 153

Query: 479 RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML 538
           R K+++F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 154 RVKLSDFGFCAQVSK---EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210

Query: 539 SGKEAPALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            G+  P  ++E  +    ++ D L P L          H + PS++G             
Sbjct: 211 DGE--PPYFNEPPLKAMKMIRDNLPPKLKN-------LHKVSPSLKG------------F 249

Query: 595 IESCLKKDPSGRPAMDKI 612
           ++  L +DP+ R    ++
Sbjct: 250 LDRLLVRDPAQRATAAEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 33/174 (18%)

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
           +IA+ V  GL YL S      +H+D+K SN+L++T  + K+ +F ++          ++ 
Sbjct: 99  RIAVAVVKGLTYLWSLKI---LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-----SIA 150

Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK-EAPALYSEENMLL-VDVLN 559
              VGT  YMAPE +         DV++ G+  +E+  G+   P +   +  L+ + +L 
Sbjct: 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ 210

Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAI-----LVIRLIESCLKKDPSGRPA 608
            ++ ++                  PPV  +       +  I  C++K P  RPA
Sbjct: 211 CIVDED------------------PPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 9/147 (6%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y V E  VNG   ++   + G+F +    +  A ++A GL +LHS      +++D+K  N
Sbjct: 77  YFVME-YVNGGDLMYQIQQVGRFKE-PHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDN 131

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           V+LD++   KIA+F + +       +   T    GT  Y+APE +        +D +AFG
Sbjct: 132 VMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 188

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVL 558
           VL+ EML+G +AP    +E+ L   ++
Sbjct: 189 VLLYEMLAG-QAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.4 bits (147), Expect = 7e-10
 Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 48/284 (16%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDA--SDQIKLLNK-------INHSSLIRLLGICFNGGNW- 411
             + + K     VA+KK+  D+   + +KLL +       + H +++  +   F   +  
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT-SFIVDSEL 74

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIK 468
           Y+V      GS    +      F +    + IA    DV   L+Y+HS      +H+ +K
Sbjct: 75  YVVSPLMAYGSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVK 128

Query: 469 CSNVLLDTDFRAKIANFALARP----AERQEGEFALTSHIVGTKGYMAPEYLENGL--VS 522
            S++LL  D +  ++    +       +RQ          V    +++PE L+  L   +
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN 188

Query: 523 TKLDVYAFGVLMLEMLSG----KEAPALYSEENMLLVDVLNPV----------LHKEDGE 568
            K D+Y+ G+   E+ +G    K+ PA      MLL  V   V          L+++   
Sbjct: 189 EKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGTVPCLLDKSTYPLYEDSMS 244

Query: 569 ESLRHLMDPSMQGNYP-PVTAIL---VIRLIESCLKKDPSGRPA 608
           +S      P+ + +   P T        + +E CL++DP  RP+
Sbjct: 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.5 bits (147), Expect = 7e-10
 Identities = 81/278 (29%), Positives = 125/278 (44%), Gaps = 67/278 (24%)

Query: 371 GDFVAIKKVYGDASD----------QIKLLNKINHSSLIRLLGIC-------FNGGNWYL 413
            + VAIKK+  +A D          +IKLL  ++H ++I +  I        FN  + Y+
Sbjct: 30  NEKVAIKKI-ANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN--DVYI 86

Query: 414 VYE------NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
           VYE      + +  S     +D    FL    R         GL Y+HS  N   +H+D+
Sbjct: 87  VYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR---------GLKYIHS-ANV--LHRDL 134

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLD 526
           K SN+LL+ +   KI +F LAR    ++G+F +T ++V T+ Y APE L N    +T +D
Sbjct: 135 KPSNLLLNANCDLKICDFGLARTTS-EKGDF-MTEYVV-TRWYRAPELLLNCSEYTTAID 191

Query: 527 VYAFGVLMLEMLS------GKEAPALYSEENMLLVDVLNP-------VLHKEDGEESLRH 573
           V++ G +  E+L       GK+    Y  +  L+ ++L          +  E     +R 
Sbjct: 192 VWSVGCIFAELLGRKPLFPGKD----YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247

Query: 574 LMDP-----SMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           L  P     S    +P     L I L+E  L  DPS R
Sbjct: 248 L--PYTPRQSFARLFPHANP-LAIDLLEKMLVFDPSKR 282

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 31/197 (15%)

Query: 363 SVYRG--KIGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWY 412
           +VY+G  +  G+ VA+K+++ DA +        +I L+ ++ H +++RL  +        
Sbjct: 15  TVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM 74

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH------SFTNPPHV-HK 465
           LV+E  ++  L  +++  G         ++ ALD  T  ++ +      +F +   V H+
Sbjct: 75  LVFE-YMDKDLKKYMDTHG---------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STK 524
           D+K  N+L++     K+A+F LAR        F   S+ V T  Y AP+ L      ST 
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 525 LDVYAFGVLMLEMLSGK 541
           +D+++ G +M EM++G+
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 13/125 (10%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++   LN+LH       +++D+K  NVLLD D   K+ ++ + +      G+   TS 
Sbjct: 102 AAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGD--TTST 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK-------EAPALYSEENMLLVD 556
             GT  Y+APE L        +D +A GVLM EM++G+       + P + +E+ +  V 
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215

Query: 557 VLNPV 561
           +  P+
Sbjct: 216 LEKPI 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 10/193 (5%)

Query: 376 IKKVYGD--ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK 433
           IKK  G+  A ++ ++L K+N   ++ L           LV      G L   I + G  
Sbjct: 38  IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP 97

Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER 493
             +  + +  A ++  GL  LH       V++D+K  N+LLD     +I++  LA   + 
Sbjct: 98  GFEEERALFYAAEILCGLEDLHRENT---VYRDLKPENILLDDYGHIRISDLGLA--VKI 152

Query: 494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
            EGE       VGT GYMAPE L N   +   D +  G L+ EM+ G ++P    +E + 
Sbjct: 153 PEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG-QSPFRGRKEKVK 209

Query: 554 LVDVLNPVLHKED 566
             +V   VL  E+
Sbjct: 210 REEVDRRVLETEE 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 33/207 (15%)

Query: 362 GSVYRGKI------GGDFVAIKKV--------YGDASDQIKLLNKINHSSLIRLLGICFN 407
           G +Y+G +          VAIK +        +G+   +  L+ +++H +++ LLG+   
Sbjct: 19  GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78

Query: 408 GGNWYLVYENAVNGSLSVWI------------NDKGGKF---LDWAQRIQIALDVATGLN 452
                +++E    G L  ++            +D+ G     LD    + IA+ +A G+ 
Sbjct: 79  EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138

Query: 453 YLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA 512
           YL S      VHKD+   N+L+      KI++  L+R     +  + +    +    +M 
Sbjct: 139 YLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YYRVQPKSLLPIRWMP 194

Query: 513 PEYLENGLVSTKLDVYAFGVLMLEMLS 539
           PE +  G  S+  D+++FGV++ E+ S
Sbjct: 195 PEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 5/96 (5%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L+YLHS  N   V++D+K  N++LD D   KI +F L +   +   + A      
Sbjct: 103 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKTFC 157

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           GT  Y+APE LE+      +D +  GV+M EM+ G+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L+ L   CF   +        VNG   ++   +  K  +   R   A +++  LNY
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 111

Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
           LH       +++D+K  NVLLD++   K+ ++ + +   R  G+   TS   GT  Y+AP
Sbjct: 112 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGD--TTSTFCGTPNYIAP 165

Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L        +D +A GVLM EM++G+    +    +       NP    ++ E+ L  
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD-------NP---DQNTEDYLFQ 215

Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           ++    Q   P   ++    +++S L KDP  R
Sbjct: 216 VI-LEKQIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 57/274 (20%), Positives = 120/274 (43%), Gaps = 46/274 (16%)

Query: 363 SVYRGKIGGDFVAIK---------KVYGDASD-QIKLLNKINHSSLIRLLG----ICFNG 408
           S+Y+G      V I+         KV  D ++ +IK L +I+ ++++++ G    I  + 
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
               L+ E    G L   ++ +  K L +  ++ +A+D   GL  L+ +TN P+ +  + 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN--LT 150

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLD 526
             + L+  +++ KI    L +               V    Y + + L +     + K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDD 204

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +Y+ GV++ E+ +GK  P     EN+   ++ + +++K +                  P+
Sbjct: 205 IYSLGVVLWEIFTGK-IPF----ENLTTKEIYDLIINKNNSL--------------KLPL 245

Query: 587 TAILVIR-LIESCLKKDPSGRPAMDKIAQSISRF 619
              L I+ ++E+C   D   RP + +I  ++S +
Sbjct: 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279

Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 75/274 (27%), Positives = 118/274 (43%), Gaps = 53/274 (19%)

Query: 371 GDFVAIKK---VYGDASD------QIKLLNKINHSSLIRLLGIC-------FNGGNWYLV 414
           G+ VAIKK   V+   SD      +IKLL  + H  ++ +  I        F   + Y+V
Sbjct: 25  GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK--DIYVV 82

Query: 415 YENAVNGSLSVWI--NDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSN 471
           +E  +   L   I  ND         +  Q  L  +   L Y+H+       H+D+K  N
Sbjct: 83  FE-LMESDLHQVIKANDDLTP-----EHHQFFLYQLLRALKYIHTANV---FHRDLKPKN 133

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN--GLVSTKLDVYA 529
           +L + D + KI +F LAR A          +  V T+ Y APE   +     +  +D+++
Sbjct: 134 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 193

Query: 530 FGVLMLEMLSGKEAPALYSEENM-----LLVDVL-NPVLHKEDG---EESLRHLMDPSMQ 580
            G +  E+L+GK    L+  +N+     L+ D+L  P          E++ R+L   SM+
Sbjct: 194 IGCIFAEVLTGK---PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS--SMR 248

Query: 581 GNYP-------PVTAILVIRLIESCLKKDPSGRP 607
              P       P    L +RL+E  L  DP  RP
Sbjct: 249 KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 56/234 (23%), Positives = 105/234 (44%), Gaps = 28/234 (11%)

Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND--KGGKFLDWAQR 440
           A+ + +LL+K++H ++++          + ++ E      L   + +    GK L   Q 
Sbjct: 49  ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV 108

Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
            +  + +  G++Y+H       +H+D+K  N+ L  +   KI +F ++R      G   L
Sbjct: 109 CEWFIQLLLGVHYMHQRRI---LHRDLKAKNIFLKNNL-LKIGDFGVSR---LLMGSCDL 161

Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP 560
            +   GT  YM+PE L++    +K D+++ G ++ EM     A   +  +N L V     
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA---FEGQNFLSV----- 213

Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           VL   +G         PS+   Y          +++S L KDPS RP+  +I +
Sbjct: 214 VLRIVEGPT-------PSLPETYSRQLNS----IMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 6/96 (6%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +         A      
Sbjct: 103 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFC 156

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           GT  Y+APE LE+      +D +  GV+M EM+ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNG-- 408
           G VYR      G+ VA+KKV  D            +I LL  + H +++ L  +      
Sbjct: 21  GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH-SFTNPPHVHKDI 467
            + +LV E      L+  +++    F + +Q   + L +  GL YLH +F     +H+D+
Sbjct: 81  DSIFLVMEYC-EQDLASLLDNMPTPFSE-SQVKCLMLQLLRGLQYLHENFI----IHRDL 134

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LD 526
           K SN+LL      KIA+F LAR          +T  +V T  Y APE L      T  +D
Sbjct: 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVV-TLWYRAPELLLGCTTYTTAID 191

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENML--LVDVL 558
           ++A G ++ E+L+ K      SE   L  ++ +L
Sbjct: 192 MWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 24/193 (12%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           G V+  R +  G  VAIKK      D         +I++L ++ H +L+ L+ +      
Sbjct: 15  GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            +LV+E   +  L+    +K  + +      +I       +N+ H      H  +H+D+K
Sbjct: 75  LHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHK-----HNCIHRDVK 127

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDV 527
             N+L+    + K+ +F  AR       ++   +  V T+ Y APE L         +DV
Sbjct: 128 PENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAPELLVGDTQYGPPVDV 184

Query: 528 YAFGVLMLEMLSG 540
           +A G +  E+L+G
Sbjct: 185 WAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 65/290 (22%)

Query: 362 GSVYRG---------KIGGDFVAIK--------KVYGDASDQIKLLNKINHSSLIRLLGI 404
           G+VY+G         KI    VAIK        K   +  D+  ++  +++  + RLLGI
Sbjct: 21  GTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 77

Query: 405 CFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQRIQIALDVATGLNYLHSFTN 459
           C       L+ +    G L  ++ +     G ++L +W  +I      A G+NYL     
Sbjct: 78  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE---E 127

Query: 460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
              VH+D+   NVL+ T    KI +F LA+     E E+      V  K +MA E + + 
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-WMALESILHR 186

Query: 520 LVSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP 577
           + + + DV+++GV + E+++    P   + + E   +  +L      E GE   +     
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL------EKGERLPQ----- 232

Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRP-------AMDKIAQSISRFL 620
                 PP+  I V  ++  C   D   RP          K+A+   R+L
Sbjct: 233 ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 31/234 (13%)

Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D+  +  LL K+ H +++         G+ Y+V E    G L   I  + GK       +
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
           Q  + +  G+ ++H       +H+DIK  N+ L  + + K+ +F  AR      G +A T
Sbjct: 104 QWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACT 159

Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
              VGT  Y+ PE  EN   + K D+++ G ++ E+ + K      S +N++L       
Sbjct: 160 --YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------- 210

Query: 562 LHKEDGEESLRHLMDPSMQGNYPPVTAILVIR---LIESCLKKDPSGRPAMDKI 612
                             QG+Y P+ +        LI+   K++P  RP+   I
Sbjct: 211 ---------------KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 43/194 (22%)

Query: 371 GDFVAIKKVY---------GDASDQIKLLNKINHSSLIRLLGIC--------FNGGNWYL 413
           G  VAIKK+Y           A  +++LL  + H ++I LL +         F+  ++YL
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH--DFYL 97

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQ----RIQ-IALDVATGLNYLHSFTNPPHVHKDIK 468
           V           ++    GK +   +    RIQ +   +  GL Y+H+      +H+D+K
Sbjct: 98  VMP---------FMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLK 145

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDV 527
             N+ ++ D   KI +F LAR  + +     +T ++V T+ Y APE + N +  T+ +D+
Sbjct: 146 PGNLAVNEDCELKILDFGLARQTDSE-----MTGYVV-TRWYRAPEVILNWMHYTQTVDI 199

Query: 528 YAFGVLMLEMLSGK 541
           ++ G +M EML+GK
Sbjct: 200 WSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 24/163 (14%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++   L +LH       V++DIK  N+LLD++    + +F L++    +E E   T    
Sbjct: 113 EIILALEHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFC 167

Query: 506 GTKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
           GT  YMAPE +       K +D ++ G+L+ E+L+G     L  E N             
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN------------- 214

Query: 565 EDGEESLRHL-MDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
              E S R L  DP     +P         L+   L+KDP  R
Sbjct: 215 TQSEVSRRILKCDPP----FPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/238 (23%), Positives = 111/238 (46%), Gaps = 37/238 (15%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI---- 441
           ++++L++ N   ++   G  ++ G   +  E+   GSL         + L  A+RI    
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKEAKRIPEEI 104

Query: 442 --QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF- 498
             ++++ V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+  
Sbjct: 105 LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLI 155

Query: 499 -ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
            ++ +  VGT+ YM+PE L+    S + D+++ G+ ++E+  G+  P    +   L    
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR-YPIPPPDAKELEAIF 214

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVT--------AILVIRLIESCLKKDPSGRP 607
             PV+   DGEE   H + P  +    PV+        A+ +  L++  + + P   P
Sbjct: 215 GRPVV---DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 6/98 (6%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           + +++  LN+LH       +++D+K  NVLLD +   K+ ++ + +   R  G+   TS 
Sbjct: 102 SAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGD--TTST 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
             GT  Y+APE L        +D +A GVLM EM++G+
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L YLHS      V++D+K  N++LD D   KI +F L +     +G  A      
Sbjct: 103 EIVSALGYLHSCDV---VYRDLKLENLMLDKDGHIKITDFGLCK-EGISDG--ATMKTFC 156

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           GT  Y+APE LE+      +D +  GV+M EM+ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 45/207 (21%)

Query: 365 YRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
             G  G  F  ++        ++K++N+I H +++ L+ +   G    LV +  +   L 
Sbjct: 57  LVGMCGIHFTTLR--------ELKIMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLK 107

Query: 425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
             ++ K    L  +Q   I L +  GLN LH +     +H+D+  +N+ +++    KIA+
Sbjct: 108 KVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIAD 162

Query: 485 FALAR----------------PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK---- 524
           F LAR                   R+E    +TS +V T  Y APE L   + + K    
Sbjct: 163 FGLARRYGYPPYSDTLSKDETMQRREE----MTSKVV-TLWYRAPELL---MGAEKYHFA 214

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN 551
           +D+++ G +  E+L+GK    L+  EN
Sbjct: 215 VDMWSVGCIFAELLTGK---PLFPGEN 238

Length = 335

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 10/93 (10%)

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +     +T + V T+ 
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGY-VATRW 180

Query: 510 YMAPEYLENGLVSTKL-DVYAFGVLMLEMLSGK 541
           Y APE + N +   +  D+++ G +M E+L+GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 20/158 (12%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L+YLHS      V++D+K  N++LD D   KI +F L +     EG  + A    
Sbjct: 103 EIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKT 154

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN------MLLVDV 557
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++      +L+ D+
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL--PFYNQDHEKLFELILMEDI 212

Query: 558 LNPVLHKEDGEESLRHLM--DPSMQGNYPPVTAILVIR 593
             P     D +  L  L+  DP+ +    P  A  ++R
Sbjct: 213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 8/94 (8%)

Query: 450 GLNYLHSFTNPPHV-HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
           GL YLHS      + H+DIK  N+L++++   KI +F LAR  E  E +  +T  +V T+
Sbjct: 115 GLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVV-TQ 168

Query: 509 GYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            Y APE L      ++ +D+++ G +  E+L  +
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 30/170 (17%)

Query: 442 QIA---LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
           QIA   L V   L++LH+      +H+DIK  ++LL +D R K+++F     A+  + E 
Sbjct: 116 QIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSK-EV 169

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL 558
                +VGT  +MAPE +      T++D+++ G++++EM+ G+  P  ++E         
Sbjct: 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE--PPYFNEP-------- 219

Query: 559 NPVLHKEDGEESLRHLMD--PSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
            P+       ++++ + D  P    N   V+  L    ++  L +DP+ R
Sbjct: 220 -PL-------QAMKRIRDNLPPKLKNLHKVSPRLR-SFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 46/194 (23%), Positives = 89/194 (45%), Gaps = 29/194 (14%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY  + K  G F A K +  ++ ++       I +L++  H +++ L    F     +
Sbjct: 19  GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCS 470
           ++ E    G+L   I  +  + L   Q   +   +   LN+LHS     H  +H+D+K  
Sbjct: 79  ILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS-----HKVIHRDLKAG 132

Query: 471 NVLLDTDFRAKIANFALA--RPAERQEGEFALTSHIVGTKGYMAPEYL-----ENGLVST 523
           N+LL  D   K+A+F ++    +  Q+         +GT  +MAPE +     ++     
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQK-----RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 524 KLDVYAFGVLMLEM 537
           K D+++ G+ ++E+
Sbjct: 188 KADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 23/175 (13%)

Query: 376 IKKVYGDAS--DQIKLLNKINHSSLIRLL-------GICFNGGNWYLVYENAVNGSLSVW 426
           IKK  G+A   ++ ++L K+N   ++ L         +C       LV      G L   
Sbjct: 38  IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC-------LVLTLMNGGDLKFH 90

Query: 427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA 486
           I + G    D  + +  A ++  GL  LH       V++D+K  N+LLD     +I++  
Sbjct: 91  IYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLG 147

Query: 487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           LA   E  EGE       VGT GYMAPE ++N   +   D +  G L+ EM+ GK
Sbjct: 148 LA--VEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 24/171 (14%)

Query: 439 QRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE 497
           Q +QI   ++   L +LH       +++DIK  N+LLD++    + +F L++     E E
Sbjct: 105 QEVQIYSGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161

Query: 498 FALTSHIVGTKGYMAPEYLENGLV--STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV 555
            A +    GT  YMAP+ +  G       +D ++ GVLM E+L+G     +  E+N    
Sbjct: 162 RAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--- 216

Query: 556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                    E     L+   +P     YP   + L   +I+  L KDP  R
Sbjct: 217 -------QAEISRRILKS--EPP----YPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 40/203 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGN 410
           G VY+G  K  G  VA+KK+  ++ +         +I LL ++ H +++ L  +      
Sbjct: 14  GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR 73

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP---H----V 463
            YL++E      LS+ +     K+LD   + Q  +D     +YL+         H    +
Sbjct: 74  LYLIFE-----FLSMDLK----KYLDSLPKGQ-YMDAELVKSYLYQILQGILFCHSRRVL 123

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYLENG 519
           H+D+K  N+L+D     K+A+F LAR        F +     +H V T  Y APE L   
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR-------AFGIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 520 -LVSTKLDVYAFGVLMLEMLSGK 541
              ST +D+++ G +  EM + K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 9/154 (5%)

Query: 388 KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++L + NH  +++L     +    Y++ E  + G L   + D+G  F ++  R  IA  V
Sbjct: 45  EILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIAC-V 102

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
                YLH   N   +++D+K  N+LLD++   K+ +F  A+  +   G+   T    GT
Sbjct: 103 VLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWT--FCGT 155

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
             Y+APE + N      +D ++ G+L+ E+L+G+
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 61/200 (30%)

Query: 374 VAIKKVY---------GDASDQIKLLNKINHSSLIRLLGICFNG-------GNWYLVYEN 417
           VAIKK+            A  ++ L+  +NH ++I LL   F          + YLV E 
Sbjct: 44  VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVME- 101

Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALD----------VATGLNYLHSFTNPPHVHKDI 467
            ++ +L               Q IQ+ LD          +  G+ +LHS      +H+D+
Sbjct: 102 LMDANL--------------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 144

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE------YLENGLV 521
           K SN+++ +D   KI +F LAR A      F +T ++V T+ Y APE      Y EN   
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVV-TRYYRAPEVILGMGYKEN--- 197

Query: 522 STKLDVYAFGVLMLEMLSGK 541
              +D+++ G +M EM+ G 
Sbjct: 198 ---VDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 27/174 (15%)

Query: 388 KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI-------NDKGGKFLDWAQR 440
           K+LN INH   + L G   +    YLV E  + G    ++       ND G     +A +
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG---CFYAAQ 139

Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           I +  +    LN          V++D+K  N+LLD D   K+ +F  A+  + +      
Sbjct: 140 IVLIFEYLQSLNI---------VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------ 184

Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
           T  + GT  Y+APE L N       D +  G+ + E+L G   P  Y+ E +L+
Sbjct: 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG--CPPFYANEPLLI 236

Length = 340

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 9/168 (5%)

Query: 376 IKKVYGD--ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK 433
           IKK  G+  A ++ ++L K+N   ++ L           LV      G L   I   G  
Sbjct: 38  IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA 97

Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER 493
             +  + +  A ++  GL  LH       V++D+K  N+LLD     +I++  LA     
Sbjct: 98  GFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA--VHV 152

Query: 494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            EG+       VGT GYMAPE ++N   +   D +A G L+ EM++G+
Sbjct: 153 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 9/151 (5%)

Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           LL  +NH S+IR+     +G    +V  +  +  L  ++  +    L   Q + I   + 
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRP-LPIDQALIIEKQIL 167

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            GL YLH+      +H+D+K  N+ ++   +  I +   A+          L     GT 
Sbjct: 168 EGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTV 220

Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
              APE L     ++K D+++ G+++ EML+
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 48/194 (24%), Positives = 89/194 (45%), Gaps = 35/194 (18%)

Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD    ++ +  VA G+++L S      +H+D+   NVLL     AKI +F LAR     
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 495 EGEFALTSHIVGTKG-------YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
                 ++++V  KG       +MAPE + + + + + DV+++G+L+ E+ S  ++P  Y
Sbjct: 266 ------SNYVV--KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--Y 315

Query: 548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
                +LV+                 ++    Q + P      +  +++ C   +P+ RP
Sbjct: 316 PG---ILVN------------SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360

Query: 608 AMDKIAQSISRFLN 621
              +I+Q I R L 
Sbjct: 361 TFSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 15/162 (9%)

Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +L +++H  ++ ++    +    Y + E  V G L   +  K G+F +   +   A ++ 
Sbjct: 71  ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHA-ELV 128

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA-RPAERQEGEFALTSHIVGT 507
               YLHS      +++D+K  N+LLD     K+ +F  A +  +R       T  + GT
Sbjct: 129 LAFEYLHSKDI---IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-------TFTLCGT 178

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
             Y+APE +++      +D +  GVL+ E ++G   P  + +
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY--PPFFDD 218

Length = 329

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 24/177 (13%)

Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
             F +   R+ IA ++   L++LH       +++DIK  N+LLD++    + +F L++  
Sbjct: 100 EHFTESEVRVYIA-EIVLALDHLHQLGI---IYRDIKLENILLDSEGHVVLTDFGLSKEF 155

Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLV--STKLDVYAFGVLMLEMLSGKEAPALYSE 549
             +E E A +    GT  YMAPE +  G       +D ++ GVL  E+L+G     +  E
Sbjct: 156 LAEEEERAYS--FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213

Query: 550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           +N                E S R L        +P   +      I+  L+KDP  R
Sbjct: 214 QN-------------SQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.2 bits (138), Expect = 9e-09
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 31/200 (15%)

Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
           +   + L     I  +  VA G+ +L S      +H+D+   N+LL  +   KI +F LA
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLA 220

Query: 489 R-----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           R     P   ++G+  L         +MAPE + + + +T+ DV++FGVL+ E+ S   +
Sbjct: 221 RDIYKDPDYVRKGDARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 274

Query: 544 PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP 603
           P  Y    +               EE  R L + +     P      +  ++  C   +P
Sbjct: 275 P--YPGVQI--------------DEEFCRRLKEGTRMRA-PEYATPEIYSIMLDCWHNNP 317

Query: 604 SGRPAMDKIAQSISRFLNAS 623
             RP   ++ + +   L  +
Sbjct: 318 EDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 14/197 (7%)

Query: 376 IKKVYGD--ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG-SLSVWINDKGG 432
           IKK  G+  A ++ ++L K+N S  +  L   +   +   +    +NG  L   I + G 
Sbjct: 38  IKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN 96

Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
              D  + I  A ++  GL  L        V++D+K  N+LLD     +I++  LA   +
Sbjct: 97  PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA--VQ 151

Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
             EGE       VGT GYMAPE + N   +   D +  G L+ EM+ G ++P    +E +
Sbjct: 152 IPEGETVRGR--VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG-QSPFRKRKERV 208

Query: 553 LLVDVLNPVLHKEDGEE 569
              +V   V  KED EE
Sbjct: 209 KREEVDRRV--KEDQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 31/196 (15%)

Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR--- 489
           K L     I  +  VA G+ +L S      +H+D+   N+LL  +   KI +F LAR   
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 490 --PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
             P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P   
Sbjct: 231 KDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 282

Query: 548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
                       P +  +  EE  R L + + +   P  T   + + +  C   +PS RP
Sbjct: 283 ------------PGVKID--EEFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRP 327

Query: 608 AMDKIAQSISRFLNAS 623
              ++ + +   L A+
Sbjct: 328 TFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 11/121 (9%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A +VA+ + YLHS      +++D+K  N+LLD+     + +F L +     E     TS 
Sbjct: 102 AAEVASAIGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TST 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE L        +D +  G ++ EML G   P  YS +   + D    +LH
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG--LPPFYSRDVSQMYD---NILH 210

Query: 564 K 564
           K
Sbjct: 211 K 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 46/170 (27%), Positives = 67/170 (39%), Gaps = 37/170 (21%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YLV E    G L   +  K     + A R  IA ++   L+ +H       +H+DIK  N
Sbjct: 77  YLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIA-ELVLALDSVHKLG---FIHRDIKPDN 131

Query: 472 VLLDTDFRAKIANFALA----------------------------RPAERQEGEFALTSH 503
           +L+D D   K+A+F L                             R   +Q    A +  
Sbjct: 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS-- 189

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
            VGT  Y+APE L       + D ++ GV++ EML G   P  YS+    
Sbjct: 190 TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG--FPPFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 32/243 (13%)

Query: 378 KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN--DKGGKFL 435
           K   D   +I LL ++NH ++I+ L          +V E A  G LS  I    K  + +
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103

Query: 436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
                 +  + + + + ++HS      +H+DIK +NV +      K+ +  L R      
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFS--- 157

Query: 496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV 555
            +      +VGT  YM+PE +     + K D+++ G L+ EM +  ++P  Y ++  L  
Sbjct: 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSP-FYGDKMNLF- 214

Query: 556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT----AILVIRLIESCLKKDPSGRPAMDK 611
                         SL   ++   Q +YPP+     +  +  L+  C+  DP  RP +  
Sbjct: 215 --------------SLCQKIE---QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGY 257

Query: 612 IAQ 614
           + Q
Sbjct: 258 VHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 35/191 (18%)

Query: 374 VAIKKVYGDASD----------QIKLLNKINHSSLIRLLGICF----NGGNWYLVYENAV 419
           VAIKK+   A D          ++K+L    H ++I +  I      +  + Y+V +  +
Sbjct: 33  VAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD-LM 90

Query: 420 NGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              L   I+       +  +    Q+      GL Y+HS      +H+D+K SN+L++ D
Sbjct: 91  ESDLHHIIHSDQPLTEEHIRYFLYQLL----RGLKYIHSANV---IHRDLKPSNLLVNED 143

Query: 478 FRAKIANFALARPA--ERQEGEFALTSHIVGTKGYMAPEYLENGLV----STKLDVYAFG 531
              +I +F +AR       E ++ +T + V T+ Y APE L   L     +T +D+++ G
Sbjct: 144 CELRIGDFGMARGLSSSPTEHKYFMTEY-VATRWYRAPELL---LSLPEYTTAIDMWSVG 199

Query: 532 VLMLEMLSGKE 542
            +  EML  ++
Sbjct: 200 CIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 39/160 (24%), Positives = 85/160 (53%), Gaps = 17/160 (10%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QI 443
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +  K G+     ++I  ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRI---PEQILGKV 108

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALT 501
           ++ V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ 
Sbjct: 109 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMA 159

Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +  VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 20/165 (12%)

Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGG-------NWYLVYENAVNGSLSVWINDKGGKFL 435
           A  ++ LL  +NH ++I LL + F          + YLV E  ++ +L   I+ +    L
Sbjct: 67  AYRELVLLKCVNHKNIISLLNV-FTPQKSLEEFQDVYLVME-LMDANLCQVIHME----L 120

Query: 436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
           D  +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A    
Sbjct: 121 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN- 176

Query: 496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             F +T ++V T+ Y APE +        +D+++ G +M E++ G
Sbjct: 177 --FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 58/186 (31%), Positives = 88/186 (47%), Gaps = 17/186 (9%)

Query: 399 IRLLGICFNGGNW-YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSF 457
           I  L   F   N+ YLV +  V G L   ++    KF D          +A  +  +HS 
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLS----KFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 458 TNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL- 516
               +VH+DIK  NVLLD +   ++A+F        Q+G    +S  VGT  Y++PE L 
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM-NQDGTVQ-SSVAVGTPDYISPEILQ 176

Query: 517 --ENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR 572
             E+G+     + D ++ GV M EML G E P  Y+E    LV+    +++ E+  +   
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG-ETP-FYAES---LVETYGKIMNHEERFQFPS 231

Query: 573 HLMDPS 578
           H+ D S
Sbjct: 232 HITDVS 237

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 27/223 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLL--------NKINHSSLIRLLGICFNGGNWYL 413
           G  +RG +    V +K++   A+   +LL         ++NH ++++ LG C     + L
Sbjct: 14  GEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLL 72

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQR---IQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
           V E    G L  ++    G     AQ+    ++A +VA+GL +LH       +H D+   
Sbjct: 73  VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALR 129

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE----NGLV---ST 523
           N  L  D   KI ++ LA     ++       H V  + ++APE +E    + L    + 
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLPKDQTK 188

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           K ++++ GV M E+ +  + P  Y + +     VL  V+ ++D
Sbjct: 189 KSNIWSLGVTMWELFTAADQP--YPDLSDE--QVLKQVVREQD 227

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 47/193 (24%), Positives = 94/193 (48%), Gaps = 13/193 (6%)

Query: 360 IKGSVYRGKIGGDFVAIK--KVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNW 411
           +K  VY+ +     VAIK  K   + S       + ++++++++  ++R++G+C      
Sbjct: 11  VKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEAL 69

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV E A  G L+ +++ K  + +  +  +++   V+ G+ YL        VH+D+   N
Sbjct: 70  MLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARN 125

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           VLL     AKI++F L++     +  +   S       + APE +     S++ DV+++G
Sbjct: 126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 185

Query: 532 VLMLEMLSGKEAP 544
           + M E  S  + P
Sbjct: 186 ITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 44/262 (16%)

Query: 364 VYRGK--IGGDFVAIKKVY----------GDASDQIKLLNKINHSSLIRLLGICFNGGNW 411
           VYR    + G  VA+KKV            D   +I LL ++NH ++I+           
Sbjct: 18  VYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77

Query: 412 YLVYENAVNGSLSVWIN--DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
            +V E A  G LS  I    K  + +      +  + + + L ++HS      +H+DIK 
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV---MHRDIKP 134

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           +NV +      K+ +  L R    +         +VGT  YM+PE +     + K D+++
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT-- 587
            G L+ EM +  ++P  Y        D +N           L  L     Q +YPP+   
Sbjct: 192 LGCLLYEM-AALQSP-FYG-------DKMN-----------LYSLCKKIEQCDYPPLPSD 231

Query: 588 --AILVIRLIESCLKKDPSGRP 607
             +  + +L+  C+  DP  RP
Sbjct: 232 HYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 34/200 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G VY+   ++  + +A+KK+  +  D+         I LL ++ H +++RL  +  +   
Sbjct: 16  GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPH--VHKDI 467
            YLV+E  ++  L   + D    F    + I+  L  +  G+ Y HS     H  +H+D+
Sbjct: 76  LYLVFE-YLDLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHS-----HRVLHRDL 128

Query: 468 KCSNVLLDTDFRA-KIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYLENGL-V 521
           K  N+L+D    A K+A+F LAR        F +     +H V T  Y APE L      
Sbjct: 129 KPQNLLIDRRTNALKLADFGLARA-------FGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ K
Sbjct: 182 STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           + +GL +LH       +++D+K  NVLLD D   +I++  LA   E ++G+ + T    G
Sbjct: 106 IISGLEHLHQRRI---IYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQ-SKTKGYAG 159

Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T G+MAPE L+       +D +A GV + EM++ +
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 10/93 (10%)

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      VH+D+K SN+L++ +   KI +F LAR  + Q     +T + V T+ 
Sbjct: 120 GLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGY-VSTRY 170

Query: 510 YMAPE-YLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y APE  L       ++D+++ G +  EML GK
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 34/208 (16%)

Query: 362 GSVYRGK--IGGDFVAIK--KVYGDASDQIKL----LNKINHSSLIRLLGICF------- 406
           G VY+G+    G   AIK   V  D  ++IKL    L K +H   I      F       
Sbjct: 30  GQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFL--DWAQRIQIALDVATGLNYLHSFTNPPHV- 463
           +    +LV E    GS++  + +  G  L  DW     I  ++  GL +LH+      V 
Sbjct: 90  HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH----KVI 143

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---EN-- 518
           H+DIK  NVLL  +   K+ +F ++   +R  G     +  +GT  +MAPE +   EN  
Sbjct: 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPD 200

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPAL 546
                + D+++ G+  +EM  G  AP L
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEG--APPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 27/199 (13%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICFN 407
           G+VY  R    G FVA+K V    ++             +K L   +H +++RL+ +C  
Sbjct: 14  GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73

Query: 408 G-----GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                     LV+E+ V+  L  +++      L       +      GL++LH   N   
Sbjct: 74  SRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCI- 129

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           VH+D+K  N+L+ +  + K+A+F LAR    Q    ALT  +V T  Y APE L     +
Sbjct: 130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVV-TLWYRAPEVLLQSTYA 185

Query: 523 TKLDVYAFGVLMLEMLSGK 541
           T +D+++ G +  EM   K
Sbjct: 186 TPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 48/276 (17%)

Query: 362 GSVYRGKIGGDF------VAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGICFN 407
           G+VY+G    D       VAIK +  + S        D+  ++  +    + RLLGIC  
Sbjct: 21  GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                LV +    G L  ++ +   +      L+W  +I      A G++YL        
Sbjct: 81  S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEEVR---L 130

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           VH+D+   NVL+ +    KI +F LAR  +  E E+      V  K +MA E + +   +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILHRRFT 189

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + DV+++GV + E+++    P                  +       +  L++   +  
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKP------------------YDGIPAREIPDLLEKGERLP 231

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
            PP+  I V  ++  C   D   RP   ++    SR
Sbjct: 232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 9/130 (6%)

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YLV +    G L  W   K G+F +   +  IA ++   L +LH +     V++D+K  N
Sbjct: 72  YLVTDYMSGGEL-FWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYDI---VYRDLKPEN 126

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDVYAF 530
           +LLD      + +F L++           T+   GT  Y+APE L +    TK +D ++ 
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183

Query: 531 GVLMLEMLSG 540
           GVL+ EM  G
Sbjct: 184 GVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 51/217 (23%)

Query: 362 GSVYRG--KIGGDFVAIKKV-YGDASD--------QIKLLNKINHSSLIRLL-------- 402
           G VY+      G  VA+KK+   +  D        +IK+L K+ H +++ L+        
Sbjct: 22  GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81

Query: 403 GICFNGGNWYLVY---ENAVNGSL---SVWINDKGGKFLDWAQRIQIALDVATGLNYLHS 456
                 G+ Y+V    ++ ++G L   SV + +   K           L +  G+NYLH 
Sbjct: 82  KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC--------YMLQLLEGINYLHE 133

Query: 457 FTNPPHV-HKDIKCSNVLLDTDFRAKIANFALARPAE---------RQEGEFALTSHIVG 506
                H+ H+DIK +N+L+D     KIA+F LARP +            G    T+ +V 
Sbjct: 134 ----NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV- 188

Query: 507 TKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y  PE L  G    +T +D++  G +  EM + +
Sbjct: 189 TRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.5 bits (132), Expect = 5e-08
 Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 26/196 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGG- 409
           G VYR   K  G+ VA+KK+  +   +         I +L K+ H +++ +  +      
Sbjct: 19  GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78

Query: 410 -NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
              Y+V E  V   L   +      FL  ++   + L + +G+ +LH      +  +H+D
Sbjct: 79  DKIYMVME-YVEHDLKSLMETMKQPFLQ-SEVKCLMLQLLSGVAHLHD-----NWILHRD 131

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKL 525
           +K SN+LL+     KI +F LAR        +   + +V T  Y APE  L     ST +
Sbjct: 132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPY---TQLVVTLWYRAPELLLGAKEYSTAI 188

Query: 526 DVYAFGVLMLEMLSGK 541
           D+++ G +  E+L+ K
Sbjct: 189 DMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 10/93 (10%)

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      +H+D+K SNV ++ D   +I +F LAR A+ +     +T + V T+ 
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGY-VATRW 180

Query: 510 YMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           Y APE + N +  +  +D+++ G +M E+L GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 54/245 (22%), Positives = 106/245 (43%), Gaps = 40/245 (16%)

Query: 390 LNKINHSSLIRLLGICFNGGNW------YLVYENAVNGSL-SVWINDKGG---KFLDWAQ 439
           + + +H +++RL+G+C             ++     +G L S  +  + G   ++L    
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM 113

Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
            ++   D+A+G+ YL S      +H+D+   N +L+ +    +A+F L++  +   G++ 
Sbjct: 114 LVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSK--KIYNGDYY 168

Query: 500 LTSHIVGTK-GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL 558
               I      ++A E L + + +TK DV++FGV M E+ +  + P     EN  + D L
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP-YPGVENSEIYDYL 227

Query: 559 NPVLHKEDGEESLRHLMDPSMQGN---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
                                QGN    PP     +  L+ SC   +P  RP+ + +   
Sbjct: 228 R--------------------QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267

Query: 616 ISRFL 620
           + + L
Sbjct: 268 LEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 26/163 (15%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++A+ L YLHS      +++D+K  N+LLD+     + +F L +  E  E     TS 
Sbjct: 102 AAEIASALGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHS-KTTST 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE L        +D +  G ++ EML G   P  YS +   + D    +L+
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRDTAEMYD---NILN 210

Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           K      L+  +  S +             L+E  L+KD + R
Sbjct: 211 K---PLRLKPNISVSARH------------LLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 50/220 (22%)

Query: 362 GSVYRGK----IGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFN 407
           G VY+ K      G   AIKK  GD              I LL ++ H +++ L+ +   
Sbjct: 14  GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73

Query: 408 GGN--WYLVYENAVNG----------SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH 455
             +   YL+++ A +           +  V I     K L W    QI L+   G++YLH
Sbjct: 74  HADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----QI-LN---GVHYLH 125

Query: 456 SFTNPPHV-HKDIKCSNVLLDTDF----RAKIANFALARPAERQEGEFALTSHIVGTKGY 510
           S  N   V H+D+K +N+L+  +       KI +  LAR         A    +V T  Y
Sbjct: 126 S--N--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 511 MAPEYLENGLVSTK-LDVYAFGVLMLEMLS------GKEA 543
            APE L      TK +D++A G +  E+L+      G+EA
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 48.2 bits (116), Expect = 1e-07
 Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 2/45 (4%)

Query: 187 YLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVP 231
           Y VK G+T+  I+KR+G+  +   E NGLS  +PN+Y    L +P
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNGLS--SPNLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 11/122 (9%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++A+ L YLHS      V++D+K  N+LLD+     + +F L +    Q      T+ 
Sbjct: 102 AAEIASALGYLHSINI---VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTT 155

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE +        +D +  G ++ EML G   P  Y  +   + D    +LH
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG--LPPFYCRDVAEMYD---NILH 210

Query: 564 KE 565
           K 
Sbjct: 211 KP 212

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 5/156 (3%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I+LL  + H  +++  G   +     +  E    GS+   +   G   L      +   
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTR 111

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            +  G+ YLHS      VH+DIK +N+L D+    K+ +F  ++  +           + 
Sbjct: 112 QILEGVEYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           GT  +M+PE +       K DV++ G  ++EML+ K
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 43/261 (16%)

Query: 362 GSVYR--GKIGGDFVAIKKV--YGDASDQIKLLNKI-----NHSSLIRLLGICFN----- 407
           G VY+   K  G   A+K +    D  ++I+    I     NH ++++  G+ +      
Sbjct: 36  GKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95

Query: 408 GGNWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
           GG  +LV E    GS++  +      G+ LD A    I      GL +LH   N   +H+
Sbjct: 96  GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHR 152

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGL 520
           D+K +N+LL T+   K+ +F ++  A+         +  VGT  +MAPE +      +  
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTS-VGTPFWMAPEVIACEQQYDYS 209

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL-----NP---VLHKEDGEESLR 572
              + DV++ G+  +E+  G   P L+   +M  V  L     NP   +LH E    S  
Sbjct: 210 YDARCDVWSLGITAIELGDGD--PPLF---DMHPVKTLFKIPRNPPPTLLHPEKWCRSFN 264

Query: 573 HLMDPSMQGNY---PPVTAIL 590
           H +   +  ++   P VT +L
Sbjct: 265 HFISQCLIKDFEARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 16/159 (10%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN--DKGGKFLDWAQRIQI 443
           +I++L   NH  +++LLG  +  G  +++ E    G++   +   D+G   L   Q   I
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVI 115

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
              +   L YLHS      +H+D+K  NVLL  D   K+A+F +   + +          
Sbjct: 116 CRQMLEALQYLHSMKI---IHRDLKAGNVLLTLDGDIKLADFGV---SAKNVKTLQRRDS 169

Query: 504 IVGTKGYMAPEY-----LENGLVSTKLDVYAFGVLMLEM 537
            +GT  +MAPE      +++     K D+++ G+ ++EM
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 20/109 (18%)

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
           +IA+ +   L YLHS  +   +H+D+K SNVL++ + + K+ +F ++       G   L 
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGIS-------GY--LV 155

Query: 502 SHIV-----GTKGYMAPEYLENGL----VSTKLDVYAFGVLMLEMLSGK 541
             +      G K YMAPE +   L       K DV++ G+ M+E+ +G+
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 23/168 (13%)

Query: 387 IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN-DKGGKFLDWAQRIQIAL 445
             L+++++H  L++L G+C    N  +V E    G L V+++ +K    L W  ++ +A 
Sbjct: 52  ASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAK 108

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLL-------DTDFRAKIANFALARPAERQEGEF 498
            +A+ L+YL        VH ++   N+L+             K+++  +      +E   
Sbjct: 109 QLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE--- 162

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKL--DVYAFGVLMLEMLSGKEAP 544
                 V    ++APE + NG  S  +  D ++FG  +LE+ S  E P
Sbjct: 163 ----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 24/192 (12%)

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           N YLV +  V G L   ++    +  +   R  +A ++   ++ +H      +VH+DIK 
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQLG---YVHRDIKP 130

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHI-VGTKGYMAPEYLE-----NGLVST 523
            NVLLD +   ++A+F       R   +  + S++ VGT  Y++PE L+      G    
Sbjct: 131 DNVLLDKNGHIRLADFG---SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
           + D ++ GV M EML G E P  Y+E    LV+    +++ ++      H   P    + 
Sbjct: 188 ECDWWSLGVCMYEMLYG-ETP-FYAES---LVETYGKIMNHKE------HFQFPPDVTDV 236

Query: 584 PPVTAILVIRLI 595
                 L+ RLI
Sbjct: 237 SEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL ++H   N   V++D+K +N+LLD     +I++  LA    +++   +    
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSG 540
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G
Sbjct: 156 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL ++H   N   V++D+K +N+LLD     +I++  LA    +++   +    
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSG 540
            VGT GYMAPE L+ G    +  D ++ G ++ ++L G
Sbjct: 156 -VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 11/90 (12%)

Query: 463 VHKDIKCSNVLLD-TDFR--AKIANFAL------ARPAERQEGEFALTSHIVGTKGYMAP 513
           VH+D+K  N+++  T  R  AK+ +F +       R A+        T+ ++GT  Y AP
Sbjct: 101 VHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT--LTRTTEVLGTPTYCAP 158

Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           E L    V+   D+YA+G++ LE L+G+  
Sbjct: 159 EQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 31/93 (33%), Positives = 55/93 (59%), Gaps = 10/93 (10%)

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +     +T + V T+ 
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGY-VATRW 182

Query: 510 YMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 69/307 (22%), Positives = 114/307 (37%), Gaps = 67/307 (21%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQIKLLNK-----------INHSSLIRLLGICFNG 408
           G VY     +    VA+KK+  D S+   LL K           + H  ++ +  IC +G
Sbjct: 16  GEVYLAYDPVCSRRVALKKIREDLSEN-PLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74

Query: 409 GNWYLVYENAVNGSL-----SVWINDKGGKFLDWAQRI----QIALDVATGLNYLHSFTN 459
              Y         +L     SVW  +   K L     +     I   +   + Y+HS   
Sbjct: 75  DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--- 131

Query: 460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS---------------HI 504
              +H+D+K  N+LL       I ++  A   + +E +                     I
Sbjct: 132 KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191

Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
           VGT  YMAPE L     S   D+YA GV++ +ML+                 +  P   K
Sbjct: 192 VGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-----------------LSFPYRRK 234

Query: 565 EDGEESLRH-LMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGR-PAMDKIAQSISRF 619
           +  + S R  ++ P     Y   PP  + + ++ +      DP+ R  ++ ++ Q +   
Sbjct: 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAV----DPAERYSSVQELKQDLEPH 290

Query: 620 LNASLAW 626
           L  S  W
Sbjct: 291 LQGSPEW 297

Length = 932

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 23/178 (12%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           +  VA G+ +L S      +H+D+   N+LL  +   KI +F LAR   +        S 
Sbjct: 180 SFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
            +  K +MAPE + + + +T+ DV++FGVL+ E+ S   +P    + N            
Sbjct: 237 RLPLK-WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------------ 283

Query: 564 KEDGEESLRHLMDPS-MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               EE  + L D + M+   P      + R++ +C + DP  RP    + + +   L
Sbjct: 284 ----EEFCQRLKDGTRMRA--PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 29/194 (14%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQIKLLNKINHSS-------------LIRLLGICF 406
           G V+  + K  G+ VA+K++       +  LN++ H               L++LL    
Sbjct: 15  GQVFLAKKKDTGEIVALKRM---KKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
           +    YL  E    G     +N+ G    D A R  +A ++   ++ LH      ++H+D
Sbjct: 72  DDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-RFYMA-EMFEAVDALHELG---YIHRD 126

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLD 526
           +K  N L+D     K+ +F L++      G     + +VG+  YMAPE L        +D
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDYMAPEVLRGKGYDFTVD 180

Query: 527 VYAFGVLMLEMLSG 540
            ++ G ++ E L G
Sbjct: 181 YWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.0 bits (123), Expect = 5e-07
 Identities = 45/155 (29%), Positives = 62/155 (40%), Gaps = 29/155 (18%)

Query: 425 VWIND--KGG---------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           V I D  K G           L  A+  +I   +   LN LH       +H DIK  NVL
Sbjct: 85  VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVL 141

Query: 474 LDTDFRAK----IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            D   RAK    + ++ L +      G     S   GT  Y +PE ++        D +A
Sbjct: 142 YD---RAKDRIYLCDYGLCKI----IG---TPSCYDGTLDYFSPEKIKGHNYDVSFDWWA 191

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
            GVL  E+L+GK  P    E+  L ++ L     K
Sbjct: 192 VGVLTYELLTGKH-PFKEDEDEELDLESLLKRQQK 225

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           N YLV +  V G L   ++    +  +   R  +A ++   ++ +H      +VH+DIK 
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQLH---YVHRDIKP 130

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLVSTK 524
            N+L+D +   ++A+F      +  E     +S  VGT  Y++PE L+      G    +
Sbjct: 131 DNILMDMNGHIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPE 188

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL-HKE 565
            D ++ GV M EML G E P  Y+E    LV+    ++ HKE
Sbjct: 189 CDWWSLGVCMYEMLYG-ETP-FYAES---LVETYGKIMNHKE 225

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 8/152 (5%)

Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +L  + H  ++ L+     GG  YL+ E    G L + + ++ G F++      ++ +++
Sbjct: 53  ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLS-EIS 110

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L +LH       +++D+K  N+LLD     K+ +F L +     EG   +T    GT 
Sbjct: 111 LALEHLHQQGI---IYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGT--VTHTFCGTI 164

Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            YMAPE L        +D ++ G LM +ML+G
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 6/114 (5%)

Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           L +   +  +  VA G+ +L S      VH+D+   NVL+      KI +F LAR   R 
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM--LSGKEAPAL 546
               +  S  +  K +MAPE + N L +T  DV++FG+L+ E+  L G   P L
Sbjct: 293 SNYISKGSTFLPLK-WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 23/173 (13%)

Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
           IA+     LNYL        +H+D+K SN+LLD +   K+ +F +   + +     A T 
Sbjct: 112 IAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGI---SGQLVDSIAKT- 165

Query: 503 HIVGTKGYMAPEYLENGLVS---TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
              G + YMAPE ++         + DV++ G+ + E+ +GK  P  Y + N +   +  
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK-FP--YPKWNSVFDQLTQ 222

Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            V     G+        P +  +     +   +  I  CL KD S RP   ++
Sbjct: 223 VV----KGDP-------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 30/196 (15%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G+V++ K     + VA+K+V  D  D+         I LL ++ H +++RL  +  +   
Sbjct: 14  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIKC 469
             LV+E   +  L  + +   G  +D          +  GL + HS     +V H+D+K 
Sbjct: 74  LTLVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKP 127

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYLENG-LVSTK 524
            N+L++ +   K+A+F LAR        F +     S  V T  Y  P+ L    L ST 
Sbjct: 128 QNLLINKNGELKLADFGLARA-------FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180

Query: 525 LDVYAFGVLMLEMLSG 540
           +D+++ G +  E+ + 
Sbjct: 181 IDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 17/113 (15%)

Query: 439 QRIQIALD----------VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
           Q IQ+ LD          +  G+ +LHS      +H+D+K SN+++ +D   KI +F LA
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           R A      F +T ++V T+ Y APE +        +D+++ G +M EM+ G 
Sbjct: 174 RTAGTS---FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 4/125 (3%)

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
           Y+ + +  +   ++D G + L     +     VA G+ +L S      VH+D+   NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC---VHRDLAARNVLL 270

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
                 KI +F LAR         +  S  +  K +MAPE + + L +T  DV+++G+L+
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK-WMAPESIFDNLYTTLSDVWSYGILL 329

Query: 535 LEMLS 539
            E+ S
Sbjct: 330 WEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)

Query: 383 ASDQIKLLNKINHSSLIRLLGICF------NGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME----LD 117

Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 172

Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 173 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 14/139 (10%)

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA-LDVATGLNYLHSFTNPPHVHKDIK 468
           N YLV E    G L   +N    +F +   +  +A L +A     +HS     +VH+DIK
Sbjct: 75  NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA-----IHSVHQMGYVHRDIK 129

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE------NGLVS 522
             NVL+D     K+A+F  A      +   +     VGT  Y+APE L        G   
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEVLTTMNGDGKGTYG 187

Query: 523 TKLDVYAFGVLMLEMLSGK 541
            + D ++ GV+  EM+ G+
Sbjct: 188 VECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 37/177 (20%)

Query: 441 IQIALDVATGLNYLHSFTNPPH-VHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEF 498
           IQ+ L V    +++HS     H +H+DIK +N+LL ++   K+ +F  ++  A     + 
Sbjct: 150 IQVLLAV----HHVHS----KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL 558
             T    GT  Y+APE       S K D+++ GVL+ E+L+ K                 
Sbjct: 202 GRT--FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR---------------- 243

Query: 559 NPVLHKEDGEESLRHLMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            P     DG E++  +M  ++ G Y   PP  +  +  ++ + L  DP  RP+  K+
Sbjct: 244 -PF----DG-ENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294

Length = 496

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 26/156 (16%)

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           +H+D+K +N+ L      K+ +F  ++          + S   GT  Y+APE  E    S
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            K D+++ GV++ E+L+                      LH+     S R +M   + G 
Sbjct: 250 KKADMWSLGVILYELLT----------------------LHRPFKGPSQREIMQQVLYGK 287

Query: 583 YPPVTAIL---VIRLIESCLKKDPSGRPAMDKIAQS 615
           Y P    +   +  L++  L K+P+ RP   ++  +
Sbjct: 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323

Length = 478

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 38/181 (20%), Positives = 71/181 (39%), Gaps = 34/181 (18%)

Query: 442 QIALDVATGLNYL---HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA-RPAERQEGE 497
           ++ + +   L+YL   H       +H+D+K SN+LLD     K+ +F ++ R  + +   
Sbjct: 118 KMTVAIVKALHYLKEKHGV-----IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-- 170

Query: 498 FALTSHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
               +   G   YMAPE ++    N     + DV++ G+ ++E+ +G+        E  +
Sbjct: 171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227

Query: 554 LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA 613
           L  +L          E                         ++ CL KD   RP   ++ 
Sbjct: 228 LTKILQEEPPSLPPNEGFSPDF----------------CSFVDLCLTKDHRKRPKYRELL 271

Query: 614 Q 614
           Q
Sbjct: 272 Q 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 41/238 (17%)

Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI-NDKGGKFLDWAQRIQIALDV 447
           L+++++H  L  + G+C  G    +V E   +G L V +  +KG   + W  +I +A  +
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLL-------DTDFRAKIANFALARPAERQEGEFAL 500
           A+ L+YL    +   VH ++   N+LL        T    K+++  ++  A  +E     
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER--- 180

Query: 501 TSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
               V    ++APE +  G  +ST  D ++FG  +LE+    E P          +    
Sbjct: 181 ----VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP----------LKERT 226

Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           P   KE   E    L +PS +          +  LI  CL  +P+ RP+   I + ++
Sbjct: 227 PS-EKERFYEKKHRLPEPSCKE---------LATLISQCLTYEPTQRPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 25/180 (13%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVNGSLSVWINDKGGKF--LDWAQRI 441
           ++ ++ ++ H +++R +    N  N   Y++ E    G LS  I      F  ++    +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 442 QIALDVATGLNYLHSFTNPPH----VHKDIKCSNVLLDTDFR--AKI---ANFALARPAE 492
            I   +   L Y H+  + P+    +H+D+K  N+ L T  R   KI   AN    RP  
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 493 RQEGEFALTSHI---------VGTKGYMAPEYL--ENGLVSTKLDVYAFGVLMLEMLSGK 541
           +  G+F L+ +I         VGT  Y +PE L  E      K D++A G ++ E+ SGK
Sbjct: 182 KI-GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 28/109 (25%), Positives = 56/109 (51%), Gaps = 14/109 (12%)

Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE-----RQE 495
           ++  +D+A+G+ YL   ++   +H+D+   N +L+ +    +A+F L++        RQ 
Sbjct: 116 VRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172

Query: 496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               L         ++A E L + + +T  DV+AFGV M E+++  + P
Sbjct: 173 CASKLPVK------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 12/140 (8%)

Query: 430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
           + G+F     R   A ++   L  LH F     +++D+K  N+LLD      + +F L +
Sbjct: 86  REGRFDLSRARFYTA-ELLCALENLHKFNV---IYRDLKPENILLDYQGHIALCDFGLCK 141

Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGKEAPALYS 548
              + + +   T+   GT  Y+APE L  G   TK +D +  GVL+ EML+G   P  Y 
Sbjct: 142 LNMKDDDK---TNTFCGTPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTG--LPPFYD 195

Query: 549 EE-NMLLVDVLNPVLHKEDG 567
           E  N +   +L   L   DG
Sbjct: 196 ENVNEMYRKILQEPLRFPDG 215

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 7/164 (4%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLV--YENAVNGSLSVWINDKGGKFLDWAQRIQI 443
           +I+LL  + H  +++  G   +     L    E    GS+   +   G   L  +   + 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKY 111

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
              +  G++YLHS      VH+DIK +N+L D+    K+ +F  ++  +           
Sbjct: 112 TRQILEGMSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168

Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
           + GT  +M+PE +       K DV++ G  ++EML+ K   A Y
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 51/241 (21%)

Query: 394 NHSSLIRLLGICF-----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ------ 442
           +H ++++  G+ +     NG   +LV E    GS    + D    FL   +R++      
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS----VTDLVKGFLKRGERMEEPIIAY 128

Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
           I  +   GL +LH       +H+D+K +N+LL T+   K+ +F ++        +   T 
Sbjct: 129 ILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTR 178

Query: 503 H----IVGTKGYMAPEYL--ENGLVST---KLDVYAFGVLMLEMLSGKEAPALYSEENML 553
                 VGT  +MAPE +  E  L ST   + DV++ G+  +E+  G    A       L
Sbjct: 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238

Query: 554 LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA 613
                NP                P++    P + +      I  CL KD   RP +  + 
Sbjct: 239 FKIPRNP---------------PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Query: 614 Q 614
           Q
Sbjct: 282 Q 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 49/192 (25%), Positives = 94/192 (48%), Gaps = 21/192 (10%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNW 411
            +V++G  K+  + VA+K++  +        A  ++ LL  + H++++ L  I     + 
Sbjct: 20  ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCS 470
            LV+E  ++  L  +++D G   +     ++I L  +  GL Y H       +H+D+K  
Sbjct: 80  TLVFE-YLDKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQ 133

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLDVYA 529
           N+L++     K+A+F LAR        +   S+ V T  Y  P+  L +   ST++D++ 
Sbjct: 134 NLLINERGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190

Query: 530 FGVLMLEMLSGK 541
            G +  EM SG+
Sbjct: 191 VGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 19/191 (9%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNW 411
            +VY+G  K+  + VA+K++  +        A  ++ LL  + H++++ L  I     + 
Sbjct: 20  ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV+E  ++  L  +++D  G  ++          +  GLNY H       +H+D+K  N
Sbjct: 80  TLVFE-YLDKDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQN 134

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAF 530
           +L++     K+A+F LAR        +   S+ V T  Y  P+ L      ST++D++  
Sbjct: 135 LLINERGELKLADFGLARAKSIPTKTY---SNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191

Query: 531 GVLMLEMLSGK 541
           G +  EM +G+
Sbjct: 192 GCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 20/188 (10%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASD-------QIKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+ +    G+  A+K +  +  D       +I ++ +  H +++   G   +    +
Sbjct: 23  GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +  E    GSL    +  G   L   Q   +  +   GL YLHS      +H+DIK +N+
Sbjct: 83  ICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANI 137

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
           LL  +   K+A+F +   A +     A     +GT  +MAPE     +NG  +   D++A
Sbjct: 138 LLTDNGDVKLADFGV---AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWA 194

Query: 530 FGVLMLEM 537
            G+  +E+
Sbjct: 195 VGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 37/161 (22%), Positives = 76/161 (47%), Gaps = 20/161 (12%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I +L   +H ++++LL   +   N +++ E    G++   + +      +   R+ +  
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCK 110

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA----RPAERQEGEFALT 501
                LNYLH       +H+D+K  N+L   D   K+A+F ++    R  +R++      
Sbjct: 111 QTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----- 162

Query: 502 SHIVGTKGYMAPEYL-----ENGLVSTKLDVYAFGVLMLEM 537
              +GT  +MAPE +     ++     K DV++ G+ ++EM
Sbjct: 163 --FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 34/231 (14%)

Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIA 444
           ++ +L+K     ++   G  F  G  Y+  E    GSL  ++      + +      +I 
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V  GL +L    N   +H+D+K +NVL++ + + K+ +F ++          +L    
Sbjct: 109 YAVVKGLKFLKEEHNI--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-----SLAKTN 161

Query: 505 VGTKGYMAPEYL------ENGLVSTKLDVYAFGVLMLEMLSGK--EAPALYSEENMLLVD 556
           +G + YMAPE +      +N   + + DV++ G+ +LEM  G+    P  Y+     +  
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFA 217

Query: 557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
            L+ ++  +           P++   Y       V      CL K P+ RP
Sbjct: 218 QLSAIVDGD----------PPTLPSGYSDDAQDFV----AKCLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 20/188 (10%)

Query: 362 GSVYRGK--IGGDFVAIKKV-------YGDASDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+ +    G+  AIK +       +     +I ++    HS+++   G        +
Sbjct: 23  GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +  E    GSL    +  G   L  +Q   ++ +   GL YLH   +   +H+DIK +N+
Sbjct: 83  ICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANI 137

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
           LL  +   K+A+F +   + +     A     +GT  +MAPE       G  +   D++A
Sbjct: 138 LLTDNGHVKLADFGV---SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWA 194

Query: 530 FGVLMLEM 537
            G+  +E+
Sbjct: 195 VGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 21/186 (11%)

Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD    +  +  VA G+++L S      +H+D+   N+LL      KI +F LAR   R 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDI-RN 266

Query: 495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
           +  + +  +      +MAPE + N + + + DV+++G+L+ E+ S   +P       M  
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGM-- 320

Query: 555 VDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                PV  K         ++    +   P      +  +++SC   DP  RP   +I Q
Sbjct: 321 -----PVDSK------FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Query: 615 SISRFL 620
            I + L
Sbjct: 370 LIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 13/118 (11%)

Query: 436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
            WA R   A +V   L+ +HS      +H+D+K  N+LLD     K+A+F      +   
Sbjct: 142 KWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-N 195

Query: 496 GEFALTSHIVGTKGYMAPEYLEN----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
           G        VGT  Y++PE L++    G    + D ++ GV + EML G      Y++
Sbjct: 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYAD 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 45/224 (20%)

Query: 362 GSVYRGKIGGDF----VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICFNGG 409
           G V  G++   +    V +K++   AS  +Q+K L +      + HS+L++ LG C    
Sbjct: 9   GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT 68

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI------------QIALDVATGLNYLHSF 457
            + LV E    G L  ++          + R             ++A ++A GL +LH  
Sbjct: 69  PYLLVMEFCPLGDLKGYLR---------SCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 458 TNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE 517
                +H D+   N LL  D   KI ++ L+   + +E  +     +     ++APE ++
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 518 ----NGLV---STKLDVYAFGVLMLEMLS-GKEAPALYSEENML 553
               N LV   + + +V++ GV + E+   G +     S+E +L
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 29/197 (14%)

Query: 363 SVYRG--KIGGDFVAIKKVYGDASDQI--------KLLNKINHSSLIRLLGICFNGGNWY 412
           +VY+G  +I G  VA+K +     + +         LL  + H++++ L  I        
Sbjct: 20  TVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIKCSN 471
            V+E  ++  L+ ++    G    +  R+     +  GL Y+H      H+ H+D+K  N
Sbjct: 80  FVFE-YMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG----QHILHRDLKPQN 133

Query: 472 VLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLD 526
           +L+      K+A+F LAR    P++    E       V T  Y  P+ L      S+ LD
Sbjct: 134 LLISYLGELKLADFGLARAKSIPSQTYSSE-------VVTLWYRPPDVLLGATDYSSALD 186

Query: 527 VYAFGVLMLEMLSGKEA 543
           ++  G + +EML G+ A
Sbjct: 187 IWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 59/265 (22%), Positives = 109/265 (41%), Gaps = 34/265 (12%)

Query: 366 RGKIGGDFVAIKKVYGDASD----------QIKLLNKINHSSLIRLLGICFNGGNWYLVY 415
           R K   + VAIKK + D+ +          ++K+L  +   +++ L       G  YLV+
Sbjct: 21  RHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E      L +      G   +  +     L  A  +++ H       VH+DIK  N+L+ 
Sbjct: 80  EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA--IHWCH---KNDIVHRDIKPENLLIS 134

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
            +   K+ +F  AR     EG  A  +  V T+ Y +PE L        +D+++ G ++ 
Sbjct: 135 HNDVLKLCDFGFAR--NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILG 192

Query: 536 EMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG-NYPPVT------- 587
           E+  G+  P    E  +  +  +  VL     E+      +P   G  +P V        
Sbjct: 193 ELSDGQ--PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLER 250

Query: 588 ------AILVIRLIESCLKKDPSGR 606
                 + +++ L+++ LK +P+ R
Sbjct: 251 RYLGILSGVLLDLMKNLLKLNPTDR 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 15/166 (9%)

Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWA------ 438
           ++I  L ++NH +++++  I  +  N Y++ +   +  L  ++ D+     DW       
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQK-YDFDLYSFMYDEA---FDWKDRPLLK 267

Query: 439 QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
           Q   I   +   + Y+H       +H+DIK  N+ L+ D +  + +F  A P E++   F
Sbjct: 268 QTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                 VGT    +PE L         D+++ G+++L+MLS    P
Sbjct: 325 DYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368

Length = 501

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 19/186 (10%)

Query: 366 RGKIGGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           R K+  + VA+K++  +        A  ++ LL  + H++++ L  I        LV+E 
Sbjct: 25  RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE- 83

Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDT 476
            ++  L  ++++ G   L     ++I +  +  GL+Y H       +H+D+K  N+L++ 
Sbjct: 84  YLDSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINE 138

Query: 477 DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLML 535
               K+A+F LAR        +   S+ V T  Y  P+ L      ST +D++  G ++ 
Sbjct: 139 KGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILY 195

Query: 536 EMLSGK 541
           EM +G+
Sbjct: 196 EMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 33/203 (16%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLI-RLLGICF--- 406
           G VY  R K  G  VA+KK   +  ++         I LL  ++ S  I RLL +     
Sbjct: 15  GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74

Query: 407 NGG--NWYLVYENAVNGSLSVWINDKGGKF---LDWAQRIQIALDVATGLNYLHSFTNPP 461
             G  + YLV+E  ++  L  +++  G      L           +  G+ + H      
Sbjct: 75  KNGKPSLYLVFE-YLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK----- 128

Query: 462 H--VHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
           H  +H+D+K  N+L+D      KIA+  L R        +   +H + T  Y APE L  
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY---THEIVTLWYRAPEVLLG 185

Query: 519 GL-VSTKLDVYAFGVLMLEMLSG 540
               ST +D+++ G +  EM   
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 36/223 (16%)

Query: 362 GSVYRGKIGG-------DFVAIK----KVYGDASDQIK----LLNKINHSSLIRLLGICF 406
           G VY+G + G         VAIK    K  G   ++ K    + +++ H +++ LLG+  
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78

Query: 407 NGGNWYLVYENAVNGSLSVWI-------------NDKGGK-FLDWAQRIQIALDVATGLN 452
                 +++    +  L  ++             +DK  K  L+ A  + I   +A G+ 
Sbjct: 79  KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138

Query: 453 YLHSFTNPPHV-HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM 511
           +L S     HV HKD+   NVL+      KI++  L R     +  + L  + +    +M
Sbjct: 139 FLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD-YYKLMGNSLLPIRWM 193

Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENML 553
           +PE +  G  S   D++++GV++ E+ S G +    YS ++++
Sbjct: 194 SPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 21/194 (10%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
            +VY+GK  + G  VA+K +     +        +  LL  + H++++ L  I       
Sbjct: 19  ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78

Query: 412 YLVYENAVNGSLSVWINDK-GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            LV+E  V+  L  +++   GG   +  +     L    GL+Y+H       +H+D+K  
Sbjct: 79  TLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQRYI---LHRDLKPQ 132

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYA 529
           N+L+      K+A+F LAR        +   S+ V T  Y  P+ L      ST LD++ 
Sbjct: 133 NLLISDTGELKLADFGLARAKSVPSHTY---SNEVVTLWYRPPDVLLGSTEYSTCLDMWG 189

Query: 530 FGVLMLEMLSGKEA 543
            G + +EM+ G  A
Sbjct: 190 VGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G++YLHS      VH+DIK +N+L D+    K+ +F  ++  +           + GT  
Sbjct: 118 GVSYLHSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +M+PE +       K D+++ G  ++EML+ K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G++YLHS      VH+DIK +N+L D+    K+ +F  ++  +           + G
Sbjct: 115 ILQGVSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
           T  +M+PE +       K DV++    ++EML+ K   A Y
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           +V   L+ +HS      +H+D+K  N+LLD     K+A+F      +  E         V
Sbjct: 150 EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD--ETGMVRCDTAV 204

Query: 506 GTKGYMAPEYLE----NGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L+    +G    + D ++ GV + EML G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 21/190 (11%)

Query: 363 SVYRG--KIGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWY 412
           +VY+G  K+ G  VA+K++  +  +        +  LL  + H++++ L  I        
Sbjct: 20  TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIKCSN 471
           LV+E  ++  L  +++D GG  L           +  GL Y H       V H+D+K  N
Sbjct: 80  LVFE-YLDTDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ----RRVLHRDLKPQN 133

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAF 530
           +L+      K+A+F LAR        +   S+ V T  Y  P+ L      ST LD++  
Sbjct: 134 LLISERGELKLADFGLARAKSVPSKTY---SNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190

Query: 531 GVLMLEMLSG 540
           G +  EM +G
Sbjct: 191 GCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 39.0 bits (92), Expect = 2e-04
 Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 1/45 (2%)

Query: 186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLV 230
           +Y VK G+T++ I+K++GV  +    AN L      IYP   L +
Sbjct: 2   TYTVKPGDTLWSIAKKYGVTVEELAAANPLI-NPDCIYPGQKLKI 45

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 41/261 (15%)

Query: 301 FDSTIVSSSFEACEKASNKKLD---EESRDFLESISDIAQSLKVY---------TFEELQ 348
            D+ +    F A  K  NK +D      +D +  I D+    + Y          F E+Q
Sbjct: 3   LDALVYDLDFPALRK--NKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ 60

Query: 349 AATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDAS---DQIKLLNKINHSSLIRLLGIC 405
                          VY  K+   F  IK+   D++   ++  ++   N   +++L    
Sbjct: 61  LVRHKST------RKVYAMKLLSKFEMIKR--SDSAFFWEERDIMAFANSPWVVQLFYAF 112

Query: 406 FNGGNWYLVYENAVNGSLSVWIN--DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV 463
            +    Y+V E    G L   ++  D   K   WA R   A +V   L+ +HS      +
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WA-RFYTA-EVVLALDAIHSMG---FI 164

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE----NG 519
           H+D+K  N+LLD     K+A+F       + EG        VGT  Y++PE L+    +G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EG-MVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 520 LVSTKLDVYAFGVLMLEMLSG 540
               + D ++ GV + EML G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 30/235 (12%)

Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H  L+   G+C  G    +V E    GSL  ++  K    ++ + ++++A  +A
Sbjct: 52  MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLA 110

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L++L         H ++   NVLL  +   K  N    + ++       L   I+  +
Sbjct: 111 WALHFLEDKGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER 167

Query: 509 -GYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
             ++ PE +EN   +S   D ++FG  + E+ SG + P       +  +D    +   ED
Sbjct: 168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP-------LSALDSQKKLQFYED 220

Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
                RH +        P      +  LI  C+  +P  RP+     ++I R LN
Sbjct: 221 -----RHQL--------PAPKWTELANLINQCMDYEPDFRPSF----RAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 6/77 (7%)

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVS 522
           H+DIK  N+L+  D   K+A+F   R    +      T +I  T+ Y APE  L +G   
Sbjct: 123 HRDIKPENILIKDD-ILKLADFGSCRGIYSKP---PYTEYI-STRWYRAPECLLTDGYYG 177

Query: 523 TKLDVYAFGVLMLEMLS 539
            K+D++A G +  E+LS
Sbjct: 178 PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 9e-04
 Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 47/173 (27%)

Query: 410 NWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
           N Y V +    G + S+ I  + G F +   R  IA ++   +  +H       +H+DIK
Sbjct: 75  NLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDIK 128

Query: 469 CSNVLLDTDFRAKIANFALA-------------------------------------RPA 491
             N+L+D D   K+ +F L                                      +P 
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188

Query: 492 ER---QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           ER   ++ +  L   +VGT  Y+APE L     +   D ++ GV++ EML G+
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 36/170 (21%)

Query: 451 LNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA-------------ERQEGE 497
           L YLH++     VH+D+K  N+L+ +    K+ +F L++               E+   E
Sbjct: 114 LEYLHNYGI---VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE-NMLLVD 556
           F L   + GT  Y+APE +        +D +A G+++ E L G      + +    L   
Sbjct: 171 F-LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG--CVPFFGDTPEELFGQ 227

Query: 557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           V++  +   +G+E+L            P     L+ RL    L+++P  R
Sbjct: 228 VISDDIEWPEGDEAL------------PADAQDLISRL----LRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 30/125 (24%), Positives = 57/125 (45%), Gaps = 16/125 (12%)

Query: 434 FLDWAQRIQIA---LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKI----ANFA 486
           F+D    + IA     V   L+Y+H      +VH+ +K S++L+  D +  +    +N +
Sbjct: 94  FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 150

Query: 487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSG---- 540
           +    +R         + V    +++PE L+  L     K D+Y+ G+   E+ +G    
Sbjct: 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Query: 541 KEAPA 545
           K+ PA
Sbjct: 211 KDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 34/126 (26%), Positives = 50/126 (39%), Gaps = 39/126 (30%)

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARP---AERQEGEF--------------------- 498
           +H+DIK  N+LLD     K+++F L      + R E                        
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 499 -----------ALTSHIVGTKGYMAPE-YLENGLVSTKLDVYAFGVLMLEMLSGKEAPAL 546
                      AL    VGT  Y+APE +L+ G  + + D ++ GV+M EML G   P  
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG--YPPF 239

Query: 547 YSEENM 552
            S+   
Sbjct: 240 CSDNPQ 245

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 36.7 bits (86), Expect = 0.001
 Identities = 13/44 (29%), Positives = 23/44 (52%), Gaps = 1/44 (2%)

Query: 187 YLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLV 230
           Y VK G+T+  I++R+G+     LE N + +   N+     L +
Sbjct: 2   YTVKKGDTLSSIARRYGISVSDLLELNNILD-PDNLQVGQKLKI 44

Length = 44

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 66/192 (34%)

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALA-------------------------------RPA 491
           +H+DIK  N+LLD+    K+++F L                                R A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 492 E---RQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKL-DVYAFGVLMLEMLSGKEAPAL 546
           E   R   + A ++  VGT  Y+APE +++ G    KL D ++ GV+M EML G      
Sbjct: 183 ETWKRNRRQLAFST--VGTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEMLIGY----- 233

Query: 547 YSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI------LVIRLIESCLK 600
                        P    E  +E+ + +M+      +PP   I      L++R    C  
Sbjct: 234 -------------PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRF--CCEW 278

Query: 601 KDPSGRPAMDKI 612
           +   G P +++I
Sbjct: 279 EHRIGAPGVEEI 290

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 52/219 (23%)

Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-------TDF------------RAKIAN 484
           A +V   L YLH       V++D+K  N+LL        +DF             +K   
Sbjct: 109 AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 485 FALARP-AERQEGEFAL------TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
               R        E         ++  VGT+ Y+APE +      + +D +  G+L+ EM
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225

Query: 538 LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR-LIE 596
           L G   P   S  +       + +L KE        +  P      PPV++    R LI 
Sbjct: 226 LYG-TTPFKGSNRDE----TFSNILKKE--------VTFPGS----PPVSSSA--RDLIR 266

Query: 597 SCLKKDPSGRPAMDKIAQSISR--FLNASLAWELSKNIS 633
             L KDPS R    + A  I +  F    + W L ++ +
Sbjct: 267 KLLVKDPSKRLGSKRGAAEIKQHPFF-RGVNWALIRHTT 304

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 39/159 (24%), Positives = 58/159 (36%), Gaps = 50/159 (31%)

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALA---RPAERQE----------GEFA---------- 499
           +H+DIK  N+LLD     K+++F L    + A R E           +F+          
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 500 ---------LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
                    L    VGT  Y+APE       +   D ++ GV+M EML G          
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY--------- 233

Query: 551 NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
                    P    E  +E+ R +M+      +PP   I
Sbjct: 234 ---------PPFCSETPQETYRKVMNWKETLVFPPEVPI 263

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 44/123 (35%)

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALA---------------------------------- 488
           +H+DIK  N+L+D D   K+ +F L                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 489 -------RPAERQ---EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML 538
                  +P ER+   + +  L   +VGT  Y+APE L     +   D ++ GV++ EML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 539 SGK 541
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	635
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.98
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.98
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.98
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK06347	592	autolysin; Reviewed	99.91
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
PRK06347	592	autolysin; Reviewed	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.81
PRK09188	365	serine/threonine protein kinase; Provisional	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.67
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.67
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.65
PRK12274	218	serine/threonine protein kinase; Provisional	99.64
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.64
PRK14879	211	serine/threonine protein kinase; Provisional	99.57
PRK10345	210	hypothetical protein; Provisional	99.56
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.54
smart00090	237	RIO RIO-like kinase.	99.53
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.53
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.49
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.47
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.42
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.39
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.29
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.12
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.09
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	99.06
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.92
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.88
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.82
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.78
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	98.77
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
PRK14125	103	cell division suppressor protein YneA; Provisional	98.73
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.72
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.64
PRK14125	103	cell division suppressor protein YneA; Provisional	98.64
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.53
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.52
COG4248	637	Uncharacterized protein with protein kinase and he	98.49
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.43
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.39
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.38
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.35
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.34
PRK09902	216	hypothetical protein; Provisional	98.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.19
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.19
smart00257	44	LysM Lysin motif.	98.18
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.14
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.12
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.08
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.01
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.0
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.94
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.93
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.85
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.73
smart00257	44	LysM Lysin motif.	97.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.66
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.6
PF01636	239	APH: Phosphotransferase enzyme family This family	97.47
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	97.41
PLN02876	822	acyl-CoA dehydrogenase	97.25
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.23
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.11
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.11
PRK10593	297	hypothetical protein; Provisional	97.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.85
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.68
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.43
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.34

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-50  Score=421.22  Aligned_cols=277  Identities=39%  Similarity=0.761  Sum_probs=237.5

Q ss_pred             ccccccHHHHHHhhcCCCCCCccc----ceEEEeeeC-CcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEE
Q 042486          338 SLKVYTFEELQAATDDFNPSCWIK----GSVYRGKIG-GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGIC  405 (635)
Q Consensus       338 ~~~~~~~~el~~at~~f~~~~~ig----g~Vy~g~~~-~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~  405 (635)
                      ..+.|+++||.+||++|+..+.||    |.||+|.+. +..||||++..       +|.+|+++|.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            457899999999999999999997    899999995 48999998743       477899999999999999999999


Q ss_pred             ecCC-eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          406 FNGG-NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       406 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                      .+.+ +.+||||||++|+|.++|.......++|..|++|+.++|+||+|||+...++|+||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 599999999999999999765432699999999999999999999998878999999999999999999999999


Q ss_pred             ecCcccccc-cCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCc-chhhHHHHhhhccc
Q 042486          485 FALARPAER-QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS-EENMLLVDVLNPVL  562 (635)
Q Consensus       485 fg~a~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~-~~~~~l~~~~~~~~  562 (635)
                      ||+++.... ...  ..+. ..||.+|+|||+...+..+.|+|||||||+|+||+||+.+.+... .....+.+|..+.+
T Consensus       221 FGLa~~~~~~~~~--~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS--VSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCcccCCccccc--eeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999976543 211  1111 179999999999999999999999999999999999998876533 23344677776555


Q ss_pred             ccCCchhhhhhhcCCcCC-CCCCh-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          563 HKEDGEESLRHLMDPSMQ-GNYPP-VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       563 ~~~~~~~~l~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ...    .+.+++|+.+. ..++. .....+..++.+|++.+|++||+|.||++.|+.+..
T Consensus       298 ~~~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEG----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCc----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            433    78889999987 66664 567779999999999999999999999999966554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=366.84  Aligned_cols=240  Identities=30%  Similarity=0.495  Sum_probs=200.7

Q ss_pred             ceEEEeeeCCcE-EEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC-eeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIGGDF-VAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG-NWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~~~~-vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||+|.+.|.. ||||++..         ++.+|+.+|++++|||||+++|+|.+.. ..++||||+++|+|.+++...
T Consensus        55 g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~  134 (362)
T KOG0192|consen   55 GTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK  134 (362)
T ss_pred             eeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence            999999998888 99999975         6889999999999999999999999877 799999999999999999774


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ....+++..+++|+.|||.||.|||+.+ + ||||||||+|||++.++ .+||+|||+++......   .......||+.
T Consensus       135 ~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~  209 (362)
T KOG0192|consen  135 RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---TSMTSVAGTYR  209 (362)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccc---ccccCCCCCcc
Confidence            3455999999999999999999999954 3 99999999999999997 99999999998655422   11223689999


Q ss_pred             ccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          510 YMAPEYLE--NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       510 y~aPE~~~--~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      |||||++.  ...++.|+||||||+++|||+||+.||..... ..                 ....+.....+...+...
T Consensus       210 wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~-----------------~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  210 WMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ-----------------VASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             ccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-----------------HHHHHHhcCCCCCCCccC
Confidence            99999999  56899999999999999999999999864333 11                 111122222233344446


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +..+..++.+||+.||+.||++.|++..|+.+.....
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            6679999999999999999999999999999876443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-44  Score=353.64  Aligned_cols=232  Identities=26%  Similarity=0.401  Sum_probs=195.5

Q ss_pred             cceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCC-eeEEEeecccCCCcchhhcc
Q 042486          361 KGSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGG-NWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       361 gg~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~  429 (635)
                      ||+|||++.  +++.+|+|.+..        ++.+|++++++.+||+||+++|.|.+++ ..+++||||++|+|++++..
T Consensus        92 gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~  171 (364)
T KOG0581|consen   92 GGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR  171 (364)
T ss_pred             CcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh
Confidence            499999988  799999999943        3568999999999999999999999988 59999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .+.  +++...-+|+.+|++||.|||+  ..+||||||||+|||++..|++||+|||.+......     .....+||..
T Consensus       172 ~g~--i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-----~a~tfvGT~~  242 (364)
T KOG0581|consen  172 VGR--IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-----IANTFVGTSA  242 (364)
T ss_pred             cCC--CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-----hccccccccc
Confidence            533  8999999999999999999996  245999999999999999999999999999866443     3456799999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh-HHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP-VTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~-~~~  588 (635)
                      |||||.+.+..|+.++||||||++++|+.+|+.|+....+..             .+..+.+..+.+.... ..|. .++
T Consensus       243 YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-------------~~~~~Ll~~Iv~~ppP-~lP~~~fS  308 (364)
T KOG0581|consen  243 YMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-------------LDIFELLCAIVDEPPP-RLPEGEFS  308 (364)
T ss_pred             ccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-------------CCHHHHHHHHhcCCCC-CCCcccCC
Confidence            999999999999999999999999999999999976431111             1223444445542221 2333 367


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .++++++..||+.||.+||+++|+++|
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            779999999999999999999999987

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=354.17  Aligned_cols=238  Identities=29%  Similarity=0.522  Sum_probs=201.2

Q ss_pred             ceEEEeeeCCc-EEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKIGGD-FVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~~~~-~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||.|.+++. .||+|.++.      +|.+|+++|++|+|+|||+++|+|..++..|||||||+.|+|.+||+...+..
T Consensus       220 G~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~  299 (468)
T KOG0197|consen  220 GEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGL  299 (468)
T ss_pred             ceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCc
Confidence            99999999776 999998875      46789999999999999999999999889999999999999999998766666


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +...+.+.++.|||+|++||++.+   +|||||..+||||+++..+||+|||+|+.....  .........-...|.|||
T Consensus       300 l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~~~~~kfPIkWtAPE  374 (468)
T KOG0197|consen  300 LNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTASEGGKFPIKWTAPE  374 (468)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC--ceeecCCCCCCceecCHH
Confidence            999999999999999999999854   999999999999999999999999999944332  222333334556899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+..+.++.|||||||||+||||+| |+.|+.....                   ..+-+.++...+-..|..++..+.+
T Consensus       375 a~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------------------~ev~~~le~GyRlp~P~~CP~~vY~  435 (468)
T KOG0197|consen  375 ALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------------------EEVLELLERGYRLPRPEGCPDEVYE  435 (468)
T ss_pred             HHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------------------HHHHHHHhccCcCCCCCCCCHHHHH
Confidence            9999999999999999999999999 5555432221                   1122233444455677788888999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ++..||+.+|++|||++.+...|+++...+
T Consensus       436 lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  436 LMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            999999999999999999999999887654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-41  Score=349.92  Aligned_cols=226  Identities=25%  Similarity=0.430  Sum_probs=193.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      .++|+++.  +|+.||+|.+.+          .+.+|+++.++|+|||||+++++|++.++.|||.|+|.+++|.+++++
T Consensus        32 A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr  111 (592)
T KOG0575|consen   32 ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR  111 (592)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh
Confidence            58999998  799999998854          356899999999999999999999999999999999999999999974


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      +  +.+++.++..++.||+.||.|||+.+   |+|||||..|+||+++.++||+|||+|........   .....+||+.
T Consensus       112 r--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---rk~TlCGTPN  183 (592)
T KOG0575|consen  112 R--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---RKKTLCGTPN  183 (592)
T ss_pred             c--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc---ccceecCCCc
Confidence            3  45999999999999999999999965   99999999999999999999999999998765432   2345799999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.....+..+||||+||+||-|+.|++||....                  ..+.+..+....  ...|...+.
T Consensus       184 YIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------------vkety~~Ik~~~--Y~~P~~ls~  243 (592)
T KOG0575|consen  184 YIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------------VKETYNKIKLNE--YSMPSHLSA  243 (592)
T ss_pred             ccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------------HHHHHHHHHhcC--cccccccCH
Confidence            999999999899999999999999999999999985321                  122222222111  123445666


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+||.++|+.||.+|||+++|+.+
T Consensus       244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  244 EAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            68999999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=332.37  Aligned_cols=190  Identities=31%  Similarity=0.467  Sum_probs=166.0

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      ++|....+||    |.||+|+.  ++..||||.+...         ...|+.+|++++|||||++++++..++..|||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            3444444455    89999998  6789999988543         3579999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC------CcEEEeeecCccc
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD------FRAKIANFALARP  490 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~------~~~kl~Dfg~a~~  490 (635)
                      ||.||+|.+|++..+.  +++.....++.|||.||++||+   ++||||||||+||||+..      -.+||+|||+|+.
T Consensus        90 yC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             eCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999987654  9999999999999999999998   459999999999999764      5689999999998


Q ss_pred             ccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcch
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE  550 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~  550 (635)
                      ....    ......+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||......
T Consensus       165 L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  165 LQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             CCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            7643    2345679999999999999999999999999999999999999998754443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-41  Score=335.91  Aligned_cols=228  Identities=26%  Similarity=0.345  Sum_probs=184.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.|-+|..  +++.||||.+..              ++.+|+++|++++|||||++++++...+..||||||++||.|.+
T Consensus       186 g~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd  265 (475)
T KOG0615|consen  186 GLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFD  265 (475)
T ss_pred             eEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHH
Confidence            67888765  899999998854              24589999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC---CcEEEeeecCcccccccCCceeeec
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD---FRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      .+-.++.  +.+..-..+++|++.|+.|||+.|   |+||||||+|||++.+   ..+||+|||+|+..+..    ..+.
T Consensus       266 ~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~----sfm~  336 (475)
T KOG0615|consen  266 KVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG----SFMK  336 (475)
T ss_pred             HHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccc----eehh
Confidence            9965543  788888899999999999999955   9999999999999655   78999999999977532    4567


Q ss_pred             ccccCCCccCccccccCCC---CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          503 HIVGTKGYMAPEYLENGLV---STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~---s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      ..+||+.|.|||++.+..+   ..+.|+||+||+||-+++|.+||.....+. .+.+.                +...+.
T Consensus       337 TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQ----------------I~~G~y  399 (475)
T KOG0615|consen  337 TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQ----------------ILKGRY  399 (475)
T ss_pred             hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHH----------------HhcCcc
Confidence            7899999999999976442   347899999999999999999986322111 01111                111111


Q ss_pred             --CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 --QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ........+.+..+||.+||..||++|||++|+++|
T Consensus       400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence              112234456778999999999999999999999987

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-41  Score=321.26  Aligned_cols=235  Identities=25%  Similarity=0.362  Sum_probs=189.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEE-EEecCCe-eEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLG-ICFNGGN-WYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lV~E~~~~gsL~~~l~  428 (635)
                      |+|||+..  +|..||.|++.-         +...|+.+|++|+|||||++++ .+.++++ .+||||||..|+|...++
T Consensus        33 g~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk  112 (375)
T KOG0591|consen   33 GEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIK  112 (375)
T ss_pred             hheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHH
Confidence            89999986  899999998852         3457999999999999999999 4445555 799999999999999984


Q ss_pred             c--cCCCCCCHHHHHHHHHHHHhhhcccccCCC-CCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          429 D--KGGKFLDWAQRIQIALDVATGLNYLHSFTN-PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       429 ~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      .  ...+.++++.+++++.|++.||.++|..-. ..|+||||||.||+|+.+|.+||+|||+++......   ......+
T Consensus       113 ~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~---tfA~S~V  189 (375)
T KOG0591|consen  113 HFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT---TFAHSLV  189 (375)
T ss_pred             HHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh---HHHHhhc
Confidence            3  345569999999999999999999998441 238999999999999999999999999999876543   3345679


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC-
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP-  584 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~-  584 (635)
                      |||.||+||.+....|++|+||||+||++|||..-+.||...     .+......             +-.... ...| 
T Consensus       190 GTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-------------I~qgd~-~~~p~  250 (375)
T KOG0591|consen  190 GTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-------------IEQGDY-PPLPD  250 (375)
T ss_pred             CCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-------------HHcCCC-CCCcH
Confidence            999999999999999999999999999999999999998643     11111111             111111 1233 


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ..++..+..||..|+..||+.||+.-.++..+..
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            5678889999999999999999996555544443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.1e-40  Score=357.74  Aligned_cols=240  Identities=27%  Similarity=0.482  Sum_probs=200.7

Q ss_pred             ceEEEeeeC-------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|+..       ...||||.+++        ||.+|+++|.+++|||||+|+|+|.+++..+||+|||..|+|.++
T Consensus       500 GkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eF  579 (774)
T KOG1026|consen  500 GKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEF  579 (774)
T ss_pred             hhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHH
Confidence            999999872       35799999875        578999999999999999999999999999999999999999999


Q ss_pred             hcccC--------CC----CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          427 INDKG--------GK----FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       427 l~~~~--------~~----~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |....        +.    +|+..+.+.|+.|||.|+.||-++.   +|||||..+|+||.++..+||+|||+++..-..
T Consensus       580 Lra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss  656 (774)
T KOG1026|consen  580 LRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSS  656 (774)
T ss_pred             HHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhh
Confidence            95321        22    3889999999999999999999866   999999999999999999999999999865443


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      +.. .......-..+|||||.+..+++|.+||||||||+|||+++ |+.|+....++                  +.+..
T Consensus       657 DYY-k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------------------EVIe~  717 (774)
T KOG1026|consen  657 DYY-KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------------------EVIEC  717 (774)
T ss_pred             hhh-cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------------------HHHHH
Confidence            311 11112334568999999999999999999999999999998 67776544333                  33333


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +.+..+ -..|..++.++.+|+..||+.+|++||+++||-..|+++...+.
T Consensus       718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            444444 56788888889999999999999999999999999999987653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=338.25  Aligned_cols=245  Identities=26%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             ccccHHHHHHhhcCCCCCCccc----ceEEEeeeCCcEEEEEEeccChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          340 KVYTFEELQAATDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       340 ~~~~~~el~~at~~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ..+.|++|.+.       .|+|    |.||.|++.++.||||++++--..+|+-|++|+|+||+.+.|+|....-+||||
T Consensus       119 WeiPFe~IsEL-------eWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  119 WEIPFEEISEL-------EWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             ccCCHHHhhhh-------hhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            44566666543       2444    899999999999999999988888999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      |||..|-|.+.|+...  .+.......|.++||.|+.|||.+.   |||||||+-||||..+..+||+|||-++......
T Consensus       192 EfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             eccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            9999999999996543  3888899999999999999999965   9999999999999999999999999988654432


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                          ..-.+.||..|||||++.+...++|.||||||||||||+||..|+..-+.     ...+..             +-
T Consensus       267 ----TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----sAIIwG-------------VG  324 (904)
T KOG4721|consen  267 ----TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----SAIIWG-------------VG  324 (904)
T ss_pred             ----hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----heeEEe-------------cc
Confidence                22347899999999999999999999999999999999999998642111     011111             11


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ...+.-..|..++..+.-|++.||+..|..||++.+|+.||.-
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            1223334566777779999999999999999999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=311.36  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=187.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.|||++.  +|+.||||++.+.         ..+|+++|++++|+|+|.|+.+|.....++||+||++..-|.+ |...
T Consensus        16 GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~e-Le~~   94 (396)
T KOG0593|consen   16 GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHE-LERY   94 (396)
T ss_pred             eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHH-HHhc
Confidence            89999987  8999999999652         4589999999999999999999999999999999998755544 4332


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..++.+.+.+++.|++.|+.|+|+++   ++||||||+||||+.++.+||||||+|+......   ...+..+.|.+|
T Consensus        95 p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg---d~YTDYVATRWY  167 (396)
T KOG0593|consen   95 P-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG---DNYTDYVATRWY  167 (396)
T ss_pred             c-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc---chhhhhhhhhhc
Confidence            2 23899999999999999999999955   9999999999999999999999999999876432   223456899999


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHH--HHhhhcccccC----CchhhhhhhcCCcCC---
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL--VDVLNPVLHKE----DGEESLRHLMDPSMQ---  580 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l--~~~~~~~~~~~----~~~~~l~~~~d~~~~---  580 (635)
                      +|||.+.+ .+|....||||+||++.||++|.+.|...++-++..  ...+..+...-    .....+..+.-|...   
T Consensus       168 RaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~e  247 (396)
T KOG0593|consen  168 RAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPE  247 (396)
T ss_pred             cChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCcc
Confidence            99999887 789999999999999999999998887665543221  11111111000    000111111111111   


Q ss_pred             ---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         ..+ +..+..+.++++.||+.||.+|++.+|++.|
T Consensus       248 pLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  248 PLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             chhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence               112 2234468999999999999999999999865

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=332.80  Aligned_cols=227  Identities=23%  Similarity=0.381  Sum_probs=191.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||.++.  +++.||||++.-       -+.+|+.+|+..+|+|||++++.|..+++++.||||+++|+|.+.+.... 
T Consensus       287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~-  365 (550)
T KOG0578|consen  287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR-  365 (550)
T ss_pred             cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc-
Confidence            89999987  788999999842       25689999999999999999999999999999999999999999996543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                        +++.++..|+.+++.||+|||..+   |+|||||.+|||++.+|.+||+|||++........   .....+||+.|||
T Consensus       366 --~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---KR~TmVGTPYWMA  437 (550)
T KOG0578|consen  366 --MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---KRSTMVGTPYWMA  437 (550)
T ss_pred             --ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC---ccccccCCCCccc
Confidence              899999999999999999999855   99999999999999999999999999987665432   3456899999999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC-CcCCCCCChHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPPVTAILV  591 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d-~~~~~~~~~~~~~~l  591 (635)
                      ||+.....|++|.||||||++++||+.|.+|+.....-                  ..+..+.+ ....-..+...+..+
T Consensus       438 PEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------------------rAlyLIa~ng~P~lk~~~klS~~~  499 (550)
T KOG0578|consen  438 PEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------------------RALYLIATNGTPKLKNPEKLSPEL  499 (550)
T ss_pred             hhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------------------HHHHHHhhcCCCCcCCccccCHHH
Confidence            99999999999999999999999999999987531111                  11111111 111223355567779


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||+.|+++|+++.|+|+|
T Consensus       500 kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  500 KDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHHhhcchhcCCCHHHHhcC
Confidence            999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=324.72  Aligned_cols=237  Identities=30%  Similarity=0.444  Sum_probs=191.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCC--eeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||.+..  +|+..|||.+...       +.+|+.+|++++|||||+++|......  .+++.|||+++|+|.+++.+.
T Consensus        31 G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~  110 (313)
T KOG0198|consen   31 GSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY  110 (313)
T ss_pred             eEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc
Confidence            99999998  4799999998665       689999999999999999999855444  689999999999999999877


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ++ .+++..+..++.|+++||.|||+.+   |+||||||+|||++. ++.+||+|||++.................||+.
T Consensus       111 g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~  186 (313)
T KOG0198|consen  111 GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPN  186 (313)
T ss_pred             CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCcc
Confidence            65 5999999999999999999999854   999999999999999 799999999999866531111223445789999


Q ss_pred             ccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |||||++.++ ...+++|||||||++.||+||+.||....+..                ...+...... .....|...+
T Consensus       187 ~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~----------------~~~~~ig~~~-~~P~ip~~ls  249 (313)
T KOG0198|consen  187 YMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA----------------EALLLIGRED-SLPEIPDSLS  249 (313)
T ss_pred             ccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH----------------HHHHHHhccC-CCCCCCcccC
Confidence            9999999964 34469999999999999999999986420000                0111111111 1124566677


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      ....+++..|+..||++|||++|++++--.-
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            7789999999999999999999999986543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.1e-38  Score=322.07  Aligned_cols=232  Identities=19%  Similarity=0.351  Sum_probs=187.6

Q ss_pred             ceEEEeeeCCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEec----CCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIGGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+++|+.||||+++.          .+.+|+.+|++++||||++++|++.+    ....++||||+++|+|.+++
T Consensus        34 ~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l  113 (283)
T PHA02988         34 NSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL  113 (283)
T ss_pred             eEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHH
Confidence            78999999999999998864          23489999999999999999999876    34679999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ....  .+++.....++.+++.||.|||+.  .+++||||||+||++++++.+||+|||+++......      ....++
T Consensus       114 ~~~~--~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~  183 (283)
T PHA02988        114 DKEK--DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------FKNVNF  183 (283)
T ss_pred             hhCC--CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------ccccCc
Confidence            6543  489999999999999999999973  248899999999999999999999999987543221      124678


Q ss_pred             CCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          508 KGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       508 ~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ..|+|||.+.+  ..++.++|||||||++|||++|+.||.......  ...                .+.........+.
T Consensus       184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~----------------~i~~~~~~~~~~~  245 (283)
T PHA02988        184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYD----------------LIINKNNSLKLPL  245 (283)
T ss_pred             ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHH----------------HHHhcCCCCCCCC
Confidence            89999999976  678999999999999999999999986432211  111                1111111112233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ..+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            345669999999999999999999999999997753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=329.15  Aligned_cols=249  Identities=26%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|..+..+|    .+|++++.  +++.+|||++.+.          +..|-+.|.+| +||.|++|+-.|.++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4444445555    68999987  7899999988543          44688899999 899999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      +||+++|+|.+++.+.+.  +++.-...++.+|+.||+|||+.|   ||||||||+|||||+|+++||+|||.|+.+...
T Consensus       153 Le~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            999999999999977654  899999999999999999999955   999999999999999999999999999876543


Q ss_pred             CCc--------eee--ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc
Q 042486          495 EGE--------FAL--TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       495 ~~~--------~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      ...        ...  ...++||-.|.+||++..+..++.+|+|+|||+||+|+.|++||...++               
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---------------  292 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---------------  292 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---------------
Confidence            211        011  1448999999999999999999999999999999999999999854322               


Q ss_pred             CCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       565 ~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                         -..++++++-  ...+|+..+....+|+++.|..||.+|++.+||.+|   -+-+.++|+.
T Consensus       293 ---yliFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H---pFF~~Vdw~n  348 (604)
T KOG0592|consen  293 ---YLIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH---PFFEGVDWEN  348 (604)
T ss_pred             ---HHHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC---cccccCChhh
Confidence               1222333321  223455555668999999999999999999998887   3556688865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=324.46  Aligned_cols=245  Identities=29%  Similarity=0.397  Sum_probs=196.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh--------HHHHHHHhhhc-cCCcccEEEEEecCC-eeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA--------SDQIKLLNKIN-HSSLIRLLGICFNGG-NWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~--------~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||+|+.  ++..||||+++..+        .+|++.|++|+ ||||++|.+++.+.+ .+|+|||||+ .+|.+++++
T Consensus        24 GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~  102 (538)
T KOG0661|consen   24 GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD  102 (538)
T ss_pred             eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh
Confidence            99999987  78899999998764        37999999998 999999999999887 8999999995 599999977


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      + ++.+++..+..|+.||++||+|+|++|   +.|||+||+|||+..+..+||+|||+||.......    .+..+.|.+
T Consensus       103 R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP----YTeYVSTRW  174 (538)
T KOG0661|consen  103 R-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP----YTEYVSTRW  174 (538)
T ss_pred             c-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCC----cchhhhccc
Confidence            6 677999999999999999999999966   99999999999999999999999999997765432    234678999


Q ss_pred             ccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCCch-hhhhhhcCCcCCCCCC-
Q 042486          510 YMAPEYLE-NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKEDGE-ESLRHLMDPSMQGNYP-  584 (635)
Q Consensus       510 y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~~-~~l~~~~d~~~~~~~~-  584 (635)
                      |+|||++. .+.|+.+.|+||+||+++|+.+-++.|.+.++-++.  +.+++...-...+.+ ..+...+.-.+....+ 
T Consensus       175 YRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~  254 (538)
T KOG0661|consen  175 YRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPS  254 (538)
T ss_pred             ccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCC
Confidence            99999875 688999999999999999999999888765554322  222222222222222 3444444433221111 


Q ss_pred             ------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 ------PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                            +..+.+..++|.+|+..||.+|||+.|.+++
T Consensus       255 ~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  255 PLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                  2256678999999999999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=317.41  Aligned_cols=241  Identities=25%  Similarity=0.348  Sum_probs=195.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      ++||+|+.  .+..||||++.-        .+.+|++.|+.++||||++++..|..+..+|+||.||.+|++.+.+...-
T Consensus        40 a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~  119 (516)
T KOG0582|consen   40 AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY  119 (516)
T ss_pred             eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc
Confidence            78999988  689999999853        35689999999999999999999999999999999999999999997655


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeee-cccccCCCc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGY  510 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~~gt~~y  510 (635)
                      ...+++..+..|++++++||.|||+.|   .||||||+.||||+++|.+||+|||.....-......... ...+||+.|
T Consensus       120 ~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~w  196 (516)
T KOG0582|consen  120 PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCW  196 (516)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccc
Confidence            555999999999999999999999955   9999999999999999999999999887654432221222 567999999


Q ss_pred             cCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          511 MAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       511 ~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      ||||++..  ..|+.|+||||||++..||.+|..||..+..-.+.+....+.......          ..+..+......
T Consensus       197 mAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t----------~~~~~d~~k~~~  266 (516)
T KOG0582|consen  197 MAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT----------SGLDKDEDKKFS  266 (516)
T ss_pred             cChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc----------ccCChHHhhhhc
Confidence            99999543  568999999999999999999999998776655555544443321110          001111112234


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+++..||+.||.+|||+++++++
T Consensus       267 ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  267 KSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            468999999999999999999999876

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=316.33  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|..-..||    |.||..+.  +++.+|+|.+++.          ..+|..+|.+++||.||++...|++.+.+|||+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            3455555555    89998876  7899999988653          457999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+.||.|..+|++.+.  +++..+.-++.+|+.||.|||+.+   ||||||||+|||||++|.++|+|||+++......
T Consensus       105 d~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             eccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999999976554  888888889999999999999955   9999999999999999999999999998544332


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                         ..+..++||+.|||||++....++..+|.||||+++|||++|.+||...+..                  +..+.+.
T Consensus       180 ---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------------------~~~~~I~  238 (357)
T KOG0598|consen  180 ---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------------------KMYDKIL  238 (357)
T ss_pred             ---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------------------HHHHHHh
Confidence               2355689999999999999999999999999999999999999998643321                  1122222


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC----CHHHHHHHHHHHHhhcccccc
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRP----AMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~L~~~~~~s~~w~~  628 (635)
                      .... ...+...+...+++++++|..||++|.    .+.+|-+|   -+-..++|+.
T Consensus       239 ~~k~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H---pfF~~inW~~  291 (357)
T KOG0598|consen  239 KGKL-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH---PFFKGINWEK  291 (357)
T ss_pred             cCcC-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC---cccccCCHHH
Confidence            2111 122333556689999999999999995    45554433   3445577764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=342.83  Aligned_cols=263  Identities=22%  Similarity=0.396  Sum_probs=213.0

Q ss_pred             ccccHHHHHHhhcCCCC---------CCccc----ceEEEeee--C---CcEEEEEEecc--------ChHHHHHHHhhh
Q 042486          340 KVYTFEELQAATDDFNP---------SCWIK----GSVYRGKI--G---GDFVAIKKVYG--------DASDQIKLLNKI  393 (635)
Q Consensus       340 ~~~~~~el~~at~~f~~---------~~~ig----g~Vy~g~~--~---~~~vavK~~~~--------~~~~E~~~l~~l  393 (635)
                      ..++|||--+|..+|..         +..||    |.||+|++  .   ...||||.++.        +|..|..||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            34577777677666643         22344    89999998  3   34899998864        688899999999


Q ss_pred             ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEE
Q 042486          394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL  473 (635)
Q Consensus       394 ~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIl  473 (635)
                      .||||++|.|+........+|.|||+||+|+.+|+.+.++ +.+.+...+++.||.|++||.+++   +|||||..+|||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNIL  763 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNIL  763 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhhee
Confidence            9999999999999999999999999999999999887766 899999999999999999999866   999999999999


Q ss_pred             ECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhh
Q 042486          474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENM  552 (635)
Q Consensus       474 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~  552 (635)
                      ++.+...|++|||+++..++.......+..-.-..+|.|||.+..++++.++||||||++|||.++ |..|+-..++   
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---  840 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---  840 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---
Confidence            999999999999999977655422222221222358999999999999999999999999999887 6666422111   


Q ss_pred             HHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccc
Q 042486          553 LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA  625 (635)
Q Consensus       553 ~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~  625 (635)
                                     .+.+.. ++...+-..|.+++..|.+|+..||++|-.+||.+.+|+..|.+++.+.-+
T Consensus       841 ---------------QdVIka-Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  841 ---------------QDVIKA-IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             ---------------HHHHHH-HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence                           122222 222334456788899999999999999999999999999999999976544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-37  Score=319.37  Aligned_cols=245  Identities=29%  Similarity=0.340  Sum_probs=187.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.|||++.  +|+.||+|+++-+         ..+||.+|++|+||||++|.+...+.  +.+|||+|||+. +|.-++.
T Consensus       131 g~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~  209 (560)
T KOG0600|consen  131 GQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS  209 (560)
T ss_pred             hheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc
Confidence            89999998  7999999999643         35899999999999999999999876  689999999976 8888886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... -.+++.++..+++||+.||+|||+.   +|+|||||.+|||||.+|.+||+|||+|++.......  ..+..+-|.
T Consensus       210 ~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~--~~T~rVvTL  283 (560)
T KOG0600|consen  210 SPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA--PYTSRVVTL  283 (560)
T ss_pred             CCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCc--ccccceEEe
Confidence            543 3499999999999999999999995   4999999999999999999999999999977654422  234467899


Q ss_pred             CccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC----CchhhhhhhcCCcCCCCC
Q 042486          509 GYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE----DGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       509 ~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----~~~~~l~~~~d~~~~~~~  583 (635)
                      +|+|||.+.+ ..|+.+.|+||.||||.||++|++.+....+-+  ..+.+..+....    +....+...........+
T Consensus       284 WYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y  361 (560)
T KOG0600|consen  284 WYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPY  361 (560)
T ss_pred             eccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHhCCCChhccccccCCcccccCCCCcc
Confidence            9999999886 579999999999999999999998776543322  111221111111    111111111111111112


Q ss_pred             Ch-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          584 PP-------VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       584 ~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..       ..+....+|+..+|..||.+|.|+.+++++
T Consensus       362 ~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  362 KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            21       123446889999999999999999998875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-36  Score=360.55  Aligned_cols=262  Identities=23%  Similarity=0.433  Sum_probs=205.3

Q ss_pred             ccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecCCeeE
Q 042486          342 YTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  412 (635)
                      ++++++..   .+.....+|    |.||+|+.  ++..||||+++..   ..+|++.+++++||||++++|+|.+++..+
T Consensus       683 ~~~~~~~~---~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        683 ITINDILS---SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hhHHHHHh---hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            44555543   344555555    89999986  7889999998642   356899999999999999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +||||+++|+|.++++.     ++|..+.+|+.|++.||+|||..+.++++||||||+||+++.++..++. ||......
T Consensus       760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            99999999999999953     8999999999999999999997655789999999999999999888875 66544321


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      .       .....++..|+|||++.+..++.++|||||||++|||+||+.|+...........+|.......    ....
T Consensus       834 ~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  902 (968)
T PLN00113        834 T-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----CHLD  902 (968)
T ss_pred             c-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc----cchh
Confidence            1       1123678999999999999999999999999999999999999854333333344443332221    1233


Q ss_pred             hhcCCcCCCC--CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          573 HLMDPSMQGN--YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       573 ~~~d~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .++|+.+...  .+......+.+++.+||+.||++||+|+|+++.|+++...+
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            4556555332  33455667889999999999999999999999999997754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-37  Score=325.34  Aligned_cols=226  Identities=28%  Similarity=0.404  Sum_probs=190.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.|-.|+.  +|+.+|||.+...          +.+|+-+|+-++|||++++++++.+..++|+|.||+++|-|.+++-.
T Consensus        26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~  105 (786)
T KOG0588|consen   26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR  105 (786)
T ss_pred             ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh
Confidence            67887876  8999999998654          56899999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ++.  +++.+..++++||+.|+.|+|..+   |+|||+||+|+|||.++++||+|||+|......    ......+|.+.
T Consensus       106 kG~--l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g----klLeTSCGSPH  176 (786)
T KOG0588|consen  106 KGP--LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG----KLLETSCGSPH  176 (786)
T ss_pred             hCC--CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC----ccccccCCCcc
Confidence            654  899999999999999999999977   999999999999999999999999999754432    23455789999


Q ss_pred             ccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |.+||++.+..| ..++||||+|||||.|+||+.||+. +.-...+..+....+                   +.|...+
T Consensus       177 YA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f-------------------~MPs~Is  236 (786)
T KOG0588|consen  177 YAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF-------------------EMPSNIS  236 (786)
T ss_pred             cCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc-------------------cCCCcCC
Confidence            999999998776 6799999999999999999999862 111122222222221                   2345556


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+..+|+.+|+..||++|.|++||++|-
T Consensus       237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  237 SEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHHHHHHHHHhccCccccccHHHHhhCc
Confidence            6689999999999999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.5e-37  Score=322.64  Aligned_cols=239  Identities=26%  Similarity=0.421  Sum_probs=185.1

Q ss_pred             ceEEEeee-------CCcEEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecC-CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNG-GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~lV~E~~~~gsL~  424 (635)
                      |.||+|..       +++.||||+++.        .+.+|+.+|.++ +||||++++++|... +..++||||+++|+|.
T Consensus        21 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (338)
T cd05102          21 GKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLS  100 (338)
T ss_pred             ceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHH
Confidence            89999974       346899999864        255799999999 899999999998764 4579999999999999


Q ss_pred             hhhcccC------------------------------------------------------------CCCCCHHHHHHHH
Q 042486          425 VWINDKG------------------------------------------------------------GKFLDWAQRIQIA  444 (635)
Q Consensus       425 ~~l~~~~------------------------------------------------------------~~~l~~~~~~~i~  444 (635)
                      +++....                                                            ...+++..+..++
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  180 (338)
T cd05102         101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS  180 (338)
T ss_pred             HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence            9985421                                                            1247888999999


Q ss_pred             HHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcc
Q 042486          445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK  524 (635)
Q Consensus       445 ~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  524 (635)
                      .|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....... ........++..|+|||++.+..++.+
T Consensus       181 ~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~  256 (338)
T cd05102         181 FQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLKWMAPESIFDKVYTTQ  256 (338)
T ss_pred             HHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCccccCcHHhhcCCCCcc
Confidence            9999999999984   599999999999999999999999999976532211 111223346678999999998889999


Q ss_pred             cchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCC
Q 042486          525 LDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP  603 (635)
Q Consensus       525 sDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP  603 (635)
                      +||||||+++|||++ |..||........ ....                +.+.. ....+...+..+.+++.+||+.||
T Consensus       257 sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~----------------~~~~~-~~~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         257 SDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQR----------------LKDGT-RMRAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             cCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHH----------------HhcCC-CCCCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999997 8888754222111 1110                00000 011123344568999999999999


Q ss_pred             CCCCCHHHHHHHHHHHHhh
Q 042486          604 SGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       604 ~~RPs~~evl~~L~~~~~~  622 (635)
                      ++||++.|+++.|++++.+
T Consensus       319 ~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         319 KERPTFSALVEILGDLLQE  337 (338)
T ss_pred             hhCcCHHHHHHHHHHHHhc
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=310.73  Aligned_cols=255  Identities=25%  Similarity=0.423  Sum_probs=188.5

Q ss_pred             ceEEEeeeCCcEEEEEEecc----ChHHHHHHHh--hhccCCcccEEEEEecCC----eeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG----DASDQIKLLN--KINHSSLIRLLGICFNGG----NWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~----~~~~E~~~l~--~l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||||+++++.||||++..    .+.+|-++.+  .++|+||+++++.-....    +++||+||.++|+|.+||..+.
T Consensus       224 g~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt  303 (534)
T KOG3653|consen  224 GCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT  303 (534)
T ss_pred             ceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc
Confidence            99999999999999999954    4566766665  468999999999877555    7899999999999999997654


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCC------CCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFT------NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                         ++|....+|+..+++||+|||+..      +++|+|||||++||||..|++..|+|||+|......... ..+...+
T Consensus       304 ---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~-~d~~~qV  379 (534)
T KOG3653|consen  304 ---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQ-GDTHGQV  379 (534)
T ss_pred             ---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCC-cchhhhh
Confidence               899999999999999999999743      467999999999999999999999999999877644322 1223378


Q ss_pred             cCCCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCC-CcchhhH-HHHhhhcccccCCchhhhhh-hcC
Q 042486          506 GTKGYMAPEYLENGL------VSTKLDVYAFGVLMLEMLSGKEAPAL-YSEENML-LVDVLNPVLHKEDGEESLRH-LMD  576 (635)
Q Consensus       506 gt~~y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG~~p~~~-~~~~~~~-l~~~~~~~~~~~~~~~~l~~-~~d  576 (635)
                      ||.+|||||++.+..      .-.+.||||+|.+||||++....... .-.+.+. +...+..    ....+.+++ .+.
T Consensus       380 GT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~----hPt~e~mq~~VV~  455 (534)
T KOG3653|consen  380 GTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN----HPTLEEMQELVVR  455 (534)
T ss_pred             hhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC----CCCHHHHHHHHHh
Confidence            999999999997632      12368999999999999997654321 1111000 0000000    000111111 111


Q ss_pred             CcCCCCCCh-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          577 PSMQGNYPP-----VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       577 ~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      .+.+...+.     .....+.+.++.||+.||+.|.|+.=+.+++..+....-
T Consensus       456 kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  456 KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            122222221     234558999999999999999999999999998875443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=321.78  Aligned_cols=239  Identities=28%  Similarity=0.492  Sum_probs=192.0

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |+||+|+|.|+ ||||.++.         .|.+|+..|++-+|.||+-++|+|..... .+|.-+|+|-+|..+++..+.
T Consensus       406 GtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et  483 (678)
T KOG0193|consen  406 GTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET  483 (678)
T ss_pred             cceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhh
Confidence            99999999886 89999964         37899999999999999999999987777 999999999999999976654


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      + ++....+.|+.|+++|+.|||.   ++|||||||+.|||+.+++.|||+|||++.......+. .......|...|||
T Consensus       484 k-fdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~-~q~~qp~gsilwmA  558 (678)
T KOG0193|consen  484 K-FDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE-QQLEQPHGSLLWMA  558 (678)
T ss_pred             h-hhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccc-cccCCCccchhhhc
Confidence            4 8999999999999999999998   55999999999999999999999999999755433221 12233567788999


Q ss_pred             cccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||++..   ..|++.+||||||+++|||+||..|+. ....+..++..-...+             .+.+ ......++.
T Consensus       559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l-------------~pd~-s~~~s~~pk  623 (678)
T KOG0193|consen  559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYL-------------MPDL-SKIRSNCPK  623 (678)
T ss_pred             HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEeccccc-------------Cccc-hhhhccCHH
Confidence            999863   568999999999999999999999986 2222222211111110             1111 011234456


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      ++.+|+..||..++++||.+.+|+..|+.++.+
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            699999999999999999999999999988863

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-36  Score=289.02  Aligned_cols=244  Identities=30%  Similarity=0.361  Sum_probs=190.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.  +|+.||||+++-         ...+|++.|+.++|+||+.+++.|.+.+...||+||++. +|+..+++.
T Consensus        16 gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~   94 (318)
T KOG0659|consen   16 GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDK   94 (318)
T ss_pred             EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccc
Confidence            89999998  799999999853         246899999999999999999999999999999999965 899998765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..++..++..++.++++||+|||+..   |+||||||.|+|++++|.+||+|||+++........   ..+.+.|.+|
T Consensus        95 ~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~---~~~~V~TRWY  167 (318)
T KOG0659|consen   95 N-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI---QTHQVVTRWY  167 (318)
T ss_pred             c-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc---cccceeeeec
Confidence            4 45999999999999999999999955   999999999999999999999999999987755432   2334789999


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC--chhhhhhhcC-------CcC-
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED--GEESLRHLMD-------PSM-  579 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~~l~~~~d-------~~~-  579 (635)
                      +|||.+.+ ..|+...|+||.||++.||+-|.+.+...++-+ .+...+.. +....  ....+..+.|       |.. 
T Consensus       168 RAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~-LGTP~~~~WP~~~~lpdY~~~~~~P~~~  245 (318)
T KOG0659|consen  168 RAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRA-LGTPTPDQWPEMTSLPDYVKIQQFPKPP  245 (318)
T ss_pred             cChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHH-cCCCCcccCccccccccHHHHhcCCCCc
Confidence            99998875 679999999999999999999986665444332 22222221 11111  0111111111       111 


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....-+..+....+|+.+|+..||.+|+++.|.+++
T Consensus       246 ~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  246 LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111223345557999999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-37  Score=316.04  Aligned_cols=225  Identities=27%  Similarity=0.425  Sum_probs=191.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc----C-----hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----D-----ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||||+.  +.+.||+|.+.+    +     +.+|++++++++||||+.++++|+...+.++|.||+.| +|..++...
T Consensus        16 g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d   94 (808)
T KOG0597|consen   16 GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQD   94 (808)
T ss_pred             ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhc
Confidence            89999986  778999998743    2     67899999999999999999999999999999999977 999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      +.  ++++.+..|+.+++.||.|||+.+   |.|||+||.|||++.++.+|++|||+|+......   .+.....||+.|
T Consensus        95 ~~--lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t---~vltsikGtPlY  166 (808)
T KOG0597|consen   95 GK--LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT---SVLTSIKGTPLY  166 (808)
T ss_pred             cC--CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc---eeeeeccCcccc
Confidence            54  999999999999999999999955   9999999999999999999999999999776532   445668899999


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      ||||.+.+..|+..+|.||+||++||+++|++||...+  ...+.                +.+...  ...+|...+..
T Consensus       167 mAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv----------------~~I~~d--~v~~p~~~S~~  226 (808)
T KOG0597|consen  167 MAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLV----------------KSILKD--PVKPPSTASSS  226 (808)
T ss_pred             cCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHH----------------HHHhcC--CCCCcccccHH
Confidence            99999999999999999999999999999999985311  11111                111111  12345567778


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+++...|..||.+|.+..+++.|
T Consensus       227 f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  227 FVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHHHHHhhcChhhcccHHHHhcC
Confidence            9999999999999999999998876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=316.29  Aligned_cols=231  Identities=28%  Similarity=0.369  Sum_probs=189.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------------hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------------ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------------~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |+|+.|..  ++..||+|.+..+            +.+|+.++++++ ||||++++.++......|+||||+.+|+|.++
T Consensus        31 gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~  110 (370)
T KOG0583|consen   31 GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDY  110 (370)
T ss_pred             eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHH
Confidence            89999977  7899999965442            237999999999 99999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      +...+  .+.+.....++.|++.|++|||+.+   |+||||||+|||++.+ +++||+|||++.....   ........+
T Consensus       111 i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~---~~~~l~t~c  182 (370)
T KOG0583|consen  111 IVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG---EDGLLKTFC  182 (370)
T ss_pred             HHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC---CCCcccCCC
Confidence            97733  3899999999999999999999955   9999999999999999 9999999999987641   112345679


Q ss_pred             cCCCccCccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          506 GTKGYMAPEYLENGL-VS-TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       506 gt~~y~aPE~~~~~~-~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      ||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||......  .                ....+...  ...+
T Consensus       183 Gsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~----------------l~~ki~~~--~~~~  242 (370)
T KOG0583|consen  183 GSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--N----------------LYRKIRKG--EFKI  242 (370)
T ss_pred             CCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--H----------------HHHHHhcC--CccC
Confidence            999999999999866 64 8899999999999999999998642111  1                11111111  1233


Q ss_pred             ChHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          584 PPVT-AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       584 ~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      |... +..+..|+.+||..||.+|+++.||+.  ..|+..
T Consensus       243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~  280 (370)
T KOG0583|consen  243 PSYLLSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK  280 (370)
T ss_pred             CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence            4444 677899999999999999999999993  356654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=340.17  Aligned_cols=240  Identities=30%  Similarity=0.495  Sum_probs=194.4

Q ss_pred             ceEEEeee---CCc----EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI---GGD----FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~---~~~----~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|.+   ++.    .||||.+++        +|.+|..+|++++|||||+++|+|.+.+..++++|||++|+|..+
T Consensus       706 G~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sf  785 (1025)
T KOG1095|consen  706 GEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSF  785 (1025)
T ss_pred             cceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHH
Confidence            99999998   333    499999865        477899999999999999999999999999999999999999999


Q ss_pred             hccc-----CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeee
Q 042486          427 INDK-----GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT  501 (635)
Q Consensus       427 l~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  501 (635)
                      |++.     ....|+..+.+.++.|||+|++||++.+   +|||||..+|+||++...+||+|||+|+.+...+.  ...
T Consensus       786 lr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~y--yr~  860 (1025)
T KOG1095|consen  786 LRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDY--YRK  860 (1025)
T ss_pred             HHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchh--eec
Confidence            9764     1345899999999999999999999954   99999999999999999999999999995443321  111


Q ss_pred             c-ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          502 S-HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       502 ~-~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      . ...-...|||||.+..+.++.|+|||||||++||++|...++......                 .+.+..++... +
T Consensus       861 ~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------------~~v~~~~~~gg-R  922 (1025)
T KOG1095|consen  861 HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------------FEVLLDVLEGG-R  922 (1025)
T ss_pred             cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------------HHHHHHHHhCC-c
Confidence            1 123345899999999999999999999999999999955443221111                 11122122222 3


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      -+.|..++..+.+++..||+.+|++||++..|++.+..+.+...
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            35677788889999999999999999999999999999887653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-35  Score=310.18  Aligned_cols=244  Identities=21%  Similarity=0.335  Sum_probs=187.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  ++..+|+|.+..        .+.+|+++|++++|+||+++++++..++..++||||+++|+|.+++....
T Consensus        19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (331)
T cd06649          19 GVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK   98 (331)
T ss_pred             EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC
Confidence            89999998  578899998753        35689999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||++.......     .....|+..|+
T Consensus        99 --~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~g~~~y~  169 (331)
T cd06649          99 --RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYM  169 (331)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-----cccCCCCcCcC
Confidence              389999999999999999999973  349999999999999999999999999987553221     23356899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhc-ccccCCc-----------------------
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP-VLHKEDG-----------------------  567 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~-~~~~~~~-----------------------  567 (635)
                      |||++.+..++.++|||||||++|||++|+.||.......  +...... .......                       
T Consensus       170 aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (331)
T cd06649         170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDS  247 (331)
T ss_pred             CHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccccccccccccccccc
Confidence            9999998889999999999999999999999986433222  1111111 0000000                       


Q ss_pred             ------hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          568 ------EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       568 ------~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                            .+....+.............+..+.+|+.+||+.||++|||++|++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         248 RPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                  0000111111111111123456689999999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-35  Score=300.15  Aligned_cols=234  Identities=24%  Similarity=0.401  Sum_probs=188.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|.+  .+..||+|.+..+      +.+|++++++++|+||+++++++..++..+++|||+++++|.+++......
T Consensus        20 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~   99 (263)
T cd05052          20 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ   99 (263)
T ss_pred             ceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCC
Confidence            89999987  5789999988653      457999999999999999999999999999999999999999999665545


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++........  .......++..|+||
T Consensus       100 ~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~aP  174 (263)
T cd05052         100 EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAP  174 (263)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee--eccCCCCCccccCCH
Confidence            689999999999999999999985   499999999999999999999999999876543211  111122345689999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      |.+.+..++.++||||||+++|||++ |..|+.....+.  ......                 .......+...+..+.
T Consensus       175 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~  235 (263)
T cd05052         175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE-----------------KGYRMERPEGCPPKVY  235 (263)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH-----------------CCCCCCCCCCCCHHHH
Confidence            99998889999999999999999998 887765322211  111111                 0111122333445689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +++.+||+.||++||++.++++.|+.+
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.1e-36  Score=306.24  Aligned_cols=231  Identities=26%  Similarity=0.313  Sum_probs=185.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  +++.||+|.+...          +.+|++++++++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        14 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   93 (285)
T cd05631          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHh
Confidence            89999987  7899999987531          34689999999999999999999999999999999999999988865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.......    ......||..
T Consensus        94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~~~  166 (285)
T cd05631          94 MGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVG  166 (285)
T ss_pred             hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----eecCCCCCCC
Confidence            44445899999999999999999999854   9999999999999999999999999987643221    1233578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||.........  +            .....+...  ...++...+.
T Consensus       167 y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~------------~~~~~~~~~--~~~~~~~~s~  230 (285)
T cd05631         167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--E------------EVDRRVKED--QEEYSEKFSE  230 (285)
T ss_pred             ccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--H------------HHHHHhhcc--cccCCccCCH
Confidence            99999999999999999999999999999999998643221100  0            000001010  1123333455


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .+.+|+.+||+.||++||+     ++|++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            6899999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.3e-36  Score=312.66  Aligned_cols=226  Identities=25%  Similarity=0.352  Sum_probs=184.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.++..          +.+|++++++++||||+++++++..++..|+||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   88 (323)
T cd05571           9 GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR   88 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999987  7889999988642          34688999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   .......||+.
T Consensus        89 ~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt~~  160 (323)
T cd05571          89 ER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPE  160 (323)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---CcccceecCcc
Confidence            43  4899999999999999999999855   9999999999999999999999999987532211   11234579999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||...+.+.  ...                .+....  ...+...+.
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~----------------~~~~~~--~~~p~~~~~  220 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----------------LILMEE--IRFPRTLSP  220 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHH----------------HHHcCC--CCCCCCCCH
Confidence            999999998889999999999999999999999985432211  111                111100  122334455


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||+.||++||     ++.+++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            689999999999999999     79998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.4e-35  Score=309.41  Aligned_cols=226  Identities=25%  Similarity=0.398  Sum_probs=176.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  +++.||||.+..        .+.+|++++++++|+||+++++++.+++..++||||+++|+|.+..    
T Consensus        88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----  163 (353)
T PLN00034         88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH----  163 (353)
T ss_pred             eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc----
Confidence            89999987  688999999853        2567999999999999999999999999999999999999986543    


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        ...+..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.......   ......||..|+
T Consensus       164 --~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~  235 (353)
T PLN00034        164 --IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYM  235 (353)
T ss_pred             --cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc---cccccccCcccc
Confidence              2567788899999999999999855   99999999999999999999999999876543211   123357899999


Q ss_pred             Ccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          512 APEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       512 aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |||++..     ...+.++|||||||++|||++|+.||.......  +...             ...... ......+..
T Consensus       236 aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~-------------~~~~~~-~~~~~~~~~  299 (353)
T PLN00034        236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASL-------------MCAICM-SQPPEAPAT  299 (353)
T ss_pred             CccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH-------------HHHHhc-cCCCCCCCc
Confidence            9998743     234568999999999999999999986322111  0000             000000 001112233


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+|+.+||+.||++||++.|++++
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            45568999999999999999999999987

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-35  Score=303.40  Aligned_cols=235  Identities=25%  Similarity=0.490  Sum_probs=187.2

Q ss_pred             ceEEEeeeCC-------cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGG-------DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~-------~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|...+       ..||+|.++..        +.+|++++++++|+||+++++++.+.+..+++|||+++++|.++
T Consensus        19 g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~   98 (283)
T cd05048          19 GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF   98 (283)
T ss_pred             CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHH
Confidence            8999998732       46999988642        56799999999999999999999988899999999999999999


Q ss_pred             hcccCC--------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          427 INDKGG--------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       427 l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +.....              ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~  175 (283)
T cd05048          99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY  175 (283)
T ss_pred             HHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeecc
Confidence            854311              35889999999999999999999854   9999999999999999999999999987543


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .... ........++..|+|||.+.++.++.++|||||||++|||++ |..||......+  ....              
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~--------------  238 (283)
T cd05048         176 SADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEM--------------  238 (283)
T ss_pred             cccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH--------------
Confidence            3221 112233456788999999988889999999999999999998 888875432211  1111              


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                        +. .......+...+..+.+|+.+||+.||.+||++.||+++|+++
T Consensus       239 --i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         239 --IR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             --HH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence              11 1111122344556799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-36  Score=293.13  Aligned_cols=244  Identities=24%  Similarity=0.295  Sum_probs=187.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|++  +++.||+|+++.+         ..+||.+|.+++|||||.+-.+...  -+..||||||++. +|...+.
T Consensus        90 GiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d  168 (419)
T KOG0663|consen   90 GVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLME  168 (419)
T ss_pred             eeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHH
Confidence            89999998  7889999999764         3589999999999999999998874  4568999999977 8988886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... +.+...+..-++.|+++|++|||+..   |+|||||++|+|++..|.+||+|||+|+.++.....   .+..+-|.
T Consensus       169 ~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~---~T~lVVTL  241 (419)
T KOG0663|consen  169 TMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP---YTPLVVTL  241 (419)
T ss_pred             hcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCccc---CcceEEEe
Confidence            655 44888999999999999999999966   999999999999999999999999999988765322   34467899


Q ss_pred             CccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-----hhhhhhh--------
Q 042486          509 GYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-----EESLRHL--------  574 (635)
Q Consensus       509 ~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----~~~l~~~--------  574 (635)
                      +|+|||.+.+ ..|+...|+||+|||+.||+++++.|...++-++  .+.+-..+.....     ...+...        
T Consensus       242 WYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~  319 (419)
T KOG0663|consen  242 WYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEH  319 (419)
T ss_pred             eecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccCCCccccchhhccccCCC
Confidence            9999999876 5689999999999999999999987765444322  1111111111100     0011100        


Q ss_pred             cCCcCCCCCChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 MDPSMQGNYPPV-TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~d~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      -...++..++.. ....-.+|+..+|..||++|.|++|.+++
T Consensus       320 pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  320 PYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            000111112211 34556899999999999999999999887

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-35  Score=316.50  Aligned_cols=236  Identities=25%  Similarity=0.407  Sum_probs=183.7

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||++++       ++..||||+++..        +.+|+++|+.+ +||||++++++|.+++..++||||+++|+|.+
T Consensus        49 G~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~  128 (375)
T cd05104          49 GKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLN  128 (375)
T ss_pred             ceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHH
Confidence            89999864       3558999998642        45799999999 89999999999999999999999999999999


Q ss_pred             hhcccC-------------------------------------------------------------------------C
Q 042486          426 WINDKG-------------------------------------------------------------------------G  432 (635)
Q Consensus       426 ~l~~~~-------------------------------------------------------------------------~  432 (635)
                      ++....                                                                         .
T Consensus       129 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (375)
T cd05104         129 FLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDE  208 (375)
T ss_pred             HHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccC
Confidence            885321                                                                         1


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++........ .......++..|+|
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~a  284 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMA  284 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc-cccCCCCCCcceeC
Confidence            2478899999999999999999985   4999999999999999999999999999765432211 11222345668999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      ||.+.+..++.++||||||+++|||++ |..||....... .....+.                 .......+...+..+
T Consensus       285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~l  346 (375)
T cd05104         285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIK-----------------EGYRMLSPECAPSEM  346 (375)
T ss_pred             hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHH-----------------hCccCCCCCCCCHHH
Confidence            999999999999999999999999998 777764322211 1111111                 111111122234568


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .+|+.+||+.||++||++.||++.|++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            9999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.8e-36  Score=313.68  Aligned_cols=223  Identities=20%  Similarity=0.323  Sum_probs=182.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.++.          .+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus        32 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  111 (329)
T PTZ00263         32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK  111 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH
Confidence            89999988  678999998853          245799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......      ....||+.
T Consensus       112 ~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~  180 (329)
T PTZ00263        112 AG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTLCGTPE  180 (329)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc------ceecCChh
Confidence            43  3889999999999999999999855   9999999999999999999999999997653321      23468999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||.......                  ....+.....  ..+...+.
T Consensus       181 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------------------~~~~i~~~~~--~~p~~~~~  240 (329)
T PTZ00263        181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------------------IYEKILAGRL--KFPNWFDG  240 (329)
T ss_pred             hcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------------------HHHHHhcCCc--CCCCCCCH
Confidence            999999998889999999999999999999999985322111                  1111111111  12233445


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .+.+|+.+||+.||++||+     +++++.|
T Consensus       241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            6889999999999999997     6888766

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-35  Score=316.38  Aligned_cols=237  Identities=26%  Similarity=0.438  Sum_probs=185.4

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.       ++..||||+++..        +.+|+++++++ +|+||++++++|...+..++||||+++|+|.+
T Consensus        52 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~  131 (374)
T cd05106          52 GKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN  131 (374)
T ss_pred             ccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHH
Confidence            89999875       2347999998642        45799999999 89999999999999999999999999999999


Q ss_pred             hhcccC--------------------------------------------------------------------CCCCCH
Q 042486          426 WINDKG--------------------------------------------------------------------GKFLDW  437 (635)
Q Consensus       426 ~l~~~~--------------------------------------------------------------------~~~l~~  437 (635)
                      ++....                                                                    ...+++
T Consensus       132 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  211 (374)
T cd05106         132 FLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDL  211 (374)
T ss_pred             HHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCH
Confidence            884321                                                                    124788


Q ss_pred             HHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccc
Q 042486          438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE  517 (635)
Q Consensus       438 ~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  517 (635)
                      ..+.+++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++....... ........++..|+|||++.
T Consensus       212 ~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         212 DDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccCCCCccceeCHHHhc
Confidence            89999999999999999984   499999999999999999999999999875533221 11222334567899999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHH
Q 042486          518 NGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIE  596 (635)
Q Consensus       518 ~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~  596 (635)
                      +..++.++||||||+++|||++ |+.||....... ......                 ........+...+..+.+++.
T Consensus       288 ~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~  349 (374)
T cd05106         288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMV-----------------KRGYQMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHH-----------------HcccCccCCCCCCHHHHHHHH
Confidence            8899999999999999999997 998875432211 111111                 111111112223456899999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          597 SCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       597 ~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +||+.||++||++.+|++.|++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         350 MCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.2e-35  Score=306.18  Aligned_cols=240  Identities=24%  Similarity=0.419  Sum_probs=182.0

Q ss_pred             ceEEEeeeC------------------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          362 GSVYRGKIG------------------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       362 g~Vy~g~~~------------------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      |.||++.+.                  +..||+|.++.        ++.+|+++|.+++|+||+++++++.+.+..++||
T Consensus        19 g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   98 (304)
T cd05096          19 GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT   98 (304)
T ss_pred             eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEE
Confidence            899999752                  33699998864        3567999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccC-----------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC
Q 042486          416 ENAVNGSLSVWINDKG-----------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF  478 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~  478 (635)
                      ||+++|+|.+++....                 ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~  175 (304)
T cd05096          99 EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENL  175 (304)
T ss_pred             ecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCc
Confidence            9999999999884321                 124788899999999999999999855   99999999999999999


Q ss_pred             cEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhC--CCCCCCCcchhhHHHH
Q 042486          479 RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG--KEAPALYSEENMLLVD  556 (635)
Q Consensus       479 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG--~~p~~~~~~~~~~l~~  556 (635)
                      .+||+|||+++....... ........++..|+|||++..+.++.++||||||+++|||+++  ..|+......  ....
T Consensus       176 ~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~--~~~~  252 (304)
T cd05096         176 TIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE--QVIE  252 (304)
T ss_pred             cEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH--HHHH
Confidence            999999999975533221 1223334567889999999888899999999999999999975  4455432221  1111


Q ss_pred             hhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       557 ~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .....+....          .......++..+..+.+++.+||+.||++|||++||.+.|+
T Consensus       253 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         253 NAGEFFRDQG----------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHhhhcc----------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            1111110000          00001112234456899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-36  Score=308.21  Aligned_cols=223  Identities=23%  Similarity=0.355  Sum_probs=183.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+..          .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (291)
T cd05612          15 GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN   94 (291)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH
Confidence            89999988  588999998843          245799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.....      .....|++.
T Consensus        95 ~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~  163 (291)
T cd05612          95 SG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPE  163 (291)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC------cccccCChh
Confidence            43  3899999999999999999999854   999999999999999999999999998765332      123468999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++|||||||++|||++|+.||.......  .                ...+....  ...+...+.
T Consensus       164 y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~----------------~~~i~~~~--~~~~~~~~~  223 (291)
T cd05612         164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--I----------------YEKILAGK--LEFPRHLDL  223 (291)
T ss_pred             hcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H----------------HHHHHhCC--cCCCccCCH
Confidence            999999998889999999999999999999999986432211  1                11111111  112233345


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .+.+++++||+.||.+||+     ++|++++
T Consensus       224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            6899999999999999995     8888877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-35  Score=299.81  Aligned_cols=233  Identities=24%  Similarity=0.381  Sum_probs=184.7

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|.+     .+..||+|.++..        +.+|+..+++++||||+++++++..++..++||||+++|+|.+++.
T Consensus        19 g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   98 (266)
T cd05064          19 GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR   98 (266)
T ss_pred             CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHH
Confidence            89999975     3568999988643        4579999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+|++|||.+.......  ........++.
T Consensus        99 ~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~  172 (266)
T cd05064          99 KHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA--IYTTMSGKSPV  172 (266)
T ss_pred             hCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc--hhcccCCCCce
Confidence            543 24899999999999999999999854   9999999999999999999999999876432211  11111234567


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++|||||||++||+++ |+.||.......  ....+                .+ ......+...
T Consensus       173 ~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~----------------~~-~~~~~~~~~~  233 (266)
T cd05064         173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAV----------------ED-GFRLPAPRNC  233 (266)
T ss_pred             eecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH----------------HC-CCCCCCCCCC
Confidence            8999999999999999999999999999875 888875332211  11111                00 0111123344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +..+.+++.+||+.+|.+||+++||.+.|+++
T Consensus       234 ~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         234 PNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            55689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-35  Score=297.66  Aligned_cols=233  Identities=26%  Similarity=0.416  Sum_probs=186.1

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|.. ++..||+|.++.      ++.+|++++++++|+||+++++++...+..+++|||+++++|.+++.......
T Consensus        20 ~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   99 (261)
T cd05068          20 GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA   99 (261)
T ss_pred             ccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCC
Confidence            79999987 567899999864      35679999999999999999999999999999999999999999997655456


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++.......  ........+..|+|||
T Consensus       100 ~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE  174 (261)
T cd05068         100 LKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--EAREGAKFPIKWTAPE  174 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc--cccCCCcCceeccCcc
Confidence            89999999999999999999985   499999999999999999999999999886542211  1111122345799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      ++.+..++.++||||||+++|||++ |+.|+......  .....+.                 .......+...+..+.+
T Consensus       175 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~~  235 (261)
T cd05068         175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVD-----------------QGYRMPCPPGCPKELYD  235 (261)
T ss_pred             ccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH-----------------cCCCCCCCCcCCHHHHH
Confidence            9998889999999999999999999 88777532211  1111111                 00111122334456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ++.+|++.||++||+++++.+.|+.
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHHHHhc
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=286.14  Aligned_cols=233  Identities=24%  Similarity=0.422  Sum_probs=194.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+|...+.  ++..+|+|.+..+          ..+|..+|+.+.||.++++.+.|.+.+..||||||.+||.|..++++
T Consensus        58 GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk  137 (355)
T KOG0616|consen   58 GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK  137 (355)
T ss_pred             ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh
Confidence            88988876  7899999998653          45799999999999999999999999999999999999999999977


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .+.  +++....-++.+|+.||+|||+.+   |++|||||+|||+|.+|.+||+|||+|+....      .+...+||+.
T Consensus       138 ~~r--F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~------rT~TlCGTPe  206 (355)
T KOG0616|consen  138 SGR--FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG------RTWTLCGTPE  206 (355)
T ss_pred             cCC--CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC------cEEEecCCcc
Confidence            554  899999999999999999999966   99999999999999999999999999986643      2556899999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+....+..++|.|||||++|||+.|.+||.....                  .....+++...+  .+|...+.
T Consensus       207 YLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------------~~iY~KI~~~~v--~fP~~fs~  266 (355)
T KOG0616|consen  207 YLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------------IQIYEKILEGKV--KFPSYFSS  266 (355)
T ss_pred             ccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------------HHHHHHHHhCcc--cCCcccCH
Confidence            9999999999999999999999999999999999864322                  122333333332  45666777


Q ss_pred             HHHHHHHHhhhcCCCCC-----CCHHHHHHHHHHHHhhcccccc
Q 042486          590 LVIRLIESCLKKDPSGR-----PAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~R-----Ps~~evl~~L~~~~~~s~~w~~  628 (635)
                      .+.+|++..|+.|-.+|     .-..+|..|  .|+. +.+|+.
T Consensus       267 ~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H--~wF~-~v~W~~  307 (355)
T KOG0616|consen  267 DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH--PWFK-GVDWEA  307 (355)
T ss_pred             HHHHHHHHHHhhhhHhhhcCcCCCccccccC--cccc-cccHHH
Confidence            79999999999999999     233344444  3333 566765

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.7e-36  Score=301.69  Aligned_cols=232  Identities=32%  Similarity=0.551  Sum_probs=179.0

Q ss_pred             ceEEEeeeC------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIG------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|.+.      +..|+||.++.        ++.+|++.+++++||||++++|++...+..++|+||+++|+|.+++
T Consensus        13 g~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L   92 (259)
T PF07714_consen   13 GKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYL   92 (259)
T ss_dssp             EEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHH
T ss_pred             cEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccc
Confidence            899999987      67899999954        3567899999999999999999999888899999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .......+++..+..|+.|++.||.|||+.   +++|+||+++||++++++.+||+|||++........ ..........
T Consensus        93 ~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-~~~~~~~~~~  168 (259)
T PF07714_consen   93 KSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-YKNDSSQQLP  168 (259)
T ss_dssp             HHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-EEESTTSESG
T ss_pred             cccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            776445599999999999999999999985   499999999999999999999999999986632211 1222334567


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+....++.++||||||+++|||++ |+.|+......  ..                ...+.+.. ....+..
T Consensus       169 ~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~----------------~~~~~~~~-~~~~~~~  229 (259)
T PF07714_consen  169 LRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EI----------------IEKLKQGQ-RLPIPDN  229 (259)
T ss_dssp             GGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HH----------------HHHHHTTE-ETTSBTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccc--cc----------------cccccccc-cceeccc
Confidence            78999999998889999999999999999999 56665433211  11                11111111 1122333


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+..+.+++.+||+.||++||++.++++.|
T Consensus       230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            455689999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=300.72  Aligned_cols=244  Identities=27%  Similarity=0.342  Sum_probs=189.9

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------------------ChHHHHHHHhhhccCCcccEEE
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------------------DASDQIKLLNKINHSSLIRLLG  403 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------------------~~~~E~~~l~~l~h~nIv~l~~  403 (635)
                      .+.|.....||    |.|-+++.  +++.||||.+.+                     .+.+||.+|++++|+|||+|+.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            34454444555    88888887  789999998843                     2458999999999999999999


Q ss_pred             EEec--CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEE
Q 042486          404 ICFN--GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK  481 (635)
Q Consensus       404 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  481 (635)
                      +..+  .+.+|||+|||..|.+...-....  .+++.+.++++.++..||+|||.++   |+||||||+|+||+++|++|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEE
Confidence            9875  456899999999888755432221  1899999999999999999999955   99999999999999999999


Q ss_pred             EeeecCccccccc--CCceeeecccccCCCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHH
Q 042486          482 IANFALARPAERQ--EGEFALTSHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV  555 (635)
Q Consensus       482 l~Dfg~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~  555 (635)
                      |+|||.+......  .+........+||+.|+|||....+.    .+.+.||||+||+||-|+.|+.||....       
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-------  323 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-------  323 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-------
Confidence            9999998755222  11112223478999999999887633    4678999999999999999999985311       


Q ss_pred             HhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       556 ~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                                 ..+..+++++..+.....++....+.+||++||+.||++|.+..+|..|.-
T Consensus       324 -----------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  324 -----------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             -----------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence                       123334444444433333456677999999999999999999999988754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=307.87  Aligned_cols=242  Identities=24%  Similarity=0.423  Sum_probs=193.9

Q ss_pred             ceEEEeeeCC-cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGG-DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~-~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.|..+..++ ..||||.+++        +|.+|+++|.+++||||++|+|+|..++.+++++||+++|+|.+++.....
T Consensus       552 GEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea  631 (807)
T KOG1094|consen  552 GEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL  631 (807)
T ss_pred             ceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC
Confidence            8899998865 8999999976        367899999999999999999999999999999999999999999977654


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+.-.....|+.||+.||+||.+..   +|||||.++|+|+|+++++||+|||+++..-..+. +......+-..+|||
T Consensus       632 pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y-y~vqgr~vlpiRwma  707 (807)
T KOG1094|consen  632 PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY-YRVQGRAVLPIRWMA  707 (807)
T ss_pred             cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc-eeeecceeeeeeehh
Confidence            43556677789999999999999966   99999999999999999999999999996544332 222334556689999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      ||.+..++++.++|||+||+++||+++  ...|+....++  ...+....++....          +......|..++..
T Consensus       708 wEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~----------~~~~l~~P~~cp~~  775 (807)
T KOG1094|consen  708 WESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQG----------RQVVLSRPPACPQG  775 (807)
T ss_pred             HHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCC----------cceeccCCCcCcHH
Confidence            999999999999999999999999866  44565432222  22222222222111          11122346667788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +.+++.+||..|.++||+++++...|.+.
T Consensus       776 lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  776 LYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            99999999999999999999999998864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.6e-35  Score=296.59  Aligned_cols=234  Identities=24%  Similarity=0.403  Sum_probs=186.5

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|.. ++..||+|.+..      .+.+|+.++++++|+||+++++.+.+.+..+++|||+++++|.+++.......
T Consensus        20 g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~   99 (261)
T cd05072          20 GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK   99 (261)
T ss_pred             ceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCC
Confidence            89999987 567899998764      34579999999999999999999999999999999999999999997655556


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........  .......++..|+|||
T Consensus       100 ~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE  174 (261)
T cd05072         100 VLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPE  174 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce--eccCCCccceecCCHH
Confidence            899999999999999999999854   99999999999999999999999999986543221  1112234567899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      ++..+.++.++||||||+++|+|++ |+.||.......  ....+...             .    ........+..+.+
T Consensus       175 ~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~-------------~----~~~~~~~~~~~~~~  235 (261)
T cd05072         175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRG-------------Y----RMPRMENCPDELYD  235 (261)
T ss_pred             HhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcC-------------C----CCCCCCCCCHHHHH
Confidence            9988889999999999999999998 888875322211  11111100             0    00111223455899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      ++.+||..+|++||+++++.+.|+++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=310.79  Aligned_cols=231  Identities=21%  Similarity=0.310  Sum_probs=184.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||+++..          +.+|++++++++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (333)
T cd05600          15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN   94 (333)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence            89999998  5789999998642          45689999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....      ......||+.
T Consensus        95 ~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------~~~~~~gt~~  163 (333)
T cd05600          95 LG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPD  163 (333)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc------ccCCcccCcc
Confidence            43  3899999999999999999999855   99999999999999999999999999975543      1234578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||........  ...+....      ..   +..+.. .......+.
T Consensus       164 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~------~~---~~~~~~-~~~~~~~s~  231 (333)
T cd05600         164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWK------ET---LQRPVY-DDPRFNLSD  231 (333)
T ss_pred             ccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhcc------cc---ccCCCC-CccccccCH
Confidence            9999999988999999999999999999999999864332211  11100000      00   000000 000112355


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||..+|.+||+++|++++
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            68999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=294.70  Aligned_cols=235  Identities=24%  Similarity=0.424  Sum_probs=186.6

Q ss_pred             ceEEEeeeC-----CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|++.     ...||||.++..        +.+|+.++++++|+||+++++++..++..+++|||+++++|.+++.
T Consensus        18 g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~   97 (266)
T cd05033          18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR   97 (266)
T ss_pred             ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHH
Confidence            899999872     347999987642        4568999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .... .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+++........ .......++.
T Consensus        98 ~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~  172 (266)
T cd05033          98 ENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPI  172 (266)
T ss_pred             hccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc-eeccCCCCCc
Confidence            5443 489999999999999999999984   4999999999999999999999999999876522211 1122234567


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++||||||+++|||++ |..|+.......  ..+.+..                . .....+...
T Consensus       173 ~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~----------------~-~~~~~~~~~  233 (266)
T cd05033         173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVED----------------G-YRLPPPMDC  233 (266)
T ss_pred             cccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHc----------------C-CCCCCCCCC
Confidence            8999999998889999999999999999998 888874322211  1111110                0 001112234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +..+.+++.+||+.+|++||+++|++++|++++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=306.10  Aligned_cols=226  Identities=22%  Similarity=0.308  Sum_probs=182.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.++..          +.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   86 (312)
T cd05585           7 GKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR   86 (312)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh
Confidence            89999987  5789999988532          34689999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   .......||+.
T Consensus        87 ~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~  158 (312)
T cd05585          87 EG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNTFCGTPE  158 (312)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC---CccccccCCcc
Confidence            43  3899999999999999999999855   9999999999999999999999999987543221   12234578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++|||||||++|||++|+.||.......                  ....+....  ...+...+.
T Consensus       159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------------------~~~~~~~~~--~~~~~~~~~  218 (312)
T cd05585         159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------------------MYRKILQEP--LRFPDGFDR  218 (312)
T ss_pred             cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------------------HHHHHHcCC--CCCCCcCCH
Confidence            999999999889999999999999999999999985422211                  111111111  122333455


Q ss_pred             HHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPA---MDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs---~~evl~~  615 (635)
                      .+.+++.+||+.||++||+   +.|++.+
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            6899999999999999985   5666554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.7e-35  Score=303.55  Aligned_cols=248  Identities=23%  Similarity=0.403  Sum_probs=190.6

Q ss_pred             CCCCCccc----ceEEEeee--CCc----EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          354 FNPSCWIK----GSVYRGKI--GGD----FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~--~~~----~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      |.....||    |.||+|++  ++.    .||+|.++.        ++.+|+.++++++|+||++++|+|... ..++++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            44444444    89999986  333    489999853        245788999999999999999999764 568999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        88 e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          88 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             ecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCC
Confidence            9999999999997543 23889999999999999999999854   9999999999999999999999999998665332


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      ... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.......  +....                
T Consensus       164 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~----------------  224 (316)
T cd05108         164 KEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----------------  224 (316)
T ss_pred             cce-eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----------------
Confidence            211 1122234668999999999999999999999999999998 888875322211  11111                


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                       ........+......+.+++.+||+.||.+||++.+++..|.++......|
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~  275 (316)
T cd05108         225 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  275 (316)
T ss_pred             -hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence             011111112233455889999999999999999999999999998766443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-34  Score=304.49  Aligned_cols=248  Identities=20%  Similarity=0.333  Sum_probs=186.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||++..  ++..+|+|.+..        .+.+|++++++++|+||++++++|.+++..++||||+++|+|.+++....
T Consensus        19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (333)
T cd06650          19 GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   98 (333)
T ss_pred             EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC
Confidence            89999988  578899998753        25689999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++.....++.+++.||.|||+.  .+++||||||+||+++.++.+||+|||++.......     .....|+..|+
T Consensus        99 --~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~y~  169 (333)
T cd06650          99 --RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYM  169 (333)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-----cccCCCCcccc
Confidence              388999999999999999999972  359999999999999999999999999987543221     12346899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc------------------------
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG------------------------  567 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------------------------  567 (635)
                      |||++.+..++.++|||||||++|||++|+.||.........  ............                        
T Consensus       170 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (333)
T cd06650         170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRP  247 (333)
T ss_pred             CHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCccchhhhhcccccc
Confidence            999999888999999999999999999999998643322111  110000000000                        


Q ss_pred             ----hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          568 ----EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       568 ----~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                          ......+.............+..+.+|+.+||+.||++||+++|++++  .++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h--~~~~~  304 (333)
T cd06650         248 PMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH--AFIKR  304 (333)
T ss_pred             cccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC--HHHhc
Confidence                000000000000000011234568999999999999999999999876  45543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.3e-35  Score=307.48  Aligned_cols=226  Identities=24%  Similarity=0.351  Sum_probs=183.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+..+          +.+|++++++++||||+++++++..++..++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~   88 (328)
T cd05593           9 GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR   88 (328)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh
Confidence            89999987  6889999998642          34688999999999999999999999999999999999999998865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+.
T Consensus        89 ~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~~  160 (328)
T cd05593          89 ER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATMKTFCGTPE  160 (328)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc---cccccccCCcC
Confidence            43  3899999999999999999999854   9999999999999999999999999987532211   11233578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||...+...  ....                +...  ....+...+.
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~----------------~~~~--~~~~p~~~~~  220 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL----------------ILME--DIKFPRTLSA  220 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHH----------------hccC--CccCCCCCCH
Confidence            999999998889999999999999999999999985432211  1000                0000  0112333455


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||+.||++||     ++.|++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            689999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.8e-35  Score=300.25  Aligned_cols=244  Identities=22%  Similarity=0.313  Sum_probs=183.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||+|+++.         .+.+|++++++++|+||+++++++..++..++||||++++.+..+....
T Consensus        15 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   94 (287)
T cd07848          15 GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP   94 (287)
T ss_pred             EEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC
Confidence            89999998  578999998753         2457999999999999999999999999999999999987776554332


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                        ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  .......|+..|
T Consensus        95 --~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y  167 (287)
T cd07848          95 --NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWY  167 (287)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc--cccccccccccc
Confidence              34899999999999999999999854   99999999999999999999999999986543221  112235689999


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh---------hhcCCcCC-
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR---------HLMDPSMQ-  580 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~---------~~~d~~~~-  580 (635)
                      +|||++.+..++.++|||||||++|||++|+.||......... .. +....... ..+...         ....+... 
T Consensus       168 ~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~-~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  244 (287)
T cd07848         168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL-FT-IQKVLGPL-PAEQMKLFYSNPRFHGLRFPAVNH  244 (287)
T ss_pred             CCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH-HH-HHHhhCCC-CHHHHHhhhccchhcccccCcccC
Confidence            9999999888999999999999999999999988654332211 10 00000000 000000         00000000 


Q ss_pred             -----CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 -----GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                           ..+....+..+.+|+.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                 01111234568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=303.87  Aligned_cols=227  Identities=26%  Similarity=0.412  Sum_probs=188.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||||.+  .++.||+|.+.-        +..+|+.+|.+++++||.+++|.+..+..++++|||+.||++.+.++...
T Consensus        27 G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~  106 (467)
T KOG0201|consen   27 GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN  106 (467)
T ss_pred             ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC
Confidence            99999998  688999999853        35579999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+.-|+++++.||.|||..+   .+|||||+.|||+..+|.+||+|||.+-......   .....++||+.||
T Consensus       107 --~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---~rr~tfvGTPfwM  178 (467)
T KOG0201|consen  107 --ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---KRRKTFVGTPFWM  178 (467)
T ss_pred             --CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh---hcccccccccccc
Confidence              2578888889999999999999955   9999999999999999999999999997665433   2235689999999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||++....|+.|+||||||++.+||.+|.+|+.......         +      .-.+.+-.-|.+.+    ..+..+
T Consensus       179 APEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------v------lflIpk~~PP~L~~----~~S~~~  239 (467)
T KOG0201|consen  179 APEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------V------LFLIPKSAPPRLDG----DFSPPF  239 (467)
T ss_pred             chhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------E------EEeccCCCCCcccc----ccCHHH
Confidence            9999998899999999999999999999999975322210         0      01111111223322    445569


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++..||+.||+.||++.++++|
T Consensus       240 kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  240 KEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhh
Confidence            999999999999999999999876

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-36  Score=278.79  Aligned_cols=236  Identities=26%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|+.+..+|    |.||.|+.  ++..||+|++..          ++.+|+++-+.|+||||++++++|.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            4555555555    89999988  677999998854          3568999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||..+|.|...|.......+++.....++.|+|.||.|+|.   ++++||||||+|+|++.++.+||+|||-+.....  
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  176 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence            99999999999986666668999999999999999999998   5599999999999999999999999998865432  


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                         ......+||..|.+||...+...+...|+|++|++.||++.|.+||.....+                  +..+++.
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------------------etYkrI~  235 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------------------ETYKRIR  235 (281)
T ss_pred             ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------------------HHHHHHH
Confidence               1234578999999999999999999999999999999999999998654321                  1222221


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .-  .-.+|...+....++|.+|+..+|.+|.+..|++++
T Consensus       236 k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  236 KV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             Hc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            11  112345556668999999999999999999999987

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.9e-35  Score=307.15  Aligned_cols=226  Identities=25%  Similarity=0.348  Sum_probs=183.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.++.+          +.+|++++++++||||+++++.+..++..|+||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~   88 (323)
T cd05595           9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   88 (323)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999987  6889999998642          34688999999999999999999999999999999999999988865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......   .......||+.
T Consensus        89 ~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~~  160 (323)
T cd05595          89 ER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPE  160 (323)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC---CccccccCCcC
Confidence            43  3899999999999999999999855   9999999999999999999999999987532211   11223568999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||...+....                  ...+....  ...+...+.
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------------------~~~~~~~~--~~~p~~~~~  220 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------------------FELILMEE--IRFPRTLSP  220 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------------------HHHHhcCC--CCCCCCCCH
Confidence            9999999988999999999999999999999999854322211                  11111111  012333455


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||+.||++||     ++.+++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            689999999999999998     88888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-34  Score=298.06  Aligned_cols=242  Identities=24%  Similarity=0.446  Sum_probs=190.4

Q ss_pred             ceEEEeee-------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++.       ++..+|+|.+..       ++.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus        19 ~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (288)
T cd05093          19 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL   98 (288)
T ss_pred             eeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHH
Confidence            89999974       235689998854       3567999999999999999999999999999999999999999998


Q ss_pred             cccC-----------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          428 NDKG-----------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       428 ~~~~-----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      ....           ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        99 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  175 (288)
T cd05093          99 RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY  175 (288)
T ss_pred             HHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCce
Confidence            5322           234899999999999999999999854   99999999999999999999999999875533221


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                       ........++..|+|||.+.+..++.++||||||+++|||++ |..||.......  ...                .+.
T Consensus       176 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~----------------~i~  236 (288)
T cd05093         176 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----------------CIT  236 (288)
T ss_pred             -eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----------------HHH
Confidence             111223445778999999998889999999999999999999 787765332211  111                111


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                      .... ...+...+..+.+++.+||+.||.+||+++|+++.|+++...+..|
T Consensus       237 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~  286 (288)
T cd05093         237 QGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY  286 (288)
T ss_pred             cCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence            1000 0111123345899999999999999999999999999999887665

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-34  Score=292.13  Aligned_cols=233  Identities=24%  Similarity=0.420  Sum_probs=183.7

Q ss_pred             ceEEEeee----CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|.+    ++..+|+|.++.         ++.+|+.++++++|+||+++++++. ++.+++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   87 (257)
T cd05116           9 GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ   87 (257)
T ss_pred             cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH
Confidence            89999965    567899998753         2457899999999999999999885 456799999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.................++.
T Consensus        88 ~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  162 (257)
T cd05116          88 KNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV  162 (257)
T ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCc
Confidence            543  3899999999999999999999854   99999999999999999999999999986544332111112233457


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+....++.++||||||+++|||++ |+.||......  .....+.                 .......+...
T Consensus       163 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~-----------------~~~~~~~~~~~  223 (257)
T cd05116         163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIE-----------------SGERMECPQRC  223 (257)
T ss_pred             cccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH-----------------CCCCCCCCCCC
Confidence            8999999988889999999999999999998 88887543221  1111111                 11111223334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +..+.+++.+||+.||++||++.+|.+.|+..
T Consensus       224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            56689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.5e-35  Score=300.91  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=182.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|..  +++.||+|.++.        .+.+|++++++++|+||+++++++..++..++||||+++ +|.+++....
T Consensus        19 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~   97 (288)
T cd07871          19 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG   97 (288)
T ss_pred             EEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcC
Confidence            89999987  688999998753        245899999999999999999999999999999999975 8998886543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   ......++..|+
T Consensus        98 -~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~---~~~~~~~~~~y~  170 (288)
T cd07871          98 -NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK---TYSNEVVTLWYR  170 (288)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc---cccCceeccccc
Confidence             34789999999999999999999854   99999999999999999999999999875432221   122346789999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccc----cCCchhhhhhhcCCcCCCC--
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLH----KEDGEESLRHLMDPSMQGN--  582 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~----~~~~~~~l~~~~d~~~~~~--  582 (635)
                      |||.+.+ ..++.++|||||||++|||++|+.||......+..  ..........    .-...+.......+.....  
T Consensus       171 aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (288)
T cd07871         171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPL  250 (288)
T ss_pred             ChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCch
Confidence            9998865 56899999999999999999999998654322211  1111000000    0000011111111111100  


Q ss_pred             --CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 --YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .....+....+|+.+||+.||.+|||++|+++|
T Consensus       251 ~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         251 INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              011224457899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-34  Score=292.56  Aligned_cols=230  Identities=27%  Similarity=0.440  Sum_probs=182.1

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.+ ++..+|+|.++.      ++.+|+++|++++|+||+++++++..++..++||||+++|+|.+++..... .
T Consensus        18 ~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~   96 (256)
T cd05114          18 GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-K   96 (256)
T ss_pred             ceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc-C
Confidence            79999988 456899998754      356799999999999999999999999999999999999999999865433 3


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||.++.......  .......++..|+|||
T Consensus        97 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE  171 (256)
T cd05114          97 LSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPPE  171 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce--eccCCCCCchhhCChh
Confidence            899999999999999999999854   99999999999999999999999999875532211  1112233556899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.||.......  ....+..                .. ....+...+..+.+
T Consensus       172 ~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i~~----------------~~-~~~~~~~~~~~~~~  232 (256)
T cd05114         172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMISR----------------GF-RLYRPKLASMTVYE  232 (256)
T ss_pred             hcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC----------------CC-CCCCCCCCCHHHHH
Confidence            9988889999999999999999999 887875332211  1111110                00 00112223456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      ++.+||+.||++||+++|+++.|
T Consensus       233 li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=291.22  Aligned_cols=229  Identities=29%  Similarity=0.505  Sum_probs=187.6

Q ss_pred             ceEEEeeeCCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||++...++.||+|.++.+      +.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.......+
T Consensus        20 g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~   99 (256)
T cd05039          20 GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI   99 (256)
T ss_pred             ceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCC
Confidence            899999999999999998764      44689999999999999999999988899999999999999999976554469


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      ++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.++.......      ....+..|+|||+
T Consensus       100 ~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~ape~  170 (256)
T cd05039         100 TLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD------SGKLPVKWTAPEA  170 (256)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc------cCCCcccccCchh
Confidence            99999999999999999999855   99999999999999999999999999986532211      2234567999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      +..+.++.++||||||+++|||++ |+.||.......  +......                 ......+...+..+.++
T Consensus       171 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~l  231 (256)
T cd05039         171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEK-----------------GYRMEAPEGCPPEVYKV  231 (256)
T ss_pred             hcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhc-----------------CCCCCCccCCCHHHHHH
Confidence            998889999999999999999997 888875432211  1111110                 00111222334568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      +.+||..+|++||+++|+++.|+.
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHhccChhhCcCHHHHHHHHhc
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=310.32  Aligned_cols=237  Identities=28%  Similarity=0.482  Sum_probs=192.9

Q ss_pred             ceEEEeee---CC--cE-EEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI---GG--DF-VAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~---~~--~~-vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|++   ++  .. ||||..+.          ++.+|.++|++++|+|||+++|++..+..+++|||+|.||+|.+
T Consensus       171 GeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~  250 (474)
T KOG0194|consen  171 GEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDD  250 (474)
T ss_pred             cEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHH
Confidence            99999988   22  23 89998874          25689999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeec-cc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS-HI  504 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~~  504 (635)
                      +|+..+. .++..+++.++.+.|.||+|||+.   +++||||..+|+|++.++.+||+|||+++.....    .... ..
T Consensus       251 ~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~----~~~~~~~  322 (474)
T KOG0194|consen  251 YLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY----VMKKFLK  322 (474)
T ss_pred             HHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce----eeccccc
Confidence            9987654 499999999999999999999994   4999999999999999999999999998755421    1111 22


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      .-...|+|||.+..+.+++++|||||||++||+++ |..|+......                  +....+.....+...
T Consensus       323 klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------------------~v~~kI~~~~~r~~~  384 (474)
T KOG0194|consen  323 KLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------------------EVKAKIVKNGYRMPI  384 (474)
T ss_pred             cCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------------------HHHHHHHhcCccCCC
Confidence            34568999999999999999999999999999999 67776432221                  111112122222334


Q ss_pred             ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       584 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +...+..+..++.+||..||++||+|.++.+.|+.+.....
T Consensus       385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            44566678999999999999999999999999999987654

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-34  Score=293.93  Aligned_cols=236  Identities=25%  Similarity=0.412  Sum_probs=185.1

Q ss_pred             ceEEEeee--CCc---EEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGD---FVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~---~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  ++.   .+|+|.++..        +.+|++++++++|+||+++.+++.+.+..++||||+++++|.+++.
T Consensus        19 g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   98 (268)
T cd05063          19 GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR   98 (268)
T ss_pred             ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHH
Confidence            79999987  333   7999988643        4568999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..................+.
T Consensus        99 ~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  174 (268)
T cd05063          99 DHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI  174 (268)
T ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCc
Confidence            543 34899999999999999999999854   99999999999999999999999999876543322111111223345


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||++.+..++.++||||||+++|||++ |+.|+.......  ....+.                . ......+...
T Consensus       175 ~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~----------------~-~~~~~~~~~~  235 (268)
T cd05063         175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAIN----------------D-GFRLPAPMDC  235 (268)
T ss_pred             eecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHh----------------c-CCCCCCCCCC
Confidence            7999999988889999999999999999998 998875322211  111111                0 0111112233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +..+.+++.+||+.+|++||++.+|++.|.+++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-34  Score=293.07  Aligned_cols=236  Identities=24%  Similarity=0.316  Sum_probs=187.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||||.++.          ++.+|++++++++||||+++++++.+.+..++++||+++|+|.+++..
T Consensus        16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08228          16 SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKY   95 (267)
T ss_pred             eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHH
Confidence            79999987  789999997642          246799999999999999999999999999999999999999998843


Q ss_pred             --cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 --KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 --~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        .....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........   ......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~  169 (267)
T cd08228          96 FKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT  169 (267)
T ss_pred             hhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH---HHhcCCCC
Confidence              2234488999999999999999999985   499999999999999999999999999876543221   11234688


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ..|+|||.+.+..++.++|+||||+++|||++|+.|+.............+.                ........+...
T Consensus       170 ~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~  233 (267)
T cd08228         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE----------------QCDYPPLPTEHY  233 (267)
T ss_pred             ccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh----------------cCCCCCCChhhc
Confidence            8999999998888899999999999999999999997532211111111110                001111112234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         234 SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            56689999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-34  Score=297.81  Aligned_cols=235  Identities=23%  Similarity=0.444  Sum_probs=184.7

Q ss_pred             ceEEEeee------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|..      .+..||+|.++.        ++.+|++++++++|+||+++++++..++..++||||+++++|.+++
T Consensus        19 g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   98 (283)
T cd05090          19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL   98 (283)
T ss_pred             cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHH
Confidence            89999974      457899999863        3567999999999999999999999999999999999999999998


Q ss_pred             cccC---------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          428 NDKG---------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       428 ~~~~---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      ....               ...+++.+.+.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (283)
T cd05090          99 IMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY  175 (283)
T ss_pred             HhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEecccccccccc
Confidence            4221               134789999999999999999999854   9999999999999999999999999997654


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++ |..||......  ...+....           
T Consensus       176 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~-----------  241 (283)
T cd05090         176 SADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMVRK-----------  241 (283)
T ss_pred             CCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc-----------
Confidence            32211 11233445678999999988889999999999999999999 87776432211  11111110           


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                            ......+...+..+.+++.+||+.||++||++.+|.++|.+|
T Consensus       242 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05090         242 ------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW  283 (283)
T ss_pred             ------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence                  000112223345689999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-34  Score=300.52  Aligned_cols=245  Identities=24%  Similarity=0.287  Sum_probs=180.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.||||.++.        .+.+|+.++++++|+||+++++++.+++..++||||+. ++|.+++....
T Consensus        19 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   97 (303)
T cd07869          19 ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP   97 (303)
T ss_pred             EEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC
Confidence            89999998  688999998853        24579999999999999999999999999999999995 68888775433


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   ......+++.|+
T Consensus        98 -~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~  170 (303)
T cd07869          98 -GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH---TYSNEVVTLWYR  170 (303)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc---cCCCCcccCCCC
Confidence             33889999999999999999999855   99999999999999999999999999875432211   122346789999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-----hhhhhhhcCCcCCCCCCh
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-----EESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----~~~l~~~~d~~~~~~~~~  585 (635)
                      |||.+.+ ..++.++|||||||++|||++|+.||....+....+...... ......     ......+.........+.
T Consensus       171 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T cd07869         171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPNEDTWPGVHSLPHFKPERFTLYSPK  249 (303)
T ss_pred             ChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-hCCCChhhccchhhccccccccccccCCc
Confidence            9998865 457889999999999999999999987543322222111110 000000     000000000000000000


Q ss_pred             ---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 ---------VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                               .....+.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         250 NLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence                     012457899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=292.22  Aligned_cols=240  Identities=20%  Similarity=0.292  Sum_probs=187.8

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEE
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      +|.....+|    |.||++..  +++.+|+|.+..            .+.+|++++++++|+||+++++++.+++..++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            344444444    79999976  688999998742            245689999999999999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      +||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.....
T Consensus        83 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          83 MEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999986543  3889999999999999999999855   999999999999999999999999998754332


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      ...........++..|+|||.+.+..++.++||||||+++|||++|+.||...+....                  ....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------------------~~~~  219 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------------------IFKI  219 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------------------HHHH
Confidence            1111111234577899999999988899999999999999999999998753221110                  0111


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .........+......+.+++.+||..+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11111122333445568999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-34  Score=297.68  Aligned_cols=238  Identities=24%  Similarity=0.457  Sum_probs=188.4

Q ss_pred             ceEEEeee-------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++.       ++..+++|.++.       .+.+|++++++++|+||+++++++..++..++||||+++++|.+++
T Consensus        19 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (291)
T cd05094          19 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL   98 (291)
T ss_pred             CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHH
Confidence            89999975       245689998864       3567899999999999999999999999999999999999999998


Q ss_pred             cccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          428 NDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       428 ~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ....              ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~  175 (291)
T cd05094          99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS  175 (291)
T ss_pred             HhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCC
Confidence            5432              134899999999999999999999854   99999999999999999999999999875543


Q ss_pred             cCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      ... ........++..|+|||++.+..++.++||||||+++|||++ |+.|+.......  ..+.               
T Consensus       176 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~---------------  237 (291)
T cd05094         176 TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIEC---------------  237 (291)
T ss_pred             Cce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---------------
Confidence            221 112233456788999999998889999999999999999999 888875432221  1111               


Q ss_pred             hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       573 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                       +..... ...+...+..+.+++.+||+.||++||+++++++.|+++...
T Consensus       238 -~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 -ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             111000 011222345689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-35  Score=308.59  Aligned_cols=223  Identities=24%  Similarity=0.300  Sum_probs=181.7

Q ss_pred             ceEEEeeeC---CcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG---GDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~---~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++..   +..||+|++..          .+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++.
T Consensus        44 g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~  123 (340)
T PTZ00426         44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR  123 (340)
T ss_pred             eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            899999862   35899998743          24469999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......      .....||+
T Consensus       124 ~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~------~~~~~gt~  192 (340)
T PTZ00426        124 RNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCGTP  192 (340)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC------cceecCCh
Confidence            543  3899999999999999999999855   999999999999999999999999999765322      12357899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  .                ...+....  ..++...+
T Consensus       193 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~----------------~~~i~~~~--~~~p~~~~  252 (340)
T PTZ00426        193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--I----------------YQKILEGI--IYFPKFLD  252 (340)
T ss_pred             hhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--H----------------HHHHhcCC--CCCCCCCC
Confidence            9999999998889999999999999999999999986432211  0                11111111  11233344


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ..+.+++++||+.||++|+     +++|++++
T Consensus       253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            5578999999999999995     89988876

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-34  Score=290.74  Aligned_cols=232  Identities=26%  Similarity=0.461  Sum_probs=182.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.+|+|....        .+.+|++++++++|+||+++++++...+..++||||+++++|.+++....
T Consensus         9 g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   88 (252)
T cd05084           9 GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG   88 (252)
T ss_pred             ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC
Confidence            89999987  788999998753        25679999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......... ........+..|+
T Consensus        89 -~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~  163 (252)
T cd05084          89 -PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-STGGMKQIPVKWT  163 (252)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc-ccCCCCCCceeec
Confidence             34899999999999999999999854   999999999999999999999999998754321110 0011112345699


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      |||.+.++.++.++||||||+++|||++ |..|+.......  ...                 ..........+...+..
T Consensus       164 aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~-----------------~~~~~~~~~~~~~~~~~  224 (252)
T cd05084         164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TRE-----------------AIEQGVRLPCPELCPDA  224 (252)
T ss_pred             CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHH-----------------HHHcCCCCCCcccCCHH
Confidence            9999998889999999999999999998 777764322111  000                 00011111223334556


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      +.+++.+||+.||++||++.|+++.|+
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-34  Score=293.73  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=188.3

Q ss_pred             ceEEEeee------CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI------GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||.+.+      ++..||+|.++..        +.+|+++|++++|+||+++++++...  ...+++|||+++++|.+
T Consensus        18 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (283)
T cd05080          18 GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD   97 (283)
T ss_pred             cEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHH
Confidence            78977653      5678999988642        35799999999999999999998753  35799999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++...   .+++.++..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++................
T Consensus        98 ~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  171 (283)
T cd05080          98 YLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD  171 (283)
T ss_pred             HHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCC
Confidence            99653   289999999999999999999985   499999999999999999999999999986543322111122234


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|+|||.+.+..++.++||||||+++|||++|+.|+.............   ... ......+....+.......+.
T Consensus       172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~  247 (283)
T cd05080         172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP---KQG-QMTVVRLIELLERGMRLPCPK  247 (283)
T ss_pred             CCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc---ccc-ccchhhhhhhhhcCCCCCCCC
Confidence            5667999999988889999999999999999999999875432221111111   000 011111222222222223344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ..+..+.+++.+||+.||++||+++++++.|+++.
T Consensus       248 ~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         248 NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            45567999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-34  Score=294.20  Aligned_cols=240  Identities=27%  Similarity=0.415  Sum_probs=184.3

Q ss_pred             ceEEEeee--CCc----EEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++  +++    .+++|.+...        +.+|+..+++++|+||+++++++. +...++++||+++|+|.+++
T Consensus        21 ~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l   99 (279)
T cd05111          21 GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHV   99 (279)
T ss_pred             cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHH
Confidence            89999998  454    4788877532        345677888999999999999885 45578999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++........ .......++
T Consensus       100 ~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~  174 (279)
T cd05111         100 RQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKTP  174 (279)
T ss_pred             Hhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc-cccCCCCCc
Confidence            6543 3489999999999999999999984   4999999999999999999999999999765432211 112234567


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.++.++.++||||||+++|||++ |+.|+.......  ..+...                 .......+..
T Consensus       175 ~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~  235 (279)
T cd05111         175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE-----------------KGERLAQPQI  235 (279)
T ss_pred             ccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH-----------------CCCcCCCCCC
Confidence            78999999998889999999999999999998 888875332211  111111                 0000011112


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                      ....+.+++.+||..||++||++.|+++.|..+...+-.|
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence            2345788999999999999999999999999988765443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-34  Score=293.08  Aligned_cols=237  Identities=24%  Similarity=0.323  Sum_probs=189.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  +++.+|||.+..          ++.+|+.++++++|+||+++++++..++..+++|||+++++|.+++..
T Consensus        16 g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08229          16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHH
Confidence            89999986  788999997642          355789999999999999999999999999999999999999999853


Q ss_pred             --cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 --KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 --~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   ......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~  169 (267)
T cd08229          96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT  169 (267)
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc---ccccccCC
Confidence              22345899999999999999999999854   99999999999999999999999999876543221   11234688


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..||.....+......                .+.........+...
T Consensus       170 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~  233 (267)
T cd08229         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----------------KIEQCDYPPLPSDHY  233 (267)
T ss_pred             cCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh----------------hhhcCCCCCCCcccc
Confidence            8999999998888999999999999999999999997532221111110                111111111112235


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            566999999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.7e-34  Score=290.67  Aligned_cols=235  Identities=22%  Similarity=0.393  Sum_probs=183.0

Q ss_pred             ceEEEeee----CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|++    .+..||+|.+...        +.+|+.++++++|+||+++++++. .+..++||||+++++|.+++..
T Consensus         9 g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~   87 (257)
T cd05115           9 GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG   87 (257)
T ss_pred             ccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh
Confidence            89999976    2456999988542        457899999999999999999885 4567999999999999999864


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.................++..
T Consensus        88 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~  163 (257)
T cd05115          88 KK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK  163 (257)
T ss_pred             CC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcc
Confidence            33 34899999999999999999999854   999999999999999999999999998755433221111122233578


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||.+.+..++.++||||||+++|||++ |..||.......  ....+                 ........+...+
T Consensus       164 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~  224 (257)
T cd05115         164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFI-----------------EQGKRLDCPAECP  224 (257)
T ss_pred             cCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH-----------------HCCCCCCCCCCCC
Confidence            999999988889999999999999999996 888875332211  11111                 0111112233445


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ..+.+++.+||..||++||++.+|.+.|+.+.
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            66899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-34  Score=297.34  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=179.3

Q ss_pred             ceEEEeee---CCcEEEEEEecc---------ChHHHHHHHhhh---ccCCcccEEEEEec-----CCeeEEEeecccCC
Q 042486          362 GSVYRGKI---GGDFVAIKKVYG---------DASDQIKLLNKI---NHSSLIRLLGICFN-----GGNWYLVYENAVNG  421 (635)
Q Consensus       362 g~Vy~g~~---~~~~vavK~~~~---------~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~~~lV~E~~~~g  421 (635)
                      |.||+++.   +++.||+|+++.         .+.+|+.+++++   +||||++++++|..     ....++||||+. +
T Consensus        15 g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~   93 (290)
T cd07862          15 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q   93 (290)
T ss_pred             eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-C
Confidence            89999986   467899998753         234677777766   69999999999862     345899999996 6


Q ss_pred             CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeee
Q 042486          422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT  501 (635)
Q Consensus       422 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  501 (635)
                      +|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....    ...
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~  166 (290)
T cd07862          94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MAL  166 (290)
T ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC----ccc
Confidence            8999986655455899999999999999999999854   999999999999999999999999998755432    122


Q ss_pred             cccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccc--ccCCchhhh---hhhcC
Q 042486          502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL--HKEDGEESL---RHLMD  576 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~~~~~~l---~~~~d  576 (635)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.+ .+........  ...+.....   .....
T Consensus       167 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  245 (290)
T cd07862         167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVALPRQAFH  245 (290)
T ss_pred             ccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchhhhcccchhcc
Confidence            34568999999999988889999999999999999999999886543322 1111111100  000000000   00000


Q ss_pred             CcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +...   ....+..+..+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         246 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000   00111234557899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-34  Score=298.50  Aligned_cols=245  Identities=24%  Similarity=0.416  Sum_probs=190.6

Q ss_pred             CCCCCCccc----ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeE
Q 042486          353 DFNPSCWIK----GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  412 (635)
                      +|.....||    |.||++..       .+..||||.++..        +.+|+++++++ +|+||+++++++...+..+
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            344444444    78999864       2447999987642        55799999999 7999999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      ++|||+.+|+|.+++.......+++.++..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++...
T Consensus       116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            999999999999999765444589999999999999999999985   49999999999999999999999999987554


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .... ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....               
T Consensus       193 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~---------------  255 (302)
T cd05055         193 NDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYK---------------  255 (302)
T ss_pred             CCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHH---------------
Confidence            3221 112223356778999999998889999999999999999998 888865322211 1111               


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                        ..+.......+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       256 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 --LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              1111111111222345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.6e-34  Score=296.08  Aligned_cols=239  Identities=27%  Similarity=0.441  Sum_probs=187.4

Q ss_pred             ceEEEeeeC-------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|+..       ...+|+|.+..        ++.+|++++++++||||+++++.+..++..++++||+.+++|.++
T Consensus        14 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (290)
T cd05045          14 GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF   93 (290)
T ss_pred             cceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHH
Confidence            899999862       24688888753        245799999999999999999999999999999999999999998


Q ss_pred             hccc----------------------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          427 INDK----------------------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       427 l~~~----------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                      +...                      ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        94 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~d  170 (290)
T cd05045          94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISD  170 (290)
T ss_pred             HHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEecc
Confidence            7431                      1134889999999999999999999854   99999999999999999999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccc
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                      ||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .+.+...    
T Consensus       171 fg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~----  243 (290)
T cd05045         171 FGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--RLFNLLK----  243 (290)
T ss_pred             ccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHh----
Confidence            9998754322211 11122345678999999988889999999999999999998 88887533221  1111111    


Q ss_pred             cCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                                   .......+...+..+.+++.+||+.||++||++.|+++.|++++..+
T Consensus       244 -------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~~  290 (290)
T cd05045         244 -------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS  290 (290)
T ss_pred             -------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhcC
Confidence                         11111222334456899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-34  Score=290.90  Aligned_cols=230  Identities=27%  Similarity=0.463  Sum_probs=184.6

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEe-cCCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||++...+..||+|..+.+     +.+|+.++++++|+|++++++++. .++..+++|||+++++|.+++.......+
T Consensus        20 ~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   99 (256)
T cd05082          20 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL   99 (256)
T ss_pred             CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCC
Confidence            799999999999999988654     557999999999999999999865 45568999999999999999976555558


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      ++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......      ....++..|+|||+
T Consensus       100 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~  170 (256)
T cd05082         100 GGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEA  170 (256)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC------CCCccceeecCHHH
Confidence            99999999999999999999854   9999999999999999999999999987543221      12234567999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      +.+..++.++||||||+++|||++ |+.|+.......  ....+.                 .......+...+..+.++
T Consensus       171 ~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~~l  231 (256)
T cd05082         171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE-----------------KGYKMDAPDGCPPVVYDV  231 (256)
T ss_pred             HccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh-----------------cCCCCCCCCCCCHHHHHH
Confidence            998889999999999999999998 887764322111  111110                 001111223345568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +.+||+.||++|||+.++++.|+++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.2e-35  Score=302.89  Aligned_cols=252  Identities=21%  Similarity=0.293  Sum_probs=194.8

Q ss_pred             hhcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEE
Q 042486          350 ATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYL  413 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  413 (635)
                      ..++|..-..||    |.||.++-  +|+.+|+|++++.          +..|-++|...++++||+|+..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            345666555565    99999976  8999999999753          4568889999999999999999999999999


Q ss_pred             EeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ||||++||++..+|...+.  |++.....++.+++.|++-||++|   +|||||||+|+|||..|++||+|||++.-...
T Consensus       219 iMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence            9999999999999976544  999999999999999999999966   99999999999999999999999999853211


Q ss_pred             --------------------cCCcee------------------------eecccccCCCccCccccccCCCCcccchhh
Q 042486          494 --------------------QEGEFA------------------------LTSHIVGTKGYMAPEYLENGLVSTKLDVYA  529 (635)
Q Consensus       494 --------------------~~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S  529 (635)
                                          ......                        .....+|||.|||||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                000000                        012357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCcchh--hHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC
Q 042486          530 FGVLMLEMLSGKEAPALYSEEN--MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP  607 (635)
Q Consensus       530 lGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  607 (635)
                      ||||+||||.|.+||.......  ..+..|-..+-                  .......+.+..+||.+|+. ||++|.
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------------------fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------------------FPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------------------CCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999987544332  11222211111                  11111223557899999999 999997


Q ss_pred             C---HHHHHHHHHHHHhhcccccc
Q 042486          608 A---MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       608 s---~~evl~~L~~~~~~s~~w~~  628 (635)
                      -   ++||.+|   -.-..++|+.
T Consensus       435 G~~G~~EIK~H---PfF~~v~W~~  455 (550)
T KOG0605|consen  435 GSKGAEEIKKH---PFFKGVDWDH  455 (550)
T ss_pred             CcccHHHHhcC---CccccCCcch
Confidence            5   5555444   3455677865

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-35  Score=318.58  Aligned_cols=239  Identities=21%  Similarity=0.312  Sum_probs=192.7

Q ss_pred             ceEEEeee-CC-cEEEEEEecc-------ChHHHHHHHhhhc-cCCcccEEEE-Eec------CCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-GG-DFVAIKKVYG-------DASDQIKLLNKIN-HSSLIRLLGI-CFN------GGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-~~-~~vavK~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~-~~~------~~~~~lV~E~~~~gsL~  424 (635)
                      +.||.+++ .+ ..+|+|++.-       .+.+|+++|++|. |+|||.+++. ...      .-+.+|.||||.||+|-
T Consensus        51 a~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lv  130 (738)
T KOG1989|consen   51 AQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLV  130 (738)
T ss_pred             EEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHH
Confidence            79999998 34 8999999853       2568999999996 9999999993 321      13579999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc---eee-
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE---FAL-  500 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~-  500 (635)
                      +++..+....|++.++++|+.|+++|+.+||... ++|||||||-+||||+.++..||||||.+...-.....   ... 
T Consensus       131 d~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~v  209 (738)
T KOG1989|consen  131 DFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYV  209 (738)
T ss_pred             HHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHH
Confidence            9997554445999999999999999999999986 99999999999999999999999999999743322210   000 


Q ss_pred             --ecccccCCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          501 --TSHIVGTKGYMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       501 --~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                        .-...-|+.|+|||.+.   +..+++|+|||||||+||-|+....||+....                      .+++
T Consensus       210 e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------------------laIl  267 (738)
T KOG1989|consen  210 EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------------------LAIL  267 (738)
T ss_pred             HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------------------eeEE
Confidence              01135789999999874   66789999999999999999999999853211                      1233


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +....-...+.++..|.+||+.||+.||.+||++-+|+.++.++....
T Consensus       268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            443333333567888999999999999999999999999999988654

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-34  Score=293.79  Aligned_cols=232  Identities=27%  Similarity=0.473  Sum_probs=187.9

Q ss_pred             ceEEEeee-CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|.. ++..+|+|.+..       ++.+|++++++++|+||+++++++.+.+..++||||+++++|.+++......
T Consensus        20 ~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~   99 (261)
T cd05148          20 GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ   99 (261)
T ss_pred             ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCC
Confidence            89999998 678899998764       3457899999999999999999999999999999999999999999765556


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||.+.......   .......++..|+||
T Consensus       100 ~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~~~~~~P  173 (261)
T cd05148         100 VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTAP  173 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc---ccccCCCCceEecCH
Confidence            689999999999999999999984   49999999999999999999999999997653321   111233456789999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      |.+.+..++.++||||||+++|+|++ |+.|+.......                  .+..+. .......+...+..+.
T Consensus       174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------------------~~~~~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05148         174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------------------VYDQIT-AGYRMPCPAKCPQEIY  234 (261)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------------------HHHHHH-hCCcCCCCCCCCHHHH
Confidence            99988889999999999999999998 787775322111                  111111 1111122334456689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      +++.+||+.||.+|||++++++.|+.
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-34  Score=303.13  Aligned_cols=239  Identities=24%  Similarity=0.404  Sum_probs=184.8

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecC-CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNG-GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~lV~E~~~~gsL~  424 (635)
                      |.||+|..       +++.||+|+++..        +.+|++++.++ +|+||++++++|... ...+++|||+++++|.
T Consensus        21 g~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~  100 (337)
T cd05054          21 GKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLS  100 (337)
T ss_pred             ceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHH
Confidence            89999964       2468999998642        34689999999 899999999988754 5678999999999999


Q ss_pred             hhhcccC-----------------------------------------------------------CCCCCHHHHHHHHH
Q 042486          425 VWINDKG-----------------------------------------------------------GKFLDWAQRIQIAL  445 (635)
Q Consensus       425 ~~l~~~~-----------------------------------------------------------~~~l~~~~~~~i~~  445 (635)
                      +++....                                                           ...++|..+..++.
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  180 (337)
T cd05054         101 NYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF  180 (337)
T ss_pred             HHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHH
Confidence            9884321                                                           12589999999999


Q ss_pred             HHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCccc
Q 042486          446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL  525 (635)
Q Consensus       446 ~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ks  525 (635)
                      |++.||.|||+.   +|+||||||+||++++++.+||+|||+++........ .......++..|+|||++.+..++.++
T Consensus       181 qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  256 (337)
T cd05054         181 QVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPESIFDKVYTTQS  256 (337)
T ss_pred             HHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccccCcHHhcCCCCCccc
Confidence            999999999984   5999999999999999999999999999865432211 112234566789999999999999999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCC
Q 042486          526 DVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS  604 (635)
Q Consensus       526 DV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~  604 (635)
                      |||||||++|||++ |..||......+ .+...+                 ........+......+.+++.+||+.+|+
T Consensus       257 Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         257 DVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRL-----------------KEGTRMRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHH-----------------hccCCCCCCccCCHHHHHHHHHHccCChh
Confidence            99999999999998 888875322111 111110                 00011111223345689999999999999


Q ss_pred             CCCCHHHHHHHHHHHHhh
Q 042486          605 GRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       605 ~RPs~~evl~~L~~~~~~  622 (635)
                      +||++.|++++|++++..
T Consensus       319 ~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         319 DRPTFSELVEILGDLLQE  336 (337)
T ss_pred             hCcCHHHHHHHHHHHHhc
Confidence            999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-34  Score=309.16  Aligned_cols=257  Identities=19%  Similarity=0.276  Sum_probs=186.6

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEec-cChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVY-GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      +|.....||    |.||+++.  .++.||||... ..+.+|+++|++++|+||+++++++..++..++|||++. ++|.+
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~  248 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYT  248 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHH
Confidence            344444454    79999998  57889999753 356789999999999999999999999999999999994 68888


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++.... ..+++.+++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ .......
T Consensus       249 ~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~~  323 (461)
T PHA03211        249 YLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST-PFHYGIA  323 (461)
T ss_pred             HHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc-ccccccC
Confidence            885433 24999999999999999999999854   999999999999999999999999999765332111 1122356


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcch------hhHHHHhhhccc------ccCCchhhhhh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE------NMLLVDVLNPVL------HKEDGEESLRH  573 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~------~~~l~~~~~~~~------~~~~~~~~l~~  573 (635)
                      ||..|+|||++.+..++.++|||||||++|||++|..++......      ...+...+....      ...........
T Consensus       324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~  403 (461)
T PHA03211        324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ  403 (461)
T ss_pred             CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence            999999999999989999999999999999999988765432111      111111111100      00000000000


Q ss_pred             hcC---CcCCC--CCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          574 LMD---PSMQG--NYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       574 ~~d---~~~~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..   .....  ..+     ......+.+|+.+||+.||++|||+.|++++
T Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000   00000  000     0123457899999999999999999999986

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-34  Score=294.76  Aligned_cols=243  Identities=25%  Similarity=0.407  Sum_probs=185.4

Q ss_pred             cCCCCCCccc----ceEEEeeeC-------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeE
Q 042486          352 DDFNPSCWIK----GSVYRGKIG-------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~~-------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  412 (635)
                      ++|.....+|    |.||+|...       +..||||++..        ++.+|+.++++++|+||+++++++..++..+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            3444444554    799998753       35799998753        2457899999999999999999999889999


Q ss_pred             EEeecccCCCcchhhcccC--------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          413 LVYENAVNGSLSVWINDKG--------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                      +||||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999985422        12367889999999999999999984   499999999999999999999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccc
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                      ||+++........ .......++..|+|||++.++.++.++||||||+++|||++ |..||.......  ....      
T Consensus       163 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~------  233 (277)
T cd05062         163 FGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRF------  233 (277)
T ss_pred             CCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH------
Confidence            9998754332211 11122345678999999998889999999999999999999 566764322211  1111      


Q ss_pred             cCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                                ...... ...+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       234 ----------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 ----------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ----------HHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                      111110 0112233456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.7e-35  Score=305.82  Aligned_cols=245  Identities=25%  Similarity=0.363  Sum_probs=180.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC-----CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG-----GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|+.  ++..||||++..         .+.+|++++++++||||+++++++...     ...|+||||+. ++|.+
T Consensus        14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~   92 (338)
T cd07859          14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ   92 (338)
T ss_pred             eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHH
Confidence            89999987  688999998853         245799999999999999999988643     24799999995 68988


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++................
T Consensus        93 ~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~  167 (338)
T cd07859          93 VIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV  167 (338)
T ss_pred             HHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCC
Confidence            886543  3899999999999999999999855   99999999999999999999999999975433222112223457


Q ss_pred             cCCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------chhhhh
Q 042486          506 GTKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------GEESLR  572 (635)
Q Consensus       506 gt~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~  572 (635)
                      ||..|+|||++.+  ..++.++|||||||++|||++|+.||...+...  ....+........           ..+.+.
T Consensus       168 ~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  245 (338)
T cd07859         168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPETISRVRNEKARRYLS  245 (338)
T ss_pred             CCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence            8999999999865  678999999999999999999999886433211  1111111111000           001111


Q ss_pred             hhcCCcCCCCC---ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.. ......   -+..+..+.+++.+||+.||++||+++|++++
T Consensus       246 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         246 SMRK-KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhcc-cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1110 000000   01123457899999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-34  Score=297.32  Aligned_cols=236  Identities=28%  Similarity=0.464  Sum_probs=185.7

Q ss_pred             ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||++...       ...+|+|.+..+        +.+|+++++++ +|+||+++++++..++..+++|||+++|+|.+
T Consensus        26 g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~  105 (293)
T cd05053          26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD  105 (293)
T ss_pred             ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHH
Confidence            899999862       257999988643        44689999999 89999999999999999999999999999999


Q ss_pred             hhccc--------------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          426 WINDK--------------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       426 ~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      ++...              ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~  182 (293)
T cd05053         106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI  182 (293)
T ss_pred             HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCcccccccc
Confidence            98532              234589999999999999999999984   4999999999999999999999999999865


Q ss_pred             cccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       492 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+.......  ....             
T Consensus       183 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~-------------  246 (293)
T cd05053         183 HHIDYY-RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKL-------------  246 (293)
T ss_pred             ccccce-eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HHHH-------------
Confidence            432211 11122234578999999988889999999999999999998 877764322111  1111             


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                          +........+...+..+.+|+.+||+.||++|||+.|+++.|++++
T Consensus       247 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 ----LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                1111111223334556899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-34  Score=303.10  Aligned_cols=226  Identities=23%  Similarity=0.396  Sum_probs=182.5

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC-----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD-----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~-----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.     +++.||||.++..           +.+|+++|++++||||+++++.+..++..|+||||+++|+|.+
T Consensus        10 g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   89 (323)
T cd05584          10 GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM   89 (323)
T ss_pred             eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHH
Confidence            89999875     5789999988531           3468999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+.+..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......
T Consensus        90 ~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~  161 (323)
T cd05584          90 HLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFC  161 (323)
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---CcccccC
Confidence            996543  3788889999999999999999855   9999999999999999999999999987432221   1123357


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|+|||++.+..++.++||||||+++|||++|+.||.......                  ....+....  ...+.
T Consensus       162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------------------~~~~~~~~~--~~~~~  221 (323)
T cd05584         162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------------------TIDKILKGK--LNLPP  221 (323)
T ss_pred             CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------------------HHHHHHcCC--CCCCC
Confidence            8999999999998888999999999999999999999986432211                  111111111  12233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ..+..+.+++.+||+.||++||     ++++++++
T Consensus       222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            3455689999999999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-34  Score=289.51  Aligned_cols=229  Identities=27%  Similarity=0.390  Sum_probs=186.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  ++..|++|.+..         ++.+|++++++++|+||+++++++.+++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   93 (256)
T cd08529          14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh
Confidence            79999987  688999998742         2457899999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++..+..++.+++.||.|||+.   +++|+||||+||++++++.++|+|||++........   ......++..|
T Consensus        94 ~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y  167 (256)
T cd08529          94 RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---FANTIVGTPYY  167 (256)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc---hhhccccCccc
Confidence            445689999999999999999999984   599999999999999999999999999876543321   12234678899


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      +|||++.+..++.++|+||||++++||++|+.|+.......  ...                ...... ....+...+..
T Consensus       168 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~----------------~~~~~~-~~~~~~~~~~~  228 (256)
T cd08529         168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LIL----------------KIIRGV-FPPVSQMYSQQ  228 (256)
T ss_pred             cCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH----------------HHHcCC-CCCCccccCHH
Confidence            99999998889999999999999999999999986433211  100                011000 11122234456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         229 LAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHhhC
Confidence            8999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.8e-34  Score=293.69  Aligned_cols=251  Identities=24%  Similarity=0.416  Sum_probs=185.2

Q ss_pred             ceEEEeee------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||++..      ++..||+|++..       .+.+|++++++++|+||+++++++..  ....++||||+++++|.++
T Consensus        18 g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   97 (284)
T cd05081          18 GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY   97 (284)
T ss_pred             ceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHH
Confidence            89999874      477899999864       35679999999999999999998764  3467999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +.... ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++................+
T Consensus        98 l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  173 (284)
T cd05081          98 LQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES  173 (284)
T ss_pred             HHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCC
Confidence            96543 2389999999999999999999985   4999999999999999999999999999865433221111222234


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      +..|+|||++.+..++.++||||||+++|||++|..++......   .................+.+.+........+..
T Consensus       174 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (284)
T cd05081         174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPG  250 (284)
T ss_pred             ceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHHHHhcCCcCCCCCC
Confidence            45699999999888999999999999999999988765322111   001100000000001111112221111122233


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         251 CPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            455699999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-34  Score=295.03  Aligned_cols=232  Identities=25%  Similarity=0.314  Sum_probs=184.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||++..  +++.+|+|.+..+          +..|++++++++|+||+++.+++..++..++||||+++|+|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   86 (280)
T cd05608           7 GEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYN   86 (280)
T ss_pred             eeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999987  6889999998532          34689999999999999999999999999999999999999988743


Q ss_pred             --cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 --KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 --~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........   ......||
T Consensus        87 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~g~  160 (280)
T cd05608          87 VDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGT  160 (280)
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---cccccCCC
Confidence              22345899999999999999999999854   99999999999999999999999999875543221   12335689


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||.........              .+.........  ...+...
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~--~~~~~~~  224 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--------------KELKQRILNDS--VTYPDKF  224 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--------------HHHHHhhcccC--CCCcccC
Confidence            9999999999999999999999999999999999998643221100              01111111111  1223344


Q ss_pred             HHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      +..+.+++.+||+.||++||     ++++++++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            56689999999999999999     77888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-34  Score=307.68  Aligned_cols=255  Identities=19%  Similarity=0.233  Sum_probs=187.6

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc-ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      +|.....||    |.||++..  +++.||+|.... .+.+|+++|++++||||+++++++..++..++|+|++. ++|.+
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~  171 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC  171 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence            444444444    89999987  688999998754 46789999999999999999999999999999999985 68888


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......  .......
T Consensus       172 ~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~  244 (391)
T PHA03212        172 YLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA--NKYYGWA  244 (391)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc--ccccccc
Confidence            885543  3899999999999999999999854   99999999999999999999999999975332211  1122357


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc------hhhHHHHhhhcc---ccc--CCchhhhhhh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE------ENMLLVDVLNPV---LHK--EDGEESLRHL  574 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~------~~~~l~~~~~~~---~~~--~~~~~~l~~~  574 (635)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.|+.....      ....+...+...   ...  .+....+...
T Consensus       245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~  324 (391)
T PHA03212        245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI  324 (391)
T ss_pred             CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence            99999999999988899999999999999999999987653221      011111111100   000  0000111110


Q ss_pred             c----CC--cCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 M----DP--SMQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~----d~--~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .    ..  ......+     ...+..+.+|+.+||+.||++|||++|++++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0    00  0000111     1235568999999999999999999999975

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.6e-34  Score=308.41  Aligned_cols=238  Identities=24%  Similarity=0.391  Sum_probs=185.3

Q ss_pred             ceEEEeeeC-------CcEEEEEEecc--------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYG--------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~--------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|+..       +..||||+++.        .+.+|+++|++++ ||||++++++|.+.+..||||||+++|+|.+
T Consensus        51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~  130 (400)
T cd05105          51 GKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVN  130 (400)
T ss_pred             ceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHH
Confidence            899999862       23699999864        2457999999996 9999999999999999999999999999999


Q ss_pred             hhcccC--------------------------------------------------------------------------
Q 042486          426 WINDKG--------------------------------------------------------------------------  431 (635)
Q Consensus       426 ~l~~~~--------------------------------------------------------------------------  431 (635)
                      ++....                                                                          
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (400)
T cd05105         131 YLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDR  210 (400)
T ss_pred             HHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccc
Confidence            874321                                                                          


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          432 --------------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       432 --------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                                          ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus       211 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~  287 (400)
T cd05105         211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDI  287 (400)
T ss_pred             cccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceec
Confidence                                12478888999999999999999985   4999999999999999999999999998755


Q ss_pred             cccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       492 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....+... .....           
T Consensus       288 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-~~~~~-----------  354 (400)
T cd05105         288 MHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-YNKIK-----------  354 (400)
T ss_pred             cccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-HHHHh-----------
Confidence            332211 11223456778999999998889999999999999999997 88887532211111 00000           


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                            .......+...+..+.+++.+||+.||++||++.+|.+.|++++.
T Consensus       355 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         355 ------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                  000111223345568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.4e-35  Score=304.91  Aligned_cols=227  Identities=25%  Similarity=0.349  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.++.+          +.+|++++++++|+||+++.+++..++..|+||||+++|+|.+++..
T Consensus         9 g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~   88 (325)
T cd05594           9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR   88 (325)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999986  7889999988642          24678899999999999999999999999999999999999998865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.......   ......||+.
T Consensus        89 ~~--~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~  161 (325)
T cd05594          89 ER--VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPE  161 (325)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---ccccccCCcc
Confidence            43  389999999999999999999961  3599999999999999999999999999874322211   1223569999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||.....+..  ...                +....  ...+...+.
T Consensus       162 y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~----------------i~~~~--~~~p~~~~~  221 (325)
T cd05594         162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FEL----------------ILMEE--IRFPRTLSP  221 (325)
T ss_pred             cCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHH----------------HhcCC--CCCCCCCCH
Confidence            9999999988999999999999999999999999854322211  010                00000  112223345


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||+.||++|+     ++.+++++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            689999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-34  Score=289.87  Aligned_cols=230  Identities=28%  Similarity=0.455  Sum_probs=182.4

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++++ ++..+|+|.+..      ++.+|++++++++|+||+++++++...+..++||||+++++|.+++..... .
T Consensus        18 ~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~   96 (256)
T cd05059          18 GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-K   96 (256)
T ss_pred             ceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-C
Confidence            89999988 456899998764      356799999999999999999999999999999999999999999965433 4


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.......  .......++..|+|||
T Consensus        97 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe  171 (256)
T cd05059          97 LGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPE  171 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc--cccCCCCCCccccCHH
Confidence            899999999999999999999854   99999999999999999999999999875532211  1111122345799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.||.......  ....+.                 .......+...+..+.+
T Consensus       172 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~~  232 (256)
T cd05059         172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVS-----------------AGYRLYRPKLAPTEVYT  232 (256)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHH-----------------cCCcCCCCCCCCHHHHH
Confidence            9998889999999999999999999 777775432211  111110                 00111122234556999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      ++.+||..+|++||++.|+++.|
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHHh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=301.31  Aligned_cols=234  Identities=27%  Similarity=0.419  Sum_probs=193.2

Q ss_pred             ceEEEeeeCC------cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIGG------DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~~------~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|.+..      -.||||..+.+        |..|..+|++++||||++|+|+|. +...++|||.++-|.|..||
T Consensus       403 GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmEL~~~GELr~yL  481 (974)
T KOG4257|consen  403 GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVMELAPLGELREYL  481 (974)
T ss_pred             cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEecccchhHHHHH
Confidence            8999999832      26999988763        678999999999999999999995 45678999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      +.++.. |+......++.||+.||.|||+   .++|||||..+|||+.....+||+|||+++..+....  ...+...-.
T Consensus       482 q~nk~s-L~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y--YkaS~~kLP  555 (974)
T KOG4257|consen  482 QQNKDS-LPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY--YKASRGKLP  555 (974)
T ss_pred             Hhcccc-chHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccch--hhccccccc
Confidence            766543 8989999999999999999999   4599999999999999999999999999998876542  122223345


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|||||.+....++.++|||-|||++||++. |..||..-...+     .+..              +...-+...|+.
T Consensus       556 IKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----VI~~--------------iEnGeRlP~P~n  616 (974)
T KOG4257|consen  556 IKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----VIGH--------------IENGERLPCPPN  616 (974)
T ss_pred             eeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----eEEE--------------ecCCCCCCCCCC
Confidence            68999999999999999999999999999876 888886433221     1111              111223456777


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ++..|..|+.+||++||.+||++.|+...|+.++.
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            78889999999999999999999999999999886

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.2e-34  Score=289.89  Aligned_cols=231  Identities=28%  Similarity=0.431  Sum_probs=182.9

Q ss_pred             ceEEEeeeC-CcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKIG-GDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~~-~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|++. +..+|+|.++..      +.+|+.++++++||||+++++++...+..+++|||+.+|+|.+++..... .
T Consensus        18 ~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~   96 (256)
T cd05113          18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-R   96 (256)
T ss_pred             ceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-C
Confidence            899999884 446999988653      56799999999999999999999988889999999999999999965433 4


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||.++......  ........++..|+|||
T Consensus        97 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~y~~pe  171 (256)
T cd05113          97 FQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPE  171 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc--eeecCCCccChhhCCHH
Confidence            899999999999999999999854   9999999999999999999999999987553321  11112234567899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.|+.......  .....                ... .....+...+..+.+
T Consensus       172 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~----------------~~~-~~~~~~~~~~~~~~~  232 (256)
T cd05113         172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKV----------------SQG-LRLYRPHLASEKVYA  232 (256)
T ss_pred             HHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH----------------hcC-CCCCCCCCCCHHHHH
Confidence            9988889999999999999999999 888875433211  11110                000 000112223456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ++.+||+.||.+||++.++++.|+
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHhhC
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-35  Score=304.49  Aligned_cols=227  Identities=25%  Similarity=0.408  Sum_probs=192.5

Q ss_pred             EEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCe-eEEEeecccCCCcchhhcccCCC
Q 042486          364 VYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGN-WYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       364 Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      .++++.++..+++|++.-         ...+|+.++++++|||||.+.+.|..++. .+|||+|++||+|.+.+.+..+.
T Consensus        22 lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~  101 (426)
T KOG0589|consen   22 LVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGV  101 (426)
T ss_pred             hhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhc
Confidence            445566888999998853         35689999999999999999999998888 89999999999999999777677


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .++++.+..++.|++.|+.|||+   +.|+|||||+.|||++.++.+||+|||+|+......   .......||+.||.|
T Consensus       102 ~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~---~~a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  102 LFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED---SLASTVVGTPYYMCP  175 (426)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch---hhhheecCCCcccCH
Confidence            79999999999999999999997   459999999999999999999999999999876554   234557899999999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      |.+.+..|..|+|||||||++|||++-+++|...+-..                  .+.++.... ....|..++..+..
T Consensus       176 Eil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------------------Li~ki~~~~-~~Plp~~ys~el~~  236 (426)
T KOG0589|consen  176 EILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------------------LILKINRGL-YSPLPSMYSSELRS  236 (426)
T ss_pred             HHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------------------HHHHHhhcc-CCCCCccccHHHHH
Confidence            99999999999999999999999999998876433221                  111111111 23445667778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.|+..+|..||++.+++.+
T Consensus       237 lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  237 LVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHhhcCCccCCCHHHHhhC
Confidence            9999999999999999999986

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=306.73  Aligned_cols=245  Identities=26%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccCh----------HHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGDA----------SDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~~----------~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.--..+|    |+|+.+..  +++.+|||.++++.          ..|..++... +||.+++|+..|...++.|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            4454444444    89999988  67899999998752          3466666666 599999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+.||++..+.+...   +++....-++..|+.||+|||+.+   ||+||||.+|||||.+|.+||+|||+++..-..
T Consensus       448 mey~~Ggdm~~~~~~~~---F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIHTDV---FSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEecCCCcEEEEEeccc---ccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999766665432   899999999999999999999955   999999999999999999999999999854322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                         ...+..++||+.|||||++.+..|+...|.|||||+||||+.|..||...+++                  +....+
T Consensus       522 ---g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------e~FdsI  580 (694)
T KOG0694|consen  522 ---GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------EVFDSI  580 (694)
T ss_pred             ---CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------------HHHHHH
Confidence               23567799999999999999999999999999999999999999998654433                  233333


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHHHHhhcccccc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM-----DKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~~~~~s~~w~~  628 (635)
                      +..  ...||...+.+..++++++|..+|++|.-+     ++|..   .-+-.+++|+.
T Consensus       581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~---hpFFr~i~w~~  634 (694)
T KOG0694|consen  581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK---HPFFRSIDWDD  634 (694)
T ss_pred             hcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh---CCccccCCHHH
Confidence            322  235778888889999999999999999866     33433   34555677765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.9e-34  Score=292.80  Aligned_cols=233  Identities=26%  Similarity=0.489  Sum_probs=184.4

Q ss_pred             ceEEEeee-------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|+.       ++..||||.++.        ++.+|+++|++++|+||+++++++...+..++||||+++++|.++
T Consensus        19 ~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (280)
T cd05049          19 GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF   98 (280)
T ss_pred             ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHH
Confidence            89999976       246899998854        355799999999999999999999999999999999999999999


Q ss_pred             hcccC------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          427 INDKG------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       427 l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      +...+            ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        99 i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~  175 (280)
T cd05049          99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT  175 (280)
T ss_pred             HHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccC
Confidence            95432            234789999999999999999999854   999999999999999999999999998754322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .. ........++..|+|||++.+..++.++||||||+++|||++ |+.||.......  ..+..               
T Consensus       176 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~---------------  237 (280)
T cd05049         176 DY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECI---------------  237 (280)
T ss_pred             cc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH---------------
Confidence            11 111223345778999999999999999999999999999998 988875332221  11111               


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                       ..... ...+...+..+.+++.+||+.||++||+++|+++.|+
T Consensus       238 -~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 -TQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             11111 1112234456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-35  Score=308.49  Aligned_cols=232  Identities=23%  Similarity=0.319  Sum_probs=184.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||+++..          +.+|++++.+++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (350)
T cd05573          15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR   94 (350)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH
Confidence            89999998  5899999998532          45789999999999999999999999999999999999999999966


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-------------  496 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------------  496 (635)
                      .  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........             
T Consensus        95 ~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~  169 (350)
T cd05573          95 K--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF  169 (350)
T ss_pred             c--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccc
Confidence            5  34899999999999999999999854   99999999999999999999999999976543220             


Q ss_pred             -------------ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc
Q 042486          497 -------------EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       497 -------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                                   .........||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~----  244 (350)
T cd05573         170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-YNKIIN----  244 (350)
T ss_pred             cccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-HHHHhc----
Confidence                         00112335689999999999999999999999999999999999999864332111 001000    


Q ss_pred             cCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 042486          564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-MDKIAQS  615 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  615 (635)
                                .. ...........+..+.+++.+|+. ||.+||+ ++|++++
T Consensus       245 ----------~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         245 ----------WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ----------cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                      00 000000011135568999999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.5e-34  Score=292.24  Aligned_cols=233  Identities=27%  Similarity=0.431  Sum_probs=181.1

Q ss_pred             ceEEEeeeC-------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|.+.       +..||+|....        ++.+|+.++++++|+||+++++++.+.+..++||||+++++|.++
T Consensus        20 g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   99 (277)
T cd05036          20 GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF   99 (277)
T ss_pred             CcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHH
Confidence            899999883       36789998753        256788999999999999999999988899999999999999999


Q ss_pred             hcccC-----CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC---cEEEeeecCcccccccCCce
Q 042486          427 INDKG-----GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF---RAKIANFALARPAERQEGEF  498 (635)
Q Consensus       427 l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +....     ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++   .+||+|||+++....... .
T Consensus       100 i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~  175 (277)
T cd05036         100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-Y  175 (277)
T ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccc-e
Confidence            85432     124899999999999999999999854   99999999999998654   699999999986532211 0


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      ........+..|+|||++.+..++.++|||||||++|||++ |+.||.......  ..+.+.                 .
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~-----------------~  236 (277)
T cd05036         176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVT-----------------G  236 (277)
T ss_pred             ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH-----------------c
Confidence            11112233567999999998889999999999999999997 888875332211  111111                 1


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ......+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111223334556899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.2e-34  Score=282.03  Aligned_cols=245  Identities=26%  Similarity=0.338  Sum_probs=185.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCC-cccEEEEEecCC------eeEEEeecccCCCc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSS-LIRLLGICFNGG------NWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~~~lV~E~~~~gsL  423 (635)
                      |+||+|+.  +|+.||+|+++-+         ..+|+.+|++++|+| |++|++++...+      .+++||||+.. +|
T Consensus        25 g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL  103 (323)
T KOG0594|consen   25 GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DL  103 (323)
T ss_pred             eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cH
Confidence            89999987  8899999998643         358999999999999 999999999876      78999999954 99


Q ss_pred             chhhcccCC--CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeee
Q 042486          424 SVWINDKGG--KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT  501 (635)
Q Consensus       424 ~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  501 (635)
                      ..++.....  ..++...+..++.||+.||.|||+++   |+||||||.||||+++|.+||+|||+|+...-...   ..
T Consensus       104 ~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~---~y  177 (323)
T KOG0594|consen  104 KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR---TY  177 (323)
T ss_pred             HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc---cc
Confidence            999965442  34787899999999999999999966   99999999999999999999999999996543322   13


Q ss_pred             cccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC--chhhhhhhcCCc
Q 042486          502 SHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED--GEESLRHLMDPS  578 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~~l~~~~d~~  578 (635)
                      .+.++|..|+|||++.+. .|+...||||+||++.||++++..|....+.++ +.... ..+....  .......+.+-.
T Consensus       178 t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If-~~lGtP~e~~Wp~v~~~~~~k  255 (323)
T KOG0594|consen  178 TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIF-RLLGTPNEKDWPGVSSLPDYK  255 (323)
T ss_pred             cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHH-HHcCCCCccCCCCcccccccc
Confidence            445789999999999875 799999999999999999999987776555322 11111 1111110  011111111111


Q ss_pred             --CCCCC-ChHH-------HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 --MQGNY-PPVT-------AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 --~~~~~-~~~~-------~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ..... +...       .....+++.+||+.+|.+|.|++..++|
T Consensus       256 ~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  256 APFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              00000 1111       1357899999999999999999999987

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-34  Score=301.11  Aligned_cols=226  Identities=25%  Similarity=0.374  Sum_probs=181.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.||||.++.+          +..|.+++..+ +||||+++++++.+++..|+||||+++|+|..++.
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~   88 (321)
T cd05591           9 GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ   88 (321)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence            89999987  5779999998642          33577788766 79999999999999999999999999999999886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......   .......||.
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~  160 (321)
T cd05591          89 RSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTP  160 (321)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC---ccccccccCc
Confidence            543  3899999999999999999999855   9999999999999999999999999987532221   1123356899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||........                  +..+....  ...+...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------------------~~~i~~~~--~~~p~~~~  220 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------------------FESILHDD--VLYPVWLS  220 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------------------HHHHHcCC--CCCCCCCC
Confidence            99999999988899999999999999999999999864332211                  11111111  11222344


Q ss_pred             HHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRP-------AMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RP-------s~~evl~~  615 (635)
                      ..+.+++.+||+.||++||       ++++++++
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            5689999999999999999       78888766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.5e-34  Score=288.72  Aligned_cols=234  Identities=26%  Similarity=0.451  Sum_probs=184.4

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|+. ++..||+|+++.      ++.+|++++++++|+||+++++++. ++..++||||+++|+|.+++.......
T Consensus        20 ~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~   98 (262)
T cd05071          20 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKY   98 (262)
T ss_pred             CcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccC
Confidence            79999988 445799998864      2567999999999999999999874 456799999999999999997654455


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||.++.......  .......++..|+|||
T Consensus        99 ~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE  173 (262)
T cd05071          99 LRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQGAKFPIKWTAPE  173 (262)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc--ccccCCcccceecCHh
Confidence            89999999999999999999984   499999999999999999999999999976543221  1112234667899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      +..+..++.++||||||+++|||++ |..||.......  ....                +.. ......+...+..+.+
T Consensus       174 ~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~----------------~~~-~~~~~~~~~~~~~l~~  234 (262)
T cd05071         174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ----------------VER-GYRMPCPPECPESLHD  234 (262)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHH----------------Hhc-CCCCCCccccCHHHHH
Confidence            9988889999999999999999999 666664322111  1110                000 0011122334556899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ++.+|++.||++||++.++++.|+.++
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-34  Score=308.86  Aligned_cols=240  Identities=22%  Similarity=0.270  Sum_probs=187.6

Q ss_pred             hhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEE
Q 042486          350 ATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYL  413 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  413 (635)
                      ..++|.....||    |.||+++.  +++.||+|.+..          .+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            345565555555    89999987  688999998853          14578999999999999999999999999999


Q ss_pred             EeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ||||+++|+|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999998653   2788889999999999999999854   99999999999999999999999999876533


Q ss_pred             cCCceeeecccccCCCccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLEN----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE  569 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (635)
                      ...  .......||+.|+|||.+.+    ..++.++|||||||++|||++|+.||.......                  
T Consensus       195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------------------  254 (370)
T cd05596         195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------------  254 (370)
T ss_pred             CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------------------
Confidence            211  11234579999999998864    347899999999999999999999986432211                  


Q ss_pred             hhhhhcCCcCCCCCC--hHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 042486          570 SLRHLMDPSMQGNYP--PVTAILVIRLIESCLKKDPSG--RPAMDKIAQS  615 (635)
Q Consensus       570 ~l~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  615 (635)
                      ....+++......++  ...+..+.+++.+||+.+|++  |++++|++++
T Consensus       255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111111111000111  123556889999999999988  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=295.55  Aligned_cols=231  Identities=26%  Similarity=0.315  Sum_probs=185.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  +++.||+|++..+          +.+|+.++++++|+||+++++.+..++..++||||+++|+|.+++..
T Consensus        14 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05605          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN   93 (285)
T ss_pred             eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh
Confidence            89999987  6889999988532          34699999999999999999999999999999999999999998865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......    ......|+..
T Consensus        94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~  166 (285)
T cd05605          94 MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVG  166 (285)
T ss_pred             cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----ccccccCCCC
Confidence            44445899999999999999999999854   9999999999999999999999999987653221    1123468999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++||||||+++|||++|+.||........ . +             .+...+.. ....++...+.
T Consensus       167 y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~-~-------------~~~~~~~~-~~~~~~~~~~~  230 (285)
T cd05605         167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-R-E-------------EVERRVKE-DQEEYSEKFSE  230 (285)
T ss_pred             ccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-H-H-------------HHHHHhhh-cccccCcccCH
Confidence            9999999988899999999999999999999999864322110 0 0             00000000 11123344556


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+|+.+||+.||++||     ++++++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            689999999999999999     88888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6e-34  Score=289.62  Aligned_cols=235  Identities=23%  Similarity=0.401  Sum_probs=184.6

Q ss_pred             ceEEEeee--C---CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--G---GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~---~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +   +..+|+|.++.        .+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.
T Consensus        18 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   97 (267)
T cd05066          18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR   97 (267)
T ss_pred             CceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHH
Confidence            89999986  2   23799998864        24678999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .... .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.................++.
T Consensus        98 ~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  173 (267)
T cd05066          98 KHDG-QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI  173 (267)
T ss_pred             hcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccce
Confidence            5433 4899999999999999999999854   99999999999999999999999999986644322111112223356


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++|+||||+++||+++ |..||.......  ....+..                . .....+...
T Consensus       174 ~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~----------------~-~~~~~~~~~  234 (267)
T cd05066         174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEE----------------G-YRLPAPMDC  234 (267)
T ss_pred             eecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhC----------------C-CcCCCCCCC
Confidence            8999999998889999999999999999887 998875332211  1111110                0 000112223


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            45689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.3e-34  Score=300.84  Aligned_cols=226  Identities=26%  Similarity=0.405  Sum_probs=180.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||||.++.+          +..|..++.++ +||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~   88 (320)
T cd05590           9 GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ   88 (320)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH
Confidence            89999987  5789999988642          23577777766 69999999999999999999999999999999886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        89 ~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~  160 (320)
T cd05590          89 KSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTP  160 (320)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---CcccccccCc
Confidence            543  3899999999999999999999855   9999999999999999999999999987532221   1223457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.......  .                ...+....  ...+...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~----------------~~~i~~~~--~~~~~~~~  220 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--L----------------FEAILNDE--VVYPTWLS  220 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--H----------------HHHHhcCC--CCCCCCCC
Confidence            9999999998889999999999999999999999986433221  1                11111111  11223345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAM------DKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~------~evl~~  615 (635)
                      ..+.+++.+||+.||++||++      ++++++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            568999999999999999998      555544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-34  Score=288.00  Aligned_cols=243  Identities=25%  Similarity=0.337  Sum_probs=197.5

Q ss_pred             ceEEEeeeC--CcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKIG--GDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~~--~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||.+++.  +...|+|++.++          +..|-+||+.++||.++.|++.+..++..|++||||+||+|...+++
T Consensus        91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk  170 (459)
T KOG0610|consen   91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK  170 (459)
T ss_pred             eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh
Confidence            999999994  479999999653          34588999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc---------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ---------------  494 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~---------------  494 (635)
                      +.++.+++..+.-++.+++.||+|||-.|   ||.|||||+||||.++|.+-|+||.++......               
T Consensus       171 Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~  247 (459)
T KOG0610|consen  171 QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQ  247 (459)
T ss_pred             CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCC
Confidence            88888999999999999999999999966   999999999999999999999999987532110               


Q ss_pred             -----------------C-C--------------------ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHH
Q 042486          495 -----------------E-G--------------------EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLE  536 (635)
Q Consensus       495 -----------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~e  536 (635)
                                       . .                    ....+..++||..|+|||++.+...+.+.|.|+||+++||
T Consensus       248 ~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYE  327 (459)
T KOG0610|consen  248 PSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYE  327 (459)
T ss_pred             cccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHH
Confidence                             0 0                    0012234689999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC----HHHH
Q 042486          537 MLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA----MDKI  612 (635)
Q Consensus       537 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev  612 (635)
                      |+.|..||...+.                  ++.+..++...+.-...+..+....+||++.|..||++|..    +.||
T Consensus       328 mLyG~TPFKG~~~------------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  328 MLYGTTPFKGSNN------------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             HHhCCCCcCCCCc------------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            9999999865433                  33344444333322222355667899999999999999988    7777


Q ss_pred             HHHHHHHHhhcccccc
Q 042486          613 AQSISRFLNASLAWEL  628 (635)
Q Consensus       613 l~~L~~~~~~s~~w~~  628 (635)
                      -+|   -+-+.+.|.-
T Consensus       390 K~H---pFF~gVnWaL  402 (459)
T KOG0610|consen  390 KRH---PFFEGVNWAL  402 (459)
T ss_pred             hcC---ccccCCChhh
Confidence            665   3344566653

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-34  Score=287.05  Aligned_cols=234  Identities=26%  Similarity=0.405  Sum_probs=183.8

Q ss_pred             ceEEEeee--CC---cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GG---DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~---~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|++  .+   ..+|+|.+..+        +.+|++++++++|+||+++++++. .+..++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05060           9 GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK   87 (257)
T ss_pred             eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH
Confidence            89999987  22   68999987643        446899999999999999999875 456799999999999999997


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++................++.
T Consensus        88 ~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~  162 (257)
T cd05060          88 KRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL  162 (257)
T ss_pred             hCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccc
Confidence            554  4899999999999999999999854   99999999999999999999999999986643322111111223456


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+...                 .....+...
T Consensus       163 ~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~-----------------~~~~~~~~~  223 (257)
T cd05060         163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESG-----------------ERLPRPEEC  223 (257)
T ss_pred             cccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcC-----------------CcCCCCCCC
Confidence            7999999998889999999999999999998 88887543221  111111110                 001122334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +..+.+++.+||..+|++||++.++++.|+++.
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            456899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-34  Score=314.08  Aligned_cols=231  Identities=19%  Similarity=0.279  Sum_probs=183.4

Q ss_pred             ceEEEeee--C-CcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc-
Q 042486          362 GSVYRGKI--G-GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK-  430 (635)
Q Consensus       362 g~Vy~g~~--~-~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-  430 (635)
                      |.||++..  + +..||+|.+..       .+.+|+.+|++++||||+++++++..++..|+||||+++|+|.+++... 
T Consensus        81 g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~  160 (478)
T PTZ00267         81 TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL  160 (478)
T ss_pred             cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHH
Confidence            89999976  3 67788887643       2457999999999999999999999999999999999999999988532 


Q ss_pred             -CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 -GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 -~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                       ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ........||+.
T Consensus       161 ~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-~~~~~~~~gt~~  236 (478)
T PTZ00267        161 KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-LDVASSFCGTPY  236 (478)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-cccccccCCCcc
Confidence             234588999999999999999999985   499999999999999999999999999986543221 112334579999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||.......                  .+..+..... ...+...+.
T Consensus       237 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------------------~~~~~~~~~~-~~~~~~~s~  297 (478)
T PTZ00267        237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------------------IMQQVLYGKY-DPFPCPVSS  297 (478)
T ss_pred             ccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHhCCC-CCCCccCCH
Confidence            999999998899999999999999999999999985432211                  1111111110 012223445


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++||++++++.+
T Consensus       298 ~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        298 GMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHhC
Confidence            68999999999999999999998754

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.8e-34  Score=287.48  Aligned_cols=236  Identities=24%  Similarity=0.338  Sum_probs=188.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|..  +++.||+|.++.          .+.+|++++++++|+|++++++++..++..++||||+++++|.+++..
T Consensus        16 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   95 (267)
T cd08224          16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999988  688999997742          355799999999999999999999999999999999999999998853


Q ss_pred             --cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 --KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 --~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        .....+++.++..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........   ......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~  169 (267)
T cd08224          96 FKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT  169 (267)
T ss_pred             hcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCc---ccceecCC
Confidence              22345899999999999999999999855   99999999999999999999999999875543221   11234578


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh-H
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP-V  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~-~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|+|++|+.|+...........+.                +.... ....+. .
T Consensus       170 ~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------------~~~~~-~~~~~~~~  232 (267)
T cd08224         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----------------IEKCD-YPPLPADH  232 (267)
T ss_pred             ccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh----------------hhcCC-CCCCChhh
Confidence            89999999988889999999999999999999999875322111111111                00000 111111 3


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      .+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            4556899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=307.21  Aligned_cols=232  Identities=21%  Similarity=0.266  Sum_probs=180.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||+++..          +.+|+++|++++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~   94 (364)
T cd05599          15 GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK   94 (364)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH
Confidence            89999987  6889999998642          34699999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-----------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-----------  498 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-----------  498 (635)
                      ..  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..........           
T Consensus        95 ~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  169 (364)
T cd05599          95 KD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS  169 (364)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccc
Confidence            43  3899999999999999999999855   9999999999999999999999999987542211000           


Q ss_pred             ------------------------eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHH
Q 042486          499 ------------------------ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL  554 (635)
Q Consensus       499 ------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l  554 (635)
                                              .......||+.|+|||++....++.++|||||||++|||++|+.||........ .
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~-~  248 (364)
T cd05599         170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET-Y  248 (364)
T ss_pred             cccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-H
Confidence                                    001124689999999999988899999999999999999999999864332111 1


Q ss_pred             HHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 042486          555 VDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA---MDKIAQS  615 (635)
Q Consensus       555 ~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  615 (635)
                      ......    .           ..+........+..+.+++.+|+. +|.+|++   ++|++++
T Consensus       249 ~~i~~~----~-----------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         249 RKIINW----K-----------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             HHHHcC----C-----------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            111000    0           000000011124457899999996 9999998   8888775

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.7e-34  Score=292.25  Aligned_cols=234  Identities=24%  Similarity=0.279  Sum_probs=183.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+|+|.+..+          ...|++++++++||||+++++++.++...++||||+++++|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~   86 (277)
T cd05607           7 GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN   86 (277)
T ss_pred             eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh
Confidence            89999987  6899999988531          23589999999999999999999999999999999999999998865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......    ......|+..
T Consensus        87 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~  159 (277)
T cd05607          87 VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNG  159 (277)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----eeeccCCCCC
Confidence            55555899999999999999999999854   9999999999999999999999999987654321    1123468899


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||........ ...             ............ .....+.
T Consensus       160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~-------------~~~~~~~~~~~~-~~~~~~~  224 (277)
T cd05607         160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEE-------------LKRRTLEDEVKF-EHQNFTE  224 (277)
T ss_pred             ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHH-------------HHHHhhcccccc-ccccCCH
Confidence            9999999988899999999999999999999999854322110 000             111111111110 0112345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .+.+++.+||+.||++||++.|+++.+.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            5899999999999999999977664433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-35  Score=302.66  Aligned_cols=238  Identities=24%  Similarity=0.379  Sum_probs=198.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||.|.|  -.-.||||.++++      |..|..+|+.++|||+|+|+|+|..+..+|||.|||..|+|.+||++....
T Consensus       281 GeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~  360 (1157)
T KOG4278|consen  281 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS  360 (1157)
T ss_pred             cceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh
Confidence            79999999  4568999999875      668999999999999999999999999999999999999999999877666


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .++....+.++.||..|++||..   +.+|||||..+|+|+.++..+|++|||+++.+......  ..........|.||
T Consensus       361 ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT--AHAGAKFPIKWTAP  435 (1157)
T KOG4278|consen  361 EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAP  435 (1157)
T ss_pred             hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee--cccCccCcccccCc
Confidence            68888899999999999999998   45999999999999999999999999999987654311  11112345679999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLSGK-EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      |.+....++.|+|||+|||+|||+.|.. .|+...+                   ...+-.++....+-+.|..++..+.
T Consensus       436 EsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------------------lSqVY~LLEkgyRM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  436 ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------------------LSQVYGLLEKGYRMDGPEGCPPKVY  496 (1157)
T ss_pred             ccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------------------HHHHHHHHhccccccCCCCCCHHHH
Confidence            9999999999999999999999999854 4432211                   1112223333344455667778899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +|++.||+..|.+||++.|+-+.++.++.++
T Consensus       497 eLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            9999999999999999999999999998765

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.2e-35  Score=289.83  Aligned_cols=243  Identities=26%  Similarity=0.352  Sum_probs=184.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecC--C---eeEEEeecccCCCcchhhccc-
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNG--G---NWYLVYENAVNGSLSVWINDK-  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~--~---~~~lV~E~~~~gsL~~~l~~~-  430 (635)
                      |.||+|+.  ++..||||++-.+   -.+|+++|+++.|||||+|.-+|...  +   ...+||||++. +|.+.++.. 
T Consensus        38 g~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~  116 (364)
T KOG0658|consen   38 GVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYT  116 (364)
T ss_pred             ceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHh
Confidence            89999998  6789999999654   34899999999999999999988742  2   24789999986 888888631 


Q ss_pred             -CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccccCC
Q 042486          431 -GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       431 -~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                       .+..++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.....+..    .....|.
T Consensus       117 ~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn----iSYicSR  189 (364)
T KOG0658|consen  117 RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN----ISYICSR  189 (364)
T ss_pred             hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc----eeEEEec
Confidence             2234788888889999999999999955   9999999999999977 99999999999987665433    2235678


Q ss_pred             CccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh-------cCCcCC
Q 042486          509 GYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-------MDPSMQ  580 (635)
Q Consensus       509 ~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-------~d~~~~  580 (635)
                      .|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+.. ..+...++ ++..... +.+..+       ..+.+.
T Consensus       190 yYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik-~lG~Pt~-e~I~~mn~~y~~~~~p~ik  266 (364)
T KOG0658|consen  190 YYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIK-VLGTPTR-EDIKSMNPNYTEFKFPQIK  266 (364)
T ss_pred             cccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHH-HhCCCCH-HHHhhcCcccccccCcccc
Confidence            8999998876 67999999999999999999999887653332 22333322 2222221 111111       111111


Q ss_pred             C-----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 G-----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .     -.....+.+..+|+.++|..+|.+|.++.|++.+
T Consensus       267 ~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  267 AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            1     1223345668999999999999999999998865

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=286.84  Aligned_cols=244  Identities=30%  Similarity=0.411  Sum_probs=186.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec-----CCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN-----GGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~  425 (635)
                      |.|+++..  +|..||||++.+-         ..+|+.+|+.++|+||+.+++.+..     -+..|+|+|+| ..+|..
T Consensus        36 GvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~  114 (359)
T KOG0660|consen   36 GVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQ  114 (359)
T ss_pred             eeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHH
Confidence            89999887  7899999999743         3489999999999999999999875     34689999999 558999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      .++....  |+......++.|++.||+|+|+.+   ++||||||+|++++.+..+||+|||+|+..... ......+..+
T Consensus       115 iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mTeYV  188 (359)
T KOG0660|consen  115 IIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMTEYV  188 (359)
T ss_pred             HHHcCcc--ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc-Ccccchhcce
Confidence            8865433  899999999999999999999965   999999999999999999999999999987644 2223345578


Q ss_pred             cCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc--------C
Q 042486          506 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM--------D  576 (635)
Q Consensus       506 gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~--------d  576 (635)
                      .|.+|+|||.+.. ..|+...||||.||++.||++|++.|.+.+.-  .....+....... .++.+..+-        .
T Consensus       189 aTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP-~~e~l~~i~s~~ar~yi~  265 (359)
T KOG0660|consen  189 ATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTP-SEEDLQKIRSEKARPYIK  265 (359)
T ss_pred             eeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCC-CHHHHHHhccHHHHHHHH
Confidence            8999999998764 67999999999999999999999887653322  2222222222222 122222221        1


Q ss_pred             --CcCCC-C---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 --PSMQG-N---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 --~~~~~-~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        +.... .   .-+.......+|+++||..||.+|+|++|.++|
T Consensus       266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              11000 0   001234457899999999999999999999986

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.8e-34  Score=300.48  Aligned_cols=235  Identities=21%  Similarity=0.336  Sum_probs=182.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||+|.++.+          +..|..++.++ +||||+++++++.+++..|+||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~   88 (329)
T cd05588           9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ   88 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence            89999987  6789999998642          34677888888 79999999999999999999999999999999886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......   .......||.
T Consensus        89 ~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~  160 (329)
T cd05588          89 RQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTSTFCGTP  160 (329)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC---CccccccCCc
Confidence            543  3899999999999999999999854   9999999999999999999999999987432211   1123357899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.........         ...........+....  ...|...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---------~~~~~~~~~~~~~~~~--~~~p~~~~  229 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP---------DQNTEDYLFQVILEKQ--IRIPRSLS  229 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc---------cccchHHHHHHHHcCC--CCCCCCCC
Confidence            999999999989999999999999999999999998532111000         0000000111111111  12233445


Q ss_pred             HHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPA------MDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs------~~evl~~  615 (635)
                      ..+.+++.+||+.||.+||+      +++++++
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            56899999999999999997      5677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.2e-34  Score=300.39  Aligned_cols=225  Identities=27%  Similarity=0.386  Sum_probs=177.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHH---HhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKL---LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~---l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||++..  +++.||||.++..          +.+|+++   +++++||||+++++++.+.+..|+||||+++|+|..+
T Consensus        13 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~   92 (324)
T cd05589          13 GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMH   92 (324)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHH
Confidence            89999987  6889999998642          2234443   4567899999999999999999999999999999988


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......   .......|
T Consensus        93 ~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~g  163 (324)
T cd05589          93 IHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---DRTSTFCG  163 (324)
T ss_pred             hhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC---Cccccccc
Confidence            8543   3899999999999999999999854   9999999999999999999999999987432221   11234578


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ++.|+|||.+.+..++.++|||||||++|||++|+.||...+...                  ....+....  ...+..
T Consensus       164 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------------------~~~~i~~~~--~~~p~~  223 (324)
T cd05589         164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------------------VFDSIVNDE--VRYPRF  223 (324)
T ss_pred             CccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHhCC--CCCCCC
Confidence            999999999999889999999999999999999999986432221                  111111111  112333


Q ss_pred             HHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+..+.+++.+||+.||.+||     ++.+++++
T Consensus       224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            455688999999999999999     56676664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=275.54  Aligned_cols=242  Identities=24%  Similarity=0.288  Sum_probs=187.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCC-----eeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l  427 (635)
                      ..||.++.  +++.+|+|++.-       ...+|++..++++|||+++++++...+.     +.||+++|+..|+|.+.+
T Consensus        35 sfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i  114 (302)
T KOG2345|consen   35 SFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEI  114 (302)
T ss_pred             eeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHH
Confidence            46777764  888999999842       2567999999999999999999876433     479999999999999999


Q ss_pred             cc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCcee------
Q 042486          428 ND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA------  499 (635)
Q Consensus       428 ~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~------  499 (635)
                      ..  .++..+++.++++|+.+|++||++||+.. +++.||||||.||++.+.+.++|.|||.++...-.-....      
T Consensus       115 ~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQ  193 (302)
T KOG2345|consen  115 ERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQ  193 (302)
T ss_pred             HHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHH
Confidence            54  34456999999999999999999999976 7899999999999999999999999999986543211100      


Q ss_pred             eecccccCCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          500 LTSHIVGTKGYMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                      .-.....|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-+.+.                ..--++..
T Consensus       194 e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg----------------SlaLAv~n  257 (302)
T KOG2345|consen  194 EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG----------------SLALAVQN  257 (302)
T ss_pred             HHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC----------------eEEEeeec
Confidence            001235688999999886   45678999999999999999999999863211110                00111122


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +.+........+..+.+++++|++.||.+||++.+++.++..++
T Consensus       258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            22211112226677999999999999999999999999998764

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6e-34  Score=288.36  Aligned_cols=232  Identities=26%  Similarity=0.450  Sum_probs=183.5

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.. ++..+|+|.++.      ++.+|+.++++++|+|++++++++. .+..+++|||+++++|.+++.......
T Consensus        20 ~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05070          20 GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRA   98 (260)
T ss_pred             ceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCC
Confidence            89999987 567899998864      3568999999999999999999874 456899999999999999997654455


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.+++.||.|||+.+   ++||||||+||++++++.++|+|||++........  .......++..|+|||
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE  173 (260)
T cd05070          99 LKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--TARQGAKFPIKWTAPE  173 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc--ccccCCCCCccccChH
Confidence            899999999999999999999854   99999999999999999999999999976543221  1111223556799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |..||......  ...+...                 .......+...+..+.+
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~~  234 (260)
T cd05070         174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVE-----------------RGYRMPCPQDCPISLHE  234 (260)
T ss_pred             HHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH-----------------cCCCCCCCCcCCHHHHH
Confidence            9988889999999999999999999 77776432211  1111111                 01111223344566999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ++.+||+.||++|||++++.+.|+.
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHHHHhc
Confidence            9999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-35  Score=304.57  Aligned_cols=222  Identities=23%  Similarity=0.352  Sum_probs=179.4

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++.     +++.+|+|.++..         +..|+++|++++|+||+++++++.+++..|+||||+++|+|.+++
T Consensus        10 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   89 (318)
T cd05582          10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL   89 (318)
T ss_pred             EEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence            89998764     5789999988642         346899999999999999999999999999999999999999998


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ....  .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......   ......|+
T Consensus        90 ~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~g~  161 (318)
T cd05582          90 SKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGT  161 (318)
T ss_pred             HHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---ceecccCC
Confidence            6543  3899999999999999999999855   99999999999999999999999999875433211   12345789


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||.......  .                ...+....  ...+...
T Consensus       162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~----------------~~~i~~~~--~~~p~~~  221 (318)
T cd05582         162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--T----------------MTMILKAK--LGMPQFL  221 (318)
T ss_pred             hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--H----------------HHHHHcCC--CCCCCCC
Confidence            99999999998888999999999999999999999986432211  1                11111111  1123334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDK  611 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~e  611 (635)
                      +..+.+++.+||+.||++||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            456889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=287.19  Aligned_cols=226  Identities=25%  Similarity=0.387  Sum_probs=187.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.|-++..  .|+.||||.++++          +.+|+++|+.|+||||+.++.+|++.+...|||||..+|.|.+|+.+
T Consensus        67 GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe  146 (668)
T KOG0611|consen   67 GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE  146 (668)
T ss_pred             cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH
Confidence            66766654  7899999988653          46899999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .+.  |++.+..+++.||..|+.|+|+.+   ++|||||.+|||+|.|+++||+|||++..+....    ....++|++-
T Consensus       147 r~~--LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k----fLqTFCGSPL  217 (668)
T KOG0611|consen  147 RGS--LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK----FLQTFCGSPL  217 (668)
T ss_pred             hcc--ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc----HHHHhcCCcc
Confidence            654  999999999999999999999854   9999999999999999999999999997665432    2345799999


Q ss_pred             ccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |.+||++.+..| .+..|-||||++||-|+.|..||+..+...  +                ++++......   .+..+
T Consensus       218 YASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--l----------------vrQIs~GaYr---EP~~P  276 (668)
T KOG0611|consen  218 YASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--L----------------VRQISRGAYR---EPETP  276 (668)
T ss_pred             cCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--H----------------HHHhhccccc---CCCCC
Confidence            999999998766 689999999999999999999987544322  1                1222221111   11122


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ....-||++||..+|++|.|+.+|..|.-
T Consensus       277 SdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  277 SDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             chHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            23567999999999999999999998853

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-34  Score=291.98  Aligned_cols=251  Identities=23%  Similarity=0.414  Sum_probs=187.4

Q ss_pred             ceEEEeee------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||.+++      ++..||+|.++.        .+.+|++++++++|+||+++.+++...  ...++||||+++++|.+
T Consensus        18 g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~   97 (284)
T cd05079          18 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE   97 (284)
T ss_pred             eeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHH
Confidence            89998874      577899999863        355799999999999999999999865  56799999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++.... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++................
T Consensus        98 ~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  173 (284)
T cd05079          98 YLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD  173 (284)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCC
Confidence            996543 2489999999999999999999984   599999999999999999999999999986644332222223455


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|+|||.+.+..++.++||||||+++|||++++.|.......   ......+... +.........+........+.
T Consensus       174 ~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  249 (284)
T cd05079         174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHG-QMTVTRLVRVLEEGKRLPRPP  249 (284)
T ss_pred             CCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccc-cccHHHHHHHHHcCccCCCCC
Confidence            677899999998888999999999999999999987654221110   0000000000 000011111111111112233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ..+..+.+|+.+||+.||++||+++++++.|+.++
T Consensus       250 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         250 NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            34567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.2e-34  Score=292.10  Aligned_cols=230  Identities=26%  Similarity=0.408  Sum_probs=179.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhh-ccCCcccEEEEEecC------CeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKI-NHSSLIRLLGICFNG------GNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|..  +++.||+|.+..      ++.+|+.+++++ +|+||+++++++...      ...+++|||+.+++|.++
T Consensus        20 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (272)
T cd06637          20 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL   99 (272)
T ss_pred             eEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHH
Confidence            89999987  678999998853      356789999998 799999999998753      457999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........   ......|
T Consensus       100 l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~g  173 (272)
T cd06637         100 IKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIG  173 (272)
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc---cCCcccc
Confidence            97654455899999999999999999999854   99999999999999999999999999875433211   1233568


Q ss_pred             CCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCC
Q 042486          507 TKGYMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG  581 (635)
Q Consensus       507 t~~y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~  581 (635)
                      +..|+|||++.     +..++.++|||||||++|||++|+.|+............               ..   .....
T Consensus       174 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---------------~~---~~~~~  235 (272)
T cd06637         174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---------------PR---NPAPR  235 (272)
T ss_pred             cccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---------------hc---CCCCC
Confidence            89999999986     345788999999999999999999987532221111000               00   00000


Q ss_pred             CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+...+..+.+++.+||..||.+||+++|++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            1112234458999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5e-34  Score=303.71  Aligned_cols=233  Identities=21%  Similarity=0.266  Sum_probs=177.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||+++.  +++.||||.++.          .+.+|+.++.+++|+||+++++.+.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (363)
T cd05628          15 GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK   94 (363)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh
Confidence            89999987  688999999864          245689999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE------------  497 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------------  497 (635)
                      ..  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++........            
T Consensus        95 ~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~  169 (363)
T cd05628          95 KD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS  169 (363)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccc
Confidence            43  3899999999999999999999855   999999999999999999999999998754321100            


Q ss_pred             --------------------eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHh
Q 042486          498 --------------------FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV  557 (635)
Q Consensus       498 --------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~  557 (635)
                                          ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~-~~~~i  248 (363)
T cd05628         170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE-TYKKV  248 (363)
T ss_pred             cccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence                                000123479999999999998889999999999999999999999986433211 11111


Q ss_pred             hhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 042486          558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK--KDPSGRPAMDKIAQS  615 (635)
Q Consensus       558 ~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~  615 (635)
                      ...    .      ..+   .+...  ...+..+.+++.+++.  .++..||+++||+++
T Consensus       249 ~~~----~------~~~---~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         249 MNW----K------ETL---IFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HcC----c------Ccc---cCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            000    0      000   00000  0123446777777554  233456899999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.3e-34  Score=300.04  Aligned_cols=235  Identities=23%  Similarity=0.353  Sum_probs=181.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.+|+|.++..          +.+|+.++.++ +||||+++++++..++..++||||+++|+|..++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~   88 (329)
T cd05618           9 AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ   88 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence            89999987  6789999998643          33577777776 89999999999999999999999999999998886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   .......||.
T Consensus        89 ~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~  160 (329)
T cd05618          89 RQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTP  160 (329)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---CccccccCCc
Confidence            543  3899999999999999999999855   9999999999999999999999999987532211   1123457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.........         ...........+....  ...|...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---------~~~~~~~~~~~i~~~~--~~~p~~~~  229 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---------DQNTEDYLFQVILEKQ--IRIPRSLS  229 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc---------ccccHHHHHHHHhcCC--CCCCCCCC
Confidence            999999999999999999999999999999999998532111000         0000000111111111  12334445


Q ss_pred             HHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPA------MDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs------~~evl~~  615 (635)
                      ..+.+++.+||+.||++||+      +.++++|
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            66889999999999999998      4676655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-33  Score=289.26  Aligned_cols=240  Identities=25%  Similarity=0.399  Sum_probs=185.5

Q ss_pred             ceEEEeee--CCc----EEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++  +++    .||+|.++.+        +.+|+.+++.++|+||+++++++.. ...++++||+++|+|.+++
T Consensus        21 g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l   99 (279)
T cd05109          21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYV   99 (279)
T ss_pred             ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHH
Confidence            89999986  444    4899988642        4468889999999999999999975 4568999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++........ .......++
T Consensus       100 ~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~-~~~~~~~~~  174 (279)
T cd05109         100 RENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-YHADGGKVP  174 (279)
T ss_pred             hhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce-eecCCCccc
Confidence            6543 2489999999999999999999984   5999999999999999999999999999866432211 111222346


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |..|+.......  +...+..                 ......+..
T Consensus       175 ~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~  235 (279)
T cd05109         175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEK-----------------GERLPQPPI  235 (279)
T ss_pred             hhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC-----------------CCcCCCCcc
Confidence            78999999988889999999999999999998 787765322111  1111111                 001111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                      .+..+.+++.+||+.||++||++.|+++.|+++......|
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF  275 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence            3456889999999999999999999999999887665444

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.7e-34  Score=291.74  Aligned_cols=234  Identities=23%  Similarity=0.390  Sum_probs=184.0

Q ss_pred             ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|+..       +..||||+++.+        +.+|+.++++++|+||+++++++...+..++++||+.+++|.++
T Consensus        19 g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~   98 (283)
T cd05091          19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF   98 (283)
T ss_pred             CeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHH
Confidence            899999862       468999998643        45688899999999999999999999999999999999999999


Q ss_pred             hccc--------------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          427 INDK--------------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       427 l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +...              ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (283)
T cd05091          99 LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY  175 (283)
T ss_pred             HHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccc
Confidence            8421              1234788899999999999999999855   9999999999999999999999999987654


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .... ........+++.|+|||.+.++.++.++||||||+++|||++ |..|+......  ..                .
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~----------------~  236 (283)
T cd05091         176 AADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV----------------I  236 (283)
T ss_pred             cchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HH----------------H
Confidence            3221 112233456778999999988889999999999999999998 66666432221  11                1


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ..+.+.. ....+...+..+.+++.+||+.+|++||+++||+..|+.
T Consensus       237 ~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111111 112233455668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-33  Score=292.33  Aligned_cols=236  Identities=32%  Similarity=0.466  Sum_probs=184.1

Q ss_pred             ceEEEeee--CC--cEEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GG--DFVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~--~~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|..  ++  ..+++|.++.        ++.+|++++.++ +||||+++++++...+..++++||+++++|.+++.
T Consensus        16 g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   95 (297)
T cd05089          16 GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR   95 (297)
T ss_pred             ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHH
Confidence            89999987  33  2478888764        356799999999 79999999999999899999999999999999985


Q ss_pred             ccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          429 DKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       429 ~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ...              ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  172 (297)
T cd05089          96 KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY  172 (297)
T ss_pred             hccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccce
Confidence            421              12488999999999999999999985   4999999999999999999999999998643211


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .    .......+..|+|||++....++.++|||||||++|||++ |+.||.......  ...                .
T Consensus       173 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~----------------~  230 (297)
T cd05089         173 V----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYE----------------K  230 (297)
T ss_pred             e----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----------------H
Confidence            1    1111223457999999988889999999999999999998 888875332211  111                0


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +. .......+...+..+.+|+.+||+.||.+||+++++++.|+.+....
T Consensus       231 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         231 LP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             Hh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            00 01111122234456899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.5e-34  Score=286.50  Aligned_cols=234  Identities=26%  Similarity=0.422  Sum_probs=185.8

Q ss_pred             ceEEEeeeC---C--cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG---G--DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~---~--~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|.+.   +  ..||||.+..+        +.+|++++++++|+||+++++.+.+ ...++||||+++++|.+++.
T Consensus         9 ~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05040           9 GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLR   87 (257)
T ss_pred             ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHH
Confidence            899999872   2  26999998653        4469999999999999999999988 88899999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.................++.
T Consensus        88 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  164 (257)
T cd05040          88 KDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF  164 (257)
T ss_pred             hcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCc
Confidence            65434589999999999999999999984   599999999999999999999999999987654332222233355778


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||++.+..++.++||||||+++|||++ |+.|+.......  .......                .......+...
T Consensus       165 ~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~----------------~~~~~~~~~~~  226 (257)
T cd05040         165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK----------------EGERLERPEAC  226 (257)
T ss_pred             eecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh----------------cCCcCCCCccC
Confidence            9999999998889999999999999999999 998875332221  1111100                00001112233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      +..+.+++.+||+.+|++||++.|+++.|.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         227 PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-34  Score=294.87  Aligned_cols=241  Identities=29%  Similarity=0.451  Sum_probs=186.7

Q ss_pred             ceEEEeee--CCc--EEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGD--FVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~--~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||++.+  ++.  .+|+|+++.        .+.+|++++.++ +|+||+++++++..++..++||||+++++|.+++.
T Consensus        21 g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  100 (303)
T cd05088          21 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  100 (303)
T ss_pred             ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHH
Confidence            89999986  343  468887754        245699999999 89999999999999999999999999999999985


Q ss_pred             ccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          429 DKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       429 ~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ...              ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  177 (303)
T cd05088         101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  177 (303)
T ss_pred             hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchh
Confidence            432              23488999999999999999999985   4999999999999999999999999998643211


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .    ......++..|+|||++.+..++.++||||||+++|||+| |..||.......  ..+...              
T Consensus       178 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~--------------  237 (303)
T cd05088         178 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP--------------  237 (303)
T ss_pred             h----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHh--------------
Confidence            1    1111234567999999988888999999999999999998 888875322211  111100              


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                        . ......+...+..+.+++.+||+.+|++||++++++..|.+++.....|-.
T Consensus       238 --~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~  289 (303)
T cd05088         238 --Q-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  289 (303)
T ss_pred             --c-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence              0 001111222344589999999999999999999999999999877655543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.8e-34  Score=286.81  Aligned_cols=232  Identities=25%  Similarity=0.429  Sum_probs=185.1

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.. +++.||+|.+..      ++.+|+.++++++|+||+++++++ ..+..+++|||+++++|.+++.......
T Consensus        20 g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05067          20 GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIK   98 (260)
T ss_pred             ceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCC
Confidence            89999988 678999998864      356899999999999999999987 4556899999999999999986655556


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........  .......++..|+|||
T Consensus        99 ~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~pe  173 (260)
T cd05067          99 LTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPE  173 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc--ccccCCcccccccCHH
Confidence            899999999999999999999855   99999999999999999999999999876542211  1112234567899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      ++....++.++||||||+++|||++ |+.||.......  .......                 ......+...+..+.+
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~  234 (260)
T cd05067         174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLER-----------------GYRMPRPDNCPEELYE  234 (260)
T ss_pred             HhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHc-----------------CCCCCCCCCCCHHHHH
Confidence            9998889999999999999999999 888875332211  1111110                 0011122223456999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ++.+||+.+|++||+++++++.|+.
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHHHhhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-33  Score=286.23  Aligned_cols=232  Identities=26%  Similarity=0.448  Sum_probs=183.2

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.. .+..+|+|.+..      .+.+|++++++++|+|++++++++. .+..+++|||+++++|.+++.......
T Consensus        20 ~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05069          20 GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKY   98 (260)
T ss_pred             CeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCC
Confidence            89999988 445799998764      3567999999999999999999874 456799999999999999997655555


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........  .......++..|+|||
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe  173 (260)
T cd05069          99 LKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--TARQGAKFPIKWTAPE  173 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc--cccCCCccchhhCCHH
Confidence            899999999999999999999854   99999999999999999999999999976543221  1112234567899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      ...+..++.++||||||+++|||++ |+.|+.......  .......                 ......+...+..+.+
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~  234 (260)
T cd05069         174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVER-----------------GYRMPCPQGCPESLHE  234 (260)
T ss_pred             HhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-----------------CCCCCCCcccCHHHHH
Confidence            9988889999999999999999999 787765322211  1111110                 0011122334566899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ++.+||..||++||+++++++.|++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-34  Score=303.54  Aligned_cols=231  Identities=23%  Similarity=0.270  Sum_probs=181.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.++..          +.+|+.++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (330)
T cd05601          15 GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR   94 (330)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH
Confidence            89999987  7889999998642          45788899999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........  .......||+.
T Consensus        95 ~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~gt~~  168 (330)
T cd05601          95 YE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGTPD  168 (330)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc--eeeecccCCcc
Confidence            43 24899999999999999999999855   99999999999999999999999999976543221  12233578999


Q ss_pred             ccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          510 YMAPEYLE------NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       510 y~aPE~~~------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      |+|||++.      ...++.++|||||||++|||++|+.||....... ........               ........
T Consensus       169 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---------------~~~~~~~~  232 (330)
T cd05601         169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---------------QRFLKFPE  232 (330)
T ss_pred             ccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---------------CCccCCCC
Confidence            99999986      4567899999999999999999999985432211 11111000               00000011


Q ss_pred             ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       584 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+..+.+|+..||. +|++||++++++++
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            11234558899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.1e-34  Score=301.47  Aligned_cols=231  Identities=22%  Similarity=0.337  Sum_probs=180.7

Q ss_pred             ceEEEeee-----CCcEEEEEEecc-----------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYG-----------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~-----------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      |.||+++.     +++.||+|.+..           .+.+|+++++++ +|+||+++++++..++..++||||+++|+|.
T Consensus        14 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~   93 (332)
T cd05614          14 GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF   93 (332)
T ss_pred             EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHH
Confidence            89998875     578999998853           134688999999 5999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  ......
T Consensus        94 ~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~--~~~~~~  166 (332)
T cd05614          94 THLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSF  166 (332)
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCC--Cccccc
Confidence            9986543  3899999999999999999999855   99999999999999999999999999875433221  122345


Q ss_pred             ccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          505 VGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      .||..|+|||.+.+. .++.++|||||||++|||++|+.||.........              ......+..  .....
T Consensus       167 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------------~~~~~~~~~--~~~~~  230 (332)
T cd05614         167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--------------SEVSRRILK--CDPPF  230 (332)
T ss_pred             cCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--------------HHHHHHHhc--CCCCC
Confidence            799999999998764 4788999999999999999999998543221100              000011111  01122


Q ss_pred             ChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          584 PPVTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       584 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      +...+..+.+++.+||+.||++||     ++++++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            333455689999999999999999     77788766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.5e-34  Score=297.52  Aligned_cols=225  Identities=28%  Similarity=0.429  Sum_probs=177.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh----------HHHHHHHhh-hccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA----------SDQIKLLNK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~----------~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||||.++.+.          ..|..++.. .+||||+++++++..++..++||||+++|+|.+++.
T Consensus         9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~   88 (316)
T cd05592           9 GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ   88 (316)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence            89999987  57789999886431          235555554 489999999999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......   .......||+
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~gt~  160 (316)
T cd05592          89 SSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTP  160 (316)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---CccccccCCc
Confidence            543  389999999999999999999985   49999999999999999999999999987543222   1223457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  ...                .+...  ....+...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~----------------~i~~~--~~~~~~~~~  220 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFD----------------SILND--RPHFPRWIS  220 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHH----------------HHHcC--CCCCCCCCC
Confidence            9999999998889999999999999999999999986433211  111                11100  112233345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMD-KIAQ  614 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~-evl~  614 (635)
                      ..+.+++.+||+.||++||++. ++++
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            5688999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=306.70  Aligned_cols=232  Identities=18%  Similarity=0.228  Sum_probs=177.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||++..          .+.+|++++++++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (377)
T cd05629          15 GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK   94 (377)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh
Confidence            89999987  788999998753          245689999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc----------e-
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE----------F-  498 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~-  498 (635)
                      ..  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++........          . 
T Consensus        95 ~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~  169 (377)
T cd05629          95 YD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN  169 (377)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccc
Confidence            43  3889999999999999999999855   999999999999999999999999998632210000          0 


Q ss_pred             ---------------------------------eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 042486          499 ---------------------------------ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA  545 (635)
Q Consensus       499 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~  545 (635)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~  249 (377)
T cd05629         170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC  249 (377)
T ss_pred             ccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCC
Confidence                                             00012469999999999998889999999999999999999999986


Q ss_pred             CCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 042486          546 LYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR---PAMDKIAQS  615 (635)
Q Consensus       546 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~  615 (635)
                      ...... ........    .           ..+........+..+.+++.+||. +|.+|   +++.|++++
T Consensus       250 ~~~~~~-~~~~i~~~----~-----------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         250 SENSHE-TYRKIINW----R-----------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CCCHHH-HHHHHHcc----C-----------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            433211 11111000    0           000000011234458899999997 66665   599998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-33  Score=292.61  Aligned_cols=239  Identities=26%  Similarity=0.451  Sum_probs=186.0

Q ss_pred             ceEEEeee---------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKI---------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~---------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++.         ++..||+|.+..+        +.+|+.+++++ +|+||+++++++...+..+++|||+++|+|
T Consensus        29 g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  108 (304)
T cd05101          29 GQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  108 (304)
T ss_pred             ceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcH
Confidence            89999974         2347999988642        45789999999 899999999999999999999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++
T Consensus       109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~  185 (304)
T cd05101         109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR  185 (304)
T ss_pred             HHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccce
Confidence            99985431              134788999999999999999999854   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......++..|+|||++.+..++.++||||||+++|||++ |..|+.......  ....+.         
T Consensus       186 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~---------  253 (304)
T cd05101         186 DVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLLK---------  253 (304)
T ss_pred             eccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH---------
Confidence            65432211 11222345678999999988889999999999999999998 666654322111  111110         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                             . ......+...+..+.+++.+||+.+|++||++.|+++.|++++...
T Consensus       254 -------~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         254 -------E-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             -------c-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence                   0 0011112234456899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.4e-34  Score=297.56  Aligned_cols=226  Identities=27%  Similarity=0.399  Sum_probs=179.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  ++..||+|.++.+          ...|..++.+. +|+||+++++++.+++..|+||||+.+|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~   88 (316)
T cd05620           9 GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ   88 (316)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH
Confidence            89999988  6789999998643          23466667654 89999999999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   .......||.
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~  160 (316)
T cd05620          89 DKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NRASTFCGTP  160 (316)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC---CceeccCCCc
Confidence            543  3899999999999999999999854   9999999999999999999999999987432211   1123457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  +.+.+                ...  ....+...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~----------------~~~--~~~~~~~~~  220 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESI----------------RVD--TPHYPRWIT  220 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH----------------HhC--CCCCCCCCC
Confidence            9999999999899999999999999999999999986433211  11111                000  011223344


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMD-KIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~-evl~~  615 (635)
                      ..+.+++.+||+.||++||++. +++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            5688999999999999999984 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-33  Score=303.71  Aligned_cols=237  Identities=23%  Similarity=0.405  Sum_probs=185.6

Q ss_pred             ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|++.       +..||||+++..        +.+|+++|.++. |+||++++++|...+..++||||+++|+|.+
T Consensus        51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~  130 (401)
T cd05107          51 GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVD  130 (401)
T ss_pred             eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHH
Confidence            899999863       358999999643        446999999997 9999999999999899999999999999999


Q ss_pred             hhcccC--------------------------------------------------------------------------
Q 042486          426 WINDKG--------------------------------------------------------------------------  431 (635)
Q Consensus       426 ~l~~~~--------------------------------------------------------------------------  431 (635)
                      +++...                                                                          
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (401)
T cd05107         131 YLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYE  210 (401)
T ss_pred             HHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcC
Confidence            985421                                                                          


Q ss_pred             ----------------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          432 ----------------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       432 ----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                                            ...+++..+..++.|++.||.|||+   ++++||||||+||++++++.+||+|||+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~kL~DfGla~  287 (401)
T cd05107         211 SPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR  287 (401)
T ss_pred             CchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCEEEEEecCcce
Confidence                                  1236788889999999999999998   459999999999999999999999999997


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ ..             
T Consensus       288 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~-------------  352 (401)
T cd05107         288 DIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FY-------------  352 (401)
T ss_pred             eccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HH-------------
Confidence            54322111 11122356788999999998889999999999999999998 7777643222111 11             


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                          ..+........+...+..+.+++.+||..+|.+||+++||++.|++++
T Consensus       353 ----~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 ----NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                111111111223334566899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.5e-34  Score=305.35  Aligned_cols=233  Identities=21%  Similarity=0.287  Sum_probs=178.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||+++.  +++.||||++...          +.+|++++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (381)
T cd05626          15 GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (381)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh
Confidence            89999987  6789999998532          45789999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE------------  497 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------------  497 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........            
T Consensus        95 ~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~  169 (381)
T cd05626          95 ME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD  169 (381)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccccc
Confidence            43  3889999999999999999999855   999999999999999999999999997533110000            


Q ss_pred             --------------------------------eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 042486          498 --------------------------------FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA  545 (635)
Q Consensus       498 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~  545 (635)
                                                      ........||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  249 (381)
T cd05626         170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFL  249 (381)
T ss_pred             ccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCc
Confidence                                            001123479999999999998889999999999999999999999986


Q ss_pred             CCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHH--hhhcCCCCCCCHHHHHHH
Q 042486          546 LYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIES--CLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       546 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~~  615 (635)
                      ......... .....               ............+..+.+++.+  |+..+|..||+++|+++|
T Consensus       250 ~~~~~~~~~-~i~~~---------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         250 APTPTETQL-KVINW---------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             CCCHHHHHH-HHHcc---------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            533221111 11000               0000000111233457788887  445666679999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-33  Score=285.62  Aligned_cols=228  Identities=29%  Similarity=0.506  Sum_probs=182.7

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLD  436 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~  436 (635)
                      |.||+|+.+++.||+|..+.+     +.+|+.++++++|+|++++++++..+ ..+++|||+++++|.+++.......++
T Consensus        20 g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~   98 (254)
T cd05083          20 GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVS   98 (254)
T ss_pred             CceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCC
Confidence            899999999999999998654     56799999999999999999998654 479999999999999999765545589


Q ss_pred             HHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcccc
Q 042486          437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL  516 (635)
Q Consensus       437 ~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  516 (635)
                      +..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......      .....+..|+|||.+
T Consensus        99 ~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~y~~pe~~  169 (254)
T cd05083          99 VIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------DNSKLPVKWTAPEAL  169 (254)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC------CCCCCCceecCHHHh
Confidence            999999999999999999984   49999999999999999999999999987543211      112345679999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHH
Q 042486          517 ENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI  595 (635)
Q Consensus       517 ~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li  595 (635)
                      .++.++.++|+||||+++|||++ |+.||.......  ......                 .......+...+..+.+++
T Consensus       170 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVE-----------------KGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh-----------------CCCCCCCCCcCCHHHHHHH
Confidence            88889999999999999999998 888875332211  111110                 0111111223345688999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHH
Q 042486          596 ESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       596 ~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      .+||+.+|++||+++++++.|++
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         231 TSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHcCCChhhCcCHHHHHHHHcc
Confidence            99999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.2e-34  Score=298.08  Aligned_cols=221  Identities=24%  Similarity=0.374  Sum_probs=175.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHH-HHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIK-LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||+|.+...          +..|.. +++.++||||+++++.+.+.+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~   88 (323)
T cd05575           9 GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ   88 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH
Confidence            89999998  6899999998642          122333 5677899999999999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~  160 (323)
T cd05575          89 RER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KTTSTFCGTP  160 (323)
T ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---CccccccCCh
Confidence            543  3899999999999999999999854   9999999999999999999999999987532221   1223457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  .                ...+.....  ..+...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~----------------~~~i~~~~~--~~~~~~~  220 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--M----------------YDNILNKPL--RLKPNIS  220 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--H----------------HHHHHcCCC--CCCCCCC
Confidence            9999999999889999999999999999999999986432211  1                111111111  1122234


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMD  610 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~  610 (635)
                      ..+.+++.+||+.||++||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            5689999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-33  Score=282.74  Aligned_cols=231  Identities=23%  Similarity=0.429  Sum_probs=183.0

Q ss_pred             ceEEEeee-CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|.. ++..+|+|.++..        +.+|++++++++|+||+++++++...+..++||||+++++|.+++.... 
T Consensus         9 g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-   87 (250)
T cd05085           9 GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-   87 (250)
T ss_pred             ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-
Confidence            89999987 6788999987643        4578999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++........  .......++..|+|
T Consensus        88 ~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~a  162 (250)
T cd05085          88 DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--SSSGLKQIPIKWTA  162 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc--ccCCCCCCcccccC
Confidence            2389999999999999999999985   499999999999999999999999999875432211  11112234567999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      ||++..+.++.++||||||+++||+++ |..||.......  .......                 ......+...+..+
T Consensus       163 PE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~  223 (250)
T cd05085         163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEK-----------------GYRMSCPQKCPDDV  223 (250)
T ss_pred             HHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc-----------------CCCCCCCCCCCHHH
Confidence            999998889999999999999999998 888875322211  0010000                 00111222344568


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .+++.+||+.+|++||++.|+++.|.
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHhc
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-33  Score=293.85  Aligned_cols=238  Identities=27%  Similarity=0.441  Sum_probs=185.3

Q ss_pred             ceEEEeeeC---------CcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++..         ...+|+|.++.+        +.+|+++++++ +|+||+++++++..++..++||||+++|+|
T Consensus        32 g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  111 (307)
T cd05098          32 GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  111 (307)
T ss_pred             eeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcH
Confidence            799998752         246999988643        44689999999 799999999999999999999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus       112 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~  188 (307)
T cd05098         112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR  188 (307)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccc
Confidence            99996432              12489999999999999999999985   49999999999999999999999999987


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....+.  ....+.         
T Consensus       189 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~---------  256 (307)
T cd05098         189 DIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLK---------  256 (307)
T ss_pred             cccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHH---------
Confidence            55322111 11112234568999999998889999999999999999998 777764322111  111110         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                              .......+...+..+.+++.+||..+|++||++.|+++.|.+++..
T Consensus       257 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         257 --------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             --------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                    0111122333455688999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.1e-35  Score=276.32  Aligned_cols=219  Identities=27%  Similarity=0.378  Sum_probs=178.5

Q ss_pred             CCcEEEEEEecc---------------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          370 GGDFVAIKKVYG---------------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       370 ~~~~vavK~~~~---------------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      +|...|+|++..               ...+|+.+|+++ .||+|+++.+++..+...++|+|.|+.|.|.|+|...-  
T Consensus        41 t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V--  118 (411)
T KOG0599|consen   41 TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--  118 (411)
T ss_pred             cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe--
Confidence            677888887732               234789999998 69999999999999999999999999999999996653  


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .++++...+|++|+.+|++|||.   ++||||||||+|||+|++.++||+|||+++.......    ....+||++|+||
T Consensus       119 tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek----LrelCGTPgYLAP  191 (411)
T KOG0599|consen  119 TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK----LRELCGTPGYLAP  191 (411)
T ss_pred             eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCchh----HHHhcCCCcccCh
Confidence            39999999999999999999998   4599999999999999999999999999998766542    3567999999999


Q ss_pred             ccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC--Ch
Q 042486          514 EYLEN------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--PP  585 (635)
Q Consensus       514 E~~~~------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~--~~  585 (635)
                      |.+..      ..|+...|+||+||++|-|+.|.+||.-  ...+                -.++.++.....-..  ..
T Consensus       192 EtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQm----------------lMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  192 ETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQM----------------LMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             hheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHH----------------HHHHHHHhcccccCCcchh
Confidence            98853      4578899999999999999999998731  1111                112222332222111  23


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+....+||.+||+.||.+|.|++|.+.|
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            345668999999999999999999999876

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.7e-34  Score=296.37  Aligned_cols=225  Identities=29%  Similarity=0.417  Sum_probs=178.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.||||.++.+          ...|..+++.. +||||+++++++.+++..++||||+++|+|.+++.
T Consensus         9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~   88 (316)
T cd05619           9 GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ   88 (316)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999987  5789999988653          23466777654 89999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......   ......||.
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~  160 (316)
T cd05619          89 SCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---KTCTFCGTP  160 (316)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---ceeeecCCc
Confidence            543  3899999999999999999999854   99999999999999999999999999874322111   123356899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  ....+.              ...+    .++...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~--------------~~~~----~~~~~~~  220 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIR--------------MDNP----CYPRWLT  220 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH--------------hCCC----CCCccCC
Confidence            9999999998889999999999999999999999986433211  111100              0001    1223344


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMD-KIAQ  614 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~-evl~  614 (635)
                      ..+.+++.+||+.||++||++. ++.+
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            5688999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.6e-34  Score=297.20  Aligned_cols=226  Identities=27%  Similarity=0.391  Sum_probs=181.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  ++..||||.++.+          +..|..++..+ +|+||+++++++.+.+..|+||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (318)
T cd05570           9 GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ   88 (318)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence            89999988  5789999988642          23577788777 79999999999999999999999999999999886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++......   .......|+.
T Consensus        89 ~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g~~  160 (318)
T cd05570          89 RSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTP  160 (318)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC---CcccceecCc
Confidence            543  3899999999999999999999854   9999999999999999999999999987432221   1123356899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  ...                .+....  ...+...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~----------------~i~~~~--~~~~~~~~  220 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQ----------------SILEDE--VRYPRWLS  220 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHH----------------HHHcCC--CCCCCcCC
Confidence            9999999999999999999999999999999999986433211  111                111111  11223345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAM-----DKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~-----~evl~~  615 (635)
                      ..+.+++.+||+.||++||++     .+++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            568999999999999999999     777765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-33  Score=287.37  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=189.4

Q ss_pred             HHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeE
Q 042486          346 ELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       346 el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  412 (635)
                      |++.+++++.....+|    |.||+|+.  ++..||+|.+...       +.+|+.++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            3455667776666665    89999987  5678999987542       557899999999999999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCC--CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFL--DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALAR  489 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~  489 (635)
                      +|+||+++++|.+++..... .+  ++..+..++.|++.||.|||+.   +++||||||+||+++. ++.++|+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999999965322 24  7888899999999999999984   5999999999999976 6799999999987


Q ss_pred             cccccCCceeeecccccCCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  567 (635)
                      .......   ......++..|+|||++....  ++.++||||||+++|+|++|+.|+.............          
T Consensus       158 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~----------  224 (268)
T cd06624         158 RLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV----------  224 (268)
T ss_pred             ecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh----------
Confidence            5532211   122245788999999986543  7889999999999999999999875322211111000          


Q ss_pred             hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                             .........+......+.+++.+||+.+|++||++.|++++
T Consensus       225 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 -------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -------hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                   00001112333445668999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.4e-33  Score=285.74  Aligned_cols=235  Identities=22%  Similarity=0.378  Sum_probs=179.7

Q ss_pred             ceEEEeeeC--Cc--EEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCC
Q 042486          362 GSVYRGKIG--GD--FVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~~--~~--~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gs  422 (635)
                      |.||+|++.  +.  .+|+|.++.         .+.+|++++++++|+||+++++++...      ...+++|||+++|+
T Consensus        13 g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~   92 (272)
T cd05075          13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD   92 (272)
T ss_pred             ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCc
Confidence            899999983  32  689998753         245688999999999999999988532      24689999999999


Q ss_pred             cchhhcc----cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          423 LSVWIND----KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       423 L~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      |.+++..    .....+++.....++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++........ 
T Consensus        93 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  168 (272)
T cd05075          93 LHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY-  168 (272)
T ss_pred             HHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccce-
Confidence            9998732    1234489999999999999999999984   5999999999999999999999999999865432211 


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      .......++..|++||.+.+..++.++||||||+++|||++ |+.||......  ...+....                .
T Consensus       169 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~----------------~  230 (272)
T cd05075         169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ----------------G  230 (272)
T ss_pred             ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc----------------C
Confidence            11122345678999999998889999999999999999999 67776432221  11111110                0


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      . ....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       231 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 N-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0 0011223345589999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=285.55  Aligned_cols=233  Identities=27%  Similarity=0.460  Sum_probs=185.9

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.. ++..+|||.+..      ++.+|+.++++++|+||+++++++..+...++||||+++++|.+++.......
T Consensus        20 ~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~   99 (261)
T cd05034          20 GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK   99 (261)
T ss_pred             eEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCC
Confidence            89999987 557899998864      36689999999999999999999998889999999999999999997665556


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++........  ........+..|+|||
T Consensus       100 ~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE  174 (261)
T cd05034         100 LRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPE  174 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh--hhhhccCCCccccCHH
Confidence            899999999999999999999854   99999999999999999999999999876543211  1111223456899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++|+||||++++||++ |+.|+....... .+ +....                 ......+...+..+.+
T Consensus       175 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~-~~~~~-----------------~~~~~~~~~~~~~~~~  235 (261)
T cd05034         175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VL-EQVER-----------------GYRMPRPPNCPEELYD  235 (261)
T ss_pred             HhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH-HHHHc-----------------CCCCCCCCCCCHHHHH
Confidence            9998889999999999999999999 888874322211 11 11100                 0001112223456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ++.+||..+|++||+++++.+.|+.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHHHHhc
Confidence            9999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-33  Score=320.23  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=193.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|..  +++.||||+++.          ++.+|++++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        16 G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s   95 (932)
T PRK13184         16 GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKS   95 (932)
T ss_pred             EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHH
Confidence            89999987  688999999864          245799999999999999999999999999999999999999998853


Q ss_pred             c---------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC----
Q 042486          430 K---------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG----  496 (635)
Q Consensus       430 ~---------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----  496 (635)
                      .         ....+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......    
T Consensus        96 ~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~  172 (932)
T PRK13184         96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD  172 (932)
T ss_pred             hhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccc
Confidence            1         112366778899999999999999985   499999999999999999999999999986521110    


Q ss_pred             -----------ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC
Q 042486          497 -----------EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE  565 (635)
Q Consensus       497 -----------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  565 (635)
                                 .........||+.|+|||++.+..++.++|||||||++|||+||+.||............         
T Consensus       173 l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~---------  243 (932)
T PRK13184        173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD---------  243 (932)
T ss_pred             cccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhh---------
Confidence                       001112356999999999999989999999999999999999999998542221111000         


Q ss_pred             CchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHhhccccccc
Q 042486          566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP-AMDKIAQSISRFLNASLAWELS  629 (635)
Q Consensus       566 ~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~s~~w~~~  629 (635)
                             ...++... ......+..+.+++.+||+.||++|| +++++.+.|+.++.....|.+.
T Consensus       244 -------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~~~  300 (932)
T PRK13184        244 -------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTVK  300 (932)
T ss_pred             -------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccccc
Confidence                   00010000 00112345588999999999999995 6888999999999887777653

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-33  Score=291.62  Aligned_cols=244  Identities=20%  Similarity=0.318  Sum_probs=185.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  ++..+|+|.+..+        +.+|++++++++|+||+++++.+..++..++||||+++++|.+++... 
T Consensus        15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-   93 (308)
T cd06615          15 GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-   93 (308)
T ss_pred             eEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-
Confidence            89999987  6788999987532        557999999999999999999999999999999999999999999654 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++......     ......++..|+
T Consensus        94 -~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~  165 (308)
T cd06615          94 -GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYM  165 (308)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-----ccccCCCCcCcc
Confidence             3389999999999999999999972  35999999999999999999999999998654322     123356889999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC--------------------chhhh
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED--------------------GEESL  571 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--------------------~~~~l  571 (635)
                      |||.+.+..++.++||||||+++|+|++|+.|+...+..  ..............                    ..+..
T Consensus       166 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (308)
T cd06615         166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL  243 (308)
T ss_pred             ChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCCccchhhHHHHH
Confidence            999998888999999999999999999999997543321  11111111000000                    00001


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      ................+..+.+++.+||..||++||+++|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         244 DYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             HHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            111110000000112445689999999999999999999999883

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.1e-33  Score=287.67  Aligned_cols=238  Identities=24%  Similarity=0.393  Sum_probs=186.3

Q ss_pred             ceEEEeeeC------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEec-CCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|...      +..|++|+++..        +.+|+.++++++|+||+++++++.. +...++++||+++++|.++
T Consensus        20 g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~   99 (280)
T cd05043          20 GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF   99 (280)
T ss_pred             ceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHH
Confidence            899999973      578999988653        4578999999999999999999876 4678999999999999999


Q ss_pred             hcccCC------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          427 INDKGG------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       427 l~~~~~------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      +.....      ..+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++........ ..
T Consensus       100 l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~-~~  175 (280)
T cd05043         100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CL  175 (280)
T ss_pred             HHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE-Ee
Confidence            854321      4589999999999999999999985   4999999999999999999999999999755332211 11


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      .....++..|+|||++.+..++.++||||||+++||+++ |+.|+.....  ..+.......                 .
T Consensus       176 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~-----------------~  236 (280)
T cd05043         176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDG-----------------Y  236 (280)
T ss_pred             CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcC-----------------C
Confidence            122345678999999988889999999999999999999 8888753221  1111111110                 0


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      ....+...+..+.+++.+||..||++||++.|+++.|+.+...
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            0011122345689999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.1e-34  Score=303.97  Aligned_cols=244  Identities=22%  Similarity=0.271  Sum_probs=188.1

Q ss_pred             HHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCC
Q 042486          346 ELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGG  409 (635)
Q Consensus       346 el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~  409 (635)
                      ++....++|.....||    |.||+++.  +++.+|+|.+..          .+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3344445666655665    89999987  678999998753          1447899999999999999999999999


Q ss_pred             eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       410 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999999999643   2788999999999999999999854   9999999999999999999999999997


Q ss_pred             cccccCCceeeecccccCCCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENG----LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE  565 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  565 (635)
                      .......  .......||+.|+|||++...    .++.++|||||||++|||++|+.||.......              
T Consensus       191 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------------  254 (370)
T cd05621         191 KMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------------  254 (370)
T ss_pred             ecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------------
Confidence            6543221  122345799999999998653    37889999999999999999999986432211              


Q ss_pred             CchhhhhhhcCCcCCCCCC--hHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 042486          566 DGEESLRHLMDPSMQGNYP--PVTAILVIRLIESCLKKDPSG--RPAMDKIAQS  615 (635)
Q Consensus       566 ~~~~~l~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  615 (635)
                          ....+++.......+  ...+..+.+++..|+..++.+  |+++.|+++|
T Consensus       255 ----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         255 ----TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                111111111111111  123456789999999855543  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.2e-33  Score=292.67  Aligned_cols=238  Identities=28%  Similarity=0.464  Sum_probs=184.7

Q ss_pred             ceEEEeee---------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKI---------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~---------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++.         ....+|+|.++..        +.+|+++++++ +|+||+++++++.+++..+++|||+++|+|
T Consensus        26 g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (314)
T cd05099          26 GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL  105 (314)
T ss_pred             ccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcH
Confidence            89999874         2357999987642        45789999999 699999999999998899999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++
T Consensus       106 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~  182 (314)
T cd05099         106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR  182 (314)
T ss_pred             HHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccc
Confidence            99995422              234899999999999999999999854   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  ......         
T Consensus       183 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~---------  250 (314)
T cd05099         183 GVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKLLR---------  250 (314)
T ss_pred             cccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---------
Confidence            65432211 11112234467999999988889999999999999999999 777764322111  111110         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                             .. .....+...+..+.+++.+||..||++||++.|+++.|.++...
T Consensus       251 -------~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         251 -------EG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             -------cC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                   00 01112233345688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.2e-33  Score=284.28  Aligned_cols=238  Identities=26%  Similarity=0.390  Sum_probs=180.2

Q ss_pred             ceEEEeee-----CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEe-cCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+.     ....||+|++..        .+.+|+.++++++|+||+++++++. .++..+++|||+.+|+|.+++
T Consensus         9 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   88 (262)
T cd05058           9 GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI   88 (262)
T ss_pred             ceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHH
Confidence            89999986     235799998743        2446888999999999999999876 455679999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeeccccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTSHIVG  506 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~g  506 (635)
                      ..... .+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++........ ........+
T Consensus        89 ~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  164 (262)
T cd05058          89 RSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL  164 (262)
T ss_pred             HhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcC
Confidence            65432 368888899999999999999985   4999999999999999999999999998754322110 011122345


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      +..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......                .... ....+..
T Consensus       165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~----------------~~~~-~~~~~~~  226 (262)
T cd05058         165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DITVYL----------------LQGR-RLLQPEY  226 (262)
T ss_pred             CccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----------------hcCC-CCCCCCc
Confidence            678999999988889999999999999999999765543221111 111111                0000 0011122


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      .+..+.+++.+||+.+|++||++.|+++.|++++.
T Consensus       227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            34468899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-33  Score=287.11  Aligned_cols=235  Identities=24%  Similarity=0.450  Sum_probs=183.5

Q ss_pred             ceEEEeee--CC---cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GG---DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~---~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  ++   ..||||.++.        ++..|+.++++++||||+++++++.+++..++||||+++++|.+++.
T Consensus        18 g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   97 (269)
T cd05065          18 GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR   97 (269)
T ss_pred             CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHh
Confidence            89999987  23   3699999864        34568999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc--c
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV--G  506 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~--g  506 (635)
                      .... .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.................  .
T Consensus        98 ~~~~-~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  173 (269)
T cd05065          98 QNDG-QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI  173 (269)
T ss_pred             hCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCc
Confidence            5433 4899999999999999999999854   99999999999999999999999999876543322111111111  2


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +..|+|||++.+..++.++||||||+++|||++ |..||.......  ....+...                 .....+.
T Consensus       174 ~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~~~-----------------~~~~~~~  234 (269)
T cd05065         174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIEQD-----------------YRLPPPM  234 (269)
T ss_pred             ceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcC-----------------CcCCCcc
Confidence            357999999998889999999999999999887 888875322211  11111100                 0011122


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +.+..+.+++.+||+.+|.+||++++++..|+++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            3345688999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-33  Score=284.94  Aligned_cols=235  Identities=23%  Similarity=0.369  Sum_probs=182.0

Q ss_pred             ceEEEeeeC-----CcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCe------eEEEeecccCC
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN------WYLVYENAVNG  421 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lV~E~~~~g  421 (635)
                      |.||+|+..     +..||+|+++.+         +.+|++.+++++|+||+++++++...+.      .++++||+++|
T Consensus        13 g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~   92 (273)
T cd05035          13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHG   92 (273)
T ss_pred             ceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCC
Confidence            899999872     267999988642         4568999999999999999999876544      79999999999


Q ss_pred             Ccchhhccc----CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          422 SLSVWINDK----GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       422 sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +|..++...    ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++........
T Consensus        93 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  169 (273)
T cd05035          93 DLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY  169 (273)
T ss_pred             CHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccc
Confidence            999988432    223589999999999999999999985   4999999999999999999999999998865432211


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                       .......++..|+|||.+.+..++.++||||||+++|||++ |..|+......  ...+..                .+
T Consensus       170 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~----------------~~  230 (273)
T cd05035         170 -RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL----------------RH  230 (273)
T ss_pred             -cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----------------Hc
Confidence             11112234678999999988889999999999999999999 77776432211  111111                11


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .. ....+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       231 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10 1112233455689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-33  Score=294.73  Aligned_cols=251  Identities=18%  Similarity=0.268  Sum_probs=182.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||++..  +++.||+|++..+         +.+|+++++.++||||+++++++..++..++||||+++|+|.+++...
T Consensus        14 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   93 (327)
T cd08227          14 MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH   93 (327)
T ss_pred             EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh
Confidence            68999987  7899999998643         346899999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce----eeeccccc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF----ALTSHIVG  506 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~g  506 (635)
                      ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+............    .......+
T Consensus        94 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (327)
T cd08227          94 FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK  170 (327)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccc
Confidence            4445899999999999999999999855   9999999999999999999999998654332111100    01122356


Q ss_pred             CCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC----chhhhh-----hhc
Q 042486          507 TKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED----GEESLR-----HLM  575 (635)
Q Consensus       507 t~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----~~~~l~-----~~~  575 (635)
                      +..|+|||++.+  ..++.++|||||||++|||++|+.||.....................+    ..+.+.     ...
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (327)
T cd08227         171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGA  250 (327)
T ss_pred             eecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCC
Confidence            778999999875  458899999999999999999999986433222111111000000000    000000     000


Q ss_pred             CC-----------------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          576 DP-----------------SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       576 d~-----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.                 ..........+..+.+++.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         251 NSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            00                 00001122345578999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.5e-34  Score=296.81  Aligned_cols=226  Identities=26%  Similarity=0.363  Sum_probs=178.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccC-CcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHS-SLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.||||.++.+          +..|.+++..++|+ +|+++++++.+.+..|+||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~   93 (324)
T cd05587          14 GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ   93 (324)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence            89999988  5679999988642          34577888888765 58889999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........   ......||+
T Consensus        94 ~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~  165 (324)
T cd05587          94 QVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTP  165 (324)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC---ceeeecCCc
Confidence            543  3899999999999999999999854   99999999999999999999999999864322111   123356899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.......                  ....+....  ..++...+
T Consensus       166 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------------------~~~~i~~~~--~~~~~~~~  225 (324)
T cd05587         166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------------------LFQSIMEHN--VSYPKSLS  225 (324)
T ss_pred             cccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHcCC--CCCCCCCC
Confidence            9999999999889999999999999999999999986433221                  111111111  12233345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAM-----DKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~-----~evl~~  615 (635)
                      ..+.+++.+||..||.+|++.     ++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            568899999999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-33  Score=286.63  Aligned_cols=232  Identities=23%  Similarity=0.360  Sum_probs=180.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|+.  +++.||+|++...       +.+|+.++++++|+||+++++++..++..++||||+++++|.+++.... 
T Consensus        23 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-  101 (267)
T cd06646          23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-  101 (267)
T ss_pred             eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-
Confidence            89999987  6789999988532       4579999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++........   ......++..|+|
T Consensus       102 -~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~  174 (267)
T cd06646         102 -PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA---KRKSFIGTPYWMA  174 (267)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc---ccCccccCccccC
Confidence             389999999999999999999985   499999999999999999999999999875532211   1123468889999


Q ss_pred             ccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||.+.   ...++.++||||||+++|||++|+.|+......... ...     ..       ..+..+...  .....+.
T Consensus       175 PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~-----~~-------~~~~~~~~~--~~~~~~~  239 (267)
T cd06646         175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM-----SK-------SNFQPPKLK--DKTKWSS  239 (267)
T ss_pred             HhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eee-----ec-------CCCCCCCCc--cccccCH
Confidence            99874   345788999999999999999999987432211100 000     00       000001110  0112345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+.+++.+||..||++||++++++++|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            689999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-33  Score=289.29  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=187.5

Q ss_pred             CCCCCCccc----ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEE
Q 042486          353 DFNPSCWIK----GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYL  413 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  413 (635)
                      +|.....+|    |.||+|...       +..||+|.+...        +.+|+.++++++|+||+++++++.+.+..++
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            344444444    899998642       447999987532        4468889999999999999999998889999


Q ss_pred             EeecccCCCcchhhcccC--------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          414 VYENAVNGSLSVWINDKG--------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                      ||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Df  163 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDF  163 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcC
Confidence            999999999999995421        12356788899999999999999984   4999999999999999999999999


Q ss_pred             cCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhccccc
Q 042486          486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       486 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      |+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..|+.....++  ..         
T Consensus       164 g~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~---------  231 (288)
T cd05061         164 GMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VL---------  231 (288)
T ss_pred             Cccccccccccc-cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---------
Confidence            998754332211 11122345678999999998889999999999999999999 666664322111  11         


Q ss_pred             CCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       565 ~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                             ..+.+... ...+...+..+.+++.+||+.||++||++.++++.|++.+..+
T Consensus       232 -------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  282 (288)
T cd05061         232 -------KFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS  282 (288)
T ss_pred             -------HHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence                   11111110 0112223456999999999999999999999999999877554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-33  Score=291.18  Aligned_cols=228  Identities=23%  Similarity=0.378  Sum_probs=183.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|+.  +++.||+|.+..       .+.+|+.++++++|+||+++++.+..+...++||||+++++|.+++...  
T Consensus        34 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  111 (296)
T cd06654          34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--  111 (296)
T ss_pred             eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--
Confidence            89999986  688999998854       2457899999999999999999999999999999999999999998543  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........   ......+++.|+|
T Consensus       112 -~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~a  184 (296)
T cd06654         112 -CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMA  184 (296)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc---ccCcccCCccccC
Confidence             3789999999999999999999854   99999999999999999999999999875433221   1123468889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.+..++.++|||||||++|+|++|+.||.......... ...                ..+......+......+.
T Consensus       185 PE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-~~~----------------~~~~~~~~~~~~~~~~l~  247 (296)
T cd06654         185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIA----------------TNGTPELQNPEKLSAIFR  247 (296)
T ss_pred             HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-HHh----------------cCCCCCCCCccccCHHHH
Confidence            999998888999999999999999999999985433211110 000                000001112233445689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||..||++||++.|++++
T Consensus       248 ~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         248 DFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHCcCCcccCcCHHHHhhC
Confidence            99999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-33  Score=296.52  Aligned_cols=239  Identities=26%  Similarity=0.414  Sum_probs=182.5

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecC-CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNG-GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~lV~E~~~~gsL~  424 (635)
                      |.||+|..       +++.||||+++.+        +.+|+.+|.++ +|+||+++++++... ...+++|||+++|+|.
T Consensus        21 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (343)
T cd05103          21 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  100 (343)
T ss_pred             ceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHH
Confidence            89999973       4678999998642        45799999999 789999999988754 4579999999999999


Q ss_pred             hhhcccC-----------------------------------------------------------------CCCCCHHH
Q 042486          425 VWINDKG-----------------------------------------------------------------GKFLDWAQ  439 (635)
Q Consensus       425 ~~l~~~~-----------------------------------------------------------------~~~l~~~~  439 (635)
                      +++....                                                                 ...+++..
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (343)
T cd05103         101 NYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED  180 (343)
T ss_pred             HHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHH
Confidence            9885321                                                                 12368888


Q ss_pred             HHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC
Q 042486          440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG  519 (635)
Q Consensus       440 ~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  519 (635)
                      +..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++........ ........++..|+|||.+.+.
T Consensus       181 ~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~  256 (343)
T cd05103         181 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDR  256 (343)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCCCCcceECcHHhcCC
Confidence            999999999999999985   499999999999999999999999999876432211 1111223456789999999888


Q ss_pred             CCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHh
Q 042486          520 LVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESC  598 (635)
Q Consensus       520 ~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~c  598 (635)
                      .++.++||||||+++|||++ |..|+........ .....                 ........+...+..+.+++.+|
T Consensus       257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~c  318 (343)
T cd05103         257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL-----------------KEGTRMRAPDYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHH-----------------hccCCCCCCCCCCHHHHHHHHHH
Confidence            89999999999999999997 7777643221111 11100                 00000111222334589999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          599 LKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       599 l~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      |+.||++||++.||+++|+.+++.
T Consensus       319 l~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         319 WHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.3e-34  Score=313.22  Aligned_cols=241  Identities=22%  Similarity=0.283  Sum_probs=186.9

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCC-------
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGG-------  409 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~-------  409 (635)
                      ++|.....||    |.||+++.  +++.||||.+..+         +.+|+..+..++|+||+++++.+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4444444454    89999987  7899999988532         456888999999999999988775332       


Q ss_pred             -eeEEEeecccCCCcchhhccc--CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          410 -NWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       410 -~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                       ..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence             368999999999999998542  234589999999999999999999984   49999999999999999999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED  566 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  566 (635)
                      +++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......               
T Consensus       189 ls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---------------  252 (496)
T PTZ00283        189 FSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------------  252 (496)
T ss_pred             cCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence            98765432111 12234679999999999999899999999999999999999999985422111               


Q ss_pred             chhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         .+........ ...+...+..+.+++.+||+.||.+||++.+++++
T Consensus       253 ---~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 ---VMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ---HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence               1111111111 11233445668999999999999999999999875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.6e-34  Score=297.02  Aligned_cols=226  Identities=26%  Similarity=0.375  Sum_probs=178.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||||.++.+          ...|..++..+ +|++|+++++++.+.+..++||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~   93 (323)
T cd05616          14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ   93 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence            89999987  5679999988643          23456666666 58899999999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......   .......||+
T Consensus        94 ~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~  165 (323)
T cd05616          94 QVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTP  165 (323)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC---CccccCCCCh
Confidence            543  3899999999999999999999855   9999999999999999999999999987533211   1123457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  +                ...+....  ..++...+
T Consensus       166 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~----------------~~~i~~~~--~~~p~~~s  225 (323)
T cd05616         166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--L----------------FQSIMEHN--VAYPKSMS  225 (323)
T ss_pred             hhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--H----------------HHHHHhCC--CCCCCcCC
Confidence            9999999999999999999999999999999999986433221  1                11111111  12233345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAM-----DKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~-----~evl~~  615 (635)
                      ..+.+++.+||+.||.+|++.     .++.++
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            568999999999999999985     555543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.9e-34  Score=297.94  Aligned_cols=221  Identities=24%  Similarity=0.340  Sum_probs=174.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHH-HHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQI-KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||+|.+...          +.+|. .+++.++|+||+++++++.+.+..|+||||+++|+|..++.
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (321)
T cd05603           9 GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ   88 (321)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence            89999988  6789999988532          22333 35778899999999999999999999999999999998886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   .......||+
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~  160 (321)
T cd05603          89 RER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---ETTSTFCGTP  160 (321)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---CccccccCCc
Confidence            543  3888899999999999999999854   9999999999999999999999999987532221   1223457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||.+.+..++.++|||||||++|||++|+.||...+...  ..                ..+....  ...+....
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~----------------~~i~~~~--~~~~~~~~  220 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--MY----------------DNILHKP--LQLPGGKT  220 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--HH----------------HHHhcCC--CCCCCCCC
Confidence            9999999998889999999999999999999999985432211  11                1111111  11223344


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMD  610 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~  610 (635)
                      ..+.+++.+||+.||.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            5689999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-33  Score=283.59  Aligned_cols=229  Identities=24%  Similarity=0.350  Sum_probs=184.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  ++..+|+|.++.        ++.+|+.++++++|+||+++++.+.+++..+++|||+++++|.+++....
T Consensus        14 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   93 (255)
T cd08219          14 GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR   93 (255)
T ss_pred             eEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc
Confidence            78999987  688999998742        24578899999999999999999999999999999999999999986555


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      ...+++...+.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||.+.......   .......++..|+
T Consensus        94 ~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~  167 (255)
T cd08219          94 GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYVGTPYYV  167 (255)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---cccccccCCcccc
Confidence            555899999999999999999999854   9999999999999999999999999987554321   1122356888999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||++.+..++.++|+||||+++|+|++|+.||...+.... ...                 +.... ....+...+..+
T Consensus       168 aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~-----------------~~~~~-~~~~~~~~~~~~  228 (255)
T cd08219         168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-ILK-----------------VCQGS-YKPLPSHYSYEL  228 (255)
T ss_pred             CHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-HHH-----------------HhcCC-CCCCCcccCHHH
Confidence            99999988899999999999999999999999864322111 000                 00000 011122344568


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||+.||++||++.|++..
T Consensus       229 ~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         229 RSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHhCCcccCCCHHHHhhc
Confidence            899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=288.71  Aligned_cols=233  Identities=26%  Similarity=0.439  Sum_probs=183.2

Q ss_pred             ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|...       +..||+|.+...        +.+|+.++++++|+||+++++++...+..++||||+++|+|.++
T Consensus        20 g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   99 (277)
T cd05032          20 GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY   99 (277)
T ss_pred             ceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHH
Confidence            899999873       267999998643        45789999999999999999999999999999999999999999


Q ss_pred             hcccC--------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          427 INDKG--------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       427 l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +....        ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....... .
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~-~  175 (277)
T cd05032         100 LRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY-Y  175 (277)
T ss_pred             HHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcc-c
Confidence            85422        22478899999999999999999984   499999999999999999999999999875543221 1


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+.......  .....                .+.
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~----------------~~~  237 (277)
T cd05032         176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFV----------------IDG  237 (277)
T ss_pred             ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHH----------------hcC
Confidence            11223456788999999988889999999999999999998 777764322211  11111                111


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      . ....+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       238 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 G-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             C-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            0 11122333566899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.2e-33  Score=287.68  Aligned_cols=233  Identities=23%  Similarity=0.451  Sum_probs=182.0

Q ss_pred             ceEEEeee-------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||++..       ++..+|+|.+..       ++.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (280)
T cd05092          19 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFL   98 (280)
T ss_pred             CeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHH
Confidence            89999864       355789998764       4668999999999999999999999999999999999999999998


Q ss_pred             cccCC-------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          428 NDKGG-------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       428 ~~~~~-------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      .....             ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  175 (280)
T cd05092          99 RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  175 (280)
T ss_pred             HhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCC
Confidence            54321             24889999999999999999999854   999999999999999999999999998754322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .. ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........  ..                .
T Consensus       176 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----------------~  236 (280)
T cd05092         176 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IE----------------C  236 (280)
T ss_pred             ce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HH----------------H
Confidence            11 111122345678999999998889999999999999999998 7877643222111  00                0


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .... .....+...+..+.+++.+||+.||.+||+++||++.|+
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1000 001112223455899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-33  Score=285.24  Aligned_cols=233  Identities=30%  Similarity=0.467  Sum_probs=181.3

Q ss_pred             ceEEEeee--CCc--EEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGD--FVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~--~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|++  ++.  .+++|.++.        .+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   88 (270)
T cd05047           9 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR   88 (270)
T ss_pred             ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHH
Confidence            89999987  333  578888763        244699999999 89999999999999999999999999999999985


Q ss_pred             ccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          429 DKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       429 ~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ...              ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~  165 (270)
T cd05047          89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  165 (270)
T ss_pred             hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence            432              12478999999999999999999984   5999999999999999999999999998632211


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .    .......+..|+|||++....++.++||||||+++|||++ |+.||.......  ......              
T Consensus       166 ~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~--------------  225 (270)
T cd05047         166 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP--------------  225 (270)
T ss_pred             h----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHHHh--------------
Confidence            1    1111233567999999988889999999999999999997 888874322111  111110              


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                         .......+...+..+.+++.+||+.||.+||++.|++..|.+++
T Consensus       226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         226 ---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence               00011112223445889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.4e-34  Score=297.78  Aligned_cols=224  Identities=24%  Similarity=0.345  Sum_probs=176.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHH-HHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQI-KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||+|.+...          +..|. .+++.++|+||+++++++..++..|+||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (325)
T cd05602           9 GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ   88 (325)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence            89999987  6778999998542          11222 34677899999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++.....++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   ......||+
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~~~~~~gt~  160 (325)
T cd05602          89 RER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCGTP  160 (325)
T ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---CcccccCCc
Confidence            543  3788888899999999999999855   99999999999999999999999999875322211   123457999


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.......  ...                .+.....  ..++..+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~----------------~i~~~~~--~~~~~~~  220 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYD----------------NILNKPL--QLKPNIT  220 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHH----------------HHHhCCc--CCCCCCC
Confidence            9999999999899999999999999999999999986432221  111                1111100  1122334


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIA  613 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl  613 (635)
                      ..+.+++.+||+.||.+||++.+.+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCH
Confidence            5589999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-33  Score=283.53  Aligned_cols=230  Identities=22%  Similarity=0.313  Sum_probs=178.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||++..  ++..||+|++..            .+.+|+.++++++|+||+++++++.+  ++..++++||+++++|.+
T Consensus        16 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~   95 (266)
T cd06651          16 GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD   95 (266)
T ss_pred             EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHH
Confidence            89999986  688999998742            24568999999999999999999875  356799999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||+++................
T Consensus        96 ~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  170 (266)
T cd06651          96 QLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT  170 (266)
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCC
Confidence            996543  3899999999999999999999854   99999999999999999999999999875432211111122345


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|+|||.+.+..++.++||||||+++|||++|+.||.......                  ..............+.
T Consensus       171 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------------------~~~~~~~~~~~~~~~~  232 (266)
T cd06651         171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------------------AIFKIATQPTNPQLPS  232 (266)
T ss_pred             ccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------------------HHHHHhcCCCCCCCch
Confidence            7889999999998889999999999999999999999975322111                  0111111111122233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+.+++ +||..+|++||+++||+++
T Consensus       233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         233 HISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            4445577777 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-33  Score=303.29  Aligned_cols=232  Identities=21%  Similarity=0.283  Sum_probs=177.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+|+|.+..          .+.+|++++++++|+||+++++.+.+++..|+||||+++|+|.+++.+
T Consensus        15 g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (382)
T cd05625          15 GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (382)
T ss_pred             EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  678999999854          245799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-------------  496 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------------  496 (635)
                      ..  .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........             
T Consensus        95 ~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~  169 (382)
T cd05625          95 MG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD  169 (382)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccc
Confidence            43  3888999999999999999999855   99999999999999999999999999753211000             


Q ss_pred             -------------------------------ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 042486          497 -------------------------------EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA  545 (635)
Q Consensus       497 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~  545 (635)
                                                     .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~  249 (382)
T cd05625         170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL  249 (382)
T ss_pred             cccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCC
Confidence                                           0001123468999999999998889999999999999999999999986


Q ss_pred             CCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 042486          546 LYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA---MDKIAQS  615 (635)
Q Consensus       546 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  615 (635)
                      ........ ......               ............+....+++.+|+ .+|++|++   ++|+++|
T Consensus       250 ~~~~~~~~-~~i~~~---------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         250 AQTPLETQ-MKVINW---------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             CCCHHHHH-HHHHcc---------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            43322111 111000               000000111123345678887775 59999987   8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-33  Score=295.62  Aligned_cols=233  Identities=22%  Similarity=0.349  Sum_probs=181.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.+|+|.++.+          +.+|..++.++ +|+||+++++++.+.+..|+||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (327)
T cd05617           9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ   88 (327)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999987  6789999998743          34677888888 69999999999999999999999999999998886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||+++......   .......||+
T Consensus        89 ~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~  160 (327)
T cd05617          89 RQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGTP  160 (327)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC---CceecccCCc
Confidence            543  3899999999999999999999854   9999999999999999999999999987432211   1123457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.........           .........+....  ...|...+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~--~~~p~~~~  227 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-----------NTEDYLFQVILEKP--IRIPRFLS  227 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-----------ccHHHHHHHHHhCC--CCCCCCCC
Confidence            999999999999999999999999999999999998542211100           00000111111111  12233345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAM------DKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~------~evl~~  615 (635)
                      ..+.+++.+||+.||++|+++      ++++++
T Consensus       228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            568899999999999999985      466554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.9e-33  Score=285.66  Aligned_cols=229  Identities=24%  Similarity=0.357  Sum_probs=180.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  ++..||+|.+..+        +.+|++++++++|+||+++++++..++..++||||+++++|..+.    
T Consensus        15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----   90 (279)
T cd06619          15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR----   90 (279)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh----
Confidence            89999987  7889999987532        457999999999999999999999999999999999999996652    


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......     .....++..|+
T Consensus        91 --~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~y~  160 (279)
T cd06619          91 --KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-----AKTYVGTNAYM  160 (279)
T ss_pred             --cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----ccCCCCChhhc
Confidence              2688889999999999999999855   9999999999999999999999999987543221     22357889999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||++.+..++.++||||||+++|+|++|+.||..........           ........+.++..........+..+
T Consensus       161 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-----------MPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             CceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-----------chHHHHHHHhccCCCCCCCCcCCHHH
Confidence            9999998889999999999999999999999985422111000           00011111111111111112234458


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||+.||++||+++|++++
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcC
Confidence            999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.7e-33  Score=290.47  Aligned_cols=182  Identities=26%  Similarity=0.354  Sum_probs=148.4

Q ss_pred             ceEEEeee----CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.    +++.+|+|.+..     ...+|+++|++++||||+++++++..  +...+++|||+. ++|.+++...
T Consensus        15 g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   93 (317)
T cd07868          15 GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH   93 (317)
T ss_pred             eEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhc
Confidence            89999985    457899999864     35689999999999999999999864  456799999985 5887776421


Q ss_pred             -------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE----CCCCcEEEeeecCcccccccCCcee
Q 042486          431 -------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       431 -------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                             ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++..........
T Consensus        94 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  170 (317)
T cd07868          94 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  170 (317)
T ss_pred             ccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcccc
Confidence                   1234889999999999999999999855   9999999999999    4567899999999986543322222


Q ss_pred             eecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 042486          500 LTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALY  547 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~  547 (635)
                      ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            2334578999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-33  Score=287.53  Aligned_cols=244  Identities=25%  Similarity=0.368  Sum_probs=179.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhh---ccCCcccEEEEEec-----CCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKI---NHSSLIRLLGICFN-----GGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~~~lV~E~~~~gs  422 (635)
                      |.||+++.  +++.||+|.++.         ...+|+++++++   +|+||+++++++..     ....+++|||+.+ +
T Consensus        14 g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~   92 (288)
T cd07863          14 GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-D   92 (288)
T ss_pred             eEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-C
Confidence            89999987  688999998853         234677777766   69999999998864     2457999999974 8


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeec
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      |.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......    ..
T Consensus        93 l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~----~~  165 (288)
T cd07863          93 LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA----LT  165 (288)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc----CC
Confidence            988886654455899999999999999999999855   99999999999999999999999999976543211    12


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchh---hh---hhhcC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE---SL---RHLMD  576 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~---~l---~~~~d  576 (635)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||....... .+...... ........   ..   .....
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  243 (288)
T cd07863         166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDL-IGLPPEDDWPRDVTLPRGAFS  243 (288)
T ss_pred             CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHH-hCCCChhhCcccccccccccC
Confidence            3467899999999998889999999999999999999998875433221 11111110 00000000   00   00000


Q ss_pred             CcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +...   ....+..+..+.+++.+||+.||++|||+.|++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000   01112334567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-33  Score=289.23  Aligned_cols=231  Identities=26%  Similarity=0.327  Sum_probs=183.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  +++.+|+|.+...          +.+|+.++++++|++++++++.+.+++..++||||+++++|.+++..
T Consensus        14 g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   93 (285)
T cd05630          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH   93 (285)
T ss_pred             eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHH
Confidence            89999988  6889999987532          34689999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++........    .....|+..
T Consensus        94 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~g~~~  166 (285)
T cd05630          94 MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IKGRVGTVG  166 (285)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc----ccCCCCCcc
Confidence            4444589999999999999999999985   499999999999999999999999999875432211    123468999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||........               .+....+.+. .....+.....
T Consensus       167 y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---------------~~~~~~~~~~-~~~~~~~~~~~  230 (285)
T cd05630         167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---------------REEVERLVKE-VQEEYSEKFSP  230 (285)
T ss_pred             ccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---------------HHHHHhhhhh-hhhhcCccCCH
Confidence            9999999988899999999999999999999999864322110               0000000000 00112223345


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .+.+|+.+||+.||++|||     ++|++++
T Consensus       231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         231 DARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            5899999999999999999     8888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.2e-34  Score=303.98  Aligned_cols=232  Identities=20%  Similarity=0.273  Sum_probs=179.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.+..          .+.+|+++|++++|+||+++++.+.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~   94 (376)
T cd05598          15 GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (376)
T ss_pred             eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  688999998853          245799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-------------  496 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------------  496 (635)
                      ..  .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........             
T Consensus        95 ~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~  169 (376)
T cd05598          95 LG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD  169 (376)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccc
Confidence            43  3888999999999999999999855   99999999999999999999999999753210000             


Q ss_pred             ---------------------------ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 042486          497 ---------------------------EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE  549 (635)
Q Consensus       497 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~  549 (635)
                                                 .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  249 (376)
T cd05598         170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  249 (376)
T ss_pred             cccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH
Confidence                                       00011234799999999999988899999999999999999999999865433


Q ss_pred             hhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 042486          550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP---AMDKIAQS  615 (635)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~  615 (635)
                      ..... .....               ............+..+.+++.+|+ .+|.+|+   ++.|++++
T Consensus       250 ~~~~~-~i~~~---------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         250 AETQL-KVINW---------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             HHHHH-HHhcc---------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            22110 00000               000000111123445778888876 5999999   89999877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-33  Score=289.13  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=192.3

Q ss_pred             cccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhh-ccCCcccEEEEEe-
Q 042486          341 VYTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKI-NHSSLIRLLGICF-  406 (635)
Q Consensus       341 ~~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~-  406 (635)
                      .+.++++..++++|.....||    |.||+++.  +++.+|+|....      ++.+|+.+++++ +|+||+++++++. 
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            355667777777887777775    89999987  678999998753      355789999999 6999999999884 


Q ss_pred             ----cCCeeEEEeecccCCCcchhhcc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcE
Q 042486          407 ----NGGNWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA  480 (635)
Q Consensus       407 ----~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~  480 (635)
                          .++..++||||+++++|.+++..  .....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                34568999999999999998743  22345889999999999999999999854   9999999999999999999


Q ss_pred             EEeeecCcccccccCCceeeecccccCCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHH
Q 042486          481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV  555 (635)
Q Consensus       481 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~  555 (635)
                      ||+|||+++.......   ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+........ +.
T Consensus       164 kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LF  239 (286)
T ss_pred             EEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hh
Confidence            9999999875533211   1223468899999998853     4478899999999999999999998753322110 00


Q ss_pred             HhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       556 ~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      ..    ..          ...+.  ...+...+..+.+++.+||+.||++||++.|++++.
T Consensus       240 ~~----~~----------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KI----PR----------NPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hc----cc----------cCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00    00          00000  011122334589999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.2e-33  Score=281.81  Aligned_cols=230  Identities=27%  Similarity=0.418  Sum_probs=185.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|+.  +++.+++|.+..     ++.+|++++++++|+||+++++++.++...|+++||+++++|.+++.... ..
T Consensus        17 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~   95 (256)
T cd06612          17 GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KT   95 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cC
Confidence            89999998  478999998864     36689999999999999999999999999999999999999999986433 34


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   ......++..|+|||
T Consensus        96 l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE  169 (256)
T cd06612          96 LTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---KRNTVIGTPFWMAPE  169 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc---ccccccCCccccCHH
Confidence            899999999999999999999854   99999999999999999999999999886543321   122345788999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      ++.+..++.++||||||+++|+|++|+.|+........... .              .....+  ....+......+.++
T Consensus       170 ~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-~--------------~~~~~~--~~~~~~~~~~~~~~~  232 (256)
T cd06612         170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-I--------------PNKPPP--TLSDPEKWSPEFNDF  232 (256)
T ss_pred             HHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-h--------------ccCCCC--CCCchhhcCHHHHHH
Confidence            99888899999999999999999999998764322111100 0              000000  011122344568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 042486          595 IESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+||+.||++||++.|++++
T Consensus       233 i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcC
Confidence            999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3e-33  Score=287.77  Aligned_cols=243  Identities=25%  Similarity=0.404  Sum_probs=185.8

Q ss_pred             CCCCCCccc----ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEE
Q 042486          353 DFNPSCWIK----GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYL  413 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  413 (635)
                      +|.....+|    |.||+++.       ++..||+|.+...        +.+|+.++++++|+||+++++++.+++..++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL   85 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence            444444444    89999986       3578999987542        5578999999999999999999999999999


Q ss_pred             EeecccCCCcchhhcccC--------------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEE
Q 042486          414 VYENAVNGSLSVWINDKG--------------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL  473 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIl  473 (635)
                      +|||+++|+|.+++....                    ...+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil  162 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL  162 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence            999999999999985321                    12478899999999999999999984   5999999999999


Q ss_pred             ECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhh
Q 042486          474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENM  552 (635)
Q Consensus       474 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~  552 (635)
                      +++++.++|+|||++......... ........+..|+|||.+.+..++.++|||||||++|||++ |..|+......+ 
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-  240 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-  240 (288)
T ss_pred             ecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999998754322110 11112234567999999988889999999999999999998 777764322111 


Q ss_pred             HHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          553 LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       553 ~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                                       ....+.+... ...+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       241 -----------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -----------------VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----------------HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                             1111111111 11122344568999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-33  Score=286.53  Aligned_cols=250  Identities=22%  Similarity=0.390  Sum_probs=189.2

Q ss_pred             ceEEEeeeC------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++++      +..+|||.++.        ++.+|++++++++|+||+++++++..  +...+++|||+++++|.+
T Consensus        18 ~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (284)
T cd05038          18 GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD   97 (284)
T ss_pred             eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence            899999863      57899998853        25578999999999999999999887  557899999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++..... .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.................
T Consensus        98 ~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  173 (284)
T cd05038          98 YLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE  173 (284)
T ss_pred             HHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCC
Confidence            9965443 3899999999999999999999854   99999999999999999999999999987653322212222234


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|++||.+.+..++.++||||||++++||++|+.|+.........   ..... ........+...+........+.
T Consensus       174 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  249 (284)
T cd05038         174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIA-QGQMIVTRLLELLKEGERLPRPP  249 (284)
T ss_pred             CcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccc-cccccHHHHHHHHHcCCcCCCCc
Confidence            556799999998888999999999999999999999886532221100   00000 00011111222222222222233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      ..+..+.+++.+||+.+|++||++.||++.|+++
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         250 SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            4456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-33  Score=294.20  Aligned_cols=220  Identities=25%  Similarity=0.369  Sum_probs=175.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||+|.+..+          +..|..++..+. |++|+++++++.+.+..|+||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~   93 (323)
T cd05615          14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ   93 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH
Confidence            89999987  6889999988642          335777787775 5678889999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++......   .......||.
T Consensus        94 ~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~---~~~~~~~gt~  165 (323)
T cd05615          94 QVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTP  165 (323)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC---ccccCccCCc
Confidence            543  3899999999999999999999854   9999999999999999999999999987533221   1123456899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.......                  ....++...  ..++...+
T Consensus       166 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------------------~~~~i~~~~--~~~p~~~~  225 (323)
T cd05615         166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------------------LFQSIMEHN--VSYPKSLS  225 (323)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHhCC--CCCCccCC
Confidence            9999999998889999999999999999999999986433211                  111111111  12233344


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH
Q 042486          589 ILVIRLIESCLKKDPSGRPAM  609 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~  609 (635)
                      ..+.+++.+||+.||.+|++.
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         226 KEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHHHHHHHcccCHhhCCCC
Confidence            568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.1e-33  Score=286.43  Aligned_cols=240  Identities=24%  Similarity=0.419  Sum_probs=182.8

Q ss_pred             ceEEEeeeC------------------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          362 GSVYRGKIG------------------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       362 g~Vy~g~~~------------------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      |.||+++..                  +..||+|.+..+        +.+|++++++++|+||+++++++..++..+++|
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   98 (296)
T cd05051          19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIM   98 (296)
T ss_pred             ccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEE
Confidence            789988762                  246899998643        446899999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccC---------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          416 ENAVNGSLSVWINDKG---------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                      ||+++++|.+++....         ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg  175 (296)
T cd05051          99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFG  175 (296)
T ss_pred             ecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEcccc
Confidence            9999999999985533         125899999999999999999999855   9999999999999999999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCcchhhHHHHhhhccccc
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      +++....... ........++..|+|||++.+..++.++||||||+++|||++  +..|+......  .........+..
T Consensus       176 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~  252 (296)
T cd05051         176 MSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ--QVIENAGHFFRD  252 (296)
T ss_pred             ceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH--HHHHHHHhcccc
Confidence            9875433221 122234456788999999988889999999999999999998  55555432211  111111111111


Q ss_pred             CCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       565 ~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ..          .......+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       253 ~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         253 DG----------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cc----------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            00          00001112233456999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-33  Score=281.74  Aligned_cols=230  Identities=27%  Similarity=0.449  Sum_probs=182.5

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.+ +++.+|+|.++.      ++.+|++++++++|+|++++++++......++||||+++++|.+++..... .
T Consensus        18 g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~   96 (256)
T cd05112          18 GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-K   96 (256)
T ss_pred             ceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc-C
Confidence            89999988 478899998864      366899999999999999999999999999999999999999999865433 3


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......  .......++.+|+|||
T Consensus        97 ~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~aPe  171 (256)
T cd05112          97 FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSSPE  171 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc--cccCCCccchhhcCHh
Confidence            889999999999999999999855   99999999999999999999999999875432211  1111233557899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.++.++.++||||||+++|||++ |+.|+.......  ..+....                 ......+...+..+.+
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~  232 (256)
T cd05112         172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETINA-----------------GFRLYKPRLASQSVYE  232 (256)
T ss_pred             HhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHhC-----------------CCCCCCCCCCCHHHHH
Confidence            9998889999999999999999998 888775322211  1111100                 0000111223456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      |+.+||+.+|++||+++|++++|
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHhh
Confidence            99999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-33  Score=280.81  Aligned_cols=233  Identities=28%  Similarity=0.508  Sum_probs=187.9

Q ss_pred             ceEEEeeeC-----CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||++...     +..+++|.+...        +.+|++.+++++|+||+++++++..++..++||||+++++|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (262)
T cd00192           9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR   88 (262)
T ss_pred             eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHh
Confidence            899999984     779999998653        3468999999999999999999999899999999999999999996


Q ss_pred             ccC-------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeee
Q 042486          429 DKG-------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT  501 (635)
Q Consensus       429 ~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  501 (635)
                      ...       ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+........ ....
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  164 (262)
T cd00192          89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-YRKK  164 (262)
T ss_pred             hccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccc-cccc
Confidence            541       24589999999999999999999984   499999999999999999999999999987654321 1223


Q ss_pred             cccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      ....++..|+|||.+....++.++||||||+++|||++ |..|+.......  ..+.                +.+ ...
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~----------------~~~-~~~  225 (262)
T cd00192         165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEY----------------LRK-GYR  225 (262)
T ss_pred             cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH----------------HHc-CCC
Confidence            34567889999999988889999999999999999999 577775432211  1111                111 111


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ...+...+..+.+++.+||+.||++||++.|++++|+
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1223334566899999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.5e-33  Score=288.71  Aligned_cols=232  Identities=24%  Similarity=0.398  Sum_probs=185.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|..  +++.||+|.+..       .+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++...  
T Consensus        33 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  110 (296)
T cd06655          33 GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--  110 (296)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--
Confidence            89999986  788999998753       2457899999999999999999999999999999999999999998643  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++.++..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++........   ......++..|+|
T Consensus       111 -~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~a  183 (296)
T cd06655         111 -CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMA  183 (296)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc---cCCCcCCCccccC
Confidence             3899999999999999999999855   99999999999999999999999999875443221   1223468889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.+..++.++|||||||++|+|++|+.||...+...... ....                ........+...+..+.
T Consensus       184 PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-~~~~----------------~~~~~~~~~~~~~~~~~  246 (296)
T cd06655         184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIAT----------------NGTPELQNPEKLSPIFR  246 (296)
T ss_pred             cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh----------------cCCcccCCcccCCHHHH
Confidence            999998889999999999999999999999986433221110 0000                00000111223345688


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      +++.+||..||++||++.+++++  .++.
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~--~~~~  273 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQH--PFLK  273 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhC--hHhh
Confidence            99999999999999999999976  4444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.4e-33  Score=281.49  Aligned_cols=232  Identities=22%  Similarity=0.395  Sum_probs=183.7

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||++.. .+..+|+|.+..      .+.+|++++++++|+||+++++++.+ ...+++|||+++++|.+++.......
T Consensus        20 ~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05073          20 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK   98 (260)
T ss_pred             eEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccc
Confidence            89999987 556799998864      35579999999999999999999877 77899999999999999997655556


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.+........  .......++..|+|||
T Consensus        99 ~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~y~~PE  173 (260)
T cd05073          99 QPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPE  173 (260)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc--ccccCCcccccccCHh
Confidence            899999999999999999999854   99999999999999999999999999875533211  1122234567799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      ++..+.++.++|+||||+++|++++ |+.|+...+...  .......                 ......+...+..+.+
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~~~~  234 (260)
T cd05073         174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALER-----------------GYRMPRPENCPEELYN  234 (260)
T ss_pred             HhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhC-----------------CCCCCCcccCCHHHHH
Confidence            9998889999999999999999999 887775322211  1111110                 0001112233456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ++.+||+.+|++||++.++.+.|+.
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.6e-33  Score=287.41  Aligned_cols=246  Identities=25%  Similarity=0.322  Sum_probs=180.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.  ++..||||+++.         .+.+|+.++++++|+||+++++++.+++..++||||++ ++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~   92 (285)
T cd07861          14 GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSL   92 (285)
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcC
Confidence            89999987  688999998752         25679999999999999999999999999999999997 6888888543


Q ss_pred             C-CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 G-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      . ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........   ......++..
T Consensus        93 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~  166 (285)
T cd07861          93 PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTLW  166 (285)
T ss_pred             CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc---cccCCccccc
Confidence            2 24589999999999999999999985   499999999999999999999999999875432211   1123356889


Q ss_pred             ccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcc---c----ccCCchhhhhhhcCCcCC-
Q 042486          510 YMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV---L----HKEDGEESLRHLMDPSMQ-  580 (635)
Q Consensus       510 y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---~----~~~~~~~~l~~~~d~~~~-  580 (635)
                      |+|||.+.+ ..++.++||||||+++|||+||+.|+........ ........   .    .................. 
T Consensus       167 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (285)
T cd07861         167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKG  245 (285)
T ss_pred             ccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcc
Confidence            999998865 4468899999999999999999988864332211 11111000   0    000000000000000000 


Q ss_pred             --CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 --GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .......+..+.+++.+||+.||++|||+++++++
T Consensus       246 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         246 SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              00111234567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-33  Score=291.54  Aligned_cols=244  Identities=23%  Similarity=0.346  Sum_probs=180.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.||+|.++.        .+.+|++++++++|+||+++++++..++..++||||+++ +|.+++....
T Consensus        20 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   98 (309)
T cd07872          20 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG   98 (309)
T ss_pred             EEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcC
Confidence            89999987  678999998853        245799999999999999999999999999999999975 8888875443


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......   ......++..|+
T Consensus        99 -~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~  171 (309)
T cd07872          99 -NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK---TYSNEVVTLWYR  171 (309)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc---cccccccccccc
Confidence             3488999999999999999999985   499999999999999999999999999875432221   112346788999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc--------hhhhhhhcCCcCCC-
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG--------EESLRHLMDPSMQG-  581 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~~l~~~~d~~~~~-  581 (635)
                      |||.+.+ ..++.++||||||+++|||++|+.||...+..+. +... ...+.....        .......-.+.... 
T Consensus       172 aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
T cd07872         172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLI-FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQ  249 (309)
T ss_pred             CCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HHHhCCCCHHHHhhhcchhhhhhhhcCccCCC
Confidence            9998865 5688999999999999999999999865433211 1111 011100000        00000000010000 


Q ss_pred             ---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 ---NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         ......+..+.+++.+||+.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         250 PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence               0011234557899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-33  Score=287.08  Aligned_cols=240  Identities=25%  Similarity=0.449  Sum_probs=180.2

Q ss_pred             ceEEEeeeC----------------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          362 GSVYRGKIG----------------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       362 g~Vy~g~~~----------------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      |.||+++..                ...||+|.++.+        +.+|++++++++|+|++++++++..++..++||||
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   98 (295)
T cd05097          19 GEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEY   98 (295)
T ss_pred             ceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEec
Confidence            789988652                125899988653        45799999999999999999999999999999999


Q ss_pred             ccCCCcchhhcccC----------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecC
Q 042486          418 AVNGSLSVWINDKG----------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL  487 (635)
Q Consensus       418 ~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  487 (635)
                      +++++|.+++....          ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~  175 (295)
T cd05097          99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGM  175 (295)
T ss_pred             CCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEeccccc
Confidence            99999999985421          123788999999999999999999855   99999999999999999999999999


Q ss_pred             cccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhC--CCCCCCCcchhhHHHHhhhcccccC
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG--KEAPALYSEENMLLVDVLNPVLHKE  565 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG--~~p~~~~~~~~~~l~~~~~~~~~~~  565 (635)
                      +........ ........++..|+|||.+.++.++.++||||||+++|||+++  ..|+.......  ........+...
T Consensus       176 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--~~~~~~~~~~~~  252 (295)
T cd05097         176 SRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIENTGEFFRNQ  252 (295)
T ss_pred             ccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--HHHHHHHhhhhc
Confidence            875433221 1122233456789999999888899999999999999999984  44554322211  111111100000


Q ss_pred             CchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       566 ~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                                ........+...+..+.+|+.+||+.||++||++++|++.|+
T Consensus       253 ----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         253 ----------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ----------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                      000001112223456999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.3e-33  Score=282.84  Aligned_cols=232  Identities=26%  Similarity=0.406  Sum_probs=183.2

Q ss_pred             ceEEEeee-CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+. +++.+|+|.++.             .+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++
T Consensus        14 ~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   93 (265)
T cd06631          14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL   93 (265)
T ss_pred             eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHH
Confidence            89999987 788999998752             2457999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC---ceeeeccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG---EFALTSHI  504 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~  504 (635)
                      .+..  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........   ........
T Consensus        94 ~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  168 (265)
T cd06631          94 NRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM  168 (265)
T ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccccccccccc
Confidence            6543  3789999999999999999999854   99999999999999999999999999875432111   01112335


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .++..|+|||++.+..++.++||||||+++|+|++|+.||...+...... .....            ....+    ..+
T Consensus       169 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-~~~~~------------~~~~~----~~~  231 (265)
T cd06631         169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAH------------RGLMP----RLP  231 (265)
T ss_pred             CCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-Hhhhc------------cCCCC----CCC
Confidence            68899999999998889999999999999999999999985432211100 00000            00011    122


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+++.+||+.+|.+||++.|++++
T Consensus       232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2344568999999999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-33  Score=280.00  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=184.2

Q ss_pred             ceEEEeeeCCcEEEEEEeccC----hHHHHHHHhh--hccCCcccEEEEEecCC----eeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD----ASDQIKLLNK--INHSSLIRLLGICFNGG----NWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+|.|..||||.+...    ..+|.++.+.  |+|+||+.+++.-..++    +++||.+|.+.|||.|||.+..
T Consensus       225 GEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t  304 (513)
T KOG2052|consen  225 GEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT  304 (513)
T ss_pred             cceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc
Confidence            899999999999999999643    4467777665  59999999998765332    4799999999999999997743


Q ss_pred             CCCCCHHHHHHHHHHHHhhhccccc-----CCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeecccc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHS-----FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTSHIV  505 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~-----~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~  505 (635)
                         ++....++++..+|.||+|||.     .+.+.|.|||||+.|||+..++...|+|+|+|......... ....+..+
T Consensus       305 ---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rV  381 (513)
T KOG2052|consen  305 ---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRV  381 (513)
T ss_pred             ---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCcc
Confidence               8999999999999999999995     45678999999999999999999999999999866544222 22235578


Q ss_pred             cCCCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh-cCCc
Q 042486          506 GTKGYMAPEYLENGL------VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-MDPS  578 (635)
Q Consensus       506 gt~~y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-~d~~  578 (635)
                      ||.+|||||++....      .-..+||||||.++||+.-...--...++-...+.++    .......+..++. ...+
T Consensus       382 GTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~----Vp~DPs~eeMrkVVCv~~  457 (513)
T KOG2052|consen  382 GTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV----VPSDPSFEEMRKVVCVQK  457 (513)
T ss_pred             ceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC----CCCCCCHHHHhcceeecc
Confidence            999999999986422      1236899999999999976421100000000000111    1111111222221 1122


Q ss_pred             CCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          579 MQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       579 ~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ++...|     ......+.+|++.||..+|..|-|+--+-+.|.++.+
T Consensus       458 ~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  458 LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            222222     3345668999999999999999999999999999875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-34  Score=293.91  Aligned_cols=230  Identities=26%  Similarity=0.387  Sum_probs=185.5

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      ..||++.. +.+.+|+|++..         .+.+|+..|.++ .|.+||+|++|-..++.+|||||| ...+|..+|...
T Consensus       375 SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd~DL~kiL~k~  453 (677)
T KOG0596|consen  375 SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GDIDLNKILKKK  453 (677)
T ss_pred             ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-ccccHHHHHHhc
Confidence            58999998 567788887753         256899999999 589999999999999999999995 467999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ......| .+..+..|++.|+.++|.++   |||.||||.|+|+- .|.+||+|||.|..+..... .......+||+.|
T Consensus       454 ~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT-sI~kdsQvGT~NY  527 (677)
T KOG0596|consen  454 KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT-SIVKDSQVGTVNY  527 (677)
T ss_pred             cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc-ceeeccccCcccc
Confidence            6554556 77788999999999999977   99999999999985 57999999999987765443 2344567899999


Q ss_pred             cCccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          511 MAPEYLENG-----------LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       511 ~aPE~~~~~-----------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      |+||.+...           +.++++|||||||+||+|+.|+.||..+.                 +....+..++||..
T Consensus       528 MsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----------------n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  528 MSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----------------NQIAKLHAITDPNH  590 (677)
T ss_pred             cCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----------------HHHHHHHhhcCCCc
Confidence            999988531           25789999999999999999999985321                 12245667777755


Q ss_pred             CCCCChHHHHH-HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGNYPPVTAIL-VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~~~~~~~~~-l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .-++|..-... +.++++.||..||++||++.|++++
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            44444322222 8999999999999999999999875

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.3e-33  Score=287.94  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=193.1

Q ss_pred             cccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhh-ccCCcccEEEEEec
Q 042486          341 VYTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKI-NHSSLIRLLGICFN  407 (635)
Q Consensus       341 ~~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~  407 (635)
                      .++.+++..++++|.....++    |.||++..  +++.+|+|.+..      .+.+|+.++.++ +|+|++++++++..
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            355667777888887777776    79999987  678999998853      245788999998 89999999999874


Q ss_pred             C-----CeeEEEeecccCCCcchhhcc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcE
Q 042486          408 G-----GNWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA  480 (635)
Q Consensus       408 ~-----~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~  480 (635)
                      .     +..++||||+++++|.+++..  .....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998853  2234589999999999999999999985   49999999999999999999


Q ss_pred             EEeeecCcccccccCCceeeecccccCCCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHH
Q 042486          481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-----LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV  555 (635)
Q Consensus       481 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~  555 (635)
                      ||+|||++........   ......++..|+|||.+...     .++.++|||||||++|||++|+.|+....... .+.
T Consensus       168 kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLF  243 (291)
T ss_pred             EEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHH
Confidence            9999999876543221   11234678899999987643     36889999999999999999999875432211 111


Q ss_pred             HhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       556 ~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....              ..+.+  ..+......+.+++.+||+.||++||++.|++++
T Consensus       244 ~~~~~--------------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KIPRN--------------PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHhcC--------------CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11000              00000  1122234458999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-33  Score=295.74  Aligned_cols=223  Identities=23%  Similarity=0.334  Sum_probs=175.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHH-HHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIK-LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.+|+|.+...          +..|.. +++.++||||+++++.+..++..++||||+++|+|..++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (325)
T cd05604           9 GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ   88 (325)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence            89999987  6889999988542          123333 4677899999999999999999999999999999998886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||.
T Consensus        89 ~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~  160 (325)
T cd05604          89 RER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---DTTTTFCGTP  160 (325)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---CCcccccCCh
Confidence            543  3899999999999999999999854   9999999999999999999999999987432211   1123457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  .                ...+....+  ..++..+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~----------------~~~~~~~~~--~~~~~~~  220 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--M----------------YDNILHKPL--VLRPGAS  220 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--H----------------HHHHHcCCc--cCCCCCC
Confidence            9999999999899999999999999999999999986432211  1                111111111  1112234


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKI  612 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~ev  612 (635)
                      ..+.+++.+|++.||.+||++.+.
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCCC
Confidence            557899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.6e-33  Score=280.40  Aligned_cols=229  Identities=27%  Similarity=0.381  Sum_probs=182.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec-CCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+|+|++..         .+.+|++++++++|+|++++++.+.. +...+++|||+++++|.+++..
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   93 (257)
T cd08223          14 GEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE   93 (257)
T ss_pred             eEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH
Confidence            89999987  678999998753         24568899999999999999998764 4467999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++.++..++.+++.||.+||+.+   ++||||||+||+++.++.++|+|||++........   ......+++.
T Consensus        94 ~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  167 (257)
T cd08223          94 QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGTPY  167 (257)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC---ccccccCCcC
Confidence            54556899999999999999999999854   99999999999999999999999999876533221   2233568889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++++|++|+.|+...+.... ....                 ....+ ...+...+.
T Consensus       168 y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~-----------------~~~~~-~~~~~~~~~  228 (257)
T cd08223         168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRI-----------------IEGKL-PPMPKDYSP  228 (257)
T ss_pred             ccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHH-----------------HhcCC-CCCccccCH
Confidence            9999999998899999999999999999999998753322111 0011                 00000 112334456


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++||++.|++++
T Consensus       229 ~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         229 ELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHhcC
Confidence            68999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-33  Score=295.57  Aligned_cols=255  Identities=20%  Similarity=0.275  Sum_probs=185.0

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc-ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      .+|.....||    |.||+|+.  +++.||+|.... ....|+.++++++|+||+++++++..++..++|+||+. ++|.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~  144 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY  144 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHH
Confidence            3455555554    89999998  567899997643 45689999999999999999999999999999999994 6888


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++.... ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......    .....
T Consensus       145 ~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~~  216 (357)
T PHA03209        145 TYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP----AFLGL  216 (357)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc----ccccc
Confidence            8885433 34899999999999999999999855   9999999999999999999999999987533221    11235


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh---------hHHHHhhhcc------cccCCchh
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN---------MLLVDVLNPV------LHKEDGEE  569 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~---------~~l~~~~~~~------~~~~~~~~  569 (635)
                      .||..|+|||++.+..++.++|||||||++|||+++..++.......         ..+.+.+...      +.......
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            68999999999999899999999999999999999766553221110         1111111110      00000011


Q ss_pred             hhhhhcCCcCCCCCC---------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          570 SLRHLMDPSMQGNYP---------PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       570 ~l~~~~d~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+.+.......+         ...+..+.+||.+||+.||++|||+.|+++|
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            111111100000000         0123346679999999999999999999976

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-33  Score=282.39  Aligned_cols=230  Identities=25%  Similarity=0.441  Sum_probs=183.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+|..  +++.+|+|.+..                .+.+|++++++++|+||+++++++.+.+..+++|||+++++|
T Consensus        14 ~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (267)
T cd06628          14 GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV   93 (267)
T ss_pred             eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCH
Confidence            89999987  678999997742                245789999999999999999999999999999999999999


Q ss_pred             chhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc---eee
Q 042486          424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE---FAL  500 (635)
Q Consensus       424 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~  500 (635)
                      .+++....  .+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.++........   ...
T Consensus        94 ~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (267)
T cd06628          94 AALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA  168 (267)
T ss_pred             HHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCcccc
Confidence            99996543  3889999999999999999999854   999999999999999999999999998866422111   011


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ...              ......+   
T Consensus       169 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~--------------~~~~~~~---  230 (267)
T cd06628         169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFK--------------IGENASP---  230 (267)
T ss_pred             ccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HHH--------------HhccCCC---
Confidence            1224578899999999988899999999999999999999999864322110 000              0001111   


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ..+...+..+.+++.+||+.||.+||++.|++++
T Consensus       231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         231 -EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             2223345568999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-33  Score=299.49  Aligned_cols=248  Identities=20%  Similarity=0.239  Sum_probs=190.6

Q ss_pred             cHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEe
Q 042486          343 TFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICF  406 (635)
Q Consensus       343 ~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~  406 (635)
                      .+.++....++|.....||    |.||+++.  +++.+|+|.+..          .+.+|+.+++.++||||+++++.+.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3455555667777777676    89999988  678999998753          1447889999999999999999999


Q ss_pred             cCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       407 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                      +++..++||||+++|+|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999999998653   2788889999999999999999855   9999999999999999999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccc
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENG----LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL  562 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  562 (635)
                      +++.......  .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+... .         
T Consensus       188 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~---------  255 (371)
T cd05622         188 TCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-T---------  255 (371)
T ss_pred             ceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-H---------
Confidence            9976543211  122345799999999998653    37899999999999999999999986432211 1         


Q ss_pred             ccCCchhhhhhhcCC--cCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 042486          563 HKEDGEESLRHLMDP--SMQGNYPPVTAILVIRLIESCLKKDPSG--RPAMDKIAQSI  616 (635)
Q Consensus       563 ~~~~~~~~l~~~~d~--~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  616 (635)
                              ...++..  .+........+..+.+++.+||..++.+  |++++|++++.
T Consensus       256 --------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         256 --------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             --------HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                    1111110  0111111234556889999999844433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-33  Score=306.19  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=181.6

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecC--------CeeEEEe
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNG--------GNWYLVY  415 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~lV~  415 (635)
                      +|.....||    |.||+|..  +++.||||++..+   ..+|+.+|++++|+||+++++++...        ...++||
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm  146 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM  146 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence            454444554    89999987  6789999988643   45799999999999999999987532        2367999


Q ss_pred             ecccCCCcchhhcc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCccccc
Q 042486          416 ENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAE  492 (635)
Q Consensus       416 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~  492 (635)
                      ||+++ +|.+++..  .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       147 E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            99975 77776632  22345899999999999999999999855   99999999999998664 79999999998654


Q ss_pred             ccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      ....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..... .+.... .+.+
T Consensus       223 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~-~~~~p~-~~~~  295 (440)
T PTZ00036        223 AGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQ-VLGTPT-EDQL  295 (440)
T ss_pred             CCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCCCC-HHHH
Confidence            3221    123468999999998865 468999999999999999999999986543222 1111111 111110 0111


Q ss_pred             hhh----cC---C-----cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          572 RHL----MD---P-----SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       572 ~~~----~d---~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+    .+   +     .+...+|...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            100    00   0     01111222334568999999999999999999999976

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-32  Score=281.94  Aligned_cols=226  Identities=25%  Similarity=0.392  Sum_probs=184.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  ++..||+|.+..        .+.+|+.++++++|+||+++++.+.+++..++||||+++++|.+++... 
T Consensus        18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-   96 (277)
T cd06640          18 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-   96 (277)
T ss_pred             eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC-
Confidence            89999987  578999998753        2557899999999999999999999999999999999999999998643 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++.+...++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........   ......++..|+
T Consensus        97 --~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~  168 (277)
T cd06640          97 --PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWM  168 (277)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc---ccccccCccccc
Confidence              388999999999999999999984   599999999999999999999999999875543221   122345788999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||++.+..++.++|+||||+++|||++|+.|+........  ..                 ..........+...+..+
T Consensus       169 apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~-----------------~~~~~~~~~~~~~~~~~~  229 (277)
T cd06640         169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LF-----------------LIPKNNPPTLTGEFSKPF  229 (277)
T ss_pred             CHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hh-----------------hhhcCCCCCCchhhhHHH
Confidence            99999888899999999999999999999998753221110  00                 000111122334456678


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||+.+|++||++++++.+
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         230 KEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHcccCcccCcCHHHHHhC
Confidence            999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.2e-33  Score=286.45  Aligned_cols=231  Identities=25%  Similarity=0.319  Sum_probs=183.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||++..  +++.+|+|.+...          +.+|+++|++++|+||+++.+.+..++..+++|||+++++|.+++..
T Consensus        14 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05632          14 GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHH
Confidence            89999988  6889999987531          45699999999999999999999999999999999999999998865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........    .....|+..
T Consensus        94 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~~~~g~~~  166 (285)
T cd05632          94 MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES----IRGRVGTVG  166 (285)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc----ccCCCCCcC
Confidence            54445999999999999999999999854   99999999999999999999999999865432211    123468999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++|+||||+++|||++|+.||........ .......             ....  ...++...+.
T Consensus       167 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-------------~~~~--~~~~~~~~~~  230 (285)
T cd05632         167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-------------VLET--EEVYSAKFSE  230 (285)
T ss_pred             ccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-------------hhcc--ccccCccCCH
Confidence            9999999988899999999999999999999999864322111 0000000             0000  0112233345


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .+.+|+.+||+.||++||+     +++++.+
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            5789999999999999999     6677665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-32  Score=281.77  Aligned_cols=230  Identities=23%  Similarity=0.362  Sum_probs=180.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|+.  ++..+++|.+..       .+.+|++++++++|+||+++++++..++..++|+||+++++|..++.... 
T Consensus        19 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-   97 (282)
T cd06643          19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-   97 (282)
T ss_pred             eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-
Confidence            89999998  567889998753       24568999999999999999999999999999999999999998875432 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   .......++..|+|
T Consensus        98 ~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~a  171 (282)
T cd06643          98 RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYWMA  171 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc---cccccccccccccC
Confidence            34899999999999999999999854   9999999999999999999999999987543221   11233568899999


Q ss_pred             ccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          513 PEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       513 PE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||++.     +..++.++|||||||++|||++|+.|+........ .......              ..+.  ...+...
T Consensus       172 PE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~--------------~~~~--~~~~~~~  234 (282)
T cd06643         172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKS--------------EPPT--LAQPSRW  234 (282)
T ss_pred             HhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhc--------------CCCC--CCCcccc
Confidence            99984     34578899999999999999999988754322111 1111000              0000  0112234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++.+||+.||.+||++.+++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         235 SSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            4568999999999999999999998765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.2e-33  Score=285.65  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=186.4

Q ss_pred             HHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhh-ccCCcccEEEEEec---
Q 042486          344 FEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKI-NHSSLIRLLGICFN---  407 (635)
Q Consensus       344 ~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~---  407 (635)
                      +.++..+.+.|.....+|    |.||+|+.  +++.+|+|.+..      ++..|+.+++++ +|+||+++++++..   
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            334444445555444444    89999998  678999998743      345688888888 79999999999863   


Q ss_pred             ---CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          408 ---GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       408 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                         .+..+++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~d  164 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD  164 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence               456899999999999999996654455889999999999999999999855   99999999999999999999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN  559 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~  559 (635)
                      ||++........   ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......... .    
T Consensus       165 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~----  236 (282)
T cd06636         165 FGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-F----  236 (282)
T ss_pred             Ccchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-h----
Confidence            999875432211   122356889999999875     345788999999999999999999998532211100 0    


Q ss_pred             cccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       560 ~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                   ...............+..+.+++.+||+.||.+||++.|++++
T Consensus       237 -------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 -------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                         0000000011112234568999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-32  Score=277.22  Aligned_cols=232  Identities=26%  Similarity=0.462  Sum_probs=183.0

Q ss_pred             ceEEEeee-CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++.. +++.||+|..+.        .+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.....
T Consensus         9 g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~   88 (251)
T cd05041           9 GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN   88 (251)
T ss_pred             ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC
Confidence            89999998 489999998764        245799999999999999999999999999999999999999999965432


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++......... ........+..|+|
T Consensus        89 -~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~~  163 (251)
T cd05041          89 -RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSDGLKQIPIKWTA  163 (251)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-eccccCcceeccCC
Confidence             488999999999999999999984   4999999999999999999999999998755321110 11112233567999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      ||.+.++.++.++|+||||+++|||++ |..|+.......  .....                 ........+...+..+
T Consensus       164 PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~~  224 (251)
T cd05041         164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERI-----------------ESGYRMPAPQLCPEEI  224 (251)
T ss_pred             hHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHH-----------------hcCCCCCCCccCCHHH
Confidence            999988889999999999999999999 676664322211  11111                 0111111233345569


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .+++.+||..+|++||++.|+++.|.
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHhh
Confidence            99999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-33  Score=283.71  Aligned_cols=233  Identities=28%  Similarity=0.510  Sum_probs=181.9

Q ss_pred             ceEEEeeeCC--------cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIGG--------DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~~--------~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|+..+        ..+|+|.+..        .+.+|++++++++|+||+++++++...+..++||||+++++|.+
T Consensus         9 g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (269)
T cd05044           9 GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS   88 (269)
T ss_pred             eeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHH
Confidence            7999998732        5789997743        24578999999999999999999999889999999999999999


Q ss_pred             hhccc-----CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-----cEEEeeecCcccccccC
Q 042486          426 WINDK-----GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-----RAKIANFALARPAERQE  495 (635)
Q Consensus       426 ~l~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~Dfg~a~~~~~~~  495 (635)
                      ++...     ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||++.......
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~  165 (269)
T cd05044          89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD  165 (269)
T ss_pred             HHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccccccccccc
Confidence            99542     2234889999999999999999999854   99999999999998877     89999999987553221


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      . ........++..|+|||++.++.++.++||||||+++|||++ |+.||.......  ....+.               
T Consensus       166 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---------------  227 (269)
T cd05044         166 Y-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVT---------------  227 (269)
T ss_pred             c-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHh---------------
Confidence            1 111122345678999999999999999999999999999998 888875322211  111110               


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                        .......+...+..+.+++.+||..+|.+||+++++++.|.
T Consensus       228 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 --AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              00011122334566899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.5e-33  Score=286.40  Aligned_cols=237  Identities=26%  Similarity=0.422  Sum_probs=183.5

Q ss_pred             ceEEEeee--CCc----EEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|.+  ++.    .||+|.+..+        +.+|+.++++++|+||++++++|... ..++++||+++|+|.+++
T Consensus        21 g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~   99 (303)
T cd05110          21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYV   99 (303)
T ss_pred             ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHH
Confidence            89999987  444    5788877643        45788999999999999999998654 467999999999999998


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++........ .......++
T Consensus       100 ~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~  174 (303)
T cd05110         100 HEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-YNADGGKMP  174 (303)
T ss_pred             Hhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccc-cccCCCccc
Confidence            6543 2389999999999999999999985   4999999999999999999999999999865432211 111223456


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||.......  ..++...                 ......+..
T Consensus       175 ~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~  235 (303)
T cd05110         175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEK-----------------GERLPQPPI  235 (303)
T ss_pred             cccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHC-----------------CCCCCCCCC
Confidence            78999999998889999999999999999998 888875322111  1111110                 000011122


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+..+.+++.+||..+|++||+++++++.|+++....
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            3345889999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.4e-33  Score=289.83  Aligned_cols=182  Identities=26%  Similarity=0.360  Sum_probs=147.8

Q ss_pred             ceEEEeee----CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.    ++..||+|.+..     .+.+|+++|++++|+||+++++++..  +...++||||+.+ +|.+++...
T Consensus        15 g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   93 (317)
T cd07867          15 GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFH   93 (317)
T ss_pred             eeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhh
Confidence            89999986    346899998865     35689999999999999999999864  4567999999864 777776321


Q ss_pred             -------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE----CCCCcEEEeeecCcccccccCCcee
Q 042486          431 -------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       431 -------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                             ....+++..+..++.|++.||.|||+.+   ++||||||+||++    +.++.+||+|||+++..........
T Consensus        94 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  170 (317)
T cd07867          94 RASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  170 (317)
T ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccccc
Confidence                   1234889999999999999999999854   9999999999999    5667999999999986543322212


Q ss_pred             eecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 042486          500 LTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALY  547 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~  547 (635)
                      ......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            2234578999999999876 45799999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-32  Score=281.21  Aligned_cols=237  Identities=25%  Similarity=0.427  Sum_probs=186.0

Q ss_pred             ceEEEeee--CCc----EEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|..  ++.    .+|+|....+        +.+|+.++++++|+||+++++++.. ...++||||+++|+|.+++
T Consensus        21 g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l   99 (279)
T cd05057          21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYV   99 (279)
T ss_pred             ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHH
Confidence            89999986  332    6899987543        4578999999999999999999987 7889999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ..... .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......... ......++
T Consensus       100 ~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~~~~~  174 (279)
T cd05057         100 RNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY-HAEGGKVP  174 (279)
T ss_pred             HhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccce-ecCCCccc
Confidence            66443 389999999999999999999984   49999999999999999999999999998665332211 11112235


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+....++.++|+||||+++||+++ |+.||.....++  +...+.                 .......+..
T Consensus       175 ~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~  235 (279)
T cd05057         175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLE-----------------KGERLPQPPI  235 (279)
T ss_pred             ccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHh-----------------CCCCCCCCCC
Confidence            67999999988889999999999999999999 998875432211  111110                 0001111222


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+..+.+++.+||..||++||++.++++.|+++....
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            3455889999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.2e-33  Score=283.25  Aligned_cols=226  Identities=26%  Similarity=0.395  Sum_probs=182.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|..  ++..||+|.+..        .+.+|++++++++|+||+++++++..++..++||||+++++|.+++... 
T Consensus        18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-   96 (277)
T cd06642          18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-   96 (277)
T ss_pred             eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC-
Confidence            89999987  578999998763        2567999999999999999999999999999999999999999998642 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........   ......++..|+
T Consensus        97 --~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~  168 (277)
T cd06642          97 --PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWM  168 (277)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch---hhhcccCccccc
Confidence              389999999999999999999984   599999999999999999999999999876543221   112245788999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||++.+..++.++||||||+++|||++|+.|+.........  ..                 .........+...+..+
T Consensus       169 aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~-----------------~~~~~~~~~~~~~~~~~  229 (277)
T cd06642         169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FL-----------------IPKNSPPTLEGQYSKPF  229 (277)
T ss_pred             CHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hh-----------------hhcCCCCCCCcccCHHH
Confidence            999999888999999999999999999999887532211100  00                 00000111122344568


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||+.+|++||++.|++++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         230 KEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-33  Score=299.25  Aligned_cols=246  Identities=21%  Similarity=0.260  Sum_probs=183.9

Q ss_pred             ceEEEeee----CCcEEEEEEecc--ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG--DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||++..    .+..||+|.+..  ...+|+++|++++|+||+++++++..++..+++||++. ++|.+++...  ..+
T Consensus       106 g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l  182 (392)
T PHA03207        106 GEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS--GPL  182 (392)
T ss_pred             eEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc--CCC
Confidence            89999875    346899998865  45689999999999999999999999999999999985 6888888433  348


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      ++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ .......||..|+|||+
T Consensus       183 ~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~  258 (392)
T PHA03207        183 PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLETNSPEL  258 (392)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccc-ccccccccccCccCHhH
Confidence            99999999999999999999854   999999999999999999999999999765433211 12234579999999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHhCCCCCCCCcch--hhHHHHhhhccc------ccCCch---hhhhhhcCCcCCCCC-
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE--NMLLVDVLNPVL------HKEDGE---ESLRHLMDPSMQGNY-  583 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~------~~~~~~---~~l~~~~d~~~~~~~-  583 (635)
                      +....++.++|||||||++|||++|+.||......  ...+.......-      ......   ..+..+.. .....+ 
T Consensus       259 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  337 (392)
T PHA03207        259 LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAI-VLRPPYT  337 (392)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcc-cccCCcc
Confidence            99888999999999999999999999998653321  111111111100      000000   00111100 000000 


Q ss_pred             -C-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          584 -P-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       584 -~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       +     ...+..+.++|.+||..||++||++.|++.+
T Consensus       338 ~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        338 IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0     1124457899999999999999999999987

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-32  Score=280.00  Aligned_cols=237  Identities=22%  Similarity=0.338  Sum_probs=176.8

Q ss_pred             ceEEEeeeC----CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKIG----GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~~----~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+..    +..+|+|+++.        .+.+|+.++++++|+||+++++++.+....++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05087           9 GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRS   88 (269)
T ss_pred             ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHH
Confidence            899999863    35799998864        245689999999999999999999988889999999999999999954


Q ss_pred             cC---CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          430 KG---GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       430 ~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      ..   ....++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ ........+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~  164 (269)
T cd05087          89 CRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-YVTPDQLWV  164 (269)
T ss_pred             hhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce-eecCCCcCC
Confidence            22   224677888899999999999999854   99999999999999999999999999875432211 111123456


Q ss_pred             CCCccCccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          507 TKGYMAPEYLENG-------LVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       507 t~~y~aPE~~~~~-------~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      +..|+|||++.+.       .++.++||||||+++|||++ |+.||...............          ....+.++.
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~  234 (269)
T cd05087         165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE----------QQLKLPKPR  234 (269)
T ss_pred             cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc----------ccCCCCCCc
Confidence            7889999988642       35789999999999999996 99888543322211110000          000111122


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      +..    .....+.+++..|+ .+|++|||++||+..|+
T Consensus       235 ~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111    12344788999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-32  Score=280.32  Aligned_cols=235  Identities=26%  Similarity=0.364  Sum_probs=183.7

Q ss_pred             ceEEEeeeC-----CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|...     ...||||.....        +.+|+.++++++|+||+++++++.+ +..++||||+++|+|.+++.
T Consensus        20 g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   98 (270)
T cd05056          20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ   98 (270)
T ss_pred             eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHH
Confidence            899999872     236899987542        4579999999999999999999865 55789999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .... .+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......  .......++.
T Consensus        99 ~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~  172 (270)
T cd05056          99 VNKY-SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY--YKASKGKLPI  172 (270)
T ss_pred             hCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc--eecCCCCccc
Confidence            5432 4899999999999999999999854   99999999999999999999999999876543311  1112223456


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+....++.++||||||+++|||++ |..||........  ......             ..    ....+...
T Consensus       173 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~-------------~~----~~~~~~~~  233 (270)
T cd05056         173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIEN-------------GE----RLPMPPNC  233 (270)
T ss_pred             cccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHc-------------CC----cCCCCCCC
Confidence            8999999988889999999999999999986 9988754332211  111100             00    00112334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +..+.+++.+|+..+|.+||++.++++.|+.+..+
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            45689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.6e-33  Score=280.38  Aligned_cols=230  Identities=22%  Similarity=0.294  Sum_probs=179.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|..  +++.||||.+..            .+.+|++++++++|+||+++++++.+.  ...+++|||+++++|.+
T Consensus        16 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~   95 (265)
T cd06652          16 GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD   95 (265)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHH
Confidence            89999987  678999998742            234689999999999999999988763  45789999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++................
T Consensus        96 ~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  170 (265)
T cd06652          96 QLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT  170 (265)
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCC
Confidence            986543  3788999999999999999999855   99999999999999999999999999875532211111122345


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|+|||.+.+..++.++||||||+++|||++|+.||.......                  ...+..........+.
T Consensus       171 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~  232 (265)
T cd06652         171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------------------AIFKIATQPTNPVLPP  232 (265)
T ss_pred             CCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------------------HHHHHhcCCCCCCCch
Confidence            8889999999988889999999999999999999999975322111                  0111111111122344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+.+++.+|+. +|++||+++|++++
T Consensus       233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         233 HVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            556678899999995 99999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-33  Score=300.62  Aligned_cols=230  Identities=22%  Similarity=0.294  Sum_probs=177.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.++.          .+.+|+.++.+++|+||+++++.+.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (360)
T cd05627          15 GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK   94 (360)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh
Confidence            89999987  688999998853          244688999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc------------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE------------  497 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------------  497 (635)
                      ..  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.........            
T Consensus        95 ~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~  169 (360)
T cd05627          95 KD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS  169 (360)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcc
Confidence            43  3899999999999999999999854   999999999999999999999999998754321100            


Q ss_pred             --------------------eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHh
Q 042486          498 --------------------FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV  557 (635)
Q Consensus       498 --------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~  557 (635)
                                          ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~-~---  245 (360)
T cd05627         170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET-Y---  245 (360)
T ss_pred             cccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHH-H---
Confidence                                0011234699999999999998999999999999999999999999864332211 0   


Q ss_pred             hhcccccCCchhhhhhhcCCcCCCCCCh--HHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 042486          558 LNPVLHKEDGEESLRHLMDPSMQGNYPP--VTAILVIRLIESCLKKDPSGRPA---MDKIAQS  615 (635)
Q Consensus       558 ~~~~~~~~~~~~~l~~~~d~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  615 (635)
                                    ..++........+.  ..+..+.+++.+|+ .||.+|++   ++|+++|
T Consensus       246 --------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         246 --------------RKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             --------------HHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence                          11111000000111  12345788888876 49999985   5666655

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.4e-33  Score=287.44  Aligned_cols=228  Identities=23%  Similarity=0.386  Sum_probs=183.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||+|.+..       .+.+|+.++++++|+||+++++++..++..++||||+++++|.+++...  
T Consensus        33 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  110 (297)
T cd06656          33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--  110 (297)
T ss_pred             eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--
Confidence            89999986  789999998853       2457899999999999999999999999999999999999999998643  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........   ......+++.|+|
T Consensus       111 -~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~a  183 (297)
T cd06656         111 -CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMA  183 (297)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc---CcCcccCCccccC
Confidence             3799999999999999999999854   99999999999999999999999999875433221   1123467889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.+..++.++|+||||+++|+|++|+.||...+.......     .            ..........+...+..+.
T Consensus       184 PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~------------~~~~~~~~~~~~~~~~~~~  246 (297)
T cd06656         184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----I------------ATNGTPELQNPERLSAVFR  246 (297)
T ss_pred             HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----e------------ccCCCCCCCCccccCHHHH
Confidence            9999988899999999999999999999999854322111000     0            0000001112233455688


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||..||++||++++++++
T Consensus       247 ~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         247 DFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-33  Score=285.19  Aligned_cols=245  Identities=23%  Similarity=0.292  Sum_probs=181.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +|..+|+|+++.         .+.+|++++++++|+||+++++++.+.+..++++||++ ++|.+++...
T Consensus        14 ~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   92 (284)
T cd07839          14 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC   92 (284)
T ss_pred             eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc
Confidence            89999998  688999998853         35679999999999999999999999999999999996 5788887543


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......   ......++..|
T Consensus        93 ~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y  165 (284)
T cd07839          93 N-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---CYSAEVVTLWY  165 (284)
T ss_pred             C-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---CcCCCccccCC
Confidence            3 33899999999999999999999854   99999999999999999999999999875533221   11234578899


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc--hhhhhhhcCCcCCC------
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG--EESLRHLMDPSMQG------  581 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~l~~~~d~~~~~------  581 (635)
                      +|||.+.+. .++.++||||||+++|||++|+.|+.........+..... .+.....  ........+.....      
T Consensus       166 ~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
T cd07839         166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEESWPGVSKLPDYKPYPMYPATT  244 (284)
T ss_pred             cChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH-HhCCCChHHhHHhhhcccccccCCCCCcc
Confidence            999988764 4689999999999999999999886543322222111111 1110000  00011111110000      


Q ss_pred             ---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 ---NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         ......+..+.+++.+||+.||.+|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         245 SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence               0112234568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-33  Score=289.11  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=180.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  ++..||+|.++.        .+.+|+.++++++|+||+++++++..++..++||||++ ++|.+++....
T Consensus        20 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~   98 (301)
T cd07873          20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG   98 (301)
T ss_pred             EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC
Confidence            89999987  678999998853        24579999999999999999999999999999999997 58988886543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++........   ......++..|+
T Consensus        99 -~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~  171 (301)
T cd07873          99 -NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYSNEVVTLWYR  171 (301)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC---cccccceeeccc
Confidence             24889999999999999999999854   99999999999999999999999999875432221   112245688999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc--------hhhhhhhcCCcCCCC
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG--------EESLRHLMDPSMQGN  582 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~~l~~~~d~~~~~~  582 (635)
                      |||.+.+ ..++.++||||||+++|||++|+.||...+....  ...+...+.....        .+.......+.....
T Consensus       172 ~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (301)
T cd07873         172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD  249 (301)
T ss_pred             CcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCChhhchhhhccccccccccCccccc
Confidence            9998865 4578899999999999999999999865433221  1111111100000        000000000111000


Q ss_pred             ----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 ----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          .....+..+.+|+.+||+.||.+|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         250 CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                111234458899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.7e-33  Score=297.24  Aligned_cols=244  Identities=24%  Similarity=0.287  Sum_probs=180.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC-----eeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~  425 (635)
                      |.||++..  +++.||||++..         .+.+|+++++.++|+||+++++++...+     ..|+|+||+. ++|.+
T Consensus        14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (372)
T cd07853          14 GVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHK   92 (372)
T ss_pred             EEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHH
Confidence            89999986  789999998854         2457999999999999999999998766     7899999996 57888


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......  .......
T Consensus        93 ~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~  165 (372)
T cd07853          93 IIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES--KHMTQEV  165 (372)
T ss_pred             HHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc--ccCCCCC
Confidence            775433  4899999999999999999999855   99999999999999999999999999975433221  1122346


Q ss_pred             cCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchh------hhhhhc-CC
Q 042486          506 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE------SLRHLM-DP  577 (635)
Q Consensus       506 gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------~l~~~~-d~  577 (635)
                      ++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ..+.+...+.......      .....+ ..
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  243 (372)
T cd07853         166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMRSACEGARAHILRG  243 (372)
T ss_pred             cCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhC
Confidence            7889999999876 457899999999999999999999986543221  1111111111111100      000000 00


Q ss_pred             cCC-------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 SMQ-------GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...       .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000       01112234568899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-33  Score=288.34  Aligned_cols=243  Identities=24%  Similarity=0.356  Sum_probs=188.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  +++.+|+|.+..+          +.+|++++++++|+||+++++.+.+++..++||||+.+++|.+++..
T Consensus        15 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (316)
T cd05574          15 GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR   94 (316)
T ss_pred             EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh
Confidence            89999988  5789999988542          45689999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-----------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-----------  498 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-----------  498 (635)
                      .....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..........           
T Consensus        95 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~  171 (316)
T cd05574          95 QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS  171 (316)
T ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccc
Confidence            54456899999999999999999999854   9999999999999999999999999987543221100           


Q ss_pred             ---------------eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc
Q 042486          499 ---------------ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       499 ---------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                                     .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... +         
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~---------  241 (316)
T cd05574         172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-F---------  241 (316)
T ss_pred             cccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-H---------
Confidence                           011234678899999999988899999999999999999999999864332211 1         


Q ss_pred             cCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC----HHHHHHHHHHHHhhcccccc
Q 042486          564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA----MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~L~~~~~~s~~w~~  628 (635)
                              ..+.+...........+..+.+++.+||+.||++||+    ++|++.+  .++.. .+|..
T Consensus       242 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~--~~~~~-~~~~~  299 (316)
T cd05574         242 --------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH--PFFRG-VNWAL  299 (316)
T ss_pred             --------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC--chhhc-CChhh
Confidence                    1111111111111114566999999999999999999    7777775  33332 44543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=277.66  Aligned_cols=232  Identities=25%  Similarity=0.356  Sum_probs=183.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.+++|.+..       .+.+|++++++++|+||+++++++.+++..+++|||+++++|.+++.... 
T Consensus        17 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-   95 (262)
T cd06613          17 GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-   95 (262)
T ss_pred             eEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-
Confidence            79999987  578899998754       25679999999999999999999999999999999999999999986542 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........   ......++..|+|
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~  169 (262)
T cd06613          96 GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA---KRKSFIGTPYWMA  169 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh---ccccccCCccccC
Confidence            23899999999999999999999855   99999999999999999999999999875543211   1223467889999


Q ss_pred             ccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLENG---LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||.+.+.   .++.++|+||||+++|||++|+.|+.......... .....            .+..+.  ...+...+.
T Consensus       170 Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~------------~~~~~~--~~~~~~~~~  234 (262)
T cd06613         170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKS------------NFPPPK--LKDKEKWSP  234 (262)
T ss_pred             chhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc------------cCCCcc--ccchhhhhH
Confidence            9998766   78999999999999999999999986433221111 00000            000000  111233456


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||..||.+||++.+++.+
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            68999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-32  Score=289.86  Aligned_cols=239  Identities=27%  Similarity=0.443  Sum_probs=185.1

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||++...         +..||+|.++.        ++.+|+++++++ +|+||++++++|..++..+++|||+++|+|
T Consensus        26 g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (334)
T cd05100          26 GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL  105 (334)
T ss_pred             CcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcH
Confidence            889998741         23689998764        245789999999 899999999999999999999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus       106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~  182 (334)
T cd05100         106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (334)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccce
Confidence            99985421              23488999999999999999999985   49999999999999999999999999987


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....+.  ....           
T Consensus       183 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~-----------  248 (334)
T cd05100         183 DVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKL-----------  248 (334)
T ss_pred             eccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH-----------
Confidence            65432211 11122334567999999998889999999999999999998 777764322111  1111           


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                           +.. ......+...+..+.+++.+||+.+|++||++.|+++.|+++...+
T Consensus       249 -----~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         249 -----LKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -----HHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                 100 0111122233456889999999999999999999999999998544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-32  Score=278.62  Aligned_cols=223  Identities=20%  Similarity=0.322  Sum_probs=172.0

Q ss_pred             ceEEEeeeC--------------CcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccC
Q 042486          362 GSVYRGKIG--------------GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN  420 (635)
Q Consensus       362 g~Vy~g~~~--------------~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~  420 (635)
                      |.||+|+..              ...|++|.+..       .+.+|+.++++++||||+++++++..+...++||||+++
T Consensus         9 ~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   88 (262)
T cd05077           9 TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEF   88 (262)
T ss_pred             ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccC
Confidence            899999852              12588898753       245678899999999999999999998899999999999


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc-------EEEeeecCcccccc
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR-------AKIANFALARPAER  493 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~Dfg~a~~~~~  493 (635)
                      |+|..++.... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.       ++++|||++.....
T Consensus        89 ~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~  164 (262)
T cd05077          89 GPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS  164 (262)
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC
Confidence            99998886543 3389999999999999999999984   4999999999999987654       89999999865432


Q ss_pred             cCCceeeecccccCCCccCccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLMLEML-SGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SlGvvl~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .       ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+........  .                
T Consensus       165 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~----------------  219 (262)
T cd05077         165 R-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--E----------------  219 (262)
T ss_pred             c-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--H----------------
Confidence            1       1245778899999886 466899999999999999998 46666542211110  0                


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                       .+......  ........+.+|+.+||+.||.+||++.+|++.|
T Consensus       220 -~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 -RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             00000000  0111234588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.6e-33  Score=304.86  Aligned_cols=258  Identities=21%  Similarity=0.316  Sum_probs=184.8

Q ss_pred             HHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhccC------CcccEEEEEe
Q 042486          345 EELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKINHS------SLIRLLGICF  406 (635)
Q Consensus       345 ~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~h~------nIv~l~~~~~  406 (635)
                      +++...+++|.....||    |+||++..  .++.||||+++.      +...|++++++++|.      +++++++++.
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445566777666676    89999987  678999999854      245688888888654      4888888887


Q ss_pred             cC-CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-------
Q 042486          407 NG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-------  478 (635)
Q Consensus       407 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-------  478 (635)
                      .+ +..|+|||++ +++|.+++.+..  .+++..+..|+.||+.||.|||+.  .+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence            54 5689999987 778988886543  389999999999999999999972  3499999999999998665       


Q ss_pred             ---------cEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 042486          479 ---------RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE  549 (635)
Q Consensus       479 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~  549 (635)
                               .+||+|||.+......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             ccccCCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                     4999999987643221      2335799999999999999999999999999999999999999865433


Q ss_pred             hhhHHHHhhhcccccCC-------chhhhhhhcCC------cCC-----------CCCChHHHHHHHHHHHHhhhcCCCC
Q 042486          550 ENMLLVDVLNPVLHKED-------GEESLRHLMDP------SMQ-----------GNYPPVTAILVIRLIESCLKKDPSG  605 (635)
Q Consensus       550 ~~~~l~~~~~~~~~~~~-------~~~~l~~~~d~------~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~  605 (635)
                      .+.  ...+...+....       .......+.+.      ...           ..........+.+||.+||+.||++
T Consensus       351 ~~~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        351 LEH--LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             HHH--HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            211  111111100000       00000000000      000           0000012345789999999999999


Q ss_pred             CCCHHHHHHH
Q 042486          606 RPAMDKIAQS  615 (635)
Q Consensus       606 RPs~~evl~~  615 (635)
                      |||++|+++|
T Consensus       429 R~ta~e~L~H  438 (467)
T PTZ00284        429 RLNARQMTTH  438 (467)
T ss_pred             CCCHHHHhcC
Confidence            9999999986

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=281.35  Aligned_cols=227  Identities=25%  Similarity=0.405  Sum_probs=183.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.||+|.+..+        +.+|++++++++|+||+++++++.++...++|+||+++++|.+++... 
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-   93 (274)
T cd06609          15 GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-   93 (274)
T ss_pred             eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-
Confidence            89999987  6789999987532        457999999999999999999999999999999999999999999654 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.......   ......++..|+
T Consensus        94 --~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~  165 (274)
T cd06609          94 --KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---KRNTFVGTPFWM  165 (274)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc---ccccccCCcccc
Confidence              4899999999999999999999854   99999999999999999999999999976653321   123356788999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||.+.+..++.++||||||+++|+|++|+.|+...+.... . ..             +.....+.....   ..+..+
T Consensus       166 ~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~-~~-------------~~~~~~~~~~~~---~~~~~~  227 (274)
T cd06609         166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-L-FL-------------IPKNNPPSLEGN---KFSKPF  227 (274)
T ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-H-HH-------------hhhcCCCCCccc---ccCHHH
Confidence            99999988899999999999999999999999854321110 0 00             000011111111   034458


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||..||++||++++++++
T Consensus       228 ~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         228 KDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhC
Confidence            899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-32  Score=276.93  Aligned_cols=230  Identities=22%  Similarity=0.339  Sum_probs=184.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||.++.  +++.+++|.+..         ++.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++...
T Consensus        14 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~   93 (256)
T cd08221          14 GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ   93 (256)
T ss_pred             ceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc
Confidence            66666655  788999998643         2568999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++.++..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++........   ......++..|
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~~~~~~~~y  167 (256)
T cd08221          94 KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAETVVGTPYY  167 (256)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc---cccccCCCccc
Confidence            4455899999999999999999999855   99999999999999999999999999876543221   12335688999


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      +|||.+.+..++.++||||||+++|||++|+.|+.......                  ....+...... ..+...+..
T Consensus       168 ~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------------------~~~~~~~~~~~-~~~~~~~~~  228 (256)
T cd08221         168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------------------LVVKIVQGNYT-PVVSVYSSE  228 (256)
T ss_pred             cCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------------------HHHHHHcCCCC-CCccccCHH
Confidence            99999988888999999999999999999998875322111                  11111111111 112233456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      +.+++.+||..+|.+||+++|+++++
T Consensus       229 ~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         229 LISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhhCc
Confidence            89999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-32  Score=293.00  Aligned_cols=240  Identities=25%  Similarity=0.305  Sum_probs=177.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCC------eeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGG------NWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~E~~~~gsL~  424 (635)
                      |.||++..  ++..||||++...         +.+|+.++++++|+||+++++++...+      ..|+||||+++ +|.
T Consensus        35 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  113 (359)
T cd07876          35 GIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLC  113 (359)
T ss_pred             EEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHH
Confidence            89999987  6889999998532         447899999999999999999986443      46999999965 566


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +.+..    .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......    .....
T Consensus       114 ~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~~  182 (359)
T cd07876         114 QVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF----MMTPY  182 (359)
T ss_pred             HHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc----cCCCC
Confidence            66532    2788899999999999999999855   9999999999999999999999999987543221    12335


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc------hhhhhhhcCC-
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG------EESLRHLMDP-  577 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~~~l~~~~d~-  577 (635)
                      .+|..|+|||.+.+..++.++|||||||++|+|++|+.||...+... .+...... +.....      ......+... 
T Consensus       183 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  260 (359)
T cd07876         183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQ-LGTPSAEFMNRLQPTVRNYVENR  260 (359)
T ss_pred             cccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCcHHHHHHHHHHHHHHHhhC
Confidence            68999999999999899999999999999999999999987543221 11111110 000000      0000000000 


Q ss_pred             -cCC----------------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 -SMQ----------------GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 -~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ...                ..........+.+|+.+||+.||++|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence             000                00111224558999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.4e-33  Score=283.56  Aligned_cols=239  Identities=23%  Similarity=0.316  Sum_probs=184.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |+||++..  ++..+|+|.+..        .+.+|++++++++|+||+++++++...+..++||||+++++|.+++...+
T Consensus        19 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   98 (284)
T cd06620          19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG   98 (284)
T ss_pred             eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc
Confidence            89999988  588999997643        24579999999999999999999999999999999999999999986543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.+++.||.|||+.  .+++||||+|+||++++++.++|+|||++.......     .....++..|+
T Consensus        99 --~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-----~~~~~~~~~~~  169 (284)
T cd06620          99 --PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADTFVGTSTYM  169 (284)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-----cCccccCcccC
Confidence              389999999999999999999972  349999999999999999999999999986442211     22356889999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||++.+..++.++|||||||++|+|++|+.||..........       .......+.+..+.............+..+
T Consensus       170 aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd06620         170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-------DDPMGILDLLQQIVQEPPPRLPSSDFPEDL  242 (284)
T ss_pred             CHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-------hhhhHHHHHHHHHhhccCCCCCchhcCHHH
Confidence            9999988889999999999999999999999986433211000       000000011111111111111111244568


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+++.+||+.||.+||+++|++++.
T Consensus       243 ~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         243 RDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCc
Confidence            9999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-32  Score=277.79  Aligned_cols=229  Identities=24%  Similarity=0.366  Sum_probs=184.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.+|+++.  +++.+|+|++..         ++.+|+.++++++|+||+++++++...+..++|+||+++++|.+++...
T Consensus        14 g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   93 (256)
T cd08218          14 GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ   93 (256)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc
Confidence            78998877  788999998742         3567999999999999999999999999999999999999999998665


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   ......++..|
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~  167 (256)
T cd08218          94 RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYY  167 (256)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---hhhhccCCccc
Confidence            4445899999999999999999999854   99999999999999999999999999875543221   12234578899


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      +|||++.+...+.++|+||||+++++|++|+.|+...+...                  ....+..... ...+...+..
T Consensus       168 ~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------------------~~~~~~~~~~-~~~~~~~~~~  228 (256)
T cd08218         168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------------------LVLKIIRGSY-PPVSSHYSYD  228 (256)
T ss_pred             cCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------------------HHHHHhcCCC-CCCcccCCHH
Confidence            99999998889999999999999999999999875322111                  1111111110 1122334556


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+++.+||+.+|.+||++.||+++
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         229 LRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhhC
Confidence            8999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=293.65  Aligned_cols=224  Identities=28%  Similarity=0.420  Sum_probs=185.1

Q ss_pred             ceEEEeee--CCcEEEEEEec----------cChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVY----------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~----------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||.++.  +...||||++.          .|+.+|+.+|.+++|||++.+.|+|..+...|||||||- |+-.|++.-
T Consensus        40 GAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleV  118 (948)
T KOG0577|consen   40 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEV  118 (948)
T ss_pred             ceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHH
Confidence            89999987  78899999984          257789999999999999999999999999999999995 588887743


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. +++.+..+..|+.+.+.||.|||+++   .||||||..|||+++.|.+||+|||.|....+.       ..++||+.
T Consensus       119 hk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-------nsFvGTPy  187 (948)
T KOG0577|consen  119 HK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-------NSFVGTPY  187 (948)
T ss_pred             Hh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-------hcccCCcc
Confidence            32 45899999999999999999999976   999999999999999999999999999866543       34789999


Q ss_pred             ccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |||||++.   .|.|+-|+||||||++..||...++|....+.-. .++..              ..--.|.+   ...+
T Consensus       188 wMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALYHI--------------AQNesPtL---qs~e  249 (948)
T KOG0577|consen  188 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHI--------------AQNESPTL---QSNE  249 (948)
T ss_pred             ccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHHHH--------------HhcCCCCC---CCch
Confidence            99999875   5889999999999999999999998864322111 11111              00111222   2456


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++..||+.-|.+|||.+++++|
T Consensus       250 WS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  250 WSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             hHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            77889999999999999999999999876

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.8e-32  Score=277.76  Aligned_cols=238  Identities=24%  Similarity=0.388  Sum_probs=190.7

Q ss_pred             ceEEEeeeC--CcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKIG--GDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~~--~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++..  +..+|+|.+..          .+.+|++++++++|+||+++++.+.+++..++++||+++++|.+++.+
T Consensus         7 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (262)
T cd05572           7 GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD   86 (262)
T ss_pred             eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh
Confidence            899999984  88999998753          245789999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......    ......++..
T Consensus        87 ~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~  157 (262)
T cd05572          87 RG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPE  157 (262)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccccccCCcC
Confidence            43  389999999999999999999984   49999999999999999999999999998664332    1223467889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |++||.+.+..++.++|+||||+++|+|++|..|+.....+..                +....+.+......++...+.
T Consensus       158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~  221 (262)
T cd05572         158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----------------EIYNDILKGNGKLEFPNYIDK  221 (262)
T ss_pred             ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----------------HHHHHHhccCCCCCCCcccCH
Confidence            9999999888889999999999999999999999864332111                111122211112233434466


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHHHHHHHhhccccc
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~~~s~~w~  627 (635)
                      .+.+++.+||+.||++||+     ++|++++  .++. +.+|+
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~--~~~~-~~~~~  261 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKH--KWFN-GFDWE  261 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhcC--hhhh-CCCCC
Confidence            7999999999999999999     7777764  4555 46775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.2e-33  Score=281.08  Aligned_cols=231  Identities=24%  Similarity=0.360  Sum_probs=180.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||+|.++..       +.+|+.++++++|+||+++++.+..++..++||||+++++|.+++...+ 
T Consensus        23 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  101 (267)
T cd06645          23 GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-  101 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-
Confidence            89999987  6889999987542       4568999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......   .......|+..|+|
T Consensus       102 -~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~a  174 (267)
T cd06645         102 -PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI---AKRKSFIGTPYWMA  174 (267)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc---cccccccCcccccC
Confidence             3899999999999999999999855   9999999999999999999999999987543221   11233568899999


Q ss_pred             ccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||.+.   ...++.++|+|||||++|+|++|+.|+......... .......            ...+....  ....+.
T Consensus       175 PE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~------------~~~~~~~~--~~~~~~  239 (267)
T cd06645         175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKSN------------FQPPKLKD--KMKWSN  239 (267)
T ss_pred             hhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-HhhhccC------------CCCCcccc--cCCCCH
Confidence            99874   456889999999999999999999987532221110 0000000            00000000  011234


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++||++++++++
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcC
Confidence            58899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2e-32  Score=280.86  Aligned_cols=246  Identities=23%  Similarity=0.365  Sum_probs=182.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||+|++..         .+.+|++++++++|+|++++++++......++||||++++.|..++...
T Consensus        15 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~   94 (286)
T cd07847          15 GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP   94 (286)
T ss_pred             eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC
Confidence            89999988  588999998742         2457999999999999999999999999999999999998888877543


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      .  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........   ......++..|
T Consensus        95 ~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~  166 (286)
T cd07847          95 R--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---DYTDYVATRWY  166 (286)
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc---cccCccccccc
Confidence            3  3899999999999999999999854   99999999999999999999999999986543321   12234577889


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccC----CchhhhhhhcCCcCCCCC
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKE----DGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~----~~~~~l~~~~d~~~~~~~  583 (635)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+..  ............    ...........+......
T Consensus       167 ~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (286)
T cd07847         167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE  246 (286)
T ss_pred             CCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCccccc
Confidence            99999875 55789999999999999999999988644332211  111111110000    000000001111111000


Q ss_pred             C-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          584 P-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       584 ~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +     ...+..+.+++.+||+.||++||++.|++.+
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0     1224568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-33  Score=281.15  Aligned_cols=242  Identities=25%  Similarity=0.381  Sum_probs=184.1

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhh-ccCCcccEEEEEecCC------ee
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKI-NHSSLIRLLGICFNGG------NW  411 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------~~  411 (635)
                      +++|.....++    |.||+|+.  +++.+++|.+..      ++.+|+.+++++ +|+||+++++++....      ..
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            34454444444    78999998  578899998753      356799999999 7999999999997544      48


Q ss_pred             EEEeecccCCCcchhhcccC--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          412 YLVYENAVNGSLSVWINDKG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       412 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccce
Confidence            99999999999999985432  345899999999999999999999855   9999999999999999999999999987


Q ss_pred             cccccCCceeeecccccCCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      ......   .......++..|+|||.+..     ..++.++||||||+++++|++|+.||....... .......     
T Consensus       162 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----  232 (275)
T cd06608         162 QLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPR-----  232 (275)
T ss_pred             ecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhc-----
Confidence            543321   11233468889999998753     346789999999999999999999985322111 1111000     


Q ss_pred             CCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       565 ~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                 .+......+...+..+.+++.+||..||++|||++|++++
T Consensus       233 -----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 -----------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -----------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                       0000111122345568999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.6e-33  Score=283.55  Aligned_cols=245  Identities=25%  Similarity=0.342  Sum_probs=181.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  ++..||||+++.         .+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~   92 (284)
T cd07860          14 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS   92 (284)
T ss_pred             eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC
Confidence            89999987  688999998853         35679999999999999999999999999999999995 6899988655


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++........   ......++..|
T Consensus        93 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y  166 (284)
T cd07860          93 PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWY  166 (284)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---ccccccccccc
Confidence            4455899999999999999999999854   99999999999999999999999999875533211   11223567889


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-----------hhhhhhhcCCc
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-----------EESLRHLMDPS  578 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----------~~~l~~~~d~~  578 (635)
                      +|||.+.+. .++.++||||||+++|||+||+.||...++.. ...............           ...........
T Consensus       167 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd07860         167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQD  245 (284)
T ss_pred             cCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccC
Confidence            999988654 36889999999999999999999886443322 111111110000000           00000000000


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      . .......+..+.+++.+||+.||++||+++|++++
T Consensus       246 ~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         246 F-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             H-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0 00011233457899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-32  Score=277.91  Aligned_cols=237  Identities=22%  Similarity=0.370  Sum_probs=174.4

Q ss_pred             ceEEEeee----CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|..    ....+|+|.+...        +.+|+..++.++|+||+++++.+.+.+..++||||+++|+|.+++..
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05042           9 GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRS   88 (269)
T ss_pred             ceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHh
Confidence            89999975    2347888877532        45788999999999999999999999999999999999999999965


Q ss_pred             cCC---CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          430 KGG---KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       430 ~~~---~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      ...   ...++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........ ........+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~  164 (269)
T cd05042          89 NRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITKDCHAV  164 (269)
T ss_pred             ccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh-eeccCCCCC
Confidence            322   23567888999999999999999854   99999999999999999999999999865432211 111122345


Q ss_pred             CCCccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          507 TKGYMAPEYLEN-------GLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       507 t~~y~aPE~~~~-------~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      +..|+|||++..       ..++.++||||||+++|||++ |..|+....+.. .+.......         ...+.++.
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~---------~~~~~~~~  234 (269)
T cd05042         165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ---------DIKLPKPQ  234 (269)
T ss_pred             cccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc---------CccCCCCc
Confidence            678999998742       356889999999999999999 666664332211 111111100         00111111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .    +...+..+.+++..|+ .||++||+++||++.|+
T Consensus       235 ~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 L----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             c----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1    2233445778888998 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=289.75  Aligned_cols=233  Identities=21%  Similarity=0.245  Sum_probs=177.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+..          .+.+|+.++++++|+||+++++++.+++..|+||||+++|+|.+++.+
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (331)
T cd05597          15 GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH
Confidence            89999987  688999999853          145788899999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........  .......||+.
T Consensus        95 ~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~  168 (331)
T cd05597          95 FE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPD  168 (331)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--ccccceecccc
Confidence            33 23899999999999999999999854   99999999999999999999999999875433221  11222468999


Q ss_pred             ccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          510 YMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       510 y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      |+|||++..     ..++.++|||||||++|||++|+.||........ ....    .....       .  ..+. ...
T Consensus       169 y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i----~~~~~-------~--~~~~-~~~  233 (331)
T cd05597         169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKI----MNHKE-------H--FQFP-PDV  233 (331)
T ss_pred             ccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHH----HcCCC-------c--ccCC-Ccc
Confidence            999999863     4578899999999999999999999854322110 0000    00000       0  0000 001


Q ss_pred             hHHHHHHHHHHHHhhhcCCC--CCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPS--GRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  615 (635)
                      ...+..+.+++.+|+..+++  .||++++++++
T Consensus       234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            12345578889888865443  48899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-32  Score=279.63  Aligned_cols=231  Identities=23%  Similarity=0.387  Sum_probs=184.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||++..  +++.+|+|.+...        +.+|++++++++|+||+++++.+..++..++++||+++++|.+++....
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (265)
T cd06605          15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ   94 (265)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc
Confidence            89999988  5889999987543        4578999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhccccc-CCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                       ..+++..+..++.|++.||.|||+ .+   ++|+||||+||++++++.++|+|||.+........     ....++..|
T Consensus        95 -~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~y  165 (265)
T cd06605          95 -GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KTFVGTSSY  165 (265)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-----hcccCChhc
Confidence             348999999999999999999998 55   99999999999999999999999999875533211     115678899


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH-HHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV-TAI  589 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~-~~~  589 (635)
                      +|||.+.+..++.++||||||+++|+|++|+.|+...........+             ....+...... ..+.. .+.
T Consensus       166 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~~~~~-~~~~~~~~~  231 (265)
T cd06605         166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-------------LLQYIVNEPPP-RLPSGKFSP  231 (265)
T ss_pred             cCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH-------------HHHHHhcCCCC-CCChhhcCH
Confidence            9999999889999999999999999999999998543221111111             11111111111 11111 455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.++|.+||..||++||++.|++.+
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            68999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-32  Score=281.42  Aligned_cols=230  Identities=24%  Similarity=0.396  Sum_probs=179.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|+.  ++..+++|.+...       +.+|++++++++|+||+++++.+..++..++||||+++++|..++.+.. 
T Consensus        26 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-  104 (292)
T cd06644          26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-  104 (292)
T ss_pred             eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-
Confidence            89999987  5789999998543       4568899999999999999999999999999999999999988875433 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......   .......++..|+|
T Consensus       105 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~a  178 (292)
T cd06644         105 RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL---QRRDSFIGTPYWMA  178 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc---cccceecCCccccC
Confidence            34899999999999999999999854   9999999999999999999999999986533221   11223467889999


Q ss_pred             ccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          513 PEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       513 PE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||++.     ...++.++|||||||++|||++|+.|+....... ........              ..+.  ...+...
T Consensus       179 PE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~--------------~~~~--~~~~~~~  241 (292)
T cd06644         179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS--------------EPPT--LSQPSKW  241 (292)
T ss_pred             ceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcC--------------CCcc--CCCCccc
Confidence            99884     3456889999999999999999999875432211 11111000              0000  0112233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++.+||+.||++||+++|++++
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            4568899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-33  Score=295.40  Aligned_cols=227  Identities=26%  Similarity=0.416  Sum_probs=180.5

Q ss_pred             ceEEEeee--CCcEEEEEEe------c-----cChHHHHHHHhhhccCCcccEEEEEecCCe--eEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKV------Y-----GDASDQIKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~------~-----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lV~E~~~~gsL~~~  426 (635)
                      -+||||.+  +|..||=-.+      +     ..+..|+.+|+.|+|+||++++.++.+...  .-+|.|.+..|+|..|
T Consensus        54 KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y  133 (632)
T KOG0584|consen   54 KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREY  133 (632)
T ss_pred             eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHH
Confidence            58999988  4545542111      1     246789999999999999999999997655  7899999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      +.+.+.  ++.+.+..|++||++||.|||++. ++|+|||||.+||||+.+ |.+||+|+|+|.......     ..+..
T Consensus       134 ~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-----aksvI  205 (632)
T KOG0584|consen  134 RKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-----AKSVI  205 (632)
T ss_pred             HHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-----cceec
Confidence            976654  889999999999999999999986 999999999999999765 899999999998765443     23478


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      |||.|||||... ..|.+..||||||++++||+|+..|+......-+.+..+....     ....+.++-          
T Consensus       206 GTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi-----KP~sl~kV~----------  269 (632)
T KOG0584|consen  206 GTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI-----KPAALSKVK----------  269 (632)
T ss_pred             cCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-----CHHHhhccC----------
Confidence            999999999987 7799999999999999999999999753333222222222111     112222222          


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ..++.+||.+||.. .++|||+.|++++
T Consensus       270 --dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 --DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             --CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence              23489999999999 9999999999875

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-32  Score=279.69  Aligned_cols=213  Identities=23%  Similarity=0.338  Sum_probs=165.0

Q ss_pred             EEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHH
Q 042486          373 FVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL  445 (635)
Q Consensus       373 ~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  445 (635)
                      .||+|.+..       .+.+|++++++++|+||++++++|.+++..++||||+++|+|..++.... ..+++..+..++.
T Consensus        46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~  124 (274)
T cd05076          46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQ  124 (274)
T ss_pred             eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence            588998854       24567889999999999999999999999999999999999999986533 3489999999999


Q ss_pred             HHHhhhcccccCCCCCeEeecccCCCEEECCCC-------cEEEeeecCcccccccCCceeeecccccCCCccCcccccc
Q 042486          446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-------RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN  518 (635)
Q Consensus       446 ~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  518 (635)
                      |++.||+|||+.   +++||||||+||+++.++       .+|++|||++......       ....++..|+|||.+.+
T Consensus       125 qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~  194 (274)
T cd05076         125 QLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPG  194 (274)
T ss_pred             HHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcC
Confidence            999999999984   599999999999997643       4899999987643221       12356788999998865


Q ss_pred             -CCCCcccchhhHHHHHHHHH-hCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHH
Q 042486          519 -GLVSTKLDVYAFGVLMLEML-SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIE  596 (635)
Q Consensus       519 -~~~s~ksDV~SlGvvl~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~  596 (635)
                       ..++.++||||||+++|||+ +|+.|+........  ......               ...    .+......+.+++.
T Consensus       195 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~---------------~~~----~~~~~~~~~~~li~  253 (274)
T cd05076         195 GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--ERFYEK---------------KHR----LPEPSCKELATLIS  253 (274)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--HHHHHh---------------ccC----CCCCCChHHHHHHH
Confidence             56899999999999999995 68877653222111  000000               000    11112235889999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHH
Q 042486          597 SCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       597 ~cl~~dP~~RPs~~evl~~L~  617 (635)
                      +||+.+|++||++.++++.|+
T Consensus       254 ~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         254 QCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHcccChhhCcCHHHHHHhhC
Confidence            999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-33  Score=293.52  Aligned_cols=227  Identities=19%  Similarity=0.270  Sum_probs=174.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh---ccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI---NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +++.||||.+...          ...|..++.+.   +||||+++++.+.+.+..|+||||+++|+|.++
T Consensus         7 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   86 (330)
T cd05586           7 GQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWH   86 (330)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHH
Confidence            89999987  6889999998532          12355566555   699999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......   .......|
T Consensus        87 l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~g  158 (330)
T cd05586          87 LQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNTFCG  158 (330)
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---CCccCccC
Confidence            86543  3899999999999999999999854   9999999999999999999999999987532221   11234579


Q ss_pred             CCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      |..|+|||.+.+. .++.++|||||||++|||++|+.||.......  ...                .+....... ...
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~~----------------~i~~~~~~~-~~~  219 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYR----------------NIAFGKVRF-PKN  219 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HHH----------------HHHcCCCCC-CCc
Confidence            9999999998754 47899999999999999999999985432211  111                110000000 011


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRP----AMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RP----s~~evl~~  615 (635)
                      ..+..+.+++.+||+.||++||    ++.|++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            2344578999999999999998    46666554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-32  Score=282.65  Aligned_cols=230  Identities=23%  Similarity=0.443  Sum_probs=173.7

Q ss_pred             cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC---------CCC
Q 042486          372 DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG---------GKF  434 (635)
Q Consensus       372 ~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~  434 (635)
                      ..+|+|.++..        +.+|++++++++|+||+++++++..++..++||||+++++|.+++....         ...
T Consensus        47 ~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  126 (296)
T cd05095          47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT  126 (296)
T ss_pred             eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccc
Confidence            46899988642        4579999999999999999999999999999999999999999985432         124


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++....... ........++..|++||
T Consensus       127 ~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         127 ISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHH
Confidence            778899999999999999999855   99999999999999999999999999875533211 11122234467899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ....+.++.++|||||||++|||++  |..|+.......  ........+....          .......+...+..+.
T Consensus       203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~  270 (296)
T cd05095         203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ--VIENTGEFFRDQG----------RQVYLPKPALCPDSLY  270 (296)
T ss_pred             HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--HHHHHHHHHhhcc----------ccccCCCCCCCCHHHH
Confidence            9888889999999999999999998  556664322211  1111111110000          0000011222345689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      +++.+||+.||++||++.||.+.|+
T Consensus       271 ~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         271 KLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHHHh
Confidence            9999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-32  Score=278.28  Aligned_cols=234  Identities=25%  Similarity=0.398  Sum_probs=184.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  ++..+|+|.+..             ++.+|++++++++|+||+++++++.+.+..++||||+++++|.++
T Consensus        14 ~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~   93 (268)
T cd06630          14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL   93 (268)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHH
Confidence            89999986  788999998853             245799999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCc-eeeeccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGE-FALTSHI  504 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~-~~~~~~~  504 (635)
                      +.+..  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||.+......... .......
T Consensus        94 l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  168 (268)
T cd06630          94 LSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL  168 (268)
T ss_pred             HHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccc
Confidence            96543  4899999999999999999999854   99999999999998775 5999999998765432111 1112234


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .++..|+|||.+.+..++.++||||+|+++++|++|+.|+........               .....+..........+
T Consensus       169 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~  233 (268)
T cd06630         169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---------------LALIFKIASATTAPSIP  233 (268)
T ss_pred             ccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---------------HHHHHHHhccCCCCCCc
Confidence            678899999999888889999999999999999999998753221110               00111111111122334


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+++.+||..+|.+||++.|++++
T Consensus       234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            4556678999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-32  Score=292.57  Aligned_cols=251  Identities=25%  Similarity=0.282  Sum_probs=182.2

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC------Ce
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG------GN  410 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~------~~  410 (635)
                      ++|.....||    |.||++..  .++.||||++...         +.+|+.+++.++|+||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            3444444444    89999986  6889999998642         34689999999999999999988643      34


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      .++||||+++ +|.+++..    .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             eEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccccc
Confidence            6999999965 67666643    2788999999999999999999854   99999999999999999999999999975


Q ss_pred             ccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC-----
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE-----  565 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-----  565 (635)
                      .....    ......+|..|+|||.+.+..++.++|||||||++|||++|+.||...+... .....+.......     
T Consensus       169 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         169 AGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             CCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            43321    1233568999999999998889999999999999999999999986533221 1111111000000     


Q ss_pred             CchhhhhhhcC----------C-----c-C--CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          566 DGEESLRHLMD----------P-----S-M--QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       566 ~~~~~l~~~~d----------~-----~-~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ........+.+          +     . .  ....+......+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000000000          0     0 0  001112234568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-32  Score=289.78  Aligned_cols=230  Identities=21%  Similarity=0.232  Sum_probs=178.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+|+|.+..          .+.+|+.++..++|+||+++++.+.+++..++||||+++|+|.+++.+
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~   94 (332)
T cd05623          15 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK   94 (332)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH
Confidence            89999988  577899998853          145788899999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........  .......||+.
T Consensus        95 ~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--~~~~~~~gt~~  168 (332)
T cd05623          95 FE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPD  168 (332)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc--ceecccccCcc
Confidence            33 23899999999999999999999855   99999999999999999999999999875432211  12233579999


Q ss_pred             ccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCC---
Q 042486          510 YMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG---  581 (635)
Q Consensus       510 y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~---  581 (635)
                      |+|||++.     ...++.++|||||||++|||++|+.||...+... .                 ...+.......   
T Consensus       169 y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-~-----------------~~~i~~~~~~~~~p  230 (332)
T cd05623         169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-T-----------------YGKIMNHKERFQFP  230 (332)
T ss_pred             ccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-H-----------------HHHHhCCCccccCC
Confidence            99999986     3467899999999999999999999986432211 1                 11111110000   


Q ss_pred             CCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 042486          582 NYPPVTAILVIRLIESCLKKDPSG--RPAMDKIAQS  615 (635)
Q Consensus       582 ~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  615 (635)
                      ......+..+.+++.+|+..++++  |++++|++++
T Consensus       231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            111223456889999988665444  7899999888

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.6e-32  Score=276.67  Aligned_cols=232  Identities=22%  Similarity=0.381  Sum_probs=181.5

Q ss_pred             ceEEEeeeC---CcEEEEEEecc-----------------ChHHHHHHHhh-hccCCcccEEEEEecCCeeEEEeecccC
Q 042486          362 GSVYRGKIG---GDFVAIKKVYG-----------------DASDQIKLLNK-INHSSLIRLLGICFNGGNWYLVYENAVN  420 (635)
Q Consensus       362 g~Vy~g~~~---~~~vavK~~~~-----------------~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~E~~~~  420 (635)
                      |.||+|...   ++.+|+|.+..                 ++.+|+.++.+ ++|+||+++++++.+++..+++|||+++
T Consensus        14 ~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (269)
T cd08528          14 GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEG   93 (269)
T ss_pred             ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCC
Confidence            899999983   57899998742                 13457777765 7999999999999999999999999999


Q ss_pred             CCcchhhcc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          421 GSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       421 gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      ++|.+++..  .....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.+||+|||.+.......   
T Consensus        94 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---  168 (269)
T cd08528          94 APLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---  168 (269)
T ss_pred             CcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccceeeccccc---
Confidence            999998843  223458999999999999999999996  2459999999999999999999999999997654332   


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                       ......++..|+|||.+.++.++.++||||||+++|||++|+.|+....... ..                 ..+.+..
T Consensus       169 -~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-~~-----------------~~~~~~~  229 (269)
T cd08528         169 -KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-LA-----------------TKIVEAV  229 (269)
T ss_pred             -ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-HH-----------------HHHhhcc
Confidence             1233568889999999998889999999999999999999998875322111 00                 0111111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .........+..+.+++.+||+.||++||++.|+..+++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            100011123456899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=293.68  Aligned_cols=229  Identities=26%  Similarity=0.385  Sum_probs=187.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |+||.|++  +...+|||.+...       ..+|+.+.++++|.|||+++|.|..++.+-+.||-++||+|.++|+..= 
T Consensus       589 G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW-  667 (1226)
T KOG4279|consen  589 GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW-  667 (1226)
T ss_pred             eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc-
Confidence            89999998  5667899988653       4579999999999999999999999999999999999999999996542 


Q ss_pred             CCC--CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFL--DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .++  .+..+-.+.+||++||.|||+..   |||||||-+|+|++ -.|.+||+|||-++.....   ...+..+-||..
T Consensus       668 GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---nP~TETFTGTLQ  741 (1226)
T KOG4279|consen  668 GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---NPCTETFTGTLQ  741 (1226)
T ss_pred             CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC---Cccccccccchh
Confidence            235  67778888999999999999854   99999999999995 4689999999998865433   245667889999


Q ss_pred             ccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          510 YMAPEYLENG--LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       510 y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      |||||++..+  .|..++|||||||++.||.||++||.........                 .-++-.-+.....|.+.
T Consensus       742 YMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----------------MFkVGmyKvHP~iPeel  804 (1226)
T KOG4279|consen  742 YMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----------------MFKVGMYKVHPPIPEEL  804 (1226)
T ss_pred             hhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----------------hhhhcceecCCCCcHHH
Confidence            9999999864  5889999999999999999999998532221100                 00000112234667888


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~  614 (635)
                      +.+...+|.+|+.+||.+||++.+++.
T Consensus       805 saeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  805 SAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888999999999999999999999875

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-32  Score=277.70  Aligned_cols=234  Identities=23%  Similarity=0.380  Sum_probs=182.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gs  422 (635)
                      |.||+|..  +++.+|+|.++.                 .+.+|+.++++++|+|++++++++...+..++||||+++++
T Consensus        15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   94 (272)
T cd06629          15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGS   94 (272)
T ss_pred             eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCc
Confidence            89999976  688999998742                 24568999999999999999999999999999999999999


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeec
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      |.+++....  .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++........ ....
T Consensus        95 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~  168 (272)
T cd06629          95 IGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN-DQNM  168 (272)
T ss_pred             HHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccc-cccc
Confidence            999996653  489999999999999999999985   4999999999999999999999999998754332111 1123


Q ss_pred             ccccCCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          503 HIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      ...++..|+|||.+....  ++.++|+||||+++|||++|..|+....... ...+....             ...+...
T Consensus       169 ~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-------------~~~~~~~  234 (272)
T cd06629         169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-AMFKLGNK-------------RSAPPIP  234 (272)
T ss_pred             cccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-HHHHhhcc-------------ccCCcCC
Confidence            346788999999987654  7899999999999999999999875322111 11111000             0001111


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .......+..+.+++.+||..||.+||++++++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11112234568999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=281.18  Aligned_cols=230  Identities=24%  Similarity=0.394  Sum_probs=181.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  ++..+|+|....       ++.+|++++++++|+||+++++.+..++..++||||+++++|.+++.... 
T Consensus        19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-   97 (280)
T cd06611          19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-   97 (280)
T ss_pred             ceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-
Confidence            89999988  578999998753       25579999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   ......++..|+|
T Consensus        98 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~  171 (280)
T cd06611          98 RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDTFIGTPYWMA  171 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc---ccceeecchhhcC
Confidence            34899999999999999999999854   99999999999999999999999998865432211   1223468889999


Q ss_pred             ccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          513 PEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       513 PE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||.+.     ...++.++|+||||+++|||++|+.|+...+.... ......              ...+.  ...+...
T Consensus       172 PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~--------------~~~~~--~~~~~~~  234 (280)
T cd06611         172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKILK--------------SEPPT--LDQPSKW  234 (280)
T ss_pred             HHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHHhc--------------CCCCC--cCCcccC
Confidence            99874     34467899999999999999999999754322111 111100              00000  1112233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++.+||+.||.+||++.+++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            4568899999999999999999999887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.2e-33  Score=279.02  Aligned_cols=231  Identities=29%  Similarity=0.464  Sum_probs=182.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh---------HHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~---------~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||+++.  +++.+|+|.+....         .+|+.++++++|+||+++++++.+.+..++||||+++++|.+++...
T Consensus        13 g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~   92 (260)
T PF00069_consen   13 GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN   92 (260)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH
T ss_pred             EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccccc
Confidence            89999998  56689999986531         24889999999999999999999999999999999999999999733


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                        ..+++..+..++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+......   ........++..|
T Consensus        93 --~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~~y  164 (260)
T PF00069_consen   93 --KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---NENFNPFVGTPEY  164 (260)
T ss_dssp             --SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST---TSEBSSSSSSGGG
T ss_pred             --cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc---ccccccccccccc
Confidence              23899999999999999999999955   999999999999999999999999998753111   1223446788999


Q ss_pred             cCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--hHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          511 MAPEYLE-NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       511 ~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +|||.+. +...+.++||||||+++|+|++|+.|+.......  ............     .        ..  ......
T Consensus       165 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~--------~~--~~~~~~  229 (260)
T PF00069_consen  165 MAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP-----S--------SS--QQSREK  229 (260)
T ss_dssp             SCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH-----H--------HT--TSHTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc-----c--------cc--cccchh
Confidence            9999998 8889999999999999999999999986541111  111111100000     0        00  000011


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2569999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4e-32  Score=273.85  Aligned_cols=231  Identities=27%  Similarity=0.483  Sum_probs=182.8

Q ss_pred             ceEEEeeeCC------cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIGG------DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~~------~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++..+      ..||+|.++..        +.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++
T Consensus        13 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~   92 (258)
T smart00219       13 GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYL   92 (258)
T ss_pred             cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHH
Confidence            8999999843      78999998643        446899999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .......+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........  ......++
T Consensus        93 ~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~  167 (258)
T smart00219       93 RKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--KKKGGKLP  167 (258)
T ss_pred             HhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccc--ccccCCCc
Confidence            6544333899999999999999999999854   999999999999999999999999999766543211  11123367


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++++|++ |+.|+......  .......                ... ....+..
T Consensus       168 ~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~----------------~~~-~~~~~~~  228 (258)
T smart00219      168 IRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLK----------------KGY-RLPKPEN  228 (258)
T ss_pred             ccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh----------------cCC-CCCCCCc
Confidence            89999999988889999999999999999998 66665432211  1111110                000 0111222


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+..+.+++.+||..||++|||+.|+++.|
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      229 CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            455689999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-33  Score=291.66  Aligned_cols=233  Identities=25%  Similarity=0.376  Sum_probs=197.6

Q ss_pred             ceEEEeee---CCc--EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI---GGD--FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~---~~~--~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.|++|.|   +|+  .||||.++.        +|.+|+.+|.+|+|+|+++|+|+..+ ....||||+++.|+|.+.|+
T Consensus       124 gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLr  202 (1039)
T KOG0199|consen  124 GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLR  202 (1039)
T ss_pred             eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHh
Confidence            89999999   343  689999875        57899999999999999999999987 67899999999999999998


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      +.....|-......++.|||.||.||..   +++|||||..+|+++-....+||+|||+.+.....+..+.+.....-..
T Consensus       203 ka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPf  279 (1039)
T KOG0199|consen  203 KAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPF  279 (1039)
T ss_pred             hccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcc
Confidence            7555568888889999999999999998   4499999999999999999999999999999888777766666666777


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|.|||.+....++.++|||+|||++|||+|+ ..||.....                   ..+-+.+|.+.+-..|..+
T Consensus       280 AWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------------------~qIL~~iD~~erLpRPk~c  340 (1039)
T KOG0199|consen  280 AWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------------------IQILKNIDAGERLPRPKYC  340 (1039)
T ss_pred             cccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------------------HHHHHhccccccCCCCCCC
Confidence            89999999999999999999999999999995 456643221                   2222334444444567788


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      +..+.+++++||..+|++||++..|.+.+-
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            899999999999999999999999985443

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-32  Score=289.57  Aligned_cols=230  Identities=21%  Similarity=0.251  Sum_probs=177.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+...          +.+|..++.+++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~   94 (331)
T cd05624          15 GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999987  6789999988531          45678889999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........  .......||+.
T Consensus        95 ~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~gt~~  168 (331)
T cd05624          95 FE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--VQSSVAVGTPD  168 (331)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--eeeccccCCcc
Confidence            33 23899999999999999999999854   99999999999999999999999999875543221  11233569999


Q ss_pred             ccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          510 YMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       510 y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      |+|||++.+     +.++.++||||||+++|||++|+.||...+...                  ....++........+
T Consensus       169 y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------------------~~~~i~~~~~~~~~p  230 (331)
T cd05624         169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------------------TYGKIMNHEERFQFP  230 (331)
T ss_pred             cCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------------------HHHHHHcCCCcccCC
Confidence            999999865     567889999999999999999999985432211                  111111110000011


Q ss_pred             ---hHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 042486          585 ---PVTAILVIRLIESCLKKDPSG--RPAMDKIAQS  615 (635)
Q Consensus       585 ---~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  615 (635)
                         ...+..+.+++.+|+..++++  |+++++++++
T Consensus       231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               123456889999999866554  5688888776

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.6e-32  Score=282.10  Aligned_cols=244  Identities=28%  Similarity=0.333  Sum_probs=181.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|..  +++.||||+++..            +.+|++++++++|+||+++++++.+++..++||||+ +++|.+++
T Consensus        14 ~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i   92 (298)
T cd07841          14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVI   92 (298)
T ss_pred             cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHH
Confidence            89999987  6789999998643            246899999999999999999999999999999999 89999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.......   ......++
T Consensus        93 ~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~  165 (298)
T cd07841          93 KDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---KMTHQVVT  165 (298)
T ss_pred             hccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc---cccccccc
Confidence            6544 34899999999999999999999855   99999999999999999999999999976543321   11223467


Q ss_pred             CCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch-----hhhhhhcCCcCCC
Q 042486          508 KGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE-----ESLRHLMDPSMQG  581 (635)
Q Consensus       508 ~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-----~~l~~~~d~~~~~  581 (635)
                      ..|+|||.+.+ ..++.++||||||++++||++|..++....+.. .+...... +......     .............
T Consensus       166 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T cd07841         166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEA-LGTPTEENWPGVTSLPDYVEFKPFP  243 (298)
T ss_pred             eeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHH-cCCCchhhhhhcccccccccccccC
Confidence            78999998854 457899999999999999999976665333211 11111111 1000000     0000000000000


Q ss_pred             C-----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 N-----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .     .....+..+.+++.+||+.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         244 PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0     112235668999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.3e-32  Score=291.03  Aligned_cols=240  Identities=26%  Similarity=0.303  Sum_probs=177.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~  424 (635)
                      |.||++..  .++.||||++..         .+.+|+.+++.++|+||+++++++...      ...|+||||+++ +|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  116 (364)
T cd07875          38 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC  116 (364)
T ss_pred             eEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHH
Confidence            89999987  688999999864         244789999999999999999987643      357999999965 677


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++..    .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......    .....
T Consensus       117 ~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~----~~~~~  185 (364)
T cd07875         117 QVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPY  185 (364)
T ss_pred             HHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC----cccCC
Confidence            77643    278899999999999999999985   49999999999999999999999999997653321    12335


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc------hhhhhhhcC--
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG------EESLRHLMD--  576 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~~~l~~~~d--  576 (635)
                      .+|..|+|||++.+..++.++|||||||++|||++|+.||...+... .....+.. +.....      .........  
T Consensus       186 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  263 (364)
T cd07875         186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ-LGTPCPEFMKKLQPTVRTYVENR  263 (364)
T ss_pred             cccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCCHHHHHhhhHHHHHHHhhC
Confidence            68999999999999899999999999999999999999986543321 11111110 000000      000000000  


Q ss_pred             ------------CcC----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 ------------PSM----QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ------------~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                  +..    ...........+.+|+.+||+.||++|||++|++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                        000    001111123468899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-32  Score=286.44  Aligned_cols=228  Identities=27%  Similarity=0.343  Sum_probs=190.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +|+.+|+|.+..          ++.+|+.+|+++. ||||+.+.+.+.+....++|||++.||.|.+.+.
T Consensus        49 g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~  128 (382)
T KOG0032|consen   49 GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIV  128 (382)
T ss_pred             eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHH
Confidence            89999987  689999998843          4568999999998 9999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC----CCcEEEeeecCcccccccCCceeeeccc
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT----DFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      ..  . +++.....++.|++.++.|||+.+   ++||||||+|+|+..    ++.+|++|||++......    ......
T Consensus       129 ~~--~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~~~~~  198 (382)
T KOG0032|consen  129 KK--H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG----ERLHTI  198 (382)
T ss_pred             Hc--c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC----ceEeee
Confidence            65  2 899999999999999999999955   999999999999943    357999999999877652    234567


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      +||+.|+|||++....++..+||||+|+++|.|++|..||....+..... .....               +........
T Consensus       199 ~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~---------------~~~f~~~~w  262 (382)
T KOG0032|consen  199 VGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRG---------------DFDFTSEPW  262 (382)
T ss_pred             cCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcC---------------CCCCCCCCc
Confidence            99999999999999999999999999999999999999986544332221 11111               011222333


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+....+++..|+..||.+|+++.++++|
T Consensus       263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  263 DDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            4456778999999999999999999999997

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.5e-32  Score=274.31  Aligned_cols=228  Identities=24%  Similarity=0.361  Sum_probs=182.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++..  +++.+|||.+..         .+.+|++++++++|+|++++++.+..++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (256)
T cd08220          14 GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh
Confidence            78999877  788999998743         2567999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ....+++..+..++.+++.+|.|||+.   +++|+||+|+||+++.+ +.+||+|||++........    .....++..
T Consensus        94 ~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~  166 (256)
T cd08220          94 CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPC  166 (256)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc----ccccccCCc
Confidence            555689999999999999999999985   49999999999999755 5689999999986543221    123467889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|+|++|+.|+...+.....                  ....... ....+...+.
T Consensus       167 y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~------------------~~~~~~~-~~~~~~~~~~  227 (256)
T cd08220         167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV------------------LKIMSGT-FAPISDRYSP  227 (256)
T ss_pred             ccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH------------------HHHHhcC-CCCCCCCcCH
Confidence            99999999888899999999999999999999887543221110                  0000000 0111223445


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++|||++|++.+
T Consensus       228 ~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         228 DLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhC
Confidence            68999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=298.08  Aligned_cols=238  Identities=26%  Similarity=0.422  Sum_probs=196.9

Q ss_pred             cceEEEeee--CC----cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          361 KGSVYRGKI--GG----DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       361 gg~Vy~g~~--~~----~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      .|+||||.|  .+    -+||||.+..        ++.+|.-.|.+++|+|++||+|+|.... ..||++|++.|+|.+|
T Consensus       709 fGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDy  787 (1177)
T KOG1025|consen  709 FGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDY  787 (1177)
T ss_pred             ceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHH
Confidence            399999998  33    4799998854        3568899999999999999999997665 7899999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      ++.++.. +..+..+.|..|||+||.|||+.   +++||||..+|||+.+-..+|+.|||+++.......+.. .....-
T Consensus       788 vr~hr~~-igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~-~~~gK~  862 (1177)
T KOG1025|consen  788 VREHRDN-IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS-APGGKV  862 (1177)
T ss_pred             HHHhhcc-ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc-cccccc
Confidence            9765443 88899999999999999999984   499999999999999999999999999997766544322 222334


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      .+.|||-|.+....++.++|||||||++||++| |..|++...                   .+.+..++....+-..|+
T Consensus       863 pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-------------------~~eI~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  863 PIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-------------------AEEIPDLLEKGERLSQPP  923 (1177)
T ss_pred             CcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-------------------HHHhhHHHhccccCCCCC
Confidence            567999999999999999999999999999998 666654321                   233344444444456788


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+...+..++.+||..|++.||+++++...+.++..+.
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            88888999999999999999999999999999987654

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.9e-32  Score=282.33  Aligned_cols=250  Identities=20%  Similarity=0.276  Sum_probs=184.4

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      +.||+++.+++.||||++..         .+.+|++++++++|+||+++++++.+++..+++|||+++|+|.+++.....
T Consensus        16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~   95 (314)
T cd08216          16 VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP   95 (314)
T ss_pred             EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc
Confidence            45666666899999999753         245799999999999999999999999999999999999999999976544


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC----ceeeecccccCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG----EFALTSHIVGTK  508 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~gt~  508 (635)
                      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+........    .........++.
T Consensus        96 ~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (314)
T cd08216          96 EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL  172 (314)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccc
Confidence            45899999999999999999999855   99999999999999999999999998865432211    011123345777


Q ss_pred             CccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccc----ccCCchh---hhh----hhc
Q 042486          509 GYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL----HKEDGEE---SLR----HLM  575 (635)
Q Consensus       509 ~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~----~~~~~~~---~l~----~~~  575 (635)
                      .|+|||.+..  ..++.++|+||||+++|||++|+.||.......... +......    .......   ...    ...
T Consensus       173 ~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T cd08216         173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE  251 (314)
T ss_pred             cccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCCcCccccccc
Confidence            8999999875  357889999999999999999999986533222111 1111100    0000000   000    000


Q ss_pred             CCc----CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          576 DPS----MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       576 d~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ++.    ............+.+++.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            000    0112233445678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.6e-32  Score=277.63  Aligned_cols=233  Identities=23%  Similarity=0.443  Sum_probs=181.6

Q ss_pred             ceEEEeee-------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.       +.+.|++|.+..        ++.+|++++++++|+||+++++++.+.+..++||||+++|+|.++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (275)
T cd05046          19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF   98 (275)
T ss_pred             eEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHH
Confidence            89999986       246799998743        356799999999999999999999988899999999999999999


Q ss_pred             hcccCC-------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCcee
Q 042486          427 INDKGG-------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       427 l~~~~~-------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                      +.....       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||++.......  ..
T Consensus        99 i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~--~~  173 (275)
T cd05046          99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE--YY  173 (275)
T ss_pred             HHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccc--cc
Confidence            965431       14899999999999999999999855   9999999999999999999999999986443221  11


Q ss_pred             eecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      ......++..|+|||.+.+...+.++||||||+++|+|++ |..||.......  ....                .....
T Consensus       174 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~----------------~~~~~  235 (275)
T cd05046         174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNR----------------LQAGK  235 (275)
T ss_pred             ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHH----------------HHcCC
Confidence            1223355678999999988888999999999999999999 666664322111  1111                00011


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .....+...+..+.+++.+||+.||++||++.|+++.|.
T Consensus       236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111112233456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.3e-32  Score=273.91  Aligned_cols=232  Identities=22%  Similarity=0.350  Sum_probs=184.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||++..  ++..+|+|.+..         .+.+|++++++++|+||+++++++..  +...+++|||+++++|.+++.
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~   93 (265)
T cd08217          14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ   93 (265)
T ss_pred             eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHH
Confidence            89999987  678999998753         24468999999999999999998764  455799999999999999985


Q ss_pred             cc--CCCCCCHHHHHHHHHHHHhhhcccccCC--CCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          429 DK--GGKFLDWAQRIQIALDVATGLNYLHSFT--NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       429 ~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      ..  ....+++..++.++.+++.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++........   .....
T Consensus        94 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~  170 (265)
T cd08217          94 KCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS---FAKTY  170 (265)
T ss_pred             HHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc---ccccc
Confidence            42  2345899999999999999999999432  36699999999999999999999999999986654321   12234


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .++..|+|||.+.+..++.++|+||||+++++|++|+.|+...+...  ..+..                .. ......+
T Consensus       171 ~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~----------------~~-~~~~~~~  231 (265)
T cd08217         171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKI----------------KE-GKFRRIP  231 (265)
T ss_pred             ccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHHH----------------hc-CCCCCCc
Confidence            68899999999998889999999999999999999999986433111  11111                11 1111223


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+++.+||+.+|++||++++|+++
T Consensus       232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            3445668999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.1e-32  Score=279.05  Aligned_cols=256  Identities=21%  Similarity=0.220  Sum_probs=183.1

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      ++|.....||    |.||+|..  ++..||+|.+..        .+.+|++++++++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            4444444444    79999986  688999998753        245799999999999999999999999999999999


Q ss_pred             ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       418 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +. ++|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          85 MH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             cc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence            95 67777764432 33788889999999999999999855   99999999999999999999999999875433211 


Q ss_pred             eeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-ch---hhhh
Q 042486          498 FALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-GE---ESLR  572 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~---~~l~  572 (635)
                        ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+.+.......... ..   ..+.
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              1122457889999999875 357889999999999999999999986544332222221110000000 00   0000


Q ss_pred             hhcCCcCCCCCC---------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMDPSMQGNYP---------PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...........+         ......+.+++.+|++.||++|||++|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000000000000         0113457899999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.4e-32  Score=275.14  Aligned_cols=236  Identities=27%  Similarity=0.406  Sum_probs=185.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|..  ++..+|+|++..        ++.+|++.++.++|+||+++++.+..++..++|+||+++++|.+++....
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~   94 (267)
T cd06610          15 AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY   94 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc
Confidence            89999987  678999998853        24578999999999999999999999999999999999999999996543


Q ss_pred             C-CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-eeecccccCCC
Q 042486          432 G-KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-ALTSHIVGTKG  509 (635)
Q Consensus       432 ~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~  509 (635)
                      . ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......... .......++..
T Consensus        95 ~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~  171 (267)
T cd06610          95 PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC  171 (267)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChh
Confidence            2 45899999999999999999999854   9999999999999999999999999987654432211 12233468899


Q ss_pred             ccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC-ChHH
Q 042486          510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY-PPVT  587 (635)
Q Consensus       510 y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~-~~~~  587 (635)
                      |+|||++... ..+.++|+||||+++|||++|+.||....... ........              ..+...... ....
T Consensus       172 y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~--------------~~~~~~~~~~~~~~  236 (267)
T cd06610         172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN--------------DPPSLETGADYKKY  236 (267)
T ss_pred             hcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC--------------CCCCcCCccccccc
Confidence            9999998876 78999999999999999999999985432211 11111110              001111110 1234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++.+||+.||++||+++|++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            4568999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.5e-32  Score=273.63  Aligned_cols=227  Identities=28%  Similarity=0.425  Sum_probs=182.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|..  +++.|++|.+..            .+.+|++++++++|+||+++++++.+++..++++||+++++|.+++
T Consensus        14 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (258)
T cd06632          14 GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL   93 (258)
T ss_pred             ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHH
Confidence            89999987  688999997642            2457899999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......    ......++
T Consensus        94 ~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----~~~~~~~~  164 (258)
T cd06632          94 KKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAKSFKGS  164 (258)
T ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc----cccccCCC
Confidence            6543  3889999999999999999999855   9999999999999999999999999987653322    12335688


Q ss_pred             CCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|++||.+.... ++.++|+||||+++|+|++|+.||....... ......                 ........+..
T Consensus       165 ~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~-----------------~~~~~~~~~~~  226 (258)
T cd06632         165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIG-----------------RSKELPPIPDH  226 (258)
T ss_pred             cceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHH-----------------hcccCCCcCCC
Confidence            8999999987766 8999999999999999999999975433111 110000                 00001112233


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+.+++.+||+.+|.+||++++++.+
T Consensus       227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         227 LSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            45568899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-32  Score=278.97  Aligned_cols=231  Identities=23%  Similarity=0.358  Sum_probs=182.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  ++..+|+|.++.        .+.+|++++++++|+||+++++.+..++..++||||+++++|..++....
T Consensus        15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   94 (286)
T cd06622          15 GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV   94 (286)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc
Confidence            89999998  588999998753        24579999999999999999999999999999999999999999886531


Q ss_pred             -CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          432 -GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       432 -~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                       ...+++..+..++.+++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.......     .....++..|
T Consensus        95 ~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~y  167 (286)
T cd06622          95 ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-----AKTNIGCQSY  167 (286)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-----cccCCCccCc
Confidence             23589999999999999999999962  359999999999999999999999999987543221     2234578899


Q ss_pred             cCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          511 MAPEYLENG------LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       511 ~aPE~~~~~------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      +|||.+.+.      .++.++|+|||||++|+|++|+.||.......  ..             ..+..+.+.. ....+
T Consensus       168 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~-------------~~~~~~~~~~-~~~~~  231 (286)
T cd06622         168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IF-------------AQLSAIVDGD-PPTLP  231 (286)
T ss_pred             cCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HH-------------HHHHHHhhcC-CCCCC
Confidence            999998654      34889999999999999999999985322111  00             1111111111 11233


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+++.+||+.+|++||++++++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            4456668999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-32  Score=278.06  Aligned_cols=225  Identities=19%  Similarity=0.357  Sum_probs=174.3

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|...         ...+|+|.+..       .+.+|+.++++++|+|++++++++..++..++||||+++|+|.+
T Consensus         9 ~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~   88 (258)
T cd05078           9 TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT   88 (258)
T ss_pred             hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHH
Confidence            889999762         23488887753       24578889999999999999999999889999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc--------EEEeeecCcccccccCCc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR--------AKIANFALARPAERQEGE  497 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~Dfg~a~~~~~~~~~  497 (635)
                      ++..... .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.        ++++|||++......   
T Consensus        89 ~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---  161 (258)
T cd05078          89 YLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---  161 (258)
T ss_pred             HHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCCc---
Confidence            9965443 489999999999999999999985   4999999999999987765        699999988654321   


Q ss_pred             eeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          498 FALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                          ....++..|+|||.+.+ ..++.++||||||+++|||++|..++....+.... ....                 .
T Consensus       162 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~-----------------~  219 (258)
T cd05078         162 ----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFY-----------------E  219 (258)
T ss_pred             ----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHH-----------------H
Confidence                22457888999999986 45789999999999999999996443221111100 0000                 0


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .  ....+......+.+++.+||+.||++|||++++++.|+
T Consensus       220 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0  01122223355899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-32  Score=289.83  Aligned_cols=238  Identities=26%  Similarity=0.339  Sum_probs=175.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~  424 (635)
                      |.||++..  +++.||||++...         +.+|+++|++++|+||+++++++...      ...|+++|++ +++|.
T Consensus        29 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~  107 (343)
T cd07878          29 GSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLN  107 (343)
T ss_pred             eEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHH
Confidence            89999986  6789999998642         34799999999999999999987643      3468999987 77998


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++...   .+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.....      ....
T Consensus       108 ~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~  175 (343)
T cd07878         108 NIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGY  175 (343)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC------cCCc
Confidence            887542   3899999999999999999999855   999999999999999999999999999755332      1234


Q ss_pred             ccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-------hhhhhhhcC
Q 042486          505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-------EESLRHLMD  576 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~d  576 (635)
                      .||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... .+..... .......       .+.......
T Consensus       176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  253 (343)
T cd07878         176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIME-VVGTPSPEVLKKISSEHARKYIQ  253 (343)
T ss_pred             cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH-HhCCCCHHHHHhcchhhHHHHhh
Confidence            68999999999876 568899999999999999999999885432211 1111110 0000000       000000000


Q ss_pred             CcCCCCCC-------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQGNYP-------PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       .+.....       ......+.+|+.+||+.||++|||+.|++++
T Consensus       254 -~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         254 -SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             -ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000       0112347899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=4.5e-32  Score=274.00  Aligned_cols=222  Identities=22%  Similarity=0.383  Sum_probs=173.5

Q ss_pred             ceEEEeeeC--C----------cEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG--G----------DFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~--~----------~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+|...  +          ..+++|.+..      .+.+|+.++++++|+||+++++++.. +..++||||+++|+|
T Consensus         9 ~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L   87 (259)
T cd05037           9 TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPL   87 (259)
T ss_pred             ceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcH
Confidence            899999983  2          2478887653      34578999999999999999999988 778999999999999


Q ss_pred             chhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-------cEEEeeecCcccccccCC
Q 042486          424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-------RAKIANFALARPAERQEG  496 (635)
Q Consensus       424 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~Dfg~a~~~~~~~~  496 (635)
                      .+++..... .+++..++.++.|++.||.|||+.   +++||||||+||+++.++       .+||+|||++......  
T Consensus        88 ~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~--  161 (259)
T cd05037          88 DVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR--  161 (259)
T ss_pred             HHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc--
Confidence            999975442 489999999999999999999984   499999999999999887       7999999998765331  


Q ss_pred             ceeeecccccCCCccCccccccC--CCCcccchhhHHHHHHHHHhC-CCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          497 EFALTSHIVGTKGYMAPEYLENG--LVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                           ....++..|+|||++...  .++.++||||||+++|||++| ..|+........  ...                
T Consensus       162 -----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~~----------------  218 (259)
T cd05037         162 -----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ERF----------------  218 (259)
T ss_pred             -----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HHH----------------
Confidence                 123466789999999876  789999999999999999995 555533211110  000                


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .....   ..+......+.+++.+||..+|.+||++.|+++.|
T Consensus       219 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         219 YQDQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             HhcCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            00000   00111115689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.98  E-value=5.3e-32  Score=277.75  Aligned_cols=245  Identities=29%  Similarity=0.360  Sum_probs=182.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.  +++.||+|++..         .+.+|+.++++++|+||+++++++..++..++||||+ +++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~   92 (286)
T cd07832          14 GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE   92 (286)
T ss_pred             cEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc
Confidence            89999987  688999998853         3557899999999999999999999999999999999 99999998654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  .......++..|
T Consensus        93 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y  166 (286)
T cd07832          93 E-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RLYSHQVATRWY  166 (286)
T ss_pred             C-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--CccccccCcccc
Confidence            3 44899999999999999999999855   99999999999999999999999999886543321  112235688999


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc--hhhh------hhhcCCcCC-
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG--EESL------RHLMDPSMQ-  580 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~l------~~~~d~~~~-  580 (635)
                      +|||.+.+. .++.++||||||++++||++|+.++....+. ..+..... .+.....  ....      ..+..+... 
T Consensus       167 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (286)
T cd07832         167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFR-TLGTPNEETWPGLTSLPDYNKITFPESKP  244 (286)
T ss_pred             cCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHH-HcCCCChHHHhhccCcchhhcccCCCCCc
Confidence            999988654 4689999999999999999997666433221 11111111 1110000  0000      000000000 


Q ss_pred             ---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         ..........+.+++.+||+.||++||++++++++
T Consensus       245 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         245 IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               00111234678999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=7.6e-32  Score=280.16  Aligned_cols=224  Identities=27%  Similarity=0.396  Sum_probs=177.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||+|.+..          ++.+|++++++++|+||+++.++|.+++..++||||+. |+|.+++..
T Consensus        29 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~  107 (307)
T cd06607          29 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV  107 (307)
T ss_pred             eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH
Confidence            89999987  688999998742          25578999999999999999999999999999999996 577777753


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......       ....++..
T Consensus       108 ~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-------~~~~~~~~  176 (307)
T cd06607         108 HK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-------NSFVGTPY  176 (307)
T ss_pred             cc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-------CCccCCcc
Confidence            32 34899999999999999999999854   999999999999999999999999998754322       12457889


Q ss_pred             ccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||.+.   .+.++.++||||||+++|||++|+.|+...+..... ...                 .........+..
T Consensus       177 y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-~~~-----------------~~~~~~~~~~~~  238 (307)
T cd06607         177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHI-----------------AQNDSPTLSSND  238 (307)
T ss_pred             ccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-HHH-----------------hcCCCCCCCchh
Confidence            99999874   456889999999999999999999887533221110 000                 000000111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++.+||+.||++||++.+++.+
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         239 WSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            45568999999999999999999999886

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=4e-32  Score=279.80  Aligned_cols=223  Identities=27%  Similarity=0.377  Sum_probs=182.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+|+|.+..          .+.+|++++++++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        15 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   94 (290)
T cd05580          15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK   94 (290)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH
Confidence            89999988  678999998753          245689999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......      .....+++.
T Consensus        95 ~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~  163 (290)
T cd05580          95 SG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPE  163 (290)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------CCCCCCCcc
Confidence            53  489999999999999999999985   4999999999999999999999999998765432      223468899


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+...+.++||||||+++|+|++|+.||...+...                  ....+....  ...+...+.
T Consensus       164 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------------~~~~~~~~~--~~~~~~~~~  223 (290)
T cd05580         164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------------------IYEKILEGK--VRFPSFFSP  223 (290)
T ss_pred             ccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------------------HHHHHhcCC--ccCCccCCH
Confidence            999999988888999999999999999999999975433111                  011111111  112233355


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||..||.+|+     +++|++++
T Consensus       224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            689999999999999999     77788765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.98  E-value=6.5e-32  Score=276.26  Aligned_cols=226  Identities=25%  Similarity=0.390  Sum_probs=182.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|..  ++..+|+|....        ++.+|+.++++++|+||+++++++..++..++||||+++++|.+++... 
T Consensus        18 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-   96 (277)
T cd06641          18 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-   96 (277)
T ss_pred             eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC-
Confidence            89999986  678999998752        3557899999999999999999999999999999999999999998643 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||++........   ......++..|+
T Consensus        97 --~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~  168 (277)
T cd06641          97 --PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWM  168 (277)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh---hhccccCCcccc
Confidence              389999999999999999999985   499999999999999999999999999875533211   112245788999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||.+.+...+.++|+||||+++|+|++|..|+.......  ......                 .......+...+..+
T Consensus       169 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~  229 (277)
T cd06641         169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIP-----------------KNNPPTLEGNYSKPL  229 (277)
T ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHh-----------------cCCCCCCCcccCHHH
Confidence            9999988888999999999999999999999875322111  001000                 000111222344558


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||+.+|.+||++.+++++
T Consensus       230 ~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         230 KEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHccCChhhCcCHHHHHhC
Confidence            899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=7.5e-32  Score=273.02  Aligned_cols=230  Identities=27%  Similarity=0.406  Sum_probs=185.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  +++.|+||++...        +.+|++.+++++|+|++++++++...+..++||||+++++|.+++... 
T Consensus        15 ~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   93 (264)
T cd06623          15 GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-   93 (264)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-
Confidence            78999988  5889999987543        557899999999999999999999999999999999999999999654 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhccccc-CCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                       ..+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||.+.........   .....++..|
T Consensus        94 -~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y  166 (264)
T cd06623          94 -GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---CNTFVGTVTY  166 (264)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc---ccceeecccc
Confidence             348999999999999999999998 66   999999999999999999999999998865433221   1234578899


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH-HHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV-TAI  589 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~-~~~  589 (635)
                      +|||.+.+..++.++|+||||+++|+|++|+.|+.......  .             .+....+..... ...+.. .+.
T Consensus       167 ~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~-------------~~~~~~~~~~~~-~~~~~~~~~~  230 (264)
T cd06623         167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--F-------------FELMQAICDGPP-PSLPAEEFSP  230 (264)
T ss_pred             cCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--H-------------HHHHHHHhcCCC-CCCCcccCCH
Confidence            99999998889999999999999999999999986433100  0             011111111111 111222 456


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||..+|++||++.|++++
T Consensus       231 ~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         231 EFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhC
Confidence            69999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.9e-34  Score=316.98  Aligned_cols=241  Identities=25%  Similarity=0.363  Sum_probs=192.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      -++..+..||    |.||.+..  +|...|+|-++-         ...+|+.+|..++|||+|+++|+-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            3444555665    89999987  788999996643         35689999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      ||++|+|.+.+...+.  .++.....+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|........
T Consensus      1315 yC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999965432  566666778899999999999977   99999999999999999999999999987654421


Q ss_pred             c-eeeecccccCCCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          497 E-FALTSHIVGTKGYMAPEYLENG---LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       497 ~-~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      . ........||+.|||||++.+.   ....+.||||+|||++||+||+.||...+.+-...+.+..             
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------- 1456 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------- 1456 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-------------
Confidence            1 1122457899999999999752   3456899999999999999999999765554322222211             


Q ss_pred             hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                           .-....|...+.+-.+++.+||+.||++|.++.|++++
T Consensus      1457 -----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                 11223455566778999999999999999999988876

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.98  E-value=4.1e-32  Score=281.92  Aligned_cols=245  Identities=20%  Similarity=0.252  Sum_probs=185.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  .++.||+|.+...          +.+|++++++++|+||+++++.+..++..++||||+++++|.+++..
T Consensus        15 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (305)
T cd05609          15 GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN   94 (305)
T ss_pred             eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH
Confidence            79999987  5789999987542          34788999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC------------c
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG------------E  497 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------------~  497 (635)
                      ..  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......            .
T Consensus        95 ~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~  169 (305)
T cd05609          95 IG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR  169 (305)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchh
Confidence            43  3899999999999999999999854   99999999999999999999999999864211100            0


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      ........++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ........            ....+
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~------------~~~~~  236 (305)
T cd05609         170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISD------------DIEWP  236 (305)
T ss_pred             hccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc------------ccCCC
Confidence            001112457889999999988889999999999999999999999975322111 11000000            00011


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                      ..    ....+..+.+++.+||+.||++||++.++.+.|+.-.-...+|..
T Consensus       237 ~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         237 EG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             Cc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence            11    112345589999999999999999977666666664434455543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=3.8e-32  Score=279.10  Aligned_cols=246  Identities=25%  Similarity=0.379  Sum_probs=183.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++..  +++.||+|+++.         .+.+|++++++++|+||+++++++..++..+++|||++++.+..+....
T Consensus        15 ~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~   94 (288)
T cd07833          15 GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP   94 (288)
T ss_pred             eeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC
Confidence            79999987  578999998753         3568999999999999999999999999999999999987776665443


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                        ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++.........  ......++..|
T Consensus        95 --~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~  167 (288)
T cd07833          95 --GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--PLTDYVATRWY  167 (288)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc--cccCcccccCC
Confidence              2389999999999999999999985   4999999999999999999999999998866543321  12234678899


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhh---hccccc----CCchhhhh--hhcCCc--
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL---NPVLHK----EDGEESLR--HLMDPS--  578 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~---~~~~~~----~~~~~~l~--~~~d~~--  578 (635)
                      +|||++... .++.++||||||+++|+|++|+.||......+. +....   ......    ........  ++.+..  
T Consensus       168 ~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (288)
T cd07833         168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQP  246 (288)
T ss_pred             cCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCc
Confidence            999999877 789999999999999999999988864333211 11110   000000    00000000  000000  


Q ss_pred             --CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 --MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ....++...+..+.+++++||..+|++||++++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         247 ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              0011223346679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=2.8e-32  Score=282.07  Aligned_cols=228  Identities=21%  Similarity=0.362  Sum_probs=182.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  +++.||+|.+..       .+.+|+.++++++||||+++++++..++..++++||+++++|.+++...  
T Consensus        35 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--  112 (297)
T cd06659          35 GIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--  112 (297)
T ss_pred             eeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc--
Confidence            89999987  688999998743       3557899999999999999999999999999999999999999887542  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   .......++..|+|
T Consensus       113 -~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~a  185 (297)
T cd06659         113 -RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PKRKSLVGTPYWMA  185 (297)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc---ccccceecCccccC
Confidence             3899999999999999999999854   9999999999999999999999999986543221   11223568899999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||++.+..++.++||||||+++|||++|+.||........ + ......             ..+..  ......+..+.
T Consensus       186 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~-------------~~~~~--~~~~~~~~~l~  248 (297)
T cd06659         186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-M-KRLRDS-------------PPPKL--KNAHKISPVLR  248 (297)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHhcc-------------CCCCc--cccCCCCHHHH
Confidence            9999888899999999999999999999999864322111 1 111000             00000  01112334588


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||+.+|++||+++|++++
T Consensus       249 ~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         249 DFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHhcCCcccCcCHHHHhhC
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-34  Score=272.68  Aligned_cols=230  Identities=27%  Similarity=0.401  Sum_probs=190.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |+|||+..  .|+.+|||++.-     ++.+|+.+|.+++.+++|+++|.+.....+++|||||..|++.+.++.+ +++
T Consensus        47 GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R-~K~  125 (502)
T KOG0574|consen   47 GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR-RKP  125 (502)
T ss_pred             hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh-cCC
Confidence            88998866  899999999864     3568999999999999999999999999999999999999999999644 356


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      |++.++..++.+-++||+|||...   -+|||||..|||++.+|.+||+|||.+-......   .......||+.|||||
T Consensus       126 L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPE  199 (502)
T KOG0574|consen  126 LSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPE  199 (502)
T ss_pred             ccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH---HhhCccccCcccccHH
Confidence            999999999999999999999865   8999999999999999999999999987554332   2345578999999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      ++..-.|..++||||||+...||..|++|+.....-.        ..+-         ---.|......|...+..+.++
T Consensus       200 VI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------AIFM---------IPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  200 VIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------AIFM---------IPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             HHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------eeEe---------ccCCCCCCCCChHhhhhHHHHH
Confidence            9998889999999999999999999999864211100        0000         0001122233467778889999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 042486          595 IESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++||-..|++|-|+.++++|
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhh
Confidence            999999999999999998876

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=4.6e-32  Score=278.03  Aligned_cols=245  Identities=26%  Similarity=0.348  Sum_probs=182.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|..  +|..||+|++..         .+.+|++++++++|+|++++++++.+++..+++|||++ ++|.+++...
T Consensus        13 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~   91 (283)
T cd07835          13 GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS   91 (283)
T ss_pred             eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC
Confidence            89999987  689999998752         35579999999999999999999999999999999995 6899998665


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++........   ......++..|
T Consensus        92 ~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~  165 (283)
T cd07835          92 PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---TYTHEVVTLWY  165 (283)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc---ccCccccccCC
Confidence            434589999999999999999999984   499999999999999999999999999875432211   11223568899


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------chhhhhhhcCCc
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------GEESLRHLMDPS  578 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~~~~d~~  578 (635)
                      +|||++.+. .++.++||||||+++|+|++|+.||...+... .+.+..........           ............
T Consensus       166 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T cd07835         166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQD  244 (283)
T ss_pred             CCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccc
Confidence            999987654 56889999999999999999999886433221 11111111100000           000000000000


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      . .......+..+.+++.+||+.||++||+++|++++
T Consensus       245 ~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         245 L-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             h-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 01122234568899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.98  E-value=2.2e-31  Score=271.11  Aligned_cols=237  Identities=17%  Similarity=0.345  Sum_probs=172.6

Q ss_pred             ceEEEeee-CC---cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI-GG---DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~-~~---~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+. ++   ..+++|.++.        .+.+|+.++++++||||+++++.|.+....++||||+++|+|.+++..
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   88 (268)
T cd05086           9 GKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQ   88 (268)
T ss_pred             ceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHh
Confidence            89999976 32   3466776543        355788889999999999999999999999999999999999999965


Q ss_pred             cC--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 KG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 ~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ..  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........ ........++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~  164 (268)
T cd05086          89 EQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IETEDDKCVP  164 (268)
T ss_pred             hhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh-hhcccCCcCc
Confidence            32  234677788899999999999999854   99999999999999999999999999764322110 1112234678


Q ss_pred             CCccCcccccc-------CCCCcccchhhHHHHHHHHHhC-CCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          508 KGYMAPEYLEN-------GLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       508 ~~y~aPE~~~~-------~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      ..|+|||++..       ..++.++||||||+++|||+++ ..|+......+ .+.....         +....+.++.+
T Consensus       165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~---------~~~~~~~~~~~  234 (268)
T cd05086         165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIK---------DQQVKLFKPQL  234 (268)
T ss_pred             ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh---------hcccccCCCcc
Confidence            89999998753       2357899999999999999985 44553322211 1111110         00011222222


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ..    .....+.+++..|| .+|++||+++||++.|.
T Consensus       235 ~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 EL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22    23445788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.8e-32  Score=278.30  Aligned_cols=220  Identities=21%  Similarity=0.358  Sum_probs=188.3

Q ss_pred             eeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHH
Q 042486          368 KIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWA  438 (635)
Q Consensus       368 ~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~  438 (635)
                      .++|..||||++.+         .+.+|++.|+-++|||||+|+.+......+|||+|+=.+|+|.+|+-+... .+.+.
T Consensus        40 VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~  118 (864)
T KOG4717|consen   40 VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE-GLNED  118 (864)
T ss_pred             hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc-cccHH
Confidence            34889999999854         356899999999999999999999999999999999999999999955432 39999


Q ss_pred             HHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE-CCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccc
Q 042486          439 QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL-DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE  517 (635)
Q Consensus       439 ~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  517 (635)
                      ...+++.||+.|+.|+|+.+   +|||||||+|+++ ..-|-+||.|||++-...+...    ....+|...|-|||++.
T Consensus       119 La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k----L~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  119 LAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK----LTTSCGSLAYSAPEILL  191 (864)
T ss_pred             HHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch----hhcccchhhccCchhhh
Confidence            99999999999999999988   9999999999977 5568999999999976655432    34578999999999999


Q ss_pred             cCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHH
Q 042486          518 NGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIE  596 (635)
Q Consensus       518 ~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~  596 (635)
                      +..| .++.|||||||+||.|++|+.||..                  .+..+.+..+||-..  ..|...+.+..+||.
T Consensus       192 GDsYDAPAVDiWSLGVILyMLVCGq~PFqe------------------ANDSETLTmImDCKY--tvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  192 GDSYDAPAVDIWSLGVILYMLVCGQPPFQE------------------ANDSETLTMIMDCKY--TVPSHVSKECRDLIQ  251 (864)
T ss_pred             cCccCCcchhhhHHHHHHHHHHhCCCcccc------------------ccchhhhhhhhcccc--cCchhhhHHHHHHHH
Confidence            8777 4689999999999999999999753                  333466677777543  467888889999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 042486          597 SCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       597 ~cl~~dP~~RPs~~evl~~  615 (635)
                      +||..||++|.+.+||+.+
T Consensus       252 sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             HHHhcCchhhccHHHHhcc
Confidence            9999999999999999865

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.98  E-value=2.2e-32  Score=282.18  Aligned_cols=228  Identities=22%  Similarity=0.384  Sum_probs=182.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  ++..||||++..       .+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++...  
T Consensus        36 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  113 (292)
T cd06658          36 GIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--  113 (292)
T ss_pred             eEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--
Confidence            89999987  688999998754       3557899999999999999999999999999999999999999988543  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........   ......++..|+|
T Consensus       114 -~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~a  186 (292)
T cd06658         114 -RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKSLVGTPYWMA  186 (292)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---cCceeecCccccC
Confidence             3899999999999999999999854   99999999999999999999999999875432211   1223468899999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.+..++.++||||||+++|||++|+.|+........ . .             .+.....+....  ....+..+.
T Consensus       187 PE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~-~-------------~~~~~~~~~~~~--~~~~~~~~~  249 (292)
T cd06658         187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M-R-------------RIRDNLPPRVKD--SHKVSSVLR  249 (292)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-H-------------HHHhcCCCcccc--ccccCHHHH
Confidence            9999888899999999999999999999999753222110 0 0             011111111111  112344588


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||..||++|||++|++++
T Consensus       250 ~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         250 GFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHccCChhHCcCHHHHhhC
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.98  E-value=6.6e-32  Score=278.13  Aligned_cols=244  Identities=24%  Similarity=0.320  Sum_probs=178.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.||||.+...        +.+|++++++++|+||+++++++.+++..++||||+.+ +|.+++....
T Consensus        19 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~   97 (291)
T cd07844          19 ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCG   97 (291)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCC
Confidence            79999987  6789999987532        35799999999999999999999999999999999975 8999886543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      . .+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........   .....++..|+
T Consensus        98 ~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~  170 (291)
T cd07844          98 G-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYR  170 (291)
T ss_pred             C-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc---ccccccccccC
Confidence            3 4899999999999999999999854   999999999999999999999999998754322111   11234678899


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh------c--------C
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL------M--------D  576 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~------~--------d  576 (635)
                      |||.+.+ ..++.++||||||+++|||++|+.||.........+... ......... +.....      .        .
T Consensus       171 aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T cd07844         171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI-FRVLGTPTE-ETWPGVSSNPEFKPYSFPFYPP  248 (291)
T ss_pred             CcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH-HHhcCCCCh-hhhhhhhhccccccccccccCC
Confidence            9998865 457899999999999999999999885433211111111 010100000 000000      0        0


Q ss_pred             CcCCCCCC-hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQGNYP-PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+....+ ......+.+++.+||+.||++||++.|++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         249 RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000000 0011457899999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=3.2e-32  Score=309.94  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=182.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV  414 (635)
                      ++|.....||    |.||+++.  .+..+|+|.+..         .+..|+.+|++++||||++++++|.+  .+.+|||
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            3444444444    89999987  677899998753         25579999999999999999998864  3568999


Q ss_pred             eecccCCCcchhhccc--CCCCCCHHHHHHHHHHHHhhhcccccCCC----CCeEeecccCCCEEECC------------
Q 042486          415 YENAVNGSLSVWINDK--GGKFLDWAQRIQIALDVATGLNYLHSFTN----PPHVHKDIKCSNVLLDT------------  476 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~----~~ivH~Dikp~NIll~~------------  476 (635)
                      |||+++|+|.+++...  ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            9999999999999542  22348999999999999999999998542    45999999999999964            


Q ss_pred             -----CCcEEEeeecCcccccccCCceeeecccccCCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 042486          477 -----DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSE  549 (635)
Q Consensus       477 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~  549 (635)
                           .+.+||+|||++.......    ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                 3458999999997654321    1234578999999999854  4588999999999999999999999864322


Q ss_pred             hhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+ ..+..               .+.+.   ....+..+.+||..||..+|.+||++.|++.+
T Consensus       249 ~~qli-~~lk~---------------~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        249 FSQLI-SELKR---------------GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHH-HHHhc---------------CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            11111 11000               00000   01124558999999999999999999999864

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=1.1e-31  Score=271.90  Aligned_cols=233  Identities=26%  Similarity=0.440  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|..  +++.+|+|.++..         +.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (264)
T cd06626          14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG   93 (264)
T ss_pred             cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc
Confidence            79999987  6789999987542         457899999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee-ecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL-TSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~gt~~  509 (635)
                      .  .+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++............ .....++..
T Consensus        94 ~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T cd06626          94 R--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA  168 (264)
T ss_pred             C--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcC
Confidence            3  3789999999999999999999855   999999999999999999999999998865443221111 123467889


Q ss_pred             ccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLENGL---VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||++....   .+.++||||||+++|||++|+.||...+...........              ...+.+..  ...
T Consensus       169 ~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--------------~~~~~~~~--~~~  232 (264)
T cd06626         169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--------------GHKPPIPD--SLQ  232 (264)
T ss_pred             ccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--------------CCCCCCCc--ccc
Confidence            99999998765   889999999999999999999998643222111111000              00011100  111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++.+||+.||.+||++.|++.+
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         233 LSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            24557899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1e-31  Score=281.99  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=182.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||+++.  +++.||+|.+..         .+.+|+.+++.++|+||+++++++..++..++|+||+.+++|.+++...
T Consensus        14 ~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~   93 (328)
T cd08226          14 TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY   93 (328)
T ss_pred             eeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh
Confidence            68999987  789999998753         2456888888899999999999999999999999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc----eeeeccccc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE----FALTSHIVG  506 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~g  506 (635)
                      ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+.........    ........+
T Consensus        94 ~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (328)
T cd08226          94 FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS  170 (328)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccC
Confidence            444589999999999999999999985   4999999999999999999999999865432211100    000111234


Q ss_pred             CCCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC------------------
Q 042486          507 TKGYMAPEYLENG--LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED------------------  566 (635)
Q Consensus       507 t~~y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------------------  566 (635)
                      +..|+|||++.+.  .++.++|||||||++|||++|+.||.....................+                  
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (328)
T cd08226         171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV  250 (328)
T ss_pred             ccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhh
Confidence            5679999998763  47899999999999999999999986543322111111100000000                  


Q ss_pred             ----chhhhh-----hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 ----GEESLR-----HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ----~~~~l~-----~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ......     ...+..+....+......+.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         251 DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                000000     0111111222234456778999999999999999999999866

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=2.6e-32  Score=280.16  Aligned_cols=246  Identities=26%  Similarity=0.397  Sum_probs=181.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++..  +++.||+|++..         .+.+|++++++++|+||+++++++..++..++|+||+++++|.++....
T Consensus        15 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   94 (286)
T cd07846          15 GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP   94 (286)
T ss_pred             eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc
Confidence            79999998  578999998743         2457999999999999999999999999999999999999998877543


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      .  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........   ......++..|
T Consensus        95 ~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y  166 (286)
T cd07846          95 N--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWY  166 (286)
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc---ccCcccceeec
Confidence            2  3899999999999999999999854   99999999999999999999999999876533221   12234578899


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhh--HHHHhhhcccccCCc----hhhhhhhcCCcCCC--
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNPVLHKEDG----EESLRHLMDPSMQG--  581 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~----~~~l~~~~d~~~~~--  581 (635)
                      +|||++.+ ..++.++||||||+++|||++|+.|+........  ...............    .........+....  
T Consensus       167 ~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (286)
T cd07846         167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIE  246 (286)
T ss_pred             cCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcc
Confidence            99998865 4578899999999999999999988754322110  011111110000000    00000000111100  


Q ss_pred             ---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 ---NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         ...+..+..+.+++.+||+.||++||++.+++++
T Consensus       247 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         247 PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence               0012235668999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-34  Score=267.12  Aligned_cols=227  Identities=24%  Similarity=0.288  Sum_probs=177.6

Q ss_pred             ceEEEeee--CCcEEEEEEec---------cChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVY---------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~---------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      +.||+...  +|+.+|+|.+.         +++.+|+.+.+.++||||++|.+....++..|||+|++.|++|..-+-.+
T Consensus        25 SvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R  104 (355)
T KOG0033|consen   25 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR  104 (355)
T ss_pred             HHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH
Confidence            34555543  56666666542         24668999999999999999999999999999999999999997666332


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        ...++...-..+.||++||.|+|.   ++|||||+||.|+++..   .--+||+|||+|......    ..-....||
T Consensus       105 --~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g----~~~~G~~Gt  175 (355)
T KOG0033|consen  105 --EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG----EAWHGFAGT  175 (355)
T ss_pred             --HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCc----cccccccCC
Confidence              347888999999999999999998   55999999999999943   345999999999877632    223457899


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc--CCCCCCh
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS--MQGNYPP  585 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~--~~~~~~~  585 (635)
                      ++|||||++....++..+|||+.||+||-|+.|.+||...+.  ..+.+.                ++...  +.+.+.+
T Consensus       176 P~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye~----------------I~~g~yd~~~~~w~  237 (355)
T KOG0033|consen  176 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYEQ----------------IKAGAYDYPSPEWD  237 (355)
T ss_pred             CcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHHH----------------HhccccCCCCcccC
Confidence            999999999999999999999999999999999999853222  222222                22111  1122233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...++..+|+++||..||++|.|+.|.++|
T Consensus       238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  238 TVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            445667899999999999999999998765

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.98  E-value=1.3e-31  Score=273.07  Aligned_cols=235  Identities=21%  Similarity=0.354  Sum_probs=179.2

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCC------eeEEEeecccCC
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGG------NWYLVYENAVNG  421 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~E~~~~g  421 (635)
                      |.||+|.+     ++..||||.++.+         +.+|++++++++||||+++++++...+      ..++++||+.+|
T Consensus        13 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (273)
T cd05074          13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHG   92 (273)
T ss_pred             CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCC
Confidence            89999986     3578999988653         457899999999999999999886532      247899999999


Q ss_pred             Ccchhhccc----CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          422 SLSVWINDK----GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       422 sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +|.+++...    ....+++.....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....... 
T Consensus        93 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~-  168 (273)
T cd05074          93 DLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-  168 (273)
T ss_pred             cHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcc-
Confidence            999887321    122478999999999999999999985   499999999999999999999999999886533221 


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                      ........++..|++||.+.+..++.++||||||+++|||++ |+.|+......  ........                
T Consensus       169 ~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~----------------  230 (273)
T cd05074         169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIK----------------  230 (273)
T ss_pred             eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHc----------------
Confidence            111122345578999999998889999999999999999999 77776432221  11111110                


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .. ....+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       231 ~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00 0011123345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=3.9e-32  Score=288.38  Aligned_cols=244  Identities=22%  Similarity=0.338  Sum_probs=185.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhc-c-----CCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKIN-H-----SSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.|.|+..  +++.||||.++.+      ...|+.+|..|+ |     -|+|+++++|...++.|||+|.+ ..+|.+++
T Consensus       200 GQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYell  278 (586)
T KOG0667|consen  200 GQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELL  278 (586)
T ss_pred             ceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHH
Confidence            89999987  7899999999874      346899999997 3     48999999999999999999988 55999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC--CcEEEeeecCcccccccCCceeeecccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD--FRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      +.+.-..++...+..|+.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||.++......-      ...
T Consensus       279 K~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy------tYi  349 (586)
T KOG0667|consen  279 KNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY------TYI  349 (586)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce------eee
Confidence            8877777999999999999999999999865   9999999999999543  4799999999987654321      345


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhh--------------ccccc-CC--
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLN--------------PVLHK-ED--  566 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~--------------~~~~~-~~--  566 (635)
                      .+..|+|||++.+..|+.+.||||||||+.||++|.+.|...++.++.  +.+.+.              .++.. ..  
T Consensus       350 QSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~  429 (586)
T KOG0667|consen  350 QSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFP  429 (586)
T ss_pred             eccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCce
Confidence            778899999999999999999999999999999997666554433211  011100              11111 00  


Q ss_pred             ----ch------------hhhhhhcCCc-CC-------CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 ----GE------------ESLRHLMDPS-MQ-------GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ----~~------------~~l~~~~d~~-~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ..            ..+....+.. ..       ..........+.+++++||+.||.+|+|..|.++|
T Consensus       430 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  430 RLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             eeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                00            0000001110 00       01112345568999999999999999999999987

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=5.3e-32  Score=273.14  Aligned_cols=229  Identities=23%  Similarity=0.390  Sum_probs=183.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++..  ++..+|+|.+..         .+.+|++++++++|+||+++++.+..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (257)
T cd08225          14 GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ   93 (257)
T ss_pred             ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc
Confidence            79999988  678999998743         2457999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+........   ......|+..
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~  167 (257)
T cd08225          94 RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPY  167 (257)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc---cccccCCCcc
Confidence            5445899999999999999999999855   99999999999998885 569999999876543221   1223468889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|+||||++++||++|+.|+......... ...                 ...... ..+...+.
T Consensus       168 ~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~-----------------~~~~~~-~~~~~~~~  228 (257)
T cd08225         168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV-LKI-----------------CQGYFA-PISPNFSR  228 (257)
T ss_pred             ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHH-----------------hcccCC-CCCCCCCH
Confidence            99999998888999999999999999999999997543221111 111                 111110 11122344


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||..+|++||+++|++++
T Consensus       229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         229 DLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhhC
Confidence            58999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=1.2e-31  Score=274.86  Aligned_cols=230  Identities=22%  Similarity=0.337  Sum_probs=174.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHH-HhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKL-LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||+|+++..        +..|+.. ++..+|+||+++++++..++..+++|||++ |+|.+++...
T Consensus        15 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   93 (283)
T cd06617          15 GVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKV   93 (283)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHh
Confidence            89999988  6899999988653        2234444 555689999999999999999999999996 6888777432


Q ss_pred             --CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          431 --GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       431 --~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                        ....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.......    ......++.
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~  167 (283)
T cd06617          94 YDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV----AKTIDAGCK  167 (283)
T ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc----ccccccCCc
Confidence              234589999999999999999999983  259999999999999999999999999987553221    112246788


Q ss_pred             CccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          509 GYMAPEYLEN----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       509 ~y~aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .|+|||.+.+    ..++.++|+||||+++|||++|+.|+.........+                 .............
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~  230 (283)
T cd06617         168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-----------------KQVVEEPSPQLPA  230 (283)
T ss_pred             cccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH-----------------HHHHhcCCCCCCc
Confidence            9999998864    446889999999999999999999975322111111                 1111110000001


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+++.+||..+|++||++++++++
T Consensus       231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1234568999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=1.3e-31  Score=275.64  Aligned_cols=233  Identities=24%  Similarity=0.345  Sum_probs=181.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++..  +++.+|+|.+..        ++.+|++++++++|+||+++++++.+.  +..++||||+++++|.+++..
T Consensus        15 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (287)
T cd06621          15 GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK   94 (287)
T ss_pred             eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence            89999998  678999998763        256899999999999999999998653  468999999999999988743


Q ss_pred             --cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 --KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 --~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        .....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......     .....++
T Consensus        95 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~  166 (287)
T cd06621          95 VKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----AGTFTGT  166 (287)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc-----cccccCC
Confidence              22344889999999999999999999854   9999999999999999999999999987543221     1124577


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcch---hhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE---NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      ..|+|||.+.+..++.++||||||+++|+|++|+.|+......   ......+...             ...+.+.....
T Consensus       167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~  233 (287)
T cd06621         167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-------------MPNPELKDEPG  233 (287)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-------------CCchhhccCCC
Confidence            8899999999888999999999999999999999998643211   0111111110             00011111111


Q ss_pred             --hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 --PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 --~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ...+..+.+++.+||+.||.+|||+.|++++
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence              1235668999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=1.7e-31  Score=271.82  Aligned_cols=226  Identities=22%  Similarity=0.263  Sum_probs=177.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccChHH--HHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDASD--QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLD  436 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~~~--E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~  436 (635)
                      |.||++..  ++..+|+|........  |+.....+ +|+||+++++.+..++..++||||+++++|.+++....  .++
T Consensus        30 g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~  107 (267)
T PHA03390         30 GKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLS  107 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCC
Confidence            89999986  6789999998654322  34333323 79999999999999999999999999999999996553  489


Q ss_pred             HHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       437 ~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      +.++..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||++......       ....++..|+|||+
T Consensus       108 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~  177 (267)
T PHA03390        108 EAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEK  177 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------ccCCCCCcccChhh
Confidence            9999999999999999999855   99999999999999988 9999999998755322       12357889999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI  595 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li  595 (635)
                      +.+..++.++||||||+++|||++|+.||.....+......+...              ...  ....+...+..+.+++
T Consensus       178 ~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~~~--~~~~~~~~~~~~~~li  241 (267)
T PHA03390        178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR--------------QQK--KLPFIKNVSKNANDFV  241 (267)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh--------------hcc--cCCcccccCHHHHHHH
Confidence            998889999999999999999999999986433222111111110              000  0112224556689999


Q ss_pred             HHhhhcCCCCCCC-HHHHHHH
Q 042486          596 ESCLKKDPSGRPA-MDKIAQS  615 (635)
Q Consensus       596 ~~cl~~dP~~RPs-~~evl~~  615 (635)
                      .+||+.||.+||+ ++|++++
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHHhccChhhCCchHHHHhcC
Confidence            9999999999996 6988864

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=8.8e-32  Score=275.32  Aligned_cols=241  Identities=27%  Similarity=0.352  Sum_probs=186.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||++..  +++.+|+|.+..          .+.+|+++|++++|+||+++++.+...+..|+||||+++++|.+++..
T Consensus         7 g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (277)
T cd05577           7 GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN   86 (277)
T ss_pred             eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHH
Confidence            89999986  688999998743          134689999999999999999999999999999999999999999966


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+.......    ......++..
T Consensus        87 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~  159 (277)
T cd05577          87 VGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KIKGRAGTPG  159 (277)
T ss_pred             cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----ccccccCCCC
Confidence            55445899999999999999999999855   9999999999999999999999999987553311    1223457789


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++++|++|+.||.........               ..+..... ......+...+.
T Consensus       160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~-~~~~~~~~~~~~  223 (277)
T cd05577         160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---------------EELKRRTL-EMAVEYPDKFSP  223 (277)
T ss_pred             cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---------------HHHHhccc-cccccCCccCCH
Confidence            99999998888999999999999999999999998543221100               00000000 001122333456


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHHHHHHHhhcccccc
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~~~s~~w~~  628 (635)
                      .+.+++.+||+.||.+||     ++.+++.+  .++ ..++|..
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h--~~~-~~~~~~~  264 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVREH--PLF-KDLNWRR  264 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHhC--hhh-hcCChhh
Confidence            689999999999999999     66666653  222 2355643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=1.2e-31  Score=276.61  Aligned_cols=244  Identities=24%  Similarity=0.324  Sum_probs=180.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.+|+|.++.         .+.+|++++++++|+||+++++++...  +..|+||||+. ++|.+++.
T Consensus        19 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~   97 (293)
T cd07843          19 GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLME   97 (293)
T ss_pred             eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHH
Confidence            89999998  578999998853         235799999999999999999999877  78999999997 48988886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .... .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.........   .....++.
T Consensus        98 ~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~  170 (293)
T cd07843          98 TMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP---YTQLVVTL  170 (293)
T ss_pred             hccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc---cccccccc
Confidence            5432 4899999999999999999999855   999999999999999999999999998865443211   12245688


Q ss_pred             CccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc--h-----------hhhhhh
Q 042486          509 GYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG--E-----------ESLRHL  574 (635)
Q Consensus       509 ~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--~-----------~~l~~~  574 (635)
                      .|+|||.+.+. ..+.++|+||||+++|||++|+.||........ ...... .+.....  .           ......
T Consensus       171 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (293)
T cd07843         171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFK-LLGTPTEKIWPGFSELPGAKKKTFTKY  248 (293)
T ss_pred             cccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-HhCCCchHHHHHhhccchhcccccccc
Confidence            89999988754 468899999999999999999998865432211 111100 0000000  0           000000


Q ss_pred             cCCcCCCCCChH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 MDPSMQGNYPPV-TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~d~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+...++.. ....+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            011111122222 35668999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=271.17  Aligned_cols=230  Identities=21%  Similarity=0.276  Sum_probs=180.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||++..  ++..||+|.+..            .+.+|++++++++|+||+++++++.+.  +..++++||+++++|.+
T Consensus        16 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~   95 (264)
T cd06653          16 GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD   95 (264)
T ss_pred             eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHH
Confidence            79999987  688999998631            245689999999999999999998754  45789999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++................
T Consensus        96 ~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  170 (264)
T cd06653          96 QLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT  170 (264)
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccC
Confidence            986543  3789999999999999999999855   99999999999999999999999999986532211111112346


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|+|||.+.+..++.++|+||||++++||++|+.||......                  +...+..........+.
T Consensus       171 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------------~~~~~~~~~~~~~~~p~  232 (264)
T cd06653         171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------------------AAIFKIATQPTKPMLPD  232 (264)
T ss_pred             CcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------------------HHHHHHHcCCCCCCCCc
Confidence            888999999998888899999999999999999999997532111                  11111111111223445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+.+++.+||. +|..||++.+++.|
T Consensus       233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            566679999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=5.7e-32  Score=273.69  Aligned_cols=240  Identities=25%  Similarity=0.367  Sum_probs=186.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+++|.+..+          +.+|++++++++|+||+++++.+..++..|++|||+++++|.+++.+
T Consensus         7 ~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (265)
T cd05579           7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN   86 (265)
T ss_pred             eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH
Confidence            89999998  4899999988542          44688999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-----eeeeccc
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-----FALTSHI  504 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~  504 (635)
                      ..  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.........     .......
T Consensus        87 ~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~  161 (265)
T cd05579          87 VG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI  161 (265)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCc
Confidence            44  4899999999999999999999854   999999999999999999999999998754332110     0112334


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .++..|++||.......+.++||||||+++++|++|+.|+.....+..                  ...+.....  ..+
T Consensus       162 ~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------------------~~~~~~~~~--~~~  221 (265)
T cd05579         162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------------------FQNILNGKI--EWP  221 (265)
T ss_pred             ccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------------------HHHHhcCCc--CCC
Confidence            678899999999888889999999999999999999999854332211                  111111000  011


Q ss_pred             hH--HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          585 PV--TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       585 ~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                      ..  .+..+.+++.+||+.+|++||++.++.+.|+.-.-+.++|
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            11  2456899999999999999999966666555433345555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=9.2e-32  Score=277.65  Aligned_cols=228  Identities=24%  Similarity=0.385  Sum_probs=182.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  +++.||+|.+..       .+.+|+.++++++|||++++++.+...+..++|+||+++++|.+++.+.  
T Consensus        33 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  110 (293)
T cd06647          33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--  110 (293)
T ss_pred             eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--
Confidence            89999986  678999998753       2457899999999999999999999999999999999999999998653  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........   ......++..|+|
T Consensus       111 -~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~  183 (293)
T cd06647         111 -CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMA  183 (293)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc---ccccccCChhhcC
Confidence             2789999999999999999999854   99999999999999999999999998875443221   1223468889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+....++.++|+||||+++|+|++|+.||......... .    ...            ..+......+...+..+.
T Consensus       184 PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~----~~~------------~~~~~~~~~~~~~~~~l~  246 (293)
T cd06647         184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-Y----LIA------------TNGTPELQNPEKLSAIFR  246 (293)
T ss_pred             chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-e----ehh------------cCCCCCCCCccccCHHHH
Confidence            99998888899999999999999999999998543221100 0    000            000001111223445688


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||+.+|++||++++++.+
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.2e-31  Score=275.57  Aligned_cols=230  Identities=27%  Similarity=0.394  Sum_probs=183.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||++..  ++..+++|.+..      .+.+|++++++++|+|++++++.+..++..++++||+++++|.+++.... .
T Consensus        33 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~  111 (286)
T cd06614          33 GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-V  111 (286)
T ss_pred             eEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-c
Confidence            89999998  488999998864      35679999999999999999999999999999999999999999997654 3


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........   ......++..|++|
T Consensus       112 ~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~P  185 (286)
T cd06614         112 RMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---KRNSVVGTPYWMAP  185 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh---hhccccCCcccCCH
Confidence            499999999999999999999984   499999999999999999999999998865433221   11224577899999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      |.+.+..++.++|+||||+++|+|++|+.|+......... ......                .......+...+..+.+
T Consensus       186 E~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~-~~~~~~----------------~~~~~~~~~~~~~~l~~  248 (286)
T cd06614         186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL-FLITTK----------------GIPPLKNPEKWSPEFKD  248 (286)
T ss_pred             hHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc----------------CCCCCcchhhCCHHHHH
Confidence            9998888999999999999999999999987533221111 000000                00000111123456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 042486          594 LIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ++.+||+.+|.+||++.+++++
T Consensus       249 li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhhC
Confidence            9999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=2.2e-31  Score=277.97  Aligned_cols=232  Identities=28%  Similarity=0.388  Sum_probs=182.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  ++..+|+|++..          ++.+|++++++++|+|++++++++.+++..++||||+. |+|.+++..
T Consensus        39 ~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~  117 (317)
T cd06635          39 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV  117 (317)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH
Confidence            79999987  678999998752          24578999999999999999999999999999999996 578777754


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++.++..++.+++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......       ....++..
T Consensus       118 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~  186 (317)
T cd06635         118 HK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-------NSFVGTPY  186 (317)
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-------ccccCCcc
Confidence            33 34899999999999999999999854   999999999999999999999999998654322       22467889


Q ss_pred             ccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||++.   .+.++.++||||||+++|||++|+.|+....... ....                 +............
T Consensus       187 y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-----------------~~~~~~~~~~~~~  248 (317)
T cd06635         187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH-----------------IAQNESPTLQSNE  248 (317)
T ss_pred             ccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHH-----------------HHhccCCCCCCcc
Confidence            99999874   4568899999999999999999999875322111 1111                 1111111111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+..+.+++.+||+.+|.+||++.++++++-.+....
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            4456899999999999999999999999876554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=272.96  Aligned_cols=227  Identities=25%  Similarity=0.445  Sum_probs=180.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhc---cCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKIN---HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.+|+|.++.        ++.+|+.++++++   |+|++++++++..+...++||||+++++|.+++.
T Consensus        15 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   94 (277)
T cd06917          15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK   94 (277)
T ss_pred             ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence            89999997  688999998753        2457888999996   9999999999999999999999999999999986


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ..   .+++...+.++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........   ......|+.
T Consensus        95 ~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~  165 (277)
T cd06917          95 AG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS---KRSTFVGTP  165 (277)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc---ccccccCCc
Confidence            53   4899999999999999999999855   99999999999999999999999999876543321   122346888


Q ss_pred             CccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.++ .++.++|+||||+++|+|++|+.||.......  .....             .....+.+...   ..
T Consensus       166 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~-------------~~~~~~~~~~~---~~  227 (277)
T cd06917         166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--AMMLI-------------PKSKPPRLEDN---GY  227 (277)
T ss_pred             ceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--hhhcc-------------ccCCCCCCCcc---cC
Confidence            99999988754 46889999999999999999999985322111  00000             00001111111   13


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+.+++.+||+.||++||++.|++++
T Consensus       228 ~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         228 SKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            4568999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=2.1e-31  Score=273.14  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=180.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  ++..||||.++.        .+.+|++++++++|+||+++++++.+.+..++||||+++ +|.+++....
T Consensus        14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   92 (284)
T cd07836          14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG   92 (284)
T ss_pred             eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC
Confidence            89999998  688999998753        234799999999999999999999999999999999985 8888885433


Q ss_pred             -CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          432 -GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       432 -~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                       ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........   ......++..|
T Consensus        93 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y  166 (284)
T cd07836          93 VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---TFSNEVVTLWY  166 (284)
T ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc---ccccccccccc
Confidence             235899999999999999999999854   99999999999999999999999999875433211   11224568899


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC-CcCCCC------
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGN------  582 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d-~~~~~~------  582 (635)
                      ++||.+.+ ..++.++||||||+++|+|++|+.||...+..+. ....... ..... ......+.+ +.....      
T Consensus       167 ~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd07836         167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRI-MGTPT-ESTWPGISQLPEYKPTFPRYPP  243 (284)
T ss_pred             cChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHH-hCCCC-hhhHHHHhcCchhcccccCCCh
Confidence            99998865 4568899999999999999999998865433221 1111110 00000 000000000 000000      


Q ss_pred             -----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 -----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                           ..+..+..+.+++.+|++.||.+||++.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         244 QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 111234568899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=3.2e-31  Score=265.70  Aligned_cols=229  Identities=26%  Similarity=0.453  Sum_probs=184.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  ++..+++|++...       +.+|++++++++|+|++++++++..++..++++||+++++|.+++.... 
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-   92 (253)
T cd05122          14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-   92 (253)
T ss_pred             eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-
Confidence            89999998  5889999988543       5579999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.+++.||.+||+.   +++||||+|+||++++++.++|+|||.+........    .....++..|+|
T Consensus        93 ~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~  165 (253)
T cd05122          93 QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNTMVGTPYWMA  165 (253)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc----ccceecCCcccC
Confidence            3489999999999999999999984   499999999999999999999999999876654321    233568889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.....+.++|+||||+++++|++|+.|+...+.......  ...             ..-+..  ..+...+..+.
T Consensus       166 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~-------------~~~~~~--~~~~~~~~~~~  228 (253)
T cd05122         166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--IAT-------------NGPPGL--RNPEKWSDEFK  228 (253)
T ss_pred             HHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--HHh-------------cCCCCc--CcccccCHHHH
Confidence            9999888899999999999999999999998764322111100  000             000000  01111245689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||+.||++|||+.|++++
T Consensus       229 ~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         229 DFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHccCChhhCCCHHHHhcC
Confidence            99999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=8.1e-32  Score=277.01  Aligned_cols=233  Identities=22%  Similarity=0.338  Sum_probs=177.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhh---
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI---  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l---  427 (635)
                      |.||+++.  +++.+|+|.+..        .+.+|+.++.++. |+||+++++++..++..+++|||+.. +|.++.   
T Consensus        18 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~   96 (288)
T cd06616          18 GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYV   96 (288)
T ss_pred             eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHH
Confidence            89999988  678999998853        2456888999996 99999999999998899999999864 555443   


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .......+++..+..++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||+++......    ......++
T Consensus        97 ~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~  170 (288)
T cd06616          97 YEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI----AKTRDAGC  170 (288)
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC----ccccccCc
Confidence            222334589999999999999999999972  359999999999999999999999999987543221    11223578


Q ss_pred             CCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          508 KGYMAPEYLENG---LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       508 ~~y~aPE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      ..|+|||.+.+.   .++.++||||||+++|||++|+.||.......    +........          ..+.+....+
T Consensus       171 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~----------~~~~~~~~~~  236 (288)
T cd06616         171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF----DQLTQVVKG----------DPPILSNSEE  236 (288)
T ss_pred             cCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH----HHHhhhcCC----------CCCcCCCcCC
Confidence            899999998765   68999999999999999999999985432111    111110000          0111111222


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+|+.+||+.||++||+++||+++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2345568999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-31  Score=279.64  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=180.0

Q ss_pred             ceEEEeee----CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|+.    ++..||+|.+..          ...+|+.++++++||||+++++++.+.  +..++||||+++ +|.+
T Consensus        14 g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   92 (316)
T cd07842          14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQ   92 (316)
T ss_pred             EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHH
Confidence            89999998    468999999876          245799999999999999999999987  789999999975 6766


Q ss_pred             hhccc---CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC----CCcEEEeeecCcccccccCCce
Q 042486          426 WINDK---GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT----DFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       426 ~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      ++...   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+|||++..........
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  169 (316)
T cd07842          93 IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL  169 (316)
T ss_pred             HHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccc
Confidence            66321   2235899999999999999999999854   999999999999999    9999999999998654432211


Q ss_pred             eeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--------hHHHHhhhcccccCCch-
Q 042486          499 ALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--------MLLVDVLNPVLHKEDGE-  568 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--------~~l~~~~~~~~~~~~~~-  568 (635)
                      .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||.....+.        ..+...+.. +...... 
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~  248 (316)
T cd07842         170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV-LGTPTEKD  248 (316)
T ss_pred             cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH-hCCCchhH
Confidence            22233567889999998765 457899999999999999999999986543321        011111110 0000000 


Q ss_pred             -hh------hhhhcCCcCCCCCC-----------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          569 -ES------LRHLMDPSMQGNYP-----------PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       569 -~~------l~~~~d~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ..      .....+......++           ...+..+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         249 WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             00      00000000000111           0233458899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=2.2e-31  Score=273.74  Aligned_cols=228  Identities=21%  Similarity=0.365  Sum_probs=181.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  +++.+++|++..       .+.+|+.++++++|+||+++++++..++..++++||+++++|.+++...  
T Consensus        33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--  110 (285)
T cd06648          33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT--  110 (285)
T ss_pred             eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC--
Confidence            89999986  678999998743       2457899999999999999999999999999999999999999998662  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||.+........   ......|+..|+|
T Consensus       111 -~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~a  183 (285)
T cd06648         111 -RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMA  183 (285)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---ccccccCCccccC
Confidence             3899999999999999999999855   99999999999999999999999998865433211   1223468899999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.+..++.++||||||+++|||++|+.|+.......  ....             +.....+...  .+...+..+.
T Consensus       184 PE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--~~~~-------------~~~~~~~~~~--~~~~~~~~l~  246 (285)
T cd06648         184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--AMKR-------------IRDNLPPKLK--NLHKVSPRLR  246 (285)
T ss_pred             HHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--HHHH-------------HHhcCCCCCc--ccccCCHHHH
Confidence            999988889999999999999999999999875322111  0000             0000001111  1112345689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||+.+|++||++.+++++
T Consensus       247 ~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         247 SFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             HHHHHHcccChhhCcCHHHHccC
Confidence            99999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=2e-31  Score=274.96  Aligned_cols=245  Identities=25%  Similarity=0.320  Sum_probs=177.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhc-cCCcccEEEEEecCCe-----eEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKIN-HSSLIRLLGICFNGGN-----WYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~-----~~lV~E~~~~gsL~  424 (635)
                      |.||+|..  +++.||||+.+.         .+.+|+.++++++ |+||+++++++...+.     .|+||||+++ +|.
T Consensus        15 g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   93 (295)
T cd07837          15 GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLK   93 (295)
T ss_pred             eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHH
Confidence            89999987  688999998753         2457999999995 6999999999986655     7999999985 888


Q ss_pred             hhhcccC---CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceee
Q 042486          425 VWINDKG---GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       425 ~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      +++....   ...+++..+..++.||+.||.|||+.   +++||||+|+||+++. ++.+||+|||++........   .
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~---~  167 (295)
T cd07837          94 KFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK---S  167 (295)
T ss_pred             HHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCcc---c
Confidence            8874322   24589999999999999999999985   4999999999999998 89999999999875433211   1


Q ss_pred             ecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch-----hhhhhh
Q 042486          501 TSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE-----ESLRHL  574 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-----~~l~~~  574 (635)
                      .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+... .+....... ......     ......
T Consensus       168 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~  245 (295)
T cd07837         168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLL-GTPTEQVWPGVSKLRDW  245 (295)
T ss_pred             cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHh-CCCChhhCcchhhccch
Confidence            122356788999998865 457899999999999999999998886433221 111111100 000000     000000


Q ss_pred             c-CCcCC----CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 M-DPSMQ----GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~-d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      . .+...    ....+..+..+.++|.+||..||.+||+++|++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0 00000    00011244568999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=2e-31  Score=273.07  Aligned_cols=227  Identities=20%  Similarity=0.313  Sum_probs=175.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHh---hhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLN---KINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +++.+|+|.+...          ..+|..+++   ..+|+||+.+.+.+..++..++||||+++|+|.++
T Consensus         8 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   87 (279)
T cd05633           8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   87 (279)
T ss_pred             eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHH
Confidence            89999987  6789999987542          123333333   34799999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +....  .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......     .....|
T Consensus        88 i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~  157 (279)
T cd05633          88 LSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVG  157 (279)
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-----ccCcCC
Confidence            86543  3899999999999999999999855   9999999999999999999999999986543221     122468


Q ss_pred             CCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +..|+|||.+.+ ..++.++|||||||++|||++|+.||..........                +.... .......+.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----------------~~~~~-~~~~~~~~~  220 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----------------IDRMT-LTVNVELPD  220 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----------------HHHHh-hcCCcCCcc
Confidence            999999998864 557899999999999999999999985432211110                00000 001112233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ..+..+.+++.+||..||++||     +++|++++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            4456689999999999999999     59988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=1.7e-31  Score=275.50  Aligned_cols=245  Identities=26%  Similarity=0.342  Sum_probs=178.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.  +++.||+|++..         .+.+|++++++++|+||+++++++.+++..++||||++ ++|.+++...
T Consensus        16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   94 (294)
T PLN00009         16 GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS   94 (294)
T ss_pred             EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC
Confidence            89999987  678999998743         24579999999999999999999999999999999995 5888887554


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ....+++.....++.||+.||+|||+.   +++|+||+|+||+++. ++.+||+|||++........   ......++..
T Consensus        95 ~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~  168 (294)
T PLN00009         95 PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---TFTHEVVTLW  168 (294)
T ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc---ccccCceeec
Confidence            444468888899999999999999984   4999999999999985 56799999999975432211   1123456889


Q ss_pred             ccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----chhhhhhhcC--CcCCC
Q 042486          510 YMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----GEESLRHLMD--PSMQG  581 (635)
Q Consensus       510 y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----~~~~l~~~~d--~~~~~  581 (635)
                      |+|||.+.+ ..++.++||||||+++|+|+||+.||......+. ...... ......     ....+.....  +....
T Consensus       169 y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (294)
T PLN00009        169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFR-ILGTPNEETWPGVTSLPDYKSAFPKWPP  246 (294)
T ss_pred             ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCChhhccccccchhhhhhcccCCC
Confidence            999998865 4578999999999999999999998864332221 111110 000000     0000000000  00000


Q ss_pred             ----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 ----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ...+..+..+.+++.+|++.||++||++.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        247 KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0112234558899999999999999999999975

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.2e-31  Score=267.94  Aligned_cols=214  Identities=18%  Similarity=0.147  Sum_probs=172.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCH
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDW  437 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~  437 (635)
                      |.||+++.  +++.+|+|+++..  ..+|...+....||||+++++++.+.+..+++|||+++|+|.+++....  .+++
T Consensus         7 ~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~   84 (237)
T cd05576           7 DKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPE   84 (237)
T ss_pred             ceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCCH
Confidence            88999987  7889999999764  4556666666689999999999999999999999999999999986543  3899


Q ss_pred             HHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccc
Q 042486          438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE  517 (635)
Q Consensus       438 ~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  517 (635)
                      ..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||.+.......      ....++..|+|||...
T Consensus        85 ~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~y~aPE~~~  155 (237)
T cd05576          85 ECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVENMYCAPEVGG  155 (237)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcCccccCCcccC
Confidence            99999999999999999985   49999999999999999999999999876543321      1234567899999998


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHH
Q 042486          518 NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIES  597 (635)
Q Consensus       518 ~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~  597 (635)
                      ...++.++||||+|+++|||++|+.|+......           .             ........+...+..+.+++.+
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~-------------~~~~~~~~~~~~~~~~~~li~~  211 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------I-------------NTHTTLNIPEWVSEEARSLLQQ  211 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------c-------------ccccccCCcccCCHHHHHHHHH
Confidence            888899999999999999999999765321100           0             0000011233344568999999


Q ss_pred             hhhcCCCCCCCHH
Q 042486          598 CLKKDPSGRPAMD  610 (635)
Q Consensus       598 cl~~dP~~RPs~~  610 (635)
                      ||+.||++||++.
T Consensus       212 ~l~~dp~~R~~~~  224 (237)
T cd05576         212 LLQFNPTERLGAG  224 (237)
T ss_pred             HccCCHHHhcCCC
Confidence            9999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=268.96  Aligned_cols=238  Identities=24%  Similarity=0.304  Sum_probs=179.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHH-HhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKL-LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||++..  +++.||+|.++..          +..|..+ ....+|+|++++++++..++..|+|+||+++++|.+++.
T Consensus        10 ~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   89 (260)
T cd05611          10 GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK   89 (260)
T ss_pred             eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH
Confidence            89999987  6789999988542          1123333 334589999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||+++....       .....++.
T Consensus        90 ~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~~~~~~  157 (260)
T cd05611          90 TLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKKFVGTP  157 (260)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------cccCCCCc
Confidence            543  3899999999999999999999854   99999999999999999999999999875432       12345788


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||.+.+..++.++||||||+++|||++|..|+........ .......               ............+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---------------~~~~~~~~~~~~~  221 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSR---------------RINWPEEVKEFCS  221 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhc---------------ccCCCCcccccCC
Confidence            99999999888889999999999999999999999854322211 1000000               0000111112234


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccccc
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~  627 (635)
                      ..+.+++.+||+.||++||++.++.+.|+.-.-....|+
T Consensus       222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             HHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence            568999999999999999977655554444333445553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=4.4e-31  Score=265.83  Aligned_cols=231  Identities=27%  Similarity=0.398  Sum_probs=187.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.|++|.+...         +.+|++++++++|+||+++++.+...  +..++++||+++++|.+++.
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   93 (260)
T cd06606          14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK   93 (260)
T ss_pred             eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHH
Confidence            89999998  4889999987543         45789999999999999999999988  88999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......... .......++.
T Consensus        94 ~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~  167 (260)
T cd06606          94 KFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRGTP  167 (260)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-ccccCCCCCc
Confidence            554  489999999999999999999984   4999999999999999999999999998866543211 0123356888


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||.+.....+.++||||||+++++|++|+.||...........                 ...........+...+
T Consensus       168 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~  230 (260)
T cd06606         168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-----------------KIGSSGEPPEIPEHLS  230 (260)
T ss_pred             cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-----------------hccccCCCcCCCcccC
Confidence            99999999888899999999999999999999999865432111111                 1111111122333446


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+++.+|++.||++||++.|++++
T Consensus       231 ~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         231 EEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            679999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2.3e-31  Score=268.21  Aligned_cols=227  Identities=29%  Similarity=0.413  Sum_probs=184.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  ++..+|+|.+..         ++.+|++++++++|+||+++++++.+....++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   93 (256)
T cd08530          14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR   93 (256)
T ss_pred             eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHH
Confidence            78999977  678999998753         2457889999999999999999999999999999999999999998542


Q ss_pred             --CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          431 --GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       431 --~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                        ....+++..++.++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......     ......++.
T Consensus        94 ~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~  165 (256)
T cd08530          94 KKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTP  165 (256)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-----CcccccCCc
Confidence              2245899999999999999999999855   999999999999999999999999998766443     122345788


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|++||.+.+..++.++|+||||+++|||++|+.|+...+....  ...                ... ......+...+
T Consensus       166 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~----------------~~~-~~~~~~~~~~~  226 (256)
T cd08530         166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYK----------------VQR-GKYPPIPPIYS  226 (256)
T ss_pred             cccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----------------Hhc-CCCCCCchhhC
Confidence            99999999988899999999999999999999999864332211  000                000 11112223455


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+++.+||..+|++||++.|++++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         227 QDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            668999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=1e-31  Score=271.65  Aligned_cols=227  Identities=27%  Similarity=0.336  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  ++..+|+|.+..          .+.+|++++++++||||+++++.+.+++..++|+||+.+++|.+++..
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   93 (258)
T cd05578          14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ   93 (258)
T ss_pred             ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh
Confidence            79999998  588999998853          245789999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......    ......++..
T Consensus        94 ~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~  164 (258)
T cd05578          94 K--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGTPG  164 (258)
T ss_pred             c--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc----cccccCCChh
Confidence            4  34899999999999999999999854   9999999999999999999999999987654332    1223467889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++|+||||+++|+|++|+.|+.........   ...             ..... .....+...+.
T Consensus       165 y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~-------------~~~~~-~~~~~~~~~~~  227 (258)
T cd05578         165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIR-------------AKQET-ADVLYPATWST  227 (258)
T ss_pred             hcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHH-------------HHhcc-ccccCcccCcH
Confidence            99999998888999999999999999999999998643321100   000             00000 11122333456


Q ss_pred             HHHHHHHHhhhcCCCCCCCH--HHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAM--DKIAQ  614 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~--~evl~  614 (635)
                      .+.+++.+||+.||.+||++  +|+++
T Consensus       228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         228 EAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             HHHHHHHHHccCChhHcCCccHHHHhc
Confidence            78999999999999999999  66653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-31  Score=282.46  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=185.5

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecC-----CeeE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNG-----GNWY  412 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~  412 (635)
                      ++|.....+|    |.||+|+.  ++..||||++..        .+.+|+.++++++|+||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            3444444444    89999987  688999998753        245699999999999999999987644     3579


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +++||+.+ +|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999964 777777442   3899999999999999999999855   9999999999999999999999999987654


Q ss_pred             ccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...  ....+...+..... +..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~-~~~  234 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQ-EDL  234 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCH-HHH
Confidence            32221112233568899999998654 568899999999999999999999885432211  11111111111111 111


Q ss_pred             hhhcCCcC---------CCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHh
Q 042486          572 RHLMDPSM---------QGNY-----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS--ISRFLN  621 (635)
Q Consensus       572 ~~~~d~~~---------~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~  621 (635)
                      ..+.+...         ....     .+..+..+.+++.+||+.||++||++.|++++  ++.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            11111000         0000     01224558899999999999999999999998  555543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=7.4e-31  Score=268.70  Aligned_cols=241  Identities=24%  Similarity=0.347  Sum_probs=177.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhc-cCCcccEEEEEecC--CeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKIN-HSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.+|+|+++..        ..+|+..+.++. |+|++++++++.++  +..++||||++ ++|.+++.
T Consensus        13 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~   91 (282)
T cd07831          13 SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIK   91 (282)
T ss_pred             ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHH
Confidence            89999987  6889999988653        135888888885 99999999999987  88999999996 58888875


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||+++.......    .....++.
T Consensus        92 ~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~----~~~~~~~~  162 (282)
T cd07831          92 GRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP----YTEYISTR  162 (282)
T ss_pred             hcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC----cCCCCCCc
Confidence            433 34899999999999999999999854   999999999999999 9999999999976543221    11245788


Q ss_pred             CccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh--------cCCcC
Q 042486          509 GYMAPEYLE-NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL--------MDPSM  579 (635)
Q Consensus       509 ~y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~--------~d~~~  579 (635)
                      .|+|||.+. ++.++.++|||||||++|||++|+.||...+..+  .............. +.....        ..+..
T Consensus       163 ~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07831         163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDA-EVLKKFRKSRHMNYNFPSK  239 (282)
T ss_pred             ccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCH-HHHHhhcccccccccCccc
Confidence            999999765 4557889999999999999999999886543221  11111111111110 000000        00000


Q ss_pred             CC----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QG----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..    ......+..+.+++.+||+.||++||++++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00    0012345679999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=255.03  Aligned_cols=230  Identities=20%  Similarity=0.348  Sum_probs=175.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccChH--------HHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDAS--------DQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~~--------~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+.+.  +|...|||.+++.-.        ..++++.+- ..|+||+.+|+|..+...++.||.|. ..++.++.+-
T Consensus       106 G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkri  184 (391)
T KOG0983|consen  106 GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRI  184 (391)
T ss_pred             cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHh
Confidence            89999998  679999999976422        223333333 37999999999999999999999884 3555555443


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . +++++...-++...+.+||.||.+  ..+|+|||+||+|||+|+.|.+||||||.+-.......    .....|.+.|
T Consensus       185 k-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA----htrsAGC~~Y  257 (391)
T KOG0983|consen  185 K-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA----HTRSAGCAAY  257 (391)
T ss_pred             c-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc----cccccCCccc
Confidence            3 348888888999999999999987  35699999999999999999999999999875543321    2335788999


Q ss_pred             cCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          511 MAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       511 ~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||||.+.   ...|+.++||||||+.++||.||+.|+...+.+-..+...++..              .|.+.+.  ...
T Consensus       258 MaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--------------PP~L~~~--~gF  321 (391)
T KOG0983|consen  258 MAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--------------PPLLPGH--MGF  321 (391)
T ss_pred             cCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--------------CCCCCcc--cCc
Confidence            9999986   45789999999999999999999999876444433333322210              0111111  114


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++..||..|+.+||...++++|
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            5668999999999999999999999876

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=4.3e-31  Score=274.73  Aligned_cols=244  Identities=28%  Similarity=0.359  Sum_probs=178.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.||+|.++.+         ..+|+.++++++|+||+++++++.+.  +..++||||+.+ +|.+++.
T Consensus        21 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~   99 (309)
T cd07845          21 GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLD   99 (309)
T ss_pred             EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHH
Confidence            89999988  6889999988532         34799999999999999999998754  468999999964 8888886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........   .....++.
T Consensus       100 ~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~  172 (309)
T cd07845         100 NMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP---MTPKVVTL  172 (309)
T ss_pred             hcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC---CCcccccc
Confidence            433 34899999999999999999999955   999999999999999999999999998765432211   12234577


Q ss_pred             CccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch--hhhhh------hcCCcC
Q 042486          509 GYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE--ESLRH------LMDPSM  579 (635)
Q Consensus       509 ~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~l~~------~~d~~~  579 (635)
                      .|+|||.+.+ ..++.++||||||+++|||++|+.||...+... .+.... .........  ..+..      +..+..
T Consensus       173 ~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (309)
T cd07845         173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-QLLGTPNESIWPGFSDLPLVGKFTLPKQ  250 (309)
T ss_pred             cccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCChhhchhhhcccccccccccCC
Confidence            8999998865 557899999999999999999999886433221 111111 111100000  00000      000000


Q ss_pred             CCC----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGN----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...    .....+..+.+++.+||+.||++|||++|++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             CCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000    001124557899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=5e-31  Score=265.48  Aligned_cols=229  Identities=27%  Similarity=0.390  Sum_probs=185.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++..  ++..+|+|++...         +.+|++++++++|+|++++.+.+..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   93 (258)
T cd08215          14 GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQ   93 (258)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHh
Confidence            89999998  4889999998642         457899999999999999999999999999999999999999999654


Q ss_pred             C--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          431 G--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       431 ~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .  ...+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   .......+++
T Consensus        94 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  167 (258)
T cd08215          94 KKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---DLAKTVVGTP  167 (258)
T ss_pred             hccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc---ceecceeeee
Confidence            2  355999999999999999999999854   9999999999999999999999999987654432   1223356888


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||.+.+..++.++|+||+|+++++|++|+.|+...+...                  ......... ....+...+
T Consensus       168 ~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------------------~~~~~~~~~-~~~~~~~~~  228 (258)
T cd08215         168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------------------LALKILKGQ-YPPIPSQYS  228 (258)
T ss_pred             cccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------------------HHHHHhcCC-CCCCCCCCC
Confidence            9999999988889999999999999999999999875432111                  000111110 111223345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+++.+||..+|++||++.|++++
T Consensus       229 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         229 SELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=3.7e-31  Score=280.63  Aligned_cols=240  Identities=27%  Similarity=0.327  Sum_probs=178.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~  424 (635)
                      |.||+++.  +++.||||.+..         .+.+|+.++++++|+||+++++++...      ...|+||||+. ++|.
T Consensus        30 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  108 (353)
T cd07850          30 GIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLC  108 (353)
T ss_pred             EEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHH
Confidence            89999987  788999998853         234699999999999999999998643      34699999995 5888


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++...    +++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......    .....
T Consensus       109 ~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~~~  177 (353)
T cd07850         109 QVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPY  177 (353)
T ss_pred             HHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC----CCCCC
Confidence            877532    788999999999999999999854   9999999999999999999999999997654321    12234


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-----------------
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-----------------  567 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----------------  567 (635)
                      .++..|+|||.+.+..++.++|||||||++|+|++|+.||...+... ........ +.....                 
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  255 (353)
T cd07850         178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQ-LGTPSDEFMSRLQPTVRNYVENR  255 (353)
T ss_pred             cccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHh-cCCCCHHHHHHhhhhhhHHhhcC
Confidence            57889999999999899999999999999999999999986443211 11111110 000000                 


Q ss_pred             ----hhhhhhhcC----CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 ----EESLRHLMD----PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ----~~~l~~~~d----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ...+.....    +......+...+..+.+++.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         256 PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000001110    111111122345568899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=268.15  Aligned_cols=244  Identities=26%  Similarity=0.374  Sum_probs=180.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhh---ccCCcccEEEEEecCCe-----eEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKI---NHSSLIRLLGICFNGGN-----WYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-----~~lV~E~~~~gs  422 (635)
                      |.||+|+.  ++..+|+|+++.         .+.+|+.+++++   +|+|++++++++...+.     .+++|||+. ++
T Consensus        13 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~   91 (287)
T cd07838          13 GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QD   91 (287)
T ss_pred             eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cC
Confidence            89999998  478999999863         234677777666   59999999999987766     899999996 48


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeec
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      |.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........    ..
T Consensus        92 l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~----~~  164 (287)
T cd07838          92 LATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LT  164 (287)
T ss_pred             HHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc----cc
Confidence            988886544445899999999999999999999854   99999999999999999999999999876543221    12


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc---------hhhhhh
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG---------EESLRH  573 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---------~~~l~~  573 (635)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|+.|+......+ .+.............         ......
T Consensus       165 ~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T cd07838         165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVSLPRSSFPS  243 (287)
T ss_pred             cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCcccchhhccc
Confidence            2357888999999998889999999999999999999988876433221 111111111000000         000000


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...... ..........+.+++.+||+.||++||+++|++.+
T Consensus       244 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         244 YTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            000000 11112345667899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=8.2e-31  Score=272.19  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=176.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCC--------eeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGG--------NWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~~~lV~E~~~~gs  422 (635)
                      |.||+++.  +++.||||.+..+         +.+|++++++++||||+++++++...+        ..++||||+.+ +
T Consensus        26 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~  104 (310)
T cd07865          26 GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-D  104 (310)
T ss_pred             EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-C
Confidence            89999987  6889999987432         346999999999999999999987543        35999999964 7


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-eee
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-ALT  501 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  501 (635)
                      |.+++.... ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......... ...
T Consensus       105 l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  180 (310)
T cd07865         105 LAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY  180 (310)
T ss_pred             HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCc
Confidence            888775443 24899999999999999999999854   9999999999999999999999999997654322110 111


Q ss_pred             cccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc--------cCCchhhhh
Q 042486          502 SHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH--------KEDGEESLR  572 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--------~~~~~~~l~  572 (635)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......  ....+.....        .........
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (310)
T cd07865         181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGSITPEVWPGVDKLELFK  258 (310)
T ss_pred             cCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhcccccchhhhh
Confidence            234577889999988654 46889999999999999999998876443221  1111111100        000000000


Q ss_pred             hhcCCcCC-----C-CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMDPSMQ-----G-NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~-----~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.-.     . ..+......+.+++.+||..||.+||+++|++++
T Consensus       259 ~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000000     0 0000123446799999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=7.9e-31  Score=272.70  Aligned_cols=226  Identities=26%  Similarity=0.379  Sum_probs=177.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  ++..+|+|.+..          ++.+|++++++++|+|++++++++...+..++||||+. |+|.+++..
T Consensus        29 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~  107 (308)
T cd06634          29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV  107 (308)
T ss_pred             EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH
Confidence            89999987  678999998742          24578999999999999999999999999999999996 688777743


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......       ....++..
T Consensus       108 ~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~  176 (308)
T cd06634         108 HK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGTPY  176 (308)
T ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-------ccccCCcc
Confidence            33 34899999999999999999999854   999999999999999999999999998754322       22457889


Q ss_pred             ccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||.+.   .+.++.++|||||||++|+|++|+.|+........ .....                 ........+..
T Consensus       177 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~-----------------~~~~~~~~~~~  238 (308)
T cd06634         177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA-----------------QNESPALQSGH  238 (308)
T ss_pred             ccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHh-----------------hcCCCCcCccc
Confidence            99999874   35678899999999999999999988753221110 00110                 00000111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      .+..+.+++.+||+.+|++||++++++++-.
T Consensus       239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             ccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            4456899999999999999999999998744

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1.4e-30  Score=271.50  Aligned_cols=224  Identities=27%  Similarity=0.386  Sum_probs=176.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.|++|++..          ++.+|++++++++|+|++++++++.++...++||||+. |+|.+++..
T Consensus        35 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~  113 (313)
T cd06633          35 GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV  113 (313)
T ss_pred             eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Confidence            89999987  688999998752          24578999999999999999999999999999999995 578777754


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......       ....++..
T Consensus       114 ~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-------~~~~~~~~  182 (313)
T cd06633         114 HK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-------NSFVGTPY  182 (313)
T ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-------CCcccccc
Confidence            33 34899999999999999999999854   999999999999999999999999998643221       23468889


Q ss_pred             ccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||++.   .+.++.++||||||+++|||++|..|+...+..... ....                 ...........
T Consensus       183 y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~-----------------~~~~~~~~~~~  244 (313)
T cd06633         183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIA-----------------QNDSPTLQSNE  244 (313)
T ss_pred             ccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH-----------------hcCCCCCCccc
Confidence            99999984   456888999999999999999999987543221111 0000                 00000011112


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++.+||+.+|.+||++.+++.+
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            33458899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=9.7e-31  Score=268.23  Aligned_cols=245  Identities=28%  Similarity=0.415  Sum_probs=180.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.  +++.+|+|++...         +.+|++++++++|+|++++++++.+.  +..++|+||+++ +|.+++.
T Consensus        13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   91 (287)
T cd07840          13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD   91 (287)
T ss_pred             eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHh
Confidence            89999988  5789999998643         45799999999999999999999987  789999999975 8888886


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........  .......++.
T Consensus        92 ~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~  165 (287)
T cd07840          92 SPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--ADYTNRVITL  165 (287)
T ss_pred             ccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--cccccccccc
Confidence            543 34899999999999999999999854   99999999999999999999999999986644321  1112245678


Q ss_pred             CccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch--hhhhh---h--cCC---
Q 042486          509 GYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE--ESLRH---L--MDP---  577 (635)
Q Consensus       509 ~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~l~~---~--~d~---  577 (635)
                      .|+|||.+.+ ..++.++||||||+++|||++|+.|+........ + .............  .....   .  ..+   
T Consensus       166 ~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T cd07840         166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-L-EKIFELCGSPTDENWPGVSKLPWFENLKPKKP  243 (287)
T ss_pred             ccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-H-HHHHHHhCCCchhhccccccchhhhhcccccc
Confidence            8999997764 4578999999999999999999998865432211 1 1111100000000  00000   0  000   


Q ss_pred             ---cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 ---SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         .+.......++..+.+++.+||+.+|.+||++++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         244 YKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             chhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               00000111125568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-31  Score=270.41  Aligned_cols=246  Identities=28%  Similarity=0.393  Sum_probs=181.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.  +++.|+||++...        ..+|+..+++++ |+|++++++++.+++..++||||+ +|+|.+++...
T Consensus        13 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~   91 (283)
T cd07830          13 GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR   91 (283)
T ss_pred             eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence            89999998  5789999988653        235888999998 999999999999999999999999 88999988665


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........    .....++..|
T Consensus        92 ~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~  164 (283)
T cd07830          92 KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWY  164 (283)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC----cCCCCCcccc
Confidence            4445899999999999999999999854   99999999999999999999999999875543221    1224578899


Q ss_pred             cCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCCc-hhhhhhhcCCcCCC-----
Q 042486          511 MAPEYLE-NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKEDG-EESLRHLMDPSMQG-----  581 (635)
Q Consensus       511 ~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~-~~~l~~~~d~~~~~-----  581 (635)
                      +|||.+. ...++.++|+||||++++||++|+.||.........  .............. ...+...++.....     
T Consensus       165 ~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T cd07830         165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTS  244 (283)
T ss_pred             cCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccccc
Confidence            9999875 455789999999999999999999887544322211  01111110000000 00000001100000     


Q ss_pred             --CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 --NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .........+.+++++||+.||++||+++|++.+
T Consensus       245 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         245 LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             HHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence              0011114568999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1e-30  Score=267.75  Aligned_cols=227  Identities=22%  Similarity=0.326  Sum_probs=175.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHH---HHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIK---LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +++.||+|.+...          +.+|..   .++..+|++|+++.+++.+++..++||||+.+|+|.++
T Consensus         8 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~   87 (278)
T cd05606           8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH   87 (278)
T ss_pred             eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHH
Confidence            89999887  6789999987532          123333   34445799999999999999999999999999999998


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......     .....|
T Consensus        88 l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~  157 (278)
T cd05606          88 LSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVG  157 (278)
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-----CcCcCC
Confidence            86543  4899999999999999999999854   9999999999999999999999999987543221     123468


Q ss_pred             CCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +..|+|||.+.++ .++.++||||||+++|||++|+.||.............             ......    ...+.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~~----~~~~~  220 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------MTLTMA----VELPD  220 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-------------HhhccC----CCCCC
Confidence            9999999998754 58899999999999999999999985432111100000             000011    12223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ..+..+.+++.+||..+|.+||     ++.|++++
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            3356689999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.3e-32  Score=261.60  Aligned_cols=259  Identities=25%  Similarity=0.297  Sum_probs=187.9

Q ss_pred             CCCCCccc----ceEEEeee----C--CcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec-CCeeEE
Q 042486          354 FNPSCWIK----GSVYRGKI----G--GDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN-GGNWYL  413 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~----~--~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l  413 (635)
                      |...+.||    |.|||++.    +  ...+|||+++.+         .-+|+.+++.++|+|++.|..++.. +...+|
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            44444454    89999965    2  237899999765         4589999999999999999999987 778899


Q ss_pred             EeecccCCCcchhhcc---cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC----CcEEEeeec
Q 042486          414 VYENAVNGSLSVWIND---KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD----FRAKIANFA  486 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg  486 (635)
                      ++||++. +|.+.++-   ...+.++...+..|+.||+.|+.|||+..   |+||||||.|||+..+    |++||+|||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999987 88888732   23356899999999999999999999955   9999999999999777    999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchh-------hHHHHhh
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN-------MLLVDVL  558 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~-------~~l~~~~  558 (635)
                      +++.....-.........+-|..|+|||.+.+ ..|+++.||||.||++.||+|-.+.|...+...       .+..+.+
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            99987665444444456788999999999886 568999999999999999999987776543321       1111111


Q ss_pred             hcccccCCc--hhhhhhhcCC---------cCCCCC--ChH------HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          559 NPVLHKEDG--EESLRHLMDP---------SMQGNY--PPV------TAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       559 ~~~~~~~~~--~~~l~~~~d~---------~~~~~~--~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      -.++.....  ...+.++-+-         ....+.  ...      -+..-.+|+..+|..||.+|.|+++.+++.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            111111110  0111111000         000000  000      011257899999999999999999998873

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=258.81  Aligned_cols=233  Identities=21%  Similarity=0.274  Sum_probs=185.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc--ChHHHHHHHhhh-ccCCcccEEEEEec----CCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--DASDQIKLLNKI-NHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.|-.+..  +++.+|+|.+.+  ..++|+++.-+. .|+|||.+++++.+    ...+.+|||.|+||.|...+++++.
T Consensus        76 GkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~  155 (400)
T KOG0604|consen   76 GKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD  155 (400)
T ss_pred             CceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc
Confidence            77776654  788999999865  477899876655 69999999999874    3457899999999999999988888


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..+++.+.-.|++||+.|+.|||+..   |.||||||+|+|...   |-.+||+|||+|+......    .....+.|+.
T Consensus       156 ~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~----~L~TPc~TPy  228 (400)
T KOG0604|consen  156 QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG----DLMTPCFTPY  228 (400)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCc----cccCCccccc
Confidence            88999999999999999999999965   999999999999954   5679999999998655321    2344688999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC--CCCCChHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM--QGNYPPVT  587 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~--~~~~~~~~  587 (635)
                      |.|||++...+|+...|+||+||++|-|++|.+||......-          +. .   ..-+++.....  ...-....
T Consensus       229 YvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------is-p---gMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------IS-P---GMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             ccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CC-h---hHHhHhhccCccCCChhHhHH
Confidence            999999999999999999999999999999999986433210          00 0   11111222111  11122345


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +....++|+.+|..+|.+|.|++|++++
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            6778999999999999999999999987

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.9e-31  Score=278.41  Aligned_cols=252  Identities=27%  Similarity=0.388  Sum_probs=180.7

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC------Ce
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG------GN  410 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~  410 (635)
                      ++|.....||    |.||+|+.  ++..||||++..         .+.+|+.++++++|+||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4454444444    89999986  688999998853         245799999999999999999998754      34


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      .++|+||+.. +|..++.    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             EEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            6999999864 6766652    23899999999999999999999855   99999999999999999999999999875


Q ss_pred             ccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchh
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE  569 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (635)
                      .....      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+... .+..... ..... ...
T Consensus       167 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~-~~~  237 (342)
T cd07879         167 ADAEM------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK-VTGVP-GPE  237 (342)
T ss_pred             CCCCC------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCCC-CHH
Confidence            43221      22456888999999876 468899999999999999999999986433211 1111111 00000 000


Q ss_pred             hhhhhcC----------CcC-CCCC---ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHH
Q 042486          570 SLRHLMD----------PSM-QGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS--ISRFL  620 (635)
Q Consensus       570 ~l~~~~d----------~~~-~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  620 (635)
                      ....+.+          +.. ....   .+..+..+.+++.+||+.||++||+++|++.+  ++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0000000          000 0000   01123457899999999999999999999976  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=5.5e-31  Score=270.90  Aligned_cols=244  Identities=20%  Similarity=0.339  Sum_probs=190.1

Q ss_pred             ceEEEeee-----CCcEEEEEEecc-----------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYG-----------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~-----------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      |.||+++.     +++.||||.++.           .+.+|++++.++ +|+||+++++.+..++..++||||+++|+|.
T Consensus        14 ~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (288)
T cd05583          14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF   93 (288)
T ss_pred             ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHH
Confidence            78999875     467899998853           245789999999 6999999999999899999999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++....  .+++..+..++.|++.+|.|||+.   +++||||+|+||+++.++.++|+|||+++.......  ......
T Consensus        94 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  166 (288)
T cd05583          94 THLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE--ERAYSF  166 (288)
T ss_pred             HHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccc--cccccc
Confidence            9986543  388999999999999999999984   499999999999999999999999999876543221  112234


Q ss_pred             ccCCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          505 VGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      .++..|+|||.+.+..  .+.++||||||+++|||++|..|+....... ...+.             .......  ...
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~-------------~~~~~~~--~~~  230 (288)
T cd05583         167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEI-------------SRRILKS--KPP  230 (288)
T ss_pred             cCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHH-------------HHHHHcc--CCC
Confidence            6788999999987654  7889999999999999999999975322110 00000             0111110  012


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                      .+...+..+.+++.+||+.||++|||+.++.+.|+...-...+|+.
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~  276 (288)
T cd05583         231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD  276 (288)
T ss_pred             CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence            2333445689999999999999999999998888888778888864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=7.1e-31  Score=268.81  Aligned_cols=243  Identities=30%  Similarity=0.404  Sum_probs=182.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.+++|++...         +.+|++++++++|+||+++++++..++..++|+||+++ +|.+++...
T Consensus        13 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~   91 (283)
T cd05118          13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR   91 (283)
T ss_pred             ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh
Confidence            79999987  6889999987542         45789999999999999999999999999999999975 888888654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+........   ......++..|
T Consensus        92 ~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~  164 (283)
T cd05118          92 Q-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWY  164 (283)
T ss_pred             c-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc---cccCccCcccc
Confidence            3 34899999999999999999999855   99999999999999999999999999876544321   11224577889


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC---------Cc--
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD---------PS--  578 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d---------~~--  578 (635)
                      +|||.+.+. ..+.++|+||||+++|+|++|+.||...+..+. +...... +.... .+....+.+         +.  
T Consensus       165 ~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05118         165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRT-LGTPD-PEVWPKFTSLARNYKFSFPKKA  241 (283)
T ss_pred             cCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH-cCCCc-hHhcccchhhhhhhhhhhcccc
Confidence            999998776 789999999999999999999988754433221 1111110 00000 000000000         00  


Q ss_pred             --CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 --MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .........+..+.+++.+||+.||.+||++.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             ccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence              0001122345678999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.1e-30  Score=270.00  Aligned_cols=230  Identities=20%  Similarity=0.330  Sum_probs=174.2

Q ss_pred             ceEEEeeeC--CcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIG--GDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~--~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++..  ++.||||.++..        +..|+.++.+. .|+||+++++++.++...|++|||+. ++|.+++...
T Consensus        29 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~  107 (296)
T cd06618          29 GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI  107 (296)
T ss_pred             eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh
Confidence            899999984  899999998642        23466666666 49999999999999999999999985 4777766443


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..+++..+..++.|++.||.|||+.  .+++||||+|+||++++++.+||+|||++........    .....++..|
T Consensus       108 ~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~----~~~~~~~~~y  180 (296)
T cd06618         108 Q-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA----KTRSAGCAAY  180 (296)
T ss_pred             c-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc----ccCCCCCccc
Confidence            2 2589999999999999999999972  3599999999999999999999999999875433211    1223577899


Q ss_pred             cCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          511 MAPEYLENGL----VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       511 ~aPE~~~~~~----~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      +|||.+....    ++.++||||||+++|||++|+.||.....+...+.......              .+..  .....
T Consensus       181 ~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------------~~~~--~~~~~  244 (296)
T cd06618         181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--------------PPSL--PPNEG  244 (296)
T ss_pred             cCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--------------CCCC--CCCCC
Confidence            9999987543    78899999999999999999999854322211111111100              0000  00112


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++.+||+.||++||++++++++
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            34558999999999999999999999877

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.4e-30  Score=268.82  Aligned_cols=228  Identities=21%  Similarity=0.375  Sum_probs=181.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  ++..||||++..       .+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++...  
T Consensus        34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  111 (292)
T cd06657          34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--  111 (292)
T ss_pred             eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--
Confidence            89999987  688999998743       2557899999999999999999999999999999999999999987543  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........   ......++..|+|
T Consensus       112 -~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~  184 (292)
T cd06657         112 -RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMA  184 (292)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc---cccccccCccccC
Confidence             3799999999999999999999854   99999999999999999999999998875433211   1123467889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||.+.+..++.++|+||||+++|+|++|..|+........  ....             .....+.+.  .....+..+.
T Consensus       185 pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~~~-------------~~~~~~~~~--~~~~~~~~l~  247 (292)
T cd06657         185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMI-------------RDNLPPKLK--NLHKVSPSLK  247 (292)
T ss_pred             HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-------------HhhCCcccC--CcccCCHHHH
Confidence            9999888889999999999999999999999754322110  0000             000111110  0112334578


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +++.+||+.||.+||++.+++++
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcC
Confidence            99999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=260.71  Aligned_cols=227  Identities=28%  Similarity=0.450  Sum_probs=183.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.+++|.+...         +.+|++++++++|+|++++++++.+++..+++|||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   93 (254)
T cd06627          14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF   93 (254)
T ss_pred             eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc
Confidence            89999987  6789999988543         467899999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                        ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||.+.........   .....++..|
T Consensus        94 --~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~y  165 (254)
T cd06627          94 --GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASVVGTPYW  165 (254)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc---ccccccchhh
Confidence              34899999999999999999999854   999999999999999999999999999866543321   2234678899


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      +|||...+...+.++||||||+++++|++|+.|+....... .......                  ......+...+..
T Consensus       166 ~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-~~~~~~~------------------~~~~~~~~~~~~~  226 (254)
T cd06627         166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-ALFRIVQ------------------DDHPPLPEGISPE  226 (254)
T ss_pred             cCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHhc------------------cCCCCCCCCCCHH
Confidence            99999988778999999999999999999999875332111 1111100                  0001122233456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+++.+||..+|++||++.+++.+
T Consensus       227 ~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         227 LKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HHHHHHHHHhCChhhCcCHHHHhcC
Confidence            8999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=1.4e-30  Score=274.38  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=179.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhh-ccCCcccEEEEEecC--CeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKI-NHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|..  ++..+|+|++...         +.+|+.+++++ +|+||+++++++...  ...++||||++ ++|.+++
T Consensus        21 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~   99 (337)
T cd07852          21 GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVI   99 (337)
T ss_pred             eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHH
Confidence            89999987  6789999988432         44699999999 999999999998643  36799999997 5998888


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc--eeeecccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE--FALTSHIV  505 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~  505 (635)
                      ...   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........  ........
T Consensus       100 ~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~  173 (337)
T cd07852         100 RAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV  173 (337)
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccc
Confidence            654   489999999999999999999985   4999999999999999999999999999865432211  01223356


Q ss_pred             cCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccc-------cCCchhhhhhhc
Q 042486          506 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLH-------KEDGEESLRHLM  575 (635)
Q Consensus       506 gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~-------~~~~~~~l~~~~  575 (635)
                      ++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........  ..........       .......+....
T Consensus       174 ~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (337)
T cd07852         174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP  253 (337)
T ss_pred             ccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcc
Confidence            8899999998754 55788999999999999999999988643322110  0000000000       000000000000


Q ss_pred             CCcCC--CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          576 DPSMQ--GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       576 d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....  .......+..+.+++.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         254 SRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             cccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000  00011135668999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=279.41  Aligned_cols=230  Identities=23%  Similarity=0.369  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.|||++.  .+-..|-|.+.-       ++.-||+||..+.||+||+|++.|..++.++|+.|||.||-.+..+-.-+ 
T Consensus        46 GKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~-  124 (1187)
T KOG0579|consen   46 GKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG-  124 (1187)
T ss_pred             hhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc-
Confidence            89999987  444566777642       45568999999999999999999999999999999999999988885543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..|.+.++..+++++++||.|||+   ++|||||||..|||++-+|.++|+|||.+......   ......+.||+.|||
T Consensus       125 r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t---~qkRDsFIGTPYWMA  198 (1187)
T KOG0579|consen  125 RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST---RQKRDSFIGTPYWMA  198 (1187)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH---HhhhccccCCccccc
Confidence            349999999999999999999998   55999999999999999999999999997643322   123345789999999


Q ss_pred             ccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          513 PEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       513 PE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||+..     ...|+.++||||||++|.||..+.+|...-+.     ..++...-.          --.|.  -..|...
T Consensus       199 PEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVllKiaK----------SePPT--LlqPS~W  261 (1187)
T KOG0579|consen  199 PEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAK----------SEPPT--LLQPSHW  261 (1187)
T ss_pred             chheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHHHHHhh----------cCCCc--ccCcchh
Confidence            99874     56789999999999999999999987532111     111111100          00111  1235667


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+.+++++||..||..||++.++++|
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            7789999999999999999999999875

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=1.3e-30  Score=269.77  Aligned_cols=243  Identities=26%  Similarity=0.363  Sum_probs=176.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC----------eeEEEeecccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG----------NWYLVYENAVN  420 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~----------~~~lV~E~~~~  420 (635)
                      |.||+|..  +++.||+|.++.         .+.+|++++++++||||+++++++.+..          ..++|+||+++
T Consensus        21 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T cd07864          21 GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH  100 (302)
T ss_pred             EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc
Confidence            89999998  678999998853         2357999999999999999999987654          78999999976


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                       +|...+.... ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++.........  .
T Consensus       101 -~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~--~  173 (302)
T cd07864         101 -DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR--P  173 (302)
T ss_pred             -cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCccc--c
Confidence             6767665432 3489999999999999999999985   4999999999999999999999999998765433211  1


Q ss_pred             ecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh-----
Q 042486          501 TSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-----  574 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-----  574 (635)
                      .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...+... .+... ........ ......+     
T Consensus       174 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~-~~~~~~~~-~~~~~~~~~~~~  250 (302)
T cd07864         174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELI-SRLCGSPC-PAVWPDVIKLPY  250 (302)
T ss_pred             cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HHHhCCCC-hhhccccccccc
Confidence            122345778999998764 457889999999999999999998886433211 11111 11100000 0000000     


Q ss_pred             ---cC------CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 ---MD------PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ---~d------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         .+      ...... ....+..+.+++.+||+.||.+||++++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         251 FNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             ccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00      000000 11124568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=5.4e-31  Score=269.12  Aligned_cols=229  Identities=28%  Similarity=0.397  Sum_probs=184.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  ++..||+|.+..          .+.+|.+++++++ |+||+++++++.+++..++||||+++++|.+++.
T Consensus        15 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   94 (280)
T cd05581          15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR   94 (280)
T ss_pred             eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH
Confidence            89999988  788999998854          2456889999998 9999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-----------
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-----------  497 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-----------  497 (635)
                      ...  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........           
T Consensus        95 ~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  169 (280)
T cd05581          95 KYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID  169 (280)
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccc
Confidence            653  4999999999999999999999855   999999999999999999999999998765432210           


Q ss_pred             ------eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          498 ------FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       498 ------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                            ........++..|+|||.+....++.++|+||||++++++++|+.|+.......                  .+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------------~~  231 (280)
T cd05581         170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------------------TF  231 (280)
T ss_pred             ccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------------------HH
Confidence                  012233467889999999988889999999999999999999999976433111                  01


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM----DKIAQS  615 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~  615 (635)
                      .....  .....+...+..+.+++.+||+.||.+||++    ++++++
T Consensus       232 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 QKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            11111  1112233345568999999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=8e-31  Score=260.30  Aligned_cols=237  Identities=24%  Similarity=0.361  Sum_probs=185.8

Q ss_pred             ceEEEeee-------CCcEEEEEEeccCh--------HHHHHHHhhhccCCcccEEEEEecC-CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGDA--------SDQIKLLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~~--------~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|.|       +.+.|-+|.++...        ..|--+|..+.|||+..+.+++.++ ...+.+|.++.-|+|..
T Consensus       298 Gri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~  377 (563)
T KOG1024|consen  298 GRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKS  377 (563)
T ss_pred             hheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHH
Confidence            89999966       23457777776643        3466667777899999999999865 45689999999999999


Q ss_pred             hhcc------cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCcee
Q 042486          426 WIND------KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       426 ~l~~------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                      +|..      ...+.++..+...++.|++.|++|||+++   +||.||..+|++||+..++||+|=.+++..-+.+. .+
T Consensus       378 FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DY-hc  453 (563)
T KOG1024|consen  378 FLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDY-HC  453 (563)
T ss_pred             HHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccc-cc
Confidence            9962      22345788889999999999999999966   99999999999999999999999999986544332 12


Q ss_pred             eecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      ..........||+||.+.+..++..+|||||||+||||+| |+.|+..-+..                   ....++...
T Consensus       454 LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------------------Em~~ylkdG  514 (563)
T KOG1024|consen  454 LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------------------EMEHYLKDG  514 (563)
T ss_pred             cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------------------HHHHHHhcc
Confidence            2223345568999999999999999999999999999998 66665422221                   122222233


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      .+-..|..++++|..++.-||..+|++||++++++.-|+++..
T Consensus       515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            3344566778889999999999999999999999999998754

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=274.14  Aligned_cols=250  Identities=28%  Similarity=0.343  Sum_probs=185.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC-----eeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.  ++..+|||++..         .+.+|+.++++++|+||+++++++...+     ..|++|||++ ++|.+
T Consensus        14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (330)
T cd07834          14 GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHK   92 (330)
T ss_pred             eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHH
Confidence            89999997  578999998754         3557999999999999999999998765     7899999997 48988


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++.................
T Consensus        93 ~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~  167 (330)
T cd07834          93 VIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV  167 (330)
T ss_pred             HHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccc
Confidence            886543  4999999999999999999999855   99999999999999999999999999986554321111123346


Q ss_pred             cCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------chhhhhh
Q 042486          506 GTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------GEESLRH  573 (635)
Q Consensus       506 gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~~  573 (635)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ .... ........           ....+..
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (330)
T cd07834         168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLI-VEVLGTPSEEDLKFITSEKARNYLKS  245 (330)
T ss_pred             cccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHH-HHhcCCCChhHhhhccccchhhHHhh
Confidence            78899999999877 789999999999999999999999865433221 1111 11110000           0000010


Q ss_pred             hcCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHH
Q 042486          574 LMDPSMQ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS--ISRFL  620 (635)
Q Consensus       574 ~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  620 (635)
                      . .....   .......+..+.+++.+||+.||.+||++++++.+  ++.+.
T Consensus       246 ~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         246 L-PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             c-ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            0 00000   00112235568999999999999999999999987  44443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=8.8e-31  Score=275.56  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=179.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec----CCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  ++..||+|++...         +.+|+.+|++++|+||+++++++..    ....++||||+. ++|.++
T Consensus        19 g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   97 (334)
T cd07855          19 GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHI   97 (334)
T ss_pred             eEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHH
Confidence            78999987  6889999988642         3468999999999999999998763    346799999995 689998


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeecccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTSHIV  505 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~  505 (635)
                      +....  .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......... ........
T Consensus        98 ~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  172 (334)
T cd07855          98 IHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV  172 (334)
T ss_pred             hccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccc
Confidence            86543  3899999999999999999999854   999999999999999999999999998755432211 11122346


Q ss_pred             cCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC-------CchhhhhhhcCC
Q 042486          506 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE-------DGEESLRHLMDP  577 (635)
Q Consensus       506 gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-------~~~~~l~~~~d~  577 (635)
                      ++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... + ..+.......       .....+.+..+.
T Consensus       173 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~-~~~~~~~g~~~~~~~~~~~~~~~~~~~~~  250 (334)
T cd07855         173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-L-KLILSVLGSPSEEVLNRIGSDRVRKYIQN  250 (334)
T ss_pred             ccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-H-HHHHHHhCCChhHhhhhhchhhHHHHHhh
Confidence            8889999998765 5688999999999999999999999864332211 0 0000000000       000111111110


Q ss_pred             -cCCCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 -SMQGNY-----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 -~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ......     ....+..+.+++.+||+.||.+||++++++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             000011     12235668999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.8e-30  Score=272.45  Aligned_cols=256  Identities=26%  Similarity=0.341  Sum_probs=184.6

Q ss_pred             HHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec-CCe
Q 042486          347 LQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN-GGN  410 (635)
Q Consensus       347 l~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~  410 (635)
                      +...+++|.....||    |.||++..  +++.||+|++..         .+.+|++++++++||||+++.+++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            344556666555554    89999986  688999998742         35579999999999999999999875 557


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      .++++||+ +++|.+++...   .+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+..
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            89999998 56898887543   3788888899999999999999854   99999999999999999999999999875


Q ss_pred             ccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--hHHHHhhhccc----c
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--MLLVDVLNPVL----H  563 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~----~  563 (635)
                      .....      ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  ..+.+......    .
T Consensus       158 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         158 QDPQM------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cCCCc------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            43211      12356788999998765 568999999999999999999998886433211  01111111000    0


Q ss_pred             cCCchhhhhhhcCCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          564 KEDGEESLRHLMDPSMQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .........-+..-......+     ...+..+.+++.+||+.+|++||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000000011111     1234568999999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=6.1e-31  Score=276.54  Aligned_cols=225  Identities=22%  Similarity=0.361  Sum_probs=184.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      +.|..++.  ++..||||.+.+.         +.+|+++|+.++|||||+++.+......+|+||||+.+|.+.+++...
T Consensus        70 ~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~  149 (596)
T KOG0586|consen   70 AKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH  149 (596)
T ss_pred             EEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc
Confidence            67888876  7899999988653         458999999999999999999999999999999999999999999766


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      +.  +.+.....++.|+..|++|||+..   |+|||||.+||||+.+..+||+|||++......    ......+|++.|
T Consensus       150 gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~----~~lqt~cgsppy  220 (596)
T KOG0586|consen  150 GR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG----LMLQTFCGSPPY  220 (596)
T ss_pred             cc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc----ccccccCCCCCc
Confidence            54  666888889999999999999854   999999999999999999999999999877643    234557899999


Q ss_pred             cCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          511 MAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       511 ~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      .|||++.+..+ .+++|+||+|+++|-|+.|..||+...-.                  +.-++.+-..+  ..+.....
T Consensus       221 AaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------~Lr~rvl~gk~--rIp~~ms~  280 (596)
T KOG0586|consen  221 AAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------ELRPRVLRGKY--RIPFYMSC  280 (596)
T ss_pred             cChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------------------cccchheeeee--cccceeec
Confidence            99999987654 78999999999999999999998632111                  00011111111  12233344


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...++|+++|-.+|.+|++++++.++
T Consensus       281 dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  281 DCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             hhHHHHHHhhccCccccCCHHHhhhh
Confidence            57899999999999999999999876

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=3.1e-30  Score=265.61  Aligned_cols=231  Identities=24%  Similarity=0.359  Sum_probs=178.2

Q ss_pred             ceEEEeee-----CCcEEEEEEecc-----------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYG-----------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~-----------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      |.||+++.     +|..||+|.++.           .+.+|+++++++ +|+||+++++.+..++..++||||+++++|.
T Consensus        14 g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (290)
T cd05613          14 GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELF   93 (290)
T ss_pred             ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHH
Confidence            78999875     678999998853           244689999999 5999999999999888999999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++....  .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++........  ......
T Consensus        94 ~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  166 (290)
T cd05613          94 THLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYSF  166 (290)
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccccc--cccccc
Confidence            9996543  3889999999999999999999854   99999999999999999999999999876533221  112235


Q ss_pred             ccCCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          505 VGTKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       505 ~gt~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      .++..|+|||.+..  ..++.++||||||+++|+|++|+.|+....... ...             +....+...  ...
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~-------------~~~~~~~~~--~~~  230 (290)
T cd05613         167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQA-------------EISRRILKS--EPP  230 (290)
T ss_pred             cCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHH-------------HHHHHhhcc--CCC
Confidence            68889999999875  346789999999999999999999875321110 000             111111111  012


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ++......+.+++.+||+.||++||     ++++++.+
T Consensus       231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            2333455689999999999999997     67777665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=267.32  Aligned_cols=242  Identities=26%  Similarity=0.317  Sum_probs=194.7

Q ss_pred             HHHHhh-cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecC
Q 042486          346 ELQAAT-DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNG  408 (635)
Q Consensus       346 el~~at-~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~  408 (635)
                      |.+..| +.|..-+.+|    |.||-.+.  +|+.+|.|++.+.          ..+|-.+|.+++.+.||.+-..|+..
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            334344 3465555554    78997765  8999999877431          45799999999999999999999999


Q ss_pred             CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCc
Q 042486          409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA  488 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  488 (635)
                      +.+|+|+..|.||+|.-+|...+...+++.....++.+|+.||++||+..   ||.||+||+|||+|+.|+++|+|+|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999997777667999999999999999999999855   999999999999999999999999999


Q ss_pred             ccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       489 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ..+.....    ....+||.+|||||++.++.|+...|.|||||++|||+.|+.||....+..               ..
T Consensus       335 vei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~  395 (591)
T KOG0986|consen  335 VEIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KR  395 (591)
T ss_pred             EecCCCCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hH
Confidence            87765432    233589999999999999999999999999999999999999985432211               11


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD  610 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  610 (635)
                      +.+.+..- .....++...+.+..+|.+..|..||++|.-..
T Consensus       396 eEvdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  396 EEVDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            12221111 112356666777889999999999999996543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.3e-30  Score=274.58  Aligned_cols=251  Identities=28%  Similarity=0.389  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC-----CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG-----GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.  ++..||||++...         +.+|+.++++++|+||+++++++...     ...|+|+||+. ++|.+
T Consensus        19 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~   97 (337)
T cd07858          19 GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQ   97 (337)
T ss_pred             eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHH
Confidence            89999987  6889999987542         34689999999999999999988644     34799999995 68988


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   .......
T Consensus        98 ~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~  169 (337)
T cd07858          98 IIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTEYV  169 (337)
T ss_pred             HHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc---ccccccc
Confidence            886543  3899999999999999999999854   9999999999999999999999999998654322   1122345


Q ss_pred             cCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhh--HHHHhhhcc-------cccCCchhhhhhh-
Q 042486          506 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNPV-------LHKEDGEESLRHL-  574 (635)
Q Consensus       506 gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~--~l~~~~~~~-------~~~~~~~~~l~~~-  574 (635)
                      ++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+....  .........       .......+..... 
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (337)
T cd07858         170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLP  249 (337)
T ss_pred             cccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcC
Confidence            7889999998764 4688999999999999999999998864322110  011111000       0000000111000 


Q ss_pred             --cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHhh
Q 042486          575 --MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS--ISRFLNA  622 (635)
Q Consensus       575 --~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~  622 (635)
                        .++... ......+..+.+++.+||+.||++||+++|++++  ++.+...
T Consensus       250 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         250 YTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             cccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence              000000 0112245568999999999999999999999998  6655443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-30  Score=259.42  Aligned_cols=222  Identities=27%  Similarity=0.395  Sum_probs=180.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.+|+|.+..          .+.+|++++++++|+||+++++.+..++..+++|||+++++|.+++..
T Consensus         7 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~   86 (250)
T cd05123           7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK   86 (250)
T ss_pred             eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh
Confidence            79999988  578999998754          355789999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   .......++..
T Consensus        87 ~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  158 (250)
T cd05123          87 EG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTPE  158 (250)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccCCcCCcc
Confidence            43  389999999999999999999984   49999999999999999999999999987654321   11233567889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |++||...+...+.++|+||||+++|+|++|+.|+...+...  .                ...+...  ....+...+.
T Consensus       159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~----------------~~~~~~~--~~~~~~~~~~  218 (250)
T cd05123         159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--I----------------YEKILKD--PLRFPEFLSP  218 (250)
T ss_pred             ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--H----------------HHHHhcC--CCCCCCCCCH
Confidence            999999988888999999999999999999999985433211  1                1111111  1122333356


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDK  611 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~e  611 (635)
                      .+.+++.+||..||++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            6899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=3.4e-30  Score=267.69  Aligned_cols=249  Identities=27%  Similarity=0.362  Sum_probs=175.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC--------eeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG--------NWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~~~lV~E~~~~gs  422 (635)
                      |.||+++.  +++.+|||++..         .+.+|++++++++|+||+++++++....        ..++|+||+.+ +
T Consensus        22 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~  100 (311)
T cd07866          22 GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-D  100 (311)
T ss_pred             EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-C
Confidence            89999987  678999998742         2467999999999999999999876433        46999999865 6


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce----
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF----  498 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----  498 (635)
                      |...+.... ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||+++.........    
T Consensus       101 l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  176 (311)
T cd07866         101 LSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG  176 (311)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCC
Confidence            777665432 34899999999999999999999855   9999999999999999999999999997554322110    


Q ss_pred             ----eeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhh--HHHHhhhcccccC-Cchhh
Q 042486          499 ----ALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNPVLHKE-DGEES  570 (635)
Q Consensus       499 ----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~-~~~~~  570 (635)
                          .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ............. .....
T Consensus       177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T cd07866         177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS  256 (311)
T ss_pred             cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhh
Confidence                01122356788999998765 4578999999999999999999988864333211  1111100000000 00000


Q ss_pred             hhhhcCCcCCCCCC-------hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          571 LRHLMDPSMQGNYP-------PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       571 l~~~~d~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +....+.......+       ......+.+++.+||+.||++|||+.|++.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         257 LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             cccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            11100000000011       1122458899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.6e-30  Score=270.13  Aligned_cols=245  Identities=26%  Similarity=0.321  Sum_probs=179.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA  418 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~  418 (635)
                      |.||+++.  +++.||||.++.                     .+.+|++++++++|+||+++++++..++..++||||+
T Consensus        23 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  102 (335)
T PTZ00024         23 GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM  102 (335)
T ss_pred             eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecc
Confidence            89999986  688999998753                     2457999999999999999999999999999999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC--
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--  496 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--  496 (635)
                      . |+|.+++....  .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus       103 ~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~  176 (335)
T PTZ00024        103 A-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD  176 (335)
T ss_pred             c-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecccccccc
Confidence            6 68999886533  3899999999999999999999855   99999999999999999999999999876541100  


Q ss_pred             ---------ceeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC
Q 042486          497 ---------EFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED  566 (635)
Q Consensus       497 ---------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  566 (635)
                               .........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..+. +..... ......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~i~~-~~~~~~  254 (335)
T PTZ00024        177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGRIFE-LLGTPN  254 (335)
T ss_pred             cccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCc
Confidence                     00111223467889999998764 468999999999999999999998865443221 111111 010000


Q ss_pred             ch-----hhhh------hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 GE-----ESLR------HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ~~-----~~l~------~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..     ..+.      ....+... ......+..+.+++.+||+.||++||+++|++.+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        255 EDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             hhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            00     0000      00000000 0011224558899999999999999999999975

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=279.87  Aligned_cols=253  Identities=25%  Similarity=0.377  Sum_probs=190.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCC------eeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGG------NWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|+.  +|+.||||.++..        ..+|+++|++++|+|||+++++-....      ...+|||||.+|||..
T Consensus        27 g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~  106 (732)
T KOG4250|consen   27 GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRK  106 (732)
T ss_pred             ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHH
Confidence            89999985  8999999988652        347999999999999999999866443      4689999999999999


Q ss_pred             hhcccC-CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE--CC--CCcEEEeeecCcccccccCCceee
Q 042486          426 WINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL--DT--DFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       426 ~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll--~~--~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      .|.+.. ...|++.+.+.++.+++.||.|||++   +|+||||||.||++  .+  .-..||+|||.|+..+...    .
T Consensus       107 ~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s----~  179 (732)
T KOG4250|consen  107 VLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS----L  179 (732)
T ss_pred             HhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC----e
Confidence            996543 34599999999999999999999984   49999999999998  23  3357999999999776554    3


Q ss_pred             ecccccCCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh----hHHHHhhhcc---c----ccCCch
Q 042486          501 TSHIVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN----MLLVDVLNPV---L----HKEDGE  568 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~----~~l~~~~~~~---~----~~~~~~  568 (635)
                      ....+||..|++||... .+.++...|.|||||++||+.||..||.......    ..+.....+.   .    ..++..
T Consensus       180 ~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgp  259 (732)
T KOG4250|consen  180 FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGP  259 (732)
T ss_pred             eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCc
Confidence            45689999999999998 5889999999999999999999999987644432    1111111100   0    000000


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHhhc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP--AMDKIAQSISRFLNAS  623 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~s  623 (635)
                      -.....+ |. ...........+...+..+|..+|++|.  ...+....+..++...
T Consensus       260 v~~s~~l-P~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  260 VEWSSTL-PQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eeeeccC-CC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            0000000 00 1111233445567788899999999999  8888888888887655

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.1e-30  Score=286.58  Aligned_cols=227  Identities=21%  Similarity=0.296  Sum_probs=160.8

Q ss_pred             hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC---CCCCCHHHHHHHHHHHHhhhcccccCCC
Q 042486          383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG---GKFLDWAQRIQIALDVATGLNYLHSFTN  459 (635)
Q Consensus       383 ~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~  459 (635)
                      +.+|+++|++++|+||+++++++...+..|+|+|++. ++|.+++....   ...........|+.||+.||.|||+.+ 
T Consensus       210 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-  287 (501)
T PHA03210        210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-  287 (501)
T ss_pred             HHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence            5689999999999999999999999999999999985 57777764321   112345667789999999999999854 


Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS  539 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt  539 (635)
                        |+||||||+|||++.++.+||+|||+++.......  .......||..|+|||++.+..++.++|||||||++|||++
T Consensus       288 --IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~  363 (501)
T PHA03210        288 --LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS  363 (501)
T ss_pred             --eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence              99999999999999999999999999986543221  12233579999999999999899999999999999999999


Q ss_pred             CCCCCCCCc--chhhHHHHhhhccc--cc--CCchhhhhhhcCCc-C---CCCCCh-----HHHHHHHHHHHHhhhcCCC
Q 042486          540 GKEAPALYS--EENMLLVDVLNPVL--HK--EDGEESLRHLMDPS-M---QGNYPP-----VTAILVIRLIESCLKKDPS  604 (635)
Q Consensus       540 G~~p~~~~~--~~~~~l~~~~~~~~--~~--~~~~~~l~~~~d~~-~---~~~~~~-----~~~~~l~~li~~cl~~dP~  604 (635)
                      |+.++....  .....+.+.+....  ..  .+....+..+++.. .   ....+.     ..+..+.+++.+||+.||+
T Consensus       364 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~  443 (501)
T PHA03210        364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH  443 (501)
T ss_pred             CCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence            986543221  11122222221110  00  00001111111100 0   000000     1123467889999999999


Q ss_pred             CCCCHHHHHHH
Q 042486          605 GRPAMDKIAQS  615 (635)
Q Consensus       605 ~RPs~~evl~~  615 (635)
                      +|||+.|++.+
T Consensus       444 ~Rpsa~elL~h  454 (501)
T PHA03210        444 LRPGAAELLAL  454 (501)
T ss_pred             cCcCHHHHhhC
Confidence            99999999875

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.3e-30  Score=273.55  Aligned_cols=265  Identities=23%  Similarity=0.291  Sum_probs=190.4

Q ss_pred             ccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEe
Q 042486          342 YTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICF  406 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~  406 (635)
                      ...+++...+++|.....||    |.||++..  ++..||+|++...         +.+|++++++++|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34456677778887666665    79999986  6889999988642         346899999999999999999886


Q ss_pred             cC------CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcE
Q 042486          407 NG------GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA  480 (635)
Q Consensus       407 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~  480 (635)
                      ..      ...+++++++ +++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence            43      3467888876 78998888543   3899999999999999999999855   9999999999999999999


Q ss_pred             EEeeecCcccccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh
Q 042486          481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN  559 (635)
Q Consensus       481 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~  559 (635)
                      ||+|||+++.....      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.....
T Consensus       160 kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~  232 (345)
T cd07877         160 KILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILR  232 (345)
T ss_pred             EEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            99999998754322      122467889999998865 567889999999999999999999885432221 1111111


Q ss_pred             ccc----------ccCCchhhhhhhcCCcCCC---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          560 PVL----------HKEDGEESLRHLMDPSMQG---NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       560 ~~~----------~~~~~~~~l~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ...          .....+..+.. +......   ......+..+.+++.+||+.||.+||++.+++.+  .++..-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~f~~~  306 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQY  306 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHH-hcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC--hhhhhc
Confidence            000          00000000000 0000000   0001124458899999999999999999999987  445443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-30  Score=262.21  Aligned_cols=243  Identities=28%  Similarity=0.392  Sum_probs=181.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.  +++.+|+|.+...         +.+|+.++++++|+|++++++++.+.+..++||||++ ++|.+++...
T Consensus        13 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~   91 (282)
T cd07829          13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR   91 (282)
T ss_pred             ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh
Confidence            89999998  5889999988642         3568999999999999999999999999999999997 5899999664


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..+++..+..++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||.+........   ......++..|
T Consensus        92 ~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~  164 (282)
T cd07829          92 P-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---TYTHEVVTLWY  164 (282)
T ss_pred             c-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc---ccCccccCcCc
Confidence            3 24899999999999999999999854   99999999999999999999999999876543221   11223456789


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch------------hhhhhhcCC
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE------------ESLRHLMDP  577 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------------~~l~~~~d~  577 (635)
                      +|||.+.+. .++.++||||||++++||++|+.||....... .+.... .........            .........
T Consensus       165 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (282)
T cd07829         165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIF-QILGTPTEESWPGVTKLPDYKPTFPKFPPK  242 (282)
T ss_pred             CChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH-HHhCCCcHHHHHhhcccccccccccccCcc
Confidence            999998766 78999999999999999999988875433221 111111 111000000            000000000


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...... +.....+.+++.+||+.||++||++++++.+
T Consensus       243 ~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         243 DLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             chHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000001 1124568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=253.48  Aligned_cols=239  Identities=26%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh----------HHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA----------SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~----------~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.|-.++-  +++.+|+|.+++++          ..|-++|+..+||.+..|...|...+.+|+||||+.||.|.-+|.+
T Consensus       182 GKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr  261 (516)
T KOG0690|consen  182 GKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR  261 (516)
T ss_pred             ceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh
Confidence            67766654  89999999998763          2466789999999999999999999999999999999999999966


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++.....+..+|+.||.|||+   ++||.||||.+|.|+|.+|.+||+|||+++..-..   ...+..++||+.
T Consensus       262 er--~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~---g~t~kTFCGTPE  333 (516)
T KOG0690|consen  262 ER--VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY---GDTTKTFCGTPE  333 (516)
T ss_pred             hh--cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc---cceeccccCChh
Confidence            43  37888778889999999999999   45999999999999999999999999999743322   234667899999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++....|....|.|.+||++|||++|+.||...+.+  .+.+.                ++-..+  .+|...+.
T Consensus       334 YLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLFeL----------------Il~ed~--kFPr~ls~  393 (516)
T KOG0690|consen  334 YLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLFEL----------------ILMEDL--KFPRTLSP  393 (516)
T ss_pred             hcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HHHHH----------------HHhhhc--cCCccCCH
Confidence            99999999999999999999999999999999998643322  11111                111111  24445556


Q ss_pred             HHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHhhcccccc
Q 042486          590 LVIRLIESCLKKDPSGRP--AMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~s~~w~~  628 (635)
                      +...|+...|..||++|.  -.+++.+..+.-+-.+++|+.
T Consensus       394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            678899999999999995  356666666667778899975

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.5e-30  Score=274.60  Aligned_cols=246  Identities=23%  Similarity=0.309  Sum_probs=174.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecC--------------CeeEEEeecc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNG--------------GNWYLVYENA  418 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~--------------~~~~lV~E~~  418 (635)
                      |.||+|..  ++..||+|++..       .+.+|++++++++|+||+++++++...              ...++||||+
T Consensus        19 g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~   98 (342)
T cd07854          19 GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM   98 (342)
T ss_pred             EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecc
Confidence            89999987  678999998743       256799999999999999999876543              3579999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCc
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      + ++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++ +++.+||+|||+++........
T Consensus        99 ~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~  171 (342)
T cd07854          99 E-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH  171 (342)
T ss_pred             c-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCcccc
Confidence            7 5888887542   3899999999999999999999855   99999999999997 4567899999998754322111


Q ss_pred             eeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC--Cchhh---h
Q 042486          498 FALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE--DGEES---L  571 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~~---l  571 (635)
                      ........++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ............  .....   +
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07854         172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDRNELLNVI  250 (342)
T ss_pred             ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhhhhhh
Confidence            111122357889999998654 5578899999999999999999999864432211 111111100000  00000   0


Q ss_pred             hhhcC-CcCCCC-----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          572 RHLMD-PSMQGN-----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       572 ~~~~d-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+. ......     .....+..+.+++.+||+.||++||+++|++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000 000000     011234568899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.4e-30  Score=260.79  Aligned_cols=228  Identities=23%  Similarity=0.351  Sum_probs=176.2

Q ss_pred             ceEEEeeeC--CcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIG--GDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~--~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++..  +..+++|.++.            ++..|+.++++++||||+++++++.+....++||||+++++|.+++
T Consensus        14 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   93 (260)
T cd08222          14 GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKL   93 (260)
T ss_pred             ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHH
Confidence            899999873  34455555432            1346888999999999999999999888999999999999999988


Q ss_pred             cc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          428 ND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       428 ~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ..  .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++.......   .......
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~---~~~~~~~  166 (260)
T cd08222          94 EELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC---DLATTFT  166 (260)
T ss_pred             HHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCc---ccccCCC
Confidence            53  22345899999999999999999999854   999999999999975 569999999987653322   1122345


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......     .             ....... .....+.
T Consensus       167 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~-------------~~~~~~~-~~~~~~~  227 (260)
T cd08222         167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----V-------------VLRIVEG-PTPSLPE  227 (260)
T ss_pred             CCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----H-------------HHHHHcC-CCCCCcc
Confidence            7889999999988888999999999999999999999875321110     0             0011110 0111233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+..+.+++.+||..||++||++.|++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            455678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.1e-30  Score=271.49  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=181.2

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC------
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG------  409 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  409 (635)
                      .++|.....||    |.||++..  ++..||||++..         .+.+|+++|++++|+||+++++++..+.      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            34454444444    79999987  688999998853         2457999999999999999999987543      


Q ss_pred             eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       410 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..++||||+ +++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            458999998 77998888542   3899999999999999999999855   9999999999999999999999999987


Q ss_pred             cccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcc-------
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV-------  561 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-------  561 (635)
                      ......      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .........       
T Consensus       167 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  239 (343)
T cd07880         167 QTDSEM------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccCc------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence            553321      22457889999998875 457899999999999999999999986433211 111111100       


Q ss_pred             ---cccCCchhhhhhh---cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          562 ---LHKEDGEESLRHL---MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       562 ---~~~~~~~~~l~~~---~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         +...........+   ....+ .......+..+.+++.+|++.||++|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0000000000000   00000 00111234458899999999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-30  Score=286.52  Aligned_cols=238  Identities=27%  Similarity=0.437  Sum_probs=189.1

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.|++|...         ...||||.++.        ++..|+++|+.+ +|+||+.++|.|..++..++|+||+..|+|
T Consensus       310 G~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L  389 (609)
T KOG0200|consen  310 GQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDL  389 (609)
T ss_pred             cceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcH
Confidence            899999752         34799999874        356799999998 699999999999999999999999999999


Q ss_pred             chhhcccC------------C--CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG------------G--KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~------------~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .++++..+            .  ..++..+.+.++.|||.|++||++   .+++||||..+|||+.++..+||+|||+++
T Consensus       390 ~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~~kIaDFGlar  466 (609)
T KOG0200|consen  390 LEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKVIKIADFGLAR  466 (609)
T ss_pred             HHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCEEEEcccccee
Confidence            99996544            0  138899999999999999999998   459999999999999999999999999999


Q ss_pred             cccccCCceeeecccc--cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc
Q 042486          490 PAERQEGEFALTSHIV--GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  567 (635)
                      ........  ......  -...|||||.+....++.++||||||++|||++|...++...-...                
T Consensus       467 ~~~~~~~y--~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----------------  528 (609)
T KOG0200|consen  467 DHYNKDYY--RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----------------  528 (609)
T ss_pred             ccCCCCce--EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH----------------
Confidence            65443321  111122  2346999999999999999999999999999999554432210000                


Q ss_pred             hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      .+. -+.+....+-..|..+..++.++++.||+.+|++||++.|+.+.|...+.
T Consensus       529 ~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  529 EEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            111 11223333345566667789999999999999999999999999999765

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.1e-29  Score=262.19  Aligned_cols=237  Identities=17%  Similarity=0.178  Sum_probs=165.7

Q ss_pred             ceEEEeeeC-----CcEEEEEEecc---ChHH---------------HHHHHhhhccCCcccEEEEEecCC----eeEEE
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYG---DASD---------------QIKLLNKINHSSLIRLLGICFNGG----NWYLV  414 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~---~~~~---------------E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV  414 (635)
                      |.||+|+..     +..+|+|....   .+..               ++..+..++|+|++++++.+....    ..+++
T Consensus        26 G~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~  105 (294)
T PHA02882         26 GCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL  105 (294)
T ss_pred             ceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEE
Confidence            899999973     34566664321   1111               122344568999999999776443    34778


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      +|++. .++.+.+....  ..++..+..|+.|++.||.|||+.   +++||||||+|||++.++.++|+|||+++.....
T Consensus       106 ~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~  179 (294)
T PHA02882        106 LEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH  179 (294)
T ss_pred             Eehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccC
Confidence            88764 35666654322  257888899999999999999985   4999999999999999999999999999765322


Q ss_pred             CCce----eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          495 EGEF----ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       495 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                      ....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||...............         +.
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~---------~~  250 (294)
T PHA02882        180 GKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC---------DF  250 (294)
T ss_pred             CcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH---------HH
Confidence            1110    1112346999999999999999999999999999999999999999754322211110000         00


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      +..+..+...   ....+..+.+++..|+..+|++||+++++.+.|
T Consensus       251 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        251 IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1111111110   112245689999999999999999999999876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-31  Score=283.63  Aligned_cols=232  Identities=27%  Similarity=0.386  Sum_probs=179.6

Q ss_pred             cceEEEeeeCCcEEEEEEeccC----hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc--CCC
Q 042486          361 KGSVYRGKIGGDFVAIKKVYGD----ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGK  433 (635)
Q Consensus       361 gg~Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~  433 (635)
                      |+.||+|.+.++.||||++-.+    +.+|++.|+.- +|||||++++.-.+++..|+..|.|. .+|++++...  ...
T Consensus       523 Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~  601 (903)
T KOG1027|consen  523 GTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVE  601 (903)
T ss_pred             CcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchh
Confidence            3689999999999999999765    45899999988 69999999999889999999999994 5999999663  111


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-----CCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-----DFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...-...+.+..|+++||+|||+.+   ||||||||.||||+.     ..+++|+|||+++................||.
T Consensus       602 ~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~  678 (903)
T KOG1027|consen  602 MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTS  678 (903)
T ss_pred             hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcc
Confidence            1121345678899999999999976   999999999999965     35799999999998876665555566788999


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +|+|||++....-+...||||+||++|+.++| ..||...-+.+.++..-.          ..+..+.      . ..++
T Consensus       679 GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~----------~~L~~L~------~-~~d~  741 (903)
T KOG1027|consen  679 GWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN----------YTLVHLE------P-LPDC  741 (903)
T ss_pred             cccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc----------cceeeec------c-CchH
Confidence            99999999988888899999999999999997 677753222111111000          0000000      0 0111


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ...+||.+|+.+||..||++.+|+.|
T Consensus       742 --eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  742 --EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             --HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence              46899999999999999999999854

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.9e-30  Score=271.61  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=181.0

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCe------
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGN------  410 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------  410 (635)
                      ++|.....||    |.||+|+.  ++..||||++..         .+.+|+.++++++|+|++++++++...+.      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            3444444443    89999998  578999998753         23468999999999999999998775554      


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      .++|+||+ +++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        95 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccc
Confidence            89999998 67999988652   3899999999999999999999854   99999999999999999999999999876


Q ss_pred             ccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC---
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED---  566 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---  566 (635)
                      ....      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..... ......   
T Consensus       168 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~-~~~~~~~~~  239 (343)
T cd07851         168 TDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMN-LVGTPDEEL  239 (343)
T ss_pred             cccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-hcCCCCHHH
Confidence            5332      122457888999998865 467899999999999999999999886432211 1111111 000000   


Q ss_pred             ----chhhhhhhcCCcC---CCCC---ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 ----GEESLRHLMDPSM---QGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ----~~~~l~~~~d~~~---~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          .......++....   ...+   ....+..+.+++.+||+.||++|||+.||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                0000011111000   0000   01124568999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.6e-29  Score=251.54  Aligned_cols=227  Identities=31%  Similarity=0.435  Sum_probs=183.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.+|+|++..        .+.+|++.+++++|+|++++++++......++++||+++++|.+++....
T Consensus         3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~   82 (244)
T smart00220        3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG   82 (244)
T ss_pred             eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence            78999998  468999999853        45689999999999999999999999899999999999999999996544


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      .  +++..+..++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......    ......++..|+
T Consensus        83 ~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~  153 (244)
T smart00220       83 R--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYM  153 (244)
T ss_pred             C--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCCC
Confidence            3  899999999999999999999854   9999999999999999999999999998665432    223356788999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh-HHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP-VTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~-~~~~~  590 (635)
                      +||.+....++.++||||||+++++|++|..|+....+.. ...+...                .......... ..+..
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~----------------~~~~~~~~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIG----------------KPKPPFPPPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHh----------------ccCCCCccccccCCHH
Confidence            9999988888999999999999999999998875422211 1111111                0000000000 03456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~  614 (635)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=2.8e-29  Score=263.92  Aligned_cols=245  Identities=28%  Similarity=0.375  Sum_probs=175.4

Q ss_pred             ceEEEeeeC----CcEEEEEEecc---------ChHHHHHHHhhh-ccCCcccEEEEEecC----CeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG----GDFVAIKKVYG---------DASDQIKLLNKI-NHSSLIRLLGICFNG----GNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~----~~~vavK~~~~---------~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~~lV~E~~~~gsL  423 (635)
                      |.||+++..    +..||+|++..         .+.+|+++++++ +|+||+++++.+...    ...++++||+. ++|
T Consensus        14 g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L   92 (332)
T cd07857          14 GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADL   92 (332)
T ss_pred             eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCH
Confidence            899999983    66899998764         245689999999 599999999976432    34688899885 689


Q ss_pred             chhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeec
Q 042486          424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTS  502 (635)
Q Consensus       424 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~  502 (635)
                      .+++....  .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ .....
T Consensus        93 ~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  167 (332)
T cd07857          93 HQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT  167 (332)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccccc
Confidence            99885433  4899999999999999999999855   999999999999999999999999999755432211 11122


Q ss_pred             ccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC----
Q 042486          503 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP----  577 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~----  577 (635)
                      ...|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+... .+..... .+.... .+.+..+.++    
T Consensus       168 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~~~-~~~~~~~~~~~~~~  244 (332)
T cd07857         168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQ-VLGTPD-EETLSRIGSPKAQN  244 (332)
T ss_pred             CcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHH-HhCCCC-HHHHHhhhhhhHHH
Confidence            3568899999998765 468899999999999999999998876433221 1111110 000000 0001110000    


Q ss_pred             -------cCCC---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 -------SMQG---NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 -------~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                             ....   .........+.+++.+||+.||++||+++|++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                   0000   0001124568999999999999999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-30  Score=269.47  Aligned_cols=221  Identities=24%  Similarity=0.314  Sum_probs=177.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      +.|-++..  +++..++|.+.+.   ..+|+.++.+. +|+||+++.+.+.++.+.|+|||.+.++-|.+.+.....  .
T Consensus       336 s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~  413 (612)
T KOG0603|consen  336 SAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--F  413 (612)
T ss_pred             cceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch--h
Confidence            44555554  6778899988665   67888777766 799999999999999999999999999988777754432  2


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE-CCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL-DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      . ..+..|+.+|+.|+.|||+++   +|||||||+|||+ ++.+.++|+|||.++.....      ....+-|..|.|||
T Consensus       414 ~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp~~t~~y~APE  483 (612)
T KOG0603|consen  414 C-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDTPALTLQYVAPE  483 (612)
T ss_pred             H-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh------hcccchhhcccChh
Confidence            3 677789999999999999955   9999999999999 68899999999999866543      12346788999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      ++....+++++|+||||++||+|++|+.|+.....+.                 +....+..+.    +....+....+|
T Consensus       484 vl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-----------------ei~~~i~~~~----~s~~vS~~AKdL  542 (612)
T KOG0603|consen  484 VLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-----------------EIHTRIQMPK----FSECVSDEAKDL  542 (612)
T ss_pred             hhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-----------------HHHHhhcCCc----cccccCHHHHHH
Confidence            9999999999999999999999999999986543331                 1111222221    124456668999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 042486          595 IESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+||+.||.+||+|+++..+
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HHHhccCChhhCcChhhhccC
Confidence            999999999999999999887

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=245.90  Aligned_cols=258  Identities=20%  Similarity=0.295  Sum_probs=191.0

Q ss_pred             ccHHHHHHhhcCCCCCCcccceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhh-ccCCcccEEEEEecCCee
Q 042486          342 YTFEELQAATDDFNPSCWIKGSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKI-NHSSLIRLLGICFNGGNW  411 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~igg~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  411 (635)
                      -+|+|+.+.|++.-.++-- ++|-.++.  +|..+|||.+.+       .+.+|++++.+. .|+||+.|+++|+++..+
T Consensus        73 g~F~d~YkLt~e~LGeGAy-asVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAY-ASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             chHHHHHHhHHHHhcCccc-eeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            4577888888776544322 55655543  899999999865       356899999998 599999999999999999


Q ss_pred             EEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC---cEEEeeecCc
Q 042486          412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF---RAKIANFALA  488 (635)
Q Consensus       412 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a  488 (635)
                      |||||-|.||+|..++.++.  .+++.+..++.++|+.||.|||.   ++|.|||+||+|||..+..   -+||+||.++
T Consensus       152 YLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             EEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccc
Confidence            99999999999999996653  48999999999999999999998   4599999999999996554   4899999987


Q ss_pred             ccccccCCc----eeeecccccCCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh
Q 042486          489 RPAERQEGE----FALTSHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN  559 (635)
Q Consensus       489 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~  559 (635)
                      .-......-    .......+|+..|||||+..     ...|+.++|.|||||++|-|++|.+||...-+++-.+     
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW-----  301 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW-----  301 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc-----
Confidence            643322111    11123467888999999874     3468899999999999999999999997543322100     


Q ss_pred             cccccCC---c-hhhhhhhcCCcCCCCCC----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 042486          560 PVLHKED---G-EESLRHLMDPSMQGNYP----PVTAILVIRLIESCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       560 ~~~~~~~---~-~~~l~~~~d~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  614 (635)
                        -.++.   . ...+..+.+...  ++|    ...+.+-.+++...+..|+.+|.++.+++.
T Consensus       302 --drGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 --DRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             --cCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              00000   0 111222222221  223    234556789999999999999999998887

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=5e-29  Score=284.10  Aligned_cols=123  Identities=25%  Similarity=0.418  Sum_probs=111.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|..  +++.||||+++.          .+..|+.+++.++|+||+++++.+...+..|+||||+.+++|.+++..
T Consensus        18 g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~   97 (669)
T cd05610          18 GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI   97 (669)
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh
Confidence            89999998  488999999863          355788999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..  .+++..++.|+.||+.||.|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          98 YG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            43  388999999999999999999985   49999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=1.6e-29  Score=281.90  Aligned_cols=181  Identities=26%  Similarity=0.360  Sum_probs=129.8

Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      +||-||||+...|.++++++... -.....++++.+|++||.|+|+.+   +|||||||.||++|+++.+||+|||+|..
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            47888899887777777654321 135677899999999999999955   99999999999999999999999999987


Q ss_pred             cc----c----------cC-CceeeecccccCCCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCcchhh
Q 042486          491 AE----R----------QE-GEFALTSHIVGTKGYMAPEYLENG---LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM  552 (635)
Q Consensus       491 ~~----~----------~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~  552 (635)
                      ..    .          .. ......+..+||.-|+|||.+.+.   .|+.|+|+||||++++||+.   ||....+.- 
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-  822 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-  822 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH-
Confidence            21    0          00 011122456899999999999764   49999999999999999986   343222221 


Q ss_pred             HHHHhhhcccccCCchhhhhhhcCCcCCCC--CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          553 LLVDVLNPVLHKEDGEESLRHLMDPSMQGN--YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       553 ~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                      ..+..+.++.+...  +.......=..+|++|++.||.+|||+.|++..
T Consensus       823 ----------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  823 ----------------SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             ----------------HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence                            12222222222222  111122234789999999999999999998863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=7e-29  Score=222.47  Aligned_cols=246  Identities=26%  Similarity=0.327  Sum_probs=186.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||||+.  +++.||+|+++-+         ..+|+-+|+.++|.|||++++....+...-+|+|||. .+|..+....
T Consensus        16 gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsl   94 (292)
T KOG0662|consen   16 GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSL   94 (292)
T ss_pred             eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhc
Confidence            99999987  6789999998643         4689999999999999999999999999999999995 4888888654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      .+. ++.+....++.|+++||.|+|++.   +.|||+||.|.+|+.+|++|++|||+++..+-.-   ...+..+.|..|
T Consensus        95 ng~-~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv---rcysaevvtlwy  167 (292)
T KOG0662|consen   95 NGD-LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---RCYSAEVVTLWY  167 (292)
T ss_pred             CCc-CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce---Eeeeceeeeeec
Confidence            433 899999999999999999999966   9999999999999999999999999998665432   122334678999


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccc-ccCCchhhhhhhcCCcCCCCCChH--
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL-HKEDGEESLRHLMDPSMQGNYPPV--  586 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-~~~~~~~~l~~~~d~~~~~~~~~~--  586 (635)
                      ++|.++.+ ..|+...|+||-||++.|+.....|.....+-...+...+..+- ..++....+.++-|-..-..+|..  
T Consensus       168 rppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypatts  247 (292)
T KOG0662|consen  168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTS  247 (292)
T ss_pred             cCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccch
Confidence            99999876 45899999999999999998866564433332222322222111 111222333344443333333321  


Q ss_pred             -------HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 -------TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 -------~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                             ....-++++.+.+.-+|.+|.++++.+++
T Consensus       248 wsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  248 WSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             HHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence                   22234789999999999999999998765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-29  Score=268.15  Aligned_cols=231  Identities=24%  Similarity=0.377  Sum_probs=185.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhh-ccCCcccEEEEEe-----cCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKI-NHSSLIRLLGICF-----NGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l-~h~nIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++.  +++.+|+|+...+      ...|.++|+.+ +|||++.++|++.     .+++++||||||.+||..|++
T Consensus        33 gkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLV  112 (953)
T KOG0587|consen   33 GKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLV  112 (953)
T ss_pred             eeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHH
Confidence            67777765  8899999988543      34566778777 7999999999987     357899999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      +...+..+.|..+..|+..++.||.+||..   .++|||||-.|||++.++.+||.|||.+.......   .......||
T Consensus       113 Kn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~---grRnT~iGt  186 (953)
T KOG0587|consen  113 KNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV---GRRNTFIGT  186 (953)
T ss_pred             hhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc---ccccCcCCC
Confidence            766567799999999999999999999984   49999999999999999999999999987665433   234557899


Q ss_pred             CCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          508 KGYMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       508 ~~y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      +.|||||++..     ..|+.++|+||||++..||.-|.+|+.....-                 +..+.-..+|...-.
T Consensus       187 P~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-----------------raLF~IpRNPPPkLk  249 (953)
T KOG0587|consen  187 PYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-----------------RALFLIPRNPPPKLK  249 (953)
T ss_pred             cccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----------------hhhccCCCCCCcccc
Confidence            99999999853     45778999999999999999999886422111                 111111123333334


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .|.....++.++|..||..|-++||++.++++|
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            566778889999999999999999999998764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=250.99  Aligned_cols=244  Identities=19%  Similarity=0.250  Sum_probs=181.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhcc--C----CcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKINH--S----SLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~h--~----nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.|-+..+  .+..||||+++.      ...-|+++|.++++  |    -++.+.++|.-.++.|+|+|.+ |-|+.+++
T Consensus       103 GkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFl  181 (415)
T KOG0671|consen  103 GKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFL  181 (415)
T ss_pred             cceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHh
Confidence            66776655  578999998864      34568999999943  2    2778888898899999999987 66999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC--------------------CCcEEEeeecC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT--------------------DFRAKIANFAL  487 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~--------------------~~~~kl~Dfg~  487 (635)
                      ..+...+++...+..|+.|++++++|||+.+   ++|.||||+|||+.+                    +..++|+|||.
T Consensus       182 k~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGs  258 (415)
T KOG0671|consen  182 KENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGS  258 (415)
T ss_pred             ccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCC
Confidence            8877778999999999999999999999955   999999999999931                    34589999999


Q ss_pred             cccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh-hHHHHhhhccccc--
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN-MLLVDVLNPVLHK--  564 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~--  564 (635)
                      |+......      ...+.|..|+|||++.+-.++.++||||+||||+||.||...|...++.+ ..+.+.+...+..  
T Consensus       259 Atf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~m  332 (415)
T KOG0671|consen  259 ATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRM  332 (415)
T ss_pred             cceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHH
Confidence            98665433      34678999999999999999999999999999999999998887654322 1111111111000  


Q ss_pred             ---CCchhh----------------hhhhcCCcC----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          565 ---EDGEES----------------LRHLMDPSM----QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       565 ---~~~~~~----------------l~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                         ...++.                .+...++-.    .-.....+...|.+|+++||..||.+|+|+.|++.+
T Consensus       333 i~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  333 IKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             hhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence               000000                000111000    001123456679999999999999999999999875

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=280.44  Aligned_cols=255  Identities=25%  Similarity=0.281  Sum_probs=202.1

Q ss_pred             HHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecC
Q 042486          345 EELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNG  408 (635)
Q Consensus       345 ~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~  408 (635)
                      .+++-..++|.....||    |.|...+.  +++.+|+|++.+          .|..|-++|.--+.+-|++++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34444555666555555    88888876  788999998854          267889999988999999999999999


Q ss_pred             CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCc
Q 042486          409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA  488 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  488 (635)
                      .++|+|||||+||+|-.++.+..  .+++.....++..|+.||.-||+.|   +|||||||+|||||..|++||+|||.+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999997765  4899989999999999999999977   999999999999999999999999998


Q ss_pred             ccccccCCceeeecccccCCCccCccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc
Q 042486          489 RPAERQEGEFALTSHIVGTKGYMAPEYLE----N-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       489 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                      -.+....  .......+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||...+               
T Consensus       223 lkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads---------------  285 (1317)
T KOG0612|consen  223 LKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS---------------  285 (1317)
T ss_pred             HhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---------------
Confidence            7665432  24456679999999999985    3 679999999999999999999999985311               


Q ss_pred             cCCchhhhhhhcCCcCCCCCC--hHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHHHHhhcccccc
Q 042486          564 KEDGEESLRHLMDPSMQGNYP--PVTAILVIRLIESCLKKDPSGRPA---MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~~~~~s~~w~~  628 (635)
                         .-+...++++-.-.-.+|  .+.+....+||.+.+. +|+.|..   ++++..|   .+-...+|+.
T Consensus       286 ---lveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H---pFF~g~~W~~  348 (1317)
T KOG0612|consen  286 ---LVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH---PFFEGIDWDN  348 (1317)
T ss_pred             ---HHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC---ccccCCChhh
Confidence               113333444432222333  3456678899988776 6778877   8877776   4556688865

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-29  Score=256.61  Aligned_cols=237  Identities=26%  Similarity=0.363  Sum_probs=187.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||-|+.  +|+.||||.+.+         ..++|+.||.+++||.||.+...|+..+..+.|||-+.|.-|+-.|...
T Consensus       578 G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsE  657 (888)
T KOG4236|consen  578 GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSE  657 (888)
T ss_pred             eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhh
Confidence            89999987  899999998843         3578999999999999999999999999999999999554444444433


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC---CcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD---FRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      . ..|++..-..++.||+.||.|||.   ++|+|+||||+|||+.+.   ..+||||||+|+.++...    ..+..+||
T Consensus       658 k-gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----FRrsVVGT  729 (888)
T KOG4236|consen  658 K-GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----FRRSVVGT  729 (888)
T ss_pred             c-ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh----hhhhhcCC
Confidence            3 338998888899999999999998   559999999999999543   579999999999887643    34567999


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|+|||++.+..|....|+||.||++|--++|..||...++-.    +.+..           .++|-|.   +...+.
T Consensus       730 PAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn----dQIQN-----------AaFMyPp---~PW~ei  791 (888)
T KOG4236|consen  730 PAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN----DQIQN-----------AAFMYPP---NPWSEI  791 (888)
T ss_pred             ccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh----HHhhc-----------cccccCC---Cchhhc
Confidence            99999999999999999999999999999999999986332211    11110           1122211   122344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                      +....+||...|+..-.+|-|.+.-+.+  -|+++-..|
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~lsh--~Wlq~yq~w  828 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSLSH--PWLQDYQTW  828 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhccc--hhhhcchHH
Confidence            5567899999999999999999987776  345555555

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=1.1e-28  Score=274.64  Aligned_cols=255  Identities=17%  Similarity=0.176  Sum_probs=165.7

Q ss_pred             hhcCCCCCCccc----ceEEEeee--C----CcEEEEEEeccChHHHHHHHhhhcc---CCcccEEEE------EecCCe
Q 042486          350 ATDDFNPSCWIK----GSVYRGKI--G----GDFVAIKKVYGDASDQIKLLNKINH---SSLIRLLGI------CFNGGN  410 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~--~----~~~vavK~~~~~~~~E~~~l~~l~h---~nIv~l~~~------~~~~~~  410 (635)
                      ..++|.....||    |.||+|+.  +    +..||||++......|..+..++.|   .++..+...      +..+..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            445666666676    89999998  4    6799999987765556555555433   223222221      235667


Q ss_pred             eEEEeecccCCCcchhhcccCCC------------------CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCE
Q 042486          411 WYLVYENAVNGSLSVWINDKGGK------------------FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV  472 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NI  472 (635)
                      .++||||+.+++|.+++......                  ...+..+..++.|++.||.|||+.   +|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence            89999999999999988543210                  112344567999999999999985   499999999999


Q ss_pred             EECC-CCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC----------------------CCCcccchhh
Q 042486          473 LLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG----------------------LVSTKLDVYA  529 (635)
Q Consensus       473 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV~S  529 (635)
                      |+++ ++.+||+|||+++.......  .......+++.|+|||.+...                      .++.++||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            9986 57999999999975533221  223446789999999965322                      2345679999


Q ss_pred             HHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC------CChHHHHHHHHHHHHhhhcCC
Q 042486          530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN------YPPVTAILVIRLIESCLKKDP  603 (635)
Q Consensus       530 lGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~------~~~~~~~~l~~li~~cl~~dP  603 (635)
                      |||++|||+++..+...   +...+...+...   ............+....+      ..........+|+.+||+.||
T Consensus       365 lGviL~el~~~~~~~~~---~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDS---NLIQFNRQLKRN---DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHhCcCCCch---HHHHHHHHHHhc---CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            99999999997655321   111111111100   000111111111110000      000112235689999999999


Q ss_pred             CCCCCHHHHHHH
Q 042486          604 SGRPAMDKIAQS  615 (635)
Q Consensus       604 ~~RPs~~evl~~  615 (635)
                      ++|||++|+++|
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999987

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=244.74  Aligned_cols=228  Identities=27%  Similarity=0.374  Sum_probs=186.0

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccChH----------HHHHHHhhh-ccCCcccEEEEEecCCeeEEEe
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGDAS----------DQIKLLNKI-NHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~~~----------~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      +|+--..+|    |.|..+..  +...+|||.+++++.          .|-++|.-. +-|.++.++..|..-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            455444554    77888766  556899999987642          455666555 5678999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+.||+|.-.++.-+.  +.+....-++.+||-||-+||+.   +|+.||||.+||++|.+|.+||+|||+++..--. 
T Consensus       430 EyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-  503 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-  503 (683)
T ss_pred             EEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC-
Confidence            99999999999976543  77888889999999999999994   4999999999999999999999999999743222 


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                        ...+...+||+.|+|||++....|+...|.|||||+||||+.|++||+..++                  .+.++.++
T Consensus       504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------------------~elF~aI~  563 (683)
T KOG0696|consen  504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------------DELFQAIM  563 (683)
T ss_pred             --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH------------------HHHHHHHH
Confidence              2446678999999999999999999999999999999999999999865333                  34445555


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA  608 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  608 (635)
                      +...  .||...+.+..++.+..|...|.+|.-
T Consensus       564 ehnv--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  564 EHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence            5433  567777888899999999999999953

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=246.50  Aligned_cols=236  Identities=22%  Similarity=0.368  Sum_probs=183.9

Q ss_pred             ceEEEeee--CCcEEEEEEec--c------------ChHHHHHHHhhhccCCcccEEEEEe-cCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVY--G------------DASDQIKLLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~--~------------~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~E~~~~gsL~  424 (635)
                      ..|||+.+  ..+.||||.-.  +            ...+|.+|.+.|.||.||++++++. +.+.+|-|+|||+|.+|+
T Consensus       477 SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLD  556 (775)
T KOG1151|consen  477 SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD  556 (775)
T ss_pred             HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchh
Confidence            47999976  78899999752  1            2447899999999999999999997 567789999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC---CCCcEEEeeecCcccccccCC----c
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD---TDFRAKIANFALARPAERQEG----E  497 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~----~  497 (635)
                      -||....  .+++++...|+.||+.||.||.+.. ++|||-||||.|||+.   .-|.+||+|||+++.+.....    .
T Consensus       557 FYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdG  633 (775)
T KOG1151|consen  557 FYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDG  633 (775)
T ss_pred             HHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccc
Confidence            9997654  3899999999999999999999976 9999999999999993   458899999999998765432    2


Q ss_pred             eeeecccccCCCccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          498 FALTSHIVGTKGYMAPEYLEN----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      ...+....||.+|++||.+.-    ..++.|.||||.||++|..+.|+.||.........+.+.  ..+.       ..+
T Consensus       634 meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN--TIlk-------AtE  704 (775)
T KOG1151|consen  634 MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN--TILK-------ATE  704 (775)
T ss_pred             eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh--chhc-------cee
Confidence            456677889999999998853    457889999999999999999999986432221111000  0000       000


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  614 (635)
                      +     .....+..+.+..++|++||++.-++|....++..
T Consensus       705 V-----qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  705 V-----QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             c-----cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            1     11112344556789999999999999998888765

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-29  Score=239.72  Aligned_cols=233  Identities=21%  Similarity=0.326  Sum_probs=172.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh--------HHHHHHH-hhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc--
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA--------SDQIKLL-NKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN--  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~--------~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~--  428 (635)
                      |+|+|-..  .|+..|||+++-..        ..|.+.. +.-+.||||+++|.+..++..++.||.|. .||+.+..  
T Consensus        78 G~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~v  156 (361)
T KOG1006|consen   78 GTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRV  156 (361)
T ss_pred             hhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHH
Confidence            89998776  79999999997532        2233322 22368999999999999999999999984 47765542  


Q ss_pred             -ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          429 -DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       429 -~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                       ......+++...-+|..-.++||.||.+  ...|+|||+||+|||+|..|.+||||||.+-.....-    ..+.-.|.
T Consensus       157 y~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si----AkT~daGC  230 (361)
T KOG1006|consen  157 YSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI----AKTVDAGC  230 (361)
T ss_pred             HHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH----HhhhccCC
Confidence             2223348888888999999999999987  3569999999999999999999999999986543221    12334688


Q ss_pred             CCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC-CC
Q 042486          508 KGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN-YP  584 (635)
Q Consensus       508 ~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~-~~  584 (635)
                      ..|||||.+..  ..|+.++||||||++|+|+.||+.|+..++.--..+...+    .+..          |.+..+ ..
T Consensus       231 rpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv----~gdp----------p~l~~~~~~  296 (361)
T KOG1006|consen  231 RPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV----IGDP----------PILLFDKEC  296 (361)
T ss_pred             ccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH----cCCC----------CeecCcccc
Confidence            89999999863  3489999999999999999999999754433211111111    1110          111111 11


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ......+..+|..|+..|-.+||...++.++
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2356679999999999999999999998764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.1e-29  Score=233.96  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=178.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec--------CCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN--------GGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~lV~E~~~~gs  422 (635)
                      |.||+++.  .++.||+|++.-         +..+|+++|..++|+|++.++..|..        ...+|+||++|+. +
T Consensus        31 geVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-D  109 (376)
T KOG0669|consen   31 GEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-D  109 (376)
T ss_pred             HHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-h
Confidence            67887766  677899987632         35689999999999999999998863        2358999999976 7


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeee
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALT  501 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  501 (635)
                      |.-+|.... ..++...+.+++.++..||.|+|..   .|+|||+|+.|+||+.++.+||+|||+++........ ....
T Consensus       110 LaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpry  185 (376)
T KOG0669|consen  110 LAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRY  185 (376)
T ss_pred             HHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCc
Confidence            888886543 2388999999999999999999984   4999999999999999999999999999765433221 1122


Q ss_pred             cccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhh-HHHHhhhc-----ccccCCchhhhhhh
Q 042486          502 SHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM-LLVDVLNP-----VLHKEDGEESLRHL  574 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~-----~~~~~~~~~~l~~~  574 (635)
                      ...+.|..|++||.+.+ ..++++.|||.-||++.||+|+.+.+....+... .+...+-.     ++..-+.-+....+
T Consensus       186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~si  265 (376)
T KOG0669|consen  186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSI  265 (376)
T ss_pred             ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhc
Confidence            34567999999998875 6799999999999999999999977655433221 11111111     11110111111111


Q ss_pred             cCCcCC-CCC--------ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          575 MDPSMQ-GNY--------PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       575 ~d~~~~-~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      --+.+. +.+        |..-.....+|+..++..||.+|+.+++++.+-
T Consensus       266 e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  266 ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            111010 000        111123467899999999999999999988763

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.4e-29  Score=252.63  Aligned_cols=237  Identities=22%  Similarity=0.324  Sum_probs=192.5

Q ss_pred             ceEEEeeeCCcE--EEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKIGGDF--VAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~~~~~--vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.|=..+.+++.  .|+|.+++.          +..|-.+|.+.+.+.||+++.-|.+....|++||-|-||.|+..|++
T Consensus       434 GRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd  513 (732)
T KOG0614|consen  434 GRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD  513 (732)
T ss_pred             ceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh
Confidence            788888876655  788877542          45688899999999999999999999999999999999999999977


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ++.  ++......++..+.+|++|||+.+   ||.|||||+|.++|.+|.+||.|||+|+......    .+..++||+.
T Consensus       514 Rg~--Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~----KTwTFcGTpE  584 (732)
T KOG0614|consen  514 RGS--FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR----KTWTFCGTPE  584 (732)
T ss_pred             cCC--cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC----ceeeecCCcc
Confidence            654  888888889999999999999955   9999999999999999999999999999876654    4667899999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |.|||++.+...+...|.||||+++|||++|++||...+.-  ..+..+                +...-.-.+|.....
T Consensus       585 YVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--ktYn~I----------------LkGid~i~~Pr~I~k  646 (732)
T KOG0614|consen  585 YVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--KTYNLI----------------LKGIDKIEFPRRITK  646 (732)
T ss_pred             cccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--HHHHHH----------------Hhhhhhhhcccccch
Confidence            99999999999999999999999999999999998654321  111111                111111234455555


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHHHHHHHHhhcccccc
Q 042486          590 LVIRLIESCLKKDPSGRPA-----MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~~~s~~w~~  628 (635)
                      ...+|+++.+..+|.+|.-     +.+|-+|  +|+ ..+||+-
T Consensus       647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH--~Wf-~gfdweg  687 (732)
T KOG0614|consen  647 TATDLIKKLCRDNPTERLGYQKGGINDIKKH--RWF-EGFDWEG  687 (732)
T ss_pred             hHHHHHHHHHhcCcHhhhccccCChHHHHhh--hhh-hcCChhh
Confidence            6789999999999999976     6677766  344 3588875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7.6e-27  Score=253.84  Aligned_cols=253  Identities=22%  Similarity=0.184  Sum_probs=169.7

Q ss_pred             hcCCCCCCccc----ceEEEeee------------------CCcEEEEEEeccC-------h--------------HHHH
Q 042486          351 TDDFNPSCWIK----GSVYRGKI------------------GGDFVAIKKVYGD-------A--------------SDQI  387 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~------------------~~~~vavK~~~~~-------~--------------~~E~  387 (635)
                      .++|...+.||    |.||+|..                  .++.||||+++.+       +              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56777777776    89999964                  3467999998532       1              2366


Q ss_pred             HHHhhhccCCc-----ccEEEEEec--------CCeeEEEeecccCCCcchhhcccC----------------------C
Q 042486          388 KLLNKINHSSL-----IRLLGICFN--------GGNWYLVYENAVNGSLSVWINDKG----------------------G  432 (635)
Q Consensus       388 ~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------~  432 (635)
                      .++.+++|.++     ++++++|..        ++..+|||||+++++|.++++...                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777776654     677887753        356799999999999999885321                      1


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.|++.+|.|||+.+   |+||||||+||+++.++.+||+|||++........  .......+++.|+|
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~a  378 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSP  378 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeC
Confidence            12467788999999999999999854   99999999999999999999999999875432211  11112335789999


Q ss_pred             ccccccCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCCCcchhhHHHHhhhcccccCCchh
Q 042486          513 PEYLENGLV----------------------STKLDVYAFGVLMLEMLSGKE-APALYSEENMLLVDVLNPVLHKEDGEE  569 (635)
Q Consensus       513 PE~~~~~~~----------------------s~ksDV~SlGvvl~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (635)
                      ||.+.....                      ..+.||||+||++++|++|.. |+.....-...+...       .....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-------~~~~~  451 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-------DNDLN  451 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-------cchHH
Confidence            998754321                      234799999999999999986 432111000000000       00000


Q ss_pred             hhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 042486          570 SLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP---SGRPAMDKIAQS  615 (635)
Q Consensus       570 ~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~  615 (635)
                      ..+....................+|+.+||..+|   .+|+|++|+++|
T Consensus       452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0111111111111112234567899999999766   689999999976

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.6e-27  Score=227.58  Aligned_cols=253  Identities=23%  Similarity=0.382  Sum_probs=185.8

Q ss_pred             cCCCCCCccc-c---eEEEeee--CCcEEEEEEeccChH----------HHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK-G---SVYRGKI--GGDFVAIKKVYGDAS----------DQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig-g---~Vy~g~~--~~~~vavK~~~~~~~----------~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|..-..|| |   .|-.++.  +.+.+|+|.++++..          .|-.+..+- +||.+|-++.+|..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            3455555555 3   3444444  678899999877543          244444443 799999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      .||++||+|.-++++...  |+++....+..+|+.||.|||+.+   |+.||||.+|+|+|.+|.+||+|+|+++..-..
T Consensus       330 ieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999999999888865433  899999999999999999999954   999999999999999999999999999854332


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhh-
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH-  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~-  573 (635)
                      .   ..++.++||+.|.|||.+.+..|....|.|+|||+++||+.|+.||+.-..++           ...+.+..+-+ 
T Consensus       405 g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n-----------~d~ntedylfqv  470 (593)
T KOG0695|consen  405 G---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN-----------PDMNTEDYLFQV  470 (593)
T ss_pred             C---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC-----------cccchhHHHHHH
Confidence            2   34677899999999999999999999999999999999999999997422111           00111111111 


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHHHHHHHhhcccccc
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA------MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~L~~~~~~s~~w~~  628 (635)
                      ++...+  ..|...+.....+++.-|..||++|..      +.++..+   -+-.++||+.
T Consensus       471 ilekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h---~ffr~idwd~  526 (593)
T KOG0695|consen  471 ILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH---AFFRSIDWDL  526 (593)
T ss_pred             Hhhhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc---hhhhhCCHHH
Confidence            122111  234444455678899999999999853      2333332   2333688875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-26  Score=232.86  Aligned_cols=110  Identities=31%  Similarity=0.378  Sum_probs=96.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhc-----c---CCcccEEEEEec----CCeeEEEeecccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKIN-----H---SSLIRLLGICFN----GGNWYLVYENAVNG  421 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~-----h---~nIv~l~~~~~~----~~~~~lV~E~~~~g  421 (635)
                      .+||.+-+  +.+.||+|+++.      ...+||++|++++     |   .+||+|+++|..    +.+.|||+|++ |.
T Consensus        92 STVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-Gd  170 (590)
T KOG1290|consen   92 STVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GD  170 (590)
T ss_pred             ceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hh
Confidence            79999987  788999999975      3568999999983     2   469999999984    56789999988 77


Q ss_pred             CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE
Q 042486          422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL  474 (635)
Q Consensus       422 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll  474 (635)
                      +|..++.....+.++...+.+|+.||+.||.|||..  .+|||.||||+|||+
T Consensus       171 nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  171 NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence            999999776667799999999999999999999984  479999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=7.6e-27  Score=217.05  Aligned_cols=237  Identities=19%  Similarity=0.292  Sum_probs=179.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----ChHHHHHHHhhhc-cCCcccEEEEEecCC--eeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----DASDQIKLLNKIN-HSSLIRLLGICFNGG--NWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      +.||.|..  ++..++||.+++    .+.+|+.+|..+. |+||++|++...+..  ...|++||..+.+...+...   
T Consensus        52 SEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t---  128 (338)
T KOG0668|consen   52 SEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT---  128 (338)
T ss_pred             hhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh---
Confidence            57888874  788999999865    5789999999996 999999999998654  46899999999877666533   


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        |+..++...+.+++.||.|+|+.|   |.|||+||.|++||.. -.++|+|+|+|.+......    ....+.+..|-
T Consensus       129 --l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e----YnVRVASRyfK  199 (338)
T KOG0668|consen  129 --LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVRVASRYFK  199 (338)
T ss_pred             --hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce----eeeeeehhhcC
Confidence              777888899999999999999966   9999999999999865 5699999999987765432    12345677788


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------------------c
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------------------G  567 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------------------~  567 (635)
                      -||.+.. ..++...|+|||||++..|+..+.||....++...++....- +...+                       .
T Consensus       200 GPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV-LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~  278 (338)
T KOG0668|consen  200 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV-LGTDELYAYLNKYQIDLDPQFEDILGRHS  278 (338)
T ss_pred             CchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH-hChHHHHHHHHHHccCCChhHhhHhhccc
Confidence            9998865 568889999999999999999999987655544444333221 11111                       0


Q ss_pred             hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.....++.+.-+    .-...+..+++.+.|..|..+|+|++|.+.|
T Consensus       279 rk~w~~Fi~~~n~----hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  279 RKPWSRFINSENQ----HLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             cccHHHhCCcccc----ccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1111122222111    1123557899999999999999999998876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=1.3e-25  Score=217.59  Aligned_cols=197  Identities=35%  Similarity=0.571  Sum_probs=171.7

Q ss_pred             ceEEEeeeC--CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKIG--GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~~--~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++..  ++.+++|.+...        +.+|++.++++.|++++++++++......++++||+.+++|.+++....
T Consensus         7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~   86 (215)
T cd00180           7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE   86 (215)
T ss_pred             eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc
Confidence            899999995  899999998654        6689999999999999999999999899999999999999999996542


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                       ..+++..+..++.+++.+|.+||+.   +++|+||+|+||+++. ++.++|+|||.+........   ......+...|
T Consensus        87 -~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~  159 (215)
T cd00180          87 -GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAY  159 (215)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCCCCc
Confidence             2389999999999999999999985   4999999999999999 89999999999876543321   12234577889


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ++||.+... ..+.+.|+|++|+++++|                                                   .
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------------~  188 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------------P  188 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------------H
Confidence            999999877 788999999999999999                                                   2


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+.+++.+|++.||++||++.++++++
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            378999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.1e-26  Score=238.03  Aligned_cols=245  Identities=23%  Similarity=0.277  Sum_probs=181.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhc------cCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKIN------HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~------h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      ++|.+|+.  .|..||||+++..      -..|+++|++|+      ..|+++|+..|...+++|||||-+ ..+|.+.|
T Consensus       446 s~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevL  524 (752)
T KOG0670|consen  446 STVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVL  524 (752)
T ss_pred             eeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHH
Confidence            68888887  5779999999764      347999999995      358999999999999999999976 56999999


Q ss_pred             cccC-CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccc
Q 042486          428 NDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       428 ~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ...+ ...|....+..++.|+..||..|-.++   |+|.||||+|||+++. ..+||||||.|......+-.     ...
T Consensus       525 KKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-----PYL  596 (752)
T KOG0670|consen  525 KKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEIT-----PYL  596 (752)
T ss_pred             HHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccccccc-----HHH
Confidence            6533 345888999999999999999999976   9999999999999875 67899999999877654422     123


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH-HHHhhhccc-----ccC--------------
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML-LVDVLNPVL-----HKE--------------  565 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~-l~~~~~~~~-----~~~--------------  565 (635)
                      .+..|.|||++.+-.|+...|+||.||+||||.||+..|.......+. +..-+...+     .+.              
T Consensus       597 VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~  676 (752)
T KOG0670|consen  597 VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFL  676 (752)
T ss_pred             HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceE
Confidence            455799999999999999999999999999999999888765444322 111010000     000              


Q ss_pred             ----C---chhhhh--hhcCC------cC--CCCCC---hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          566 ----D---GEESLR--HLMDP------SM--QGNYP---PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       566 ----~---~~~~l~--~~~d~------~~--~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          +   ..+...  ..+.|      .+  ...++   ......|.+|+..||..||++|.|..+.+.|
T Consensus       677 ~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  677 YIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             EEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                0   000000  00001      00  01122   2334568899999999999999999998875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=226.45  Aligned_cols=232  Identities=26%  Similarity=0.308  Sum_probs=171.9

Q ss_pred             CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcchhhcccCCCC
Q 042486          370 GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       370 ~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      .++.||+|++..         ...+|+.++..++|+||++++.++.-.      .+.|+|||+|. .+|...+...    
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~e----  114 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILME----  114 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHh----
Confidence            678899998743         356899999999999999999999743      35799999994 5888888632    


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      ++-+.+..|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+++.....    ...+..+.|..|.|||
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrape  187 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD----FMMTPYVVTRYYRAPE  187 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc----cccCchhheeeccCch
Confidence            677788899999999999999955   999999999999999999999999999855432    2344567889999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch---------------------hhh-h
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE---------------------ESL-R  572 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~---------------------~~l-~  572 (635)
                      ++.+-.+.+.+||||+||++.||++|+-.|...+.  ...+..+...+...+..                     -.. +
T Consensus       188 vil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~--idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~  265 (369)
T KOG0665|consen  188 VILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH--IDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSE  265 (369)
T ss_pred             heeccCCcccchhhhhhhHHHHHhhceEEecCchH--HHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhh
Confidence            99887799999999999999999999977653221  11111111111111100                     000 0


Q ss_pred             hhcCCcCCC--CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMDPSMQG--NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+-|.....  +.++.......+++.+||..||++|.+++++++|
T Consensus       266 ~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  266 LFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            011111110  1112234457899999999999999999999876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=210.91  Aligned_cols=187  Identities=24%  Similarity=0.347  Sum_probs=147.6

Q ss_pred             eEEEeeeCCcEEEEEEeccChH--------HHHHHHhh-hccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc--cC
Q 042486          363 SVYRGKIGGDFVAIKKVYGDAS--------DQIKLLNK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND--KG  431 (635)
Q Consensus       363 ~Vy~g~~~~~~vavK~~~~~~~--------~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~  431 (635)
                      .+|+...+|...|+|+++..+.        .|+++..+ ..+|.+|.++|...+++..++.||.|. .||+.+-..  ..
T Consensus        63 ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~  141 (282)
T KOG0984|consen   63 EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKK  141 (282)
T ss_pred             hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhc
Confidence            4667777999999999976532        34443333 258999999999999999999999984 588776633  23


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      +...++..+-+|+..+..||.|||+  +-.++|||+||+|||++.+|++|+||||.+-.....-.    .+...|...||
T Consensus       142 g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA----kt~daGCkpYm  215 (282)
T KOG0984|consen  142 GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA----KTMDAGCKPYM  215 (282)
T ss_pred             CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH----HHHhcCCCccC
Confidence            4458999999999999999999998  46799999999999999999999999999875543221    12245778999


Q ss_pred             Ccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 042486          512 APEYLEN----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD  556 (635)
Q Consensus       512 aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~  556 (635)
                      |||.+..    ..|+.|+||||||+.+.||.+++.|+..+...-+.+..
T Consensus       216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq  264 (282)
T KOG0984|consen  216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ  264 (282)
T ss_pred             ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence            9998853    46899999999999999999999998765544444333

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=8.6e-26  Score=235.97  Aligned_cols=199  Identities=22%  Similarity=0.304  Sum_probs=158.6

Q ss_pred             cHHHHHHhhcCCC---CCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEE
Q 042486          343 TFEELQAATDDFN---PSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLG  403 (635)
Q Consensus       343 ~~~el~~at~~f~---~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~  403 (635)
                      .|-.|.+|.-+-+   .-.-||    |.|..+.-  +...+|+|.+++.          +..|-+||..-..+-||+|+-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            4455666654422   222222    78887765  5667899987542          456899999999999999999


Q ss_pred             EEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEe
Q 042486          404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA  483 (635)
Q Consensus       404 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  483 (635)
                      .|.+.+.+|+||||++||++..+|-+.+-  +.+.....++.++..|+++.|+.|   +|||||||+|||||.+|.+||+
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence            99999999999999999999999865543  788888888899999999999966   9999999999999999999999


Q ss_pred             eecCccccc---------ccCC---------------c---------------eeeecccccCCCccCccccccCCCCcc
Q 042486          484 NFALARPAE---------RQEG---------------E---------------FALTSHIVGTKGYMAPEYLENGLVSTK  524 (635)
Q Consensus       484 Dfg~a~~~~---------~~~~---------------~---------------~~~~~~~~gt~~y~aPE~~~~~~~s~k  524 (635)
                      |||++.-..         ..+.               .               .......+||+.|+|||++....++..
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~  851 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL  851 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence            999985221         0000               0               000122479999999999999899999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCC
Q 042486          525 LDVYAFGVLMLEMLSGKEAPAL  546 (635)
Q Consensus       525 sDV~SlGvvl~elltG~~p~~~  546 (635)
                      +|.||.||+||||+.|+.||..
T Consensus       852 cdwws~gvil~em~~g~~pf~~  873 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLA  873 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccC
Confidence            9999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=4.7e-25  Score=209.64  Aligned_cols=171  Identities=19%  Similarity=0.220  Sum_probs=128.2

Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      |+|.+++...+ ..+++.+++.|+.|++.||.|||+.+         ||+||+++.++.+|+  ||++.......     
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence            68999996543 34999999999999999999999843         999999999999999  99987654321     


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+...........           +. .
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~-~  128 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-----------PR-D  128 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-----------cc-c
Confidence               25889999999999999999999999999999999999997543222111211111111000           00 0


Q ss_pred             CCCChHHHH--HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          581 GNYPPVTAI--LVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       581 ~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ...+.....  .+.+++.+||..||++||++.|+++++.....++
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            011122222  5899999999999999999999999998876554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.6e-26  Score=216.14  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=178.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC-----CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG-----GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~  425 (635)
                      |.||...+  +|+.||+|++..         .+-+|+++|.-++|.|++..++...-.     .+.|.+.|.|.. +|..
T Consensus        67 GVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHK  145 (449)
T KOG0664|consen   67 GVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHK  145 (449)
T ss_pred             eEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhh
Confidence            99999988  899999999854         355799999999999999999887633     346888998854 7777


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      .+-..  ..|+...+.-+..||++||+|||+.+   |.||||||.|.|++.|..+||+|||+++..+..+..  .....+
T Consensus       146 IIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~--hMTqEV  218 (449)
T KOG0664|consen  146 IIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL--NMTHEV  218 (449)
T ss_pred             eeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh--hhHHHH
Confidence            77433  34888888889999999999999955   999999999999999999999999999976544322  223456


Q ss_pred             cCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch-------hhhhhhcCC
Q 042486          506 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE-------ESLRHLMDP  577 (635)
Q Consensus       506 gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-------~~l~~~~d~  577 (635)
                      -|..|+|||.+.+ ..|+...||||.||++.||+..+-.|...+.-.  ..+.+..++.....+       .....++..
T Consensus       219 VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACEGAk~H~LR~  296 (449)
T KOG0664|consen  219 VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACEGAKNHVLRA  296 (449)
T ss_pred             HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhhhhHHHhhcc
Confidence            7889999999986 568999999999999999998887665433221  112222222222111       111111111


Q ss_pred             -----cCCC----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          578 -----SMQG----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       578 -----~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                           .+..    ..+.....+-..+...++..||.+|.+..+.+.++-
T Consensus       297 ~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  297 GLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             CCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                 1110    011223344567888999999999999998887653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=6.8e-25  Score=227.80  Aligned_cols=173  Identities=27%  Similarity=0.361  Sum_probs=150.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------------hHHHHHHHhhhc---cCCcccEEEEEecCCeeEEEeecc-cC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------------ASDQIKLLNKIN---HSSLIRLLGICFNGGNWYLVYENA-VN  420 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------------~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~E~~-~~  420 (635)
                      |.|+.+..  +...|+||.++++               +.-|++||..++   |+||++++++|++++.+||+||-- ++
T Consensus       575 GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~g  654 (772)
T KOG1152|consen  575 GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEG  654 (772)
T ss_pred             ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCC
Confidence            89999987  5678999987543               346999999997   999999999999999999999965 34


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      -+|.+++..+..  +++.+...|++|++.|+++||+.+   |||||||-+|+.++.+|-+||+|||.+......+.    
T Consensus       655 IDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----  725 (772)
T KOG1152|consen  655 IDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----  725 (772)
T ss_pred             cchhhhhhccCc--cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCCc----
Confidence            589999976544  999999999999999999999955   99999999999999999999999999987665443    


Q ss_pred             ecccccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~  544 (635)
                       ..++||..|.|||++.+..| ...-|||++|++||-++....|+
T Consensus       726 -d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  726 -DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             -ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence             23689999999999998766 56789999999999998877775

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.4e-25  Score=257.64  Aligned_cols=201  Identities=18%  Similarity=0.204  Sum_probs=139.0

Q ss_pred             HHhhhcc-CCcccEEEEEe-------cCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCC
Q 042486          389 LLNKINH-SSLIRLLGICF-------NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNP  460 (635)
Q Consensus       389 ~l~~l~h-~nIv~l~~~~~-------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~  460 (635)
                      ..+.++| .||++++++|.       +.+.+++++||+ +++|.+++.... ..+++.+++.++.||+.||.|||+.+  
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             ccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            3455667 68888999872       234567888987 669999996533 34899999999999999999999854  


Q ss_pred             CeEeecccCCCEEECCCC-------------------cEEEeeecCcccccccCCc-------------eeeecccccCC
Q 042486          461 PHVHKDIKCSNVLLDTDF-------------------RAKIANFALARPAERQEGE-------------FALTSHIVGTK  508 (635)
Q Consensus       461 ~ivH~Dikp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~~~-------------~~~~~~~~gt~  508 (635)
                       |+||||||+||||+..+                   .+|++|||+++........             ........||+
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             99999999999996544                   4555555555432110000             00001135788


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|||||++.+..++.++|||||||+||||++|..|+....   .......             .....+..     ....
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~-------------~~~~~~~~-----~~~~  238 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLR-------------HRVLPPQI-----LLNW  238 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHH-------------HhhcChhh-----hhcC
Confidence            9999999999899999999999999999999887643110   0000000             00111110     0112


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+++.+||+.||.+||++.|++++
T Consensus       239 ~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        239 PKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            235678899999999999999999875

>PRK06347 autolysin; Reviewed

Probab=99.91  E-value=2.7e-24  Score=234.34  Aligned_cols=166  Identities=17%  Similarity=0.186  Sum_probs=132.6

Q ss_pred             eeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeeccccCC----------------CCceeeeEE
Q 042486           59 FLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSG----------------KHYQANTTY  122 (635)
Q Consensus        59 ~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~~c~~----------------~~~~~~~~y  122 (635)
                      +..|+|++ ||||+.||++||+++++|+++|++. .+.+.+||.|.||..-.-..                ........|
T Consensus       405 ~~~ytVk~-GDTL~sIA~kygVSv~~L~~~N~l~-s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~Y  482 (592)
T PRK06347        405 AKVYTVVK-GDSLWRIANNNKVTIANLKSWNNLK-SDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVY  482 (592)
T ss_pred             ceeEEecC-CCCHHHHHHHhCCCHHHHHHHhCCC-cceeccCcEEEEecCCcccccccccccccccccccccccccceee
Confidence            45799998 9999999999999999999999985 46799999999997421100                001123479


Q ss_pred             EEecCCchhhhhhhhcCCCccHHHHHhhc-CCCCCCCCCcEEEEeeeccCCCCCC-----CCCCeeeEEEEEeecCChHH
Q 042486          123 FVQNGDTYFLIANNTFQGLSTCQALQDQH-GNVSNFGVGTRLLAPLRCACPTKNQ-----TDSGVHYLLSYLVKGGNTVY  196 (635)
Q Consensus       123 ~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~~~~c~~~~~-----~~~~~~~~~~y~v~~gdtl~  196 (635)
                      +|++|||||.|| ++|+  +++++|++|| +..+.|++||+|.||....-.....     .........+|+|++|||||
T Consensus       483 tVk~GDTL~sIA-kkyg--VSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~  559 (592)
T PRK06347        483 TVAKGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLW  559 (592)
T ss_pred             eecCCCCHHHHH-HHHC--CCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHH
Confidence            999999999999 8898  9999999999 7778999999999997543211000     00011124589999999999


Q ss_pred             hHHHHhCCChhHHHHhcCCCCCCCCcccceecccC
Q 042486          197 GISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVP  231 (635)
Q Consensus       197 ~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP  231 (635)
                      +||++|||++++|++||+|.. + .|++||.|.|+
T Consensus       560 sIA~KygvSv~~L~~~N~L~~-~-~L~~GQ~L~I~  592 (592)
T PRK06347        560 AISRQYKTTVDNIKAWNKLTS-N-MIHVGQKLTIK  592 (592)
T ss_pred             HHHHHhCCCHHHHHHhcCCCc-c-cCCCCCEEecC
Confidence            999999999999999999974 4 59999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=3.3e-25  Score=233.66  Aligned_cols=230  Identities=24%  Similarity=0.372  Sum_probs=181.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.|||++.  .++.+|+|.++-+       ..+|+-+++..+|+||+.++|.+...+..++.||||.+|+|++.-+-.+ 
T Consensus        29 gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg-  107 (829)
T KOG0576|consen   29 GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG-  107 (829)
T ss_pred             cchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc-
Confidence            88999988  7899999998643       4579999999999999999999999999999999999999999876544 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       ++++.++...+++.++||+|||+.+   -+|||||-.||++++.+.+|+.|||.+-.+...-   .....+.||+.|||
T Consensus       108 -plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati---~KrksfiGtpywma  180 (829)
T KOG0576|consen  108 -PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI---AKRKSFIGTPYWMA  180 (829)
T ss_pred             -cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh---hhhhcccCCccccc
Confidence             3999999999999999999999955   8999999999999999999999999986554322   33456789999999


Q ss_pred             cccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYL---ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~---~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||+.   ..+.|..++|||++|+...|+-.-++|...-..  +.....    ..+        ...+|... ..+.....
T Consensus       181 pEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l~L----mTk--------S~~qpp~l-kDk~kws~  245 (829)
T KOG0576|consen  181 PEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRALFL----MTK--------SGFQPPTL-KDKTKWSE  245 (829)
T ss_pred             hhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHHHH----hhc--------cCCCCCcc-cCCccchH
Confidence            9976   357789999999999999999887766421110  000000    000        01111111 11223455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~  614 (635)
                      .+-++++.|+-.+|++||+++.++.
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee
Confidence            6889999999999999999998765

>PRK06347 autolysin; Reviewed

Probab=99.90  E-value=2.8e-23  Score=226.39  Aligned_cols=170  Identities=19%  Similarity=0.186  Sum_probs=135.0

Q ss_pred             eeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeeccccCC-----------------CCceeee
Q 042486           58 AFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSG-----------------KHYQANT  120 (635)
Q Consensus        58 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~~c~~-----------------~~~~~~~  120 (635)
                      ....|+|++ ||||+.||++||+++++|+++|++. .+.|.+||.|+||..-.-..                 .......
T Consensus       329 ~~~~Y~V~s-GDTL~~IA~rygvSv~eL~~~N~l~-~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~  406 (592)
T PRK06347        329 NAKIYTVVK-GDSLWRIANNHKVTVANLKAWNNLK-SDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAK  406 (592)
T ss_pred             CceEEEeCC-CCCHHHHHHHhCCCHHHHHHHhCCC-ccccccCcEEEEeccccccccccccccccccccccccccccCce
Confidence            567799998 9999999999999999999999985 56899999999997421100                 0011235


Q ss_pred             EEEEecCCchhhhhhhhcCCCccHHHHHhhc-CCCCCCCCCcEEEEeeeccC------CCCCC-----CCCCeeeEEEEE
Q 042486          121 TYFVQNGDTYFLIANNTFQGLSTCQALQDQH-GNVSNFGVGTRLLAPLRCAC------PTKNQ-----TDSGVHYLLSYL  188 (635)
Q Consensus       121 ~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~~~~c------~~~~~-----~~~~~~~~~~y~  188 (635)
                      .|+|++||||+.|| ++|+  +++++|+++| +..+.|.+||+|.||..-.-      +....     .........+|+
T Consensus       407 ~ytVk~GDTL~sIA-~kyg--VSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~Yt  483 (592)
T PRK06347        407 VYTVVKGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYT  483 (592)
T ss_pred             eEEecCCCCHHHHH-HHhC--CCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeee
Confidence            79999999999999 8899  9999999999 76778999999999964211      10000     000111235799


Q ss_pred             eecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCCCC
Q 042486          189 VKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN  234 (635)
Q Consensus       189 v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~  234 (635)
                      |++|||||+||++||+++++|++||++.. + .|++||.|.||...
T Consensus       484 Vk~GDTL~sIAkkygVSv~~L~~~N~l~s-~-~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        484 VAKGDSLWRIANNNKVTIANLKSWNNLKS-D-FIYPGQKLKVSAGS  527 (592)
T ss_pred             ecCCCCHHHHHHHHCCCHHHHHHhcCCCc-c-cccCCcEEEEecCc
Confidence            99999999999999999999999999974 3 59999999999754

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=5.5e-24  Score=215.10  Aligned_cols=256  Identities=22%  Similarity=0.315  Sum_probs=185.0

Q ss_pred             cCCCCCCccc----ceEEEeee-----CCcEEEEEEecc-----ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEee
Q 042486          352 DDFNPSCWIK----GSVYRGKI-----GGDFVAIKKVYG-----DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~-----~~~~vavK~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      +.|...++||    ++||++.+     .++.||+|.+..     .+.+|+++|..+ .+.||+++.+++..++...+|+|
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            3444455555    68999876     357899999864     467999999999 58999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQE  495 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~  495 (635)
                      |++.....++...     ++..++..+++.++.||.++|..|   ||||||||+|++.+. .++-.|.|||+|...+...
T Consensus       116 ~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             ccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            9999988888855     678889999999999999999954   999999999999975 4778999999997211000


Q ss_pred             --------------------------------Ccee---------eecccccCCCccCcccccc-CCCCcccchhhHHHH
Q 042486          496 --------------------------------GEFA---------LTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVL  533 (635)
Q Consensus       496 --------------------------------~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvv  533 (635)
                                                      ....         ......||++|+|||++.. ...+++.||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                                            0000         0112469999999998864 667899999999999


Q ss_pred             HHHHHhCCCCCCCCcchhhHHHHhhh---------------c--ccccCC---chhhhhhhcCC---cC---------CC
Q 042486          534 MLEMLSGKEAPALYSEENMLLVDVLN---------------P--VLHKED---GEESLRHLMDP---SM---------QG  581 (635)
Q Consensus       534 l~elltG~~p~~~~~~~~~~l~~~~~---------------~--~~~~~~---~~~~l~~~~d~---~~---------~~  581 (635)
                      ++-+++++.||....++-..+.+.+.               .  ++...+   ..+....+...   ..         ..
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            99999999999766554322222111               1  111000   01111111111   00         00


Q ss_pred             CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ......+..+.+++.+|++.||.+|.|++|.++|
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            1112234468999999999999999999999876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=4.4e-23  Score=203.06  Aligned_cols=179  Identities=33%  Similarity=0.514  Sum_probs=153.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||++..  +++.+|+|.+..        .+.+|++.+++++|+|++++++++......++++||+++++|.+++....
T Consensus        13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   92 (225)
T smart00221       13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG   92 (225)
T ss_pred             eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc
Confidence            79999998  368999998864        34568999999999999999999998899999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      .. +++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.........  ......++..|+
T Consensus        93 ~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~  166 (225)
T smart00221       93 GK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA--LLKTVKGTPFYL  166 (225)
T ss_pred             cC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--cccceeccCCcC
Confidence            22 789999999999999999999854   999999999999999999999999998865443200  123346778899


Q ss_pred             Ccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 042486          512 APEYL-ENGLVSTKLDVYAFGVLMLEMLSGKEAPAL  546 (635)
Q Consensus       512 aPE~~-~~~~~s~ksDV~SlGvvl~elltG~~p~~~  546 (635)
                      +||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       167 ~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      167 APEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            99998 666778899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-23  Score=198.42  Aligned_cols=232  Identities=19%  Similarity=0.296  Sum_probs=165.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccChHHHHHHHhhh-------ccCCcccEEEE-EecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKI-------NHSSLIRLLGI-CFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~~~E~~~l~~l-------~h~nIv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.+-.++.  ++..+++|.+.+......++.+..       .|.||+.-++. |...+.+++++||++.|+|.+-+...+
T Consensus        38 gkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G  117 (378)
T KOG1345|consen   38 GKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG  117 (378)
T ss_pred             eeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc
Confidence            55555555  677899999876544434444433       48899987665 456678899999999999999886643


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE-C-CCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL-D-TDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll-~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                         +.+....+++.|+++||.|||+   +++||||||.+|||| + +..++||||||..+..+..-      ....-+..
T Consensus       118 ---igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV------~~~~~~~~  185 (378)
T KOG1345|consen  118 ---IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV------KYLEYVNN  185 (378)
T ss_pred             ---ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCcee------hhhhhhcc
Confidence               7888899999999999999999   459999999999999 3 33589999999987554321      12234557


Q ss_pred             ccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          510 YMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       510 y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      |.+||....     -...+.+|||.||+++|.++||+.||....-.+..+++|....-..           .+.+...+.
T Consensus       186 y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk-----------~~~~P~~F~  254 (378)
T KOG1345|consen  186 YHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK-----------NPALPKKFN  254 (378)
T ss_pred             cCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-----------CccCchhhc
Confidence            899997642     2357889999999999999999999975544455555554432111           111211111


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                       -.+..+..+.++-|.++|++|--..++.+...
T Consensus       255 -~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  255 -PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             -ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence             12344678888999999999955555555433

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1e-22  Score=194.02  Aligned_cols=232  Identities=22%  Similarity=0.389  Sum_probs=183.8

Q ss_pred             ceEEEeeeCCcEEEEEEe---------ccChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGGDFVAIKKV---------YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |..|+|++.|..+++|.+         .++|.+|.-.|+-+.||||+.++|.|....+..++..||+.|+|...|+...+
T Consensus       204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~  283 (448)
T KOG0195|consen  204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS  283 (448)
T ss_pred             cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc
Confidence            899999998887877765         34678888899999999999999999999999999999999999999988777


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ...+..+..+++.+++.|+.|||+.. +-|..--|.+..+++|++.+++|+- +-+++.-.       .....-.+.||+
T Consensus       284 vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsfq-------e~gr~y~pawms  354 (448)
T KOG0195|consen  284 VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ-------EVGRAYSPAWMS  354 (448)
T ss_pred             EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeeee-------ccccccCcccCC
Confidence            77888899999999999999999975 4455557899999999998887752 11111111       111234678999


Q ss_pred             ccccccCCC---CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLENGLV---STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~~~~~---s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||.+....-   -..+|+|||.+++|||.|...||...+.-+                  --.++.-+.++...|+..+.
T Consensus       355 pealqrkped~n~raadmwsfaillwel~trevpfadlspme------------------cgmkialeglrv~ippgis~  416 (448)
T KOG0195|consen  355 PEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------------------CGMKIALEGLRVHIPPGISR  416 (448)
T ss_pred             HHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------------------hhhhhhhccccccCCCCccH
Confidence            999875432   357899999999999999999986332211                  11112223445566777788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      .+..|+.-|+..||.+||.++.|+-.|+++.
T Consensus       417 hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            8999999999999999999999999999875

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.84  E-value=1.4e-20  Score=201.74  Aligned_cols=165  Identities=20%  Similarity=0.248  Sum_probs=126.7

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcC-CCCCcccCCC-cEEEEeeccccC-------CC------------Ccee
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINS-VSETATFETN-QMVIVPVNCSCS-------GK------------HYQA  118 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~-~~~~~~~~~g-q~l~ip~~~~c~-------~~------------~~~~  118 (635)
                      ....+.. +.+|..||+++|+++++|.++|. +......+.| +.|+||....-.       +.            ....
T Consensus       264 ~~V~v~~-~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~  342 (456)
T PRK10783        264 ARVDLGQ-QIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLN  342 (456)
T ss_pred             EEEecCC-CcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCC
Confidence            3344444 67999999999999999999995 4333233344 778888753210       00            0012


Q ss_pred             eeEEEEecCCchhhhhhhhcCCCccHHHHHhhc-CCCCCCCCCcEEEEeeeccCCCCCCCCCCeeeEEEEEeecCChHHh
Q 042486          119 NTTYFVQNGDTYFLIANNTFQGLSTCQALQDQH-GNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYG  197 (635)
Q Consensus       119 ~~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~  197 (635)
                      ..+|+|++|||++.|| +.|+  ++.++|.++| ...+.|.+||+|.||..+.|...    ......++|+|++||||++
T Consensus       343 ~~~y~Vk~GDTL~sIA-~r~g--vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~----~~~~~~~~Y~Vr~GDTL~s  415 (456)
T PRK10783        343 SRSYKVRSGDTLSGIA-SRLN--VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRL----ANNSDSITYRVRKGDSLSS  415 (456)
T ss_pred             ceEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCcccCCCCCEEEecCCcccccc----cccccceeEEeCCCCCHHH
Confidence            3579999999999999 7788  8999999999 66688999999999976665321    1123346899999999999


Q ss_pred             HHHHhCCChhHHHHhcCCCCCCCCcccceecccCCCC
Q 042486          198 ISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN  234 (635)
Q Consensus       198 Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~  234 (635)
                      ||++|||++++|++||++...  .|+|||+|.|++..
T Consensus       416 IA~kygVtv~~L~~~N~l~~~--~L~pGq~L~l~v~~  450 (456)
T PRK10783        416 IAKRHGVNIKDVMRWNSDTAK--NLQPGDKLTLFVKN  450 (456)
T ss_pred             HHHHhCCCHHHHHHhcCCCCC--cCCCCCEEEEecCC
Confidence            999999999999999998643  69999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=5.5e-19  Score=184.64  Aligned_cols=243  Identities=18%  Similarity=0.167  Sum_probs=179.8

Q ss_pred             ceEEEeeeCC---cEEEEEEecc-------ChHHHHHHHhhhcc----CCcccEEEEE-ecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGG---DFVAIKKVYG-------DASDQIKLLNKINH----SSLIRLLGIC-FNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~---~~vavK~~~~-------~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||.+....   ..+|+|....       .+..|..++..+.+    +++.++++.. ..+...|+||+.+ |.+|.++
T Consensus        32 G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl  110 (322)
T KOG1164|consen   32 GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDL  110 (322)
T ss_pred             ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHH
Confidence            8999999833   4688886643       35679999999873    5899999998 4777889999976 8899998


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-----CcEEEeeecCccccc--ccCCce-
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-----FRAKIANFALARPAE--RQEGEF-  498 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~Dfg~a~~~~--~~~~~~-  498 (635)
                      ........++....+.|+.|++.+|++||+.|   ++||||||+|+++...     ..+.|.|||+++...  ...... 
T Consensus       111 ~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~  187 (322)
T KOG1164|consen  111 RKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNL  187 (322)
T ss_pred             HHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCccc
Confidence            86555556999999999999999999999965   9999999999999754     469999999998322  221110 


Q ss_pred             --ee--ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          499 --AL--TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       499 --~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                        ..  .....||..|.+++.+.+...+.+.|+||++.++.|++.|..||.........               ..+.+.
T Consensus       188 ~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---------------~~~~~~  252 (322)
T KOG1164|consen  188 RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---------------SKFEKD  252 (322)
T ss_pred             ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---------------HHHHHH
Confidence              11  12356999999999999999999999999999999999999998543321110               000000


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .............+..+.++...+-..+..++|....+...|+......
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            0000000011222334666666666789999999999999998887653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.6e-19  Score=187.18  Aligned_cols=152  Identities=22%  Similarity=0.232  Sum_probs=114.4

Q ss_pred             cCCCCCCccc----ceEEEeee---CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeE
Q 042486          352 DDFNPSCWIK----GSVYRGKI---GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~---~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  412 (635)
                      ++|.....||    |+||+|..   +++.||||++..            .+.+|+++|++++|+|+++.+..   .+..|
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~   94 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG   94 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence            4455555565    89999986   567789998542            25689999999999999863332   24579


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecc-cCCCEEECCCCcEEEeeecCcccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI-KCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      +||||++|++|... ..     ..   ...++.+++.+|.|||+.+   |+|||| ||+|||++.++.+||+|||+++..
T Consensus        95 LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         95 LVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             EEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            99999999999632 11     11   1467889999999999854   999999 999999999999999999999866


Q ss_pred             cccCCceee-----ecccccCCCccCcccccc
Q 042486          492 ERQEGEFAL-----TSHIVGTKGYMAPEYLEN  518 (635)
Q Consensus       492 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~  518 (635)
                      .........     .....+++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            543211111     134678889999999853

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=1.7e-18  Score=169.94  Aligned_cols=250  Identities=17%  Similarity=0.173  Sum_probs=185.8

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEec-----cChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccC
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVY-----GDASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVN  420 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~-----~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~  420 (635)
                      +|..+.+||    |.++.|+.  ++.+||||.-.     .++..|....+.|. .+.|...+-+...+.+-.||+|.+ |
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            455556665    88999986  99999999653     24678999999884 688999888888888889999987 7


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-----CCcEEEeeecCcccccccC
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-----DFRAKIANFALARPAERQE  495 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~a~~~~~~~  495 (635)
                      .||+|++.-.+++ ++.+.+..+|.|++.-++|+|+..   +|.|||||+|+||..     ...+.++|||+|+......
T Consensus       108 PSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  108 PSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             cCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            8999988654433 899999999999999999999955   999999999999953     3468999999999765543


Q ss_pred             Cc----eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          496 GE----FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       496 ~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      ..    ........||.+||+-....+...+.+.|+-|||-++++.+-|..||..-..+               ...+..
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~---------------tnK~kY  248 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD---------------TNKEKY  248 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc---------------chHHHH
Confidence            22    11224467999999999999999999999999999999999999999753222               112222


Q ss_pred             hhhcCCcCCCC---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          572 RHLMDPSMQGN---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       572 ~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .++-+..-...   .-...+.++..-++-.-..+-.+-|..+-+...+.++++.
T Consensus       249 eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  249 EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            22222111000   0011233455666666677788888888777777776643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=1.9e-19  Score=191.42  Aligned_cols=219  Identities=24%  Similarity=0.394  Sum_probs=162.5

Q ss_pred             HhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccC
Q 042486          390 LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC  469 (635)
Q Consensus       390 l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp  469 (635)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.... ..++|.....+.++++.||.|||..  +-..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence            467899999999999999999999999999999999997643 3499999999999999999999983  3339999999


Q ss_pred             CCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC-------CCCcccchhhHHHHHHHHHhCCC
Q 042486          470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-------LVSTKLDVYAFGVLMLEMLSGKE  542 (635)
Q Consensus       470 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SlGvvl~elltG~~  542 (635)
                      +|+++|..+.+||+|||+........ .........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999987664310 00111112234579999998753       14678999999999999999999


Q ss_pred             CCCCCcchhh--HHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          543 APALYSEENM--LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       543 p~~~~~~~~~--~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ||........  .+...+..     ..    .....|.+...  .+....+..++.+||..+|.+||+++++-..++.+.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~----~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GG----SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cC----CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9875332221  11111111     00    00011111100  023335899999999999999999999999999887


Q ss_pred             hhc
Q 042486          621 NAS  623 (635)
Q Consensus       621 ~~s  623 (635)
                      ...
T Consensus       226 ~~~  228 (484)
T KOG1023|consen  226 KGG  228 (484)
T ss_pred             ccc
Confidence            643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.78  E-value=1.1e-17  Score=172.80  Aligned_cols=241  Identities=27%  Similarity=0.403  Sum_probs=179.9

Q ss_pred             ceEEEeeeCCcEEEEEEecc----------ChHHHHHHHhhhccC-CcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIGGDFVAIKKVYG----------DASDQIKLLNKINHS-SLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~----------~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++... ..+++|.+..          .+.+|+.++..+.|+ +++++.+.+......+++++++.++++.+++...
T Consensus        14 ~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~   92 (384)
T COG0515          14 GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI   92 (384)
T ss_pred             eEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            789999887 7788888753          255788899999988 7999999997777789999999999999777543


Q ss_pred             CC-CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCce---eeecccc
Q 042486          431 GG-KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEF---ALTSHIV  505 (635)
Q Consensus       431 ~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~---~~~~~~~  505 (635)
                      .. ..+.......+..+++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.++.........   .......
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  169 (384)
T COG0515          93 GRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV  169 (384)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccc
Confidence            31 24888999999999999999999955   99999999999999988 79999999998544332211   1235578


Q ss_pred             cCCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcch--hhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          506 GTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE--NMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       506 gt~~y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      |+..|++||.+..   ...+...|+||+|++++++++|..|+......  .......+......         .......
T Consensus       170 ~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  240 (384)
T COG0515         170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---------SLASPLS  240 (384)
T ss_pred             cccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---------ccccccC
Confidence            9999999999987   57899999999999999999999986543321  11111111111100         0000000


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..........+.+++..|+..+|..|.++.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00001223457899999999999999999987776

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=4.7e-20  Score=205.07  Aligned_cols=213  Identities=20%  Similarity=0.238  Sum_probs=159.8

Q ss_pred             HHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEe
Q 042486          385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH  464 (635)
Q Consensus       385 ~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH  464 (635)
                      .|+-+-..++|+|++..+..+.+....+-+|||+++ +|...+....  .+...++..+++|++.|++|||+.+   +.|
T Consensus       370 sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iah  443 (601)
T KOG0590|consen  370 SEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAH  443 (601)
T ss_pred             hheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---cee
Confidence            344455667999998888877776666666999999 9999986542  3788889999999999999999966   999


Q ss_pred             ecccCCCEEECCCCcEEEeeecCcccccccCC-ceeeecccccCCCccCccccccCCCCc-ccchhhHHHHHHHHHhCCC
Q 042486          465 KDIKCSNVLLDTDFRAKIANFALARPAERQEG-EFALTSHIVGTKGYMAPEYLENGLVST-KLDVYAFGVLMLEMLSGKE  542 (635)
Q Consensus       465 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~SlGvvl~elltG~~  542 (635)
                      ||+|++|++++.++.+||+|||.+........ ........+|+..|+|||.+....|.+ ..||||.|+++..|.+|+.
T Consensus       444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~  523 (601)
T KOG0590|consen  444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF  523 (601)
T ss_pred             ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence            99999999999999999999999876543321 123445678999999999999888866 5899999999999999999


Q ss_pred             CCCCCcchhhHHHHhhh-cccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          543 APALYSEENMLLVDVLN-PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       543 p~~~~~~~~~~l~~~~~-~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ||.....++....+... ........            ........+...+.++.+||+.||.+|.|+++|++.
T Consensus       524 ~Wk~a~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  524 PWKVAKKSDNSFKTNNYSDQRNIFEG------------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccccccchhhhccccccccccC------------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            98754443322100000 00000000            001123345567899999999999999999999864

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=7.8e-19  Score=195.00  Aligned_cols=230  Identities=22%  Similarity=0.307  Sum_probs=162.9

Q ss_pred             eEEEeeeCCcEEEEEEeccC--------hHH---HHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          363 SVYRGKIGGDFVAIKKVYGD--------ASD---QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       363 ~Vy~g~~~~~~vavK~~~~~--------~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      +|.+++.....|+||++.+.        +.+   |++ ..-++|||.+++.-+-..+.-.|||-+|..+ +|.|.+..+ 
T Consensus        38 Kv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTR-  114 (1431)
T KOG1240|consen   38 KVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTR-  114 (1431)
T ss_pred             hhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccc-
Confidence            57788886666999987432        233   334 4445899999988776667777999999865 899998654 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC---Ccee-eecccccC
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE---GEFA-LTSHIVGT  507 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~-~~~~~~gt  507 (635)
                       .+|...+.+.|+.|++.||..+|+.+   |+|||||.+||||+.-+-+.|+||..-+..--.+   .++. .......-
T Consensus       115 -PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRR  190 (1431)
T KOG1240|consen  115 -PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRR  190 (1431)
T ss_pred             -hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCce
Confidence             45888889999999999999999965   9999999999999999999999998776432211   1111 11112233


Q ss_pred             CCccCcccccc-----------CCCCcccchhhHHHHHHHHHhC-CCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          508 KGYMAPEYLEN-----------GLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       508 ~~y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                      ..|+|||.+..           ...+++.||||+||++.||++- +++|...     .+...-..  ...+.+..++++-
T Consensus       191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~--~~~~~e~~Le~Ie  263 (1431)
T KOG1240|consen  191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG--NADDPEQLLEKIE  263 (1431)
T ss_pred             eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc--CccCHHHHHHhCc
Confidence            47999998743           1267899999999999999885 5555321     11111000  0112233334433


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      |.            .+++++..|++.||++|.++++.++.-+.
T Consensus       264 d~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  264 DV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             Cc------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            32            37899999999999999999999987443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=9.6e-18  Score=168.05  Aligned_cols=186  Identities=22%  Similarity=0.273  Sum_probs=128.3

Q ss_pred             eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE--CCC--CcEEEeee
Q 042486          410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL--DTD--FRAKIANF  485 (635)
Q Consensus       410 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll--~~~--~~~kl~Df  485 (635)
                      ..|+||..++ .+|.+++..+.   .+.....-|+.|+++|+.|||+++   |.|||+|++|||+  |+|  ..+.|+||
T Consensus       317 tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  317 TLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             eEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccc
Confidence            4789999875 48999996543   566667778999999999999976   9999999999999  333  35789999


Q ss_pred             cCcccccccCCceee---ecccccCCCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 042486          486 ALARPAERQEGEFAL---TSHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD  556 (635)
Q Consensus       486 g~a~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~  556 (635)
                      |++-..+...-....   .-...|.-.-||||+.....      --.|+|.|+.|.+.||+++...||....+-....  
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--  467 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--  467 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--
Confidence            987533221100001   11235777889999875311      1348999999999999999999986422211110  


Q ss_pred             hhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       557 ~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                                  ...++-.-|.+    |..++..+.+++...|+.||++|++..-....|.-.+
T Consensus       468 ------------r~Yqe~qLPal----p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsL  515 (598)
T KOG4158|consen  468 ------------RTYQESQLPAL----PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSL  515 (598)
T ss_pred             ------------hhhhhhhCCCC----cccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHH
Confidence                        01111112233    3334455889999999999999999887776665433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=2.4e-17  Score=155.23  Aligned_cols=238  Identities=16%  Similarity=0.149  Sum_probs=176.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhcc-CCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINH-SSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.+|.|..  +|..||||.-..     ....|..+...+++ ..|..+..+..+...-.+|||.+ |.+|++++.-... 
T Consensus        29 GdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-  106 (341)
T KOG1163|consen   29 GDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-  106 (341)
T ss_pred             hheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhh-
Confidence            88999987  899999997654     45678888888875 46777777777888889999977 8899999854332 


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC---CCCcEEEeeecCcccccccCCc----eeeeccccc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD---TDFRAKIANFALARPAERQEGE----FALTSHIVG  506 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~g  506 (635)
                      .++....+-++-|++.-++|+|..+   ++||||||+|+|..   ....+.|+|||+++........    ........|
T Consensus       107 ~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltG  183 (341)
T KOG1163|consen  107 RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTG  183 (341)
T ss_pred             hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccce
Confidence            2889999999999999999999855   99999999999995   3467999999999866443222    112244679


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh-cC---CcCCCC
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-MD---PSMQGN  582 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-~d---~~~~~~  582 (635)
                      |.+|.+-..+.+...+.+.|+-|+|.+|.++.-|..||..........            .-|.+.+. +.   ..+..-
T Consensus       184 TaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q------------KyEkI~EkK~s~~ie~LC~G  251 (341)
T KOG1163|consen  184 TARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ------------KYEKISEKKMSTPIEVLCKG  251 (341)
T ss_pred             eeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH------------HHHHHHHhhcCCCHHHHhCC
Confidence            999999988888888999999999999999999999997533221110            00111110 00   011122


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      +    +.++.-.+.-|-..--++-|...-+.+.++-++
T Consensus       252 ~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  252 F----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             C----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            2    344667788898888889998877766666554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=5.6e-18  Score=180.05  Aligned_cols=208  Identities=22%  Similarity=0.313  Sum_probs=170.0

Q ss_pred             hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCC
Q 042486          383 ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP  461 (635)
Q Consensus       383 ~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~  461 (635)
                      ...|..++..++ ||.++++...+..+...+++++|..+|.|...+.....  +.+.........++-+++++|+.+   
T Consensus        43 t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~---  117 (612)
T KOG0603|consen   43 TKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG---  117 (612)
T ss_pred             cccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH---
Confidence            346788888886 99999999999999999999999999999888865443  666777778889999999999966   


Q ss_pred             eEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 042486          462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK  541 (635)
Q Consensus       462 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~  541 (635)
                      ++|||+|++||+++.+|.+++.|||+.+..-....       .+||..|||||++.  ......|.||||++++||+||.
T Consensus       118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~  188 (612)
T KOG0603|consen  118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGT  188 (612)
T ss_pred             HHHhcccccceeecccCccccCCchhhhHhHhhhh-------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCC
Confidence            99999999999999999999999999886544321       27999999999998  4567899999999999999999


Q ss_pred             CCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH--HHHHHHHHHH
Q 042486          542 EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM--DKIAQSISRF  619 (635)
Q Consensus       542 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~~  619 (635)
                      .||..                      +..+.++.  .....|.+......+++..++..+|..|--.  +.+.+..+.-
T Consensus       189 ~pf~~----------------------~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~  244 (612)
T KOG0603|consen  189 LPFGG----------------------DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE  244 (612)
T ss_pred             CCCch----------------------HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence            98753                      11111111  1124566777778999999999999999765  6777778878


Q ss_pred             Hhhcccccc
Q 042486          620 LNASLAWEL  628 (635)
Q Consensus       620 ~~~s~~w~~  628 (635)
                      .-.+.+|..
T Consensus       245 f~~~i~~~~  253 (612)
T KOG0603|consen  245 FFQSIDWNE  253 (612)
T ss_pred             hheeeeHhh
Confidence            888899984

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.70  E-value=6.9e-17  Score=155.20  Aligned_cols=123  Identities=18%  Similarity=0.157  Sum_probs=96.8

Q ss_pred             ceEEEeee-CCcEEEEEEeccCh---------------------------------HHHHHHHhhhccCCcccEEEEEec
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGDA---------------------------------SDQIKLLNKINHSSLIRLLGICFN  407 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~~---------------------------------~~E~~~l~~l~h~nIv~l~~~~~~  407 (635)
                      |.||+|.. +|+.||||.++.+.                                 ..|++.|.++.++++.....+.. 
T Consensus        11 ~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~-   89 (190)
T cd05147          11 ANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL-   89 (190)
T ss_pred             eEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe-
Confidence            89999987 78999999985421                                 12889999998887754333322 


Q ss_pred             CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhccc-ccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL-HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       408 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                       ...+|||||++++++.......  ..+++.....++.|++.+|.++ |+.+   |+||||||+||+++ ++.++|+|||
T Consensus        90 -~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG  162 (190)
T cd05147          90 -KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVS  162 (190)
T ss_pred             -cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEcc
Confidence             2238999999988776553222  2488999999999999999999 6744   99999999999998 4789999999


Q ss_pred             Cccccc
Q 042486          487 LARPAE  492 (635)
Q Consensus       487 ~a~~~~  492 (635)
                      ++....
T Consensus       163 ~a~~~~  168 (190)
T cd05147         163 QSVEHD  168 (190)
T ss_pred             ccccCC
Confidence            997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=1.3e-17  Score=174.20  Aligned_cols=175  Identities=25%  Similarity=0.424  Sum_probs=129.4

Q ss_pred             eeEEEeecccCCCcchhhc-ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCc
Q 042486          410 NWYLVYENAVNGSLSVWIN-DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA  488 (635)
Q Consensus       410 ~~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  488 (635)
                      ..|+.|+++...+|.+|+. +......++.....++.|++.|++|   .   +.+|+|+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            4789999999999999995 3344557888999999999999999   2   3999999999999999999999999998


Q ss_pred             ccccccCC---ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhccccc
Q 042486          489 RPAERQEG---EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       489 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      ........   .........||..||+||.+.+..|+.|+||||||++|+||+. -..++.    ....+          
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~----------  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATL----------  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhh----------
Confidence            86654431   1122344689999999999999999999999999999999998 222211    00000          


Q ss_pred             CCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 042486          565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI  612 (635)
Q Consensus       565 ~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  612 (635)
                         .+.-...++|....++|.+     ..|+.+++...|.+||++.+.
T Consensus       470 ---~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 ---TDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ---hhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence               0111112222222334433     578999999999999954443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.67  E-value=5.4e-17  Score=158.08  Aligned_cols=148  Identities=11%  Similarity=0.087  Sum_probs=114.5

Q ss_pred             ceEEEeeeCCcEEEEEEeccC----------------hHHHHHHHhhhccCCcccEEEEEecC--------CeeEEEeec
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD----------------ASDQIKLLNKINHSSLIRLLGICFNG--------GNWYLVYEN  417 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~----------------~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~lV~E~  417 (635)
                      |.||....+++.+|||.+++.                +.+|++.+.+++|++|..+.+++...        +..+|+|||
T Consensus        45 ~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEy  124 (232)
T PRK10359         45 TKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEY  124 (232)
T ss_pred             eEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEE
Confidence            899987777888999998642                35788899999999999999886633        357999999


Q ss_pred             ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       418 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      ++|.+|.++..      ++.    ....+++.+|..+|+.+   ++|||+||+||+++.++ ++|+|||...........
T Consensus       125 i~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~  190 (232)
T PRK10359        125 IEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK  190 (232)
T ss_pred             ECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH
Confidence            99999988742      232    24568999999999855   99999999999999988 999999988654322110


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHH
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML  538 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ell  538 (635)
                                     ..++....+..++|+|+||+.+..+.
T Consensus       191 ---------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        191 ---------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ---------------HHHHHHhHhcccccccceeEeehHHH
Confidence                           01223334557899999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.67  E-value=3.8e-16  Score=150.42  Aligned_cols=122  Identities=19%  Similarity=0.186  Sum_probs=98.0

Q ss_pred             ceEEEeee-CCcEEEEEEeccC---------------------------------hHHHHHHHhhhccCCcccEEEEEec
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD---------------------------------ASDQIKLLNKINHSSLIRLLGICFN  407 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~---------------------------------~~~E~~~l~~l~h~nIv~l~~~~~~  407 (635)
                      |.||+|+. +|+.||||.++..                                 ...|.+.+.++.|+++.....+...
T Consensus        11 ~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   90 (190)
T cd05145          11 ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK   90 (190)
T ss_pred             cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence            89999987 6999999987643                                 1357888999999987554444333


Q ss_pred             CCeeEEEeecccCCCcchh-hcccCCCCCCHHHHHHHHHHHHhhhccccc-CCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          408 GGNWYLVYENAVNGSLSVW-INDKGGKFLDWAQRIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       408 ~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                        ..+|||||++++++... +..   ..++......++.+++.++.+||+ .+   |+||||||+||+++ ++.++|+||
T Consensus        91 --~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDF  161 (190)
T cd05145          91 --KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDV  161 (190)
T ss_pred             --CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEc
Confidence              24899999998865443 332   237888999999999999999998 55   99999999999998 889999999


Q ss_pred             cCccccc
Q 042486          486 ALARPAE  492 (635)
Q Consensus       486 g~a~~~~  492 (635)
                      |++....
T Consensus       162 G~a~~~~  168 (190)
T cd05145         162 SQAVELD  168 (190)
T ss_pred             ccceecC
Confidence            9997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=3.6e-16  Score=177.52  Aligned_cols=231  Identities=18%  Similarity=0.179  Sum_probs=168.6

Q ss_pred             ceEEEeee-CCcEEEEEEeccChH----HHHHHHhhhc---cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGDAS----DQIKLLNKIN---HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~~~----~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |+||+|.. +|+.||+|.-+.-..    =-.+++.||+   -+.|..+...+.-.+..+||+||.+-|+|.+++.  ..+
T Consensus       712 ~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~  789 (974)
T KOG1166|consen  712 GSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN--TNK  789 (974)
T ss_pred             eEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc--cCC
Confidence            89999987 789999999877433    3345555555   2345555555556677899999999999999997  345


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-------CCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-------TDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      .++|...+.++.|++..+++||.++   |||+||||+|+||.       ++.-++|+|||.+..+...... .......+
T Consensus       790 ~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~  865 (974)
T KOG1166|consen  790 VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWH  865 (974)
T ss_pred             CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC-cEEeeeec
Confidence            5999999999999999999999966   99999999999993       2356999999999876654433 23345678


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |-.+-.+|.+.+..++...|.|.|..+++-|+.|+..-            ..+....  .....+++..+          
T Consensus       866 td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~g~~~--~~~~~~~Ry~~----------  921 (974)
T KOG1166|consen  866 TDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKNGSSW--MVKTNFPRYWK----------  921 (974)
T ss_pred             cccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcCCcce--eccccchhhhh----------
Confidence            89999999999999999999999999999999998320            0000000  00000111111          


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                       .....++...+|..|-..=|...++...|+.++...
T Consensus       922 -~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  922 -RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             -HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence             111345666777755555688888888888887543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=6.4e-16  Score=147.41  Aligned_cols=168  Identities=15%  Similarity=0.089  Sum_probs=125.3

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----------hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----------ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----------~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||.....+..++.+.+...           +.+|+++|+++. |+++++++++    +..+++|||+.|.+|.+.+..
T Consensus        16 ~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~   91 (218)
T PRK12274         16 GRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR   91 (218)
T ss_pred             ceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh
Confidence            889977778888887776532           568999999995 5789999886    346999999999888654321


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecc-cCCCEEECCCCcEEEeeecCcccccccCCce---e------
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI-KCSNVLLDTDFRAKIANFALARPAERQEGEF---A------  499 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~------  499 (635)
                               ....++.+++.+|.++|+.+   |+|||| ||+|||++.++.++|+|||++..........   .      
T Consensus        92 ---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~  159 (218)
T PRK12274         92 ---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRH  159 (218)
T ss_pred             ---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence                     11357789999999999955   999999 7999999999999999999998544322100   0      


Q ss_pred             -eecccccCCCccCccccccC-CCC-cccchhhHHHHHHHHHhCCCCCC
Q 042486          500 -LTSHIVGTKGYMAPEYLENG-LVS-TKLDVYAFGVLMLEMLSGKEAPA  545 (635)
Q Consensus       500 -~~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~SlGvvl~elltG~~p~~  545 (635)
                       .......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+..
T Consensus       160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence             01112357778888754321 223 56788999999999999997753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.64  E-value=4e-16  Score=156.53  Aligned_cols=162  Identities=22%  Similarity=0.261  Sum_probs=108.0

Q ss_pred             eEEEeecccCCCcchhhc---cc--CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          411 WYLVYENAVNGSLSVWIN---DK--GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~---~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                      .+++|+-+ .++|.+.+.   ..  ....+....++.+..|+++.+++||+.+   ++|+||+|+|++++.+|.++|+||
T Consensus       114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F  189 (288)
T PF14531_consen  114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF  189 (288)
T ss_dssp             EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred             hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence            36788876 558877753   11  1223556677888899999999999966   999999999999999999999999


Q ss_pred             cCcccccccCCceeeecccccCCCccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHh
Q 042486          486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLEN--------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV  557 (635)
Q Consensus       486 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~  557 (635)
                      +.....+...     .. ...+..|.+||....        -.++.+.|.|+||+++|.|++++.|+.....+.....  
T Consensus       190 ~~~~r~g~~~-----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--  261 (288)
T PF14531_consen  190 SSLVRAGTRY-----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--  261 (288)
T ss_dssp             GGEEETTEEE-----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--
T ss_pred             HHHeecCcee-----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--
Confidence            8876443321     11 344577999997643        2478899999999999999999999875433211000  


Q ss_pred             hhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC
Q 042486          558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR  606 (635)
Q Consensus       558 ~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  606 (635)
                                           .-..+. ..++.+..||..+|+.||.+|
T Consensus       262 ---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 ---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                                 112344 677789999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.57  E-value=7e-15  Score=143.99  Aligned_cols=119  Identities=18%  Similarity=0.259  Sum_probs=103.1

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|...+..|++|+...               .+.+|++++.+++|+++.....++.+.+..+++|||++|++|.++
T Consensus        10 ~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~   89 (211)
T PRK14879         10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDL   89 (211)
T ss_pred             EEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHH
Confidence            89999999999999997542               244688999999999998877777777888999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      +...     .+ .+..++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++|+|||.+..
T Consensus        90 ~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         90 INSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            8542     22 78889999999999999855   99999999999999 78999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.56  E-value=1.5e-14  Score=140.44  Aligned_cols=118  Identities=14%  Similarity=0.168  Sum_probs=91.2

Q ss_pred             ceEEEeeeCCcEEEEEEecc-------ChHHHHHHHhhh-----ccCCcccEEEEEecCC---e-eEEEeec--ccCCCc
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-------DASDQIKLLNKI-----NHSSLIRLLGICFNGG---N-WYLVYEN--AVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-------~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~lV~E~--~~~gsL  423 (635)
                      |.||....++.. +||++..       ++.+|+.+++++     +||||++++|++.++.   . +.+|+||  +.+|+|
T Consensus        16 ~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL   94 (210)
T PRK10345         16 RKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITL   94 (210)
T ss_pred             eEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhH
Confidence            789974445444 6898753       367899999999     5799999999998763   4 3478999  557999


Q ss_pred             chhhcccCCCCCCHHHHHHHHHHHHhhh-cccccCCCCCeEeecccCCCEEECC----CCcEEEeeecCc
Q 042486          424 SVWINDKGGKFLDWAQRIQIALDVATGL-NYLHSFTNPPHVHKDIKCSNVLLDT----DFRAKIANFALA  488 (635)
Q Consensus       424 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~a  488 (635)
                      .+++.+..   +++.  ..++.+++.++ +|||+.+   |+||||||+|||++.    +..++|+||+.+
T Consensus        95 ~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         95 TEFAEQCR---YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHccc---ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            99996532   5555  35677888787 9999955   999999999999963    348999995443

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.54  E-value=1.8e-14  Score=154.85  Aligned_cols=105  Identities=16%  Similarity=0.242  Sum_probs=91.2

Q ss_pred             eeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeeccccCC-CCceeeeEEEEecCCchhhhhhhh
Q 042486           59 FLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSG-KHYQANTTYFVQNGDTYFLIANNT  137 (635)
Q Consensus        59 ~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~~c~~-~~~~~~~~y~V~~gdtl~~Ia~~~  137 (635)
                      ...|+|++ ||||++||++||+++++|+++|++.. +.+.+||.|.||.++.|.. ........|+|++||||++|| ++
T Consensus       343 ~~~y~Vk~-GDTL~sIA~r~gvs~~~L~~~N~l~~-~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA-~k  419 (456)
T PRK10783        343 SRSYKVRS-GDTLSGIASRLNVSTKDLQQWNNLRG-SKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIA-KR  419 (456)
T ss_pred             ceEEEECC-CCcHHHHHHHHCcCHHHHHHHcCCCc-ccCCCCCEEEecCCcccccccccccceeEEeCCCCCHHHHH-HH
Confidence            45799999 99999999999999999999999865 7899999999998877642 122334689999999999999 89


Q ss_pred             cCCCccHHHHHhhc-CCCCCCCCCcEEEEeee
Q 042486          138 FQGLSTCQALQDQH-GNVSNFGVGTRLLAPLR  168 (635)
Q Consensus       138 ~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~~  168 (635)
                      |+  +++++|+++| ...+.|++||+|.|++.
T Consensus       420 yg--Vtv~~L~~~N~l~~~~L~pGq~L~l~v~  449 (456)
T PRK10783        420 HG--VNIKDVMRWNSDTAKNLQPGDKLTLFVK  449 (456)
T ss_pred             hC--CCHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence            99  9999999999 54449999999999864

>smart00090 RIO RIO-like kinase

Probab=99.53  E-value=4.1e-14  Score=140.65  Aligned_cols=120  Identities=17%  Similarity=0.127  Sum_probs=94.7

Q ss_pred             ceEEEee---eCCcEEEEEEeccC-------------------------------hHHHHHHHhhhccCC--cccEEEEE
Q 042486          362 GSVYRGK---IGGDFVAIKKVYGD-------------------------------ASDQIKLLNKINHSS--LIRLLGIC  405 (635)
Q Consensus       362 g~Vy~g~---~~~~~vavK~~~~~-------------------------------~~~E~~~l~~l~h~n--Iv~l~~~~  405 (635)
                      |.||+|.   .+|+.||||.++..                               +..|++.++++.+..  +.+++++ 
T Consensus        42 g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~-  120 (237)
T smart00090       42 ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW-  120 (237)
T ss_pred             eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe-
Confidence            8999998   27899999987532                               246889999997633  3444443 


Q ss_pred             ecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCC-eEeecccCCCEEECCCCcEEEee
Q 042486          406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP-HVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       406 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                         ...++||||+++++|..+.....  .+.......++.|++.+|.+||+   .+ ++||||||+||+++ ++.++|+|
T Consensus       121 ---~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~-~~~i~LiD  191 (237)
T smart00090      121 ---RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH-DGKVVIID  191 (237)
T ss_pred             ---cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE-CCCEEEEE
Confidence               23589999999988877653322  25666678899999999999998   56 99999999999999 88999999


Q ss_pred             ecCcccc
Q 042486          485 FALARPA  491 (635)
Q Consensus       485 fg~a~~~  491 (635)
                      ||.+...
T Consensus       192 Fg~a~~~  198 (237)
T smart00090      192 VSQSVEL  198 (237)
T ss_pred             Chhhhcc
Confidence            9998744

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.53  E-value=2.7e-14  Score=138.50  Aligned_cols=116  Identities=19%  Similarity=0.237  Sum_probs=97.1

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|.+++..|++|....               .+.+|++++.+++|+++.....++...+..++||||++|++|.++
T Consensus         8 ~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~   87 (199)
T TIGR03724         8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDV   87 (199)
T ss_pred             EEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHH
Confidence            89999999999999998542               133689999999988766655566667778999999999999988


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      +....   .      .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++..
T Consensus        88 ~~~~~---~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        88 IEEGN---D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HhhcH---H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            75421   1      78999999999999855   99999999999999 88999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.49  E-value=5.2e-14  Score=157.20  Aligned_cols=115  Identities=18%  Similarity=0.193  Sum_probs=97.7

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|.+.+..+++|+...               .+.+|++++++++|++++....++.+....++||||+++++|.++
T Consensus       347 g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~  426 (535)
T PRK09605        347 ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDV  426 (535)
T ss_pred             EEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHH
Confidence            89999999776666654311               245799999999999999888888777788999999999999988


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      +.          ....++.+++.+|.+||+.+   ++||||||+||++ +++.++|+|||+++.
T Consensus       427 l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        427 LE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            74          34678999999999999855   9999999999999 678999999999874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=1.8e-14  Score=141.72  Aligned_cols=207  Identities=22%  Similarity=0.287  Sum_probs=143.1

Q ss_pred             HHHHhhhccCCcccEEEEEecCC-----eeEEEeecccCCCcchhhccc--CCCCCCHHHHHHHHHHHHhhhcccccCCC
Q 042486          387 IKLLNKINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQIALDVATGLNYLHSFTN  459 (635)
Q Consensus       387 ~~~l~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~  459 (635)
                      ++-|-++.|.|||+++.|+.+..     ...++.|||..|+|..+|++.  ..+.+......+|+-||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            44566778999999999987543     368999999999999999652  3355888899999999999999999976 


Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCccccccc-CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHH
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML  538 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ell  538 (635)
                      ++|+|+++..+-|++..++-+|+.--.-....... ......+....+-++|.+||+-.....+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999998887532111100000 00001112234678999999887777788999999999999998


Q ss_pred             hCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       539 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+.--.......          +.    .++.+...+-..   .-+     .-++++..|++..|..||+|++++.|.
T Consensus       277 ilEiq~tnseS~----------~~----~ee~ia~~i~~l---en~-----lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESK----------VE----VEENIANVIIGL---ENG-----LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcce----------ee----hhhhhhhheeec---cCc-----cccCcCcccccCCCCCCcchhhhhcCc
Confidence            876332110000          00    011111111000   000     014678899999999999999988764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.49  E-value=1.8e-13  Score=132.72  Aligned_cols=116  Identities=16%  Similarity=0.105  Sum_probs=92.3

Q ss_pred             ceEEEeee-CCcEEEEEEeccC-----------------------------hHHHHHHHhhhccC--CcccEEEEEecCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD-----------------------------ASDQIKLLNKINHS--SLIRLLGICFNGG  409 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~-----------------------------~~~E~~~l~~l~h~--nIv~l~~~~~~~~  409 (635)
                      |.||++.. +|+.||||.++..                             ...|+.++.++.|+  .+.+.++    .+
T Consensus        29 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~  104 (198)
T cd05144          29 SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WN  104 (198)
T ss_pred             eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cC
Confidence            78999988 7899999975421                             34678888889887  4445544    23


Q ss_pred             eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       410 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..++||||+++++|.+....        .....++.+++.++.++|+.+   ++||||||+||++++++.++|+|||++.
T Consensus       105 ~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~  173 (198)
T cd05144         105 RHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMV  173 (198)
T ss_pred             CceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccc
Confidence            45899999999998776431        234568889999999999854   9999999999999999999999999986


Q ss_pred             ccc
Q 042486          490 PAE  492 (635)
Q Consensus       490 ~~~  492 (635)
                      ...
T Consensus       174 ~~~  176 (198)
T cd05144         174 STD  176 (198)
T ss_pred             cCC
Confidence            544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.47  E-value=6.5e-13  Score=139.86  Aligned_cols=170  Identities=16%  Similarity=0.197  Sum_probs=99.6

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeeccccCC---------------CCceeeeEEEE
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSG---------------KHYQANTTYFV  124 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~~c~~---------------~~~~~~~~y~V  124 (635)
                      -.|.|++ |||||.||++||+++++|+++|++. .+.|.+||.|.||-...-..               .-.++...-.+
T Consensus        28 ~tytVq~-GDTLw~IA~~ygvtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgsl  105 (481)
T PRK13914         28 STVVVEA-GDTLWGIAQSKGTTVDAIKKANNLT-TDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITSI  105 (481)
T ss_pred             ceEEECC-CCCHHHHHHHHCCCHHHHHHHhCCC-cccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeeee
Confidence            3489998 9999999999999999999999984 56899999999996532100               01112223334


Q ss_pred             ecCCchhhhhh---hh----cC-C---CccHHHHHhhcCCCCCCCCCcEEEE--------ee----------ecc-CCCC
Q 042486          125 QNGDTYFLIAN---NT----FQ-G---LSTCQALQDQHGNVSNFGVGTRLLA--------PL----------RCA-CPTK  174 (635)
Q Consensus       125 ~~gdtl~~Ia~---~~----~~-~---l~~~~~l~~~N~~~~~l~~G~~l~i--------p~----------~~~-c~~~  174 (635)
                      .+|+.+..+..   ..    |. |   -+.-+-|...= ....+..-|++.=        |.          +.+ .|..
T Consensus       106 ~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (481)
T PRK13914        106 KGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKV-TSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPAP  184 (481)
T ss_pred             cCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCC-ccCccccchhhhhccccccccchhcccchhccCCcccCCcc
Confidence            55555544320   00    10 0   00000000000 0000000011100        00          000 0000


Q ss_pred             C-----CCCCCeeeEEEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCCCC
Q 042486          175 N-----QTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN  234 (635)
Q Consensus       175 ~-----~~~~~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~  234 (635)
                      .     ....-.....+|+|++|||||.||++||+++++|++||++...  .|++||.|.||...
T Consensus       185 ~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s~--~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        185 KVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSSS--SIYVGQKLAIKQTA  247 (481)
T ss_pred             cccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCcc--ccCCCCEEEecCCC
Confidence            0     0000111235899999999999999999999999999999753  59999999999754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.45  E-value=6.1e-13  Score=121.96  Aligned_cols=120  Identities=19%  Similarity=0.159  Sum_probs=104.4

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhcc--CCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINH--SSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      +.||+++.++..+++|.....     +.+|+..+.+++|  .++++++++....+..+++|||++++.+..+        
T Consensus        12 ~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------   83 (155)
T cd05120          12 NRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------   83 (155)
T ss_pred             cceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------
Confidence            789999998889999988653     6789999999987  4899999988877889999999998877654        


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                       +......++.+++.+|.+||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        84 -~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 -SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             -CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence             4566778899999999999986556799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=6.8e-14  Score=156.17  Aligned_cols=160  Identities=22%  Similarity=0.309  Sum_probs=112.7

Q ss_pred             HhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC------------ceeeecccccCCCccCccc
Q 042486          448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG------------EFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       448 a~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~~gt~~y~aPE~  515 (635)
                      +.+++|||+.+   |+|||+||+|.+|+.-|.+|+.|||+.+.......            ........+||+.|+|||+
T Consensus       153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            78999999955   99999999999999999999999999874322110            0112244689999999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI  595 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li  595 (635)
                      +....|....|.|++|+++||.+-|..||+....++. +-.++.....          +.+      -......+.++++
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i~----------wpE------~dea~p~Ea~dli  292 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIE----------WPE------EDEALPPEAQDLI  292 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhhcc----------ccc------cCcCCCHHHHHHH
Confidence            9988899999999999999999999999875433321 1111111000          000      0112233478999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHHHhhccccc
Q 042486          596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       596 ~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~  627 (635)
                      .++|+.+|..|--....++.-+.=+-..+||.
T Consensus       293 ~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  293 EQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             HHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            99999999999654444444444444557775

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.42  E-value=8.1e-13  Score=131.62  Aligned_cols=120  Identities=16%  Similarity=0.160  Sum_probs=95.3

Q ss_pred             ceEEEeeeCCcEEEEEEecc--------------------ChHHHHHHHhhhccCCc--ccEEEEEecCCe----eEEEe
Q 042486          362 GSVYRGKIGGDFVAIKKVYG--------------------DASDQIKLLNKINHSSL--IRLLGICFNGGN----WYLVY  415 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~--------------------~~~~E~~~l~~l~h~nI--v~l~~~~~~~~~----~~lV~  415 (635)
                      |+||+...++..++||+...                    .+.+|++++.+++|++|  ++.+++...+..    .++||
T Consensus        46 gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~  125 (239)
T PRK01723         46 GTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI  125 (239)
T ss_pred             ccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence            79999999899999987732                    13469999999998885  677776543322    25999


Q ss_pred             ecccC-CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          416 ENAVN-GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       416 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      |++++ .+|.+++...   .++..    .+.+++.+|.+||+.+   |+||||||.|||++.++.++|+|||.+...
T Consensus       126 e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        126 ERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             EecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            99997 6898888542   24543    3568899999999855   999999999999999899999999988743

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=8.4e-14  Score=155.30  Aligned_cols=212  Identities=23%  Similarity=0.281  Sum_probs=158.5

Q ss_pred             HHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccc-cCCCCCe
Q 042486          385 DQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH-SFTNPPH  462 (635)
Q Consensus       385 ~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~i  462 (635)
                      .|..+-+++. |+|++++++...+.+..+++.||..++++.+-+........+....-.++.|+..++.|+| .   .++
T Consensus        69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~  145 (601)
T KOG0590|consen   69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGV  145 (601)
T ss_pred             ccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---ccc
Confidence            3555555555 9999999999999999999999999999999883222213556667778999999999999 6   459


Q ss_pred             EeecccCCCEEECCCC-cEEEeeecCcccccccCCceeeeccccc-CCCccCcccccc-CCCCcccchhhHHHHHHHHHh
Q 042486          463 VHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVG-TKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLS  539 (635)
Q Consensus       463 vH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~-~~~s~ksDV~SlGvvl~ellt  539 (635)
                      .|+||||+|.+++..+ ..++.|||+|.......+........+| ++.|+|||...+ ....+..|+||.|+++.-+++
T Consensus       146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~  225 (601)
T KOG0590|consen  146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT  225 (601)
T ss_pred             ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc
Confidence            9999999999999999 9999999999877663333344455678 999999999887 456788999999999999999


Q ss_pred             CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 042486          540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       540 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  614 (635)
                      |..||............|....       .        ...............+++.+++..+|..|.+.+++..
T Consensus       226 g~~p~~~~~~~~~~~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  226 GELPWDFPSRKDGRYSSWKSNK-------G--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             CCCCccccccccccceeecccc-------c--------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            9999876544332222221110       0        0001111222334678888999999999999988754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.29  E-value=1.2e-11  Score=118.56  Aligned_cols=119  Identities=18%  Similarity=0.192  Sum_probs=86.5

Q ss_pred             ceEEEeee-CCcEEEEEEeccCh-------------------------------HHHHHHHhhhccCC--cccEEEEEec
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGDA-------------------------------SDQIKLLNKINHSS--LIRLLGICFN  407 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~~-------------------------------~~E~~~l~~l~h~n--Iv~l~~~~~~  407 (635)
                      |+||++.. +++.||||.++...                               ..|.+.+.++.+..  +.+.++.   
T Consensus        11 g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~---   87 (187)
T cd05119          11 ADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL---   87 (187)
T ss_pred             eeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence            89999988 58999999876421                               23455555554443  4444443   


Q ss_pred             CCeeEEEeecccCCCcchh-hcccCCCCCCHHHHHHHHHHHHhhhccccc-CCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          408 GGNWYLVYENAVNGSLSVW-INDKGGKFLDWAQRIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       408 ~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                       ...++||||++++.+... +....   .. .....++.+++.++.++|. .+   ++|+||||+||+++ ++.++|+||
T Consensus        88 -~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDf  158 (187)
T cd05119          88 -NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDV  158 (187)
T ss_pred             -CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEEC
Confidence             245899999999654322 21111   11 5677899999999999998 54   99999999999999 899999999


Q ss_pred             cCccccc
Q 042486          486 ALARPAE  492 (635)
Q Consensus       486 g~a~~~~  492 (635)
                      |.+....
T Consensus       159 g~a~~~~  165 (187)
T cd05119         159 PQAVEID  165 (187)
T ss_pred             ccccccc
Confidence            9987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.25  E-value=4e-11  Score=129.82  Aligned_cols=77  Identities=19%  Similarity=0.116  Sum_probs=59.6

Q ss_pred             CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHh-hhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecC
Q 042486          409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT-GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL  487 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  487 (635)
                      ...+|||||++|++|.++....... .   .+..++..++. .+..+|..+   ++|+|+||.||+++++++++++|||+
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~  303 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGI  303 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCC
Confidence            4568999999999999887432111 2   23456666665 467788744   99999999999999999999999999


Q ss_pred             ccccc
Q 042486          488 ARPAE  492 (635)
Q Consensus       488 a~~~~  492 (635)
                      +....
T Consensus       304 ~~~l~  308 (437)
T TIGR01982       304 VGRLS  308 (437)
T ss_pred             eeECC
Confidence            87654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.14  E-value=2.5e-10  Score=107.46  Aligned_cols=115  Identities=17%  Similarity=0.105  Sum_probs=88.1

Q ss_pred             ceEEEeeeCCcEEEEEEeccC------hHHHHHHHhhhccCCcc-cEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD------ASDQIKLLNKINHSSLI-RLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      +.||+.+..+..+++|.....      ...|..+++.+.+.+++ +++.+.  ....++||||++|.++.+..       
T Consensus        12 ~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~-------   82 (170)
T cd05151          12 NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED-------   82 (170)
T ss_pred             CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc-------
Confidence            789999998999999987543      46899999999766554 455443  33458999999998886541       


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCC--CCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFT--NPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..   ...++.+++++|..||+.+  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        83 ~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          83 FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            11   1235678999999999865  23369999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=5e-11  Score=127.50  Aligned_cols=229  Identities=22%  Similarity=0.256  Sum_probs=164.1

Q ss_pred             ceEEEeee----CCcEEEEEEeccCh---------HHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI----GGDFVAIKKVYGDA---------SDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~~~---------~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++.    ++..+|+|+-+.-+         .+|+...+++ .|+|.++.+..+...+..|+-.|++. .+|..+.
T Consensus       130 ~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~  208 (524)
T KOG0601|consen  130 GSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYC  208 (524)
T ss_pred             ceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhh
Confidence            88998876    56789999854332         3566666666 49999999999999999999999884 6888877


Q ss_pred             cccCCCCCCHHHHHHHHHHHHh----hhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCc--eee
Q 042486          428 NDKGGKFLDWAQRIQIALDVAT----GLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGE--FAL  500 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~--~~~  500 (635)
                      .... ..++....+.+..+...    ||.++|.   ..++|-|+||.||++..+ ...+++|||+...+......  ...
T Consensus       209 ~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~  284 (524)
T KOG0601|consen  209 HTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKV  284 (524)
T ss_pred             hccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcceeEEccCCccccceee
Confidence            5433 23666777777777777    9999998   459999999999999999 88999999999877655422  122


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      .....|...|++||..+ +.++...|+|++|.+..+..++...+...-.                .....++...   +.
T Consensus       285 ~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------------~~W~~~r~~~---ip  344 (524)
T KOG0601|consen  285 SKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----------------SSWSQLRQGY---IP  344 (524)
T ss_pred             eecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----------------CCcccccccc---Cc
Confidence            23336778899999876 4578899999999999999998766432100                0011111111   11


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .++-..-...+...+..|++.+|..|++.+.+..+
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            11111122335568899999999999998877653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.12  E-value=6.3e-10  Score=120.19  Aligned_cols=158  Identities=18%  Similarity=0.289  Sum_probs=119.8

Q ss_pred             CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHH
Q 042486          370 GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ  442 (635)
Q Consensus       370 ~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~  442 (635)
                      ++.+|.|...+..       ..+-++.|+.++||||+++++.+..++..|+|+|.+.  .|..++.+     +.......
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHHHH
Confidence            6777777766432       3456788999999999999999999999999999873  57777755     33455666


Q ss_pred             HHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCC
Q 042486          443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS  522 (635)
Q Consensus       443 i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  522 (635)
                      .+.||+.||.|||+  +.+++|++|.-+.|++++.|+.||++|.++........   ......--..|..|+.+....  
T Consensus       109 Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  109 GLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc--
Confidence            78999999999997  35699999999999999999999999998865443221   011112223466676544322  


Q ss_pred             cccchhhHHHHHHHHHhCC
Q 042486          523 TKLDVYAFGVLMLEMLSGK  541 (635)
Q Consensus       523 ~ksDV~SlGvvl~elltG~  541 (635)
                      ...|.|-||++++|++.|.
T Consensus       182 ~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cchhhhhHHHHHHHHhCcc
Confidence            3469999999999999994

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.09  E-value=5.9e-11  Score=84.87  Aligned_cols=43  Identities=33%  Similarity=0.690  Sum_probs=35.9

Q ss_pred             EEeecCChHHhHHHHhCCChhHHHHhc-CCCCCCCCcccceecccC
Q 042486          187 YLVKGGNTVYGISKRFGVDTDRTLEAN-GLSEGAPNIYPFTTLLVP  231 (635)
Q Consensus       187 y~v~~gdtl~~Ia~~~~~~~~~l~~~N-~~~~~~~~~~~~~~l~iP  231 (635)
                      |+|++|||+|+||++||++.++|+++| ++....  |++||.|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~--l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDN--LQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGC--GGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCccc--CCCCCEEEeC
Confidence            899999999999999999999999999 775444  9999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=99.06  E-value=2.3e-10  Score=101.97  Aligned_cols=111  Identities=23%  Similarity=0.346  Sum_probs=90.6

Q ss_pred             HHHHhCCChHhHhhhcCCCC-CcccCCCcEEEEeeccccCCCCceeeeEEEEecCCchhhhhhhhcCCCccHHHHHhhcC
Q 042486           74 ISTLLASKPSQLSKINSVSE-TATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQHG  152 (635)
Q Consensus        74 Ia~~~~~~~~~i~~~N~~~~-~~~~~~gq~l~ip~~~~c~~~~~~~~~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N~  152 (635)
                      ||..|+++++++.++|.+.. .+.+.+||.+.+|..           ..+.+..|++.+..+...+..  ..        
T Consensus         1 ia~~~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~--~~--------   59 (124)
T COG1388           1 IASKYGVSVKALKKANALTGKSDAIKPGQVLKIPGD-----------ISSTVNAGQTLSSLSNKVSDS--SS--------   59 (124)
T ss_pred             CcccccccHHHHHHHhcccCCCCccccCceEEccCC-----------cccccccccccccccceeecc--cc--------
Confidence            57899999999999998863 889999999999965           358889999999999433331  10        


Q ss_pred             CCCCCCCCcEEEEeeeccCCCCCCCCCCeeeEEEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCC
Q 042486          153 NVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPL  232 (635)
Q Consensus       153 ~~~~l~~G~~l~ip~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~  232 (635)
                                               .....+..+|+|+.||+|+.||++||+++.+|+++|++..+  .+++||.|.+|.
T Consensus        60 -------------------------~~~~~~~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~~~--~i~~gq~l~~~~  112 (124)
T COG1388          60 -------------------------ASKAPPVVTYTVKKGDTLSKIARKYGVTVAELKQLNNLSSD--KIKVGQKLKLPV  112 (124)
T ss_pred             -------------------------ccccCCCceEEEecCCCHHHHHHHhCCCHHHHHHHhccCCC--ceecCcEEEEec
Confidence                                     00112234899999999999999999999999999999754  699999999986

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.01  E-value=4.7e-10  Score=123.00  Aligned_cols=75  Identities=17%  Similarity=0.141  Sum_probs=52.6

Q ss_pred             CeeEEEeecccCCCcchhh--cccCC--CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----cE
Q 042486          409 GNWYLVYENAVNGSLSVWI--NDKGG--KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RA  480 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~  480 (635)
                      ...+|||||++|+.+.++-  ...+.  +.+.......++.|+.       .   .+++|+|+||.||+++.++    ++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~---~GffHaDpHPGNIlv~~~g~~~~~i  303 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------R---DGFFHADMHPGNIFVSYDPPENPRY  303 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h---CCeeeCCCChHHeEEecCCCCCCeE
Confidence            4567999999999998753  22110  1133333334444443       3   3499999999999999888    99


Q ss_pred             EEeeecCcccccc
Q 042486          481 KIANFALARPAER  493 (635)
Q Consensus       481 kl~Dfg~a~~~~~  493 (635)
                      +++|||++.....
T Consensus       304 ~llDFGivg~l~~  316 (537)
T PRK04750        304 IALDFGIVGSLNK  316 (537)
T ss_pred             EEEecceEEECCH
Confidence            9999999876644

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=6e-09  Score=96.31  Aligned_cols=117  Identities=18%  Similarity=0.183  Sum_probs=89.4

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      ..+|.+.+-|..+++|.-.+               ...+|..++.+++--.|.--.=+..+.+...|+|||.+|..|.+.
T Consensus        10 a~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~   89 (204)
T COG3642          10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDA   89 (204)
T ss_pred             eeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHH
Confidence            56788877776777775422               234689999998766665555555677788899999999999988


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      +...         ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++|||++...
T Consensus        90 l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          90 LEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             HHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            8654         2456667777777899855   99999999999997664 999999998744

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.89  E-value=1.3e-08  Score=97.38  Aligned_cols=97  Identities=13%  Similarity=0.133  Sum_probs=72.4

Q ss_pred             HHHHHHhhhcc--CCcccEEEEEecCCeeEEEeecccCCCcch-hhcccCCCCCCHHHHHHHHHHHHhhhccc-ccCCCC
Q 042486          385 DQIKLLNKINH--SSLIRLLGICFNGGNWYLVYENAVNGSLSV-WINDKGGKFLDWAQRIQIALDVATGLNYL-HSFTNP  460 (635)
Q Consensus       385 ~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~  460 (635)
                      +|...|+++..  -++.+.+++    ...+|||||+.++.+.. .+.+.   .++..+...+..+++.+|..| |+.+  
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~g--  145 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECN--  145 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence            68889999864  356666654    45689999997654422 22221   245556677889999999999 7744  


Q ss_pred             CeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          461 PHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       461 ~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                       ++|+||++.||+++ ++.+.|+|||.+....
T Consensus       146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             -eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence             99999999999997 4689999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.88  E-value=1.1e-08  Score=93.99  Aligned_cols=127  Identities=19%  Similarity=0.201  Sum_probs=94.7

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccC-CCcch
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN-GSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~-gsL~~  425 (635)
                      +.|+++.+.|+...||.-..               ...+|.+.|.++.--.|.--.=++.+...-.|+|||.++ .++.+
T Consensus        21 Arv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~  100 (229)
T KOG3087|consen   21 ARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKD  100 (229)
T ss_pred             eeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHH
Confidence            68999999999999985432               234799999998766665555556666667899999976 47788


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC---cEEEeeecCcccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF---RAKIANFALARPA  491 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~  491 (635)
                      ++...-...........++.++-..+.-||..+   ++|+||..+||++..++   .+.++|||++...
T Consensus       101 ~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  101 FILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            875432222333334678888999999999855   99999999999995543   4589999998643

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.87  E-value=2.3e-08  Score=105.04  Aligned_cols=158  Identities=17%  Similarity=0.257  Sum_probs=122.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEe----cCCeeEEEeecccC-CCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICF----NGGNWYLVYENAVN-GSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~l  427 (635)
                      .+.||+..  +|..+++|++..+       ...-++.++++.|.|+|++..++.    ++...++||+|+++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            67888875  8999999999432       235688999999999999999887    34568999999987 5676654


Q ss_pred             ccc-------------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          428 NDK-------------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       428 ~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ...             .+...++..+|.++.|+..||.++|+.|   +.-+-|.+.+|+++.+.+++|+..|........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            211             1234778999999999999999999966   888999999999999999999988876544332


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE  542 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~  542 (635)
                      ..                 |-+..   ..+-|.=.||.+++.|.||..
T Consensus       447 ~~-----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  447 PT-----------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC-----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            20                 11111   235789999999999999974

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=1.5e-08  Score=102.17  Aligned_cols=125  Identities=16%  Similarity=0.176  Sum_probs=96.0

Q ss_pred             ceEEEeeeCCcEEEEEEecc------------------ChHHHHHHHhhhccCCc--ccEEEEEec-----CCeeEEEee
Q 042486          362 GSVYRGKIGGDFVAIKKVYG------------------DASDQIKLLNKINHSSL--IRLLGICFN-----GGNWYLVYE  416 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~------------------~~~~E~~~l~~l~h~nI--v~l~~~~~~-----~~~~~lV~E  416 (635)
                      ..|++..++|+.+.||+...                  .+.+|...+.++...+|  .+.+++...     ....+||+|
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            46778888999999996632                  15688898888865444  445556543     234689999


Q ss_pred             cccCC-CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-------CCcEEEeeecCc
Q 042486          417 NAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-------DFRAKIANFALA  488 (635)
Q Consensus       417 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~Dfg~a  488 (635)
                      ++++. +|.+++........+...+..++.+++..+.-||..+   |+|+|++++|||++.       +..+.|+||+.+
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99886 8988885322223566777889999999999999955   999999999999975       578999999987


Q ss_pred             c
Q 042486          489 R  489 (635)
Q Consensus       489 ~  489 (635)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            5

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.83  E-value=1.9e-09  Score=115.58  Aligned_cols=238  Identities=21%  Similarity=0.243  Sum_probs=161.6

Q ss_pred             HHhhcCCCCCCccc----ceEEEeee---CCcEEEEEEeccCh---------HHHHHHHhhh-ccCCcccEEEEEecCCe
Q 042486          348 QAATDDFNPSCWIK----GSVYRGKI---GGDFVAIKKVYGDA---------SDQIKLLNKI-NHSSLIRLLGICFNGGN  410 (635)
Q Consensus       348 ~~at~~f~~~~~ig----g~Vy~g~~---~~~~vavK~~~~~~---------~~E~~~l~~l-~h~nIv~l~~~~~~~~~  410 (635)
                      ..-+.+|.....|+    +.|++...   ++..+++|.+.+..         ..|+.+...+ .|.++++....+....+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            33445565555554    45555443   56678888765431         2455555555 58889998888887788


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALAR  489 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~  489 (635)
                      .|+--||++++++...+.-.  ..+++..++++..|++.++.++|+   +.++|+|+||+||++..+ +.-++.|||.+.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             ccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence            88999999999887766221  237778889999999999999998   449999999999999776 888999999986


Q ss_pred             cccccCCceeeecccccCCCc-cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGY-MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........     ....+..| .+++......+..+.|+||||.-+.|.+++........    .               
T Consensus       416 ~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~---------------  471 (524)
T KOG0601|consen  416 RLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----Q---------------  471 (524)
T ss_pred             ccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCcccc----c---------------
Confidence            43221111     11222334 35666667788899999999999999999975321100    0               


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                        ...+.... ....+... ..+..+.+.+...++..||.+.++..+...
T Consensus       472 --~~~i~~~~-~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  472 --SLTIRSGD-TPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             --ceeeeccc-ccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence              00000000 01112222 557888899999999999999988776553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.82  E-value=1.8e-09  Score=121.45  Aligned_cols=211  Identities=20%  Similarity=0.250  Sum_probs=144.3

Q ss_pred             cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE
Q 042486          395 HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL  474 (635)
Q Consensus       395 h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll  474 (635)
                      ||-+++...-+.-....+|+++|+.+++|...++....  .+..-.......+..++++||..   .+.|+|++|.|++.
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~  937 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLI  937 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhh
Confidence            45555444444456778999999999999998876542  44444445566788899999984   38999999999999


Q ss_pred             CCCCcEEEeeecCccccccc---------------------C-------CceeeecccccCCCccCccccccCCCCcccc
Q 042486          475 DTDFRAKIANFALARPAERQ---------------------E-------GEFALTSHIVGTKGYMAPEYLENGLVSTKLD  526 (635)
Q Consensus       475 ~~~~~~kl~Dfg~a~~~~~~---------------------~-------~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksD  526 (635)
                      ..++..++.|||........                     .       ..........+|+.|.+||.+.+......+|
T Consensus       938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen  938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred             cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence            99999999999843321100                     0       0001122357899999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCC-CCChHHHHHHHHHHHHhhhcCCCC
Q 042486          527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG-NYPPVTAILVIRLIESCLKKDPSG  605 (635)
Q Consensus       527 V~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~  605 (635)
                      .|++|++++|.++|..||.....+                  ..++.+....+.. .-+...+....+++...+..+|.+
T Consensus      1018 ~~~~g~~l~e~l~g~pp~na~tpq------------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQ------------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred             hhhhhhhhhhhhcCCCCCCCcchh------------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence            999999999999999987542221                  1112222211111 123334555788999999999999


Q ss_pred             CCCHHHHHHHHHHHHhhcccccc
Q 042486          606 RPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       606 RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                      |-.+.--.+.=..-+....+|+.
T Consensus      1080 r~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1080 RLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             ccCcccccccccCCccCCCCccc
Confidence            98877433333334555566655

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.78  E-value=5.6e-08  Score=95.48  Aligned_cols=126  Identities=22%  Similarity=0.303  Sum_probs=98.5

Q ss_pred             ceEEEeeeCC-cEEEEEEecc--------ChHHHHHHHhhhccC--CcccEEEEEecC---CeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIGG-DFVAIKKVYG--------DASDQIKLLNKINHS--SLIRLLGICFNG---GNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~~-~~vavK~~~~--------~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~~lV~E~~~~gsL~~~l  427 (635)
                      +.+|+....+ ..+++|....        ++..|.++++.+++.  ++.+++.+....   +..++||||++|.++.+.+
T Consensus        12 n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~   91 (223)
T cd05154          12 NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL   91 (223)
T ss_pred             ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence            6899998854 8899997653        356899999999764  467788877654   2568999999999888766


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCC-------------------------------------------------
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFT-------------------------------------------------  458 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------  458 (635)
                      ..   ..++..++..++.+++++|..||+..                                                 
T Consensus        92 ~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (223)
T cd05154          92 LR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHL  168 (223)
T ss_pred             CC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhC
Confidence            42   23677788888888888888888531                                                 


Q ss_pred             ----CCCeEeecccCCCEEECC--CCcEEEeeecCccc
Q 042486          459 ----NPPHVHKDIKCSNVLLDT--DFRAKIANFALARP  490 (635)
Q Consensus       459 ----~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~  490 (635)
                          ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       169 ~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         169 PADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             CCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                245799999999999988  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=98.77  E-value=5.6e-09  Score=74.57  Aligned_cols=43  Identities=19%  Similarity=0.364  Sum_probs=35.8

Q ss_pred             eecCCCCCCHHHHHHHhCCChHhHhhhc-CCCCCcccCCCcEEEEe
Q 042486           62 FRSKPPFNTVASISTLLASKPSQLSKIN-SVSETATFETNQMVIVP  106 (635)
Q Consensus        62 y~~~~~g~tl~~Ia~~~~~~~~~i~~~N-~~~~~~~~~~gq~l~ip  106 (635)
                      |+|++ |||+++||++||++.++|.++| ++.... |.+||.|.||
T Consensus         1 y~V~~-gDtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQP-GDTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP   44 (44)
T ss_dssp             EEE-T-T--HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred             CEECc-CCcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence            78998 9999999999999999999999 775545 9999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=3.4e-09  Score=115.04  Aligned_cols=153  Identities=22%  Similarity=0.276  Sum_probs=104.6

Q ss_pred             HHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc------eeeecccccCCCccCccccc
Q 042486          444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE------FALTSHIVGTKGYMAPEYLE  517 (635)
Q Consensus       444 ~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~  517 (635)
                      +.++++|+.|+|.  ..++||++|.|++|.++.++..||+.|+++.........      .....-......|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455699999998  578999999999999999999999999988655442111      11111223456899999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCC-CCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHH
Q 042486          518 NGLVSTKLDVYAFGVLMLEMLSGKEA-PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIE  596 (635)
Q Consensus       518 ~~~~s~ksDV~SlGvvl~elltG~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~  596 (635)
                      +...++++|+||+|+++|.+..|+.+ +......                .........+..-...++...+.++.+=+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----------------~~~~~~~~~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----------------LSYSFSRNLLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCc----------------chhhhhhcccccccccccccCcHHHHHHHH
Confidence            98889999999999999999955433 2211110                001111111111112233445566888889


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 042486          597 SCLKKDPSGRPAMDKIAQ  614 (635)
Q Consensus       597 ~cl~~dP~~RPs~~evl~  614 (635)
                      +++..++.-||++.++..
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            999999999998877653

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.73  E-value=1.2e-08  Score=86.24  Aligned_cols=50  Identities=18%  Similarity=0.411  Sum_probs=42.5

Q ss_pred             EEEEEeecCChHHhHHHHhCCC--------hhHHHHhcCCCCCCCCcccceecccCCCCC
Q 042486          184 LLSYLVKGGNTVYGISKRFGVD--------TDRTLEANGLSEGAPNIYPFTTLLVPLENP  235 (635)
Q Consensus       184 ~~~y~v~~gdtl~~Ia~~~~~~--------~~~l~~~N~~~~~~~~~~~~~~l~iP~~~~  235 (635)
                      ..+|+|++|||||+||++|+.+        ++.|++.|++.++  .|+|||+|.||....
T Consensus        36 ~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~~--~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         36 YVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPSG--HIKAGDKLVIPVLKS   93 (103)
T ss_pred             cEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCCC--cCCCCCEEEEecCCC
Confidence            3589999999999999999876        4678888999754  599999999997653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=5.5e-08  Score=92.59  Aligned_cols=118  Identities=19%  Similarity=0.198  Sum_probs=77.4

Q ss_pred             eEEEeee-CCcEEEEEEecc---------------------------------ChHHHHHHHhhhccC--CcccEEEEEe
Q 042486          363 SVYRGKI-GGDFVAIKKVYG---------------------------------DASDQIKLLNKINHS--SLIRLLGICF  406 (635)
Q Consensus       363 ~Vy~g~~-~~~~vavK~~~~---------------------------------~~~~E~~~l~~l~h~--nIv~l~~~~~  406 (635)
                      .||.|.. +|..+|||..+.                                 ...+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899987 788999997632                                 023689999999766  466666542 


Q ss_pred             cCCeeEEEeeccc--CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcc-cccCCCCCeEeecccCCCEEECCCCcEEEe
Q 042486          407 NGGNWYLVYENAV--NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY-LHSFTNPPHVHKDIKCSNVLLDTDFRAKIA  483 (635)
Q Consensus       407 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~-LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  483 (635)
                         ..+|||||++  |..+..+....    ++......++.+++..+.. +|..+   ++|+|+.+.||+++++ .+.++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence               3479999998  54554433221    1233455667777775555 46744   9999999999999887 99999


Q ss_pred             eecCccccc
Q 042486          484 NFALARPAE  492 (635)
Q Consensus       484 Dfg~a~~~~  492 (635)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999876443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.64  E-value=2.5e-08  Score=71.06  Aligned_cols=42  Identities=40%  Similarity=0.704  Sum_probs=37.2

Q ss_pred             eecCChHHhHHHHhCCChhHHHHhcC-CCCCCCCcccceecccC
Q 042486          189 VKGGNTVYGISKRFGVDTDRTLEANG-LSEGAPNIYPFTTLLVP  231 (635)
Q Consensus       189 v~~gdtl~~Ia~~~~~~~~~l~~~N~-~~~~~~~~~~~~~l~iP  231 (635)
                      |++|||+|+||++||++.++|.++|+ +.... .+++||+|.||
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~-~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPN-LIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCC-CcCCCCEEecC
Confidence            68999999999999999999999997 43334 79999999998

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.64  E-value=1.1e-07  Score=80.39  Aligned_cols=53  Identities=13%  Similarity=0.203  Sum_probs=45.8

Q ss_pred             cceeeeeecCCCCCCHHHHHHHhCCC--------hHhHhhhcCCCCCcccCCCcEEEEeeccc
Q 042486           56 CLAFLIFRSKPPFNTVASISTLLASK--------PSQLSKINSVSETATFETNQMVIVPVNCS  110 (635)
Q Consensus        56 c~~~~~y~~~~~g~tl~~Ia~~~~~~--------~~~i~~~N~~~~~~~~~~gq~l~ip~~~~  110 (635)
                      +..|..|+|++ |||||+||++|+.+        ++.|.+.|++.+ +.|.+||.|.||+.-+
T Consensus        33 ~~~~~~~tV~~-GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         33 KNQYVEITVQE-GDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLKS   93 (103)
T ss_pred             CCCcEEEEECC-CCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCCC
Confidence            56888999999 99999999999865        578888999964 4799999999998655

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.53  E-value=1.2e-07  Score=67.58  Aligned_cols=45  Identities=36%  Similarity=0.634  Sum_probs=40.9

Q ss_pred             EEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccC
Q 042486          186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVP  231 (635)
Q Consensus       186 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP  231 (635)
                      +|+|++|||+++||++||++.++|.++|+..... .+.+|+.+.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~-~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPD-NLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCcc-ccCCCCEEecC
Confidence            6999999999999999999999999999984444 79999999887

This domain may have a general peptidoglycan binding function.

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.52  E-value=1.6e-07  Score=96.47  Aligned_cols=92  Identities=21%  Similarity=0.170  Sum_probs=82.6

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeeccccCCCCceeeeEEEEecCCchhhhhhhhcC
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCSGKHYQANTTYFVQNGDTYFLIANNTFQ  139 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~~c~~~~~~~~~~y~V~~gdtl~~Ia~~~~~  139 (635)
                      .+|.|+| ||++..|+++|+.+..+|...|.+.+ +.+.+||++.||..-.          .|.|++|||+++|| .++.
T Consensus         2 ~i~~~~p-g~~~~~i~~~~~~~~~~i~~~~~~~~-d~~~~~q~~~v~~~~~----------~y~~~~~d~~~Sia-~~~~   68 (423)
T COG3858           2 SIHLVGP-GDSRLIIAVYFPYTNNRIVNGNDYTN-DDLVDGQTFVVPPSGH----------FYDVGPGDTLTSIA-RTVG   68 (423)
T ss_pred             EEEEccC-Cceeeeehhhcccccccccccccccc-ccccCceeEEECCcce----------EEEecCCcchhhhh-hhhc
Confidence            4677787 99999999999999999977778777 8999999999997543          79999999999999 7888


Q ss_pred             CCccHHHHHhhc--CCCCCCCCCcEEEEe
Q 042486          140 GLSTCQALQDQH--GNVSNFGVGTRLLAP  166 (635)
Q Consensus       140 ~l~~~~~l~~~N--~~~~~l~~G~~l~ip  166 (635)
                        ||.+.+...|  ..+..+.+|-.+.+|
T Consensus        69 --vt~~~~~~m~~~~~~~~l~~~~~l~~P   95 (423)
T COG3858          69 --VTQDSAAIMNFVICPGYLQYGLNLYIP   95 (423)
T ss_pred             --CCHHHHHhhcccccccceeeeeEEecc
Confidence              9999999999  567799999999999

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.49  E-value=2.1e-06  Score=88.42  Aligned_cols=201  Identities=15%  Similarity=0.206  Sum_probs=128.0

Q ss_pred             eEEEeecccCC-Ccchhhc----ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          411 WYLVYENAVNG-SLSVWIN----DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       411 ~~lV~E~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                      .-++|..+.+. .+..++.    +..-....|...++.+..++.+..-||.+|   .+-+|++++|+|+.+++.+.|.|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence            56777776654 2222321    122335789999999999999999999976   999999999999999999999985


Q ss_pred             cCcccccccCCceeeecccccCCCccCccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCcch---hhHHH-
Q 042486          486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEE---NMLLV-  555 (635)
Q Consensus       486 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~---~~~l~-  555 (635)
                      ..-.....    .......+|...|.+||.-.     +..-+...|-|.||+++++++.| +.|+......   ..-+. 
T Consensus       162 Dsfqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         162 DSFQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             cceeeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            43322211    12233467899999999754     34457789999999999999887 7887642110   00000 


Q ss_pred             HhhhcccccCCchhhhhhhcCCcCCCCCC-hHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHhh
Q 042486          556 DVLNPVLHKEDGEESLRHLMDPSMQGNYP-PVTAILVIRLIESCLKK--DPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       556 ~~~~~~~~~~~~~~~l~~~~d~~~~~~~~-~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +.....+....  ..-... .+. ....| ...+..+..|..+|+..  .+.-|||++..+..|..+.++
T Consensus       238 ~Ia~g~f~ya~--~~~~g~-~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         238 DIAHGRFAYAS--DQRRGL-KPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hhhcceeeech--hccCCC-CCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            11111111000  000000 010 11112 23455678888999975  366899999988888776544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=1.4e-06  Score=95.35  Aligned_cols=167  Identities=15%  Similarity=0.167  Sum_probs=101.3

Q ss_pred             cchhhhhhhhhhhhhhcccccccHHHHHHhh------------cCCCCCCccc---ceEEEeee-CCcEEEEEEeccChH
Q 042486          321 LDEESRDFLESISDIAQSLKVYTFEELQAAT------------DDFNPSCWIK---GSVYRGKI-GGDFVAIKKVYGDAS  384 (635)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~el~~at------------~~f~~~~~ig---g~Vy~g~~-~~~~vavK~~~~~~~  384 (635)
                      .+.-+.++...+....+....++++++.+..            .+|+..-.-.   |.||+|++ +|+.||||+.++.+.
T Consensus        83 ~Dl~p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~  162 (517)
T COG0661          83 PDLVPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIR  162 (517)
T ss_pred             ccccCHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChH
Confidence            3344455566666667777777776654333            3455322211   89999999 699999998865321


Q ss_pred             -----------------------------------------------HHHHHHhhhc----cCCcccEEEEEe-cCCeeE
Q 042486          385 -----------------------------------------------DQIKLLNKIN----HSSLIRLLGICF-NGGNWY  412 (635)
Q Consensus       385 -----------------------------------------------~E~~~l~~l~----h~nIv~l~~~~~-~~~~~~  412 (635)
                                                                     +|..-+.+++    +..-+++=.++. -.+...
T Consensus       163 ~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~V  242 (517)
T COG0661         163 ERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRV  242 (517)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcE
Confidence                                                           2333333331    122222222332 245668


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      |+|||++|-.+.+...-.. ...+.+.+.....++.--.-+-|     +++|.|.+|.||+++.++++.+.|||+.....
T Consensus       243 LtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         243 LTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             EEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHhc-----CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999988852222 12453333332222222112223     39999999999999999999999999987655


Q ss_pred             c
Q 042486          493 R  493 (635)
Q Consensus       493 ~  493 (635)
                      .
T Consensus       317 ~  317 (517)
T COG0661         317 P  317 (517)
T ss_pred             H
Confidence            4

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.43  E-value=2.1e-07  Score=93.18  Aligned_cols=48  Identities=21%  Similarity=0.368  Sum_probs=43.6

Q ss_pred             eeEEEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccC
Q 042486          182 HYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVP  231 (635)
Q Consensus       182 ~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP  231 (635)
                      .-+.+|+|++|||||.||+|||+++++|+++|++. ++ .|++||+|+||
T Consensus       291 ~~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~-~~-~L~~GQ~L~IP  338 (338)
T TIGR02907       291 TKLRMCIVQEGDTIETIAERYEISVSQLIRHNQLE-DF-EVNEGQILYIP  338 (338)
T ss_pred             cccEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC-cc-ccCCCCEEEeC
Confidence            34458999999999999999999999999999997 44 79999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.39  E-value=3e-07  Score=93.23  Aligned_cols=48  Identities=25%  Similarity=0.230  Sum_probs=44.7

Q ss_pred             EEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCCCC
Q 042486          186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN  234 (635)
Q Consensus       186 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~  234 (635)
                      +|+|++|||||.||.+||+++.+|.+||+|.++. .|++||+|.||...
T Consensus        62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~-~I~~GQ~L~i~~~~  109 (319)
T PRK10871         62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPY-SLNVGQTLQVGNAS  109 (319)
T ss_pred             ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCc-cccCCCEEEeCCCC
Confidence            7999999999999999999999999999998777 89999999998643

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.38  E-value=4.2e-07  Score=93.44  Aligned_cols=96  Identities=21%  Similarity=0.217  Sum_probs=80.4

Q ss_pred             EEEEecCCchhhhhhhhcCCCccHHHHHhhc-CCCCCCCCCcEEEEeeeccCCCCCCCCCCeeeEEEEEeecCChHHhHH
Q 042486          121 TYFVQNGDTYFLIANNTFQGLSTCQALQDQH-GNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGIS  199 (635)
Q Consensus       121 ~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~Ia  199 (635)
                      .|.|++||+++.|| .+|.  .+...|...| ...+.|.+||.+.||..             .  ..|.|++|||+++||
T Consensus         3 i~~~~pg~~~~~i~-~~~~--~~~~~i~~~~~~~~d~~~~~q~~~v~~~-------------~--~~y~~~~~d~~~Sia   64 (423)
T COG3858           3 IHLVGPGDSRLIIA-VYFP--YTNNRIVNGNDYTNDDLVDGQTFVVPPS-------------G--HFYDVGPGDTLTSIA   64 (423)
T ss_pred             EEEccCCceeeeeh-hhcc--ccccccccccccccccccCceeEEECCc-------------c--eEEEecCCcchhhhh
Confidence            58999999999999 7888  6667776666 33389999999999931             1  279999999999999


Q ss_pred             HHhCCChhHHHHhcCCCCCCCCcccceecccCCCCC
Q 042486          200 KRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENP  235 (635)
Q Consensus       200 ~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~~  235 (635)
                      ++|||+.+.+..+|....+. .+.+|-.+.+|....
T Consensus        65 ~~~~vt~~~~~~m~~~~~~~-~l~~~~~l~~P~~~~   99 (423)
T COG3858          65 RTVGVTQDSAAIMNFVICPG-YLQYGLNLYIPSARK   99 (423)
T ss_pred             hhhcCCHHHHHhhccccccc-ceeeeeEEeccCCCC
Confidence            99999999999999876555 788998999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.35  E-value=2.5e-06  Score=83.18  Aligned_cols=104  Identities=21%  Similarity=0.198  Sum_probs=82.0

Q ss_pred             hHHHHHHHhhhccCC--cccEEEEEecCC----eeEEEeecccCC-CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccc
Q 042486          383 ASDQIKLLNKINHSS--LIRLLGICFNGG----NWYLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH  455 (635)
Q Consensus       383 ~~~E~~~l~~l~h~n--Iv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH  455 (635)
                      ..+|...+.++....  ..+.+++.....    ..++|+|++++. +|.+++.....  ++......++.+++..+.-||
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHH
Confidence            457888888885443  456677765422    348999999884 79999865332  566778889999999999999


Q ss_pred             cCCCCCeEeecccCCCEEECCCC---cEEEeeecCcccc
Q 042486          456 SFTNPPHVHKDIKCSNVLLDTDF---RAKIANFALARPA  491 (635)
Q Consensus       456 ~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~  491 (635)
                      +.+   |+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       136 ~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            955   99999999999998887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.34  E-value=7e-07  Score=63.43  Aligned_cols=43  Identities=14%  Similarity=0.132  Sum_probs=37.7

Q ss_pred             cCCCCCCHHHHHHHhCCChHhHhhhcC-CCCCcccCCCcEEEEee
Q 042486           64 SKPPFNTVASISTLLASKPSQLSKINS-VSETATFETNQMVIVPV  107 (635)
Q Consensus        64 ~~~~g~tl~~Ia~~~~~~~~~i~~~N~-~~~~~~~~~gq~l~ip~  107 (635)
                      |++ |||||+||++|++++++|.++|+ +.+...+.+||.|.||.
T Consensus         1 v~~-gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip~   44 (44)
T TIGR02899         1 VQK-GDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS   44 (44)
T ss_pred             CCC-CCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence            355 99999999999999999999996 55567799999999983

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>PRK09902 hypothetical protein; Provisional

Probab=98.30  E-value=7.1e-06  Score=78.77  Aligned_cols=125  Identities=14%  Similarity=0.184  Sum_probs=95.8

Q ss_pred             ceEEEeeeCCcEEEEEEecc-------------ChHHHHHHHhhhccCC--cccEEEEEe---cCC--eeEEEeecccC-
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-------------DASDQIKLLNKINHSS--LIRLLGICF---NGG--NWYLVYENAVN-  420 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-------------~~~~E~~~l~~l~h~n--Iv~l~~~~~---~~~--~~~lV~E~~~~-  420 (635)
                      +.|++-.++|..+-+|+-..             .+.+|+..|.++...+  +.+.. ++.   ...  .-+||+|-+++ 
T Consensus        32 SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~  110 (216)
T PRK09902         32 SGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGF  110 (216)
T ss_pred             ceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCC
Confidence            57888888888899997642             3678999999986433  44444 332   122  35899997764 


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc--EEEeeecCccc
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR--AKIANFALARP  490 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~  490 (635)
                      -+|.+++........+...+..++.+++..+.-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            58999986544344678888999999999999999965   999999999999986666  99999987763

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.19  E-value=1.4e-05  Score=87.18  Aligned_cols=162  Identities=12%  Similarity=0.121  Sum_probs=99.1

Q ss_pred             hhhhhhhhhhhhhcccccccHHHHHHhhc------------CCCCCCcc---cceEEEeee-CCcEEEEEEeccChH---
Q 042486          324 ESRDFLESISDIAQSLKVYTFEELQAATD------------DFNPSCWI---KGSVYRGKI-GGDFVAIKKVYGDAS---  384 (635)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~el~~at~------------~f~~~~~i---gg~Vy~g~~-~~~~vavK~~~~~~~---  384 (635)
                      -+.++...++.+.+....++++|+.+...            .|++.-.-   .|.||++++ +|..||||+-++.+.   
T Consensus       122 lP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~  201 (538)
T KOG1235|consen  122 LPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLI  201 (538)
T ss_pred             CcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHH
Confidence            34455566666677777777777654432            34432211   189999999 889999998765311   


Q ss_pred             -----------------------------------HHHHHHh----------hhccCC------cccEEEEEecCCeeEE
Q 042486          385 -----------------------------------DQIKLLN----------KINHSS------LIRLLGICFNGGNWYL  413 (635)
Q Consensus       385 -----------------------------------~E~~~l~----------~l~h~n------Iv~l~~~~~~~~~~~l  413 (635)
                                                         .|++.+.          .+.|-+      |.+++-.+  .....|
T Consensus       202 ~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVL  279 (538)
T KOG1235|consen  202 MLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVL  279 (538)
T ss_pred             HHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEE
Confidence                                               1222222          223444      33333222  345789


Q ss_pred             EeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC----CCcEEEeeecCcc
Q 042486          414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT----DFRAKIANFALAR  489 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~a~  489 (635)
                      +|||++|..+.|.-.-... .++...+..-+.+...-+-+-     .|++|+|-+|.||+++.    ++++.+.|||+..
T Consensus       280 tME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qIf~-----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~  353 (538)
T KOG1235|consen  280 TMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQIFK-----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA  353 (538)
T ss_pred             EEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHHHh-----cCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence            9999999988776522111 155554444333332222222     34999999999999983    6789999999987


Q ss_pred             cccc
Q 042486          490 PAER  493 (635)
Q Consensus       490 ~~~~  493 (635)
                      ....
T Consensus       354 ~is~  357 (538)
T KOG1235|consen  354 VISH  357 (538)
T ss_pred             cccH
Confidence            6543

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.19  E-value=2.7e-06  Score=60.29  Aligned_cols=45  Identities=22%  Similarity=0.351  Sum_probs=41.3

Q ss_pred             eeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEe
Q 042486           61 IFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVP  106 (635)
Q Consensus        61 ~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip  106 (635)
                      .|++++ |||+++||..|+++..+|+++|+......+.+|+.|.||
T Consensus         2 ~~~v~~-gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKK-GDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECC-CCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence            478888 999999999999999999999998667789999999987

This domain may have a general peptidoglycan binding function.

>smart00257 LysM Lysin motif

Probab=98.18  E-value=2e-06  Score=60.30  Aligned_cols=44  Identities=30%  Similarity=0.508  Sum_probs=37.9

Q ss_pred             EEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceeccc
Q 042486          186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLV  230 (635)
Q Consensus       186 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~i  230 (635)
                      +|+|++|||+++||++||++..++.++|+..... .+.+|+.+.|
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~-~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPD-NLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCcc-ccCCCCEEeC
Confidence            4899999999999999999999999999954444 6899987754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.14  E-value=1.2e-05  Score=79.18  Aligned_cols=116  Identities=18%  Similarity=0.110  Sum_probs=80.5

Q ss_pred             ceEEEeee-CCcEEEEEEecc-----------------------------ChHHHHHHHhhhccC--CcccEEEEEecCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG-----------------------------DASDQIKLLNKINHS--SLIRLLGICFNGG  409 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~-----------------------------~~~~E~~~l~~l~h~--nIv~l~~~~~~~~  409 (635)
                      +.||.|.. .|.++|||.-+.                             ...+|.+.|.++...  .+.+.+++    +
T Consensus       105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----n  180 (304)
T COG0478         105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----N  180 (304)
T ss_pred             ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----c
Confidence            78999998 699999995321                             134789999998655  66666653    4


Q ss_pred             eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       410 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ...+||||.+|--|...--       +....-.|+..|+.-+.-+-..   ++||+|+.+-||+++++|.+.++||--+.
T Consensus       181 RHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         181 RHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             cceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCcccc
Confidence            4579999998866654331       1222223333444433333343   49999999999999999999999997655


Q ss_pred             cc
Q 042486          490 PA  491 (635)
Q Consensus       490 ~~  491 (635)
                      ..
T Consensus       251 ~~  252 (304)
T COG0478         251 PI  252 (304)
T ss_pred             cC
Confidence            43

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.12  E-value=2.1e-06  Score=91.15  Aligned_cols=46  Identities=30%  Similarity=0.447  Sum_probs=42.4

Q ss_pred             EEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCCC
Q 042486          186 SYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLE  233 (635)
Q Consensus       186 ~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~  233 (635)
                      +|+|++|||||.||++||+++++|+++|++.. + .|++||.|.||..
T Consensus        29 tytVq~GDTLw~IA~~ygvtv~~I~~~N~l~~-~-~I~~Gq~L~Ip~~   74 (481)
T PRK13914         29 TVVVEAGDTLWGIAQSKGTTVDAIKKANNLTT-D-KIVPGQKLQVNEV   74 (481)
T ss_pred             eEEECCCCCHHHHHHHHCCCHHHHHHHhCCCc-c-cccCCCEEEeCCC
Confidence            79999999999999999999999999999964 3 6999999999954

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.08  E-value=7.4e-06  Score=83.27  Aligned_cols=48  Identities=15%  Similarity=0.134  Sum_probs=45.1

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeec
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVN  108 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~  108 (635)
                      -.|+|++ ||||+.||.+||+++.+|+++|++.++..|.+||.|.||.+
T Consensus        61 ~~y~Vk~-GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         61 STYTVKK-GDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             CceEECC-CCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            3699999 99999999999999999999999998999999999999854

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.04  E-value=5.2e-06  Score=83.28  Aligned_cols=47  Identities=17%  Similarity=0.226  Sum_probs=43.8

Q ss_pred             eeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEe
Q 042486           58 AFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVP  106 (635)
Q Consensus        58 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip  106 (635)
                      .+..|+|++ ||||++||++||++++.|+++|++. ++.+.+||.|+||
T Consensus       292 ~~~~YiVq~-GDTL~sIAkRYGVSV~~L~r~N~L~-~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQE-GDTIETIAERYEISVSQLIRHNQLE-DFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECC-CCCHHHHHHHHCcCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence            567799998 9999999999999999999999996 7899999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.01  E-value=1.8e-05  Score=75.58  Aligned_cols=104  Identities=23%  Similarity=0.184  Sum_probs=81.2

Q ss_pred             HHHHHHhhhcc-CCcccEEEEEecCCeeEEEeecccCCCcchhhcc-cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCe
Q 042486          385 DQIKLLNKINH-SSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH  462 (635)
Q Consensus       385 ~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i  462 (635)
                      +|.-+|+.+++ +++.+++|+|-    .++|.||...+++...-.. ......+|..|.+|+.++++.+++|++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888876 69999999992    2679999987765421100 000126999999999999999999998544448


Q ss_pred             EeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          463 VHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       463 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      ...|++++|+-+++++++|++|...+....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            889999999999999999999998876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.00  E-value=5.5e-05  Score=75.70  Aligned_cols=128  Identities=12%  Similarity=0.072  Sum_probs=81.5

Q ss_pred             ceEEEeeeCCcEEEEEEecc----ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhh---------
Q 042486          362 GSVYRGKIGGDFVAIKKVYG----DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI---------  427 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l---------  427 (635)
                      ..||+...++..+.||....    +..+|+++++.+. +--+.+++++...++..++|||+++|.+|.+..         
T Consensus        13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~   92 (244)
T cd05150          13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLV   92 (244)
T ss_pred             CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHH
Confidence            67999987777888888765    4788999999884 444667888777666789999999998776432         


Q ss_pred             ----------cccC--CCCCCH--HHHHHH-----------------------HHHHHhhhcccc-cCCCCCeEeecccC
Q 042486          428 ----------NDKG--GKFLDW--AQRIQI-----------------------ALDVATGLNYLH-SFTNPPHVHKDIKC  469 (635)
Q Consensus       428 ----------~~~~--~~~l~~--~~~~~i-----------------------~~~ia~aL~~LH-~~~~~~ivH~Dikp  469 (635)
                                +...  ......  ..+...                       ..++...|.... ....+.++|+|+.|
T Consensus        93 ~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~  172 (244)
T cd05150          93 DALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACL  172 (244)
T ss_pred             HHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCC
Confidence                      1100  001110  011100                       011111111100 01125589999999


Q ss_pred             CCEEECCCCcEEEeeecCcc
Q 042486          470 SNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       470 ~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .||+++++....|+||+.+.
T Consensus       173 ~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         173 PNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ccEEEeCCcEEEEEEccccc
Confidence            99999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.94  E-value=7.6e-06  Score=74.72  Aligned_cols=45  Identities=36%  Similarity=0.517  Sum_probs=39.2

Q ss_pred             EEEeecCChHHhHHHHhCC---ChhHHHHhcC--CCCCCCCcccceecccC
Q 042486          186 SYLVKGGNTVYGISKRFGV---DTDRTLEANG--LSEGAPNIYPFTTLLVP  231 (635)
Q Consensus       186 ~y~v~~gdtl~~Ia~~~~~---~~~~l~~~N~--~~~~~~~~~~~~~l~iP  231 (635)
                      +|+|++|||||+||++|+.   ....|+++|+  +.... .|+|||+|.||
T Consensus        97 ~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~-~I~pGq~L~IP  146 (147)
T PRK11198         97 FYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPD-KIYPGQVLRIP  146 (147)
T ss_pred             EEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcC-CcCcCCEEecC
Confidence            7999999999999999853   4678999998  66555 79999999998

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.93  E-value=4.4e-05  Score=73.70  Aligned_cols=114  Identities=18%  Similarity=0.146  Sum_probs=75.7

Q ss_pred             ceEEEeeeCCcEEEEEEeccCh----------------HHHHHHHhhhccCC---cccEEEEEe-----cCCeeEEEeec
Q 042486          362 GSVYRGKIGGDFVAIKKVYGDA----------------SDQIKLLNKINHSS---LIRLLGICF-----NGGNWYLVYEN  417 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~~----------------~~E~~~l~~l~h~n---Iv~l~~~~~-----~~~~~~lV~E~  417 (635)
                      ..|.+-..++...++|..+.+.                .+++..+.+++...   ...++....     -....+|+|||
T Consensus        45 ~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EY  124 (229)
T PF06176_consen   45 NYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEY  124 (229)
T ss_pred             cEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEE
Confidence            3466666688889999775532                23344444443322   223222222     12345799999


Q ss_pred             ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       418 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ++|..|.+...      +++    .+...+.+++.-||+.|   +.|+|.+|.|++++++ .++++||+..+
T Consensus       125 IeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  125 IEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             ecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence            99988877642      222    24456777899999966   9999999999999855 59999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.85  E-value=0.00014  Score=71.76  Aligned_cols=125  Identities=13%  Similarity=0.104  Sum_probs=74.5

Q ss_pred             ceEEEeeeCCcEEEEEEecc-----ChHHHHHHHhhhccCC--cccEEEEEecCCeeEEEeecccCCC-cchhh------
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-----DASDQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGS-LSVWI------  427 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-----~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l------  427 (635)
                      +.||+.  .++.+++|....     +..+|.++++.+..-.  +.+.+++....+...+|||+++|.. +...+      
T Consensus        15 ~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~   92 (226)
T TIGR02172        15 GESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSR   92 (226)
T ss_pred             cceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHH
Confidence            578873  244567887654     3568999999987544  4678888877778899999998863 21111      


Q ss_pred             ---------------cccCCCCCCHHHHHH-HHHHH----------Hh-hhccccc-CCCCCeEeecccCCCEEECCCCc
Q 042486          428 ---------------NDKGGKFLDWAQRIQ-IALDV----------AT-GLNYLHS-FTNPPHVHKDIKCSNVLLDTDFR  479 (635)
Q Consensus       428 ---------------~~~~~~~l~~~~~~~-i~~~i----------a~-aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~  479 (635)
                                     +.-............ +..++          .. ...+|.. .....++|+|+.|.||++++++ 
T Consensus        93 ~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-  171 (226)
T TIGR02172        93 LEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-  171 (226)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-
Confidence                           110000011111000 00000          00 0111111 1124578999999999999888 


Q ss_pred             EEEeeecCcc
Q 042486          480 AKIANFALAR  489 (635)
Q Consensus       480 ~kl~Dfg~a~  489 (635)
                      +.++||+.+.
T Consensus       172 ~~iIDwe~a~  181 (226)
T TIGR02172       172 TYWIDLGDFG  181 (226)
T ss_pred             cEEEechhcC
Confidence            9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.73  E-value=6.3e-05  Score=68.68  Aligned_cols=47  Identities=21%  Similarity=0.287  Sum_probs=39.5

Q ss_pred             eEEEEecCCchhhhhhhhcCCCccHHHHHhhc--C--CCCCCCCCcEEEEe
Q 042486          120 TTYFVQNGDTYFLIANNTFQGLSTCQALQDQH--G--NVSNFGVGTRLLAP  166 (635)
Q Consensus       120 ~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N--~--~~~~l~~G~~l~ip  166 (635)
                      ..|+|++|||||.||.++|..-..++.|.++|  .  +++.|++||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            46999999999999966666556788999999  2  46789999999998

>smart00257 LysM Lysin motif

Probab=97.69  E-value=6.6e-05  Score=52.31  Aligned_cols=43  Identities=19%  Similarity=0.286  Sum_probs=37.8

Q ss_pred             eecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEE
Q 042486           62 FRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIV  105 (635)
Q Consensus        62 y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~i  105 (635)
                      |++++ |||+++||+.|+++..+|.++|+......+.+|+.+.|
T Consensus         2 ~~v~~-gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        2 YTVKK-GDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             eEeCC-CCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEeC
Confidence            77888 99999999999999999999998656677889988764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.66  E-value=0.00051  Score=67.17  Aligned_cols=121  Identities=21%  Similarity=0.216  Sum_probs=81.6

Q ss_pred             ceEEEeee-CCcEEEEEEeccC-------------------------------hHHHHHHHhhhcc--CCcccEEEEEec
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD-------------------------------ASDQIKLLNKINH--SSLIRLLGICFN  407 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~-------------------------------~~~E~~~l~~l~h--~nIv~l~~~~~~  407 (635)
                      ..||+|.. ++..+|||+.+..                               ..+|+.-|+++..  =.+.+-+++.  
T Consensus        62 A~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~--  139 (268)
T COG1718          62 ANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR--  139 (268)
T ss_pred             eEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec--
Confidence            58999886 6899999987532                               1246667777643  3344445443  


Q ss_pred             CCeeEEEeecccCC-CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          408 GGNWYLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       408 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                        +-.|||||+... .-.-.|.+-.   +...+...+..++++.+.-|-.  ..++||+||..-|||+. ++.+.++|||
T Consensus       140 --~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~  211 (268)
T COG1718         140 --NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVS  211 (268)
T ss_pred             --CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECc
Confidence              236999998654 1111222211   3333566667777777777766  23499999999999999 8899999999


Q ss_pred             Cccccc
Q 042486          487 LARPAE  492 (635)
Q Consensus       487 ~a~~~~  492 (635)
                      -+....
T Consensus       212 QaV~~~  217 (268)
T COG1718         212 QAVTID  217 (268)
T ss_pred             cccccC
Confidence            887554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.60  E-value=3.4e-05  Score=83.68  Aligned_cols=170  Identities=20%  Similarity=0.188  Sum_probs=121.4

Q ss_pred             ceEEEeeeC-CcEEEEEEeccC--hHHHHHHHhhhccCC-cccEEEEEecCCeeEEEeecccCC-CcchhhcccCCCCCC
Q 042486          362 GSVYRGKIG-GDFVAIKKVYGD--ASDQIKLLNKINHSS-LIRLLGICFNGGNWYLVYENAVNG-SLSVWINDKGGKFLD  436 (635)
Q Consensus       362 g~Vy~g~~~-~~~vavK~~~~~--~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~  436 (635)
                      +++||.+-. .+....+.+...  ..-++++|.+++||| .++.++-+..+...+++++++.++ +-..-.... ...+.
T Consensus       256 tknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~  334 (829)
T KOG0576|consen  256 TKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS-EIALE  334 (829)
T ss_pred             cCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh-hHhhh
Confidence            677777763 233335555443  345899999999999 777777776777789999999877 222222111 11144


Q ss_pred             HHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcccc
Q 042486          437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL  516 (635)
Q Consensus       437 ~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  516 (635)
                      ..+...+...-.+++++||+..   -+|+|    ||+..+ +..+..||+.........    ..+...+++.++|||+.
T Consensus       335 ~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~  402 (829)
T KOG0576|consen  335 QYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVI  402 (829)
T ss_pred             hhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCchhh
Confidence            4555667777889999999843   48888    777654 688999999887655432    34456799999999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 042486          517 ENGLVSTKLDVYAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       517 ~~~~~s~ksDV~SlGvvl~elltG~~p~  544 (635)
                      ..+.+..+-|+|++|+--.++--|-+|.
T Consensus       403 ~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  403 QENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccccccCCCccCCCcchhhcCCCCCCC
Confidence            9999999999999998777777776653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.47  E-value=0.00063  Score=67.01  Aligned_cols=128  Identities=20%  Similarity=0.149  Sum_probs=73.8

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCC--cccEEEEEec---CCeeEEEeecccCCCcch------
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSS--LIRLLGICFN---GGNWYLVYENAVNGSLSV------  425 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~n--Iv~l~~~~~~---~~~~~lV~E~~~~gsL~~------  425 (635)
                      +.||+...+++.+++|.....     +.+|..+++.+....  +.+++.....   ....+++|+++++..+..      
T Consensus        11 n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~   90 (239)
T PF01636_consen   11 NRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQ   90 (239)
T ss_dssp             SEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHH
T ss_pred             eeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccc
Confidence            689999997789999998654     557888888886443  5677765543   234689999999987777      


Q ss_pred             ----------hh---ccc--CCCCCCHHH---------HHHH------------HHHHHh-hhccccc----CCCCCeEe
Q 042486          426 ----------WI---NDK--GGKFLDWAQ---------RIQI------------ALDVAT-GLNYLHS----FTNPPHVH  464 (635)
Q Consensus       426 ----------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-aL~~LH~----~~~~~ivH  464 (635)
                                .+   +..  ......+..         ....            ...+.. .+..+++    .....++|
T Consensus        91 ~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H  170 (239)
T PF01636_consen   91 RPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIH  170 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-
T ss_pred             cccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEE
Confidence                      11   111  101111100         0000            011111 2223322    12355999


Q ss_pred             ecccCCCEEEC-CCCcEEEeeecCcc
Q 042486          465 KDIKCSNVLLD-TDFRAKIANFALAR  489 (635)
Q Consensus       465 ~Dikp~NIll~-~~~~~kl~Dfg~a~  489 (635)
                      +|+.+.||+++ +++.+-|+||+.+.
T Consensus       171 gD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  171 GDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             eccccccceeeeccceeEEEecccce
Confidence            99999999999 66777899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=97.41  E-value=0.00018  Score=63.88  Aligned_cols=49  Identities=18%  Similarity=0.333  Sum_probs=44.7

Q ss_pred             eeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeec
Q 042486           58 AFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVN  108 (635)
Q Consensus        58 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~  108 (635)
                      .+.+|+|++ ||||+.||+.|++++.+|+++|.+.+. .+.+||.|.+|..
T Consensus        65 ~~~~~~V~~-gdtL~~Ia~~~~~tv~~l~~~n~l~~~-~i~~gq~l~~~~~  113 (124)
T COG1388          65 PVVTYTVKK-GDTLSKIARKYGVTVAELKQLNNLSSD-KIKVGQKLKLPVS  113 (124)
T ss_pred             CCceEEEec-CCCHHHHHHHhCCCHHHHHHHhccCCC-ceecCcEEEEecc
Confidence            457899999 999999999999999999999999655 9999999999973

>PLN02876 acyl-CoA dehydrogenase

Probab=97.25  E-value=0.0026  Score=75.02  Aligned_cols=62  Identities=11%  Similarity=0.298  Sum_probs=44.0

Q ss_pred             ceEEEeeeCC----cEEEEEEec--------cChHHHHHHHhhhc-cCCc--ccEEEEEecC---CeeEEEeecccCCCc
Q 042486          362 GSVYRGKIGG----DFVAIKKVY--------GDASDQIKLLNKIN-HSSL--IRLLGICFNG---GNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~~----~~vavK~~~--------~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lV~E~~~~gsL  423 (635)
                      +.+|+-...+    ..+++|+..        ..+.+|.++|+.+. |.++  .+++.+|.+.   +..|+||||++|..+
T Consensus        52 n~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         52 NPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            4677666533    356677652        24678999999995 6665  7888888764   457899999988654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.23  E-value=0.00055  Score=79.34  Aligned_cols=195  Identities=18%  Similarity=0.208  Sum_probs=131.6

Q ss_pred             HHHHHHhhhccCCcccEEEEEecCCee----EEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCC
Q 042486          385 DQIKLLNKINHSSLIRLLGICFNGGNW----YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNP  460 (635)
Q Consensus       385 ~E~~~l~~l~h~nIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~  460 (635)
                      -|+..+.++.|+|++.++.|.......    .+..|++...++...+.....  .+....+.+..++.+||.|+|+..  
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~--  306 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLS--  306 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhc--
Confidence            467778889999999999988754332    344567777777777755433  677888888999999999999853  


Q ss_pred             CeEeecccCC---CEEECCCCcEEEe--eecCcccccccCCceeeecccccCCCccCccccccCCCCc--ccchhhHHHH
Q 042486          461 PHVHKDIKCS---NVLLDTDFRAKIA--NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST--KLDVYAFGVL  533 (635)
Q Consensus       461 ~ivH~Dikp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~SlGvv  533 (635)
                       ..|.-+..+   +--.+.++...++  ||+...........    ........+.++|.........  ..|+|.+|..
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence             555544444   3444566667766  88887765543322    1123445677888776655444  4799999999


Q ss_pred             HHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 042486          534 MLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA  613 (635)
Q Consensus       534 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  613 (635)
                      ...+..|..+....                     .....+++..    ..    ..+.+....|+..++++|+++.+++
T Consensus       382 ~~~~~~~~~i~~~~---------------------~~~~~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKS---------------------AVPVSLLDVL----ST----SELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HhhhhhcCcccccc---------------------cchhhhhccc----cc----hhhhhhhhhhcchhhhhccchhhhh
Confidence            99999987553210                     1111111111    00    1367788899999999999999999


Q ss_pred             HHHH
Q 042486          614 QSIS  617 (635)
Q Consensus       614 ~~L~  617 (635)
                      .+..
T Consensus       433 ~~~f  436 (1351)
T KOG1035|consen  433 THPF  436 (1351)
T ss_pred             hchh
Confidence            8754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.11  E-value=0.004  Score=62.74  Aligned_cols=123  Identities=13%  Similarity=0.125  Sum_probs=72.4

Q ss_pred             ceEEEeeeCCcEEEEEEecc-------ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCcchh-------
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-------DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSLSVW-------  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-------~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL~~~-------  426 (635)
                      +.+|+...++..+++|....       +..+|.++++.+....+ .++++...    -++||||++|..+...       
T Consensus        10 n~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~   85 (256)
T TIGR02721        10 NRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDL   85 (256)
T ss_pred             CCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchh
Confidence            67888887777888886432       34679999999965444 44554432    3689999998766432       


Q ss_pred             ----------hcccC--CCCCCHHHH-HHHHH------------HHHhhhcccc--cCCCCCeEeecccCCCEEECCCCc
Q 042486          427 ----------INDKG--GKFLDWAQR-IQIAL------------DVATGLNYLH--SFTNPPHVHKDIKCSNVLLDTDFR  479 (635)
Q Consensus       427 ----------l~~~~--~~~l~~~~~-~~i~~------------~ia~aL~~LH--~~~~~~ivH~Dikp~NIll~~~~~  479 (635)
                                ++...  ...++...+ .....            ++...+....  ......++|+|+.|.||++++++ 
T Consensus        86 ~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-  164 (256)
T TIGR02721        86 LLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-  164 (256)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-
Confidence                      11111  111222211 11111            1111111110  00124589999999999999876 


Q ss_pred             EEEeeecCcc
Q 042486          480 AKIANFALAR  489 (635)
Q Consensus       480 ~kl~Dfg~a~  489 (635)
                      +.|+||+.+.
T Consensus       165 ~~lIDwE~a~  174 (256)
T TIGR02721       165 LKLIDWEYAS  174 (256)
T ss_pred             CEEEeccccC
Confidence            7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.11  E-value=0.0066  Score=60.21  Aligned_cols=59  Identities=15%  Similarity=0.171  Sum_probs=39.7

Q ss_pred             ceEEEeeeC---CcEEEEEEecc------ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKIG---GDFVAIKKVYG------DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~~---~~~vavK~~~~------~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      ..+|+....   +..+++|....      +..+|+.+++.+....+ .++++.+.    ..++|||++|.++.
T Consensus        12 N~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l~   80 (235)
T cd05157          12 NKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTLE   80 (235)
T ss_pred             ceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcCC
Confidence            578888764   46788886643      23479999999854444 44544332    24899999987764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.05  E-value=0.0068  Score=62.55  Aligned_cols=62  Identities=11%  Similarity=0.004  Sum_probs=45.8

Q ss_pred             ceEEEeeeCCcEEEEEEecc-----ChHHHHHHHhhhcc---CCcccEEEEEecC---CeeEEEeecccCCCc
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-----DASDQIKLLNKINH---SSLIRLLGICFNG---GNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-----~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~lV~E~~~~gsL  423 (635)
                      +.||+-...+..+.+|..+.     .+..|.+.|+.+..   -.+.+++++|..+   +..+||||+++++++
T Consensus        28 ~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         28 AALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             eeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            67888876544566666543     35789999998853   3688899888643   668999999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.02  E-value=0.0028  Score=63.04  Aligned_cols=30  Identities=20%  Similarity=0.339  Sum_probs=25.9

Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..++|+|+.+.||+++++...-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            458999999999999877666799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.85  E-value=0.0061  Score=56.60  Aligned_cols=113  Identities=19%  Similarity=0.097  Sum_probs=76.9

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCccc-EEEEEecCCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIR-LLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||.|.+.|..+|+|+-+.+     +..|.++|..++-.++-+ ++.|-.    -++.|||..|-.|.++-...     
T Consensus        36 s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~-----  106 (201)
T COG2112          36 SVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG-----  106 (201)
T ss_pred             cEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhcc-----
Confidence            789999999999999988765     567999999998776654 444432    24559999998887776431     


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeeccc-CCCEEECCCCcEEEeeecCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK-CSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dik-p~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      +.+...    .+++.---|..   .+|-|+.|. |..++|-.+..+.|+||..|+.
T Consensus       107 ~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         107 DRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            223333    33333222333   348888876 4444554555999999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.68  E-value=0.016  Score=55.71  Aligned_cols=94  Identities=18%  Similarity=0.262  Sum_probs=64.7

Q ss_pred             HHHHHHHhhhc------cCCcccEEEEEecCCeeEEEeecccC--C----CcchhhcccCCCCCCHHHHHHHHHHHHhhh
Q 042486          384 SDQIKLLNKIN------HSSLIRLLGICFNGGNWYLVYENAVN--G----SLSVWINDKGGKFLDWAQRIQIALDVATGL  451 (635)
Q Consensus       384 ~~E~~~l~~l~------h~nIv~l~~~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL  451 (635)
                      .+|+.-..++.      +.+|.+++|+...+.-..+|+|...+  |    +|.+++....   ++. ...+.+.++.+  
T Consensus        59 ~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f~~--  132 (199)
T PF10707_consen   59 RRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEFKR--  132 (199)
T ss_pred             HHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHHHH--
Confidence            45766666655      78999999999988888999998754  2    5777774432   555 44444555544  


Q ss_pred             cccccCCCCCeEeecccCCCEEECCC---C-cEEEee-ecC
Q 042486          452 NYLHSFTNPPHVHKDIKCSNVLLDTD---F-RAKIAN-FAL  487 (635)
Q Consensus       452 ~~LH~~~~~~ivH~Dikp~NIll~~~---~-~~kl~D-fg~  487 (635)
                       ||-+.+   |+.+|++|.||++..+   . .+.|+| ||.
T Consensus       133 -~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  133 -YLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             -HHHHcC---CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence             444433   9999999999999432   2 577877 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.66  E-value=0.021  Score=58.80  Aligned_cols=128  Identities=16%  Similarity=0.112  Sum_probs=75.8

Q ss_pred             ceEEEeeeCCcEEEEEEecc----ChHHHHHHHhhhccCC--cccEEEE------EecCCeeEEEeecccCCCcchh---
Q 042486          362 GSVYRGKIGGDFVAIKKVYG----DASDQIKLLNKINHSS--LIRLLGI------CFNGGNWYLVYENAVNGSLSVW---  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~----~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lV~E~~~~gsL~~~---  426 (635)
                      ..+|+...++..+++|....    +...|++++..+.+..  +.+++..      ...++..++|++|++|..+...   
T Consensus        28 n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~  107 (296)
T cd05153          28 NTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAA  107 (296)
T ss_pred             cceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHH
Confidence            46898877777888898753    2446888888885443  4444432      1234456899999998776430   


Q ss_pred             --------h---ccc----CC-----CCCCHHHHHH----------HHHHHHhhhccccc----CCCCCeEeecccCCCE
Q 042486          427 --------I---NDK----GG-----KFLDWAQRIQ----------IALDVATGLNYLHS----FTNPPHVHKDIKCSNV  472 (635)
Q Consensus       427 --------l---~~~----~~-----~~l~~~~~~~----------i~~~ia~aL~~LH~----~~~~~ivH~Dikp~NI  472 (635)
                              +   +..    ..     ....|.....          ....+..++.++.+    .....++|+|+.|.||
T Consensus       108 ~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Ni  187 (296)
T cd05153         108 HCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNV  187 (296)
T ss_pred             HHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccE
Confidence                    0   100    00     0112221110          01112223333332    1124699999999999


Q ss_pred             EECCCCcEEEeeecCcc
Q 042486          473 LLDTDFRAKIANFALAR  489 (635)
Q Consensus       473 ll~~~~~~kl~Dfg~a~  489 (635)
                      +++++....|+||+.+.
T Consensus       188 l~~~~~~~~iIDfe~a~  204 (296)
T cd05153         188 LFDGDELSGVIDFYFAC  204 (296)
T ss_pred             EEeCCceEEEeehhhhc
Confidence            99988778899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.43  E-value=0.027  Score=58.18  Aligned_cols=60  Identities=18%  Similarity=0.239  Sum_probs=40.2

Q ss_pred             ceEEEeeeC--------CcEEEEEEecc------ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG--------GDFVAIKKVYG------DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~--------~~~vavK~~~~------~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      ..+|+....        ++.+++|....      +..+|.++++.+....+ .++++++.+    .+|+||++|..+..
T Consensus        12 N~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~~   86 (302)
T cd05156          12 NAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLTT   86 (302)
T ss_pred             ceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCCH
Confidence            467777663        46788887654      34678889998864444 456665532    36899999877653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.34  E-value=0.023  Score=54.38  Aligned_cols=104  Identities=18%  Similarity=0.238  Sum_probs=71.7

Q ss_pred             ceEEEeeeCCcEEEEEEecc----------------------------ChHHHHHHHhhh---ccCCc--ccEEEEEecC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG----------------------------DASDQIKLLNKI---NHSSL--IRLLGICFNG  408 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~----------------------------~~~~E~~~l~~l---~h~nI--v~l~~~~~~~  408 (635)
                      |.|||.+++|+.+|+|.++.                            .|..|.+...+|   .+.++  ++++||..-.
T Consensus        52 ~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~  131 (207)
T PF13095_consen   52 GYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLT  131 (207)
T ss_pred             eEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEc
Confidence            78999999999999998321                            133566665555   45566  9999998522


Q ss_pred             ------------------CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCC
Q 042486          409 ------------------GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS  470 (635)
Q Consensus       409 ------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~  470 (635)
                                        -.+.||.||.+...           .+....    +.+|.+-|..+|..+   |+-+|+++.
T Consensus       132 ~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~k~g---I~~~Dv~~~  193 (207)
T PF13095_consen  132 EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILHKLG---IVPRDVKPR  193 (207)
T ss_pred             hHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHHHCC---eeeccCccc
Confidence                              01356777665432           133333    345556667799866   999999999


Q ss_pred             CEEECCCCcEEEeeecCc
Q 042486          471 NVLLDTDFRAKIANFALA  488 (635)
Q Consensus       471 NIll~~~~~~kl~Dfg~a  488 (635)
                      |..     .-||+|||.+
T Consensus       194 ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  194 NYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccc-----CCEEEecccC
Confidence            986     5689999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	635
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-37
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-37
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-23
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		3e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/298 (30%), Positives = 163/298 (54%), Gaps = 24/298 (8%)
Query: 338 SLKVYTFEELQAATDDFNPSCWIK----GSVYRGKIG-GDFVAIKKVYGDASD------- 385
            LK ++  ELQ A+D+F+    +     G VY+G++  G  VA+K++  +          
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 386 -QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQ 442
            ++++++   H +L+RL G C       LVY    NGS++  + ++      LDW +R +
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
           IAL  A GL YLH   +P  +H+D+K +N+LLD +F A + +F LA+  + ++       
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 202
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA---PALYSEENMLLVDVLN 559
            + GT G++APEYL  G  S K DV+ +GV++LE+++G+ A     L ++++++L+D + 
Sbjct: 203 -VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            +L     E+ L  L+D  +QGNY       +I++   C +  P  RP M ++ + + 
Sbjct: 262 GLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  152 bits (384), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/298 (30%), Positives = 163/298 (54%), Gaps = 24/298 (8%)
Query: 338 SLKVYTFEELQAATDDFNPSCWIK----GSVYRGKIG-GDFVAIKKVYGDASD------- 385
            LK ++  ELQ A+D+F     +     G VY+G++  G  VA+K++  + +        
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 386 -QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQ 442
            ++++++   H +L+RL G C       LVY    NGS++  + ++      LDW +R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
           IAL  A GL YLH   +P  +H+D+K +N+LLD +F A + +F LA+  + ++    +  
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH--VXX 193
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA---PALYSEENMLLVDVLN 559
            + G  G++APEYL  G  S K DV+ +GV++LE+++G+ A     L ++++++L+D + 
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            +L     E+ L  L+D  +QGNY       +I++   C +  P  RP M ++ + + 
Sbjct: 254 GLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 149/295 (50%), Gaps = 32/295 (10%)
Query: 342 YTFEELQAATDDFNPSCWIKGS----------VYRGKIGGDFVAIKKVYG---------- 381
           ++F EL+  T++F+      G           VY+G +    VA+KK+            
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 382 -DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-KGGKFLDWAQ 439
                +IK++ K  H +L+ LLG   +G +  LVY    NGSL   ++   G   L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           R +IA   A G+N+LH      H+H+DIK +N+LLD  F AKI++F LAR +E+   +  
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQTV 190
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
           + S IVGT  YMAPE L  G ++ K D+Y+FGV++LE+++G  A   + E  +LL     
Sbjct: 191 MXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               ++  E+ +   M+ +   +   V A+  +     CL +  + RP + K+ Q
Sbjct: 250 IEDEEKTIEDYIDKKMNDA---DSTSVEAMYSV--ASQCLHEKKNKRPDIKKVQQ 299

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 148/295 (50%), Gaps = 32/295 (10%)
Query: 342 YTFEELQAATDDFNPSCWIKGS----------VYRGKIGGDFVAIKKVYG---------- 381
           ++F EL+  T++F+      G           VY+G +    VA+KK+            
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 382 -DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-KGGKFLDWAQ 439
                +IK++ K  H +L+ LLG   +G +  LVY    NGSL   ++   G   L W  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           R +IA   A G+N+LH      H+H+DIK +N+LLD  F AKI++F LAR +E+   +  
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQTV 190
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
           +   IVGT  YMAPE L  G ++ K D+Y+FGV++LE+++G  A   + E  +LL     
Sbjct: 191 MXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               ++  E+ +   M+ +   +   V A+  +     CL +  + RP + K+ Q
Sbjct: 250 IEDEEKTIEDYIDKKMNDA---DSTSVEAMYSV--ASQCLHEKKNKRPDIKKVQQ 299

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/235 (34%), Positives = 125/235 (53%), Gaps = 27/235 (11%)
Query: 342 YTFEELQAATDDFNPSCWIKGS----------VYRGKIGGDFVAIKKVYG---------- 381
           ++F EL+  T++F+      G           VY+G +    VA+KK+            
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 382 -DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-KGGKFLDWAQ 439
                +IK++ K  H +L+ LLG   +G +  LVY    NGSL   ++   G   L W  
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           R +IA   A G+N+LH      H+H+DIK +N+LLD  F AKI++F LAR +E+   +  
Sbjct: 129 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQXV 184
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
           +   IVGT  YMAPE L  G ++ K D+Y+FGV++LE+++G  A   + E  +LL
Sbjct: 185 MXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/235 (34%), Positives = 123/235 (52%), Gaps = 27/235 (11%)
Query: 342 YTFEELQAATDDFNPSCWIKGS----------VYRGKIGGDFVAIKKVYG---------- 381
           ++F EL+  T++F+      G           VY+G +    VA+KK+            
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 382 -DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-KGGKFLDWAQ 439
                +IK+  K  H +L+ LLG   +G +  LVY    NGSL   ++   G   L W  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           R +IA   A G+N+LH      H+H+DIK +N+LLD  F AKI++F LAR +E+   +  
Sbjct: 126 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQXV 181
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
             S IVGT  Y APE L  G ++ K D+Y+FGV++LE+++G  A   + E  +LL
Sbjct: 182 XXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 150/317 (47%), Gaps = 56/317 (17%)
Query: 331 SISDIAQSLKVYTFE-------ELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKK 378
           SI+D   S  +  FE       +L+ AT++F+    I     G VY+G +  G  VA+K+
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 379 VYGDASD-------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS--VWIND 429
              ++S        +I+ L+   H  L+ L+G C       L+Y+   NG+L   ++ +D
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                + W QR++I +  A GL+YLH+      +H+D+K  N+LLD +F  KI +F +++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFGISK 187
Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP----- 544
               + G+  L   + GT GY+ PEY   G ++ K DVY+FGV++ E+L  + A      
Sbjct: 188 KGT-ELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 545 ---------ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
                    A+ S  N  L  +++P L  +   ESLR   D +++               
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK--------------- 291
Query: 596 ESCLKKDPSGRPAMDKI 612
             CL      RP+M  +
Sbjct: 292 --CLALSSEDRPSMGDV 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 149/317 (47%), Gaps = 56/317 (17%)
Query: 331 SISDIAQSLKVYTFE-------ELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKK 378
           SI+D   S  +  FE       +L+ AT++F+    I     G VY+G +  G  VA+K+
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 379 VYGDASD-------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS--VWIND 429
              ++S        +I+ L+   H  L+ L+G C       L+Y+   NG+L   ++ +D
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                + W QR++I +  A GL+YLH+      +H+D+K  N+LLD +F  KI +F +++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFGISK 187
Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP----- 544
                + +  L   + GT GY+ PEY   G ++ K DVY+FGV++ E+L  + A      
Sbjct: 188 KGTELD-QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 545 ---------ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
                    A+ S  N  L  +++P L  +   ESLR   D +++               
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK--------------- 291
Query: 596 ESCLKKDPSGRPAMDKI 612
             CL      RP+M  +
Sbjct: 292 --CLALSSEDRPSMGDV 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 32/273 (11%)
Query: 362 GSVYRGKIGGDFVAIK---------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+V+R +  G  VA+K         +   +   ++ ++ ++ H +++  +G      N  
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 413 LVYENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +V E    GSL   ++  G +  LD  +R+ +A DVA G+NYLH+  NPP VH+D+K  N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRDLKSPN 169
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +L+D  +  K+ +F L+R    +   F  +    GT  +MAPE L +   + K DVY+FG
Sbjct: 170 LLVDKKYTVKVCDFGLSR---LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           V++ E+ + ++        N+    V+  V  K    E  R+L         P V AI  
Sbjct: 227 VILWELATLQQPWG-----NLNPAQVVAAVGFKCKRLEIPRNL--------NPQVAAI-- 271
Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
              IE C   +P  RP+   I   +   + +++
Sbjct: 272 ---IEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 32/273 (11%)
Query: 362 GSVYRGKIGGDFVAIK---------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+V+R +  G  VA+K         +   +   ++ ++ ++ H +++  +G      N  
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 413 LVYENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +V E    GSL   ++  G +  LD  +R+ +A DVA G+NYLH+  NPP VH+++K  N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPN 169
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +L+D  +  K+ +F L+R    +   F  +    GT  +MAPE L +   + K DVY+FG
Sbjct: 170 LLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           V++ E+ + ++        N+    V+  V  K    E  R+L         P V AI  
Sbjct: 227 VILWELATLQQPWG-----NLNPAQVVAAVGFKCKRLEIPRNL--------NPQVAAI-- 271
Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
              IE C   +P  RP+   I   +   + +++
Sbjct: 272 ---IEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 27/199 (13%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQI-----------KLLNKINHSSLIRLLGICFNGGN 410
           G VYR    GD VA+K    D  + I           KL   + H ++I L G+C    N
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
             LV E A  G L+  ++   GK +     +  A+ +A G+NYLH     P +H+D+K S
Sbjct: 81  LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 471 NVLLDTDFR--------AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           N+L+              KI +F LAR   R     A      G   +MAPE +   + S
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-----AGAYAWMAPEVIRASMFS 192
Query: 523 TKLDVYAFGVLMLEMLSGK 541
              DV+++GVL+ E+L+G+
Sbjct: 193 KGSDVWSYGVLLWELLTGE 211

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 135/281 (48%), Gaps = 49/281 (17%)
Query: 362 GSVYRGKIGGD--FVAIKK-VYGDASDQIKLLNK-------------INHSSLIRLLGIC 405
           G V++G++  D   VAIK  + GD+  + +++ K             +NH ++++L G+ 
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
            N     +V E    G L   + DK    + W+ ++++ LD+A G+ Y+ +  NPP VH+
Sbjct: 93  HNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-QNPPIVHR 148
Query: 466 DIKCSNVLL-----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL--EN 518
           D++  N+ L     +    AK+A+F+L++ +          S ++G   +MAPE +  E 
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS------VSGLLGNFQWMAPETIGAEE 202
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
              + K D Y+F +++  +L+G+     YS   +  ++++         EE LR    P+
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--------EEGLR----PT 250
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
           +  + PP     +  +IE C   DP  RP    I + +S  
Sbjct: 251 IPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 134/281 (47%), Gaps = 49/281 (17%)
Query: 362 GSVYRGKIGGD--FVAIKK-VYGDASDQIKLLNK-------------INHSSLIRLLGIC 405
           G V++G++  D   VAIK  + GD+  + +++ K             +NH ++++L G+ 
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
            N     +V E    G L   + DK    + W+ ++++ LD+A G+ Y+ +  NPP VH+
Sbjct: 93  HNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-QNPPIVHR 148
Query: 466 DIKCSNVLL-----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL--EN 518
           D++  N+ L     +    AK+A+F L++ +          S ++G   +MAPE +  E 
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEE 202
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
              + K D Y+F +++  +L+G+     YS   +  ++++         EE LR    P+
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--------EEGLR----PT 250
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
           +  + PP     +  +IE C   DP  RP    I + +S  
Sbjct: 251 IPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 31/228 (13%)
Query: 339 LKVYTFEELQAATDDFNPSCWIK----------------GSVYRGKIGGDFVAIKKVYGD 382
           +K    E   AA D+F  S W                  G V  G   G+ VA+K +  D
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND 227
Query: 383 ASDQIKL-----LNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A+ Q  L     + ++ HS+L++LLG+     G  Y+V E    GSL  ++  +G   L 
Sbjct: 228 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 287
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
               ++ +LDV   + YL        VH+D+   NVL+  D  AK+++F L + A   + 
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
              L         + APE L     STK DV++FG+L+ E+ S    P
Sbjct: 345 TGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 124/273 (45%), Gaps = 44/273 (16%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           G V + K     VAIK++  ++       +++ L+++NH ++++L G C N     LV E
Sbjct: 23  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVME 80
Query: 417 NAVNGSL-SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
            A  GSL +V    +   +   A  +   L  + G+ YLHS      +H+D+K  N+LL 
Sbjct: 81  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 140
Query: 476 TDFRA-KIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLVSTKLDVYAFG 531
                 KI +F  A           + +H+   KG   +MAPE  E    S K DV+++G
Sbjct: 141 AGGTVLKICDFGTA---------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWG 191
Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL- 590
           +++ E+++ ++                      E G  + R +M     G  PP+   L 
Sbjct: 192 IILWEVITRRKP-------------------FDEIGGPAFR-IMWAVHNGTRPPLIKNLP 231
Query: 591 --VIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
             +  L+  C  KDPS RP+M++I + ++  + 
Sbjct: 232 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKL-----LNKINHSSLIRLLGICFN-GGNWYLVY 415
           G V  G   G+ VA+K +  DA+ Q  L     + ++ HS+L++LLG+     G  Y+V 
Sbjct: 26  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 85
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E    GSL  ++  +G   L     ++ +LDV   + YL        VH+D+   NVL+ 
Sbjct: 86  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS 142
Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
            D  AK+++F L + A   +    L         + APE L     STK DV++FG+L+ 
Sbjct: 143 EDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKSDVWSFGILLW 196
Query: 536 EMLSGKEAP 544
           E+ S    P
Sbjct: 197 EIYSFGRVP 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 124/273 (45%), Gaps = 44/273 (16%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           G V + K     VAIK++  ++       +++ L+++NH ++++L G C N     LV E
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVME 79
Query: 417 NAVNGSL-SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
            A  GSL +V    +   +   A  +   L  + G+ YLHS      +H+D+K  N+LL 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139
Query: 476 TDFRA-KIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLVSTKLDVYAFG 531
                 KI +F  A           + +H+   KG   +MAPE  E    S K DV+++G
Sbjct: 140 AGGTVLKICDFGTA---------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWG 190
Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL- 590
           +++ E+++ ++                      E G  + R +M     G  PP+   L 
Sbjct: 191 IILWEVITRRKP-------------------FDEIGGPAFR-IMWAVHNGTRPPLIKNLP 230
Query: 591 --VIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
             +  L+  C  KDPS RP+M++I + ++  + 
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKL-----LNKINHSSLIRLLGICFN-GGNWYLVY 415
           G V  G   G+ VA+K +  DA+ Q  L     + ++ HS+L++LLG+     G  Y+V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E    GSL  ++  +G   L     ++ +LDV   + YL        VH+D+   NVL+ 
Sbjct: 80  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS 136
Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
            D  AK+++F L + A   +    L         + APE L     STK DV++FG+L+ 
Sbjct: 137 EDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLW 190
Query: 536 EMLSGKEAP 544
           E+ S    P
Sbjct: 191 EIYSFGRVP 199

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 349 AATDDFNPSCWIK----------------GSVYRGKIGGDFVAIKKVYGDASDQIKL--- 389
           AA D+F  S W                  G V  G   G+ VA+K +  DA+ Q  L   
Sbjct: 6   AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEA 65
Query: 390 --LNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
             + ++ HS+L++LLG+     G  Y+V E    GSL  ++  +G   L     ++ +LD
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           V   + YL        VH+D+   NVL+  D  AK+++F L + A   +    L      
Sbjct: 126 VCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--- 179
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
              + APE L     STK DV++FG+L+ E+ S    P
Sbjct: 180 ---WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 133/281 (47%), Gaps = 49/281 (17%)
Query: 362 GSVYRGKIGGD--FVAIKK-VYGDASDQIKLLNK-------------INHSSLIRLLGIC 405
           G V++G++  D   VAIK  + GD+  + +++ K             +NH ++++L G+ 
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
            N     +V E    G L   + DK    + W+ ++++ LD+A G+ Y+ +  NPP VH+
Sbjct: 93  HNPPR--MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-QNPPIVHR 148
Query: 466 DIKCSNVLL-----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL--EN 518
           D++  N+ L     +    AK+A+F  ++ +          S ++G   +MAPE +  E 
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS------VSGLLGNFQWMAPETIGAEE 202
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
              + K D Y+F +++  +L+G+     YS   +  ++++         EE LR    P+
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--------EEGLR----PT 250
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
           +  + PP     +  +IE C   DP  RP    I + +S  
Sbjct: 251 IPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 45/270 (16%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VA+K +  G  S+     + + + K++H  L++  G+C      Y+V
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++   G K L+ +Q +++  DV  G+ +L S      +H+D+   N L+
Sbjct: 82  TEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLV 137
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVY 528
           D D   K+++F + R        + L    V + G      + APE       S+K DV+
Sbjct: 138 DRDLCVKVSDFGMTR--------YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 529 AFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
           AFG+LM E+ S GK    LY+   +        VL    G    R           P + 
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEV--------VLKVSQGHRLYR-----------PHLA 230
Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  + +++ SC  + P  RP   ++  SI 
Sbjct: 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 106/240 (44%), Gaps = 32/240 (13%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++K++  + H ++++ +G+ +       + E    G+L   I     ++  W+QR+  A 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-PWSQRVSFAK 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR----PAERQEGEFALT 501
           D+A+G+ YLHS      +H+D+   N L+  +    +A+F LAR       + EG  +L 
Sbjct: 116 DIASGMAYLHSMNI---IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 502 SH-------IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
                    +VG   +MAPE +       K+DV++FG+++ E++    A   Y    M  
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-- 230
Query: 555 VDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                      D   ++R  +D     N PP    + +R    C   DP  RP+  K+  
Sbjct: 231 -----------DFGLNVRGFLDRYCPPNCPPSFFPITVR----CCDLDPEKRPSFVKLEH 275

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ KI H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV-SEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 37/268 (13%)
Query: 362 GSVYRGKIGGD--FVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNW 411
           G V+ G++  D   VA+K         +K        +L + +H +++RL+G+C      
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y+V E    G    ++  +G + L     +Q+  D A G+ YL S      +H+D+   N
Sbjct: 188 YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARN 243
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHI--VGTKGYMAPEYLENGLVSTKLDVYA 529
            L+      KI++F ++R  E  +G +A +  +  V  K + APE L  G  S++ DV++
Sbjct: 244 CLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVK-WTAPEALNYGRYSSESDVWS 300
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FG+L+ E  S   +P                  +     +  R  ++   +   P +   
Sbjct: 301 FGILLWETFSLGASP------------------YPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            V RL+E C   +P  RP+   I Q + 
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G+ S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 199 GEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 257
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 258 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 314
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F L R  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 315 GENLVCKVADFGLGRLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 366
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 367 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRMPC--------PPECP 408
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 409 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 443

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 21  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 79
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 80  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 136
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 137 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 188
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 189 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 230
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 231 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 265

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 23  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 81
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 82  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 138
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 139 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 190
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 191 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 232
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 233 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEXTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  CEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 313
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 365
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 366 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRMPC--------PPECP 407
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 112/244 (45%), Gaps = 36/244 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + +++ K+ H  L++L  +  +    Y+V E    GSL  ++  + GK+L   Q + +A 
Sbjct: 312 EAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEFA 499
            +A+G+ Y+       +VH+D++ +N+L+  +   K+A+F LAR  E      RQ  +F 
Sbjct: 371 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
           +         + APE    G  + K DV++FG+L+ E+ +    P       M+  +VL+
Sbjct: 428 IK--------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLD 475
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
            V      E   R           PP     +  L+  C +K+P  RP  + +   +  +
Sbjct: 476 QV------ERGYRMPC--------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
Query: 620 LNAS 623
             ++
Sbjct: 522 FTST 525

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 313
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 365
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 366 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRMPC--------PPECP 407
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G+  VAIK +  G  S     ++ +++ K+ H  L++L  +  +    Y+V
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV-SEEPIYIV 81
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++ D  G+ L     + +A  VA G+ Y+       ++H+D++ +N+L+
Sbjct: 82  TEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILV 138
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
                 KIA+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 139 GNGLICKIADFGLARLIEDNEXTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 190
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+++    P  Y   N           ++E  E+  R    P      P    
Sbjct: 191 SFGILLTELVTKGRVP--YPGMN-----------NREVLEQVERGYRMPC-----PQDCP 232
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           I +  L+  C KKDP  RP  + +   +  +  A+
Sbjct: 233 ISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTAT 267

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 257 GEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 313
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 365
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 366 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRMPC--------PPECP 407
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 25  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 83
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 84  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 140
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 141 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 192
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 193 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 234
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 235 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 269

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 134/286 (46%), Gaps = 38/286 (13%)
Query: 362 GSVYRGKIGGDFVAIK------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNW---- 411
           G V++ ++  DFVA+K      K    +  +I     + H +L++ +     G N     
Sbjct: 29  GCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVEL 88
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT--------NPPHV 463
           +L+      GSL+ ++    G  + W +   +A  ++ GL+YLH            P   
Sbjct: 89  WLITAFHDKGSLTDYLK---GNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIA 145
Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH-IVGTKGYMAPEYLENGL-- 520
           H+D K  NVLL +D  A +A+F LA     + G+    +H  VGT+ YMAPE LE  +  
Sbjct: 146 HRDFKSKNVLLKSDLTAVLADFGLA--VRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 203
Query: 521 ---VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV---LNPVLHKEDGEESLRH- 573
                 ++D+YA G+++ E++S  +A     +E ML  +     +P L  E+ +E + H 
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSL--EELQEVVVHK 261
Query: 574 LMDPSMQGNY--PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            M P+++ ++   P  A L +  IE C   D   R +   + + +S
Sbjct: 262 KMRPTIKDHWLKHPGLAQLCV-TIEECWDHDAEARLSAGCVEERVS 306

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 37/268 (13%)
Query: 362 GSVYRGKIGGD--FVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNW 411
           G V+ G++  D   VA+K         +K        +L + +H +++RL+G+C      
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y+V E    G    ++  +G + L     +Q+  D A G+ YL S      +H+D+   N
Sbjct: 188 YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARN 243
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHI--VGTKGYMAPEYLENGLVSTKLDVYA 529
            L+      KI++F ++R  E  +G  A +  +  V  K + APE L  G  S++ DV++
Sbjct: 244 CLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVK-WTAPEALNYGRYSSESDVWS 300
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FG+L+ E  S   +P                  +     +  R  ++   +   P +   
Sbjct: 301 FGILLWETFSLGASP------------------YPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            V RL+E C   +P  RP+   I Q + 
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D+  +N+L+
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLAAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    G L  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  MEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 118/273 (43%), Gaps = 49/273 (17%)
Query: 366 RGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           R K  G  VAIKK      D         +IKLL ++ H +L+ LL +C     WYLV+E
Sbjct: 45  RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 417 ---NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
              + +   L ++ N      LD+    +    +  G+ + HS      +H+DIK  N+L
Sbjct: 105 FVDHTILDDLELFPNG-----LDYQVVQKYLFQIINGIGFCHSHNI---IHRDIKPENIL 156
Query: 474 LDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDVY 528
           +      K+ +F  AR    P E  + E       V T+ Y APE L   +   K +DV+
Sbjct: 157 VSQSGVVKLCDFGFARTLAAPGEVYDDE-------VATRWYRAPELLVGDVKYGKAVDVW 209
Query: 529 AFGVLMLEMLSGK-------EAPALYSEENMLLVDVLNPVLHKE--DGEESLRHLMDPSM 579
           A G L+ EM  G+       +   LY    M+ +  L P  H+E  +       +  P +
Sbjct: 210 AIGCLVTEMFMGEPLFPGDSDIDQLYH--IMMCLGNLIP-RHQELFNKNPVFAGVRLPEI 266
Query: 580 QGNYP-----PVTAILVIRLIESCLKKDPSGRP 607
           +   P     P  + +VI L + CL  DP  RP
Sbjct: 267 KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 90
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    G L  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 91  TEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 147
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 148 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 199
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 200 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 241
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +KDP  RP  + +   +  +  ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 130/275 (47%), Gaps = 37/275 (13%)
Query: 362 GSVYRGKIGG-----DFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           G V RG++         VAIK + G  +++ +        ++ +  H ++IRL G+  N 
Sbjct: 28  GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNS 87
Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
               ++ E   NG+L  ++    G+F    Q + +   +A+G+ YL   +   +VH+D+ 
Sbjct: 88  MPVMILTEFMENGALDSFLRLNDGQFTV-IQLVGMLRGIASGMRYLAEMS---YVHRDLA 143
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT--KGYMAPEYLENGLVSTKLD 526
             N+L++++   K+++F L+R  E    +   TS + G     + APE +     ++  D
Sbjct: 144 ARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASD 203
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
            +++G++M E++S  E P      +M   DV+N +      E+  R  + P      PP 
Sbjct: 204 AWSYGIVMWEVMSFGERPYW----DMSNQDVINAI------EQDYR--LPP------PPD 245
Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
               + +L+  C +KD + RP   ++  ++ + + 
Sbjct: 246 CPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 24/249 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ + +H ++IRL G+   G    +V E   NGSL  ++    G+F    Q + +  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT-IMQLVGMLR 158
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHI 504
            V  G+ YL       +VH+D+   NVL+D++   K+++F L+R  E   +  +  T   
Sbjct: 159 GVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
           +  + + APE +     S+  DV++FGV+M E+L+  E P      NM   DV++ V   
Sbjct: 216 IPIR-WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW----NMTNRDVISSV--- 267
Query: 565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
              EE  R    P+  G         + +L+  C  KD + RP   +I   +   + +  
Sbjct: 268 ---EEGYRL---PAPMG-----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
Query: 625 AWELSKNIS 633
           +   +  +S
Sbjct: 317 SLRATATVS 325

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 87
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + ++  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 88  TEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLRAANILV 144
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 145 GENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 196
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 197 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 238
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 79
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 135
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 136 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 194
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 195 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 240
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 241 AMK----RLMAECLKKKRDERPLFPQILASI 267

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 42/265 (15%)
Query: 372 DFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           D VAIK +        D  ++ +++ K++H  L++L G+C       LV+E   +G LS 
Sbjct: 32  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  + G F      + + LDV  G+ YL        +H+D+   N L+  +   K+++F
Sbjct: 92  YLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDF 147
Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        F L      + G      + +PE       S+K DV++FGVLM E+ S
Sbjct: 148 GMTR--------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P     EN    +V+      ED     R L  P +   +       V +++  C 
Sbjct: 200 EGKIPY----ENRSNSEVV------EDISTGFR-LYKPRLASTH-------VYQIMNHCW 241
Query: 600 KKDPSGRPAMDKIAQSISRFLNASL 624
           K+ P  RPA  ++ + ++    + L
Sbjct: 242 KERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 79
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 135
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 136 FLHEDLTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 194
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 195 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 240
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                  RL+  CLKK    RP   +I  SI 
Sbjct: 241 AMK----RLMAECLKKKRDERPLFPQILASIE 268

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +    Y+V
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 87
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + ++  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 88  TEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLRAANILV 144
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 145 GENLVCKVADFGLARLIEDNEWTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 196
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 197 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 238
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 42/265 (15%)
Query: 372 DFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           D VAIK +        D  ++ +++ K++H  L++L G+C       LV+E   +G LS 
Sbjct: 30  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  + G F      + + LDV  G+ YL        +H+D+   N L+  +   K+++F
Sbjct: 90  YLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDF 145
Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        F L      + G      + +PE       S+K DV++FGVLM E+ S
Sbjct: 146 GMTR--------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P     EN    +V+      ED     R L  P +   +       V +++  C 
Sbjct: 198 EGKIPY----ENRSNSEVV------EDISTGFR-LYKPRLASTH-------VYQIMNHCW 239
Query: 600 KKDPSGRPAMDKIAQSISRFLNASL 624
           K+ P  RPA  ++ + ++    + L
Sbjct: 240 KERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 130/275 (47%), Gaps = 37/275 (13%)
Query: 362 GSVYRGKIGG-----DFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           G V RG++         VAIK + G  +++ +        ++ +  H ++IRL G+  N 
Sbjct: 30  GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNS 89
Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
               ++ E   NG+L  ++    G+F    Q + +   +A+G+ YL   +   +VH+D+ 
Sbjct: 90  MPVMILTEFMENGALDSFLRLNDGQFTV-IQLVGMLRGIASGMRYLAEMS---YVHRDLA 145
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT--KGYMAPEYLENGLVSTKLD 526
             N+L++++   K+++F L+R  E    +   TS + G     + APE +     ++  D
Sbjct: 146 ARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASD 205
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
            +++G++M E++S  E P      +M   DV+N +      E+  R  + P      PP 
Sbjct: 206 AWSYGIVMWEVMSFGERPYW----DMSNQDVINAI------EQDYR--LPP------PPD 247
Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
               + +L+  C +KD + RP   ++  ++ + + 
Sbjct: 248 CPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 121/256 (47%), Gaps = 22/256 (8%)
Query: 370 GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICF-NGGNWY-LVYENAVNGSLSVWI 427
           GG+ +A      D   +I++L  + H ++++  GIC  +GGN   L+ E   +GSL  ++
Sbjct: 51  GGNHIA------DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 104
Query: 428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL 487
                K ++  Q+++ A+ +  G++YL S     +VH+D+   NVL++++ + KI +F L
Sbjct: 105 PKNKNK-INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 160
Query: 488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
            +  E  +    +         + APE L         DV++FGV + E+L+  ++    
Sbjct: 161 TKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD--- 217
Query: 548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY---PPVTAILVIRLIESCLKKDPS 604
           S    L + ++ P      G+ ++  L++   +G     PP     V +L+  C +  PS
Sbjct: 218 SSPMALFLKMIGPT----HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPS 273
Query: 605 GRPAMDKIAQSISRFL 620
            R +   + +     L
Sbjct: 274 NRTSFQNLIEGFEALL 289

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 22/248 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ + +H ++IRL G+   G    +V E   NGSL  ++    G+F    Q + +  
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT-IMQLVGMLR 158
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V  G+ YL       +VH+D+   NVL+D++   K+++F L+R  E        T+   
Sbjct: 159 GVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
               + APE +     S+  DV++FGV+M E+L+  E P      NM   DV++ V    
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW----NMTNRDVISSV---- 267
Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA 625
             EE  R    P+  G         + +L+  C  KD + RP   +I   +   + +  +
Sbjct: 268 --EEGYRL---PAPMG-----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317
Query: 626 WELSKNIS 633
              +  +S
Sbjct: 318 LRATATVS 325

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 24  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 81
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 82  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 137
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 138 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 196
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 197 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 242
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 243 AMK----RLMAECLKKKRDERPLFPQILASI 269

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 42/265 (15%)
Query: 372 DFVAIKKVY------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           D VAIK +        D  ++ +++ K++H  L++L G+C       LV+E   +G LS 
Sbjct: 52  DKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 111
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  + G F      + + LDV  G+ YL        +H+D+   N L+  +   K+++F
Sbjct: 112 YLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDF 167
Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        F L      + G      + +PE       S+K DV++FGVLM E+ S
Sbjct: 168 GMTR--------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P     EN    +V+      ED     R L  P +   +       V +++  C 
Sbjct: 220 EGKIPY----ENRSNSEVV------EDISTGFR-LYKPRLASTH-------VYQIMNHCW 261
Query: 600 KKDPSGRPAMDKIAQSISRFLNASL 624
           K+ P  RPA  ++ + ++    + L
Sbjct: 262 KERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 79
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 135
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 136 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 194
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 195 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 240
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 241 AMK----RLMAECLKKKRDERPLFPQILASI 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 115/258 (44%), Gaps = 42/258 (16%)
Query: 372 DFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           D VAIK +        D  ++ +++ K++H  L++L G+C       LV+E   +G LS 
Sbjct: 32  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  + G F      + + LDV  G+ YL   +    +H+D+   N L+  +   K+++F
Sbjct: 92  YLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEASV---IHRDLAARNCLVGENQVIKVSDF 147
Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        F L      + G      + +PE       S+K DV++FGVLM E+ S
Sbjct: 148 GMTR--------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P     EN    +V+      ED     R L  P +   +       V +++  C 
Sbjct: 200 EGKIPY----ENRSNSEVV------EDISTGFR-LYKPRLASTH-------VYQIMNHCW 241
Query: 600 KKDPSGRPAMDKIAQSIS 617
           K+ P  RPA  ++ + ++
Sbjct: 242 KERPEDRPAFSRLLRQLA 259

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 121/257 (47%), Gaps = 22/257 (8%)
Query: 370 GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICF-NGGNWY-LVYENAVNGSLSVWI 427
           GG+ +A      D   +I++L  + H ++++  GIC  +GGN   L+ E   +GSL  ++
Sbjct: 63  GGNHIA------DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116
Query: 428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL 487
                K ++  Q+++ A+ +  G++YL S     +VH+D+   NVL++++ + KI +F L
Sbjct: 117 PKNKNK-INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172
Query: 488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
            +  E  +    +         + APE L         DV++FGV + E+L+  ++    
Sbjct: 173 TKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD--- 229
Query: 548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY---PPVTAILVIRLIESCLKKDPS 604
           S    L + ++ P      G+ ++  L++   +G     PP     V +L+  C +  PS
Sbjct: 230 SSPMALFLKMIGPT----HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPS 285
Query: 605 GRPAMDKIAQSISRFLN 621
            R +   + +     L 
Sbjct: 286 NRTSFQNLIEGFEALLK 302

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 27  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 84
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 140
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 141 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 199
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 200 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 245
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 246 AMK----RLMAECLKKKRDERPLFPQILASI 272

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 42  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 99
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 100 IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 155
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 156 FLHEDLTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 214
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 215 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 260
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 261 AMK----RLMAECLKKKRDERPLFPQILASI 287

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 46/284 (16%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 95
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 96  IVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKSI---IHRDLKSNNI 151
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   ++   S + DVYA
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK--------------VRSNCPK 256
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELS 629
                + RL+  CLKK    RP+  +I   I       LA ELS
Sbjct: 257 ----RMKRLMAECLKKKRDERPSFPRILAEIE-----ELARELS 291

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 27  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 84
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 140
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 141 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 199
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 200 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 245
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 246 AMK----RLMAECLKKKRDERPLFPQILASI 272

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 50  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 107
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 163
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 164 FLHEDLTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 222
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 223 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 268
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 269 AMK----RLMAECLKKKRDERPLFPQILASI 295

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 46/284 (16%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 26  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 83
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 84  IVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKSI---IHRDLKSNNI 139
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   ++   S + DVYA
Sbjct: 140 FLHEDNTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 198
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 199 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK--------------VRSNCPK 244
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELS 629
                  RL+  CLKK    RP+  +I   I       LA ELS
Sbjct: 245 RMK----RLMAECLKKKRDERPSFPRILAEIE-----ELARELS 279

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 42/265 (15%)
Query: 372 DFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           D VAIK +        D  ++ +++ K++H  L++L G+C       LV+E   +G LS 
Sbjct: 35  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  + G F      + + LDV  G+ YL        +H+D+   N L+  +   K+++F
Sbjct: 95  YLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDF 150
Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        F L      + G      + +PE       S+K DV++FGVLM E+ S
Sbjct: 151 GMTR--------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P     EN    +V+      ED     R L  P +   +       V +++  C 
Sbjct: 203 EGKIPY----ENRSNSEVV------EDISTGFR-LYKPRLASTH-------VYQIMNHCW 244
Query: 600 KKDPSGRPAMDKIAQSISRFLNASL 624
           ++ P  RPA  ++ + ++    + L
Sbjct: 245 RERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 49  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 106
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 162
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 163 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 221
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 222 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 267
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 268 AMK----RLMAECLKKKRDERPLFPQILASI 294

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 41/274 (14%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 96  IVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKSI---IHRDLKSNNI 151
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   ++   S + DVYA
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK--------------VRSNCPK 256
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
                + RL+  CLKK    RP+  +I   I   
Sbjct: 257 ----RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 43/275 (15%)
Query: 362 GSVYRGKIGGD-FVAIKKVY-GDAS-----DQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +  G  S      + +++ K+ H  L++L  +  +     +V
Sbjct: 22  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIXIV 80
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 81  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 137
Query: 475 DTDFRAKIANFALARPAE------RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             +   K+A+F LAR  E      RQ  +F +         + APE    G  + K DV+
Sbjct: 138 GENLVCKVADFGLARLIEDNEXTARQGAKFPIK--------WTAPEAALYGRFTIKSDVW 189
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FG+L+ E+ +    P       M+  +VL+ V      E   R           PP   
Sbjct: 190 SFGILLTELTTKGRVPY----PGMVNREVLDQV------ERGYRM--------PCPPECP 231
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             +  L+  C +K+P  RP  + +   +  +  ++
Sbjct: 232 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 266

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 37/184 (20%)
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD  Q   I  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A      
Sbjct: 116 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA------ 166
Query: 495 EGEFALT----SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYS 548
            G+   T    +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   L+ 
Sbjct: 167 -GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHP 224
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
            + + L+   NP                P+++GNY    +  +   +E+CL K+PS RP 
Sbjct: 225 MKVLFLIPKNNP----------------PTLEGNY----SKPLKEFVEACLNKEPSFRPT 264
Query: 609 MDKI 612
             ++
Sbjct: 265 AKEL 268

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 37/184 (20%)
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD  Q   I  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA------ 151
Query: 495 EGEFALT----SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYS 548
            G+   T    +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   L+ 
Sbjct: 152 -GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHP 209
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
            + + L+   NP                P+++GNY    +  +   +E+CL K+PS RP 
Sbjct: 210 MKVLFLIPKNNP----------------PTLEGNY----SKPLKEFVEACLNKEPSFRPT 249
Query: 609 MDKI 612
             ++
Sbjct: 250 AKEL 253

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 41/271 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A          +++ +L K  H +++  +G         
Sbjct: 50  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 107
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH+ +    +H+D+K +N+
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNI 163
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 164 FLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 222
Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDV----LNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           FG+++ E+++G+   +  +  + ++  V    L+P L K              ++ N P 
Sbjct: 223 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK--------------VRSNCPK 268
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
                  RL+  CLKK    RP   +I  SI
Sbjct: 269 AMK----RLMAECLKKKRDERPLFPQILASI 295

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 37/184 (20%)
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD  Q   I  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA------ 151
Query: 495 EGEFALT----SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYS 548
            G+   T    +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   L+ 
Sbjct: 152 -GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHP 209
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
            + + L+   NP                P+++GNY    +  +   +E+CL K+PS RP 
Sbjct: 210 MKVLFLIPKNNP----------------PTLEGNY----SKPLKEFVEACLNKEPSFRPT 249
Query: 609 MDKI 612
             ++
Sbjct: 250 AKEL 253

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 120/258 (46%), Gaps = 32/258 (12%)
Query: 373 FVAIK--------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           FVAIK        K   D   +  ++ + +H ++I L G+        ++ E   NGSL 
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
            ++    G+F    Q + +   +A G+ YL       +VH+D+   N+L++++   K+++
Sbjct: 123 SFLRQNDGQFT-VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSD 178
Query: 485 FALARPAERQEGEFALTSHIVGT--KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
           F L+R  E    +   TS + G     + APE ++    ++  DV+++G++M E++S  E
Sbjct: 179 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P      +M   DV+N +      E+  R  + P M           + +L+  C +KD
Sbjct: 239 RPYW----DMTNQDVINAI------EQDYR--LPPPMD------CPSALHQLMLDCWQKD 280
Query: 603 PSGRPAMDKIAQSISRFL 620
            + RP   +I  ++ + +
Sbjct: 281 RNHRPKFGQIVNTLDKMI 298

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 37/195 (18%)
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
           LD  Q   I  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A      
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA------ 171
Query: 495 EGEFALT----SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYS 548
            G+   T    +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   L+ 
Sbjct: 172 -GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHP 229
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
            + + L+   NP                P+++GNY    +  +   +E+CL K+PS RP 
Sbjct: 230 MKVLFLIPKNNP----------------PTLEGNY----SKPLKEFVEACLNKEPSFRPT 269
Query: 609 MDKIAQSISRFLNAS 623
             ++ +      NA 
Sbjct: 270 AKELLKHKFILRNAK 284

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 55/275 (20%)
Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 423 LSVWINDKGGKFLDWA--------------QRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    L+++                +  A  VA G+ YL S      +H+D+ 
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLA 177
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK-WMAPEALFDRIYTHQSDVW 236
Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPP 585
           +FGVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N   
Sbjct: 237 SFGVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE-- 280
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                +  ++  C    PS RP   ++ + + R +
Sbjct: 281 -----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 55/275 (20%)
Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 423 LSVWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    L+++                +  A  VA G+ YL S      +H+D+ 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLA 218
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVW 277
Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPP 585
           +FGVL+ E+  L G   P +  EE   L+        KE       H MD PS   N   
Sbjct: 278 SFGVLLWEIFTLGGSPYPGVPVEELFKLL--------KEG------HRMDKPSNCTNE-- 321
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                +  ++  C    PS RP   ++ + + R +
Sbjct: 322 -----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 51/273 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 425 VWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    L+++                +  A  VA G+ YL S      +H+D+   
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAAR 168
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSF 227
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPPVT 587
           GVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N     
Sbjct: 228 GVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE---- 269
Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              +  ++  C    PS RP   ++ + + R +
Sbjct: 270 ---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 55/275 (20%)
Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 423 LSVWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    L+++                +  A  VA G+ YL S      +H+D+ 
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLA 169
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 170 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVW 228
Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPP 585
           +FGVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N   
Sbjct: 229 SFGVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE-- 272
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                +  ++  C    PS RP   ++ + + R +
Sbjct: 273 -----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 55/275 (20%)
Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 423 LSVWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    L+++                +  A  VA G+ YL S      +H+D+ 
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLA 170
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVW 229
Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPP 585
           +FGVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N   
Sbjct: 230 SFGVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE-- 273
Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                +  ++  C    PS RP   ++ + + R +
Sbjct: 274 -----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 51/273 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 425 VWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    L+++                +  A  VA G+ YL S      +H+D+   
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAAR 179
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSF 238
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPPVT 587
           GVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N     
Sbjct: 239 GVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE---- 280
Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              +  ++  C    PS RP   ++ + + R +
Sbjct: 281 ---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 51/273 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 425 VWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    L+++                +  A  VA G+ YL S      +H+D+   
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAAR 179
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSF 238
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPPVT 587
           GVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N     
Sbjct: 239 GVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE---- 280
Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              +  ++  C    PS RP   ++ + + R +
Sbjct: 281 ---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 51/273 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 425 VWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    L++                 +  A  VA G+ YL S      +H+D+   
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAAR 164
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSF 223
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPPVT 587
           GVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N     
Sbjct: 224 GVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE---- 265
Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              +  ++  C    PS RP   ++ + + R +
Sbjct: 266 ---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 115/265 (43%), Gaps = 42/265 (15%)
Query: 372 DFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           D VAIK +        D  ++ +++ K++H  L++L G+C       LV E   +G LS 
Sbjct: 33  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  + G F      + + LDV  G+ YL        +H+D+   N L+  +   K+++F
Sbjct: 93  YLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDF 148
Query: 486 ALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + R        F L      + G      + +PE       S+K DV++FGVLM E+ S
Sbjct: 149 GMTR--------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             + P     EN    +V+      ED     R L  P +   +       V +++  C 
Sbjct: 201 EGKIPY----ENRSNSEVV------EDISTGFR-LYKPRLASTH-------VYQIMNHCW 242
Query: 600 KKDPSGRPAMDKIAQSISRFLNASL 624
           ++ P  RPA  ++ + ++    + L
Sbjct: 243 RERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 35/286 (12%)
Query: 362 GSVYRGKIGGDFVAIK------KVYGDASDQIKLLNKINHSSLIRLLGICFNGG----NW 411
           G V++ ++  ++VA+K      K       ++  L  + H ++++ +G    G     + 
Sbjct: 38  GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT-------NPPHVH 464
           +L+      GSLS ++       + W +   IA  +A GL YLH           P   H
Sbjct: 98  WLITAFHEKGSLSDFLK---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH-IVGTKGYMAPEYLENGL--- 520
           +DIK  NVLL  +  A IA+F LA   E   G+ A  +H  VGT+ YMAPE LE  +   
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFE--AGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 521 --VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV---LNPVLHKEDGEESLRHLM 575
                ++D+YA G+++ E+ S   A     +E ML  +     +P L  ED +E + H  
Sbjct: 213 RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL--EDMQEVVVHKK 270
Query: 576 DPSMQGNYPPVTA--ILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
              +  +Y    A   ++   IE C   D   R +   + + I++ 
Sbjct: 271 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 38/267 (14%)
Query: 375 AIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           A++   G   ++I +L+KI H +++ L  I  +GG+ YL+ +    G L   I +KG  F
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--F 112
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL---LDTDFRAKIANFALARPA 491
                  ++   V   + YLH       VH+D+K  N+L   LD D +  I++F L+   
Sbjct: 113 YTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLS--- 166
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN 551
            + E   ++ S   GT GY+APE L     S  +D ++ GV+   +L G   P  Y E +
Sbjct: 167 -KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG--YPPFYDEND 223
Query: 552 MLLVDVLNPVLHKED----------GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKK 601
             L + +    ++ D           ++ +RHLM+   +  +    A+           +
Sbjct: 224 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL-----------Q 272
Query: 602 DP--SGRPAMDK-IAQSISRFLNASLA 625
            P  +G  A+DK I QS+S  +  + A
Sbjct: 273 HPWIAGDTALDKNIHQSVSEQIKKNFA 299

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 14/187 (7%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           GSVY+   K  G  VAIK+V  ++  Q     I ++ + +   +++  G  F   + ++V
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GS+S  I  +  K L   +   I      GL YLH       +H+DIK  N+LL
Sbjct: 103 MEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILL 158
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
           +T+  AK+A+F +A    +     A  + ++GT  +MAPE ++    +   D+++ G+  
Sbjct: 159 NTEGHAKLADFGVAG---QLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITA 215
Query: 535 LEMLSGK 541
           +EM  GK
Sbjct: 216 IEMAEGK 222

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/255 (22%), Positives = 112/255 (43%), Gaps = 37/255 (14%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           ++  ++ +L  + H ++++        G+ Y+V +    G L   IN + G      Q +
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
              + +   L ++H   +   +H+DIK  N+ L  D   ++ +F +AR          L 
Sbjct: 129 DWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---STVELA 182
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
              +GT  Y++PE  EN   + K D++A G ++ E+ + K A    S +N++L       
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------- 235
Query: 562 LHKEDGEESLRHLMDPSMQGNYPPVT---AILVIRLIESCLKKDPSGRPAMDK------I 612
                            + G++PPV+   +  +  L+    K++P  RP+++       I
Sbjct: 236 ---------------KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
Query: 613 AQSISRFLNASLAWE 627
           A+ I +FL+  L  E
Sbjct: 281 AKRIEKFLSPQLIAE 295

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 122/287 (42%), Gaps = 56/287 (19%)
Query: 366 RGKIGGDFVAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           +G+ G   VA+K +  +AS         +  +L ++NH  +I+L G C   G   L+ E 
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 418 AVNGSLSVWIND--KGG--------------------KFLDWAQRIQIALDVATGLNYLH 455
           A  GSL  ++ +  K G                    + L     I  A  ++ G+ YL 
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167
Query: 456 SFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY 515
             +    VH+D+   N+L+    + KI++F L+R    ++     +   +  K +MA E 
Sbjct: 168 EMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIES 223
Query: 516 LENGLVSTKLDVYAFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           L + + +T+ DV++FGVL+ E+  L G   P +  E                     L +
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--------------------LFN 263
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           L+    +   P   +  + RL+  C K++P  RP    I++ + + +
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 51/273 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 425 VWINDKGGKFLDWAQR--------------IQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    L++                 +  A  VA G+ YL S      +H+D+   
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAAR 179
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  D   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSF 238
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD-PSMQGNYPPVT 587
           GVL+ E+  L G   P +  EE   L+         ++G     H MD PS   N     
Sbjct: 239 GVLLWEIFTLGGSPYPGVPVEELFKLL---------KEG-----HRMDKPSNCTNE---- 280
Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              +  ++  C    PS RP   ++ + + R +
Sbjct: 281 ---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 38/267 (14%)
Query: 375 AIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           A++   G   ++I +L+KI H +++ L  I  +GG+ YL+ +    G L   I +KG  F
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--F 112
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL---LDTDFRAKIANFALARPA 491
                  ++   V   + YLH       VH+D+K  N+L   LD D +  I++F L+   
Sbjct: 113 YTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLS--- 166
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN 551
            + E   ++ S   GT GY+APE L     S  +D ++ GV+   +L G   P  Y E +
Sbjct: 167 -KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG--YPPFYDEND 223
Query: 552 MLLVDVLNPVLHKED----------GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKK 601
             L + +    ++ D           ++ +RHLM+   +  +    A+           +
Sbjct: 224 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL-----------Q 272
Query: 602 DP--SGRPAMDK-IAQSISRFLNASLA 625
            P  +G  A+DK I QS+S  +  + A
Sbjct: 273 HPWIAGDTALDKNIHQSVSEQIKKNFA 299

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 61/294 (20%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 31  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 148
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +MAP
Sbjct: 149 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI------YETAYYRKGGKGLLPVRWMAP 201
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  D+++FGV++ E+ S  E P                       E+ L+ 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKF 244
Query: 574 LMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
           +MD    G Y   P      V  L+  C + +P  RP   +I   +   L+ S 
Sbjct: 245 VMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 7/161 (4%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI-NDKGGKFLDWAQRIQI 443
           ++  L+  + H  L+RL  +       Y++ E    GSL  ++ +D+GGK L   + I  
Sbjct: 57  EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDF 115
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           +  +A G+ Y+       ++H+D++ +NVL+      KIA+F LAR  E  + E+     
Sbjct: 116 SAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREG 170
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                 + APE +  G  + K DV++FG+L+ E+++  + P
Sbjct: 171 AKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 420 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVH 476
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 477 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 38/267 (14%)
Query: 375 AIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           A++   G   ++I +L+KI H +++ L  I  +GG+ YL+ +    G L   I +KG  F
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--F 112
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL---LDTDFRAKIANFALARPA 491
                  ++   V   + YLH       VH+D+K  N+L   LD D +  I++F L+   
Sbjct: 113 YTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLS--- 166
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN 551
            + E   ++ S   GT GY+APE L     S  +D ++ GV+   +L G   P  Y E +
Sbjct: 167 -KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG--YPPFYDEND 223
Query: 552 MLLVDVLNPVLHKED----------GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKK 601
             L + +    ++ D           ++ +RHLM+   +  +    A+           +
Sbjct: 224 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL-----------Q 272
Query: 602 DP--SGRPAMDK-IAQSISRFLNASLA 625
            P  +G  A+DK I QS+S  +  + A
Sbjct: 273 HPWIAGDTALDKNIHQSVSEQIKKNFA 299

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 31/266 (11%)
Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWYL 413
           G+VY+GK  GD  V I KV     +Q       + +L K  H +++  +G      N  +
Sbjct: 50  GTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MTKDNLAI 108
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           V +     SL   ++ +  KF    Q I IA   A G++YLH+      +H+D+K +N+ 
Sbjct: 109 VTQWCEGSSLYKHLHVQETKF-QMFQLIDIARQTAQGMDYLHAKNI---IHRDMKSNNIF 164
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYAF 530
           L      KI +F LA    R  G         G+  +MAPE +   +N   S + DVY++
Sbjct: 165 LHEGLTVKIGDFGLATVKSRWSGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSY 223
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           G+++ E+++G E P  +      ++ ++             R    P +   Y      +
Sbjct: 224 GIVLYELMTG-ELPYSHINNRDQIIFMVG------------RGYASPDLSKLYKNCPKAM 270
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI 616
             RL+  C+KK    RP   +I  SI
Sbjct: 271 K-RLVADCVKKVKEERPLFPQILSSI 295

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 421 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVH 477
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 478 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++  +  + +     I++  
Sbjct: 78  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVH 134
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 135 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++  +  + +     I++  
Sbjct: 78  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVH 134
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 135 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 61/294 (20%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 31  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 148
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +MAP
Sbjct: 149 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAP 201
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  D+++FGV++ E+ S  E P                       E+ L+ 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKF 244
Query: 574 LMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
           +MD    G Y   P      V  L+  C + +P  RP   +I   +   L+ S 
Sbjct: 245 VMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 159 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 209
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 252
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 253 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 62  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 119 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 71  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 130 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPI 184
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLHKED 566
            + APE +  G  + K DV++FG+L+ E+++    P            + NP  + + E 
Sbjct: 185 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQNLER 235
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 236 GYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 281

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 76  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 132
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 133 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 33  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 92
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 152
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 153 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 203
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 246
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 247 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 56/287 (19%)
Query: 366 RGKIGGDFVAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           +G+ G   VA+K +  +AS         +  +L ++NH  +I+L G C   G   L+ E 
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 418 AVNGSLSVWIND--KGG--------------------KFLDWAQRIQIALDVATGLNYLH 455
           A  GSL  ++ +  K G                    + L     I  A  ++ G+ YL 
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167
Query: 456 SFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY 515
                  VH+D+   N+L+    + KI++F L+R    ++     +   +  K +MA E 
Sbjct: 168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIES 223
Query: 516 LENGLVSTKLDVYAFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           L + + +T+ DV++FGVL+ E+  L G   P +  E                     L +
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--------------------LFN 263
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           L+    +   P   +  + RL+  C K++P  RP    I++ + + +
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 30  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 89
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 90  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 149
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 150 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 200
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 243
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 244 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 32  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 91
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 151
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 152 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 202
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 245
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 246 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 31  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 148
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               VH+D+   N ++  DF  KI +F + R     +        ++  + +MAPE L++
Sbjct: 149 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKD 206
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ +T  D+++FGV++ E+ S  E P                       E+ L+ +MD  
Sbjct: 207 GVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKFVMD-- 247
Query: 579 MQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
             G Y   P      V  L+  C + +P+ RP   +I   +   L+ S 
Sbjct: 248 --GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 26  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 85
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 146 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 196
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 239
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 240 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 32  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 91
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 151
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 152 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 202
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 245
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 246 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 31  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 148
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               VH+D+   N ++  DF  KI +F + R     +        ++  + +MAPE L++
Sbjct: 149 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKD 206
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ +T  D+++FGV++ E+ S  E P                       E+ L+ +MD  
Sbjct: 207 GVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKFVMD-- 247
Query: 579 MQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
             G Y   P      V  L+  C + +P  RP   +I   +   L+ S 
Sbjct: 248 --GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++        +         ++ IQ+A ++A G+ YL++  
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 159 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 209
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 252
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 253 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 67  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 126 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPI 180
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLHKED 566
            + APE +  G  + K DV++FG+L+ E+++    P            + NP  + + E 
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQNLER 231
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 232 GYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 124/278 (44%), Gaps = 45/278 (16%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 24  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 83
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 84  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 143
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               VH+D+   N ++  DF  KI +F + R     +        ++  + +M+PE L++
Sbjct: 144 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMSPESLKD 199
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ +T  DV++FGV++ E+ +  E P                       E+ LR +M+  
Sbjct: 200 GVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRFVMEGG 242
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +  + P     +++ L+  C + +P  RP+  +I  SI
Sbjct: 243 LL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 61  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 120
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 180
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 181 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 231
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 274
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 275 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 66  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 125 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPI 179
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLHKED 566
            + APE +  G  + K DV++FG+L+ E+++    P            + NP  + + E 
Sbjct: 180 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQNLER 230
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 231 GYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 276

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 29  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 88
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++        +         ++ IQ+A ++A G+ YL++  
Sbjct: 89  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 148
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 149 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 199
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 242
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 243 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 61/294 (20%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 30  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 89
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 90  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 147
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N ++  DF  KI +F + R        +    +  G KG     +MAP
Sbjct: 148 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAP 200
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  D+++FGV++ E+ S  E P                       E+ L+ 
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKF 243
Query: 574 LMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
           +MD    G Y   P      V  L+  C + +P  RP   +I   +   L+ S 
Sbjct: 244 VMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 293

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 68  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 124
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 125 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 62  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 119 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 61  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPI 174
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLHKED 566
            + APE +  G  + K DV++FG+L+ E+++    P            + NP  + + E 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQNLER 225
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 226 GYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 56/287 (19%)
Query: 366 RGKIGGDFVAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
           +G+ G   VA+K +  +AS         +  +L ++NH  +I+L G C   G   L+ E 
Sbjct: 48  KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 418 AVNGSLSVWIND--KGG--------------------KFLDWAQRIQIALDVATGLNYLH 455
           A  GSL  ++ +  K G                    + L     I  A  ++ G+ YL 
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167
Query: 456 SFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY 515
                  VH+D+   N+L+    + KI++F L+R    ++     +   +  K +MA E 
Sbjct: 168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-WMAIES 223
Query: 516 LENGLVSTKLDVYAFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           L + + +T+ DV++FGVL+ E+  L G   P +  E                     L +
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--------------------LFN 263
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           L+    +   P   +  + RL+  C K++P  RP    I++ + + +
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 375 AIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           A++   G   ++I +L+KI H +++ L  I  +GG+ YL+ +    G L   I +KG  F
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--F 112
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL---LDTDFRAKIANFALARPA 491
                  ++   V   + YLH       VH+D+K  N+L   LD D +  I++F L+   
Sbjct: 113 YTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLS--- 166
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN 551
            + E   ++ S   GT GY+APE L     S  +D ++ GV+   +L G   P  Y E +
Sbjct: 167 -KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG--YPPFYDEND 223
Query: 552 MLLVDVLNPVLHKED----------GEESLRHLMDPSMQGNY 583
             L + +    ++ D           ++ +RHLM+   +  +
Sbjct: 224 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF 265

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 28  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 87
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 88  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 145
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               VH+D+   N ++  DF  KI +F + R     +        ++  + +MAPE L++
Sbjct: 146 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKD 203
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ +T  D+++FGV++ E+ S  E P                       E+ L+ +MD  
Sbjct: 204 GVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKFVMD-- 244
Query: 579 MQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
             G Y   P      V  L+  C + +P  RP   +I   +   L+ S 
Sbjct: 245 --GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 291

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 58  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 114
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 115 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +  ++ ++++  ++R++GIC    +W LV E A  G L+ ++     + +     I++  
Sbjct: 56  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
            V+ G+ YL        VH+D+   NVLL T   AKI++F L++     E  +   +H  
Sbjct: 113 QVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
               + APE +     S+K DV++FGVLM E  S  + P
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 45/278 (16%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 33  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 92
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 152
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               VH+D+   N ++  DF  KI +F + R     +        ++  + +M+PE L++
Sbjct: 153 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMSPESLKD 208
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ +T  DV++FGV++ E+ +  E P                       E+ LR +M+  
Sbjct: 209 GVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRFVMEGG 251
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +  + P     ++  L+  C + +P  RP+  +I  SI
Sbjct: 252 LL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 55/283 (19%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS  ++I+ LN+       N   ++RLLG+  
Sbjct: 26  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 85
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLD--------WAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++     +  +         ++ IQ+A ++A G+ YL++  
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+D+   N  +  DF  KI +F + R        +    +  G KG     +M+P
Sbjct: 146 ---FVHRDLAARNCXVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 196
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  DV++FGV++ E+ +  E P                       E+ LR 
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRF 239
Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI 616
           +M+  +  + P     +++ L+  C + +P  RP+  +I  SI
Sbjct: 240 VMEGGLL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 87
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 88  IIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 144
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 145 VGENHLVKVADFGLSR---LMTGD-TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 199
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 200 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 241
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 284

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 149 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 204 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 245
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 288

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 85  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 141
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 142 VGENHLVKVADFGLSR---LMTGD-TFTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 196
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+ +   +P             ++P          +  L++   +   P      
Sbjct: 197 GVLLWEIATYGMSP----------YPGIDP--------SQVYELLEKDYRMERPEGCPEK 238
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 281

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 40  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 99
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 100 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 156
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 157 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 211
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 212 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 253
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 254 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 296

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 120/258 (46%), Gaps = 32/258 (12%)
Query: 373 FVAIK--------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           FVAIK        K   D   +  ++ + +H ++I L G+        ++ E   NGSL 
Sbjct: 37  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
            ++    G+F    Q + +   +A G+ YL       +VH+ +   N+L++++   K+++
Sbjct: 97  SFLRQNDGQFTV-IQLVGMLRGIAAGMKYLADMN---YVHRALAARNILVNSNLVCKVSD 152
Query: 485 FALARPAERQEGEFALTSHIVGT--KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
           F L+R  E    +   TS + G     + APE ++    ++  DV+++G++M E++S  E
Sbjct: 153 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 212
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P      +M   DV+N +      E+  R  + P M  + P     L++     C +KD
Sbjct: 213 RPYW----DMTNQDVINAI------EQDYR--LPPPM--DCPSALHQLML----DCWQKD 254
Query: 603 PSGRPAMDKIAQSISRFL 620
            + RP   +I  ++ + +
Sbjct: 255 RNHRPKFGQIVNTLDKMI 272

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 28/236 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 56  LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 115 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPI 169
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLHKED 566
            + APE +  G  + K DV++FG+L+ E+++    P            + NP  + + E 
Sbjct: 170 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQNLER 220
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
           G   +R           P      + +L+  C K+ P  RP  D +   +  F  A
Sbjct: 221 GYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMD------KPANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 89  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 145
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 146 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 201 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 242
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 285

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 89  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 145
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 146 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 201 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 242
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 285

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 40/243 (16%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 69  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEFALTS 502
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E      R+  +F +  
Sbjct: 128 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK- 183
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP-- 560
                  + APE +  G  + K DV++FG+L+ E+++    P            + NP  
Sbjct: 184 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEV 227
Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           + + E G   +R           P      + +L+  C K+ P  RP  D +   +  F 
Sbjct: 228 IQNLERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 276
Query: 621 NAS 623
            A+
Sbjct: 277 TAT 279

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 67  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  E      +   G K
Sbjct: 126 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-----XTAREGAK 177
Query: 509 ---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLH 563
               + APE +  G  + K DV++FG+L+ E+++    P            + NP  + +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQN 228
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            E G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 229 LERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 149 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 204 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 245
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 288

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 61/294 (20%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 32  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 91
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 92  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 149
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+++   N ++  DF  KI +F + R        +    +  G KG     +MAP
Sbjct: 150 -KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAP 202
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  D+++FGV++ E+ S  E P                       E+ L+ 
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKF 245
Query: 574 LMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
           +MD    G Y   P      V  L+  C + +P+ RP   +I   +   L+ S 
Sbjct: 246 VMD----GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 295

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 87  IIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 143
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 144 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 199 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 240
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 40/243 (16%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 61  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEFALTS 502
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E      R+  +F +  
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK- 175
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP-- 560
                  + APE +  G  + K DV++FG+L+ E+++    P            + NP  
Sbjct: 176 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEV 219
Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           + + E G   +R           P      + +L+  C K+ P  RP  D +   +  F 
Sbjct: 220 IQNLERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
Query: 621 NAS 623
            A+
Sbjct: 269 TAT 271

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 61/294 (20%)
Query: 362 GSVYRGK----IGGDF---VAIKKVYGDAS--DQIKLLNK------INHSSLIRLLGICF 406
           G VY G     I G+    VA+K V   AS  ++I+ LN+           ++RLLG+  
Sbjct: 31  GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 407 NGGNWYLVYENAVNGSLSVWI--------NDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
            G    +V E   +G L  ++        N+ G       + IQ+A ++A G+ YL++  
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 148
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAP 513
               VH+++   N ++  DF  KI +F + R        +    +  G KG     +MAP
Sbjct: 149 -KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAP 201
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           E L++G+ +T  D+++FGV++ E+ S  E P                       E+ L+ 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGLSNEQVLKF 244
Query: 574 LMDPSMQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
           +MD    G Y   P      V  L+  C + +P+ RP   +I   +   L+ S 
Sbjct: 245 VMD----GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 294

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 99  SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 154
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +  F +         + APE L     S   DV++FGV++ E+ +
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 425 VW--------------INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            +              IN    + + +   +     +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMD------KPANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL++ HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 40/243 (16%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 70  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEFALTS 502
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E      R+  +F +  
Sbjct: 129 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK- 184
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP-- 560
                  + APE +  G  + K DV++FG+L+ E+++    P            + NP  
Sbjct: 185 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEV 228
Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           + + E G   +R           P      + +L+  C K+ P  RP  D +   +  F 
Sbjct: 229 IQNLERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 277
Query: 621 NAS 623
            A+
Sbjct: 278 TAT 280

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 85  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 141
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 142 VGENHLVKVADFGLSR---LMTGD-TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 196
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+ +   +P             ++P          +  L++   +   P      
Sbjct: 197 GVLLWEIATYGMSP----------YPGIDP--------SQVYELLEKDYRMERPEGCPEK 238
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 281

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 143
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 144 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 199 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 240
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 87  IIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 143
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 144 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 199 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 240
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 40/243 (16%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 61  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEFALTS 502
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E      R+  +F +  
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK- 175
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP-- 560
                  + APE +  G  + K DV++FG+L+ E+++    P            + NP  
Sbjct: 176 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEV 219
Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           + + E G   +R           P      + +L+  C K+ P  RP  D +   +  F 
Sbjct: 220 IQNLERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
Query: 621 NAS 623
            A+
Sbjct: 269 TAT 271

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 62  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  E      +   G K
Sbjct: 121 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-----XTAREGAK 172
Query: 509 ---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLH 563
               + APE +  G  + K DV++FG+L+ E+++    P            + NP  + +
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQN 223
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            E G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 224 LERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 61  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  E      +   G K
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-----XTAREGAK 171
Query: 509 ---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLH 563
               + APE +  G  + K DV++FG+L+ E+++    P            + NP  + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQN 222
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            E G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 223 LERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 40/243 (16%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 63  LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE------RQEGEFALTS 502
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E      R+  +F +  
Sbjct: 122 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK- 177
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP-- 560
                  + APE +  G  + K DV++FG+L+ E+++    P            + NP  
Sbjct: 178 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEV 221
Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           + + E G   +R           P      + +L+  C K+ P  RP  D +   +  F 
Sbjct: 222 IQNLERGYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 270
Query: 621 NAS 623
            A+
Sbjct: 271 TAT 273

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 143
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 144 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 199 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 240
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I +L++ + S + +  G    G   +++ E    GS    +  + G F D  Q   +  
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPF-DEFQIATMLK 127
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT---- 501
           ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A       G+   T    
Sbjct: 128 EILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA-------GQLTDTQIKR 177
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLN 559
           +  VGT  +MAPE ++     +K D+++ G+  +E+  G E P   ++    + L+   N
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-EPPNSDMHPMRVLFLIPKNN 236
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           P                P++ G++           I++CL KDPS RP   ++
Sbjct: 237 P----------------PTLVGDFTKSFK----EFIDACLNKDPSFRPTAKEL 269

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 232
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 291
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 292 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMD------KPANCT 331
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 83/161 (51%), Gaps = 7/161 (4%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI-NDKGGKFLDWAQRIQI 443
           ++  L+  + H  L+RL  +       Y++ E    GSL  ++ +D+GGK L   + I  
Sbjct: 56  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDF 114
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           +  +A G+ Y+       ++H+D++ +NVL+      KIA+F LAR  E  + E+     
Sbjct: 115 SAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREG 169
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                 + APE +  G  + K +V++FG+L+ E+++  + P
Sbjct: 170 AKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLTAR 173
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 232
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 233 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 272
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 273 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 149 VGENHLVKVADFGLSR---LMTGD-TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 204 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 245
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           V  L+ +C + +PS RP+  +I Q+       S
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 53/274 (19%)
Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 119
Query: 423 LSVWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    ++++  I                   +A G+ YL S      +H+D+ 
Sbjct: 120 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLA 176
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 177 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVW 235
Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FGVLM E+  L G   P +  EE   L+         ++G     H MD       P  
Sbjct: 236 SFGVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PAN 275
Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               +  ++  C    PS RP   ++ + + R L
Sbjct: 276 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 175
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 234
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 235 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 274
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 275 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 91  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 147
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 148 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 202
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 203 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 244
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           V  L+ +C + +PS RP+  +I Q+       S
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 351 TDDFNPSCWIK---------GSVYRGKIGGDF------VAIKKVYGDASDQIK------- 388
           T + +PSC  +         G VY+G +          VAIK +    +++ +       
Sbjct: 38  TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 389 -LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
            ++ + +H ++IRL G+        ++ E   NG+L  ++ +K G+F    Q + +   +
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF-SVLQLVGMLRGI 156
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHIVG 506
           A G+ YL    N  +VH+D+   N+L++++   K+++F L+R  E   E  +  +   + 
Sbjct: 157 AAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + + APE +     ++  DV++FG++M E+++  E P
Sbjct: 214 IR-WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 144 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 199 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 240
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           V  L+ +C + +PS RP+  +I Q+       S
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 122/259 (47%), Gaps = 36/259 (13%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK +    +D+ +        ++ + +H ++I L G+        ++ E   NGSL  
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++    G+F    Q + +   + +G+ YL   +   +VH+D+   N+L++++   K+++F
Sbjct: 105 FLRKNDGRFT-VIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDF 160
Query: 486 ALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
            ++R  E  + E A T+   G K    + APE +     ++  DV+++G++M E++S  E
Sbjct: 161 GMSRVLE-DDPEAAYTTR--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 217
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P      +M   DV+  +      EE  R  + P M         I + +L+  C +K+
Sbjct: 218 RPYW----DMSNQDVIKAI------EEGYR--LPPPMD------CPIALHQLMLDCWQKE 259
Query: 603 PSGRPAMDKIAQSISRFLN 621
            S RP   +I   + + + 
Sbjct: 260 RSDRPKFGQIVNMLDKLIR 278

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 53/274 (19%)
Query: 374 VAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
           VA+K +  DA+++           +K++ K  H ++I LLG C   G  Y++ E A  G+
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 127
Query: 423 LSVWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIK 468
           L  ++  +    ++++  I                   +A G+ YL S      +H+D+ 
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLA 184
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV+
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVW 243
Query: 529 AFGVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           +FGVLM E+  L G   P +  EE   L+         ++G     H MD       P  
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PAN 283
Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               +  ++  C    PS RP   ++ + + R L
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE  L     
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGXKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 76  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 123
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 180
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 24  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 83
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 84  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 131
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 188
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 189 STAVDIWSLGCIFAEMVTRR 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 76  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 123
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 180
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L+ ++ H  L+RL  +       Y++ E   NGSL  ++    G  L   + + +A  +A
Sbjct: 57  LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H++++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 116 EGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPI 170
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP--VLHKED 566
            + APE +  G  + K DV++FG+L+ E+++    P            + NP  + + E 
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP---------YPGMTNPEVIQNLER 221
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G   +R           P      + +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 222 GYRMVR-----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 267

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 122/259 (47%), Gaps = 36/259 (13%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK +    +D+ +        ++ + +H ++I L G+        ++ E   NGSL  
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++    G+F    Q + +   + +G+ YL   +   +VH+D+   N+L++++   K+++F
Sbjct: 99  FLRKNDGRFTV-IQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDF 154
Query: 486 ALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
            ++R  E  + E A T+   G K    + APE +     ++  DV+++G++M E++S  E
Sbjct: 155 GMSRVLE-DDPEAAYTTR--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 211
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P      +M   DV+  +      EE  R  + P M         I + +L+  C +K+
Sbjct: 212 RPYW----DMSNQDVIKAI------EEGYR--LPPPMD------CPIALHQLMLDCWQKE 253
Query: 603 PSGRPAMDKIAQSISRFLN 621
            S RP   +I   + + + 
Sbjct: 254 RSDRPKFGQIVNMLDKLIR 272

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 50/266 (18%)
Query: 375 AIKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL---------- 423
           A K  + D + ++++L K+ +H ++I LLG C + G  YL  E A +G+L          
Sbjct: 64  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 123
Query: 424 ----SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
               +  I +     L   Q +  A DVA G++YL   +    +H+D+   N+L+  ++ 
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 180
Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLM 534
           AKIA+F L+R  E          ++  T G     +MA E L   + +T  DV+++GVL+
Sbjct: 181 AKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E++S    P       M   ++   +      E+ L    D              V  L
Sbjct: 232 WEIVSLGGTPYC----GMTCAELYEKLPQGYRLEKPLN--CDDE------------VYDL 273
Query: 595 IESCLKKDPSGRPAMDKIAQSISRFL 620
           +  C ++ P  RP+  +I  S++R L
Sbjct: 274 MRQCWREKPYERPSFAQILVSLNRML 299

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 24  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 83
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 84  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 131
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE  L     
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGXKYY 188
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 189 STAVDIWSLGCIFAEMVTRR 208

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E+         ++    KF+D +    I L         +  GL + HS      
Sbjct: 80  LYLVFEH---------VDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 127
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 184
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 78  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 125
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 182
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 43/265 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 127
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 128 FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 183
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 184 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 236
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 237 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 278
Query: 601 KDPSGRPAMDKIAQSISRFLNASLA 625
            DPS RP   ++   +S  L    A
Sbjct: 279 YDPSRRPRFTELKAQLSTILEEEKA 303

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 21  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 80
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 81  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 128
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 185
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 50/266 (18%)
Query: 375 AIKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL---------- 423
           A K  + D + ++++L K+ +H ++I LLG C + G  YL  E A +G+L          
Sbjct: 54  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 113
Query: 424 ----SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
               +  I +     L   Q +  A DVA G++YL   +    +H+D+   N+L+  ++ 
Sbjct: 114 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 170
Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLM 534
           AKIA+F L+R  E          ++  T G     +MA E L   + +T  DV+++GVL+
Sbjct: 171 AKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 221
Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E++S    P       M   ++   +      E+ L    D              V  L
Sbjct: 222 WEIVSLGGTPYC----GMTCAELYEKLPQGYRLEKPLN--CDDE------------VYDL 263
Query: 595 IESCLKKDPSGRPAMDKIAQSISRFL 620
           +  C ++ P  RP+  +I  S++R L
Sbjct: 264 MRQCWREKPYERPSFAQILVSLNRML 289

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 19/192 (9%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            YLV+E+ V+  L  +++      +           +  GL + HS      +H+D+K  
Sbjct: 76  LYLVFEH-VHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQ 131
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYA 529
           N+L++T+   K+A+F LAR        +   +H V T  Y APE L      ST +D+++
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 530 FGVLMLEMLSGK 541
            G +  EM++ +
Sbjct: 189 LGCIFAEMVTRR 200

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 85  IIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 141
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 142 VGENHLVKVADFGLSR---LMTGD-TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 196
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+ +   +P             ++P          +  L++   +   P      
Sbjct: 197 GVLLWEIATYGMSP----------YPGIDP--------SQVYELLEKDYRMERPEGCPEK 238
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           V  L+ +C + +PS RP+  +I Q+       S
Sbjct: 239 VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 37/267 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 149 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 204 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 245
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSIS 617
           V  L+ +C + +PS RP+  +I Q+  
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 37/267 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 92  IIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 148
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 149 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 204 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 245
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSIS 617
           V  L+ +C + +PS RP+  +I Q+  
Sbjct: 246 VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++I L G+        +V E   NGSL  ++    G+F    Q 
Sbjct: 72  GEAS----IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV-IQL 126
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   ++ G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 127 VGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 182
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + APE +     ++  DV+++G++M E++S  E P  Y E  M   DV
Sbjct: 183 TTR--GGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP--YWE--MTNQDV 236
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      EE  R    PS     P      + +L+  C +K+ + RP  D+I   + 
Sbjct: 237 IKAV------EEGYRL---PS-----PMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLD 282
Query: 618 RFLN 621
           + + 
Sbjct: 283 KLIR 286

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 43/265 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 102
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 103 FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 158
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 159 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 211
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 212 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 253
Query: 601 KDPSGRPAMDKIAQSISRFLNASLA 625
            DPS RP   ++   +S  L    A
Sbjct: 254 YDPSRRPRFTELKAQLSTILEEEKA 278

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 7/150 (4%)
Query: 392 KINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGL 451
           +++H +++ ++ +      +YLV E     +LS +I   G   +D A  I     +  G+
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTA--INFTNQILDGI 124
Query: 452 NYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM 511
            + H       VH+DIK  N+L+D++   KI +F +A+     E     T+H++GT  Y 
Sbjct: 125 KHAHDMRI---VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYF 179
Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +PE  +        D+Y+ G+++ EML G+
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 130 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 185
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL   ++  +VH+D+   N+L++++   K+++F LAR  E  + E A 
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 76  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 123
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 180
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 76  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 123
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 180
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 110/261 (42%), Gaps = 38/261 (14%)
Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVN 420
           G+ VA+K +  DA  Q        I +L  + H  +I+  G C + G  +  LV E    
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++       +  AQ +  A  +  G+ YLH+     ++H+D+   NVLLD D   
Sbjct: 120 GSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLV 173
Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML-- 538
           KI +F LA+        + +         + APE L+        DV++FGV + E+L  
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
Query: 539 --SGKEAPALYSE-----ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
             S +  P  + E     +  + V  L  +L  E GE   R           P      V
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELL--ERGERLPR-----------PDKCPAEV 280
Query: 592 IRLIESCLKKDPSGRPAMDKI 612
             L+++C + + S RP  + +
Sbjct: 281 YHLMKNCWETEASFRPTFENL 301

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 43/265 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 104
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 105 FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 161 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 213
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 214 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 255
Query: 601 KDPSGRPAMDKIAQSISRFLNASLA 625
            DPS RP   ++   +S  L    A
Sbjct: 256 YDPSRRPRFTELKAQLSTILEEEKA 280

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 79  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 126
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 183
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++ E A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   +IA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 80  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 127
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 184
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 79  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 126
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 183
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 97  SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 152
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 130/285 (45%), Gaps = 38/285 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 273 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 332
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+++   N L
Sbjct: 333 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCL 389
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 390 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 444
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 445 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 486
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNISE 634
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K + +
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 531

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 43/265 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 96
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 97  FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 153 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 205
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 206 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 247
Query: 601 KDPSGRPAMDKIAQSISRFLNASLA 625
            DPS RP   ++   +S  L    A
Sbjct: 248 YDPSRRPRFTELKAQLSTILEEEKA 272

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 79  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 126
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 183
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 43/265 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 101
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 102 FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 157
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 158 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 210
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 211 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 252
Query: 601 KDPSGRPAMDKIAQSISRFLNASLA 625
            DPS RP   ++   +S  L    A
Sbjct: 253 YDPSRRPRFTELKAQLSTILEEEKA 277

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 78  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 125
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 182
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 104 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 159
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 98  SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 153
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 102 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 157
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 114/261 (43%), Gaps = 43/261 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 99
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 100 FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 156 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 208
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 209 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 250
Query: 601 KDPSGRPAMDKIAQSISRFLN 621
            DPS RP   ++   +S  L 
Sbjct: 251 YDPSRRPRFTELKAQLSTILE 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 37/267 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 143
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 144 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 199 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 240
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSIS 617
           V  L+ +C + +PS RP+  +I Q+  
Sbjct: 241 VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 80  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 127
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 184
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 36/259 (13%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK +    +D+ +        ++ + +H ++I L G+        ++ E   NGSL  
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++    G+F    Q + +   + +G+ YL   +    VH+D+   N+L++++   K+++F
Sbjct: 120 FLRKNDGRFT-VIQLVGMLRGIGSGMKYLSDMS---AVHRDLAARNILVNSNLVCKVSDF 175
Query: 486 ALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
            ++R  E  + E A T+   G K    + APE +     ++  DV+++G++M E++S  E
Sbjct: 176 GMSRVLE-DDPEAAYTTR--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 232
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
            P      +M   DV+  +      EE  R  + P M         I + +L+  C +K+
Sbjct: 233 RPYW----DMSNQDVIKAI------EEGYR--LPPPMD------CPIALHQLMLDCWQKE 274
Query: 603 PSGRPAMDKIAQSISRFLN 621
            S RP   +I   + + + 
Sbjct: 275 RSDRPKFGQIVNMLDKLIR 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 21  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 80
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 81  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 128
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 185
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 186 STAVDIWSLGCIFAEMVTRR 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 99  SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 154
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 106 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 161
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 78  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 125
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 182
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 103 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 158
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 78  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 125
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 182
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 99  SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 154
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 114/261 (43%), Gaps = 43/261 (16%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 99
Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           ++  +    LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +F
Sbjct: 100 FLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L  
Sbjct: 156 GLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 208
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLK 600
              P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C  
Sbjct: 209 GVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCWA 250
Query: 601 KDPSGRPAMDKIAQSISRFLN 621
            DPS RP   ++   +S  L 
Sbjct: 251 YDPSRRPRFTELKAQLSTILE 271

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 45/262 (17%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 99
Query: 426 WINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
           ++  +  KF LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +
Sbjct: 100 FLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGD 154
Query: 485 FALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           F L+R  E        ++    +KG     +MAPE +     ++  DV+ FGV M E+L 
Sbjct: 155 FGLSRYMED-------STXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
               P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C 
Sbjct: 208 HGVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCW 249
Query: 600 KKDPSGRPAMDKIAQSISRFLN 621
             DPS RP   ++   +S  L 
Sbjct: 250 AYDPSRRPRFTELKAQLSTILE 271

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 45/262 (17%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 99
Query: 426 WINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
           ++  +  KF LD A  I  A  ++T L YL S      VH+DI   NVL+      K+ +
Sbjct: 100 FLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGD 154
Query: 485 FALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           F L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L 
Sbjct: 155 FGLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
               P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C 
Sbjct: 208 HGVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCW 249
Query: 600 KKDPSGRPAMDKIAQSISRFLN 621
             DPS RP   ++   +S  L 
Sbjct: 250 AYDPSRRPRFTELKAQLSTILE 271

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 105 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 160
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 66  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-IQL 120
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL   ++  +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 176
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 177 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 230
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 231 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276
Query: 618 RFLN 621
           + + 
Sbjct: 277 KLIR 280

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 102 SLREYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 157
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 116/262 (44%), Gaps = 45/262 (17%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 479
Query: 426 WINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
           ++  +  KF LD A  I  A  ++T L YL S      VH+DI   NVL+ ++   K+ +
Sbjct: 480 FLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGD 534
Query: 485 FALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           F L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L 
Sbjct: 535 FGLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
               P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C 
Sbjct: 588 HGVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCW 629
Query: 600 KKDPSGRPAMDKIAQSISRFLN 621
             DPS RP   ++   +S  L 
Sbjct: 630 AYDPSRRPRFTELKAQLSTILE 651

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 25/196 (12%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 82
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 83  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 138
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKG------YMAPEYLENGLVSTKLDVY 528
           +     K+++F L+R        + L      ++G      +  PE L     S+K D++
Sbjct: 139 NDQGVVKVSDFGLSR--------YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 529 AFGVLMLEMLSGKEAP 544
           AFGVLM E+ S  + P
Sbjct: 191 AFGVLMWEIYSLGKMP 206

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 117 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 172
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+++   N L
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCL 350
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 351 VGENHLVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAF 405
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 406 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 447
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 117 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 172
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 66  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 120
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL   ++  +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 176
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 177 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 230
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 231 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 276
Query: 618 RFLN 621
           + + 
Sbjct: 277 KLIR 280

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 127/283 (44%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 87
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 88  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 144
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+    +   G K    + APE L     S K DV+AF
Sbjct: 145 VGENHLVKVADFGLSR---LMTGD--TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAF 199
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 200 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 241
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 242 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 284

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 78  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 133
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           +     K+++F L+R     E      +  VG+K    +  PE L     S+K D++AFG
Sbjct: 134 NDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188
Query: 532 VLMLEMLSGKEAP 544
           VLM E+ S  + P
Sbjct: 189 VLMWEIYSLGKMP 201

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++  K  + +D  + +Q    +  G+ YL +     ++H+++   N+L++ + R K
Sbjct: 100 SLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRNLATRNILVENENRVK 155
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +  + +         + APE L     S   DV++FGV++ E+ +
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL   ++  +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 127/283 (44%), Gaps = 38/283 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + ++    + +A  +++ + YL        +H+D+   N L
Sbjct: 89  ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCL 145
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+    +   G K    + APE L     S K DV+AF
Sbjct: 146 VGENHLVKVADFGLSR---LMTGD--TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 201 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYELLEKDYRMERPEGCPEK 242
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSI-SRFLNASLAWELSKNI 632
           V  L+ +C + +PS RP+  +I Q+  + F  +S++ E+ K +
Sbjct: 243 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 285

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 93  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 147
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 148 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 203
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 204 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 257
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 258 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 303
Query: 618 RFLN 621
           + + 
Sbjct: 304 KLIR 307

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 80  LYLVFE---------FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 127
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 128 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 184
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 83  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 137
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL       +VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 138 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 193
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 194 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 247
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 248 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 293
Query: 618 RFLN 621
           + + 
Sbjct: 294 KLIR 297

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 98  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 153
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           +     K+++F L+R     E      +  VG+K    +  PE L     S+K D++AFG
Sbjct: 154 NDQGVVKVSDFGLSRYVLDDE-----ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208
Query: 532 VLMLEMLSGKEAP 544
           VLM E+ S  + P
Sbjct: 209 VLMWEIYSLGKMP 221

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 22  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 81
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 82  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 137
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           +     K+++F L+R     E      +  VG+K    +  PE L     S+K D++AFG
Sbjct: 138 NDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 192
Query: 532 VLMLEMLSGKEAP 544
           VLM E+ S  + P
Sbjct: 193 VLMWEIYSLGKMP 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+ K+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+ K+  D         A  +I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 76  LYLVFE---------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 123
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +   +H V T  Y APE L      
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYY 180
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 50/266 (18%)
Query: 375 AIKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL---------- 423
           A K  + D + ++++L K+ +H ++I LLG C + G  YL  E A +G+L          
Sbjct: 61  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 120
Query: 424 ----SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
               +  I +     L   Q +  A DVA G++YL   +    +H+++   N+L+  ++ 
Sbjct: 121 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYV 177
Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLM 534
           AKIA+F L+R  E          ++  T G     +MA E L   + +T  DV+++GVL+
Sbjct: 178 AKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 228
Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E++S    P       M   ++   +      E+ L    D              V  L
Sbjct: 229 WEIVSLGGTPYC----GMTCAELYEKLPQGYRLEKPLN--CDDE------------VYDL 270
Query: 595 IESCLKKDPSGRPAMDKIAQSISRFL 620
           +  C ++ P  RP+  +I  S++R L
Sbjct: 271 MRQCWREKPYERPSFAQILVSLNRML 296

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++    KF+D +    I L         +  GL + HS      
Sbjct: 78  LYLVFE---------FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 125
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 182
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 183 STAVDIWSLGCIFAEMVTRR 202

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 119/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL   ++  +VH+D+   N+L++++   K+++F L R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 371 GDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNG 421
           G+ VA+KK+         D   +I++L  + H ++++  G+C++ G  N  L+ E    G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
           SL  ++     + +D  + +Q    +  G+ YL +     ++H+D+   N+L++ + R K
Sbjct: 102 SLRDYLQAHAER-IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 157
Query: 482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           I +F L +   + +    +         + APE L     S   DV++FGV++ E+ +
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E      LS+ + D    F+D +    I L         +  GL + HS      
Sbjct: 79  LYLVFE-----FLSMDLKD----FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 126
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 183
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 184 STAVDIWSLGCIFAEMVTRR 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 98  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 153
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           +     K+++F L+R     E      +  VG+K    +  PE L     S+K D++AFG
Sbjct: 154 NDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208
Query: 532 VLMLEMLSGKEAP 544
           VLM E+ S  + P
Sbjct: 209 VLMWEIYSLGKMP 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E      LS+ + D    F+D +    I L         +  GL + HS      
Sbjct: 80  LYLVFE-----FLSMDLKD----FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 127
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 184
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 82
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 83  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 138
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           +     K+++F L+R     E      +  VG+K    +  PE L     S+K D++AFG
Sbjct: 139 NDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 193
Query: 532 VLMLEMLSGKEAP 544
           VLM E+ S  + P
Sbjct: 194 VLMWEIYSLGKMP 206

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 362 GSVYRGKIGGDF-VAIKKVY-GDASD-----QIKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +  G  S+     + K++  ++H  L++L G+C      +++
Sbjct: 29  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 88
Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL S      +H+D+   N L+
Sbjct: 89  TEYMANGCLLNYLREMRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLV 144
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
           +     K+++F L+R     E      +  VG+K    +  PE L     S+K D++AFG
Sbjct: 145 NDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 199
Query: 532 VLMLEMLSGKEAP 544
           VLM E+ S  + P
Sbjct: 200 VLMWEIYSLGKMP 212

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++   A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 45/262 (17%)
Query: 374 VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV 425
           VAIK      SD ++         + + +H  +++L+G+      W ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 479
Query: 426 WINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN 484
           ++  +  KF LD A  I  A  ++T L YL S      VH+DI   NVL+      K+ +
Sbjct: 480 FLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGD 534
Query: 485 FALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           F L+R  E        +++   +KG     +MAPE +     ++  DV+ FGV M E+L 
Sbjct: 535 FGLSRYMED-------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
Query: 540 GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
               P    + N    DV+  +   E+GE   R  M P    N PP     +  L+  C 
Sbjct: 588 HGVKPFQGVKNN----DVIGRI---ENGE---RLPMPP----NCPPT----LYSLMTKCW 629
Query: 600 KKDPSGRPAMDKIAQSISRFLN 621
             DPS RP   ++   +S  L 
Sbjct: 630 AYDPSRRPRFTELKAQLSTILE 651

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 117
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIANF  ++  P+ R+       + 
Sbjct: 118 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR-------TT 167
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 209
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 210 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 20/191 (10%)
Query: 361 KGSVYRGKIGGDFVAIK----------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGN 410
           K  V + ++ G  VA+K           V G    +I+ L    H  +I+L  +     +
Sbjct: 31  KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++V E    G L  +I   G   LD  +  ++   + +G++Y H       VH+D+K  
Sbjct: 91  IFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMV---VHRDLKPE 145
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS-TKLDVYA 529
           NVLLD    AKIA+F L+      +GEF   S   G+  Y APE +   L +  ++D+++
Sbjct: 146 NVLLDAHMNAKIADFGLSNMM--SDGEFLRXS--CGSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 530 FGVLMLEMLSG 540
            GV++  +L G
Sbjct: 202 SGVILYALLCG 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 117/244 (47%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL        VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++     F+D +    I L         +  GL + HS      
Sbjct: 77  LYLVFE---------FLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 124
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 181
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIANF  ++  P+ R+       + 
Sbjct: 119 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR-------TT 168
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 210
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 211 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 142
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 143 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 197
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 201
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 202 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGA 256
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 103 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 161
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 162 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 216
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 217 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 256

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 76  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 134
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 135 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 189
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 190 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++ + +H +++ L G+   G    +V E   NG+L  ++    G+F    Q + +   +A
Sbjct: 97  IMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT-VIQLVGMLRGIA 155
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ-EGEFALTSHIVGT 507
            G+ YL       +VH+D+   N+L++++   K+++F L+R  E   E  +  T   +  
Sbjct: 156 AGMRYLADMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           + + APE ++    ++  DV+++G++M E++S  E P
Sbjct: 213 R-WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 49/272 (18%)
Query: 374 VAIKKVYGDASD--------QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K +  DA++        +++++  I  H ++I LLG C   G  Y++   A  G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 425 VWINDKGGKFLDWAQRIQ--------------IALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  +    ++++  I                   +A G+ YL S      +H+D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAAR 186
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           NVL+  +   KIA+F LAR     +     T+  +  K +MAPE L + + + + DV++F
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSF 245
Query: 531 GVLMLEM--LSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           GVLM E+  L G   P +  EE   L+         ++G     H MD       P    
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLL---------KEG-----HRMDK------PANCT 285
Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  ++  C    PS RP   ++ + + R L
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 35/200 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G VY  R K+ G+ VA+KK+  D         A  +I LL ++NH ++++LL +      
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL--------DVATGLNYLHSFTNPPH 462
            YLV+E         +++     F+D +    I L         +  GL + HS      
Sbjct: 80  LYLVFE---------FLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV--- 127
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLV 521
           +H+D+K  N+L++T+   K+A+F LAR        +    H V T  Y APE L      
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---XHEVVTLWYRAPEILLGCKYY 184
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           ST +D+++ G +  EM++ +
Sbjct: 185 STAVDIWSLGCIFAEMVTRR 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 142
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 143 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 197
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 140
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 141 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 195
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 235

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 119/244 (48%), Gaps = 32/244 (13%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G+AS    ++ + +H ++IRL G+        +V E   NGSL  ++     +F    Q 
Sbjct: 95  GEAS----IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-IQL 149
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           + +   +A+G+ YL   ++   VH+D+   N+L++++   K+++F L+R  E  + E A 
Sbjct: 150 VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAY 205
Query: 501 TSHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           T+   G K    + +PE +     ++  DV+++G+++ E++S  E P  Y E  M   DV
Sbjct: 206 TTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWE--MSNQDV 259
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V      +E  R  + P M           + +L+  C +KD + RP  ++I   + 
Sbjct: 260 IKAV------DEGYR--LPPPMD------CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 618 RFLN 621
           + + 
Sbjct: 306 KLIR 309

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 139
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 140 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 194
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 102 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 160
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 161 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 215
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 216 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 255

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 141
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 142 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 196
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E+    +  G 
Sbjct: 138 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGA 192
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 140
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 141 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGA 195
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 235

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 142
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 143 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGA 197
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 143
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 144 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGA 198
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 238

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TE 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G +   +  K  KF D  +      
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ-KLSKF-DEQRTATYIT 120
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 121 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 170
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 212
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 213 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 142
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 143 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGA 197
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGD-------FVAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 201
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R  G +      +    +M PE    
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGGCAMLPVKWMPPEAFME 260
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 308
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 309 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 30/199 (15%)
Query: 362 GSVYRGK--IGGDFVAIKKV-YGD--ASDQIKLLNKINHSSLIRLLGICFNGGNW----- 411
           G V++ K  I G    IK+V Y +  A  ++K L K++H +++   G C++G ++     
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETS 83
Query: 412 ------------YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTN 459
                       ++  E    G+L  WI  + G+ LD    +++   +  G++Y+HS   
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--- 140
Query: 460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
              +++D+K SN+ L    + KI +F L   + + +G+   +    GT  YM+PE + + 
Sbjct: 141 KKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRXRSK---GTLRYMSPEQISSQ 196
Query: 520 LVSTKLDVYAFGVLMLEML 538
               ++D+YA G+++ E+L
Sbjct: 197 DYGKEVDLYALGLILAELL 215

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 89  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 147
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 148 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGA 202
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 203 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 242

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 143
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ +L S      VH+D+   N +LD  F  K+A+F LAR  +  + EF    +  G 
Sbjct: 144 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMLDKEFDSVHNKTGA 198
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 238

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 333 SDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKK-------------- 378
            ++A   K    ++ Q A +DF     I   + +GK G  ++A +K              
Sbjct: 15  EELASKQKNEESKKRQWALEDFE----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 70
Query: 379 ------VYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
                 V      ++++ + + H +++RL G   +    YL+ E A  G++   +  K  
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLS 129
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARP 490
           KF D  +      ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P
Sbjct: 130 KF-DEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP 185
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
           + R++        + GT  Y+ PE +E  +   K+D+++ GVL  E L GK         
Sbjct: 186 SSRRDD-------LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--------- 229
Query: 551 NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD 610
                    P       +E+ + +    ++  +P         LI   LK +PS RP + 
Sbjct: 230 ---------PPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLR 278
Query: 611 KIAQ 614
           ++ +
Sbjct: 279 EVLE 282

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K+NH +++R +G+  
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 118
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 119 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 175
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 176 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 234
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 235 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 282
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 283 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K+NH +++R +G+  
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 104
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 161
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 220
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 221 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 268
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 269 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 20/196 (10%)
Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L +L   CF   +        VNG   ++   K  +F D A+    A ++ + L +
Sbjct: 82  NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEIISALMF 139
Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIVGTKGYM 511
           LH   +   +++D+K  NVLLD +   K+A+F + +     EG      T+   GT  Y+
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYI 191
Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN-----PVLHKED 566
           APE L+  L    +D +A GVL+ EML G  AP     E+ L   +LN     P    ED
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCG-HAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 567 GEESLRHLM--DPSMQ 580
               L+  M  +P+M+
Sbjct: 251 ATGILKSFMTKNPTMR 266

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 51  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 109
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 110 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +  + +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 166 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 57  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 115
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 116 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +  + +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 47  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 105
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 106 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +  + +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 38/261 (14%)
Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVN 420
           G+ VA+K +  D   Q        I +L  + H  +I+  G C + G  +  LV E    
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++       +  AQ +  A  +  G+ YLHS     ++H+++   NVLLD D   
Sbjct: 103 GSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRLV 156
Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML-- 538
           KI +F LA+        + +         + APE L+        DV++FGV + E+L  
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216
Query: 539 --SGKEAPALYSE-----ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
             S +  P  + E     +  + V  L  +L  E GE   R           P      V
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVLRLTELL--ERGERLPR-----------PDKCPCEV 263
Query: 592 IRLIESCLKKDPSGRPAMDKI 612
             L+++C + + S RP  + +
Sbjct: 264 YHLMKNCWETEASFRPTFENL 284

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGD-------FVAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 62  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 121
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 122 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 178
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R  G +      +    +M PE    
Sbjct: 179 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGGCAMLPVKWMPPEAFME 237
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 238 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 285
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 286 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 116
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R++        
Sbjct: 117 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT------- 166
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 208
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 209 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TD 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 116
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 117 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TD 166
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 208
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 209 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 51  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 109
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 110 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +  + +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 166 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R++        
Sbjct: 119 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD------- 168
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 210
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 211 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 47  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 105
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 106 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +  + +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 119 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 175
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 176 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 234
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 235 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 282
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 283 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 333 SDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKK-------------- 378
            ++A   K    ++ Q A +DF     I   + +GK G  ++A +K              
Sbjct: 15  EELASKQKNEESKKRQWALEDFE----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 70
Query: 379 ------VYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
                 V      ++++ + + H +++RL G   +    YL+ E A  G++   +  K  
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLS 129
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARP 490
           KF D  +      ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P
Sbjct: 130 KF-DEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP 185
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
           + R+       + + GT  Y+ PE +E  +   K+D+++ GVL  E L GK         
Sbjct: 186 SSRR-------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--------- 229
Query: 551 NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD 610
                    P       +E+ + +    ++  +P         LI   LK +PS RP + 
Sbjct: 230 ---------PPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLR 278
Query: 611 KIAQ 614
           ++ +
Sbjct: 279 EVLE 282

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TD 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G +   +  K  KF D  +      
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ-KLSKF-DEQRTATYIT 120
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 121 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------XX 170
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 171 LXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 212
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 213 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 120
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 121 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TD 170
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 212
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 213 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 119 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 168
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 210
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 211 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++   +H +++ LLGIC    G+  +V     +G L  +I ++          I   L V
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 141
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL S      VH+D+   N +LD  F  K+A+F LAR  +  + E     +  G 
Sbjct: 142 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGA 196
Query: 508 K---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           K    +MA E L+    +TK DV++FGVL+ E+++    P
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 236

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 161
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 220
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 221 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 268
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 269 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 36  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 95
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 96  QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 152
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 153 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 211
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 212 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 259
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 260 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 333 SDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKK-------------- 378
            ++A   K    ++ Q A +DF     I   + +GK G  ++A +K              
Sbjct: 6   EELASKQKNEESKKRQWALEDFE----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKA 61
Query: 379 ------VYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
                 V      ++++ + + H +++RL G   +    YL+ E A  G++   +  K  
Sbjct: 62  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLS 120
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARP 490
           KF D  +      ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P
Sbjct: 121 KF-DEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP 176
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
           + R+       + + GT  Y+ PE +E  +   K+D+++ GVL  E L GK         
Sbjct: 177 SSRR-------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--------- 220
Query: 551 NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD 610
                    P       +E+ + +    ++  +P         LI   LK +PS RP + 
Sbjct: 221 ---------PPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLR 269
Query: 611 KIAQ 614
           ++ +
Sbjct: 270 EVLE 273

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TX 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGD-------FVAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 61  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 120
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 121 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 177
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 178 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 236
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 237 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 284
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 285 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 119 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------- 168
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 210
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 211 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 120
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 121 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 170
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 212
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 213 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 28/200 (14%)
Query: 362 GSVYRG---KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICF 406
           G V++    K GG FVA+K+V     ++            ++ L    H +++RL  +C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 407 -----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                      LV+E+ V+  L+ +++      +       +   +  GL++LHS     
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV-- 141
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+K  N+L+ +  + K+A+F LAR    Q    ALTS +V T  Y APE L     
Sbjct: 142 -VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS-VVVTLWYRAPEVLLQSSY 196
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           +T +D+++ G +  EM   K
Sbjct: 197 ATPVDLWSVGCIFAEMFRRK 216

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 119 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 168
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 210
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 211 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 104 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 160
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 219
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 267
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 268 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGD-------FVAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 51  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 110
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 111 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 167
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 168 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 226
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 227 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 274
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 275 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 119
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 120 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 169
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 211
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 212 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 160
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 219
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 267
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 268 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 12/168 (7%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI- 443
           ++I L   + H ++++ LG     G   +  E    GSLS  +  K G   D  Q I   
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTS 502
              +  GL YLH   +   VH+DIK  NVL++T     KI++F  ++   R  G    T 
Sbjct: 128 TKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTE 181
Query: 503 HIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYS 548
              GT  YMAPE ++ G        D+++ G  ++EM +GK  P  Y 
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFYE 227

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 113 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 162
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 204
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 205 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 388 KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++L  ++    +  L  CF   +        VNG   ++   + GKF +  Q +  A ++
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-PQAVFYAAEI 129
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           + GL +LH       +++D+K  NV+LD++   KIA+F + +     +G    T    GT
Sbjct: 130 SIGLFFLHKRGI---IYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDG--VTTREFCGT 183
Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG 567
             Y+APE +        +D +A+GVL+ EML+G+                  P    ED 
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ------------------PPFDGEDE 225
Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           +E  + +M+ ++  +YP   +   + + +  + K P+ R
Sbjct: 226 DELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPAKR 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------- 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 21/272 (7%)
Query: 367 GKIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGG--NWYLVYEN 417
           G   G  VA+K++     DQ       I++L  ++   +++  G+ +  G  +  LV E 
Sbjct: 48  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
             +G L  ++     + LD ++ +  +  +  G+ YL S      VH+D+   N+L++++
Sbjct: 108 LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESE 163
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              KIA+F LA+     +  + +         + APE L + + S + DV++FGV++ E+
Sbjct: 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 538 LSGKEAPALYSEE--NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
            +  +     S E   M+  +   P L +          + P+     PP     V  L+
Sbjct: 224 FTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL-PA-----PPACPAEVHELM 277
Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWE 627
           + C    P  RP+   +   +    + S   E
Sbjct: 278 KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 114
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 115 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 164
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 206
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 207 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGD-------FVAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 71  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 130
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 131 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 187
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 188 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 246
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 247 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 294
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 295 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 117
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 118 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------XX 167
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 209
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 210 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 38/261 (14%)
Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVN 420
           G+ VA+K +  D   Q        I +L  + H  +I+  G C + G  +  LV E    
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++       +  AQ +  A  +  G+ YLH+     ++H+++   NVLLD D   
Sbjct: 103 GSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLV 156
Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML-- 538
           KI +F LA+        + +         + APE L+        DV++FGV + E+L  
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216
Query: 539 --SGKEAPALYSE-----ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
             S +  P  + E     +  + V  L  +L  E GE   R           P      V
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVLRLTELL--ERGERLPR-----------PDKCPCEV 263
Query: 592 IRLIESCLKKDPSGRPAMDKI 612
             L+++C + + S RP  + +
Sbjct: 264 YHLMKNCWETEASFRPTFENL 284

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51
Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 112 ---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 166 ITPEQSK---RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 219
Query: 551 NML 553
           N L
Sbjct: 220 NPL 222

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 116
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA--RPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  +   P+ R+       + 
Sbjct: 117 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR-------TT 166
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 167 LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 208
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 209 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 21/272 (7%)
Query: 367 GKIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGG--NWYLVYEN 417
           G   G  VA+K++     DQ       I++L  ++   +++  G+ +  G  +  LV E 
Sbjct: 36  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 95
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
             +G L  ++     + LD ++ +  +  +  G+ YL S      VH+D+   N+L++++
Sbjct: 96  LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESE 151
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              KIA+F LA+     +  + +         + APE L + + S + DV++FGV++ E+
Sbjct: 152 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211
Query: 538 LSGKEAPALYSEE--NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
            +  +     S E   M+  +   P L +          + P+     PP     V  L+
Sbjct: 212 FTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL-PA-----PPACPAEVHELM 265
Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWE 627
           + C    P  RP+   +   +    + S   E
Sbjct: 266 KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 297

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 28/200 (14%)
Query: 362 GSVYRG---KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICF 406
           G V++    K GG FVA+K+V     ++            ++ L    H +++RL  +C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 407 -----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                      LV+E+ V+  L+ +++      +       +   +  GL++LHS     
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV-- 141
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+K  N+L+ +  + K+A+F LAR    Q    ALTS +V T  Y APE L     
Sbjct: 142 -VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS-VVVTLWYRAPEVLLQSSY 196
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           +T +D+++ G +  EM   K
Sbjct: 197 ATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 28/200 (14%)
Query: 362 GSVYRG---KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICF 406
           G V++    K GG FVA+K+V     ++            ++ L    H +++RL  +C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 407 -----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                      LV+E+ V+  L+ +++      +       +   +  GL++LHS     
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV-- 141
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+K  N+L+ +  + K+A+F LAR    Q    ALTS +V T  Y APE L     
Sbjct: 142 -VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS-VVVTLWYRAPEVLLQSSY 196
Query: 522 STKLDVYAFGVLMLEMLSGK 541
           +T +D+++ G +  EM   K
Sbjct: 197 ATPVDLWSVGCIFAEMFRRK 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 12/168 (7%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI- 443
           ++I L   + H ++++ LG     G   +  E    GSLS  +  K G   D  Q I   
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTS 502
              +  GL YLH   +   VH+DIK  NVL++T     KI++F  ++   R  G    T 
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTE 167
Query: 503 HIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYS 548
              GT  YMAPE ++ G        D+++ G  ++EM +GK  P  Y 
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFYE 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 119 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 175
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +AR   R          ++  K +M PE    
Sbjct: 176 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPPEAFME 234
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 235 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 282
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 283 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           +++ ++   +H +++ +      G   ++V E    G+L+  +       ++  Q   + 
Sbjct: 91  NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVC 147
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
           L V   L+YLH   N   +H+DIK  ++LL +D R K+++F       +   E      +
Sbjct: 148 LSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK---EVPKRKXL 201
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
           VGT  +MAPE +      T++D+++ G++++EM+ G+  P  ++E
Sbjct: 202 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE--PPYFNE 244

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 374 VAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK 433
           V +K+V    +D+  +L+ + H  +IR+ G   +    +++ +    G L   +  K  +
Sbjct: 45  VRLKQV-EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQR 102
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER 493
           F +   +   A +V   L YLHS      +++D+K  N+LLD +   KI +F  A+    
Sbjct: 103 FPNPVAKF-YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP- 157
Query: 494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG----KEAPALYSE 549
                 +T  + GT  Y+APE +     +  +D ++FG+L+ EML+G     ++  + + 
Sbjct: 158 -----DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
Query: 550 ENMLLVDVLNPVLHKEDGEESLRHLM 575
           E +L  ++  P    ED ++ L  L+
Sbjct: 213 EKILNAELRFPPFFNEDVKDLLSRLI 238

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 21/272 (7%)
Query: 367 GKIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGG--NWYLVYEN 417
           G   G  VA+K++     DQ       I++L  ++   +++  G+ +  G  +  LV E 
Sbjct: 35  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 94
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
             +G L  ++     + LD ++ +  +  +  G+ YL S      VH+D+   N+L++++
Sbjct: 95  LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESE 150
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              KIA+F LA+     +  + +         + APE L + + S + DV++FGV++ E+
Sbjct: 151 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210
Query: 538 LSGKEAPALYSEE--NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
            +  +     S E   M+  +   P L +          + P+     PP     V  L+
Sbjct: 211 FTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRL-PA-----PPACPAEVHELM 264
Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWE 627
           + C    P  RP+   +   +    + S   E
Sbjct: 265 KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 296

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 119 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------XX 168
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 210
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 211 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 116 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------XX 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 47  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 105
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 106 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +    +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 162 PQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 3   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 52
Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 53  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 112
Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 113 ---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 166
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 167 ITPEQSK---RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 220
Query: 551 NML 553
           N L
Sbjct: 221 NPL 223

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51
Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 112 ---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 166 ITPEQSK---RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 219
Query: 551 NML 553
           N L
Sbjct: 220 NPL 222

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51
Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 112 ---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 166 ITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 219
Query: 551 NML 553
           N L
Sbjct: 220 NPL 222

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 100/212 (47%), Gaps = 43/212 (20%)
Query: 362 GSVYRGK--IGGDFVAIKKV-YGD--ASDQIKLLNKINHSSLIRLLGICFNGGNW----- 411
           G V++ K  I G    I++V Y +  A  ++K L K++H +++   G C++G ++     
Sbjct: 26  GQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETS 84
Query: 412 -------------------------YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
                                    ++  E    G+L  WI  + G+ LD    +++   
Sbjct: 85  DDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 144
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G++Y+HS      +H+D+K SN+ L    + KI +F L   + + +G+   +    G
Sbjct: 145 ITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRTRSK---G 197
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEML 538
           T  YM+PE + +     ++D+YA G+++ E+L
Sbjct: 198 TLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 120
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+       + 
Sbjct: 121 ELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TT 170
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E      K+D+++ GVL  E L GK                  P   
Sbjct: 171 LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK------------------PPFE 212
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +E+ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 213 ANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 5/173 (2%)
Query: 372 DFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG 431
           D ++  +   D   ++  ++ ++H +LIRL G+        +V E A  GSL   +    
Sbjct: 57  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ 115
Query: 432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA 491
           G FL      + A+ VA G+ YL S      +H+D+   N+LL T    KI +F L R  
Sbjct: 116 GHFL-LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + +    +  H      + APE L+    S   D + FGV + EM +  + P
Sbjct: 172 PQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 38/242 (15%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQ 439
           D+  ++  ++H  L+RLLG+C +     LV +   +G L  ++++          L+W  
Sbjct: 89  DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC- 146
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+ YL        VH+D+   NVL+ +    KI +F LAR  E  E E+ 
Sbjct: 147 -----VQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 198
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENMLLVDV 557
                +  K +MA E +     + + DV+++GV + E+++  GK    + + E   + D+
Sbjct: 199 ADGGKMPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL 254
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           L      E GE   +           PP+  I V  ++  C   D   RP   ++A   S
Sbjct: 255 L------EKGERLPQ-----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 297
Query: 618 RF 619
           R 
Sbjct: 298 RM 299

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++  ++H  +++L+GI      W ++ E    G L  ++ ++    L     +  +L + 
Sbjct: 78  IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQIC 135
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             + YL S      VH+DI   N+L+ +    K+ +F L+R  E ++   A  + +    
Sbjct: 136 KAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PI 190
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE 568
            +M+PE +     +T  DV+ F V M E+LS  + P  + E      DV+  VL K D  
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIG-VLEKGD-- 243
Query: 569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                L  P +    PPV   L+ R    C   DPS RP   ++  S+S
Sbjct: 244 ----RLPKPDLC---PPVLYTLMTR----CWDYDPSDRPRFTELVCSLS 281

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 39/185 (21%)
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT- 501
           I  ++  GL+YLHS      +H+DIK +NVLL      K+A+F +A       G+   T 
Sbjct: 121 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA-------GQLTDTQ 170
Query: 502 ---SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVD 556
              +  VGT  +MAPE ++      K D+++ G+  +E+  G E P   L+    + L+ 
Sbjct: 171 IKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-EPPNSDLHPMRVLFLIP 229
Query: 557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS- 615
             +P                P+++G +    +      +E+CL KDP  RP   ++ +  
Sbjct: 230 KNSP----------------PTLEGQH----SKPFKEFVEACLNKDPRFRPTAKELLKHK 269
Query: 616 -ISRF 619
            I+R+
Sbjct: 270 FITRY 274

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++  ++H  +++L+GI      W ++ E    G L  ++ ++    L     +  +L + 
Sbjct: 66  IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQIC 123
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             + YL S      VH+DI   N+L+ +    K+ +F L+R  E ++   A  + +    
Sbjct: 124 KAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PI 178
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE 568
            +M+PE +     +T  DV+ F V M E+LS  + P  + E      DV+  VL K D  
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIG-VLEKGD-- 231
Query: 569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                L  P +    PPV   L+ R    C   DPS RP   ++  S+S
Sbjct: 232 ----RLPKPDLC---PPVLYTLMTR----CWDYDPSDRPRFTELVCSLS 269

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 118/273 (43%), Gaps = 37/273 (13%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +      +  ++ +I H +L++LLG+C     +Y+
Sbjct: 46  GEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYI 105
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           V E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 106 VTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 162
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  +   K+A+F L+R      G+   T+H  G K    + APE L     S K DV+AF
Sbjct: 163 VGENHVVKVADFGLSR---LMTGD-TYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAF 217
Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           GVL+ E+       A Y       +D+             +  L++   +   P      
Sbjct: 218 GVLLWEI-------ATYGMSPYPGIDL-----------SQVYDLLEKGYRMEQPEGCPPK 259
Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           V  L+ +C K  P+ RP+  +  Q+     + S
Sbjct: 260 VYELMRACWKWSPADRPSFAETHQAFETMFHDS 292

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 38/242 (15%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQ 439
           D+  ++  ++H  L+RLLG+C +     LV +   +G L  ++++          L+W  
Sbjct: 66  DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+ YL        VH+D+   NVL+ +    KI +F LAR  E  E E+ 
Sbjct: 124 -----VQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENMLLVDV 557
                +  K +MA E +     + + DV+++GV + E+++  GK    + + E   + D+
Sbjct: 176 ADGGKMPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL 231
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           L      E GE   +           PP+  I V  ++  C   D   RP   ++A   S
Sbjct: 232 L------EKGERLPQ-----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 274
Query: 618 RF 619
           R 
Sbjct: 275 RM 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +L  +NH  +++L       G  YL+ +    G L   ++ K   F +   +  +A ++A
Sbjct: 83  ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLA-ELA 140
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            GL++LHS      +++D+K  N+LLD +   K+ +F L++ A   E +        GT 
Sbjct: 141 LGLDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK---AYSFCGTV 194
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            YMAPE +     S   D +++GVLM EML+G
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++  ++H  +++L+GI      W ++ E    G L  ++ ++    L     +  +L + 
Sbjct: 62  IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQIC 119
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             + YL S      VH+DI   N+L+ +    K+ +F L+R  E ++   A  + +    
Sbjct: 120 KAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PI 174
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE 568
            +M+PE +     +T  DV+ F V M E+LS  + P  + E      DV+  VL K D  
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIG-VLEKGD-- 227
Query: 569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                L  P +    PPV   L+ R    C   DPS RP   ++  S+S
Sbjct: 228 ----RLPKPDLC---PPVLYTLMTR----CWDYDPSDRPRFTELVCSLS 265

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 10/163 (6%)
Query: 379 VYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWA 438
           V G    +I+ L    H  +I+L  +     ++++V E    G L  +I  K G+  +  
Sbjct: 54  VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEME 112
Query: 439 QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
            R ++   + + ++Y H       VH+D+K  NVLLD    AKIA+F L+      +GEF
Sbjct: 113 AR-RLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEF 166
Query: 499 ALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
             TS   G+  Y APE +   L +  ++D+++ GV++  +L G
Sbjct: 167 LRTS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  KF D  +      
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ-KLSKF-DEQRTATYIT 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL +    KIA+F  ++  P+ R+         
Sbjct: 116 ELANALSYCHSKKV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------- 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  +   K+D+++ GVL  E L GK                  P   
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFE 207
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +++ + +    ++  +P         LI   LK +PS RP + ++ +
Sbjct: 208 ANTYQDTYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 111/257 (43%), Gaps = 45/257 (17%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR--- 440
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 441 ---------IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-- 489
                    I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR  
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 490 ---PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPAL 546
              P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P  
Sbjct: 199 XKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-- 250
Query: 547 YSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           Y    +               EE  R L +   +   P  T   + + +  C   +PS R
Sbjct: 251 YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295
Query: 607 PAMDKIAQSISRFLNAS 623
           P   ++ + +   L A+
Sbjct: 296 PTFSELVEHLGNLLQAN 312

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 111/255 (43%), Gaps = 43/255 (16%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 439 -----QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---- 489
                  I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR    
Sbjct: 140 FLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKIXDFGLARDIYK 196
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P  Y 
Sbjct: 197 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YP 248
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
              +               EE  R L +   +   P  T   + + +  C   +PS RP 
Sbjct: 249 GVKI--------------DEEFXRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 293
Query: 609 MDKIAQSISRFLNAS 623
             ++ + +   L A+
Sbjct: 294 FSELVEHLGNLLQAN 308

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQIKL--------LNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q +L        ++K NH +++R +G+  
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGK-----FLDWAQRIQIALDVATGLNYLHSFTNPP 461
                +++ E    G L  ++ +   +      L     + +A D+A G  YL       
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 161
Query: 462 HVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
            +H+DI   N LL        AKI +F +A+   R          ++  K +M PE    
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK-WMPPEAFME 220
Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ ++K D ++FGVL+ E+ S    P   S+ N  +++ +        G       MDP 
Sbjct: 221 GIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFVT-----SGGR------MDPP 268
Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                P      V R++  C +  P  RP    I + I 
Sbjct: 269 KNCPGP------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 38/246 (15%)
Query: 389 LLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFLDWAQR------- 440
           L+  +NH +++ L+GI     G  +++     +G L         +F+   QR       
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL--------QFIRSPQRNPTVKDL 126
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPA-ERQEGEFA 499
           I   L VA G+ YL        VH+D+   N +LD  F  K+A+F LAR   +R+     
Sbjct: 127 ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
              H      + A E L+    +TK DV++FGVL+ E+L+    P  +          ++
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH----------ID 233
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
           P          L H +    +   P      + ++++ C + DP+ RP    +   + + 
Sbjct: 234 PF--------DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
Query: 620 LNASLA 625
           ++A L 
Sbjct: 286 VSALLG 291

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF------- 434
           D   + +LL  + H  +++  G+C +G    +V+E   +G L+ ++   G          
Sbjct: 63  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 435 -------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL 487
                  L  +Q + IA  +A+G+ YL S      VH+D+   N L+  +   KI +F +
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
           +R     +  + +  H +    +M PE +     +T+ DV++FGV++ E+ +  + P
Sbjct: 180 SRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 362 GSVYRGK--IGGDFVAIK--KVYGDASDQIK----LLNKINHSSLIRLLGICFNGGN--- 410
           G VY+G+    G   AIK   V GD  ++IK    +L K +H   I      F   N   
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97
Query: 411 ----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
                +LV E    GS++  I +  G  L       I  ++  GL++LH       +H+D
Sbjct: 98  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRD 154
Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLV 521
           IK  NVLL  +   K+ +F ++   +R  G     +  +GT  +MAPE +      +   
Sbjct: 155 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDATY 211
Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNPVLHKEDGEESLRHLMDPSM 579
             K D+++ G+  +EM  G  AP L     M  L +   NP    +  + S +       
Sbjct: 212 DFKSDLWSLGITAIEMAEG--APPLCDMHPMRALFLIPRNPAPRLKSKKWSKK------- 262
Query: 580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                          IESCL K+ S RPA +++ +
Sbjct: 263 -----------FQSFIESCLVKNHSQRPATEQLMK 286

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIR---LLGICFNGGNWYLVYENA 418
           G V+RGK  G+ VA+K              +I  + ++R   +LG        ++  +N 
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG--------FIAADNK 94
Query: 419 VNGSLS-VW-IND--KGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
            NG+ + +W ++D  + G   D+  R        I++AL  A+GL +LH     +   P 
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 154
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
             H+D+K  N+L+  +    IA+  LA   +       +  +H VGTK YMAPE L++ +
Sbjct: 155 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 214
Query: 521 VS------TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL--NPV---LHKEDGEE 569
                    + D+YA G++  E+        ++ +  +   D++  +P    + K   E+
Sbjct: 215 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 274
Query: 570 SLRHLMDPSMQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
            LR    P++   +    A+ V+ +++  C   + + R    +I +++S+ 
Sbjct: 275 KLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIR---LLGICFNGGNWYLVYENA 418
           G V+RGK  G+ VA+K              +I  + ++R   +LG        ++  +N 
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG--------FIAADNK 69
Query: 419 VNGSLS-VW-IND--KGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
            NG+ + +W ++D  + G   D+  R        I++AL  A+GL +LH     +   P 
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 129
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
             H+D+K  N+L+  +    IA+  LA   +       +  +H VGTK YMAPE L++ +
Sbjct: 130 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 189
Query: 521 VS------TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL--NPV---LHKEDGEE 569
                    + D+YA G++  E+        ++ +  +   D++  +P    + K   E+
Sbjct: 190 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 249
Query: 570 SLRHLMDPSMQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
            LR    P++   +    A+ V+ +++  C   + + R    +I +++S+ 
Sbjct: 250 KLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 296

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 384 SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI 443
           S++  LL  + H  L+ L          Y V +  +NG    +   +   FL+   R   
Sbjct: 87  SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD-YINGGELFYHLQRERCFLEPRARF-Y 144
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++A+ L YLHS      V++D+K  N+LLD+     + +F L +  E  E   + TS 
Sbjct: 145 AAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHN-STTST 198
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD-VLN-PV 561
             GT  Y+APE L        +D +  G ++ EML G   P  YS     + D +LN P+
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYDNILNKPL 256
Query: 562 LHKEDGEESLRHLMDPSMQGN 582
             K +   S RHL++  +Q +
Sbjct: 257 QLKPNITNSARHLLEGLLQKD 277

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIR---LLGICFNGGNWYLVYENA 418
           G V+RGK  G+ VA+K              +I  + ++R   +LG        ++  +N 
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG--------FIAADNK 107
Query: 419 VNGSLS-VW-IND--KGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
            NG+ + +W ++D  + G   D+  R        I++AL  A+GL +LH     +   P 
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
             H+D+K  N+L+  +    IA+  LA   +       +  +H VGTK YMAPE L++ +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227
Query: 521 VS------TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL--NPV---LHKEDGEE 569
                    + D+YA G++  E+        ++ +  +   D++  +P    + K   E+
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
Query: 570 SLRHLMDPSMQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
            LR    P++   +    A+ V+ +++  C   + + R    +I +++S+ 
Sbjct: 288 KLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 111/255 (43%), Gaps = 43/255 (16%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 439 -----QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---- 489
                  I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR    
Sbjct: 140 FLTLEHLICYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P  Y 
Sbjct: 197 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YP 248
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
              +               EE  R L +   +   P  T   + + +  C   +PS RP 
Sbjct: 249 GVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 293
Query: 609 MDKIAQSISRFLNAS 623
             ++ + +   L A+
Sbjct: 294 FSELVEHLGNLLQAN 308

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIR---LLGICFNGGNWYLVYENA 418
           G V+RGK  G+ VA+K              +I  + ++R   +LG        ++  +N 
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG--------FIAADNK 74
Query: 419 VNGSLS-VW-IND--KGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
            NG+ + +W ++D  + G   D+  R        I++AL  A+GL +LH     +   P 
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 134
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
             H+D+K  N+L+  +    IA+  LA   +       +  +H VGTK YMAPE L++ +
Sbjct: 135 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 194
Query: 521 VS------TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL--NPV---LHKEDGEE 569
                    + D+YA G++  E+        ++ +  +   D++  +P    + K   E+
Sbjct: 195 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 254
Query: 570 SLRHLMDPSMQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
            LR    P++   +    A+ V+ +++  C   + + R    +I +++S+ 
Sbjct: 255 KLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 301

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIR---LLGICFNGGNWYLVYENA 418
           G V+RGK  G+ VA+K              +I  + ++R   +LG        ++  +N 
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG--------FIAADNK 71
Query: 419 VNGSLS-VW-IND--KGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
            NG+ + +W ++D  + G   D+  R        I++AL  A+GL +LH     +   P 
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 131
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
             H+D+K  N+L+  +    IA+  LA   +       +  +H VGTK YMAPE L++ +
Sbjct: 132 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 191
Query: 521 VS------TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL--NPV---LHKEDGEE 569
                    + D+YA G++  E+        ++ +  +   D++  +P    + K   E+
Sbjct: 192 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 251
Query: 570 SLRHLMDPSMQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
            LR    P++   +    A+ V+ +++  C   + + R    +I +++S+ 
Sbjct: 252 KLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 298

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIR---LLGICFNGGNWYLVYENA 418
           G V+RGK  G+ VA+K              +I  + ++R   +LG        ++  +N 
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG--------FIAADNK 68
Query: 419 VNGSLS-VW-IND--KGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
            NG+ + +W ++D  + G   D+  R        I++AL  A+GL +LH     +   P 
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
             H+D+K  N+L+  +    IA+  LA   +       +  +H VGTK YMAPE L++ +
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188
Query: 521 VS------TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL--NPV---LHKEDGEE 569
                    + D+YA G++  E+        ++ +  +   D++  +P    + K   E+
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248
Query: 570 SLRHLMDPSMQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
            LR    P++   +    A+ V+ +++  C   + + R    +I +++S+ 
Sbjct: 249 KLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 104/259 (40%), Gaps = 45/259 (17%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF------- 434
           D   + +LL  + H  ++R  G+C  G    +V+E   +G L+ ++   G          
Sbjct: 89  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 435 ------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                 L   Q + +A  VA G+ YL        VH+D+   N L+      KI +F ++
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 489 RPAERQEGEFALTSHIVGTK-----GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           R        ++   + VG +      +M PE +     +T+ DV++FGV++ E+ +  + 
Sbjct: 206 RDI------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 544 PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP 603
           P  Y   N   +D +        G E  R    P      P V AI+       C +++P
Sbjct: 260 P-WYQLSNTEAIDCIT------QGRELERPRACP------PEVYAIM-----RGCWQREP 301
Query: 604 SGRPAMDKIAQSISRFLNA 622
             R ++  +   +     A
Sbjct: 302 QQRHSIKDVHARLQALAQA 320

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 373 FVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
            VA+K +  DASD        + +LL  + H  +++  G+C  G    +V+E   +G L+
Sbjct: 45  LVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 425 VWINDKGGKF-----------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
            ++   G              L  +Q + IA  +A G+ YL S      VH+D+   N L
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCL 160
Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 533
           +  +   KI +F ++R     +  + +  H +    +M PE +     +T+ DV++ GV+
Sbjct: 161 VGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 219
Query: 534 MLEMLSGKEAP 544
           + E+ +  + P
Sbjct: 220 LWEIFTYGKQP 230

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVNGSLSVWIND--KGGKFLDWAQRI 441
           ++ LL ++ H +++R      +  N   Y+V E    G L+  I    K  ++LD    +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 442 QIALDVATGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           ++   +   L   H  ++  H  +H+D+K +NV LD     K+ +F LAR     E +FA
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE-DFA 173
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
                VGT  YM+PE +     + K D+++ G L+ E+
Sbjct: 174 --KEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L+YLHS  N   V++D+K  N++LD D   KI +F L +   +   + A      
Sbjct: 256 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKTFC 310
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++       
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELI------- 361
Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                   LM+   +  +P         L+   LKKDP  R
Sbjct: 362 --------LME---EIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L+YLHS  N   V++D+K  N++LD D   KI +F L +   +   + A      
Sbjct: 259 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKTFC 313
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++       
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELI------- 364
Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                   LM+   +  +P         L+   LKKDP  R
Sbjct: 365 --------LME---EIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 34/196 (17%)
Query: 374 VAIK--KVYGDASDQIKLLNKI-------NHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
           VA+K  K   D+S++  L++++       +H +++ LLG C   G  YL++E    G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 425 VWINDKGGKF---------------------LDWAQRIQIALDVATGLNYLHSFTNPPHV 463
            ++  K  KF                     L +   +  A  VA G+ +L        V
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 194
Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           H+D+   NVL+      KI +F LAR     +  + +  +      +MAPE L  G+ + 
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDI-MSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 524 KLDVYAFGVLMLEMLS 539
           K DV+++G+L+ E+ S
Sbjct: 254 KSDVWSYGILLWEIFS 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L+YLHS  N   V++D+K  N++LD D   KI +F L +   +   + A      
Sbjct: 116 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKXFC 170
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++       
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELI------- 221
Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                   LM+   +  +P         L+   LKKDP  R
Sbjct: 222 --------LME---EIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  +F D  +      
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSRF-DEQRTATYIT 119
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL ++   KIA+F  ++  P+ R++        
Sbjct: 120 ELANALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT------- 169
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + GT  Y+ PE +E  +   K+D+++ GVL  E L G
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 21/182 (11%)
Query: 368 KIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL---- 423
           K   D ++IK  Y D  ++++++  I +   +   GI  N    Y++YE   N S+    
Sbjct: 75  KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134
Query: 424 -SVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK 481
              ++ DK        Q I+ I   V    +Y+H+  N    H+D+K SN+L+D + R K
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVK 192
Query: 482 IANFALARPAERQEGEFALTSHIVGTKG---YMAPEYL--ENGLVSTKLDVYAFGVLMLE 536
           +++F         E E+ +   I G++G   +M PE+   E+     K+D+++ G+ +  
Sbjct: 193 LSDFG--------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 537 ML 538
           M 
Sbjct: 245 MF 246

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 114/268 (42%), Gaps = 21/268 (7%)
Query: 367 GKIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGN--WYLVYEN 417
           G   G  VA+K++     DQ       I++L  ++   +++  G+ +  G     LV E 
Sbjct: 32  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEY 91
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
             +G L  ++     + LD ++ +  +  +  G+ YL S      VH+D+   N+L++++
Sbjct: 92  LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESE 147
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              KIA+F LA+     +    +         + APE L + + S + DV++FGV++ E+
Sbjct: 148 AHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207
Query: 538 LSGKEAPALYSEE--NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
            +  +     S E   M+  +   P L +          + P+     PP     V  L+
Sbjct: 208 FTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL-PA-----PPACPAEVHELM 261
Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           + C    P  RP+   +   +    + S
Sbjct: 262 KLCWAPSPQDRPSFSALGPQLDMLWSGS 289

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L+YLHS  N   V++D+K  N++LD D   KI +F L +   +   + A      
Sbjct: 117 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKXFC 171
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++       
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELI------- 222
Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                   LM+   +  +P         L+   LKKDP  R
Sbjct: 223 --------LME---EIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 104/259 (40%), Gaps = 45/259 (17%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF------- 434
           D   + +LL  + H  ++R  G+C  G    +V+E   +G L+ ++   G          
Sbjct: 60  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 119
Query: 435 ------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                 L   Q + +A  VA G+ YL        VH+D+   N L+      KI +F ++
Sbjct: 120 DVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 176
Query: 489 RPAERQEGEFALTSHIVGTK-----GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           R        ++   + VG +      +M PE +     +T+ DV++FGV++ E+ +  + 
Sbjct: 177 RDI------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230
Query: 544 PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP 603
           P  Y   N   +D +        G E  R    P      P V AI+       C +++P
Sbjct: 231 P-WYQLSNTEAIDCIT------QGRELERPRACP------PEVYAIM-----RGCWQREP 272
Query: 604 SGRPAMDKIAQSISRFLNA 622
             R ++  +   +     A
Sbjct: 273 QQRHSIKDVHARLQALAQA 291

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++ + L+YLHS  N   V++D+K  N++LD D   KI +F L +   +   + A      
Sbjct: 118 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKXFC 172
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++       
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELI------- 223
Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                   LM+   +  +P         L+   LKKDP  R
Sbjct: 224 --------LME---EIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 104/259 (40%), Gaps = 45/259 (17%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF------- 434
           D   + +LL  + H  ++R  G+C  G    +V+E   +G L+ ++   G          
Sbjct: 66  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 125
Query: 435 ------LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                 L   Q + +A  VA G+ YL        VH+D+   N L+      KI +F ++
Sbjct: 126 DVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 182
Query: 489 RPAERQEGEFALTSHIVGTK-----GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           R        ++   + VG +      +M PE +     +T+ DV++FGV++ E+ +  + 
Sbjct: 183 RDI------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236
Query: 544 PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDP 603
           P  Y   N   +D +        G E  R    P      P V AI+       C +++P
Sbjct: 237 P-WYQLSNTEAIDCIT------QGRELERPRACP------PEVYAIM-----RGCWQREP 278
Query: 604 SGRPAMDKIAQSISRFLNA 622
             R ++  +   +     A
Sbjct: 279 QQRHSIKDVHARLQALAQA 297

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 111/258 (43%), Gaps = 46/258 (17%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 81  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDL 140
Query: 439 --------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR- 489
                     I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 490 ----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA 545
               P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P 
Sbjct: 198 IXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP- 250
Query: 546 LYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG 605
            Y    +               EE  R L +   +   P  T   + + +  C   +PS 
Sbjct: 251 -YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQ 294
Query: 606 RPAMDKIAQSISRFLNAS 623
           RP   ++ + +   L A+
Sbjct: 295 RPTFSELVEHLGNLLQAN 312

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR--- 440
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ + +    
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 441 -----------IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 199 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 253 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 295
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 296 QRPTFSELVEHLGNLLQAN 314

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++ + + H +++RL G   +    YL+ E A  G++   +  K  +F D  +      
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSRF-DEQRTATYIT 119
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y HS      +H+DIK  N+LL ++   KIA+F  ++  P+ R+       + 
Sbjct: 120 ELANALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR-------TT 169
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + GT  Y+ PE +E  +   K+D+++ GVL  E L G
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/321 (22%), Positives = 130/321 (40%), Gaps = 54/321 (16%)
Query: 323 EESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGD 382
           E  R+ +E + DI +      F+        + P   +   + + +   D  A      D
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA------D 96
Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW---------------- 426
              +  L+ + ++ ++++LLG+C  G    L++E    G L+ +                
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 427 ------INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
                 ++  G   L  A+++ IA  VA G+ YL   +    VH+D+   N L+  +   
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVV 213
Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           KIA+F L+R     +   A  +  +  + +M PE +     +T+ DV+A+GV++ E+ S 
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 541 KEAP--ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESC 598
              P   +  EE +  V   N +   E+    L +LM                 RL   C
Sbjct: 273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLM-----------------RL---C 312
Query: 599 LKKDPSGRPAMDKIAQSISRF 619
             K P+ RP+   I + + R 
Sbjct: 313 WSKLPADRPSFCSIHRILQRM 333

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 197 DIYKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 251 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 294 QRPTFSELVEHLGNLLQAN 312

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 371 GDFVAIKKVYGDASDQIKLL-NKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSL 423
           G  VA+KK+      + +LL N++       H +++ +      G   ++V E    G+L
Sbjct: 176 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
           +  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D R K++
Sbjct: 236 TDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 289
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           +F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+ G+  
Sbjct: 290 DFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-- 344
Query: 544 PALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           P  ++E  +    ++ D L P L          H + PS++G             ++  L
Sbjct: 345 PPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLDRLL 385
Query: 600 KKDPSGR 606
            +DP+ R
Sbjct: 386 VRDPAQR 392

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 110/261 (42%), Gaps = 45/261 (17%)
Query: 362 GSVY--RGKIGGDFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGG 409
           G+VY  R     + VAIKK+          + D   +++ L K+ H + I+  G      
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             +LV E  + GS S  + +   K L   +   +      GL YLHS      +H+D+K 
Sbjct: 128 TAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKA 182
Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY---LENGLVSTKLD 526
            N+LL      K+ +F  A          A  +  VGT  +MAPE    ++ G    K+D
Sbjct: 183 GNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVD 235
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           V++ G+  +E+   K  P L+   NM  +  L  +   E           P++Q  +   
Sbjct: 236 VWSLGITCIELAERK--PPLF---NMNAMSALYHIAQNE----------SPALQSGH--- 277
Query: 587 TAILVIRLIESCLKKDPSGRP 607
            +      ++SCL+K P  RP
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRP 298

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 197 DIXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 251 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 294 QRPTFSELVEHLGNLLQAN 312

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL +LHS      V++D+K  N+LLD D   KIA+F + +  E   G+ A T+ 
Sbjct: 125 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGD-AKTNE 178
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
             GT  Y+APE L     +  +D ++FGVL+ EML G+       EE + 
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 228

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 188 DIXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 242 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 284
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 285 QRPTFSELVEHLGNLLQAN 303

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 375 AIKKVYGDASDQIK------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
            +KK      D+++      +L ++NH  +++L       G  YL+ +    G L   ++
Sbjct: 59  VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            K   F +   +  +A ++A  L++LHS      +++D+K  N+LLD +   K+ +F L+
Sbjct: 119 -KEVMFTEEDVKFYLA-ELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + +   E +        GT  YMAPE +     +   D ++FGVLM EML+G
Sbjct: 174 KESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 114/263 (43%), Gaps = 49/263 (18%)
Query: 362 GSVY--RGKIGGDFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGG 409
           G+VY  R     + VAIKK+          + D   +++ L K+ H + I+  G      
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 410 NWYLVYENAVNGSLS--VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
             +LV E  + GS S  + ++ K  + ++ A     AL    GL YLHS      +H+D+
Sbjct: 89  TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNM---IHRDV 141
Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY---LENGLVSTK 524
           K  N+LL      K+ +F  A          A  +  VGT  +MAPE    ++ G    K
Sbjct: 142 KAGNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
           +DV++ G+  +E+   K  P L+   NM  +  L  +   E           P++Q  + 
Sbjct: 195 VDVWSLGITCIELAERK--PPLF---NMNAMSALYHIAQNE----------SPALQSGH- 238
Query: 585 PVTAILVIRLIESCLKKDPSGRP 607
              +      ++SCL+K P  RP
Sbjct: 239 --WSEYFRNFVDSCLQKIPQDRP 259

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 153 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 188 DIXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 242 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 284
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 285 QRPTFSELVEHLGNLLQAN 303

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 379 VYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWA 438
           V G    +I+ L    H  +I+L  +     ++++V E    G L  +I  K G+  +  
Sbjct: 54  VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEME 112
Query: 439 QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
            R ++   + + ++Y H       VH+D+K  NVLLD    AKIA+F L+      +GEF
Sbjct: 113 AR-RLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEF 166
Query: 499 ALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
              S   G+  Y APE +   L +  ++D+++ GV++  +L G
Sbjct: 167 LRDS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL +LHS      V++D+K  N+LLD D   KIA+F + +  E   G+ A T+ 
Sbjct: 124 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGD-AKTNX 177
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
             GT  Y+APE L     +  +D ++FGVL+ EML G+       EE + 
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 135 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 135 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 141 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 9/158 (5%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVNGSLSVWIND--KGGKFLDWAQRI 441
           ++ LL ++ H +++R      +  N   Y+V E    G L+  I    K  ++LD    +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 442 QIALDVATGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           ++   +   L   H  ++  H  +H+D+K +NV LD     K+ +F LAR     +  FA
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFA 173
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
            T   VGT  YM+PE +     + K D+++ G L+ E+
Sbjct: 174 KT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 234 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 288 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 330
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 331 QRPTFSELVEHLGNLLQAN 349

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 138 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 20/178 (11%)
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA----LARP 490
           LD +    I  +V  GL YLH       +H+D+K  N+LL  D   +IA+F     LA  
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATG 169
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
            +    +   T   VGT  +MAPE +E       K D+++FG+  +E+ +G      Y  
Sbjct: 170 GDITRNKVRKT--FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 227
Query: 550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
             +L++ + N     E G      + D  M   Y         ++I  CL+KDP  RP
Sbjct: 228 MKVLMLTLQNDPPSLETG------VQDKEMLKKYGKSFR----KMISLCLQKDPEKRP 275

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 139 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 130 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 153 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 131 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 131 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 55/290 (18%)
Query: 364 VYRGKIGGDFVAIKKVYGD----ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENA 418
           VYRG      VA+K++  +    A  +++LL + + H ++IR      +    Y+  E  
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE-L 99
Query: 419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-- 476
              +L  ++  K    L   + I +     +GL +LHS      VH+D+K  N+L+    
Sbjct: 100 CAATLQEYVEQKDFAHLGL-EPITLLQQTTSGLAHLHSLNI---VHRDLKPHNILISMPN 155
Query: 477 ---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST---KLDVYAF 530
                +A I++F L +        F+  S + GT+G++APE L           +D+++ 
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 531 GVLMLEMLSGKEAP---ALYSEENMLL----VDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
           G +   ++S    P   +L  + N+LL    +D L+P  H++                  
Sbjct: 216 GCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED------------------ 257
Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
                ++   LIE  +  DP  RP+   +       L     W L K + 
Sbjct: 258 -----VIARELIEKMIAMDPQKRPSAKHV-------LKHPFFWSLEKQLQ 295

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+L++T    KI +F LAR A+ +       +  V 
Sbjct: 153 ILRGLKYIHSANV---LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 197 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 251 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 294 QRPTFSELVEHLGNLLQAN 312

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 20/178 (11%)
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA----LARP 490
           LD +    I  +V  GL YLH       +H+D+K  N+LL  D   +IA+F     LA  
Sbjct: 118 LDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSE 549
            +    +   T   VGT  +MAPE +E       K D+++FG+  +E+ +G      Y  
Sbjct: 175 GDITRNKVRKT--FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
             +L++ + N     E G      + D  M   Y         ++I  CL+KDP  RP
Sbjct: 233 MKVLMLTLQNDPPSLETG------VQDKEMLKKYGKSFR----KMISLCLQKDPEKRP 280

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+         +  V 
Sbjct: 135 ILRGLKYIHSANV---LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTA-EIV 142
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANSFV 195
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L     S   D++A G ++ ++++G
Sbjct: 196 GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 188 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
                   + +D           EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 242 Y-----PGVKID-----------EEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 284
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 285 QRPTFSELVEHLGNLLQAN 303

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 47/259 (18%)
Query: 386 QIKLLNKINHS-SLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWA----- 438
           ++K+L  I H  +++ LLG C   GG   ++ E    G+LS ++  K  +F+ +      
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 439 ---------QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                      I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 490 -----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P
Sbjct: 188 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 545 ALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS 604
             Y    +               EE  R L +   +   P  T   + + +  C   +PS
Sbjct: 242 --YPGVKI--------------DEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPS 284
Query: 605 GRPAMDKIAQSISRFLNAS 623
            RP   ++ + +   L A+
Sbjct: 285 QRPTFSELVEHLGNLLQAN 303

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 371 GDFVAIKKVYGDASDQIKLL-NKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSL 423
           G  VA+KK+      + +LL N++       H +++ +      G   ++V E    G+L
Sbjct: 54  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 113
Query: 424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
           +  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D R K++
Sbjct: 114 TDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 167
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           +F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+ G+  
Sbjct: 168 DFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-- 222
Query: 544 PALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           P  ++E  +    ++ D L P L          H + PS++G             ++  L
Sbjct: 223 PPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLDRLL 263
Query: 600 KKDPSGR 606
            +DP+ R
Sbjct: 264 VRDPAQR 270

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG--------GKFLD 436
           ++K+++ +  H +++ LLG C +GG   ++ E    G L  ++  K         G+ L+
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
               +  +  VA G+ +L S      +H+D+   NVLL     AKI +F LAR     + 
Sbjct: 151 LRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDS 206
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + +  +      +MAPE + + + + + DV+++G+L+ E+ S
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 371 GDFVAIKKVYGDASDQIKLL-NKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSL 423
           G  VA+KK+      + +LL N++       H +++ +      G   ++V E    G+L
Sbjct: 99  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158
Query: 424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
           +  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D R K++
Sbjct: 159 TDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 212
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           +F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+ G+  
Sbjct: 213 DFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-- 267
Query: 544 PALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           P  ++E  +    ++ D L P L          H + PS++G             ++  L
Sbjct: 268 PPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLDRLL 308
Query: 600 KKDPSGR 606
            +DP+ R
Sbjct: 309 VRDPAQR 315

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 371 GDFVAIKKVYGDASDQIKLL-NKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSL 423
           G  VA+KK+      + +LL N++       H +++ +      G   ++V E    G+L
Sbjct: 56  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 115
Query: 424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
           +  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D R K++
Sbjct: 116 TDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 169
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           +F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+ G+  
Sbjct: 170 DFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-- 224
Query: 544 PALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           P  ++E  +    ++ D L P L          H + PS++G             ++  L
Sbjct: 225 PPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLDRLL 265
Query: 600 KKDPSGR 606
            +DP+ R
Sbjct: 266 VRDPAQR 272

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y V E    G L   I  + G+F +    +  A ++A GL +L S      +++D+K  N
Sbjct: 418 YFVMEYVNGGDLMYHIQ-QVGRFKE-PHAVFYAAEIAIGLFFLQSKGI---IYRDLKLDN 472
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           V+LD++   KIA+F + +       +   T    GT  Y+APE +        +D +AFG
Sbjct: 473 VMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529
Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLN 559
           VL+ EML+G +AP    +E+ L   ++ 
Sbjct: 530 VLLYEMLAG-QAPFEGEDEDELFQSIME 556

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 375 AIKKVYGDASDQIK------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
            +KK      D+++      +L ++NH  +++L       G  YL+ +    G L   ++
Sbjct: 60  VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 119
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            K   F +   +  +A ++A  L++LHS      +++D+K  N+LLD +   K+ +F L+
Sbjct: 120 -KEVMFTEEDVKFYLA-ELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLS 174
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + +   E +        GT  YMAPE +     +   D ++FGVLM EML+G
Sbjct: 175 KESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 375 AIKKVYGDASDQIK------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
            +KK      D+++      +L ++NH  +++L       G  YL+ +    G L   ++
Sbjct: 59  VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            K   F +   +  +A ++A  L++LHS      +++D+K  N+LLD +   K+ +F L+
Sbjct: 119 -KEVMFTEEDVKFYLA-ELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + +   E +        GT  YMAPE +     +   D ++FGVLM EML+G
Sbjct: 174 KESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG--------GKFLD 436
           ++K+++ +  H +++ LLG C +GG   ++ E    G L  ++  K         G+ L+
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
               +  +  VA G+ +L S      +H+D+   NVLL     AKI +F LAR     + 
Sbjct: 159 LRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDS 214
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
            + +  +      +MAPE + + + + + DV+++G+L+ E+ S
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
             +++K+  ++ H S++ L     +    YLV E   NG ++ ++ ++   F +   R  
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-H 116
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER-QEGEFALT 501
               + TG+ YLHS      +H+D+  SN+LL  +   KIA+F LA   +   E  + L 
Sbjct: 117 FMHQIITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL- 172
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
               GT  Y++PE         + DV++ G +   +L G+  P   ++    + + LN V
Sbjct: 173 ---CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR--PPFDTDT---VKNTLNKV 224
Query: 562 LHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           +           L D  M    P   +I    LI   L+++P+ R ++  +
Sbjct: 225 V-----------LADYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSV 260

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+LL+T    KI +F LAR A+            V 
Sbjct: 138 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
           T+ Y APE + N    TK +D+++ G ++ EMLS +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 374 VAIKKVY-------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW 426
           VAIKK+          A  +IK++ +++H +++++  I    G+       ++    SV+
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 427 INDK-----------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           I  +            G  L+   R+     +  GL Y+HS      +H+D+K +N+ ++
Sbjct: 99  IVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKYIHSANV---LHRDLKPANLFIN 154
Query: 476 T-DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVL 533
           T D   KI +F LAR  +         S  + TK Y +P  L +    TK +D++A G +
Sbjct: 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 214
Query: 534 MLEMLSGKEAPALYSE-ENMLLVDVLNPVLHKEDGEESL 571
             EML+GK   A   E E M L+    PV+H+ED +E L
Sbjct: 215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 18/179 (10%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++LL K++H ++++L  I  +  ++Y+V E    G L   I  +  K        +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTS 502
            V +G+ Y+H       VH+D+K  N+LL++   D   KI +F L+   ++         
Sbjct: 129 QVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMK 181
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
             +GT  Y+APE L  G    K DV++ GV++  +LSG   P  Y +      D+L  V
Sbjct: 182 DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEY---DILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 18/179 (10%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++LL K++H ++++L  I  +  ++Y+V E    G L   I  +  K        +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTS 502
            V +G+ Y+H       VH+D+K  N+LL++   D   KI +F L+   ++         
Sbjct: 129 QVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMK 181
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV 561
             +GT  Y+APE L  G    K DV++ GV++  +LSG   P  Y +      D+L  V
Sbjct: 182 DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEY---DILKRV 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           ++++++H   ++L   CF +    Y     A NG L  +I  K G F +   R   A ++
Sbjct: 90  VMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EI 146
Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHI 504
            + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  
Sbjct: 147 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXF 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           VGT  Y++PE L         D++A G ++ ++++G
Sbjct: 200 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 33/198 (16%)
Query: 362 GSVYRGKIG-GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ K   G  VA+K++  DA D+         I LL +++H +++ L+ +  +    
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIK 468
            LV+E        V   +K G      Q  QI +    +  G+ + H       +H+D+K
Sbjct: 95  TLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQLLRGVAHCHQHRI---LHRDLK 146
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYLE-NGLVST 523
             N+L+++D   K+A+F LAR        F +     +H V T  Y AP+ L  +   ST
Sbjct: 147 PQNLLINSDGALKLADFGLAR-------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 524 KLDVYAFGVLMLEMLSGK 541
            +D+++ G +  EM++GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           +++ ++    H +++ +      G   +++ E    G+L+  ++      L+  Q   + 
Sbjct: 91  NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVC 147
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V   L YLH+      +H+DIK  ++LL  D R K+++F       +   +      +
Sbjct: 148 EAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKXL 201
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
           VGT  +MAPE +   L +T++D+++ G++++EM+ G+  P  +S+         +PV   
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE--PPYFSD---------SPV--- 247
Query: 565 EDGEESLRHLMD--PSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
               ++++ L D  P    N   V+ +L    +E  L +DP  R
Sbjct: 248 ----QAMKRLRDSPPPKLKNSHKVSPVLR-DFLERMLVRDPQER 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 371 GDFVAIKKVYGDASDQIKLL-NKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSL 423
           G  VA+KK+      + +LL N++       H +++ +      G   ++V E    G+L
Sbjct: 49  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 108
Query: 424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
           +  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D R K++
Sbjct: 109 TDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 162
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           +F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+ G+  
Sbjct: 163 DFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-- 217
Query: 544 PALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           P  ++E  +    ++ D L P L          H + PS++G             ++  L
Sbjct: 218 PPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLDRLL 258
Query: 600 KKDPSGR 606
            +DP+ R
Sbjct: 259 VRDPAQR 265

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 33/198 (16%)
Query: 362 GSVYRGKIG-GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ K   G  VA+K++  DA D+         I LL +++H +++ L+ +  +    
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIK 468
            LV+E        V   +K G      Q  QI +    +  G+ + H       +H+D+K
Sbjct: 95  TLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQLLRGVAHCHQHRI---LHRDLK 146
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALT----SHIVGTKGYMAPEYLE-NGLVST 523
             N+L+++D   K+A+F LAR        F +     +H V T  Y AP+ L  +   ST
Sbjct: 147 PQNLLINSDGALKLADFGLAR-------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 524 KLDVYAFGVLMLEMLSGK 541
            +D+++ G +  EM++GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 111/247 (44%), Gaps = 41/247 (16%)
Query: 371 GDFVAIKKVYGDASDQIKLL-NKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSL 423
           G  VA+KK+      + +LL N++       H +++ +      G   ++V E    G+L
Sbjct: 45  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
           +  +       ++  Q   + L V   L+ LH+      +H+DIK  ++LL  D R K++
Sbjct: 105 TDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 158
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA 543
           +F       +   E      +VGT  +MAPE +       ++D+++ G++++EM+ G+  
Sbjct: 159 DFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-- 213
Query: 544 PALYSEENM----LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
           P  ++E  +    ++ D L P L          H + PS++G             ++  L
Sbjct: 214 PPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLDRLL 254
Query: 600 KKDPSGR 606
            +DP+ R
Sbjct: 255 VRDPAQR 261

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 14/185 (7%)
Query: 375 AIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           A+K       ++I +L KI H +++ L  I  +  + YLV +    G L   I +KG  F
Sbjct: 59  ALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG--F 116
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPA 491
                   +   V   + YLH       VH+D+K  N+L    D + +  I++F L++  
Sbjct: 117 YTEKDASTLIRQVLDAVYYLHRMGI---VHRDLKPENLLYYSQDEESKIMISDFGLSK-- 171
Query: 492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN 551
              EG+  + S   GT GY+APE L     S  +D ++ GV+   +L G   P  Y E +
Sbjct: 172 --MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG--YPPFYDEND 227
Query: 552 MLLVD 556
             L +
Sbjct: 228 SKLFE 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 14/185 (7%)
Query: 360 IKGSVY-RGKIGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA 418
           IK S + +G+   D   I+K + +  ++I LL  ++H ++I+L  +  +   +YLV E  
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD- 477
             G L   I ++  KF D      I   + +G+ YLH       VH+DIK  N+LL+   
Sbjct: 129 EGGELFEQIINR-HKF-DECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKN 183
Query: 478 --FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
                KI +F L+    +   ++ L   + GT  Y+APE L+    + K DV++ GV+M 
Sbjct: 184 SLLNIKIVDFGLSSFFSK---DYKLRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMY 238
Query: 536 EMLSG 540
            +L G
Sbjct: 239 ILLCG 243

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 94/191 (49%), Gaps = 26/191 (13%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI---- 441
           ++++L++ N   ++   G  ++ G   +  E+   GSL         + L  A+RI    
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKEAKRIPEEI 115
Query: 442 --QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF- 498
             ++++ V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+  
Sbjct: 116 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLI 166
Query: 499 -ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
            ++ +  VGT+ YMAPE L+    S + D+++ G+ ++E+  G+  P    +   L    
Sbjct: 167 DSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR-YPIPPPDAKELEAIF 225
Query: 558 LNPVLHKEDGE 568
             PV+  E+GE
Sbjct: 226 GRPVVDGEEGE 236

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/237 (21%), Positives = 102/237 (43%), Gaps = 28/237 (11%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++  + H  L++L  +       Y++ E    GSL  ++    G      + I  +  +A
Sbjct: 236 VMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 295 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPI 349
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GK-EAPALYSEENMLLVDVLNPVLHKED 566
            + APE +  G  + K DV++FG+L++E+++ G+   P + + E +  ++    +   E+
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             E L ++M                      C K  P  RP  + I   +  F  A+
Sbjct: 410 CPEELYNIM--------------------MRCWKNRPEERPTFEYIQSVLDDFYTAT 446

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++LL K++H ++++L  I  +  ++Y+V E    G L   I  +  K        +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTS 502
            V +G+ Y+H       VH+D+K  N+LL++   D   KI +F L+   ++         
Sbjct: 129 QVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMK 181
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY 547
             +GT  Y+APE L  G    K DV++ GV++  +LSG   P  Y
Sbjct: 182 DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG--TPPFY 223

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 63  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 120
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 121 SALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 173
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++  + H  L++L  +       Y++ E    GSL  ++    G      + I  +  +A
Sbjct: 63  VMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 121
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR  E  + E+          
Sbjct: 122 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPI 176
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP 544
            + APE +  G  + K DV++FG+L++E+++    P
Sbjct: 177 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y V E    G L   I  + G+F +    +  A ++A GL +L S      +++D+K  N
Sbjct: 97  YFVMEYVNGGDLMYHIQ-QVGRFKE-PHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDN 151
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           V+LD++   KIA+F + +       +   T    GT  Y+APE +        +D +AFG
Sbjct: 152 VMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFG 208
Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLN 559
           VL+ EML+G +AP    +E+ L   ++ 
Sbjct: 209 VLLYEMLAG-QAPFEGEDEDELFQSIME 235

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 350 ATDDFNPSCWIK----GSVYRGK--IGGDFVAIKKVYGDASDQ------------IKLLN 391
           AT  + P   I     G+VY+ +    G FVA+K V     ++            ++ L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 392 KINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
              H +++RL+ +C            LV+E+ V+  L  +++      L       +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
              GL++LH+      VH+D+K  N+L+ +    K+A+F LAR    Q   F     +V 
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP----VVV 173
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T  Y APE L     +T +D+++ G +  EM   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 32/196 (16%)
Query: 363 SVYRGKIGGDFVAIKKVY---------GDASDQIKLLNKINHSSLIRLLGI------CFN 407
           S   G+ G   VAIKK+Y           A  +++LL  + H ++I LL +        +
Sbjct: 43  SAVDGRTGAK-VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101
Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKD 466
             ++YLV          +  ++K G+      RIQ +   +  GL Y+H+      +H+D
Sbjct: 102 FTDFYLVMPFMGTDLGKLMKHEKLGE-----DRIQFLVYQMLKGLRYIHAAGI---IHRD 153
Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-L 525
           +K  N+ ++ D   KI +F LAR A+ +          V T+ Y APE + N +  T+ +
Sbjct: 154 LKPGNLAVNEDCELKILDFGLARQADSE------MXGXVVTRWYRAPEVILNWMRYTQTV 207
Query: 526 DVYAFGVLMLEMLSGK 541
           D+++ G +M EM++GK
Sbjct: 208 DIWSVGCIMAEMITGK 223

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 27/165 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIA 444
           +++LL +++H ++++L     + G +YLV E    G L    I+ K    +D A+ I+  
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-- 133
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V +G+ Y+H       VH+D+K  N+LL++  ++K AN  +         +F L++H 
Sbjct: 134 -QVLSGITYMH---KNKIVHRDLKPENLLLES--KSKDANIRII--------DFGLSTHF 179
Query: 505 ---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    +GT  Y+APE L +G    K DV++ GV++  +LSG
Sbjct: 180 EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 85/164 (51%), Gaps = 18/164 (10%)
Query: 376 IKKVYGDASDQIKLLNKINHSSLIRLLGICF--NGGNWYLVYENAVNGSLSVWINDKGGK 433
           I++VY     +I +L K++H ++++L+ +    N  + Y+V+E    G +   +     K
Sbjct: 80  IEQVY----QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLK 132
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER 493
            L   Q      D+  G+ YLH       +H+DIK SN+L+  D   KIA+F ++     
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSN---E 186
Query: 494 QEGEFALTSHIVGTKGYMAPEYLE--NGLVSTK-LDVYAFGVLM 534
            +G  AL S+ VGT  +MAPE L     + S K LDV+A GV +
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 26/256 (10%)
Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVN 420
           G+ VA+K +      Q        I++L  + H  +++  G C + G  +  LV E    
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++       +  AQ +  A  +  G+ YLH+     ++H+ +   NVLLD D   
Sbjct: 98  GSLRDYLPRH---CVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLV 151
Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           KI +F LA+        + +         + APE L+        DV++FGV + E+L+ 
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT- 210
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN---YPPVTAILVIRLIES 597
                 Y + N         ++    G+ ++  L +   +G     P      +  L+++
Sbjct: 211 ------YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKN 264
Query: 598 CLKKDPSGRPAMDKIA 613
           C + + S RP    + 
Sbjct: 265 CWETEASFRPTFQNLV 280

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 27/165 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIA 444
           +++LL +++H ++++L     + G +YLV E    G L    I+ K    +D A+ I+  
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-- 139
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V +G+ Y+H       VH+D+K  N+LL++  ++K AN  +         +F L++H 
Sbjct: 140 -QVLSGITYMH---KNKIVHRDLKPENLLLES--KSKDANIRII--------DFGLSTHF 185
Query: 505 ---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    +GT  Y+APE L +G    K DV++ GV++  +LSG
Sbjct: 186 EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 60  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 117
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 118 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 170
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 29/177 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGN------------WYLVYENAVNGSLSVWINDKGGK 433
           ++K L K+ H  ++R                       Y+  +     +L  W+N  G  
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRC 110
Query: 434 FLDWAQR---IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
            ++  +R   + I L +A  + +LHS      +H+D+K SN+    D   K+ +F L   
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 491 AERQEGE---------FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML 538
            ++ E E         +A  +  VGTK YM+PE +     S K+D+++ G+++ E+L
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 118
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 171
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 27/165 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIA 444
           +++LL +++H ++++L     + G +YLV E    G L    I+ K    +D A+ I+  
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-- 156
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V +G+ Y+H       VH+D+K  N+LL++  ++K AN  +         +F L++H 
Sbjct: 157 -QVLSGITYMH---KNKIVHRDLKPENLLLES--KSKDANIRII--------DFGLSTHF 202
Query: 505 ---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    +GT  Y+APE L +G    K DV++ GV++  +LSG
Sbjct: 203 EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L+ L   CF   +        VNG   ++   +  K  +   R   A +++  LNY
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 121
Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
           LH       +++D+K  NVLLD++   K+ ++ + +   R  G+   TS   GT  Y+AP
Sbjct: 122 LHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD--TTSXFCGTPNYIAP 175
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           E L        +D +A GVLM EM++G+
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L+ L   CF   +        VNG   ++   +  K  +   R   A +++  LNY
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 125
Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
           LH       +++D+K  NVLLD++   K+ ++ + +   R  G+   TS   GT  Y+AP
Sbjct: 126 LHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGD--TTSXFCGTPNYIAP 179
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           E L        +D +A GVLM EM++G+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 140
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 193
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 62  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 119
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 120 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 172
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 140
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 193
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 27/165 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIA 444
           +++LL +++H ++++L     + G +YLV E    G L    I+ K    +D A+ I+  
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-- 157
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V +G+ Y+H       VH+D+K  N+LL++  ++K AN  +         +F L++H 
Sbjct: 158 -QVLSGITYMH---KNKIVHRDLKPENLLLES--KSKDANIRII--------DFGLSTHF 203
Query: 505 ---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    +GT  Y+APE L +G    K DV++ GV++  +LSG
Sbjct: 204 EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L+ L   CF   +        VNG   ++   +  K  +   R   A +++  LNY
Sbjct: 79  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 136
Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
           LH       +++D+K  NVLLD++   K+ ++ + +   R  G+   TS   GT  Y+AP
Sbjct: 137 LHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD--TTSXFCGTPNYIAP 190
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           E L        +D +A GVLM EM++G+
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 140
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 193
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 143
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 144 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 196
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 143
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 144 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANSFV 196
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 9/158 (5%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGN--WYLVYENAVNGSLSVWIND--KGGKFLDWAQRI 441
           ++ LL ++ H +++R      +  N   Y+V E    G L+  I    K  ++LD    +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 442 QIALDVATGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
           ++   +   L   H  ++  H  +H+D+K +NV LD     K+ +F LAR       + +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DTS 171
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
                VGT  YM+PE +     + K D+++ G L+ E+
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 26/256 (10%)
Query: 371 GDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVN 420
           G+ VA+K +      Q        I++L  + H  +++  G C + G  +  LV E    
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           GSL  ++       +  AQ +  A  +  G+ YLH+     ++H+ +   NVLLD D   
Sbjct: 97  GSLRDYLPRH---CVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLV 150
Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           KI +F LA+        + +         + APE L+        DV++FGV + E+L+ 
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT- 209
Query: 541 KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN---YPPVTAILVIRLIES 597
                 Y + N         ++    G+ ++  L +   +G     P      +  L+++
Sbjct: 210 ------YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKN 263
Query: 598 CLKKDPSGRPAMDKIA 613
           C + + S RP    + 
Sbjct: 264 CWETEASFRPTFQNLV 279

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 394 NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNY 453
           NH  L+ L   CF   +        VNG   ++   +  K  +   R   A +++  LNY
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNY 168
Query: 454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
           LH       +++D+K  NVLLD++   K+ ++ + +   R  G+   TS   GT  Y+AP
Sbjct: 169 LHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD--TTSTFCGTPNYIAP 222
Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           E L        +D +A GVLM EM++G+
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 142
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 195
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 88  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 145
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 146 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 198
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 199 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 44/212 (20%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLNKIN--------HSSLIRLL----GICFNGG 409
           G+VY+G +    VA+K V+  A+ Q   +N+ N        H ++ R +     +  +G 
Sbjct: 27  GAVYKGSLDERPVAVK-VFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84
Query: 410 NWYL-VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS------FTNPPH 462
             YL V E   NGSL  +++       DW    ++A  V  GL YLH+         P  
Sbjct: 85  MEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALA---------RPAERQEGEFALTSHIVGTKGYMAP 513
            H+D+   NVL+  D    I++F L+         RP E  E   A++   VGT  YMAP
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE--EDNAAISE--VGTIRYMAP 197
Query: 514 EYLENGL-------VSTKLDVYAFGVLMLEML 538
           E LE  +          ++D+YA G++  E+ 
Sbjct: 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 142
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 195
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 142
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 195
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 196 GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 142
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 195
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 142
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 195
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 67  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 124
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 125 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 177
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 139
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 140 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANXFV 192
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 139
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 140 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANSFV 192
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++++++H   ++L     +    Y     A NG L  +I  K G F +   R   A ++ 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIV 140
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---PAERQEGEFALTSHIV 505
           + L YLH       +H+D+K  N+LL+ D   +I +F  A+   P  +Q    A  +  V
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ----ARANAFV 193
Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L         D++A G ++ ++++G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 33/243 (13%)
Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRGK--IGGDFVAIK 377
           DEE  + L  I  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 3   DEEILEKLRIIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 52
Query: 378 KVYGDAS-------DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++            ++I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 53  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 112
Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H++IK  N+LL  D   K+ +F     
Sbjct: 113 ---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQ 166
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
              ++ +    S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 167 ITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 220
Query: 551 NML 553
           N L
Sbjct: 221 NPL 223

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 118 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKX 169
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 222
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 223 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKX 164
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 217
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 218 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 174
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 175 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 224
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKX 164
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 217
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 218 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKX 164
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 217
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 218 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 124/278 (44%), Gaps = 53/278 (19%)
Query: 362 GSVYRGKIGGDFVAIK---------KVYGDASDQIKLLNKINHSSLIRLLGICFN--GGN 410
           G +++G+  G+ + +K         +   D +++   L   +H +++ +LG C +    +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTN--PPHVHKDIK 468
             L+      GSL   +++     +D +Q ++ ALD+A G+ +LH+     P H    + 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA---LN 140
Query: 469 CSNVLLDTDFRAKIA----NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
             +V++D D  A+I+     F+   P              +    ++APE L+     T 
Sbjct: 141 SRSVMIDEDMTARISMADVKFSFQSPGR------------MYAPAWVAPEALQKKPEDTN 188
Query: 525 ---LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
               D+++F VL+ E+++ +E P           D+ N  +  +   E LR    P++  
Sbjct: 189 RRSADMWSFAVLLWELVT-REVP---------FADLSNMEIGMKVALEGLR----PTI-- 232
Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
             PP  +  V +L++ C+ +DP+ RP  D I   + + 
Sbjct: 233 --PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 116 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKT 167
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 220
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 221 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKT 164
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 217
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 218 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 30/163 (18%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH 503
           ++ + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A    
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKT 164
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
             GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++++  L +++     
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELI----- 217
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                     LM+   +  +P   +     L+   LKKDP  R
Sbjct: 218 ----------LME---EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/251 (21%), Positives = 112/251 (44%), Gaps = 45/251 (17%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+    + + 
Sbjct: 116 -VIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDEMANE 165
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+     Y    M + ++L+ ++ 
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR-----YPRPPMAIFELLDYIV- 219
Query: 564 KEDGEESLRHLMDPSMQGNYPP------VTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                             N PP      V ++     +  CL K+P+ R  + ++   + 
Sbjct: 220 ------------------NEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLM--VH 259
Query: 618 RFLNASLAWEL 628
            F+  S A E+
Sbjct: 260 AFIKRSDAEEV 270

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 99/202 (49%), Gaps = 28/202 (13%)
Query: 370 GGDFVA--IKKVYGDASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVW 426
           GG F A  ++++      ++ +L K++ H ++I+L         ++LV++    G L  +
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY 114
Query: 427 INDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           + +K        ++I  AL +V   L+ L+       VH+D+K  N+LLD D   K+ +F
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNI------VHRDLKPENILLDDDMNIKLTDF 168
Query: 486 ALA---RPAERQEGEFALTSHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLMLE 536
             +    P E+          + GT  Y+APE +E  +         ++D+++ GV+M  
Sbjct: 169 GFSCQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 537 MLSGKEAPALYSEENMLLVDVL 558
           +L+G  +P  +  + ML++ ++
Sbjct: 222 LLAG--SPPFWHRKQMLMLRMI 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 350 ATDDFNPSCWIK----GSVYRGK--IGGDFVAIKKVYGDASDQ------------IKLLN 391
           AT  + P   I     G+VY+ +    G FVA+K V     ++            ++ L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 392 KINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
              H +++RL+ +C            LV+E+ V+  L  +++      L       +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
              GL++LH+      VH+D+K  N+L+ +    K+A+F LAR    Q    AL   +V 
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAP-VVV 173
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T  Y APE L     +T +D+++ G +  EM   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 99/202 (49%), Gaps = 28/202 (13%)
Query: 370 GGDFVA--IKKVYGDASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVW 426
           GG F A  ++++      ++ +L K++ H ++I+L         ++LV++    G L  +
Sbjct: 42  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY 101
Query: 427 INDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           + +K        ++I  AL +V   L+ L+       VH+D+K  N+LLD D   K+ +F
Sbjct: 102 LTEKVTLSEKETRKIMRALLEVICALHKLNI------VHRDLKPENILLDDDMNIKLTDF 155
Query: 486 ALA---RPAERQEGEFALTSHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLMLE 536
             +    P E+          + GT  Y+APE +E  +         ++D+++ GV+M  
Sbjct: 156 GFSCQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 208
Query: 537 MLSGKEAPALYSEENMLLVDVL 558
           +L+G  +P  +  + ML++ ++
Sbjct: 209 LLAG--SPPFWHRKQMLMLRMI 228

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 112/244 (45%), Gaps = 34/244 (13%)
Query: 314 EKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVYR--G 367
           +K    +LDE+ R  LE+   + Q  KV   ++     DDF     +     G V++   
Sbjct: 2   KKLEELELDEQQRKRLEAF--LTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSH 54
Query: 368 KIGGDFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGGNWYLVYENAV 419
           K  G  +A K ++ +    I+        +L++ N   ++   G  ++ G   +  E+  
Sbjct: 55  KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
            GSL   +   G        ++ IA  V  GL YL        +H+D+K SN+L+++   
Sbjct: 115 GGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHKI--MHRDVKPSNILVNSRGE 170
Query: 480 AKIANFALARPAERQEGEF--ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
            K+ +F ++       G+   ++ +  VGT+ YM+PE L+    S + D+++ G+ ++EM
Sbjct: 171 IKLCDFGVS-------GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 538 LSGK 541
             G+
Sbjct: 224 AVGR 227

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 362 GSVYRGKIGGDFVAIKKVYG--DAS----DQIKLLNKINHSSLIRLLGICFNG-GNW--- 411
           G V+ GK  G+ VA+K  +   +AS     +I     + H +++  +     G G+W   
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FT---NPPHVHKD 466
           YL+ +   NGSL  ++       LD    +++A    +GL +LH+  F+    P   H+D
Sbjct: 111 YLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI-VGTKGYMAPEYLENGLVSTKL 525
           +K  N+L+  +    IA+  LA        E  +  +  VGTK YM PE L+  L     
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 526 ------DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL-RHLMDPS 578
                 D+Y+FG+++ E+     +  +  E  +   D++      ED  E +    + PS
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS 287
Query: 579 MQGNYPPVTAILVI-RLIESCLKKDPSGRPAMDKIAQSISRF 619
               +     +  + +L+  C   +P+ R    ++ +++++ 
Sbjct: 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G    +VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 350 ATDDFNPSCWIK----GSVYRGK--IGGDFVAIKKVYGDASDQ------------IKLLN 391
           AT  + P   I     G+VY+ +    G FVA+K V     ++            ++ L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 392 KINHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
              H +++RL+ +C            LV+E+ V+  L  +++      L       +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
              GL++LH+      VH+D+K  N+L+ +    K+A+F LAR    Q    AL   +V 
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDP-VVV 173
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T  Y APE L     +T +D+++ G +  EM   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI--NDKGGKFLDWAQRIQI 443
           +I++L  ++H ++I++  +  +  N Y+V E    G L   I      GK L      ++
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 444 ALDVATGLNYLHSFTNPPH-VHKDIKCSNVLL-DTDFRA--KIANFALARPAERQEGEFA 499
              +   L Y HS     H VHKD+K  N+L  DT   +  KI +F LA   +  E    
Sbjct: 130 MKQMMNALAYFHS----QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--- 182
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
            +++  GT  YMAPE  +   V+ K D+++ GV+M  +L+G             L +V  
Sbjct: 183 -STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG-----CLPFTGTSLEEVQQ 235
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
              +KE           P+      P+T    + L++  L KDP  RP+  ++
Sbjct: 236 KATYKE-----------PNYAVECRPLTP-QAVDLLKQMLTKDPERRPSAAQV 276

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 99/202 (49%), Gaps = 28/202 (13%)
Query: 370 GGDFVA--IKKVYGDASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVW 426
           GG F A  ++++      ++ +L K++ H ++I+L         ++LV++    G L  +
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY 114
Query: 427 INDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
           + +K        ++I  AL +V   L+ L+       VH+D+K  N+LLD D   K+ +F
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNI------VHRDLKPENILLDDDMNIKLTDF 168
Query: 486 ALA---RPAERQEGEFALTSHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLMLE 536
             +    P E+          + GT  Y+APE +E  +         ++D+++ GV+M  
Sbjct: 169 GFSCQLDPGEKLRS-------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 537 MLSGKEAPALYSEENMLLVDVL 558
           +L+G  +P  +  + ML++ ++
Sbjct: 222 LLAG--SPPFWHRKQMLMLRMI 241

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/240 (21%), Positives = 101/240 (42%), Gaps = 44/240 (18%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           ++  + H  L++L  +       Y++ E    GSL  ++    G      + I  +  +A
Sbjct: 230 VMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 288
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
            G+ ++       ++H+D++ +N+L+      KIA+F LAR               VG K
Sbjct: 289 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR---------------VGAK 330
Query: 509 ---GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GK-EAPALYSEENMLLVDVLNPVLH 563
               + APE +  G  + K DV++FG+L++E+++ G+   P + + E +  ++    +  
Sbjct: 331 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 390
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            E+  E L ++M                      C K  P  RP  + I   +  F  A+
Sbjct: 391 PENCPEELYNIM--------------------MRCWKNRPEERPTFEYIQSVLDDFYTAT 430

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 113 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 162
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 113 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 162
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 350 ATDDFNPSCWIK----GSVYRGK--IGGDFVAIKKVYG------------DASDQIKLLN 391
           AT  + P   I     G+VY+ +    G FVA+K V                  ++ LL 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 392 KIN---HSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI 443
           ++    H +++RL+ +C            LV+E+ V+  L  +++      L       +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
                 GL++LH+      VH+D+K  N+L+ +    K+A+F LAR    Q    ALT  
Sbjct: 126 MRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTP- 178
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +V T  Y APE L     +T +D+++ G +  EM   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 113 -VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 162
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +L ++ H  ++ L+     GG  YL+ E    G L + + ++ G F++      +A +++
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLA-EIS 131
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L +LH       +++D+K  N++L+     K+ +F L + +     +  +T    GT 
Sbjct: 132 MALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH---DGTVTHXFCGTI 185
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD 556
            YMAPE L     +  +D ++ G LM +ML+G  AP    E     +D
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTG--APPFTGENRKKTID 231

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 435 LDWAQRIQIALDVATGLNYLH-----SFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
           LD    ++I L +A+GL +LH     +   P   H+D+K  N+L+  + +  IA+  LA 
Sbjct: 131 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 190
Query: 490 PAERQEGEFALTSH-IVGTKGYMAPEYLENGLVS------TKLDVYAFGVLMLEMLSGKE 542
              +   +  + ++  VGTK YMAPE L+  +         ++D++AFG+++ E+     
Sbjct: 191 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV----- 245
Query: 543 APALYSEENMLLVDVLNP---VLHKEDGEESLRHLM-----DPSMQGNY---PPVTAILV 591
             A     N ++ D   P   V+  +   E +R ++      P++   +   P +T++  
Sbjct: 246 --ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-- 301
Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRF 619
            +L++ C  ++PS R    +I +++++ 
Sbjct: 302 AKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +L ++ H  ++ L+     GG  YL+ E    G L + + ++ G F++      +A +++
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLA-EIS 131
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L +LH       +++D+K  N++L+     K+ +F L + +     +  +T    GT 
Sbjct: 132 MALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH---DGTVTHTFCGTI 185
Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD 556
            YMAPE L     +  +D ++ G LM +ML+G  AP    E     +D
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTG--APPFTGENRKKTID 231

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/251 (21%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 131
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 132 -VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 181
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+  P      +M + ++L+ ++ 
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR-YPIGSGSGSMAIFELLDYIV- 239
Query: 564 KEDGEESLRHLMDPSMQGNYPP------VTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
                             N PP      V ++     +  CL K+P+ R  + ++   + 
Sbjct: 240 ------------------NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM--VH 279
Query: 618 RFLNASLAWEL 628
            F+  S A E+
Sbjct: 280 AFIKRSDAEEV 290

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 113 -VIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 162
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++L++ N   ++   G  ++ G   +  E+   GSL   +   G        ++ IA 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA- 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF--ALTSH 503
            V  GL YL        +H+D+K SN+L+++    K+ +F ++       G+   ++ + 
Sbjct: 113 -VIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANS 162
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 27/165 (16%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL-SVWINDKGGKFLDWAQRIQIA 444
           +++LL +++H ++ +L     + G +YLV E    G L    I+ K    +D A+ I+  
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
           L   +G+ Y H       VH+D+K  N+LL++  ++K AN  +         +F L++H 
Sbjct: 136 L---SGITYXH---KNKIVHRDLKPENLLLES--KSKDANIRII--------DFGLSTHF 179
Query: 505 ---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    +GT  Y+APE L +G    K DV++ GV++  +LSG
Sbjct: 180 EASKKXKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           I++  D    LN+ H       +H+D+K +N+L+      K+ +F +AR           
Sbjct: 119 IEVIADACQALNFSHQNGI---IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T+ ++GT  Y++PE      V  + DVY+ G ++ E+L+G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
            +VY+G  K  G +VA+K+V  D+ +        +I L+ ++ H +++RL  +       
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78
Query: 412 YLVYENAVNGSLSVWINDKG------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
            LV+E  ++  L  +++ +       G  L+  +  Q  L    GL + H       +H+
Sbjct: 79  TLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHENKI---LHR 132
Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STK 524
           D+K  N+L++   + K+ +F LAR        F+  S +V T  Y AP+ L      ST 
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS--SEVV-TLWYRAPDVLMGSRTYSTS 189
Query: 525 LDVYAFGVLMLEMLSGKEA-PALYSEENMLLV 555
           +D+++ G ++ EM++GK   P    EE + L+
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 32/191 (16%)
Query: 368 KIGGDFVAIKKV---------YGDASDQIKLLNKINHSSLIRLLGI------CFNGGNWY 412
           K  G+ VAIKK+            A  ++ LL  + H ++I LL +        N  ++Y
Sbjct: 46  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           LV          +     G KF +  ++IQ +   +  GL Y+HS      VH+D+K  N
Sbjct: 106 LVMPFMQTDLQKI----MGLKFSE--EKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGN 156
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAF 530
           + ++ D   KI +F LAR A+ +     +T ++V T+ Y APE + + +  +  +D+++ 
Sbjct: 157 LAVNEDCELKILDFGLARHADAE-----MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSV 210
Query: 531 GVLMLEMLSGK 541
           G +M EML+GK
Sbjct: 211 GCIMAEMLTGK 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 35/187 (18%)
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-----PAERQE 495
           I  +  VA G+ +L S      +H+D+   N+LL  +   KI +F LAR     P   ++
Sbjct: 202 ISYSFQVARGMEFLSSRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS--GKEAPALYSEENML 553
           G+  L         +MAPE + + + STK DV+++GVL+ E+ S  G   P +  +E+  
Sbjct: 259 GDTRLPLK------WMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC 312
Query: 554 LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA 613
                            LR      M+   P  +   + +++  C  +DP  RP   ++ 
Sbjct: 313 ---------------SRLRE----GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELV 353
Query: 614 QSISRFL 620
           + +   L
Sbjct: 354 EKLGDLL 360

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 435 LDWAQRIQIALDVATGLNYLH-----SFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
           LD    ++I L +A+GL +LH     +   P   H+D+K  N+L+  + +  IA+  LA 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 490 PAERQEGEFALTSH-IVGTKGYMAPEYLENGLVS------TKLDVYAFGVLMLEMLSGKE 542
              +   +  + ++  VGTK YMAPE L+  +         ++D++AFG+++ E+     
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLM-----DPSMQGNY---PPVTAILVIRL 594
           +  +  +      DV+      +   E +R ++      P++   +   P +T++   +L
Sbjct: 222 SNGIVEDYKPPFYDVVP----NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL--AKL 275
Query: 595 IESCLKKDPSGRPAMDKIAQSISRF 619
           ++ C  ++PS R    +I +++++ 
Sbjct: 276 MKECWYQNPSARLTALRIKKTLTKI 300

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 435 LDWAQRIQIALDVATGLNYLH-----SFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
           LD    ++I L +A+GL +LH     +   P   H+D+K  N+L+  + +  IA+  LA 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 490 PAERQEGEFALTSH-IVGTKGYMAPEYLENGLVS------TKLDVYAFGVLMLEMLSGKE 542
              +   +  + ++  VGTK YMAPE L+  +         ++D++AFG+++ E+     
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
Query: 543 APALYSEENMLLVDVLNPVLHKEDGEESLRHLM-----DPSMQGNY---PPVTAILVIRL 594
           +  +  +      DV+      +   E +R ++      P++   +   P +T++   +L
Sbjct: 222 SNGIVEDYKPPFYDVVP----NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL--AKL 275
Query: 595 IESCLKKDPSGRPAMDKIAQSISRF 619
           ++ C  ++PS R    +I +++++ 
Sbjct: 276 MKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G  YLH       +H+D+K  N+ L+ D   KI +F LA   E  +GE   T  + G
Sbjct: 130 IVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKT--LCG 183
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L     S ++DV++ G +M  +L GK  P     E   L +     L  + 
Sbjct: 184 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF---ETSCLKET---YLRIKK 235
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            E S+   ++P            +   LI+  L+ DP+ RP ++++
Sbjct: 236 NEYSIPKHINP------------VAASLIQKMLQTDPTARPTINEL 269

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G  YLH       +H+D+K  N+ L+ D   KI +F LA   E  +GE   T  + G
Sbjct: 126 IVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKT--LCG 179
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L     S ++DV++ G +M  +L GK  P     E   L +     L  + 
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF---ETSCLKET---YLRIKK 231
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            E S+   ++P            +   LI+  L+ DP+ RP ++++
Sbjct: 232 NEYSIPKHINP------------VAASLIQKMLQTDPTARPTINEL 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 107/263 (40%), Gaps = 44/263 (16%)
Query: 363 SVYRGK--IGGDFVAIKKV----------YGDASDQIKLLNKINHSSLIRLLGICFNGGN 410
            VYR    + G  VA+KKV            D   +I LL ++NH ++I+          
Sbjct: 47  EVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106
Query: 411 WYLVYENAVNGSLSVWIN--DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
             +V E A  G LS  I    K  + +      +  + + + L ++HS      +H+DIK
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV---MHRDIK 163
Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
            +NV +      K+ +  L R       +      +VGT  YM+PE +     + K D++
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           + G L+ EM +  ++P           D +N           L  L     Q +YPP+ +
Sbjct: 221 SLGCLLYEM-AALQSP--------FYGDKMN-----------LYSLCKKIEQCDYPPLPS 260
Query: 589 IL----VIRLIESCLKKDPSGRP 607
                 + +L+  C+  DP  RP
Sbjct: 261 DHYSEELRQLVNMCINPDPEKRP 283

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +LS  I  +    LD
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ GV+M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I++ + + H +++R+     +    YL+ E A  G L   +  K G+F D  +      
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRF-DEQRSATFME 121
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y H       +H+DIK  N+L+      KIA+F  ++  P+ R+         
Sbjct: 122 ELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX------- 171
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + GT  Y+ PE +E      K+D++  GVL  E L G
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G  YLH       +H+D+K  N+ L+ D   KI +F LA   E  +GE   T  + G
Sbjct: 126 IVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKT--LCG 179
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L     S ++DV++ G +M  +L GK  P     E   L +     L  + 
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF---ETSCLKET---YLRIKK 231
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            E S+   ++P            +   LI+  L+ DP+ RP ++++
Sbjct: 232 NEYSIPKHINP------------VAASLIQKMLQTDPTARPTINEL 265

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +LS  I  +    LD
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ GV+M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I++ + + H +++R+     +    YL+ E A  G L   +  K G+F D  +      
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRF-DEQRSATFME 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L+Y H       +H+DIK  N+L+      KIA+F  ++  P+ R+         
Sbjct: 123 ELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX------- 172
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           + GT  Y+ PE +E      K+D++  GVL  E L G
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 118/243 (48%), Gaps = 21/243 (8%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKEIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 123 APGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+ +F LA+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIKVTDFGLAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSG 540
            +G
Sbjct: 232 AAG 234

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 35  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 94
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 95  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 151
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 152 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 207
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 208 WSAGCVLAELLLGQ 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 62  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 121
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 122 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 178
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 179 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 234
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 235 WSAGCVLAELLLGQ 248

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 47  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 106
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 107 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 163
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 164 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 219
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 220 WSAGCVLAELLLGQ 233

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/255 (21%), Positives = 106/255 (41%), Gaps = 38/255 (14%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL--------- 435
           ++K+L+ + NH +++ LLG C  GG   ++ E    G L  ++  K   F+         
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 436 -------DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                  D    +  +  VA G+ +L S      +H+D+   N+LL      KI +F LA
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 215
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
           R   + +  + +  +      +MAPE + N + + + DV+++G+ + E+ S   +P    
Sbjct: 216 RDI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
             +     ++         E +   + D                 ++++C   DP  RP 
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPT 317
Query: 609 MDKIAQSISRFLNAS 623
             +I Q I + ++ S
Sbjct: 318 FKQIVQLIEKQISES 332

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 53  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 112
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 113 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 169
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 170 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 225
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 226 WSAGCVLAELLLGQ 239

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 184
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 240
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 241 WSAGCVLAELLLGQ 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 184
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 240
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 241 WSAGCVLAELLLGQ 254

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/255 (21%), Positives = 106/255 (41%), Gaps = 38/255 (14%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL--------- 435
           ++K+L+ + NH +++ LLG C  GG   ++ E    G L  ++  K   F+         
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 436 -------DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                  D    +  +  VA G+ +L S      +H+D+   N+LL      KI +F LA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 192
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
           R   + +  + +  +      +MAPE + N + + + DV+++G+ + E+ S   +P    
Sbjct: 193 RDI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
             +     ++         E +   + D                 ++++C   DP  RP 
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPT 294
Query: 609 MDKIAQSISRFLNAS 623
             +I Q I + ++ S
Sbjct: 295 FKQIVQLIEKQISES 309

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 42  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 101
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 102 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 158
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 159 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDV 214
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 215 WSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 106 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 162
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 163 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDV 218
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 219 WSAGCVLAELLLGQ 232

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y+V E     +L   ++ +G   +   + I++  D    LN+ H       +H+D+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGI---IHRDVKPAN 146
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +++      K+ +F +AR           T+ ++GT  Y++PE      V  + DVY+ G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 532 VLMLEMLSGK 541
            ++ E+L+G+
Sbjct: 207 CVLYEVLTGE 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 123 APGGEMFSHLR-RIGRFXEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIKVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y+V E     +L   ++ +G   +   + I++  D    LN+ H       +H+D+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGI---IHRDVKPAN 146
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +++      K+ +F +AR           T+ ++GT  Y++PE      V  + DVY+ G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 532 VLMLEMLSGK 541
            ++ E+L+G+
Sbjct: 207 CVLYEVLTGE 216

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/255 (21%), Positives = 106/255 (41%), Gaps = 38/255 (14%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL--------- 435
           ++K+L+ + NH +++ LLG C  GG   ++ E    G L  ++  K   F+         
Sbjct: 94  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 153
Query: 436 -------DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                  D    +  +  VA G+ +L S      +H+D+   N+LL      KI +F LA
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 210
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
           R   + +  + +  +      +MAPE + N + + + DV+++G+ + E+ S   +P    
Sbjct: 211 RDI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 269
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
             +     ++         E +   + D                 ++++C   DP  RP 
Sbjct: 270 PVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPT 312
Query: 609 MDKIAQSISRFLNAS 623
             +I Q I + ++ S
Sbjct: 313 FKQIVQLIEKQISES 327

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 70  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 129
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 130 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 186
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 187 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 242
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 243 WSAGCVLAELLLGQ 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 106 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 162
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 163 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 218
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 219 WSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 38  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 97
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 98  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 154
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 155 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 210
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 211 WSAGCVLAELLLGQ 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y+V E     +L   ++ +G   +   + I++  D    LN+ H       +H+D+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGI---IHRDVKPAN 146
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +++      K+ +F +AR           T+ ++GT  Y++PE      V  + DVY+ G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 532 VLMLEMLSGK 541
            ++ E+L+G+
Sbjct: 207 CVLYEVLTGE 216

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 72  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 131
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 132 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 188
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 189 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 244
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 245 WSAGCVLAELLLGQ 258

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 39  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 98
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 99  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 155
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 156 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 211
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 212 WSAGCVLAELLLGQ 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 32/149 (21%)
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE--- 497
           + I + +A  + +LHS      +H+D+K SN+    D   K+ +F L    ++ E E   
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 498 ------FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML------------- 538
                 +A     VGTK YM+PE +     S K+D+++ G+++ E+L             
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283
Query: 539 ---SGKEAPAL----YSEENMLLVDVLNP 560
                 + P L    Y +E+M++ D+L+P
Sbjct: 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSP 312

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/255 (21%), Positives = 106/255 (41%), Gaps = 38/255 (14%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL--------- 435
           ++K+L+ + NH +++ LLG C  GG   ++ E    G L  ++  K   F+         
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 436 -------DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                  D    +  +  VA G+ +L S      +H+D+   N+LL      KI +F LA
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 215
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
           R   + +  + +  +      +MAPE + N + + + DV+++G+ + E+ S   +P    
Sbjct: 216 RHI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
             +     ++         E +   + D                 ++++C   DP  RP 
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPT 317
Query: 609 MDKIAQSISRFLNAS 623
             +I Q I + ++ S
Sbjct: 318 FKQIVQLIEKQISES 332

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           I++  D    LN+ H       +H+D+K +N+++      K+ +F +AR           
Sbjct: 119 IEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T+ ++GT  Y++PE      V  + DVY+ G ++ E+L+G+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 123 VPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+A+F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIKVADFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 32/191 (16%)
Query: 368 KIGGDFVAIKKV---------YGDASDQIKLLNKINHSSLIRLLGI------CFNGGNWY 412
           K  G+ VAIKK+            A  ++ LL  + H ++I LL +        N  ++Y
Sbjct: 64  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           LV          +     G +F +  ++IQ +   +  GL Y+HS      VH+D+K  N
Sbjct: 124 LVMPFMQTDLQKI----MGMEFSE--EKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGN 174
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAF 530
           + ++ D   KI +F LAR A+ +     +T ++V T+ Y APE + + +  +  +D+++ 
Sbjct: 175 LAVNEDCELKILDFGLARHADAE-----MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSV 228
Query: 531 GVLMLEMLSGK 541
           G +M EML+GK
Sbjct: 229 GCIMAEMLTGK 239

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVYGDA---SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  D    + +++++ K++H +++RL    ++ G     VY
Sbjct: 113 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 172
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 173 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 229
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 230 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 285
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 286 WSAGCVLAELLLGQ 299

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 126
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 127 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 179 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 232
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 233 SILEK--GERLPQ-----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 279
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 280 ARDPQRYL 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           I++  D    LN+ H       +H+D+K +N+++      K+ +F +AR           
Sbjct: 136 IEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           T+ ++GT  Y++PE      V  + DVY+ G ++ E+L+G+
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/255 (21%), Positives = 106/255 (41%), Gaps = 38/255 (14%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL--------- 435
           ++K+L+ + NH +++ LLG C  GG   ++ E    G L  ++  K   F+         
Sbjct: 92  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 151
Query: 436 -------DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
                  D    +  +  VA G+ +L S      +H+D+   N+LL      KI +F LA
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 208
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
           R   + +  + +  +      +MAPE + N + + + DV+++G+ + E+ S   +P    
Sbjct: 209 RDI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 267
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
             +     ++         E +   + D                 ++++C   DP  RP 
Sbjct: 268 PVDSKFYKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPT 310
Query: 609 MDKIAQSISRFLNAS 623
             +I Q I + ++ S
Sbjct: 311 FKQIVQLIEKQISES 325

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 123 MPGGDMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+A+F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIKVADFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 19/169 (11%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR---- 440
           ++K+++ +  H +++ LLG C +GG   ++ E    G L  ++  K    L+++      
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 441 ----------IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
                     +  +  VA G+ +L S      +H+D+   NVLL     AKI +F LAR 
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
               +  + +  +      +MAPE + + + + + DV+++G+L+ E+ S
Sbjct: 216 I-MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 106/250 (42%), Gaps = 45/250 (18%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 124 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P               
Sbjct: 176 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------------- 220
Query: 560 PVLHKEDG--EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MD 610
                 DG     +  +++   +   PP+  I V  ++  C   D   RP          
Sbjct: 221 ------DGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
Query: 611 KIAQSISRFL 620
           K+A+   R+L
Sbjct: 275 KMARDPQRYL 284

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 133
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 134 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 186 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 239
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 240 SILEK--GERLPQ-----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 286
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 287 ARDPQRYL 294

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 123 APGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIKVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 26/176 (14%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG------------- 431
           ++K+++ +  H +++ LLG C +GG   ++ E    G L  ++  K              
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 432 --------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIA 483
                   G+ L+    +  +  VA G+ +L S      +H+D+   NVLL     AKI 
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIG 200
Query: 484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           +F LAR     +  + +  +      +MAPE + + + + + DV+++G+L+ E+ S
Sbjct: 201 DFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 115/252 (45%), Gaps = 30/252 (11%)
Query: 301 FDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWI 360
            D+++  S F   E+  +KKL  +  + L  I+DI            +    +F     +
Sbjct: 310 MDTSVFESPFSDPEELKDKKLFLKRDNLL--IADI------------ELGCGNFGS---V 352
Query: 361 KGSVYRGKIGGDFVAIK--KVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNWY 412
           +  VYR +     VAIK  K   + +D      + ++++++++  ++RL+G+C       
Sbjct: 353 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 411
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           LV E A  G L  ++  K  + +  +   ++   V+ G+ YL        VH+++   NV
Sbjct: 412 LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNV 467
Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 532
           LL     AKI++F L++     +  +   S       + APE +     S++ DV+++GV
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 533 LMLEMLSGKEAP 544
            M E LS  + P
Sbjct: 528 TMWEALSYGQKP 539

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 126/269 (46%), Gaps = 28/269 (10%)
Query: 321 LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK----GSVYRGKI--GGD 372
           L +   DFL+   + AQ +  +  FE ++   T  F     +K    G+ Y  KI     
Sbjct: 19  LAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQK 78
Query: 373 FVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
            V +K++    +++ ++L  +N   L++L     +  N Y+V E    G +   +  + G
Sbjct: 79  VVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIG 136
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
           +F +   R   A  V T   YLHS      +++D+K  N+L+D     K+A+F  A+   
Sbjct: 137 RFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK--- 189
Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
           R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ +
Sbjct: 190 RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPI 244
Query: 553 LLVD------VLNPVLHKEDGEESLRHLM 575
            + +      V  P     D ++ LR+L+
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 7/159 (4%)
Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           A ++ ++L K+N   ++ L           LV      G L   I   G      A+ + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
            A ++  GL  LH       V++D+K  N+LLD     +I++  LA      EG+     
Sbjct: 291 YAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQ--TIK 343
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
             VGT GYMAPE ++N   +   D +A G L+ EM++G+
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 80/165 (48%), Gaps = 13/165 (7%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++K+++ +  H +++ LLG C +GG   ++ E    G L  ++  K  + L+      IA
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS-RVLETDPAFAIA 157
Query: 445 LDVATGLNYLHSFTNPPH----------VHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
              A+  + LH  +              +H+D+   NVLL     AKI +F LAR     
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MN 216
Query: 495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
           +  + +  +      +MAPE + + + + + DV+++G+L+ E+ S
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      +H+D+K SNV ++ D   +I +F LAR A+ +     +T + V T+ 
Sbjct: 143 GLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGY-VATRW 193
Query: 510 YMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           Y APE + N +  +  +D+++ G +M E+L GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      +H+D+K SNV ++ D   +I +F LAR A+ +     +T + V T+ 
Sbjct: 135 GLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGY-VATRW 185
Query: 510 YMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           Y APE + N +  +  +D+++ G +M E+L GK
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           GL Y+HS      +H+D+K SNV ++ D   +I +F LAR A+ +     +T + V T+ 
Sbjct: 143 GLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGY-VATRW 193
Query: 510 YMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           Y APE + N +  +  +D+++ G +M E+L GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 7/159 (4%)
Query: 383 ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           A ++ ++L K+N   ++ L           LV      G L   I   G      A+ + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
            A ++  GL  LH       V++D+K  N+LLD     +I++  LA      EG+     
Sbjct: 291 YAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQ--TIK 343
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
             VGT GYMAPE ++N   +   D +A G L+ EM++G+
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 127
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 128 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 179
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 180 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 233
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 234 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 281 ARDPQRYL 288

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 362 GSVY--RGKIGGDFVAIKKV----YGDASD--------QIKLLNKINHSSLIRLLGICFN 407
            +VY  R K     VAIKK+      +A D        +IKLL +++H ++I LL    +
Sbjct: 24  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83
Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
             N  LV++  +   L V I D     L  +      L    GL YLH       +H+D+
Sbjct: 84  KSNISLVFD-FMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDL 138
Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLD 526
           K +N+LLD +   K+A+F LA+        +    H V T+ Y APE L    +    +D
Sbjct: 139 KPNNLLLDENGVLKLADFGLAKSFGSPNRAY---XHQVVTRWYRAPELLFGARMYGVGVD 195
Query: 527 VYAFGVLMLEML 538
           ++A G ++ E+L
Sbjct: 196 MWAVGCILAELL 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 8   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 56
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 114
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 115 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 170
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 148
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 149 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 200
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 201 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 254
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 255 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 301
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 302 ARDPQRYL 309

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 125
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 126 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 178 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 231
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 232 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 279 ARDPQRYL 286

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 118/243 (48%), Gaps = 21/243 (8%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKEIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 123 APGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F LA+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIQVTDFGLAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSG 540
            +G
Sbjct: 232 AAG 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 130
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 131 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 183 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 236
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 237 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 284 ARDPQRYL 291

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVY-GDA--SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  G A  + +++++ K++H +++RL    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----XICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFR- 120
Query: 446 DVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
            + + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF   + +
Sbjct: 121 QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKL 169
Query: 505 ---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
               G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWC- 124
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 125 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 177 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 230
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 231 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 278 ARDPQRYL 285

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 124 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 176 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 229
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 230 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 277 ARDPQRYL 284

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 130
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 131 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 183 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 236
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 237 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 284 ARDPQRYL 291

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 124
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 125 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 177 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 230
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 231 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 278 ARDPQRYL 285

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFR- 120
Query: 446 DVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
            + + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF   + +
Sbjct: 121 QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKL 169
Query: 505 ---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
               G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 126
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 127 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 179 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 232
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 233 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 280 ARDPQRYL 287

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEIXI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/299 (22%), Positives = 127/299 (42%), Gaps = 55/299 (18%)
Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQIKLLN-KINHSSLIR---LLGICFNGGNWYLVYEN 417
           G V+RG   G+ VA+K ++    +Q      +I ++ L+R   +LG   +          
Sbjct: 22  GEVWRGLWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASD-------MT 73
Query: 418 AVNGSLSVWI---NDKGGKFLDWAQR--------IQIALDVATGLNYLH-----SFTNPP 461
           + N S  +W+     + G   D+ QR        +++A+  A GL +LH     +   P 
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPA 133
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH-IVGTKGYMAPEYLENGL 520
             H+D K  NVL+ ++ +  IA+  LA    +      + ++  VGTK YMAPE L+  +
Sbjct: 134 IAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQI 193
Query: 521 VSTKL------DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL--- 571
            +         D++AFG+++ E+        +  +      DV+      ED ++ +   
Sbjct: 194 RTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVD 253
Query: 572 --------RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
                   R   DP + G         + +++  C   +PS R    +I +++ +  N+
Sbjct: 254 QQTPTIPNRLAADPVLSG---------LAQMMRECWYPNPSARLTALRIKKTLQKISNS 303

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEIXI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 125
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 126 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 178 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 231
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 232 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 279 ARDPQRYL 286

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFR- 120
Query: 446 DVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
            + + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF   + +
Sbjct: 121 QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKL 169
Query: 505 ---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
               G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 170 DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 130
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 131 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 183 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 236
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 237 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 284 ARDPQRYL 291

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFR- 120
Query: 446 DVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
            + + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF   + +
Sbjct: 121 QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKL 169
Query: 505 ---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
               G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++   +N   L++L     +  N Y+V E A  G +   +  + G+F +   R   A
Sbjct: 91  NEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR-RIGRFSEPHARFYAA 149
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     K+A+F  A+   R +G    T  +
Sbjct: 150 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK---RVKGR---TWXL 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 257
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 258 FPSHFSSDLKDLLRNLL 274

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E A  G +   +  + G+F +   R   A
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAA 149
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+++D     K+ +F  A+   R +G    T  +
Sbjct: 150 QIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK---RVKGR---TWXL 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 257
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 258 FPSHFSSDLKDLLRNLL 274

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G  YLH       +H+D+K  N+ L+ D   KI +F LA   E  +GE      + G
Sbjct: 148 IVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCG 201
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L     S ++DV++ G +M  +L GK  P     E   L +     L  + 
Sbjct: 202 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF---ETSCLKET---YLRIKK 253
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            E S+   ++P            +   LI+  L+ DP+ RP ++++
Sbjct: 254 NEYSIPKHINP------------VAASLIQKMLQTDPTARPTINEL 287

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 129
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 130 -----VQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 181
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 182 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 235
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 236 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 282
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 283 ARDPQRYL 290

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 9   DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEICI 57
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 115
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 116 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLP 171
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G  YLH       +H+D+K  N+ L+ D   KI +F LA   E  +GE      + G
Sbjct: 124 IVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCG 177
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L     S ++DV++ G +M  +L GK  P     E   L +     L  + 
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF---ETSCLKET---YLRIKK 229
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            E S+   ++P            +   LI+  L+ DP+ RP ++++
Sbjct: 230 NEYSIPKHINP------------VAASLIQKMLQTDPTARPTINEL 263

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 126
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 127 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 179 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 232
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 233 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 280 ARDPQRYL 287

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 124 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 176 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 229
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 230 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 277 ARDPQRYL 284

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 124 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 176 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 229
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 230 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 277 ARDPQRYL 284

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 124 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 176 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 229
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 230 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 277 ARDPQRYL 284

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  G  YLH       +H+D+K  N+ L+ D   KI +F LA   E  +GE      + G
Sbjct: 150 IVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCG 203
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
           T  Y+APE L     S ++DV++ G +M  +L GK  P     E   L +     L  + 
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF---ETSCLKET---YLRIKK 255
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
            E S+   ++P            +   LI+  L+ DP+ RP ++++
Sbjct: 256 NEYSIPKHINP------------VAASLIQKMLQTDPTARPTINEL 289

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 126
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 127 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 179 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 232
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 233 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 280 ARDPQRYL 287

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 334 DIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVYGDASDQIK---LL 390
           D+ Q+L    + E+Q A +           V    +    V +K+   D  + IK    +
Sbjct: 10  DLVQTLGEGAYGEVQLAVN----------RVTEEAVAVKIVDMKRAV-DCPENIKKEIXI 58
Query: 391 NK-INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT 449
           NK +NH ++++  G    G   YL  E    G L   I    G     AQR    L    
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MA 116
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  
Sbjct: 117 GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLP 172
Query: 510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L+     +  +DV++ G+++  ML+G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 360 IKGSVYRGKIGGDFVAIK--KVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNW 411
           ++  VYR +     VAIK  K   + +D      + ++++++++  ++RL+G+C      
Sbjct: 26  VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV E A  G L  ++  K  + +  +   ++   V+ G+ YL        VH+D+   N
Sbjct: 85  MLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARN 140
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           VLL     AKI++F L++     +  +   S       + APE +     S++ DV+++G
Sbjct: 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 532 VLMLEMLSGKEAP 544
           V M E LS  + P
Sbjct: 201 VTMWEALSYGQKP 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 29/284 (10%)
Query: 345 EELQAATDDFNPSCWIKGSVYR--GKIGGDFVAIKKVYGDA--SDQIKLLNKINHSSLIR 400
           EE+  AT          G V+R   K  G   A+KKV  +   ++++     +    ++ 
Sbjct: 90  EEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVP 149
Query: 401 LLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNP 460
           L G    G    +  E    GSL   + ++G    D A  +        GL YLHS    
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRA--LYYLGQALEGLEYLHSRRI- 206
Query: 461 PHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQE-GEFALTS-HIVGTKGYMAPEYLE 517
             +H D+K  NVLL +D   A + +F  A   +    G+  LT  +I GT+ +MAPE + 
Sbjct: 207 --LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 518 NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP 577
                 K+DV++   +ML ML+G                  +P      G   L+   +P
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNG-----------------CHPWTQFFRGPLCLKIASEP 307
Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
                 PP  A L  + I+  L+K+P  R +  ++   ++R L 
Sbjct: 308 PPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQ 351

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 5   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 64
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L +L     +  N Y+V E 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLTKLEFSFKDNSNLYMVMEY 123
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 124 APGGEMFSHLR-RIGRFXEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 178
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 179 GYIKVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 233 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  +++E + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADEPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +LS  I  +    LD
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 117
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL    +   VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 118 -----VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 170 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 223
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 224 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 271 ARDPQRYL 278

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 120
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 121 -----VQIAEGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 172
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 173 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 226
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 227 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 273
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 274 ARDPQRYL 281

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFR- 121
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI- 504
            + + + Y H       VH+D+K  N+LLD D   KIA+F  +        EF + + + 
Sbjct: 122 QIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFS-------NEFTVGNKLD 171
Query: 505 --VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
              G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 172 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFR- 120
Query: 446 DVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
            + + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF   + +
Sbjct: 121 QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKL 169
Query: 505 ---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
               G   Y APE  +       ++DV++ GV++  ++SG
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   F      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   F      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   F      V 
Sbjct: 130 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF------VA 180
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLMDPSMQ---GNYP 584
            P     D ++ LR+L+   +    GN P
Sbjct: 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLP 285

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 386 QIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK------------GG 432
           ++K+++ +  H +++ LLG C +GG   ++ E    G L  ++  K              
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
             L     +  +  VA G+ +L S      +H+D+   NVLL     AKI +F LAR   
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDI- 214
Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS 539
             +  + +  +      +MAPE + + + + + DV+++G+L+ E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 368 KIGGDFVAIK----KVYGDASDQIK---LLNK-INHSSLIRLLGICFNGGNWYLVYENAV 419
           ++  + VA+K    K   D  + IK    +NK +NH ++++  G    G   YL  E   
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
            G L   I    G     AQR    L    G+ YLH        H+DIK  N+LLD    
Sbjct: 88  GGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDN 142
Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEML 538
            KI++F LA    R      L + + GT  Y+APE L+     +  +DV++ G+++  ML
Sbjct: 143 LKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 539 SGK 541
           +G+
Sbjct: 202 AGE 204

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 395 HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL 454
           H  +I L+    +    +LV++    G L  ++ +K    L   +   I   +   +++L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 455 HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA---RPAERQEGEFALTSHIVGTKGYM 511
           H+      VH+D+K  N+LLD + + ++++F  +    P E+          + GT GY+
Sbjct: 217 HANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-------LRELCGTPGYL 266
Query: 512 APEYLENGLVST------KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           APE L+  +  T      ++D++A GV++  +L+G  +P  +    +L+           
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWHRRQILM----------- 313
Query: 566 DGEESLRHLMDPSMQGNYPPV--TAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                LR +M+   Q + P     +  V  LI   L+ DP  R   ++  Q
Sbjct: 314 -----LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVY-GDA--SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  G A  + +++++ K++H +++RL    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAA 169
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 170 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 219
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 277
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 278 FPSHFSSDLKDLLRNLL 294

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 106/250 (42%), Gaps = 45/250 (18%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 157
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F LA+    +E E+ 
Sbjct: 158 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 209
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P               
Sbjct: 210 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------------- 254
Query: 560 PVLHKEDG--EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MD 610
                 DG     +  +++   +   PP+  I V  ++  C   D   RP          
Sbjct: 255 ------DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 308
Query: 611 KIAQSISRFL 620
           K+A+   R+L
Sbjct: 309 KMARDPQRYL 318

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 362 GSVYRGKIG-GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ +   G+  A+KK+  +  D+         I +L ++ HS++++L  +       
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV+E+       +    +GG  L+        L +  G+ Y H       +H+D+K  N
Sbjct: 76  VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQN 130
Query: 472 VLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLE-NGLVSTKLD 526
           +L++ +   KIA+F LAR    P  +        +H V T  Y AP+ L  +   ST +D
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRK-------YTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLL 554
           +++ G +  EM++G       SE + L+
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLM 211

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 5   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 64
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L +L     +  N Y+V E 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLTKLEFSFKDNSNLYMVMEY 123
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 124 APGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 178
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              K+ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 179 GYIKVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 233 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 362 GSVYRGKI--GGDFVAIKKVY-GDA--SDQIKLLNKINHSSLIRLLGICFNGGNWY-LVY 415
           G VY+ K+   G+ VAIKKV  G A  + +++++ K++H +++RL    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQI------ALDVATGLNYLHSFTNPPHVHKDIKC 469
            N V   +   +      +    Q + +         +   L Y+HSF      H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKP 150
Query: 470 SNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDV 527
            N+LLD D    K+ +F  A+   R E   +     + ++ Y APE +      ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELIFGATDYTSSIDV 206
Query: 528 YAFGVLMLEMLSGK 541
           ++ G ++ E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 112/268 (41%), Gaps = 42/268 (15%)
Query: 374 VAIKKVYGDASDQIKL---------LNKINHSSLIRLLGICFNGGNW-----YLVYENAV 419
           VA+K +  D S Q ++         +   +H ++IRLLG+C    +       ++     
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 420 NGSLSVWIN----DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
            G L  ++     + G K +     ++  +D+A G+ YL   +N   +H+D+   N +L 
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLR 181
Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTK-GYMAPEYLENGLVSTKLDVYAFGVLM 534
            D    +A+F L++      G++     I      ++A E L + + ++K DV+AFGV M
Sbjct: 182 DDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E+ +    P     +N  + D L      +  E+ L  L +                 +
Sbjct: 240 WEIATRGMTP-YPGVQNHEMYDYLLHGHRLKQPEDCLDELYE-----------------I 281
Query: 595 IESCLKKDPSGRPAMDKIAQSISRFLNA 622
           + SC + DP  RP    +   + + L +
Sbjct: 282 MYSCWRTDPLDRPTFSVLRLQLEKLLES 309

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 362 GSVYRGKIG-GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ +   G+  A+KK+  +  D+         I +L ++ HS++++L  +       
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV+E+       +    +GG  L+        L +  G+ Y H       +H+D+K  N
Sbjct: 76  VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQN 130
Query: 472 VLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLE-NGLVSTKLD 526
           +L++ +   KIA+F LAR    P  +        +H V T  Y AP+ L  +   ST +D
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRK-------YTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLL 554
           +++ G +  EM++G       SE + L+
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLM 211

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 135/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
           A  G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+++D  
Sbjct: 123 APGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I  L  + H  +I+L  +     +  +V E A  G L  +I +K     D  +R    +
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
             A    + H       VH+D+K  N+LLD +   KIA+F L+      +G F  TS   
Sbjct: 118 ICAIEYCHRHKI-----VHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTS--C 168
Query: 506 GTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSGK 541
           G+  Y APE +   L +  ++DV++ G+++  ML G+
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YL+ E A  G +  ++   G +  +   R +   
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFR- 118
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI- 504
            + + + Y H       VH+D+K  N+LLD D   KIA+F  +        EF +   + 
Sbjct: 119 QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLD 168
Query: 505 --VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
              G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 85  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAA 143
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 144 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 193
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 251
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 252 FPSHFSSDLKDLLRNLL 268

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 30/166 (18%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL------SVWINDKGGKFLDWAQ 439
           +++++  +NH ++++L  +       YLV E A  G +        W+ +K  +    A+
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR----AK 111
Query: 440 RIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
             QI     + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF
Sbjct: 112 FRQIV----SAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADFGFS-------NEF 156
Query: 499 ALTSHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
              + +    G+  Y APE  +       ++DV++ GV++  ++SG
Sbjct: 157 TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           +++ +L  ++H ++++L     +  N+YLV E    G L   I  +  KF +    + I 
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAV-II 142
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALT 501
             V +G+ YLH       VH+D+K  N+LL++   D   KI +F L+   E Q+      
Sbjct: 143 KQVLSGVTYLHKHNI---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK----M 195
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
              +GT  Y+APE L       K DV++ GV++  +L+G
Sbjct: 196 KERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAG 233

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +LS  I  +    LD
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 29/284 (10%)
Query: 345 EELQAATDDFNPSCWIKGSVYR--GKIGGDFVAIKKVYGDA--SDQIKLLNKINHSSLIR 400
           EE+  AT          G V+R   K  G   A+KKV  +   ++++     +    ++ 
Sbjct: 71  EEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVP 130
Query: 401 LLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNP 460
           L G    G    +  E    GSL   + ++G    D A  +        GL YLHS    
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRA--LYYLGQALEGLEYLHSRRI- 187
Query: 461 PHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQE-GEFALTS-HIVGTKGYMAPEYLE 517
             +H D+K  NVLL +D   A + +F  A   +    G+  LT  +I GT+ +MAPE + 
Sbjct: 188 --LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 518 NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP 577
                 K+DV++   +ML ML+G                  +P      G   L+   +P
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNG-----------------CHPWTQFFRGPLCLKIASEP 288
Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
                 PP  A L  + I+  L+K+P  R +  ++   ++R L 
Sbjct: 289 PPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQ 332

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 52/279 (18%)
Query: 362 GSVYRGKIGGDF------VAIKKVYGDAS--------DQIKLLNKINHSSLIRLLGICFN 407
           G+VY+G    D       VAIK +  + S        D+  ++  +    + RLLGIC  
Sbjct: 31  GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLT 90
Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKF-----LDWAQRIQIALDVATGLNYLHSFTNPPH 462
                LV +    G L   + +  G+      L+W  +I      A G++YL        
Sbjct: 91  S-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYLEDVR---L 140
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           VH+D+   NVL+ +    KI +F LAR  +  E E+      V  K +MA E +     +
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILRRRFT 199
Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG--EESLRHLMDPSMQ 580
            + DV+++GV + E+++    P                     DG     +  L++   +
Sbjct: 200 HQSDVWSYGVTVWELMTFGAKPY--------------------DGIPAREIPDLLEKGER 239
Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
              PP+  I V  ++  C   D   RP   ++    SR 
Sbjct: 240 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 393 INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLN 452
           +NH ++++  G    G   YL  E    G L   I    G     AQR    L    G+ 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVV 119
Query: 453 YLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA 512
           YLH        H+DIK  N+LLD     KI++F LA    R      L + + GT  Y+A
Sbjct: 120 YLHGIGI---THRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVA 175
Query: 513 PEYLENG-LVSTKLDVYAFGVLMLEMLSGK 541
           PE L+     +  +DV++ G+++  ML+G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 125
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F  A+    +E E+ 
Sbjct: 126 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 178 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 231
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 232 SILEK--GERLPQ-----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 279 ARDPQRYL 286

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFAEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 123 VPGGEMFSHLR-RIGRFXEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 121/253 (47%), Gaps = 23/253 (9%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 5   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 64
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 124 VPGGEMFSHLR-RIGRFXEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 178
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 179 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
Query: 538 LSGKEAPALYSEE 550
            +G   P  ++++
Sbjct: 233 AAG--YPPFFADQ 243

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 321 LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK----GSVYRGKI--GGD 372
           L +   DFL+   + AQ +  +  FE ++   T  F     +K    G+ Y  KI     
Sbjct: 20  LAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK 79
Query: 373 FVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
            V +K++    +++ ++L  +N   L +L     +  N Y+V E A  G +   +  + G
Sbjct: 80  VVKLKQIEHTLNEK-RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIG 137
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
           +F +   R   A  V T   YLHS      +++D+K  N+++D     K+ +F  A+   
Sbjct: 138 RFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK--- 190
Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
           R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ +
Sbjct: 191 RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPI 245
Query: 553 LLVD------VLNPVLHKEDGEESLRHLM 575
            + +      V  P     D ++ LR+L+
Sbjct: 246 QIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I+++  ++H ++IRL     +  + YLV E    G L   +  K  +    +   +I  
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMK 113
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTS 502
           DV + + Y H        H+D+K  N L  T   D   K+ +F LA  A  + G+   T 
Sbjct: 114 DVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKMMRTK 168
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             VGT  Y++P+ LE GL   + D ++ GV+M  +L G
Sbjct: 169 --VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 123 VAGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +LS  I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  +NH ++++L  +       YL+ E A  G +  ++    G+  +   R +   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFR- 121
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI- 504
            + + + Y H       VH+D+K  N+LLD D   KIA+F  +        EF +   + 
Sbjct: 122 QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLD 171
Query: 505 --VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
              G   Y APE  +       ++DV++ GV++  ++SG
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +LS  I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 125
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F  A+    +E E+ 
Sbjct: 126 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 178 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 231
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 232 SILEK--GERLPQ-----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 279 ARDPQRYL 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 362 GSVYRGKIG-GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ +   G+  A+KK+  +  D+         I +L ++ HS++++L  +       
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV+E+       +    +GG  L+        L +  G+ Y H       +H+D+K  N
Sbjct: 76  VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQN 130
Query: 472 VLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLE-NGLVSTKLD 526
           +L++ +   KIA+F LAR    P  +        +H + T  Y AP+ L  +   ST +D
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRK-------YTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLL 554
           +++ G +  EM++G       SE + L+
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLM 211

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I++   ++H +++RL    ++    YL+ E A  G L   +  K   F D  +   I  
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQ-KSCTF-DEQRTATIME 130
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF--ALARPAERQEGEFALTSH 503
           ++A  L Y H       +H+DIK  N+LL      KIA+F  ++  P+ R++        
Sbjct: 131 ELADALMYCHGKKV---IHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT------- 180
Query: 504 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           + GT  Y+ PE +E  + + K+D++  GVL  E+L G                  NP   
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG------------------NPPFE 222
Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA 613
                E+ R ++   ++  +P         LI   L+ +PS R  + +++
Sbjct: 223 SASHNETYRRIVKVDLK--FPASVPTGAQDLISKLLRHNPSERLPLAQVS 270

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 10/165 (6%)
Query: 380 YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS---LSVWINDKGGKFLD 436
           Y  A  + K+L K+ HS  I  L   F       +    +NG      ++  D+      
Sbjct: 229 YQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             + I     + +GL +LH       +++D+K  NVLLD D   +I++  LA   E + G
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +   T    GT G+MAPE L        +D +A GV + EM++ +
Sbjct: 343 Q-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I+++  ++H ++IRL     +  + YLV E    G L   +  K  +    +   +I  
Sbjct: 73  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMK 130
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
           DV + + Y H        H+D+K  N L  TD      K+ +F LA  A  + G+   T 
Sbjct: 131 DVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKMMRTK 185
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             VGT  Y++P+ LE GL   + D ++ GV+M  +L G
Sbjct: 186 --VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 321 LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK----GSVYRGKI--GGD 372
           L +   DFL+   + AQ +  +  FE ++   T  F     +K    G+ Y  KI     
Sbjct: 19  LAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK 78
Query: 373 FVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
            V +K++    +++ ++L  +N   L++L     +  N Y+V E    G +   +  + G
Sbjct: 79  VVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIG 136
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
           +F +   R   A  V T   YLHS      +++D+K  N+L+D     ++ +F  A+   
Sbjct: 137 RFXEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189
Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
           R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ +
Sbjct: 190 RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPI 244
Query: 553 LLVD------VLNPVLHKEDGEESLRHLM 575
            + +      V  P     D ++ LR+L+
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 366 RGKIGGDFVAIKKV-----YGDAS--DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA 418
           + ++ G   A+K +     + D+S  ++I +L KI H +++ L  I  +  ++YLV +  
Sbjct: 29  KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88
Query: 419 VNGSLSVWINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL--- 474
             G L   I ++G     D +  IQ    V + + YLH       VH+D+K  N+L    
Sbjct: 89  SGGELFDRILERGVYTEKDASLVIQ---QVLSAVKYLH---ENGIVHRDLKPENLLYLTP 142
Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
           + + +  I +F L++  +       + S   GT GY+APE L     S  +D ++ GV+ 
Sbjct: 143 EENSKIMITDFGLSKMEQN-----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
Query: 535 LEMLSGKEAPALYSE 549
             +L G   P  Y E
Sbjct: 198 YILLCG--YPPFYEE 210

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG-KFLDWAQRIQIA 444
           +I +L +++H ++I+L  I        LV E    G L   I +KG     D A  ++  
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALT 501
           L+    + YLH       VH+D+K  N+L  T   D   KIA+F L++  E Q     L 
Sbjct: 158 LE---AVAYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLM 207
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKE 542
             + GT GY APE L       ++D+++ G++   +L G E
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 77  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 135
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 136 QIVLT-FEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAK---RVKGR---TWXL 185
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 243
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 244 FPSHFSSDLKDLLRNLL 260

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 10/165 (6%)
Query: 380 YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS---LSVWINDKGGKFLD 436
           Y  A  + K+L K+ HS  I  L   F       +    +NG      ++  D+      
Sbjct: 229 YQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             + I     + +GL +LH       +++D+K  NVLLD D   +I++  LA   E + G
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +   T    GT G+MAPE L        +D +A GV + EM++ +
Sbjct: 343 Q-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 10/165 (6%)
Query: 380 YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS---LSVWINDKGGKFLD 436
           Y  A  + K+L K+ HS  I  L   F       +    +NG      ++  D+      
Sbjct: 229 YQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             + I     + +GL +LH       +++D+K  NVLLD D   +I++  LA   E + G
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +   T    GT G+MAPE L        +D +A GV + EM++ +
Sbjct: 343 Q-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARFYAA 141
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 142 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 191
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 249
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 250 FPSHFSSDLKDLLRNLL 266

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 149
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 150 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 257
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 258 FPSHFSSDLKDLLRNLL 274

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 10/165 (6%)
Query: 380 YGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS---LSVWINDKGGKFLD 436
           Y  A  + K+L K+ HS  I  L   F       +    +NG      ++  D+      
Sbjct: 229 YQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             + I     + +GL +LH       +++D+K  NVLLD D   +I++  LA   E + G
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           +   T    GT G+MAPE L        +D +A GV + EM++ +
Sbjct: 343 Q-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 111/251 (44%), Gaps = 40/251 (15%)
Query: 377 KKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK--- 433
           ++ +   +D +  +  ++H+ ++RLLG+C  G +  LV +    GSL   +    G    
Sbjct: 56  RQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP 114
Query: 434 --FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-- 489
              L+W       + +A G+ YL        VH+++   NVLL +  + ++A+F +A   
Sbjct: 115 QLLLNW------GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLL 165
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P ++Q     L S       +MA E +  G  + + DV+++GV + E+++    P  Y+
Sbjct: 166 PPDDKQ----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YA 219
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
              + L +V +              L++   +   P +  I V  ++  C   D + RP 
Sbjct: 220 --GLRLAEVPD--------------LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPT 263
Query: 609 MDKIAQSISRF 619
             ++A   +R 
Sbjct: 264 FKELANEFTRM 274

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ LL  +NH ++I LL +           + YLV E  ++ +L   I+ +    LD
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME----LD 122
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---ST 176
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M E++ G
Sbjct: 177 NFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 111/251 (44%), Gaps = 40/251 (15%)
Query: 377 KKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK--- 433
           ++ +   +D +  +  ++H+ ++RLLG+C  G +  LV +    GSL   +    G    
Sbjct: 74  RQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP 132
Query: 434 --FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-- 489
              L+W       + +A G+ YL        VH+++   NVLL +  + ++A+F +A   
Sbjct: 133 QLLLNW------GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLL 183
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P ++Q     L S       +MA E +  G  + + DV+++GV + E+++    P  Y+
Sbjct: 184 PPDDKQ----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YA 237
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
              + L +V +              L++   +   P +  I V  ++  C   D + RP 
Sbjct: 238 --GLRLAEVPD--------------LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPT 281
Query: 609 MDKIAQSISRF 619
             ++A   +R 
Sbjct: 282 FKELANEFTRM 292

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 123 VPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 5   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 64
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 124 VPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 178
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 179 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 233 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 139 ILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY------VA 189
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 139 ILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY------VA 189
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 321 LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK----GSVYRGKI--GGD 372
           L +   DFL+   + AQ +  +  FE ++   T  F     +K    G+ Y  KI     
Sbjct: 19  LAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK 78
Query: 373 FVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
            V +K++    +++ ++L  +N   L++L     +  N Y+V E    G +   +  + G
Sbjct: 79  VVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIG 136
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
           +F +   R   A  V T   YLHS      +++D+K  N+L+D     ++ +F  A+   
Sbjct: 137 RFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189
Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
           R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ +
Sbjct: 190 RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPI 244
Query: 553 LLVD------VLNPVLHKEDGEESLRHLM 575
            + +      V  P     D ++ LR+L+
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 63
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 123 VPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 178 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 232 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 125
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F  A+    +E E+ 
Sbjct: 126 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 178 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 231
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 232 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 279 ARDPQRYL 286

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 145 ILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY------VA 195
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 115/271 (42%), Gaps = 53/271 (19%)
Query: 362 GSVYRGKIGGDFVAIK---------KVYGDASDQIKLLNKINHSSLIRLLGICFN--GGN 410
           G +++G+  G+ + +K         +   D +++   L   +H +++ +LG C +    +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTN--PPHVHKDIK 468
             L+      GSL   +++     +D +Q ++ ALD A G  +LH+     P H    + 
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA---LN 140
Query: 469 CSNVLLDTDFRAKIA----NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
             +V +D D  A+I+     F+   P                   ++APE L+     T 
Sbjct: 141 SRSVXIDEDXTARISXADVKFSFQSPGRXY------------APAWVAPEALQKKPEDTN 188
Query: 525 ---LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
               D ++F VL+ E+++ +E P           D+ N  +  +   E LR    P++  
Sbjct: 189 RRSADXWSFAVLLWELVT-REVP---------FADLSNXEIGXKVALEGLR----PTI-- 232
Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
             PP  +  V +L + C  +DP+ RP  D I
Sbjct: 233 --PPGISPHVSKLXKICXNEDPAKRPKFDXI 261

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+   + AQ +  +  FE ++   T  F     +K  
Sbjct: 5   AAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHM 64
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 124 VPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 178
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 179 GYIQVTDFGFAK---RVKGR---TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 233 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 141
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 142 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 191
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 249
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 250 FPSHFSSDLKDLLRNLL 266

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 40/196 (20%)
Query: 366 RGKIGGDFVAIKKVYGDASD---------QIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           R +  G  VAIKK      D         +I++L ++ H +L+ LL +       +LV+E
Sbjct: 23  RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82
Query: 417 NAVNGSLSVWINDKGGKFLDWAQR-------IQIALDVATGLNYLHSFTNPPHVHKDIKC 469
              +  L           LD  QR         I       +N+ H       +H+D+K 
Sbjct: 83  YCDHTVLHE---------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC---IHRDVKP 130
Query: 470 SNVLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYL-ENGLVSTK 524
            N+L+      K+ +F  AR    P++  + E       V T+ Y +PE L  +      
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDE-------VATRWYRSPELLVGDTQYGPP 183
Query: 525 LDVYAFGVLMLEMLSG 540
           +DV+A G +  E+LSG
Sbjct: 184 VDVWAIGCVFAELLSG 199

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 321 LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK----GSVYRGKI--GGD 372
           L +   DFL+   + AQ +  +  FE ++   T  F     +K    G+ Y  KI     
Sbjct: 5   LAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK 64
Query: 373 FVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG 432
            V +K++    +++ ++L  +N   L++L     +  N Y+V E    G +   +  + G
Sbjct: 65  VVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIG 122
Query: 433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE 492
           +F +   R   A  V T   YLHS      +++D+K  N+L+D     ++ +F  A+   
Sbjct: 123 RFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 175
Query: 493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
           R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ +
Sbjct: 176 RVKGR---TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPI 230
Query: 553 LLVD------VLNPVLHKEDGEESLRHLM 575
            + +      V  P     D ++ LR+L+
Sbjct: 231 QIYEKIVSGKVRFPSHFSSDLKDLLRNLL 259

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 133/284 (46%), Gaps = 29/284 (10%)
Query: 307 SSSFEACEKASNKK-LDEESRDFLESISDIAQ-SLKVYTFEELQA-ATDDFNPSCWIK-- 361
           +++ +  E+ S K+ L +   DFL+     AQ +  +  FE ++   T  F     +K  
Sbjct: 25  AAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHK 84
Query: 362 --GSVYRGKI--GGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN 417
             G+ Y  KI      V +K++    +++ ++L  +N   L++L     +  N Y+V E 
Sbjct: 85  ETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD 477
              G +   +  + G+F +   R   A  V T   YLHS      +++D+K  N+L+D  
Sbjct: 144 VPGGEMFSHLR-RIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQ 198
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEM 537
              ++ +F  A+   R +G    T  + GT  Y+APE + +   +  +D +A GVL+ EM
Sbjct: 199 GYIQVTDFGFAK---RVKGR---TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252
Query: 538 LSGKEAPALYSEENMLLVD------VLNPVLHKEDGEESLRHLM 575
            +G   P  ++++ + + +      V  P     D ++ LR+L+
Sbjct: 253 AAG--YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 294

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 130
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F  A+    +E E+ 
Sbjct: 131 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 182
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 183 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 236
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 237 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 284 ARDPQRYL 291

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC- 127
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F  A+    +E E+ 
Sbjct: 128 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 180 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 233
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 234 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 281 ARDPQRYL 288

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 149
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 150 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 257
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 258 FPSHFSSDLKDLLRNLL 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+++D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 169
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+  +        T  +
Sbjct: 170 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GATWTL 219
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 277
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 278 FPSHFSSDLKDLLRNLL 294

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ LL  +NH ++I LL +           + YLV E  ++ +L   I+ +    LD
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---CT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +     +  +D+++ G +M E++ G
Sbjct: 179 NFMMTPYVV-TRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 162
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 149
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 150 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 257
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 258 FPSHFSSDLKDLLRNLL 274

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 130 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 180
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 131 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 181
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 149
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 150 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 199
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 257
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 258 FPSHFSSDLKDLLRNLL 274

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 132 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 182
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 139 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 189
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 131 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 181
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 133 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 183
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME----LD 117
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 118 HERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 171
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 172 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 139 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 189
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 136 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 186
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 136 ILRGLKYIHSADI---IHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY------VA 186
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 140 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 190
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 146 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 196
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK----GGKFL-DWAQ 439
           D+  ++  +++  + RLLGIC       L+ +    G L  ++ +     G ++L +W  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC- 123
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                + +A G+NYL        VH+D+   NVL+ T    KI +F  A+    +E E+ 
Sbjct: 124 -----VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
                V  K +MA E + + + + + DV+++GV + E+++    P      + +    ++
Sbjct: 176 AEGGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEIS 229
Query: 560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-------MDKI 612
            +L K  GE   +           PP+  I V  ++  C   D   RP          K+
Sbjct: 230 SILEK--GERLPQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 613 AQSISRFL 620
           A+   R+L
Sbjct: 277 ARDPQRYL 284

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 144 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 194
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 136 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 186
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 141 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 191
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 153 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 203
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 140 ILRGLKYIHSADI---IHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY------VA 190
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 17/165 (10%)
Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
           +  N YLV +  V G L   ++    +  +   R  +A ++   ++ +H      +VH+D
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLH---YVHRD 200
Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLV 521
           IK  N+L+D +   ++A+F      +  E     +S  VGT  Y++PE L+      G  
Sbjct: 201 IKPDNILMDMNGHIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258
Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL-HKE 565
             + D ++ GV M EML G E P  Y+E    LV+    ++ HKE
Sbjct: 259 GPECDWWSLGVCMYEMLYG-ETP-FYAES---LVETYGKIMNHKE 298

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 136 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 186
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 146 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 196
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 26/166 (15%)
Query: 386 QIKLLNKINHSSLIRLLGIC--------FNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +++LL  + H ++I LL +         FN  + YLV  + +   L+  +  K  K  D 
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFN--DVYLV-THLMGADLNNIV--KCQKLTD- 153
Query: 438 AQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
              +Q  +  +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +  
Sbjct: 154 -DHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 209
Query: 497 EFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            +      V T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 210 GY------VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 154 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 204
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 130 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 180
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 146 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 196
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 26/166 (15%)
Query: 386 QIKLLNKINHSSLIRLLGIC--------FNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +++LL  + H ++I LL +         FN  + YLV  + +   L+  +  K  K  D 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFN--DVYLV-THLMGADLNNIV--KCAKLTD- 120
Query: 438 AQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
              +Q  +  +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +  
Sbjct: 121 -DHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 497 EFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            +      V T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 177 GY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 154 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 204
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +       +  V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGXVA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 157 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 207
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 157 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY------VA 207
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 145 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 195
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 153 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 203
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 140 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 190
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 140 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VA 190
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 162
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+APE + +   +  +D +A GVL+ +M +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 101/239 (42%), Gaps = 26/239 (10%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +++K++H  L+   G+CF G    LV E    GSL  ++  K    ++   ++++A  +A
Sbjct: 65  MMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLA 123
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             +++L   T    +H ++   N+LL  +   K  N    + ++       L   I+  +
Sbjct: 124 WAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 509 -GYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
             ++ PE +EN   ++   D ++FG  + E+ SG + P                 L   D
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-----------------LSALD 223
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA 625
            +  L+   D   +   P   A  +  LI +C+  +P  RP+   I + ++      L 
Sbjct: 224 SQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++++   +NH ++++L  +       YLV E A  G +  ++    G+  +   R +   
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLV-AHGRXKEKEARAKFR- 120
Query: 446 DVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
            + + + Y H  F     VH+D+K  N+LLD D   KIA+F  +        EF   + +
Sbjct: 121 QIVSAVQYCHQKFI----VHRDLKAENLLLDADXNIKIADFGFS-------NEFTFGNKL 169
Query: 505 ---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSG 540
               G   Y APE  +       ++DV++ GV++  ++SG
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 125
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 179
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 180 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 125
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 179
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 180 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 118
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 172
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 173 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T ++V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 125
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 179
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 180 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 69  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 123
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 124 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 177
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 178 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 118
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 172
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 173 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 117
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 171
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 172 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + YLV E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YLV +  V G L   ++    K  +   R  I  ++   ++ +H      +VH+DIK  N
Sbjct: 166 YLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG-EMVLAIDSIHQLH---YVHRDIKPDN 221
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGL--VSTKLD 526
           VLLD +   ++A+F      +  +     +S  VGT  Y++PE L   E+G+     + D
Sbjct: 222 VLLDVNGHIRLADFGSC--LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 279
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
            ++ GV M EML G E P  Y+E    LV+    +++ E+  +   H+ D S +      
Sbjct: 280 WWSLGVCMYEMLYG-ETP-FYAES---LVETYGKIMNHEERFQFPSHVTDVSEEAK---- 330
Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
              L+ RLI  C ++   G+  ++   +         L WE  +N+ 
Sbjct: 331 --DLIQRLI--CSRERRLGQNGIEDFKKHA---FFEGLNWENIRNLE 370

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F +T  +V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 179 SFMMTPEVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 119
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 120 FYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 172
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YLV +  V G L   ++    K  +   R  I  ++   ++ +H      +VH+DIK  N
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG-EMVLAIDSIHQLH---YVHRDIKPDN 205
Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGL--VSTKLD 526
           VLLD +   ++A+F      +  +     +S  VGT  Y++PE L   E+G+     + D
Sbjct: 206 VLLDVNGHIRLADFGSC--LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 263
Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
            ++ GV M EML G E P  Y+E    LV+    +++ E+  +   H+ D S +      
Sbjct: 264 WWSLGVCMYEMLYG-ETP-FYAES---LVETYGKIMNHEERFQFPSHVTDVSEEAK---- 314
Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
              L+ RLI  C ++   G+  ++   +         L WE  +N+ 
Sbjct: 315 --DLIQRLI--CSRERRLGQNGIEDFKKHA---FFEGLNWENIRNLE 354

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  + +          V 
Sbjct: 154 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGXVA 204
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH   N   +H+D+K  N+ L+ D   KI +F LA   E  +GE   T  + GT  
Sbjct: 154 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKT--LCGTPN 207
Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L     S ++D+++ G ++  +L GK
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-PAERQEGEFALTSHIV 505
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  A+   G        V
Sbjct: 141 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-------YV 190
Query: 506 GTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 119
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 120 FYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 172
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-PAERQEGEFALTSHIV 505
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  A+   G        V
Sbjct: 141 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-------YV 190
Query: 506 GTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 119
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 120 FYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 172
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 118
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 119 FYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 171
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI  F LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-PAERQEGEFALTSHIV 505
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +F LAR  A+   G        V
Sbjct: 141 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-------YV 190
Query: 506 GTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 125
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 126 FYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 178
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+ K    G   A K +   + ++       I++L   +H  +++LLG  ++ G  +
Sbjct: 33  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92
Query: 413 LVYENAVNGSLSVWIN--DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
           ++ E    G++   +   D+G   L   Q   +   +   LN+LHS      +H+D+K  
Sbjct: 93  IMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAG 146
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY-----LENGLVSTKL 525
           NVL+  +   ++A+F +   + +           +GT  +MAPE      +++     K 
Sbjct: 147 NVLMTLEGDIRLADFGV---SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 526 DVYAFGVLMLEM 537
           D+++ G+ ++EM
Sbjct: 204 DIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+ K    G   A K +   + ++       I++L   +H  +++LLG  ++ G  +
Sbjct: 25  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 84
Query: 413 LVYENAVNGSLSVWIN--DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
           ++ E    G++   +   D+G   L   Q   +   +   LN+LHS      +H+D+K  
Sbjct: 85  IMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAG 138
Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY-----LENGLVSTKL 525
           NVL+  +   ++A+F ++    +           +GT  +MAPE      +++     K 
Sbjct: 139 NVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 526 DVYAFGVLMLEM 537
           D+++ G+ ++EM
Sbjct: 196 DIWSLGITLIEM 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI ++ LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSL--SVWINDKGGKFLDWAQRIQ 442
           D++ +L +++H ++++L     +  N+YLV E    G L   + +  K  + +D A    
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE-VDAA---V 125
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFA 499
           I   V +G  YLH       VH+D+K  N+LL++  R    KI +F L+  A  + G   
Sbjct: 126 IMKQVLSGTTYLHKHNI---VHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVG--G 178
Query: 500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                +GT  Y+APE L       K DV++ GV++  +L G
Sbjct: 179 KMKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 364 VYRGKIGGDFVAIKKVYGDASD----QIKLLNKIN-HSSLIRLLGICFNGGNWYLVYE-- 416
           V++G   G  VA+K++  D  D    +IKLL + + H ++IR           Y+  E  
Sbjct: 50  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 109
Query: 417 --NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
             N  +   S  ++D+  K       I +   +A+G+ +LHS      +H+D+K  N+L+
Sbjct: 110 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILV 166
Query: 475 DT-------------DFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
            T             + R  I++F L +  +  +  F    ++  GT G+ APE LE   
Sbjct: 167 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEEST 226
Query: 521 ---VSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESLRHLM 575
              ++  +D+++ G +   +LS  + P    YS E+ ++  + +         + ++ L 
Sbjct: 227 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL--------DEMKCLH 278
Query: 576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL 635
           D S+              LI   +  DP  RP   K+       L   L W  SK +  L
Sbjct: 279 DRSLIAE--------ATDLISQMIDHDPLKRPTAMKV-------LRHPLFWPKSKKLEFL 323

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 364 VYRGKIGGDFVAIKKVYGDASD----QIKLLNKIN-HSSLIRLLGICFNGGNWYLVYE-- 416
           V++G   G  VA+K++  D  D    +IKLL + + H ++IR           Y+  E  
Sbjct: 50  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 109
Query: 417 --NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
             N  +   S  ++D+  K       I +   +A+G+ +LHS      +H+D+K  N+L+
Sbjct: 110 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI---IHRDLKPQNILV 166
Query: 475 DT-------------DFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLENGL 520
            T             + R  I++F L +  +  +  F    ++  GT G+ APE LE   
Sbjct: 167 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEEST 226
Query: 521 ---VSTKLDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESLRHLM 575
              ++  +D+++ G +   +LS  + P    YS E+ ++  + +         + ++ L 
Sbjct: 227 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL--------DEMKCLH 278
Query: 576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISEL 635
           D S+              LI   +  DP  RP   K+       L   L W  SK +  L
Sbjct: 279 DRSLIAE--------ATDLISQMIDHDPLKRPTAMKV-------LRHPLFWPKSKKLEFL 323

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 24/171 (14%)
Query: 439 QRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE 497
             +QI + ++   L +LH       +++DIK  N+LLD++    + +F L++     E E
Sbjct: 159 HEVQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 498 FALTSHIVGTKGYMAPEYLENGLV--STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLV 555
            A      GT  YMAP+ +  G       +D ++ GVLM E+L+G     +  E+N    
Sbjct: 216 RAYD--FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---- 269
Query: 556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                       E S R L     +  YP   + L   LI+  L KDP  R
Sbjct: 270 ---------SQAEISRRIL---KSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 18/188 (9%)
Query: 362 GSVYRGKIGGDFVAIKKV-YGDASDQIKLLNKINHSSL-----IRLLGICFNGGNWYLVY 415
             + R K+  + VA+K +  G A D+      INH SL     +R   +     +  ++ 
Sbjct: 36  ARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E A  G L   I +  G+F +   R      + +G++Y HS       H+D+K  N LLD
Sbjct: 96  EYASGGELYERICN-AGRFSEDEARFFFQ-QLLSGVSYCHSMQI---CHRDLKLENTLLD 150
Query: 476 TD--FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVYAFGV 532
                R KI +F  ++ +       +     VGT  Y+APE L       K+ DV++ GV
Sbjct: 151 GSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 533 LMLEMLSG 540
            +  ML G
Sbjct: 207 TLYVMLVG 214

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT  Y+AP  + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 244
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 245 FYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 297
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK--GGKFLDWAQRIQI 443
           +I++L K+NH  +I++    F+  ++Y+V E    G L     DK  G K L  A     
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF----DKVVGNKRLKEATCKLY 258
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFAL 500
              +   + YLH       +H+D+K  NVLL   + D   KI +F  ++      GE +L
Sbjct: 259 FYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSL 311
Query: 501 TSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSG 540
              + GT  Y+APE L +      +  +D ++ GV++   LSG
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 127/304 (41%), Gaps = 58/304 (19%)
Query: 364 VYRGKIGGDFVAIKKVYGDASD----QIKLLNKIN-HSSLIRLLGICFNGGNWYLVYE-- 416
           V++G   G  VA+K++  D  D    +IKLL + + H ++IR           Y+  E  
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91
Query: 417 --NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
             N  +   S  ++D+  K       I +   +A+G+ +LHS      +H+D+K  N+L+
Sbjct: 92  NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI---IHRDLKPQNILV 148
Query: 475 DT-------------DFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLE--N 518
            T             + R  I++F L +  +  +  F    ++  GT G+ APE LE  N
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208
Query: 519 GLVSTK-----LDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESL 571
            L + +     +D+++ G +   +LS  + P    YS E+ ++  + +         + +
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL--------DEM 260
Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKN 631
           + L D S+              LI   +  DP  RP   K+       L   L W  SK 
Sbjct: 261 KCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAMKV-------LRHPLFWPKSKK 305
Query: 632 ISEL 635
           +  L
Sbjct: 306 LEFL 309

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL ++H   N   V++D+K +N+LLD     +I++  LA    +++   +    
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSG 540
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL ++H   N   V++D+K +N+LLD     +I++  LA    +++   +    
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSG 540
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL ++H   N   V++D+K +N+LLD     +I++  LA    +++   +    
Sbjct: 297 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 349
Query: 504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSG 540
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G
Sbjct: 350 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 386 QIKLLNKINHSSLIRLLGIC--------FNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +++LL  + H ++I LL +         FN  + YLV  + +   L+  +  K  K  D 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFN--DVYLV-THLMGADLNNIV--KSQKLTD- 124
Query: 438 AQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
              +Q  +  +  GL Y+HS      +H+D+K SN+ ++ D   KI +F L R  + +  
Sbjct: 125 -DHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT 180
Query: 497 EFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
            +      V T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 181 GY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH 503
           A ++  GL ++H   N   V++D+K +N+LLD     +I++  LA    +++   +    
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSG 540
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 337 QSLKVYTFEELQAATDDFNPS-CW-IKGSVYRGKIGGDF---------VAIKKVYGDASD 385
           QS+K Y     +  T D NP   W I G +  G  G  +         +A  KV    S+
Sbjct: 21  QSMKQY-----EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE 75
Query: 386 Q--------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +        I +L   +H ++++LL   +   N +++ E    G++   +  +  + L  
Sbjct: 76  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA-VMLELERPLTE 134
Query: 438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE 497
           +Q   +       LNYLH   +   +H+D+K  N+L   D   K+A+F ++    R    
Sbjct: 135 SQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX--- 188
Query: 498 FALTSHIVGTKGYMAPEYL-----ENGLVSTKLDVYAFGVLMLEM 537
                  +GT  +MAPE +     ++     K DV++ G+ ++EM
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
           D+++ L YLH       +H+D+K  N++L    +    KI +   A+  E  +GE  L +
Sbjct: 130 DISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGE--LCT 182
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             VGT  Y+APE LE    +  +D ++FG L  E ++G
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
           D+++ L YLH       +H+D+K  N++L    +    KI +   A+  E  +GE  L +
Sbjct: 129 DISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGE--LCT 181
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             VGT  Y+APE LE    +  +D ++FG L  E ++G
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH   N   +H+D+K  N+ L+ D   KI +F LA   E  +GE      + GT  
Sbjct: 138 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGE--RKKDLCGTPN 191
Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L     S ++D+++ G ++  +L GK
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---- 489
           FL     I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR    
Sbjct: 187 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 243
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P    
Sbjct: 244 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 294
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
               + +D           EE  R L +   +   P  T   + + +  C   +PS RP 
Sbjct: 295 --PGVKID-----------EEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 340
Query: 609 MDKIAQSISRFLNAS 623
             ++ + +   L A+
Sbjct: 341 FSELVEHLGNLLQAN 355

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 44/229 (19%)
Query: 337 QSLKVYTFEELQAATDDFNPS-CW-IKGSVYRGKIGGDF---------VAIKKVYGDASD 385
           QS+K Y     +  T D NP   W I G +  G  G  +         +A  KV    S+
Sbjct: 21  QSMKQY-----EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE 75
Query: 386 Q--------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +        I +L   +H ++++LL   +   N +++ E    G++   +  +  + L  
Sbjct: 76  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA-VMLELERPLTE 134
Query: 438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA----RPAER 493
           +Q   +       LNYLH   +   +H+D+K  N+L   D   K+A+F ++    R  +R
Sbjct: 135 SQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 494 QEGEFALTSHIVGTKGYMAPEYL-----ENGLVSTKLDVYAFGVLMLEM 537
           ++         +GT  +MAPE +     ++     K DV++ G+ ++EM
Sbjct: 192 RDS-------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---- 489
           FL     I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR    
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P    
Sbjct: 246 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 296
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
               + +D           EE  R L +   +   P  T   + + +  C   +PS RP 
Sbjct: 297 --PGVKID-----------EEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 342
Query: 609 MDKIAQSISRFLNAS 623
             ++ + +   L A+
Sbjct: 343 FSELVEHLGNLLQAN 357

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 337 QSLKVYTFEELQAATDDFNPS-CW-IKGSVYRGKIGGDF---------VAIKKVYGDASD 385
           QS+K Y     +  T D NP   W I G +  G  G  +         +A  KV    S+
Sbjct: 21  QSMKQY-----EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE 75
Query: 386 Q--------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDW 437
           +        I +L   +H ++++LL   +   N +++ E    G++   +  +  + L  
Sbjct: 76  EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA-VMLELERPLTE 134
Query: 438 AQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE 497
           +Q   +       LNYLH   +   +H+D+K  N+L   D   K+A+F ++    R    
Sbjct: 135 SQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX--- 188
Query: 498 FALTSHIVGTKGYMAPEYL-----ENGLVSTKLDVYAFGVLMLEM 537
                  +GT  +MAPE +     ++     K DV++ G+ ++EM
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 127/304 (41%), Gaps = 58/304 (19%)
Query: 364 VYRGKIGGDFVAIKKVYGDASD----QIKLLNKIN-HSSLIRLLGICFNGGNWYLVYE-- 416
           V++G   G  VA+K++  D  D    +IKLL + + H ++IR           Y+  E  
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91
Query: 417 --NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
             N  +   S  ++D+  K       I +   +A+G+ +LHS      +H+D+K  N+L+
Sbjct: 92  NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI---IHRDLKPQNILV 148
Query: 475 DT-------------DFRAKIANFALARPAERQEGEFALT-SHIVGTKGYMAPEYLE--N 518
            T             + R  I++F L +  +  +  F    ++  GT G+ APE LE  N
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESN 208
Query: 519 GLVSTK-----LDVYAFGVLMLEMLSGKEAP--ALYSEENMLLVDVLNPVLHKEDGEESL 571
            L + +     +D+++ G +   +LS  + P    YS E+ ++  + +         + +
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL--------DEM 260
Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKN 631
           + L D S+              LI   +  DP  RP   K+       L   L W  SK 
Sbjct: 261 KCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAMKV-------LRHPLFWPKSKK 305
Query: 632 ISEL 635
           +  L
Sbjct: 306 LEFL 309

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/239 (20%), Positives = 100/239 (41%), Gaps = 26/239 (10%)
Query: 389 LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           +++K++H  L+   G+C  G    LV E    GSL  ++  K    ++   ++++A  +A
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLA 123
Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             +++L   T    +H ++   N+LL  +   K  N    + ++       L   I+  +
Sbjct: 124 AAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 509 -GYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
             ++ PE +EN   ++   D ++FG  + E+ SG + P                 L   D
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-----------------LSALD 223
Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA 625
            +  L+   D   +   P   A  +  LI +C+  +P  RP+   I + ++      L 
Sbjct: 224 SQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 38/202 (18%)
Query: 371 GDFVAIKKVYG---DASD------QIKLLNKIN-HSSLIRLLGICF--NGGNWYLVYENA 418
           G+ VA+KK++    +++D      +I +L +++ H +++ LL +    N  + YLV++  
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD-Y 92
Query: 419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF 478
           +   L   I       L+   +  +   +   + YLHS      +H+D+K SN+LL+ + 
Sbjct: 93  METDLHAVIR---ANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAEC 146
Query: 479 RAKIANFALARP------------------AERQEGEFALTSHIVGTKGYMAPEYLENGL 520
             K+A+F L+R                    E  + +  + +  V T+ Y APE L    
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 521 VSTK-LDVYAFGVLMLEMLSGK 541
             TK +D+++ G ++ E+L GK
Sbjct: 207 KYTKGIDMWSLGCILGEILCGK 228

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH   N   +H+D+K  N+ L+ D   KI +F LA   E  +GE      + GT  
Sbjct: 154 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGE--RKKDLCGTPN 207
Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L     S ++D+++ G ++  +L GK
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 15/173 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++   + H +++RL       G  YLV++    G L   I  +  ++   A       
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCIH 137
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAE-RQEGEFALT 501
            +   +N++H       VH+D+K  N+LL +  +    K+A+F LA   +  Q+  F   
Sbjct: 138 QILESVNHIHQHDI---VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA 194
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
               GT GY++PE L        +D++A GV++  +L G   P  + E+   L
Sbjct: 195 ----GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG--YPPFWDEDQHKL 241

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 381 GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR 440
           G  + +I +L+++ H+++I++L I  N G + LV E   +G       D+  + LD    
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLA 132
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
             I   + + + YL        +H+DIK  N+++  DF  K+ +F  A   ER  G+   
Sbjct: 133 SYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFY 187
Query: 501 TSHIVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLMLEML--------------SGKEAPA 545
           T    GT  Y APE L  N     +L++++ GV +  ++              +    P 
Sbjct: 188 T--FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY 245
Query: 546 LYSEENMLLVD-VLNPVLHKEDGEESLRHLMDP 577
           L S+E M LV  +L PV  +    E L  + DP
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKL--VTDP 276

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---- 489
           FL     I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR    
Sbjct: 194 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 250
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P    
Sbjct: 251 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 301
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
               + +D           EE  R L +   +   P  T   + + +  C   +PS RP 
Sbjct: 302 --PGVKID-----------EEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 347
Query: 609 MDKIAQSISRFLNAS 623
             ++ + +   L A+
Sbjct: 348 FSELVEHLGNLLQAN 362

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 111/236 (47%), Gaps = 42/236 (17%)
Query: 366 RGKIGGDFVAIKKVYGDASD----------QIKLLNKINHSSLIRLLGI---CFNGGNWY 412
           R ++ G  VAIKK+  +A D          ++K+L    H ++I +  I       G + 
Sbjct: 75  RRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 133
Query: 413 LVYE--NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            VY   + +   L   I+      L+  +     L    GL Y+HS      +H+D+K S
Sbjct: 134 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL--LRGLKYMHSAQV---IHRDLKPS 188
Query: 471 NVLLDTDFRAKIANFALAR-----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK- 524
           N+L++ +   KI +F +AR     PAE Q   + +T + V T+ Y APE + +    T+ 
Sbjct: 189 NLLVNENCELKIGDFGMARGLCTSPAEHQ---YFMTEY-VATRWYRAPELMLSLHEYTQA 244
Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN--------MLLVDVLNPVLHKEDGEESLR 572
           +D+++ G +  EML+ ++   L+  +N        M+++   +P + +  G E +R
Sbjct: 245 IDLWSVGCIFGEMLARRQ---LFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVR 297

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YLH   N   +H+D+K  N+ L+ D   KI +F LA   E  +GE      + GT  
Sbjct: 154 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGE--RKKXLCGTPN 207
Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y+APE L     S ++D+++ G ++  +L GK
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR---- 489
           FL     I  +  VA G+ +L S      +H+D+   N+LL      KI +F LAR    
Sbjct: 196 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 252
Query: 490 -PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ S   +P    
Sbjct: 253 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 303
Query: 549 EENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
               + +D           EE  R L +   +   P  T   + + +  C   +PS RP 
Sbjct: 304 --PGVKID-----------EEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 349
Query: 609 MDKIAQSISRFLNAS 623
             ++ + +   L A+
Sbjct: 350 FSELVEHLGNLLQAN 364

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 91/195 (46%), Gaps = 27/195 (13%)
Query: 362 GSVYRGK--IGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
            +VY+GK  +  + VA+K++  +  +        ++ LL  + H++++ L  I     + 
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 75
Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV+E  ++  L  +++D  G  ++          +  GL Y H       +H+D+K  N
Sbjct: 76  TLVFE-YLDKDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQN 130
Query: 472 VLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLD 526
           +L++     K+A+F LAR    P +  + E       V T  Y  P+ L      ST++D
Sbjct: 131 LLINERGELKLADFGLARAKSIPTKTYDNE-------VVTLWYRPPDILLGSTDYSTQID 183
Query: 527 VYAFGVLMLEMLSGK 541
           ++  G +  EM +G+
Sbjct: 184 MWGVGCIFYEMATGR 198

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           D++ +L +++H ++++L     +  N+YLV E    G L   I  +  KF +    + I 
Sbjct: 53  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR-QKFSEVDAAV-IM 110
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALT 501
             V +G  YLH       VH+D+K  N+LL++  R    KI +F L+   E         
Sbjct: 111 KQVLSGTTYLHKHNI---VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG----GKM 163
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
              +GT  Y+APE L       K DV++ GV++  +L G
Sbjct: 164 KERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCG 201

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 72  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 126
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A    G
Sbjct: 127 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA----G 179
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
              +    V T+ Y APE +        +D+++ G +M EM+ G
Sbjct: 180 TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 75  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 129
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 130 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 183
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 184 SFMMTPYVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA 444
           ++ ++L  +N   L++L     +  N Y+V E    G +   +  + G+F +   R   A
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA 148
Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             V T   YLHS      +++D+K  N+L+D     ++ +F  A+   R +G    T  +
Sbjct: 149 QIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGR---TWXL 198
Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD------VL 558
            GT   +APE + +   +  +D +A GVL+ EM +G   P  ++++ + + +      V 
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG--YPPFFADQPIQIYEKIVSGKVR 256
Query: 559 NPVLHKEDGEESLRHLM 575
            P     D ++ LR+L+
Sbjct: 257 FPSHFSSDLKDLLRNLL 273

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 413 LVYENAVNGSLSVWIND----KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
           LV E   +G+L  ++      K      W ++I        GL +LH+ T PP +H+D+K
Sbjct: 106 LVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLHTRT-PPIIHRDLK 158
Query: 469 CSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           C N+ +       KI +  LA     +   FA    ++GT  + APE  E     + +DV
Sbjct: 159 CDNIFITGPTGSVKIGDLGLATL---KRASFA--KAVIGTPEFXAPEXYEEKYDES-VDV 212
Query: 528 YAFGVLMLEMLSGKEAPALYSE 549
           YAFG   LE  +  E P  YSE
Sbjct: 213 YAFGXCXLEXATS-EYP--YSE 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 111/236 (47%), Gaps = 42/236 (17%)
Query: 366 RGKIGGDFVAIKKVYGDASD----------QIKLLNKINHSSLIRLLGI---CFNGGNWY 412
           R ++ G  VAIKK+  +A D          ++K+L    H ++I +  I       G + 
Sbjct: 74  RRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132
Query: 413 LVYE--NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            VY   + +   L   I+      L+  +     L    GL Y+HS      +H+D+K S
Sbjct: 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL--LRGLKYMHSAQV---IHRDLKPS 187
Query: 471 NVLLDTDFRAKIANFALAR-----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK- 524
           N+L++ +   KI +F +AR     PAE Q   + +T + V T+ Y APE + +    T+ 
Sbjct: 188 NLLVNENCELKIGDFGMARGLCTSPAEHQ---YFMTEY-VATRWYRAPELMLSLHEYTQA 243
Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN--------MLLVDVLNPVLHKEDGEESLR 572
           +D+++ G +  EML+ ++   L+  +N        M+++   +P + +  G E +R
Sbjct: 244 IDLWSVGCIFGEMLARRQ---LFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVR 296

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 64  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 118
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A     
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 172
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            F +T ++V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 173 SFMMTPYVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++  K+ H +++RL          YLV++    G L   I  +  +F   A       
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
            +   + Y HS      VH+++K  N+LL +  +    K+A+F LA      E       
Sbjct: 113 QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 168
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
              GT GY++PE L+    S  +D++A GV++  +L G   P  + E+   L
Sbjct: 169 ---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQHRL 215

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++  K+ H +++RL          YLV++    G L   I  +  +F   A       
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 111
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
            +   + Y HS      VH+++K  N+LL +  +    K+A+F LA      E       
Sbjct: 112 QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 167
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
              GT GY++PE L+    S  +D++A GV++  +L G   P  + E+   L
Sbjct: 168 ---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQHRL 214

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 116
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 117 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 172
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 173 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 228
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 229 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++  K+ H +++RL          YLV++    G L   I  +  +F   A       
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 112
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
            +   + Y HS      VH+++K  N+LL +  +    K+A+F LA      E       
Sbjct: 113 QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 168
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
              GT GY++PE L+    S  +D++A GV++  +L G   P  + E+   L
Sbjct: 169 ---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQHRL 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 116
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 117 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 172
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 173 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 228
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 229 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 131
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   ++ +H       VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 132 YWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 188 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 238
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 239 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 18/188 (9%)
Query: 362 GSVYRGKIGGDFVAIKKV-YGDASDQIKLLNKINHSSL-----IRLLGICFNGGNWYLVY 415
             + R K   + VA+K +  G+  D+      INH SL     +R   +     +  +V 
Sbjct: 35  ARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVM 94
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E A  G L   I +  G+F +   R      + +G++Y H+       H+D+K  N LLD
Sbjct: 95  EYASGGELFERICN-AGRFSEDEARF-FFQQLISGVSYAHAMQV---AHRDLKLENTLLD 149
Query: 476 TD--FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVYAFGV 532
                R KIA+F  ++ +       +     VGT  Y+APE L       K+ DV++ GV
Sbjct: 150 GSPAPRLKIADFGYSKASVLH----SQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGV 205
Query: 533 LMLEMLSG 540
            +  ML G
Sbjct: 206 TLYVMLVG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G+V++ K     + VA+K+V  D  D+         I LL ++ H +++RL  +  +   
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
             LV+E   +  L  + +   G  LD          +  GL + HS      +H+D+K  
Sbjct: 76  LTLVFE-FCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKPQ 130
Query: 471 NVLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKL 525
           N+L++ +   K+ANF LAR    P      E       V T  Y  P+ L    L ST +
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRCYSAE-------VVTLWYRPPDVLFGAKLYSTSI 183
Query: 526 DVYAFGVLMLEM 537
           D+++ G +  E+
Sbjct: 184 DMWSAGCIFAEL 195

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 159
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   ++ +H       VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 160 YWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 216 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 266
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 267 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 112
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   ++ +H       VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 113 YWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 169 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 219
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 220 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 369 IGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
           I    +A   + G    +I  L  + H  +I+L  +  +     +V E A N  L  +I 
Sbjct: 37  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 95
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            +       A+R      + + + Y H       VH+D+K  N+LLD     KIA+F L+
Sbjct: 96  QRDKMSEQEARRF--FQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLS 150
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSGKEAPALY 547
                 +G F  TS   G+  Y APE +   L +  ++DV++ GV++  ML  +  P  +
Sbjct: 151 NIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLP--F 203
Query: 548 SEENMLLVDVLNPVLHKE--DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG 605
            +E++       PVL K   +G  +L   + P   G            LI+  L  +P  
Sbjct: 204 DDESI-------PVLFKNISNGVYTLPKFLSPGAAG------------LIKRMLIVNPLN 244
Query: 606 RPAMDKIAQS 615
           R ++ +I Q 
Sbjct: 245 RISIHEIMQD 254

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++  K+ H +++RL          YLV++    G L   I  +  +F   A       
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 135
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTS 502
            +   + Y HS      VH+++K  N+LL +  +    K+A+F LA      E       
Sbjct: 136 QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-- 190
Query: 503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
              GT GY++PE L+    S  +D++A GV++  +L G   P  + E+   L
Sbjct: 191 --AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQHRL 238

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 159
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   L  +H+      VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 160 YWKNM---LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 216 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 266
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 267 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 131
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   ++ +H       VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 132 YWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDS 187
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 188 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 238
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 239 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 115
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   ++ +H       VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 116 YWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 171
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 172 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 222
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 223 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 268

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +  LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +  LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 369 IGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
           I    +A   + G    +I  L  + H  +I+L  +  +     +V E A N  L  +I 
Sbjct: 41  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 99
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            +       A+R      + + + Y H       VH+D+K  N+LLD     KIA+F L+
Sbjct: 100 QRDKMSEQEARRF--FQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLS 154
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSGKEAPALY 547
                 +G F  TS   G+  Y APE +   L +  ++DV++ GV++  ML  +  P  +
Sbjct: 155 NIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLP--F 207
Query: 548 SEENMLLVDVLNPVLHK--EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG 605
            +E++       PVL K   +G  +L   + P   G            LI+  L  +P  
Sbjct: 208 DDESI-------PVLFKNISNGVYTLPKFLSPGAAG------------LIKRMLIVNPLN 248
Query: 606 RPAMDKIAQS 615
           R ++ +I Q 
Sbjct: 249 RISIHEIMQD 258

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 45/209 (21%)
Query: 366 RGKIGGDFVAIKKVYGDASD------QIKLLNKINHSSLIRLLGICFNGGNW-------- 411
           R  +   + AIKK+            ++ LL  +NH  ++R         N+        
Sbjct: 26  RNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85
Query: 412 -----YLVYENAVNGSL-----SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                ++  E   NG+L     S  +N +  ++  W    ++   +   L+Y+HS     
Sbjct: 86  KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY--W----RLFRQILEALSYIHS---QG 136
Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH-----------IVGTKGY 510
            +H+D+K  N+ +D     KI +F LA+   R      L S             +GT  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 511 MAPEYLE-NGLVSTKLDVYAFGVLMLEML 538
           +A E L+  G  + K+D+Y+ G++  EM+
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L +I H ++I L  I  N  +  L+ E    G L  ++ +K     D A   Q   
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA--TQFLK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGEFALT 501
            +  G++YLHS       H D+K  N+ LLD +    R K+ +F +A   E    EF   
Sbjct: 123 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEF--- 175
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           +  ++I ++N+++H++LI+L     +  +  LV E    G L   I D+     +    I
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE-LDTI 190
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVL-LDTDFRA-KIANFALAR---PAERQEG 496
                +  G+ ++H       +H D+K  N+L ++ D +  KI +F LAR   P E+ + 
Sbjct: 191 LFMKQICEGIRHMHQMYI---LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            F       GT  ++APE +    VS   D+++ GV+   +LSG
Sbjct: 248 NF-------GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 55  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 111
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   ++ +H       VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 112 YWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 167
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 168 Q-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 218
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 219 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 264

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L +I H ++I L  I  N  +  L+ E    G L  ++ +K     D A   Q   
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA--TQFLK 115
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGEFALT 501
            +  G++YLHS       H D+K  N+ LLD +    R K+ +F +A   E    EF   
Sbjct: 116 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF--- 168
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 369 IGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
           I    +A   + G    +I  L  + H  +I+L  +  +     +V E A N  L  +I 
Sbjct: 46  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 104
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            +       A+R      + + + Y H       VH+D+K  N+LLD     KIA+F L+
Sbjct: 105 QRDKMSEQEARRF--FQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLS 159
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSGKEAPALY 547
                 +G F  TS   G+  Y APE +   L +  ++DV++ GV++  ML  +  P  +
Sbjct: 160 NIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLP--F 212
Query: 548 SEENMLLVDVLNPVLHKE--DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG 605
            +E++       PVL K   +G  +L   + P   G            LI+  L  +P  
Sbjct: 213 DDESI-------PVLFKNISNGVYTLPKFLSPGAAG------------LIKRMLIVNPLN 253
Query: 606 RPAMDKIAQS 615
           R ++ +I Q 
Sbjct: 254 RISIHEIMQD 263

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 369 IGGDFVAIKKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
           I    +A   + G    +I  L  + H  +I+L  +  +     +V E A N  L  +I 
Sbjct: 47  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 105
Query: 429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALA 488
            +       A+R      + + + Y H       VH+D+K  N+LLD     KIA+F L+
Sbjct: 106 QRDKMSEQEARRF--FQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLS 160
Query: 489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSGKEAPALY 547
                 +G F  TS   G+  Y APE +   L +  ++DV++ GV++  ML  +  P  +
Sbjct: 161 NIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLP--F 213
Query: 548 SEENMLLVDVLNPVLHK--EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG 605
            +E++       PVL K   +G  +L   + P   G            LI+  L  +P  
Sbjct: 214 DDESI-------PVLFKNISNGVYTLPKFLSPGAAG------------LIKRMLIVNPLN 254
Query: 606 RPAMDKIAQS 615
           R ++ +I Q 
Sbjct: 255 RISIHEIMQD 264

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICF 406
           G VY+G + G         VAIK +   A   ++        L  ++ H +++ LLG+  
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99
Query: 407 NGGNWYLVYENAVNGSLSVWI-------------NDKGGK-FLDWAQRIQIALDVATGLN 452
                 +++    +G L  ++             +D+  K  L+    + +   +A G+ 
Sbjct: 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 159
Query: 453 YLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA 512
           YL S      VHKD+   NVL+      KI++  L R     +    L + ++  + +MA
Sbjct: 160 YLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR-WMA 215
Query: 513 PEYLENGLVSTKLDVYAFGVLMLEMLS 539
           PE +  G  S   D++++GV++ E+ S
Sbjct: 216 PEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 15/173 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++   + H +++RL       G+ YL+++    G L   I  +  ++   A       
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQ 128
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAE-RQEGEFALT 501
            +   + + H       VH+D+K  N+LL +  +    K+A+F LA   E  Q+  F   
Sbjct: 129 QILEAVLHCHQMGV---VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 185
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
               GT GY++PE L        +D++A GV++  +L G   P  + E+   L
Sbjct: 186 ----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--YPPFWDEDQHRL 232

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L +I H ++I L  I  N  +  L+ E    G L  ++ +K     D A   Q   
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA--TQFLK 136
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGEFALT 501
            +  G++YLHS       H D+K  N+ LLD +    R K+ +F +A   E    EF   
Sbjct: 137 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF--- 189
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 190 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +  GL Y+HS      +H+D+K SN+ ++ D   KI +  LAR  + +   +      V 
Sbjct: 134 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY------VA 184
Query: 507 TKGYMAPEYLENGL-VSTKLDVYAFGVLMLEMLSGK 541
           T+ Y APE + N +  +  +D+++ G +M E+L+G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   ++ +L +I H ++I L  +  N  +  L+ E    G L  ++ +K    L   +  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEAT 117
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEGE 497
           +    +  G+ YLHS       H D+K  N+ LLD +    R KI +F LA   +    E
Sbjct: 118 EFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NE 173
Query: 498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           F    +I GT  ++APE +    +  + D+++ GV+   +LSG  +P L   +   L +V
Sbjct: 174 F---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDTKQETLANV 229
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                            ++   +  Y   T+ L    I   L KDP  R
Sbjct: 230 ---------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 362 GSVYRGKIGG-------DFVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICF 406
           G VY+G + G         VAIK +   A   ++        L  ++ H +++ LLG+  
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 407 NGGNWYLVYENAVNGSLSVWI-------------NDKGGK-FLDWAQRIQIALDVATGLN 452
                 +++    +G L  ++             +D+  K  L+    + +   +A G+ 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142
Query: 453 YLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA 512
           YL S      VHKD+   NVL+      KI++  L R     +    L + ++  + +MA
Sbjct: 143 YLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR-WMA 198
Query: 513 PEYLENGLVSTKLDVYAFGVLMLEMLS 539
           PE +  G  S   D++++GV++ E+ S
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 441 IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL 500
           ++  +D+A G+ YL S      +H+D+   N +L  D    +A+F L+R     +     
Sbjct: 140 VRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP 560
            +  +  K ++A E L + L +   DV+AFGV M E+++  + P    E      ++ N 
Sbjct: 197 CASKLPVK-WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN----AEIYNY 251
Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA 608
           ++    G   L+           PP     V  L+  C   DP  RP+
Sbjct: 252 LI----GGNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPS 285

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 35/193 (18%)
Query: 374 VAIKKVYGDASD------------------QIKLLNKINHSSLIRLLGICFN-----GGN 410
           VAIK+V+   SD                  +I+LLN  +H +++ L  I  +        
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKC 469
            YLV E  +   L+  I+D+  + +   Q IQ  +  +  GL+ LH       VH+D+  
Sbjct: 109 LYLVTE-LMRTDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHP 162
Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVY 528
            N+LL  +    I +F LA    R++   A  +H V  + Y APE +      TKL D++
Sbjct: 163 GNILLADNNDITICDFNLA----REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMW 218
Query: 529 AFGVLMLEMLSGK 541
           + G +M EM + K
Sbjct: 219 SAGCVMAEMFNRK 231

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 13/171 (7%)
Query: 375 AIKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK 433
            I K   D S++I++L +   H ++I L  +  +G + YLV E    G L   I  +  K
Sbjct: 59  VIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--K 116
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL-LDTDFRA---KIANFALAR 489
           F    +   +   +   + YLHS      VH+D+K SN+L +D        +I +F  A+
Sbjct: 117 FFSEREASFVLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAK 173
Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
               + G      +   T  ++APE L+        D+++ G+L+  ML+G
Sbjct: 174 QLRAENGLLMTPCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 15/104 (14%)
Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH--- 503
           +   L+Y+HS      +H+D+K  N+ +D     KI +F LA+   R      L S    
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 504 --------IVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLMLEML 538
                    +GT  Y+A E L+  G  + K+D+Y+ G++  EM+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G+V++ K     + VA+K+V  D  D+         I LL ++ H +++RL  +  +   
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
             LV+E   +  L  + +   G  LD          +  GL + HS      +H+D+K  
Sbjct: 76  LTLVFE-FCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKPQ 130
Query: 471 NVLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKL 525
           N+L++ +   K+A+F LAR    P      E       V T  Y  P+ L    L ST +
Sbjct: 131 NLLINRNGELKLADFGLARAFGIPVRCYSAE-------VVTLWYRPPDVLFGAKLYSTSI 183
Query: 526 DVYAFGVLMLEM 537
           D+++ G +  E+
Sbjct: 184 DMWSAGCIFAEL 195

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQE-GEFALTS-HIVG 506
           GL YLH+      +H D+K  NVLL +D  RA + +F  A   +    G+  LT  +I G
Sbjct: 162 GLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           T+ +MAPE +       K+D+++   +ML ML+G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 35/193 (18%)
Query: 374 VAIKKVYGDASD------------------QIKLLNKINHSSLIRLLGICFN-----GGN 410
           VAIK+V+   SD                  +I+LLN  +H +++ L  I  +        
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL-DVATGLNYLHSFTNPPHVHKDIKC 469
            YLV E  +   L+  I+D+  + +   Q IQ  +  +  GL+ LH       VH+D+  
Sbjct: 109 LYLVTE-LMRTDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHP 162
Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVY 528
            N+LL  +    I +F LA    R++   A  +H V  + Y APE +      TKL D++
Sbjct: 163 GNILLADNNDITICDFNLA----REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMW 218
Query: 529 AFGVLMLEMLSGK 541
           + G +M EM + K
Sbjct: 219 SAGCVMAEMFNRK 231

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 52/230 (22%)
Query: 368 KIGGDFVAIKK---VYGDASD------QIKLLNKINHSSLIRLLGICFNGG-----NWYL 413
           K+    VAIKK   V+ D  D      +I +LN++NH  ++++L I            Y+
Sbjct: 75  KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           V E A +    ++   +   +L       +  ++  G+ Y+HS      +H+D+K +N L
Sbjct: 135 VLEIADSDFKKLF---RTPVYLTELHIKTLLYNLLVGVKYVHSAGI---LHRDLKPANCL 188
Query: 474 LDTDFRAKIANFALAR------------PAERQEGEF-------------ALTSHIVGTK 508
           ++ D   K+ +F LAR            P   +E +               LT H+V T+
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV-TR 247
Query: 509 GYMAPEYL---ENGLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLL 554
            Y APE +   EN   +  +DV++ G +  E+L+  KE  A +++   L 
Sbjct: 248 WYRAPELILLQEN--YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 345 EELQAATDDFNPSCWIKGSVY------RGKIGGDFVAIKKVYG--DASDQIKLLNKINHS 396
           +  +   DD  P   +    Y      R    G  +A+K++    ++ +Q +LL  ++ S
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 397 S-------LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI------QI 443
                    +   G  F  G+ ++  E  ++ SL  +      + +D  Q I      +I
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICME-LMDTSLDKFYK----QVIDKGQTIPEDILGKI 158
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG---EFAL 500
           A+ +   L +LHS  +   +H+D+K SNVL++   + K+ +F ++       G   +   
Sbjct: 159 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDSVA 209
Query: 501 TSHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLMLEM 537
            +   G K YMAPE +   L     S K D+++ G+ M+E+
Sbjct: 210 KTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A    G
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA----G 177
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
              +    V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 178 TSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 13/171 (7%)
Query: 375 AIKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK 433
            I K   D S++I++L +   H ++I L  +  +G + YLV E    G L   I  +  K
Sbjct: 59  VIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--K 116
Query: 434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL-LDTDFRA---KIANFALAR 489
           F    +   +   +   + YLHS      VH+D+K SN+L +D        +I +F  A+
Sbjct: 117 FFSEREASFVLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAK 173
Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
               + G      +   T  ++APE L+        D+++ G+L+  ML+G
Sbjct: 174 QLRAENGLLMTPCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQE-GEFALTS-HIVG 506
           GL YLH+      +H D+K  NVLL +D  RA + +F  A   +    G+  LT  +I G
Sbjct: 176 GLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           T+ +MAPE +       K+D+++   +ML ML+G
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   +  + + + H  ++ LL    + G  Y+V+E      L   I  +      +++ +
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 442 --QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEG 496
                  +   L Y H       +H+D+K  NVLL   +     K+ +F +A     Q G
Sbjct: 132 ASHYMRQILEALRYCHDNNI---IHRDVKPENVLLASKENSAPVKLGDFGVAI----QLG 184
Query: 497 EFALTSH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           E  L +   VGT  +MAPE ++       +DV+  GV++  +LSG
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQE-GEFALTS-HIVG 506
           GL YLH+      +H D+K  NVLL +D  RA + +F  A   +    G+  LT  +I G
Sbjct: 178 GLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           T+ +MAPE +       K+D+++   +ML ML+G
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 376 IKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           I K   D +++I++L +   H ++I L  +  +G   Y+V E    G L   I  +  KF
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KF 112
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARP 490
               +   +   +   + YLH+      VH+D+K SN+L   +       +I +F  A+ 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
              + G      +   T  ++APE LE        D+++ GVL+  ML+G
Sbjct: 170 LRAENGLLMTPCY---TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 18/184 (9%)
Query: 366 RGKIGGDFVAIKKV-YGDASDQIKLLNKINHSSL-----IRLLGICFNGGNWYLVYENAV 419
           R K   + VA+K +  G+  D+      INH SL     +R   +     +  +V E A 
Sbjct: 38  RDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 97
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-- 477
            G L   I +  G+F +   R      + +G++Y H+       H+D+K  N LLD    
Sbjct: 98  GGELFERICN-AGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPA 152
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLMLE 536
            R KI +F  ++ +       +     VGT  Y+APE L       K+ DV++ GV +  
Sbjct: 153 PRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 208
Query: 537 MLSG 540
           ML G
Sbjct: 209 MLVG 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 38/235 (16%)
Query: 385 DQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ 442
           ++I  LNK+   S  +IRL          Y+V E   N  L+ W+  K  K +D  +R  
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKS 159
Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
              ++   L  +H+      VH D+K +N L+  D   K+ +F +A   +         S
Sbjct: 160 YWKNM---LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 503 HIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLMLEMLSGKEAPALYSEEN 551
             VG   YM PE +       ENG   +K+    DV++ G ++  M  GK          
Sbjct: 216 Q-VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------- 266
Query: 552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                ++N +         L  ++DP+ +  +P +    +  +++ CLK+DP  R
Sbjct: 267 --FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 15/173 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++   + HS+++RL       G  YLV++    G L   I  +  ++   A       
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCIQ 110
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAE-RQEGEFALT 501
            +   + + H       VH+D+K  N+LL +  +    K+A+F LA   +  Q+  F   
Sbjct: 111 QILEAVLHCHQMGV---VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
               GT GY++PE L        +D++A GV++  +L G   P  + E+   L
Sbjct: 168 ----GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG--YPPFWDEDQHKL 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 24/164 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I+ ++ + H +L+ L     +     ++YE    G L   + D+  K  +  + ++   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DEAVEYMR 262
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI- 504
            V  GL ++H      +VH D+K  N++           F   R  E +  +F LT+H+ 
Sbjct: 263 QVCKGLCHMHENN---YVHLDLKPENIM-----------FTTKRSNELKLIDFGLTAHLD 308
Query: 505 --------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    GT  + APE  E   V    D+++ GVL   +LSG
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 383 ASDQIKLLNKINHSSLIRLLGI------CFNGGNWYLVYENAVNGSLSVWINDKGGKFLD 436
           A  ++ L+  +NH ++I LL +           + Y+V E  ++ +L   I  +    LD
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LD 124
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
             +   +   +  G+ +LHS      +H+D+K SN+++ +D   KI +F LAR A    G
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA----G 177
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
              +    V T+ Y APE +        +D+++ G +M EM+  K
Sbjct: 178 TSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 18/184 (9%)
Query: 366 RGKIGGDFVAIK------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV 419
           R K   + VA+K      K+  +   +I     + H +++R   +     +  +V E A 
Sbjct: 39  RDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 98
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-- 477
            G L   I +  G+F +   R      + +G++Y H+       H+D+K  N LLD    
Sbjct: 99  GGELFERICN-AGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPA 153
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLMLE 536
            R KI +F  ++ +       +     VGT  Y+APE L       K+ DV++ GV +  
Sbjct: 154 PRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 537 MLSG 540
           ML G
Sbjct: 210 MLVG 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 81/204 (39%), Gaps = 40/204 (19%)
Query: 362 GSVY--RGKIGGDFVAIKKV---YGDASDQIKLLNKI-------NHSSLIRLLGICFNGG 409
           G V+  R K  G   A+K+    +    D+ + L ++        H   +RL      GG
Sbjct: 71  GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 410 NWYLVYE---NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
             YL  E    ++      W     G  L  AQ      D    L +LHS      VH D
Sbjct: 131 ILYLQTELCGPSLQQHCEAW-----GASLPEAQVWGYLRDTLLALAHLHSQGL---VHLD 182
Query: 467 IKCSNVLLDTDFRAKIANFAL------ARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
           +K +N+ L    R K+ +F L      A   E QEG+            YMAPE L+ G 
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGD----------PRYMAPELLQ-GS 231
Query: 521 VSTKLDVYAFGVLMLEMLSGKEAP 544
             T  DV++ G+ +LE+    E P
Sbjct: 232 YGTAADVFSLGLTILEVACNMELP 255

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 15/173 (8%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           + ++   + H +++RL       G+ YL+++    G L   I  +  ++   A       
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQ 117
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA---KIANFALARPAE-RQEGEFALT 501
            +   + + H       VH+++K  N+LL +  +    K+A+F LA   E  Q+  F   
Sbjct: 118 QILEAVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
               GT GY++PE L        +D++A GV++  +L G   P  + E+   L
Sbjct: 175 ----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--YPPFWDEDQHRL 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 24/164 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +I+ ++ + H +L+ L     +     ++YE    G L   + D+  K  +  + ++   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DEAVEYMR 156
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI- 504
            V  GL ++H      +VH D+K  N++           F   R  E +  +F LT+H+ 
Sbjct: 157 QVCKGLCHMHENN---YVHLDLKPENIM-----------FTTKRSNELKLIDFGLTAHLD 202
Query: 505 --------VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                    GT  + APE  E   V    D+++ GVL   +LSG
Sbjct: 203 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 347 LQAATDDFNPSCWIKGSVY------RGKIGGDFVAIKKVYG--DASDQIKLLNKINHSS- 397
           ++   DD  P   +    Y      R    G  +A+K++    ++ +Q +LL  ++ S  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 398 ------LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI------QIAL 445
                  +   G  F  G+ ++  E  ++ SL  +      + +D  Q I      +IA+
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICME-LMDTSLDKFYK----QVIDKGQTIPEDILGKIAV 116
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI- 504
            +   L +LHS  +   +H+D+K SNVL++   + K+ +F ++           L   + 
Sbjct: 117 SIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISG---------YLVDDVA 165
Query: 505 ----VGTKGYMAPEYLENGL----VSTKLDVYAFGVLMLEM 537
                G K YMAPE +   L     S K D+++ G+ M+E+
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQ 439
           +   +I+LL ++ H ++I+L+ + +N      Y+V E  V G +   ++    K     Q
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ 110
Query: 440 RIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA 499
                  +  GL YLHS      VHKDIK  N+LL T    KI+   +A         FA
Sbjct: 111 AHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALH----PFA 163
Query: 500 LTSHIVGTKGYMA--PEYLENGLVS---TKLDVYAFGVLMLEMLSG 540
                  ++G  A  P  + NGL +    K+D+++ GV +  + +G
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 362 GSVYRGKIGGDFVAIK--KVYGDASDQIKLLNK-------INHSSLIRLLGICFNGGNWY 412
           G VY G+  G+ VAI+   +  D  DQ+K   +         H +++  +G C +  +  
Sbjct: 47  GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105
Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           ++       +L   + D     LD  +  QIA ++  G+ YLH+      +HKD+K  NV
Sbjct: 106 IITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNV 161
Query: 473 LLDTDFRAKIANFAL-----ARPAERQEGEFALTSHIVGTKGYMAPEYL--------ENG 519
             D   +  I +F L        A R+E +  + +   G   ++APE +        E+ 
Sbjct: 162 FYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEIIRQLSPDTEEDK 217
Query: 520 L-VSTKLDVYAFGVLMLEMLSGKEAP 544
           L  S   DV+A G +  E L  +E P
Sbjct: 218 LPFSKHSDVFALGTIWYE-LHAREWP 242

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 18/184 (9%)
Query: 366 RGKIGGDFVAIKKV-YGDASDQIKLLNKINHSSL-----IRLLGICFNGGNWYLVYENAV 419
           R K   + VA+K +  G+  D+      INH SL     +R   +     +  +V E A 
Sbjct: 39  RDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 98
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-- 477
            G L   I +  G+F +   R      + +G++Y H+       H+D+K  N LLD    
Sbjct: 99  GGELFERICN-AGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPA 153
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLMLE 536
            R KI  F  ++ +       +     VGT  Y+APE L       K+ DV++ GV +  
Sbjct: 154 PRLKICAFGYSKSSVLH----SQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 537 MLSG 540
           ML G
Sbjct: 210 MLVG 213

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 18/184 (9%)
Query: 366 RGKIGGDFVAIKKV-YGDASDQIKLLNKINHSSL-----IRLLGICFNGGNWYLVYENAV 419
           R K   + VA+K +  G+  D+      INH SL     +R   +     +  +V E A 
Sbjct: 39  RDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 98
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-- 477
            G L   I +  G+F +   R      + +G++Y H+       H+D+K  N LLD    
Sbjct: 99  GGELFERICN-AGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPA 153
Query: 478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLMLE 536
            R KI  F  ++ +       +     VGT  Y+APE L       K+ DV++ GV +  
Sbjct: 154 PRLKICAFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 537 MLSG 540
           ML G
Sbjct: 210 MLVG 213

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 25/178 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA- 444
           + ++   + H +++RL       G  YLV++    G L          F D   R   + 
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----------FEDIVAREYYSE 102
Query: 445 LDVATGLNYLHSFTNPPH----VHKDIKCSNVLLDTDFRA---KIANFALARPAE-RQEG 496
            D +  +  +    N  H    VH+D+K  N+LL +  +    K+A+F LA   +  Q+ 
Sbjct: 103 ADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQA 162
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
            F       GT GY++PE L        +D++A GV++  +L G   P  + E+   L
Sbjct: 163 WFGF----AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG--YPPFWDEDQHRL 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 25/178 (14%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIA- 444
           + ++   + H +++RL       G  YLV++    G L          F D   R   + 
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----------FEDIVAREYYSE 102
Query: 445 LDVATGLNYLHSFTNPPH----VHKDIKCSNVLLDTDFRA---KIANFALARPAE-RQEG 496
            D +  +  +    N  H    VH+D+K  N+LL +  +    K+A+F LA   +  Q+ 
Sbjct: 103 ADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQA 162
Query: 497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
            F       GT GY++PE L        +D++A GV++  +L G   P  + E+   L
Sbjct: 163 WFGFA----GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG--YPPFWDEDQHRL 214

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 349 AATDDFNPSCWIKGSVYRGKI-------GGDFVAIKKVYGDASDQIKLLNKINHS----- 396
           A TDD+  S  + G    GK+        G   A+K +Y    D  K   +++H      
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKARQEVDHHWQASG 80
Query: 397 --SLIRLLGICFNGGN----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATG 450
              ++ +L +  N  +      ++ E    G L   I ++G +     +  +I  D+ T 
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 451 LNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           + +LHS       H+D+K  N+L    + D   K+ +F  A+    +  + AL +    T
Sbjct: 141 IQFLHSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCY-T 192
Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
             Y+APE L         D+++ GV+M  +L G   P  YS
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG--FPPFYS 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           +++++  + H  L+ L     +  + ++V +  + G L   +  +   F +   ++ I  
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFIC- 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           ++   L+YL    N   +H+D+K  N+LLD      I +F +A    R   E  +T+ + 
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITT-MA 175
Query: 506 GTKGYMAPEYL---ENGLVSTKLDVYAFGVLMLEMLSGK 541
           GTK YMAPE     +    S  +D ++ GV   E+L G+
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 349 AATDDFNPSCWIKGSVYRGKI-------GGDFVAIKKVYGDASDQIKLLNKINHS----- 396
           A TDD+  S  + G    GK+        G   A+K +Y    D  K   +++H      
Sbjct: 6   AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKARQEVDHHWQASG 61
Query: 397 --SLIRLLGICFNGGN----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATG 450
              ++ +L +  N  +      ++ E    G L   I ++G +     +  +I  D+ T 
Sbjct: 62  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 451 LNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           + +LHS       H+D+K  N+L    + D   K+ +F  A+    +  + AL +    T
Sbjct: 122 IQFLHSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCY-T 173
Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS 548
             Y+APE L         D+++ GV+M  +L G   P  YS
Sbjct: 174 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG--FPPFYS 212

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV 505
           +V   L+ +HS      +H+D+K  N+LLD     K+A+F      +  E         V
Sbjct: 182 EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAV 236
Query: 506 GTKGYMAPEYLE----NGLVSTKLDVYAFGVLMLEMLSG 540
           GT  Y++PE L+    +G    + D ++ GV + EML G
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 376 IKKVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF 434
           I K   D +++I++L +   H ++I L  +  +G   Y+V E    G L   I  +  KF
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ--KF 112
Query: 435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARP 490
               +   +   +   + YLH+      VH+D+K SN+L   +       +I +F  A+ 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
              + G      +   T  ++APE LE        D+++ GVL+   L+G
Sbjct: 170 LRAENGLLXTPCY---TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
           WA R   A +V   L+ +HS      +H+D+K  N+LLD     K+A+F       + EG
Sbjct: 169 WA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EG 222
Query: 497 EFALTSHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVLMLEMLSG 540
                   VGT  Y++PE L+    +G    + D ++ GV + EML G
Sbjct: 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/318 (20%), Positives = 120/318 (37%), Gaps = 67/318 (21%)
Query: 366 RGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           R K  G++V ++++  +A           ++ +    NH +++            ++V  
Sbjct: 31  RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 90
Query: 417 NAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIKCSNVL 473
               GS    I      F+D    + IA     V   L+Y+H      +VH+ +K S++L
Sbjct: 91  FMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHIL 144
Query: 474 LDTDFRAKI----ANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLDV 527
           +  D +  +    +N ++    +RQ        + V    +++PE L+  L     K D+
Sbjct: 145 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 204
Query: 528 YAFGVLMLEMLSG----KEAPALYSEENMLLVDVLN---PVLHKEDGEESLRHLMDPSM- 579
           Y+ G+   E+ +G    K+ PA       +L++ LN   P L       +    M PS  
Sbjct: 205 YSVGITACELANGHVPFKDMPA-----TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 259
Query: 580 ------------------QGNYP--PVTAIL---VIRLIESCLKKDPSGRPAMDKIAQSI 616
                              G+ P  P            +E CL+++P  RP       S 
Sbjct: 260 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP-------SA 312
Query: 617 SRFLNASLAWELSKNISE 634
           S  LN S   ++ +  SE
Sbjct: 313 STLLNHSFFKQIKRRASE 330

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/318 (20%), Positives = 120/318 (37%), Gaps = 67/318 (21%)
Query: 366 RGKIGGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           R K  G++V ++++  +A           ++ +    NH +++            ++V  
Sbjct: 47  RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106
Query: 417 NAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIKCSNVL 473
               GS    I      F+D    + IA     V   L+Y+H      +VH+ +K S++L
Sbjct: 107 FMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHIL 160
Query: 474 LDTDFRAKI----ANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLDV 527
           +  D +  +    +N ++    +RQ        + V    +++PE L+  L     K D+
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220
Query: 528 YAFGVLMLEMLSG----KEAPALYSEENMLLVDVLN---PVLHKEDGEESLRHLMDPSM- 579
           Y+ G+   E+ +G    K+ PA       +L++ LN   P L       +    M PS  
Sbjct: 221 YSVGITACELANGHVPFKDMPA-----TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275
Query: 580 ------------------QGNYP--PVTAIL---VIRLIESCLKKDPSGRPAMDKIAQSI 616
                              G+ P  P            +E CL+++P  RP       S 
Sbjct: 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP-------SA 328
Query: 617 SRFLNASLAWELSKNISE 634
           S  LN S   ++ +  SE
Sbjct: 329 STLLNHSFFKQIKRRASE 346

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 384 SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQI 443
            ++I ++N+++H  LI L     +     L+ E    G L   I  +  K  + A+ I  
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-AEVINY 154
Query: 444 ALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA--KIANFALARPAERQEGEFALT 501
                 GL ++H  +    VH DIK  N++ +T   +  KI +F LA      E    + 
Sbjct: 155 MRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IV 207
Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
                T  + APE ++   V    D++A GVL   +LSG
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
           WA R   A +V   L+ +HS      +H+D+K  N+LLD     K+A+F       + EG
Sbjct: 174 WA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EG 227
Query: 497 EFALTSHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVLMLEMLSG 540
                   VGT  Y++PE L+    +G    + D ++ GV + EML G
Sbjct: 228 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
           +I L     LN+L    N   +H+DIK SN+LLD     K+ +F ++     Q  +    
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAK 182
Query: 502 SHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           +   G + YMAPE ++          + DV++ G+ + E+ +G+     Y + N +  D 
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP---YPKWNSVF-DQ 238
Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
           L  V+  +  +      +  S +  + P      I  +  CL KD S RP
Sbjct: 239 LTQVVKGDPPQ------LSNSEEREFSPS----FINFVNLCLTKDESKRP 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 437 WAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG 496
           WA R   A +V   L+ +HS      +H+D+K  N+LLD     K+A+F       + EG
Sbjct: 174 WA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EG 227
Query: 497 EFALTSHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVLMLEMLSG 540
                   VGT  Y++PE L+    +G    + D ++ GV + EML G
Sbjct: 228 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGIC----- 405
           G V+  R +  G  VA+KKV  +         A  +IK+L  + H +++ L+ IC     
Sbjct: 32  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 91
Query: 406 -FN--GGNWYLVY---ENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFT 458
            +N   G+ YLV+   E+ + G LS  +     KF L   +R+   L    GL Y+H   
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML--LNGLYYIHRNK 145
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEFALTSHIVGTKGYMAPEYLE 517
               +H+D+K +NVL+  D   K+A+F LAR  +  +  +     + V T  Y  PE L 
Sbjct: 146 I---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 518 NGL-VSTKLDVYAFGVLMLEM 537
                   +D++  G +M EM
Sbjct: 203 GERDYGPPIDLWGAGCIMAEM 223

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 38/197 (19%)
Query: 368 KIGGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGI----CFNGGNWYLVY 415
           K  G+ VAIKK+              +IK+L    H ++I +  I     F   N   + 
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 416 ENAVNGSLSVWI------NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           +  +   L   I      +D    F+    R   A+ V  G N          +H+D+K 
Sbjct: 93  QELMQTDLHRVISTQMLSDDHIQYFIYQTLR---AVKVLHGSNV---------IHRDLKP 140
Query: 470 SNVLLDTDFRAKIANFALAR-----PAERQE--GEFALTSHIVGTKGYMAPE-YLENGLV 521
           SN+L++++   K+ +F LAR      A+  E  G+ +  +  V T+ Y APE  L +   
Sbjct: 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKY 200
Query: 522 STKLDVYAFGVLMLEML 538
           S  +DV++ G ++ E+ 
Sbjct: 201 SRAMDVWSCGCILAELF 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 38/197 (19%)
Query: 368 KIGGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGI----CFNGGNWYLVY 415
           K  G+ VAIKK+              +IK+L    H ++I +  I     F   N   + 
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 416 ENAVNGSLSVWI------NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           +  +   L   I      +D    F+    R   A+ V  G N          +H+D+K 
Sbjct: 93  QELMQTDLHRVISTQMLSDDHIQYFIYQTLR---AVKVLHGSNV---------IHRDLKP 140
Query: 470 SNVLLDTDFRAKIANFALAR-----PAERQE--GEFALTSHIVGTKGYMAPE-YLENGLV 521
           SN+L++++   K+ +F LAR      A+  E  G+ +  +  V T+ Y APE  L +   
Sbjct: 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKY 200
Query: 522 STKLDVYAFGVLMLEML 538
           S  +DV++ G ++ E+ 
Sbjct: 201 SRAMDVWSCGCILAELF 217

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 46/203 (22%)
Query: 374 VAIKKV---YGDASD------QIKLLNKINHSSLIRLLGIC-----FNGGNWYLVYENAV 419
           VAIKKV   + D  D      +I +LN++    +IRL  +            Y+V E A 
Sbjct: 54  VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
           +    ++   K   FL       I  ++  G N++H       +H+D+K +N LL+ D  
Sbjct: 114 SDLKKLF---KTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCS 167
Query: 480 AKIANFALARPAERQEG--------------------EFALTSHIVGTKGYMAPEYL--- 516
            K+ +F LAR    ++                     +  LTSH+V T+ Y APE +   
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQ 226
Query: 517 ENGLVSTKLDVYAFGVLMLEMLS 539
           EN   +  +D+++ G +  E+L+
Sbjct: 227 EN--YTKSIDIWSTGCIFAELLN 247

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 398 LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSF 457
           +I L  +  N     L+ E A  G +      +  + +     I++   +  G+ YLH  
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 458 TNPPHVHKDIKCSNVLLDTDF---RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
                VH D+K  N+LL + +     KI +F ++R      G       I+GT  Y+APE
Sbjct: 151 NI---VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----GHACELREIMGTPEYLAPE 203
Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
            L    ++T  D++  G++   ML    +P +                  ED +E+  ++
Sbjct: 204 ILNYDPITTATDMWNIGIIAY-MLLTHTSPFV-----------------GEDNQETYLNI 245
Query: 575 MDPSMQGNYPPVTAI--LVIRLIESCLKKDPSGRPAMD 610
              ++  +    +++  L    I+S L K+P  RP  +
Sbjct: 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGIC----- 405
           G V+  R +  G  VA+KKV  +         A  +IK+L  + H +++ L+ IC     
Sbjct: 31  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90
Query: 406 -FN--GGNWYLVY---ENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFT 458
            +N   G+ YLV+   E+ + G LS  +     KF L   +R+   L    GL Y+H   
Sbjct: 91  PYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML--LNGLYYIHRNK 144
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEFALTSHIVGTKGYMAPEYLE 517
               +H+D+K +NVL+  D   K+A+F LAR  +  +  +     + V T  Y  PE L 
Sbjct: 145 I---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 201
Query: 518 NGL-VSTKLDVYAFGVLMLEM 537
                   +D++  G +M EM
Sbjct: 202 GERDYGPPIDLWGAGCIMAEM 222

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 101/253 (39%), Gaps = 42/253 (16%)
Query: 316 ASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWI--------------- 360
           AS    D+   DFL+    I   LK     E++   DDF     I               
Sbjct: 30  ASELAQDKYVADFLQWAEPIVVRLK-----EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ 84
Query: 361 KGSVYRGKIGGDFVAIKKVYGDAS----DQIKLLNKINHSSLIRLLGICFNGGNW-YLVY 415
            G VY  KI   +  +K+  G+ S    ++  L+N       I  L   F   N+ YLV 
Sbjct: 85  TGQVYAMKIMNKWDMLKR--GEVSCFREERDVLVN--GDRRWITQLHFAFQDENYLYLVM 140
Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E  V G L   ++  G +      R  +A ++   ++ +H      +VH+DIK  N+LLD
Sbjct: 141 EYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLD 196
Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-------NGLVSTKLDVY 528
                ++A+F             +L +  VGT  Y++PE L+        G    + D +
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVA--VGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 529 AFGVLMLEMLSGK 541
           A GV   EM  G+
Sbjct: 255 ALGVFAYEMFYGQ 267

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 34/203 (16%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGIC----- 405
           G V+  R +  G  VA+KKV  +         A  +IK+L  + H +++ L+ IC     
Sbjct: 32  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 91
Query: 406 -FN--GGNWYLVY---ENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFT 458
            +N   G+ YLV+   E+ + G LS  +     KF L   +R+   L    GL Y+H   
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML--LNGLYYIHRNK 145
Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEFALTSHIVGTKGYMAPEYLE 517
               +H+D+K +NVL+  D   K+A+F LAR  +  +  +     + V T  Y  PE L 
Sbjct: 146 I---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 518 NGL-VSTKLDVYAFGVLMLEMLS 539
                   +D++  G +M EM +
Sbjct: 203 GERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   +  + + + H  ++ LL    + G  Y+V+E      L   I  +      +++ +
Sbjct: 74  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 133
Query: 442 --QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEG 496
                  +   L Y H       +H+D+K   VLL   +     K+  F +A     Q G
Sbjct: 134 ASHYMRQILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVAI----QLG 186
Query: 497 EFALTSH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           E  L +   VGT  +MAPE ++       +DV+  GV++  +LSG
Sbjct: 187 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L ++ H ++I L  +  N  +  L+ E    G L  ++  K    L   +      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEG-EFAL 500
            +  G+NYLH+       H D+K  N+ LLD +      K+ +F LA   E  +G EF  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF-- 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 38/197 (19%)
Query: 368 KIGGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGI----CFNGGNWYLVY 415
           K  G+ VAIKK+              +IK+L    H ++I +  I     F   N   + 
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 416 ENAVNGSLSVWI------NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           +  +   L   I      +D    F+    R   A+ V  G N          +H+D+K 
Sbjct: 93  QELMQTDLHRVISTQMLSDDHIQYFIYQTLR---AVKVLHGSNV---------IHRDLKP 140
Query: 470 SNVLLDTDFRAKIANFALAR-----PAERQE--GEFALTSHIVGTKGYMAPE-YLENGLV 521
           SN+L++++   K+ +F LAR      A+  E  G+ +     V T+ Y APE  L +   
Sbjct: 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200
Query: 522 STKLDVYAFGVLMLEML 538
           S  +DV++ G ++ E+ 
Sbjct: 201 SRAMDVWSCGCILAELF 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L ++ H ++I L  +  N  +  L+ E    G L  ++  K    L   +      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEG-EFAL 500
            +  G+NYLH+       H D+K  N+ LLD +      K+ +F LA   E ++G EF  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF-- 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L ++ H ++I L  +  N  +  L+ E    G L  ++  K    L   +      
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEG-EFAL 500
            +  G+NYLH+       H D+K  N+ LLD +      K+ +F LA   E  +G EF  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF-- 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 382 DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI 441
           D   +  + + + H  ++ LL    + G  Y+V+E      L   I  +      +++ +
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 442 --QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEG 496
                  +   L Y H       +H+D+K   VLL   +     K+  F +A     Q G
Sbjct: 132 ASHYMRQILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVAI----QLG 184
Query: 497 EFALTSH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
           E  L +   VGT  +MAPE ++       +DV+  GV++  +LSG
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L ++ H ++I L  +  N  +  L+ E    G L  ++  K    L   +      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEG-EFAL 500
            +  G+NYLH+       H D+K  N+ LLD +      K+ +F LA   E  +G EF  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF-- 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L ++ H ++I L  +  N  +  L+ E    G L  ++  K    L   +      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEG-EFAL 500
            +  G+NYLH+       H D+K  N+ LLD +      K+ +F LA   E  +G EF  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF-- 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 386 QIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL 445
           ++ +L ++ H ++I L  +  N  +  L+ E    G L  ++  K    L   +      
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 446 DVATGLNYLHSFTNPPHVHKDIKCSNV-LLDTDF---RAKIANFALARPAERQEG-EFAL 500
            +  G+NYLH+       H D+K  N+ LLD +      K+ +F LA   E  +G EF  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEF-- 175
Query: 501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
             +I GT  ++APE +    +  + D+++ GV+   +LSG
Sbjct: 176 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 362 GSVY--RGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGN 410
           G V+  R +  G  VA+KKV  +         A  +IK+L  + H +++ L+ IC    +
Sbjct: 32  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 91
Query: 411 WYLVYENAVNGSLSVWINDKGG-------KF-LDWAQRIQIALDVATGLNYLHSFTNPPH 462
            Y   + ++        +D  G       KF L   +R+   L    GL Y+H       
Sbjct: 92  PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--LNGLYYIHRNKI--- 146
Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEFALTSHIVGTKGYMAPEYLENGL- 520
           +H+D+K +NVL+  D   K+A+F LAR  +  +  +     + V T  Y  PE L     
Sbjct: 147 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERD 206
Query: 521 VSTKLDVYAFGVLMLEMLS 539
               +D++  G +M EM +
Sbjct: 207 YGPPIDLWGAGCIMAEMWT 225

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	635
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-78
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-76
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-73
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-63
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-45
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	2e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-32
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-30
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-24
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-12
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-09
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	3e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-06
1qzv_F	154	Plant photosystem I: subunit PSAF; photosynthesis,	6e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-05
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	7e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  250 bits (641), Expect = 2e-78
 Identities = 96/311 (30%), Positives = 158/311 (50%), Gaps = 34/311 (10%)

Query: 330 ESISDIAQSLKVYTFEELQAATDDFNPSCWIK----------GSVYRGKIGGDFVAIKK- 378
           +S+         ++F EL+  T++F+                G VY+G +    VA+KK 
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKL 62

Query: 379 --VYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN 428
             +    +++        IK++ K  H +L+ LLG   +G +  LVY    NGSL   ++
Sbjct: 63  AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122

Query: 429 DKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL 487
              G   L W  R +IA   A G+N+LH      H+H+DIK +N+LLD  F AKI++F L
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGL 179

Query: 488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPAL- 546
           AR +E +  +  +TS IVGT  YMAPE L  G ++ K D+Y+FGV++LE+++G   PA+ 
Sbjct: 180 ARASE-KFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGL--PAVD 235

Query: 547 YSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
              E  LL+D+    +  E+   ++   +D  M  +    +   +  +   CL +  + R
Sbjct: 236 EHREPQLLLDIKEE-IEDEEK--TIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291

Query: 607 PAMDKIAQSIS 617
           P + K+ Q + 
Sbjct: 292 PDIKKVQQLLQ 302

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  245 bits (629), Expect = 2e-76
 Identities = 91/296 (30%), Positives = 163/296 (55%), Gaps = 26/296 (8%)

Query: 338 SLKVYTFEELQAATDDFNPSCWIK----GSVYRGKIG-GDFVAIKKVYGDASDQ------ 386
            LK ++  ELQ A+D+F+    +     G VY+G++  G  VA+K++  +   Q      
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQF 74

Query: 387 ---IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI--NDKGGKFLDWAQRI 441
              +++++   H +L+RL G C       LVY    NGS++  +    +    LDW +R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 442 QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
           +IAL  A GL YLH   +P  +H+D+K +N+LLD +F A + +F LA+  +    +  +T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVT 192

Query: 502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK---EAPALYSEENMLLVDVL 558
           + + GT G++APEYL  G  S K DV+ +GV++LE+++G+   +   L ++++++L+D +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 559 NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
             +L ++  E     L+D  +QGNY       +I++   C +  P  RP M ++ +
Sbjct: 253 KGLLKEKKLEA----LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  236 bits (605), Expect = 5e-73
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 27/302 (8%)

Query: 325 SRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKV 379
             D L S   +          +L+ AT++F+    I     G VY+G +  G  VA+K+ 
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71

Query: 380 YGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI--ND 429
             + S Q        I+ L+   H  L+ L+G C       L+Y+   NG+L   +  +D
Sbjct: 72  TPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130

Query: 430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR 489
                + W QR++I +  A GL+YLH       +H+D+K  N+LLD +F  KI +F +++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA--PALY 547
               +  +  L++ + GT GY+ PEY   G ++ K DVY+FGV++ E+L  + A   +L 
Sbjct: 188 KGT-ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
            E  + L +      +       L  ++DP++     P +          CL      RP
Sbjct: 247 REM-VNLAEWAVESHNNGQ----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301

Query: 608 AM 609
           +M
Sbjct: 302 SM 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  211 bits (540), Expect = 1e-63
 Identities = 72/304 (23%), Positives = 122/304 (40%), Gaps = 33/304 (10%)

Query: 343 TFEELQAATDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGDASDQ------IKLLNK 392
             E L   +              G V++ ++  ++VA+K               +  L  
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74

Query: 393 INHSSLIRLLGICFNGGN----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           + H ++++ +G    G +     +L+      GSLS ++       + W +   IA  +A
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAETMA 131

Query: 449 TGLNYLHS-------FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT 501
            GL YLH           P   H+DIK  NVLL  +  A IA+F LA   E        T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE-AGKSAGDT 190

Query: 502 SHIVGTKGYMAPEYLENGL-----VSTKLDVYAFGVLMLEMLSGKEAPALYSEENML-LV 555
              VGT+ YMAPE LE  +        ++D+YA G+++ E+ S   A     +E ML   
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 556 DVLNPVLHKEDGEES-LRHLMDPSMQGNYPPVTAI-LVIRLIESCLKKDPSGRPAMDKIA 613
           + +      ED +E  +     P ++  +     + ++   IE C   D   R +   + 
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

Query: 614 QSIS 617
           + I+
Sbjct: 311 ERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  194 bits (495), Expect = 3e-57
 Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 32/273 (11%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G+V+R +  G  VA+K +                + ++ ++ H +++  +G      N  
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110

Query: 413 LVYENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +V E    GSL   ++  G +  LD  +R+ +A DVA G+NYLH+  NPP VH+++K  N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPN 169

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +L+D  +  K+ +F L+R   +     +  S   GT  +MAPE L +   + K DVY+FG
Sbjct: 170 LLVDKKYTVKVCDFGLSR--LKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           V++ E+ + ++ P  +   N+    V+  V  K       R      +  N  P     V
Sbjct: 227 VILWELATLQQ-P--W--GNLNPAQVVAAVGFK-----CKR----LEIPRNLNPQ----V 268

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
             +IE C   +P  RP+   I   +   + +++
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  184 bits (469), Expect = 2e-53
 Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 32/266 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           G V + K     VAIK++  ++  +     ++ L+++NH ++++L G C N     LV E
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79

Query: 417 NAVNGSLSVWINDKGGK-FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
            A  GSL   ++      +   A  +   L  + G+ YLHS      +H+D+K  N+LL 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139

Query: 476 TDFR-AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
                 KI +F  A      + +  +T++  G+  +MAPE  E    S K DV+++G+++
Sbjct: 140 AGGTVLKICDFGTAC-----DIQTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E+++ ++ P  + E       ++  V          R    P +  N P      +  L
Sbjct: 194 WEVITRRK-P--FDEIGGPAFRIMWAV------HNGTR----PPLIKNLPKP----IESL 236

Query: 595 IESCLKKDPSGRPAMDKIAQSISRFL 620
           +  C  KDPS RP+M++I + ++  +
Sbjct: 237 MTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  183 bits (467), Expect = 6e-53
 Identities = 72/334 (21%), Positives = 115/334 (34%), Gaps = 53/334 (15%)

Query: 343 TFEELQAATDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGDASDQ------IKLLNK 392
              E     D+      I     G+VY+G +    VA+K               I  +  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPL 63

Query: 393 INHSSLIRLLGICFNGG-----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           + H ++ R +             + LV E   NGSL  +++       DW    ++A  V
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSV 120

Query: 448 ATGLNYLHS------FTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR-----PAERQEG 496
             GL YLH+         P   H+D+   NVL+  D    I++F L+         R   
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 497 EFALTSHIVGTKGYMAPEYLENGL-------VSTKLDVYAFGVLMLEMLSGKEAPALYS- 548
           E       VGT  YMAPE LE  +          ++D+YA G++  E+            
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

Query: 549 --EENMLLVDVLNPVLHKED-----GEESLRHLMDPSMQGNYPPVTAIL--VIRLIESCL 599
             E  M     +      ED       E  R    P     +   +  +  +   IE C 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQR----PKFPEAWKENSLAVRSLKETIEDCW 296

Query: 600 KKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
            +D   R       + ++  +     WE +K++S
Sbjct: 297 DQDAEARLTAQXAEERMAELMM---IWERNKSVS 327

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  177 bits (451), Expect = 2e-51
 Identities = 74/272 (27%), Positives = 111/272 (40%), Gaps = 45/272 (16%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNGGN 410
           G VYR    GD VA+K    D  +             KL   + H ++I L G+C    N
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
             LV E A  G L+  ++   GK +     +  A+ +A G+NYLH     P +H+D+K S
Sbjct: 81  LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137

Query: 471 NVLLDTDFR--------AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           N+L+              KI +F LAR   R            G   +MAPE +   + S
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFS 192

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
              DV+++GVL+ E+L+G+  P  +    +  + V   V         L       +   
Sbjct: 193 KGSDVWSYGVLLWELLTGEV-P--F--RGIDGLAVAYGVAMN-----KLA----LPIPST 238

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
            P        +L+E C   DP  RP+   I  
Sbjct: 239 CPEP----FAKLMEDCWNPDPHSRPSFTNILD 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  176 bits (448), Expect = 1e-50
 Identities = 68/281 (24%), Positives = 129/281 (45%), Gaps = 49/281 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------------IKLLNKINHSSLIRLLGIC 405
           G V++G        VAIK +    S+               + +++ +NH ++++L G+ 
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
            N     +V E    G L   + DK    + W+ ++++ LD+A G+ Y+ +  NPP VH+
Sbjct: 93  HNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHR 148

Query: 466 DIKCSNVLLDT-----DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL--EN 518
           D++  N+ L +        AK+A+F L++ +          S ++G   +MAPE +  E 
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEE 202

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
              + K D Y+F +++  +L+G+  P  + E +   +  +N +  +      LR    P+
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEG-P--FDEYSYGKIKFINMIREE-----GLR----PT 250

Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF 619
           +  + PP     +  +IE C   DP  RP    I + +S  
Sbjct: 251 IPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  173 bits (441), Expect = 7e-50
 Identities = 54/274 (19%), Positives = 117/274 (42%), Gaps = 41/274 (14%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFN--GGN 410
           G +++G+  G+ + +K +                   L   +H +++ +LG C +    +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
             L+      GSL   +++     +D +Q ++ ALD+A G+ +LH+   P      +   
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSR 142

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN---GLVSTKLDV 527
           +V++D D  A+I+   +          F     +     ++APE L+           D+
Sbjct: 143 SVMIDEDMTARISMADVKF-------SFQSPGRM-YAPAWVAPEALQKKPEDTNRRSADM 194

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
           ++F VL+ E+++ +  P  +   ++  +++   V       E LR    P++     P  
Sbjct: 195 WSFAVLLWELVTREV-P--F--ADLSNMEIGMKV-----ALEGLR----PTIPPGISPH- 239

Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
              V +L++ C+ +DP+ RP  D I   + +  +
Sbjct: 240 ---VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (437), Expect = 1e-48
 Identities = 62/289 (21%), Positives = 116/289 (40%), Gaps = 35/289 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGG----NW 411
           G V+ GK  G+ VA+K  +            I     + H +++  +     G       
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT-----NPPHVHKD 466
           YL+ +   NGSL  ++       LD    +++A    +GL +LH+        P   H+D
Sbjct: 111 YLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI-VGTKGYMAPEYLENGL----- 520
           +K  N+L+  +    IA+  LA        E  +  +  VGTK YM PE L+  L     
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227

Query: 521 -VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----GEESLRHL 574
                 D+Y+FG+++ E+     +  +  E  +   D++      ED       + LR  
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR-- 285

Query: 575 MDPSMQGNYPPVTAILVIR-LIESCLKKDPSGRPAMDKIAQSISRFLNA 622
             PS    +     +  +  L+  C   +P+ R    ++ +++++   +
Sbjct: 286 --PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (430), Expect = 1e-47
 Identities = 61/286 (21%), Positives = 117/286 (40%), Gaps = 33/286 (11%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGN----W 411
           G V+RGK  G+ VA+K               I     + H +++  +             
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT-----NPPHVHKD 466
           +LV +   +GSL  ++N      +     I++AL  A+GL +LH         P   H+D
Sbjct: 116 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS-HIVGTKGYMAPEYLENGL----- 520
           +K  N+L+  +    IA+  LA   +       +   H VGTK YMAPE L++ +     
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232

Query: 521 -VSTKLDVYAFGVLMLEMLSGKEAPALYSE-----ENMLLVDVLNPVLHKEDGEESLRHL 574
               + D+YA G++  E+        ++ +      +++  D     + K   E+ LR  
Sbjct: 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-P 291

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             P+   +   +  +   +++  C   + + R    +I +++S+  
Sbjct: 292 NIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKKTLSQLS 335

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  167 bits (424), Expect = 3e-47
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 35/272 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A            + +L K  H +++  +G         
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    K  +  + I IA   A G++YLH+      +H+D+K +N+
Sbjct: 96  IVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNI 151

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE---YLENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G         G+  +MAPE     ++   S + DVYA
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS-GSILWMAPEVIRMQDSNPYSFQSDVYA 210

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVD-VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           FG+++ E+++G+  P  Y   N+   D ++  V                 ++ N P    
Sbjct: 211 FGIVLYELMTGQL-P--Y--SNINNRDQIIEMVGRG------SLSPDLSKVRSNCPKR-- 257

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             + RL+  CLKK    RP+  +I   I    
Sbjct: 258 --MKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (421), Expect = 1e-46
 Identities = 57/285 (20%), Positives = 121/285 (42%), Gaps = 35/285 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGN----W 411
           G V+RG   G+ VA+K               +     + H +++  +       +     
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS-----FTNPPHVHKD 466
           +L+      GSL  ++       LD    ++I L +A+GL +LH         P   H+D
Sbjct: 82  WLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH-IVGTKGYMAPEYLENGLV---- 521
           +K  N+L+  + +  IA+  LA    +   +  + ++  VGTK YMAPE L+  +     
Sbjct: 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198

Query: 522 --STKLDVYAFGVLMLEMLSGKEAPALYSE-----ENMLLVDVLNPVLHKEDGEESLRHL 574
               ++D++AFG+++ E+     +  +  +      +++  D     + K    +  R  
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-- 256

Query: 575 MDPSMQGNYPPVTAILVIR-LIESCLKKDPSGRPAMDKIAQSISR 618
             P++   +     +  +  L++ C  ++PS R    +I +++++
Sbjct: 257 --PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  165 bits (421), Expect = 1e-46
 Identities = 55/280 (19%), Positives = 109/280 (38%), Gaps = 41/280 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G   +   +  G+ + +K++     +        +K++  + H ++++ +G+ +      
Sbjct: 24  GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
            + E    G+L   I     +   W+QR+  A D+A+G+ YLHS      +H+D+   N 
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNC 139

Query: 473 LLDTDFRAKIANFALAR-----------PAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
           L+  +    +A+F LAR               ++ +      +VG   +MAPE +     
Sbjct: 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
             K+DV++FG+++ E++    A     +     +D    V         L          
Sbjct: 200 DEKVDVFSFGIVLCEIIGRVNA---DPDYLPRTMDFGLNV------RGFLD----RYCPP 246

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
           N PP        +   C   DP  RP+  K+   +     
Sbjct: 247 NCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 8e-45
 Identities = 47/279 (16%), Positives = 101/279 (36%), Gaps = 44/279 (15%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY G+  G+ VAI+ +  +  ++         +    +  H +++  +G C +  +  
Sbjct: 47  GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           ++       +L   + D     LD  +  QIA ++  G+ YLH+      +HKD+K  NV
Sbjct: 106 IITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNV 161

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHI--VGTKGYMAPEYLENGLV--------- 521
             D + +  I +F L   +   +            G   ++APE +              
Sbjct: 162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           S   DV+A G +  E+ + +  P  +  +      ++  +         ++  +      
Sbjct: 221 SKHSDVFALGTIWYELHAREW-P--F--KTQPAEAIIWQM------GTGMKPNLSQI--- 266

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
                    +  ++  C   +   RP   K+   + +  
Sbjct: 267 GMGKE----ISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score =  137 bits (345), Expect = 2e-37
 Identities = 42/210 (20%), Positives = 80/210 (38%), Gaps = 20/210 (9%)

Query: 53  NRSCLAFLIFRSKPPFNTVASISTLLASKPSQLSKIN---------SVSETATFETNQMV 103
             SC   L         T++ I+  L S  +   +IN         ++ +    +    V
Sbjct: 2   RTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRV 61

Query: 104 IVPVNCSCS-GKHYQANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQ-HGNVSNFGVGT 161
           +VP  C C  G     N +Y V+  DTY  +A + +  L+T ++LQ +     +N  +  
Sbjct: 62  LVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSA 121

Query: 162 RLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPN 221
            L   + C+C  ++ +       ++Y ++  +++  I++  GV  D     N    G   
Sbjct: 122 TLNVLVNCSCGDESVS-KDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNP---GVNF 177

Query: 222 IYPFTTLLVPLENPPSSSQTTEQRPLPPSS 251
                 + VP  +P  +       P   S 
Sbjct: 178 NSGNGIVYVPGRDPNGA-----FPPFKSSK 202

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (351), Expect = 3e-36
 Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 33/269 (12%)

Query: 362 GSVYRGKIGGDF--VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G V+ G++  D   VA+K                  ++L + +H +++RL+G+C      
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           Y+V E    G    ++  +G + L     +Q+  D A G+ YL S      +H+D+   N
Sbjct: 188 YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARN 243

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
            L+      KI++F ++R         +     V  K + APE L  G  S++ DV++FG
Sbjct: 244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK-WTAPEALNYGRYSSESDVWSFG 302

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           +L+ E  S   +P  Y   N+        V   E G       +        P +    V
Sbjct: 303 ILLWETFSLGASP--Y--PNLSNQQTREFV---EKG-----GRLPC------PELCPDAV 344

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFL 620
            RL+E C   +P  RP+   I Q +    
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (346), Expect = 8e-35
 Identities = 63/272 (23%), Positives = 115/272 (42%), Gaps = 35/272 (12%)

Query: 362 GSVYRGKIGGDF--VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYL 413
           G VY G        VA+K +  D  +  + L       +I H +L++LLG+C     +Y+
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHKDIKCSN 471
           + E    G+L  ++ +   + +     + +A  +++ + YL    F     +H+++   N
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-----IHRNLAARN 348

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
            L+  +   K+A+F L+R        +   +       + APE L     S K DV+AFG
Sbjct: 349 CLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 406

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           VL+ E+ +   +P  Y    + L  V   +   E       + M+       P      V
Sbjct: 407 VLLWEIATYGMSP--Y--PGIDLSQVYELL---EKD-----YRMER------PEGCPEKV 448

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             L+ +C + +PS RP+  +I Q+       S
Sbjct: 449 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 480

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  128 bits (324), Expect = 2e-33
 Identities = 58/262 (22%), Positives = 100/262 (38%), Gaps = 42/262 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNG-- 408
            +VY+G        VA  ++      +          ++L  + H +++R      +   
Sbjct: 40  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99

Query: 409 --GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
                 LV E   +G+L  ++  K  K +           +  GL +LH+   PP +H+D
Sbjct: 100 GKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRD 156

Query: 467 IKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           +KC N+ +       KI +  LA               ++GT  +MAPE  E       +
Sbjct: 157 LKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEK-YDESV 210

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           DVYAFG+ MLEM +  E P  YSE        +   +       S   +  P ++     
Sbjct: 211 DVYAFGMCMLEMATS-EYP--YSECQNAA--QIYRRVTSGVKPASFDKVAIPEVK----- 260

Query: 586 VTAILVIRLIESCLKKDPSGRP 607
                   +IE C++++   R 
Sbjct: 261 -------EIIEGCIRQNKDERY 275

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (334), Expect = 2e-33
 Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 41/269 (15%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICF-NGGNWYLVY 415
           G V  G   G+ VA+K +  DA+ Q       ++ ++ HS+L++LLG+     G  Y+V 
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHKDIKCSNVL 473
           E    GSL  ++  +G   L     ++ +LDV   + YL    F     VH+D+   NVL
Sbjct: 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-----VHRDLAARNVL 321

Query: 474 LDTDFRAKIANFALARPA--ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +  D  AK+++F L + A   +  G+  +       K + APE L     STK DV++FG
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDTGKLPV-------K-WTAPEALREKKFSTKSDVWSFG 373

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           +L+ E+ S    P  Y    + L DV+  V   E G     + MD       P      V
Sbjct: 374 ILLWEIYSFGRVP--Y--PRIPLKDVVPRV---EKG-----YKMDA------PDGCPPAV 415

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             ++++C   D + RP   ++ + +    
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  132 bits (333), Expect = 2e-33
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 35/271 (12%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +          L       K+ H  L++L  +       Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIV 256

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHKDIKCSNV 472
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+    +     VH+D++ +N+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-----VHRDLRAANI 311

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 532
           L+  +   K+A+F LAR  E  + E+           + APE    G  + K DV++FG+
Sbjct: 312 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369

Query: 533 LMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI 592
           L+ E+ +    P  Y    M+  +VL+ V   E G     + M        PP     + 
Sbjct: 370 LLTELTTKGRVP--Y--PGMVNREVLDQV---ERG-----YRMPC------PPECPESLH 411

Query: 593 RLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            L+  C +K+P  RP  + +   +  +  ++
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (326), Expect = 4e-33
 Identities = 62/287 (21%), Positives = 114/287 (39%), Gaps = 50/287 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKV-YGDASDQ--------IKLLNKINHSSLIRLLGICFNGGN 410
           G          G    IK++     S +        + +L  + H ++++        G+
Sbjct: 38  GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS 97

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIKC 469
            Y+V +    G L   IN + G      Q +   + +   L ++H       + H+DIK 
Sbjct: 98  LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD----RKILHRDIKS 153

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+ L  D   ++ +F +AR       E A     +GT  Y++PE  EN   + K D++A
Sbjct: 154 QNIFLTKDGTVQLGDFGIARVLN-STVELARA--CIGTPYYLSPEICENKPYNNKSDIWA 210

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            G ++ E+ + K   A  +                     S+++L+   + G++PPV+  
Sbjct: 211 LGCVLYELCTLK--HAFEA--------------------GSMKNLVLKIISGSFPPVSLH 248

Query: 590 L---VIRLIESCLKKDPSGRP------AMDKIAQSISRFLNASLAWE 627
               +  L+    K++P  RP          IA+ I +FL+  L  E
Sbjct: 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAE 295

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (320), Expect = 5e-33
 Identities = 74/271 (27%), Positives = 123/271 (45%), Gaps = 43/271 (15%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICF-NGGNWYLVY 415
           G V  G   G+ VA+K +  DA+ Q       ++ ++ HS+L++LLG+     G  Y+V 
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSNVL 473
           E    GSL  ++  +G   L     ++ +LDV   + YL  ++F     VH+D+   NVL
Sbjct: 95  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-----VHRDLAARNVL 149

Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAF 530
           +  D  AK+++F L + A   +            K    + APE L     STK DV++F
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWTAPEALREKKFSTKSDVWSF 200

Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           G+L+ E+ S    P  Y    + L DV+  V   E G     + MD       P      
Sbjct: 201 GILLWEIYSFGRVP--Y--PRIPLKDVVPRV---EKG-----YKMDA------PDGCPPA 242

Query: 591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
           V  ++++C   D + RP+  ++ + +     
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 1e-32
 Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 42/271 (15%)

Query: 361 KGS----VYRGKIGGDFVAIKKV----YGDASDQIKLLNKIN-HSSLIRLLGICFNGGNW 411
            G+    VYRG      VA+K++    +  A  +++LL + + H ++IR      +    
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
           Y+  E     +L  ++  K    L   + I +     +GL +LHS        VH+D+K 
Sbjct: 94  YIAIEL-CAATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHS-----LNIVHRDLKP 146

Query: 470 SNVLL-----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE---NGLV 521
            N+L+         +A I++F L +        F+  S + GT+G++APE L        
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           +  +D+++ G +   ++S    P  + +      ++L        G  SL  L       
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQANILL-------GACSLDCL------- 250

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           +      ++   LIE  +  DP  RP+   +
Sbjct: 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (318), Expect = 1e-32
 Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 45/277 (16%)

Query: 362 GSVYRGKIGGDF--VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYL 413
           G VY G        VA+K +  D  +  + L       +I H +L++LLG+C     +Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSN 471
           + E    G+L  ++ +   + +     + +A  +++ + YL   +F     +H+D+   N
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-----IHRDLAARN 141

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLD 526
            L+  +   K+A+F L+R             +           + APE L     S K D
Sbjct: 142 CLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           V+AFGVL+ E+ +   +P  Y    + L  V   +   E       + M+       P  
Sbjct: 195 VWAFGVLLWEIATYGMSP--Y--PGIDLSQVYELL---EKD-----YRMER------PEG 236

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
               V  L+ +C + +PS RP+  +I Q+       S
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  130 bits (328), Expect = 3e-32
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 35/271 (12%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +          L       K+ H  L++L  +       Y+V
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIV 339

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHKDIKCSNV 472
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+    +     VH+D++ +N+
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-----VHRDLRAANI 394

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 532
           L+  +   K+A+F LAR  E  + E+           + APE    G  + K DV++FG+
Sbjct: 395 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452

Query: 533 LMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI 592
           L+ E+ +    P  Y    M+  +VL+ V   E G     + M        PP     + 
Sbjct: 453 LLTELTTKGRVP--Y--PGMVNREVLDQV---ERG-----YRMPC------PPECPESLH 494

Query: 593 RLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            L+  C +K+P  RP  + +   +  +  ++
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  125 bits (317), Expect = 4e-32
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 48/278 (17%)

Query: 362 GSVYRGKIGGDF------VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFN 407
           G+VY+G    +       VAIK++    S +          ++  +++  + RLLGIC  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL- 87

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHK 465
                L+ +    G L  ++ +     +     +   + +A G+NYL          VH+
Sbjct: 88  TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL-----VHR 141

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVS 522
           D+   NVL+ T    KI +F LA+    +E E+       G K    +MA E + + + +
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYT 197

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + DV+++GV + E+++    P  Y  + +   ++ + +   E GE   R  +       
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP--Y--DGIPASEISSIL---EKGE---R--LPQ----- 240

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
            PP+  I V  ++  C   D   RP   ++    S+  
Sbjct: 241 -PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  124 bits (313), Expect = 4e-32
 Identities = 66/275 (24%), Positives = 116/275 (42%), Gaps = 41/275 (14%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V+ G       VAIK +   A  +   +       K++H  L++L G+C       LV
Sbjct: 22  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSNV 472
            E   +G LS ++  + G        + + LDV  G+ YL          +H+D+   N 
Sbjct: 82  TEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACV-----IHRDLAARNC 135

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYA 529
           L+  +   K+++F + R     +     TS   GTK    + +PE       S+K DV++
Sbjct: 136 LVGENQVIKVSDFGMTRFVLDDQ----YTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWS 190

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FGVLM E+ S  + P  Y  EN    +V+  +     G       +        P + + 
Sbjct: 191 FGVLMWEVFSEGKIP--Y--ENRSNSEVVEDI---STG-----FRLYK------PRLAST 232

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
            V +++  C ++ P  RPA  ++ + ++    + L
Sbjct: 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  123 bits (312), Expect = 7e-32
 Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 41/272 (15%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VAIK +   +  + + +        ++H  L++L G+C      +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSNV 472
            E   NG L  ++ +   +     Q +++  DV   + YL    F     +H+D+   N 
Sbjct: 98  TEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQF-----LHRDLAARNC 151

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYA 529
           L++     K+++F L+R     E     TS  VG+K    +  PE L     S+K D++A
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDE----YTSS-VGSKFPVRWSPPEVLMYSKFSSKSDIWA 206

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FGVLM E+ S  + P  Y  E     +    +     G       +        P + + 
Sbjct: 207 FGVLMWEIYSLGKMP--Y--ERFTNSETAEHI---AQG-----LRLYR------PHLASE 248

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
            V  ++ SC  +    RP    +  +I   ++
Sbjct: 249 KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (311), Expect = 8e-32
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 41/273 (15%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G + VA+K +   +  + +         K++H  L++  G+C      Y+V
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDIKCSNV 472
            E   NG L  ++   G   L+ +Q +++  DV  G+ +L  H F     +H+D+   N 
Sbjct: 82  TEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQF-----IHRDLAARNC 135

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYA 529
           L+D D   K+++F + R     +      S  VGTK    + APE       S+K DV+A
Sbjct: 136 LVDRDLCVKVSDFGMTRYVLDDQ----YVSS-VGTKFPVKWSAPEVFHYFKYSSKSDVWA 190

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FG+LM E+ S  + P  Y  +     +V+  V     G     H +        P + + 
Sbjct: 191 FGILMWEVFSLGKMP--Y--DLYTNSEVVLKV---SQG-----HRLYR------PHLASD 232

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
            + +++ SC  + P  RP   ++  SI      
Sbjct: 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (311), Expect = 2e-31
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 59/293 (20%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G VY G   G         VAIK V   AS +          ++ + N   ++RLLG+  
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98

Query: 407 NGGNWYLVYENAVNGSL--------SVWINDKGGKFLDWAQRIQIALDVATGLNYLHS-- 456
            G    ++ E    G L            N+        ++ IQ+A ++A G+ YL++  
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158

Query: 457 FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY-----M 511
           F     VH+D+   N ++  DF  KI +F + R     +       +  G KG      M
Sbjct: 159 F-----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWM 207

Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL 571
           +PE L++G+ +T  DV++FGV++ E+ +  E P  Y    +    VL  V+         
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQ--GLSNEQVLRFVME-------- 255

Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
             L+D       P     ++  L+  C + +P  RP+  +I  SI   +    
Sbjct: 256 GGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (316), Expect = 5e-31
 Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 37/272 (13%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V+         VA+K +   +      L        + H  L++L  +       Y++
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 260

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++    G      + I  +  +A G+ ++       ++H+D++ +N+L+
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILV 317

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLVSTKLDVYAFG 531
                 KIA+F LAR  E  E          G K    + APE +  G  + K DV++FG
Sbjct: 318 SASLVCKIADFGLARVIEDNEYT-----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 372

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           +L++E+++    P  Y    M   +V+  +   E G     + M        P      +
Sbjct: 373 ILLMEIVTYGRIP--Y--PGMSNPEVIRAL---ERG-----YRMPR------PENCPEEL 414

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             ++  C K  P  RP  + I   +  F  A+
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  121 bits (306), Expect = 9e-31
 Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 51/286 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKV-YGDASDQ---------IKLLNKINHSSLIRLLGICFNGG 409
             VYR    + G  VA+KKV   D  D          I LL ++NH ++I+         
Sbjct: 46  SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105

Query: 410 NWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHK 465
              +V E A  G LS  I    K  + +      +  + + + L ++HS        +H+
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-----RRVMHR 160

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           DIK +NV +      K+ +  L R     +   A +  +VGT  YM+PE +     + K 
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKS 217

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           D+++ G L+ EM + +     Y +                  + +L  L     Q +YPP
Sbjct: 218 DIWSLGCLLYEMAALQ--SPFYGD------------------KMNLYSLCKKIEQCDYPP 257

Query: 586 VTAIL----VIRLIESCLKKDPSGRPAMD---KIAQSISRFLNASL 624
           + +      + +L+  C+  DP  RP +     +A+ +     +SL
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (302), Expect = 2e-30
 Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 37/272 (13%)

Query: 362 GSVYRGKIGGDF-VAIKKVYGDASDQIKLLN------KINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VA+K +   +      L       ++ H  L+RL  +       Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NGSL  ++    G  L   + + +A  +A G+ ++       ++H+D++ +N+L+
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILV 142

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTKLDVYAFG 531
                 KIA+F LAR  E  E     T+   G K    + APE +  G  + K DV++FG
Sbjct: 143 SDTLSCKIADFGLARLIEDNE----YTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           +L+ E+++    P  Y    M   +V+  +   E G     + M        P      +
Sbjct: 198 ILLTEIVTHGRIP--Y--PGMTNPEVIQNL---ERG-----YRMVR------PDNCPEEL 239

Query: 592 IRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            +L+  C K+ P  RP  D +   +  F  A+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  119 bits (301), Expect = 3e-30
 Identities = 55/278 (19%), Positives = 113/278 (40%), Gaps = 58/278 (20%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICF-------- 406
           G V++   +I G    IK+V    +++     +K L K++H +++   G C+        
Sbjct: 25  GQVFKAKHRIDGKTYVIKRV--KYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPE 81

Query: 407 ---------NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSF 457
                         ++  E    G+L  WI  + G+ LD    +++   +  G++Y+HS 
Sbjct: 82  TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK 141

Query: 458 TNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE 517
                +++D+K SN+ L    + KI +F L    +         +   GT  YM+PE + 
Sbjct: 142 K---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQIS 194

Query: 518 NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP 577
           +     ++D+YA G+++ E+L   +      E +    D+ + ++               
Sbjct: 195 SQDYGKEVDLYALGLILAELLHVCDTA---FETSKFFTDLRDGII--------------S 237

Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
            +   +          L++  L K P  RP   +I ++
Sbjct: 238 DI---FDKK----EKTLLQKLLSKKPEDRPNTSEILRT 268

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (300), Expect = 3e-30
 Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 45/271 (16%)

Query: 362 GSVY--RGKIGGDFVAIKKV-YGDASDQ--------IKLLNKINHSSLIRLLG--ICFNG 408
           G     R K  G  +  K++ YG  ++         + LL ++ H +++R     I    
Sbjct: 20  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79

Query: 409 GNWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
              Y+V E    G L+  I    K  ++LD    +++   +   L   H  ++  H  +H
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K +NV LD     K+ +F LAR     +  FA T   VGT  YM+PE +     + K
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT--FVGTPYYMSPEQMNRMSYNEK 196

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            D+++ G L+ E+ +    P   +                     S + L     +G + 
Sbjct: 197 SDIWSLGCLLYELCALM--PPFTA--------------------FSQKELAGKIREGKFR 234

Query: 585 PVTAIL---VIRLIESCLKKDPSGRPAMDKI 612
            +       +  +I   L      RP++++I
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  120 bits (302), Expect = 4e-30
 Identities = 60/281 (21%), Positives = 123/281 (43%), Gaps = 46/281 (16%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G VY+G +          VAIK +    +++          ++ + +H ++IRL G+   
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHK 465
                ++ E   NG+L  ++ +K G+     Q + +   +A G+ YL   ++     VH+
Sbjct: 118 YKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNY-----VHR 171

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVS 522
           D+   N+L++++   K+++F L+R  E        TS   G K    + APE +     +
Sbjct: 172 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS---GGKIPIRWTAPEAISYRKFT 228

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
           +  DV++FG++M E+++  E P  Y    +   +V+  +    DG       +       
Sbjct: 229 SASDVWSFGIVMWEVMTYGERP--Y--WELSNHEVMKAI---NDGF-----RLPT----- 271

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            P      + +L+  C +++ + RP    I   + + + A 
Sbjct: 272 -PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (302), Expect = 4e-30
 Identities = 61/286 (21%), Positives = 117/286 (40%), Gaps = 41/286 (14%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNG 408
           GSV   +           VA+K++     DQ       I++L  ++   +++  G+ +  
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96

Query: 409 GN--WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVH 464
           G     LV E   +G L  ++     + LD ++ +  +  +  G+ YL S        VH
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC-----VH 150

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENG 519
           +D+   N+L++++   KIA+F LA+     +  +     +V   G     + APE L + 
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-----VVREPGQSPIFWYAPESLSDN 205

Query: 520 LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR--HLMDP 577
           + S + DV++FGV++ E+ +  +     S E + ++     V       E L     +  
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265

Query: 578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
                 PP     V  L++ C    P  RP+   +   +    + S
Sbjct: 266 ------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  118 bits (298), Expect = 6e-30
 Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 45/278 (16%)

Query: 362 GSVYRGKIGGDF----VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG 409
           GSV +G          VAIK +                ++++++++  ++RL+G+C    
Sbjct: 24  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDI 467
              LV E A  G L  ++  K  + +  +   ++   V+ G+ YL   +F     VH+D+
Sbjct: 83  ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF-----VHRDL 136

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTK 524
              NVLL     AKI++F L++     +  +   S     K    + APE +     S++
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---AGKWPLKWYAPECINFRKFSSR 193

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            DV+++GV M E LS  + P  Y  + M   +V+  +   E G+   R  M+       P
Sbjct: 194 SDVWSYGVTMWEALSYGQKP--Y--KKMKGPEVMAFI---EQGK---R--MEC------P 235

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
           P     +  L+  C       RP    + Q +     +
Sbjct: 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  118 bits (298), Expect = 8e-30
 Identities = 65/283 (22%), Positives = 110/283 (38%), Gaps = 49/283 (17%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQ--IKLLN------KINHSSLIRLLGICFNG 408
           G VY G+           AIK +      Q     L        +NH +++ L+GI    
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94

Query: 409 -GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHK 465
            G  +++     +G L  +I             I   L VA G+ YL    F     VH+
Sbjct: 95  EGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQKF-----VHR 148

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGL 520
           D+   N +LD  F  K+A+F LAR    +E      S            + A E L+   
Sbjct: 149 DLAARNCMLDESFTVKVADFGLARDILDRE----YYSVQQHRHARLPVKWTALESLQTYR 204

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            +TK DV++FGVL+ E+L+    P  Y   ++   D+ + +     G       +     
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPP--YR--HIDPFDLTHFL---AQG-----RRLPQ--- 249

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
              P      + ++++ C + DP+ RP    +   + + ++A 
Sbjct: 250 ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  119 bits (300), Expect = 9e-30
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 45/290 (15%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNG 408
           G V  G++         VAIK +    +++          ++ + +H ++IRL G+   G
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKD 466
               +V E   NGSL  ++    G+     Q + +   V  G+ YL    +     VH+D
Sbjct: 123 RLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGY-----VHRD 176

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVST 523
           +   NVL+D++   K+++F L+R  E        T+   G K    + APE +     S+
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT---GGKIPIRWTAPEAIAFRTFSS 233

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
             DV++FGV+M E+L+  E P  Y   NM   DV++ V   E+G    R  +        
Sbjct: 234 ASDVWSFGVVMWEVLAYGERP--Y--WNMTNRDVISSV---EEGY---R--LPA------ 275

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNIS 633
           P      + +L+  C  KD + RP   +I   +   + +  +   +  +S
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  118 bits (299), Expect = 1e-29
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 48/278 (17%)

Query: 362 GSVYRGKIGGDF------VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFN 407
           G+VY+G    +       VAIK++    S +          ++  +++  + RLLGIC  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL- 87

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHK 465
                L+ +    G L  ++ +     +     +   + +A G+NYL          VH+
Sbjct: 88  TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL-----VHR 141

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVS 522
           D+   NVL+ T    KI +F LA+    +E E+       G K    +MA E + + + +
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYT 197

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + DV+++GV + E+++    P  Y  + +   ++ + +   E GE   R  +       
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP--Y--DGIPASEISSIL---EKGE---R--LPQ----- 240

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
            PP+  I V  ++  C   D   RP   ++    S+  
Sbjct: 241 -PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  119 bits (301), Expect = 1e-29
 Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 49/283 (17%)

Query: 362 GSVYRGKIGGD-----FVAIKKVYGDASDQ--IKLLN------KINHSSLIRLLGICF-N 407
           G VY G +  +       A+K +          + L         +H +++ LLGIC  +
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHK 465
            G+  +V     +G L  +I ++          I   L VA G+ +L S  F     VH+
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKF-----VHR 216

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGL 520
           D+   N +LD  F  K+A+F LAR    +E +         T       +MA E L+   
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMALESLQTQK 272

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            +TK DV++FGVL+ E+++    P  Y   ++   D+   +     G       +     
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPP--YP--DVNTFDITVYL---LQG-----RRLLQ--- 317

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
              P      +  ++  C       RP+  ++   IS   +  
Sbjct: 318 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  116 bits (294), Expect = 3e-29
 Identities = 57/298 (19%), Positives = 116/298 (38%), Gaps = 66/298 (22%)

Query: 362 GSVYRGKIGGD-------FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G V+  +            VA+K +  D +           +LL  + H  +++  G+C 
Sbjct: 29  GKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 87

Query: 407 NGGNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVATGLN 452
           +G    +V+E   +G L                    +    L  +Q + IA  +A+G+ 
Sbjct: 88  DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 147

Query: 453 YL--HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG- 509
           YL    F     VH+D+   N L+  +   KI +F ++R     +       + VG    
Sbjct: 148 YLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD------YYRVGGHTM 196

Query: 510 ----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
               +M PE +     +T+ DV++FGV++ E+ +  + P  +    +   +V+  +    
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WF--QLSNTEVIECI---T 249

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            G      +++       P V    V  ++  C +++P  R  + +I + +     A+
Sbjct: 250 QG-----RVLER------PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (298), Expect = 3e-29
 Identities = 70/301 (23%), Positives = 124/301 (41%), Gaps = 68/301 (22%)

Query: 362 GSVYRGKIGGDF---------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLG 403
           G V   +  G           VA+K +  DA+++        ++++  I  H ++I LLG
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154

Query: 404 ICFNGGNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVAT 449
            C   G  Y++ E A  G+L              S  IN    + + +   +     +A 
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214

Query: 450 GLNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           G+ YL S        +H+D+   NVL+  +   KIA+F LAR     +       +   T
Sbjct: 215 GMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNID------YYKKTT 263

Query: 508 KG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL 562
            G     +MAPE L + + + + DV++FGVLM E+ +   +P  Y    + + ++   + 
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP--GIPVEELFKLL- 318

Query: 563 HKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
             ++G     H MD       P      +  ++  C    PS RP   ++ + + R L  
Sbjct: 319 --KEG-----HRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

Query: 623 S 623
           +
Sbjct: 366 T 366

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  117 bits (294), Expect = 4e-29
 Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 56/278 (20%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSL--IRLLGICFNGG 409
             V++         AIK V  + +D          I  LNK+   S   IRL        
Sbjct: 42  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPH--VHK 465
             Y+V E   N  L+ W+  K        +     +       ++ +H      H  VH 
Sbjct: 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIHQ-----HGIVHS 151

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN------- 518
           D+K +N L+  D   K+ +F +A   +         S  VGT  YM PE +++       
Sbjct: 152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSREN 209

Query: 519 ----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
                 +S K DV++ G ++  M  GK                  P     +    L  +
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGK--T---------------PFQQIINQISKLHAI 252

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           +DP+ +  +P +    +  +++ CLK+DP  R ++ ++
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (295), Expect = 4e-29
 Identities = 70/301 (23%), Positives = 124/301 (41%), Gaps = 68/301 (22%)

Query: 362 GSVYRGKIGGDF---------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLG 403
           G V   +  G           VA+K +  DA+++        ++++  I  H ++I LLG
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108

Query: 404 ICFNGGNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVAT 449
            C   G  Y++ E A  G+L              S  IN    + + +   +     +A 
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168

Query: 450 GLNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           G+ YL S        +H+D+   NVL+  +   KIA+F LAR     +       +   T
Sbjct: 169 GMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNID------YYKKTT 217

Query: 508 KG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL 562
            G     +MAPE L + + + + DV++FGVLM E+ +   +P  Y    + + ++   + 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--Y--PGIPVEELFKLL- 272

Query: 563 HKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
             ++G     H MD       P      +  ++  C    PS RP   ++ + + R L  
Sbjct: 273 --KEG-----HRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

Query: 623 S 623
           +
Sbjct: 320 T 320

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  115 bits (291), Expect = 5e-29
 Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 52/281 (18%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           G V++G           VAIK      SD ++         + + +H  +++L+G+    
Sbjct: 29  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 87

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKD 466
              +++ E    G L  ++  +    LD A  I  A  ++T L YL    F     VH+D
Sbjct: 88  NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRF-----VHRD 141

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLV 521
           I   NVL+ ++   K+ +F L+R  E          +   +KG     +MAPE +     
Sbjct: 142 IAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIKWMAPESINFRRF 194

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           ++  DV+ FGV M E+L     P  +  + +   DV+  +   E+G       +      
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP--F--QGVKNNDVIGRI---ENG-----ERLPM---- 238

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
             PP     +  L+  C   DPS RP   ++   +S  L  
Sbjct: 239 --PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (294), Expect = 6e-29
 Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 56/278 (20%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSL--IRLLGICFNGG 409
             V++         AIK V  + +D          I  LNK+   S   IRL        
Sbjct: 23  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPH--VHK 465
             Y+V E   N  L+ W+  K        +     +       ++ +H      H  VH 
Sbjct: 83  YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIHQ-----HGIVHS 132

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN------- 518
           D+K +N L+  D   K+ +F +A   +         S  VGT  YM PE +++       
Sbjct: 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDMSSSREN 190

Query: 519 ----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
                 +S K DV++ G ++  M  GK                  P     +    L  +
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK--T---------------PFQQIINQISKLHAI 233

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           +DP+ +  +P +    +  +++ CLK+DP  R ++ ++
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  115 bits (290), Expect = 6e-29
 Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 48/280 (17%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           G VY G           VA+K    D +   K        ++  ++H  +++L+GI    
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EE 84

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKD 466
              +++ E    G L  ++       L     +  +L +   + YL   +      VH+D
Sbjct: 85  EPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINC-----VHRD 138

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVST 523
           I   N+L+ +    K+ +F L+R  E ++           T+    +M+PE +     +T
Sbjct: 139 IAVRNILVASPECVKLGDFGLSRYIEDED-----YYKASVTRLPIKWMSPESINFRRFTT 193

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
             DV+ F V M E+LS  + P  +    +   DV+  +   E G+      +        
Sbjct: 194 ASDVWMFAVCMWEILSFGKQP--F--FWLENKDVIGVL---EKGD-----RLPK------ 235

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           P +   ++  L+  C   DPS RP   ++  S+S      
Sbjct: 236 PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  116 bits (293), Expect = 6e-29
 Identities = 57/297 (19%), Positives = 111/297 (37%), Gaps = 65/297 (21%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G V+  +            VA+K +  +AS+          +LL  + H  ++R  G+C 
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113

Query: 407 NGGNWYLVYENAVNGSL-------------SVWINDKGGKFLDWAQRIQIALDVATGLNY 453
            G    +V+E   +G L                  D     L   Q + +A  VA G+ Y
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173

Query: 454 L--HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-- 509
           L    F     VH+D+   N L+      KI +F ++R     +       + VG +   
Sbjct: 174 LAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD------YYRVGGRTML 222

Query: 510 ---YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
              +M PE +     +T+ DV++FGV++ E+ +  + P  +    +   + ++ +     
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WY--QLSNTEAIDCI---TQ 275

Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G       ++       P      V  ++  C +++P  R ++  +   +     A 
Sbjct: 276 G-----RELER------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  116 bits (293), Expect = 7e-29
 Identities = 57/303 (18%), Positives = 111/303 (36%), Gaps = 60/303 (19%)

Query: 362 GSVYRGKIGGD-----FVAIKKVYGDASDQI---------KLLNKINHSSLIRLLGICFN 407
           GSV   ++  +      VA+K +  D                + + +H  + +L+G+   
Sbjct: 37  GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96

Query: 408 GGNW------YLVYENAVNGSLSVWI----NDKGGKFLDWAQRIQIALDVATGLNYLHS- 456
                      ++     +G L  ++      +    L     ++  +D+A G+ YL S 
Sbjct: 97  SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156

Query: 457 -FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----Y 510
            F     +H+D+   N +L  D    +A+F L+R     +       +  G        +
Sbjct: 157 NF-----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD------YYRQGCASKLPVKW 205

Query: 511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES 570
           +A E L + L +   DV+AFGV M E+++  + P  Y+   +   ++ N +     G   
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAG--IENAEIYNYL---IGG--- 255

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSK 630
             + +        PP     V  L+  C   DP  RP+   +   +   L        S+
Sbjct: 256 --NRLKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307

Query: 631 NIS 633
           +  
Sbjct: 308 DPL 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  115 bits (291), Expect = 8e-29
 Identities = 60/283 (21%), Positives = 123/283 (43%), Gaps = 40/283 (14%)

Query: 362 GSVYRGKI------GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G V   +        G+ VA+K +  ++           I++L  + H ++++  GIC  
Sbjct: 35  GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94

Query: 408 GGN--WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHV 463
            G     L+ E   +GSL  ++     K ++  Q+++ A+ +  G++YL S  +     V
Sbjct: 95  DGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQY-----V 148

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGL 520
           H+D+   NVL++++ + KI +F L +  E  +  + +            + APE L    
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD---DRDSPVFWYAPECLMQSK 205

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
                DV++FGV + E+L+       Y + +   + +   ++    G+ ++  L++   +
Sbjct: 206 FYIASDVWSFGVTLHELLT-------YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258

Query: 581 GN---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           G     PP     V +L+  C +  PS R +   + +     L
Sbjct: 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 9e-29
 Identities = 62/265 (23%), Positives = 90/265 (33%), Gaps = 43/265 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKV---YGDASDQIKLLNKIN-------HSSLIRLLGICFNGG 409
           G V++   K  G   A+K+    +    D+ + L ++        H   +RL      GG
Sbjct: 71  GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             YL  E     SL       G    + AQ      D    L +LHS      VH D+K 
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPE-AQVWGYLRDTLLALAHLHSQGL---VHLDVKP 185

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           +N+ L    R K+ +F L    E             G   YMAPE L+     T  DV++
Sbjct: 186 ANIFLGPRGRCKLGDFGLLV--ELGTAGAGEV--QEGDPRYMAPELLQGSY-GTAADVFS 240

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            G+ +LE+    E P        L    L P        E LR                 
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSE-LRS---------------- 283

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQ 614
               ++   L+ DP  R   + +  
Sbjct: 284 ----VLVMMLEPDPKLRATAEALLA 304

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  115 bits (290), Expect = 9e-29
 Identities = 60/296 (20%), Positives = 104/296 (35%), Gaps = 65/296 (21%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G VY+G + G         VAIK +   A             L  ++ H +++ LLG+  
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82

Query: 407 NGGNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVATGLN 452
                 +++    +G L              S   +      L+    + +   +A G+ 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142

Query: 453 YL--HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG- 509
           YL  H       VHKD+   NVL+      KI++  L R     +       + +     
Sbjct: 143 YLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD------YYKLLGNSL 191

Query: 510 ----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
               +MAPE +  G  S   D++++GV++ E+ S    P  Y        DV+  +    
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YC--GYSNQDVVEMI---R 244

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
           +       ++        P      V  L+  C  + PS RP    I   +  + N
Sbjct: 245 NR-----QVLPC------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  115 bits (290), Expect = 9e-29
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 47/277 (16%)

Query: 362 GSVYRGKIGGDF----VAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNG 408
           G+V +G          VA+K +  +A+D            ++ ++++  ++R++GIC   
Sbjct: 31  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKD 466
            +W LV E A  G L+ ++  +  + +     I++   V+ G+ YL   +F     VH+D
Sbjct: 90  ESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF-----VHRD 142

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVST 523
           +   NVLL T   AKI++F L++     E  +   +     K    + APE +     S+
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT---HGKWPVKWYAPECINYYKFSS 199

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
           K DV++FGVLM E  S  + P  Y    M   +V   +   E GE   R  M        
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKP--Y--RGMKGSEVTAML---EKGE---R--MGC------ 241

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           P      +  L+  C   D   RP    +   +  + 
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (291), Expect = 1e-28
 Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 46/288 (15%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G V               VA+K +  DA  Q        I +L  + H  +I+  G C +
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104

Query: 408 GGN--WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHV 463
            G     LV E    GSL  ++       +  AQ +  A  +  G+ YLH+  +     +
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHY-----I 156

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLEN 518
           H+D+   NVLLD D   KI +F LA+        +      V   G     + APE L+ 
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-----RVREDGDSPVFWYAPECLKE 211

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
                  DV++FGV + E+L+       + + +         ++    G+ ++  L +  
Sbjct: 212 YKFYYASDVWSFGVTLYELLT-------HCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 579 MQGNY---PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            +G     P      V  L+++C + + S RP  + +   +       
Sbjct: 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  115 bits (290), Expect = 1e-28
 Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 49/283 (17%)

Query: 362 GSVYRGKIGGD-----FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF-N 407
           G VY G +  +       A+K +                 ++   +H +++ LLGIC  +
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHK 465
            G+  +V     +G L  +I ++          I   L VA G+ YL S  F     VH+
Sbjct: 99  EGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLASKKF-----VHR 152

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGL 520
           D+   N +LD  F  K+A+F LAR    +E           T       +MA E L+   
Sbjct: 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----TGAKLPVKWMALESLQTQK 208

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            +TK DV++FGVL+ E+++    P  Y   ++   D+   +     G       +     
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPP--YP--DVNTFDITVYL---LQG-----RRLLQ--- 253

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
              P      +  ++  C       RP+  ++   IS   +  
Sbjct: 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  116 bits (293), Expect = 1e-28
 Identities = 62/277 (22%), Positives = 123/277 (44%), Gaps = 45/277 (16%)

Query: 362 GSVYRGKIGGD-----FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNG 408
           G V  G++         VAIK +    +++          ++ + +H ++IRL G+    
Sbjct: 59  GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKD 466
               +V E   NGSL  ++     +     Q + +   +A+G+ YL    +     VH+D
Sbjct: 119 KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGY-----VHRD 172

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVST 523
           +   N+L++++   K+++F L R  E    E A T+   G K    + +PE +     ++
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTR--GGKIPIRWTSPEAIAYRKFTS 229

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
             DV+++G+++ E++S  E P  Y    M   DV+  V   ++G       + P      
Sbjct: 230 ASDVWSYGIVLWEVMSYGERP--Y--WEMSNQDVIKAV---DEGY-----RLPP------ 271

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           P      + +L+  C +KD + RP  ++I   + + +
Sbjct: 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  117 bits (294), Expect = 1e-28
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 68/312 (21%)

Query: 362 GSVYRGKIGGDF---------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLG 403
           G V   +  G           VA+K +  DA+++        ++++  I  H ++I LLG
Sbjct: 83  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142

Query: 404 ICFNGGNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVAT 449
            C   G  Y++ E A  G+L              S   +    + L     +  A  VA 
Sbjct: 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202

Query: 450 GLNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           G+ YL S        +H+D+   NVL+  D   KIA+F LAR     +       +   T
Sbjct: 203 GMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHID------YYKKTT 251

Query: 508 KG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL 562
            G     +MAPE L + + + + DV++FGVL+ E+ +   +P  Y    + + ++   + 
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP--GVPVEELFKLL- 306

Query: 563 HKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
             ++G     H MD       P      +  ++  C    PS RP   ++ + + R +  
Sbjct: 307 --KEG-----HRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

Query: 623 SLAWELSKNISE 634
           +   E+      
Sbjct: 354 TSNQEMGYYHHH 365

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (294), Expect = 1e-28
 Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 52/276 (18%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSL--IRLLGICFNGG 409
             V++         AIK V  + +D          I  LNK+   S   IRL        
Sbjct: 70  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDI 467
             Y+V E   N  L+ W+  K    +D  +R     ++   ++ +H      H  VH D+
Sbjct: 130 YIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ-----HGIVHSDL 181

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN--------- 518
           K +N L+  D   K+ +F +A   +         S  VG   YM PE +++         
Sbjct: 182 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEAIKDMSSSRENGK 239

Query: 519 --GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD 576
               +S K DV++ G ++  M  GK                  P     +    L  ++D
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGK--T---------------PFQQIINQISKLHAIID 282

Query: 577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           P+ +  +P +    +  +++ CLK+DP  R ++ ++
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/293 (18%), Positives = 116/293 (39%), Gaps = 54/293 (18%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNG 408
           GSV   +           VA+KK+     +        I++L  + H ++++  G+C++ 
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83

Query: 409 GN--WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVH 464
           G     L+ E    GSL  ++     + +D  + +Q    +  G+ YL +  +     +H
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRY-----IH 137

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLV 521
           +D+   N+L++ + R KI +F L +   + +  F +       +    + APE L     
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESPIFWYAPESLTESKF 194

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEE-----------NMLLVDVLNPVLHKEDGEES 570
           S   DV++FGV++ E+ +  E       E            M++  ++  +   ++    
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL---KNNG-- 249

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            R  +        P      +  ++  C   + + RP+   +A  + +  +  
Sbjct: 250 -R--LPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (290), Expect = 2e-28
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 66/296 (22%)

Query: 362 GSVYRGKIGGD----FVAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGICFNG 408
           G V + +I  D      AIK++   AS          +++L K+ +H ++I LLG C + 
Sbjct: 39  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98

Query: 409 GNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVATGLNYL 454
           G  YL  E A +G+L              +  I +     L   Q +  A DVA G++YL
Sbjct: 99  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158

Query: 455 --HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG--- 509
               F     +H+D+   N+L+  ++ AKIA+F L+R  E          ++  T G   
Sbjct: 159 SQKQF-----IHRDLAARNILVGENYVAKIADFGLSRGQE---------VYVKKTMGRLP 204

Query: 510 --YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG 567
             +MA E L   + +T  DV+++GVL+ E++S    P  Y    M   ++   +     G
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC--GMTCAELYEKL---PQG 257

Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
                + ++       P      V  L+  C ++ P  RP+  +I  S++R L   
Sbjct: 258 -----YRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (287), Expect = 2e-28
 Identities = 57/289 (19%), Positives = 105/289 (36%), Gaps = 62/289 (21%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G V+  + K+     AIK++     +         +K L K+ H  ++R           
Sbjct: 19  GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78

Query: 412 ------------YLVYENAVNGSLSVWIND-KGGKFLDWAQRIQIALDVATGLNYLHSFT 458
                       Y+  +     +L  W+N     +  + +  + I L +A  + +LHS  
Sbjct: 79  EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138

Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE---------GEFALTSHIVGTKG 509
               +H+D+K SN+    D   K+ +F L    ++ E           +A  +  VGTK 
Sbjct: 139 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195

Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE 569
           YM+PE +     S K+D+++ G+++ E+L          E    L DV            
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQ---MERVRTLTDV------------ 240

Query: 570 SLRHLMDPSMQGNYPPVTAIL---VIRLIESCLKKDPSGRPAMDKIAQS 615
                        +PP+          +++  L   P  RP    I ++
Sbjct: 241 ---------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  118 bits (298), Expect = 3e-28
 Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 45/278 (16%)

Query: 362 GSVYRGKIGGD----FVAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNGG 409
           GSV +G          VAIK +                 +++++++  ++RL+G+C    
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 408

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHKDI 467
              LV E A  G L  ++  K  + +  +   ++   V+ G+ YL   +F     VH+++
Sbjct: 409 ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF-----VHRNL 462

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVSTK 524
              NVLL     AKI++F L++     +  +   S     K    + APE +     S++
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---AGKWPLKWYAPECINFRKFSSR 519

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            DV+++GV M E LS  + P  Y  + M   +V+  +   E G+   R  M+       P
Sbjct: 520 SDVWSYGVTMWEALSYGQKP--Y--KKMKGPEVMAFI---EQGK---R--MEC------P 561

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
           P     +  L+  C       RP    + Q +     +
Sbjct: 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 3e-28
 Identities = 52/293 (17%), Positives = 116/293 (39%), Gaps = 54/293 (18%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNG 408
           GSV   +           VA+KK+     +        I++L  + H ++++  G+C++ 
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 409 GN--WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVH 464
           G     L+ E    GSL  ++     + +D  + +Q    +  G+ YL +  +     +H
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRY-----IH 168

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG---YMAPEYLENGLV 521
           +D+   N+L++ + R KI +F L +   + +  + +       +    + APE L     
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE---PGESPIFWYAPESLTESKF 225

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEE-----------NMLLVDVLNPVLHKEDGEES 570
           S   DV++FGV++ E+ +  E       E            M++  ++  +   ++    
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL---KNNG-- 280

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            R  +        P      +  ++  C   + + RP+   +A  + +  +  
Sbjct: 281 -R--LPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  114 bits (288), Expect = 3e-28
 Identities = 70/292 (23%), Positives = 108/292 (36%), Gaps = 59/292 (20%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q          +++K NH +++R +G+  
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103

Query: 407 NGGNWYLVYENAVNGSL-----SVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTN 459
                +++ E    G L                L     + +A D+A G  YL  + F  
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF-- 161

Query: 460 PPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGY-----M 511
              +H+DI   N LL        AKI +F +AR   R         +  G         M
Sbjct: 162 ---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS------YYRKGGCAMLPVKWM 212

Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL 571
            PE    G+ ++K D ++FGVL+ E+ S    P  Y   +    +VL  V     G    
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YP--SKSNQEVLEFV---TSG---- 261

Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
              MDP      P      V R++  C +  P  RP    I + I       
Sbjct: 262 -GRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  114 bits (287), Expect = 4e-28
 Identities = 60/291 (20%), Positives = 114/291 (39%), Gaps = 59/291 (20%)

Query: 362 GSVYRGKIGGD-----FVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFN 407
           GSV  G +  +      VA+K +  D S Q            +   +H ++IRLLG+C  
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107

Query: 408 GG-----NWYLVYENAVNGSLSVWI----NDKGGKFLDWAQRIQIALDVATGLNYL--HS 456
                     ++      G L  ++     + G K +     ++  +D+A G+ YL   +
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167

Query: 457 FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YM 511
           F     +H+D+   N +L  D    +A+F L++     +       +  G        ++
Sbjct: 168 F-----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD------YYRQGRIAKMPVKWI 216

Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL 571
           A E L + + ++K DV+AFGV M E+ +    P  Y    +   ++ + +     G    
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPG--VQNHEMYDYL---LHG---- 265

Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
            H +        P      +  ++ SC + DP  RP    +   + + L +
Sbjct: 266 -HRLKQ------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  113 bits (286), Expect = 5e-28
 Identities = 53/290 (18%), Positives = 102/290 (35%), Gaps = 54/290 (18%)

Query: 362 GSVY--RGKIGGDFVAIKKVY-GDASDQ------IKLLNKINHSSLIRLLGICFNGGNW- 411
             V    G   G F A+K++   +  D+        +    NH +++RL+  C       
Sbjct: 43  SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102

Query: 412 ---YLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
              +L+      G+L   I      G FL   Q + + L +  GL  +H+     + H+D
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRD 159

Query: 467 IKCSNVLLDTDFRAKIANFALARPA--------ERQEGEFALTSHIVGTKGYMAPEYLE- 517
           +K +N+LL  + +  + +      A        +    +         T  Y APE    
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR--CTISYRAPELFSV 217

Query: 518 --NGLVSTKLDVYAFGVLMLEMLSGK---EAPALYSEENMLLVDVLNPVLHKEDGEESLR 572
             + ++  + DV++ G ++  M+ G+   +      +   L V                 
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---------------QN 262

Query: 573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
            L  P      P  ++ L  +L+ S +  DP  RP +  +   +      
Sbjct: 263 QLSIPQ----SPRHSSAL-WQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  114 bits (288), Expect = 5e-28
 Identities = 67/306 (21%), Positives = 119/306 (38%), Gaps = 73/306 (23%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G V++ +  G         VA+K +  +AS            L+ + ++ ++++LLG+C 
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 407 NGGNWYLVYENAVNGSL----------------------SVWINDKGGKFLDWAQRIQIA 444
            G    L++E    G L                         ++  G   L  A+++ IA
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 445 LDVATGLNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
             VA G+ YL    F     VH+D+   N L+  +   KIA+F L+R     +       
Sbjct: 181 RQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD------Y 229

Query: 503 HIVGTKGY-----MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           +            M PE +     +T+ DV+A+GV++ E+ S    P  Y    M   +V
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YY--GMAHEEV 285

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
           +  V    DG     +++        P    + +  L+  C  K P+ RP+   I + + 
Sbjct: 286 IYYV---RDG-----NILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331

Query: 618 RFLNAS 623
           R    +
Sbjct: 332 RMCERA 337

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  113 bits (286), Expect = 5e-28
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 48/278 (17%)

Query: 362 GSVYRGKIGGDF------VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFN 407
           G+V++G    +       V IK +   +  Q           +  ++H+ ++RLLG+C  
Sbjct: 27  GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVHK 465
           G +  LV +    GSL   +    G  L     +   + +A G+ YL  H       VH+
Sbjct: 86  GSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGM-----VHR 139

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLVS 522
           ++   NVLL +  + ++A+F +A      + +   +      K    +MA E +  G  +
Sbjct: 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS----EAKTPIKWMALESIHFGKYT 195

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + DV+++GV + E+++    P  Y    + L +V + +   E GE   R  +       
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP--Y--AGLRLAEVPDLL---EKGE---R--LAQ----- 238

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
            P +  I V  ++  C   D + RP   ++A   +R  
Sbjct: 239 -PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  112 bits (283), Expect = 7e-28
 Identities = 59/283 (20%), Positives = 102/283 (36%), Gaps = 47/283 (16%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQIKLLN----------KINHSSLIRLLGICF 406
           G V RG+          VA+K +  D   Q + ++           ++H +LIRL G+  
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHVH 464
                 +V E A  GSL   +    G         + A+ VA G+ YL    F     +H
Sbjct: 92  -TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRF-----IH 144

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK---GYMAPEYLENGLV 521
           +D+   N+LL T    KI +F L R   + +  + +       K    + APE L+    
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE---HRKVPFAWCAPESLKTRTF 201

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           S   D + FGV + EM +  + P  +    +    +L+ +       +     +      
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEP--W--IGLNGSQILHKI-------DKEGERLPR---- 246

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
             P      +  ++  C    P  RP    +   +       +
Sbjct: 247 --PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  113 bits (284), Expect = 2e-27
 Identities = 70/290 (24%), Positives = 108/290 (37%), Gaps = 59/290 (20%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G VY G++ G         VA+K +    S+Q          +++K NH +++R +G+  
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144

Query: 407 NGGNWYLVYENAVNGSL-----SVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTN 459
                +++ E    G L                L     + +A D+A G  YL  + F  
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF-- 202

Query: 460 PPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGY-----M 511
              +H+DI   N LL        AKI +F +AR   R         +  G         M
Sbjct: 203 ---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG------YYRKGGCAMLPVKWM 253

Query: 512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL 571
            PE    G+ ++K D ++FGVL+ E+ S    P  Y   +    +VL  V     G    
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YP--SKSNQEVLEFV---TSG---- 302

Query: 572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
              MDP      P      V R++  C +  P  RP    I + I     
Sbjct: 303 -GRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  116 bits (292), Expect = 2e-27
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 52/282 (18%)

Query: 362 GSVYRGKIGGDF-----VAIKKVYGDASDQIK--------LLNKINHSSLIRLLGICFNG 408
           G V++G           VAIK      SD ++         + + +H  +++L+G+    
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 462

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS--FTNPPHVHKD 466
              +++ E    G L  ++  +    LD A  I  A  ++T L YL S  F     VH+D
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKRF-----VHRD 516

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLV 521
           I   NVL+ ++   K+ +F L+R  E          +   +KG     +MAPE +     
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIKWMAPESINFRRF 569

Query: 522 STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG 581
           ++  DV+ FGV M E+L     P  +  + +   DV+  +   E+G       +      
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP--F--QGVKNNDVIGRI---ENG-----ERLPM---- 613

Query: 582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
             PP     +  L+  C   DPS RP   ++   +S  L   
Sbjct: 614 --PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (279), Expect = 3e-27
 Identities = 47/306 (15%), Positives = 106/306 (34%), Gaps = 72/306 (23%)

Query: 362 GSVYRGKIGGDF---------VAIKKVYGDASDQIK-------LLNKINHSSLIRLLGIC 405
             +++G               V +K +     +  +       +++K++H  L+   G+C
Sbjct: 22  TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81

Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL--HSFTNPPHV 463
             G    LV E    GSL  ++       ++   ++++A  +A  +++L  ++      +
Sbjct: 82  VCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEENTL-----I 135

Query: 464 HKDIKCSNVLLDTDFR--------AKIANFALARPAERQEGEFALTSHIVGTKGY----- 510
           H ++   N+LL  +           K+++  ++               ++          
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-------------TVLPKDILQERIP 182

Query: 511 -MAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE 568
            + PE +EN    +   D ++FG  + E+ SG + P       +     L      ED  
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--L--SALDSQRKLQFY---EDR- 234

Query: 569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL 628
               H +          +       LI +C+  +P  RP+   I + ++      L    
Sbjct: 235 ----HQLPAPKA---AELA-----NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282

Query: 629 SKNISE 634
           S +   
Sbjct: 283 SHHHHH 288

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  110 bits (278), Expect = 5e-27
 Identities = 67/306 (21%), Positives = 123/306 (40%), Gaps = 73/306 (23%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G V +              VA+K +  +AS            +L ++NH  +I+L G C 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96

Query: 407 NGGNWYLVYENAVNGSL----------------------SVWINDKGGKFLDWAQRIQIA 444
             G   L+ E A  GSL                      S  ++    + L     I  A
Sbjct: 97  QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156

Query: 445 LDVATGLNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
             ++ G+ YL          VH+D+   N+L+    + KI++F L+R    ++      S
Sbjct: 157 WQISQGMQYLAEMKL-----VHRDLAARNILVAEGRKMKISDFGLSRDVYEED------S 205

Query: 503 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
           ++  ++G     +MA E L + + +T+ DV++FGVL+ E+++    P  Y    +    +
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YP--GIPPERL 261

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS 617
            N +   + G     H M+       P   +  + RL+  C K++P  RP    I++ + 
Sbjct: 262 FNLL---KTG-----HRMER------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

Query: 618 RFLNAS 623
           + +   
Sbjct: 308 KMMVKR 313

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  110 bits (276), Expect = 7e-27
 Identities = 61/292 (20%), Positives = 106/292 (36%), Gaps = 65/292 (22%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNW-- 411
           G V   R  +   + AIKK+             + LL  +NH  ++R         N+  
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79

Query: 412 -----------YLVYENAVNGSLSVWINDKGGKFL-DWAQRI--QIALDVATGLNYLHSF 457
                      ++  E   NG+L   I+ +      D   R+  QI       L+Y+HS 
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE----ALSYIHS- 134

Query: 458 TNPPH--VHKDIKCSNVLLDTDFRAKIANFALAR-----------PAERQEGEFALTSHI 504
                  +H+D+K  N+ +D     KI +F LA+            ++   G     +  
Sbjct: 135 ----QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190

Query: 505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           +GT  Y+A E L+  G  + K+D+Y+ G++  EM+     P     E + ++  L     
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI----YPFSTGMERVNILKKLR---- 242

Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
                        P    N       +  ++I   +  DP+ RP    +  S
Sbjct: 243 --SVSIEF----PPDFDDNKMK----VEKKIIRLLIDHDPNKRPGARTLLNS 284

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (281), Expect = 1e-26
 Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 53/282 (18%)

Query: 364 VYRGKIGGDFVAIKKV----YGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENA 418
           V++G   G  VA+K++       A  +IKLL +  +H ++IR           Y+  E  
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL- 90

Query: 419 VNGSLSVWINDKG-----GKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCSN 471
            N +L   +  K       K       I +   +A+G+ +LHS        +H+D+K  N
Sbjct: 91  CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-----LKIIHRDLKPQN 145

Query: 472 VLLDT-------------DFRAKIANFALARPAERQEGEF-ALTSHIVGTKGYMAPEYLE 517
           +L+ T             + R  I++F L +  +  +  F    ++  GT G+ APE LE
Sbjct: 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLE 205

Query: 518 NGLV-------STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES 570
                      +  +D+++ G +   +LS  + P  + ++     +++        G  S
Sbjct: 206 ESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP--FGDKYSRESNIIR-------GIFS 256

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
           L  +        +          LI   +  DP  RP   K+
Sbjct: 257 LDEMKCL-----HDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (277), Expect = 1e-26
 Identities = 60/297 (20%), Positives = 109/297 (36%), Gaps = 63/297 (21%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGIC 405
           G V      G         VA+K +   A           +K+++ +  H +++ LLG C
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119

Query: 406 FNGGNWYLVYENAVNGSL------------SVWINDKGGKFLDWAQRIQIALDVATGLNY 453
            +GG   ++ E    G L            +                +  +  VA G+ +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179

Query: 454 LHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG-- 509
           L S        +H+D+   NVLL     AKI +F LAR            ++IV      
Sbjct: 180 LASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS------NYIVKGNARL 228

Query: 510 ---YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
              +MAPE + + + + + DV+++G+L+ E+ S    P  Y    ++       V   +D
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGI-LVNSKFYKLV---KD 282

Query: 567 GEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           G     + M        P      +  ++++C   +P+ RP   +I   +       
Sbjct: 283 G-----YQMAQ------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (274), Expect = 2e-26
 Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 70/302 (23%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGIC 405
           G V      G         VA+K +   A+          +K+L  I +H +++ LLG C
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100

Query: 406 F-NGGNWYLVYENAVNGSL--------------SVWINDKGGKFLDWAQRIQIALDVATG 450
              GG   ++ E    G+L               V   D    FL     I  +  VA G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160

Query: 451 LNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
           + +L S        +H+D+   N+LL      KI +F LAR   +         ++    
Sbjct: 161 MEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGD 209

Query: 509 G-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS--EENMLLVDVLNPV 561
                 +MAPE + + + + + DV++FGVL+ E+ S   +P  Y   + +      L   
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRL--- 264

Query: 562 LHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
              ++G       M        P  T   + + +  C   +PS RP   ++ + +   L 
Sbjct: 265 ---KEG-----TRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

Query: 622 AS 623
           A+
Sbjct: 311 AN 312

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (270), Expect = 4e-26
 Identities = 55/285 (19%), Positives = 95/285 (33%), Gaps = 62/285 (21%)

Query: 362 GSVYRG--KIGGDFVAIKKV---YGDASDQIKLLNKIN-HSSL------IRLLGICFNGG 409
           GSV++   ++ G   AIK+       + D+   L ++  H+ L      +R         
Sbjct: 25  GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84

Query: 410 NWYLVYENAVNGSLSVWI--NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHK 465
           +  +  E    GSL+  I  N +   +   A+   + L V  GL Y+HS        VH 
Sbjct: 85  HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-----MSLVHM 139

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQE------GEFALTSHI------VGTKGYMAP 513
           DIK SN+ +        A+                 G+    + I       G   ++A 
Sbjct: 140 DIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLAN 199

Query: 514 EYL-ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR 572
           E L EN     K D++A  + ++     +  P                            
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------------------------- 234

Query: 573 HLMDPSMQGNYPPVTAIL---VIRLIESCLKKDPSGRPAMDKIAQ 614
                  QG  P +  +L      L++  +  DP  RP+   + +
Sbjct: 235 DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (265), Expect = 3e-25
 Identities = 48/249 (19%), Positives = 95/249 (38%), Gaps = 34/249 (13%)

Query: 377 KKVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-KGGKFL 435
                  S +I+ ++  +  + +  L         Y+  +     +L  W+N     +  
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
           +    + I + +A  + +LHS      +H+D+K SN+    D   K+ +F L    ++ E
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 496 ---------GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPAL 546
                      +A  +  VGTK YM+PE +     S K+D+++ G+++ E+L        
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ-- 276

Query: 547 YSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
             E   ++ DV N                 P +     P        +++  L   P+ R
Sbjct: 277 -MERVRIITDVRNLKF--------------PLLFTQKYPQEH----MMVQDMLSPSPTER 317

Query: 607 PAMDKIAQS 615
           P    I ++
Sbjct: 318 PEATDIIEN 326

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  105 bits (265), Expect = 3e-25
 Identities = 72/323 (22%), Positives = 117/323 (36%), Gaps = 40/323 (12%)

Query: 303 STIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFN-PSCWIK 361
           S  VSS       +  K     S        +   +  V   E+L+    ++     W+ 
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 362 ----------GSVYRG--KIGGDFVAIKKVYGDASDQ--IKLLNKINHSSLIRLLGICFN 407
                     G V+R   K  G   A+KKV  +      +     ++   ++ L G    
Sbjct: 62  HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 121

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
           G    +  E    GSL   I  + G      + +        GL YLH+      +H D+
Sbjct: 122 GPWVNIFMELLEGGSLGQLIK-QMGCL-PEDRALYYLGQALEGLEYLHTRRI---LHGDV 176

Query: 468 KCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSH--IVGTKGYMAPEYLENGLVSTK 524
           K  NVLL +D  RA + +F  A   +      +L +   I GT+ +MAPE +       K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
           +D+++   +ML ML+G                   P+         L+   +P      P
Sbjct: 237 VDIWSSCCMMLHMLNGC--HPWTQYFRG-------PLC--------LKIASEPPPIREIP 279

Query: 585 PVTAILVIRLIESCLKKDPSGRP 607
           P  A L  + I+  L+K+P  R 
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRA 302

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (263), Expect = 5e-25
 Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 71/303 (23%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGIC 405
           G V      G         VA+K +   A           +K+L+ + NH +++ LLG C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 406 FNGGNWYLVYENAVNGSL----------------SVWINDKGGKFLDWAQRIQIALDVAT 449
             GG   ++ E    G L                S  I +     LD    +  +  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 450 GLNYLHS--FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           G+ +L S        +H+D+   N+LL      KI +F LAR  +         +++V  
Sbjct: 157 GMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDS------NYVVKG 205

Query: 508 KG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS--EENMLLVDVLNP 560
                  +MAPE + N + + + DV+++G+ + E+ S   +P  Y     +     ++  
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMPVDSKFYKMI-- 261

Query: 561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
               ++G       M        P      +  ++++C   DP  RP   +I Q I + +
Sbjct: 262 ----KEG-----FRMLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

Query: 621 NAS 623
           + S
Sbjct: 307 SES 309

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (261), Expect = 2e-24
 Identities = 51/292 (17%), Positives = 102/292 (34%), Gaps = 52/292 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
            +V     K  G++V ++++  +A            + +    NH +++           
Sbjct: 41  MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++V      GS    I       ++      I   V   L+Y+H      +VH+ +K S
Sbjct: 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKAS 157

Query: 471 NVLLDTDFRAKIANF----ALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV--STK 524
           ++L+  D +  ++      ++    +RQ        + V    +++PE L+  L     K
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN---MLLVDVLN--PVLHKEDGEESLRHLMDPSM 579
            D+Y+ G+   E+ +G   P  + +     MLL  +    P L       +    M PS 
Sbjct: 218 SDIYSVGITACELANG-HVP--FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274

Query: 580 QGNYPPVTAILVIR------------------------LIESCLKKDPSGRP 607
                 ++  L                            +E CL+++P  RP
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  103 bits (260), Expect = 2e-24
 Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 76/308 (24%)

Query: 362 GSVYRGKIGGDF-------VAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGIC 405
           G V      G         VA+K +   A           +K++ ++ +H +++ LLG C
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118

Query: 406 FNGGNWYLVYENAVNGSL---------------------SVWINDKGGKFLDWAQRIQIA 444
              G  YL++E    G L                          ++    L +   +  A
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178

Query: 445 LDVATGLNYL--HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
             VA G+ +L   S      VH+D+   NVL+      KI +F LAR            +
Sbjct: 179 YQVAKGMEFLEFKSC-----VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS------N 227

Query: 503 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYS--EENMLLV 555
           ++V         +MAPE L  G+ + K DV+++G+L+ E+ S    P  Y     +    
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGIPVDANFY 285

Query: 556 DVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
            ++      ++G       MD       P      +  +++SC   D   RP+   +   
Sbjct: 286 KLI------QNG-----FKMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 616 ISRFLNAS 623
           +   L  +
Sbjct: 329 LGCQLADA 336

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/264 (21%), Positives = 115/264 (43%), Gaps = 44/264 (16%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQIKLLNK----------INHSSLIRLLGICFNGG 409
            +VY  +  I    VAIK ++    ++ + L +          ++H +++ ++ +     
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84

Query: 410 NWYLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
            +YLV E  + G +LS +I   G   L     I     +  G+ + H         VH+D
Sbjct: 85  CYYLVMEY-IEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHD-----MRIVHRD 136

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLD 526
           IK  N+L+D++   KI +F +A+     E     T+H++GT  Y +PE  +        D
Sbjct: 137 IKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD--PSMQGNYP 584
           +Y+ G+++ EML G+  P  ++ E  + +              +++H+ D  P++  +  
Sbjct: 195 IYSIGIVLYEMLVGE-PP--FNGETAVSI--------------AIKHIQDSVPNVTTDVR 237

Query: 585 PVTAILVIRLIESCLKKDPSGRPA 608
                 +  +I    +KD + R  
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYK 261

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  101 bits (254), Expect = 6e-24
 Identities = 67/262 (25%), Positives = 101/262 (38%), Gaps = 42/262 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY G        +AIK++    S         I L   + H ++++ LG     G   
Sbjct: 36  GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +  E    GSLS  +  K G   D  Q I      +  GL YLH       VH+DIK  N
Sbjct: 96  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI---VHRDIKGDN 152

Query: 472 VLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV--STKLDVY 528
           VL++T     KI++F  ++   R  G    T    GT  YMAPE ++ G        D++
Sbjct: 153 VLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           + G  ++EM +GK  P  +        ++  P             +    M   +P +  
Sbjct: 210 SLGCTIIEMATGK-PP--FY-------ELGEPQ----------AAMFKVGMFKVHPEIPE 249

Query: 589 IL---VIRLIESCLKKDPSGRP 607
            +       I  C + DP  R 
Sbjct: 250 SMSAEAKAFILKCFEPDPDKRA 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  100 bits (251), Expect = 1e-23
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 56/272 (20%)

Query: 362 GSVY--RGKIGGDFVAIKKVY------GDASDQ----IKLLNKINHSSLIRLLGICFNGG 409
           G+VY  R K     +A+K ++           Q    +++ + + H +++RL G   +  
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIK 468
             YL+ E A  G++   +  K  KF +         ++A  L+Y HS      V H+DIK
Sbjct: 83  RVYLILEYAPLGTVYRELQ-KLSKFDEQRTA-TYITELANALSYCHSK----RVIHRDIK 136

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             N+LL +    KIA+F  +  A            + GT  Y+ PE +E  +   K+D++
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAP---SSRRTD--LCGTLDYLPPEMIEGRMHDEKVDLW 191

Query: 529 AFGVLMLEMLSGK------EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
           + GVL  E L GK           Y  + +  V+                          
Sbjct: 192 SLGVLCYEFLVGKPPFEANTYQETY--KRISRVEF------------------------T 225

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           +P         LI   LK +PS RP + ++ +
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 53/287 (18%), Positives = 111/287 (38%), Gaps = 45/287 (15%)

Query: 362 GSVYRG--KIGGDFVAIK----KVYGDASDQ----IKLLNKINHSSLIRLLGI--CFNGG 409
            +V+RG  K  GD  AIK      +    D      ++L K+NH ++++L  I       
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82

Query: 410 NWYLVYENAVNGSLSVWINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
           +  L+ E    GSL   + +      L  ++ + +  DV  G+N+L       +  VH++
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-----NGIVHRN 137

Query: 467 IKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           IK  N++     D     K+ +F  AR  E ++ E  ++  + GT+ Y+ P+  E  ++ 
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVS--LYGTEEYLHPDMYERAVLR 193

Query: 523 T--------KLDVYAFGVLMLEMLSGK---EAPALYSEENMLLVDVLN------PVLHKE 565
                     +D+++ GV      +G               ++  ++           ++
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
                +    D  +  +      +L+  ++ + L+ D       D+ 
Sbjct: 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 43/206 (20%), Positives = 91/206 (44%), Gaps = 39/206 (18%)

Query: 412 YLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
           Y+V E  V+G +L   ++ +G   +   + I++  D    LN+ H      +  +H+D+K
Sbjct: 92  YIVMEY-VDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ-----NGIIHRDVK 143

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
            +N+++      K+ +F +AR           T+ ++GT  Y++PE      V  + DVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           + G ++ E+L+G+  P  ++ ++ + V              + +H+ +        P +A
Sbjct: 204 SLGCVLYEVLTGE-PP--FTGDSPVSV--------------AYQHVREDP-----IPPSA 241

Query: 589 IL------VIRLIESCLKKDPSGRPA 608
                   +  ++   L K+P  R  
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQ 267

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 99.5 bits (248), Expect = 1e-22
 Identities = 55/296 (18%), Positives = 114/296 (38%), Gaps = 45/296 (15%)

Query: 362 GSVYRG--KIGGDFVAIK----KVYGDASDQ----IKLLNKINHSSLIRLLGI--CFNGG 409
            +V+RG  K  GD  AIK      +    D      ++L K+NH ++++L  I       
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82

Query: 410 NWYLVYENAVNGSLSVWINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
           +  L+ E    GSL   + +      L  ++ + +  DV  G+N+L       +  VH++
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-----NGIVHRN 137

Query: 467 IKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           IK  N++     D     K+ +F  AR  E ++ E  ++  + GT+ Y+ P+  E  ++ 
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVS--LYGTEEYLHPDMYERAVLR 193

Query: 523 T--------KLDVYAFGVLMLEMLSGK---EAPALYSEENMLLVDVLN------PVLHKE 565
                     +D+++ GV      +G               ++  ++           ++
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
                +    D  +  +      +L+  ++ + L+ D       D+     S  L+
Sbjct: 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  101 bits (253), Expect = 1e-22
 Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 37/280 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGI------C 405
           G V R   +  G+ VAIK+   + S +        I+++ K+NH +++    +       
Sbjct: 28  GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87

Query: 406 FNGGNWYLVYENAVNGSLSVWINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPH-- 462
                  L  E    G L  ++N       L       +  D+++ L YLH      +  
Sbjct: 88  APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-----NRI 142

Query: 463 VHKDIKCSNVLLDTDFRA---KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
           +H+D+K  N++L    +    KI +   A+  E  +GE       VGT  Y+APE LE  
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEF--VGTLQYLAPELLEQK 198

Query: 520 LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL-----NPVLHKEDGEESLRHL 574
             +  +D ++FG L  E ++G   P L + + +     +       ++  +D   +++  
Sbjct: 199 KYTVTVDYWSFGTLAFECITGF-RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                  +   + A  + R ++  L      R    +   
Sbjct: 258 SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 47/291 (16%), Positives = 79/291 (27%), Gaps = 50/291 (17%)

Query: 362 GSVYRGK-------IGGDFVAIKKV-------YGDASDQIKLLNKINHSSLIRLLGICFN 407
             VY                 +K         +   +  ++ L        ++       
Sbjct: 79  AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138

Query: 408 GGNWYLVYENAVNGSLSVWINDKG---GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
                LV E    G+L   IN       K +     I  A+ +   +  +H       +H
Sbjct: 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIH 195

Query: 465 KDIKCSNVLL-----------DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP 513
            DIK  N +L           D      + +   +   +        T+    T G+   
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCV 254

Query: 514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE-----------------NMLLVD 556
           E L N   + ++D +     +  ML G                           N     
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHV 314

Query: 557 VLN-PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
           +LN P  H     + LR  +    Q +Y      L  RLI   L+   S +
Sbjct: 315 MLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 365

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 59/274 (21%), Positives = 111/274 (40%), Gaps = 57/274 (20%)

Query: 362 GSVY--RGKIGGDFVAIKKVY------GDASDQ----IKLLNKINHSSLIRLLGICFNGG 409
             VY       G  VAIK +            +    +K+  ++ H S++ L     +  
Sbjct: 25  AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDW-AQRI--QIALDVATGLNYLHSFTNPPHV-HK 465
             YLV E   NG ++ ++ ++   F +  A+    QI     TG+ YLHS      + H+
Sbjct: 85  YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSH----GILHR 136

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           D+  SN+LL  +   KIA+F LA   +    E   T  + GT  Y++PE         + 
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLK-MPHEKHYT--LCGTPNYISPEIATRSAHGLES 193

Query: 526 DVYAFGVLMLEMLSGK---EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
           DV++ G +   +L G+   +                          +++++ ++  +  +
Sbjct: 194 DVWSLGCMFYTLLIGRPPFD-------------------------TDTVKNTLNKVVLAD 228

Query: 583 Y--PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           Y  P   +I    LI   L+++P+ R ++  +  
Sbjct: 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (250), Expect = 4e-22
 Identities = 52/266 (19%), Positives = 88/266 (33%), Gaps = 64/266 (24%)

Query: 362 GSVYRGK---IGGDFVAIK--KVYGDASDQI------KLLNKINHSSLIRLL-----GIC 405
           G +Y      + G  V +K     GDA  Q       + L ++ H S++++         
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153

Query: 406 FNGGNWYLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH-- 462
                 Y+V E  V G SL      K    L  A+ I   L++   L+YLHS        
Sbjct: 154 HGDPVGYIVMEY-VGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHS-----IGL 203

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           V+ D+K  N++L  + + K+ +                  ++ GT G+ APE +  G  +
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVSRINS-------FGYLYGTPGFQAPEIVRTG-PT 254

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
              D+Y  G  +  +                            +G   +  L +      
Sbjct: 255 VATDIYTVGRTLAALTLDLPT---------------------RNG-RYVDGLPEDDPVLK 292

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPA 608
                     RL+   +  DP  R  
Sbjct: 293 TYDS----YGRLLRRAIDPDPRQRFT 314

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 43/212 (20%), Positives = 79/212 (37%), Gaps = 46/212 (21%)

Query: 408 GGNWYLVYENAVNG-SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
            G  Y+     +NG  L+  +  +G   L   + + I   + + L+  H+         H
Sbjct: 106 DGQLYVDMR-LINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHA-----AGATH 157

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS--HIVGTKGYMAPEYLENGLVS 522
           +D+K  N+L+  D  A + +F +A        +  LT   + VGT  YMAPE       +
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASAT----TDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + D+YA   ++ E L+G   P  Y  + + ++                 H+        
Sbjct: 214 YRADIYALTCVLYECLTGS-PP--YQGDQLSVM---------------GAHINQAI---- 251

Query: 583 YPPVTAIL------VIRLIESCLKKDPSGRPA 608
            P  + +          +I   + K+P  R  
Sbjct: 252 -PRPSTVRPGIPVAFDAVIARGMAKNPEDRYV 282

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 48/287 (16%), Positives = 99/287 (34%), Gaps = 43/287 (14%)

Query: 362 GSVYRGKIGGDFVAIKKV--------------------YGDASDQIK----LLNKINHSS 397
             +   +    F A+KK                          D  K    ++  I +  
Sbjct: 45  NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104

Query: 398 LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI------QIALDVATGL 451
            +   GI  N    Y++YE   N S+  +         ++   I       I   V    
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSF 164

Query: 452 NYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM 511
           +Y+H+  N    H+D+K SN+L+D + R K+++F  +      + +    S   GT  +M
Sbjct: 165 SYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGES--EYMVDKKIK-GS--RGTYEFM 217

Query: 512 APEYLENGLV--STKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLNPVLHKEDG 567
            PE+  N       K+D+++ G+ +  M           + ++  L  ++    +     
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNV--VPFSLKISLVELFNNIRTKNIEYPLD 275

Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                + +            +   I  ++  L+K+P+ R   +   +
Sbjct: 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 58/272 (21%), Positives = 101/272 (37%), Gaps = 56/272 (20%)

Query: 362 GSVY--RGKIGGDFVAIKKVY------GDASDQIK----LLNKINHSSLIRLLGICFNGG 409
           G+VY  R K     +A+K ++           Q++    + + + H +++R+     +  
Sbjct: 28  GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDIK 468
             YL+ E A  G L   +  K G+F +      +  ++A  L+Y H       V H+DIK
Sbjct: 88  RIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFME-ELADALHYCHER----KVIHRDIK 141

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             N+L+      KIA+F  +            T    GT  Y+ PE +E      K+D++
Sbjct: 142 PENLLMGYKGELKIADFGWSV---HAPSLRRRTM--CGTLDYLPPEMIEGKTHDEKVDLW 196

Query: 529 AFGVLMLEMLSG------KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
             GVL  E L G            +    ++ VD+                         
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTETH--RRIVNVDL------------------------K 230

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           +PP  +     LI   L+  P  R  +  + +
Sbjct: 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 93.7 bits (233), Expect = 5e-21
 Identities = 44/294 (14%), Positives = 98/294 (33%), Gaps = 67/294 (22%)

Query: 362 GSVY--RGKIGGDFVAIKKVYGDASDQIKLLNK--------INHSSLIRLLGICF----- 406
             VY  +    G   A+K++  +  ++ + + +          H ++++           
Sbjct: 42  AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101

Query: 407 --NGGNWYLVYENAVNGSLSVWIND-KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV 463
              G   +L+      G L  ++   +    L     ++I       + ++H    PP +
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPII 160

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPA-----------ERQEGEFALTSHIVGTKGYMA 512
           H+D+K  N+LL      K+ +F  A               R   E  +T +   T  Y  
Sbjct: 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN--TTPMYRT 218

Query: 513 PEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE 569
           PE ++   N  +  K D++A G ++  +   +     + +   L +              
Sbjct: 219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---FEDGAKLRI-------------- 261

Query: 570 SLRHLMDPSMQGNY-----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR 618
                    + G Y          +    LI + L+ +P  R ++ ++   +  
Sbjct: 262 ---------VNGKYSIPPHDTQYTVF-HSLIRAMLQVNPEERLSIAEVVHQLQE 305

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 93.5 bits (232), Expect = 1e-20
 Identities = 35/248 (14%), Positives = 73/248 (29%), Gaps = 61/248 (24%)

Query: 387 IKLLNKINHSSLIRLLGIC--FNGGNWYLVYENAVNGSLSVWIND-----KGGKFLDWAQ 439
             L+       +IR+          + + +Y      +L  +           K L    
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 440 RIQIALDVATGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE 497
           R+Q+ L V   L  LH      +  VH  ++  +++LD      +  F         +G 
Sbjct: 208 RLQLTLQVIRLLASLHH-----YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR----DGA 258

Query: 498 FALTSHIVGTKGYMAPEYL-----------ENGLVSTKLDVYAFGVLMLEMLSGKEAPAL 546
             ++     ++G+  PE                L++   D +A G+++  +      P  
Sbjct: 259 RVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD-LP-- 312

Query: 547 YSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG--NYPPVTAILVIRLIESCLKKDPS 604
                                +++     +   +   N P      V  L+E  L+    
Sbjct: 313 -------------------ITKDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKE 349

Query: 605 GRPAMDKI 612
            R    + 
Sbjct: 350 DRLLPLQA 357

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 55/286 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G V++   K  G  +A K ++ +            +++L++ N   ++   G  ++ G  
Sbjct: 47  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRI------QIALDVATGLNYLHSFTNPPHVHK 465
            +  E+   GSL         + L  A RI      ++++ V  GL YL        +H+
Sbjct: 107 SICMEHMDGGSLD--------QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHR 156

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           D+K SN+L+++    K+ +F ++          ++ +  VGT+ YM+PE L+    S + 
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQS 211

Query: 526 DVYAFGVLMLEMLSGK--EAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY 583
           D+++ G+ ++EM  G+    P    E  ++    +     +                 + 
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 584 PPVTAILVI----------------------RLIESCLKKDPSGRP 607
            P  AI  +                        +  CL K+P+ R 
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 57/271 (21%), Positives = 96/271 (35%), Gaps = 52/271 (19%)

Query: 362 GSVYRGK--IGGDFVAIKKVY------GDASDQ----IKLLNKINHSSLIRLLGICFNGG 409
              +        +  A K V           ++    I +   + H  ++   G   +  
Sbjct: 29  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPH--VHK 465
             ++V E     SL      +       A+    QI      G  YLH      +  +H+
Sbjct: 89  FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLHR-----NRVIHR 139

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           D+K  N+ L+ D   KI +F LA   E  +GE      + GT  Y+APE L     S ++
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCGTPNYIAPEVLSKKGHSFEV 196

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY-- 583
           DV++ G +M  +L GK                       E     L+       +  Y  
Sbjct: 197 DVWSIGCIMYTLLVGK--------------------PPFET--SCLKETYLRIKKNEYSI 234

Query: 584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           P     +   LI+  L+ DP+ RP ++++  
Sbjct: 235 PKHINPVAASLIQKMLQTDPTARPTINELLN 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 28/218 (12%), Positives = 54/218 (24%), Gaps = 32/218 (14%)

Query: 406 FNGGNWYLVYENAVNGSLSVWIN-----DKGGKFLDWAQRIQIALDVATGLNYLHSFTNP 460
           +   N+ L+   A +  L +  +                   +   +      L S    
Sbjct: 158 YAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---- 212

Query: 461 PH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL-- 516
               VH      N+ +  D R  + + +                       Y   E+L  
Sbjct: 213 -KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAPREFLNA 265

Query: 517 ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD 576
                +  L+ +  G+ +  +               L   ++ P +       SLR    
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLF-----------LPFGLVTPGIKGSWKRPSLRVPGT 314

Query: 577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
            S+           V  LI   L  D   R    +  +
Sbjct: 315 DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 68/267 (25%), Positives = 117/267 (43%), Gaps = 60/267 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
           G V++G        VAIK +  + ++        +I +L++ +   + +  G        
Sbjct: 36  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIK 468
           +++ E    GS    +  + G         QIA    ++  GL+YLHS      +H+DIK
Sbjct: 96  WIIMEYLGGGSALDLL--EPGPL----DETQIATILREILKGLDYLHSEK---KIHRDIK 146

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSH----IVGTKGYMAPEYLENGLVSTK 524
            +NVLL      K+A+F +A       G+   T       VGT  +MAPE ++     +K
Sbjct: 147 AANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEEN----MLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
            D+++ G+  +E+  G E P  +SE +    + L+   NP                P+++
Sbjct: 200 ADIWSLGITAIELARG-EPP--HSELHPMKVLFLIPKNNP----------------PTLE 240

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRP 607
           GNY       +   +E+CL K+PS RP
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRP 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 57/272 (20%), Positives = 96/272 (35%), Gaps = 54/272 (19%)

Query: 362 GSVYRGK--IGGDFVAIKKVY------GDASDQ----IKLLNKINHSSLIRLLGICFNGG 409
              +        +  A K V           ++    I +   + H  ++   G   +  
Sbjct: 55  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQR---IQIALDVATGLNYLHSFTNPPH--VH 464
             ++V E     SL      +     +   R    QI      G  YLH      +  +H
Sbjct: 115 FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIV----LGCQYLHR-----NRVIH 164

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K  N+ L+ D   KI +F LA   E  +GE      + GT  Y+APE L     S +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCGTPNYIAPEVLSKKGHSFE 221

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY- 583
           +DV++ G +M  +L GK                       E     L+       +  Y 
Sbjct: 222 VDVWSIGCIMYTLLVGK--------------------PPFET--SCLKETYLRIKKNEYS 259

Query: 584 -PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
            P     +   LI+  L+ DP+ RP ++++  
Sbjct: 260 IPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 26/195 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G V +   K  G  VAIKK      D+         IKLL ++ H +L+ LL +C     
Sbjct: 39  GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPH--VHKDI 467
           WYLV+E  V+ ++   +           Q +Q     +  G+ + HS     H  +H+DI
Sbjct: 99  WYLVFE-FVDHTILDDLELFPNGLDY--QVVQKYLFQIINGIGFCHS-----HNIIHRDI 150

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL-ENGLVSTKLD 526
           K  N+L+      K+ +F  AR        +      V T+ Y APE L  +      +D
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVY---DDEVATRWYRAPELLVGDVKYGKAVD 207

Query: 527 VYAFGVLMLEMLSGK 541
           V+A G L+ EM  G+
Sbjct: 208 VWAIGCLVTEMFMGE 222

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 46/272 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
             V         + VAIK++  +            I+ +++ +H +++            
Sbjct: 29  AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRI---QIAL---DVATGLNYLHSFTNPPHVHK 465
           +LV +    GS+   I     K    +  +    IA    +V  GL YLH       +H+
Sbjct: 89  WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHR 145

Query: 466 DIKCSNVLLDTDFRAKIANF----ALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
           D+K  N+LL  D   +IA+F     LA   +    +   T   VGT  +MAPE +E    
Sbjct: 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTPCWMAPEVMEQVRG 203

Query: 522 -STKLDVYAFGVLMLEMLSGKEAPALYSEEN-----MLLVDVLNPVLHKEDGEESLRHLM 575
              K D+++FG+  +E+ +G  AP  Y +       ML +    P L     ++ +    
Sbjct: 204 YDFKADIWSFGITAIELATG-AAP--YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY 260

Query: 576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
             S +            ++I  CL+KDP  RP
Sbjct: 261 GKSFR------------KMISLCLQKDPEKRP 280

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.9 bits (225), Expect = 1e-19
 Identities = 31/222 (13%), Positives = 66/222 (29%), Gaps = 52/222 (23%)

Query: 410 NWYLVYENAV--NGSLSVWINDKG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPH--V 463
           + + +Y        +    +       K L    R+Q+ L V   L  LH      +  V
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-----YGLV 233

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL------- 516
           H  ++  +++LD      +  F         +G  A++      +G+  PE         
Sbjct: 234 HTYLRPVDIVLDQRGGVFLTGFEHLVR----DGASAVSP---IGRGFAPPETTAERMLPF 286

Query: 517 ---ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
                 L++   D +  G+ +  +      P   +++    +     +            
Sbjct: 287 GQHHPTLMTFAFDTWTLGLAIYWIWCAD-LP--NTDDA--ALGGSEWIFRSCK------- 334

Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS 615
                   N P      V  L+E  L+     R    +  ++
Sbjct: 335 --------NIPQ----PVRALLEGFLRYPKEDRLLPLQAMET 364

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 24/194 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G V++   +  G  VAIKK      D          I++L ++ H +L+ LL +      
Sbjct: 17  GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            +LV+E   + ++   + D+  + +       I       +N+ H      H  +H+D+K
Sbjct: 77  LHLVFE-YCDHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHK-----HNCIHRDVK 129

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDV 527
             N+L+      K+ +F  AR        +      V T+ Y +PE L         +DV
Sbjct: 130 PENILITKHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSPELLVGDTQYGPPVDV 186

Query: 528 YAFGVLMLEMLSGK 541
           +A G +  E+LSG 
Sbjct: 187 WAIGCVFAELLSGV 200

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 53/267 (19%), Positives = 107/267 (40%), Gaps = 45/267 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQIK---------LLNKINHSSLIRLLGICFNGGN 410
           GSV +   K  G  +A+K++     ++ +         ++   +   +++  G  F  G+
Sbjct: 36  GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95

Query: 411 WYLVYENAVNGSLS---VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
            ++  E  ++ S      ++       +      +I L     LN+L        +H+DI
Sbjct: 96  CWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI--IHRDI 152

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALT---SHIVGTKGYMAPEYLENGLV--- 521
           K SN+LLD     K+ +F ++       G+   +   +   G + YMAPE ++       
Sbjct: 153 KPSNILLDRSGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205

Query: 522 -STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
              + DV++ G+ + E+ +G+         ++   D L  V+      +  +  +  S +
Sbjct: 206 YDVRSDVWSLGITLYELATGR--FPYPKWNSVF--DQLTQVVK----GDPPQ--LSNSEE 255

Query: 581 GNYPPVTAILVIRLIESCLKKDPSGRP 607
             + P      I  +  CL KD S RP
Sbjct: 256 REFSPSF----INFVNLCLTKDESKRP 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 56/271 (20%), Positives = 103/271 (38%), Gaps = 57/271 (21%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQIK---------LLNKINHSSLIRLLGICFNGGN 410
           G V +      G  +A+K++    + Q +          +  ++    +   G  F  G+
Sbjct: 21  GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRI------QIALDVATGLNYLHSFTNPPHVH 464
            ++  E  ++ SL         + +D  Q I      +IA+ +   L +LHS  +   +H
Sbjct: 81  VWICME-LMDTSLD----KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV--IH 133

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT---SHIVGTKGYMAPEYLENGLV 521
           +D+K SNVL++   + K+ +F ++       G            G K YMAPE +   L 
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGIS-------GYLVDDVAKDIDAGCKPYMAPERINPELN 186

Query: 522 ----STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP 577
               S K D+++ G+ M+E+   +  P  Y          L  V+ +            P
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR-FP--YDSWGTPF-QQLKQVVEEPS----------P 232

Query: 578 SM-QGNYPPVTAILVIRLIESCLKKDPSGRP 607
            +    +        +     CLKK+   RP
Sbjct: 233 QLPADKFSAEF----VDFTSQCLKKNSKERP 259

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 23/193 (11%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ K   G  VA+K++  DA D+         I LL +++H +++ L+ +  +    
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
            LV+E  +   L   +++      D +Q       +  G+ + H      H  +H+D+K 
Sbjct: 95  TLVFE-FMEKDLKKVLDENKTGLQD-SQIKIYLYQLLRGVAHCHQ-----HRILHRDLKP 147

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDVY 528
            N+L+++D   K+A+F LAR        +   +H V T  Y AP+ L      ST +D++
Sbjct: 148 QNLLINSDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDVLMGSKKYSTSVDIW 204

Query: 529 AFGVLMLEMLSGK 541
           + G +  EM++GK
Sbjct: 205 SIGCIFAEMITGK 217

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 49/267 (18%), Positives = 99/267 (37%), Gaps = 50/267 (18%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQIK---------LLNKINHSSLIRLLGICFNGGN 410
           G V++   +  G  +A+K++    + +           +L   +   +++  G      +
Sbjct: 39  GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            ++  E  +            G   +     ++ + +   L YL        +H+D+K S
Sbjct: 99  VFIAME-LMGTCAEKLKKRMQGPIPE-RILGKMTVAIVKALYYLKEKHG--VIHRDVKPS 154

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALT---SHIVGTKGYMAPEYLENGLV-----S 522
           N+LLD   + K+ +F ++       G            G   YMAPE ++          
Sbjct: 155 NILLDERGQIKLCDFGIS-------GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + DV++ G+ ++E+ +G + P  Y        +VL  VL +E           P + G+
Sbjct: 208 IRADVWSLGISLVELATG-QFP--YKNCKTDF-EVLTKVLQEE----------PPLLPGH 253

Query: 583 --YPPVTAILVIRLIESCLKKDPSGRP 607
             +           ++ CL KD   RP
Sbjct: 254 MGFSGDF----QSFVKDCLTKDHRKRP 276

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 45/193 (23%), Positives = 87/193 (45%), Gaps = 23/193 (11%)

Query: 362 GSVYRGKIG--GDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
            +VY+GK     + VA+K++  +  +        ++ LL  + H++++ L  I     + 
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 75

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
            LV+E  ++  L  +++D G    +          +  GL Y H         +H+D+K 
Sbjct: 76  TLVFE-YLDKDLKQYLDDCGNII-NMHNVKLFLFQLLRGLAYCHR-----QKVLHRDLKP 128

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDVY 528
            N+L++     K+A+F LAR        +    + V T  Y  P+ L      ST++D++
Sbjct: 129 QNLLINERGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPDILLGSTDYSTQIDMW 185

Query: 529 AFGVLMLEMLSGK 541
             G +  EM +G+
Sbjct: 186 GVGCIFYEMATGR 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.1 bits (209), Expect = 5e-18
 Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 24/196 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G+V++   +   + VA+K+V  D  D+         I LL ++ H +++RL  +  +   
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
             LV+E   +  L  + +   G   D          +  GL + HS        +H+D+K
Sbjct: 76  LTLVFE-FCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS-----RNVLHRDLK 128

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDV 527
             N+L++ +   K+ANF LAR        +   S  V T  Y  P+ L    + ST +D+
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDM 185

Query: 528 YAFGVLMLEMLSGKEA 543
           ++ G +  E+ +    
Sbjct: 186 WSAGCIFAELANAGRP 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.9 bits (206), Expect = 1e-17
 Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 23/193 (11%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ +   G+  A+KK+  +  D+         I +L ++ HS++++L  +       
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
            LV+E  ++  L   ++   G   +        L +  G+ Y H         +H+D+K 
Sbjct: 76  VLVFE-HLDQDLKKLLDVCEGGL-ESVTAKSFLLQLLNGIAYCHD-----RRVLHRDLKP 128

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDVY 528
            N+L++ +   KIA+F LAR       ++   +H + T  Y AP+ L      ST +D++
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKY---THEIVTLWYRAPDVLMGSKKYSTTIDIW 185

Query: 529 AFGVLMLEMLSGK 541
           + G +  EM++G 
Sbjct: 186 SVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 47/207 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICFN 407
            +VY+   K     VAIKK+      +            IKLL +++H ++I LL    +
Sbjct: 24  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHK 465
             N  LV++  +   L V I D        +      L    GL YLH      H  +H+
Sbjct: 84  KSNISLVFD-FMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQ-----HWILHR 136

Query: 466 DIKCSNVLLDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPE------- 514
           D+K +N+LLD +   K+A+F LA+    P        A T  +V T+ Y APE       
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNR------AYTHQVV-TRWYRAPELLFGARM 189

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGK 541
           Y         +D++A G ++ E+L   
Sbjct: 190 Y------GVGVDMWAVGCILAELLLRV 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 44/210 (20%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGIC----- 405
           G V++   +  G  VA+KKV  +   +         IK+L  + H +++ L+ IC     
Sbjct: 31  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90

Query: 406 ---FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                 G+ YLV++      L+  +++   KF   ++  ++   +  GL Y+H      +
Sbjct: 91  PYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTL-SEIKRVMQMLLNGLYYIHR-----N 143

Query: 463 --VHKDIKCSNVLLDTDFRAKIANFALARP--AERQEGEFALTSHIVGTKGYMAPE---- 514
             +H+D+K +NVL+  D   K+A+F LAR     +       T+ +V T  Y  PE    
Sbjct: 144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLG 202

Query: 515 ---YLENGLVSTKLDVYAFGVLMLEMLSGK 541
              Y         +D++  G +M EM +  
Sbjct: 203 ERDY------GPPIDLWGAGCIMAEMWTRS 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 38/205 (18%)

Query: 362 GSVYRG---KIGGDFVAIKKVYGDASDQ---------IKLL---NKINHSSLIRLLGIC- 405
           G V++    K GG FVA+K+V     ++         + +L       H +++RL  +C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84

Query: 406 ----FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                      LV+E  V+  L+ +++      +       +   +  GL++LHS     
Sbjct: 85  VSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS----- 138

Query: 462 H--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT---SHIVGTKGYMAPEYL 516
           H  VH+D+K  N+L+ +  + K+A+F LAR        ++     + +V T  Y APE L
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARI-------YSFQMALTSVVVTLWYRAPEVL 191

Query: 517 ENGLVSTKLDVYAFGVLMLEMLSGK 541
                +T +D+++ G +  EM   K
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRK 216

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 61/268 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           GSVY+   K  G  VAIK+V              I ++ + +   +++  G  F   + +
Sbjct: 43  GSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIKC 469
           +V E    GS+S  I  +           +IA        GL YLH       +H+DIK 
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTL----TEDEIATILQSTLKGLEYLHFMRK---IHRDIKA 153

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSH----IVGTKGYMAPEYLENGLVSTKL 525
            N+LL+T+  AK+A+F +A       G+   T      ++GT  +MAPE ++    +   
Sbjct: 154 GNILLNTEGHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVA 206

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL-----NPVL-HKEDGEESLRHLMDPSM 579
           D+++ G+  +EM  G + P  Y++ + +    +      P     E   ++         
Sbjct: 207 DIWSLGITAIEMAEG-KPP--YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD------ 257

Query: 580 QGNYPPVTAILVIRLIESCLKKDPSGRP 607
                          ++ CL K P  R 
Sbjct: 258 --------------FVKQCLVKSPEQRA 271

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 53/300 (17%)

Query: 322 DEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWIKGSVYRG--KIGGDFVAIK 377
           DEE  + L SI  +    K YT FE++ Q A+          G+VY       G  VAI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51

Query: 378 KVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK 430
           ++      +       I ++ +  + +++  L     G   ++V E    GSL+  + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111

Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP 490
               +D  Q   +  +    L +LHS      +H+DIK  N+LL  D   K+ +F     
Sbjct: 112 C---MDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGF--- 162

Query: 491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE 550
             +   E +  S +VGT  +MAPE +       K+D+++ G++ +EM+ G E P  Y  E
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPP--YLNE 219

Query: 551 NMLLVDVL---NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
           N L    L   N     ++ E+      D                  +  CL+ D   R 
Sbjct: 220 NPLRALYLIATNGTPELQNPEKLSAIFRD-----------------FLNRCLEMDVEKRG 262

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 44/272 (16%)

Query: 352 DDFNPSCWI-KGS---VY--RGKIGGDFVAIK---KVYGDASDQIK-------LLNKINH 395
           +DF     + +GS   V   R        AIK   K +    +++        ++++++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 396 SSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL 454
              ++L    F +    Y     A NG L  +I  K G F +   R   A ++ + L YL
Sbjct: 90  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALEYL 146

Query: 455 HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
           H       +H+D+K  N+LL+ D   +I +F  A+     E + A  +  VGT  Y++PE
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPE 202

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
            L         D++A G ++ ++++G   P   +    L+      ++  E         
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIFQ---KIIKLE-----YD-- 250

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                   +P         L+E  L  D + R
Sbjct: 251 --------FPEKFFPKARDLVEKLLVLDATKR 274

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 26/197 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD--------QIKLLNKINHSSLIRLLGICFNGGNW 411
            +VY+G  K  G +VA+K+V  D+ +        +I L+ ++ H +++RL  +       
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78

Query: 412 YLVYENAVNGSLSVWINDKG----GKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHK 465
            LV+E  ++  L  +++ +      + L+          +  GL + H      +  +H+
Sbjct: 79  TLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-----NKILHR 132

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STK 524
           D+K  N+L++   + K+ +F LAR        F   S  V T  Y AP+ L      ST 
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDVLMGSRTYSTS 189

Query: 525 LDVYAFGVLMLEMLSGK 541
           +D+++ G ++ EM++GK
Sbjct: 190 IDIWSCGCILAEMITGK 206

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 30/199 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G VY+    +  + VAIK++  +  ++         + LL ++ H ++I L  +  +   
Sbjct: 48  GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
            +L++E      L  +++      +           +  G+N+ HS        +H+D+K
Sbjct: 108 LHLIFE-YAENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHS-----RRCLHRDLK 159

Query: 469 CSNVLLDTDFRA-----KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-S 522
             N+LL     +     KI +F LAR       +F   +H + T  Y  PE L      S
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF---THEIITLWYRPPEILLGSRHYS 216

Query: 523 TKLDVYAFGVLMLEMLSGK 541
           T +D+++   +  EML   
Sbjct: 217 TSVDIWSIACIWAEMLMKT 235

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 26/193 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYL 413
           G V+R            K V    +DQ      I +LN   H +++ L     +     +
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 414 VYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKC 469
           ++E      +   IN    +    +    +    +    L +LHS     H   H DI+ 
Sbjct: 79  IFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQFLHS-----HNIGHFDIRP 130

Query: 470 SNVLLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
            N++  T      KI  F  AR  + + G+      +     Y APE  ++ +VST  D+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRL--LFTAPEYYAPEVHQHDVVSTATDM 186

Query: 528 YAFGVLMLEMLSG 540
           ++ G L+  +LSG
Sbjct: 187 WSLGTLVYVLLSG 199

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 80.7 bits (200), Expect = 8e-17
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 40/207 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------------IKLL---NKINHSSLIRLLGI 404
           G+VY+      G FVA+K V                   + LL       H +++RL+ +
Sbjct: 23  GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82

Query: 405 CFNGGNW-----YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTN 459
           C            LV+E  V+  L  +++      L       +      GL++LH+   
Sbjct: 83  CATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--- 138

Query: 460 PPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT---SHIVGTKGYMAPE 514
             +  VH+D+K  N+L+ +    K+A+F LAR        ++     + +V T  Y APE
Sbjct: 139 --NCIVHRDLKPENILVTSGGTVKLADFGLAR-------IYSYQMALTPVVVTLWYRAPE 189

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGK 541
            L     +T +D+++ G +  EM   K
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 63/319 (19%), Positives = 128/319 (40%), Gaps = 53/319 (16%)

Query: 303 STIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYT-FEEL-QAATDDFNPSCWI 360
           S+ V    E     S     E+ +  L  + D      +   + ++ + +T         
Sbjct: 8   SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGST--------- 58

Query: 361 KGSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNW 411
            G V     K  G  VA+K +      +       + ++    H +++ +      G   
Sbjct: 59  -GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           +++ E    G+L+  ++      L+  Q   +   V   L YLH+      +H+DIK  +
Sbjct: 118 WVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDS 171

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +LL  D R K+++F       +   +      +VGT  +MAPE +   L +T++D+++ G
Sbjct: 172 ILLTLDGRVKLSDFGF---CAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG 228

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVL---NPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           ++++EM+ G E P  Y  ++ +        +P                P ++ ++  V+ 
Sbjct: 229 IMVIEMVDG-EPP--YFSDSPVQAMKRLRDSPP---------------PKLKNSH-KVSP 269

Query: 589 ILVIRLIESCLKKDPSGRP 607
           +L    +E  L +DP  R 
Sbjct: 270 VL-RDFLERMLVRDPQERA 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 23/192 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G V+R   K  G     K +              I ++N+++H  LI L     +     
Sbjct: 65  GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124

Query: 413 LVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
           L+ E    G L   I  +  K    +    ++ A +   GL ++H  +    VH DIK  
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEHS---IVHLDIKPE 178

Query: 471 NVLLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
           N++ +T      KI +F LA      E    +      T  + APE ++   V    D++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMW 234

Query: 529 AFGVLMLEMLSG 540
           A GVL   +LSG
Sbjct: 235 AIGVLGYVLLSG 246

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 56/272 (20%), Positives = 107/272 (39%), Gaps = 62/272 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+   K  G   A K +   + ++       I++L   +H  +++LLG  ++ G  +
Sbjct: 33  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKDIKC 469
           ++ E    G++   + +            QI +    +   LN+LHS      +H+D+K 
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNFLHSKRI---IHRDLKA 145

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSH----IVGTKGYMAPEYLENGLVS--- 522
            NVL+  +   ++A+F ++        +   T       +GT  +MAPE +    +    
Sbjct: 146 GNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198

Query: 523 --TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL-----NPVLHKEDGEESLRHLM 575
              K D+++ G+ ++EM    E P  + E N + V +       P L      +      
Sbjct: 199 YDYKADIWSLGITLIEMAQI-EPP--HHELNPMRVLLKIAKSDPPTL--LTPSKWSVEFR 253

Query: 576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRP 607
           D                  ++  L K+P  RP
Sbjct: 254 D-----------------FLKIALDKNPETRP 268

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 80.7 bits (199), Expect = 5e-16
 Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 23/192 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKV-YGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G V+R   +  G+  A K V     SD+      I+ ++ + H +L+ L     +     
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230

Query: 413 LVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
           ++YE    G L   + D+  K    +  + ++       GL ++H      +VH D+K  
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHENN---YVHLDLKPE 284

Query: 471 NVLLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
           N++  T      K+ +F L    + ++          GT  + APE  E   V    D++
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340

Query: 529 AFGVLMLEMLSG 540
           + GVL   +LSG
Sbjct: 341 SVGVLSYILLSG 352

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 66/278 (23%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----------IKLLNKINHSSLIRLLGI 404
           G V+    K     V +K     KV  D   +          I +L+++ H+++I++L I
Sbjct: 38  GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97

Query: 405 CFNGGNWYLVYENAVNGS-LSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPP 461
             N G + LV E   +G  L  +I+         A  I  Q+     + + YL       
Sbjct: 98  FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLRL----- 148

Query: 462 H--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-N 518
              +H+DIK  N+++  DF  K+ +F  A  A  + G+   T    GT  Y APE L  N
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSA--AYLERGKLFYTF--CGTIEYCAPEVLMGN 204

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
                +L++++ GV +  ++  +                 NP     + EE++       
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEE-----------------NPF---CELEETVE------ 238

Query: 579 MQGNY--PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                  P + +  ++ L+   L+  P  R  ++K+  
Sbjct: 239 --AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 46/239 (19%), Positives = 77/239 (32%), Gaps = 64/239 (26%)

Query: 362 GSVYRG--KIGGDFVAIKKV------------YGDASDQIKLLNKINHSSLIRLLGICFN 407
           G V            AIK +                  +++L+ K++H ++ RL  +  +
Sbjct: 40  GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQ------------------------- 442
                LV E    G L   +N                                       
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159

Query: 443 -------------IALDVATGLNYLHSFTNPPH--VHKDIKCSNVLLDTDFRA--KIANF 485
                        I   + + L+YLH+         H+DIK  N L  T+     K+ +F
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHN-----QGICHRDIKPENFLFSTNKSFEIKLVDF 214

Query: 486 ALARPAER-QEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGK 541
            L++   +   GE+   +   GT  ++APE L         K D ++ GVL+  +L G 
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 58/258 (22%), Positives = 105/258 (40%), Gaps = 47/258 (18%)

Query: 371 GDFVAIK---KVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG 421
           G  VAIK   K   + +        ++++  +NH ++++L  +       YL+ E A  G
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99

Query: 422 SLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR 479
            +  ++   G      A+    QI     + + Y H       VH+D+K  N+LLD D  
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR---IVHRDLKAENLLLDADMN 152

Query: 480 AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLMLEML 538
            KIA+F  +   E   G         G   Y APE  +       ++DV++ GV++  ++
Sbjct: 153 IKIADFGFS--NEFTVGGKLDAF--CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208

Query: 539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--PPVTAILVIRLIE 596
           SG            L  D            ++L+ L +  ++G Y  P   +     L++
Sbjct: 209 SGS-----------LPFD-----------GQNLKELRERVLRGKYRIPFYMSTDCENLLK 246

Query: 597 SCLKKDPSGRPAMDKIAQ 614
             L  +P  R  +++I +
Sbjct: 247 RFLVLNPIKRGTLEQIMK 264

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 33/204 (16%)

Query: 426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF 485
              D    FL     I  +  VA G+ +L S      +H+D+   N+LL      KI +F
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDF 237

Query: 486 ALARPAERQEGEFALTSHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLMLEMLSG 540
            LAR   +         ++          +MAPE + + + + + DV++FGVL+ E+ S 
Sbjct: 238 GLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291

Query: 541 KEAPALYSEENMLLVDVLNPVLHK-EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCL 599
             +P  Y       V +      + ++G       M        P  T   + + +  C 
Sbjct: 292 GASP--YPG-----VKIDEEFCRRLKEG-----TRMRA------PDYTTPEMYQTMLDCW 333

Query: 600 KKDPSGRPAMDKIAQSISRFLNAS 623
             +PS RP   ++ + +   L A+
Sbjct: 334 HGEPSQRPTFSELVEHLGNLLQAN 357

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.8 bits (197), Expect = 9e-16
 Identities = 70/316 (22%), Positives = 116/316 (36%), Gaps = 45/316 (14%)

Query: 310 FEACEKASNKKLDEE-SRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWI-KGS---V 364
           F+   + +++ L      D+L+SI    + L+    E      + F     + KG    V
Sbjct: 142 FQELTRLTHEYLSVAPFADYLDSIY-FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200

Query: 365 Y--RGKIGGDFVAIKKVYGD---ASDQI-------KLLNKINHSSLIRLLGICF-NGGNW 411
              + +  G   A KK+                  ++L K+N   ++ L    +      
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY-AYETKDAL 259

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV      G L   I   G      A+ +  A ++  GL  LH       V++D+K  N
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI---VYRDLKPEN 316

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
           +LLD     +I++  LA      EG+       VGT GYMAPE ++N   +   D +A G
Sbjct: 317 ILLDDHGHIRISDLGLAV--HVPEGQTIKGR--VGTVGYMAPEVVKNERYTFSPDWWALG 372

Query: 532 VLMLEMLSGKEAPALYSE-ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
            L+ EM++G+         + +   +V   V    +                Y    +  
Sbjct: 373 CLLYEMIAGQ--SPFQQRKKKIKREEVERLVKEVPE---------------EYSERFSPQ 415

Query: 591 VIRLIESCLKKDPSGR 606
              L    L KDP+ R
Sbjct: 416 ARSLCSQLLCKDPAER 431

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 28/196 (14%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGN 410
           G V     K+     AIK      V   ++ +    + +L  ++H ++++L     +  N
Sbjct: 51  GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
           +YLV E    G L   I  +     +      I   V +G+ YLH      H  VH+D+K
Sbjct: 111 YYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK-----HNIVHRDLK 163

Query: 469 CSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
             N+LL++   D   KI +F L+   E Q+         +GT  Y+APE L       K 
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVL-RKKYDEKC 218

Query: 526 DVYAFGVLMLEMLSGK 541
           DV++ GV++  +L+G 
Sbjct: 219 DVWSIGVILFILLAGY 234

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 37/204 (18%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----------IKLLNKINHSSLIRLLGI 404
           G V     +     VAI+     K    ++ +          I++L K+NH  +I++   
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208

Query: 405 CFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH-- 462
            F+  ++Y+V E    G L   +       L  A        +   + YLH      +  
Sbjct: 209 -FDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE-----NGI 260

Query: 463 VHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
           +H+D+K  NVLL +   D   KI +F  ++     E     T  + GT  Y+APE L + 
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT--LCGTPTYLAPEVLVSV 316

Query: 520 LV---STKLDVYAFGVLMLEMLSG 540
                +  +D ++ GV++   LSG
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSG 340

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 47/196 (23%)

Query: 371 GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGI--------CFNGGNWYL 413
              VAIKK+     +Q         + L+  +NH ++I LL +         F   + Y+
Sbjct: 50  ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ--DVYI 107

Query: 414 VYE-------NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HK 465
           V E         +   L      +   +L +    Q+      G+ +LHS      + H+
Sbjct: 108 VMELMDANLCQVIQMELD----HERMSYLLY----QML----CGIKHLHS----AGIIHR 151

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           D+K SN+++ +D   KI +F LAR A      F +T + V T+ Y APE +        +
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPY-VVTRYYRAPEVILGMGYKENV 207

Query: 526 DVYAFGVLMLEMLSGK 541
           D+++ G +M EM+ G 
Sbjct: 208 DIWSVGCIMGEMIKGG 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 60/265 (22%), Positives = 103/265 (38%), Gaps = 41/265 (15%)

Query: 310 FEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWI-KGS---VY 365
            +    +   + D+   DFL+    I   LK     E++   DDF     I +G+   V 
Sbjct: 25  HQELGASELAQ-DKYVADFLQWAEPIVVRLK-----EVRLQRDDFEILKVIGRGAFSEVA 78

Query: 366 --RGKIGGDFVAIK---KVYGDASDQIK-------LLNKINHSSLIRLLGICF-NGGNWY 412
             + K  G   A+K   K       ++        +L   +   + +L    F +    Y
Sbjct: 79  VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF-AFQDENYLY 137

Query: 413 LVYENAVNGSLSVWINDKGGKF-LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           LV E  V G L   ++  G +   + A R  +A ++   ++ +H      +VH+DIK  N
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLA-EIVMAIDSVHRLG---YVHRDIKPDN 192

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY--- 528
           +LLD     ++A+F      + +      +   VGT  Y++PE L+          Y   
Sbjct: 193 ILLDRCGHIRLADFGSC--LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 529 ----AFGVLMLEMLSGKEAPALYSE 549
               A GV   EM  G+     Y++
Sbjct: 251 CDWWALGVFAYEMFYGQ--TPFYAD 273

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 61/283 (21%), Positives = 105/283 (37%), Gaps = 74/283 (26%)

Query: 362 GSVYRGK--IGGDFVAIKKV-------YGDASDQ------IKLLNKIN----HSSLIRLL 402
           G+V+ G        VAIK +       +   SD       + LL K+     H  +IRLL
Sbjct: 45  GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104

Query: 403 GICFNGGNWYLVYENAVNGS-LSVWINDKGGKFL--DWAQRI--QIALDVATGLNYLHSF 457
                   + LV E  +    L  +I +KG   L    ++    Q+       + + HS 
Sbjct: 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVV----AAIQHCHS- 157

Query: 458 TNPPH--VHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
                  VH+DIK  N+L+D     AK+ +F     A   +  +       GT+ Y  PE
Sbjct: 158 ----RGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPY-TDF--DGTRVYSPPE 208

Query: 515 YLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH 573
           ++      +    V++ G+L+ +M+ G                   P     + ++ +  
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD-----------------IPF----ERDQEI-- 245

Query: 574 LMDPSMQGNY--PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                ++     P   +     LI  CL   PS RP++++I  
Sbjct: 246 -----LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.5 bits (191), Expect = 4e-15
 Identities = 71/336 (21%), Positives = 123/336 (36%), Gaps = 46/336 (13%)

Query: 292 FFRISYKKEFDSTIVSSSFEACEKASNKKLDEES-RDFLESISDIAQSLKVYTFEELQAA 350
           F          +      F+   +A    L +   ++FL+S+    + L+    E     
Sbjct: 125 FLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLY-FLRFLQWKWLEAQPMG 183

Query: 351 TDDFNPSCWI-KGS---VY--RGKIGGDFVAIKKVYGD---ASDQI-------KLLNKIN 394
            D F     + +G    V+  + K  G   A KK+                  K+L K++
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 395 HSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKG---GKFLDWAQRIQIALDVATG 450
              ++ L    F    +  LV      G +   I +       F +       A  + +G
Sbjct: 244 SRFIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSG 301

Query: 451 LNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY 510
           L +LH       +++D+K  NVLLD D   +I++  LA   E + G+   T    GT G+
Sbjct: 302 LEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQ-TKTKGYAGTPGF 355

Query: 511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES 570
           MAPE L        +D +A GV + EM++ +      +               K + +E 
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR--GPFRARG------------EKVENKEL 401

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
            + ++       YP   +       E+ L+KDP  R
Sbjct: 402 KQRVL--EQAVTYPDKFSPASKDFCEALLQKDPEKR 435

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 27/194 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G V++      G  +A K +              I ++N+++H++LI+L     +  +  
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162

Query: 413 LVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
           LV E    G L   I D+      LD    ++   +   G+ ++H         +H D+K
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ-----MYILHLDLK 214

Query: 469 CSNVLLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLD 526
             N+L       + KI +F LAR    +  E        GT  ++APE +    VS   D
Sbjct: 215 PENILCVNRDAKQIKIIDFGLAR--RYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTD 270

Query: 527 VYAFGVLMLEMLSG 540
           +++ GV+   +LSG
Sbjct: 271 MWSVGVIAYMLLSG 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 33/199 (16%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASD---QIKLLNKINHSSLIRLLGICFNGGNW 411
           G V+    +  G    IK     +          +I++L  ++H ++I++  +  +  N 
Sbjct: 36  GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95

Query: 412 YLVYENAVNGSL---SVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
           Y+V E    G L    V    +G        A+ ++  ++    L Y HS        VH
Sbjct: 96  YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHS-----QHVVH 147

Query: 465 KDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
           KD+K  N+L          KI +F LA   +    E +      GT  YMAPE      V
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTN--AAGTALYMAPEVF-KRDV 202

Query: 522 STKLDVYAFGVLMLEMLSG 540
           + K D+++ GV+M  +L+G
Sbjct: 203 TFKCDIWSAGVVMYFLLTG 221

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 64/269 (23%), Positives = 99/269 (36%), Gaps = 61/269 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
           G+VY        + VAIKK+                 ++ L K+ H + I+  G      
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIAL---DVATGLNYLHSFTNPPHVHKD 466
             +LV E    GS S  +           Q ++IA        GL YLHS      +H+D
Sbjct: 128 TAWLVME-YCLGSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYLHSHNM---IHRD 179

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE---YLENGLVST 523
           +K  N+LL      K+ +F  A          A  +  VGT  +MAPE    ++ G    
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL-----NPVLHKEDGEESLRHLMDPS 578
           K+DV++ G+  +E+    + P      N +          +P L      E  R+     
Sbjct: 233 KVDVWSLGITCIELAER-KPP--LFNMNAMSALYHIAQNESPALQSGHWSEYFRN----- 284

Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRP 607
                           ++SCL+K P  RP
Sbjct: 285 ---------------FVDSCLQKIPQDRP 298

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 68/273 (24%), Positives = 108/273 (39%), Gaps = 47/273 (17%)

Query: 352 DDFNPSCWI-KGS---VY--RGKIGGDFVAIK---KVYGDASDQI-------KLLNKINH 395
           ++F     + KG+   V   + K  G + A+K   K    A D++       ++L    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 396 SSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL 454
             L  L    F        V E A  G L   ++ +   F +   R   A ++ + L+YL
Sbjct: 208 PFLTALKY-SFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGA-EIVSALDYL 264

Query: 455 HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
           HS  N   V++D+K  N++LD D   KI +F L +   +     A      GT  Y+APE
Sbjct: 265 HSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPE 319

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE-ENMLLVDVLNPVLHKEDGEESLRH 573
            LE+      +D +  GV+M EM+ G+     Y++    L   +L   +           
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIR---------- 367

Query: 574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                    +P         L+   LKKDP  R
Sbjct: 368 ---------FPRTLGPEAKSLLSGLLKKDPKQR 391

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 76.2 bits (188), Expect = 6e-15
 Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 42/204 (20%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---IKLLNKINHSSLIRLLGICFNGGNW------ 411
           G V++ K +  D VAIKKV  D   +   ++++  + H +++ L    ++ G+       
Sbjct: 54  GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT----------GLNYLHSFTNPP 461
            LV E  V  ++         +      +++  + +             L Y+HS     
Sbjct: 114 NLVLE-YVPETVY--------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS----- 159

Query: 462 H--VHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               H+DIK  N+LLD      K+ +F  A+     E      S+I  ++ Y APE +  
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYIC-SRYYRAPELIFG 215

Query: 519 GLV-STKLDVYAFGVLMLEMLSGK 541
               +T +D+++ G +M E++ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 45/263 (17%)

Query: 362 GSVYRG--KIGGDFVAIKKV----YGDASDQ------IKLLNKINHSSLIRLLGICFNGG 409
           G V     KI G   A+K +        +D+      ++LL +++H ++++L     + G
Sbjct: 40  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDI 467
            +YLV E    G L   I  +           +I   V +G+ Y+H      +  VH+D+
Sbjct: 100 YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK-----NKIVHRDL 152

Query: 468 KCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           K  N+LL++   D   +I +F L+     +  +       +GT  Y+APE L +G    K
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLST--HFEASKKMKD--KIGTAYYIAPEVL-HGTYDEK 207

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            DV++ GV++  +LSG   P           D+L  V   +            + +    
Sbjct: 208 CDVWSTGVILYILLSGC--PPFNGANEY---DILKKVEKGK-----------YTFELPQW 251

Query: 585 PVTAILVIRLIESCLKKDPSGRP 607
              +     LI   L   PS R 
Sbjct: 252 KKVSESAKDLIRKMLTYVPSMRI 274

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 41/204 (20%)

Query: 362 GSVYRGKI--GGDFVAIKKVYGDASDQ---IKLLNKINHSSLIRLLGICFNGGNW----- 411
           G VY+ K+   G+ VAIKKV  D   +   ++++ K++H +++RL    ++ G       
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127

Query: 412 -YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT----------GLNYLHSFTNP 460
             LV +  V  ++         +      R +  L V             L Y+HSF   
Sbjct: 128 LNLVLD-YVPETVY--------RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--- 175

Query: 461 PHV-HKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
             + H+DIK  N+LLD D    K+ +F  A+   R E      S+I  ++ Y APE +  
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYIC-SRYYRAPELIFG 230

Query: 519 GLV-STKLDVYAFGVLMLEMLSGK 541
               ++ +DV++ G ++ E+L G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 68/279 (24%)

Query: 362 GSVYRGK--IGGDFVAIKKV-------YGDASDQ------IKLLNKINHSS--LIRLLGI 404
           GSVY G        VAIK V       +G+  +       + LL K++     +IRLL  
Sbjct: 57  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116

Query: 405 CFNGGNWYLVYENAVN-GSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPP 461
                ++ L+ E       L  +I ++G    + A+    Q+       + + H+     
Sbjct: 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHCHN----- 167

Query: 462 H--VHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
              +H+DIK  N+L+D +    K+ +F     A  ++  +       GT+ Y  PE++  
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVY-TDF--DGTRVYSPPEWIRY 222

Query: 519 GL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP 577
                    V++ G+L+ +M+ G                   P     + +E +      
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGD-----------------IP----FEHDEEI------ 255

Query: 578 SMQGNY--PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
            ++G        +     LI  CL   PS RP  ++I  
Sbjct: 256 -IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 57/268 (21%), Positives = 109/268 (40%), Gaps = 39/268 (14%)

Query: 305 IVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWI-KGS 363
           I+   ++ C  +  ++ ++   ++LE        +K     +++   +DF     I +G+
Sbjct: 33  ILICLYDECNNSPLRR-EKNILEYLEWAKPFTSKVK-----QMRLHREDFEILKVIGRGA 86

Query: 364 ---VY--RGKIGGDFVAIK---KVYGDASDQI-------KLLNKINHSSLIRLLGICF-N 407
              V   + K      A+K   K       +         +L   +   +  L    F +
Sbjct: 87  FGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY-AFQD 145

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFL-DWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
             N YLV +  V G L   ++    +   + A R  +A ++   ++ +H      +VH+D
Sbjct: 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLA-EMVIAIDSVHQLH---YVHRD 200

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL- 525
           IK  N+L+D +   ++A+F      +  E     +S  VGT  Y++PE L+         
Sbjct: 201 IKPDNILMDMNGHIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258

Query: 526 ----DVYAFGVLMLEMLSGKEAPALYSE 549
               D ++ GV M EML G+     Y+E
Sbjct: 259 GPECDWWSLGVCMYEMLYGE--TPFYAE 284

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 44/223 (19%), Positives = 91/223 (40%), Gaps = 31/223 (13%)

Query: 388 KLLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
           +++  + H  L+ L    F +  + ++V +  + G L   +  +   F +   ++ I  +
Sbjct: 67  QIMQGLEHPFLVNLWY-SFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFIC-E 123

Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG 506
           +   L+YL +      +H+D+K  N+LLD      I +F +A            T  + G
Sbjct: 124 LVMALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT--MAG 176

Query: 507 TKGYMAPEYLENGLV---STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH 563
           TK YMAPE   +      S  +D ++ GV   E+L G+     +   +    ++++    
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR--RPYHIRSSTSSKEIVHTFET 234

Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                  +           YP   +  ++ L++  L+ +P  R
Sbjct: 235 TV-----VT----------YPSAWSQEMVSLLKKLLEPNPDQR 262

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 28/195 (14%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGN 410
           G V +   +I     A+K           +      ++LL K++H ++++L  I  +  +
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
           +Y+V E    G L   I  +           +I   V +G+ Y+H      H  VH+D+K
Sbjct: 96  FYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK-----HNIVHRDLK 148

Query: 469 CSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
             N+LL++   D   KI +F L+   ++      +    +GT  Y+APE L  G    K 
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKD-RIGTAYYIAPEVLR-GTYDEKC 203

Query: 526 DVYAFGVLMLEMLSG 540
           DV++ GV++  +LSG
Sbjct: 204 DVWSAGVILYILLSG 218

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 37/204 (18%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----------IKLLNKINHSSLIRLLGI 404
           G V     +     VAIK     K    ++ +          I++L K+NH  +I++   
Sbjct: 24  GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83

Query: 405 CFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH-- 462
            F+  ++Y+V E    G L   +       L  A        +   + YLH      +  
Sbjct: 84  -FDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE-----NGI 135

Query: 463 VHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
           +H+D+K  NVLL +   D   KI +F  ++     E     T  + GT  Y+APE L + 
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT--LCGTPTYLAPEVLVSV 191

Query: 520 LV---STKLDVYAFGVLMLEMLSG 540
                +  +D ++ GV++   LSG
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSG 215

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 43/194 (22%)

Query: 371 GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW------YLVY 415
              VAIKK+     +Q         + L+  +NH ++I LL +             YLV 
Sbjct: 87  DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146

Query: 416 E-------NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDI 467
           E         +   L      +   +L      Q+      G+ +LHS      + H+D+
Sbjct: 147 ELMDANLCQVIQMELD----HERMSYL----LYQMLC----GIKHLHS----AGIIHRDL 190

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           K SN+++ +D   KI +F LAR A      F +T + V T+ Y APE +        +D+
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPY-VVTRYYRAPEVILGMGYKENVDI 246

Query: 528 YAFGVLMLEMLSGK 541
           ++ G +M EM+  K
Sbjct: 247 WSVGCIMGEMVRHK 260

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 69/276 (25%), Positives = 108/276 (39%), Gaps = 54/276 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------IKLLNKI-NHSSLIRLLGICFNGGN-- 410
           G VY+G     G   AIK +     ++      I +L K  +H ++    G         
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97

Query: 411 -----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
                W LV E    GS++  I +  G  L       I  ++  GL++LH       +H+
Sbjct: 98  MDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHR 153

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS--- 522
           DIK  NVLL  +   K+ +F ++   +R  G    T   +GT  +MAPE +         
Sbjct: 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-T--FIGTPYWMAPEVIACDENPDAT 210

Query: 523 --TKLDVYAFGVLMLEMLSGKEAPALYSEENM--LLVDVLN--PVLHKEDGEESLRHLMD 576
              K D+++ G+  +EM  G   P L     M  L +   N  P L  +   +  +    
Sbjct: 211 YDFKSDLWSLGITAIEMAEGA--PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQS--- 265

Query: 577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
                             IESCL K+ S RPA +++
Sbjct: 266 -----------------FIESCLVKNHSQRPATEQL 284

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 38/206 (18%)

Query: 362 GSVYRG--KIGGDFVAIK----------------KVYGDASDQIKLLNKIN-HSSLIRLL 402
             V R   K      A+K                ++      ++ +L K++ H ++I+L 
Sbjct: 31  SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90

Query: 403 GICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                   ++LV++    G L  ++ +K     +   R +I   +   +  LH       
Sbjct: 91  DTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR-KIMRALLEVICALHK-----L 143

Query: 463 --VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
             VH+D+K  N+LLD D   K+ +F  +   +   GE      + GT  Y+APE +E  +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLRE--VCGTPSYLAPEIIECSM 199

Query: 521 VST------KLDVYAFGVLMLEMLSG 540
                    ++D+++ GV+M  +L+G
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 32/200 (16%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
             V +   K  G   A K     +                + +L ++ H ++I L  +  
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
           N  +  L+ E    G L  ++  K    L   +       +  G+NYLH+         H
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT-----KKIAH 138

Query: 465 KDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
            D+K  N++L          K+ +F LA   E ++G       I GT  ++APE +    
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN--IFGTPEFVAPEIVNYEP 194

Query: 521 VSTKLDVYAFGVLMLEMLSG 540
           +  + D+++ GV+   +LSG
Sbjct: 195 LGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 32/200 (16%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
             V +   K  G   A K     +                + +L ++ H ++I L  +  
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
           N  +  L+ E    G L  ++  K    L   +       +  G+NYLH+         H
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT-----KKIAH 138

Query: 465 KDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
            D+K  N++L          K+ +F LA   E ++G       I GT  ++APE +    
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN--IFGTPEFVAPEIVNYEP 194

Query: 521 VSTKLDVYAFGVLMLEMLSG 540
           +  + D+++ GV+   +LSG
Sbjct: 195 LGLEADMWSIGVITYILLSG 214

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 32/197 (16%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGN 410
           G V +   +I     A+K           +      ++LL K++H ++++L  I  +  +
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95

Query: 411 WYLVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
           +Y+V E    G L   I  +  +F   D A+ I+        + Y+H      H  VH+D
Sbjct: 96  FYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSG---ITYMHK-----HNIVHRD 146

Query: 467 IKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           +K  N+LL++   D   KI +F L+     Q+         +GT  Y+APE L  G    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKD--RIGTAYYIAPEVL-RGTYDE 201

Query: 524 KLDVYAFGVLMLEMLSG 540
           K DV++ GV++  +LSG
Sbjct: 202 KCDVWSAGVILYILLSG 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 30/195 (15%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYG--DASDQIKLLNKINHSSLIRLLGICFNGGNWY 412
           G V     K      A K      V        +I+++  ++H ++IRL     +  + Y
Sbjct: 23  GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82

Query: 413 LVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
           LV E    G L   +  K   F   D A+ ++  L     + Y H          H+D+K
Sbjct: 83  LVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSA---VAYCHK-----LNVAHRDLK 133

Query: 469 CSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
             N L  T   D   K+ +F LA   +   G+   T   VGT  Y++P+ LE GL   + 
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRT--KVGTPYYVSPQVLE-GLYGPEC 188

Query: 526 DVYAFGVLMLEMLSG 540
           D ++ GV+M  +L G
Sbjct: 189 DEWSAGVMMYVLLCG 203

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 71.8 bits (177), Expect = 6e-14
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 31/197 (15%)

Query: 362 GSVYRG--KIGGDFVAIK---KVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGN 410
             V R   K  G   A K        A D        ++  K+ H +++RL         
Sbjct: 20  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79

Query: 411 WYLVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
            YLV++    G L   I  +   +   D +  IQ  L+    + Y HS     +  VH++
Sbjct: 80  HYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILES---IAYCHS-----NGIVHRN 130

Query: 467 IKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           +K  N+LL +       K+A+F LA   E  + E        GT GY++PE L+    S 
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHG--FAGTPGYLSPEVLKKDPYSK 186

Query: 524 KLDVYAFGVLMLEMLSG 540
            +D++A GV++  +L G
Sbjct: 187 PVDIWACGVILYILLVG 203

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 69/275 (25%), Positives = 107/275 (38%), Gaps = 46/275 (16%)

Query: 371 GDFVAIK----KVYGDASDQIK----LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
            + VA+K    K   D  + IK    +   +NH ++++  G    G   YL  E    G 
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 423 LSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           L   I    G     AQR   Q+      G+ YLH        H+DIK  N+LLD     
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG---ITHRDIKPENLLLDERDNL 144

Query: 481 KIANFALARPAERQEGEFAL-TSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEML 538
           KI++F LA        E  L      GT  Y+APE L+     +  +DV++ G+++  ML
Sbjct: 145 KISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

Query: 539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY-PPVTAI--LVIRLI 595
           +G+                    L  +   +S +   D   +  Y  P   I    + L+
Sbjct: 203 AGE--------------------LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242

Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSK 630
              L ++PS R  +  I +   R+ N  L     +
Sbjct: 243 HKILVENPSARITIPDIKK--DRWYNKPLKKGAKR 275

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 43/196 (21%)

Query: 371 GDFVAIKKV--YGDASDQ------IKLLNKINHSSLIRLLGI-------CFNGGNWYLVY 415
              VAIKK+  +   +        IK+L +  H ++I +  I              Y+V 
Sbjct: 52  KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD--VYIVQ 109

Query: 416 E------NAV--NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKD 466
           +        +     LS   ND    FL      QI      GL Y+HS     +V H+D
Sbjct: 110 DLMETDLYKLLKTQHLS---NDHICYFL-----YQILR----GLKYIHS----ANVLHRD 153

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-L 525
           +K SN+LL+T    KI +F LAR A+         +  V T+ Y APE + N    TK +
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213

Query: 526 DVYAFGVLMLEMLSGK 541
           D+++ G ++ EMLS +
Sbjct: 214 DIWSVGCILAEMLSNR 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 64/349 (18%), Positives = 120/349 (34%), Gaps = 71/349 (20%)

Query: 299 KEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSC 358
                    S+ E  +    KK       F   I +I Q+L+   F++    +D F   C
Sbjct: 118 LACSHPFSKSAIEHVQGHLVKK-QVPPDLFQPYIEEICQNLRGDVFQKFIE-SDKFTRFC 175

Query: 359 WIKGSVYRGKIG-GDFVAIK--------KVYG---DASDQI---KLLNK----------- 392
             K       +   DF   +        +VYG     + ++   K L+K           
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235

Query: 393 -------------INHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWA 438
                         +   ++ +    F        + +    G L   ++ + G F +  
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAD 293

Query: 439 QRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF 498
            R   A ++  GL ++H+      V++D+K +N+LLD     +I++  LA      +   
Sbjct: 294 MRFYAA-EIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLAC-----DFSK 344

Query: 499 ALTSHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV 557
                 VGT GYMAPE L+ G+      D ++ G ++ ++L G         +     ++
Sbjct: 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEI 402

Query: 558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
               L                     P   +  +  L+E  L++D + R
Sbjct: 403 DRMTLTMAV---------------ELPDSFSPELRSLLEGLLQRDVNRR 436

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 55/206 (26%), Positives = 82/206 (39%), Gaps = 39/206 (18%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ---------------IKLLNKINHSSLI 399
           G V     K G    AIK     +                       I LL  ++H ++I
Sbjct: 50  GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109

Query: 400 RLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTN 459
           +L  +  +   +YLV E    G L   I ++     D      I   + +G+ YLH    
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK--- 164

Query: 460 PPH--VHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
             H  VH+DIK  N+LL+        KI +F L+    +      L    +GT  Y+APE
Sbjct: 165 --HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRD-RLGTAYYIAPE 218

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSG 540
            L     + K DV++ GV+M  +L G
Sbjct: 219 VL-KKKYNEKCDVWSCGVIMYILLCG 243

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 30/195 (15%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDAS--DQIKLLNKINHSSLIRLLGICFNGGNWY 412
             V+    ++ G   A+K       + D+S  ++I +L KI H +++ L  I  +  ++Y
Sbjct: 23  SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82

Query: 413 LVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIK 468
           LV +    G L   I ++G  +   D +  IQ    V + + YLH      +  VH+D+K
Sbjct: 83  LVMQLVSGGELFDRILERG-VYTEKDASLVIQ---QVLSAVKYLHE-----NGIVHRDLK 133

Query: 469 CSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
             N+L  T   + +  I +F L++     E    +++   GT GY+APE L     S  +
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSK----MEQNGIMST-ACGTPGYVAPEVLAQKPYSKAV 188

Query: 526 DVYAFGVLMLEMLSG 540
           D ++ GV+   +L G
Sbjct: 189 DCWSIGVITYILLCG 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 22/191 (11%)

Query: 362 GSVYRG--KIGGDFVAIK---KVYGDASDQIKLLNK-INHSSLIRLLGICFNGGNWYLVY 415
               R   K      A+K   K   D +++I++L +   H ++I L  +  +G   Y+V 
Sbjct: 36  SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCSNVL 473
           E    G L   I  +   F    +   +   +   + YLH+        VH+D+K SN+L
Sbjct: 96  ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA-----QGVVHRDLKPSNIL 148

Query: 474 L----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
                      +I +F  A+   R E    +T     T  ++APE LE        D+++
Sbjct: 149 YVDESGNPESIRICDFGFAKQL-RAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWS 205

Query: 530 FGVLMLEMLSG 540
            GVL+  ML+G
Sbjct: 206 LGVLLYTMLTG 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 32/200 (16%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
             V +   K  G   A K     ++               + +L +I H ++I L  I  
Sbjct: 19  AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
           N  +  L+ E    G L  ++ +K    L   +  Q    +  G++YLHS         H
Sbjct: 79  NKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS-----KRIAH 131

Query: 465 KDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
            D+K  N++L      + R K+ +F +A   + + G       I GT  ++APE +    
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKN--IFGTPEFVAPEIVNYEP 187

Query: 521 VSTKLDVYAFGVLMLEMLSG 540
           +  + D+++ GV+   +LSG
Sbjct: 188 LGLEADMWSIGVITYILLSG 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 40/237 (16%)

Query: 387 IKLLNKINHSSLIRLLGI--CFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--Q 442
           I +L K++H ++++L+ +    N  + Y+V+E    G + + +        D A+     
Sbjct: 87  IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQARFYFQD 145

Query: 443 IALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS 502
           +      G+ YLH       +H+DIK SN+L+  D   KIA+F +   +   +G  AL S
Sbjct: 146 LIK----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV---SNEFKGSDALLS 195

Query: 503 HIVGTKGYMAPEYLENGLVS---TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
           + VGT  +MAPE L           LDV+A GV +   + G+  P  + +E +       
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ-CP--FMDERI------- 245

Query: 560 PVLHK--EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
             LH   +           P      P +   L   LI   L K+P  R  + +I  
Sbjct: 246 MCLHSKIKSQALEF-----PD----QPDIAEDLK-DLITRMLDKNPESRIVVPEIKL 292

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 41/203 (20%), Positives = 78/203 (38%), Gaps = 46/203 (22%)

Query: 362 GSVYRG--KIGGDFVAIK----KVYGDASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV 414
               +   K      A+K    ++  +   +I  L     H ++++L  +  +  + +LV
Sbjct: 25  SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQ------------IALDVATGLNYLHSFTNPPH 462
            E              GG+  +   RI+            I   + + ++++H       
Sbjct: 85  MELL-----------NGGELFE---RIKKKKHFSETEASYIMRKLVSAVSHMHD-----V 125

Query: 463 --VHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE 517
             VH+D+K  N+L    + +   KI +F  AR  +  + +   T     T  Y APE L 
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-LKPPDNQPLKT--PCFTLHYAAPELLN 182

Query: 518 NGLVSTKLDVYAFGVLMLEMLSG 540
                   D+++ GV++  MLSG
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSG 205

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.7 bits (178), Expect = 2e-13
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           L        L +L   CF      Y V E    G L   I  + G+F +       A ++
Sbjct: 395 LALPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAA-EI 451

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIV 505
           A GL +L S      +++D+K  NV+LD++   KIA+F + +     E   +   T    
Sbjct: 452 AIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFC 503

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE-ENMLLVDVLNPVLHK 564
           GT  Y+APE +        +D +AFGVL+ EML+G+       E E+ L   ++   +  
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSIMEHNVA- 560

Query: 565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                             YP   +   + + +  + K P  R
Sbjct: 561 ------------------YPKSMSKEAVAICKGLMTKHPGKR 584

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 55/267 (20%), Positives = 100/267 (37%), Gaps = 40/267 (14%)

Query: 305 IVSSSFEACEKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWI-KGS 363
            + +     +  + +K ++   +FL    D    ++     +L+   +D+     I +G+
Sbjct: 28  GLDALVYDLDFPALRK-NKNIDNFLSRYKDTINKIR-----DLRMKAEDYEVVKVIGRGA 81

Query: 364 ---VY--RGKIGGDFVAIK---KVYGDASDQIK-------LLNKINHSSLIRLLGICF-N 407
              V   R K      A+K   K                 ++   N   +++L    F +
Sbjct: 82  FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQD 140

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFL-DWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
               Y+V E    G L   +          WA R   A +V   L+ +HS      +H+D
Sbjct: 141 DRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA-EVVLALDAIHSMG---FIHRD 193

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK-- 524
           +K  N+LLD     K+A+F      +  +         VGT  Y++PE L++        
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251

Query: 525 --LDVYAFGVLMLEMLSGKEAPALYSE 549
              D ++ GV + EML G      Y++
Sbjct: 252 RECDWWSVGVFLYEMLVGD--TPFYAD 276

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 44/205 (21%), Positives = 90/205 (43%), Gaps = 37/205 (18%)

Query: 362 GSVYRG--KIGGDFVAIK---------------KVYGDASDQIKLLNKI-NHSSLIRLLG 403
             V R   +  G   A+K               +V      +  +L ++  H  +I L+ 
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167

Query: 404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH- 462
              +    +LV++    G L  ++ +K     +   R  I   +   +++LH+     + 
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETR-SIMRSLLEAVSFLHA-----NN 220

Query: 463 -VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+K  N+LLD + + ++++F  +     + GE      + GT GY+APE L+  + 
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSC--HLEPGEKLRE--LCGTPGYLAPEILKCSMD 276

Query: 522 ------STKLDVYAFGVLMLEMLSG 540
                   ++D++A GV++  +L+G
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAG 301

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 43/196 (21%), Positives = 76/196 (38%), Gaps = 26/196 (13%)

Query: 362 GSVYRG--KIGGDFVA---IKKVYGDASDQ------IKLLNKINHS-SLIRLLGICFNGG 409
             V +   K  G   A   +KK       +      I +L        +I L  +  N  
Sbjct: 43  AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDI 467
              L+ E A  G +      +  + +     I++   +  G+ YLH      +  VH D+
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-----NNIVHLDL 157

Query: 468 KCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           K  N+LL +       KI +F ++R  +           I+GT  Y+APE L    ++T 
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELRE--IMGTPEYLAPEILNYDPITTA 213

Query: 525 LDVYAFGVLMLEMLSG 540
            D++  G++   +L+ 
Sbjct: 214 TDMWNIGIIAYMLLTH 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 43/219 (19%), Positives = 78/219 (35%), Gaps = 31/219 (14%)

Query: 362 GSVYRG--KIGGDFVAIK---------KVYGDASD---QIKLLNKINHSSLIRLLGICFN 407
             V R   +  G   A+K                D   +  + + + H  ++ LL    +
Sbjct: 38  SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPH--V 463
            G  Y+V+E      L   I  +      +++ +       +   L Y H      +  +
Sbjct: 98  DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-----NNII 152

Query: 464 HKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
           H+D+K   VLL +       K+  F +A                VGT  +MAPE ++   
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA---GGRVGTPHFMAPEVVKREP 209

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN 559
               +DV+  GV++  +LSG      Y  +  L   ++ 
Sbjct: 210 YGKPVDVWGCGVILFILLSG--CLPFYGTKERLFEGIIK 246

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 68/270 (25%), Positives = 110/270 (40%), Gaps = 50/270 (18%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGDASDQIKLLNKI----------NHSSLIRLLGICFNGG 409
           G V  G+  + G  VA+K +       + ++ KI           H  +I+L  +     
Sbjct: 25  GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDI 467
           ++++V E    G L  +I   G      A+R+  QI     + ++Y H       VH+D+
Sbjct: 85  DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRHM---VVHRDL 137

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLD 526
           K  NVLLD    AKIA+F L+      +GEF  TS   G+  Y APE +   L    ++D
Sbjct: 138 KPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTS--CGSPNYAAPEVISGRLYAGPEVD 193

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--P 584
           +++ GV++  +L G            L  D           +E +  L      G +  P
Sbjct: 194 IWSCGVILYALLCGT-----------LPFD-----------DEHVPTLFKKIRGGVFYIP 231

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                 V  L+   L+ DP  R  +  I +
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 66/259 (25%), Positives = 102/259 (39%), Gaps = 44/259 (16%)

Query: 371 GDFVAIK----KVYGDASDQIK----LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGS 422
            + VA+K    K   D  + IK    +   +NH ++++  G    G   YL  E    G 
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 423 LSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRA 480
           L   I    G     AQR   Q+      G+ YLH        H+DIK  N+LLD     
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG---ITHRDIKPENLLLDERDNL 144

Query: 481 KIANFALARPAERQEGEFAL-TSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEML 538
           KI++F LA        E  L      GT  Y+APE L+     +  +DV++ G+++  ML
Sbjct: 145 KISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

Query: 539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY-PPVTAI--LVIRLI 595
           +G+                    L  +   +S +   D   +  Y  P   I    + L+
Sbjct: 203 AGE--------------------LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242

Query: 596 ESCLKKDPSGRPAMDKIAQ 614
              L ++PS R  +  I +
Sbjct: 243 HKILVENPSARITIPDIKK 261

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 44/194 (22%)

Query: 371 GDFVAIKKV---YGDASDQ------IKLLNKINHSSLIRLLGI------CFNGGNWYLVY 415
           G+ VAIKK+   +            + LL  + H ++I LL +        N  ++YLV 
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108

Query: 416 E-------NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
                     +    S    ++  ++L +    Q+      GL Y+HS      VH+D+K
Sbjct: 109 PFMQTDLQKIMGLKFS----EEKIQYLVY----QMLK----GLKYIHS-AGV--VHRDLK 153

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLDV 527
             N+ ++ D   KI +F LAR A+ +   +      V T+ Y APE  L     +  +D+
Sbjct: 154 PGNLAVNEDCELKILDFGLARHADAEMTGY------VVTRWYRAPEVILSWMHYNQTVDI 207

Query: 528 YAFGVLMLEMLSGK 541
           ++ G +M EML+GK
Sbjct: 208 WSVGCIMAEMLTGK 221

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 29/204 (14%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLV 414
             VYR   K      A+K             +I +L +++H ++I+L  I        LV
Sbjct: 67  SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126

Query: 415 YENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCS 470
            E    G L   I +KG  +   D A  ++    +   + YLH      +  VH+D+K  
Sbjct: 127 LELVTGGELFDRIVEKG-YYSERDAADAVK---QILEAVAYLHE-----NGIVHRDLKPE 177

Query: 471 NVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           N+L  T   D   KIA+F L++    +      T  + GT GY APE L       ++D+
Sbjct: 178 NLLYATPAPDAPLKIADFGLSK--IVEHQVLMKT--VCGTPGYCAPEILRGCAYGPEVDM 233

Query: 528 YAFGVLMLEMLSGKEAPALYSEEN 551
           ++ G++   +L G      Y E  
Sbjct: 234 WSVGIITYILLCG--FEPFYDERG 255

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 51/204 (25%)

Query: 371 GDFVAIKKVYGDASDQ------------------IKLLNKINHSSLIRLLGI-------C 405
           G  VAIK+V+   SD                   I+LLN  +H +++ L  I        
Sbjct: 46  GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105

Query: 406 FNGGNWYLVYE------NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTN 459
            +    YLV E        V     + I+ +  ++  +     I L    GL+ LH    
Sbjct: 106 MHK--LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY----HILL----GLHVLHE--- 152

Query: 460 PPHV-HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
              V H+D+   N+LL  +    I +F LAR           T + V  + Y APE +  
Sbjct: 153 -AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHY-VTHRWYRAPELVMQ 207

Query: 519 GLVSTK-LDVYAFGVLMLEMLSGK 541
               TK +D+++ G +M EM + K
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRK 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 59/223 (26%), Positives = 89/223 (39%), Gaps = 36/223 (16%)

Query: 388 KLLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD 446
           ++L    H  L  L    F        V E A  G L   ++ +   F +   R   A +
Sbjct: 57  RVLQNTRHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGA-E 113

Query: 447 VATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHI 504
           + + L YLHS      V++DIK  N++LD D   KI +F L +     EG  + A     
Sbjct: 114 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTF 165

Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE-ENMLLVDVLNPVLH 563
            GT  Y+APE LE+      +D +  GV+M EM+ G+     Y++    L   +L   + 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIR 223

Query: 564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                              +P   +     L+   LKKDP  R
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 43/193 (22%), Positives = 79/193 (40%), Gaps = 24/193 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVY--GDASDQIKLLNKI-NHSSLIRLLGICFNGGNW----Y 412
           G V     +  G   A+K +Y    A  ++    +      ++ +L +  N  +      
Sbjct: 43  GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCS 470
           ++ E    G L   I ++G +     +  +I  D+ T + +LHS     H   H+D+K  
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-----HNIAHRDVKPE 157

Query: 471 NVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           N+L    + D   K+ +F  A+   +      L +    T  Y+APE L         D+
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNA----LQT-PCYTPYYVAPEVLGPEKYDKSCDM 212

Query: 528 YAFGVLMLEMLSG 540
           ++ GV+M  +L G
Sbjct: 213 WSLGVIMYILLCG 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 46/200 (23%), Positives = 78/200 (39%), Gaps = 32/200 (16%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
             V +   K  G   A K     +                + +L +I H ++I L  +  
Sbjct: 25  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
           N  +  L+ E    G L  ++ +K    L   +  +    +  G+ YLHS         H
Sbjct: 85  NKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS-----LQIAH 137

Query: 465 KDIKCSNVLLDT----DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
            D+K  N++L        R KI +F LA   +   G       I GT  ++APE +    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN--IFGTPEFVAPEIVNYEP 193

Query: 521 VSTKLDVYAFGVLMLEMLSG 540
           +  + D+++ GV+   +LSG
Sbjct: 194 LGLEADMWSIGVITYILLSG 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 65/270 (24%), Positives = 103/270 (38%), Gaps = 51/270 (18%)

Query: 362 GSVYRGK--IGGDFVAIK---KVYGDASD-------QIKLLNKINHSSLIRLLGICFNGG 409
           G V           VA+K   +     SD       +I  L  + H  +I+L  +     
Sbjct: 23  GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDI 467
           +  +V E    G L  +I +K     D  +R   QI       + Y H       VH+D+
Sbjct: 83  DIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRHK---IVHRDL 134

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLD 526
           K  N+LLD +   KIA+F L+      +G F  TS   G+  Y APE +   L    ++D
Sbjct: 135 KPENLLLDDNLNVKIADFGLS--NIMTDGNFLKTS--CGSPNYAAPEVINGKLYAGPEVD 190

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--P 584
           V++ G+++  ML G+           L  D           +E + +L        Y  P
Sbjct: 191 VWSCGIVLYVMLVGR-----------LPFD-----------DEFIPNLFKKVNSCVYVMP 228

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
              +     LI   +  DP  R  + +I +
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 43/208 (20%)

Query: 362 GSVYRGKIG--GDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGN--- 410
           G+V  GK    G  VAIKKV  D   +      ++ L  ++H ++++L    +  G    
Sbjct: 37  GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96

Query: 411 ----WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVAT----------GLNYLHS 456
                 +V E  V  +L         +      R Q+A                +  LH 
Sbjct: 97  RDIYLNVVME-YVPDTLH--------RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147

Query: 457 FTNPPHV-HKDIKCSNVLLD-TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
            +   +V H+DIK  NVL++  D   K+ +F  A+     E      ++I  ++ Y APE
Sbjct: 148 PS--VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYIC-SRYYRAPE 201

Query: 515 YLENGLV-STKLDVYAFGVLMLEMLSGK 541
            +      +T +D+++ G +  EM+ G+
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 44/210 (20%), Positives = 85/210 (40%), Gaps = 41/210 (19%)

Query: 362 GSVYRGK----IGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFNGGNW- 411
           G VY+ K          A+K++ G      A  +I LL ++ H ++I L  +  +  +  
Sbjct: 35  GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK 94

Query: 412 -YLVYE------NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH-- 462
            +L+++        +         +K    L       +   +  G++YLH+     +  
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-----NWV 149

Query: 463 VHKDIKCSNVLLDTDFRA----KIANFALARPAERQEGEFALTSHIVGTKGYMAPE---- 514
           +H+D+K +N+L+  +       KIA+   AR         A    +V T  Y APE    
Sbjct: 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209

Query: 515 ---YLENGLVSTKLDVYAFGVLMLEMLSGK 541
              Y      +  +D++A G +  E+L+ +
Sbjct: 210 ARHY------TKAIDIWAIGCIFAELLTSE 233

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 31/197 (15%)

Query: 362 GSVYRG--KIGGDFVAIK-----KVYGDASDQ----IKLLNKINHSSLIRLLGICFNGGN 410
             V R   K  G   A K     K+      +     ++  K+ H +++RL         
Sbjct: 43  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102

Query: 411 WYLVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
            YLV++    G L   I  +   +   D +  IQ  L+    + Y HS     +  VH++
Sbjct: 103 HYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILES---IAYCHS-----NGIVHRN 153

Query: 467 IKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           +K  N+LL +       K+A+F LA   E  + E        GT GY++PE L+    S 
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHG--FAGTPGYLSPEVLKKDPYSK 209

Query: 524 KLDVYAFGVLMLEMLSG 540
            +D++A GV++  +L G
Sbjct: 210 PVDIWACGVILYILLVG 226

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 30/197 (15%)

Query: 362 GSVYRG--KIGGDFVAIK---KVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGN 410
             V R    + G   A          A D        ++   + H +++RL       G+
Sbjct: 25  SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84

Query: 411 WYLVYENAVNGSLSVWINDKGGKF--LDWAQRIQIALDVATGLNYLHSFTNPPH--VHKD 466
            YL+++    G L   I  +   +   D +  IQ  L+    + + H         VH++
Sbjct: 85  HYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEA---VLHCHQ-----MGVVHRN 135

Query: 467 IKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           +K  N+LL +       K+A+F LA      EGE        GT GY++PE L       
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192

Query: 524 KLDVYAFGVLMLEMLSG 540
            +D++A GV++  +L G
Sbjct: 193 PVDLWACGVILYILLVG 209

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 25/221 (11%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
                NH  L+ L   CF      + V E    G L   +  +  K  +   R   A ++
Sbjct: 63  FEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EI 119

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIV 505
           +  LNYLH       +++D+K  NVLLD++   K+ ++ + +     EG      TS   
Sbjct: 120 SLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFC 171

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE L        +D +A GVLM EM++G  +P          +   +    + 
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP--------FDIVGSSDNPDQN 222

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
             +   + +++  ++   P   ++    +++S L KDP  R
Sbjct: 223 TEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 34/221 (15%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           L    NH  L +L   CF      + V E    G L   I  K  +F +   R   A ++
Sbjct: 77  LSLARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAA-EI 133

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIV 505
            + L +LH       +++D+K  NVLLD +   K+A+F + +     EG      T+   
Sbjct: 134 ISALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFC 185

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE L+  L    +D +A GVL+ EML G       +E      D+   +L+ E
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH--APFEAENED---DLFEAILNDE 240

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                +           YP         +++S + K+P+ R
Sbjct: 241 -----VV----------YPTWLHEDATGILKSFMTKNPTMR 266

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 25/221 (11%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
                NH  L+ L   CF      + V E    G L   +  +  K  +   R   A ++
Sbjct: 106 FEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EI 162

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIV 505
           +  LNYLH       +++D+K  NVLLD++   K+ ++ + +     EG      TS   
Sbjct: 163 SLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFC 214

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           GT  Y+APE L        +D +A GVLM EM++G  +P          +   +    + 
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP--------FDIVGSSDNPDQN 265

Query: 566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
             +   + +++  ++   P   ++    +++S L KDP  R
Sbjct: 266 TEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 54/276 (19%)

Query: 362 GSVYRGK--IGGDFVAIK-------KVYGDASDQIK----LLNKINHSSLIRLLGICFN- 407
           G V            A+K       +   +    +K    LL ++ H ++I+L+ + +N 
Sbjct: 19  GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78

Query: 408 -GGNWYLVYENAVNGSLSVWINDKGGKFLDW-AQRI--QIALDVATGLNYLHSFTNPPHV 463
                Y+V E  V G   +  +    +F    A     Q+      GL YLHS      V
Sbjct: 79  EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----DGLEYLHSQG---IV 131

Query: 464 HKDIKCSNVLLDTDFRAKIANFAL-ARPAERQEGEFALTSHIVGTKGYMAPEYLEN--GL 520
           HKDIK  N+LL T    KI+   +          +   TS   G+  +  PE        
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTF 189

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ 580
              K+D+++ GV +  + +G                        E   +++  L +   +
Sbjct: 190 SGFKVDIWSAGVTLYNITTGL--------------------YPFEG--DNIYKLFENIGK 227

Query: 581 GNY--PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           G+Y  P      +  L++  L+ +P+ R ++ +I Q
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 48/203 (23%)

Query: 371 GDFVAIKKV-YGDASD------QIKLLNKINHSSLIRLLGICFNGGNW------------ 411
              VAIKK+   D         +IK++ +++H +++++  I    G+             
Sbjct: 36  DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95

Query: 412 --YLVYE------NAV--NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
             Y+V E        V   G L     ++  +   +    Q+      GL Y+HS     
Sbjct: 96  SVYIVQEYMETDLANVLEQGPLL----EEHARLFMY----QLL----RGLKYIHS----A 139

Query: 462 HV-HKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG 519
           +V H+D+K +N+ ++T D   KI +F LAR  +         S  + TK Y +P  L + 
Sbjct: 140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199

Query: 520 LVSTK-LDVYAFGVLMLEMLSGK 541
              TK +D++A G +  EML+GK
Sbjct: 200 NNYTKAIDMWAAGCIFAEMLTGK 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 45/195 (23%)

Query: 371 GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW------YLVY 415
           G  VAIKK+Y     +         ++LL  + H ++I LL +             YLV 
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109

Query: 416 E------NAV--NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
                    +  +  L     +   +FL +    Q+      GL Y+H+      +H+D+
Sbjct: 110 PFMGTDLGKLMKHEKLG----EDRIQFLVY----QMLK----GLRYIHA---AGIIHRDL 154

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY-LENGLVSTKLD 526
           K  N+ ++ D   KI +F LAR A+ +     +T + V T+ Y APE  L     +  +D
Sbjct: 155 KPGNLAVNEDCELKILDFGLARQADSE-----MTGY-VVTRWYRAPEVILNWMRYTQTVD 208

Query: 527 VYAFGVLMLEMLSGK 541
           +++ G +M EM++GK
Sbjct: 209 IWSVGCIMAEMITGK 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 30/219 (13%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           L     H  L  +    F    N + V E    G L   I     KF         A ++
Sbjct: 71  LSLAWEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAA-EI 127

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
             GL +LHS      V++D+K  N+LLD D   KIA+F + +     +     T+   GT
Sbjct: 128 ILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGT 181

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG 567
             Y+APE L     +  +D ++FGVL+ EML G+     + ++     ++ + +      
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE---ELFHSIRMDN-- 234

Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                          YP         L+     ++P  R
Sbjct: 235 ---PF----------YPRWLEKEAKDLLVKLFVREPEKR 260

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 50/270 (18%)

Query: 362 GSVYRGK--IGGDFVAIK-----KVY-GDASDQIK----LLNKINHSSLIRLLGICFNGG 409
           G V  GK  + G  VA+K     K+   D   +I+     L    H  +I+L  +     
Sbjct: 30  GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDI 467
           + ++V E    G L  +I   G      ++R+  QI     +G++Y H       VH+D+
Sbjct: 90  DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM---VVHRDL 142

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKLD 526
           K  NVLLD    AKIA+F L+      +GEF  TS   G+  Y APE +   L    ++D
Sbjct: 143 KPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTS--CGSPNYAAPEVISGRLYAGPEVD 198

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--P 584
           +++ GV++  +L G            L  D           ++ +  L      G +  P
Sbjct: 199 IWSSGVILYALLCGT-----------LPFD-----------DDHVPTLFKKICDGIFYTP 236

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                 VI L++  L+ DP  R  +  I +
Sbjct: 237 QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 362 GSVY--RGKIGGDFVAIK---KVYGDASDQI-------KLLNKINHSSLIRLLGICFNGG 409
           G V   + K  G+  A+K   K       QI       ++L  +N   L++L     +  
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           N Y+V E  V G        + G+F +   R   A  +     YLHS      +++D+K 
Sbjct: 115 NLYMVME-YVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD---LIYRDLKP 169

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+L+D     ++ +F  A+  + +      T  + GT   +APE + +   +  +D +A
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWA 223

Query: 530 FGVLMLEMLSGKEAPALYSEENMLL 554
            GVL+ EM +G   P  ++++ + +
Sbjct: 224 LGVLIYEMAAGY--PPFFADQPIQI 246

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 31/188 (16%)

Query: 371 GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW------YLVY 415
           G  VA+KK+                ++LL  + H ++I LL +     +       YLV 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
              +   L+  +  K  K  D    +Q +   +  GL Y+HS  +   +H+D+K SN+ +
Sbjct: 114 H-LMGADLNNIV--KCQKLTD--DHVQFLIYQILRGLKYIHS-ADI--IHRDLKPSNLAV 165

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLDVYAFGVL 533
           + D   KI +F LAR          +T + V T+ Y APE  L     +  +D+++ G +
Sbjct: 166 NEDCELKILDFGLARHT-----ADEMTGY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219

Query: 534 MLEMLSGK 541
           M E+L+G+
Sbjct: 220 MAELLTGR 227

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 23/193 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKV--YGDASDQIKLLNKI-NHSSLIRLLGICFNGGNW----Y 412
           G V +   K   +  A+K +     A  +++L  +      ++R++ +  N         
Sbjct: 76  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCS 470
           +V E    G L   I D+G +     +  +I   +   + YLHS         H+D+K  
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-----INIAHRDVKPE 190

Query: 471 NVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           N+L      +   K+ +F  A+  E        T     T  Y+APE L         D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTT--PCYTPYYVAPEVLGPEKYDKSCDM 246

Query: 528 YAFGVLMLEMLSG 540
           ++ GV+M  +L G
Sbjct: 247 WSLGVIMYILLCG 259

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           L        L +L   CF      Y V E    G L   I  + G+F +       A ++
Sbjct: 74  LALPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAA-EI 130

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSHIV 505
           A GL +L S      +++D+K  NV+LD++   KIA+F + +     E   +   T    
Sbjct: 131 AIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFC 182

Query: 506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE-ENMLLVDVLNPVLHK 564
           GT  Y+APE +        +D +AFGVL+ EML+G+       E E+ L   ++   +  
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSIMEHNVA- 239

Query: 565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                             YP   +   + + +  + K P  R
Sbjct: 240 ------------------YPKSMSKEAVAICKGLMTKHPGKR 263

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 50/305 (16%), Positives = 106/305 (34%), Gaps = 70/305 (22%)

Query: 362 GSVYRGKIG--GDFVAIKKVYGDASDQ---IKLLNKINHSSLIRLLGICFNGGNWYLVYE 416
           G V        G   A+KKV  D   +   + ++  ++H ++I+L+   +  G+      
Sbjct: 21  GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80

Query: 417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDV----------------------------- 447
              +    +   + G      +  +  + +                              
Sbjct: 81  QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPM 140

Query: 448 ----------ATGLNYLHSFTNPPHV-HKDIKCSNVLLD-TDFRAKIANFALARPAERQE 495
                        + ++HS      + H+DIK  N+L++  D   K+ +F  A+     E
Sbjct: 141 NLISIYIYQLFRAVGFIHSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196

Query: 496 GEFALTSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEEN--- 551
                 ++I  ++ Y APE +      +  +D+++ G +  E++ GK    L+S E    
Sbjct: 197 ---PSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK---PLFSGETSID 249

Query: 552 --MLLVDVLN-------PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKD 602
             + ++ ++          ++    E     L     +   P  T  L I L+E  L+ +
Sbjct: 250 QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309

Query: 603 PSGRP 607
           P  R 
Sbjct: 310 PDLRI 314

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 28/259 (10%), Positives = 62/259 (23%), Gaps = 62/259 (23%)

Query: 362 GSVYRGK--IGGDFVAIKKVYGD-ASDQI---------KLLNKINHSSLIRLLGICFNGG 409
              ++         VA+  V                    L++I+   + R+L +     
Sbjct: 45  LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
              +V E    GSL    +            I+    +A   +  H              
Sbjct: 105 GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHP 157

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           S V +  D    +A                           M          + + D+  
Sbjct: 158 SRVRVSIDGDVVLAYP-----------------------ATMPD-------ANPQDDIRG 187

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            G  +  +L  +         + L          ++   +     ++P+       +   
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGL------APAERDTAGQ----PIEPADID--RDIPFQ 235

Query: 590 LVIRLIESCLKKDPSGRPA 608
           +   +    ++ D   R A
Sbjct: 236 IS-AVAARSVQGDGGIRSA 253

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 30/219 (13%)

Query: 389 LLNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
           LL  + H  L+ L    F      Y V +    G L   +  +   FL+   R   A ++
Sbjct: 92  LLKNVKHPFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAA-EI 148

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A+ L YLHS      V++D+K  N+LLD+     + +F L +           TS   GT
Sbjct: 149 ASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGT 202

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG 567
             Y+APE L        +D +  G ++ EML G   P  YS     + D    +L+K   
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL--PPFYSRNTAEMYDN---ILNKP-- 255

Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
              L+            P        L+E  L+KD + R
Sbjct: 256 ---LQ----------LKPNITNSARHLLEGLLQKDRTKR 281

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 56/287 (19%), Positives = 95/287 (33%), Gaps = 68/287 (23%)

Query: 362 GSVYRG--KIGGDFVAIK---KVYGDASDQ----IKLLNKI-NHSSLIRLLGICFNGGNW 411
             V      I     A+K   K  G    +    +++L +   H +++ L+        +
Sbjct: 27  ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQ------------IALDVATGLNYLHSFTN 459
           YLV+E             +GG  L     I             +  DVA+ L++LH+   
Sbjct: 87  YLVFEKM-----------RGGSILS---HIHKRRHFNELEASVVVQDVASALDFLHN--- 129

Query: 460 PPH--VHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSH----IVGTKGY 510
                 H+D+K  N+L +        KI +F L    +       +++       G+  Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 511 MAPEYLENGLVSTKL-----DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE 565
           MAPE +E       +     D+++ GV++  +LSG   P                    E
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY--PPFVGRC-----GSDCGWDRGE 240

Query: 566 DGEESLRHLMDPSMQGNY----PPVTAI--LVIRLIESCLKKDPSGR 606
                   L +   +G Y         I      LI   L +D   R
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 50/203 (24%)

Query: 371 GDFVAIKKV--YGDASD------QIKLLNKINHSSLIRLLGI-------CFNGGNWYLVY 415
           G+ VAIKK+  +           +IK+L    H ++I +  I        FN    Y++ 
Sbjct: 36  GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE--VYIIQ 93

Query: 416 E------NAV--NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKD 466
           E      + V     LS    D   ++  +    Q  L     +  LH      +V H+D
Sbjct: 94  ELMQTDLHRVISTQMLS----DDHIQYFIY----QT-L---RAVKVLHG----SNVIHRD 137

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI-------VGTKGYMAPEYLENG 519
           +K SN+L++++   K+ +F LAR  +    + +  +         V T+ Y APE +   
Sbjct: 138 LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197

Query: 520 LVSTK-LDVYAFGVLMLEMLSGK 541
              ++ +DV++ G ++ E+   +
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRR 220

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 30/222 (13%)

Query: 390 LNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L  I  S  +  L   F      +L+ +    G L   ++ +  +F +   +I +  ++ 
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVG-EIV 169

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L +LH       +++DIK  N+LLD++    + +F L++     E E A      GT 
Sbjct: 170 LALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTI 224

Query: 509 GYMAPEYLENGLV--STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED 566
            YMAP+ +  G       +D ++ GVLM E+L+G                        + 
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------------------SPFTVDG 266

Query: 567 GEESLRHLMDPSMQGN--YPPVTAILVIRLIESCLKKDPSGR 606
            + S   +    ++    YP   + L   LI+  L KDP  R
Sbjct: 267 EKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 7e-11
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 30/210 (14%)

Query: 361 KGS---VY--RGKIGGDFVAIK---KVYGDASDQI-------KLLNKINHSSLIRLLGIC 405
            GS   V+  R +  G + A+K   K       Q+        +L+ + H  +IR+ G  
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG-T 74

Query: 406 F-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
           F +    +++ +    G L   +  K  +F +   +   A +V   L YLHS      ++
Sbjct: 75  FQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAA-EVCLALEYLHSKD---IIY 129

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K  N+LLD +   KI +F  A+           T  + GT  Y+APE +     +  
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKS 183

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLL 554
           +D ++FG+L+ EML+G      Y    M  
Sbjct: 184 IDWWSFGILIYEMLAGY--TPFYDSNTMKT 211

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 10/153 (6%)

Query: 390 LNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L ++ H  ++ L+   F  GG  YL+ E    G L + +  + G F++      +A +++
Sbjct: 75  LEEVKHPFIVDLIY-AFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA-EIS 131

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L +LH       +++D+K  N++L+     K+ +F L + +        +T    GT 
Sbjct: 132 MALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTFCGTI 185

Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            YMAPE L     +  +D ++ G LM +ML+G 
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 390 LNKINHSSLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVA 448
           L ++NH  +++L    F   G  YL+ +    G L   ++ K   F +   +  +A ++A
Sbjct: 80  LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLA-ELA 136

Query: 449 TGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK 508
             L++LHS      +++D+K  N+LLD +   K+ +F L++ +   E          GT 
Sbjct: 137 LALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTV 190

Query: 509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE-ENMLLVDVLNPVLHKEDG 567
            YMAPE +     +   D ++FGVLM EML+G        +     +  +L   L     
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--TLPFQGKDRKETMTMILKAKLG---- 244

Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR 606
                           P   +     L+    K++P+ R
Sbjct: 245 ---------------MPQFLSPEAQSLLRMLFKRNPANR 268

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 41/203 (20%), Positives = 77/203 (37%), Gaps = 45/203 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASD----QIKLL-NKINHSSLIRLLGIC--FNGGNWY 412
             V+        + V +K +          +IK+L N     ++I L  I          
Sbjct: 50  SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALD---------VATGLNYLHSFTNPPH- 462
           LV+E          +N+      D+ Q  Q   D         +   L+Y HS       
Sbjct: 110 LVFE---------HVNN-----TDFKQLYQTLTDYDIRFYMYEILKALDYCHS-----MG 150

Query: 463 -VHKDIKCSNVLLDTDFRA-KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL 520
            +H+D+K  NV++D + R  ++ ++ LA      +         V ++ +  PE L +  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYN-VRVASRYFKGPELLVDYQ 206

Query: 521 V-STKLDVYAFGVLMLEMLSGKE 542
           +    LD+++ G ++  M+  KE
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKE 229

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 62/224 (27%)

Query: 371 GDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGIC-------FNGGNWYLV 414
              VAIKKV     D          I +LN++    +IRL  +        F+    Y+V
Sbjct: 51  EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE--LYIV 108

Query: 415 YE------NAVNGSLSVWINDKGGKFLDWAQRIQ-IALDVATGLNYLHSFTNPPHV-HKD 466
            E        +          K   FL   + I+ I  ++  G N++H       + H+D
Sbjct: 109 LEIADSDLKKL-------F--KTPIFLT-EEHIKTILYNLLLGENFIHES----GIIHRD 154

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFA--------------------LTSHIVG 506
           +K +N LL+ D   K+ +F LAR    ++                        LTSH+V 
Sbjct: 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV- 213

Query: 507 TKGYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGKEAPALYSE 549
           T+ Y APE +      TK +D+++ G +  E+L+  ++      
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 57/260 (21%), Positives = 94/260 (36%), Gaps = 46/260 (17%)

Query: 371 GDFVAIK------KVYGDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS 424
            + VA+K       +  +   +I     + H +++R   +     +  ++ E A  G L 
Sbjct: 45  KELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104

Query: 425 VWINDKGGKFLDWAQRI--QIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF--RA 480
             I + G    D A+    Q+     +G++Y HS       H+D+K  N LLD     R 
Sbjct: 105 ERICNAGRFSEDEARFFFQQLL----SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRL 157

Query: 481 KIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLS 539
           KI +F  +            ++  VGT  Y+APE L          DV++ GV +  ML 
Sbjct: 158 KICDFGYS--KSSVLHSQPKST--VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213

Query: 540 GKEAPAL-YSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--PPVTAI--LVIRL 594
           G    A  + +          P           R  +   +   Y  P    I      L
Sbjct: 214 G----AYPFEDPEE-------PRD--------YRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 595 IESCLKKDPSGRPAMDKIAQ 614
           I      DP+ R ++ +I  
Sbjct: 255 ISRIFVADPATRISIPEIKT 274

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 75/244 (30%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGIC----- 405
           G V     K+    VAIKK+     D          I +LN++NH  ++++L I      
Sbjct: 67  GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126

Query: 406 --FNGGNWYLVYE------NAV---NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYL 454
             F+    Y+V E        +      L+    +   K L +     + L    G+ Y+
Sbjct: 127 EKFDE--LYVVLEIADSDFKKLFRTPVYLT----ELHIKTLLY----NL-L---VGVKYV 172

Query: 455 HSFTNPPH--VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA------------- 499
           HS        +H+D+K +N L++ D   K+ +F LAR  +  E   +             
Sbjct: 173 HS-----AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 500 ------------LTSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPAL 546
                       LT H+V T+ Y APE +      +  +DV++ G +  E+L+  +    
Sbjct: 228 VTFPHTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286

Query: 547 YSEE 550
           Y  +
Sbjct: 287 YHAD 290

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 2e-09
 Identities = 60/353 (16%), Positives = 114/353 (32%), Gaps = 79/353 (22%)

Query: 282 LIFGMI------IFYMFFRISYKKEFDSTIVSSSFEACEKASNKKLDEESRDFLESISDI 335
            +F  +      +   F     +  +   +     E  + +   ++  E RD L + + +
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 336 AQSLKVY---TFEELQAATDDFNPSCWIKGSVYRGKIG-GDFVAIKKVYGDASDQIKLLN 391
                V     + +L+ A  +  P+  +   +  G +G G       V      Q K+  
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNV--LID-GVLGSGKTWVALDVCLSYKVQCKMDF 182

Query: 392 KI----------NHSSLIRLLGICFN-GGNWYLVYENAVNGSLSV-WINDKGGKFLDWAQ 439
           KI            + L  L  + +    NW    +++ N  L +  I  +  + L   +
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS-K 241

Query: 440 RIQIAL----DVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
             +  L    +V       ++F        ++ C  +LL T F+  + +F  A       
Sbjct: 242 PYENCLLVLLNVQNA-KAWNAF--------NLSCK-ILLTTRFKQ-VTDFLSA------- 283

Query: 496 GEFALTSHIV---GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM 552
              A T+HI     +      E     L+   LD      L  E+L+             
Sbjct: 284 ---ATTTHISLDHHSMTLTPDEVKS--LLLKYLDCRPQD-LPREVLTT------------ 325

Query: 553 LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKK-DPS 604
                 NP        ES+R     +   N+  V    +  +IES L   +P+
Sbjct: 326 ------NPRRLSIIA-ESIRD--GLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 2e-04
 Identities = 57/276 (20%), Positives = 86/276 (31%), Gaps = 69/276 (25%)

Query: 327 DFLESISDIAQSLKVYTFEELQAATDD---FNPSCWIKGSVYRGKIGGDFVAI---KKVY 380
           D L +I  I  SL V    E +   D    F PS  I   +          ++     + 
Sbjct: 353 DKLTTI--IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL---------SLIWFDVIK 401

Query: 381 GDASDQIK------LLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV---WIN-DK 430
            D    +       L+ K    S I +  I       YL  +  +    ++    ++   
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSI-------YLELKVKLENEYALHRSIVDHYN 454

Query: 431 GGKFLDWAQRIQIALDVATGLNYLHSF-----TNPPHVHKDIKCSNVLLDTDF-RAKIAN 484
             K  D    I   LD      Y +S       N  H  +      V LD  F   KI +
Sbjct: 455 IPKTFDSDDLIPPYLD-----QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH 509

Query: 485 FALARPAERQEGEFALTSHIVGTKGYMA---PEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
            + A  A            +   K Y+    P+Y    LV+  LD   F       L   
Sbjct: 510 DSTAWNA--SGSILNTLQQLKFYKPYICDNDPKY--ERLVNAILD---F-------LPKI 555

Query: 542 EAPALYSEENMLLVDVLNPVLHKEDG---EESLRHL 574
           E   + S+      D+L   L  ED    EE+ + +
Sbjct: 556 EENLICSKY----TDLLRIALMAEDEAIFEEAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 5e-04
 Identities = 55/339 (16%), Positives = 102/339 (30%), Gaps = 85/339 (25%)

Query: 321 LDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSVYRGKIGGDFVAIKKVY 380
           +D E+ +      DI   L V+      A  D+F+  C         K   D    K + 
Sbjct: 7   MDFETGEHQYQYKDI---LSVF----EDAFVDNFD--C---------KDVQDM--PKSIL 46

Query: 381 GDAS-DQIKLLNKINHSSLIRLLGI-CFNGGNWYLVYENAVNGSLSV---WINDKGGKFL 435
                D I +++K   S  +RL             + +  V   L +   ++        
Sbjct: 47  SKEEIDHI-IMSKDAVSGTLRLFWTLLSKQEE---MVQKFVEEVLRINYKFLMSP----- 97

Query: 436 DWAQR-IQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ 494
                  Q ++     +       N   V      S +      R  +      RPA+  
Sbjct: 98  -IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE---LRPAKN- 152

Query: 495 EGEFALTSHIVGTKGY----MAPEYLENGLVSTKLD--VY--AFG--------VLMLEML 538
                +     G  G     +A +   +  V  K+D  ++             + ML+ L
Sbjct: 153 -----VLID--GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205

Query: 539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESC 598
             +  P   S  +       N  L     +  LR L+       Y     +LV+  +   
Sbjct: 206 LYQIDPNWTSRSDHSS----NIKLRIHSIQAELRRLL---KSKPYE--NCLLVLLNV--- 253

Query: 599 LKKDPSGRPAMD---KI-----AQSISRFLNASLAWELS 629
             ++     A +   KI      + ++ FL+A+    +S
Sbjct: 254 --QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 62/214 (28%)

Query: 371 GDFVAIKKVY---GDASD------QIKLLNKIN-HSSLIRLLGIC----FNGGNWYLVYE 416
           G+ VA+KK++    +++D      +I +L +++ H +++ LL +           YLV++
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD--VYLVFD 91

Query: 417 ------NAV--NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV-HKDI 467
                 +AV     L         +++ +    Q+ +     + YLHS      + H+D+
Sbjct: 92  YMETDLHAVIRANILE----PVHKQYVVY----QL-I---KVIKYLHS----GGLLHRDM 135

Query: 468 KCSNVLLDTDFRAKIANFALAR-------------------PAERQEGEFALTSHIVGTK 508
           K SN+LL+ +   K+A+F L+R                        + +  LT + V T+
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY-VATR 194

Query: 509 GYMAPEYLENGLVSTK-LDVYAFGVLMLEMLSGK 541
            Y APE L      TK +D+++ G ++ E+L GK
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 44.8 bits (106), Expect = 3e-06
 Identities = 14/59 (23%), Positives = 30/59 (50%), Gaps = 1/59 (1%)

Query: 185 LSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENPPSSSQTTE 243
           L + ++ G+T+ G++ ++GV  ++   AN L     +I+   TL +P+   P     + 
Sbjct: 16  LEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTND-SIFLKKTLYIPILTEPRDLFNSG 73

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 47/236 (19%), Positives = 81/236 (34%), Gaps = 76/236 (32%)

Query: 373 FVAIK-----KVYGD-ASDQIKLLNKINHS-------SLIRLLGICF-----NGGNWYLV 414
           FVA+K     + Y + A D+I+LL  + +S        ++  L   F     NG +  +V
Sbjct: 64  FVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMV 123

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
           +E  +   L  WI     + L      +I   V  GL+YLH+      +H DIK  N+LL
Sbjct: 124 FE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL 180

Query: 475 DTD-------------------------------------------------FRAKIANF 485
             +                                                  + KIA+ 
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240

Query: 486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGK 541
             A    +        +  + T+ Y + E L     +T  D+++   +  E+ +G 
Sbjct: 241 GNACWVHKH------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154

 Score = 43.0 bits (100), Expect = 6e-05
 Identities = 14/51 (27%), Positives = 21/51 (41%), Gaps = 22/51 (43%)

Query: 314 EKASNKKLDEESRDFLESISDIAQSLKVYTFEELQAATDDFNPSCWIKGSV 364
           EK + KKL        ++      SLK+Y         DD  P+  IK ++
Sbjct: 18  EKQALKKL--------QA------SLKLY--------ADDSAPALAIKATM 46

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.5 bits (104), Expect = 7e-05
 Identities = 24/183 (13%), Positives = 39/183 (21%), Gaps = 59/183 (32%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASD------------------------QIKLLNKINHSS 397
           G V++       VAIK +  +  D                         +          
Sbjct: 34  GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93

Query: 398 LIRLLGIC------------------------------FNGGNWYLVYENAVNGSLSVWI 427
            I L  +                               F     ++V E    G     +
Sbjct: 94  FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---L 150

Query: 428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL 487
                K    A    I   +   L       +    H+D+   NVLL      K+     
Sbjct: 151 EQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLLKKTSLKKLHYTLN 208

Query: 488 ARP 490
            + 
Sbjct: 209 GKS 211

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 Length = 48

 Score = 39.4 bits (93), Expect = 7e-05
 Identities = 12/49 (24%), Positives = 26/49 (53%), Gaps = 3/49 (6%)

Query: 185 LSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLE 233
           ++Y V+ G+++  I+KR GV+    +  N  +    N+ P   L + ++
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA---NLQPGDKLTLFVK 48

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 35/193 (18%), Positives = 69/193 (35%), Gaps = 44/193 (22%)

Query: 362 GSVYRG--KIGGDFVAIKKV--YGDASDQIKLLNKI-NHSSLIRLLGIC----FNGGNWY 412
           G V +   K   +  A+K +     A  +++L  +      ++R++ +            
Sbjct: 32  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VHKDIKCS 470
           +V E    G L   I D+G +     +  +I   +   + YLHS         H+D+K  
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-----INIAHRDVKPE 146

Query: 471 NVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
           N+L  +   +   K+ +F  A+                  + Y               D+
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--------------ETTGEKY-----------DKSCDM 181

Query: 528 YAFGVLMLEMLSG 540
           ++ GV+M  +L G
Sbjct: 182 WSLGVIMYILLCG 194

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	635
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.98
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.87
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.81
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.59
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.39
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.32
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.27
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.26
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.17
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.07
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	99.06
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.05
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.85
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.83
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	98.79
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.74
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.48
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	98.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.08
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.03
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.91
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.9
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.86
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.61
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.58
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.44
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.02
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.58
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.54
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.35
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.96
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.88
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.57
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.35
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	95.3
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.2
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.9
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.65
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	94.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.41
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.34
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.83
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.23
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.89
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	83.1

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.9e-49  Score=404.85  Aligned_cols=239  Identities=23%  Similarity=0.435  Sum_probs=196.7

Q ss_pred             ceEEEeee-------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |+||+|++       ++..||||+++.       ++.+|+++|++++|||||+++|+|.+++..||||||+++|+|.++|
T Consensus        27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  106 (299)
T 4asz_A           27 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL  106 (299)
T ss_dssp             CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence            89999986       367899999964       3678999999999999999999999999999999999999999999


Q ss_pred             ccc-----------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          428 NDK-----------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       428 ~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      ...           ....++|.+++.|+.||+.||.|||+.   +|+||||||+||||++++.+||+|||+++.......
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  183 (299)
T 4asz_A          107 RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY  183 (299)
T ss_dssp             HHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred             HhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCc
Confidence            643           234599999999999999999999984   499999999999999999999999999986543321


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                       ........||+.|||||++.++.++.++|||||||++|||+| |+.||...+...  +...                +.
T Consensus       184 -~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~----------------i~  244 (299)
T 4asz_A          184 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC----------------IT  244 (299)
T ss_dssp             -EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHH----------------HH
T ss_pred             -eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----------------HH
Confidence             123344579999999999999999999999999999999999 899986433221  1111                11


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ... ....|..++..+.+|+.+||+.||++|||++||.+.|+++...+
T Consensus       245 ~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          245 QGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             cCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            110 11234445567999999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.1e-49  Score=405.69  Aligned_cols=236  Identities=24%  Similarity=0.425  Sum_probs=194.0

Q ss_pred             ceEEEeee-------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |+||+|++       +++.||||+++.        ++.+|+.+|++++|||||+++|+|.+++..+|||||+++|+|.++
T Consensus        40 G~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~  119 (308)
T 4gt4_A           40 GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF  119 (308)
T ss_dssp             CEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHH
T ss_pred             cEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHH
Confidence            89999986       357899999864        367899999999999999999999999999999999999999999


Q ss_pred             hcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          427 INDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       427 l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      |....              ...++|.+++.|+.|||.||+|||+.+   |+||||||+||||++++.+||+|||+++...
T Consensus       120 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~  196 (308)
T 4gt4_A          120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVY  196 (308)
T ss_dssp             HHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGG
T ss_pred             HHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceecc
Confidence            95421              134899999999999999999999954   9999999999999999999999999998664


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .... ........||+.|||||++.++.++.++|||||||++|||+| |+.||......+  +...              
T Consensus       197 ~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~--------------  259 (308)
T 4gt4_A          197 AADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEM--------------  259 (308)
T ss_dssp             GGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHH--------------
T ss_pred             CCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------------
Confidence            4322 123345679999999999999999999999999999999999 788876433221  1111              


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                        +.+. .....|..++..+.+|+.+||+.||++|||++||+++|+.+.
T Consensus       260 --i~~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          260 --IRNR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             --HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --HHcC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence              1111 111234455667999999999999999999999999998653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=398.20  Aligned_cols=239  Identities=26%  Similarity=0.419  Sum_probs=186.6

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |+||+|++.+ .||||.++.         .+.+|+++|++++|||||+++|+|.+ +..+|||||+++|+|.+++.....
T Consensus        50 G~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~  127 (307)
T 3omv_A           50 GTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET  127 (307)
T ss_dssp             SEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC
T ss_pred             cEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC
Confidence            8999999865 599998863         36689999999999999999999854 568999999999999999965443


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .++|.+++.|+.||+.||+|||+.   +|+||||||+||||++++.+||+|||+|+........ .......||+.|||
T Consensus       128 -~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~GT~~ymA  202 (307)
T 3omv_A          128 -KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS-QQVEQPTGSVLWMA  202 (307)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------------CCCCTTSCC
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc-eeecccccCCCccC
Confidence             399999999999999999999984   4999999999999999999999999999865433221 22345689999999


Q ss_pred             cccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||++.+   +.++.++|||||||++|||+||+.||.......... ..+..            ....|.+ ...+..++.
T Consensus       203 PE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~-~~~~~------------~~~~p~~-~~~~~~~~~  268 (307)
T 3omv_A          203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII-FMVGR------------GYASPDL-SKLYKNCPK  268 (307)
T ss_dssp             HHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-HHHHT------------TCCCCCS-TTSCTTSCH
T ss_pred             HHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH-HHHhc------------CCCCCCc-ccccccchH
Confidence            999863   468999999999999999999999986433322111 11111            0111111 122334556


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      .+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            68999999999999999999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=406.15  Aligned_cols=238  Identities=23%  Similarity=0.448  Sum_probs=188.6

Q ss_pred             ceEEEeee-------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++       ++..||||+++.       ++.+|+++|++++|||||+++|+|.+++..||||||+++|+|.+++
T Consensus        55 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  134 (329)
T 4aoj_A           55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL  134 (329)
T ss_dssp             EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence            89999986       367899999964       3678999999999999999999999999999999999999999999


Q ss_pred             cccC-------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          428 NDKG-------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       428 ~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ....             ...++|.+++.|+.||+.||.|||+.   +|+||||||+||||++++.+||+|||+++.....
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~  211 (329)
T 4aoj_A          135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  211 (329)
T ss_dssp             HTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             HhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCC
Confidence            5432             23599999999999999999999984   4999999999999999999999999999865433


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .. ........||+.|||||++.+..++.++|||||||++|||+| |+.||.......  ....+.              
T Consensus       212 ~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~--------------  274 (329)
T 4aoj_A          212 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCIT--------------  274 (329)
T ss_dssp             ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHH--------------
T ss_pred             Cc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHH--------------
Confidence            21 122345679999999999999999999999999999999999 899986433221  111111              


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                        .. .....|..++..+.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus       275 --~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          275 --QG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --HT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --cC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              00 01123444556689999999999999999999999999998765

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.1e-48  Score=398.84  Aligned_cols=249  Identities=25%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             CCCCCccc----ceEEEeee--CCcEEEEEEeccC--hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          354 FNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD--ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~--~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |....+||    |.||+++.  +|+.||||+++.+  ..+|+.+|++++|||||++++++.+++..||||||++||+|.+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~  139 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ  139 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence            44444455    89999997  6899999999754  4589999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCc--eeeec
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGE--FALTS  502 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~--~~~~~  502 (635)
                      ++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||+|+........  .....
T Consensus       140 ~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~  214 (336)
T 4g3f_A          140 LIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD  214 (336)
T ss_dssp             HHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence            997654  3999999999999999999999854   99999999999999987 6999999999876543211  11223


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ..+||+.|||||++.+..++.++|||||||++|||+||+.||........ .......                +.....
T Consensus       215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~  277 (336)
T 4g3f_A          215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASE----------------PPPIRE  277 (336)
T ss_dssp             CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHS----------------CCGGGG
T ss_pred             ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcC----------------CCCchh
Confidence            46799999999999999999999999999999999999999864332211 1111110                000012


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      .++..+..+.++|.+||+.||++|||+.|++++|.+++.+..
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            234455668999999999999999999999999999887643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.9e-48  Score=400.37  Aligned_cols=229  Identities=23%  Similarity=0.373  Sum_probs=190.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +|+.||||++..         .+.+|+++|++++|||||++++++.+++..||||||++||+|.+++...
T Consensus        38 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~  117 (350)
T 4b9d_A           38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ  117 (350)
T ss_dssp             -CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc
Confidence            89999987  689999999853         2568999999999999999999999999999999999999999999766


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++.+++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++......   ......+||+.|
T Consensus       118 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GT~~Y  191 (350)
T 4b9d_A          118 KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV---ELARACIGTPYY  191 (350)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---HHHHHHHSCCTT
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc---ccccccCCCccc
Confidence            5556899999999999999999999955   9999999999999999999999999998664321   123446899999


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      ||||++.+..++.++|||||||++|||+||+.||...+... .+..                 +..... ...+...+..
T Consensus       192 mAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~-----------------i~~~~~-~~~~~~~s~~  252 (350)
T 4b9d_A          192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLK-----------------IISGSF-PPVSLHYSYD  252 (350)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-----------------HHHTCC-CCCCTTSCHH
T ss_pred             cCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHH-----------------HHcCCC-CCCCccCCHH
Confidence            99999999999999999999999999999999986433221 1111                 111111 0122334556


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+||.+||+.||++|||++|++++
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            8999999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-47  Score=393.05  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=191.8

Q ss_pred             ceEEEeeeCCcEEEEEEeccCh------HHHHHHHhhhccCCcccEEEEEecCC----eeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGDA------SDQIKLLNKINHSSLIRLLGICFNGG----NWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~~------~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |+||+|+++|+.||||++..+.      ..|+..+.+++|||||+++|+|.+++    ..||||||+++|+|.++++...
T Consensus        17 G~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~   96 (303)
T 3hmm_A           17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT   96 (303)
T ss_dssp             SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC
T ss_pred             eEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC
Confidence            8999999999999999997542      24566677889999999999998654    5799999999999999997543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCC-----CCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-eeecccc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFT-----NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-ALTSHIV  505 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~  505 (635)
                         ++|..+.+|+.|++.||.|||+..     .++|+||||||+||||+.++.+||+|||+++......... .......
T Consensus        97 ---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~  173 (303)
T 3hmm_A           97 ---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV  173 (303)
T ss_dssp             ---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccc
Confidence               899999999999999999999851     3579999999999999999999999999998665433221 1223467


Q ss_pred             cCCCccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          506 GTKGYMAPEYLENG------LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       506 gt~~y~aPE~~~~~------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      ||+.|||||++.+.      .++.++|||||||++|||+||+.|+..............   ............+.+..+
T Consensus       174 GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~  250 (303)
T 3hmm_A          174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV---PSDPSVEEMRKVVCEQKL  250 (303)
T ss_dssp             CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS---CSSCCHHHHHHHHTTSCC
T ss_pred             ccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc---cccchHHHHHHHHhcccC
Confidence            99999999998754      467899999999999999999987654322211110000   001111122222233333


Q ss_pred             CCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          580 QGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       580 ~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +...|     .+....+.+|+.+||+.||++||||.||++.|+++.++
T Consensus       251 rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            33332     24566789999999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-47  Score=386.34  Aligned_cols=228  Identities=23%  Similarity=0.392  Sum_probs=182.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec----CCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|+.  ++..||||++..         .+.+|+++|++++|||||+++++|.+    ++.+||||||+++|+|.++
T Consensus        40 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~  119 (290)
T 3fpq_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHH
Confidence            89999998  688999999853         25689999999999999999999864    3457999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceeeecccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      +.+..  .+++..+..|+.||+.||+|||+.+ ++|+||||||+||||+. ++.+||+|||+|+.....     .....+
T Consensus       120 l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-----~~~~~~  191 (290)
T 3fpq_A          120 LKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVI  191 (290)
T ss_dssp             HHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEESC
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-----ccCCcc
Confidence            97643  3999999999999999999999865 56999999999999974 799999999999754322     234468


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|||||++.+ .++.++|||||||++|||+||+.||.......... ..+.                ........+.
T Consensus       192 GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~-~~i~----------------~~~~~~~~~~  253 (290)
T 3fpq_A          192 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RRVT----------------SGVKPASFDK  253 (290)
T ss_dssp             SSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HHHT----------------TTCCCGGGGG
T ss_pred             cCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH-HHHH----------------cCCCCCCCCc
Confidence            9999999998865 59999999999999999999999986433222111 1111                1000001112


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+..+.+||.+||+.||++|||++|+++|
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223458999999999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.5e-47  Score=392.74  Aligned_cols=228  Identities=20%  Similarity=0.357  Sum_probs=190.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|+.  +|+.||||++..       .+.+|+++|++++|||||++++++.+++..||||||+++|+|.+++...  
T Consensus        88 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--  165 (346)
T 4fih_A           88 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--  165 (346)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS--
T ss_pred             eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--
Confidence            89999998  689999999842       3678999999999999999999999999999999999999999999653  


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                       .+++.++..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++......   ......+||+.|||
T Consensus       166 -~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~YmA  238 (346)
T 4fih_A          166 -RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMA  238 (346)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---CCBCCCCSCGGGCC
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC---CcccccccCcCcCC
Confidence             3999999999999999999999955   9999999999999999999999999998664432   22345789999999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          513 PEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       513 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      ||++.+..|+.++|||||||++|||++|+.||...+...  ....+..             ...+.  ...+...+..+.
T Consensus       239 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~-------------~~~~~--~~~~~~~s~~~~  301 (346)
T 4fih_A          239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD-------------NLPPR--LKNLHKVSPSLK  301 (346)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH-------------SSCCC--CSCGGGSCHHHH
T ss_pred             HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHc-------------CCCCC--CCccccCCHHHH
Confidence            999999999999999999999999999999986433221  1111110             01111  112233456689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +||.+||+.||++|||++|+++|
T Consensus       302 dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          302 GFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcC
Confidence            99999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.1e-47  Score=391.53  Aligned_cols=250  Identities=21%  Similarity=0.312  Sum_probs=200.2

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      +|.....||    |+||+++.  +++.||||.+..          .+.+|+++|++++|||||++++++.+++..|||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            344445555    89999987  789999999853          25689999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      |++||+|.+++.+.+  .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.......
T Consensus       113 y~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          113 YAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999997654  3999999999999999999999955   99999999999999999999999999987643322


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                       .......+||+.|||||++.+..++.++|||||||++|||++|+.||...+...  +                +..+..
T Consensus       188 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~----------------~~~i~~  248 (311)
T 4aw0_A          188 -QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--I----------------FAKIIK  248 (311)
T ss_dssp             -CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----------------HHHHHH
T ss_pred             -cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--H----------------HHHHHc
Confidence             123455789999999999999999999999999999999999999986433221  1                111111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH---HHHHhhcccccc
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI---SRFLNASLAWEL  628 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L---~~~~~~s~~w~~  628 (635)
                      ..  ..+|...+..+.+||.+||+.||++|||++|++.+-   +.-.-..++|+.
T Consensus       249 ~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          249 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             TC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             CC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence            11  122333455689999999999999999999975432   112234578875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.4e-47  Score=397.50  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=201.4

Q ss_pred             hhcCCCCCCccc----ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhcc-CCcccEEEEEecC-
Q 042486          350 ATDDFNPSCWIK----GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKINH-SSLIRLLGICFNG-  408 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~h-~nIv~l~~~~~~~-  408 (635)
                      ..++|.....||    |.||+|++.       ++.||||+++..        +.+|+++|++++| ||||+++|+|.+. 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            345555555665    899999873       258999998652        5679999999965 8999999999764 


Q ss_pred             CeeEEEeecccCCCcchhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE
Q 042486          409 GNWYLVYENAVNGSLSVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL  474 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll  474 (635)
                      +..+||||||++|+|.++|+...              ...++|..++.|+.|||.||+|||+.+   ||||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence            56899999999999999995421              235899999999999999999999954   9999999999999


Q ss_pred             CCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhH
Q 042486          475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENML  553 (635)
Q Consensus       475 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~  553 (635)
                      ++++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |+.||........ 
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-  296 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-  296 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred             CCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            9999999999999986654332 234455689999999999999999999999999999999998 8988864322211 


Q ss_pred             HHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          554 LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       554 l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +...+                 ........|...+..+.+++.+||+.||++|||+.||+++|+++++++.
T Consensus       297 ~~~~i-----------------~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          297 FCRRL-----------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             HHHHH-----------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHH-----------------HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            11111                 1111122344455668999999999999999999999999999987653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=394.88  Aligned_cols=236  Identities=20%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             CCCCCccc----ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccC
Q 042486          354 FNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN  420 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~  420 (635)
                      |.....||    |.||+|+.  +|+.||||++..       .+.+|+.+|++++|||||++++++.+++.+|||||||+|
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            44444455    89999998  689999999842       367899999999999999999999999999999999999


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      |+|.+++...   .+++.++..|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++......   ..
T Consensus       233 G~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~---~~  303 (423)
T 4fie_A          233 GALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PR  303 (423)
T ss_dssp             EEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---CC
T ss_pred             CcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC---cc
Confidence            9999999653   2899999999999999999999955   9999999999999999999999999998664332   22


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......  ....+.             ....+.+ 
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~-------------~~~~~~~-  367 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIR-------------DNLPPRL-  367 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHH-------------HSCCCCC-
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHH-------------cCCCCCC-
Confidence            345789999999999999999999999999999999999999986433221  111111             0011111 


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ..+...+..+.+||.+||+.||++|||++|+++|
T Consensus       368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             1122345568999999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-45  Score=373.50  Aligned_cols=238  Identities=22%  Similarity=0.313  Sum_probs=183.9

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|.....||    |+||+++.  +|+.||||.+..          .+.+|+++|++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            3455555555    89999987  789999999853          2568999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+ +|+|.+++....  .+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 679999996543  3999999999999999999999955   9999999999999999999999999998654322


Q ss_pred             CceeeecccccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                          .....+||+.|||||++.+..+ +.++|||||||++|||+||+.||...+...  +...                +
T Consensus       167 ----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~~----------------i  224 (275)
T 3hyh_A          167 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFKN----------------I  224 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----------------H
T ss_pred             ----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHH----------------H
Confidence                2334689999999999988765 689999999999999999999986432211  1111                1


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ....  ...|...+..+.+|+.+||+.||++|||++|+++|  .|++
T Consensus       225 ~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--pw~k  267 (275)
T 3hyh_A          225 SNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD--DWFK  267 (275)
T ss_dssp             HHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC--HHHH
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC--cccc
Confidence            1111  11233345568999999999999999999999986  4554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.2e-46  Score=379.99  Aligned_cols=236  Identities=23%  Similarity=0.367  Sum_probs=185.7

Q ss_pred             ceEEEeee-----CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |+||+++.     +++.||||.++.         .+.+|+++|++++|||||++++++.+++..||||||++||+|.+++
T Consensus        38 g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l  117 (304)
T 3ubd_A           38 GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL  117 (304)
T ss_dssp             CEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHH
T ss_pred             eEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHH
Confidence            89999975     467899998853         3568999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .+..  .+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+|+......   ......+||
T Consensus       118 ~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GT  189 (304)
T 3ubd_A          118 SKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---KKAYSFCGT  189 (304)
T ss_dssp             HHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--------CCCCSCCCC
T ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC---ccccccccC
Confidence            7654  3999999999999999999999955   9999999999999999999999999998654322   123446899


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|||||++.+..++.++|||||||++|||+||+.||...+... .                 +..+....  ...|...
T Consensus       190 ~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~-----------------~~~i~~~~--~~~p~~~  249 (304)
T 3ubd_A          190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-T-----------------MTMILKAK--LGMPQFL  249 (304)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H-----------------HHHHHHCC--CCCCTTS
T ss_pred             cccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-H-----------------HHHHHcCC--CCCCCcC
Confidence            99999999999999999999999999999999999986433221 1                 11111111  1223344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHHHHhhcccccc
Q 042486          588 AILVIRLIESCLKKDPSGRPAM-----DKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~~~~~s~~w~~  628 (635)
                      +..+.+|+.+||+.||++|||+     +|+++|  .++ ..++|+.
T Consensus       250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H--p~f-~~idw~~  292 (304)
T 3ubd_A          250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH--SFF-STIDWNK  292 (304)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS--GGG-TTCCHHH
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC--ccc-cCCCHHH
Confidence            5668999999999999999984     566655  344 3467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.1e-44  Score=366.25  Aligned_cols=245  Identities=24%  Similarity=0.399  Sum_probs=176.8

Q ss_pred             CCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCC----------
Q 042486          354 FNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGG----------  409 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~----------  409 (635)
                      |.....||    |.||+++.  +++.||||+++.        .+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            44444554    89999987  689999998853        2568999999999999999999987543          


Q ss_pred             --eeEEEeecccCCCcchhhcccCC-CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          410 --NWYLVYENAVNGSLSVWINDKGG-KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       410 --~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                        ..|+||||+++|+|.+++..... ...++..++.|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence              36999999999999999965432 23567778899999999999999954   9999999999999999999999999


Q ss_pred             CcccccccCCce---------eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHh
Q 042486          487 LARPAERQEGEF---------ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV  557 (635)
Q Consensus       487 ~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~  557 (635)
                      +|+.........         ......+||+.|||||++.+..++.++|||||||++|||++   ||....+....+.  
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~--  238 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT--  238 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH--
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH--
Confidence            998765432111         11233579999999999999999999999999999999996   5532111111111  


Q ss_pred             hhcccccCCchhhhhhhcCCcCCCCCCh---HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          558 LNPVLHKEDGEESLRHLMDPSMQGNYPP---VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       558 ~~~~~~~~~~~~~l~~~~d~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                                     .+.+    ...|+   .....+.+|+.+||+.||++|||+.|++++  .++ ..++|..
T Consensus       239 ---------------~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~-~~~~~p~  290 (299)
T 4g31_A          239 ---------------DVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVF-EDLDFPG  290 (299)
T ss_dssp             ---------------HHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGG-CCC----
T ss_pred             ---------------HHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--Hhh-CCCCCCC
Confidence                           1111    11121   223446789999999999999999999885  344 3456643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.3e-42  Score=360.21  Aligned_cols=258  Identities=19%  Similarity=0.247  Sum_probs=189.3

Q ss_pred             hhcCCCCCCccc----ceEEEeee-----CCcEEEEEEeccC-----hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          350 ATDDFNPSCWIK----GSVYRGKI-----GGDFVAIKKVYGD-----ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~-----~~~~vavK~~~~~-----~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ..+.|.....||    |+||+++.     .++.||||++...     +.+|+++|+++ +||||+++++++.+++..|+|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            345666666676    89999975     3678999988643     56899999998 699999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAER  493 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~  493 (635)
                      |||+++|+|.+++..     +++.++..++.||+.||+|||+.+   |+||||||+|||++.+ +.+||+|||+|+....
T Consensus        99 mE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           99 MPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999999842     899999999999999999999955   9999999999999877 7999999999975432


Q ss_pred             cCCc-------------------------eeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 042486          494 QEGE-------------------------FALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALY  547 (635)
Q Consensus       494 ~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~  547 (635)
                      ....                         .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            2110                         0112335799999999998765 5899999999999999999999998655


Q ss_pred             cchhhHHHHhhhcc---------------------cccCCchhhhhhhcC-----CcC---------CCCCChHHHHHHH
Q 042486          548 SEENMLLVDVLNPV---------------------LHKEDGEESLRHLMD-----PSM---------QGNYPPVTAILVI  592 (635)
Q Consensus       548 ~~~~~~l~~~~~~~---------------------~~~~~~~~~l~~~~d-----~~~---------~~~~~~~~~~~l~  592 (635)
                      .++...+.....-.                     ....+.......+..     +..         ........+....
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            44332222111100                     000000010000000     000         0011122345578


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +|+.+||+.||++|||++|+++|
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHCcCChhHCcCHHHHhcC
Confidence            99999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=364.54  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=184.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec------CCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN------GGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~lV~E~~~~gsL~  424 (635)
                      |.||+|+.  +|+.||||+++..         +.+|+++|++++|||||++++++..      .+..||||||++ |+|.
T Consensus        68 G~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~  146 (398)
T 4b99_A           68 GVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLH  146 (398)
T ss_dssp             CEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHH
Confidence            89999987  7999999999642         4579999999999999999999764      356899999995 6799


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-ceeeecc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-EFALTSH  503 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~  503 (635)
                      +++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... .......
T Consensus       147 ~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~  221 (398)
T 4b99_A          147 QIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE  221 (398)
T ss_dssp             HHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCS
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCcccccccccc
Confidence            9996543  4999999999999999999999955   99999999999999999999999999986543211 1122345


Q ss_pred             cccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-------hhhhhhhc
Q 042486          504 IVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-------EESLRHLM  575 (635)
Q Consensus       504 ~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~  575 (635)
                      .+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.... +..... .......       ........
T Consensus       222 ~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~-~~g~p~~~~~~~~~~~~~~~~~  299 (398)
T 4b99_A          222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMM-VLGTPSPAVIQAVGAERVRAYI  299 (398)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHH-HHCCCCGGGTC-----CHHHHH
T ss_pred             ceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHH-hcCCCChHHhhhhhhhhhhhhh
Confidence            7899999999998764 569999999999999999999999875443321 111111 1100000       00000000


Q ss_pred             CCcC-CCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          576 DPSM-QGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       576 d~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      .... ....+     +..+..+.+||.+||..||++|||++|+++|  .++.
T Consensus       300 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~  349 (398)
T 4b99_A          300 QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH--PFLA  349 (398)
T ss_dssp             HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGT
T ss_pred             hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--HhhC
Confidence            0000 00000     1124558899999999999999999999987  4444

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.4e-41  Score=350.00  Aligned_cols=277  Identities=33%  Similarity=0.639  Sum_probs=229.8

Q ss_pred             cccccccHHHHHHhhcCCCCCCccc----ceEEEeee-CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEE
Q 042486          337 QSLKVYTFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLG  403 (635)
Q Consensus       337 ~~~~~~~~~el~~at~~f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~  403 (635)
                      ...+.++++++..++++|.....||    |.||+|+. +++.||||++..        .+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            3456789999999999999998887    89999997 688999999864        3568999999999999999999


Q ss_pred             EEecCCeeEEEeecccCCCcchhhcccC--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEE
Q 042486          404 ICFNGGNWYLVYENAVNGSLSVWINDKG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK  481 (635)
Q Consensus       404 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  481 (635)
                      ++.+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+...++|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999996543  34599999999999999999999996333699999999999999999999


Q ss_pred             EeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC---cchhhHHHHhh
Q 042486          482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALY---SEENMLLVDVL  558 (635)
Q Consensus       482 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~---~~~~~~l~~~~  558 (635)
                      |+|||+++.......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...   ........++.
T Consensus       175 l~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             ECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             eccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999986643322  2234456999999999998888999999999999999999999998532   11222233343


Q ss_pred             hcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          559 NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       559 ~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      ......    ..+..+.+.......+...+..+.+++.+||+.||++|||+.||+++|+..
T Consensus       253 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          253 KGLLKE----KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTTSS----CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHhhc----hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            333222    234455666666778888899999999999999999999999999999853

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.3e-41  Score=348.94  Aligned_cols=276  Identities=28%  Similarity=0.503  Sum_probs=222.2

Q ss_pred             cccHHHHHHhhcCCCCCCccc----ceEEEeee-CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecC
Q 042486          341 VYTFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNG  408 (635)
Q Consensus       341 ~~~~~el~~at~~f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~  408 (635)
                      .+.+.++..++++|.....||    |.||+|+. +++.||||++..       .+.+|++++++++||||+++++++.++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            455567778889999888887    89999998 688999998854       256899999999999999999999999


Q ss_pred             CeeEEEeecccCCCcchhhcccC--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          409 GNWYLVYENAVNGSLSVWINDKG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                      +..++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999996543  234899999999999999999999954   9999999999999999999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh-hHHHHhhhcccccC
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN-MLLVDVLNPVLHKE  565 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~  565 (635)
                      +++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.....   
T Consensus       185 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  260 (321)
T 2qkw_B          185 ISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH---  260 (321)
T ss_dssp             TCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH---
T ss_pred             ccccccccccc-ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc---
Confidence            99764432211 12233568999999999998899999999999999999999999986433221 11112211111   


Q ss_pred             CchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       566 ~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                       ....+...+++......+...+..+.+++.+||+.||++|||+.|++++|+.++....
T Consensus       261 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          261 -NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             -TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             -ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence             1122334556666667778889999999999999999999999999999999886543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-39  Score=336.77  Aligned_cols=273  Identities=34%  Similarity=0.592  Sum_probs=219.3

Q ss_pred             cccccHHHHHHhhcCCCCC------Cccc----ceEEEeeeCCcEEEEEEecc-----------ChHHHHHHHhhhccCC
Q 042486          339 LKVYTFEELQAATDDFNPS------CWIK----GSVYRGKIGGDFVAIKKVYG-----------DASDQIKLLNKINHSS  397 (635)
Q Consensus       339 ~~~~~~~el~~at~~f~~~------~~ig----g~Vy~g~~~~~~vavK~~~~-----------~~~~E~~~l~~l~h~n  397 (635)
                      ...|+++++..++++|+..      ..||    |.||+|+.+++.||||++..           .+.+|++++++++|||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            4678999999999999987      6666    89999999999999999853           2457999999999999


Q ss_pred             cccEEEEEecCCeeEEEeecccCCCcchhhccc-CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC
Q 042486          398 LIRLLGICFNGGNWYLVYENAVNGSLSVWINDK-GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT  476 (635)
Q Consensus       398 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~  476 (635)
                      |+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence            999999999999999999999999999999542 2345999999999999999999999955   999999999999999


Q ss_pred             CCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 042486          477 DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD  556 (635)
Q Consensus       477 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~  556 (635)
                      ++.+||+|||+++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ....
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~  245 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD  245 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred             CCcEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence            999999999999865443221 22344579999999998865 58899999999999999999999986533321 1111


Q ss_pred             hhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       557 ~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      +......   ....+...+++.+ ...+...+..+.+++.+||+.||++||+++|++++|+++..
T Consensus       246 ~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIED---EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHT---TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhh---hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1111100   1122334444443 34566778889999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-40  Score=371.04  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHH---HHHHHhhhccCCcccEEEEEecCCeeE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASD---QIKLLNKINHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~  412 (635)
                      ++|.....||    |.||+++.  +|+.||||++...          ..+   ++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5676666776    89999988  7899999998532          123   356677789999999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      |||||++||+|.+++...+.  +++..+..++.||+.||+|||+.+   ||||||||+||||+.+|.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999976543  999999999999999999999955   9999999999999999999999999998654


Q ss_pred             ccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      ...     ....+||+.|||||++.. ..|+.++|+|||||++|||++|+.||.........               +..
T Consensus       344 ~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---------------~i~  403 (689)
T 3v5w_A          344 KKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------------EID  403 (689)
T ss_dssp             SCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---------------HHH
T ss_pred             CCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---------------HHH
Confidence            322     344689999999999974 57999999999999999999999998643222110               111


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHHHHhhcccccc
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-----MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~~~s~~w~~  628 (635)
                      .......  ..+|...+..+.+||.+||+.||++|++     ++||++|  .++ ..++|+.
T Consensus       404 ~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H--pfF-~~idW~~  460 (689)
T 3v5w_A          404 RMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES--PFF-RSLDWQM  460 (689)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS--GGG-TTCCHHH
T ss_pred             HhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC--ccc-cCCCHHH
Confidence            1111111  1234445566899999999999999998     6777766  333 4467754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-40  Score=369.21  Aligned_cols=239  Identities=21%  Similarity=0.257  Sum_probs=191.9

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeeccc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV  419 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~  419 (635)
                      +|.....||    |.||+++.  +|+.||||.+..       .+.+|+++|++++|||||++++++.+++..||||||++
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            444444554    89999987  789999998854       25679999999999999999999999999999999999


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC--CcEEEeeecCcccccccCCc
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD--FRAKIANFALARPAERQEGE  497 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      ||+|.+++..... .+++.++..++.||+.||+|||+.+   |+||||||+|||++.+  +.+||+|||+++......  
T Consensus       238 gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          238 GGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            9999999965432 3899999999999999999999955   9999999999999754  899999999998765432  


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                        .....+||+.|||||++.+..++.++|||||||++|||++|+.||........ +.......+               
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~---------------  373 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDW---------------  373 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCC---------------
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCC---------------
Confidence              23346899999999999999999999999999999999999999864433221 111111000               


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+........+..+.+||.+||+.||++|||+.|+++|
T Consensus       374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01111112234558899999999999999999999886

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-40  Score=340.26  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=192.6

Q ss_pred             cCCCCCCccc----ceEEEeeeCCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecc
Q 042486          352 DDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA  418 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~  418 (635)
                      ++|.....||    |.||+++.+++.||||.+...         +.+|+++|++++||||+++++++.+.+..++||||+
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL  116 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred             hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence            4454445555    899999999999999998542         457999999999999999999999999999999999


Q ss_pred             cCCCcchhhcccCC-CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          419 VNGSLSVWINDKGG-KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       419 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      ++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++.+||+|||+++......  
T Consensus       117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--  193 (309)
T 3p86_A          117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--  193 (309)
T ss_dssp             TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred             CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence            99999999965431 24899999999999999999999854 449999999999999999999999999997543321  


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                       .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ..                ....
T Consensus       194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--~~----------------~~~~  254 (309)
T 3p86_A          194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AA----------------VGFK  254 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--HH----------------HHHS
T ss_pred             -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH----------------HHhc
Confidence             1223457999999999999999999999999999999999999998644332211  00                0000


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccc
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA  625 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~  625 (635)
                      ......+...+..+.+++.+||+.||++|||+.|+++.|+.++.....
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            111123334455689999999999999999999999999999876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=340.23  Aligned_cols=242  Identities=24%  Similarity=0.390  Sum_probs=192.6

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+.     .+..||||+++..        +.+|+.+|++++||||+++++++.+++..++||||+++|+|.+++.
T Consensus        63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  142 (325)
T 3kul_A           63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR  142 (325)
T ss_dssp             EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHH
Confidence            89999997     2446999998753        5679999999999999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .... .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++................+|.
T Consensus       143 ~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~  218 (325)
T 3kul_A          143 THDG-QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI  218 (325)
T ss_dssp             TTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCG
T ss_pred             hccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcc
Confidence            5432 3999999999999999999999955   99999999999999999999999999987654433222333445678


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+                .. ......+...
T Consensus       219 ~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~----------------~~-~~~~~~~~~~  279 (325)
T 3kul_A          219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSV----------------EE-GYRLPAPMGC  279 (325)
T ss_dssp             GGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHH----------------HT-TCCCCCCTTC
T ss_pred             cccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH----------------Hc-CCCCCCCCCc
Confidence            8999999998899999999999999999999 998875433221  11111                00 1111223344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAW  626 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w  626 (635)
                      +..+.+++.+||+.||++||++.|+++.|+.++.....-
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~  318 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL  318 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence            556899999999999999999999999999998765443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.8e-39  Score=336.76  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=193.2

Q ss_pred             ceEEEeeeCCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCC----eeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGG----NWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+..++.||||++...      ...|+.++++++||||+++++++.+..    ..++||||+++|+|.+++....
T Consensus        38 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  117 (322)
T 3soc_A           38 GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV  117 (322)
T ss_dssp             CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC
T ss_pred             eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC
Confidence            899999999999999998653      345888899999999999999998643    4699999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccC-------CCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSF-------TNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~-------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                         +++..++.++.|++.||.|||+.       ..++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus       118 ---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~  193 (322)
T 3soc_A          118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA-GDTHGQ  193 (322)
T ss_dssp             ---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCC-CCCTTC
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCc-cccccC
Confidence               89999999999999999999985       0115999999999999999999999999999765433221 122335


Q ss_pred             ccCCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          505 VGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      .||+.|+|||++.+     ..++.++|||||||++|||++|+.||.............  ....................
T Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  271 (322)
T 3soc_A          194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE--EIGQHPSLEDMQEVVVHKKK  271 (322)
T ss_dssp             CCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH--HHCSSCCHHHHHHHHTTSCC
T ss_pred             ccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh--hhccCCchhhhhhhhhcccC
Confidence            79999999999876     356678999999999999999999986543321110000  00001111111111122222


Q ss_pred             CCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          580 QGNY-----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       580 ~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      ....     ....+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            2111     223456699999999999999999999999999998754

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=1.4e-38  Score=305.99  Aligned_cols=177  Identities=21%  Similarity=0.337  Sum_probs=160.0

Q ss_pred             CCcc-eeeeeecCCCCCCHHHHHHHhCCCh--------HhHhhhc-CCCCCcccCCCcEEEEeeccccCCC-CceeeeEE
Q 042486           54 RSCL-AFLIFRSKPPFNTVASISTLLASKP--------SQLSKIN-SVSETATFETNQMVIVPVNCSCSGK-HYQANTTY  122 (635)
Q Consensus        54 ~~c~-~~~~y~~~~~g~tl~~Ia~~~~~~~--------~~i~~~N-~~~~~~~~~~gq~l~ip~~~~c~~~-~~~~~~~y  122 (635)
                      .+|+ +|+.|+|++ ||||+.||++||+++        ++|+++| ++.+.+.|.+||.|.||.+|.|.++ +.++..+|
T Consensus         3 ~~C~~a~~~Y~V~~-GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y   81 (212)
T 4eby_A            3 TSCPLALASYYLEN-GTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSY   81 (212)
T ss_dssp             CCCSCEEEEEECCT-TCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEEE
T ss_pred             CCCccceEEEEeCC-CCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceEE
Confidence            3799 999999999 999999999999999        9999999 9977889999999999999999854 56677899


Q ss_pred             EEecCCchhhhhhhhcCCCccHHHHHhhc-CCCCCCCCCcEEEEeeeccCCCCCCCCCCeeeEEEEEeecCChHHhHHHH
Q 042486          123 FVQNGDTYFLIANNTFQGLSTCQALQDQH-GNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKR  201 (635)
Q Consensus       123 ~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~  201 (635)
                      +|++|||||.||+++|+||+++++|+++| .+++.|.+||+|.||.+|+|+.. +.+.+.....+|+|++|||||.||++
T Consensus        82 ~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~~~~Y~V~~GDTL~~IA~~  160 (212)
T 4eby_A           82 SVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDE-SVSKDFGLFVTYPLRPEDSLSSIARS  160 (212)
T ss_dssp             ECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCT-TTCSSCCCEEEEECCTTCCHHHHHHH
T ss_pred             EecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCc-ccccCCCCeEEEEECCCCcHHHHHHH
Confidence            99999999999977999999999999999 88889999999999999999864 45556677789999999999999999


Q ss_pred             hCCChhHHHHhcCCCCCCCCcccceecccCCCCC
Q 042486          202 FGVDTDRTLEANGLSEGAPNIYPFTTLLVPLENP  235 (635)
Q Consensus       202 ~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~~  235 (635)
                      ||+++++|++||++..  +.+.+|+ |+||....
T Consensus       161 fgvsv~~L~~~N~~~~--~~~~~g~-l~IP~~~~  191 (212)
T 4eby_A          161 SGVSADILQRYNPGVN--FNSGNGI-VYVPGRDP  191 (212)
T ss_dssp             HTSCHHHHHHHSTTCC--TTSCSSE-EEEECCCT
T ss_pred             HCcCHHHHHHhcCCCc--cCCCCCE-EEecCCCC
Confidence            9999999999999864  2577776 99998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.4e-39  Score=330.21  Aligned_cols=238  Identities=22%  Similarity=0.359  Sum_probs=193.5

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecc
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA  418 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~  418 (635)
                      +.|.....||    |.||+++.  +++.||||++..       .+.+|+.++++++||||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            4555555665    89999986  789999998843       2568999999999999999999999999999999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      ++|+|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........  
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A          100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            999999999654   3899999999999999999999955   99999999999999999999999999876543322  


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....                ..
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~----------------~~  233 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN----------------GT  233 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHH----------------CS
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhC----------------CC
Confidence             2334579999999999999999999999999999999999999986433222111 10000                00


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+...+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0111233445668999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.3e-39  Score=340.75  Aligned_cols=239  Identities=26%  Similarity=0.440  Sum_probs=192.6

Q ss_pred             ceEEEeee---------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKI---------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~---------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++.         ++..||||.++.+        +.+|+++|+++ +||||+++++++.+++..|+||||+++|+|
T Consensus        95 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  174 (370)
T 2psq_A           95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  174 (370)
T ss_dssp             SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCH
Confidence            89999985         2357999998653        55799999999 899999999999999999999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       175 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  251 (370)
T 2psq_A          175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR  251 (370)
T ss_dssp             HHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             HHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCc
Confidence            99996532              134899999999999999999999955   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  +...+          
T Consensus       252 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~~~~~----------  318 (370)
T 2psq_A          252 DINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLL----------  318 (370)
T ss_dssp             ETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHH----------
T ss_pred             ccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----------
Confidence            65432211 12233457789999999999999999999999999999999 888875432221  11110          


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                            . .......+...+..+.+++.+||+.||++||++.|+++.|++++...
T Consensus       319 ------~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          319 ------K-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             ------H-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                  0 11111233344556999999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.7e-39  Score=342.04  Aligned_cols=249  Identities=21%  Similarity=0.375  Sum_probs=186.7

Q ss_pred             cCCCCCCccc----ceEEEeeeC-----CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKIG-----GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~~-----~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.....||    |.||+|+..     +..||||.++.        ++.+|+.+|++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            3555566665    899999863     56799999864        356899999999999999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999997543 34899999999999999999999954   999999999999999999999999999866543


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |+.||.......  ....+.              
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~--------------  264 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVD--------------  264 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHH--------------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH--------------
Confidence            222122223345778999999999999999999999999999998 998875432221  111111              


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                         .......+...+..+.+++.+||+.||++||++.||++.|++++...
T Consensus       265 ---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 ---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ---TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ---cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence               11111223334556899999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=329.74  Aligned_cols=241  Identities=22%  Similarity=0.424  Sum_probs=191.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||+|++..       .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++.... 
T Consensus        24 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  102 (310)
T 3s95_A           24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-  102 (310)
T ss_dssp             EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-
Confidence            89999998  588999998854       35689999999999999999999999999999999999999999997643 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-----------eee
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-----------ALT  501 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-----------~~~  501 (635)
                      ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.........           ...
T Consensus       103 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (310)
T 3s95_A          103 SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR  179 (310)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccc
Confidence            34899999999999999999999955   9999999999999999999999999998654332110           011


Q ss_pred             cccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCC
Q 042486          502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG  581 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~  581 (635)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........             ........+.....
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~  246 (310)
T 3s95_A          180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------------GLNVRGFLDRYCPP  246 (310)
T ss_dssp             CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------------SBCHHHHHHHTCCT
T ss_pred             cccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------------hhhhhccccccCCC
Confidence            14579999999999999999999999999999999999998875432211100             00011111111112


Q ss_pred             CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       582 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .    .+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       247 ~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          247 N----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             T----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            2    2334889999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.1e-39  Score=331.79  Aligned_cols=254  Identities=22%  Similarity=0.366  Sum_probs=191.0

Q ss_pred             ceEEEeee------CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI------GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||++++      +++.||||++...       +.+|++++++++||||+++++++...  ...++||||+++|+|.++
T Consensus        24 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  103 (295)
T 3ugc_A           24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY  103 (295)
T ss_dssp             EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHH
T ss_pred             EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHH
Confidence            89999984      6789999998653       56899999999999999999999753  458999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +.... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++................+
T Consensus       104 l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  179 (295)
T 3ugc_A          104 LQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES  179 (295)
T ss_dssp             HHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTC
T ss_pred             HHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCC
Confidence            96543 23899999999999999999999954   999999999999999999999999999876543322223334557


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      +..|+|||.+.+..++.++||||||+++|||++|..|+.....+..   ...............+...+........+..
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T 3ugc_A          180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMIVFHLIELLKNNGRLPRPDG  256 (295)
T ss_dssp             GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH---HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTT
T ss_pred             ccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH---hhhcCccccchhHHHHHHHHhccCcCCCCcC
Confidence            7889999999999999999999999999999999988754322111   1111000000001111111222222233445


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       257 ~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          257 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            566799999999999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-39  Score=325.29  Aligned_cols=237  Identities=24%  Similarity=0.424  Sum_probs=193.1

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+++. +++.||+|++...      +.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..
T Consensus        24 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~  102 (269)
T 4hcu_A           24 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GL  102 (269)
T ss_dssp             CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TC
T ss_pred             cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cc
Confidence            89999998 7889999998653      5689999999999999999999999999999999999999999996543 34


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......  .......++..|+|||
T Consensus       103 ~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE  177 (269)
T 4hcu_A          103 FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPE  177 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH--HSTTSTTCCGGGCCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc--ccccCcccccccCCHH
Confidence            899999999999999999999955   99999999999999999999999999976543211  1122345677899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.||.......  ....                +.. ......+...+..+.+
T Consensus       178 ~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~----------------~~~-~~~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          178 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVED----------------IST-GFRLYKPRLASTHVYQ  238 (269)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH----------------HHT-TCCCCCCTTSCHHHHH
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHH----------------Hhc-CccCCCCCcCCHHHHH
Confidence            9998899999999999999999999 888875433221  1111                110 0111222333456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ++.+||+.||++||++.|++++|+++.++.
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~l~~l~~~g  268 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQLAEIAESG  268 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence            999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-38  Score=330.89  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=199.7

Q ss_pred             ccccHHHHHHhhcCC----------CCCCccc----ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccC
Q 042486          340 KVYTFEELQAATDDF----------NPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHS  396 (635)
Q Consensus       340 ~~~~~~el~~at~~f----------~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~  396 (635)
                      ..++++++..+++..          .....||    |.||+|+.  +|+.||||++..       .+.+|+.++++++|+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            567888888888753          2233454    89999987  689999999853       256899999999999


Q ss_pred             CcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC
Q 042486          397 SLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT  476 (635)
Q Consensus       397 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~  476 (635)
                      ||+++++++...+..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            9999999999999999999999999999998643   3899999999999999999999954   999999999999999


Q ss_pred             CCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHH
Q 042486          477 DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVD  556 (635)
Q Consensus       477 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~  556 (635)
                      ++.+||+|||++........   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ...
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~  251 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK  251 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH
T ss_pred             CCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence            99999999999876543221   1234579999999999999999999999999999999999999986433221  111


Q ss_pred             hhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       557 ~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+             .....+..  ..+...+..+.+++.+||+.||++|||++|++++
T Consensus       252 ~~-------------~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 RL-------------RDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH-------------HHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH-------------hcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11             11111111  1122334568999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.5e-39  Score=339.30  Aligned_cols=260  Identities=24%  Similarity=0.388  Sum_probs=202.7

Q ss_pred             ccHHHHHHhhcCCCCCCccc----ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccE
Q 042486          342 YTFEELQAATDDFNPSCWIK----GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRL  401 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l  401 (635)
                      +...+.....++|.....||    |.||++++       +++.||||+++..        +.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            33444444556666666665    89999974       4578999999652        56899999999 89999999


Q ss_pred             EEEEecCCe-eEEEeecccCCCcchhhcccCC------------------------------------------------
Q 042486          402 LGICFNGGN-WYLVYENAVNGSLSVWINDKGG------------------------------------------------  432 (635)
Q Consensus       402 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------  432 (635)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987554 8999999999999999965432                                                


Q ss_pred             ----------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          433 ----------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       433 ----------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                                      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            12899999999999999999999955   99999999999999999999999999986544322


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                      . .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.......... ....                
T Consensus       249 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~----------------  310 (359)
T 3vhe_A          249 Y-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RRLK----------------  310 (359)
T ss_dssp             C-EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HHHH----------------
T ss_pred             c-hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-HHHH----------------
Confidence            1 23344678899999999999999999999999999999998 998886433222111 1110                


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                       .......+...+..+.+++.+||+.||++|||+.|++++|++++.+.
T Consensus       311 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          311 -EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence             01111223334456899999999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.7e-39  Score=323.68  Aligned_cols=232  Identities=29%  Similarity=0.465  Sum_probs=181.8

Q ss_pred             ceEEEeeeCCcEEEEEEecc-----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++..++.||||.++.           .+.+|++++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus        21 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  100 (271)
T 3dtc_A           21 GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK  100 (271)
T ss_dssp             EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS
T ss_pred             eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC
Confidence            89999999999999998753           2457999999999999999999999999999999999999999998643


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC--------CCcEEEeeecCcccccccCCceeeec
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT--------DFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                         .+++..++.++.|++.||.|||+.+..+++||||||+||+++.        ++.+||+|||++.......     ..
T Consensus       101 ---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~  172 (271)
T 3dtc_A          101 ---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KM  172 (271)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-----cc
Confidence               3899999999999999999999965334999999999999986        7789999999997654322     12


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........                  ..........
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------------~~~~~~~~~~  234 (271)
T 3dtc_A          173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------------------GVAMNKLALP  234 (271)
T ss_dssp             ---CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------------HHHTSCCCCC
T ss_pred             CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------------hhhcCCCCCC
Confidence            3568999999999999899999999999999999999999986433322111                  1111111222


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .+...+..+.+++.+||+.||++|||+.|++++|+++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            3334456689999999999999999999999999854

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-38  Score=322.28  Aligned_cols=233  Identities=22%  Similarity=0.388  Sum_probs=190.7

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+..++.||||.++.         .+.+|+.++++++||||+++++++.+.  +..++||||+++|+|.+++...
T Consensus        24 g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  103 (271)
T 3kmu_A           24 GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG  103 (271)
T ss_dssp             EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred             ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence            89999999999999999864         256799999999999999999999876  7789999999999999999776


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.++|+|||++.....        ....||+.|
T Consensus       104 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--------~~~~~t~~y  174 (271)
T 3kmu_A          104 TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAPAW  174 (271)
T ss_dssp             SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--------TTCBSCGGG
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--------cCccCCccc
Confidence            5556999999999999999999999854 5599999999999999999999999998764332        224689999


Q ss_pred             cCccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          511 MAPEYLENGLVST---KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       511 ~aPE~~~~~~~s~---ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +|||.+.+...+.   ++||||||+++|||++|+.||.........                  ............+...
T Consensus       175 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~  236 (271)
T 3kmu_A          175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------------------MKVALEGLRPTIPPGI  236 (271)
T ss_dssp             SCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------------------HHHHHSCCCCCCCTTC
T ss_pred             cChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------------------HHHHhcCCCCCCCCCC
Confidence            9999998765444   799999999999999999998643322211                  1111111112233344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      +..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            5568999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.5e-39  Score=342.12  Aligned_cols=237  Identities=25%  Similarity=0.438  Sum_probs=191.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|++  +++.||||.++.        ++.+|+++|++++||||+++++++.+++..++||||+++|+|.+++....
T Consensus       128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  207 (377)
T 3cbl_A          128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG  207 (377)
T ss_dssp             EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG
T ss_pred             CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC
Confidence            89999998  688999999864        35689999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++....... ........++..|+
T Consensus       208 -~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~-~~~~~~~~~~~~y~  282 (377)
T 3cbl_A          208 -ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVKWT  282 (377)
T ss_dssp             -GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE-ECCSSCCEEEGGGS
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce-eecCCCCCCCcCcC
Confidence             23899999999999999999999955   99999999999999999999999999975432210 00111223567899


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      |||.+.++.++.++||||||+++|||++ |+.|+.......  ..+.+                 ........+...+..
T Consensus       283 aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~-----------------~~~~~~~~~~~~~~~  343 (377)
T 3cbl_A          283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFV-----------------EKGGRLPCPELCPDA  343 (377)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHH-----------------HTTCCCCCCTTCCHH
T ss_pred             CHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-----------------HcCCCCCCCCCCCHH
Confidence            9999998899999999999999999998 888875433221  11111                 111111223334556


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +.+|+.+||+.||++|||++++++.|+++...
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            89999999999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-38  Score=345.70  Aligned_cols=235  Identities=26%  Similarity=0.437  Sum_probs=193.3

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEecCC-eeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFNGG-NWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||+|++.++.||||.++.+     +.+|+++|++++||||+++++++.+.+ ..++||||+++|+|.+++.......+
T Consensus       207 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~  286 (450)
T 1k9a_A          207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL  286 (450)
T ss_dssp             EEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTC
T ss_pred             eeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCC
Confidence            899999999999999999753     678999999999999999999987665 78999999999999999976655558


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      ++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......      ....++..|+|||.
T Consensus       287 ~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~~y~aPE~  357 (450)
T 1k9a_A          287 GGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEA  357 (450)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------------CCCTTTSCHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc------cCCCCCcceeCHHH
Confidence            99999999999999999999955   9999999999999999999999999997543221      12357889999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      +.+..++.++||||||+++|||++ |+.||........                  ...+. .......+..++..+.+|
T Consensus       358 ~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------------------~~~i~-~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------------VPRVE-KGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             HHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH------------------HHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------------------HHHHH-cCCCCCCCCcCCHHHHHH
Confidence            999999999999999999999998 9988754322211                  00110 011122334455669999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +.+||+.||++|||+.|+++.|+.+....+
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            999999999999999999999999887543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-38  Score=327.52  Aligned_cols=252  Identities=23%  Similarity=0.413  Sum_probs=196.8

Q ss_pred             ceEEEeee------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||++++      +++.||||+++.        .+.+|++++++++|+||+++++++.+.  +..++||||+++|+|.+
T Consensus        35 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  114 (302)
T 4e5w_A           35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE  114 (302)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred             eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence            89999983      688999999864        256899999999999999999999876  56899999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++..... .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.................
T Consensus       115 ~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  190 (302)
T 4e5w_A          115 YLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD  190 (302)
T ss_dssp             HHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTT
T ss_pred             HHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCC
Confidence            9955432 3899999999999999999999955   99999999999999999999999999987655443333444567


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +|..|+|||.+.+..++.++||||||+++|||++|+.|+.....   .......+... ......+...+........+.
T Consensus       191 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  266 (302)
T 4e5w_A          191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA---LFLKMIGPTHG-QMTVTRLVNTLKEGKRLPCPP  266 (302)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCG-GGHHHHHHHHHHTTCCCCCCT
T ss_pred             CCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh---HHhhccCCccc-ccCHHHHHHHHhccCCCCCCC
Confidence            88899999999998999999999999999999999987532111   11111111111 111122222222222333445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ..+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus       267 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          267 NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            556679999999999999999999999999998863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-38  Score=323.89  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=188.2

Q ss_pred             CCCCCCccc----ceEEEeeeCCcEEEEEEeccC----hHHHHHHHhh--hccCCcccEEEEEec----CCeeEEEeecc
Q 042486          353 DFNPSCWIK----GSVYRGKIGGDFVAIKKVYGD----ASDQIKLLNK--INHSSLIRLLGICFN----GGNWYLVYENA  418 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~lV~E~~  418 (635)
                      +|.....||    |.||+|+.+++.||||++..+    +..|.+++..  ++||||+++++++..    .+..++||||+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~   88 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH   88 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             cEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence            344444444    899999999999999998754    3356666666  799999999999764    34579999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCC-----CCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT-----NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ++|+|.+++...   .+++..++.++.|++.||.|||...     .++|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  165 (301)
T 3q4u_A           89 EMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ  165 (301)
T ss_dssp             TTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence            999999999543   3899999999999999999999210     15599999999999999999999999999976544


Q ss_pred             cCCcee-eecccccCCCccCccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCCCCcchhhHHHH
Q 042486          494 QEGEFA-LTSHIVGTKGYMAPEYLENG------LVSTKLDVYAFGVLMLEMLSG----------KEAPALYSEENMLLVD  556 (635)
Q Consensus       494 ~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SlGvvl~elltG----------~~p~~~~~~~~~~l~~  556 (635)
                      ...... ......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||..........  
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~--  243 (301)
T 3q4u_A          166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF--  243 (301)
T ss_dssp             TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--
T ss_pred             ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch--
Confidence            332211 12334799999999999876      456799999999999999999          66664321111000  


Q ss_pred             hhhcccccCCchhhhhhhc-CCcCCCC-----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          557 VLNPVLHKEDGEESLRHLM-DPSMQGN-----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       557 ~~~~~~~~~~~~~~l~~~~-d~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                                  ....... .......     .+...+..+.+|+.+||+.||++|||+.|+++.|+++
T Consensus       244 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          244 ------------EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             ------------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                        1111110 0111111     1234677899999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-38  Score=326.37  Aligned_cols=244  Identities=23%  Similarity=0.361  Sum_probs=191.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+..          .+.+|+.++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~  104 (294)
T 4eqm_A           25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES  104 (294)
T ss_dssp             EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999986  688999998732          256799999999999999999999999999999999999999999966


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......  .......||+.
T Consensus       105 ~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~  177 (294)
T 4eqm_A          105 HG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQ  177 (294)
T ss_dssp             HC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---------------CCS
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc--cccCccccCcc
Confidence            54  3899999999999999999999955   99999999999999999999999999986543321  22334579999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||.................               +......+...+.
T Consensus       178 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~  242 (294)
T 4eqm_A          178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV---------------PNVTTDVRKDIPQ  242 (294)
T ss_dssp             SCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC---------------CCHHHHSCTTSCH
T ss_pred             ccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC---------------CCcchhcccCCCH
Confidence            9999999999999999999999999999999999865433221111110000               0000011222345


Q ss_pred             HHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHhhccccc
Q 042486          590 LVIRLIESCLKKDPSGRP-AMDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~s~~w~  627 (635)
                      .+.+++.+||+.||++|| +++++.+.|+.++.+....+
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~  281 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE  281 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence            689999999999999998 99999999999886654433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-38  Score=332.61  Aligned_cols=259  Identities=22%  Similarity=0.368  Sum_probs=196.9

Q ss_pred             ceEEEeee------CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEe--cCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI------GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICF--NGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||++++      +++.||||++...       +.+|++++++++|+||+++++++.  +.+..++||||+++++|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (327)
T 3lxl_A           37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF  116 (327)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHH
T ss_pred             eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHH
Confidence            89999984      6789999998653       568999999999999999999987  45568999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +..... .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++................+
T Consensus       117 l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  192 (327)
T 3lxl_A          117 LQRHRA-RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS  192 (327)
T ss_dssp             HHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCS
T ss_pred             HHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCc
Confidence            965332 3899999999999999999999954   999999999999999999999999999876544333333344568


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |..|+|||.+.+..++.++||||||+++|+|++|+.||.....+...   .... .........+...+........+..
T Consensus       193 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  268 (327)
T 3lxl_A          193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR---MMGC-ERDVPALSRLLELLEEGQRLPAPPA  268 (327)
T ss_dssp             CGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HCC-----CCHHHHHHHHHHTTCCCCCCTT
T ss_pred             cccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh---hccc-ccccccHHHHHHHhhcccCCCCCCc
Confidence            88899999999888999999999999999999999987543222111   0000 0001111222222233333344555


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                      .+..+.+++.+||+.||++|||++|++++|+.+......|+.
T Consensus       269 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          269 CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence            667799999999999999999999999999999887777655

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=335.42  Aligned_cols=244  Identities=27%  Similarity=0.422  Sum_probs=195.9

Q ss_pred             ceEEEeeeC---------CcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++..         +..||||+++.+        +.+|+++++++ +||||+++++++.+++..++||||+++|+|
T Consensus        83 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  162 (382)
T 3tt0_A           83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  162 (382)
T ss_dssp             EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcH
Confidence            899999862         257999998653        55899999999 999999999999999999999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~  239 (382)
T 3tt0_A          163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR  239 (382)
T ss_dssp             HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred             HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCccc
Confidence            99996543              234899999999999999999999954   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......+|..|+|||++.+..++.++||||||+++|||++ |+.||.......  ....+.         
T Consensus       240 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~~~~~~---------  307 (382)
T 3tt0_A          240 DIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLK---------  307 (382)
T ss_dssp             CSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH---------
T ss_pred             cccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---------
Confidence            66443211 22333567889999999999999999999999999999999 888875432221  111111         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                              .......+...+..+.+|+.+||+.||++|||++|++++|++++......+.
T Consensus       308 --------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          308 --------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             --------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             --------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence                    1111122333455689999999999999999999999999999977655443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-38  Score=326.10  Aligned_cols=238  Identities=24%  Similarity=0.400  Sum_probs=196.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+++.  ++..||+|.+..+      +.+|++++++++|+||+++++++.+++..++||||+++++|.+++......
T Consensus        27 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~  106 (288)
T 3kfa_A           27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ  106 (288)
T ss_dssp             CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTT
T ss_pred             eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccC
Confidence            89999998  4889999998653      568999999999999999999999999999999999999999999765556


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  .......+++.|+||
T Consensus       107 ~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          107 EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAP  181 (288)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS--EEETTEEECGGGCCH
T ss_pred             CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc--ccccCCccccCcCCh
Confidence            6999999999999999999999955   99999999999999999999999999986654321  223345678899999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      |.+.+..++.++||||||+++|+|++ |..||.......  ..+.             +.    .......+...+..+.
T Consensus       182 E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~-------------~~----~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL-------------LE----KDYRMERPEGCPEKVY  242 (288)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH-------------HH----TTCCCCCCTTCCHHHH
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-------------Hh----ccCCCCCCCCCCHHHH
Confidence            99998899999999999999999999 888875432221  1111             11    1111122333455689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +++.+||+.||++|||+.|+++.|+.++.++
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.7e-38  Score=322.64  Aligned_cols=236  Identities=24%  Similarity=0.390  Sum_probs=192.1

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+++. ++..||||+++..      +.+|++++++++|+||+++++++.+++..++||||+++++|.+++.... ..
T Consensus        38 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~  116 (283)
T 3gen_A           38 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HR  116 (283)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GC
T ss_pred             ceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cC
Confidence            89999998 5668999998653      5689999999999999999999999999999999999999999996533 23


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......  .......+|+.|+|||
T Consensus       117 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE  191 (283)
T 3gen_A          117 FQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPE  191 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH--HSTTSTTSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc--ccccCCccCcccCCHH
Confidence            899999999999999999999955   99999999999999999999999999976543211  1122345677899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.||.........  ..+             ..    ......+...+..+.+
T Consensus       192 ~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~--~~~-------------~~----~~~~~~~~~~~~~l~~  252 (283)
T 3gen_A          192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--EHI-------------AQ----GLRLYRPHLASEKVYT  252 (283)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHH-------------HT----TCCCCCCTTCCHHHHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH--HHH-------------hc----ccCCCCCCcCCHHHHH
Confidence            9998889999999999999999998 99888643332111  110             00    0111122233456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      ++.+||+.||++|||++|++++|++++++
T Consensus       253 li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          253 IMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.4e-38  Score=327.93  Aligned_cols=256  Identities=23%  Similarity=0.353  Sum_probs=198.9

Q ss_pred             ceEEEeee------CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecC--CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI------GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNG--GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~~gsL~~  425 (635)
                      |.||++.+      +++.||||+++.+        +.+|+++|++++||||+++++++.+.  ...++||||+++|+|.+
T Consensus        45 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (318)
T 3lxp_A           45 GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD  124 (318)
T ss_dssp             EEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHH
T ss_pred             eEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHH
Confidence            89988764      6789999999753        46899999999999999999999874  57899999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....   +++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.................
T Consensus       125 ~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  198 (318)
T 3lxp_A          125 YLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD  198 (318)
T ss_dssp             HGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CC
T ss_pred             HHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCC
Confidence            997643   899999999999999999999955   99999999999999999999999999987655433333344556


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +|..|+|||.+.+..++.++||||||+++|||++|+.||............+..    .......+...+........+.
T Consensus       199 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  274 (318)
T 3lxp_A          199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ----GQMTVLRLTELLERGERLPRPD  274 (318)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC----HHHHHHHHHHHHHTTCCCCCCT
T ss_pred             CCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc----cchhHHHHHHHHhcccCCCCCc
Confidence            888999999999988999999999999999999999987543222111111000    0001112222222333333445


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccccc
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~  627 (635)
                      ..+..+.+|+.+||+.||++|||++|+++.|+++.+......
T Consensus       275 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          275 KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            556679999999999999999999999999999987655443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=322.50  Aligned_cols=227  Identities=27%  Similarity=0.341  Sum_probs=181.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------------------------------ChHHHHHHHhhhccCCcccEEEEEe
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------------------------------DASDQIKLLNKINHSSLIRLLGICF  406 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------------------------------~~~~E~~~l~~l~h~nIv~l~~~~~  406 (635)
                      |.||+++.  +++.||||.+..                                 .+.+|+++|++++||||+++++++.
T Consensus        27 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  106 (298)
T 2zv2_A           27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLD  106 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            89999987  688999998743                                 2568999999999999999999998


Q ss_pred             c--CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          407 N--GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       407 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                      +  ++..++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus       107 ~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D  180 (298)
T 2zv2_A          107 DPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIAD  180 (298)
T ss_dssp             CSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred             cCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEec
Confidence            6  5678999999999999987653   24899999999999999999999955   99999999999999999999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcc
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL---VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV  561 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  561 (635)
                      ||+++......   .......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||.......  ....+.  
T Consensus       181 fg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~--  253 (298)
T 2zv2_A          181 FGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC--LHSKIK--  253 (298)
T ss_dssp             CTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH--
T ss_pred             CCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH--HHHHHh--
Confidence            99998654332   1233457999999999997654   4788999999999999999999986432211  111100  


Q ss_pred             cccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          562 LHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       562 ~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                    ............+..+.+++.+||+.||++||++.|++++
T Consensus       254 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          254 --------------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             --------------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             --------------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence                          0000001112234558999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-38  Score=329.99  Aligned_cols=234  Identities=21%  Similarity=0.330  Sum_probs=190.1

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      +|.....||    |.||+++.  +|+.||||++...         +.+|+++|++++||||+++++++...+..|+||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            444444444    89999997  7899999998542         45799999999999999999999999999999999


Q ss_pred             ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       418 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +++|+|.+++.....  +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        96 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  168 (328)
T 3fe3_A           96 ASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--  168 (328)
T ss_dssp             CTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence            999999999965543  899999999999999999999955   9999999999999999999999999997554322  


Q ss_pred             eeeecccccCCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                        ......||+.|+|||.+.+..+. .++|||||||++|||++|+.||........                  ...+..
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------------------~~~i~~  228 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------------------RERVLR  228 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------------HHHHHH
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------------------HHHHHh
Confidence              12346799999999999887764 899999999999999999999864332211                  111111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..  ...|...+..+.+|+.+||+.||.+|||++|++++
T Consensus       229 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 GK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11  11233345568999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7e-38  Score=321.76  Aligned_cols=243  Identities=16%  Similarity=0.136  Sum_probs=192.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|+.  +++.||||.+..     .+.+|+.+++++ +|+|++++++++.++...++||||+ +++|.+++.... .
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~  101 (298)
T 1csn_A           24 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-R  101 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-T
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc-c
Confidence            89999995  789999998853     467899999999 8999999999999999999999999 999999997543 3


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc-----EEEeeecCcccccccCCce----eeeccc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR-----AKIANFALARPAERQEGEF----ALTSHI  504 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~a~~~~~~~~~~----~~~~~~  504 (635)
                      .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.     +||+|||+++.........    ......
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  178 (298)
T 1csn_A          102 KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL  178 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCC
Confidence            4899999999999999999999854   999999999999987766     9999999998665432211    123446


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh-hHHHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN-MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......+.......    ...     ....  
T Consensus       179 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~-----~~~~--  247 (298)
T 1csn_A          179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----PLR-----ELCA--  247 (298)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS----CHH-----HHTT--
T ss_pred             CCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc----cHH-----HHHh--
Confidence            79999999999999899999999999999999999999987533211 11111110000000    000     0011  


Q ss_pred             ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       584 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                        ..+..+.+++.+||+.||++||++++|++.|++++..
T Consensus       248 --~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          248 --GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             --TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence              2234589999999999999999999999999999854

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3e-38  Score=319.68  Aligned_cols=235  Identities=28%  Similarity=0.458  Sum_probs=191.0

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+++. ++..||||.++..      +.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..
T Consensus        22 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~  100 (268)
T 3sxs_A           22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KG  100 (268)
T ss_dssp             EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GG
T ss_pred             ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-CC
Confidence            89999998 5568999998653      5689999999999999999999999999999999999999999996543 34


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  ........+|..|+|||
T Consensus       101 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE  175 (268)
T 3sxs_A          101 LEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAPE  175 (268)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--EEECCSCCCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh--hhcccCCCcCcccCCHH
Confidence            899999999999999999999955   9999999999999999999999999997654332  12223345677899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.||.......... ..                 .. ......+...+..+.+
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~-----------------~~-~~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-KV-----------------SQ-GHRLYRPHLASDTIYQ  236 (268)
T ss_dssp             HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HH-----------------HT-TCCCCCCTTSCHHHHH
T ss_pred             HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-HH-----------------Hc-CCCCCCCCcChHHHHH
Confidence            9998889999999999999999999 888876443322111 00                 00 0011112223456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ++.+||+.||++|||+.|++++|+.+..
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            9999999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-38  Score=350.13  Aligned_cols=238  Identities=24%  Similarity=0.410  Sum_probs=195.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|++  ++..||||.++.+      +.+|+.+|++++||||++++++|.+++..++||||+++|+|.+++......
T Consensus       234 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~  313 (495)
T 1opk_A          234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ  313 (495)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT
T ss_pred             eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcC
Confidence            89999998  4789999998753      568999999999999999999999999999999999999999999765555


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ........++..|+||
T Consensus       314 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aP  388 (495)
T 1opk_A          314 EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAP  388 (495)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--EECCTTCCCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc--eeecCCCcCCcceeCH
Confidence            6999999999999999999999955   9999999999999999999999999998654321  1222334567889999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI  592 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~  592 (635)
                      |.+.+..++.++||||||+++|||++ |+.||.......  ..+.                 +........+...+..+.
T Consensus       389 E~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~-----------------~~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL-----------------LEKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH-----------------HHTTCCCCCCTTCCHHHH
T ss_pred             hHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH-----------------HHcCCCCCCCCCCCHHHH
Confidence            99998899999999999999999999 888875432211  1111                 111112223344556689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          593 RLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       593 ~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +|+.+||+.||++|||+.||++.|+.++...
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             HHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999886543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-38  Score=328.52  Aligned_cols=231  Identities=25%  Similarity=0.288  Sum_probs=187.7

Q ss_pred             ceEEEeee--CCcEEEEEEec--------cChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVY--------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~--------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  +++.||||.+.        ..+.+|+.++++++|+||+++++++.+++..|+||||+++|+|.+++....
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  100 (323)
T 3tki_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI  100 (323)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT
T ss_pred             EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC
Confidence            89999987  68899999874        246789999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....... ........||+.|+
T Consensus       101 --~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~  174 (323)
T 3tki_A          101 --GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYV  174 (323)
T ss_dssp             --BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCSCCSCGGGS
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc-ccccCCCccCcCcc
Confidence              3899999999999999999999855   99999999999999999999999999976543221 12233467999999


Q ss_pred             CccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          512 APEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      |||++.+..+ +.++||||||+++|||++|+.||............+....                 .........+..
T Consensus       175 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~  237 (323)
T 3tki_A          175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-----------------TYLNPWKKIDSA  237 (323)
T ss_dssp             CHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-----------------TTSTTGGGSCHH
T ss_pred             CcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-----------------ccCCccccCCHH
Confidence            9999987665 7899999999999999999999875444322222221110                 001111233455


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+|+.+||+.||++|||++|++++
T Consensus       238 ~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          238 PLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhhC
Confidence            7899999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.8e-38  Score=327.07  Aligned_cols=241  Identities=24%  Similarity=0.413  Sum_probs=195.2

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.       +++.||||.++..        +.+|+.+++++ +||||+++++++.+++..++||||+++|+|.+
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  116 (313)
T 1t46_A           37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (313)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHH
Confidence            89999984       4578999998643        45899999999 99999999999999999999999999999999


Q ss_pred             hhcccCC----------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          426 WINDKGG----------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       426 ~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ++.....                ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  193 (313)
T 1t46_A          117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR  193 (313)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccc
Confidence            9965432                24899999999999999999999955   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......         
T Consensus       194 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~---------  262 (313)
T 1t46_A          194 DIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FYKMIK---------  262 (313)
T ss_dssp             CTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HHHHHH---------
T ss_pred             cccccccc-eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-HHHHhc---------
Confidence            76543321 22334567889999999998899999999999999999999 8888754332211 111111         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                          .    ......+...+..+.+++.+||+.||.+|||+.|++++|++++.++.
T Consensus       263 ----~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          263 ----E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             ----H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             ----c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence                1    11111223344568999999999999999999999999999998654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=332.94  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=197.4

Q ss_pred             hhcCCCCCCccc----ceEEEeeeCC-------cEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCe
Q 042486          350 ATDDFNPSCWIK----GSVYRGKIGG-------DFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGN  410 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~~~-------~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~  410 (635)
                      ..++|.....||    |.||+++..+       +.||||.++.+        +.+|+.++++++||||+++++++.+++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            345555555555    8999999843       78999998653        5679999999999999999999999999


Q ss_pred             eEEEeecccCCCcchhhcccC----------------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeeccc
Q 042486          411 WYLVYENAVNGSLSVWINDKG----------------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK  468 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dik  468 (635)
                      .++||||+++|+|.+++....                      ...+++.+++.++.||+.||.|||+.+   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            999999999999999996532                      145899999999999999999999955   9999999


Q ss_pred             CCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 042486          469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALY  547 (635)
Q Consensus       469 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~  547 (635)
                      |+||+++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999976543221 112234567889999999998889999999999999999999 88887543


Q ss_pred             cchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       548 ~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .....                  ...+.+... ...+...+..+.+++.+||+.||++||++.|++++|+++...
T Consensus       281 ~~~~~------------------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          281 AHEEV------------------IYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CHHHH------------------HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             ChHHH------------------HHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            32211                  111111111 122333445689999999999999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-38  Score=330.63  Aligned_cols=250  Identities=23%  Similarity=0.405  Sum_probs=197.2

Q ss_pred             cCCCCCCccc----ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCee
Q 042486          352 DDFNPSCWIK----GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNW  411 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  411 (635)
                      ++|.....||    |.||+++.       ++..||||.++..        +.+|+.+++++ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4454455554    89999986       3568999998642        56899999999 999999999999999999


Q ss_pred             EEEeecccCCCcchhhcccCC---------------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCC
Q 042486          412 YLVYENAVNGSLSVWINDKGG---------------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS  470 (635)
Q Consensus       412 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~  470 (635)
                      ++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChh
Confidence            999999999999999965432                     23799999999999999999999955   999999999


Q ss_pred             CEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcc
Q 042486          471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSE  549 (635)
Q Consensus       471 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~  549 (635)
                      ||+++.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            99999999999999999986654332 223344567889999999998899999999999999999998 9888754332


Q ss_pred             hhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          550 ENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       550 ~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ... ....                 +........+...+..+.+|+.+||+.||.+|||+.|++++|+.++...
T Consensus       281 ~~~-~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          281 DAN-FYKL-----------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             SHH-HHHH-----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHH-HHHH-----------------HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            211 1111                 1111112223334566899999999999999999999999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.8e-38  Score=320.84  Aligned_cols=232  Identities=26%  Similarity=0.527  Sum_probs=186.0

Q ss_pred             ceEEEeee--CCcEEEEEEec--------------cChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVY--------------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~--------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.  +++.||||++.              ..+.+|++++++++|+||+++++++.+..  ++||||+++|+|.+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~  110 (287)
T 4f0f_A           33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYH  110 (287)
T ss_dssp             SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHH
T ss_pred             eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHH
Confidence            89999998  78899999884              23567999999999999999999986554  79999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc-----EEEeeecCcccccccCCceee
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR-----AKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      ++.... ..+++..++.++.|++.||.|||+.+ ++++||||||+||+++.++.     +||+|||+++.....      
T Consensus       111 ~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~------  182 (287)
T 4f0f_A          111 RLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------  182 (287)
T ss_dssp             HHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC------
T ss_pred             HHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc------
Confidence            886543 34899999999999999999999854 44999999999999988776     999999999744322      


Q ss_pred             ecccccCCCccCcccc--ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          501 TSHIVGTKGYMAPEYL--ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~--~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      .....||+.|+|||.+  ....++.++||||||+++|||++|+.||..............                ....
T Consensus       183 ~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----------------~~~~  246 (287)
T 4f0f_A          183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI----------------REEG  246 (287)
T ss_dssp             EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH----------------HHSC
T ss_pred             ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH----------------hccC
Confidence            2335789999999998  445678999999999999999999999865433322111111                1111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            12223344456699999999999999999999999999853

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-38  Score=326.05  Aligned_cols=238  Identities=26%  Similarity=0.460  Sum_probs=192.4

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.       ++..||||.++..        +.+|++++++++||||+++++++.+++..++||||+++|+|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (314)
T 2ivs_A           37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF  116 (314)
T ss_dssp             SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHH
Confidence            89999975       3478999998643        45799999999999999999999999999999999999999999


Q ss_pred             hcccCC----------------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          427 INDKGG----------------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       427 l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                      +.....                      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus       117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~D  193 (314)
T 2ivs_A          117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISD  193 (314)
T ss_dssp             HHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECC
T ss_pred             HHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEcc
Confidence            965322                      34899999999999999999999955   99999999999999999999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccc
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                      ||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.    
T Consensus       194 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~----  266 (314)
T 2ivs_A          194 FGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--LFNLLK----  266 (314)
T ss_dssp             CTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHH----
T ss_pred             cccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHhh----
Confidence            999986543322 122233467888999999998889999999999999999999 888875433221  111110    


Q ss_pred             cCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                                   .......+...+..+.+++.+||+.||++||++.|++++|++++..
T Consensus       267 -------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          267 -------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             -------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence                         0111122333455689999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-37  Score=324.41  Aligned_cols=248  Identities=17%  Similarity=0.185  Sum_probs=196.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|+.  +++.||||.+..     .+.+|+++++++ +|+||+++++++..++..++||||+ +++|.+++.... .
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~  100 (330)
T 2izr_A           23 GELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-R  100 (330)
T ss_dssp             TSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-T
T ss_pred             ceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC-C
Confidence            89999995  789999998853     477999999999 9999999999999999999999999 999999997542 3


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc-----EEEeeecCcccccccCCce----eeeccc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR-----AKIANFALARPAERQEGEF----ALTSHI  504 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~a~~~~~~~~~~----~~~~~~  504 (635)
                      .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.........    ......
T Consensus       101 ~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~  177 (330)
T 2izr_A          101 TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL  177 (330)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCc
Confidence            4999999999999999999999955   999999999999998887     9999999998654332211    112356


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhh-HHHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENM-LLVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....+........ .+        .+... 
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~--------~~~~~-  247 (330)
T 2izr_A          178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-IE--------VLCEN-  247 (330)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-HH--------HHTTT-
T ss_pred             CCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-HH--------HHhcc-
Confidence            799999999999999999999999999999999999999875432211 11111100000000 00        00011 


Q ss_pred             ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh-------cccccc
Q 042486          584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA-------SLAWEL  628 (635)
Q Consensus       584 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~-------s~~w~~  628 (635)
                         .+ .+.+++..||+.||.+||++++|.+.|+++...       ..+|+.
T Consensus       248 ---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  295 (330)
T 2izr_A          248 ---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG  295 (330)
T ss_dssp             ---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred             ---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence               22 689999999999999999999999999998865       377874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-38  Score=327.96  Aligned_cols=226  Identities=25%  Similarity=0.351  Sum_probs=186.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.++.+          +.+|+++|++++||||+++++++.+.+..|+||||+++|+|.+++..
T Consensus        19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   98 (337)
T 1o6l_A           19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  6899999998542          45789999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+.
T Consensus        99 ~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~~gt~~  170 (337)
T 1o6l_A           99 ER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPE  170 (337)
T ss_dssp             HS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT---CCBCCCEECGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC---CcccccccChh
Confidence            43  3899999999999999999999955   9999999999999999999999999997543222   12344679999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++||||||+++|||++|+.||...+...  +..                .+....  ..++...+.
T Consensus       171 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~----------------~i~~~~--~~~p~~~s~  230 (337)
T 1o6l_A          171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE----------------LILMEE--IRFPRTLSP  230 (337)
T ss_dssp             GCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----------------HHHHCC--CCCCTTSCH
T ss_pred             hCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHH----------------HHHcCC--CCCCCCCCH
Confidence            999999999999999999999999999999999986432221  111                111111  112334455


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.++|.+||+.||++||     +++|+++|
T Consensus       231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            689999999999999999     89999886

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=325.73  Aligned_cols=240  Identities=23%  Similarity=0.385  Sum_probs=185.6

Q ss_pred             ceEEEeeeC------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIG------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+..      +..||||.++..        +.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++
T Consensus        58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  137 (333)
T 1mqb_A           58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  137 (333)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHH
Confidence            899999873      235999998643        457999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++................+|
T Consensus       138 ~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  213 (333)
T 1mqb_A          138 REKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP  213 (333)
T ss_dssp             HHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCC
T ss_pred             HhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCcc
Confidence            6543 34899999999999999999999955   9999999999999999999999999998665432221222334567


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....                +.+. .....+..
T Consensus       214 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~----------------~~~~-~~~~~~~~  274 (333)
T 1mqb_A          214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKA----------------INDG-FRLPTPMD  274 (333)
T ss_dssp             GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH----------------HHTT-CCCCCCTT
T ss_pred             ccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHH----------------HHCC-CcCCCccc
Confidence            88999999998899999999999999999999 998875432211  1111                1110 01112233


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      .+..+.+++.+||+.||++||++.|+++.|++++....
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            45568999999999999999999999999999986543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-38  Score=330.14  Aligned_cols=237  Identities=24%  Similarity=0.403  Sum_probs=185.7

Q ss_pred             ceEEEeee--CCc----EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++  +++    .||+|.++.        .+.+|+.++++++||||++++++|.+++ .++|+||+.+|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l  107 (327)
T 3poz_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHH
Confidence            89999987  444    368887743        3567999999999999999999998654 78999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ .......+|
T Consensus       108 ~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~t  182 (327)
T 3poz_A          108 REHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVP  182 (327)
T ss_dssp             HHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--------CCC
T ss_pred             HhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCccc-ccccCCCcc
Confidence            6644 34899999999999999999999955   999999999999999999999999999865433221 122334568


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||........  ..                 .+........+..
T Consensus       183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~-----------------~~~~~~~~~~~~~  243 (327)
T 3poz_A          183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS-----------------ILEKGERLPQPPI  243 (327)
T ss_dssp             GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH-----------------HHHTTCCCCCCTT
T ss_pred             ccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HH-----------------HHHcCCCCCCCcc
Confidence            89999999999999999999999999999999 9988864332211  11                 1111111222334


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+..+.+++.+||+.||++||++.|++++|+++....
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            4556899999999999999999999999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=331.04  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=186.4

Q ss_pred             ceEEEeeeCCcEEEEEEeccC----hHHH--HHHHhhhccCCcccEEEEEec-----CCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD----ASDQ--IKLLNKINHSSLIRLLGICFN-----GGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~----~~~E--~~~l~~l~h~nIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+|+.+++.||||++...    +..|  +..+..++|+||+++++.+..     ....++||||+++|+|.+++...
T Consensus        27 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  106 (336)
T 3g2f_A           27 GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH  106 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC
T ss_pred             eEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc
Confidence            899999999999999998643    2233  334556899999999986542     23578999999999999999654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCC------CCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-----cee
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFT------NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-----EFA  499 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~  499 (635)
                      .   .++..+..++.||+.||.|||+..      .++|+||||||+|||++.++.+||+|||+++.......     ...
T Consensus       107 ~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~  183 (336)
T 3g2f_A          107 T---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN  183 (336)
T ss_dssp             C---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-------
T ss_pred             c---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccc
Confidence            3   689999999999999999999851      11699999999999999999999999999986543211     111


Q ss_pred             eecccccCCCccCcccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          500 LTSHIVGTKGYMAPEYLEN-------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      ......||+.|+|||++.+       ..++.++|||||||++|||++|+.|+............................
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (336)
T 3g2f_A          184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV  263 (336)
T ss_dssp             --CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH
T ss_pred             ccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHh
Confidence            2234579999999999976       456779999999999999999987764332211000000000000001111111


Q ss_pred             hhcC----CcCCCC--CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccccccc
Q 042486          573 HLMD----PSMQGN--YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELS  629 (635)
Q Consensus       573 ~~~d----~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~~  629 (635)
                      ....    +.+...  .....+..+.+|+.+||+.||++|||++|+++.|++++.   .|+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~---~~~~~  323 (336)
T 3g2f_A          264 LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM---IWERN  323 (336)
T ss_dssp             HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH---CCCC-
T ss_pred             hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH---HHHhc
Confidence            1111    111111  123466779999999999999999999999999999995   36554

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=323.68  Aligned_cols=237  Identities=25%  Similarity=0.423  Sum_probs=184.9

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC-CCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG-KFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l  435 (635)
                      |.||+++..++.||||++..+     +.+|++++++++||||+++++++.  +..++||||+++|+|.+++..... ..+
T Consensus        22 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~   99 (307)
T 2eva_A           22 GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYY   99 (307)
T ss_dssp             SEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECC
T ss_pred             ceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCcc
Confidence            899999999999999999653     568999999999999999999886  447999999999999999965432 247


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc-EEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR-AKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      ++..++.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||++......      .....||+.|+|||
T Consensus       100 ~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE  173 (307)
T 2eva_A          100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAWMAPE  173 (307)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------------CCTTSSCHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------cccCCCCCceEChh
Confidence            89999999999999999999954456999999999999988876 799999999754332      12346899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      .+.+..++.++||||||+++|||++|+.||...............             ....+    ..+...+..+.++
T Consensus       174 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------~~~~~----~~~~~~~~~l~~l  236 (307)
T 2eva_A          174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-------------NGTRP----PLIKNLPKPIESL  236 (307)
T ss_dssp             HHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-------------TTCCC----CCBTTCCHHHHHH
T ss_pred             hhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-------------cCCCC----CcccccCHHHHHH
Confidence            999989999999999999999999999998643322211110000             00011    1122234558999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +.+||+.||++|||++|+++.|+.+....
T Consensus       237 i~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          237 MTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-37  Score=320.31  Aligned_cols=265  Identities=22%  Similarity=0.393  Sum_probs=192.2

Q ss_pred             hcCCCCCCccc----ceEEEeeeCCcEEEEEEeccC----hHHHHHHHhhh--ccCCcccEEEEEecC----CeeEEEee
Q 042486          351 TDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGD----ASDQIKLLNKI--NHSSLIRLLGICFNG----GNWYLVYE  416 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~l--~h~nIv~l~~~~~~~----~~~~lV~E  416 (635)
                      .++|.....||    |.||+|+..++.||||++...    ...|.+++..+  +|+||+++++++...    ...++|||
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            35666666665    899999999999999998653    23455555544  999999999999876    67899999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCC-----CCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT-----NPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      |+++|+|.+++...   .+++..++.++.|++.||.|||+..     .++|+||||||+||+++.++.+||+|||+++..
T Consensus       116 ~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          116 YHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            99999999999654   3899999999999999999999851     126999999999999999999999999999765


Q ss_pred             cccCCcee-eecccccCCCccCccccccCCCCcc------cchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc
Q 042486          492 ERQEGEFA-LTSHIVGTKGYMAPEYLENGLVSTK------LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       492 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k------sDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      ........ ......||+.|+|||.+.+.....+      +|||||||++|||++|..|+............    ....
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~----~~~~  268 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD----LVPS  268 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT----TSCS
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh----hcCC
Confidence            43322111 1224579999999999987666655      99999999999999994433211110000000    0000


Q ss_pred             CCchhhhhh-hcCCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          565 EDGEESLRH-LMDPSMQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       565 ~~~~~~l~~-~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      ......... ..........+     ...+..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            000111111 11111222222     26677899999999999999999999999999998865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=334.62  Aligned_cols=239  Identities=25%  Similarity=0.414  Sum_probs=190.0

Q ss_pred             ceEEEeee-------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|++       ++..||||+++.        ++.+|+.++++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        85 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~  164 (367)
T 3l9p_A           85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF  164 (367)
T ss_dssp             SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHH
Confidence            89999985       356899999864        255799999999999999999999999999999999999999999


Q ss_pred             hcccC-----CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC---cEEEeeecCcccccccCCce
Q 042486          427 INDKG-----GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF---RAKIANFALARPAERQEGEF  498 (635)
Q Consensus       427 l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +....     ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++....... .
T Consensus       165 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-~  240 (367)
T 3l9p_A          165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-Y  240 (367)
T ss_dssp             HHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-C
T ss_pred             HHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccc-c
Confidence            96532     234899999999999999999999955   99999999999998554   599999999975433221 1


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  ....+                .. 
T Consensus       241 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i----------------~~-  301 (367)
T 3l9p_A          241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFV----------------TS-  301 (367)
T ss_dssp             TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----------------HT-
T ss_pred             ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----------------Hc-
Confidence            12233567899999999999999999999999999999998 888875433221  11111                10 


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ......+...+..+.+|+.+||+.||++||++.||+++|+.+....
T Consensus       302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            0111223334456899999999999999999999999999887654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=317.37  Aligned_cols=238  Identities=24%  Similarity=0.366  Sum_probs=192.8

Q ss_pred             ceEEEeee----CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|.+    ++..||||.++..        +.+|++++++++||||+++++++ ..+..++||||+++++|.+++..
T Consensus        24 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~  102 (287)
T 1u59_A           24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG  102 (287)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT
T ss_pred             eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh
Confidence            89999985    5778999998752        45799999999999999999999 55668999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.................+|+.
T Consensus       103 ~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  178 (287)
T 1u59_A          103 KR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK  178 (287)
T ss_dssp             CT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred             CC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccc
Confidence            43 34899999999999999999999955   999999999999999999999999999876543322222333457889


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.                . ......+...+
T Consensus       179 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~----------------~-~~~~~~~~~~~  239 (287)
T 1u59_A          179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE----------------Q-GKRMECPPECP  239 (287)
T ss_dssp             GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH----------------T-TCCCCCCTTCC
T ss_pred             ccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHh----------------c-CCcCCCCCCcC
Confidence            999999988889999999999999999999 999886433221  111110                0 01112233445


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ..+.+++.+||+.||++||++.|++++|+.++.+.
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            66999999999999999999999999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-37  Score=332.29  Aligned_cols=258  Identities=22%  Similarity=0.349  Sum_probs=195.8

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.....||    |.||+++.  +++.||||+++..          +..|..+|.++ +||||+++++++.+++..|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            3454455555    89999987  6889999998642          45788999887 899999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       132 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999997643  3899999999999999999999955   999999999999999999999999999853322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........         ...........+
T Consensus       207 ~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~---------~~~~~~~~~~~i  274 (396)
T 4dc2_A          207 G---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---------DQNTEDYLFQVI  274 (396)
T ss_dssp             T---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHHH
T ss_pred             C---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc---------chhhHHHHHHHH
Confidence            1   1234568999999999999999999999999999999999999998643211100         000000111111


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHH---HHHHHHHHHHhhcccccc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD---KIAQSISRFLNASLAWEL  628 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~---evl~~L~~~~~~s~~w~~  628 (635)
                      ....  ...|...+..+.+||.+||+.||++||++.   .+.+.++.-.-..++|+.
T Consensus       275 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          275 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             hccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence            1111  123444556689999999999999999962   233333333344567754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.5e-38  Score=321.40  Aligned_cols=237  Identities=25%  Similarity=0.426  Sum_probs=189.6

Q ss_pred             ceEEEeee----CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|.+    .++.||||.++..         +.+|++++++++||||+++++++ ..+..++||||+++++|.+++.
T Consensus        31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~  109 (291)
T 1xbb_A           31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ  109 (291)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH
T ss_pred             eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH
Confidence            89999965    4678999998642         55799999999999999999999 5677899999999999999997


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.................++.
T Consensus       110 ~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  184 (291)
T 1xbb_A          110 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV  184 (291)
T ss_dssp             HCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCG
T ss_pred             hCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCc
Confidence            643  3899999999999999999999955   99999999999999999999999999986654433222223345678


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.                 .......+...
T Consensus       185 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~  245 (291)
T 1xbb_A          185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLE-----------------KGERMGCPAGC  245 (291)
T ss_dssp             GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH-----------------TTCCCCCCTTC
T ss_pred             eeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH-----------------cCCCCCCCCCC
Confidence            8999999998889999999999999999999 998876433221  111110                 00111223344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +..+.+++.+||+.||++||++.|+++.|++++...
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            556999999999999999999999999999998654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.7e-38  Score=315.78  Aligned_cols=237  Identities=24%  Similarity=0.424  Sum_probs=192.0

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+++. +++.||+|.+...      +.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..
T Consensus        22 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~  100 (267)
T 3t9t_A           22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GL  100 (267)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TC
T ss_pred             eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-cc
Confidence            89999998 7789999998653      5689999999999999999999999999999999999999999996543 34


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  ........++..|+|||
T Consensus       101 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE  175 (267)
T 3t9t_A          101 FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPE  175 (267)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc--ccccccccccccccChh
Confidence            899999999999999999999955   9999999999999999999999999997653321  11122345678899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.+..++.++||||||+++|||++ |+.||.......  ....+                ... .....+...+..+.+
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i----------------~~~-~~~~~~~~~~~~l~~  236 (267)
T 3t9t_A          176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI----------------STG-FRLYKPRLASTHVYQ  236 (267)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH----------------HTT-CCCCCCTTSCHHHHH
T ss_pred             hhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHH----------------hcC-CcCCCCccCcHHHHH
Confidence            9998889999999999999999999 788875432211  11111                000 011122233456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ++.+||+.||++||++.|++++|+++.++.
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQLAEIAESG  266 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            999999999999999999999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-38  Score=345.44  Aligned_cols=237  Identities=22%  Similarity=0.412  Sum_probs=191.3

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|++ ++..||||+++.      ++.+|+++|++++||||+++++++. .+..++||||+++|+|.+++.......
T Consensus       202 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~  280 (454)
T 1qcf_A          202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK  280 (454)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHT
T ss_pred             eEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCC
Confidence            89999998 578899999975      3668999999999999999999986 667899999999999999997544334


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ........++..|+|||
T Consensus       281 ~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE  355 (454)
T 1qcf_A          281 QPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPE  355 (454)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--HHTTCSSSSCGGGSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--eeccCCCcccccccCHH
Confidence            899999999999999999999954   9999999999999999999999999998654321  11112234677899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+..+.++.++||||||+++|||++ |+.||.......  ....+..                 ......+...+..+.+
T Consensus       356 ~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~-----------------~~~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALER-----------------GYRMPRPENCPEELYN  416 (454)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHH-----------------TCCCCCCTTSCHHHHH
T ss_pred             HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-----------------CCCCCCCCCCCHHHHH
Confidence            9998899999999999999999999 998876433221  1111100                 0111223344556899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      |+.+||+.||++|||+++|++.|+.+....
T Consensus       417 li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            999999999999999999999999887643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-37  Score=328.68  Aligned_cols=229  Identities=21%  Similarity=0.293  Sum_probs=185.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +|+.||+|.++.             .+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        26 g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~  105 (361)
T 2yab_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF  105 (361)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHH
Confidence            89999988  689999998853             246899999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----cEEEeeecCcccccccCCceeeec
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      +....  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||++.......    ...
T Consensus       106 l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~~~  176 (361)
T 2yab_A          106 LAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFK  176 (361)
T ss_dssp             HTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC----CCC
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC----ccc
Confidence            96543  4899999999999999999999955   99999999999998876    79999999998654422    123


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+.......+.               ....
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~---------------~~~~  240 (361)
T 2yab_A          177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAVSYD---------------FDEE  240 (361)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC---------------CCHH
T ss_pred             cCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC---------------CCch
Confidence            4579999999999998899999999999999999999999986433221 11111110000               0000


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+..+.+||.+||..||++|||+.|+++|
T Consensus       241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            001223458899999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=331.38  Aligned_cols=246  Identities=26%  Similarity=0.398  Sum_probs=191.9

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.....||    |.||+++.  +++.||||+++.+          +.+|..+|+++ +||||+++++++.+.+..|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            4455555555    89999987  6889999998643          34688899988 799999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999996653  3899999999999999999999955   999999999999999999999999999754322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...                  ....+
T Consensus       178 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------------------~~~~i  236 (353)
T 3txo_A          178 G---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------------------LFEAI  236 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------------HHHHH
T ss_pred             C---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------------------HHHHH
Confidence            1   22345679999999999998889999999999999999999999986433221                  11111


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHHHHhhcccccc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM------DKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L~~~~~~s~~w~~  628 (635)
                      ....  ..++...+..+.+++.+||+.||++||++      +|+++|  .++ ..++|+.
T Consensus       237 ~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h--p~f-~~~~w~~  291 (353)
T 3txo_A          237 LNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH--PFF-KEIDWAQ  291 (353)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS--GGG-TTCCHHH
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC--Ccc-cCCCHHH
Confidence            1111  12233445568999999999999999998      677765  233 3456643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=324.21  Aligned_cols=230  Identities=22%  Similarity=0.257  Sum_probs=186.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+++.  +++.+|+|.+...      +.+|+.+|++++||||+++++++.+.+..++||||+++|+|.+++.... .
T Consensus        19 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~   97 (321)
T 1tki_A           19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-F   97 (321)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-C
T ss_pred             eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-C
Confidence            89999988  6889999998643      5689999999999999999999999999999999999999999996543 2


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC--CCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      .+++..+..++.|++.||.|||+.+   |+||||||+||+++.  ++.+||+|||+++......    ......||+.|+
T Consensus        98 ~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~  170 (321)
T 1tki_A           98 ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYY  170 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChhhc
Confidence            4899999999999999999999955   999999999999987  7899999999998664332    123457899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||.+.+..++.++||||||+++|+|++|+.||....... .............  ..             .....+..+
T Consensus       171 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~--~~-------------~~~~~s~~~  234 (321)
T 1tki_A          171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFD--EE-------------AFKEISIEA  234 (321)
T ss_dssp             CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCCC--HH-------------HHTTSCHHH
T ss_pred             CcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCCCC--hh-------------hhccCCHHH
Confidence            9999998889999999999999999999999986433221 1111111110000  00             001224458


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+++.+||..||++|||+.|++++
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcC
Confidence            999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.6e-38  Score=339.05  Aligned_cols=263  Identities=20%  Similarity=0.262  Sum_probs=206.1

Q ss_pred             ccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEE
Q 042486          342 YTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGIC  405 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~  405 (635)
                      ..+.++...+++|.....||    |.||+++.  +++.||||+++.          .+.+|..++.+++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34566777778888877787    89999998  578999999853          267899999999999999999999


Q ss_pred             ecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       406 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                      .+++..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999997633 33999999999999999999999955   999999999999999999999999


Q ss_pred             cCcccccccCCceeeecccccCCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhc
Q 042486          486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNP  560 (635)
Q Consensus       486 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  560 (635)
                      |+++.......  .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||...+.... .......
T Consensus       220 Gla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~  296 (437)
T 4aw2_A          220 GSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNH  296 (437)
T ss_dssp             TTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTH
T ss_pred             hhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhc
Confidence            99976543221  2233468999999999987     56789999999999999999999999864332211 1111100


Q ss_pred             ccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHHHHhhcccccc
Q 042486          561 VLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG--RPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       561 ~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                                ...+..+..    ....+..+.+||.+||..+|++  ||+++|+++|  .++. .++|+.
T Consensus       297 ----------~~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H--pff~-~i~w~~  349 (437)
T 4aw2_A          297 ----------KERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH--PFFS-GIDWDN  349 (437)
T ss_dssp             ----------HHHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS--GGGT-TCCTTT
T ss_pred             ----------cccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC--CccC-CCCHHH
Confidence                      000011111    1123455899999999888888  9999999887  4443 467764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.5e-38  Score=318.62  Aligned_cols=235  Identities=27%  Similarity=0.451  Sum_probs=186.2

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEecC-CeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFNG-GNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||+++..++.||||.++.+     +.+|++++++++|+||+++++++.+. +..++||||+++++|.+++.......+
T Consensus        35 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  114 (278)
T 1byg_A           35 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL  114 (278)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred             ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccC
Confidence            899999999999999998753     56799999999999999999997654 468999999999999999965443448


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      ++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......      ....++..|+|||.
T Consensus       115 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~y~aPE~  185 (278)
T 1byg_A          115 GGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEA  185 (278)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------------CCTTTSCHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc------cCCCccccccCHHH
Confidence            99999999999999999999955   9999999999999999999999999987544321      22357889999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      +.+..++.++||||||+++|||++ |+.||........  ...                + ........+...+..+.++
T Consensus       186 ~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~----------------~-~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR----------------V-EKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH----------------H-TTTCCCCCCTTCCHHHHHH
T ss_pred             hCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH----------------H-hcCCCCCCcccCCHHHHHH
Confidence            998899999999999999999998 8888754322111  110                0 0111112233345568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +.+||+.||++||++.|+++.|+++....+
T Consensus       247 i~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-37  Score=319.26  Aligned_cols=246  Identities=24%  Similarity=0.283  Sum_probs=184.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||+++.  +++.||||+++.         .+.+|+.++++++||||+++++++.+++..++||||+++ +|.+++...
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   94 (292)
T 3o0g_A           16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC   94 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT
T ss_pred             eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhC
Confidence            89999998  688999999853         245799999999999999999999999999999999976 555555432


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      . ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   .......||+.|
T Consensus        95 ~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y  167 (292)
T 3o0g_A           95 N-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWY  167 (292)
T ss_dssp             T-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---SCCCSCCSCGGG
T ss_pred             C-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc---ccccCCccccCC
Confidence            2 33999999999999999999999955   9999999999999999999999999998654322   122345789999


Q ss_pred             cCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-chhhhhhhcCC---------cC
Q 042486          511 MAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-GEESLRHLMDP---------SM  579 (635)
Q Consensus       511 ~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~~~l~~~~d~---------~~  579 (635)
                      +|||.+.+.. ++.++||||||+++|||++|+.|+.........+............ .........+.         ..
T Consensus       168 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T 3o0g_A          168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS  247 (292)
T ss_dssp             CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred             cChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcc
Confidence            9999997765 7999999999999999999998865443333222222211111000 00001111000         00


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ........+..+.+|+.+||+.||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            011223345668999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-37  Score=327.65  Aligned_cols=262  Identities=16%  Similarity=0.191  Sum_probs=192.9

Q ss_pred             CCCCCCccc----ceEEEeeeC-------CcEEEEEEeccC---hHHHH---------------HHHhhhccCCcccEEE
Q 042486          353 DFNPSCWIK----GSVYRGKIG-------GDFVAIKKVYGD---ASDQI---------------KLLNKINHSSLIRLLG  403 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~-------~~~vavK~~~~~---~~~E~---------------~~l~~l~h~nIv~l~~  403 (635)
                      +|.....||    |.||+|.+.       ++.||||.+..+   +.+|+               ..+++++|+||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            444444454    899999872       478999998653   22333               4455567999999999


Q ss_pred             EEecC----CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC--CC
Q 042486          404 ICFNG----GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD--TD  477 (635)
Q Consensus       404 ~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~--~~  477 (635)
                      ++...    ...++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++  .+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCT
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCC
Confidence            99864    4579999999 999999996543 34999999999999999999999954   99999999999998  88


Q ss_pred             CcEEEeeecCcccccccCCce----eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH
Q 042486          478 FRAKIANFALARPAERQEGEF----ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML  553 (635)
Q Consensus       478 ~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~  553 (635)
                      +.+||+|||+++.........    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999997654332111    1113345999999999999989999999999999999999999998643222111


Q ss_pred             HHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh-------cccc
Q 042486          554 LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA-------SLAW  626 (635)
Q Consensus       554 l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~-------s~~w  626 (635)
                      . .......     ...+..++++.+.   ....+..+.+++..||+.||++||++++|++.|++++..       ..||
T Consensus       271 ~-~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          271 V-RDSKIRY-----RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             H-HHHHHHH-----HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             H-HHHHHHh-----hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            1 1111000     1112222222221   012234589999999999999999999999999999864       3667


Q ss_pred             cc
Q 042486          627 EL  628 (635)
Q Consensus       627 ~~  628 (635)
                      +.
T Consensus       342 ~~  343 (364)
T 3op5_A          342 SV  343 (364)
T ss_dssp             --
T ss_pred             Ee
Confidence            54

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-37  Score=321.62  Aligned_cols=223  Identities=23%  Similarity=0.371  Sum_probs=185.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.++..          +.+|..++++++||||+++++++.+.+..|+||||+++|+|.+++..
T Consensus        20 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~   99 (318)
T 1fot_A           20 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK   99 (318)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence            89999987  6899999998642          34689999999999999999999999999999999999999999975


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....      .....||+.
T Consensus       100 ~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~------~~~~~gt~~  168 (318)
T 1fot_A          100 SQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPD  168 (318)
T ss_dssp             TS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCCCCSCTT
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc------cccccCCcc
Confidence            43  3899999999999999999999855   999999999999999999999999999865432      234579999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++|||||||++|||++|+.||...+...                  ....++...  ..++...+.
T Consensus       169 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------------------~~~~i~~~~--~~~p~~~~~  228 (318)
T 1fot_A          169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------------------TYEKILNAE--LRFPPFFNE  228 (318)
T ss_dssp             TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------------------HHHHHHHCC--CCCCTTSCH
T ss_pred             ccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHhCC--CCCCCCCCH
Confidence            999999999999999999999999999999999986432211                  111111111  112333455


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||..||++||     +++|+++|
T Consensus       229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            689999999999999999     88888876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-37  Score=318.81  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=192.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCC--eeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||||+++..        +.+|+++|++++||||+++++++...+  ..++||||+++++|.+++..
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  102 (319)
T 4euu_A           23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (319)
T ss_dssp             EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence            89999998  4899999998642        458999999999999999999998655  67999999999999999965


Q ss_pred             cC-CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE----CCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          430 KG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       430 ~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      .. ...+++..++.++.|++.||.|||+.+   |+||||||+||++    +.++.+||+|||+++.......    ....
T Consensus       103 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~----~~~~  175 (319)
T 4euu_A          103 PSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSL  175 (319)
T ss_dssp             GGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC----BCCC
T ss_pred             hccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc----eeec
Confidence            33 233899999999999999999999955   9999999999999    8888899999999986544321    2235


Q ss_pred             ccCCCccCccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh---hHHHHhhhcccccCCchhhhhh
Q 042486          505 VGTKGYMAPEYLE--------NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN---MLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       505 ~gt~~y~aPE~~~--------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .||..|+|||.+.        +..++.++|||||||++|||++|+.||.......   ...............  ..+..
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~  253 (319)
T 4euu_A          176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI--SGVQK  253 (319)
T ss_dssp             CSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC--EEEEC
T ss_pred             ccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc--hhhhc
Confidence            6899999999886        5778999999999999999999999986433221   111222111110000  00000


Q ss_pred             h------c--CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          574 L------M--DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       574 ~------~--d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      .      .  +-......+......+.+++.+||+.||++|||++|++++.++-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            0      0  00112244567888899999999999999999999999998854

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.4e-38  Score=326.03  Aligned_cols=237  Identities=25%  Similarity=0.401  Sum_probs=185.9

Q ss_pred             ceEEEeee--CCc----EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+.  +++    .||+|.+..        .+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++
T Consensus        27 g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l  105 (325)
T 3kex_A           27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHV  105 (325)
T ss_dssp             CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHH
T ss_pred             ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHH
Confidence            89999987  444    388887743        3568999999999999999999985 56689999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ .......++
T Consensus       106 ~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~  180 (325)
T 3kex_A          106 RQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-LLYSEAKTP  180 (325)
T ss_dssp             HSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC-CC-----CC
T ss_pred             HHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCccccc-ccccCCCCc
Confidence            6542 34899999999999999999999955   999999999999999999999999999876543322 223345678


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||........  ...+..                 ......+..
T Consensus       181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~-----------------~~~~~~~~~  241 (325)
T 3kex_A          181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PDLLEK-----------------GERLAQPQI  241 (325)
T ss_dssp             TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HHHHHT-----------------TCBCCCCTT
T ss_pred             ccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HHHHHc-----------------CCCCCCCCc
Confidence            89999999998999999999999999999999 9999864332211  111110                 001111222


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+..+.+++.+||+.||++||++.|++++|+++....
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            2334789999999999999999999999999987543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-37  Score=317.43  Aligned_cols=235  Identities=26%  Similarity=0.367  Sum_probs=178.4

Q ss_pred             ceEEEeeeC-----CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|+..     +..||+|..+.        .+.+|+.++++++||||+++++++ .++..++||||+++++|.+++.
T Consensus        29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~  107 (281)
T 1mp8_A           29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ  107 (281)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHH
T ss_pred             eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHH
Confidence            899999872     35799999764        256799999999999999999998 4567899999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......  .......+++
T Consensus       108 ~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~  181 (281)
T 1mp8_A          108 VRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPI  181 (281)
T ss_dssp             HTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------------------CCG
T ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc--cccccCCCcc
Confidence            543 34899999999999999999999955   99999999999999999999999999986543321  1123345678


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||........  ...                +... .....+...
T Consensus       182 ~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~----------------i~~~-~~~~~~~~~  242 (281)
T 1mp8_A          182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR----------------IENG-ERLPMPPNC  242 (281)
T ss_dssp             GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH----------------HHTT-CCCCCCTTC
T ss_pred             cccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHH----------------HHcC-CCCCCCCCC
Confidence            8999999998889999999999999999997 8888754332211  111                1110 011123334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +..+.+++.+||+.||++|||+.|++++|++++..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            55689999999999999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-37  Score=317.73  Aligned_cols=237  Identities=25%  Similarity=0.453  Sum_probs=190.7

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|+. ++..||||.++..      +.+|++++++++|+||+++++++. ++..++||||+++++|.+++.......
T Consensus        27 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~  105 (279)
T 1qpc_A           27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK  105 (279)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHT
T ss_pred             eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCC
Confidence            89999998 4568999998643      568999999999999999999986 456899999999999999996543334


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.......  ........++..|+|||
T Consensus       106 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE  180 (279)
T 1qpc_A          106 LTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPE  180 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc--cccccCCCCccCccChh
Confidence            899999999999999999999955   9999999999999999999999999998654322  12223345778999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.++.++.++||||||+++|||++ |+.||.......  ....+..                 ......+...+..+.+
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLER-----------------GYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT-----------------TCCCCCCTTCCHHHHH
T ss_pred             hhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhc-----------------ccCCCCcccccHHHHH
Confidence            9998889999999999999999999 888875432221  1111100                 0011122334456899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ++.+||+.||++|||++++++.|+.++...
T Consensus       242 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            999999999999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-37  Score=321.54  Aligned_cols=246  Identities=25%  Similarity=0.321  Sum_probs=184.1

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++. +++.||+|+++.         .+.+|++++++++||||+++++++.+++..++||||+++ +|.+++....
T Consensus        35 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~  113 (311)
T 3niz_A           35 GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK  113 (311)
T ss_dssp             CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCT
T ss_pred             eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhcc
Confidence            89999998 789999999863         245799999999999999999999999999999999975 7888875543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   ......+|+.|+
T Consensus       114 -~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~  186 (311)
T 3niz_A          114 -TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR---SYTHEVVTLWYR  186 (311)
T ss_dssp             -TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC------CCCCCCTTC
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc---cccCCcccCCcC
Confidence             34899999999999999999999955   99999999999999999999999999986543221   123357899999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCC-chhhhhhhcCCcCC--CC---
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKED-GEESLRHLMDPSMQ--GN---  582 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~-~~~~l~~~~d~~~~--~~---  582 (635)
                      |||.+.+ ..++.++|||||||++|||++|+.||.........  ............. ....+..+.+....  ..   
T Consensus       187 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (311)
T 3niz_A          187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPW  266 (311)
T ss_dssp             CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCH
T ss_pred             CHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcH
Confidence            9999876 56899999999999999999999998754433211  1111111100000 00001111110000  00   


Q ss_pred             --CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 --YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .....+..+.+|+.+||+.||++|||++|++++
T Consensus       267 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          267 SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              011223458899999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.4e-38  Score=335.64  Aligned_cols=258  Identities=20%  Similarity=0.247  Sum_probs=202.8

Q ss_pred             cHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEe
Q 042486          343 TFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICF  406 (635)
Q Consensus       343 ~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~  406 (635)
                      .+.++....++|.....||    |.||+++.  +++.||+|+++.          .+.+|+.++++++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3456666777888777776    89999998  688999999853          2568999999999999999999999


Q ss_pred             cCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       407 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                      +++..|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999999999653   2899999999999999999999955   9999999999999999999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccc
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL  562 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  562 (635)
                      +++......  ........||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.... ........ 
T Consensus       214 ~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~-  289 (410)
T 3v8s_A          214 TCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMNHK-  289 (410)
T ss_dssp             TCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHH-
T ss_pred             eeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHhcc-
Confidence            997654322  12234568999999999997654    78999999999999999999999864332211 11111000 


Q ss_pred             ccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHHHHhhccccc
Q 042486          563 HKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSG--RPAMDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       563 ~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~~~~s~~w~  627 (635)
                               ..     +........+..+.+||.+||..+|++  ||+++||++|  .++. ..+|+
T Consensus       290 ---------~~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H--p~f~-~~~w~  339 (410)
T 3v8s_A          290 ---------NS-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH--LFFK-NDQWA  339 (410)
T ss_dssp             ---------HH-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS--GGGC-CSSCC
T ss_pred             ---------cc-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC--cccc-CCCHH
Confidence                     00     000011123455899999999999988  9999999987  3443 35564

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-37  Score=327.84  Aligned_cols=231  Identities=22%  Similarity=0.271  Sum_probs=184.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+++.  +++.||||.+..            .+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++
T Consensus        38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l  117 (351)
T 3c0i_A           38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI  117 (351)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHH
Confidence            89999987  689999998742            3568999999999999999999999999999999999999999888


Q ss_pred             ccc--CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc---EEEeeecCcccccccCCceeeec
Q 042486          428 NDK--GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       428 ~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      ...  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+++......   ....
T Consensus       118 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~  191 (351)
T 3c0i_A          118 VKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAG  191 (351)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS---CBCC
T ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC---eeec
Confidence            432  2345899999999999999999999955   999999999999976654   9999999998654432   1233


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....+  .............  ...            
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~i~~~~~~~~--~~~------------  255 (351)
T 3c0i_A          192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFEGIIKGKYKMN--PRQ------------  255 (351)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--HHHHHHHTCCCCC--HHH------------
T ss_pred             CCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--HHHHHHcCCCCCC--ccc------------
Confidence            457999999999999988999999999999999999999998643211  1111111100000  000            


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       256 -~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          256 -WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             01123458999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=324.73  Aligned_cols=233  Identities=24%  Similarity=0.282  Sum_probs=179.5

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|.....||    |+||+|+.  +++.||||++...         ...|+..+.++ +|+||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            3455555565    89999998  6899999998542         22345555555 8999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            999 679999886543 34999999999999999999999954   9999999999999999999999999987654322


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                          ......||+.|+|||++.+ .++.++||||||+++|||++|..++.....    ......                
T Consensus       212 ----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~----------------  266 (311)
T 3p1a_A          212 ----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQ----------------  266 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTT----------------
T ss_pred             ----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhc----------------
Confidence                2234569999999998875 689999999999999999999877642111    001100                


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       .......+...+..+.+++.+||+.||++|||++|++++
T Consensus       267 -~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 -GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence             000000111234558999999999999999999999874

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=333.55  Aligned_cols=230  Identities=20%  Similarity=0.262  Sum_probs=186.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||++..  +++.+|+|.+...         +.+|++++++++||||+++++++.+++..|+||||+++|+|.+++...
T Consensus        25 g~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~  104 (444)
T 3soa_A           25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR  104 (444)
T ss_dssp             CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC
T ss_pred             eEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc
Confidence            89999987  7899999988542         468999999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC---CCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD---TDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .  .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++........   ......||
T Consensus       105 ~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~~gt  176 (444)
T 3soa_A          105 E--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGT  176 (444)
T ss_dssp             S--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC---BCCCSCSC
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc---eeecccCC
Confidence            3  3899999999999999999999955   99999999999998   467899999999976654321   12346799


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+... ...........               .........
T Consensus       177 ~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~---------------~~~~~~~~~  240 (444)
T 3soa_A          177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYD---------------FPSPEWDTV  240 (444)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC---------------CCTTTTTTS
T ss_pred             cccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCC---------------CCccccccC
Confidence            99999999999899999999999999999999999985433221 11111111000               001111223


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+|+.+||+.||++|||+.|++++
T Consensus       241 s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          241 TPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            4568999999999999999999999885

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=326.06  Aligned_cols=239  Identities=25%  Similarity=0.321  Sum_probs=179.3

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCC
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG  421 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~g  421 (635)
                      .|.....||    |.||+++.  +++.||||.++..     +.+|+++|++++||||+++++++.+.+..++||||+++|
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  133 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG  133 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence            344444454    89999998  5789999998653     567999999999999999999999999999999999999


Q ss_pred             CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCce
Q 042486          422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       422 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||+++......   
T Consensus       134 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---  205 (349)
T 2w4o_A          134 ELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---  205 (349)
T ss_dssp             BHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---
Confidence            9999996543  3899999999999999999999955   999999999999975   8899999999998654321   


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................               .
T Consensus       206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---------------~  269 (349)
T 2w4o_A          206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---------------Y  269 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC---------------C
T ss_pred             -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC---------------c
Confidence             123457899999999999989999999999999999999999998643332212111111100               0


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .........+..+.+|+.+||+.||++|||+.|++++
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011112344568999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.9e-38  Score=341.18  Aligned_cols=237  Identities=25%  Similarity=0.461  Sum_probs=187.3

Q ss_pred             ceEEEeeeC-CcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKIG-GDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~~-~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|++. +..||||.++.      ++.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++.......
T Consensus       198 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~  276 (452)
T 1fmk_A          198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY  276 (452)
T ss_dssp             CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTT
T ss_pred             eEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCC
Confidence            899999994 46899999875      36789999999999999999999866 67899999999999999997544445


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......  ........++..|+|||
T Consensus       277 ~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~~y~aPE  351 (452)
T 1fmk_A          277 LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE  351 (452)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------------CCGGGSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc--eecccCCcccccccCHh
Confidence            899999999999999999999954   9999999999999999999999999998654322  11122345678899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.++.++.++||||||+++|||++ |+.||.......  ....                +. .......+...+..+.+
T Consensus       352 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~----------------i~-~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ----------------VE-RGYRMPCPPECPESLHD  412 (452)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----------------HH-TTCCCCCCTTSCHHHHH
T ss_pred             HHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH----------------HH-cCCCCCCCCCCCHHHHH
Confidence            9998899999999999999999999 888875432211  1111                10 01111233445566899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ++.+||+.||++|||++++++.|+.++.+.
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            999999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.1e-37  Score=317.45  Aligned_cols=239  Identities=26%  Similarity=0.447  Sum_probs=178.2

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+|+..+ .||||.++.         .+.+|++++++++|+||+++++++ ..+..++||||+++++|.+++.... 
T Consensus        38 g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-  114 (289)
T 3og7_A           38 GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE-  114 (289)
T ss_dssp             EEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC--
T ss_pred             eEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc-
Confidence            8999999765 499999863         256899999999999999999965 5566899999999999999996543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ .......||+.|+|
T Consensus       115 ~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~a  190 (289)
T 3og7_A          115 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-HQFEQLSGSILWMA  190 (289)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------------------CCCTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc-ccccccCCCccccC
Confidence            34899999999999999999999955   999999999999999999999999999765432211 12234578999999


Q ss_pred             ccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          513 PEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       513 PE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      ||.+.   +..++.++||||||+++|||++|+.||.................             ..+.. .......+.
T Consensus       191 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------~~~~~-~~~~~~~~~  256 (289)
T 3og7_A          191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-------------LSPDL-SKVRSNCPK  256 (289)
T ss_dssp             HHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-------------CCCCT-TSSCTTSCH
T ss_pred             chhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-------------cCcch-hhccccCCH
Confidence            99986   56788999999999999999999999865433322111111100             01110 111223445


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      .+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       257 ~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          257 RMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            68999999999999999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-36  Score=319.20  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=196.0

Q ss_pred             hcCCCCCCccc----ceEEEeeeCCcEEEEEEeccC----hHHHHHHHhh--hccCCcccEEEEEecCC----eeEEEee
Q 042486          351 TDDFNPSCWIK----GSVYRGKIGGDFVAIKKVYGD----ASDQIKLLNK--INHSSLIRLLGICFNGG----NWYLVYE  416 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lV~E  416 (635)
                      .++|.....||    |.||+|+.+++.||||.+...    +.+|.+++..  ++||||+++++++...+    ..++|||
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            34565555565    899999999999999998654    4578888887  79999999999998765    7899999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCC-----CCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT-----NPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      |+++|+|.+++...   .+++..++.++.|++.||.|||...     ..+|+||||||+||+++.++.+||+|||++...
T Consensus       121 ~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  197 (342)
T 1b6c_B          121 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  197 (342)
T ss_dssp             CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence            99999999999653   3899999999999999999999210     145999999999999999999999999999765


Q ss_pred             cccCCcee-eecccccCCCccCccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCCCCcchhhHH
Q 042486          492 ERQEGEFA-LTSHIVGTKGYMAPEYLENG------LVSTKLDVYAFGVLMLEMLSG----------KEAPALYSEENMLL  554 (635)
Q Consensus       492 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SlGvvl~elltG----------~~p~~~~~~~~~~l  554 (635)
                      ........ ......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||........  
T Consensus       198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--  275 (342)
T 1b6c_B          198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--  275 (342)
T ss_dssp             ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--
T ss_pred             cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc--
Confidence            44332111 22345799999999998765      234789999999999999999          555532211110  


Q ss_pred             HHhhhcccccCCchhhhhhhcCCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          555 VDVLNPVLHKEDGEESLRHLMDPSMQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       555 ~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                                 ........+.........+     ......+.+|+.+||+.||++|||+.|++++|+++..+
T Consensus       276 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          276 -----------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             -----------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                       0011111112222222222     35667899999999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-37  Score=322.94  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=200.8

Q ss_pred             HHHHHHhhcCCCCCCccc----ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEE
Q 042486          344 FEELQAATDDFNPSCWIK----GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLG  403 (635)
Q Consensus       344 ~~el~~at~~f~~~~~ig----g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~  403 (635)
                      ..+.....++|.....||    |.||+++.       +++.||||.++..        +.+|+.+++++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            333444455666556665    89999974       4579999998653        45799999999 7999999999


Q ss_pred             EEecCC-eeEEEeecccCCCcchhhcccCC--------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeeccc
Q 042486          404 ICFNGG-NWYLVYENAVNGSLSVWINDKGG--------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK  468 (635)
Q Consensus       404 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dik  468 (635)
                      ++...+ ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence            998654 48999999999999999965432              22789999999999999999999954   9999999


Q ss_pred             CCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 042486          469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALY  547 (635)
Q Consensus       469 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~  547 (635)
                      |+||+++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999999999999986544322 123344567889999999999899999999999999999998 88887543


Q ss_pred             cchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          548 SEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       548 ~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ..........              ....    ....+...+..+.+++.+||+.||.+|||+.|++++|+.++...
T Consensus       255 ~~~~~~~~~~--------------~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDEEFCRRL--------------KEGT----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSHHHHHHH--------------HHTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHh--------------ccCc----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            3221111111              0000    11122233456899999999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=322.02  Aligned_cols=229  Identities=25%  Similarity=0.338  Sum_probs=185.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +++.||+|.++.             .+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        25 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  104 (326)
T 2y0a_A           25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF  104 (326)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHH
Confidence            89999998  688999998853             256899999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----cEEEeeecCcccccccCCceeeec
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      +....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++    .+||+|||+++.......    ..
T Consensus       105 l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~  175 (326)
T 2y0a_A          105 LAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FK  175 (326)
T ss_dssp             HTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC----CC
T ss_pred             HHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc----cc
Confidence            96543  4899999999999999999999955   99999999999998887    899999999986543221    23


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ +.........               ....
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~---------------~~~~  239 (326)
T 2y0a_A          176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYE---------------FEDE  239 (326)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHTCCC---------------CCHH
T ss_pred             cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHhcCCC---------------cCcc
Confidence            35799999999999988999999999999999999999999864332211 1111100000               0000


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001223458899999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.6e-37  Score=314.51  Aligned_cols=253  Identities=16%  Similarity=0.179  Sum_probs=193.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEec-----cChHHHHHHHhhhccCCcccEEEEE-ecCCeeEEEeeccc
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVY-----GDASDQIKLLNKINHSSLIRLLGIC-FNGGNWYLVYENAV  419 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~-----~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~E~~~  419 (635)
                      ++|.....||    |.||+++.  +++.||||.+.     ..+.+|++++++++|++++..++.+ ..++..++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            4455555555    89999995  78899999753     3578999999999988877777666 4667789999999 


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCC
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      +++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||+++.......
T Consensus        88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999999996433 23999999999999999999999955   9999999999999   7889999999999986654322


Q ss_pred             ce----eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--hHHHHhhhcccccCCchhh
Q 042486          497 EF----ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--MLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       497 ~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~  570 (635)
                      ..    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ..............     
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  238 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----  238 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-----
Confidence            11    12234679999999999999999999999999999999999999986533221  11111100000000     


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .     +.....    .+..+.+++.+||+.||++||+++|+++.|++++.+.
T Consensus       239 ~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          239 I-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             H-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             h-----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            0     000011    2345899999999999999999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-37  Score=325.65  Aligned_cols=239  Identities=23%  Similarity=0.291  Sum_probs=189.2

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      ++|.....||    |.||++..  +++.||+|.+..         .+.+|+.++++++||||+++++++.+++..|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            3444444554    89999987  688999999853         24579999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC---CcEEEeeecCcccccc
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD---FRAKIANFALARPAER  493 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~  493 (635)
                      |+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||++.....
T Consensus       109 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          109 LVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999999986543  4899999999999999999999955   9999999999999765   4599999999986653


Q ss_pred             cCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      ..    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ...........          
T Consensus       184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~----------  248 (362)
T 2bdw_A          184 SE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYD----------  248 (362)
T ss_dssp             CC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC----------
T ss_pred             Cc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC----------
Confidence            32    1234579999999999999899999999999999999999999986433221 11111110000          


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                           .........+..+.+|+.+||+.||++||++.|++++
T Consensus       249 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 0000112234568999999999999999999999876

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-37  Score=317.37  Aligned_cols=257  Identities=26%  Similarity=0.362  Sum_probs=189.8

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhc---cCCcccEEEEEecCC
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKIN---HSSLIRLLGICFNGG  409 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~---h~nIv~l~~~~~~~~  409 (635)
                      .++|.....||    |.||+++.  +++.||||+++.            .+.+|+.++++++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            34555555555    89999996  789999999852            3557888888775   999999999998654


Q ss_pred             -----eeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEee
Q 042486          410 -----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIAN  484 (635)
Q Consensus       410 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  484 (635)
                           ..++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence                 4799999996 59999997765556999999999999999999999955   99999999999999999999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhccc
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVL  562 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~  562 (635)
                      ||+++......    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  ..+......
T Consensus       164 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          164 FGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998654322    123467899999999999989999999999999999999999998654433211  111111000


Q ss_pred             ccCCch-hhh-hhhcCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          563 HKEDGE-ESL-RHLMDPSMQ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       563 ~~~~~~-~~l-~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...... ..+ .....+...   ....+..+..+.+|+.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000000 000 000000000   00012234568999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.5e-37  Score=319.44  Aligned_cols=240  Identities=29%  Similarity=0.457  Sum_probs=191.8

Q ss_pred             ceEEEeee--CCcE--EEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDF--VAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~--vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  ++..  ||+|.++.        .+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.
T Consensus        39 g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  118 (327)
T 1fvr_A           39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  118 (327)
T ss_dssp             CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred             ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHH
Confidence            89999987  5554  49998854        256799999999 99999999999999999999999999999999996


Q ss_pred             ccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          429 DKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       429 ~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ...              ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~  195 (327)
T 1fvr_A          119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY  195 (327)
T ss_dssp             TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             hcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence            542              235899999999999999999999955   999999999999999999999999998744322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .    ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.              
T Consensus       196 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~--------------  255 (327)
T 1fvr_A          196 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP--------------  255 (327)
T ss_dssp             C----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGG--------------
T ss_pred             c----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhh--------------
Confidence            1    1223456889999999998889999999999999999998 998885433221  111110              


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccccc
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~  627 (635)
                         .......+...+..+.+++.+||+.||++||+++|++++|++++.....+.
T Consensus       256 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          256 ---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             ---GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence               001112233344568999999999999999999999999999998765543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.7e-38  Score=324.94  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=183.1

Q ss_pred             hcCCCCCCccc----ceEEEeeeC--Cc---EEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCee-
Q 042486          351 TDDFNPSCWIK----GSVYRGKIG--GD---FVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNW-  411 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~~--~~---~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-  411 (635)
                      .++|.....||    |.||+++..  +.   .||||.++.+         +.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            34555555555    899999873  22   7999998643         56899999999999999999999876655 


Q ss_pred             -----EEEeecccCCCcchhhcccC----CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEE
Q 042486          412 -----YLVYENAVNGSLSVWINDKG----GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKI  482 (635)
Q Consensus       412 -----~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl  482 (635)
                           ++||||+++|+|.+++....    ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999994321    224899999999999999999999955   999999999999999999999


Q ss_pred             eeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcc
Q 042486          483 ANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPV  561 (635)
Q Consensus       483 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~  561 (635)
                      +|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........        
T Consensus       179 ~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--------  249 (323)
T 3qup_A          179 ADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY--------  249 (323)
T ss_dssp             CCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--------
T ss_pred             eeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH--------
Confidence            999999865433211 11223456788999999999999999999999999999999 88887543322111        


Q ss_pred             cccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          562 LHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       562 ~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                                ..+.... ....+...+..+.+++.+||+.||++|||+.|+++.|++++....
T Consensus       250 ----------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          250 ----------NYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             ----------HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ----------HHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                      1111100 112233344568999999999999999999999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-37  Score=326.21  Aligned_cols=236  Identities=28%  Similarity=0.376  Sum_probs=190.3

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.....||    |.||+++.  +++.||||.++..          +..|..++.++ +||||+++++++.+.+..|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            4555555554    89999998  6889999998642          34688888887 999999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999996543  3899999999999999999999955   999999999999999999999999999754322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  +...                +
T Consensus       172 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~----------------i  230 (345)
T 1xjd_A          172 D---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHS----------------I  230 (345)
T ss_dssp             T---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----------------H
T ss_pred             C---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHH----------------H
Confidence            2   12345689999999999999899999999999999999999999986433221  1111                1


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMD-KIAQS  615 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  615 (635)
                      ....  ..++...+..+.+++.+||+.||++||++. |+++|
T Consensus       231 ~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          231 RMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            1000  122333455689999999999999999997 66654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=327.41  Aligned_cols=257  Identities=14%  Similarity=0.168  Sum_probs=195.1

Q ss_pred             CCCCCCccc----ceEEEeeeC----------CcEEEEEEeccC--hHHHHHHHhhhccCCccc---------------E
Q 042486          353 DFNPSCWIK----GSVYRGKIG----------GDFVAIKKVYGD--ASDQIKLLNKINHSSLIR---------------L  401 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~----------~~~vavK~~~~~--~~~E~~~l~~l~h~nIv~---------------l  401 (635)
                      +|.....||    |.||+++..          ++.||||.+..+  +.+|++++++++||||++               +
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~  122 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC  122 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence            344444444    899999873          679999998654  889999999999999887               6


Q ss_pred             EEEEec-CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC--
Q 042486          402 LGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF--  478 (635)
Q Consensus       402 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~--  478 (635)
                      ++++.. ++..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||+++.++  
T Consensus       123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~  198 (352)
T 2jii_A          123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQS  198 (352)
T ss_dssp             CEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEE
T ss_pred             hhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCc
Confidence            777775 67889999999 999999997653345999999999999999999999954   99999999999999998  


Q ss_pred             cEEEeeecCcccccccCCcee----eecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHH
Q 042486          479 RAKIANFALARPAERQEGEFA----LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL  554 (635)
Q Consensus       479 ~~kl~Dfg~a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l  554 (635)
                      .+||+|||+++..........    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus       199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  278 (352)
T 2jii_A          199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI  278 (352)
T ss_dssp             EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence            999999999986654322111    1133479999999999999899999999999999999999999986543222222


Q ss_pred             HHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          555 VDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       555 ~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      ..........      ...+.+...   .....+..+.+++.+||+.||++||+++|+++.|++++..
T Consensus       279 ~~~~~~~~~~------~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          279 MKQKQKFVDK------PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             HHHHHHHHHS------CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCC------hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111000      000111000   0012235589999999999999999999999999999854

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-37  Score=323.29  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=189.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||||+++..          +.+|..+++++ +||||+++++++.+++..|+||||+++|+|.+++.
T Consensus        23 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~  102 (345)
T 3a8x_A           23 AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ  102 (345)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  6889999998643          45788999888 89999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus       103 ~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~---~~~~~~~gt~  174 (345)
T 3a8x_A          103 RQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTP  174 (345)
T ss_dssp             HHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT---CCBCCCCSCG
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC---CcccccCCCc
Confidence            543  3899999999999999999999955   9999999999999999999999999998543222   1234468999


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||.........         ...........+....  ...|...+
T Consensus       175 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------~~~~~~~~~~~i~~~~--~~~p~~~s  243 (345)
T 3a8x_A          175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---------DQNTEDYLFQVILEKQ--IRIPRSLS  243 (345)
T ss_dssp             GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------CHHHHHHHHHHCC--CCCCTTSC
T ss_pred             cccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc---------ccccHHHHHHHHHcCC--CCCCCCCC
Confidence            999999999989999999999999999999999998542111000         0000001111111111  12334455


Q ss_pred             HHHHHHHHHhhhcCCCCCCCH------HHHHHHHHHHHhhcccccc
Q 042486          589 ILVIRLIESCLKKDPSGRPAM------DKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~------~evl~~L~~~~~~s~~w~~  628 (635)
                      ..+.+++.+||+.||++||++      +|+++|   -.-...+|+.
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h---p~f~~~~w~~  286 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH---PFFRNVDWDM  286 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS---GGGTTCCHHH
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC---CccCCCCHHH
Confidence            668999999999999999996      455544   2334566653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-37  Score=325.14  Aligned_cols=249  Identities=22%  Similarity=0.390  Sum_probs=195.9

Q ss_pred             cCCCCCCccc----ceEEEeeeC--C-----cEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCee
Q 042486          352 DDFNPSCWIK----GSVYRGKIG--G-----DFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNW  411 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~~--~-----~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  411 (635)
                      ++|.....||    |.||+|+..  +     ..||+|.++..        +.+|+.+++++ +||||+++++++.+++..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            3444444554    899999872  2     47999998653        56899999999 899999999999999999


Q ss_pred             EEEeecccCCCcchhhcccC------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc
Q 042486          412 YLVYENAVNGSLSVWINDKG------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR  479 (635)
Q Consensus       412 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~  479 (635)
                      ++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCe
Confidence            99999999999999995431            234899999999999999999999954   999999999999999999


Q ss_pred             EEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhh
Q 042486          480 AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVL  558 (635)
Q Consensus       480 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~  558 (635)
                      +||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||........ .....
T Consensus       203 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~  280 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLV  280 (333)
T ss_dssp             EEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHH
T ss_pred             EEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHH
Confidence            99999999986544322 122334567889999999998899999999999999999999 8888754322211 11111


Q ss_pred             hcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          559 NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       559 ~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .                 .......+...+..+.+++.+||+.||.+|||+.|++++|+++..+
T Consensus       281 ~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          281 K-----------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             H-----------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             h-----------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            1                 1111112223345689999999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.3e-37  Score=321.88  Aligned_cols=240  Identities=26%  Similarity=0.444  Sum_probs=191.8

Q ss_pred             ceEEEeee---------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKI---------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~---------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++.         ++..||||.++.+        +.+|+++++++ +||||+++++++.+++..++||||+++|+|
T Consensus        49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  128 (334)
T 2pvf_A           49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  128 (334)
T ss_dssp             CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBH
T ss_pred             eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcH
Confidence            89999986         3568999998653        45799999999 899999999999999999999999999999


Q ss_pred             chhhcccCC--------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKGG--------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  205 (334)
T 2pvf_A          129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR  205 (334)
T ss_dssp             HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccc
Confidence            999965431              24899999999999999999999955   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.         
T Consensus       206 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---------  273 (334)
T 2pvf_A          206 DINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLLK---------  273 (334)
T ss_dssp             ECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH---------
T ss_pred             ccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--HHHHHh---------
Confidence            6544321 122233457789999999988889999999999999999999 888875432221  111110         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                          ...    ....+...+..+.+++.+||+.||.+||++.|+++.|++++....
T Consensus       274 ----~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          274 ----EGH----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             ----HTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ----cCC----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                000    111223344568999999999999999999999999999987543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.7e-37  Score=324.45  Aligned_cols=241  Identities=21%  Similarity=0.316  Sum_probs=194.1

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      +|.....||    |.||+++.  +++.||||.+..          .+.+|+++|++++||||+++++++.+++..|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            444444554    89999998  689999999853          24579999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      |+++|+|.+++.....  +++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       122 ~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             CCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999976543  899999999999999999999955   999999999999999999999999999865432  


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                  ....+..
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------------------~~~~i~~  252 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------------------IYEKIVS  252 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------------HHHHHHH
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------------------HHHHHHc
Confidence                233579999999999999899999999999999999999999986432211                  1111111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHHHHhhccccc
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-----MDKIAQSISRFLNASLAWE  627 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~~~s~~w~  627 (635)
                      ..  ...+...+..+.+++.+||+.||++||+     ++|+++|  .++ ...+|+
T Consensus       253 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h--~~f-~~~~w~  303 (350)
T 1rdq_E          253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH--KWF-ATTDWI  303 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS--GGG-TTCCHH
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC--cCc-CCCCHH
Confidence            11  1123334556899999999999999998     8888776  233 345664

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.7e-38  Score=325.41  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=197.9

Q ss_pred             HHHHhhcCCCCCCccc----ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEe
Q 042486          346 ELQAATDDFNPSCWIK----GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICF  406 (635)
Q Consensus       346 el~~at~~f~~~~~ig----g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~  406 (635)
                      +.....++|.....||    |.||+|+..       ++.||||.+...        +.+|++++++++|+||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            3334445555555555    899999763       578999998642        457999999999999999999999


Q ss_pred             cCCeeEEEeecccCCCcchhhcccC--------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC
Q 042486          407 NGGNWYLVYENAVNGSLSVWINDKG--------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF  478 (635)
Q Consensus       407 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~  478 (635)
                      +++..++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence            9999999999999999999995421        134799999999999999999999955   99999999999999999


Q ss_pred             cEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHh
Q 042486          479 RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDV  557 (635)
Q Consensus       479 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~  557 (635)
                      .+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ..  
T Consensus       176 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~--  250 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VL--  250 (322)
T ss_dssp             CEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HH--
T ss_pred             eEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HH--
Confidence            999999999986543321 112233457889999999998899999999999999999999 777775432221  11  


Q ss_pred             hhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       558 ~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                                    ..+..... ...+...+..+.+++.+||+.||.+|||+.|++++|++.+..
T Consensus       251 --------------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          251 --------------RFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             --------------HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             --------------HHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                          11111111 112233445689999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.5e-37  Score=328.66  Aligned_cols=250  Identities=18%  Similarity=0.282  Sum_probs=186.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||||+++.+         +.+|+.++++++||||+++++++.+++..++||||+++|+|.+++...
T Consensus        41 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  120 (389)
T 3gni_B           41 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH  120 (389)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT
T ss_pred             eEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh
Confidence            78999998  6899999998642         456999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC----ceeeeccccc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG----EFALTSHIVG  506 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~g  506 (635)
                      ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||.+........    .........|
T Consensus       121 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~g  197 (389)
T 3gni_B          121 FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK  197 (389)
T ss_dssp             CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTT
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccc
Confidence            4455999999999999999999999955   99999999999999999999999999865432211    1112233478


Q ss_pred             CCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc----cCC-chhh---------
Q 042486          507 TKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH----KED-GEES---------  570 (635)
Q Consensus       507 t~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~----~~~-~~~~---------  570 (635)
                      |..|+|||.+.+  ..++.++|||||||++|||++|+.||.......... ........    ... ..+.         
T Consensus       198 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (389)
T 3gni_B          198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTSTIPAEELTMSPSRSV  276 (389)
T ss_dssp             TGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC---------------------------
T ss_pred             cccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhcCCCCccccccccccccccccccccc
Confidence            999999999987  578999999999999999999999986543332211 11110000    000 0000         


Q ss_pred             ----hhhhcC---------CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          571 ----LRHLMD---------PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       571 ----l~~~~d---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ......         .......+...+..+.+|+.+||+.||++|||++|++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                000000         000011223345668999999999999999999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.7e-37  Score=320.44  Aligned_cols=235  Identities=20%  Similarity=0.234  Sum_probs=168.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----hHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----ASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+++.  +++.||||.+..+    ..+|+.+++++. ||||+++++++.+++..|+||||+++|+|.+++....  .
T Consensus        25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~  102 (325)
T 3kn6_A           25 SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--H  102 (325)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS--C
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC--C
Confidence            89999998  6889999998754    457999999997 9999999999999999999999999999999997643  4


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC---cEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF---RAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      +++..+..++.|++.||.|||+.+   |+||||||+||+++.++   .+||+|||+++......   .......||+.|+
T Consensus       103 ~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~  176 (325)
T 3kn6_A          103 FSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYA  176 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---CcccccCCCcCcc
Confidence            999999999999999999999854   99999999999997665   89999999997554322   1223456899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCC--ChHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY--PPVTAI  589 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~--~~~~~~  589 (635)
                      |||.+.+..++.++||||||+++|||++|+.||.......           ......+.+..+.........  ....+.
T Consensus       177 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (325)
T 3kn6_A          177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-----------TCTSAVEIMKKIKKGDFSFEGEAWKNVSQ  245 (325)
T ss_dssp             -------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred             CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-----------ccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence            9999999999999999999999999999999986433210           000111112222221111110  012345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+|+.+||+.||++|||++|++++
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            68999999999999999999999865

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5e-37  Score=312.93  Aligned_cols=230  Identities=24%  Similarity=0.415  Sum_probs=188.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc---ChHHHHHHHhhhccCCcccEEEEEec----------------CCeeEEEeecccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---DASDQIKLLNKINHSSLIRLLGICFN----------------GGNWYLVYENAVN  420 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~----------------~~~~~lV~E~~~~  420 (635)
                      |.||+++.  +++.||+|.++.   .+.+|++++++++||||+++++++..                ....++||||+++
T Consensus        25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  104 (284)
T 2a19_B           25 GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK  104 (284)
T ss_dssp             CCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCS
T ss_pred             eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCC
Confidence            89999998  589999999854   57799999999999999999998864                3457999999999


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      |+|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........    
T Consensus       105 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  177 (284)
T 2a19_B          105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK----  177 (284)
T ss_dssp             CBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC----
T ss_pred             CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc----
Confidence            99999996554455999999999999999999999955   99999999999999999999999999876544321    


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ  580 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~  580 (635)
                      .....+|+.|+|||.+.+..++.++||||||+++|||++|..|+...    ...                ...+.+..+.
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~----------------~~~~~~~~~~  237 (284)
T 2a19_B          178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----SKF----------------FTDLRDGIIS  237 (284)
T ss_dssp             CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHH----------------HHHHHTTCCC
T ss_pred             ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHH----------------HHHhhccccc
Confidence            22356899999999999888999999999999999999999875311    000                1111111111


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                          ...+..+.+++.+||+.||++||++.|++++|..+..+
T Consensus       238 ----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          238 ----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             ----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                22334588999999999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.5e-37  Score=313.35  Aligned_cols=258  Identities=16%  Similarity=0.193  Sum_probs=195.7

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEE-ecCCeeEEEeecccC
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGIC-FNGGNWYLVYENAVN  420 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~E~~~~  420 (635)
                      +|.....||    |.||+|+.  +++.||||.+..     ++.+|+.++++++|++++..++++ ..++..++||||+ +
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   88 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   88 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence            344444444    89999995  789999998753     467899999999998877766666 4567789999999 9


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCCc
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      ++|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||+++........
T Consensus        89 ~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           89 PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            99999996433 34999999999999999999999955   9999999999999   48899999999999866543221


Q ss_pred             e----eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--hHHHHhhhcccccCCchhhh
Q 042486          498 F----ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--MLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       498 ~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~l  571 (635)
                      .    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ..............     .
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~  239 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----I  239 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----H
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-----h
Confidence            1    11234579999999999999999999999999999999999999986532211  11111110000000     0


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc-------cccccc
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS-------LAWELS  629 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s-------~~w~~~  629 (635)
                           +.+...    .+..+.+++.+||+.||++||+++|+++.|++++...       +||+..
T Consensus       240 -----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 3uzp_A          240 -----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             -----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred             -----HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence                 000112    2345899999999999999999999999999998553       667653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.1e-37  Score=325.68  Aligned_cols=231  Identities=22%  Similarity=0.277  Sum_probs=176.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+++.  +++.||||++..      .+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++....  
T Consensus        34 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--  111 (361)
T 3uc3_A           34 GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--  111 (361)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--
T ss_pred             EEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--
Confidence            89999998  788999999864      35689999999999999999999999999999999999999999996543  


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc--EEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR--AKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.  +||+|||+++......    ......||+.|+
T Consensus       112 ~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~  184 (361)
T 3uc3_A          112 RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYI  184 (361)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------------------CTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC----CCCCCcCCCCcC
Confidence            3899999999999999999999855   999999999999987765  9999999987433221    123457999999


Q ss_pred             CccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          512 APEYLENGLVSTK-LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~s~k-sDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      |||++.+..++.+ +|||||||++|+|++|+.||........              ....+..+.............+..
T Consensus       185 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--------------YRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             CHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--------------HHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             ChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--------------HHHHHHHHhcCCCCCCCcCCCCHH
Confidence            9999988777655 8999999999999999999864322110              011111222211111111123456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+|+.+||+.||++|||+.|+++|
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhC
Confidence            8999999999999999999999988

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.9e-37  Score=318.02  Aligned_cols=243  Identities=23%  Similarity=0.350  Sum_probs=184.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc-
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK-  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-  430 (635)
                      |.||+|+.  +++.||||+++.        .+.+|++++++++||||+++++++.+++..++||||++ |+|.+++... 
T Consensus        19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~   97 (317)
T 2pmi_A           19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT   97 (317)
T ss_dssp             CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcc
Confidence            89999987  689999998853        25689999999999999999999999999999999998 5999988542 


Q ss_pred             ---CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 ---GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                         ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   ......+|
T Consensus        98 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t  171 (317)
T 2pmi_A           98 VGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEVVT  171 (317)
T ss_dssp             SSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC---CCCCCCSC
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc---cCCCCccc
Confidence               1234899999999999999999999954   99999999999999999999999999986543221   12335789


Q ss_pred             CCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCCc----------------h
Q 042486          508 KGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKEDG----------------E  568 (635)
Q Consensus       508 ~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~----------------~  568 (635)
                      +.|+|||.+.+ ..++.++|||||||++|||++|+.||.........  ..+...........                .
T Consensus       172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (317)
T 2pmi_A          172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPP  251 (317)
T ss_dssp             CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCC
T ss_pred             ccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccc
Confidence            99999999876 46899999999999999999999998754433211  11111100000000                0


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+...+.+....    ..+..+.+|+.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          252 RDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0011111111111    233458999999999999999999999876

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.8e-37  Score=313.91  Aligned_cols=244  Identities=25%  Similarity=0.340  Sum_probs=181.8

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++. +++.||+|+++.         .+.+|++++++++||||+++++++.+++..++||||+++ +|.+++....
T Consensus        16 g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   94 (288)
T 1ob3_A           16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE   94 (288)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST
T ss_pred             EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc
Confidence            89999998 588999999853         245899999999999999999999999999999999975 8998886543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   .......+|+.|+
T Consensus        95 -~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~  167 (288)
T 1ob3_A           95 -GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYR  167 (288)
T ss_dssp             -TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTTC
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc---ccccccccccccc
Confidence             33899999999999999999999954   9999999999999999999999999987553221   1123356899999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh---cccccCCch-hhhhhhcCCcCC------
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN---PVLHKEDGE-ESLRHLMDPSMQ------  580 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~---~~~~~~~~~-~~l~~~~d~~~~------  580 (635)
                      |||.+.+ ..++.++||||||+++|||++|+.||........ +.....   ......... .... ..++...      
T Consensus       168 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  245 (288)
T 1ob3_A          168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELP-KYDPNFTVYEPLP  245 (288)
T ss_dssp             CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST-TCCTTCCCCCCCC
T ss_pred             CchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhccc-ccccccccccCcc
Confidence            9999875 4589999999999999999999999875443321 111111   100000000 0000 0111110      


Q ss_pred             -CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 -GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       .......+..+.+|+.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             01112244568999999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=332.64  Aligned_cols=262  Identities=22%  Similarity=0.267  Sum_probs=204.3

Q ss_pred             ccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEE
Q 042486          342 YTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGIC  405 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~  405 (635)
                      +.++++....++|.....||    |.||+++.  +++.||||+++.          .+.+|.+++.+++|+||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            45667777778888877776    89999998  689999999853          356899999999999999999999


Q ss_pred             ecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       406 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                      .+++..|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999996543 24899999999999999999999955   999999999999999999999999


Q ss_pred             cCcccccccCCceeeecccccCCCccCccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhh
Q 042486          486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLE-------NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVL  558 (635)
Q Consensus       486 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~  558 (635)
                      |+++.......  .......||+.|+|||++.       ...++.++|||||||++|||++|+.||...+.... .....
T Consensus       207 Gla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~  283 (412)
T 2vd5_A          207 GSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIV  283 (412)
T ss_dssp             TTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH
T ss_pred             hhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence            99986543321  1233468999999999987       35689999999999999999999999865332211 11111


Q ss_pred             hcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHHHHHHHhhcccccc
Q 042486          559 NPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR---PAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       559 ~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L~~~~~~s~~w~~  628 (635)
                      ...          ..+..+..    +...+..+.+||.+||. +|++|   |+++|+++|  .++ ..++|+.
T Consensus       284 ~~~----------~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H--pff-~~i~w~~  338 (412)
T 2vd5_A          284 HYK----------EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH--PFF-FGLDWDG  338 (412)
T ss_dssp             THH----------HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS--GGG-TTCCSTT
T ss_pred             hcc----------cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC--CCc-CCCCHHH
Confidence            000          00001111    12234558999999999 99998   589998776  344 4567865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=345.73  Aligned_cols=238  Identities=23%  Similarity=0.359  Sum_probs=187.8

Q ss_pred             ceEEEeee----CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|.+    ++..||||.++.        ++.+|+++|++++||||++++++|.. +..++||||+++|+|.+++..
T Consensus       350 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~  428 (613)
T 2ozo_A          350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  428 (613)
T ss_dssp             SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT
T ss_pred             cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh
Confidence            89999987    355799999864        25689999999999999999999976 568999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++................++..
T Consensus       429 ~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~  504 (613)
T 2ozo_A          429 KR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK  504 (613)
T ss_dssp             CT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCT
T ss_pred             cc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccc
Confidence            43 34899999999999999999999954   999999999999999999999999999876543322222223346689


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||++.+..++.++|||||||++|||++ |+.||......+  ....+.                 .......+..++
T Consensus       505 y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~-----------------~~~~~~~p~~~~  565 (613)
T 2ozo_A          505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE-----------------QGKRMECPPECP  565 (613)
T ss_dssp             TSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHH-----------------TTCCCCCCTTCC
T ss_pred             eeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH-----------------cCCCCCCCCcCC
Confidence            999999998999999999999999999998 999886433221  111111                 111122334455


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ..+.+|+.+||+.||++||++.+|++.|+.++.+.
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            66999999999999999999999999999987654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-37  Score=314.78  Aligned_cols=238  Identities=24%  Similarity=0.375  Sum_probs=186.7

Q ss_pred             ceEEEeeeC-----CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|++.     +..||||.++.+        +.+|+.++++++||||+++++++.+ +..++||||+++++|.+++.
T Consensus        26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~  104 (281)
T 3cc6_A           26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLE  104 (281)
T ss_dssp             SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHH
T ss_pred             eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHH
Confidence            899999862     236999998653        4579999999999999999999864 45689999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  .......++.
T Consensus       105 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~  178 (281)
T 3cc6_A          105 RNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY--YKASVTRLPI  178 (281)
T ss_dssp             HHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-----------CCCCCG
T ss_pred             hcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc--cccccCCCCc
Confidence            543 33899999999999999999999955   99999999999999999999999999986544321  1123345788


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||........  .....             ...    ....+...
T Consensus       179 ~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~~~~-------------~~~----~~~~~~~~  239 (281)
T 3cc6_A          179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IGVLE-------------KGD----RLPKPDLC  239 (281)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HHHHH-------------HTC----CCCCCTTC
T ss_pred             ceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HHHHh-------------cCC----CCCCCCCC
Confidence            9999999998899999999999999999998 9998864332221  11110             000    01112233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA  625 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~  625 (635)
                      +..+.+++.+||+.||++||++.|++++|+++.....+
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence            45589999999999999999999999999999875543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=320.74  Aligned_cols=254  Identities=22%  Similarity=0.377  Sum_probs=193.5

Q ss_pred             ceEEEeee------CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCC--eeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI------GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~------~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~  426 (635)
                      |.||++++      +++.||||++..       .+.+|++++++++|+||+++++++...+  ..++||||+++++|.++
T Consensus        55 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  134 (326)
T 2w1i_A           55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY  134 (326)
T ss_dssp             EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHH
T ss_pred             eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHH
Confidence            89999984      688999999864       3568999999999999999999987654  67999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +.... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.................+
T Consensus       135 l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~  210 (326)
T 2w1i_A          135 LQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES  210 (326)
T ss_dssp             HHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSC
T ss_pred             HHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCC
Confidence            97643 34899999999999999999999854   999999999999999999999999999876544322222333467


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      +..|+|||.+.+..++.++||||||+++|||++|+.|+.....+.   .+..............+.+.+........+..
T Consensus       211 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (326)
T 2w1i_A          211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG  287 (326)
T ss_dssp             CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH---HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTT
T ss_pred             ceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH---HHhhccccchhhhHHHHHHHhhcCCCCCCCCc
Confidence            788999999998889999999999999999999998865321111   01100000000000111122222212223444


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .+..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       288 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          288 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            556799999999999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.4e-38  Score=324.29  Aligned_cols=239  Identities=19%  Similarity=0.267  Sum_probs=177.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCe----eEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGN----WYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.  +++.||||.++.+          +.+|++++++++||||+++++++...+.    .|+||||+++++|.+
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~  105 (311)
T 3ork_A           26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  105 (311)
T ss_dssp             EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHH
T ss_pred             EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHH
Confidence            89999996  7889999998653          4578999999999999999999876543    499999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++................
T Consensus       106 ~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  180 (311)
T 3ork_A          106 IVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI  180 (311)
T ss_dssp             HHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----------------
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccC
Confidence            996543  3899999999999999999999955   99999999999999999999999999986654433223334467


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .......   ....            ....
T Consensus       181 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~---~~~~------------~~~~  244 (311)
T 3ork_A          181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVREDP---IPPS------------ARHE  244 (311)
T ss_dssp             -CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCCC---CCHH------------HHST
T ss_pred             cCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCC---CCcc------------cccC
Confidence            9999999999999999999999999999999999999986543322111 1111000   0000            0011


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHH-HHHHHHHHHh
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDK-IAQSISRFLN  621 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~~~~  621 (635)
                      ..+..+.+++.+||+.||++||++.+ +.+.|.++..
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            13345899999999999999996555 4455555543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=324.21  Aligned_cols=230  Identities=25%  Similarity=0.386  Sum_probs=181.0

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhhcc--CCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKINH--SSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++.. +++.||||++..         .+.+|+.+|++++|  +||+++++++.+++..++||| +.+++|.+++..
T Consensus        23 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~  101 (343)
T 3dbq_A           23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  101 (343)
T ss_dssp             EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred             eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh
Confidence            89999988 688999998853         25679999999976  999999999999999999999 568899999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++.++..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++........ .......||+.
T Consensus       102 ~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~  174 (343)
T 3dbq_A          102 KK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGTVN  174 (343)
T ss_dssp             SC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------------CCCCS
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc-ccCCCCcCCcC
Confidence            43  3899999999999999999999955   99999999999997 678999999999866443211 12334579999


Q ss_pred             ccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          510 YMAPEYLEN-----------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       510 y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      |+|||++.+           ..++.++|||||||++|||++|+.||.......                 ..+...+++.
T Consensus       175 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------------~~~~~~~~~~  237 (343)
T 3dbq_A          175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----------------SKLHAIIDPN  237 (343)
T ss_dssp             SCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----------------HHHHHHHCTT
T ss_pred             cCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----------------HHHHHHhcCC
Confidence            999999864           678999999999999999999999985322211                 2222333333


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            33344444456689999999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.7e-37  Score=312.26  Aligned_cols=239  Identities=25%  Similarity=0.411  Sum_probs=189.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|.....||    |.||+++.  ++..||||.+..          .+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            3444444554    89999988  577899998843          2567999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            9999999999996543  389999999999999999999985   49999999999999999999999999986543321


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM  575 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  575 (635)
                           .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........  ...+                .
T Consensus       164 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----------------~  220 (279)
T 3fdn_A          164 -----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRI----------------S  220 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH----------------H
T ss_pred             -----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHH----------------H
Confidence                 2335789999999999999999999999999999999999999864322211  0100                0


Q ss_pred             CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          576 DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       576 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .  .....+...+..+.+|+.+||+.||++||+++|++++  .++..
T Consensus       221 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h--~~~~~  263 (279)
T 3fdn_A          221 R--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH--PWITA  263 (279)
T ss_dssp             H--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC--HHHHH
T ss_pred             h--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC--ccccC
Confidence            0  0112233344568999999999999999999999998  44443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.1e-37  Score=322.93  Aligned_cols=224  Identities=23%  Similarity=0.325  Sum_probs=184.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.+..          .+.+|+.++++++||||+++++++.+.+..++||||+ +|+|.+++..
T Consensus        23 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~  101 (336)
T 3h4j_B           23 GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE  101 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH
Confidence            89999997  788999998853          3568999999999999999999999999999999999 7899998865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.......    ......||+.
T Consensus       102 ~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~----~~~~~~gt~~  172 (336)
T 3h4j_B          102 KK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPN  172 (336)
T ss_dssp             HC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB----TTCCCTTSTT
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc----ccccccCCcC
Confidence            43  3899999999999999999999965   9999999999999999999999999998654332    1234579999


Q ss_pred             ccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||.+.+..+ ++++||||||+++|+|++|+.||.......                  ....+...  ....+...+
T Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------------~~~~i~~~--~~~~p~~~s  232 (336)
T 3h4j_B          173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------------LFKKVNSC--VYVMPDFLS  232 (336)
T ss_dssp             TSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------------CBCCCCSS--CCCCCTTSC
T ss_pred             cCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------------HHHHHHcC--CCCCcccCC
Confidence            999999987765 789999999999999999999985322110                  00001000  112233445


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+|+.+||+.||.+|||++|++++
T Consensus       233 ~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          233 PGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            668999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.2e-37  Score=349.20  Aligned_cols=237  Identities=25%  Similarity=0.420  Sum_probs=187.4

Q ss_pred             ceEEEeee----CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|.+    .++.||||+++.         ++.+|+++|++++||||+++++++.. +..++||||+++|+|.+++.
T Consensus       383 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~  461 (635)
T 4fl3_A          383 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ  461 (635)
T ss_dssp             EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred             EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh
Confidence            89999965    457899999864         35689999999999999999999964 55899999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..++.|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++................+|.
T Consensus       462 ~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~  536 (635)
T 4fl3_A          462 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV  536 (635)
T ss_dssp             HCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CG
T ss_pred             hCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCce
Confidence            543  3899999999999999999999955   99999999999999999999999999986654332222233345778


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||++.+..++.++|||||||++|||++ |+.||.......  ....+                 ........+...
T Consensus       537 ~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i-----------------~~~~~~~~p~~~  597 (635)
T 4fl3_A          537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML-----------------EKGERMGCPAGC  597 (635)
T ss_dssp             GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH-----------------HTTCCCCCCTTC
T ss_pred             eeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-----------------HcCCCCCCCCCC
Confidence            9999999999999999999999999999998 999886433221  11111                 111112233445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +..+.+|+.+||+.||++||++.+|++.|++++.+.
T Consensus       598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            566999999999999999999999999999988653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-36  Score=315.24  Aligned_cols=239  Identities=24%  Similarity=0.317  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||+++.          ++.+|+.++++++|+||+++++++..++..++||||+++++|.+++..
T Consensus        46 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  125 (310)
T 2wqm_A           46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH  125 (310)
T ss_dssp             CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHH
T ss_pred             ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHH
Confidence            89999986  789999998863          245799999999999999999999999999999999999999999854


Q ss_pred             --cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 --KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 --~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                        .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   .......++
T Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~  199 (310)
T 2wqm_A          126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGT  199 (310)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------------------C
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC---ccccccCCC
Confidence              23345899999999999999999999955   9999999999999999999999999987654322   112335689


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||.........+...+                .............
T Consensus       200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~  263 (310)
T 2wqm_A          200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------------EQCDYPPLPSDHY  263 (310)
T ss_dssp             CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----------------HTTCSCCCCTTTS
T ss_pred             eeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----------------hcccCCCCccccc
Confidence            999999999998999999999999999999999999854322211111111                0111111111233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            45689999999999999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.8e-37  Score=323.76  Aligned_cols=246  Identities=25%  Similarity=0.355  Sum_probs=193.7

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.....||    |.||+++.  +++.||||.++..          +..|..+|.++ +||||+++++++.+.+..|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            3455445555    89999998  4689999998642          34688888887 899999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999997543  3899999999999999999999955   999999999999999999999999999854322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...                  ....+
T Consensus       175 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------------------~~~~i  233 (353)
T 2i0e_A          175 G---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------------------LFQSI  233 (353)
T ss_dssp             T---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------------HHHHH
T ss_pred             C---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------------------HHHHH
Confidence            1   12345679999999999999999999999999999999999999986433221                  11111


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHHHHhhcccccc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-----MDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~~~s~~w~~  628 (635)
                      +...  ..+|...+..+.+|+.+||+.||++||+     ++|+++|   -.-..++|+.
T Consensus       234 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h---~~f~~~~w~~  287 (353)
T 2i0e_A          234 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH---AFFRYIDWEK  287 (353)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS---GGGTTCCHHH
T ss_pred             HhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC---ccccCCCHHH
Confidence            1111  1223344566899999999999999996     4666655   2223466654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-37  Score=321.84  Aligned_cols=230  Identities=23%  Similarity=0.394  Sum_probs=178.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCC----------------------
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGG----------------------  409 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~----------------------  409 (635)
                      |.||+++.  +++.||||+++.        .+.+|+++|++++||||+++++++.+.+                      
T Consensus        20 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (332)
T 3qd2_B           20 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL   99 (332)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred             eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence            89999998  689999999852        3568999999999999999999986543                      


Q ss_pred             -----------------------------------eeEEEeecccCCCcchhhcccCC-CCCCHHHHHHHHHHHHhhhcc
Q 042486          410 -----------------------------------NWYLVYENAVNGSLSVWINDKGG-KFLDWAQRIQIALDVATGLNY  453 (635)
Q Consensus       410 -----------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~  453 (635)
                                                         ..++||||+++|+|.+++..... ...++..++.++.|++.||.|
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  179 (332)
T 3qd2_B          100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF  179 (332)
T ss_dssp             --------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHH
Confidence                                               27999999999999999965432 346777899999999999999


Q ss_pred             cccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc---------eeeecccccCCCccCccccccCCCCcc
Q 042486          454 LHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE---------FALTSHIVGTKGYMAPEYLENGLVSTK  524 (635)
Q Consensus       454 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~k  524 (635)
                      ||+.+   |+||||||+||+++.++.+||+|||+++........         ........||+.|+|||.+.+..++.+
T Consensus       180 LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  256 (332)
T 3qd2_B          180 LHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK  256 (332)
T ss_dssp             HHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTH
T ss_pred             HHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcch
Confidence            99855   999999999999999999999999999866543211         011233579999999999999999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCC
Q 042486          525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPS  604 (635)
Q Consensus       525 sDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~  604 (635)
                      +||||||+++|||++|..|+.    +......                ....... ..........+.+++.+||+.||+
T Consensus       257 ~Di~slG~il~el~~~~~~~~----~~~~~~~----------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          257 VDIFSLGLILFELLYSFSTQM----ERVRIIT----------------DVRNLKF-PLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             HHHHHHHHHHHHHHSCCCCHH----HHHHHHH----------------HHHTTCC-CHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             hhHHHHHHHHHHHHHcCCChh----HHHHHHH----------------HhhccCC-CcccccCChhHHHHHHHHccCCCC
Confidence            999999999999999876531    0000000                0000000 001122334578999999999999


Q ss_pred             CCCCHHHHHHH
Q 042486          605 GRPAMDKIAQS  615 (635)
Q Consensus       605 ~RPs~~evl~~  615 (635)
                      +|||++|++++
T Consensus       316 ~Rps~~~~l~~  326 (332)
T 3qd2_B          316 ERPEATDIIEN  326 (332)
T ss_dssp             GSCCHHHHHHS
T ss_pred             cCCCHHHHhhc
Confidence            99999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=322.34  Aligned_cols=239  Identities=23%  Similarity=0.399  Sum_probs=183.5

Q ss_pred             ceEEEeee--CCc----EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGD----FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~----~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+.  +++    .||+|.+..        .+.+|+.++++++||||+++++++..+. .++|+||+.+|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l  107 (327)
T 3lzb_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHH
Confidence            89999987  444    357887643        2568999999999999999999998654 78999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ..... .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........ .......+|
T Consensus       108 ~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~~t  182 (327)
T 3lzb_A          108 REHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVP  182 (327)
T ss_dssp             HHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----------------CCC
T ss_pred             HhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc-ccccCCCcc
Confidence            65433 3899999999999999999999955   999999999999999999999999999866443221 122234567


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||........  ..                 .+........+..
T Consensus       183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~-----------------~~~~~~~~~~~~~  243 (327)
T 3lzb_A          183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SS-----------------ILEKGERLPQPPI  243 (327)
T ss_dssp             GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH-----------------HHHTTCCCCCCTT
T ss_pred             ccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HH-----------------HHHcCCCCCCCcc
Confidence            88999999999999999999999999999999 9988864332221  11                 1111111122334


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA  625 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~  625 (635)
                      .+..+.+++.+||+.||.+||++.|+++.|+++......
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  282 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence            455689999999999999999999999999999865433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.4e-37  Score=319.75  Aligned_cols=226  Identities=22%  Similarity=0.367  Sum_probs=179.7

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC-----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD-----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~-----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.     +++.||+|.++..           +.+|+++|++++||||+++++++.+++..|+||||+++|+|.+
T Consensus        31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  110 (327)
T 3a62_A           31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM  110 (327)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHH
T ss_pred             EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHH
Confidence            89999986     6789999998642           4569999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......
T Consensus       111 ~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~  182 (327)
T 3a62_A          111 QLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTFC  182 (327)
T ss_dssp             HHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-------------CTTS
T ss_pred             HHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCC---ccccccC
Confidence            996543  3899999999999999999999955   9999999999999999999999999987543221   1233467


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .                 ..+....  ...+.
T Consensus       183 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-----------------~~i~~~~--~~~p~  242 (327)
T 3a62_A          183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-I-----------------DKILKCK--LNLPP  242 (327)
T ss_dssp             SCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-----------------HHHHHTC--CCCCT
T ss_pred             CCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-H-----------------HHHHhCC--CCCCC
Confidence            99999999999988899999999999999999999999864332211 1                 1111111  11233


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ..+..+.+++.+||+.||++||     +++|+++|
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            3455689999999999999999     67777765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-37  Score=318.98  Aligned_cols=231  Identities=20%  Similarity=0.365  Sum_probs=183.3

Q ss_pred             ceEEEeee--CC-------cEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GG-------DFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~-------~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|+.  ++       ..||+|.+..       .+.+|++++++++||||+++++++.+++..++||||+++|+|.+
T Consensus        22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  101 (289)
T 4fvq_A           22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT  101 (289)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHH
T ss_pred             ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHH
Confidence            89999987  33       5799999854       25689999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc--------EEEeeecCcccccccCCc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR--------AKIANFALARPAERQEGE  497 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~Dfg~a~~~~~~~~~  497 (635)
                      ++.... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.        +||+|||++......   
T Consensus       102 ~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---  174 (289)
T 4fvq_A          102 YLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---  174 (289)
T ss_dssp             HHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---
T ss_pred             HHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---
Confidence            996543 33899999999999999999999955   999999999999988877        999999998754322   


Q ss_pred             eeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          498 FALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                          ....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+............. ..               .
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~---------------~  234 (289)
T 4fvq_A          175 ----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-ED---------------R  234 (289)
T ss_dssp             ----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HT---------------T
T ss_pred             ----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hc---------------c
Confidence                22457889999999987 778999999999999999999766654322221111100 00               0


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ...    +...+..+.+++.+||+.||++|||++|++++|++++...
T Consensus       235 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          235 HQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             CCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            011    1111234789999999999999999999999999988654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-36  Score=326.71  Aligned_cols=236  Identities=20%  Similarity=0.257  Sum_probs=178.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc--ChHHHHHHHhhh-ccCCcccEEEEEec----CCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--DASDQIKLLNKI-NHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||||+++.  .+.+|++++.++ +|+||+++++++..    .+..|+||||+++|+|.+++.....
T Consensus        76 g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~  155 (400)
T 1nxk_A           76 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD  155 (400)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC--
T ss_pred             eEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC
Confidence            89999987  688999999865  356888887554 89999999999875    5678999999999999999976555


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++......    ......||+.
T Consensus       156 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~  228 (400)
T 1nxk_A          156 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPY  228 (400)
T ss_dssp             -CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------CT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC----ccccCCCCCC
Confidence            56999999999999999999999955   999999999999987   7899999999998554321    1234578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||.........           ......+.. -............+.
T Consensus       229 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------~~~~~~i~~-~~~~~~~~~~~~~s~  296 (400)
T 1nxk_A          229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRM-GQYEFPNPEWSEVSE  296 (400)
T ss_dssp             TCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-----------CSHHHHHHH-TCCCCCTTTTTTSCH
T ss_pred             ccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-----------HHHHHHHHc-CcccCCCcccccCCH
Confidence            99999999999999999999999999999999998643221100           000000000 000000011123445


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+.+||.+||+.||++|||+.|++++-
T Consensus       297 ~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          297 EVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            689999999999999999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-36  Score=312.36  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=190.7

Q ss_pred             ceEEEeee--CC---cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCee-EEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GG---DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNW-YLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~---~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++  ++   ..||+|.+..        .+.+|+.++++++||||+++++++.+.+.. ++||||+.+|+|.+++
T Consensus        35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  114 (298)
T 3pls_A           35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI  114 (298)
T ss_dssp             EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence            89999986  22   2799999864        245799999999999999999999876655 9999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-ceeeeccccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-EFALTSHIVG  506 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~g  506 (635)
                      .... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....... .........+
T Consensus       115 ~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  190 (298)
T 3pls_A          115 RSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL  190 (298)
T ss_dssp             HCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTC
T ss_pred             hccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCC
Confidence            6533 34899999999999999999999955   99999999999999999999999999986543221 1122234567


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      +..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ......                 .......+..
T Consensus       191 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~  252 (298)
T 3pls_A          191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLA-----------------QGRRLPQPEY  252 (298)
T ss_dssp             GGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHH-----------------TTCCCCCCTT
T ss_pred             CccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhh-----------------cCCCCCCCcc
Confidence            8899999999999999999999999999999997766543222111 111110                 0011122233


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhccc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA  625 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~  625 (635)
                      .+..+.+++.+||+.||.+|||++|+++.|++++.....
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            445689999999999999999999999999999887543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=324.68  Aligned_cols=239  Identities=23%  Similarity=0.240  Sum_probs=190.3

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeeccc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV  419 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~  419 (635)
                      .|.....||    |.||+++.  +++.||+|.+...       +.+|+++|++++||||+++++++.+++..++||||++
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            344444454    89999987  6889999998643       5689999999999999999999999999999999999


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC--CCcEEEeeecCcccccccCCc
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT--DFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....... 
T Consensus       132 gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-  206 (387)
T 1kob_A          132 GGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-  206 (387)
T ss_dssp             CCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred             CCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence            999999996543 24899999999999999999999955   999999999999974  57899999999986643321 


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.......               .
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~---------------~  267 (387)
T 1kob_A          207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCD---------------W  267 (387)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCC---------------C
T ss_pred             ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC---------------C
Confidence               223479999999999999899999999999999999999999986533221 111111000               0


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..........+..+.+||.+||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            01111122334568999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.7e-37  Score=323.64  Aligned_cols=262  Identities=19%  Similarity=0.277  Sum_probs=197.0

Q ss_pred             cccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhc-----cCCcccEEE
Q 042486          341 VYTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKIN-----HSSLIRLLG  403 (635)
Q Consensus       341 ~~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~-----h~nIv~l~~  403 (635)
                      .+++++.....++|.....||    |.||+++.  +++.||||.++.      .+..|+.+++++.     |+||+++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344444444556676666665    89999998  788999999864      2456899999986     999999999


Q ss_pred             EEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-------
Q 042486          404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-------  476 (635)
Q Consensus       404 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-------  476 (635)
                      ++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.       
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccc
Confidence            999999999999999 999999997665556999999999999999999999955   999999999999975       


Q ss_pred             ------------------CCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHH
Q 042486          477 ------------------DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEML  538 (635)
Q Consensus       477 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ell  538 (635)
                                        ++.+||+|||+++......      ....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                              7899999999998644322      2357899999999999999999999999999999999


Q ss_pred             hCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh--------cC-Cc----CCCCCC----------------hHHHH
Q 042486          539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL--------MD-PS----MQGNYP----------------PVTAI  589 (635)
Q Consensus       539 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~--------~d-~~----~~~~~~----------------~~~~~  589 (635)
                      +|+.||........  ...+........ .......        .+ ..    ......                .....
T Consensus       254 ~g~~pf~~~~~~~~--~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          254 TGSLLFRTHEHMEH--LAMMESIIQPIP-KNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HSSCSCCCSSHHHH--HHHHHHHTCCCC-HHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HCCCCCCCCcHHHH--HHHHHHhcCCCC-HHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            99999875443221  111111111000 0000000        00 00    000000                00124


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+|+.+||+.||++|||++|++++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            57899999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.7e-37  Score=321.41  Aligned_cols=246  Identities=19%  Similarity=0.266  Sum_probs=188.5

Q ss_pred             ceEEEeeeCCcEEEEEEec------------------------cChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          362 GSVYRGKIGGDFVAIKKVY------------------------GDASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~------------------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      |.||+++.+++.||||.+.                        ..+.+|++++++++||||+++++++.+.+..++||||
T Consensus        45 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  124 (348)
T 2pml_X           45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY  124 (348)
T ss_dssp             CCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEEC
T ss_pred             eEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEec
Confidence            8999999999999999874                        3456899999999999999999999999999999999


Q ss_pred             ccCCCcchh------hcccCCCCCCHHHHHHHHHHHHhhhccccc-CCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          418 AVNGSLSVW------INDKGGKFLDWAQRIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       418 ~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      +++|+|.++      +.......+++..++.++.|++.||.|||+ .+   ++||||||+||+++.++.+||+|||++..
T Consensus       125 ~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  201 (348)
T 2pml_X          125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEY  201 (348)
T ss_dssp             CTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccc
Confidence            999999999      655434569999999999999999999998 55   99999999999999999999999999976


Q ss_pred             ccccCCceeeecccccCCCccCccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLENG-LVST-KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ....     ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||........................
T Consensus       202 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~  276 (348)
T 2pml_X          202 MVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR  276 (348)
T ss_dssp             CBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS
T ss_pred             cccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch
Confidence            5432     23345789999999999876 5666 999999999999999999998754432222211111111101000


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ........+..........+..+.+|+.+||+.||.+||++.|++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000000000001112344568999999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.3e-37  Score=334.89  Aligned_cols=236  Identities=25%  Similarity=0.348  Sum_probs=185.5

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|.....||    |.||+++.  +++.||||.++.          .+.+|+.+|++++||||+++++++.+.+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            3444445555    89999987  788999999864          2446889999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhccccc-CCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHS-FTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      ||+++|+|.+++....  .+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       228 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          228 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             CCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             eeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999996543  38999999999999999999997 55   999999999999999999999999999754322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  +...                +
T Consensus       303 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~----------------i  361 (446)
T 4ejn_A          303 G---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL----------------I  361 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----------------H
T ss_pred             C---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHH----------------H
Confidence            2   12344679999999999999999999999999999999999999986433221  1111                1


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ....  ...+...+..+.+||.+||+.||++||     +++|+++|
T Consensus       362 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          362 LMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            1111  112333445689999999999999999     99999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=323.73  Aligned_cols=228  Identities=21%  Similarity=0.336  Sum_probs=184.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+..          .+.+|+++|++++||||+++++++.+.+..|+||||+.+|+|.+++..
T Consensus        29 G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~  108 (384)
T 4fr4_A           29 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ  108 (384)
T ss_dssp             CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh
Confidence            89999987  678999998853          245799999999999999999999999999999999999999999975


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......    ......||+.
T Consensus       109 ~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~gt~~  179 (384)
T 4fr4_A          109 NV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKP  179 (384)
T ss_dssp             TC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC----CBCCCCSCGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC----ceeccCCCcc
Confidence            43  3899999999999999999999955   9999999999999999999999999998654322    2344679999


Q ss_pred             ccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||++..   ..++.++|||||||++|||++|+.||.........               +....+...  ...++..
T Consensus       180 Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---------------~~~~~~~~~--~~~~p~~  242 (384)
T 4fr4_A          180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---------------EIVHTFETT--VVTYPSA  242 (384)
T ss_dssp             GCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH---------------HHHHHHHHC--CCCCCTT
T ss_pred             ccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH---------------HHHHHHhhc--ccCCCCc
Confidence            999999864   45899999999999999999999998643222110               111111100  1123344


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPA-MDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs-~~evl~~  615 (635)
                      .+..+.+|+.+||+.||++||+ +++++++
T Consensus       243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            4566899999999999999998 6666553

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.1e-37  Score=323.24  Aligned_cols=225  Identities=27%  Similarity=0.397  Sum_probs=181.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||||++..          ++.+|+++|++++||||+++++++.+++..++||||+. |+|.+++..
T Consensus        68 g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~  146 (348)
T 1u5q_A           68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV  146 (348)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred             EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH
Confidence            89999986  789999999853          25689999999999999999999999999999999997 688888754


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....       ....||+.
T Consensus       147 ~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-------~~~~gt~~  215 (348)
T 1u5q_A          147 HK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPY  215 (348)
T ss_dssp             HT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CCCCSCGG
T ss_pred             hc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-------CcccCCcc
Confidence            33 34899999999999999999999955   999999999999999999999999999765432       23579999


Q ss_pred             ccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+|||++.   .+.++.++||||||+++|||++|+.||........ +......              ..+.   ..+..
T Consensus       216 y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~--------------~~~~---~~~~~  277 (348)
T 1u5q_A          216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN--------------ESPA---LQSGH  277 (348)
T ss_dssp             GCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS--------------CCCC---CCCTT
T ss_pred             eeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc--------------CCCC---CCCCC
Confidence            99999984   56789999999999999999999999864332211 1111110              0011   11222


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+..+.+++.+||+.||++|||++|++++.
T Consensus       278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            345589999999999999999999998763

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-36  Score=308.92  Aligned_cols=231  Identities=25%  Similarity=0.288  Sum_probs=186.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  +++.||||.+..        .+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++... 
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   99 (276)
T 2yex_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-   99 (276)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-
T ss_pred             cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-
Confidence            89999987  688999999853        2568999999999999999999999999999999999999999999654 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ ........|+..|+
T Consensus       100 -~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~  174 (276)
T 2yex_A          100 -IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYV  174 (276)
T ss_dssp             -TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCCCCSCGGGC
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-hhcccCCccccCcc
Confidence             34899999999999999999999955   99999999999999999999999999976543221 11233457899999


Q ss_pred             CccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          512 APEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      |||.+.+..+ +.++||||||+++|||++|+.||............+....                 .........+..
T Consensus       175 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~  237 (276)
T 2yex_A          175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-----------------TYLNPWKKIDSA  237 (276)
T ss_dssp             CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-----------------TTSTTGGGSCHH
T ss_pred             ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-----------------cccCchhhcCHH
Confidence            9999987665 7899999999999999999999875443322222221110                 000111233456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+++.+||+.||++|||++|++++
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          238 PLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHCCCCchhCCCHHHHhcC
Confidence            8899999999999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=311.76  Aligned_cols=227  Identities=25%  Similarity=0.411  Sum_probs=165.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.+..          .+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..
T Consensus        25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (278)
T 3cok_A           25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN  104 (278)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT
T ss_pred             eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh
Confidence            89999997  789999999853          256799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........   ......||+.
T Consensus       105 ~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~  177 (278)
T 3cok_A          105 RV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPN  177 (278)
T ss_dssp             CS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------
T ss_pred             cc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC---cceeccCCCC
Confidence            43 34899999999999999999999955   99999999999999999999999999976543221   1223568999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||.......                  .+.......  ...+...+.
T Consensus       178 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------------~~~~~~~~~--~~~~~~~~~  237 (278)
T 3cok_A          178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------------------TLNKVVLAD--YEMPSFLSI  237 (278)
T ss_dssp             --------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------------CCSSC--CCCCTTSCH
T ss_pred             cCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------------------HHHHHhhcc--cCCccccCH
Confidence            999999998889999999999999999999999985432211                  001111111  112333455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++||+++|++++
T Consensus       238 ~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          238 EAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            68999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8e-37  Score=320.92  Aligned_cols=248  Identities=22%  Similarity=0.235  Sum_probs=186.8

Q ss_pred             HhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCe
Q 042486          349 AATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGN  410 (635)
Q Consensus       349 ~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  410 (635)
                      ...++|.....||    |.||+++.  ++..||+|.+..            .+.+|++++++++||||+++++++.+++.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            3344555555555    89999987  678999998743            25579999999999999999999999999


Q ss_pred             eEEEeecccCCCcchhhccc--------------------------------------CCCCCCHHHHHHHHHHHHhhhc
Q 042486          411 WYLVYENAVNGSLSVWINDK--------------------------------------GGKFLDWAQRIQIALDVATGLN  452 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~aL~  452 (635)
                      .++||||+++|+|.+++...                                      ....+++..+..++.|++.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999999999998421                                      0112467788899999999999


Q ss_pred             ccccCCCCCeEeecccCCCEEECCCC--cEEEeeecCcccccccCCc-eeeecccccCCCccCcccccc--CCCCcccch
Q 042486          453 YLHSFTNPPHVHKDIKCSNVLLDTDF--RAKIANFALARPAERQEGE-FALTSHIVGTKGYMAPEYLEN--GLVSTKLDV  527 (635)
Q Consensus       453 ~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV  527 (635)
                      |||+.+   |+||||||+||+++.++  .+||+|||+++........ ........||+.|+|||.+.+  ..++.++||
T Consensus       183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            999955   99999999999998776  8999999999865432211 112334679999999999865  678999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC
Q 042486          528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP  607 (635)
Q Consensus       528 ~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  607 (635)
                      ||||+++|||++|+.||........ ...........               ........+..+.+|+.+||+.||++||
T Consensus       260 wslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKLCF---------------ENPNYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCT---------------TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhccccc---------------CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999865433221 11111111000               0001112345689999999999999999


Q ss_pred             CHHHHHHH
Q 042486          608 AMDKIAQS  615 (635)
Q Consensus       608 s~~evl~~  615 (635)
                      ++.|++++
T Consensus       324 s~~~~l~h  331 (345)
T 3hko_A          324 DAMRALQH  331 (345)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=323.42  Aligned_cols=230  Identities=23%  Similarity=0.274  Sum_probs=185.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||+|.++.       .+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.... 
T Consensus       103 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-  181 (373)
T 2x4f_A          103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-  181 (373)
T ss_dssp             -CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-
T ss_pred             EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-
Confidence            89999987  688999999865       35689999999999999999999999999999999999999999986433 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE--CCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL--DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ..+++..+..++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.......    .....||+.|
T Consensus       182 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----~~~~~gt~~y  254 (373)
T 2x4f_A          182 YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----LKVNFGTPEF  254 (373)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB----CCCCCSSCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc----cccccCCCcE
Confidence            34899999999999999999999955   9999999999999  6778999999999986543321    2234699999


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      +|||++.+..++.++|||||||++|||++|+.||....... .+.......+..               ........+..
T Consensus       255 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~---------------~~~~~~~~~~~  318 (373)
T 2x4f_A          255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDL---------------EDEEFQDISEE  318 (373)
T ss_dssp             CCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCS---------------CSGGGTTSCHH
T ss_pred             eChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCC---------------ChhhhccCCHH
Confidence            99999998899999999999999999999999986543322 111111111100               00001123455


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+|+.+||+.||++||++.|++++
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcC
Confidence            8999999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.7e-37  Score=321.46  Aligned_cols=232  Identities=23%  Similarity=0.316  Sum_probs=185.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||+++.  +++.||||.+..   +..+|++++.++ +||||+++++++.+++..|+||||+++|+|.+++....  .+
T Consensus        36 g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~  113 (342)
T 2qr7_A           36 SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FF  113 (342)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TC
T ss_pred             EEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CC
Confidence            89999988  688999999864   467899999998 79999999999999999999999999999999996543  38


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC----CcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD----FRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      ++..+..++.||+.||.|||+.+   |+||||||+|||+.++    +.+||+|||+++.......   ......||+.|+
T Consensus       114 ~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~  187 (342)
T 2qr7_A          114 SEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTANFV  187 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC---CBCCSSCCSSCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC---ceeccCCCcccc
Confidence            99999999999999999999955   9999999999998433    3599999999986543321   223457899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh-hHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN-MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      |||++.+..++.++|||||||++|||++|+.||.....+. ..+...+...              ............+..
T Consensus       188 aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------------KFSLSGGYWNSVSDT  253 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--------------CCCCCSTTTTTSCHH
T ss_pred             CHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--------------CcccCccccccCCHH
Confidence            9999988788999999999999999999999986432211 1111111000              001111222334566


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+|+.+||..||++||++.|++++
T Consensus       254 ~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcC
Confidence            8999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=345.23  Aligned_cols=237  Identities=25%  Similarity=0.465  Sum_probs=191.3

Q ss_pred             ceEEEeeeC-CcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKIG-GDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~~-~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|++. +..||||+++.      ++.+|+++|++++|+||+++++++.+ +..++||||+++|+|.+++.......
T Consensus       281 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~  359 (535)
T 2h8h_A          281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY  359 (535)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTT
T ss_pred             eEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCC
Confidence            899999994 56899999874      36789999999999999999999866 67899999999999999997544345


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++.+++.|+.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ........++..|+|||
T Consensus       360 l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE  434 (535)
T 2h8h_A          360 LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE  434 (535)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--HHTTCSTTSCGGGSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--eecccCCcCcccccCHH
Confidence            899999999999999999999954   9999999999999999999999999998654321  11112245678899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      .+.++.++.++||||||+++|||++ |+.||......+  ....+.                 .......+..++..+.+
T Consensus       435 ~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~-----------------~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE-----------------RGYRMPCPPECPESLHD  495 (535)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHH-----------------TTCCCCCCTTCCHHHHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH-----------------cCCCCCCCCCCCHHHHH
Confidence            9998899999999999999999999 888875432211  111110                 01111223344566899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ||.+||+.||++|||+++|++.|+.++...
T Consensus       496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            999999999999999999999999887643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.8e-37  Score=322.82  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=192.3

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA  418 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~  418 (635)
                      +|.....||    |.||+++.  ++..||+|.+..+        +.+|+.++++++|+||+++++++.+++..++||||+
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  113 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM  113 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence            344444454    89999998  5889999998643        568999999999999999999999999999999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      ++++|.+++....  .+++..+..++.+++.||.|||+.  .+|+||||||+||+++.++.+||+|||++.......   
T Consensus       114 ~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  186 (360)
T 3eqc_A          114 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  186 (360)
T ss_dssp             TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence            9999999996653  389999999999999999999983  149999999999999999999999999987543221   


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh-------------------
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN-------------------  559 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~-------------------  559 (635)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...............                   
T Consensus       187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence              23357899999999999999999999999999999999999998754433211100000                   


Q ss_pred             -----cccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          560 -----PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       560 -----~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                           .........+.+..+.........+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                 00000000111122222111111122345568999999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-36  Score=309.73  Aligned_cols=228  Identities=23%  Similarity=0.383  Sum_probs=181.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec----CCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|..  ++..||+|.+...         +.+|+.++++++||||+++++++..    +...++||||+++++|.++
T Consensus        40 g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  119 (290)
T 1t4h_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHH
Confidence            89999988  6789999988542         4679999999999999999999875    3558999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCceeeecccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      +....  .+++..+..++.|++.||.|||+.+ .+++||||||+||+++ .++.+||+|||++.......     .....
T Consensus       120 l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~  191 (290)
T 1t4h_A          120 LKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKAVI  191 (290)
T ss_dssp             HHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-----BEESC
T ss_pred             HHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc-----ccccc
Confidence            96543  3899999999999999999999854 4599999999999997 78999999999997543322     23356


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|+|||.+. +.++.++||||||+++|+|++|+.||................                 ......+.
T Consensus       192 ~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------------~~~~~~~~  253 (290)
T 1t4h_A          192 GTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-----------------VKPASFDK  253 (290)
T ss_dssp             SSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-----------------CCCGGGGG
T ss_pred             CCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-----------------CCccccCC
Confidence            899999999887 458999999999999999999999986433322221111110                 00001111


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+..+.+++.+||+.||++|||+.|++++
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            223458999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-37  Score=321.60  Aligned_cols=244  Identities=16%  Similarity=0.168  Sum_probs=185.5

Q ss_pred             ceEEEeee-----CCcEEEEEEeccC------------------hHHHHHHHhhhccCCcccEEEEEec----CCeeEEE
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYGD------------------ASDQIKLLNKINHSSLIRLLGICFN----GGNWYLV  414 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~~------------------~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV  414 (635)
                      |.||+|+.     ++..+|||+...+                  +.+|+..++.++|+||+++++++..    .+..++|
T Consensus        51 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  130 (345)
T 2v62_A           51 GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV  130 (345)
T ss_dssp             -CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEE
T ss_pred             eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEE
Confidence            89999998     4578999988543                  2356667777899999999999987    6788999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC--cEEEeeecCccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF--RAKIANFALARPAE  492 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~  492 (635)
                      |||+ +++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++  .+||+|||+++...
T Consensus       131 ~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~  204 (345)
T 2v62_A          131 MERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC  204 (345)
T ss_dssp             EECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESS
T ss_pred             Eecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecc
Confidence            9999 999999997654  4999999999999999999999954   99999999999998877  99999999998654


Q ss_pred             ccCCce----eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          493 RQEGEF----ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       493 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ......    .......||..|+|||.+.+..++.++||||||+++|||++|+.||................... . ..
T Consensus       205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~-~~  282 (345)
T 2v62_A          205 PNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLD-E-LP  282 (345)
T ss_dssp             GGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHH-T-TT
T ss_pred             cccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcc-c-cc
Confidence            322110    11134579999999999999889999999999999999999999985422222111111111100 0 00


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ..+.....       ....+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus       283 ~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          283 QSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            11111110       0123345899999999999999999999999998765

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-37  Score=314.08  Aligned_cols=239  Identities=25%  Similarity=0.366  Sum_probs=184.4

Q ss_pred             ceEEEeee---CCc--EEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI---GGD--FVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~---~~~--~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|++   +++  .||||.++.          .+.+|++++++++||||+++++++.+++ .++||||+++++|.++
T Consensus        32 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~  110 (291)
T 1u46_A           32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDR  110 (291)
T ss_dssp             CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHH
T ss_pred             eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHH
Confidence            89999986   223  689998853          2457999999999999999999997654 8999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.................+
T Consensus       111 l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  186 (291)
T 1u46_A          111 LRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV  186 (291)
T ss_dssp             HHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred             HHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCC
Confidence            96543 33899999999999999999999955   999999999999999999999999999876544333333344567


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      |..|+|||.+.+..++.++||||||+++|||++ |+.||........                  ...+.........+.
T Consensus       187 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~  248 (291)
T 1u46_A          187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------------------LHKIDKEGERLPRPE  248 (291)
T ss_dssp             CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------------HHHHHTSCCCCCCCT
T ss_pred             CceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------------------HHHHHccCCCCCCCc
Confidence            889999999998889999999999999999999 9988864332211                  111111111112223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ..+..+.+++.+||+.||++||++.++++.|+++....
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            34556899999999999999999999999999886543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=314.89  Aligned_cols=246  Identities=23%  Similarity=0.349  Sum_probs=180.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||||++...         +.+|++++++++||||+++++++.+.+..++||||+++++|.+++...
T Consensus        17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   96 (311)
T 4agu_A           17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ   96 (311)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS
T ss_pred             eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh
Confidence            89999998  5899999988442         457999999999999999999999999999999999999999988654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      .  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........   ......||..|
T Consensus        97 ~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y  168 (311)
T 4agu_A           97 R--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---YYDDEVATRWY  168 (311)
T ss_dssp             S--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---------------GGG
T ss_pred             c--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---ccCCCcCCccc
Confidence            3  3899999999999999999999955   99999999999999999999999999976543221   12345789999


Q ss_pred             cCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHH--HHhhhcccccCCch----hhhhhhcCCcCCCCC
Q 042486          511 MAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL--VDVLNPVLHKEDGE----ESLRHLMDPSMQGNY  583 (635)
Q Consensus       511 ~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l--~~~~~~~~~~~~~~----~~l~~~~d~~~~~~~  583 (635)
                      +|||.+.+ ..++.++||||||+++|+|++|+.||..........  ..............    ........+......
T Consensus       169 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (311)
T 4agu_A          169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME  248 (311)
T ss_dssp             CCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC
T ss_pred             cChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccc
Confidence            99999875 668999999999999999999999987544332111  11111100000000    000000000000000


Q ss_pred             C-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          584 P-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       584 ~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +     +..+..+.+|+.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0     1234558899999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-36  Score=325.04  Aligned_cols=229  Identities=24%  Similarity=0.387  Sum_probs=180.7

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhhc--cCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKIN--HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||++.. +++.||||++..         .+.+|+.+|++++  |+||+++++++..++..|+||| +.+++|.+++..
T Consensus        70 g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~  148 (390)
T 2zmd_A           70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  148 (390)
T ss_dssp             EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH
T ss_pred             eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh
Confidence            89999987 688999998853         2568999999996  5999999999999999999999 568899999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++........ .......||+.
T Consensus       149 ~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~  221 (390)
T 2zmd_A          149 KK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGAVN  221 (390)
T ss_dssp             CS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----------CCSCCCGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc-ccCCCCCcCCC
Confidence            43  4899999999999999999999855   99999999999995 589999999999866433211 12334679999


Q ss_pred             ccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          510 YMAPEYLEN-----------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       510 y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      |+|||++.+           ..++.++|||||||++|||++|+.||.......                 ..+..++++.
T Consensus       222 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----------------~~~~~~~~~~  284 (390)
T 2zmd_A          222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----------------SKLHAIIDPN  284 (390)
T ss_dssp             GCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----------------HHHHHHHCTT
T ss_pred             ccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----------------HHHHHHhCcc
Confidence            999999864           468999999999999999999999985432221                 1222233333


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+...+..+.+|+.+||+.||++||++.|++++
T Consensus       285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            3333333345568999999999999999999999976

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-36  Score=318.92  Aligned_cols=256  Identities=25%  Similarity=0.307  Sum_probs=187.8

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeE
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  412 (635)
                      .++|.....||    |.||+++.  +++.||||+++.            .+.+|++++++++||||+++++++.+.+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            34555555555    89999988  588999998853            3458999999999999999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        89 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            99999976 8888886543 34889999999999999999999955   9999999999999999999999999998654


Q ss_pred             ccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC---C-c
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE---D-G  567 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~-~  567 (635)
                      ....   ......+|+.|+|||.+.+ ..++.++|||||||++|||++|..||....... .+...........   . .
T Consensus       164 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          164 SPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             SCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSS
T ss_pred             CCcc---cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhh
Confidence            3221   2234578999999999875 458999999999999999999998876543322 1212111110000   0 0


Q ss_pred             hhhhhhhcCCcCCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 EESLRHLMDPSMQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+............+     ...+..+.+|+.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000000000000011     2234568999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7e-37  Score=316.99  Aligned_cols=239  Identities=23%  Similarity=0.374  Sum_probs=180.1

Q ss_pred             ceEEEeeeC-----CcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCe-----eEEEeecccCCC
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGN-----WYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~lV~E~~~~gs  422 (635)
                      |.||+|+..     +..||||.++.         .+.+|+.++++++||||+++++++.+.+.     .++||||+++|+
T Consensus        48 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~  127 (313)
T 3brb_A           48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD  127 (313)
T ss_dssp             CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCB
T ss_pred             eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCC
Confidence            899999862     34899999863         25679999999999999999999986543     499999999999


Q ss_pred             cchhhcc----cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          423 LSVWIND----KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       423 L~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      |.+++..    .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........ 
T Consensus       128 L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-  203 (313)
T 3brb_A          128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-  203 (313)
T ss_dssp             HHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred             HHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceeccccccc-
Confidence            9999832    23345999999999999999999999854   999999999999999999999999999865432211 


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |..||........  ...                +...
T Consensus       204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~----------------~~~~  265 (313)
T 3brb_A          204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDY----------------LLHG  265 (313)
T ss_dssp             -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHH----------------HHTT
T ss_pred             CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHH----------------HHcC
Confidence            11233457889999999999999999999999999999999 7777654322211  010                1110


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                       .....+...+..+.+++.+||+.||++||++.+++++|++++...
T Consensus       266 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          266 -HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             -CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             011122334456899999999999999999999999999998653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-36  Score=312.35  Aligned_cols=240  Identities=25%  Similarity=0.367  Sum_probs=185.6

Q ss_pred             ceEEEeeeC-----CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEec-CCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+..     ...+|+|.+..        .+.+|+.++++++||||+++++++.. ++..++||||+++|+|.+++
T Consensus        39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  118 (298)
T 3f66_A           39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  118 (298)
T ss_dssp             EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence            899999862     22589998864        25589999999999999999999764 56789999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeeccccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTSHIVG  506 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~g  506 (635)
                      .... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ ........+
T Consensus       119 ~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~  194 (298)
T 3f66_A          119 RNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL  194 (298)
T ss_dssp             HCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCB
T ss_pred             Hhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCC
Confidence            6543 34899999999999999999999955   999999999999999999999999999865433211 112233567


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.|+...............              .    .....+..
T Consensus       195 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------~----~~~~~~~~  256 (298)
T 3f66_A          195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------------G----RRLLQPEY  256 (298)
T ss_dssp             CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT--------------T----CCCCCCTT
T ss_pred             CccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc--------------C----CCCCCCcc
Confidence            88999999999989999999999999999999966554322111111111100              0    01111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .+..+.+++.+||+.||++||+++|+++.|++++...
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            3456899999999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=318.18  Aligned_cols=219  Identities=24%  Similarity=0.363  Sum_probs=182.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCC-Cc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG-SL  423 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~g-sL  423 (635)
                      |.||+++.  +++.||||.++.               .+.+|+.+|++++||||+++++++.+.+..++||||+.+| +|
T Consensus        38 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l  117 (335)
T 3dls_A           38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL  117 (335)
T ss_dssp             CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBH
T ss_pred             EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccH
Confidence            89999976  789999998854               2457999999999999999999999999999999999777 99


Q ss_pred             chhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecc
Q 042486          424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSH  503 (635)
Q Consensus       424 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  503 (635)
                      .+++....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......    ...
T Consensus       118 ~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~----~~~  188 (335)
T 3dls_A          118 FAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYT  188 (335)
T ss_dssp             HHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC----BCE
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc----eec
Confidence            99996543  3999999999999999999999955   99999999999999999999999999986544321    233


Q ss_pred             cccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          504 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       504 ~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ..||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......                    .....      .
T Consensus       189 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------~~~~~------~  242 (335)
T 3dls_A          189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------VEAAI------H  242 (335)
T ss_dssp             ECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------TTTCC------C
T ss_pred             cCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------Hhhcc------C
Confidence            579999999999987776 88999999999999999999998531110                    00000      1


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+...+..+.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122234558999999999999999999999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-36  Score=330.83  Aligned_cols=225  Identities=27%  Similarity=0.418  Sum_probs=186.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +|+.||||.+..          .+.+|+.+|++++||||+++++++.+.+..|+||||+++|+|.+++..
T Consensus        30 g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  109 (476)
T 2y94_A           30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK  109 (476)
T ss_dssp             SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  689999999853          255899999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......    ......||+.
T Consensus       110 ~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~~  180 (476)
T 2y94_A          110 NG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPN  180 (476)
T ss_dssp             SS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC----CBCCCCSCST
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc----cccccCCCcC
Confidence            43  3999999999999999999999855   9999999999999999999999999998654322    1234579999


Q ss_pred             ccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||.+.+..+ +.++|||||||++|||++|+.||.......                  ....+.+...  ..+...+
T Consensus       181 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------------------~~~~i~~~~~--~~p~~~s  240 (476)
T 2y94_A          181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------------------LFKKICDGIF--YTPQYLN  240 (476)
T ss_dssp             TCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------------------HHHHHHTTCC--CCCTTCC
T ss_pred             eEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------------------HHHHHhcCCc--CCCccCC
Confidence            999999987665 789999999999999999999986432211                  1111111111  1223334


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+|+.+||+.||++|||++|++++
T Consensus       241 ~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          241 PSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            568999999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.9e-37  Score=324.87  Aligned_cols=239  Identities=22%  Similarity=0.316  Sum_probs=183.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHH-HhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKL-LNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||||.++..          +..|..+ ++.++||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus        52 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~  131 (373)
T 2r5t_A           52 GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ  131 (373)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  6789999998542          2345554 567899999999999999999999999999999999996


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus       132 ~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~---~~~~~~~gt~  203 (373)
T 2r5t_A          132 RER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---STTSTFCGTP  203 (373)
T ss_dssp             HHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC---CCCCSBSCCC
T ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC---CccccccCCc
Confidence            543  3899999999999999999999955   9999999999999999999999999997533221   1234568999


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...                  ....++....  ..+...+
T Consensus       204 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------------------~~~~i~~~~~--~~~~~~~  263 (373)
T 2r5t_A          204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------------------MYDNILNKPL--QLKPNIT  263 (373)
T ss_dssp             CCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------------------HHHHHHHSCC--CCCSSSC
T ss_pred             cccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------------------HHHHHHhccc--CCCCCCC
Confidence            9999999999999999999999999999999999986433221                  1111111111  1223344


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH-HHHHHHhhcccccc
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQ-SISRFLNASLAWEL  628 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~-~L~~~~~~s~~w~~  628 (635)
                      ..+.+|+.+||+.||++||++.+.++ .++.-.-..++|+.
T Consensus       264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence            56899999999999999999854332 22333344566754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.1e-36  Score=307.35  Aligned_cols=243  Identities=22%  Similarity=0.290  Sum_probs=190.3

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      +|.....||    |.||++..  +++.||+|.+...         +.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            344444444    89999987  6889999998542         45799999999999999999999999999999999


Q ss_pred             ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc---EEEeeecCccccccc
Q 042486          418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFALARPAERQ  494 (635)
Q Consensus       418 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~  494 (635)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.   +||+|||++......
T Consensus        87 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           87 VTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999886543  3899999999999999999999955   999999999999976655   999999999765433


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      ..    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ..........           
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-----------  225 (284)
T 3kk8_A          162 EA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYD-----------  225 (284)
T ss_dssp             CB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC-----------
T ss_pred             cc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHHHHhcccc-----------
Confidence            21    2335789999999999999999999999999999999999999864332211 1111110000           


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                          .........+..+.+++.+||+.||++|||+.|++++  .++..
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~  267 (284)
T 3kk8_A          226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV--PWICN  267 (284)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS--HHHHS
T ss_pred             ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC--ccccC
Confidence                0001112234558999999999999999999999986  44443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-36  Score=314.17  Aligned_cols=238  Identities=18%  Similarity=0.280  Sum_probs=181.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.+...          +.+|+.++++++||||+++++++..++..++||||+++++|.+++..
T Consensus        48 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  127 (309)
T 2h34_A           48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR  127 (309)
T ss_dssp             SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH
T ss_pred             eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh
Confidence            89999987  6889999998542          45799999999999999999999999999999999999999999975


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........  .......|++.
T Consensus       128 ~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~  200 (309)
T 2h34_A          128 QG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--TQLGNTVGTLY  200 (309)
T ss_dssp             HC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------------------CCGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc--ccccccCCCcC
Confidence            43  3899999999999999999999955   99999999999999999999999999876543221  12234568999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||......  ...........            .   ....+...+.
T Consensus       201 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~------------~---~~~~~~~~~~  263 (309)
T 2h34_A          201 YMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIP------------R---PSTVRPGIPV  263 (309)
T ss_dssp             GCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCC------------C---GGGTSTTCCT
T ss_pred             ccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCC------------C---ccccCCCCCH
Confidence            99999999989999999999999999999999998643322  11111111000            0   0011222334


Q ss_pred             HHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHhhc
Q 042486          590 LVIRLIESCLKKDPSGRP-AMDKIAQSISRFLNAS  623 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~s  623 (635)
                      .+.+++.+||+.||++|| +++++++.|++++...
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            588999999999999999 9999999999877543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-36  Score=308.89  Aligned_cols=224  Identities=24%  Similarity=0.379  Sum_probs=186.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  ++..||||.+..          .+.+|++++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  107 (284)
T 2vgo_A           28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK  107 (284)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh
Confidence            89999998  578999999843          356799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......     .....|++.
T Consensus       108 ~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~  177 (284)
T 2vgo_A          108 HG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-----RRTMCGTLD  177 (284)
T ss_dssp             HS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-----BCCCCSCGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc-----cccccCCCC
Confidence            43  3899999999999999999999854   9999999999999999999999999986543321     233578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||........                  ...+....  ...+...+.
T Consensus       178 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------------~~~~~~~~--~~~~~~~~~  237 (284)
T 2vgo_A          178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------------------HRRIVNVD--LKFPPFLSD  237 (284)
T ss_dssp             GCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------------HHHHHTTC--CCCCTTSCH
T ss_pred             cCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------------------HHHHhccc--cCCCCcCCH
Confidence            9999999998999999999999999999999999864332211                  11111111  122333455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||.+||+++|++++
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            68999999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-36  Score=314.05  Aligned_cols=229  Identities=21%  Similarity=0.293  Sum_probs=185.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +++.||||.++.             .+.+|+.++++++||||+++++++.+++..++||||+++++|.++
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (321)
T 2a2a_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF  105 (321)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHH
Confidence            89999987  688999998853             256899999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----cEEEeeecCcccccccCCceeeec
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      +....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++    .+||+|||++.......    ...
T Consensus       106 l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~  176 (321)
T 2a2a_A          106 LAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFK  176 (321)
T ss_dssp             HHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC----CCC
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc----ccc
Confidence            96543  4899999999999999999999955   99999999999999887    79999999997654322    123


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ +.........               ....
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~---------------~~~~  240 (321)
T 2a2a_A          177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITSVSYD---------------FDEE  240 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCC---------------CCHH
T ss_pred             ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcccc---------------cChh
Confidence            45689999999999988999999999999999999999999864332211 1111110000               0000


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            001123458999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-36  Score=316.72  Aligned_cols=239  Identities=25%  Similarity=0.417  Sum_probs=187.5

Q ss_pred             ceEEEeee-------CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|++       ++..||||.+..        ++.+|+.++++++||||+++++++.+.+..++||||+++++|.++
T Consensus        44 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  123 (327)
T 2yfx_A           44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF  123 (327)
T ss_dssp             SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence            89999984       456899999854        255799999999999999999999999999999999999999999


Q ss_pred             hcccCC-----CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCce
Q 042486          427 INDKGG-----KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       427 l~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +.....     ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.   +..+||+|||++........ .
T Consensus       124 l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~-~  199 (327)
T 2yfx_A          124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-Y  199 (327)
T ss_dssp             HHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----
T ss_pred             HHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccc-c
Confidence            965431     34899999999999999999999955   999999999999984   45699999999875432221 1


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.                ..
T Consensus       200 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~----------------~~  261 (327)
T 2yfx_A          200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVT----------------SG  261 (327)
T ss_dssp             --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH----------------TT
T ss_pred             ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHh----------------cC
Confidence            12233567889999999998899999999999999999998 888875432211  111111                00


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                       .....+...+..+.+++.+||+.||.+||++.|++++|+.+....
T Consensus       262 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          262 -GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence             011122334456899999999999999999999999999887544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-37  Score=324.29  Aligned_cols=240  Identities=25%  Similarity=0.386  Sum_probs=178.3

Q ss_pred             ceEEEeee--C-C--cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEec-CCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--G-G--DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~-~--~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++  + +  ..||||.++.        ++.+|+.++++++||||+++++++.. ++..++||||+++|+|.+++
T Consensus       103 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  182 (373)
T 3c1x_A          103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  182 (373)
T ss_dssp             SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence            89999987  2 2  3689998854        25679999999999999999999764 45789999999999999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeeccccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTSHIVG  506 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~g  506 (635)
                      .... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........ ........+
T Consensus       183 ~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~  258 (373)
T 3c1x_A          183 RNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL  258 (373)
T ss_dssp             HCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------C
T ss_pred             hhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCC
Confidence            6543 34899999999999999999999954   999999999999999999999999999865432211 111233457


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSG-KEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +..|+|||.+.+..++.++||||||+++|||++| ..||.........  ..                +... .....+.
T Consensus       259 ~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~----------------~~~~-~~~~~p~  319 (373)
T 3c1x_A          259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VY----------------LLQG-RRLLQPE  319 (373)
T ss_dssp             CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HH----------------HHTT-CCCCCCT
T ss_pred             cccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HH----------------HHcC-CCCCCCC
Confidence            7889999999999999999999999999999995 5555332211110  00                0000 0111223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      ..+..+.+++.+||+.||++||++.|+++.|++++....
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            344568999999999999999999999999999987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=324.76  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=195.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCC--eeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGG--NWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||||+++..        +.+|+++|++++||||+++++++...+  ..++||||+++|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  102 (396)
T 4eut_A           23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (396)
T ss_dssp             EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence            89999998  5899999998642        458999999999999999999998654  67999999999999999965


Q ss_pred             cC-CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE----CCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          430 KG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       430 ~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      .. ...+++..++.++.|++.||.|||+.+   |+||||||+||++    +.++.+||+|||+++.......    ....
T Consensus       103 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~----~~~~  175 (396)
T 4eut_A          103 PSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSL  175 (396)
T ss_dssp             GGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG----SSCS
T ss_pred             hhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc----cccc
Confidence            43 233899999999999999999999955   9999999999999    7888899999999986543321    2235


Q ss_pred             ccCCCccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchh---hHHHHhhhcccccCCchhhhhh
Q 042486          505 VGTKGYMAPEYLEN--------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN---MLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       505 ~gt~~y~aPE~~~~--------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      .||..|+|||.+..        ..++.++|||||||++|||++|+.||.......   ...............  .....
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~  253 (396)
T 4eut_A          176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI--SGVQK  253 (396)
T ss_dssp             SSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC--EEEEC
T ss_pred             cCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc--hhhee
Confidence            79999999999864        567889999999999999999999986433221   112222111110000  00000


Q ss_pred             hc--------CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          574 LM--------DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       574 ~~--------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ..        +.......+......+.+++.+||+.||++||+++|+++.+++++...
T Consensus       254 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            00        001122345677888999999999999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=318.60  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=188.1

Q ss_pred             ccHHHHHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhh-ccCCcccEEEEEec-
Q 042486          342 YTFEELQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKI-NHSSLIRLLGICFN-  407 (635)
Q Consensus       342 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l-~h~nIv~l~~~~~~-  407 (635)
                      ++++++....+.|.....||    |.||+|+.  +++.||||.+..      .+.+|+.+++++ +||||+++++++.. 
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34444555566666666665    89999998  789999999853      366899999999 89999999999986 


Q ss_pred             -----CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEE
Q 042486          408 -----GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKI  482 (635)
Q Consensus       408 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl  482 (635)
                           .+..++||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence                 467899999999999999997654445899999999999999999999955   999999999999999999999


Q ss_pred             eeecCcccccccCCceeeecccccCCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHh
Q 042486          483 ANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDV  557 (635)
Q Consensus       483 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~  557 (635)
                      +|||++........   ......||+.|+|||.+.     +..++.++||||||+++|+|++|+.||......... ...
T Consensus       171 ~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~  246 (326)
T 2x7f_A          171 VDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-FLI  246 (326)
T ss_dssp             CCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHH
T ss_pred             eeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHh
Confidence            99999876543221   123357899999999987     567899999999999999999999998543322111 111


Q ss_pred             hhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          558 LNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       558 ~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...              ..+.   ..+...+..+.+++.+||..||.+||++.|++++
T Consensus       247 ~~~--------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          247 PRN--------------PAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHS--------------CCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hcC--------------cccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000              0011   1112234568999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=319.83  Aligned_cols=244  Identities=14%  Similarity=0.139  Sum_probs=193.1

Q ss_pred             cCCCCCCccc----ceEEEee-------eCCcEEEEEEeccC----hHHHHHHHhhhc---cCCcccEEEEEecCCeeEE
Q 042486          352 DDFNPSCWIK----GSVYRGK-------IGGDFVAIKKVYGD----ASDQIKLLNKIN---HSSLIRLLGICFNGGNWYL  413 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~-------~~~~~vavK~~~~~----~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l  413 (635)
                      +.|.....||    |.||+|.       .+++.||||+++..    +..|++++++++   |+||+++++++..++..++
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l  144 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL  144 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence            3444444554    8999993       26889999999764    456777777775   9999999999999999999


Q ss_pred             EeecccCCCcchhhccc---CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-----------CCc
Q 042486          414 VYENAVNGSLSVWINDK---GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-----------DFR  479 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-----------~~~  479 (635)
                      ||||+++|+|.+++...   ....+++..++.|+.||+.||+|||+.+   |+||||||+|||++.           ++.
T Consensus       145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCC
Confidence            99999999999999532   2345999999999999999999999855   999999999999988           899


Q ss_pred             EEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh
Q 042486          480 AKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN  559 (635)
Q Consensus       480 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~  559 (635)
                      +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......        
T Consensus       222 ~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------  292 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------  292 (365)
T ss_dssp             EEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred             EEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence            999999999765433222 23345679999999999999999999999999999999999999874322110        


Q ss_pred             cccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHhhc
Q 042486          560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGR-PAMDKIAQSISRFLNAS  623 (635)
Q Consensus       560 ~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~s  623 (635)
                               ..    ....+. ..+  ....+.+++..|++.+|.+| |+++++.+.|++++...
T Consensus       293 ---------~~----~~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 ---------CK----PEGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ---------EE----ECSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------ee----echhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                     00    000011 111  24457899999999999998 68999999999998763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=307.69  Aligned_cols=231  Identities=26%  Similarity=0.363  Sum_probs=183.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC-
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG-  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-  431 (635)
                      |.||+|+.  ++..||||.+..       .+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... 
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  115 (295)
T 2clq_A           36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG  115 (295)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTC
T ss_pred             EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhcc
Confidence            89999997  678999998754       25689999999999999999999999999999999999999999996542 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ...+++..+..++.|++.||.|||+.+   ++||||||+||+++. ++.+||+|||++.......   .......|+..|
T Consensus       116 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y  189 (295)
T 2clq_A          116 PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQY  189 (295)
T ss_dssp             CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--------CCCCCCGGG
T ss_pred             CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC---CcccccCCCccc
Confidence            334678999999999999999999955   999999999999987 8999999999997654322   112345789999


Q ss_pred             cCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          511 MAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       511 ~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      +|||.+.+..  ++.++||||||+++|||++|+.||..............             .....    ...+...+
T Consensus       190 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------~~~~~----~~~~~~~~  252 (295)
T 2clq_A          190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-------------MFKVH----PEIPESMS  252 (295)
T ss_dssp             CCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-------------HHCCC----CCCCTTSC
T ss_pred             cChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-------------ccccc----ccccccCC
Confidence            9999987643  78999999999999999999999854322211111100             00011    12233345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+++.+||+.||++||++.|++++
T Consensus       253 ~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          253 AEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            568999999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-36  Score=335.78  Aligned_cols=239  Identities=24%  Similarity=0.305  Sum_probs=194.6

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|.....||    |.||+++.  +++.||||++...          +.+|+++|++++||||+++++++.+.+..|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            4565556665    89999998  6899999998532          457999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999997655555999999999999999999999955   9999999999999999999999999998654332


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--hHHHHhhhcccccCCchhhhhh
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--MLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...                
T Consensus       341 ----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----------------  400 (576)
T 2acx_A          341 ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----------------  400 (576)
T ss_dssp             ----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----------------
T ss_pred             ----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----------------
Confidence                1233579999999999999889999999999999999999999986532211  111111                


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      +..  ....++...+..+.+||.+||+.||++||     +++|+++|
T Consensus       401 i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          401 VKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             hhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            100  01123334456689999999999999999     77888876

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-36  Score=315.08  Aligned_cols=264  Identities=22%  Similarity=0.300  Sum_probs=186.5

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      ++|.....||    |.||+++.  +++.||||+++.         .+.+|++++++++||||+++++++.+++..++|||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            3444444554    89999976  789999999853         35589999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE-----CCCCcEEEeeecCcccc
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL-----DTDFRAKIANFALARPA  491 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll-----~~~~~~kl~Dfg~a~~~  491 (635)
                      |++ |+|.+++.....  +++..+..++.||+.||.|||+.+   |+||||||+|||+     ++++.+||+|||+++..
T Consensus       114 ~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          114 YAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             CCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             cCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            997 499999966543  899999999999999999999955   9999999999999     45566999999999765


Q ss_pred             cccCCceeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC-Cch-
Q 042486          492 ERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE-DGE-  568 (635)
Q Consensus       492 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~-  568 (635)
                      ....   .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ +........... ... 
T Consensus       188 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          188 GIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             C--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTST
T ss_pred             CCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchhhhh
Confidence            4322   112335689999999999864 489999999999999999999999865443321 111111100000 000 


Q ss_pred             --hhhhhhcC--CcCCCC-----CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          569 --ESLRHLMD--PSMQGN-----YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       569 --~~l~~~~d--~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                        .....+..  +.....     .+...+..+.+|+.+||+.||++|||++|++++  .++. ..+|+|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~-~~~~~P  329 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH--PYFS-HNDFDP  329 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGS-SSCSCC
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC--cccC-CCCCCC
Confidence              00000000  000000     011134568899999999999999999999876  3333 345654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.1e-36  Score=305.45  Aligned_cols=228  Identities=23%  Similarity=0.295  Sum_probs=183.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  ++..||+|++..       .+.+|++++++++||||+++++++.+++..++||||+++++|.+++.... 
T Consensus        23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  101 (277)
T 3f3z_A           23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-  101 (277)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-
T ss_pred             EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-
Confidence            89999988  567899999854       35689999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                       .+++..+..++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++.......    ......||+.
T Consensus       102 -~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~t~~  173 (277)
T 3f3z_A          102 -VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPY  173 (277)
T ss_dssp             -SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS----CBCCCCSCTT
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc----chhccCCCCC
Confidence             3899999999999999999999955   9999999999999   788999999999997654332    1234579999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+. ++.++||||||+++|||++|+.||........ ............  ...             ....+.
T Consensus       174 y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~--~~~-------------~~~~~~  236 (277)
T 3f3z_A          174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTFTFP--EKD-------------WLNVSP  236 (277)
T ss_dssp             TCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCC--HHH-------------HTTSCH
T ss_pred             ccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCC--chh-------------hhcCCH
Confidence            9999998654 89999999999999999999999865333221 111111100000  000             001245


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++||++.|++++
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            58999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-36  Score=310.46  Aligned_cols=227  Identities=26%  Similarity=0.403  Sum_probs=186.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+.  +++.||||.+..        .+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++... 
T Consensus        36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-  114 (303)
T 3a7i_A           36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-  114 (303)
T ss_dssp             SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS-
T ss_pred             eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC-
Confidence            89999987  688999999853        3568999999999999999999999999999999999999999999643 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........   ......|++.|+
T Consensus       115 --~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~  186 (303)
T 3a7i_A          115 --PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWM  186 (303)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---CBCCCCSCGGGC
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc---ccCccCCCcCcc
Confidence              3899999999999999999999955   99999999999999999999999999976543321   123457899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||.+.+..++.++||||||+++|||++|+.|+.........  ...             .....+.+    +...+..+
T Consensus       187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~-------------~~~~~~~~----~~~~~~~l  247 (303)
T 3a7i_A          187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--FLI-------------PKNNPPTL----EGNYSKPL  247 (303)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHH-------------HHSCCCCC----CSSCCHHH
T ss_pred             CHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--HHh-------------hcCCCCCC----ccccCHHH
Confidence            999999999999999999999999999999998643322111  100             00011112    22234458


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQSI  616 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~L  616 (635)
                      .+++.+||+.||++|||+.|++++.
T Consensus       248 ~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhhCh
Confidence            9999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-36  Score=306.82  Aligned_cols=229  Identities=27%  Similarity=0.362  Sum_probs=178.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc-
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK-  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-  430 (635)
                      |.||+++.  ++..||+|++..+        +.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++... 
T Consensus        36 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (285)
T 3is5_A           36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ  115 (285)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHH
T ss_pred             eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhh
Confidence            89999987  6889999998542        468999999999999999999999999999999999999999998432 


Q ss_pred             -CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          431 -GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       431 -~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                       ....+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++.......    ......|
T Consensus       116 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~  188 (285)
T 3is5_A          116 ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAG  188 (285)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------------CT
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc----cCcCccc
Confidence             2345999999999999999999999954   9999999999999   456889999999997654322    1234578


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+.|+|||.+. +.++.++||||||+++|||++|+.||..............                ..+..... ...
T Consensus       189 t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~----------------~~~~~~~~-~~~  250 (285)
T 3is5_A          189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY----------------KEPNYAVE-CRP  250 (285)
T ss_dssp             TGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------------CCCCCCC---CC
T ss_pred             ccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc----------------CCcccccc-cCc
Confidence            99999999886 5689999999999999999999999865433221110000                00000000 011


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            23458899999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.5e-36  Score=309.26  Aligned_cols=230  Identities=27%  Similarity=0.403  Sum_probs=187.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|+.  +++.||||.+..     ++.+|+.++++++||||+++++++..++..++||||+++++|.+++.... ..
T Consensus        43 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~  121 (314)
T 3com_A           43 GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KT  121 (314)
T ss_dssp             CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-CC
T ss_pred             eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC-CC
Confidence            89999988  589999999854     35689999999999999999999999999999999999999999996432 34


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........   ......|+..|+|||
T Consensus       122 ~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE  195 (314)
T 3com_A          122 LTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPE  195 (314)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS---CBCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc---ccCccCCCCCccChh
Confidence            899999999999999999999955   99999999999999999999999999976543221   123457899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      .+.+..++.++||||||+++|+|++|+.||.......... ...              ....+  ....+...+..+.++
T Consensus       196 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~--------------~~~~~--~~~~~~~~~~~l~~l  258 (314)
T 3com_A          196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIP--------------TNPPP--TFRKPELWSDNFTDF  258 (314)
T ss_dssp             HHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHH--------------HSCCC--CCSSGGGSCHHHHHH
T ss_pred             hcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHh--------------cCCCc--ccCCcccCCHHHHHH
Confidence            9998889999999999999999999999986433221110 000              00000  011123334568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 042486          595 IESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+||+.||.+|||+.|++++
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHccCChhhCcCHHHHHhC
Confidence            999999999999999999885

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=315.36  Aligned_cols=237  Identities=17%  Similarity=0.267  Sum_probs=169.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhc-cCCcccEEEEEe--------cCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKIN-HSSLIRLLGICF--------NGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+++.  +++.||||++..       .+.+|+.+++++. ||||+++++++.        .....++||||+. |+|
T Consensus        42 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L  120 (337)
T 3ll6_A           42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQL  120 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEH
T ss_pred             eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCH
Confidence            89999998  789999998843       3567999999995 999999999994        3445799999995 799


Q ss_pred             chhhcc-cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce----
Q 042486          424 SVWIND-KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF----  498 (635)
Q Consensus       424 ~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----  498 (635)
                      .+++.. .....+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++.........    
T Consensus       121 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  199 (337)
T 3ll6_A          121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ  199 (337)
T ss_dssp             HHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCccccccc
Confidence            998854 22345999999999999999999999854 459999999999999999999999999998665432110    


Q ss_pred             -----eeecccccCCCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          499 -----ALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       499 -----~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                           .......||+.|+|||.+   .+..++.++||||||+++|||++|+.||.......     ..            
T Consensus       200 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~------------  262 (337)
T 3ll6_A          200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----IV------------  262 (337)
T ss_dssp             ------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----hh------------
Confidence                 011234689999999998   56678999999999999999999999985321110     00            


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                           ........+......+.+|+.+||+.||++||++.|++++|+.+...
T Consensus       263 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          263 -----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 00000011111223378999999999999999999999999998764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.2e-36  Score=307.55  Aligned_cols=226  Identities=23%  Similarity=0.328  Sum_probs=186.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+...          +.+|+.++++++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        29 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  108 (294)
T 2rku_A           29 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR  108 (294)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh
Confidence            89999998  5789999987532          45799999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........   ......||+.
T Consensus       109 ~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~  180 (294)
T 2rku_A          109 RK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPN  180 (294)
T ss_dssp             HC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCCS
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc---ccccccCCCC
Confidence            43  3899999999999999999999955   99999999999999999999999999986543221   1233578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||......... ..                 +....  ...+...+.
T Consensus       181 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~-----------------~~~~~--~~~~~~~~~  240 (294)
T 2rku_A          181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LR-----------------IKKNE--YSIPKHINP  240 (294)
T ss_dssp             SCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH-----------------HHTTC--CCCCTTSCH
T ss_pred             cCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-----------------Hhhcc--CCCccccCH
Confidence            99999999888999999999999999999999998643322110 00                 11110  112223345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++|||++|++++
T Consensus       241 ~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          241 VAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            68999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.3e-36  Score=324.23  Aligned_cols=239  Identities=22%  Similarity=0.284  Sum_probs=178.5

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGN  410 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  410 (635)
                      ++|.....||    |.||+|..  +++.||||.+..               .+.+|+++|++++||||+++++++. .+.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence            4454445555    89999987  678999998753               3568999999999999999999985 456


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC---CcEEEeeecC
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD---FRAKIANFAL  487 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~  487 (635)
                      .++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.+   +.+||+|||+
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             eEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence            899999999999999986543  3899999999999999999999855   9999999999999654   4599999999


Q ss_pred             cccccccCCceeeecccccCCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK  564 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  564 (635)
                      ++......    ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||................... 
T Consensus       289 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~-  363 (419)
T 3i6u_A          289 SKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-  363 (419)
T ss_dssp             TTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC-
T ss_pred             ceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC-
Confidence            98764322    2334679999999999853   668899999999999999999999986432221111110000000 


Q ss_pred             CCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       565 ~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                    .........+..+.+|+.+||+.||++||+++|++++
T Consensus       364 --------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          364 --------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                          0000001124558999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6e-36  Score=308.74  Aligned_cols=228  Identities=25%  Similarity=0.354  Sum_probs=185.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||+|.++..       +.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... 
T Consensus        23 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  101 (304)
T 2jam_A           23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-  101 (304)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-
T ss_pred             ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-
Confidence            89999987  6899999998542       5689999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                       .+++..+..++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++.......     .....||+.
T Consensus       102 -~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~  172 (304)
T 2jam_A          102 -VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGTPG  172 (304)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-----THHHHSCCC
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-----cccccCCCC
Confidence             3899999999999999999999955   9999999999999   788999999999987543321     223468999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||....... ..........               ..........+.
T Consensus       173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~---------------~~~~~~~~~~~~  236 (304)
T 2jam_A          173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYY---------------EFESPFWDDISE  236 (304)
T ss_dssp             BCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCC---------------CCCTTTTTTSCH
T ss_pred             ccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCC---------------CCCccccccCCH
Confidence            999999999999999999999999999999999986433221 1111111100               001111223445


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+++.+||+.||++||+++|++++
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            68999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6e-36  Score=317.22  Aligned_cols=243  Identities=22%  Similarity=0.329  Sum_probs=189.8

Q ss_pred             HHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEecc---------------ChHHHHHHHhhh-ccCCcccEEEEE
Q 042486          348 QAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------------DASDQIKLLNKI-NHSSLIRLLGIC  405 (635)
Q Consensus       348 ~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------------~~~~E~~~l~~l-~h~nIv~l~~~~  405 (635)
                      ....++|.....||    |.||+++.  +|+.||||.++.               .+.+|+++++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            33445566556665    89999998  589999998743               235789999999 899999999999


Q ss_pred             ecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeee
Q 042486          406 FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANF  485 (635)
Q Consensus       406 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  485 (635)
                      ...+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence            99999999999999999999996543  3899999999999999999999955   999999999999999999999999


Q ss_pred             cCcccccccCCceeeecccccCCCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh
Q 042486          486 ALARPAERQEGEFALTSHIVGTKGYMAPEYLEN------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN  559 (635)
Q Consensus       486 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~  559 (635)
                      |++.......    ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||....... .+.....
T Consensus       245 G~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~  319 (365)
T 2y7j_A          245 GFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-MLRMIME  319 (365)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             CcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh
Confidence            9987654332    1234679999999999863      357899999999999999999999985432211 1111111


Q ss_pred             cccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          560 PVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       560 ~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ......  ..   .          ....+..+.+++.+||+.||++||++.|++++
T Consensus       320 ~~~~~~--~~---~----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          320 GQYQFS--SP---E----------WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             TCCCCC--HH---H----------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCC--Cc---c----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000000  00   0          01123458999999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.5e-36  Score=314.33  Aligned_cols=226  Identities=23%  Similarity=0.328  Sum_probs=185.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||+|.+...          +.+|+.++++++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        55 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  134 (335)
T 2owb_A           55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR  134 (335)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc
Confidence            89999998  5789999987532          45799999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++.+++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........   ......||..
T Consensus       135 ~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~  206 (335)
T 2owb_A          135 RK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPN  206 (335)
T ss_dssp             HC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCCS
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc---cccccCCCcc
Confidence            43  3899999999999999999999955   99999999999999999999999999986543221   1234578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|||++|+.||......... .....                 ..  ...+...+.
T Consensus       207 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~-----------------~~--~~~~~~~~~  266 (335)
T 2owb_A          207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIKK-----------------NE--YSIPKHINP  266 (335)
T ss_dssp             SCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHH-----------------TC--CCCCTTSCH
T ss_pred             ccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHhc-----------------CC--CCCCccCCH
Confidence            99999999888999999999999999999999998643322111 00000                 00  011223345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+|+.+||+.||++||+++|++++
T Consensus       267 ~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          267 VAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            58899999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=313.75  Aligned_cols=240  Identities=20%  Similarity=0.290  Sum_probs=185.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEe----cCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICF----NGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||||++..       .+.+|++++++++||||+++++++.    .....++||||+++|+|.+++.
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  122 (317)
T 2buj_A           43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE  122 (317)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHH
T ss_pred             eEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHH
Confidence            89999996  789999998743       3568999999999999999999997    3446899999999999999995


Q ss_pred             cc--CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce------ee
Q 042486          429 DK--GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF------AL  500 (635)
Q Consensus       429 ~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~------~~  500 (635)
                      ..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..........      ..
T Consensus       123 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  199 (317)
T 2buj_A          123 RLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD  199 (317)
T ss_dssp             HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHH
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccc
Confidence            42  3345999999999999999999999954   9999999999999999999999999987543211100      00


Q ss_pred             ecccccCCCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          501 TSHIVGTKGYMAPEYLENGL---VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      .....||+.|+|||.+....   ++.++||||||+++|||++|+.||............             ....    
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-------------~~~~----  262 (317)
T 2buj_A          200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-------------AVQN----  262 (317)
T ss_dssp             HHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-------------HHHC----
T ss_pred             cccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-------------Hhhc----
Confidence            12245799999999987543   688999999999999999999997431111100000             0000    


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                      ......+...+..+.+++.+||+.||.+||++.|++++|+.+..
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            11111122334568999999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.3e-36  Score=331.34  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=192.2

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      ++|.....||    |.||+++.  +++.||||++...          +.+|+++|++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            3455445555    89999998  6899999998532          457999999999999999999999999999999


Q ss_pred             ecccCCCcchhhcccC--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          416 ENAVNGSLSVWINDKG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ||+++|+|.+++....  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986532  345999999999999999999999955   99999999999999999999999999986543


Q ss_pred             cCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........              ..+....
T Consensus       342 ~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--------------~~~~~~~  404 (543)
T 3c4z_A          342 GQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--------------NKELKQR  404 (543)
T ss_dssp             TC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--------------HHHHHHH
T ss_pred             CC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--------------HHHHHHH
Confidence            32   123345899999999999999999999999999999999999999864322100              0011111


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM-----DKIAQS  615 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  615 (635)
                      +....  ..++...+..+.+|+.+||+.||++||++     +|+++|
T Consensus       405 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          405 VLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             Hhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            11111  12334455668999999999999999975     566554

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-36  Score=318.07  Aligned_cols=232  Identities=23%  Similarity=0.355  Sum_probs=183.8

Q ss_pred             ceEEEeee-----CCcEEEEEEecc-----------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-----GGDFVAIKKVYG-----------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-----~~~~vavK~~~~-----------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      |.||+++.     +++.||||+++.           .+.+|+++|+++ +|+||+++++++..++..++||||+++|+|.
T Consensus        68 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  147 (355)
T 1vzo_A           68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF  147 (355)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHH
Confidence            89999987     688999998753           245799999999 6999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  ......
T Consensus       148 ~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~  220 (355)
T 1vzo_A          148 THLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDF  220 (355)
T ss_dssp             HHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG--GGGCGG
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC--CcccCc
Confidence            9996543  3899999999999999999999855   99999999999999999999999999976543221  122345


Q ss_pred             ccCCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          505 VGTKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       505 ~gt~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      .||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ ....             ...+...  ...
T Consensus       221 ~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~-------------~~~~~~~--~~~  284 (355)
T 1vzo_A          221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEI-------------SRRILKS--EPP  284 (355)
T ss_dssp             GSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHH-------------HHHHHHC--CCC
T ss_pred             ccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHH-------------HHHHhcc--CCC
Confidence            79999999999985  3478999999999999999999999864322110 0000             1111100  112


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRP-----AMDKIAQSI  616 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  616 (635)
                      ++...+..+.+|+.+||+.||++||     +++|++++.
T Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            3334455689999999999999999     899998874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=314.29  Aligned_cols=246  Identities=22%  Similarity=0.335  Sum_probs=180.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  +++.||||+++.        .+.+|+++|++++||||+++++++.+++..++||||++ |+|.+++....
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   94 (324)
T 3mtl_A           16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG   94 (324)
T ss_dssp             EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT
T ss_pred             EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC
Confidence            89999998  688999998853        24479999999999999999999999999999999997 58989886543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......   ......||+.|+
T Consensus        95 -~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~  167 (324)
T 3mtl_A           95 -NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYDNEVVTLWYR  167 (324)
T ss_dssp             -TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------------CGGGC
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---ccccccCccccc
Confidence             34899999999999999999999955   99999999999999999999999999975543221   123356899999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCC----chhhhhhhcCCcCCCC--
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKED----GEESLRHLMDPSMQGN--  582 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~----~~~~l~~~~d~~~~~~--  582 (635)
                      |||.+.+ ..++.++||||||+++|||++|+.||.........  .............    ..+.......+.....  
T Consensus       168 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (324)
T 3mtl_A          168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEAL  247 (324)
T ss_dssp             CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCH
T ss_pred             ChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhh
Confidence            9999876 56899999999999999999999998754433211  1111111000000    0011111111111000  


Q ss_pred             --CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 --YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .....+..+.+|+.+||+.||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          248 LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              011234558899999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.5e-36  Score=312.60  Aligned_cols=231  Identities=21%  Similarity=0.276  Sum_probs=184.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.++.         .+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  122 (327)
T 3lm5_A           43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP  122 (327)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH
Confidence            89999987  689999998853         356799999999 569999999999999999999999999999999966


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeeccccc
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||+++......    ......|
T Consensus       123 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~g  195 (327)
T 3lm5_A          123 ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREIMG  195 (327)
T ss_dssp             CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------------CC
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc----ccccccC
Confidence            55556999999999999999999999955   999999999999987   7899999999998654322    1234579


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......               ...........
T Consensus       196 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~---------------~~~~~~~~~~~  259 (327)
T 3lm5_A          196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-LNISQV---------------NVDYSEETFSS  259 (327)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHT---------------CCCCCTTTTTT
T ss_pred             CcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHhc---------------ccccCchhhcc
Confidence            99999999999999999999999999999999999998654332211 111000               00111111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+++.+||+.||++|||++|++++
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            44568999999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.4e-36  Score=304.98  Aligned_cols=222  Identities=23%  Similarity=0.325  Sum_probs=178.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.++..         +.+|+..+.++ +||||+++++++.+++..++||||+++++|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (289)
T 1x8b_A           25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE  104 (289)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHh
Confidence            89999998  6899999998642         44688888888 999999999999999999999999999999999965


Q ss_pred             cC--CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-------------------CCcEEEeeecCc
Q 042486          430 KG--GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-------------------DFRAKIANFALA  488 (635)
Q Consensus       430 ~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-------------------~~~~kl~Dfg~a  488 (635)
                      ..  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.                   ...+||+|||.+
T Consensus       105 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~  181 (289)
T 1x8b_A          105 NYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV  181 (289)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTC
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccc
Confidence            31  234899999999999999999999955   999999999999984                   447999999998


Q ss_pred             ccccccCCceeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc
Q 042486          489 RPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       489 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  567 (635)
                      .......       ...||+.|+|||.+.+. .++.++||||||+++|||++|..++.....    ....          
T Consensus       182 ~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~----------  240 (289)
T 1x8b_A          182 TRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEI----------  240 (289)
T ss_dssp             EETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHHH----------
T ss_pred             cccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHHH----------
Confidence            8654322       23589999999999765 567899999999999999999876532111    0000          


Q ss_pred             hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ..-..+    ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       241 ----~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          241 ----RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ----HTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----HcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                000111    1223344568999999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-36  Score=322.78  Aligned_cols=245  Identities=23%  Similarity=0.377  Sum_probs=178.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhc-cCCcccEEEEEecCC--eeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKIN-HSSLIRLLGICFNGG--NWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||++..  +++.||||++...         ..+|+.+|+++. |+||+++++++..++  ..|+||||++ ++|.+++
T Consensus        23 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~  101 (388)
T 3oz6_A           23 GIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI  101 (388)
T ss_dssp             -CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHH
Confidence            89999987  7899999998542         347899999997 999999999997544  6899999997 5899888


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC------------
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE------------  495 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~------------  495 (635)
                      ...   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......            
T Consensus       102 ~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~  175 (388)
T 3oz6_A          102 RAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE  175 (388)
T ss_dssp             HHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccc
Confidence            653   3899999999999999999999955   9999999999999999999999999997543211            


Q ss_pred             ------CceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-
Q 042486          496 ------GEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-  567 (635)
Q Consensus       496 ------~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-  567 (635)
                            ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... +.... ........ 
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~-~~~~~p~~~  253 (388)
T 3oz6_A          176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-LERII-GVIDFPSNE  253 (388)
T ss_dssp             --------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH-HHHCCCCHH
T ss_pred             cccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HhcCCCCHH
Confidence                  00112234579999999999876 6789999999999999999999999875443221 11111 11111100 


Q ss_pred             ----------hhhhhhh---c---CCcCCCC------------CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 ----------EESLRHL---M---DPSMQGN------------YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ----------~~~l~~~---~---d~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                ...+..+   .   .......            .+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          254 DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence                      0000000   0   0000000            001223458999999999999999999999988

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-36  Score=309.21  Aligned_cols=234  Identities=21%  Similarity=0.324  Sum_probs=182.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+++.  +++.||+|.+..         .+.+|++++++++||||+++++++.+  ++..++||||+++++|.+++.
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   99 (279)
T 2w5a_A           20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT   99 (279)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHH
Confidence            89999998  688999999853         25579999999999999999998854  567899999999999999995


Q ss_pred             cc--CCCCCCHHHHHHHHHHHHhhhcccccCC--CCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          429 DK--GGKFLDWAQRIQIALDVATGLNYLHSFT--NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       429 ~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      ..  ....+++..++.++.|++.||.|||+.+  ..+++||||||+||+++.++.+||+|||+++......   ......
T Consensus       100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~---~~~~~~  176 (279)
T 2w5a_A          100 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKTF  176 (279)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C---HHHHHH
T ss_pred             hhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc---cccccc
Confidence            42  2345899999999999999999999843  1239999999999999999999999999987654321   112235


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .|+..|+|||.+.+..++.++||||||+++|||++|+.||.......  ....+.             ....    ...+
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~-------------~~~~----~~~~  237 (279)
T 2w5a_A          177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIR-------------EGKF----RRIP  237 (279)
T ss_dssp             HSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-------------HTCC----CCCC
T ss_pred             CCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHHHh-------------hccc----ccCC
Confidence            68999999999998889999999999999999999999986443221  111110             0000    1122


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSIS  617 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  617 (635)
                      ...+..+.+++.+||+.||++||+++|+++++.
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            334456899999999999999999999998653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-35  Score=324.94  Aligned_cols=253  Identities=17%  Similarity=0.190  Sum_probs=194.3

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEec-----cChHHHHHHHhhhcc-CCcccEEEEEecCCeeEEEeeccc
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVY-----GDASDQIKLLNKINH-SSLIRLLGICFNGGNWYLVYENAV  419 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~-----~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~E~~~  419 (635)
                      ++|.....||    |.||+|+.  +++.||||.+.     .++.+|+++++.++| +++..+..++...+..++||||+ 
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            4455555565    89999996  68999999874     357799999999987 45666666667788889999999 


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCC
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      +++|.+++.... ..+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.......
T Consensus        86 g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            999999996433 24999999999999999999999955   9999999999999   6889999999999986654322


Q ss_pred             c----eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchh-h-HHHHhhhcccccCCchhh
Q 042486          497 E----FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN-M-LLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       497 ~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~-~-~l~~~~~~~~~~~~~~~~  570 (635)
                      .    ........||..|+|||.+.+..++.++|||||||++|||++|+.||....... . .+.........     ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----~~  236 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-----TS  236 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-----SC
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-----cc
Confidence            1    112235679999999999999999999999999999999999999987543321 1 11111110000     00


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +..+     ...+    +..+.+|+..||+.||++||++++|++.|++++...
T Consensus       237 ~~~l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          237 IEAL-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHH-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHH-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            0000     0122    345899999999999999999999999999997543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-36  Score=316.58  Aligned_cols=245  Identities=28%  Similarity=0.416  Sum_probs=182.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||||++...         +.+|++++++++||||+++++++.+.+..++||||+++++|.+++...
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~  118 (331)
T 4aaa_A           39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP  118 (331)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST
T ss_pred             EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc
Confidence            89999998  5889999987432         457999999999999999999999999999999999999998887544


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      .  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......   .......||..|
T Consensus       119 ~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y  190 (331)
T 4aaa_A          119 N--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDEVATRWY  190 (331)
T ss_dssp             T--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------------CCCCCTT
T ss_pred             c--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc---cccCCCcCCccc
Confidence            3  3899999999999999999999955   9999999999999999999999999997654322   122345789999


Q ss_pred             cCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-ch------hhhhhhcCCcCCCC
Q 042486          511 MAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-GE------ESLRHLMDPSMQGN  582 (635)
Q Consensus       511 ~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~~------~~l~~~~d~~~~~~  582 (635)
                      +|||.+.+. .++.++||||||+++|||++|+.||......... ............ ..      ........+.....
T Consensus       191 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
T 4aaa_A          191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER  269 (331)
T ss_dssp             CCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred             cCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence            999998765 7899999999999999999999998654433211 111110000000 00      00001111111111


Q ss_pred             CC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+     +..+..+.+|+.+||+.||++|||+.|++++
T Consensus       270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11     1235568999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.4e-36  Score=304.89  Aligned_cols=229  Identities=24%  Similarity=0.330  Sum_probs=182.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  +++.||+|.++.             .+.+|+.++++++||||+++++++.+.+..++||||+++++|.++
T Consensus        19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (283)
T 3bhy_A           19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF   98 (283)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHH
Confidence            89999998  588999998753             256899999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----cEEEeeecCcccccccCCceeeec
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      +....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++    .+||+|||++.......    ...
T Consensus        99 l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~----~~~  169 (283)
T 3bhy_A           99 LAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFK  169 (283)
T ss_dssp             HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC----ccc
Confidence            96543  3899999999999999999999954   99999999999998877    89999999997654322    123


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .........               .....
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---------------~~~~~  233 (283)
T 3bhy_A          170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNISAVNY---------------DFDEE  233 (283)
T ss_dssp             --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC---------------CCCHH
T ss_pred             ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhHhccc---------------CCcch
Confidence            35689999999999988999999999999999999999999864332211 111100000               00000


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+..+.+++.+||+.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            001123458999999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.6e-36  Score=311.91  Aligned_cols=244  Identities=20%  Similarity=0.277  Sum_probs=179.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+++.  +++.||||++..       .+.+|++++.++ +||||+++++++.+++..++||||+++|+|.+++....
T Consensus        27 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  106 (316)
T 2ac3_A           27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR  106 (316)
T ss_dssp             EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS
T ss_pred             EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC
Confidence            89999986  789999999854       256899999985 79999999999999999999999999999999996643


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc---EEEeeecCcccccccCCc----eeeeccc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGE----FALTSHI  504 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~----~~~~~~~  504 (635)
                        .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++.........    .......
T Consensus       107 --~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  181 (316)
T 2ac3_A          107 --HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP  181 (316)
T ss_dssp             --SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccc
Confidence              3899999999999999999999954   999999999999988766   999999998765422110    0112234


Q ss_pred             ccCCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          505 VGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      .||+.|+|||.+.+     ..++.++||||||+++|||++|+.||............   ..............+.....
T Consensus       182 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~~~  258 (316)
T 2ac3_A          182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACPACQNMLFESIQEGKY  258 (316)
T ss_dssp             CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHHHHHHHHHHHHHCCC
T ss_pred             cCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccchhHHHHHHHHHhccCc
Confidence            69999999999875     55789999999999999999999998654322100000   00000000001111111111


Q ss_pred             CCCCCh----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGNYPP----VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        ..+.    ..+..+.+|+.+||+.||++|||+.|++++
T Consensus       259 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          259 --EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             --CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              1111    134568999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-35  Score=309.13  Aligned_cols=241  Identities=18%  Similarity=0.277  Sum_probs=184.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----ChHHHHHHHhhhc-cCCcccEEEEEec--CCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----DASDQIKLLNKIN-HSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||||.++.    .+.+|++++++++ |+||+++++++.+  ....++||||+++++|.+++..   
T Consensus        50 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---  126 (330)
T 3nsz_A           50 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---  126 (330)
T ss_dssp             EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---
T ss_pred             eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---
Confidence            89999976  789999999874    3668999999997 9999999999987  5678999999999999999853   


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                        +++..+..++.|++.||.|||+.+   |+||||||+|||++.++ .+||+|||+++.......    .....++..|+
T Consensus       127 --~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~y~  197 (330)
T 3nsz_A          127 --LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRYFK  197 (330)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSCCSCGGGC
T ss_pred             --CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc----ccccccccccc
Confidence              889999999999999999999955   99999999999999776 899999999976543321    23357899999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-----------hhhhhhhcCC--
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-----------EESLRHLMDP--  577 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----------~~~l~~~~d~--  577 (635)
                      |||.+.+ ..++.++|||||||++|||++|+.||.........+....... .....           ..........  
T Consensus       198 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (330)
T 3nsz_A          198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL-GTEDLYDYIDKYNIELDPRFNDILGRHS  276 (330)
T ss_dssp             CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH-CHHHHHHHHHHTTCCCCTHHHHHHCCCC
T ss_pred             ChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc-CCchhhhHHHHhccccccchhhhhhhcc
Confidence            9999876 6789999999999999999999999854433322221111100 00000           0000000000  


Q ss_pred             ------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 ------SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                            ......+...+..+.+|+.+||+.||++|||++|++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  01111222345678999999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-35  Score=316.15  Aligned_cols=254  Identities=22%  Similarity=0.253  Sum_probs=188.7

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhc--------cCCcccEEEEEe----cC
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKIN--------HSSLIRLLGICF----NG  408 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~--------h~nIv~l~~~~~----~~  408 (635)
                      +|.....||    |.||+++.  +++.||||+++..      +.+|+.+|++++        |+||+++++++.    +.
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~  117 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG  117 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence            344444454    89999986  6889999999753      457999999996        788999999998    55


Q ss_pred             CeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----------
Q 042486          409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----------  478 (635)
Q Consensus       409 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----------  478 (635)
                      ...++||||+ +++|.+++.......+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++          
T Consensus       118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            6789999999 66777777554445599999999999999999999984  1499999999999998775          


Q ss_pred             ---------------------------------------cEEEeeecCcccccccCCceeeecccccCCCccCccccccC
Q 042486          479 ---------------------------------------RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG  519 (635)
Q Consensus       479 ---------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  519 (635)
                                                             .+||+|||+++.....      .....||+.|+|||++.+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTS
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcCC
Confidence                                                   7999999999865432      1235789999999999998


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCCcchh----hHHHHhhhcccccCCchhh-----hhhhcCC----------c--
Q 042486          520 LVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN----MLLVDVLNPVLHKEDGEES-----LRHLMDP----------S--  578 (635)
Q Consensus       520 ~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~----~~l~~~~~~~~~~~~~~~~-----l~~~~d~----------~--  578 (635)
                      .++.++|||||||++|||++|+.||.......    ......+............     ...+...          .  
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            89999999999999999999999986543221    1111111111110000000     0000000          0  


Q ss_pred             -------CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 -------MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                             .....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                   0113456677889999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-36  Score=311.61  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=185.6

Q ss_pred             cCCCCCCccc----ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecc
Q 042486          352 DDFNPSCWIK----GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA  418 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~  418 (635)
                      ++|.....||    |.||+|+..+. +|+|.++.         .+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~~-~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  111 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC  111 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESSS-EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred             HHeEEeeEeccCCceEEEEEEEcCe-EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence            3444444554    89999998664 89998853         3568999999999999999999999999999999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-  497 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  497 (635)
                      ++++|.+++.... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++ ++.+||+|||+++........ 
T Consensus       112 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          112 KGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             cCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            9999999997643 34899999999999999999999955   99999999999998 679999999998754322111 


Q ss_pred             -eeeecccccCCCccCcccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc
Q 042486          498 -FALTSHIVGTKGYMAPEYLEN---------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       498 -~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  567 (635)
                       ........|++.|+|||.+..         ..++.++||||||+++|||++|+.||.....+... .....        
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--------  257 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-WQMGT--------  257 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-HHHHT--------
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcc--------
Confidence             111233468999999999864         45788999999999999999999998644332211 11100        


Q ss_pred             hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                            ...+...   +...+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       258 ------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          258 ------GMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             ------TCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             ------CCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  0111110   11122348899999999999999999999999998876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.4e-35  Score=321.24  Aligned_cols=178  Identities=21%  Similarity=0.278  Sum_probs=155.0

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhh------ccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKI------NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|+.  +++.||||+++.+      +.+|+.+++.+      +|+||+++++++...+..++||||+. ++|.+++
T Consensus       111 g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l  189 (429)
T 3kvw_A          111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELI  189 (429)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHH
Confidence            89999987  6789999999753      45688888887      56799999999999999999999995 6999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc--EEEeeecCcccccccCCceeeecccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR--AKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      .......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||+++.....      .....
T Consensus       190 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~------~~~~~  260 (429)
T 3kvw_A          190 KKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR------VYTYI  260 (429)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSC
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc------ccccC
Confidence            7665556999999999999999999999955   999999999999999887  999999999754332      22357


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE  549 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~  549 (635)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       261 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             SCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            89999999999998899999999999999999999999865443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-35  Score=316.96  Aligned_cols=255  Identities=19%  Similarity=0.302  Sum_probs=187.5

Q ss_pred             hhcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecC------------
Q 042486          350 ATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNG------------  408 (635)
Q Consensus       350 at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~------------  408 (635)
                      ..++|.....||    |.||+++.  +++.||||++..+   ..+|+++|++++|+||+++++++...            
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            344555555555    89999987  7899999998654   45899999999999999999998542            


Q ss_pred             --------------------------CeeEEEeecccCCCcchhhcc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCC
Q 042486          409 --------------------------GNWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNP  460 (635)
Q Consensus       409 --------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~  460 (635)
                                                ...++||||++ |+|.+.+..  .....+++..+..++.||+.||.|||+.+  
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--  161 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--  161 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence                                      33789999998 587777743  23345999999999999999999999855  


Q ss_pred             CeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHH
Q 042486          461 PHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEML  538 (635)
Q Consensus       461 ~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~ell  538 (635)
                       |+||||||+||+++ .++.+||+|||+++.......    .....+|+.|+|||.+.+. .++.++|||||||++|||+
T Consensus       162 -i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          162 -ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             -EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             -CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence             99999999999997 689999999999986543321    2235689999999998764 5899999999999999999


Q ss_pred             hCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh-------cCCcCC-----CCCChHHHHHHHHHHHHhhhcCCCCC
Q 042486          539 SGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-------MDPSMQ-----GNYPPVTAILVIRLIESCLKKDPSGR  606 (635)
Q Consensus       539 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-------~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~R  606 (635)
                      +|+.||......+ .+...+.. ...... +.+..+       .-+...     ...+...+..+.+|+.+||+.||++|
T Consensus       237 ~g~~pf~~~~~~~-~~~~i~~~-~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          237 LGKPLFSGETSID-QLVRIIQI-MGTPTK-EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HSSCSSCCSSHHH-HHHHHHHH-HCCCCH-HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             hCCCCCCCCChHH-HHHHHHHH-hCCCCH-HHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999987543322 12121111 111111 111110       000000     01222344568999999999999999


Q ss_pred             CCHHHHHHH
Q 042486          607 PAMDKIAQS  615 (635)
Q Consensus       607 Ps~~evl~~  615 (635)
                      ||+.|+++|
T Consensus       314 ~t~~e~l~h  322 (383)
T 3eb0_A          314 INPYEAMAH  322 (383)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.8e-35  Score=310.13  Aligned_cols=248  Identities=24%  Similarity=0.322  Sum_probs=181.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec--------CCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN--------GGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~lV~E~~~~gs  422 (635)
                      |.||+++.  +++.||||++..         .+.+|++++++++|+||+++++++..        .+..++||||+++ +
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~  109 (351)
T 3mi9_A           31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-D  109 (351)
T ss_dssp             TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-E
T ss_pred             cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-C
Confidence            89999998  688999998843         24589999999999999999999986        4468999999975 7


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC-ceeee
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG-EFALT  501 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  501 (635)
                      |.+.+.... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....... .....
T Consensus       110 l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  185 (351)
T 3mi9_A          110 LAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY  185 (351)
T ss_dssp             HHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCC
T ss_pred             HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccccccccccccccc
Confidence            777775433 23899999999999999999999955   99999999999999999999999999986543221 11222


Q ss_pred             cccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCCc----hhhhhhh
Q 042486          502 SHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKEDG----EESLRHL  574 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~----~~~l~~~  574 (635)
                      ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........  ..............    .+....+
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  265 (351)
T 3mi9_A          186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL  265 (351)
T ss_dssp             CSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSS
T ss_pred             CCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccc
Confidence            34578999999998875 55799999999999999999999998754433211  11111111000000    0000000


Q ss_pred             cCCcCCCCCCh-H------HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 MDPSMQGNYPP-V------TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~d~~~~~~~~~-~------~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       .......... .      .+..+.+|+.+||+.||++|||++|++++
T Consensus       266 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          266 -ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             -CCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -ccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             0000000000 0      12447899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-35  Score=338.12  Aligned_cols=246  Identities=25%  Similarity=0.360  Sum_probs=196.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLV  414 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV  414 (635)
                      ++|.....||    |.||+++.  +++.||||+++.+          +..|..+|.++ +|++|+++++++.+.+..|||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            4555555565    89999998  6789999998642          34688888887 799999999999999999999


Q ss_pred             eecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       415 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      |||+++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus       421 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999997654  3899999999999999999999955   999999999999999999999999999853322


Q ss_pred             CCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .   .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..                  +....+
T Consensus       496 ~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------------------~~~~~i  554 (674)
T 3pfq_A          496 G---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------------------ELFQSI  554 (674)
T ss_dssp             T---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------HHHHHH
T ss_pred             C---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------------------HHHHHH
Confidence            2   1234568999999999999999999999999999999999999998643322                  112222


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHHHHhhcccccc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAM-----DKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~~~~~s~~w~~  628 (635)
                      +...  ..+|...+..+.+||.+||+.||++||++     +||++|   -.-..++|+.
T Consensus       555 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h---~ff~~i~w~~  608 (674)
T 3pfq_A          555 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH---AFFRYIDWEK  608 (674)
T ss_dssp             HSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS---GGGSSCCHHH
T ss_pred             HhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC---ccccCCCHHH
Confidence            2221  12344456678999999999999999998     566554   2334467754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.3e-36  Score=305.45  Aligned_cols=230  Identities=22%  Similarity=0.301  Sum_probs=170.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh---------HHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc-
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA---------SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND-  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~---------~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~-  429 (635)
                      |.||+++.  +++.||||+++...         .++...++.++||||+++++++.+++..++||||++ |+|.+++.. 
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   99 (290)
T 3fme_A           21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQV   99 (290)
T ss_dssp             EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHH
T ss_pred             eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHH
Confidence            89999998  78999999986531         233445777899999999999999999999999997 588887743 


Q ss_pred             -cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          430 -KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       430 -~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                       .....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.......    ......||+
T Consensus       100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~  173 (290)
T 3fme_A          100 IDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV----AKDIDAGCK  173 (290)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------------------CCCC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc----cccccCCCc
Confidence             2334599999999999999999999984  149999999999999999999999999997654332    122346899


Q ss_pred             CccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          509 GYMAPEYL----ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       509 ~y~aPE~~----~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      .|+|||.+    .+..++.++||||||+++|||++|+.||.........+......                 ......+
T Consensus       174 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~  236 (290)
T 3fme_A          174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-----------------PSPQLPA  236 (290)
T ss_dssp             CCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-----------------CCCCCCT
T ss_pred             cccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-----------------CCCCccc
Confidence            99999996    56678999999999999999999999986433332222221111                 1111112


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...+..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            2334568999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4e-35  Score=302.37  Aligned_cols=239  Identities=22%  Similarity=0.261  Sum_probs=185.9

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc-----------ChHHHHHHHhhhccCCcccEEEEEe--cCCeeE
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-----------DASDQIKLLNKINHSSLIRLLGICF--NGGNWY  412 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-----------~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~  412 (635)
                      ++|.....||    |.||++..  +++.||+|.++.           .+.+|++++++++|+||+++++++.  +.+..+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            4566666665    89999988  678999999853           2557999999999999999999985  445789


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +||||++++ |.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            999999876 777776544556999999999999999999999955   9999999999999999999999999998654


Q ss_pred             ccCCceeeecccccCCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                      ..... .......||..|+|||.+.+..  .+.++||||||+++|||++|+.||.......  ....+            
T Consensus       161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i------------  225 (305)
T 2wtk_C          161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFENI------------  225 (305)
T ss_dssp             TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH------------
T ss_pred             ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHH------------
Confidence            32221 2233456899999999987643  4789999999999999999999986432211  11111            


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ....  ...+...+..+.+++.+||+.||++|||++|++++
T Consensus       226 ----~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 ----GKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----HHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----hcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                0000  01222334568899999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-35  Score=301.05  Aligned_cols=225  Identities=25%  Similarity=0.379  Sum_probs=176.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||.+..          .+.+|++++++++||||+++++++.+.+..++||||+++++|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (276)
T 2h6d_A           25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK  104 (276)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc
Confidence            89999987  689999999853          245799999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......    ......+++.
T Consensus       105 ~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~  175 (276)
T 2h6d_A          105 HG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPN  175 (276)
T ss_dssp             HC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc----ceecccCCcc
Confidence            43  3899999999999999999999955   9999999999999999999999999997654322    1233568999


Q ss_pred             ccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||.+.+..+ +.++||||||+++|+|++|+.||.......  ....+..                ..  ...+...+
T Consensus       176 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~----------------~~--~~~~~~~~  235 (276)
T 2h6d_A          176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRG----------------GV--FYIPEYLN  235 (276)
T ss_dssp             -CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH----------------CC--CCCCTTSC
T ss_pred             ccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhc----------------Cc--ccCchhcC
Confidence            999999987655 689999999999999999999985432211  1111100                00  01122334


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+++.+||+.||++|||++|++++
T Consensus       236 ~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          236 RSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            568999999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-35  Score=303.71  Aligned_cols=229  Identities=22%  Similarity=0.291  Sum_probs=183.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gs  422 (635)
                      |.||+++.  +++.||||.+..                .+.+|+++++++. ||||+++++++.+++..++||||+++++
T Consensus        31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  110 (298)
T 1phk_A           31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE  110 (298)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCc
Confidence            89999998  678999999842                2457899999995 9999999999999999999999999999


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeec
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      |.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......    ...
T Consensus       111 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~  181 (298)
T 1phk_A          111 LFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLR  181 (298)
T ss_dssp             HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----CBC
T ss_pred             HHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc----ccc
Confidence            999996543  3899999999999999999999955   9999999999999999999999999997654322    123


Q ss_pred             ccccCCCccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          503 HIVGTKGYMAPEYLE------NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                      ...+++.|+|||.+.      ...++.++||||||+++|||++|+.||........ .........              
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~--------------  246 (298)
T 1phk_A          182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNY--------------  246 (298)
T ss_dssp             CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC--------------
T ss_pred             cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HHHHhcCCc--------------
Confidence            356899999999885      45688999999999999999999999854332211 111111000              


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       ..........+..+.+++.+||+.||++||++.|++++
T Consensus       247 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          247 -QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             -CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence             00001112345568999999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.2e-36  Score=307.34  Aligned_cols=241  Identities=24%  Similarity=0.355  Sum_probs=174.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc--
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND--  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--  429 (635)
                      |.||++..  +++.||||.+..        ++.+|+.++++++||||+++++++...+..++||||+++++|.+++..  
T Consensus        29 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  108 (303)
T 2vwi_A           29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV  108 (303)
T ss_dssp             CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHh
Confidence            89999987  788999998753        355789999999999999999999999999999999999999999853  


Q ss_pred             ----cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC--ceeeecc
Q 042486          430 ----KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG--EFALTSH  503 (635)
Q Consensus       430 ----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~  503 (635)
                          .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  .......
T Consensus       109 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  185 (303)
T 2vwi_A          109 AKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT  185 (303)
T ss_dssp             HTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------------
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcc
Confidence                12345899999999999999999999955   99999999999999999999999999875543211  1112234


Q ss_pred             cccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          504 IVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       504 ~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ..||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............. .....     .......++.....
T Consensus       186 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~  259 (303)
T 2vwi_A          186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPP-----SLETGVQDKEMLKK  259 (303)
T ss_dssp             --CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TSSCC-----CTTC-----CCCCC
T ss_pred             cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-ccCCC-----ccccccccchhhhh
Confidence            578999999999875 568999999999999999999999987544332211111 10000     00000111111122


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          .+..+.+++.+||+.||.+||++.|++++
T Consensus       260 ----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          260 ----YGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             ----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                33458999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-35  Score=322.80  Aligned_cols=182  Identities=26%  Similarity=0.402  Sum_probs=144.0

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC-----CeeE
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG-----GNWY  412 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~  412 (635)
                      +|.....||    |.||+++.  +++.||||++...         +.+|+++|++++|+||+++++++...     +..|
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            444445554    89999976  7899999998642         45799999999999999999999543     5689


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +||||+ +++|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       134 lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            999998 578999886543  4999999999999999999999955   9999999999999999999999999998654


Q ss_pred             ccCCc------------------------eeeecccccCCCccCcccc-ccCCCCcccchhhHHHHHHHHHhC
Q 042486          493 RQEGE------------------------FALTSHIVGTKGYMAPEYL-ENGLVSTKLDVYAFGVLMLEMLSG  540 (635)
Q Consensus       493 ~~~~~------------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SlGvvl~elltG  540 (635)
                      .....                        .......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            32111                        0112345789999999976 566799999999999999999994

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-35  Score=322.44  Aligned_cols=250  Identities=25%  Similarity=0.259  Sum_probs=181.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC------Ce
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG------GN  410 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~------~~  410 (635)
                      ++|.....||    |.||++..  +++.||||++...         +.+|+.+|++++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            3444444554    89999987  6899999998642         45799999999999999999999754      35


Q ss_pred             eEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       411 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      .|+||||++++ |.+.+..    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       142 ~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          142 VYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             EEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            69999999764 6666543    2899999999999999999999955   99999999999999999999999999986


Q ss_pred             ccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC----
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED----  566 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----  566 (635)
                      .....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. +...+. .+....    
T Consensus       214 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~-~lg~p~~~~~  287 (464)
T 3ttj_A          214 AGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIE-QLGTPCPEFM  287 (464)
T ss_dssp             ---CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-HHCSCCHHHH
T ss_pred             cCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hcCCCCHHHH
Confidence            54321    22346799999999999999999999999999999999999999865443221 111111 010000    


Q ss_pred             --chhhhhhhcCCcC---------------CCC---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 --GEESLRHLMDPSM---------------QGN---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 --~~~~l~~~~d~~~---------------~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .......+.....               ...   .....+..+.+|+.+||+.||++|||++|+++|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0011111111100               000   011125668999999999999999999999987

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.4e-35  Score=324.74  Aligned_cols=228  Identities=25%  Similarity=0.317  Sum_probs=182.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||||++..         .+.+|+++|++++||||+++++++.+.+..++||||+.+|+|.+++...
T Consensus        36 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  115 (486)
T 3mwu_A           36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR  115 (486)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc
Confidence            89999997  689999999842         2568999999999999999999999999999999999999999998654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC---CCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD---TDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .  .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++......    ......||
T Consensus       116 ~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt  186 (486)
T 3mwu_A          116 K--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGT  186 (486)
T ss_dssp             S--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--------CCTTG
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC----ccCCCcCC
Confidence            3  3899999999999999999999955   99999999999995   45679999999998654332    12345799


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+.........               .........
T Consensus       187 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~---------------~~~~~~~~~  249 (486)
T 3mwu_A          187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYA---------------FDLPQWRTI  249 (486)
T ss_dssp             GGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC---------------SCSGGGGGS
T ss_pred             CCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---------------CCCcccCCC
Confidence            99999999875 58999999999999999999999986433221 11111110000               000011223


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+|+.+||+.||++|||+.|++++
T Consensus       250 s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            4568999999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-35  Score=314.64  Aligned_cols=238  Identities=25%  Similarity=0.377  Sum_probs=181.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC------eeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG------NWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~E~~~~gsL~  424 (635)
                      |.||+|+.  +|+.||||++..         .+.+|+++|++++||||+++++++...+      ..|+||||+ +++|.
T Consensus        39 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  117 (367)
T 1cm8_A           39 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG  117 (367)
T ss_dssp             -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred             eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHH
Confidence            89999987  689999999853         2457999999999999999999998653      469999999 88999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....      ....
T Consensus       118 ~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------~~~~  185 (367)
T 1cm8_A          118 KLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGY  185 (367)
T ss_dssp             HHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS------CCSS
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc------cCcC
Confidence            998653   3899999999999999999999955   999999999999999999999999999865432      2235


Q ss_pred             ccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------chhhhh
Q 042486          505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------GEESLR  572 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~  572 (635)
                      .+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... +..... ......           ....+.
T Consensus       186 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~-~~g~~~~~~~~~~~~~~~~~~~~  263 (367)
T 1cm8_A          186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMK-VTGTPPAEFVQRLQSDEAKNYMK  263 (367)
T ss_dssp             CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-HHCCCCHHHHHTCSCHHHHHHHH
T ss_pred             cCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hcCCCCHHHHHHhhhHHHHHHHH
Confidence            78999999999876 6789999999999999999999999865433221 111111 000000           000011


Q ss_pred             hhc---CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLM---DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~---d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+-   ...+ .......+..+.+|+.+||+.||++|||++|+++|
T Consensus       264 ~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          264 GLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            100   0000 01112334568999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.5e-35  Score=304.29  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=189.9

Q ss_pred             hcCCCCCCccc----ceEEEeee---CCcEEEEEEecc---------ChHHHHHHHhhh---ccCCcccEEEEEe-----
Q 042486          351 TDDFNPSCWIK----GSVYRGKI---GGDFVAIKKVYG---------DASDQIKLLNKI---NHSSLIRLLGICF-----  406 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~---~~~~vavK~~~~---------~~~~E~~~l~~l---~h~nIv~l~~~~~-----  406 (635)
                      .++|.....||    |.||+++.   +++.||||+++.         .+.+|+.+++++   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            34455555554    89999987   578999998742         355788888877   7999999999997     


Q ss_pred             cCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeec
Q 042486          407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFA  486 (635)
Q Consensus       407 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  486 (635)
                      .....++||||+. |+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence            4567899999997 69999997655555999999999999999999999955   9999999999999999999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED  566 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  566 (635)
                      +++......    ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ +...... .....
T Consensus       166 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~-~~~~~  239 (326)
T 1blx_A          166 LARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDV-IGLPG  239 (326)
T ss_dssp             SCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH-HCCCC
T ss_pred             ccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHH-cCCCC
Confidence            998654322    12335789999999999998999999999999999999999999875443221 1111110 00000


Q ss_pred             chh-----hh-hhhcC---CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 GEE-----SL-RHLMD---PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ~~~-----~l-~~~~d---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...     .. .....   ...........+..+.+|+.+||+.||++||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000     00 00000   000011222345568999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.5e-35  Score=305.99  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=187.4

Q ss_pred             ceEEEeee---CCcEEEEEEecc------ChHHHHHHHhhhccCC------cccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI---GGDFVAIKKVYG------DASDQIKLLNKINHSS------LIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~---~~~~vavK~~~~------~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||++..   +++.||||.++.      .+.+|++++++++|++      ++++++++.+.+..++||||+ +++|.++
T Consensus        28 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~  106 (339)
T 1z57_A           28 GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDF  106 (339)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHH
Confidence            89999976   688999999974      3567999999998765      999999999999999999999 8899999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-------------------CCcEEEeeecC
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-------------------DFRAKIANFAL  487 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-------------------~~~~kl~Dfg~  487 (635)
                      +.......+++..+..++.|++.||.|||+.+   |+||||||+||+++.                   ++.+||+|||+
T Consensus       107 l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~  183 (339)
T 1z57_A          107 IKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS  183 (339)
T ss_dssp             HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSS
T ss_pred             HHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcc
Confidence            97665556899999999999999999999955   999999999999987                   66899999999


Q ss_pred             cccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccc--
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLH--  563 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~--  563 (635)
                      ++.....      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.....  ..........  
T Consensus       184 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~  257 (339)
T 1z57_A          184 ATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM  257 (339)
T ss_dssp             CEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHH
T ss_pred             cccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            9764432      12357899999999999989999999999999999999999998754433211  1111100000  


Q ss_pred             ------------------cCC-chhhhhhhcCCcC-CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          564 ------------------KED-GEESLRHLMDPSM-QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       564 ------------------~~~-~~~~l~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                        ... ..........+.. ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence                              000 0000000000000 112234567789999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-35  Score=308.50  Aligned_cols=229  Identities=23%  Similarity=0.298  Sum_probs=178.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      |.||+++.  +++.||||.+..               .+.+|+++|++++||||+++++++..++ .++||||+++++|.
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~  102 (322)
T 2ycf_A           24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELF  102 (322)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETH
T ss_pred             EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHH
Confidence            89999987  678999998753               3568999999999999999999987654 89999999999999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc---EEEeeecCcccccccCCceeee
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFALARPAERQEGEFALT  501 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~~~~~  501 (635)
                      +++....  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.   +||+|||+++......    ..
T Consensus       103 ~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~  173 (322)
T 2ycf_A          103 DKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LM  173 (322)
T ss_dssp             HHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH----HH
T ss_pred             HHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc----cc
Confidence            9986543  4899999999999999999999955   999999999999987654   9999999997654321    12


Q ss_pred             cccccCCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          502 SHIVGTKGYMAPEYLE---NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      ....||+.|+|||.+.   ...++.++||||||+++|||++|+.||...................           ..+.
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~  242 (322)
T 2ycf_A          174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-----------FIPE  242 (322)
T ss_dssp             HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC-----------CCHH
T ss_pred             ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc-----------cCch
Confidence            3356899999999874   5678999999999999999999999986433221111001000000           0000


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .    ....+..+.+++.+||+.||++||++.|++++
T Consensus       243 ~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          243 V----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             h----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            0    01124458999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-35  Score=305.91  Aligned_cols=230  Identities=22%  Similarity=0.385  Sum_probs=180.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||+|.+..       ++.+|++++++++||||+++++++.+++..++||||+++++|.+++.... 
T Consensus        33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-  111 (302)
T 2j7t_A           33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-  111 (302)
T ss_dssp             CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-
T ss_pred             eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-
Confidence            89999998  588999998853       25579999999999999999999999999999999999999999986533 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   .......||..|+|
T Consensus       112 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~a  185 (302)
T 2j7t_A          112 RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL---QKRDSFIGTPYWMA  185 (302)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH---HC-----CCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc---cccccccCChhhcC
Confidence            23899999999999999999999955   9999999999999999999999999875432211   11223568999999


Q ss_pred             cccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          513 PEYL-----ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       513 PE~~-----~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||.+     ....++.++||||||+++|+|++|+.|+........ ........              .+  ....+...
T Consensus       186 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~--------------~~--~~~~~~~~  248 (302)
T 2j7t_A          186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSD--------------PP--TLLTPSKW  248 (302)
T ss_dssp             HHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC--------------CC--CCSSGGGS
T ss_pred             CeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhccC--------------Cc--ccCCcccc
Confidence            9998     366789999999999999999999999864433211 11111000              00  01112334


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            4568999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-36  Score=323.15  Aligned_cols=228  Identities=15%  Similarity=0.193  Sum_probs=173.8

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHH---HHHhhhccCCcccEE-------EEEe
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQI---KLLNKINHSSLIRLL-------GICF  406 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~---~~l~~l~h~nIv~l~-------~~~~  406 (635)
                      +|.....||    |.||+|+.  +++.||||++..          .+.+|+   ++|++++||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            343344554    89999996  689999999852          245888   556666899999998       6666


Q ss_pred             cCCe-----------------eEEEeecccCCCcchhhcccC-----CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEe
Q 042486          407 NGGN-----------------WYLVYENAVNGSLSVWINDKG-----GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH  464 (635)
Q Consensus       407 ~~~~-----------------~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH  464 (635)
                      +.+.                 .|+||||+ +|+|.+++....     ...+++..++.|+.||+.||+|||+.+   |+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            5532                 78999999 689999996432     122446889999999999999999955   999


Q ss_pred             ecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC-----------CCCcccchhhHHHH
Q 042486          465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-----------LVSTKLDVYAFGVL  533 (635)
Q Consensus       465 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SlGvv  533 (635)
                      |||||+|||++.++.+||+|||+++....      ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999999999999999985332      1234567 999999999877           89999999999999


Q ss_pred             HHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 042486          534 MLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA  613 (635)
Q Consensus       534 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  613 (635)
                      +|||++|+.||.......                  ....+...  ...    .+..+.+|+.+||+.||++||++.|++
T Consensus       303 l~elltg~~Pf~~~~~~~------------------~~~~~~~~--~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG------------------GSEWIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHSSCCC------C------------------CSGGGGSS--CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHCCCCCccccccc------------------chhhhhhh--ccC----CCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            999999999985322111                  00011110  012    234589999999999999999999998


Q ss_pred             HH
Q 042486          614 QS  615 (635)
Q Consensus       614 ~~  615 (635)
                      ++
T Consensus       359 ~h  360 (377)
T 3byv_A          359 ET  360 (377)
T ss_dssp             TS
T ss_pred             hC
Confidence            74

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-35  Score=324.40  Aligned_cols=228  Identities=25%  Similarity=0.299  Sum_probs=181.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  ++..||||.++.         .+.+|+.+|++++||||+++++++.+.+..|+||||+++|+|.+++...
T Consensus        51 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~  130 (494)
T 3lij_A           51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR  130 (494)
T ss_dssp             -EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc
Confidence            89999998  688999999853         2468999999999999999999999999999999999999999988654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC---CcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD---FRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||++.......    ......||
T Consensus       131 ~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt  201 (494)
T 3lij_A          131 M--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGT  201 (494)
T ss_dssp             S--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB----CBCCCCSC
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc----cccccCCC
Confidence            3  3899999999999999999999955   9999999999999764   559999999998654332    12345799


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|+|||++. +.++.++|||||||++|+|++|+.||........ +..........               ........
T Consensus       202 ~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~---------------~~~~~~~~  264 (494)
T 3lij_A          202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYTF---------------DSPEWKNV  264 (494)
T ss_dssp             TTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCC---------------CSGGGTTS
T ss_pred             cCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC---------------CchhcccC
Confidence            9999999986 4689999999999999999999999865433211 11111110000               00000123


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+|+.+||+.||++|||+.|++++
T Consensus       265 s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          265 SEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            4558999999999999999999999976

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.9e-36  Score=315.39  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=186.9

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecC-----CeeEE
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNG-----GNWYL  413 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l  413 (635)
                      +|.....||    |.||+++.  +++.||||++..        .+.+|+++|++++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            344444444    89999987  688999999863        355899999999999999999999754     36899


Q ss_pred             EeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ||||+. |+|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       108 v~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            999997 5899988653   3899999999999999999999955   99999999999999999999999999986654


Q ss_pred             cCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      ............||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +.... ....... .+.+.
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~-~~~~~~~-~~~~~  257 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHIL-GILGSPS-QEDLN  257 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHH-HHHCSCC-HHHHH
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHH-HHhCCCC-HHHHH
Confidence            3322222344579999999998654 5589999999999999999999999865433221 11111 1111110 00000


Q ss_pred             h--------hc-CCcCCCCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 H--------LM-DPSMQGNY-----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~--------~~-d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .        .. ........     ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0        00 00000000     11234558999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-35  Score=326.31  Aligned_cols=228  Identities=26%  Similarity=0.315  Sum_probs=183.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++.  +++.||||++..          .+.+|+.+|++++||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        40 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  119 (484)
T 3nyv_A           40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS  119 (484)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh
Confidence            89999988  689999999742          256899999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE---CCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL---DTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      ..  .+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++......    ......|
T Consensus       120 ~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~g  190 (484)
T 3nyv_A          120 RK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIG  190 (484)
T ss_dssp             CS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHHTT
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----ccccCCC
Confidence            43  3899999999999999999999955   9999999999999   567899999999997654332    1234579


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |+.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+.........               ........
T Consensus       191 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~---------------~~~~~~~~  253 (484)
T 3nyv_A          191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKGKYT---------------FELPQWKK  253 (484)
T ss_dssp             GGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC---------------CCSGGGGG
T ss_pred             CccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC---------------CCCccccc
Confidence            999999999875 68999999999999999999999986533221 11111111000               00001123


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+|+.+||+.||++|||+.|+++|
T Consensus       254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          254 VSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            34568999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.2e-35  Score=318.75  Aligned_cols=186  Identities=26%  Similarity=0.372  Sum_probs=150.4

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecC-----CeeE
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNG-----GNWY  412 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~  412 (635)
                      +|.....||    |.||+++.  +++.||||+++.         .+.+|+++|++++|+||+++++++...     +..|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            344444444    89999987  688999999964         245899999999999999999999865     5689


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +||||++ |+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       107 lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            9999986 59999996543  3999999999999999999999955   9999999999999999999999999998654


Q ss_pred             ccCCce-------------------eeecccccCCCccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 042486          493 RQEGEF-------------------ALTSHIVGTKGYMAPEYL-ENGLVSTKLDVYAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       493 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SlGvvl~elltG~~p~  544 (635)
                      ......                   .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            332110                   112456799999999986 5667999999999999999999865443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-35  Score=324.97  Aligned_cols=237  Identities=25%  Similarity=0.307  Sum_probs=186.6

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc--------------------ChHHHHHHHhhhccCCcccEEEEEe
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------------------DASDQIKLLNKINHSSLIRLLGICF  406 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------------------~~~~E~~~l~~l~h~nIv~l~~~~~  406 (635)
                      .|.....||    |.||+++.  +++.||||.+..                    .+.+|+.+|++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            344444454    89999997  678999998753                    2457999999999999999999999


Q ss_pred             cCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC---cEEEe
Q 042486          407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF---RAKIA  483 (635)
Q Consensus       407 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~  483 (635)
                      +++..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++   .+||+
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence            9999999999999999999986543  3899999999999999999999955   99999999999998775   69999


Q ss_pred             eecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc
Q 042486          484 NFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       484 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                      |||++.......    ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||........ +.......+.
T Consensus       192 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~  265 (504)
T 3q5i_A          192 DFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-IKKVEKGKYY  265 (504)
T ss_dssp             CCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC
T ss_pred             ECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCC
Confidence            999998654432    123457999999999987 4689999999999999999999999865433211 1111110000


Q ss_pred             cCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          564 KEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       564 ~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..  ...             ....+..+.+|+.+||+.||.+|||++|++++
T Consensus       266 ~~--~~~-------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          266 FD--FND-------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CC--HHH-------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CC--ccc-------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00  000             01123558999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.6e-36  Score=318.12  Aligned_cols=240  Identities=13%  Similarity=0.032  Sum_probs=167.6

Q ss_pred             CCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhh--ccCCcccEE-------EEEecC
Q 042486          354 FNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKI--NHSSLIRLL-------GICFNG  408 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l--~h~nIv~l~-------~~~~~~  408 (635)
                      |.....||    |.||+|+.  +++.||||+++..          +.+|+.+++.+  +||||++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            44444554    89999997  7889999998763          23665444444  699988755       444432


Q ss_pred             -----------------CeeEEEeecccCCCcchhhcccCCCCCCHHHH------HHHHHHHHhhhcccccCCCCCeEee
Q 042486          409 -----------------GNWYLVYENAVNGSLSVWINDKGGKFLDWAQR------IQIALDVATGLNYLHSFTNPPHVHK  465 (635)
Q Consensus       409 -----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~~~ivH~  465 (635)
                                       ...|+||||++ |+|.+++..... .+.+..+      +.++.||+.||.|||+.+   |+||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr  218 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG  218 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence                             33799999998 899999965422 2566666      788899999999999855   9999


Q ss_pred             cccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCC
Q 042486          466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEA  543 (635)
Q Consensus       466 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p  543 (635)
                      ||||+|||++.++.+||+|||+++.....      .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.|
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999855321      113567799999999987  6789999999999999999999999


Q ss_pred             CCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          544 PALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       544 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      |..........       +..    ...................+..+.+|+.+||+.||++|||+.|++++
T Consensus       293 f~~~~~~~~~~-------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          293 FGLVTPGIKGS-------WKR----PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TTBCCTTCTTC-------CCB----CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCcCcccccc-------hhh----hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            86432221100       000    00000001111111122345668999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=307.18  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=181.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEe--------------cCCeeEEEeecc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICF--------------NGGNWYLVYENA  418 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~--------------~~~~~~lV~E~~  418 (635)
                      |.||+++.  +++.||||++..       .+.+|++++++++||||+++++++.              +.+..++||||+
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  104 (320)
T 2i6l_A           25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM  104 (320)
T ss_dssp             -CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECC
T ss_pred             eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeecc
Confidence            89999998  488999998753       3567999999999999999999874              346789999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCc
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      + |+|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++ +++.+||+|||+++........
T Consensus       105 ~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  177 (320)
T 2i6l_A          105 E-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH  177 (320)
T ss_dssp             S-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC------
T ss_pred             C-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccc
Confidence            7 6999998643   3899999999999999999999955   99999999999997 5679999999999866433221


Q ss_pred             eeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC-Cchhhhhh--
Q 042486          498 FALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE-DGEESLRH--  573 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~~l~~--  573 (635)
                      ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||........ ............ .....+..  
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  256 (320)
T 2i6l_A          178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIPVVHEEDRQELLSVI  256 (320)
T ss_dssp             --CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSCCCCHHHHHHHHTTS
T ss_pred             ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCchhhhhhhhhcC
Confidence            122334567899999998865 6789999999999999999999999875443221 111111110000 00000000  


Q ss_pred             ------hc-CCcCC-CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcccccc
Q 042486          574 ------LM-DPSMQ-GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWEL  628 (635)
Q Consensus       574 ------~~-d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~~w~~  628 (635)
                            .. .+... .......+..+.+++.+||+.||++|||++|++++  .++. ..+|..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~-~~~~p~  316 (320)
T 2i6l_A          257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH--PYMS-IYSFPM  316 (320)
T ss_dssp             CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--HHHH-TTCC--
T ss_pred             cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC--cccc-cccCcc
Confidence                  00 00000 00011234568999999999999999999999986  3443 344543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.4e-35  Score=317.31  Aligned_cols=243  Identities=26%  Similarity=0.383  Sum_probs=179.8

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcchhhcc-
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLSVWIND-  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~-  429 (635)
                      |.||+|+.  +++.||||++..+   ..+|+++|++++|+||+++++++...      ...++||||+++ +|.+.+.. 
T Consensus        68 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  146 (420)
T 1j1b_A           68 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY  146 (420)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHH
Confidence            89999998  6899999998643   45899999999999999999998632      236799999976 56555532 


Q ss_pred             -cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-CcEEEeeecCcccccccCCceeeecccccC
Q 042486          430 -KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       430 -~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                       .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.+ +.+||+|||+++.......    .....+|
T Consensus       147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~t  219 (420)
T 1j1b_A          147 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICS  219 (420)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSCCSC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC----ceeeeeC
Confidence             22345999999999999999999999855   9999999999999965 6789999999986543321    2235789


Q ss_pred             CCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhc-------CCcC
Q 042486          508 KGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM-------DPSM  579 (635)
Q Consensus       508 ~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~-------d~~~  579 (635)
                      +.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.+.+.. +... ..+.+..+-       .+.+
T Consensus       220 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~-lg~p-~~~~~~~~~~~~~~~~~p~~  296 (420)
T 1j1b_A          220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKV-LGTP-TREQIREMNPNYTEFKFPQI  296 (420)
T ss_dssp             TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-HCSC-CHHHHHHHCSCCCCCCCCCC
T ss_pred             CCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCCC-CHHHHHhhChhhhhhccCcc
Confidence            999999998764 78999999999999999999999986543322 22222211 1111 111111110       0111


Q ss_pred             CC-----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QG-----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..     .++...+..+.+|+.+||+.||++||++.|+++|
T Consensus       297 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00     0122334568999999999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-34  Score=307.46  Aligned_cols=191  Identities=21%  Similarity=0.280  Sum_probs=159.8

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhc-cC-----CcccEEEEEecCCeeE
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKIN-HS-----SLIRLLGICFNGGNWY  412 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~  412 (635)
                      .++|.....||    |.||+|+.  +++.||||+++..      +..|+.+++.++ |+     +|+++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            34555555565    89999987  6889999999753      346888888885 44     4999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC--CCCcEEEeeecCccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD--TDFRAKIANFALARP  490 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~a~~  490 (635)
                      +||||+. |+|.+++.......+++..+..++.|++.||.|||.+. .+|+||||||+|||++  .++.+||+|||+++.
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            9999996 59999997655455999999999999999999999643 6799999999999994  578899999999986


Q ss_pred             ccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 042486          491 AERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSE  549 (635)
Q Consensus       491 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~  549 (635)
                      ....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          211 LGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            5432      2235789999999999998999999999999999999999999875443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.3e-35  Score=312.12  Aligned_cols=267  Identities=25%  Similarity=0.342  Sum_probs=192.1

Q ss_pred             cHHHHHHhhcCCCCCCccc----ceEEEeee-CCcEEEEEEecc------------------ChHHHHHHHhhhccCCcc
Q 042486          343 TFEELQAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKVYG------------------DASDQIKLLNKINHSSLI  399 (635)
Q Consensus       343 ~~~el~~at~~f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~------------------~~~~E~~~l~~l~h~nIv  399 (635)
                      ..+++....++|.....||    |.||+|.. +++.||||++..                  .+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567888888888888887    89999987 788999998843                  356899999999999999


Q ss_pred             cEEEEEec-----CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE
Q 042486          400 RLLGICFN-----GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL  474 (635)
Q Consensus       400 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll  474 (635)
                      ++++++..     ....++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            99999853     335799999997 68888886443 34899999999999999999999955   9999999999999


Q ss_pred             CCCCcEEEeeecCcccccccCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH
Q 042486          475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML  553 (635)
Q Consensus       475 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~  553 (635)
                      +.++.+||+|||+++......    ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ 
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-  242 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-  242 (362)
T ss_dssp             CTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred             cCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            999999999999997543322    1234578999999999876 6789999999999999999999999875433221 


Q ss_pred             HHHhhhcccccCCch-------hhhhhhcCCcCCCC-------CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          554 LVDVLNPVLHKEDGE-------ESLRHLMDPSMQGN-------YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       554 l~~~~~~~~~~~~~~-------~~l~~~~d~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      +..... ........       ..............       .....+..+.+|+.+||+.||++|||+.|++++  .+
T Consensus       243 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~  319 (362)
T 3pg1_A          243 LNKIVE-VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH--PY  319 (362)
T ss_dssp             HHHHHH-HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GG
T ss_pred             HHHHHH-HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC--ch
Confidence            111111 00000000       00111111111000       011224558999999999999999999999986  44


Q ss_pred             Hhh
Q 042486          620 LNA  622 (635)
Q Consensus       620 ~~~  622 (635)
                      +.+
T Consensus       320 f~~  322 (362)
T 3pg1_A          320 FES  322 (362)
T ss_dssp             GTT
T ss_pred             hhh
Confidence            443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.9e-35  Score=303.21  Aligned_cols=229  Identities=24%  Similarity=0.383  Sum_probs=178.0

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhhc--cCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKIN--HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+++. +++.||||.+..         .+.+|++++++++  |+||+++++++.+++..++||| +.+++|.+++..
T Consensus        42 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~  120 (313)
T 3cek_A           42 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  120 (313)
T ss_dssp             EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred             EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh
Confidence            89999988 688999999843         2467999999997  4999999999999999999999 568899999975


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..  .+++..+..++.|++.||.|||+.+   ++||||||+||++++ +.+||+|||+++........ .......||+.
T Consensus       121 ~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~gt~~  193 (313)
T 3cek_A          121 KK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS-VVKDSQVGTVN  193 (313)
T ss_dssp             CS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC---------------CCGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcccc-ccccCCCCCCC
Confidence            43  4899999999999999999999954   999999999999964 89999999999865433211 12234578999


Q ss_pred             ccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          510 YMAPEYLEN-----------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       510 y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      |+|||.+.+           ..++.++||||||+++|||++|+.||.......                 ..+....++.
T Consensus       194 y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----------------~~~~~~~~~~  256 (313)
T 3cek_A          194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----------------SKLHAIIDPN  256 (313)
T ss_dssp             GCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----------------HHHHHHHCTT
T ss_pred             cCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----------------HHHHHHHhcc
Confidence            999999875           468889999999999999999999985432221                 1122223333


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+...+..+.+++.+||+.||++||++.|++++
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            2223333345568999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-35  Score=315.99  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=174.0

Q ss_pred             ceEEEeee----CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccEEEEEec--CCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.    +++.||||++..     .+.+|+.+|++++||||+++++++..  +...++||||+. |+|.+++...
T Consensus        35 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~  113 (405)
T 3rgf_A           35 GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH  113 (405)
T ss_dssp             -EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHH
T ss_pred             eEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHh
Confidence            89999985    367899999865     36689999999999999999999954  678899999996 4787777421


Q ss_pred             -------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE----CCCCcEEEeeecCcccccccCCcee
Q 042486          431 -------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL----DTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       431 -------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                             ....+++..++.|+.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++..........
T Consensus       114 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  190 (405)
T 3rgf_A          114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  190 (405)
T ss_dssp             HHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------
T ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccc
Confidence                   1224899999999999999999999955   9999999999999    7789999999999987654322222


Q ss_pred             eecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchh--------hHHHHhhhcccccCC----
Q 042486          500 LTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEEN--------MLLVDVLNPVLHKED----  566 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--------~~l~~~~~~~~~~~~----  566 (635)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+.        ..+...+.. +....    
T Consensus       191 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~-~g~p~~~~~  269 (405)
T 3rgf_A          191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV-MGFPADKDW  269 (405)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH-HCCCCTTTC
T ss_pred             cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh-hCCCChhhc
Confidence            3344679999999999887 458999999999999999999999986543321        111111110 00000    


Q ss_pred             --------chhhhhhhcCCcCCCC--------CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 042486          567 --------GEESLRHLMDPSMQGN--------YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN  621 (635)
Q Consensus       567 --------~~~~l~~~~d~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  621 (635)
                              .......+........        .....+..+.+|+.+||+.||++|||++|+++|  .++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h--p~f~  338 (405)
T 3rgf_A          270 EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD--PYFL  338 (405)
T ss_dssp             GGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGT
T ss_pred             chhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhc
Confidence                    0000000000000000        000013457899999999999999999999987  4443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.4e-35  Score=333.87  Aligned_cols=244  Identities=25%  Similarity=0.347  Sum_probs=189.5

Q ss_pred             CCCCCCccc----ceEEEeeeC-----CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          353 DFNPSCWIK----GSVYRGKIG-----GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~-----~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      +|.....||    |.||+|++.     +..||||+++.        .+.+|+.++++++||||+++++++. ++..++||
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~  469 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM  469 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEE
Confidence            344444454    899999872     45799999864        3567999999999999999999984 56689999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       470 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             ECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            9999999999996543 34899999999999999999999955   9999999999999999999999999998664332


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......  ....+.             ..
T Consensus       546 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~-------------~~  608 (656)
T 2j0j_A          546 Y--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE-------------NG  608 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH-------------HT
T ss_pred             c--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-------------cC
Confidence            1  12233456789999999998899999999999999999997 888875433221  111110             00


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .    ....+...+..+.+++.+||+.||++||++.|+++.|++++..
T Consensus       609 ~----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          609 E----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            0    1112333455689999999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-35  Score=316.00  Aligned_cols=241  Identities=24%  Similarity=0.370  Sum_probs=176.5

Q ss_pred             CCCCCCccc----ce-EEEeeeCCcEEEEEEeccC----hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCC
Q 042486          353 DFNPSCWIK----GS-VYRGKIGGDFVAIKKVYGD----ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGS  422 (635)
Q Consensus       353 ~f~~~~~ig----g~-Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gs  422 (635)
                      +|.....||    |+ +|++..+++.||||++..+    +.+|+++|+++ +||||+++++++.+.+..|+||||+. |+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~  103 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT  103 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence            344444554    66 6777789999999998653    57899999999 89999999999999999999999996 59


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-----CCcEEEeeecCcccccccCCc
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-----DFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      |.+++...... +.+..+..++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+++........
T Consensus       104 L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          104 LQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             HHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             HHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            99999654432 455567789999999999999955   999999999999943     346889999999876543322


Q ss_pred             eeeecccccCCCccCccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhh
Q 042486          498 FALTSHIVGTKGYMAPEYLE---NGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH  573 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  573 (635)
                      ........||+.|+|||++.   ...++.++|||||||++|||++ |..||.........   .....   .        
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---~~~~~---~--------  245 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLGA---C--------  245 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---HHTTC---C--------
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---HHhcc---C--------
Confidence            23334567999999999997   4567889999999999999999 77776432211110   00000   0        


Q ss_pred             hcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          574 LMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       574 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                        .. .....+......+.+|+.+||+.||++|||++|+++|
T Consensus       246 --~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          246 --SL-DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             --CC-TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --Cc-cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence              00 0011123445668899999999999999999999953

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.5e-35  Score=309.08  Aligned_cols=240  Identities=25%  Similarity=0.279  Sum_probs=174.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCC------eeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGG------NWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~E~~~~gsL~  424 (635)
                      |.||++..  +++.||||++..         .+.+|+.++++++||||+++++++...+      ..++||||+++ +|.
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  117 (371)
T 2xrw_A           39 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC  117 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHH
T ss_pred             EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHH
Confidence            89999987  688999999854         2457999999999999999999998654      67999999975 788


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++..    .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......    .....
T Consensus       118 ~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~~  186 (371)
T 2xrw_A          118 QVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPY  186 (371)
T ss_dssp             HHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----------------
T ss_pred             HHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc----ccCCc
Confidence            87753    2899999999999999999999955   9999999999999999999999999998654321    12345


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc------hhhh-------
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG------EESL-------  571 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~~~l-------  571 (635)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... .+...... ......      ....       
T Consensus       187 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~  264 (371)
T 2xrw_A          187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ-LGTPCPEFMKKLQPTVRTYVENR  264 (371)
T ss_dssp             ---CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC--CCCCCHHHHTTSCHHHHHHHHSS
T ss_pred             eecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCCCCHHHHHHhhhHHHHHHhhC
Confidence            78999999999999889999999999999999999999986543322 11111111 000000      0000       


Q ss_pred             --------hhhcCCcCCCC---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          572 --------RHLMDPSMQGN---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       572 --------~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                              ...........   .+...+..+.+|+.+||+.||++|||++|++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          265 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                    00000000000   012235678999999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6e-35  Score=300.06  Aligned_cols=232  Identities=22%  Similarity=0.372  Sum_probs=174.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEec-------------CCeeEEEeecccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFN-------------GGNWYLVYENAVN  420 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~-------------~~~~~lV~E~~~~  420 (635)
                      |.||+++.  +++.||||.+..      .+.+|+.++++++||||+++++++.+             .+..++||||+++
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (303)
T 1zy4_A           20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN   99 (303)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCS
T ss_pred             EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCC
Confidence            89999997  789999999864      35679999999999999999998865             3567999999999


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC----
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG----  496 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----  496 (635)
                      |+|.+++.... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........    
T Consensus       100 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (303)
T 1zy4_A          100 GTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL  175 (303)
T ss_dssp             CBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------
T ss_pred             CCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcc
Confidence            99999996543 34788999999999999999999955   99999999999999999999999999986543210    


Q ss_pred             -------ceeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          497 -------EFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       497 -------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                             .........||..|+|||.+.+. .++.++||||||+++|||++   |+....... .....+..        
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~-~~~~~~~~--------  243 (303)
T 1zy4_A          176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-NILKKLRS--------  243 (303)
T ss_dssp             ------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-HHHHHHHS--------
T ss_pred             ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-HHHHhccc--------
Confidence                   01112345689999999998754 68999999999999999998   433211111 11111100        


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                            .........+...+..+.+++.+||+.||++|||+.|++++
T Consensus       244 ------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          244 ------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence                  01112223334445568999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-35  Score=307.08  Aligned_cols=234  Identities=21%  Similarity=0.298  Sum_probs=160.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccCh--HHHHH-HHhhhccCCcccEEEEEec----CCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGDA--SDQIK-LLNKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~~--~~E~~-~l~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +++.||||++....  .+|+. .++.++|+||+++++++..    +...++||||+++|+|.+++.....
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~  122 (336)
T 3fhr_A           43 GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD  122 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C
T ss_pred             eEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC
Confidence            89999998  58999999997653  33433 4566799999999999875    4458999999999999999977655


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||+++......     .....+|+.
T Consensus       123 ~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~t~~  194 (336)
T 3fhr_A          123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPY  194 (336)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc-----cccCCCCcC
Confidence            56999999999999999999999955   999999999999976   4559999999997554321     233568999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||.+.+..++.++||||||+++|+|++|+.||.......... .. .         ..+. ..............+.
T Consensus       195 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~-~---------~~~~-~~~~~~~~~~~~~~~~  262 (336)
T 3fhr_A          195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GM-K---------RRIR-LGQYGFPNPEWSEVSE  262 (336)
T ss_dssp             ---------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------------CCCTTTSTTCCH
T ss_pred             ccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hH-H---------Hhhh-ccccccCchhhccCCH
Confidence            999999988889999999999999999999999985433221100 00 0         0000 0000011111123455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.+|+.+||+.||++|||++|++++
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          263 DAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            68999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-35  Score=316.24  Aligned_cols=244  Identities=24%  Similarity=0.336  Sum_probs=179.4

Q ss_pred             ceEEEeee-CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecCCe------eEEEeecccCCCcchhhc-cc
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNGGN------WYLVYENAVNGSLSVWIN-DK  430 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lV~E~~~~gsL~~~l~-~~  430 (635)
                      |.||+++. .+..||+|++..+   ..+|+++|++++|+||+++++++...+.      .++||||++++.+..... ..
T Consensus        54 g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  133 (394)
T 4e7w_A           54 GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK  133 (394)
T ss_dssp             EEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHh
Confidence            89999998 5667999988543   4589999999999999999999965432      789999998754443332 12


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ....+++..+..++.||+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++.......    .....+|+.
T Consensus       134 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~----~~~~~~t~~  206 (394)
T 4e7w_A          134 LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP----NVSYICSRY  206 (394)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSSCSCGG
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC----CcccccCcC
Confidence            2345899999999999999999999955   99999999999998 799999999999986543321    223568999


Q ss_pred             ccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhh----hcCCcCCC---
Q 042486          510 YMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRH----LMDPSMQG---  581 (635)
Q Consensus       510 y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~----~~d~~~~~---  581 (635)
                      |+|||.+.+. .++.++|||||||++|||++|+.||...+... .+...... ..... .+.+..    ........   
T Consensus       207 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~-~g~p~-~~~~~~~~~~~~~~~~~~~~~  283 (394)
T 4e7w_A          207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKV-LGTPS-REQIKTMNPNYMEHKFPQIRP  283 (394)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-HCCCC-HHHHHHHCGGGSSSCCCCCCC
T ss_pred             ccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH-hCCCC-HHHHHhhChhhhhhccccccC
Confidence            9999998764 58999999999999999999999987544322 12121111 11110 111111    11111100   


Q ss_pred             -----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 -----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                           .++...+..+.+|+.+||+.||++|||+.|+++|
T Consensus       284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                 0112234568999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-34  Score=306.43  Aligned_cols=260  Identities=22%  Similarity=0.237  Sum_probs=182.9

Q ss_pred             HHHhhcCCCCCCccc----ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCe----
Q 042486          347 LQAATDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGN----  410 (635)
Q Consensus       347 l~~at~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~----  410 (635)
                      .....++|.....||    |.||+|+.  +++.||||++..+      ..+|++.+++++||||+++++++...+.    
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            334455666666665    89999997  5889999988543      4567777888999999999999975333    


Q ss_pred             ---eEEEeecccCCCcchhhcc--cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEee
Q 042486          411 ---WYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIAN  484 (635)
Q Consensus       411 ---~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~D  484 (635)
                         .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||.+. .+|+||||||+|||++. ++.+||+|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEee
Confidence               7899999986 55444421  23344899999999999999999999322 55999999999999986 89999999


Q ss_pred             ecCcccccccCCceeeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc
Q 042486          485 FALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH  563 (635)
Q Consensus       485 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  563 (635)
                      ||+++.......    .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... .+...... ..
T Consensus       176 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~-~~  249 (360)
T 3e3p_A          176 FGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRV-LG  249 (360)
T ss_dssp             CTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-HC
T ss_pred             CCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHH-cC
Confidence            999986654321    2235689999999998654 48999999999999999999999987544332 11111111 10


Q ss_pred             cCCchhhhhhhcCC---------------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          564 KEDGEESLRHLMDP---------------SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       564 ~~~~~~~l~~~~d~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .. ..+.+..+...               ......+...+..+.+|+.+||+.||++|||+.|+++|
T Consensus       250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00 01111111000               00011222346679999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.8e-35  Score=308.76  Aligned_cols=239  Identities=25%  Similarity=0.328  Sum_probs=168.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~  424 (635)
                      |.||+|+.  +|+.||||++...         +.+|+++|++++||||+++++++...      ...|+|+||+ +++|.
T Consensus        43 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  121 (367)
T 2fst_X           43 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN  121 (367)
T ss_dssp             CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC
T ss_pred             eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHH
Confidence            89999986  7899999998542         44799999999999999999999754      5579999998 78999


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++...   .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....      ....
T Consensus       122 ~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~  189 (367)
T 2fst_X          122 NIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGY  189 (367)
T ss_dssp             -----C---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc------CCCc
Confidence            998652   3999999999999999999999955   999999999999999999999999999865432      2235


Q ss_pred             ccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-------hhhhhhhcC
Q 042486          505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-------EESLRHLMD  576 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~d  576 (635)
                      .||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... +... .........       .+....++.
T Consensus       190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i-~~~~g~p~~~~~~~~~~~~~~~~~~  267 (367)
T 2fst_X          190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI-LRLVGTPGAELLKKISSESARNYIQ  267 (367)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH-HHHHCSCCHHHHTTCCCHHHHHHHH
T ss_pred             CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHHhCCCCHHHHHHhhhHHHHHHHh
Confidence            78999999999876 6789999999999999999999999865443221 1111 111111000       000111110


Q ss_pred             CcCC-CCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQ-GNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .... ...+     ...+..+.+|+.+||..||++|||+.|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0000 0000     1123458999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-34  Score=307.57  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=186.7

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhc-----------cCCcccEEEEEecCC----eeEEEeecc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKIN-----------HSSLIRLLGICFNGG----NWYLVYENA  418 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~----~~~lV~E~~  418 (635)
                      |.||+++.  +++.||||.+..+      +.+|++++++++           |+||+++++++...+    ..++||||+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~  112 (373)
T 1q8y_A           33 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  112 (373)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence            89999996  7899999999753      557899999886           899999999998654    689999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC------CCCcEEEeeecCccccc
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD------TDFRAKIANFALARPAE  492 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~------~~~~~kl~Dfg~a~~~~  492 (635)
                       +++|.+++.......+++..+..++.||+.||.|||+.  .+|+||||||+|||++      ..+.+||+|||++....
T Consensus       113 -~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~  189 (373)
T 1q8y_A          113 -GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD  189 (373)
T ss_dssp             -CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred             -CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcceEEEcccccccccC
Confidence             88999999765555599999999999999999999994  1499999999999994      44589999999997654


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcch-----hhHHHHhhhcccccCCc
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE-----NMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~-----~~~l~~~~~~~~~~~~~  567 (635)
                      ..      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......     ...+...... ......
T Consensus       190 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~p~  262 (373)
T 1q8y_A          190 EH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL-LGELPS  262 (373)
T ss_dssp             BC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH-HCSCCH
T ss_pred             CC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh-cCCCCH
Confidence            32      12347899999999999988999999999999999999999998754321     1111111110 000000


Q ss_pred             h-----hhhhhhcCC-------------------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          568 E-----ESLRHLMDP-------------------SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       568 ~-----~~l~~~~d~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      .     .....+.+.                   ......+...+..+.+||.+||+.||++|||++|++++  .++...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~  340 (373)
T 1q8y_A          263 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH--PWLKDT  340 (373)
T ss_dssp             HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC--GGGTTC
T ss_pred             HHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC--hhhhcc
Confidence            0     000000000                   00123456778889999999999999999999999986  445443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-34  Score=300.62  Aligned_cols=244  Identities=18%  Similarity=0.253  Sum_probs=184.0

Q ss_pred             ceEEEeee--CC-cEEEEEEeccC------hHHHHHHHhhhccCC------cccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GG-DFVAIKKVYGD------ASDQIKLLNKINHSS------LIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~-~~vavK~~~~~------~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++.  ++ ..||||.++..      +.+|+.++++++|++      ++.+.+++...+..++||||+ +++|.++
T Consensus        33 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~  111 (355)
T 2eu9_A           33 GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEF  111 (355)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHH
Confidence            89999987  34 68999998653      457899999998766      899999999999999999999 6677777


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE-------------------CCCCcEEEeeecC
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL-------------------DTDFRAKIANFAL  487 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll-------------------~~~~~~kl~Dfg~  487 (635)
                      +.......+++..+..++.||+.||.|||+.+   |+||||||+|||+                   +.++.+||+|||+
T Consensus       112 l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~  188 (355)
T 2eu9_A          112 LKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS  188 (355)
T ss_dssp             HHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTT
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCc
Confidence            76555455999999999999999999999854   9999999999999                   5678999999999


Q ss_pred             cccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccc--
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLH--  563 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~--  563 (635)
                      ++......      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ..........  
T Consensus       189 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~  262 (355)
T 2eu9_A          189 ATFDHEHH------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM  262 (355)
T ss_dssp             CEETTSCC------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccccc------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHH
Confidence            97543321      2357899999999999989999999999999999999999998754433211  1111100000  


Q ss_pred             ------------------cCC-chhhhhhhcCCc-CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          564 ------------------KED-GEESLRHLMDPS-MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       564 ------------------~~~-~~~~l~~~~d~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                                        ... ..........+. .........+..+.+|+.+||+.||++|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                              000 000000000000 0011233456679999999999999999999999876

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.3e-34  Score=303.10  Aligned_cols=256  Identities=22%  Similarity=0.315  Sum_probs=184.5

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecC-----CeeEE
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNG-----GNWYL  413 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l  413 (635)
                      +|.....||    |.||+|+.  +++.||||++..        .+.+|++++++++|+||+++++++...     ...++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            344444444    89999998  588999999863        245799999999999999999998754     66899


Q ss_pred             EeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ||||+. ++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        92 v~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           92 IQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            999997 5899988653   3899999999999999999999955   99999999999999999999999999986543


Q ss_pred             cCCce-------eeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHH--HHhhhcccc
Q 042486          494 QEGEF-------ALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL--VDVLNPVLH  563 (635)
Q Consensus       494 ~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l--~~~~~~~~~  563 (635)
                      .....       .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...+......  .........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            22110       01223478999999998764 778999999999999999999999987544322111  111110000


Q ss_pred             cCC----chhhhhhhcCC--cCCC----CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          564 KED----GEESLRHLMDP--SMQG----NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       564 ~~~----~~~~l~~~~d~--~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...    ......+....  ....    ......+..+.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000    00000111000  0000    0012234568999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.8e-35  Score=315.40  Aligned_cols=235  Identities=25%  Similarity=0.379  Sum_probs=171.7

Q ss_pred             ceEE-EeeeCCcEEEEEEeccC----hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC--
Q 042486          362 GSVY-RGKIGGDFVAIKKVYGD----ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK--  433 (635)
Q Consensus       362 g~Vy-~g~~~~~~vavK~~~~~----~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--  433 (635)
                      |+|| ++..+|+.||||++..+    +.+|+++|+++ +||||+++++++.+++..|+||||+. |+|.+++......  
T Consensus        29 g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~  107 (434)
T 2rio_A           29 GTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDE  107 (434)
T ss_dssp             TCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC-----
T ss_pred             eEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCch
Confidence            7785 55668999999998654    45799999987 89999999999999999999999995 6999999654321  


Q ss_pred             ---CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC-------------CcEEEeeecCcccccccCCc
Q 042486          434 ---FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD-------------FRAKIANFALARPAERQEGE  497 (635)
Q Consensus       434 ---~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~-------------~~~kl~Dfg~a~~~~~~~~~  497 (635)
                         ..++..++.++.||+.||+|||+.+   |+||||||+|||++.+             +.+||+|||+++........
T Consensus       108 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~  184 (434)
T 2rio_A          108 NLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS  184 (434)
T ss_dssp             -------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----
T ss_pred             hhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCcc
Confidence               1133345789999999999999955   9999999999999654             58999999999866543221


Q ss_pred             e-eeecccccCCCccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          498 F-ALTSHIVGTKGYMAPEYLEN-------GLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       498 ~-~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      . .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||........   ........     
T Consensus       185 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~i~~~~~~-----  256 (434)
T 2rio_A          185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES---NIIRGIFS-----  256 (434)
T ss_dssp             ----------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH---HHHHTCCC-----
T ss_pred             ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH---HHhcCCCC-----
Confidence            1 11234579999999999865       668999999999999999999 8888753222211   11111100     


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                             .+......+...+..+.+++.+||+.||++|||+.|++++
T Consensus       257 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          257 -------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                   0111112234567789999999999999999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-34  Score=295.57  Aligned_cols=228  Identities=25%  Similarity=0.323  Sum_probs=180.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||||.+..         .+.+|++++++++||||+++++++.+.+..++||||+++++|.+++...
T Consensus        36 g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  115 (287)
T 2wei_A           36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR  115 (287)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc
Confidence            89999998  688999999843         2458999999999999999999999999999999999999999988654


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC---CcEEEeeecCcccccccCCceeeecccccC
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD---FRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .  .+++..++.++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+|||++........    .....++
T Consensus       116 ~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~  186 (287)
T 2wei_A          116 K--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGT  186 (287)
T ss_dssp             S--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS----CSCHHHH
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc----cccccCc
Confidence            3  3899999999999999999999955   9999999999999654   4799999999876543321    1234588


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ............           +  .  ......
T Consensus       187 ~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-----------~--~--~~~~~~  249 (287)
T 2wei_A          187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAF-----------D--L--PQWRTI  249 (287)
T ss_dssp             HTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCC-----------C--S--GGGTTS
T ss_pred             ccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCC-----------C--c--hhhhhc
Confidence            99999998875 48999999999999999999999986433221 111111100000           0  0  000123


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+++.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            4558999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.4e-34  Score=299.29  Aligned_cols=228  Identities=24%  Similarity=0.344  Sum_probs=183.6

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhc--cCCcccEEEEEecCCe
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKIN--HSSLIRLLGICFNGGN  410 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~  410 (635)
                      ++|.....||    |.||+|+.  +++.||||.++.             .+.+|+.++++++  |+||+++++++.+++.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            4444444444    89999987  788999998853             2457999999996  5999999999999999


Q ss_pred             eEEEeecccC-CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCc
Q 042486          411 WYLVYENAVN-GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALA  488 (635)
Q Consensus       411 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a  488 (635)
                      .++|||++.+ ++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++ +++.+||+|||++
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            9999999976 89999996543  3899999999999999999999955   99999999999998 7899999999999


Q ss_pred             ccccccCCceeeecccccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc
Q 042486          489 RPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       489 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  567 (635)
                      +......     .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....       .....      
T Consensus       198 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~------  259 (320)
T 3a99_A          198 ALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQ------  259 (320)
T ss_dssp             EECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCC------
T ss_pred             ccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhccc------
Confidence            8654322     223568999999999876665 7889999999999999999999853211       00000      


Q ss_pred             hhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       568 ~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                               .    ..+...+..+.+++.+||+.||++||+++|++++
T Consensus       260 ---------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          260 ---------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0    0111233458999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-34  Score=304.32  Aligned_cols=237  Identities=26%  Similarity=0.335  Sum_probs=177.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCee------EEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNW------YLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~------~lV~E~~~~gsL~  424 (635)
                      |.||+++.  +++.||||++..         .+.+|+.++++++||||+++++++...+..      ++||||+. ++|.
T Consensus        56 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  134 (371)
T 4exu_A           56 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  134 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHH
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHH
Confidence            89999987  689999999864         245799999999999999999999876654      99999997 5888


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++..    .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....      ....
T Consensus       135 ~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------~~~~  201 (371)
T 4exu_A          135 KIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGY  201 (371)
T ss_dssp             HHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--------------CT
T ss_pred             HHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC------cCCc
Confidence            87743    2899999999999999999999955   999999999999999999999999999855432      2335


Q ss_pred             ccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------chhhhh
Q 042486          505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------GEESLR  572 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~  572 (635)
                      .||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... +..... ......           ......
T Consensus       202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~  279 (371)
T 4exu_A          202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILK-VTGVPGTEFVQKLNDKAAKSYIQ  279 (371)
T ss_dssp             TCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH-HHCCCCHHHHTTCSCHHHHHHHH
T ss_pred             ccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-HhCCCcHHHHHHhhhhhhhhhhh
Confidence            78999999999877 6789999999999999999999999865433221 111111 000000           000011


Q ss_pred             hhcCCcCCCC---CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMDPSMQGN---YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+.. .....   .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       280 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          280 SLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ccCC-CcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            1100 00000   011234568999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=301.95  Aligned_cols=237  Identities=26%  Similarity=0.340  Sum_probs=178.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCe------eEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGN------WYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lV~E~~~~gsL~  424 (635)
                      |.||+|+.  +|+.||||++..         .+.+|+.++++++||||+++++++...+.      .++||||+. ++|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  116 (353)
T 3coi_A           38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  116 (353)
T ss_dssp             EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGG
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHH
Confidence            89999987  689999999854         24579999999999999999999987654      499999997 5888


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      +++..    .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....      ....
T Consensus       117 ~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~~  183 (353)
T 3coi_A          117 KIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGY  183 (353)
T ss_dssp             GTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--------------
T ss_pred             HHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC------cccc
Confidence            88743    2899999999999999999999955   999999999999999999999999999865432      2235


Q ss_pred             ccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCC-----------chhhhh
Q 042486          505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKED-----------GEESLR  572 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~  572 (635)
                      .+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... +..... ......           ....+.
T Consensus       184 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~  261 (353)
T 3coi_A          184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILK-VTGVPGTEFVQKLNDKAAKSYIQ  261 (353)
T ss_dssp             CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHH-HHCBCCHHHHTTCSCHHHHHHHH
T ss_pred             ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCCHHHHHHHhhHHHHHHHH
Confidence            78999999999876 6789999999999999999999999875443221 111111 000000           000011


Q ss_pred             hhcC---CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          573 HLMD---PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       573 ~~~d---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..   +.+ .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          262 SLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1000   000 11223345668999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=298.49  Aligned_cols=228  Identities=26%  Similarity=0.370  Sum_probs=179.8

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhh----ccCCcccEEEEEecC
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKI----NHSSLIRLLGICFNG  408 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l----~h~nIv~l~~~~~~~  408 (635)
                      ++|.....||    |.||+++.  +++.||||.+..             .+.+|+.+++++    +|+||+++++++.+.
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            4455555554    89999987  788999999853             244799999999    899999999999998


Q ss_pred             CeeEEEeec-ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeec
Q 042486          409 GNWYLVYEN-AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFA  486 (635)
Q Consensus       409 ~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg  486 (635)
                      +..++|||| +.+++|.+++....  .+++..++.++.|++.||.|||+.+   |+||||||+||+++ .++.+||+|||
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcc
Confidence            999999999 78999999997643  3899999999999999999999955   99999999999998 88999999999


Q ss_pred             CcccccccCCceeeecccccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC
Q 042486          487 LARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE  565 (635)
Q Consensus       487 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  565 (635)
                      ++.......     .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.....       ...      
T Consensus       186 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~------  247 (312)
T 2iwi_A          186 SGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILE------  247 (312)
T ss_dssp             SCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHH------
T ss_pred             hhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhh------
Confidence            998654322     233568999999999876665 4589999999999999999999753110       000      


Q ss_pred             CchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          566 DGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       566 ~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                             .  .    ...+...+..+.+++.+||+.||++||+++|++++
T Consensus       248 -------~--~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 -------A--E----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -------T--C----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------h--c----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0  0    01122334558999999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.4e-34  Score=299.86  Aligned_cols=242  Identities=21%  Similarity=0.313  Sum_probs=164.3

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC--------hHHHHH-HHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD--------ASDQIK-LLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      +|.....||    |.||++..  +++.||||+++..        +..|+. +++.++||||+++++++.+++..++||||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            344444454    89999998  5899999998653        223444 66778999999999999999999999999


Q ss_pred             ccCCCcchhhcc---cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccccc
Q 042486          418 AVNGSLSVWIND---KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQ  494 (635)
Q Consensus       418 ~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  494 (635)
                      +++ +|.+++..   .....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||+++.....
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            975 78777742   2234589999999999999999999984  14999999999999999999999999999765432


Q ss_pred             CCceeeecccccCCCccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          495 EGEFALTSHIVGTKGYMAPEYL----ENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       495 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                      .    ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.........    .......      
T Consensus       180 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~------  245 (327)
T 3aln_A          180 I----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----LTQVVKG------  245 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCS------
T ss_pred             c----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH----HHHHhcC------
Confidence            2    12234689999999998    4566899999999999999999999998643221110    0010000      


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ..+.+........+..+.+|+.+||+.||++||++.|++++
T Consensus       246 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          246 ----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                00111111122344568999999999999999999999885

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.4e-34  Score=295.57  Aligned_cols=230  Identities=19%  Similarity=0.300  Sum_probs=166.4

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |.||+++.  +++.||||.+...         +.++..+++.++||||+++++++.+++..++||||+ ++.+..+....
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~  117 (318)
T 2dyl_A           39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM  117 (318)
T ss_dssp             -CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH
T ss_pred             eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh
Confidence            89999998  6899999998643         123344677789999999999999999999999999 44454444332


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                       ...+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.......    ......+|+.|
T Consensus       118 -~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y  190 (318)
T 2dyl_A          118 -QGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK----AKDRSAGCAAY  190 (318)
T ss_dssp             -TSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC------------------CCTT
T ss_pred             -ccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc----cccccCCCccc
Confidence             23489999999999999999999983  149999999999999999999999999997554322    12235689999


Q ss_pred             cCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          511 MAPEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       511 ~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +|||.+.     ...++.++||||||+++|||++|+.||.........+.......              .+...  ...
T Consensus       191 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------~~~~~--~~~  254 (318)
T 2dyl_A          191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--------------PPLLP--GHM  254 (318)
T ss_dssp             CCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--------------CCCCC--SSS
T ss_pred             cChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--------------CCCCC--ccC
Confidence            9999984     45688999999999999999999999864332222111111110              00000  011


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+..+.+++.+||+.||.+||+++|++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            233458999999999999999999999885

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.7e-33  Score=313.75  Aligned_cols=261  Identities=21%  Similarity=0.261  Sum_probs=193.4

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEec------CCee
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFN------GGNW  411 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~  411 (635)
                      ++|.....||    |.||++..  +++.||||+++.+        +.+|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4565566665    89999987  6889999988653        5579999999999999999999765      6678


Q ss_pred             EEEeecccCCCcchhhcccC-CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCc---EEEeeecC
Q 042486          412 YLVYENAVNGSLSVWINDKG-GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFR---AKIANFAL  487 (635)
Q Consensus       412 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~  487 (635)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999996533 235899999999999999999999955   999999999999987654   99999999


Q ss_pred             cccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG  567 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  567 (635)
                      +.......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    .+..........
T Consensus       171 a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~  242 (676)
T 3qa8_A          171 AKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNE  242 (676)
T ss_dssp             CCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC-----
T ss_pred             cccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccch
Confidence            98664432    1234579999999999999999999999999999999999999986432211    111111100000


Q ss_pred             hhhhhhhcC--------CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHHHhhc
Q 042486          568 EESLRHLMD--------PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDK-----IAQSISRFLNAS  623 (635)
Q Consensus       568 ~~~l~~~~d--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~s  623 (635)
                      .........        ...........+..+.+++.+||..||++|||+.|     .++.++.++...
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            000000000        01122345567788999999999999999999988     667777776544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.98  E-value=4.1e-32  Score=279.48  Aligned_cols=210  Identities=20%  Similarity=0.289  Sum_probs=165.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc--ChHHHHHHH-hhhccCCcccEEEEEec----CCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--DASDQIKLL-NKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||++..  +++.||||.++.  .+.+|+.++ +..+||||+++++++..    ++..++||||+++|+|.+++.....
T Consensus        32 g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  111 (299)
T 3m2w_A           32 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD  111 (299)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT
T ss_pred             eEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC
Confidence            89999987  788999999865  366888888 55599999999999876    6678999999999999999977655


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||++....                 
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------  171 (299)
T 3m2w_A          112 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------  171 (299)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------
Confidence            56999999999999999999999955   999999999999988   7899999999986332                 


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCC----h
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP----P  585 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~----~  585 (635)
                              +..++.++||||||+++|||++|+.||........     .....         ..+....  ...+    .
T Consensus       172 --------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~~~---------~~~~~~~--~~~~~~~~~  227 (299)
T 3m2w_A          172 --------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMK---------TRIRMGQ--YEFPNPEWS  227 (299)
T ss_dssp             --------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSC---------CSSCTTC--CSSCHHHHT
T ss_pred             --------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hHHHH---------HHHhhcc--ccCCchhcc
Confidence                    13467899999999999999999999854322110     00000         0000000  0111    1


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+..+.+++.+||+.||++|||+.|++++
T Consensus       228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            234568999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=1.3e-32  Score=315.10  Aligned_cols=228  Identities=21%  Similarity=0.294  Sum_probs=177.8

Q ss_pred             CCCCCCccc----ceEEEeee---CCcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCe-----eE
Q 042486          353 DFNPSCWIK----GSVYRGKI---GGDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGN-----WY  412 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~---~~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~  412 (635)
                      +|.....||    |.||++.+   +++.||||++...        +.+|+++|++++||||+++++++...+.     .|
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            344444444    89999987   5789999988532        4579999999999999999999987655     69


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      +||||+++++|.+++..    .+++.+++.|+.||+.||.|||+.+   |+||||||+|||++.+ .+||+|||+++...
T Consensus       161 lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            99999999999998754    3899999999999999999999955   9999999999999886 89999999998654


Q ss_pred             ccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      ..       ....||+.|+|||++.++. +.++|||||||++|+|++|..|+......         .. .         
T Consensus       233 ~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~-~---------  285 (681)
T 2pzi_A          233 SF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GL-P---------  285 (681)
T ss_dssp             CC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SC-C---------
T ss_pred             cC-------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------cc-c---------
Confidence            32       2357999999999987654 89999999999999999998775421000         00 0         


Q ss_pred             hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHhh
Q 042486          573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRP-AMDKIAQSISRFLNA  622 (635)
Q Consensus       573 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~  622 (635)
                             ...........+.+++.+||+.||++|| +++++.+.|..++..
T Consensus       286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                   0000112235688999999999999999 577777777776543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=4.6e-32  Score=277.40  Aligned_cols=212  Identities=13%  Similarity=0.035  Sum_probs=164.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||||.+..+          +.+|+..+++++|+||+++++++.+++..|+||||+++++|.+++..
T Consensus        45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~  124 (286)
T 3uqc_A           45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT  124 (286)
T ss_dssp             CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT
T ss_pred             eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc
Confidence            89999998  4899999998642          56789999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .    ....++..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+++|                       
T Consensus       125 ~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-----------------------  174 (286)
T 3uqc_A          125 S----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-----------------------  174 (286)
T ss_dssp             C----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------------------
T ss_pred             C----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------------------
Confidence            2    355678899999999999999955   9999999999999999999998543                       


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |++|       ++.++||||||+++|||++|+.||..........  ..........  ...         .......+.
T Consensus       175 ~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~~~~--~~~---------~~~~~~~~~  234 (286)
T 3uqc_A          175 TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTAGQP--IEP---------ADIDRDIPF  234 (286)
T ss_dssp             CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECCBCTTSCB--CCH---------HHHCTTSCH
T ss_pred             ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHHHHhccCC--CCh---------hhcccCCCH
Confidence            3333       5889999999999999999999986433211000  0000000000  000         001122345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      .+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       235 ~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          235 QISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            58999999999999999 99999999999876544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2.6e-32  Score=294.04  Aligned_cols=230  Identities=14%  Similarity=0.191  Sum_probs=167.2

Q ss_pred             hcCCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhcc-CCc---------cc----
Q 042486          351 TDDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINH-SSL---------IR----  400 (635)
Q Consensus       351 t~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h-~nI---------v~----  400 (635)
                      +..|.....||    |.||+|++  +++.||||+++.          .+.+|+.+++.++| +|.         +.    
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34454455565    89999997  599999999872          24588999988876 221         11    


Q ss_pred             --------EEEEEec-----CCeeEEEeecccCCCcchhhc-----ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCe
Q 042486          401 --------LLGICFN-----GGNWYLVYENAVNGSLSVWIN-----DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH  462 (635)
Q Consensus       401 --------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i  462 (635)
                              +..++..     ....+++|+++ +++|.+++.     ......+++..++.++.|++.||.|||+.+   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                    1111111     12357777755 689998884     223345889999999999999999999855   9


Q ss_pred             EeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcccc----------ccCCCCcccchhhHHH
Q 042486          463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL----------ENGLVSTKLDVYAFGV  532 (635)
Q Consensus       463 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~SlGv  532 (635)
                      +||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++          ....++.++|||||||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            99999999999999999999999998754432      334567 999999999          5556889999999999


Q ss_pred             HHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 042486          533 LMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI  612 (635)
Q Consensus       533 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  612 (635)
                      ++|||++|+.||.......                  ....++...  ...    +..+.+|+.+||+.||++||++.|+
T Consensus       306 il~elltg~~Pf~~~~~~~------------------~~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALG------------------GSEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGS------------------CSGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHCCCCCCCcchhh------------------hHHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999986432211                  001111100  122    3458999999999999999998888


Q ss_pred             HHH
Q 042486          613 AQS  615 (635)
Q Consensus       613 l~~  615 (635)
                      +++
T Consensus       362 l~~  364 (413)
T 3dzo_A          362 MET  364 (413)
T ss_dssp             TTS
T ss_pred             HhC
Confidence            543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.1e-32  Score=288.57  Aligned_cols=221  Identities=15%  Similarity=0.162  Sum_probs=167.2

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhc---------cCCcccEEEEEe-----------
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKIN---------HSSLIRLLGICF-----------  406 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~---------h~nIv~l~~~~~-----------  406 (635)
                      |.||+++.+++.||||+++.               .+.+|+.+|++++         |+||+++.+.+.           
T Consensus        34 g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~  113 (336)
T 2vuw_A           34 GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLK  113 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHH
T ss_pred             eEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHH
Confidence            89999999999999999863               3568999999986         888888777653           


Q ss_pred             -------------------cCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccc-cCCCCCeEeec
Q 042486          407 -------------------NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH-SFTNPPHVHKD  466 (635)
Q Consensus       407 -------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~D  466 (635)
                                         +++..|+||||+++|++.+.+.+   ..+++..+..++.||+.||.||| +.+   |+|||
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrD  187 (336)
T 2vuw_A          114 AWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR---FEHRD  187 (336)
T ss_dssp             HHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSC
T ss_pred             HHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECC
Confidence                               26789999999999987777643   33899999999999999999999 755   99999


Q ss_pred             ccCCCEEECCCC--------------------cEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccc
Q 042486          467 IKCSNVLLDTDF--------------------RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLD  526 (635)
Q Consensus       467 ikp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksD  526 (635)
                      |||+|||++.++                    .+||+|||+++.....        ...||+.|+|||++.+.. +.++|
T Consensus       188 lKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aPE~~~g~~-~~~~D  258 (336)
T 2vuw_A          188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDEDLFTGDG-DYQFD  258 (336)
T ss_dssp             CCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCSGGGCCCS-SHHHH
T ss_pred             CCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccChhhhcCCC-cccee
Confidence            999999999887                    8999999999865422        247999999999998665 89999


Q ss_pred             hhhHHHH-HHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh-cCCcCCCCCChHHHHHHHHHHHHhhhcCCC
Q 042486          527 VYAFGVL-MLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL-MDPSMQGNYPPVTAILVIRLIESCLKKDPS  604 (635)
Q Consensus       527 V~SlGvv-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-~d~~~~~~~~~~~~~~l~~li~~cl~~dP~  604 (635)
                      |||||++ .+++++|..|+....    .........         .... .........+...+..+.+|+.+||+.|  
T Consensus       259 iwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~---------~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          259 IYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKM---------LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             HHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHH---------HHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             hhhhhCCCCcccccccCCCcchh----hhhHHHHhh---------hhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            9998777 777888988763100    000000000         0000 0000111123456778999999999976  


Q ss_pred             CCCCHHHHH-HH
Q 042486          605 GRPAMDKIA-QS  615 (635)
Q Consensus       605 ~RPs~~evl-~~  615 (635)
                         |++|++ +|
T Consensus       324 ---sa~e~l~~H  332 (336)
T 2vuw_A          324 ---SATDLLCQH  332 (336)
T ss_dssp             ---SHHHHHHHC
T ss_pred             ---CHHHHHhcC
Confidence               899988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=4e-28  Score=270.89  Aligned_cols=160  Identities=18%  Similarity=0.107  Sum_probs=121.2

Q ss_pred             CCcEEEEEEeccC-----------------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          370 GGDFVAIKKVYGD-----------------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       370 ~~~~vavK~~~~~-----------------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      .|+.+|+|.+..+                 +.+|+++|+++ +|+||+++++++.+++..||||||++|++|.+++...+
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~  337 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE  337 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence            6788999988542                 66899999999 79999999999999999999999999999999997654


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      .  ++..   +|+.||+.||+|||+.+   ||||||||+|||+++++.+||+|||+++......   ......+||+.||
T Consensus       338 ~--l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---~~~~t~vGTp~Ym  406 (569)
T 4azs_A          338 E--IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---SWPTNLVQSFFVF  406 (569)
T ss_dssp             C--CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC------CCSHHHHHHHHHH
T ss_pred             C--CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC---ccccCceechhhc
Confidence            3  6654   48899999999999955   9999999999999999999999999998654332   2234568999999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCC
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGK  541 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~  541 (635)
                      |||++.+ .+..++|+||+|+++++|.++.
T Consensus       407 APE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          407 VNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHC------------------CCCCTTH
T ss_pred             cHHHhCC-CCCCcccccccccchhhhcccc
Confidence            9999875 4677899999999988876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.87  E-value=3.3e-23  Score=229.84  Aligned_cols=168  Identities=15%  Similarity=0.136  Sum_probs=140.4

Q ss_pred             ceEEEeeeCCcEEEEEEecc---------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGGDFVAIKKVYG---------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~---------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+++..++.+++|+...               .+.+|+++|++++||||+++..++...+..|+||||+++++|.++
T Consensus       350 g~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~  429 (540)
T 3en9_A          350 ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDV  429 (540)
T ss_dssp             EEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHH
T ss_pred             EEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHH
Confidence            89999998999999998632               146899999999999999766666677788999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce----eeec
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF----ALTS  502 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~  502 (635)
                      +..          +..++.|++.||+|||+.+   |+||||||+|||++.  .+||+|||+++.........    ....
T Consensus       430 l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~  494 (540)
T 3en9_A          430 IED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK  494 (540)
T ss_dssp             STT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred             HHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence            965          4579999999999999855   999999999999998  99999999998765432110    0123


Q ss_pred             ccccCCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 042486          503 HIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~  544 (635)
                      ...||+.|||||++..  ..|+..+|+|+..+-.++-+.++.++
T Consensus       495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            5689999999999986  56788899999999888888777553

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.81  E-value=4.7e-20  Score=177.11  Aligned_cols=115  Identities=21%  Similarity=0.347  Sum_probs=96.4

Q ss_pred             cCCCCceeeeEEEEecCCchhhhhhhhcCCCccH--------HHHHhhc--C-CCCCCCCCcEEEEeeeccCCCCCCCCC
Q 042486          111 CSGKHYQANTTYFVQNGDTYFLIANNTFQGLSTC--------QALQDQH--G-NVSNFGVGTRLLAPLRCACPTKNQTDS  179 (635)
Q Consensus       111 c~~~~~~~~~~y~V~~gdtl~~Ia~~~~~~l~~~--------~~l~~~N--~-~~~~l~~G~~l~ip~~~~c~~~~~~~~  179 (635)
                      |..+...+..+|+|++|||||.|| +.|+  +++        ++|+++|  + +++.|.+||+|.||.+|.|....    
T Consensus         1 ~~~~C~~a~~~Y~V~~GDTL~~IA-~~~~--vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----   73 (212)
T 4eby_A            1 CRTSCPLALASYYLENGTTLSVIN-QNLN--SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----   73 (212)
T ss_dssp             CCCCCSCEEEEEECCTTCCHHHHH-HHTC--CSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----
T ss_pred             CCCCCccceEEEEeCCCCCHHHHH-HHHC--CCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----
Confidence            334444567789999999999999 7898  887        9999999  4 47899999999999999996421    


Q ss_pred             CeeeEEEEEeecCChHHhHH-HHhC--CChhHHHHhcCCCCCCCCcccceecccCCCC
Q 042486          180 GVHYLLSYLVKGGNTVYGIS-KRFG--VDTDRTLEANGLSEGAPNIYPFTTLLVPLEN  234 (635)
Q Consensus       180 ~~~~~~~y~v~~gdtl~~Ia-~~~~--~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~  234 (635)
                      ......+|+|++|||||.|| ++||  +++++|+++|++.. + .|++||+|.||...
T Consensus        74 ~~~~~~~Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~-~-~l~~Gq~L~IP~~~  129 (212)
T 4eby_A           74 FLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPA-T-NIPLSATLNVLVNC  129 (212)
T ss_dssp             EEEEEEEEECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCT-T-CCCTTCEEEEEEEC
T ss_pred             cccCceEEEecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCc-c-cCCCCCEEEEcCCC
Confidence            12334689999999999999 8999  99999999999653 4 69999999999754

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.77  E-value=1.5e-19  Score=183.90  Aligned_cols=137  Identities=13%  Similarity=0.003  Sum_probs=106.6

Q ss_pred             HHhhcCCCCCCccc----ceEEEeee-CCcEEEEEEecc-------------------------ChHHHHHHHhhhccCC
Q 042486          348 QAATDDFNPSCWIK----GSVYRGKI-GGDFVAIKKVYG-------------------------DASDQIKLLNKINHSS  397 (635)
Q Consensus       348 ~~at~~f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~-------------------------~~~~E~~~l~~l~h~n  397 (635)
                      ......|.....||    |.||+|+. +|+.||||.++.                         .+.+|+++|++++  |
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            33333333345555    89999998 688999999852                         2568999999998  4


Q ss_pred             cccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC
Q 042486          398 LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD  477 (635)
Q Consensus       398 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~  477 (635)
                       +++.+++. .+..++||||+++|+|.+ +..        .....++.|++.||.|||+.+   |+||||||+|||++ +
T Consensus       164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 -LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             -SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred             -CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence             66666553 356799999999999998 421        123469999999999999855   99999999999999 9


Q ss_pred             CcEEEeeecCcccccccCCceeeecccccCCCccCccccc
Q 042486          478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE  517 (635)
Q Consensus       478 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  517 (635)
                      +.+||+|||+++.                +..++|||++.
T Consensus       229 ~~vkl~DFG~a~~----------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVE----------------VGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred             CcEEEEECCCCeE----------------CCCCCHHHHHH
Confidence            9999999999862                33478899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.59  E-value=2e-15  Score=151.29  Aligned_cols=116  Identities=16%  Similarity=0.085  Sum_probs=91.3

Q ss_pred             ceEEEeee--CCcE--EEEEEecc-------------------------------ChHHHHHHHhhhccCCc--ccEEEE
Q 042486          362 GSVYRGKI--GGDF--VAIKKVYG-------------------------------DASDQIKLLNKINHSSL--IRLLGI  404 (635)
Q Consensus       362 g~Vy~g~~--~~~~--vavK~~~~-------------------------------~~~~E~~~l~~l~h~nI--v~l~~~  404 (635)
                      |.||+|..  +|+.  ||||.++.                               .+.+|+.+|++++|+++  ..+++.
T Consensus        61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  140 (258)
T 1zth_A           61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY  140 (258)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE
T ss_pred             EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc
Confidence            89999998  8888  99997532                               24679999999998864  444442


Q ss_pred             EecCCeeEEEeecccC-C----CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccc-cCCCCCeEeecccCCCEEECCCC
Q 042486          405 CFNGGNWYLVYENAVN-G----SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLH-SFTNPPHVHKDIKCSNVLLDTDF  478 (635)
Q Consensus       405 ~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~Dikp~NIll~~~~  478 (635)
                          +..+|||||+.+ |    +|.++...     .++..+..++.|++.+|.||| +.+   |+||||||+|||+++  
T Consensus       141 ----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--  206 (258)
T 1zth_A          141 ----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--  206 (258)
T ss_dssp             ----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--
T ss_pred             ----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--
Confidence                356899999953 4    55554422     234567789999999999999 854   999999999999988  


Q ss_pred             cEEEeeecCcccc
Q 042486          479 RAKIANFALARPA  491 (635)
Q Consensus       479 ~~kl~Dfg~a~~~  491 (635)
                      .++|+|||++...
T Consensus       207 ~~~liDFG~a~~~  219 (258)
T 1zth_A          207 KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEECCCTTCEET
T ss_pred             cEEEEECcccccC
Confidence            9999999998744

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.39  E-value=5.4e-14  Score=129.55  Aligned_cols=95  Identities=18%  Similarity=0.092  Sum_probs=74.2

Q ss_pred             eeeEEEEecCCchhhhhhhhcCCCccHHHHHhhc--CCCCCCCCCcEEEEeeeccCCCCCCCCCCeeeEEEEEeecCChH
Q 042486          118 ANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQH--GNVSNFGVGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTV  195 (635)
Q Consensus       118 ~~~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N--~~~~~l~~G~~l~ip~~~~c~~~~~~~~~~~~~~~y~v~~gdtl  195 (635)
                      +..+|+||+|||||.|| ++|.  +++.+|+++|  .+++.|++||+|.||....-+... ..........|+|+.||+|
T Consensus        61 ~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~-~~~~~~~~~~~~v~~GdtL  136 (167)
T 2l9y_A           61 GTATVTVQQGDTLRDIG-RRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGA-GNFWDSARDVRLVDGGKVL  136 (167)
T ss_dssp             SCEEEEECTTCCHHHHH-HHTT--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSS-CCGGGGEEEEEEETTTTEE
T ss_pred             CCceEEECCCCcHHHHH-HHcC--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccc-cccccccceEEEeCCcCCh
Confidence            34689999999999999 6787  9999999999  456899999999999643221100 1111122357999999999


Q ss_pred             HhHHHHhCCChhHHHHhcCCC
Q 042486          196 YGISKRFGVDTDRTLEANGLS  216 (635)
Q Consensus       196 ~~Ia~~~~~~~~~l~~~N~~~  216 (635)
                      +.||++||.+++..+.+|...
T Consensus       137 ~aIA~r~G~~v~s~i~Ln~~I  157 (167)
T 2l9y_A          137 EAELRYSGGWNRSRIYLDEHI  157 (167)
T ss_dssp             EEEEEETTEEEEEEECGGGTE
T ss_pred             HHHHHHcCCceEEEEEccccc
Confidence            999999999999988888753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.32  E-value=2.1e-12  Score=135.19  Aligned_cols=125  Identities=11%  Similarity=0.037  Sum_probs=88.1

Q ss_pred             CCCCCccc----ceEEEeee-CCcEEEEEEeccC-----------------------------hHHHHHHHhhhccCCcc
Q 042486          354 FNPSCWIK----GSVYRGKI-GGDFVAIKKVYGD-----------------------------ASDQIKLLNKINHSSLI  399 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~~-----------------------------~~~E~~~l~~l~h~nIv  399 (635)
                      +.....||    |.||+|.. +|+.||||.++..                             ..+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            34444555    79999987 7899999986421                             12356666666554432


Q ss_pred             cEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-
Q 042486          400 RLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-  478 (635)
Q Consensus       400 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-  478 (635)
                      -..-+..  ...+|||||++|++|.++...      +  ....++.|++.+|.+||+.+   ||||||||.|||+++++ 
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCCC------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhccc------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            2211111  223799999999888766432      1  23467899999999999855   99999999999998776 


Q ss_pred             ---------cEEEeeecCcccc
Q 042486          479 ---------RAKIANFALARPA  491 (635)
Q Consensus       479 ---------~~kl~Dfg~a~~~  491 (635)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     4899999977543

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.27  E-value=1.3e-12  Score=120.31  Aligned_cols=92  Identities=11%  Similarity=0.077  Sum_probs=72.6

Q ss_pred             cceeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeeccccC---CCCc-eeeeEEEEecCCchh
Q 042486           56 CLAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNCSCS---GKHY-QANTTYFVQNGDTYF  131 (635)
Q Consensus        56 c~~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~~c~---~~~~-~~~~~y~V~~gdtl~  131 (635)
                      -.+..+|+|++ |||||.||++||+++.+|+++|++.+++.|.+||.|.||....-.   .... .....|+|++||||+
T Consensus        59 ~~~~~~y~V~~-GDTL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~  137 (167)
T 2l9y_A           59 GGGTATVTVQQ-GDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLE  137 (167)
T ss_dssp             CCSCEEEEECT-TCCHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEE
T ss_pred             CCCCceEEECC-CCcHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChH
Confidence            34567899999 999999999999999999999999988999999999999754321   1111 233579999999999


Q ss_pred             hhhhhhcCCCccHHHHHhhc
Q 042486          132 LIANNTFQGLSTCQALQDQH  151 (635)
Q Consensus       132 ~Ia~~~~~~l~~~~~l~~~N  151 (635)
                      .||++ ++  .+.++....|
T Consensus       138 aIA~r-~G--~~v~s~i~Ln  154 (167)
T 2l9y_A          138 AELRY-SG--GWNRSRIYLD  154 (167)
T ss_dssp             EEEEE-TT--EEEEEEECGG
T ss_pred             HHHHH-cC--CceEEEEEcc
Confidence            99955 76  5555555555

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.26  E-value=3.2e-12  Score=102.36  Aligned_cols=62  Identities=26%  Similarity=0.443  Sum_probs=53.7

Q ss_pred             CCcEEEEeeeccCCCCCCCCCCeeeEEEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCCCC
Q 042486          159 VGTRLLAPLRCACPTKNQTDSGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLEN  234 (635)
Q Consensus       159 ~G~~l~ip~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~~  234 (635)
                      .||.|.+|..             ....+|+|++|||||.||++||+++++|+++|++...+ .|++||.|.||...
T Consensus         3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~-~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTND-SIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSS-CGGGSSCEEEEEEC
T ss_pred             CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCcc-ccCCCCEEEECCCC
Confidence            5888888832             34568999999999999999999999999999997555 79999999999754

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.17  E-value=2.6e-11  Score=126.68  Aligned_cols=112  Identities=13%  Similarity=0.093  Sum_probs=84.8

Q ss_pred             eeEEEEecCCchhhhhhhhcCCCccHHHHHhhc-CC-----CCCCCCCcEEEEeeeccCCC--------CC------CC-
Q 042486          119 NTTYFVQNGDTYFLIANNTFQGLSTCQALQDQH-GN-----VSNFGVGTRLLAPLRCACPT--------KN------QT-  177 (635)
Q Consensus       119 ~~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~-----~~~l~~G~~l~ip~~~~c~~--------~~------~~-  177 (635)
                      ..+|+|++||||+.|| ++|+  ++.++|.++| ..     .+.|++||+|.||....-.-        ..      .. 
T Consensus         7 ~~~~~Vk~GDTL~~Ia-~r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~   83 (361)
T 2gu1_A            7 RIHYMVKVGDTLSGIF-AQLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREN   83 (361)
T ss_dssp             CEEEECCTTCCHHHHH-HHTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECT
T ss_pred             ceEEEECCCCcHHHHH-HHcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecC
Confidence            4579999999999999 8898  9999999999 43     46899999999996421100        00      00 


Q ss_pred             CC----------CeeeEEEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCC----CCcccceecccCCC
Q 042486          178 DS----------GVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGA----PNIYPFTTLLVPLE  233 (635)
Q Consensus       178 ~~----------~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~----~~~~~~~~l~iP~~  233 (635)
                      ..          ......+|.|+.|||||.||++||+++++|+++|++....    ..|++|+.+.|+..
T Consensus        84 ~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           84 DGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             TSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             CCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            00          1112357999999999999999999999999999975431    15999999999863

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.07  E-value=3.7e-10  Score=112.88  Aligned_cols=121  Identities=15%  Similarity=0.088  Sum_probs=97.6

Q ss_pred             ceEEEeeeCCcEEEEEEecc-------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      +.||+....++.+++|....       ++.+|..+|+.+. +..+.++++++.+.+..|+||||++|.+|.+.+..    
T Consensus        28 ~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~----  103 (263)
T 3tm0_A           28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED----  103 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT----
T ss_pred             CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC----
Confidence            57999988889999999864       4778999999994 67788999999888899999999999998876421    


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCC-------------------------------------------------------
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFT-------------------------------------------------------  458 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------------  458 (635)
                         ......++.+++.+|..||+..                                                       
T Consensus       104 ---~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  180 (263)
T 3tm0_A          104 ---EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPE  180 (263)
T ss_dssp             ---TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCC
T ss_pred             ---cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCC
Confidence               1223467888899999999821                                                       


Q ss_pred             -CCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          459 -NPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       459 -~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                       ...++|+|+++.||+++++..+.|+||+.+.
T Consensus       181 ~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          181 EELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence             1348999999999999876566799999764

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=99.06  E-value=1.1e-10  Score=84.21  Aligned_cols=45  Identities=29%  Similarity=0.504  Sum_probs=41.3

Q ss_pred             EEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCC
Q 042486          185 LSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPL  232 (635)
Q Consensus       185 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~  232 (635)
                      .+|+|++|||||+||++||++.++|+++|+  ..+ .|+|||.|.||+
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~--~~~-~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS--DTA-NLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCS--CGG-GCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC--CCC-cCCcCCEEEEec
Confidence            379999999999999999999999999999  344 799999999996

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.05  E-value=3.4e-10  Score=118.19  Aligned_cols=107  Identities=13%  Similarity=0.079  Sum_probs=84.2

Q ss_pred             eeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCC----CcccCCCcEEEEeeccccC--------------------C
Q 042486           58 AFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSE----TATFETNQMVIVPVNCSCS--------------------G  113 (635)
Q Consensus        58 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~----~~~~~~gq~l~ip~~~~c~--------------------~  113 (635)
                      .+..|+|++ ||||++||++||+++++|.++|++..    .+.|.+||.|.||....-.                    .
T Consensus         6 ~~~~~~Vk~-GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~   84 (361)
T 2gu1_A            6 KRIHYMVKV-GDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREND   84 (361)
T ss_dssp             -CEEEECCT-TCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTT
T ss_pred             CceEEEECC-CCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCC
Confidence            467799998 99999999999999999999997642    4789999999999753210                    0


Q ss_pred             CCc----------eeeeEEEEecCCchhhhhhhhcCCCccHHHHHhhc--CCC-----CCCCCCcEEEEeee
Q 042486          114 KHY----------QANTTYFVQNGDTYFLIANNTFQGLSTCQALQDQH--GNV-----SNFGVGTRLLAPLR  168 (635)
Q Consensus       114 ~~~----------~~~~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N--~~~-----~~l~~G~~l~ip~~  168 (635)
                      +.+          .....|+|+.|||||.|| +.|+  ++.+.|+++|  ...     ..|++||+|.|+..
T Consensus        85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA-~~~G--vs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           85 GSFSYDFQEISGEWREILFSGEINGSFSVSA-RRVG--LTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             SCEEEEEEECCCEEEEEEEEEESSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             CcceeeecccCceEEEEEEEEEECCcHHHHH-HHcC--CCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            101          012358899999999999 8888  8999999999  332     46999999999863

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.85  E-value=5.5e-09  Score=103.76  Aligned_cols=118  Identities=14%  Similarity=0.191  Sum_probs=89.7

Q ss_pred             ceEEEeee-CCcEEEEEEecc----ChHHHHHHHhhhccCC--cccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG----DASDQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~----~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      +.||+... +|+.+++|....    ++.+|..+++.+.+.+  +.+++++...++..++||||++|.+|.  ...     
T Consensus        34 ~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----  106 (264)
T 1nd4_A           34 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----  106 (264)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----
T ss_pred             ceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----
Confidence            68999876 467799998764    3568999999997655  556899888878889999999998884  211     


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCC-------------------------------------------------------C
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFT-------------------------------------------------------N  459 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------------~  459 (635)
                      .+   ...++.+++..|..||+..                                                       .
T Consensus       107 ~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  183 (264)
T 1nd4_A          107 LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  183 (264)
T ss_dssp             CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCC
Confidence            11   1245667777777777642                                                       1


Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..++|+|++|.||+++++..+.|+|||.+.
T Consensus       184 ~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          184 LVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            239999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.83  E-value=1.4e-08  Score=106.43  Aligned_cols=126  Identities=11%  Similarity=0.179  Sum_probs=100.5

Q ss_pred             ceEEEeeeCCcEEEEEEec----------cChHHHHHHHhhhc--cCCcccEEEEEecC---CeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIGGDFVAIKKVY----------GDASDQIKLLNKIN--HSSLIRLLGICFNG---GNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~----------~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lV~E~~~~gsL~~~  426 (635)
                      +.+|+....+..+++|+..          .++.+|..+++.+.  +..+.++++++.+.   +..|+||||++|..+.+.
T Consensus        52 n~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~  131 (359)
T 3dxp_A           52 NPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ  131 (359)
T ss_dssp             SCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT
T ss_pred             ceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC
Confidence            5799998877888999876          24678999999997  45588899998766   457999999999888542


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCC------------------------------------------------
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFT------------------------------------------------  458 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------------------  458 (635)
                      ..    ..++..++..++.+++..|..||+..                                                
T Consensus       132 ~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  207 (359)
T 3dxp_A          132 SL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQH  207 (359)
T ss_dssp             TC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGC
T ss_pred             cc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhc
Confidence            21    12778888999999999999999731                                                


Q ss_pred             -------CCCeEeecccCCCEEECCCCc--EEEeeecCcccc
Q 042486          459 -------NPPHVHKDIKCSNVLLDTDFR--AKIANFALARPA  491 (635)
Q Consensus       459 -------~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~  491 (635)
                             ...++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       208 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          208 IPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                   246999999999999987653  689999988643

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.79  E-value=5.6e-09  Score=83.33  Aligned_cols=52  Identities=13%  Similarity=0.170  Sum_probs=47.9

Q ss_pred             ceeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEeecc
Q 042486           57 LAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPVNC  109 (635)
Q Consensus        57 ~~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~~~  109 (635)
                      ..+..|+|++ |||||.||++||+++++|+++|++.+.+.|.+||.|.||..-
T Consensus        13 ~~~~~y~V~~-GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A           13 ERRLEHQLEP-GDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             EEEEEECCCT-TCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEEEEECC-CCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            3678899999 999999999999999999999999777899999999999753

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.74  E-value=8e-09  Score=74.21  Aligned_cols=45  Identities=18%  Similarity=0.285  Sum_probs=42.0

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEee
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPV  107 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~  107 (635)
                      ..|+|++ ||||++||++||+++++|.++|+  +...+.+||.|.||+
T Consensus         3 ~~y~V~~-GDtl~~Ia~~~~~~~~~l~~~N~--~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRK-GDSLSSIAKRHGVNIKDVMRWNS--DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECT-TCCHHHHHHHHTCCHHHHHHHCS--CGGGCCTTEEEECCC
T ss_pred             EEEEEcC-CCcHHHHHHHHCcCHHHHHHhCC--CCCcCCcCCEEEEec
Confidence            4699998 99999999999999999999999  677899999999996

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.48  E-value=4.3e-08  Score=100.14  Aligned_cols=174  Identities=18%  Similarity=0.174  Sum_probs=107.9

Q ss_pred             ceEEEeeeCCcEEEEEEecc-----ChHHHHHHHhhhc-cCC--cccEEEEEecCC---eeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-----DASDQIKLLNKIN-HSS--LIRLLGICFNGG---NWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-----~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      ..||+..   +.+++|.-..     .+.+|..+|+.+. +..  +.+++......+   ..|+|||+++|.+|.+.... 
T Consensus        34 n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~-  109 (304)
T 3sg8_A           34 CIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN-  109 (304)
T ss_dssp             EEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-
T ss_pred             ceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc-
Confidence            3566543   5588887654     3568999999883 333  445555543333   34899999999888754321 


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCC----------------------------------------------------
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFT----------------------------------------------------  458 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~----------------------------------------------------  458 (635)
                         .++..++..++.+++..|..||+..                                                    
T Consensus       110 ---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  186 (304)
T 3sg8_A          110 ---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIY  186 (304)
T ss_dssp             ---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGG
T ss_pred             ---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhcccc
Confidence               1667777778888888888777521                                                    


Q ss_pred             ---CCCeEeecccCCCEEECC--CCcEEEeeecCcccccccCCceeeec-----------ccccCCCccC-ccccccCCC
Q 042486          459 ---NPPHVHKDIKCSNVLLDT--DFRAKIANFALARPAERQEGEFALTS-----------HIVGTKGYMA-PEYLENGLV  521 (635)
Q Consensus       459 ---~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~-----------~~~gt~~y~a-PE~~~~~~~  521 (635)
                         ...++|+|+++.||++++  ...+.|+||+.+..............           ......+... |+....  .
T Consensus       187 ~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~  264 (304)
T 3sg8_A          187 FKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--Y  264 (304)
T ss_dssp             TCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--H
T ss_pred             ccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--H
Confidence               134899999999999988  45688999998864322110000000           0000001111 222111  1


Q ss_pred             CcccchhhHHHHHHHHHhCCCCC
Q 042486          522 STKLDVYAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       522 s~ksDV~SlGvvl~elltG~~p~  544 (635)
                      ....+.|++|.++|.+.+|..++
T Consensus       265 ~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          265 RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHcCCHHH
Confidence            12358999999999999998653

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=98.08  E-value=1.5e-06  Score=79.91  Aligned_cols=47  Identities=28%  Similarity=0.452  Sum_probs=41.9

Q ss_pred             EEEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCC
Q 042486          184 LLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPL  232 (635)
Q Consensus       184 ~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~  232 (635)
                      +++|+|++||||+.||++|+++.++|+++|+..+.  .+.+|+.+.||.
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~--~l~~g~~i~ip~   48 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQA--GLTAGQSIVIPG   48 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGG--CCCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCC--ccCCCccccCcc
Confidence            46899999999999999999999999999986543  488999999984

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.03  E-value=1.1e-05  Score=80.47  Aligned_cols=122  Identities=16%  Similarity=0.126  Sum_probs=85.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      ..||+-..  ++..+++|+-..    ++.+|...|+.+. +--+.++++++.+++..++|||+++|.++.+.....    
T Consensus        39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----  114 (272)
T 4gkh_A           39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----  114 (272)
T ss_dssp             CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----
T ss_pred             CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----
Confidence            47898765  456788998754    4667999998884 334678999999889999999999998776654221    


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCC-------------------------------------------------------C
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFT-------------------------------------------------------N  459 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------------~  459 (635)
                        ......+..+++..|..||...                                                       .
T Consensus       115 --~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  192 (272)
T 4gkh_A          115 --PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPD  192 (272)
T ss_dssp             --GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCC
T ss_pred             --HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCC
Confidence              1112234444444444444311                                                       1


Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ..++|+|+.+.||++++++.+-|+||+.+.
T Consensus       193 ~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          193 SVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            237899999999999987777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.91  E-value=3.7e-05  Score=78.33  Aligned_cols=122  Identities=18%  Similarity=0.148  Sum_probs=81.7

Q ss_pred             ceEEEeeeCCcEEEEEEecc-----ChHHHHHHHhhhccC---CcccEEEEEe-cCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-----DASDQIKLLNKINHS---SLIRLLGICF-NGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-----~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      ..||+.   +..+++|.-..     .+..|.++|+.+.+.   .+.+.+.++. ..+..++||||++|..|.+....   
T Consensus        33 n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---  106 (306)
T 3tdw_A           33 NYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---  106 (306)
T ss_dssp             EEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---
T ss_pred             eeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---
Confidence            356766   56677887643     356899999999653   3667777774 45567899999999888663211   


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCC------------------------------------------------------
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFT------------------------------------------------------  458 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------------------------  458 (635)
                       .++..++..++.+++..|..||+..                                                      
T Consensus       107 -~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~  185 (306)
T 3tdw_A          107 -VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVY  185 (306)
T ss_dssp             -TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHH
T ss_pred             -hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCccc
Confidence             1344444445555555554444321                                                      


Q ss_pred             ---CCCeEeecccCCCEEECC---CCc-EEEeeecCccc
Q 042486          459 ---NPPHVHKDIKCSNVLLDT---DFR-AKIANFALARP  490 (635)
Q Consensus       459 ---~~~ivH~Dikp~NIll~~---~~~-~kl~Dfg~a~~  490 (635)
                         ...++|+|+++.||+++.   ++. ..|+||+.+..
T Consensus       186 ~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          186 TRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence               234799999999999987   455 48999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.90  E-value=4.5e-05  Score=79.27  Aligned_cols=64  Identities=8%  Similarity=0.028  Sum_probs=47.3

Q ss_pred             ceEEEeeeC--------CcEEEEEEecc----------ChHHHHHHHhhhcc---CCcccEEEEEecC---CeeEEEeec
Q 042486          362 GSVYRGKIG--------GDFVAIKKVYG----------DASDQIKLLNKINH---SSLIRLLGICFNG---GNWYLVYEN  417 (635)
Q Consensus       362 g~Vy~g~~~--------~~~vavK~~~~----------~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~lV~E~  417 (635)
                      ..+|+....        ++.+++|....          ++..|..+|+.+..   -.+.++++++.+.   +..++||||
T Consensus        35 n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~  114 (357)
T 3ats_A           35 SETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDY  114 (357)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEEC
T ss_pred             ceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEe
Confidence            568877654        67788887532          35689999998853   3577888887655   356899999


Q ss_pred             ccCCCcch
Q 042486          418 AVNGSLSV  425 (635)
Q Consensus       418 ~~~gsL~~  425 (635)
                      ++|..+.+
T Consensus       115 l~G~~l~~  122 (357)
T 3ats_A          115 VEGVVPPD  122 (357)
T ss_dssp             CCCBCCCB
T ss_pred             cCCCChhh
Confidence            99887764

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.58  E-value=3.2e-05  Score=70.88  Aligned_cols=45  Identities=29%  Similarity=0.392  Sum_probs=39.5

Q ss_pred             eEEEEecCCchhhhhhhhcCCCccHHHHHhhc-CCCCCCCCCcEEEEee
Q 042486          120 TTYFVQNGDTYFLIANNTFQGLSTCQALQDQH-GNVSNFGVGTRLLAPL  167 (635)
Q Consensus       120 ~~y~V~~gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~l~~G~~l~ip~  167 (635)
                      .+|+||+||||..|| +.|+  +..++|+++| .....|.+|++|.||.
T Consensus         3 ~~y~V~~GdtL~~IA-~~f~--~g~~~l~~aNp~vd~~l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHH-HHTT--CCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHH-HHhC--CCHHHHHHhCccCCCccCCCccccCcc
Confidence            579999999999999 8899  9999999999 4334689999999983

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.44  E-value=0.00053  Score=70.36  Aligned_cols=128  Identities=15%  Similarity=0.162  Sum_probs=77.9

Q ss_pred             ceEEEeeeCCcEEEEEEeccC---hHHHHHHHhhhccC--CcccEEE------EEecCCeeEEEeecccCCCcch-----
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD---ASDQIKLLNKINHS--SLIRLLG------ICFNGGNWYLVYENAVNGSLSV-----  425 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~---~~~E~~~l~~l~h~--nIv~l~~------~~~~~~~~~lV~E~~~~gsL~~-----  425 (635)
                      +.+|+...++..+++|+....   ...|..+++.+...  .+.+++.      +....+..+++|||++|..+..     
T Consensus        46 n~~~~v~~~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~  125 (346)
T 2q83_A           46 ALVWKVHTDSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQD  125 (346)
T ss_dssp             CEEEEEEETTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBCCCTTSHHH
T ss_pred             CcEEEEEeCCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCccCCCCCHHH
Confidence            689998887667999998753   33466666666421  2344443      1224567899999999876531     


Q ss_pred             ------h---hccc-C----C-------CCCCHHHHH-------------------------------HHHHHHHhhhcc
Q 042486          426 ------W---INDK-G----G-------KFLDWAQRI-------------------------------QIALDVATGLNY  453 (635)
Q Consensus       426 ------~---l~~~-~----~-------~~l~~~~~~-------------------------------~i~~~ia~aL~~  453 (635)
                            .   ++.. .    .       ..-.|....                               .+...+..++.+
T Consensus       126 ~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (346)
T 2q83_A          126 LEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDR  205 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHH
Confidence                  1   1110 0    0       011232110                               011123345666


Q ss_pred             ccc----------CCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          454 LHS----------FTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       454 LH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      |++          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       206 l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          206 LLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            653          023679999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.02  E-value=0.0024  Score=64.95  Aligned_cols=63  Identities=13%  Similarity=0.062  Sum_probs=51.0

Q ss_pred             ceEEEeeeCCcEEEEEEeccC----hHHHHHHHhhhcc---CCcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD----ASDQIKLLNKINH---SSLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~----~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      ..+|+...++..+++|.....    +..|...|+.+..   ..+.++++++...+..++||||+++..+.
T Consensus        50 n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~  119 (312)
T 3jr1_A           50 NEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK  119 (312)
T ss_dssp             SEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred             eeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence            579998888888999987543    5678888888842   56888999988888899999999988653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.93  E-value=0.0023  Score=65.50  Aligned_cols=126  Identities=16%  Similarity=0.124  Sum_probs=72.9

Q ss_pred             EEEeeeC-CcEEEEEEec----cChHHHHHHHhhhccCC--cccEEEEEecCCeeEEEeecccCCCcchhhccc------
Q 042486          364 VYRGKIG-GDFVAIKKVY----GDASDQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSVWINDK------  430 (635)
Q Consensus       364 Vy~g~~~-~~~vavK~~~----~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------  430 (635)
                      +|+.... +..+++|...    .++..|+.+++.+....  +.+++.+..+.+  +++||++.+..+.+++...      
T Consensus        35 ~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~  112 (333)
T 3csv_A           35 YQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQEMP  112 (333)
T ss_dssp             CEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGHHH
T ss_pred             EEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccHHH
Confidence            5566653 6777777653    45678999988885433  566777644333  7899999776665443210      


Q ss_pred             ---------------CC---CCCCHHHHH-------HHH-------------HHHHhhhcccc---cCCCCCeEeecccC
Q 042486          431 ---------------GG---KFLDWAQRI-------QIA-------------LDVATGLNYLH---SFTNPPHVHKDIKC  469 (635)
Q Consensus       431 ---------------~~---~~l~~~~~~-------~i~-------------~~ia~aL~~LH---~~~~~~ivH~Dikp  469 (635)
                                     ..   ..++.....       .+.             ..+...+..+.   ......++|||+.+
T Consensus       113 ~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~  192 (333)
T 3csv_A          113 LYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHA  192 (333)
T ss_dssp             HHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSG
T ss_pred             HHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCc
Confidence                           00   011111100       000             00111111110   11135699999999


Q ss_pred             CCEEECCC----CcEEEeeecCcccc
Q 042486          470 SNVLLDTD----FRAKIANFALARPA  491 (635)
Q Consensus       470 ~NIll~~~----~~~kl~Dfg~a~~~  491 (635)
                      .||+++.+    ..+.|+||+.+...
T Consensus       193 ~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          193 QNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             GGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            99999874    68999999988643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.74  E-value=0.003  Score=66.41  Aligned_cols=58  Identities=14%  Similarity=-0.020  Sum_probs=38.9

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------------ChHHHHHHHhhhcc--C-CcccEEEEEecCCeeEEEeecccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------------DASDQIKLLNKINH--S-SLIRLLGICFNGGNWYLVYENAVNG  421 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------------~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~lV~E~~~~g  421 (635)
                      +.||++..  +++.++||....              ....|.++|+.+..  + .+.+++.+  +.+..++||||+++.
T Consensus        44 n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~  120 (397)
T 2olc_A           44 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred             EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence            68999965  567899996432              13568889888753  3 34456654  344568999999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.58  E-value=0.0055  Score=62.23  Aligned_cols=128  Identities=14%  Similarity=0.017  Sum_probs=73.0

Q ss_pred             ceEEEeeeCCcEEEEEEecc-----ChHHHHHHHhhhccCC--cccEEEE------EecCCeeEEEeecccCCCcchh--
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-----DASDQIKLLNKINHSS--LIRLLGI------CFNGGNWYLVYENAVNGSLSVW--  426 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-----~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lV~E~~~~gsL~~~--  426 (635)
                      ..+|+...++..+++|....     ++..|..++..+....  +.+++..      ....+..+++++|++|..+...  
T Consensus        36 n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~  115 (322)
T 2ppq_A           36 NSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEA  115 (322)
T ss_dssp             EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCH
T ss_pred             cceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCH
Confidence            47888877655788998754     3557888888875333  2333321      1224567899999998765321  


Q ss_pred             ------------hccc----CCC---C---CCHHHHHHHH------------HHHHhhhccccc----CCCCCeEeeccc
Q 042486          427 ------------INDK----GGK---F---LDWAQRIQIA------------LDVATGLNYLHS----FTNPPHVHKDIK  468 (635)
Q Consensus       427 ------------l~~~----~~~---~---l~~~~~~~i~------------~~ia~aL~~LH~----~~~~~ivH~Dik  468 (635)
                                  ++..    ...   .   ..|.....-.            ..+...+.++++    .....++|+|++
T Consensus       116 ~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~  195 (322)
T 2ppq_A          116 KHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLF  195 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCC
T ss_pred             HHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCC
Confidence                        1110    000   0   1122211000            012222333331    112459999999


Q ss_pred             CCCEEECCCCcEEEeeecCcc
Q 042486          469 CSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       469 p~NIll~~~~~~kl~Dfg~a~  489 (635)
                      +.||+++++..+.|+||+.+.
T Consensus       196 ~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          196 QDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGEEEETTEEEEECCCTTCE
T ss_pred             ccCEEEeCCceEEEecchhcc
Confidence            999999887666899999765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.54  E-value=0.005  Score=65.34  Aligned_cols=79  Identities=9%  Similarity=-0.005  Sum_probs=47.2

Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC---CCCcccchhhHHHHHHH
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG---LVSTKLDVYAFGVLMLE  536 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SlGvvl~e  536 (635)
                      +.++|+|+++.||+++.++ ++++||+.+......-.-.....  .-...|.+|+.....   ......++......+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH--HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            5699999999999998776 99999998875432211000000  001235566544311   11223455677777887


Q ss_pred             HHhCC
Q 042486          537 MLSGK  541 (635)
Q Consensus       537 lltG~  541 (635)
                      .+.++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.35  E-value=0.0072  Score=57.21  Aligned_cols=103  Identities=13%  Similarity=0.042  Sum_probs=66.3

Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      -+|.+.|...+ .++++++++.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.+.+.+ ..+.           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            47888886544 45999999999999999987762100 11 1223456899999999888764 1110           


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA  543 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p  543 (635)
                          .....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                0122356888764 3446788899999999999886655

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.96  E-value=0.028  Score=60.19  Aligned_cols=59  Identities=10%  Similarity=-0.064  Sum_probs=42.1

Q ss_pred             ceEEEeeeCC--cEEEEEEecc------ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKIGG--DFVAIKKVYG------DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~~~--~~vavK~~~~------~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      ..+|+....+  ..+++|....      +...|..+++.+...++ .++++.+. +   .+||||++|.+|.
T Consensus       122 N~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l~  189 (458)
T 2qg7_A          122 NILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYALS  189 (458)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEECC
T ss_pred             eEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccCC
Confidence            5799988865  7888887632      12589999999965555 56777763 2   2599999886553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.88  E-value=0.03  Score=56.29  Aligned_cols=30  Identities=30%  Similarity=0.351  Sum_probs=25.3

Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCccc
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      ..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            45899999999999 5667889999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.61  E-value=0.039  Score=58.62  Aligned_cols=59  Identities=14%  Similarity=0.187  Sum_probs=41.2

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc-----ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG-----DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~-----~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      ..+|+....         ++.+++|+...     .+.+|..+++.+...++ .++++.+.+    .+|+||++|.+|.
T Consensus        87 N~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l~  160 (429)
T 1nw1_A           87 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS  160 (429)
T ss_dssp             EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred             cceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcccC
Confidence            578988763         46888998743     34578888988854444 567776542    3899999875553

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.57  E-value=0.033  Score=57.16  Aligned_cols=62  Identities=13%  Similarity=0.050  Sum_probs=42.2

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-hHHHHHHHhhhccCC---cccEEEE------EecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-ASDQIKLLNKINHSS---LIRLLGI------CFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-~~~E~~~l~~l~h~n---Iv~l~~~------~~~~~~~~lV~E~~~~gsL  423 (635)
                      ..||+...++..+++|+.... ...|+.+++.+....   +.+.+..      ....+..+++|+|++|..+
T Consensus        37 N~vy~v~~~~g~~vLK~~~~~~~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           37 AFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             CEEEEEECSSCEEEEEEEECSSCCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             cceEEEEeCCCCEEEEEecCccchHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            478998875558999987553 367888888774322   4444432      2235677999999998766

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.42  E-value=0.078  Score=52.74  Aligned_cols=59  Identities=15%  Similarity=0.097  Sum_probs=42.2

Q ss_pred             ceEEEeee-CCcEEEEEEecc-------ChHHHHHHHhhhccC---CcccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG-------DASDQIKLLNKINHS---SLIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~-------~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      +.||+.+. +|+.+.+|+-..       .+..|...|+.+...   -+.+++++.    ..++||||++++...
T Consensus        29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~~   98 (288)
T 3f7w_A           29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPPT   98 (288)
T ss_dssp             EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCCC
T ss_pred             eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCCC
Confidence            58999998 789999998543       256899999988432   345555542    347899999876543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.35  E-value=0.049  Score=56.39  Aligned_cols=58  Identities=9%  Similarity=0.066  Sum_probs=39.7

Q ss_pred             ceEEEeeeCC----------cEEEEEEecc------ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIGG----------DFVAIKKVYG------DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~~----------~~vavK~~~~------~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      ..+|+....+          +.+++|....      +...|..+++.+...++ .++++..  .  -++||||++|..+
T Consensus        47 N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~i~G~~l  121 (369)
T 3c5i_A           47 NQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEWLYGDPL  121 (369)
T ss_dssp             CEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECCCSEEC
T ss_pred             ceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEEecCCcC
Confidence            4788887643          6788887643      23578899988864454 4677654  2  2689999987654

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=95.30  E-value=0.17  Score=52.19  Aligned_cols=108  Identities=7%  Similarity=0.029  Sum_probs=73.3

Q ss_pred             ceeeeeecCCCCCCHHHHHHHhCCChHhHhhhcCCC----CCcccCCCcEEEEeeccccCC-C-Cc------e-------
Q 042486           57 LAFLIFRSKPPFNTVASISTLLASKPSQLSKINSVS----ETATFETNQMVIVPVNCSCSG-K-HY------Q-------  117 (635)
Q Consensus        57 ~~~~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~----~~~~~~~gq~l~ip~~~~c~~-~-~~------~-------  117 (635)
                      ..+-.|+|++ ||||.+|-+++|++..++.+++...    +...|.+||.|.+.+...-.- . .+      .       
T Consensus        12 ~~W~~~~V~~-GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~i~   90 (371)
T 3slu_A           12 AYWVQEAVQP-GDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVALE   90 (371)
T ss_dssp             CEEEEEECCT-TCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEEEE
T ss_pred             CceEEEEECC-CCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEEEE
Confidence            4677899999 9999999999999999999987543    568899999999987532100 0 00      0       


Q ss_pred             -eeeEEEE----------------ecCCchhhhhhhhcCCCccHHHHHhhc------CCCCCCCCCcEEEEeee
Q 042486          118 -ANTTYFV----------------QNGDTYFLIANNTFQGLSTCQALQDQH------GNVSNFGVGTRLLAPLR  168 (635)
Q Consensus       118 -~~~~y~V----------------~~gdtl~~Ia~~~~~~l~~~~~l~~~N------~~~~~l~~G~~l~ip~~  168 (635)
                       ....|++                .-+++||..| ...+  .+.+.+++.+      .+=..|++|+++.|...
T Consensus        91 ~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~-~~ag--l~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~  161 (371)
T 3slu_A           91 KKGGIWRRSASEADMKVLPTLRSVVVKTSARGSL-ARAE--VPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD  161 (371)
T ss_dssp             EETTEEEECCCGGGEEEEEEEEEEECSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred             ecCCeeEEEeeecccceeeeEEEEEEeccHHHHH-HHcC--CCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence             0011222                2278899888 5555  5656666555      22236899999999863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.27  E-value=0.054  Score=56.44  Aligned_cols=124  Identities=13%  Similarity=0.093  Sum_probs=75.9

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc------ChHHHHHHHhhhccCC-cccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG------DASDQIKLLNKINHSS-LIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~------~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      ..+|+....         ++.+++|+--.      +..+|..+++.+...+ ..++++.+.+    .+||||++|..|..
T Consensus        64 N~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~  139 (379)
T 3feg_A           64 NLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKT  139 (379)
T ss_dssp             CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCG
T ss_pred             ccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCCh
Confidence            468887763         36788887522      2457999998885333 3567776643    29999999876642


Q ss_pred             h--------------h---cccC---CCCCC--HHHHHHHHHHHHhh-------------------hccc----ccC-CC
Q 042486          426 W--------------I---NDKG---GKFLD--WAQRIQIALDVATG-------------------LNYL----HSF-TN  459 (635)
Q Consensus       426 ~--------------l---~~~~---~~~l~--~~~~~~i~~~ia~a-------------------L~~L----H~~-~~  459 (635)
                      -              |   +...   .+...  |.++.++..++...                   +..|    ... ..
T Consensus       140 ~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~  219 (379)
T 3feg_A          140 QELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSP  219 (379)
T ss_dssp             GGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCC
T ss_pred             hHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCC
Confidence            1              0   1110   11122  45555555444221                   1112    111 12


Q ss_pred             CCeEeecccCCCEEECCC----CcEEEeeecCcc
Q 042486          460 PPHVHKDIKCSNVLLDTD----FRAKIANFALAR  489 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~  489 (635)
                      ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            458999999999999876    789999999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.20  E-value=0.064  Score=54.33  Aligned_cols=127  Identities=9%  Similarity=0.113  Sum_probs=71.8

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCC--cccEEEE-----EecCCeeEEEeecccCCCcch--
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSS--LIRLLGI-----CFNGGNWYLVYENAVNGSLSV--  425 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~n--Iv~l~~~-----~~~~~~~~lV~E~~~~gsL~~--  425 (635)
                      ..||+... +|+.+++|....      .+..|..++..+....  +.+++..     ...++..+++|||++|..+..  
T Consensus        39 n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~  118 (328)
T 1zyl_A           39 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  118 (328)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             cceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCC
Confidence            57898876 466799999863      2456888888875322  3444442     122456688999998865431  


Q ss_pred             ---h---------hcc----cC---CCCCCHHHH----------------------HHHHHHHHhhhcccc-cCCCCCeE
Q 042486          426 ---W---------IND----KG---GKFLDWAQR----------------------IQIALDVATGLNYLH-SFTNPPHV  463 (635)
Q Consensus       426 ---~---------l~~----~~---~~~l~~~~~----------------------~~i~~~ia~aL~~LH-~~~~~~iv  463 (635)
                         +         ++.    ..   ...+++...                      ...+.+++..+.-+. ......++
T Consensus       119 ~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  198 (328)
T 1zyl_A          119 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  198 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeee
Confidence               0         110    00   011222211                      011111122222111 11224589


Q ss_pred             eecccCCCEEECCCCcEEEeeecCccc
Q 042486          464 HKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       464 H~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      |+|+++.||+++ + .+.|+||+.+..
T Consensus       199 HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          199 HGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            999999999999 4 899999988753

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.90  E-value=0.0039  Score=42.59  Aligned_cols=29  Identities=17%  Similarity=0.259  Sum_probs=19.0

Q ss_pred             EEehhhHHHHHHHHHHhheeeeeeeeccc
Q 042486          270 VVIGVLAGIALTLIFGMIIFYMFFRISYK  298 (635)
Q Consensus       270 i~i~v~~g~~~~~~~~~~~~~~~~r~~~~  298 (635)
                      |+.|+++|++++++++++++++++||+.+
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            67788888887766666555555554443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.65  E-value=0.0044  Score=42.24  Aligned_cols=30  Identities=30%  Similarity=0.487  Sum_probs=19.2

Q ss_pred             EEehhhHHHHHHHHHHhheeeeeeeecccc
Q 042486          270 VVIGVLAGIALTLIFGMIIFYMFFRISYKK  299 (635)
Q Consensus       270 i~i~v~~g~~~~~~~~~~~~~~~~r~~~~~  299 (635)
                      |+.|+++|+++++++++..+++++||++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            677887788777666666555555544433

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=94.32  E-value=0.039  Score=56.99  Aligned_cols=55  Identities=13%  Similarity=0.143  Sum_probs=44.2

Q ss_pred             CCeeeEEEEEeecCChHHhHHHHhCCChhHHHHhcCCCC---CCCCcccceecccCCC
Q 042486          179 SGVHYLLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSE---GAPNIYPFTTLLVPLE  233 (635)
Q Consensus       179 ~~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~---~~~~~~~~~~l~iP~~  233 (635)
                      ....++.+|+|++||||..|-+++|++.+++.+.+....   +-..|+|||++.+...
T Consensus         9 ~~~~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~   66 (371)
T 3slu_A            9 VQTAYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVG   66 (371)
T ss_dssp             CCCCEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEEC
T ss_pred             CCCCceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEEC
Confidence            345678899999999999999999999999998875431   1126999999998764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.41  E-value=0.52  Score=49.71  Aligned_cols=59  Identities=7%  Similarity=-0.011  Sum_probs=40.7

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc------ChHHHHHHHhhhccCC-cccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG------DASDQIKLLNKINHSS-LIRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~------~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      ..+|+....         ++.+++++...      +..+|..+++.+...+ ..++++.+  .  -++||||++|..|.
T Consensus        84 N~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI~G~~l~  158 (424)
T 3mes_A           84 NQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFIDGEPLT  158 (424)
T ss_dssp             SEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECCCSEECC
T ss_pred             cceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEeCCccCC
Confidence            478888775         57788887533      2358999999885434 45566543  2  27899999987653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.83  E-value=0.73  Score=43.41  Aligned_cols=123  Identities=11%  Similarity=0.072  Sum_probs=83.1

Q ss_pred             HHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEe
Q 042486          385 DQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH  464 (635)
Q Consensus       385 ~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH  464 (635)
                      .|+.+|.. .||+++.. .+-.+++.+.+.|+.-+  +...|-.-   +.++...+++++..|+....+++.     -+|
T Consensus        35 ~el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~t  102 (215)
T 4ann_A           35 HLMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----RYT  102 (215)
T ss_dssp             GGGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----SEE
T ss_pred             HHHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----ceE
Confidence            34444432 68888876 45566777666666443  23333221   127889999999999999988876     688


Q ss_pred             ecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 042486          465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       465 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~  544 (635)
                      --+.|+||+++.++.+++.-.|+-...                    +|.-     .+...=.-.+=+++..+++++..|
T Consensus       103 f~L~P~NL~f~~~~~p~i~~RGik~~l--------------------~P~~-----~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          103 FVLAPDELFFTRDGLPIAKTRGLQNVV--------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CCCSGGGEEECTTSCEEESCCEETTTB--------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEEecceEEEcCCCCEEEEEccCccCC--------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            899999999999999999887764322                    2221     111112335778899999998665

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.23  E-value=1  Score=42.53  Aligned_cols=142  Identities=9%  Similarity=0.056  Sum_probs=90.2

Q ss_pred             eEEEeeeCCcEEEEEEeccCh--HHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHH
Q 042486          363 SVYRGKIGGDFVAIKKVYGDA--SDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQR  440 (635)
Q Consensus       363 ~Vy~g~~~~~~vavK~~~~~~--~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~  440 (635)
                      .|+.- .+.-.+-+|+-.-..  ..|+.+|.. .||++  -..+-.+++.+.+.++--+++.=...++     .++...+
T Consensus        17 ~~~~k-~~~~~~~l~ks~ik~~~~~e~~lL~~-~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eK   87 (219)
T 4ano_A           17 AVMIN-DQPYTVIFQRAKLKMQDPLELEVLKE-VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSR   87 (219)
T ss_dssp             CEEEE-ETTEEEEEEGGGCCCCSGGGGGGGGG-SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHH
T ss_pred             Hheec-CCeEEEEEEHHHhccCCHHHHHHHhc-cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHH
Confidence            34433 444455556543333  234444432 67777  3444467777777777543332222222     2788999


Q ss_pred             HHHHHHHHhhhc-ccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccC
Q 042486          441 IQIALDVATGLN-YLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG  519 (635)
Q Consensus       441 ~~i~~~ia~aL~-~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  519 (635)
                      ++++..|+.... +++.     -+|--+.|+||++|.++.+++.-.|+-..                    ++|.-+   
T Consensus        88 lrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~~~--------------------lpP~e~---  139 (219)
T 4ano_A           88 IRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVKES--------------------LPPDEW---  139 (219)
T ss_dssp             HHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEETTT--------------------BSSCSC---
T ss_pred             HHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCccc--------------------CCCCCC---
Confidence            999999999888 7776     78889999999999999999988876432                    233221   


Q ss_pred             CCCcccch-hhHHHHHHHHHhCCCCC
Q 042486          520 LVSTKLDV-YAFGVLMLEMLSGKEAP  544 (635)
Q Consensus       520 ~~s~ksDV-~SlGvvl~elltG~~p~  544 (635)
                        + ..|. -.+=+++..++.++..|
T Consensus       140 --~-ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          140 --D-DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             --C-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             --C-HHHHHHHHHHHHHHHHcCCCCH
Confidence              1 2233 35778888888887554

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.89  E-value=0.052  Score=36.87  Aligned_cols=25  Identities=24%  Similarity=0.521  Sum_probs=11.7

Q ss_pred             EehhhHHHHHHHHHHhheeeeeeee
Q 042486          271 VIGVLAGIALTLIFGMIIFYMFFRI  295 (635)
Q Consensus       271 ~i~v~~g~~~~~~~~~~~~~~~~r~  295 (635)
                      +++.++|++++++++++++++++||
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehh
Confidence            3444456555444444444444443

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=83.10  E-value=0.17  Score=34.05  Aligned_cols=15  Identities=40%  Similarity=0.623  Sum_probs=9.3

Q ss_pred             EEEEehhhHHHHHHH
Q 042486          268 IYVVIGVLAGIALTL  282 (635)
Q Consensus       268 ~~i~i~v~~g~~~~~  282 (635)
                      ..|++++++|+++++
T Consensus        13 ~~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLL   27 (41)
T ss_dssp             THHHHHHHHHHHHHH
T ss_pred             EEEEeehhHHHHHHH
Confidence            345667777776644

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	635
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-10
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	1e-07
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	3e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 9e-54
 Identities = 71/271 (26%), Positives = 118/271 (43%), Gaps = 33/271 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY+GK  GD VA+K +   A            + +L K  H +++  +G         
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 79

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V +     SL   ++    KF +  + I IA   A G++YLH       +H+D+K +N+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNI 135

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL---ENGLVSTKLDVYA 529
            L  D   KI +F LA    R  G       + G+  +MAPE +   +    S + DVYA
Sbjct: 136 FLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 194

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FG+++ E+++G+      +  N    D +  ++ +      L       ++ N P     
Sbjct: 195 FGIVLYELMTGQ--LPYSNINNR---DQIIFMVGRGYLSPDL-----SKVRSNCPKA--- 241

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
            + RL+  CLKK    RP   +I  SI    
Sbjct: 242 -MKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-52
 Identities = 59/281 (20%), Positives = 118/281 (41%), Gaps = 27/281 (9%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNW---- 411
           G V+RGK  G+ VA+K               I     + H +++  +             
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSF-----TNPPHVHKD 466
           +LV +   +GSL  ++N      +     I++AL  A+GL +LH         P   H+D
Sbjct: 77  WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEF-ALTSHIVGTKGYMAPEYLENGL----- 520
           +K  N+L+  +    IA+  LA   +          +H VGTK YMAPE L++ +     
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193

Query: 521 -VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES-LRHLMDPS 578
               + D+YA G++  E+        ++ +  +   D++      E+  +      + P+
Sbjct: 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253

Query: 579 MQGNYPPVTAI-LVIRLIESCLKKDPSGRPAMDKIAQSISR 618
           +   +    A+ ++ +++  C   + + R    +I +++S+
Sbjct: 254 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 6e-52
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 33/266 (12%)

Query: 362 GSVYRGKIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICF-NGGNWYLVY 415
           G V  G   G+ VA+K +  DA+ Q       ++ ++ HS+L++LLG+     G  Y+V 
Sbjct: 21  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80

Query: 416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD 475
           E    GSL  ++  +G   L     ++ +LDV   + YL        VH+D+   NVL+ 
Sbjct: 81  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVS 137

Query: 476 TDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLML 535
            D  AK+++F L + A                  + APE L     STK DV++FG+L+ 
Sbjct: 138 EDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 191

Query: 536 EMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLI 595
           E+ S    P       + L DV+  V                      PP     V  ++
Sbjct: 192 EIYSFGRVP----YPRIPLKDVVPRVEKGY----------KMDAPDGCPPA----VYEVM 233

Query: 596 ESCLKKDPSGRPAMDKIAQSISRFLN 621
           ++C   D + RP+  ++ + +     
Sbjct: 234 KNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 8e-52
 Identities = 60/269 (22%), Positives = 112/269 (41%), Gaps = 31/269 (11%)

Query: 362 GSVYRGKI-GGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VA+K +   +           L+ ++ H  L+RL  +       Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 85

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NGSL  ++    G  L   + + +A  +A G+ ++       ++H+D++ +N+L+
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILV 142

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
                 KIA+F LAR  E  + E+           + APE +  G  + K DV++FG+L+
Sbjct: 143 SDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E+++    P        ++              ++L          N P      + +L
Sbjct: 201 TEIVTHGRIPYPGMTNPEVI--------------QNLERGYRMVRPDNCPEE----LYQL 242

Query: 595 IESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           +  C K+ P  RP  D +   +  F  A+
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (446), Expect = 6e-51
 Identities = 61/307 (19%), Positives = 130/307 (42%), Gaps = 50/307 (16%)

Query: 342 YTFEELQAATDDFNPSCWIK-------------GSVYRGKIGGD-----FVAIKKVYGDA 383
           +TFE+   A  +F     I              G V  G +        FVAIK +    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 384 SDQ--------IKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFL 435
           +++          ++ + +H ++I L G+        ++ E   NGSL  ++    G+F 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE 495
              Q + +   +A G+ YL    +  +VH+D+   N+L++++   K+++F L+R  E   
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 496 GEFALTSHI--VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML 553
            +   TS +       + APE ++    ++  DV+++G++M E++S  E P         
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233

Query: 554 LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIA 613
                    + +   + + + ++   +   P      + +L+  C +KD + RP   +I 
Sbjct: 234 ---------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 614 QSISRFL 620
            ++ + +
Sbjct: 285 NTLDKMI 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-50
 Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 31/269 (11%)

Query: 362 GSVYRGKI-GGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G   G   VAIK +              +++ K+ H  L++L  +       Y+V
Sbjct: 31  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIV 89

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E    GSL  ++  + GK+L   Q + +A  +A+G+ Y+       +VH+D++ +N+L+
Sbjct: 90  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILV 146

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
             +   K+A+F LAR    ++ E+           + APE    G  + K DV++FG+L+
Sbjct: 147 GENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E+ +    P                  +       +   ++   +   PP     +  L
Sbjct: 205 TELTTKGRVP------------------YPGMVNREVLDQVERGYRMPCPPECPESLHDL 246

Query: 595 IESCLKKDPSGRPAMDKIAQSISRFLNAS 623
           +  C +K+P  RP  + +   +  +  ++
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-50
 Identities = 55/306 (17%), Positives = 119/306 (38%), Gaps = 47/306 (15%)

Query: 347 LQAATDDFNPSCWI----KGSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNK 392
           ++   DDF     +     G V++   K  G  +A K ++ +            +++L++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 393 INHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLN 452
            N   ++   G  ++ G   +  E+   GSL   +   G   +      ++++ V  GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118

Query: 453 YLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA 512
           YL        +H+D+K SN+L+++    K+ +F ++           + +  VGT+ YM+
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMS 171

Query: 513 PEYLENGLVSTKLDVYAFGVLMLEMLSGK--------------------EAPALYSEENM 552
           PE L+    S + D+++ G+ ++EM  G+                       A       
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 553 LLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV----IRLIESCLKKDPSGRPA 608
                L+          ++  L+D  +    P + + +        +  CL K+P+ R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 609 MDKIAQ 614
           + ++  
Sbjct: 292 LKQLMV 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (440), Expect = 3e-50
 Identities = 61/280 (21%), Positives = 119/280 (42%), Gaps = 32/280 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYL 413
           G VY G  K     VA+K +  D  +         ++ +I H +L++LLG+C     +Y+
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           + E    G+L  ++ +   + +     + +A  +++ + YL        +H+D+   N L
Sbjct: 91  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCL 147

Query: 474 LDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 533
           +  +   K+A+F L+R        +   +       + APE L     S K DV+AFGVL
Sbjct: 148 VGENHLVKVADFGLSR--LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205

Query: 534 MLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR 593
           + E+ +   +P                  +       +  L++   +   P      V  
Sbjct: 206 LWEIATYGMSP------------------YPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247

Query: 594 LIESCLKKDPSGRPAMDKIAQSISRFL-NASLAWELSKNI 632
           L+ +C + +PS RP+  +I Q+       +S++ E+ K +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 4e-50
 Identities = 60/268 (22%), Positives = 117/268 (43%), Gaps = 31/268 (11%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V+ G  +  D VAIK +   A  +       +++ K++H  L++L G+C       LV
Sbjct: 19  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
           +E   +G LS ++  + G F      + + LDV  G+ YL        +H+D+   N L+
Sbjct: 79  FEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLV 134

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
             +   K+++F + R     + ++  ++       + +PE       S+K DV++FGVLM
Sbjct: 135 GENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 192

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E+ S  + P      + ++ D+                L  P +   +       V ++
Sbjct: 193 WEVFSEGKIPYENRSNSEVVEDISTGF-----------RLYKPRLASTH-------VYQI 234

Query: 595 IESCLKKDPSGRPAMDKIAQSISRFLNA 622
           +  C K+ P  RPA  ++ + ++    +
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-48
 Identities = 57/262 (21%), Positives = 107/262 (40%), Gaps = 31/262 (11%)

Query: 362 GSVYRGKI-GGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G V  GK  G   VAIK +   +  +       K++  ++H  L++L G+C      +++
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL 474
            E   NG L  ++ +   +F    Q +++  DV   + YL    +   +H+D+   N L+
Sbjct: 78  TEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLV 133

Query: 475 DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM 534
           +     K+++F L+R     + E+  +        +  PE L     S+K D++AFGVLM
Sbjct: 134 NDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191

Query: 535 LEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL 594
            E+ S  + P  Y                           +   ++   P + +  V  +
Sbjct: 192 WEIYSLGKMP--YERFT----------------NSETAEHIAQGLRLYRPHLASEKVYTI 233

Query: 595 IESCLKKDPSGRPAMDKIAQSI 616
           + SC  +    RP    +  +I
Sbjct: 234 MYSCWHEKADERPTFKILLSNI 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 2e-47
 Identities = 59/265 (22%), Positives = 110/265 (41%), Gaps = 42/265 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
           G+VY    K     +A+K ++    ++          +++ + + H +++RL G   +  
Sbjct: 20  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             YL+ E A  G++   +        D  +      ++A  L+Y HS      +H+DIK 
Sbjct: 80  RVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS---KRVIHRDIKP 134

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+LL +    KIA+F  +  A          + + GT  Y+ PE +E  +   K+D+++
Sbjct: 135 ENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWS 189

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            GVL  E L GK                  P       +E+ + +    ++  +P     
Sbjct: 190 LGVLCYEFLVGK------------------PPFEANTYQETYKRIS--RVEFTFPDFVTE 229

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQ 614
               LI   LK +PS RP + ++ +
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLE 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-47
 Identities = 61/266 (22%), Positives = 110/266 (41%), Gaps = 37/266 (13%)

Query: 362 GSVYRG----KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNG 408
           G+V +G    K     VA+K +  +A+D            ++ ++++  ++R++GIC   
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
            +W LV E A  G L+ ++       +     I++   V+ G+ YL        VH+D+ 
Sbjct: 81  -SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLA 134

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVLL T   AKI++F L++     E  +   +H      + APE +     S+K DV+
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FGVLM E  S  + P                  ++      +  +++   +   P    
Sbjct: 195 SFGVLMWEAFSYGQKP------------------YRGMKGSEVTAMLEKGERMGCPAGCP 236

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQ 614
             +  L+  C   D   RP    +  
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVEL 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 5e-47
 Identities = 60/295 (20%), Positives = 124/295 (42%), Gaps = 45/295 (15%)

Query: 351 TDDFNPSCWIK---------GSVYRGKIGGD------FVAIKKVYGDASDQ--------I 387
           T + +PSC  +         G VY+G +          VAIK +    +++         
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 388 KLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDV 447
            ++ + +H ++IRL G+        ++ E   NG+L  ++ +K G      Q + +   +
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGI 119

Query: 448 ATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT 507
           A G+ YL    N  +VH+D+   N+L++++   K+++F L+R  E        TS     
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG 567
             + APE +     ++  DV++FG++M E+++  E P                  + E  
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP------------------YWELS 218

Query: 568 EESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA 622
              +   ++   +   P      + +L+  C +++ + RP    I   + + + A
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 5e-47
 Identities = 55/269 (20%), Positives = 101/269 (37%), Gaps = 42/269 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICF---- 406
            +VY+G        VA  ++      +          ++L  + H +++R          
Sbjct: 23  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
                 LV E   +G+L  ++  K  K +           +  GL +LH+   PP +H+D
Sbjct: 83  GKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRD 139

Query: 467 IKCSNVLL-DTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           +KC N+ +       KI +  LA               ++GT  +MAPE  E       +
Sbjct: 140 LKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEEK-YDESV 193

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           DVYAFG+ MLEM + +                  P    ++  +  R +       ++  
Sbjct: 194 DVYAFGMCMLEMATSE-----------------YPYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 586 VTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           V    V  +IE C++++   R ++  +  
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 2e-46
 Identities = 60/290 (20%), Positives = 105/290 (36%), Gaps = 47/290 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
           G+VY        + VAIKK+                 ++ L K+ H + I+  G      
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             +LV E  +  +  +    K    L   +   +      GL YLHS      +H+D+K 
Sbjct: 89  TAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKA 143

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLE---NGLVSTKLD 526
            N+LL      K+ +F  A             +  VGT  +MAPE +     G    K+D
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           V++ G+  +E+   K                  P L   +   +L H+            
Sbjct: 197 VWSLGITCIELAERK------------------PPLFNMNAMSALYHIAQNESPALQSGH 238

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQS--ISRFLNASLAWELSKNISE 634
            +      ++SCL+K P  RP  + + +   + R    ++  +L +   +
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-46
 Identities = 57/265 (21%), Positives = 104/265 (39%), Gaps = 35/265 (13%)

Query: 362 GSVYRGKI----GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGG 409
           GSV +G          VAIK +                ++++++++  ++RL+G+C    
Sbjct: 23  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 81

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
              LV E A  G L  ++  K  + +  +   ++   V+ G+ YL        VH+D+  
Sbjct: 82  ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAA 137

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            NVLL     AKI++F L++     +  +   S       + APE +     S++ DV++
Sbjct: 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 197

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           +GV M E LS  + P  Y +                     +   ++   +   PP    
Sbjct: 198 YGVTMWEALSYGQKP--YKKMKG----------------PEVMAFIEQGKRMECPPECPP 239

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQ 614
            +  L+  C       RP    + Q
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQ 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 1e-45
 Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 34/264 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G V     ++  + VA+K V    +          I +   +NH ++++  G    G   
Sbjct: 19  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YL  E    G L   I    G  +      +    +  G+ YLH        H+DIK  N
Sbjct: 79  YLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPEN 133

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAF 530
           +LLD     KI++F LA    R      L + + GT  Y+APE L+     +  +DV++ 
Sbjct: 134 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192

Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL 590
           G+++  ML+G+      S+      D      +    ++     +D +            
Sbjct: 193 GIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK-----IDSAP----------- 236

Query: 591 VIRLIESCLKKDPSGRPAMDKIAQ 614
            + L+   L ++PS R  +  I +
Sbjct: 237 -LALLHKILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 53/294 (18%)

Query: 362 GSVYRGKI-------GGDFVAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGIC 405
           G V                VA+K +   A           +K+L+ + NH +++ LLG C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKF----------------LDWAQRIQIALDVAT 449
             GG   ++ E    G L  ++  K   F                LD    +  +  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ +L S      +H+D+   N+LL      KI +F LAR  +  +  + +  +      
Sbjct: 157 GMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK-NDSNYVVKGNARLPVK 212

Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE 569
           +MAPE + N + + + DV+++G+ + E+ S                            + 
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGS-----------------SPYPGMPVDS 255

Query: 570 SLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
               ++    +   P      +  ++++C   DP  RP   +I Q I + ++ S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 3e-45
 Identities = 61/296 (20%), Positives = 116/296 (39%), Gaps = 59/296 (19%)

Query: 362 GSVYRGKI-------GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G V++ +            VA+K +  +AS            L+ + ++ ++++LLG+C 
Sbjct: 27  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKF----------------------LDWAQRIQIA 444
            G    L++E    G L+ ++                             L  A+++ IA
Sbjct: 87  VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 146

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             VA G+ YL        VH+D+   N L+  +   KIA+F L+R     +  +    + 
Sbjct: 147 RQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGND 202

Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
                +M PE +     +T+ DV+A+GV++ E+ S    P                  + 
Sbjct: 203 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-----------------YYG 245

Query: 565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
              EE + ++ D ++    P    + +  L+  C  K P+ RP+   I + + R  
Sbjct: 246 MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 4e-45
 Identities = 64/279 (22%), Positives = 110/279 (39%), Gaps = 37/279 (13%)

Query: 362 GSVYRGKI-----GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNG 408
           G VY G +          A+K +                 ++   +H +++ LLGIC   
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100

Query: 409 -GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
            G+  +V     +G L  +I ++          I   L VA G+ +L    +   VH+D+
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDL 156

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTS-HIVGTKGYMAPEYLENGLVSTKLD 526
              N +LD  F  K+A+F LAR    +E +             +MA E L+    +TK D
Sbjct: 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           V++FGVL+ E+++    P  Y + N    D+   +L         R L+ P      P  
Sbjct: 217 VWSFGVLLWELMTRGAPP--YPDVN--TFDITVYLLQG-------RRLLQPE---YCPDP 262

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLA 625
               +  ++  C       RP+  ++   IS   +  + 
Sbjct: 263 ----LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 6e-45
 Identities = 53/262 (20%), Positives = 104/262 (39%), Gaps = 35/262 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G+VY       G  VAI+++      +       I ++ +  + +++  L     G   +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V E    GSL+  + +      D  Q   +  +    L +LHS      +H+DIK  N+
Sbjct: 94  VVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI 147

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 532
           LL  D   K+ +F        ++ +    S +VGT  +MAPE +       K+D+++ G+
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

Query: 533 LMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVI 592
           + +EM+ G+                  P L++           + + +   P   + +  
Sbjct: 205 MAIEMIEGE-----------------PPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247

Query: 593 RLIESCLKKDPSGRPAMDKIAQ 614
             +  CL  D   R +  ++ Q
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQ 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 64/300 (21%), Positives = 112/300 (37%), Gaps = 62/300 (20%)

Query: 362 GSVYRGK-------IGGDFVAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGIC 405
           G V                VA+K +   A           +K++ ++ +H +++ LLG C
Sbjct: 51  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110

Query: 406 FNGGNWYLVYENAVNGSLSVWINDKGGKF---------------------LDWAQRIQIA 444
              G  YL++E    G L  ++  K  KF                     L +   +  A
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170

Query: 445 LDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI 504
             VA G+ +L        VH+D+   NVL+      KI +F LAR     +  + +  + 
Sbjct: 171 YQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM-SDSNYVVRGNA 226

Query: 505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK 564
                +MAPE L  G+ + K DV+++G+L+ E+ S    P  Y    +            
Sbjct: 227 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGIPV------------ 272

Query: 565 EDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL 624
              + +   L+    + + P      +  +++SC   D   RP+   +      FL   L
Sbjct: 273 ---DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS----FLGCQL 325

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-44
 Identities = 56/287 (19%), Positives = 112/287 (39%), Gaps = 40/287 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G VY+   K      A K +   + ++       I +L   +H ++++LL   +   N +
Sbjct: 26  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           ++ E    G++   + +     L  +Q   +       LNYLH       +H+D+K  N+
Sbjct: 86  ILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNI 141

Query: 473 LLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYL-----ENGLVSTKLDV 527
           L   D   K+A+F ++    R           +GT  +MAPE +     ++     K DV
Sbjct: 142 LFTLDGDIKLADFGVSAKNTR---TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 198

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
           ++ G+ ++EM   +     + E N   + VL  +   E    +       + +       
Sbjct: 199 WSLGITLIEMAEIE---PPHHELNP--MRVLLKIAKSEPPTLAQPSRWSSNFK------- 246

Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISE 634
                  ++ CL+K+   R    ++ Q    F+       + + I+E
Sbjct: 247 -----DFLKKCLEKNVDARWTTSQLLQ--HPFVTVDSNKPIRELIAE 286

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 7e-44
 Identities = 52/270 (19%), Positives = 103/270 (38%), Gaps = 39/270 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICF--NG 408
           G   +   K  G  +  K++   +  +         + LL ++ H +++R          
Sbjct: 18  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77

Query: 409 GNWYLVYENAVNGSLSVWIND--KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH--VH 464
              Y+V E    G L+  I    K  ++LD    +++   +   L   H  ++  H  +H
Sbjct: 78  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K +NV LD     K+ +F LAR         +     VGT  YM+PE +     + K
Sbjct: 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEK 194

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            D+++ G L+ E+ +       +S++ +                  +R      +   Y 
Sbjct: 195 SDIWSLGCLLYELCALMPPFTAFSQKELA---------------GKIREGKFRRIPYRYS 239

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                 +  +I   L      RP++++I +
Sbjct: 240 D----ELNEIITRMLNLKDYHRPSVEEILE 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-43
 Identities = 64/272 (23%), Positives = 107/272 (39%), Gaps = 38/272 (13%)

Query: 362 GSVYRGKI-----GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNG 408
           G V++G           VAIK      SD            + + +H  +++L+G     
Sbjct: 21  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITE 79

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
              +++ E    G L  ++  +    LD A  I  A  ++T L YL S      VH+DI 
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDIA 135

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             NVL+ ++   K+ +F L+R    ++  +   S       +MAPE +     ++  DV+
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 193

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
            FGV M E+L     P    + N ++                + +     M  N PP   
Sbjct: 194 MFGVCMWEILMHGVKPFQGVKNNDVI--------------GRIENGERLPMPPNCPPT-- 237

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
             +  L+  C   DPS RP   ++   +S  L
Sbjct: 238 --LYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 61/268 (22%), Positives = 99/268 (36%), Gaps = 37/268 (13%)

Query: 362 GSVYRGKIGGD-----FVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICF 406
           G V RG+          VA+K +  D   Q          +  ++ ++H +LIRL G+  
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
                 +V E A  GSL   +    G F       + A+ VA G+ YL S      +H+D
Sbjct: 82  TP-PMKMVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGYLES---KRFIHRD 136

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLD 526
           +   N+LL T    KI +F L R   + +  + +  H      + APE L+    S   D
Sbjct: 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD 196

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
            + FGV + EM +  + P                     +G + L  +     +   P  
Sbjct: 197 TWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHKIDKEGERLPRPED 239

Query: 587 TAILVIRLIESCLKKDPSGRPAMDKIAQ 614
               +  ++  C    P  RP    +  
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-43
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 52/286 (18%)

Query: 362 GSVYRGKIGGD----FVAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLGICFNG 408
           G V + +I  D      AIK++   AS          +++L K+ +H ++I LLG C + 
Sbjct: 24  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83

Query: 409 GNWYLVYENAVNGSLSVWINDK--------------GGKFLDWAQRIQIALDVATGLNYL 454
           G  YL  E A +G+L  ++                     L   Q +  A DVA G++YL
Sbjct: 84  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143

Query: 455 HSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE 514
                   +H+D+   N+L+  ++ AKIA+F L+R  E         +       +MA E
Sbjct: 144 SQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIE 196

Query: 515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
            L   + +T  DV+++GVL+ E++S    P                  +       L   
Sbjct: 197 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------------------YCGMTCAELYEK 238

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL 620
           +    +   P      V  L+  C ++ P  RP+  +I  S++R L
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-42
 Identities = 56/274 (20%), Positives = 109/274 (39%), Gaps = 38/274 (13%)

Query: 362 GSVYRGKIGGD------FVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFN 407
           G+VY+G    +       VAIK++    S +          ++  +++  + RLLGIC  
Sbjct: 23  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
                L+ +    G L  ++ +           +   + +A G+NYL    +   VH+D+
Sbjct: 83  S-TVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE---DRRLVHRDL 137

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
              NVL+ T    KI +F LA+    +E E+           +MA E + + + + + DV
Sbjct: 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDV 196

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
           +++GV + E+++    P  Y                       +  +++   +   PP+ 
Sbjct: 197 WSYGVTVWELMTFGSKP--YDGIPA----------------SEISSILEKGERLPQPPIC 238

Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
            I V  ++  C   D   RP   ++    S+   
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 8e-42
 Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 46/296 (15%)

Query: 362 GSVYRGKI-------GGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICF 406
           G VY G             VAIK V   AS +          ++ + N   ++RLLG+  
Sbjct: 34  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKF--------LDWAQRIQIALDVATGLNYLHSFT 458
            G    ++ E    G L  ++                  ++ IQ+A ++A G+ YL++  
Sbjct: 94  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-- 151

Query: 459 NPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN 518
               VH+D+   N ++  DF  KI +F + R    +   +      +    +M+PE L++
Sbjct: 152 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMSPESLKD 209

Query: 519 GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS 578
           G+ +T  DV++FGV++ E+ +  E P                       E+ LR +M+  
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQP-----------------YQGLSNEQVLRFVMEGG 252

Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASLAWELSKNISE 634
           +  + P     ++  L+  C + +P  RP+  +I  SI   +      E+S   SE
Sbjct: 253 LL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR-EVSFYYSE 306

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  151 bits (382), Expect = 2e-41
 Identities = 55/266 (20%), Positives = 101/266 (37%), Gaps = 39/266 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G V+R   +  G+  A K V              I+ ++ + H +L+ L     +     
Sbjct: 40  GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           ++YE    G L   + D+  K +   + ++    V  GL ++H      +VH D+K  N+
Sbjct: 100 MIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENI 155

Query: 473 LLDTDF--RAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           +  T      K+ +F L    + ++          GT  + APE  E   V    D+++ 
Sbjct: 156 MFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211

Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM--DPSMQGNYPPVTA 588
           GVL   +LSG                        E+ +E+LR++   D +M  +     +
Sbjct: 212 GVLSYILLSGL------------------SPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQ 614
                 I   L  DP+ R  + +  +
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 59/266 (22%), Positives = 96/266 (36%), Gaps = 39/266 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------IKLLNKINHSSLIRLLGICFNGGNWY 412
           G V+R   K  G     K +              I ++N+++H  LI L     +     
Sbjct: 43  GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           L+ E    G L   I  +  K +  A+ I        GL ++H       VH DIK  N+
Sbjct: 103 LILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENI 158

Query: 473 LLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAF 530
           + +T      KI +F LA      E    +      T  + APE ++   V    D++A 
Sbjct: 159 MCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 214

Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLM--DPSMQGNYPPVTA 588
           GVL   +LSG                        ED  E+L+++   D     +     +
Sbjct: 215 GVLGYVLLSGL------------------SPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256

Query: 589 ILVIRLIESCLKKDPSGRPAMDKIAQ 614
                 I++ L+K+P  R  +    +
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 54/294 (18%)

Query: 362 GSVYRGK---------IGGDFVAIKKVYGDASDQ--------IKLLNKI-NHSSLIRLLG 403
           G V   +              VA+K +  DA+++        ++++  I  H ++I LLG
Sbjct: 27  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86

Query: 404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKF--------------LDWAQRIQIALDVAT 449
            C   G  Y++ E A  G+L  ++  +                  L     +  A  VA 
Sbjct: 87  ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 146

Query: 450 GLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG 509
           G+ YL S      +H+D+   NVL+  D   KIA+F LAR        +  T++      
Sbjct: 147 GMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVK 202

Query: 510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE 569
           +MAPE L + + + + DV++FGVL+ E+ +   +P  Y    +                E
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPV----------------E 244

Query: 570 SLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
            L  L+    + + P      +  ++  C    PS RP   ++ + + R +  +
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 40/291 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
             V     K     VAIK +   A +         I +L+KI H +++ L  I  +GG+ 
Sbjct: 23  SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
           YL+ +    G L   I +KG  F       ++   V   + YLH         K      
Sbjct: 83  YLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY 140

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
             LD D +  I++F L++  +       + S   GT GY+APE L     S  +D ++ G
Sbjct: 141 YSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 196

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
           V+   +L G   P  Y E +     +   +L  E       +  D     +         
Sbjct: 197 VIAYILLCGY--PPFYDENDA---KLFEQILKAE-------YEFDSPYWDDISD----SA 240

Query: 592 IRLIESCLKKDPSGRPAMDKIAQ--------SISRFLNASLAWELSKNISE 634
              I   ++KDP  R   ++  Q        ++ + ++ S++ ++ KN ++
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAK 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 48/265 (18%), Positives = 97/265 (36%), Gaps = 38/265 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
            +V            AIK +      +            ++++++H   ++L     +  
Sbjct: 22  STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             Y     A NG L  +I   G    D         ++ + L YLH       +H+D+K 
Sbjct: 82  KLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKP 136

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+LL+ D   +I +F  A+     E + A  +  VGT  Y++PE L         D++A
Sbjct: 137 ENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 195

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            G ++ ++++G                   P     +     + ++   ++ ++P     
Sbjct: 196 LGCIIYQLVAGL------------------PPFRAGNEYLIFQKII--KLEYDFPEKFFP 235

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQ 614
               L+E  L  D + R   +++  
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEG 260

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 62/293 (21%), Positives = 113/293 (38%), Gaps = 52/293 (17%)

Query: 362 GSVYRG-------KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGIC 405
           G V                VA+K +   A+             L++  +H +++ LLG C
Sbjct: 27  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86

Query: 406 F-NGGNWYLVYENAVNGSLSVWINDKGGKF--------------LDWAQRIQIALDVATG 450
              GG   ++ E    G+LS ++  K  +F              L     I  +  VA G
Sbjct: 87  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146

Query: 451 LNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY 510
           + +L S      +H+D+   N+LL      KI +F LAR    ++ ++           +
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDARLPLKW 202

Query: 511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES 570
           MAPE + + + + + DV++FGVL+ E+ S   +P  Y    +               +E 
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKI---------------DEE 245

Query: 571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS 623
               +    +   P  T   + + +  C   +PS RP   ++ + +   L A+
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  141 bits (357), Expect = 1e-38
 Identities = 50/277 (18%), Positives = 104/277 (37%), Gaps = 38/277 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFN-- 407
             V+          VA+K +  D +             +    +NH +++ +        
Sbjct: 21  SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80

Query: 408 --GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK 465
             G   Y+V E     +L   ++ +G   +   + I++  D    LN+ H       +H+
Sbjct: 81  PAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ---NGIIHR 135

Query: 466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKL 525
           D+K +N+++      K+ +F +AR           T+ ++GT  Y++PE      V  + 
Sbjct: 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 195

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           DVY+ G ++ E+L+G+  P    +  +    V    + +           DP        
Sbjct: 196 DVYSLGCVLYEVLTGE--PPFTGDSPV---SVAYQHVRE-----------DPIPPSARHE 239

Query: 586 VTAILVIRLIESCLKKDPSGRP-AMDKIAQSISRFLN 621
             +  +  ++   L K+P  R     ++   + R  N
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-38
 Identities = 52/263 (19%), Positives = 95/263 (36%), Gaps = 34/263 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------IKLLNKINHSSLIRLLGICFNGGNWYL 413
           G V+R            K V    +DQ      I +LN   H +++ L     +     +
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           ++E      +   IN    + L+  + +     V   L +LHS       H DI+  N++
Sbjct: 79  IFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENII 134

Query: 474 LDTD--FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFG 531
             T      KI  F  AR  +  +        +     Y APE  ++ +VST  D+++ G
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG 190

Query: 532 VLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV 591
            L+  +LSG   P L      ++ +++N                + +         +I  
Sbjct: 191 TLVYVLLSGI-NPFLAETNQQIIENIMNA---------------EYTFDEEAFKEISIEA 234

Query: 592 IRLIESCLKKDPSGRPAMDKIAQ 614
           +  ++  L K+   R    +  Q
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQ 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  137 bits (347), Expect = 3e-37
 Identities = 55/280 (19%), Positives = 99/280 (35%), Gaps = 54/280 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------------IKLLNKIN-HSSLIRLL 402
             V R   K      A+K +                       + +L K++ H ++I+L 
Sbjct: 17  SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76

Query: 403 GICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                   ++LV++    G L  ++ +K    L   +  +I   +   +  LH       
Sbjct: 77  DTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL---NI 131

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV- 521
           VH+D+K  N+LLD D   K+ +F  +   +  E        + GT  Y+APE +E  +  
Sbjct: 132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMND 187

Query: 522 -----STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD 576
                  ++D+++ GV+M  +L+G                   P          LR +M 
Sbjct: 188 NHPGYGKEVDMWSTGVIMYTLLAGS------------------PPFWHRKQMLMLRMIMS 229

Query: 577 PSMQGNYPPVTAI--LVIRLIESCLKKDPSGRPAMDKIAQ 614
            + Q   P        V  L+   L   P  R   ++   
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 9e-36
 Identities = 56/280 (20%), Positives = 102/280 (36%), Gaps = 35/280 (12%)

Query: 362 GSVYRG---KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICF 406
           G V++    K GG FVA+K+V     ++            ++ L    H +++RL  +C 
Sbjct: 21  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80

Query: 407 -----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPP 461
                      LV+E+      +          +       +   +  GL++LHS     
Sbjct: 81  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSH---R 136

Query: 462 HVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLV 521
            VH+D+K  N+L+ +  + K+A+F LAR            + +V T  Y APE L     
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLAR----IYSFQMALTSVVVTLWYRAPEVLLQSSY 192

Query: 522 STKLDVYAFGVLMLEMLSGK-------EAPALYSEENMLLVDVLNPVLHKEDGEESLRHL 574
           +T +D+++ G +  EM   K       +   L    +++ +                 H 
Sbjct: 193 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252

Query: 575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                   +      L   L+  CL  +P+ R +      
Sbjct: 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 6e-35
 Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 30/278 (10%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ--------IKLLNKINHSSLIRLLGICFNGGNW 411
           G V      +    VAIKK+               IK+L +  H ++I +  I       
Sbjct: 22  GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81

Query: 412 YLVYENAVNGSLSVWINDK-GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            +     V   +   +      + L           +  GL Y+HS      +H+D+K S
Sbjct: 82  QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPS 138

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST-KLDVYA 529
           N+LL+T    KI +F LAR A+         +  V T+ Y APE + N    T  +D+++
Sbjct: 139 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNY------ 583
            G ++ EMLS +  P    +  +  ++ +  +L     E+    +   +           
Sbjct: 199 VGCILAEMLSNR--PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256

Query: 584 -------PPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                   P      + L++  L  +P  R  +++   
Sbjct: 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 7e-35
 Identities = 61/259 (23%), Positives = 93/259 (35%), Gaps = 41/259 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-----------IKLLNKINHSSLIRLLGICFNG 408
           G V+    K    F AIK +  D                 L     H  L  +       
Sbjct: 16  GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75

Query: 409 GNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIK 468
            N + V E    G L   I        D ++    A ++  GL +LHS      V++D+K
Sbjct: 76  ENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS---KGIVYRDLK 130

Query: 469 CSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVY 528
             N+LLD D   KIA+F + +     + +    +   GT  Y+APE L     +  +D +
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIAPEILLGQKYNHSVDWW 187

Query: 529 AFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           +FGVL+ EML G+                     H +D EE    +   +    YP    
Sbjct: 188 SFGVLLYEMLIGQ------------------SPFHGQDEEELFHSIRMDNPF--YPRWLE 227

Query: 589 ILVIRLIESCLKKDPSGRP 607
                L+     ++P  R 
Sbjct: 228 KEAKDLLVKLFVREPEKRL 246

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-35
 Identities = 56/272 (20%), Positives = 98/272 (36%), Gaps = 44/272 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------------IKLLNKINHSSLIRLLGICF 406
             V +   K  G   A K +    +               + +L +I H ++I L  +  
Sbjct: 24  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
           N  +  L+ E    G L  ++ +K     + A      +     LN ++   +    H D
Sbjct: 84  NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHSLQIAHFD 138

Query: 467 IKCSNVLLDTD----FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVS 522
           +K  N++L        R KI +F LA   +          +I GT  ++APE +    + 
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLG 194

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
            + D+++ GV+   +LSG   P L   +   L +V                 ++   +  
Sbjct: 195 LEADMWSIGVITYILLSGAS-PFLGDTKQETLANVSA---------------VNYEFEDE 238

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           Y   T+ L    I   L KDP  R  +    Q
Sbjct: 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  131 bits (331), Expect = 3e-34
 Identities = 47/262 (17%), Positives = 99/262 (37%), Gaps = 43/262 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------------IKLLNKINHSSLIRLLGICF 406
           G VY       G   A+K +                    + L++  +   ++ +     
Sbjct: 18  GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77

Query: 407 NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKD 466
                  + +    G L   ++  G       +    A ++  GL ++H+      V++D
Sbjct: 78  TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--YAAEIILGLEHMHN---RFVVYRD 132

Query: 467 IKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VSTKL 525
           +K +N+LLD     +I++  LA    +++         VGT GYMAPE L+ G+   +  
Sbjct: 133 LKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSA 187

Query: 526 DVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP 585
           D ++ G ++ ++L G      +  ++   +D +                M   +  ++ P
Sbjct: 188 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------------MAVELPDSFSP 234

Query: 586 VTAILVIRLIESCLKKDPSGRP 607
                +  L+E  L++D + R 
Sbjct: 235 ----ELRSLLEGLLQRDVNRRL 252

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 5e-34
 Identities = 46/291 (15%), Positives = 87/291 (29%), Gaps = 37/291 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICFNGGNWYLV 414
           G +Y G     G+ VAIK               K+   +     I  +  C   G++ ++
Sbjct: 21  GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80

Query: 415 YENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL- 473
               +  SL    N    KF      + +A  + + + Y+HS      +H+D+K  N L 
Sbjct: 81  VMELLGPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLM 136

Query: 474 --LDTDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDV 527
                     I +F LA+        Q   +    ++ GT  Y +         S + D+
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196

Query: 528 YAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT 587
            + G +++    G                      ++   E+ +       +   YP   
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQ-------KYERISEKKMS-TPIEVLCKGYPSE- 247

Query: 588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFL-------NASLAWELSKN 631
                  +  C       +P    + Q             +    W + K 
Sbjct: 248 ---FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (322), Expect = 7e-34
 Identities = 63/273 (23%), Positives = 114/273 (41%), Gaps = 28/273 (10%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGNW 411
           G VY+ +   G+  A+KK+  +  D+         I +L ++ HS++++L  +       
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75

Query: 412 YLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN 471
            LV+E+       +    +GG  L+        L +  G+ Y H       +H+D+K  N
Sbjct: 76  VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQN 130

Query: 472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAF 530
           +L++ +   KIA+F LAR       +    +H + T  Y AP+ L      ST +D+++ 
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187

Query: 531 GVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA 588
           G +  EM++G       SE + L  +  +L     K     +     DP+     P    
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247

Query: 589 ILV-------IRLIESCLKKDPSGRPAMDKIAQ 614
             +       I L+   LK DP+ R    +  +
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 8e-34
 Identities = 53/265 (20%), Positives = 98/265 (36%), Gaps = 31/265 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKV--YGDASDQIKLLNKI-NHSSLIRLLGICFN----GGNWY 412
           G V +   K   +  A+K +     A  +++L  +      ++R++ +  N         
Sbjct: 26  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           +V E    G L   I D+G +     +  +I   +   + YLHS       H+D+K  N+
Sbjct: 86  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENL 142

Query: 473 LLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
           L  +   +   K+ +F  A+                 T  Y+APE L         D+++
Sbjct: 143 LYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDMWS 198

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            GV+M  +L G   P  YS   + +   +   +     E       + S +         
Sbjct: 199 LGVIMYILLCGY--PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE--------- 247

Query: 590 LVIRLIESCLKKDPSGRPAMDKIAQ 614
            V  LI + LK +P+ R  + +   
Sbjct: 248 -VKMLIRNLLKTEPTQRMTITEFMN 271

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 31/276 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ------------IKLLNKINHSSLIRLLGICFN 407
            +VY+   K     VAIKK+      +            IKLL +++H ++I LL    +
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDI 467
             N  LV++        +  ++         +     L    GL YLH       +H+D+
Sbjct: 72  KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQGLEYLHQ---HWILHRDL 126

Query: 468 KCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLD 526
           K +N+LLD +   K+A+F LA+            +H V T+ Y APE L    +    +D
Sbjct: 127 KPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 527 VYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV 586
           ++A G ++ E+L         S+ + L           E+    +  L D     ++P +
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 587 TAILV--------IRLIESCLKKDPSGRPAMDKIAQ 614
               +        + LI+     +P  R    +  +
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 5e-33
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 32/276 (11%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G VY+   K+ G+ VA+KK+  D   +         I LL ++NH ++++LL +      
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
            YLV+E  ++  L  +++      +           +  GL + HS      +H+D+K  
Sbjct: 76  LYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQ 131

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLDVYA 529
           N+L++T+   K+A+F LAR        +   +H V T  Y APE  L     ST +D+++
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWS 188

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP----- 584
            G +  EM++ +       +  +  +  +   L   D          P  + ++P     
Sbjct: 189 LGCIFAEMVTRR--ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246

Query: 585 ------PVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
                 P        L+   L  DP+ R +      
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 52/259 (20%), Positives = 103/259 (39%), Gaps = 43/259 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
           G V+    +  G + A+K +  +   +            +L+ + H  +IR+ G   +  
Sbjct: 18  GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             +++ +    G L   +          A+    A +V   L YLHS      +++D+K 
Sbjct: 78  QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCLALEYLHS---KDIIYRDLKP 132

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+LLD +   KI +F  A+           T  + GT  Y+APE +     +  +D ++
Sbjct: 133 ENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWS 186

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
           FG+L+ EML+G                      +  +  ++   +++  ++  +PP    
Sbjct: 187 FGILIYEMLAGY------------------TPFYDSNTMKTYEKILNAELR--FPPFFNE 226

Query: 590 LVIRLIESCLKKDPSGRPA 608
            V  L+   + +D S R  
Sbjct: 227 DVKDLLSRLITRDLSQRLG 245

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  123 bits (310), Expect = 4e-32
 Identities = 41/277 (14%), Positives = 80/277 (28%), Gaps = 34/277 (12%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-----IKLLNKINHSSLIRLLGICF-NGGNWYL 413
           G ++ G   +    VAIK     +         +    +   + I  +      G +  L
Sbjct: 19  GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78

Query: 414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVL 473
           V +  + G     + D  G+          A  +   +  +H       V++DIK  N L
Sbjct: 79  VID--LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFL 133

Query: 474 LD-----TDFRAKIANFALAR----PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +            + +F + +    P  +Q   +    ++ GT  YM+         S +
Sbjct: 134 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR 193

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
            D+ A G + +  L G                        E   E  +      +   +P
Sbjct: 194 DDLEALGHVFMYFLRGSLPWQGLKAATNKQK--------YERIGEKKQSTPLRELCAGFP 245

Query: 585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLN 621
                   + +           P  D +    S+ L 
Sbjct: 246 EE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 8e-32
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 30/275 (10%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGGN 410
           G+V++   +   + VA+K+V  D  D+         I LL ++ H +++RL  +  +   
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75

Query: 411 WYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCS 470
             LV+E         + +  G    +  +       +  GL + H   +   +H+D+K  
Sbjct: 76  LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCH---SRNVLHRDLKPQ 130

Query: 471 NVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYA 529
           N+L++ +   K+ANF LAR            S  V T  Y  P+ L    L ST +D+++
Sbjct: 131 NLLINRNGELKLANFGLAR---AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLN----------PVLHKEDGEESLRHLMDPSM 579
            G +  E+ +        ++ +  L  +            P + K    +        + 
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247

Query: 580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
             N  P        L+++ LK +P  R + ++  Q
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 55/272 (20%), Positives = 91/272 (33%), Gaps = 54/272 (19%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ-------------IKLLNKIN--HSSLIRLLGI 404
           GSVY G        VAIK V  D                 + LL K++   S +IRLL  
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77

Query: 405 CFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
                ++ L+ E             + G  L           V   + + H+      +H
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN---CGVLH 133

Query: 465 KDIKCSNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENG-LVS 522
           +DIK  N+L+D +    K+ +F      +         +   GT+ Y  PE++       
Sbjct: 134 RDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHG 188

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
               V++ G+L+ +M+ G        +E ++   V                         
Sbjct: 189 RSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVF------------------------ 222

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
           +    +     LI  CL   PS RP  ++I  
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 65/284 (22%), Positives = 109/284 (38%), Gaps = 38/284 (13%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICF---- 406
           G V++   +  G  VA+KKV  +   +         IK+L  + H +++ L+ IC     
Sbjct: 24  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83

Query: 407 ----NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPH 462
                 G+ YLV++   +    +  N      L   +R+   L     LN L+       
Sbjct: 84  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYYIHRNKI 138

Query: 463 VHKDIKCSNVLLDTDFRAKIANFALARP-AERQEGEFALTSHIVGTKGYMAPEYLENG-L 520
           +H+D+K +NVL+  D   K+A+F LAR  +  +  +    ++ V T  Y  PE L     
Sbjct: 139 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 198

Query: 521 VSTKLDVYAFGVLMLEMLSGKEAPALYSEENML------LVDVLNPVLHKEDGEESLRHL 574
               +D++  G +M EM +        +E++ L         +   V    D  E    L
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258

Query: 575 MDPSMQGNYPP------VTAILVIRLIESCLKKDPSGRPAMDKI 612
                Q           V     + LI+  L  DP+ R   D  
Sbjct: 259 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 59/274 (21%), Positives = 106/274 (38%), Gaps = 30/274 (10%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---IKLLNKINHSSLIRLLGICFNGGNW----- 411
           G VY+      G+ VAIKKV  D   +   ++++ K++H +++RL    ++ G       
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93

Query: 412 -YLVYENAVNGSLSVWIN-DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
             LV +        V  +  +  + L           +   L Y+HS       H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKP 150

Query: 470 SNVLLDTD-FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP-EYLENGLVSTKLDV 527
            N+LLD D    K+ +F  A+   R E         + ++ Y AP         ++ +DV
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDV 206

Query: 528 YAFGVLMLEMLSGKEAPALYSEENML--LVDVLN-------PVLHKEDGEESLRHLMDPS 578
           ++ G ++ E+L G+      S  + L  ++ VL          ++    E     +    
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266

Query: 579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
               + P T    I L    L+  P+ R    + 
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-29
 Identities = 58/262 (22%), Positives = 93/262 (35%), Gaps = 40/262 (15%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
           G V     K  G + A+K +  +               ++L    H  L  L        
Sbjct: 19  GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
               V E A  G L   ++ +        +      ++ + L YLHS      V++DIK 
Sbjct: 79  RLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS---RDVVYRDIKL 133

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N++LD D   KI +F L +         A      GT  Y+APE LE+      +D + 
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 190

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            GV+M EM+ G+                     + +D E     ++   ++  +P   + 
Sbjct: 191 LGVVMYEMMCGR------------------LPFYNQDHERLFELILMEEIR--FPRTLSP 230

Query: 590 LVIRLIESCLKKDPSGRPAMDK 611
               L+   LKKDP  R     
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGP 252

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-28
 Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 46/282 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICFNGG- 409
           G+V        G  VAIKK+Y     +         ++LL  + H ++I LL +      
Sbjct: 32  GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91

Query: 410 -----NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
                ++YLV          +  ++K    L   +   +   +  GL Y+H+      +H
Sbjct: 92  LDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHA---AGIIH 144

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL-VST 523
           +D+K  N+ ++ D   KI +F LAR A+ +       +  V T+ Y APE + N +  + 
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQ 198

Query: 524 KLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ--- 580
            +D+++ G +M EM++GK        +++  +  +  V      E   R   D +     
Sbjct: 199 TVDIWSVGCIMAEMITGK--TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 581 ----------GNYPPVTAILVIRLIESCLKKDPSGRPAMDKI 612
                      +     + L + L+E  L  D   R    + 
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (277), Expect = 3e-27
 Identities = 49/259 (18%), Positives = 99/259 (38%), Gaps = 43/259 (16%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ----------IKLLNKINHSSLIRLLGICFNGG 409
           G V     K  G+  A+K +      +           ++L  +N   L++L     +  
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 410 NWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKC 469
           N Y+V E    G +   +   G            A  +     YLHS      +++D+K 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKP 169

Query: 470 SNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYA 529
            N+L+D     ++ +F  A+  + +      T  + GT   +APE + +   +  +D +A
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWA 223

Query: 530 FGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI 589
            GVL+ EM +G   P  ++++ + + +                     S +  +P   + 
Sbjct: 224 LGVLIYEMAAGY--PPFFADQPIQIYE------------------KIVSGKVRFPSHFSS 263

Query: 590 LVIRLIESCLKKDPSGRPA 608
            +  L+ + L+ D + R  
Sbjct: 264 DLKDLLRNLLQVDLTKRFG 282

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-25
 Identities = 60/293 (20%), Positives = 102/293 (34%), Gaps = 53/293 (18%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGICF---- 406
           G V      +    VAIKK+     +Q         + L+  +NH ++I LL +      
Sbjct: 31  GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90

Query: 407 --NGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
                + YLV E        V         LD  +   +   +  G+ +LHS      +H
Sbjct: 91  LEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIH 142

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K SN+++ +D   KI +F LAR A        + +  V T+ Y APE +        
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKEN 198

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYP 584
           +D+++ G +M EM+  K       +       V+  +                +   N P
Sbjct: 199 VDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257

Query: 585 PVTAI-----------------------LVIRLIESCLKKDPSGRPAMDKIAQ 614
               +                           L+   L  DP+ R ++D   Q
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (252), Expect = 4e-24
 Identities = 43/282 (15%), Positives = 93/282 (32%), Gaps = 41/282 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQIK-----LLNKINHSSLIRLLGIC--FNGGNWY 412
             V+        + V +K +      +IK     L N     ++I L  I          
Sbjct: 49  SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108

Query: 413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNV 472
           LV+E+  N            + L          ++   L+Y HS      +H+D+K  NV
Sbjct: 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNV 160

Query: 473 LLDTDFR-AKIANFALARPAERQEGEFALTSHIVGTKGYMAPE-YLENGLVSTKLDVYAF 530
           ++D + R  ++ ++ LA      +      +  V ++ +  PE  ++  +    LD+++ 
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216

Query: 531 GVLMLEMLSGKEAPALYSEENMLLVDVLN------------------PVLHKEDGEESLR 572
           G ++  M+  KE      +    LV +                         +      R
Sbjct: 217 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 276

Query: 573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQ 614
              +  +      + +   +  ++  L+ D   R    +  +
Sbjct: 277 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 7e-24
 Identities = 56/267 (20%), Positives = 95/267 (35%), Gaps = 42/267 (15%)

Query: 362 GSVYRG-----KIGGDFVAIKKVYGDASDQ-----------IKLLNKINHSSLI-RLLGI 404
           G V+          G   A+K +      Q            ++L  I  S  +  L   
Sbjct: 38  GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97

Query: 405 CFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
                  +L+ +    G L   ++ +        +      ++   L +LH       ++
Sbjct: 98  FQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK---LGIIY 152

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGL--VS 522
           +DIK  N+LLD++    + +F L++     E E        GT  YMAP+ +  G     
Sbjct: 153 RDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHD 210

Query: 523 TKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN 582
             +D ++ GVLM E+L+G  +P     E     ++   +L  E                 
Sbjct: 211 KAVDWWSLGVLMYELLTGA-SPFTVDGEKNSQAEISRRILKSEP---------------P 254

Query: 583 YPPVTAILVIRLIESCLKKDPSGRPAM 609
           YP   + L   LI+  L KDP  R   
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 3e-23
 Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 40/279 (14%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGDASDQ---------IKLLNKINHSSLIRLLGIC----- 405
           GSV        G  VA+KK+                ++LL  + H ++I LL +      
Sbjct: 32  GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91

Query: 406 -FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVH 464
                + YLV    + G+    I       L       +   +  GL Y+HS      +H
Sbjct: 92  LEEFNDVYLVTH--LMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHS---ADIIH 144

Query: 465 KDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTK 524
           +D+K SN+ ++ D   KI +F LAR  + +      T ++           L     +  
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQT 199

Query: 525 LDVYAFGVLMLEMLSGKEAPALYSEENML-----LVDVLNPVLHKEDGEESLRHLMDPSM 579
           +D+++ G +M E+L+G+         + L     LV      L K+   ES R+ +    
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259

Query: 580 QGNYPPVTAILV------IRLIESCLKKDPSGRPAMDKI 612
           Q        + +      + L+E  L  D   R    + 
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.8 bits (229), Expect = 6e-21
 Identities = 54/310 (17%), Positives = 109/310 (35%), Gaps = 66/310 (21%)

Query: 362 GSVYRG--KIGGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGIC-------- 405
            +V+     +    VA+K V GD      A D+IKLL ++N +   +   +         
Sbjct: 27  STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86

Query: 406 -------FNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFT 458
                   NG +  +V+E      L++    +           QI+  +  GL+Y+H   
Sbjct: 87  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQLLLGLDYMH--R 143

Query: 459 NPPHVHKDIKCSNVLLDTD------FRAKIANFALARPAERQEGEFALTSHIVGTKGYMA 512
               +H DIK  NVL++         + KIA+   A   +         ++ + T+ Y +
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRS 197

Query: 513 PEYLENGLVSTKLDVYAFGVLMLEMLSGK-----EAPALYSEENMLLVDVLN-----PVL 562
           PE L         D+++   L+ E+++G      +    Y++++  +  ++      P  
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 563 HKEDGEESLRHLMDPSMQGN------------------YPPVTAILVIRLIESCLKKDPS 604
              +G+ +        +  N                  +    A  +   +   L+ DP 
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317

Query: 605 GRPAMDKIAQ 614
            R     +  
Sbjct: 318 KRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 57.9 bits (139), Expect = 3e-10
 Identities = 26/193 (13%), Positives = 54/193 (27%), Gaps = 33/193 (17%)

Query: 362 GSVYRGK-IGGDFVAIKKVYGDASD-----------------QIKLLNKINHSSLIRLLG 403
            +V+           +K      +                        +    +L +L G
Sbjct: 14  SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73

Query: 404 ICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHV 463
           +       Y    NAV   L   I+ K    +      ++   +   +   +       V
Sbjct: 74  LAVP--KVYAWEGNAV---LMELIDAKELYRVRVENPDEVLDMILEEVAKFYH---RGIV 125

Query: 464 HKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVST 523
           H D+   NVL+  +    I +F  +     +     L   +     Y +  Y       T
Sbjct: 126 HGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RT 178

Query: 524 KLDVYAFGVLMLE 536
           + D+ +    +L+
Sbjct: 179 EKDINSAIDRILQ 191

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 46.4 bits (110), Expect = 1e-07
 Identities = 13/48 (27%), Positives = 26/48 (54%), Gaps = 2/48 (4%)

Query: 184 LLSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVP 231
           +L+Y VK G+T+  I+  F + T   L+AN   +    +    ++++P
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQ--AGLTAGQSIVIP 46

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 41.9 bits (99), Expect = 3e-06
 Identities = 12/49 (24%), Positives = 26/49 (53%), Gaps = 3/49 (6%)

Query: 185 LSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLE 233
           ++Y V+ G+++  I+KR GV+    +  N  +    N+ P   L + ++
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA---NLQPGDKLTLFVK 48

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	635
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.74
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.4
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.39
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.1
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.09
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.1
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.59
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.47
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.71
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.51
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.5

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-47  Score=392.57  Aligned_cols=260  Identities=23%  Similarity=0.417  Sum_probs=196.1

Q ss_pred             cccHHHHHHhhcCCCCC---------Cccc----ceEEEeee--CC---cEEEEEEecc--------ChHHHHHHHhhhc
Q 042486          341 VYTFEELQAATDDFNPS---------CWIK----GSVYRGKI--GG---DFVAIKKVYG--------DASDQIKLLNKIN  394 (635)
Q Consensus       341 ~~~~~el~~at~~f~~~---------~~ig----g~Vy~g~~--~~---~~vavK~~~~--------~~~~E~~~l~~l~  394 (635)
                      .++|+++.+++.+|+.+         ..||    |+||+|++  ++   ..||||++..        ++.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            46677777887777543         3455    89999987  23   2689998754        3668999999999


Q ss_pred             cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEE
Q 042486          395 HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLL  474 (635)
Q Consensus       395 h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll  474 (635)
                      |||||+++|+|.+++..++||||+++|+|.+++..... .++|.+++.|+.||+.||+|||+.   +|+||||||+||||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            99999999999999999999999999999998865433 489999999999999999999995   49999999999999


Q ss_pred             CCCCcEEEeeecCcccccccCCcee--eecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchh
Q 042486          475 DTDFRAKIANFALARPAERQEGEFA--LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEEN  551 (635)
Q Consensus       475 ~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~  551 (635)
                      +.++.+||+|||+++..........  ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.......
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999987654322211  1223457899999999999999999999999999999998 788875432221


Q ss_pred             hHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          552 MLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       552 ~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                        +...+.                 .......+...+..+.+|+.+||+.||++|||++||++.|++++++.
T Consensus       242 --~~~~i~-----------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         242 --VINAIE-----------------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             --HHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --HHHHHH-----------------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence              111111                 11112234445566899999999999999999999999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-47  Score=381.70  Aligned_cols=237  Identities=24%  Similarity=0.428  Sum_probs=184.5

Q ss_pred             ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|++ +++.||||+++.      ++.+|++++++++||||++++|+|.+++..++||||+++|+|.+++.... ..
T Consensus        19 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~   97 (263)
T d1sm2a_          19 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GL   97 (263)
T ss_dssp             CCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TC
T ss_pred             eEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc-cC
Confidence            89999998 678899999864      36789999999999999999999999999999999999999999986543 34


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.|+.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......  .......||+.|+|||
T Consensus        98 ~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE  172 (263)
T d1sm2a_          98 FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPE  172 (263)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------------CTTSCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc--eeecceecCcccCChH
Confidence            899999999999999999999954   99999999999999999999999999986644321  2223457899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      ++.+..++.++|||||||++|||+|++.|+......... ...+..                 ......|...+..+.+|
T Consensus       173 ~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~-~~~i~~-----------------~~~~~~p~~~~~~l~~l  234 (263)
T d1sm2a_         173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDIST-----------------GFRLYKPRLASTHVYQI  234 (263)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH-HHHHHH-----------------TCCCCCCTTSCHHHHHH
T ss_pred             HhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH-HHHHHh-----------------cCCCCCccccCHHHHHH
Confidence            999999999999999999999999976555432222111 111111                 01112233345568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +.+||+.||++|||++||+++|+++.++
T Consensus       235 i~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-47  Score=385.37  Aligned_cols=239  Identities=24%  Similarity=0.390  Sum_probs=198.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |+||+|++  +++.||||+++.      ++.+|+++|++++|||||+++|+|.+++..++||||+++|+|.+++......
T Consensus        31 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~  110 (287)
T d1opja_          31 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ  110 (287)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT
T ss_pred             eEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcccc
Confidence            89999998  588999999864      3668999999999999999999999999999999999999999999766556


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAP  513 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  513 (635)
                      .+++..++.|+.||+.||+|||+.   +|+||||||+||||++++.+||+|||+++.......  .......|++.|+||
T Consensus       111 ~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~--~~~~~~~g~~~y~aP  185 (287)
T d1opja_         111 EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAP  185 (287)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS--EEETTEEECGGGCCH
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc--eeeccccccccccCh
Confidence            699999999999999999999985   499999999999999999999999999987654322  223345688999999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHH
Q 042486          514 EYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIR  593 (635)
Q Consensus       514 E~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~  593 (635)
                      |++.++.++.++|||||||++|||++|+.|+........ ..+                 .+........+...+..+.+
T Consensus       186 E~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~-----------------~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE-----------------LLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH-----------------HHHTTCCCCCCTTCCHHHHH
T ss_pred             HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHH-----------------HHhcCCCCCCCccchHHHHH
Confidence            999999999999999999999999998877643222211 111                 11112222334445567999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          594 LIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       594 li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      |+.+||+.||++|||++||++.|+.++.++
T Consensus       248 li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            999999999999999999999999887543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-47  Score=380.96  Aligned_cols=238  Identities=25%  Similarity=0.432  Sum_probs=193.7

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCCC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGKF  434 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  434 (635)
                      |.||+|++ +++.||||+++.+      +.+|+++|++++|||||+++|++. ++..++||||+++|+|.+++.......
T Consensus        27 g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~  105 (272)
T d1qpca_          27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK  105 (272)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHT
T ss_pred             cEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCC
Confidence            89999999 5678999999653      678999999999999999999885 456799999999999999886554445


Q ss_pred             CCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCcc
Q 042486          435 LDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPE  514 (635)
Q Consensus       435 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  514 (635)
                      +++..++.|+.||+.||+|||+.   +|+||||||+||||++++.+||+|||+++......  ........||+.|+|||
T Consensus       106 l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~gt~~y~APE  180 (272)
T d1qpca_         106 LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPE  180 (272)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc--cccccccCCcccccChH
Confidence            99999999999999999999985   49999999999999999999999999998764332  22334467899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          515 YLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       515 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      ++.++.++.++|||||||++|||+||+.|+.......... ..+                .. ......|...+..+.+|
T Consensus       181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~i----------------~~-~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNL----------------ER-GYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHH----------------HT-TCCCCCCTTCCHHHHHH
T ss_pred             HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HHH----------------Hh-cCCCCCcccChHHHHHH
Confidence            9999999999999999999999999776654332221111 111                10 11112233445568999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +.+||+.||++|||++||++.|+.++.++
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence            99999999999999999999999998765

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=378.79  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=190.2

Q ss_pred             CCCCCCccc----ceEEEeeeCCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeeccc
Q 042486          353 DFNPSCWIK----GSVYRGKIGGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV  419 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~  419 (635)
                      +|.....||    |+||+|++.+ .||||+++.         .+.+|+++|++++||||++++|++. ++..++||||++
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~   86 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE   86 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred             cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence            444455565    8999999865 599999853         3568999999999999999999875 456899999999


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCcee
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                      +|+|.+++..... .+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .
T Consensus        87 ~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~-~  161 (276)
T d1uwha_          87 GSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-H  161 (276)
T ss_dssp             EEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             CCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc-c
Confidence            9999999965443 399999999999999999999984   5999999999999999999999999999866543221 2


Q ss_pred             eecccccCCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          500 LTSHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                      ......||+.|||||++.+   +.++.++|||||||++|||+||+.||.......... ......            ...
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-~~~~~~------------~~~  228 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-FMVGRG------------YLS  228 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-HHHHHT------------SCC
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH-HHHhcC------------CCC
Confidence            2345679999999999864   457999999999999999999999986543322111 111110            011


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +.. ...+...+..+.+|+.+||+.||++|||++||+++|+.+..+
T Consensus       229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            111 112233445689999999999999999999999999987753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=377.89  Aligned_cols=240  Identities=24%  Similarity=0.281  Sum_probs=192.6

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENA  418 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~  418 (635)
                      +|.....||    |+||+|+.  +|+.||||++..        ++.+|+++|++++||||+++++++.+++..|+||||+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            344444454    89999987  689999998743        3678999999999999999999999999999999999


Q ss_pred             cCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          419 VNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       419 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      ++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        86 ~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~-~  159 (271)
T d1nvra_          86 SGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-E  159 (271)
T ss_dssp             TTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-E
T ss_pred             CCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc-c
Confidence            9999999996543  4999999999999999999999955   99999999999999999999999999987654321 1


Q ss_pred             eeecccccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                      ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||....+...........                 
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-----------------  222 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----------------  222 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-----------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------------
Confidence            22345689999999999987765 678999999999999999999986544332222222111                 


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..........+..+.+|+.+||+.||++|||++|++++
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111122334568899999999999999999999765

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=376.75  Aligned_cols=238  Identities=25%  Similarity=0.419  Sum_probs=191.0

Q ss_pred             ceEEEeee----CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |+||+|.+    .++.||||+++.         ++.+|+++|++++|||||+++|+|.+ +..+|||||+++|+|.+++.
T Consensus        21 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~   99 (277)
T d1xbba_          21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ   99 (277)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh
Confidence            89999986    246899999854         25689999999999999999999965 45789999999999999997


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ...  .+++..++.|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++................||+
T Consensus       100 ~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~  174 (277)
T d1xbba_         100 QNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV  174 (277)
T ss_dssp             HCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCG
T ss_pred             hcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCc
Confidence            543  3999999999999999999999854   99999999999999999999999999987654443333344567899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|||||.+.++.++.++|||||||++|||+| |+.||.......  ....+.                 .......|...
T Consensus       175 ~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~-----------------~~~~~~~p~~~  235 (277)
T d1xbba_         175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLE-----------------KGERMGCPAGC  235 (277)
T ss_dssp             GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH-----------------TTCCCCCCTTC
T ss_pred             eecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHH-----------------cCCCCCCCccc
Confidence            9999999999999999999999999999998 888876432221  111111                 11112233445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      +..+.+|+.+||+.||++|||++||++.|+.+..+..
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence            5668999999999999999999999999998875543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=375.84  Aligned_cols=240  Identities=23%  Similarity=0.390  Sum_probs=187.3

Q ss_pred             ceEEEeeeCC------cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIGG------DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~~------~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |.||+|++.+      ..||||+++.        ++.+|+++|++++|||||+++|++.+.+..++||||+.+|+|.+++
T Consensus        21 G~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~  100 (283)
T d1mqba_          21 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  100 (283)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhh
Confidence            8999998732      3799999854        3568999999999999999999999999999999999999999888


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      .... ..++|.+++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++................||
T Consensus       101 ~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt  176 (283)
T d1mqba_         101 REKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP  176 (283)
T ss_dssp             HHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCC
T ss_pred             hccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCC
Confidence            6543 34999999999999999999999954   9999999999999999999999999998765443322333445789


Q ss_pred             CCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          508 KGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       508 ~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      +.|||||++.++.++.++|||||||++|||++|+.|+......... ...                + ........+...
T Consensus       177 ~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-~~~----------------i-~~~~~~~~~~~~  238 (283)
T d1mqba_         177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKA----------------I-NDGFRLPTPMDC  238 (283)
T ss_dssp             GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHH----------------H-HTTCCCCCCTTC
T ss_pred             ccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-HHH----------------H-hccCCCCCchhh
Confidence            9999999999999999999999999999999987776432222111 111                1 111222334445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      +..+.+|+.+||+.||++|||+.||++.|++++...
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            567999999999999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=374.65  Aligned_cols=238  Identities=24%  Similarity=0.361  Sum_probs=193.4

Q ss_pred             ceEEEeee----CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI----GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~----~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|.+    ++..||||+++.        ++.+|+++|++++|||||+++|+|.+ +..|+||||+++|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~  101 (285)
T d1u59a_          23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  101 (285)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT
T ss_pred             eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc
Confidence            89999976    345799999864        25679999999999999999999865 468999999999999999854


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .. ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++................||+.
T Consensus       102 ~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~  177 (285)
T d1u59a_         102 KR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK  177 (285)
T ss_dssp             CT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred             cc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCcc
Confidence            43 3499999999999999999999994   4999999999999999999999999999876554433333345578999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      |+|||++.++.++.++|||||||++|||+| |+.||......+  ....+.                 .......|...+
T Consensus       178 y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~-----------------~~~~~~~p~~~~  238 (285)
T d1u59a_         178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE-----------------QGKRMECPPECP  238 (285)
T ss_dssp             GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH-----------------TTCCCCCCTTCC
T ss_pred             ccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH-----------------cCCCCCCCCcCC
Confidence            999999999999999999999999999998 898886433221  111111                 111122344455


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      ..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            67899999999999999999999999999887543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=371.78  Aligned_cols=233  Identities=25%  Similarity=0.406  Sum_probs=192.2

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      +|.....||    |.||+++.  +++.||||++..          .+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            344444554    89999998  688999998853          24579999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      |+++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        87 y~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          87 YAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             ecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            999999999997543  3999999999999999999999954   9999999999999999999999999998654322 


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                          .....||+.|||||++.+..++.++|||||||++|||++|+.||...+...  .                +..+..
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~----------------~~~i~~  218 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--T----------------YKRISR  218 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H----------------HHHHHT
T ss_pred             ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--H----------------HHHHHc
Confidence                234679999999999999999999999999999999999999986433221  1                111111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..  ...|...+..+.+|+.+||+.||++|||++|+++|
T Consensus       219 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         219 VE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            11  12233445668999999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=373.97  Aligned_cols=237  Identities=22%  Similarity=0.359  Sum_probs=193.2

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeeccc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV  419 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~  419 (635)
                      .|.....||    |+||+|+.  +|+.||||+++.       .+.+|+++|++++||||+++++++.+++..|+||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            344444555    89999986  699999998853       25689999999999999999999999999999999999


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCcee
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFA  499 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  499 (635)
                      +|+|.+++...   .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   .
T Consensus       101 gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---~  171 (293)
T d1yhwa1         101 GGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---S  171 (293)
T ss_dssp             TCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---C
T ss_pred             CCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc---c
Confidence            99999988653   3899999999999999999999954   9999999999999999999999999998664332   1


Q ss_pred             eecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          500 LTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       500 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +......                ...
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~----------------~~~  234 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATN----------------GTP  234 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHH----------------CSC
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhC----------------CCC
Confidence            23446799999999999999999999999999999999999999864332221 1111110                000


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ....+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112233445668999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=366.02  Aligned_cols=242  Identities=24%  Similarity=0.369  Sum_probs=196.9

Q ss_pred             cCCCCCCccc----ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccC
Q 042486          352 DDFNPSCWIK----GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVN  420 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~  420 (635)
                      ++|.....||    |.||+|++ +++.||||+++.      ++.+|+.++++++||||++++|+|.+++..++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            3555556665    89999999 677999999864      367899999999999999999999999999999999999


Q ss_pred             CCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceee
Q 042486          421 GSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFAL  500 (635)
Q Consensus       421 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  500 (635)
                      |+|.+++..... .+++..+++++.|+++||.|||+.   +|+||||||+||++++++.+||+|||+++.......  ..
T Consensus        84 g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~  157 (258)
T d1k2pa_          84 GCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TS  157 (258)
T ss_dssp             EEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--CC
T ss_pred             CcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc--ee
Confidence            999999754432 389999999999999999999985   499999999999999999999999999986654322  22


Q ss_pred             ecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          501 TSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       501 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      .....+|..|+|||.+.+..++.++|||||||++|||+| |+.||......+  ....                +.. ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~----------------i~~-~~  218 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEH----------------IAQ-GL  218 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH----------------HHT-TC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHH----------------HHh-CC
Confidence            234578999999999999999999999999999999998 788876543322  1111                111 11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      ....|...+..+.+|+.+||+.||++|||++||+++|.+
T Consensus       219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            122334445669999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=373.42  Aligned_cols=241  Identities=21%  Similarity=0.351  Sum_probs=179.8

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec--CCeeEEEe
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN--GGNWYLVY  415 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~  415 (635)
                      +|.....||    |+||+++.  +|+.||||.+...         +.+|+++|++++||||+++++++.+  ++..|+||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            344444454    89999987  6899999998532         5579999999999999999999975  45689999


Q ss_pred             ecccCCCcchhhccc--CCCCCCHHHHHHHHHHHHhhhcccccCC--CCCeEeecccCCCEEECCCCcEEEeeecCcccc
Q 042486          416 ENAVNGSLSVWINDK--GGKFLDWAQRIQIALDVATGLNYLHSFT--NPPHVHKDIKCSNVLLDTDFRAKIANFALARPA  491 (635)
Q Consensus       416 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  491 (635)
                      ||+++|+|.+++.+.  ....+++..++.++.||+.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            999999999998532  2345999999999999999999999853  235999999999999999999999999999876


Q ss_pred             cccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhh
Q 042486          492 ERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESL  571 (635)
Q Consensus       492 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  571 (635)
                      ....   .......||+.|||||++.+..++.++|||||||++|||+||+.||...+...  +..               
T Consensus       165 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~---------------  224 (269)
T d2java1         165 NHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAG---------------  224 (269)
T ss_dssp             --------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH---------------
T ss_pred             ccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHH---------------
Confidence            4332   22345689999999999999999999999999999999999999986433221  111               


Q ss_pred             hhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          572 RHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       572 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                       .+..... ...+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       225 -~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         225 -KIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence             1111111 11233345568999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-45  Score=366.81  Aligned_cols=228  Identities=23%  Similarity=0.386  Sum_probs=181.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec----CCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~  426 (635)
                      |+||+|+.  ++..||+|++..         .+.+|+++|++++||||+++++++.+    +..+|+||||+++|+|.++
T Consensus        23 g~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~  102 (270)
T d1t4ha_          23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  102 (270)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHH
Confidence            89999988  678999998853         25689999999999999999999874    3457999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC-CCCcEEEeeecCcccccccCCceeeecccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD-TDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      +.+..  .+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ +++.+||+|||+++......     .....
T Consensus       103 l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~-----~~~~~  174 (270)
T d1t4ha_         103 LKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKAVI  174 (270)
T ss_dssp             HHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-----BEESC
T ss_pred             Hhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc-----cCCcc
Confidence            96543  3899999999999999999999854 5699999999999996 57899999999997543321     23468


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|||||++.+ .++.++|||||||++|||++|+.||...............                 .......+.
T Consensus       175 GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-----------------~~~~~~~~~  236 (270)
T d1t4ha_         175 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----------------GVKPASFDK  236 (270)
T ss_dssp             SSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------------TCCCGGGGG
T ss_pred             cCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-----------------CCCCcccCc
Confidence            9999999999875 5899999999999999999999998643322211111111                 000001111


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+..+.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            223458899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=372.69  Aligned_cols=248  Identities=25%  Similarity=0.425  Sum_probs=193.0

Q ss_pred             CCCCCCccc----ceEEEeee-CCcEEEEEEecc------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCC
Q 042486          353 DFNPSCWIK----GSVYRGKI-GGDFVAIKKVYG------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNG  421 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~-~~~~vavK~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~g  421 (635)
                      +|.....||    |.||+|++ ++..||||+++.      ++.+|+.+|++++|+|||+++|+|. ++..++||||+++|
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g   96 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG   96 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCC
Confidence            344444555    79999998 566899999864      3678999999999999999999985 45689999999999


Q ss_pred             CcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeee
Q 042486          422 SLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALT  501 (635)
Q Consensus       422 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  501 (635)
                      +|.+++.......++|.+++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......  ...
T Consensus        97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~--~~~  171 (285)
T d1fmka3          97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TAR  171 (285)
T ss_dssp             BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc--eee
Confidence            9999986554445999999999999999999999854   99999999999999999999999999986543321  223


Q ss_pred             cccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCC
Q 042486          502 SHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG  581 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~  581 (635)
                      ....||+.|+|||++.++.++.++||||||+++|||++|+.|+.........+ ..+.                 .....
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~-----------------~~~~~  233 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVE-----------------RGYRM  233 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHH-----------------TTCCC
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHH-----------------hcCCC
Confidence            34578999999999999999999999999999999999877765433222111 1111                 11112


Q ss_pred             CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       582 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                      ..+...+..+.+||.+||+.||++||++++|++.|+.++.+..
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            2344455679999999999999999999999999999886653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=379.22  Aligned_cols=255  Identities=21%  Similarity=0.313  Sum_probs=193.2

Q ss_pred             cCCCCCCccc----ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeec
Q 042486          352 DDFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYEN  417 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~  417 (635)
                      ++|.....||    |+||+|+.  +|+.||+|+++.        .+.+|+.+|++++|||||+++++|.++++.|+||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4455445555    89999997  689999999853        255799999999999999999999999999999999


Q ss_pred             ccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc
Q 042486          418 AVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       418 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +++|+|.+++.+..  .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+|+......  
T Consensus        86 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  159 (322)
T d1s9ja_          86 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  159 (322)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred             CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence            99999999997654  389999999999999999999972  249999999999999999999999999998654322  


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhh--ccc-------------
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLN--PVL-------------  562 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~--~~~-------------  562 (635)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...........  ...             
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence               23468999999999999999999999999999999999999998754433211110000  000             


Q ss_pred             ---------ccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          563 ---------HKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       563 ---------~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                               ......+..................+..+.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                     00000011111111111111111234568999999999999999999999997

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-45  Score=370.60  Aligned_cols=230  Identities=22%  Similarity=0.343  Sum_probs=187.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |+||+|+.  +++.||||+++.       .+.+|+++|++++|||||++++++.+++..++||||+++|+|.+++.+.. 
T Consensus        26 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-  104 (288)
T d2jfla1          26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-  104 (288)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-
T ss_pred             cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-
Confidence            89999997  688999999853       36689999999999999999999999999999999999999999986543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMA  512 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  512 (635)
                      ..+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+.|+|
T Consensus       105 ~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y~A  178 (288)
T d2jfla1         105 RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYWMA  178 (288)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH---HHHTCCCSCCTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc---ccccccccccccCC
Confidence            34999999999999999999999955   9999999999999999999999999997554321   12234679999999


Q ss_pred             ccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          513 PEYLE-----NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       513 PE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      ||++.     +..++.++|||||||++|||++|+.||........ +......                .......+...
T Consensus       179 PE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~  241 (288)
T d2jfla1         179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKS----------------EPPTLAQPSRW  241 (288)
T ss_dssp             HHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHS----------------CCCCCSSGGGS
T ss_pred             HHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcC----------------CCCCCCccccC
Confidence            99984     45678999999999999999999999864333221 1111110                00011223344


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+|+.+||+.||++|||++|+++|
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            5668999999999999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=375.54  Aligned_cols=244  Identities=23%  Similarity=0.397  Sum_probs=194.5

Q ss_pred             CCCCCCccc----ceEEEeeeC--C-----cEEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeE
Q 042486          353 DFNPSCWIK----GSVYRGKIG--G-----DFVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWY  412 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~~--~-----~~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  412 (635)
                      +|.....||    |+||+|++.  +     ..||+|++..        .+.+|+.+|+++ +|||||++++++.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            344444554    899999872  2     2699998854        256799999999 8999999999999999999


Q ss_pred             EEeecccCCCcchhhcccCC---------------------CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCC
Q 042486          413 LVYENAVNGSLSVWINDKGG---------------------KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSN  471 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~N  471 (635)
                      +||||+++|+|.+++.....                     ..+++..++.++.||+.||+|||+.   +|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence            99999999999999964321                     3489999999999999999999995   49999999999


Q ss_pred             EEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcch
Q 042486          472 VLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEE  550 (635)
Q Consensus       472 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~  550 (635)
                      |+++.++.+||+|||+++........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876544322 23344678999999999999999999999999999999998 78887543322


Q ss_pred             hhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 042486          551 NMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISR  618 (635)
Q Consensus       551 ~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  618 (635)
                      . .+..                 ++........|...+..+.+||.+||+.||++|||++||+++|..
T Consensus       274 ~-~~~~-----------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 A-NFYK-----------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             H-HHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H-HHHH-----------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            1 1111                 111112223344455679999999999999999999999999963

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=372.17  Aligned_cols=241  Identities=21%  Similarity=0.316  Sum_probs=191.2

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||+|+.  +++.||||.+..          .+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus        22 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~  101 (288)
T d1uu3a_          22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK  101 (288)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc
Confidence            89999987  688999999853          256899999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .+  .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ .......||+.
T Consensus       102 ~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~GT~~  175 (288)
T d1uu3a_         102 IG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSFVGTAQ  175 (288)
T ss_dssp             HS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----------CCCCGG
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc-cccccccCCcc
Confidence            54  3999999999999999999999954   999999999999999999999999999866533221 22334679999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |+|||++.+..++.++|||||||++|||++|+.||...+...  +                ...+....  ...|...+.
T Consensus       176 Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~----------------~~~i~~~~--~~~p~~~s~  235 (288)
T d1uu3a_         176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--I----------------FQKIIKLE--YDFPEKFFP  235 (288)
T ss_dssp             GCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----------------HHHHHTTC--CCCCTTCCH
T ss_pred             ccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--H----------------HHHHHcCC--CCCCccCCH
Confidence            999999999999999999999999999999999986432221  1                11111111  122333455


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH---HHhhcccccc
Q 042486          590 LVIRLIESCLKKDPSGRPAMDKIAQSISR---FLNASLAWEL  628 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RPs~~evl~~L~~---~~~~s~~w~~  628 (635)
                      .+.+||.+||+.||++|||++|++++-.-   -.-++++|+.
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence            68999999999999999999998665321   1123567865

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=365.39  Aligned_cols=233  Identities=27%  Similarity=0.438  Sum_probs=185.4

Q ss_pred             ceEEEeeeCCcEEEEEEeccC-----hHHHHHHHhhhccCCcccEEEEEec-CCeeEEEeecccCCCcchhhcccCCCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGD-----ASDQIKLLNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWINDKGGKFL  435 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l  435 (635)
                      |.||+|++.|..||||+++.+     +.+|+++|++++||||++++|+|.+ .+.+++||||+++|+|.+++.......+
T Consensus        21 g~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l  100 (262)
T d1byga_          21 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL  100 (262)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred             eEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCC
Confidence            899999999999999999653     6689999999999999999999965 4568999999999999999965544458


Q ss_pred             CHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccc
Q 042486          436 DWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEY  515 (635)
Q Consensus       436 ~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  515 (635)
                      +|..+++|+.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++......      ....++..|+|||+
T Consensus       101 ~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~------~~~~~~~~y~aPE~  171 (262)
T d1byga_         101 GGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEA  171 (262)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------------CCTTTSCHHH
T ss_pred             CHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC------ccccccccCCChHH
Confidence            9999999999999999999984   59999999999999999999999999998654322      23467889999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHH
Q 042486          516 LENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRL  594 (635)
Q Consensus       516 ~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~l  594 (635)
                      +.++.+++++||||||+++|||+| |+.|+......  .....+                 ........+...+..+.+|
T Consensus       172 l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i-----------------~~~~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV-----------------EKGYKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH-----------------TTTCCCCCCTTCCHHHHHH
T ss_pred             HhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH-----------------HcCCCCCCCccCCHHHHHH
Confidence            999999999999999999999999 56655432221  111111                 1111223344455668999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          595 IESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       595 i~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +.+||+.||++|||+.|++++|+++.+.
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-44  Score=369.33  Aligned_cols=224  Identities=25%  Similarity=0.378  Sum_probs=182.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |.||+|+.  +++.||||++..          ++.+|+++|++++|||||++++++.+++..|+||||+++|+|..++..
T Consensus        29 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~  108 (309)
T d1u5ra_          29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH  108 (309)
T ss_dssp             SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh
Confidence            89999986  788999999853          256799999999999999999999999999999999999999777654


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      .  ..+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....       ....||+.
T Consensus       109 ~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-------~~~~GT~~  176 (309)
T d1u5ra_         109 K--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPY  176 (309)
T ss_dssp             T--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CCCCSCGG
T ss_pred             C--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-------CccccCcc
Confidence            3  34999999999999999999999954   999999999999999999999999999865432       23579999


Q ss_pred             ccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          510 YMAPEYLEN---GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       510 y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |||||++.+   +.++.++|||||||++|||++|+.||....... .+.....                 .......+..
T Consensus       177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~-----------------~~~~~~~~~~  238 (309)
T d1u5ra_         177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ-----------------NESPALQSGH  238 (309)
T ss_dssp             GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH-----------------SCCCCCSCTT
T ss_pred             ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh-----------------CCCCCCCCCC
Confidence            999999863   568999999999999999999999986433221 1111111                 1111111223


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+..+.+|+.+||+.||++|||++|+++|
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            34568999999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-44  Score=366.37  Aligned_cols=229  Identities=26%  Similarity=0.392  Sum_probs=175.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |+||+++.  +++.||||.+..        .+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++....
T Consensus        23 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~  102 (307)
T d1a06a_          23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG  102 (307)
T ss_dssp             GGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS
T ss_pred             eEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc
Confidence            89999987  688999998853        24579999999999999999999999999999999999999999996543


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC---CCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD---TDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                        .+++.++..++.||+.||+|||+.+   |+||||||+||++.   +++.+||+|||+++......    ......||+
T Consensus       103 --~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~GT~  173 (307)
T d1a06a_         103 --FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTP  173 (307)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------------------C
T ss_pred             --CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC----eeeeeeeCc
Confidence              4999999999999999999999854   99999999999994   57899999999998654332    223467999


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|||||++.+..++.++|||||||++|||++|+.||........ .......               +.......+...+
T Consensus       174 ~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~---------------~~~~~~~~~~~~s  237 (307)
T d1a06a_         174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKA---------------EYEFDSPYWDDIS  237 (307)
T ss_dssp             TTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTT---------------CCCCCTTTTTTSC
T ss_pred             cccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhcc---------------CCCCCCccccCCC
Confidence            99999999999999999999999999999999999864332211 1111110               0011112223345


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+.+|+.+||+.||++|||++|+++|
T Consensus       238 ~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         238 DSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            568999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-44  Score=366.38  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=197.8

Q ss_pred             HHHhhcCCCCCCccc----ceEEEeeeC-------CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEec
Q 042486          347 LQAATDDFNPSCWIK----GSVYRGKIG-------GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFN  407 (635)
Q Consensus       347 l~~at~~f~~~~~ig----g~Vy~g~~~-------~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~  407 (635)
                      ++...++|.....||    |+||+|++.       ++.||||+++.        ++.+|+++|++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            333455666666665    899999863       36899999864        36789999999999999999999999


Q ss_pred             CCeeEEEeecccCCCcchhhcccC----------------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEee
Q 042486          408 GGNWYLVYENAVNGSLSVWINDKG----------------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHK  465 (635)
Q Consensus       408 ~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~  465 (635)
                      .+..+++|||+++|+|.+++....                      ...+++..++.|+.|++.||+|||+.+   ++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            999999999999999999985321                      224899999999999999999999854   9999


Q ss_pred             cccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 042486          466 DIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPA  545 (635)
Q Consensus       466 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~  545 (635)
                      ||||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999986543322 122344678899999999999999999999999999999999975543


Q ss_pred             CCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 042486          546 LYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFL  620 (635)
Q Consensus       546 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  620 (635)
                      ........                 +..+.+.. ....+...+..+.+|+.+||+.||++||||.||++.|+++.
T Consensus       244 ~~~~~~e~-----------------~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEV-----------------IYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHH-----------------HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHH-----------------HHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            22221111                 11111111 11223344556899999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=363.86  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=191.6

Q ss_pred             ceEEEeeeCCcEEEEEEeccCh------HHHHHHHhhhccCCcccEEEEEecCC----eeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKIGGDFVAIKKVYGDA------SDQIKLLNKINHSSLIRLLGICFNGG----NWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~~~------~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |.||+|+++|+.||||+++.+.      ..|+..+++++||||++++++|.+++    ..++||||+++|+|.+++++. 
T Consensus        17 g~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-   95 (303)
T d1vjya_          17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-   95 (303)
T ss_dssp             SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-
T ss_pred             eEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-
Confidence            8999999999999999986542      23455566789999999999998654    579999999999999999764 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccC-----CCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce-eeecccc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSF-----TNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF-ALTSHIV  505 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~  505 (635)
                        .++|..+++++.|++.||.|||+.     .+++|+||||||+||||+.++.+||+|||+++......... .......
T Consensus        96 --~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~  173 (303)
T d1vjya_          96 --TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV  173 (303)
T ss_dssp             --CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CC
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceecccccee
Confidence              389999999999999999999974     13679999999999999999999999999998765433221 1234568


Q ss_pred             cCCCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcC
Q 042486          506 GTKGYMAPEYLENGL------VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSM  579 (635)
Q Consensus       506 gt~~y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~  579 (635)
                      ||+.|+|||++.+..      ++.++|||||||++|||+||..|+.............   ........+......+..+
T Consensus       174 gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  250 (303)
T d1vjya_         174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL---VPSDPSVEEMRKVVCEQKL  250 (303)
T ss_dssp             SCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT---SCSSCCHHHHHHHHTTSCC
T ss_pred             cccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc---ccccchHHHHHHHHhcccc
Confidence            999999999987542      6779999999999999999998765433221111000   0011111122222333333


Q ss_pred             CCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          580 QGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       580 ~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +...+     ......+.+|+.+||+.||++|||+.||+++|+++...
T Consensus       251 ~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            22222     23456689999999999999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-43  Score=367.05  Aligned_cols=239  Identities=21%  Similarity=0.255  Sum_probs=191.3

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeeccc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAV  419 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~  419 (635)
                      +|.....||    |.||+++.  +|+.||||++...       +.+|+++|++++||||+++++++.+++..|+||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            344344454    89999987  6899999998643       4579999999999999999999999999999999999


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC--CCCcEEEeeecCcccccccCCc
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD--TDFRAKIANFALARPAERQEGE  497 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~  497 (635)
                      +|+|.+++....+ .+++..+..|+.||+.||+|||+.+   |+||||||+|||++  .++.+||+|||+++....... 
T Consensus       107 gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-  181 (350)
T d1koaa2         107 GGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-  181 (350)
T ss_dssp             SCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred             CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence            9999999965433 3999999999999999999999955   99999999999995  468899999999986654322 


Q ss_pred             eeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCC
Q 042486          498 FALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDP  577 (635)
Q Consensus       498 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  577 (635)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||...+... .+........               
T Consensus       182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~---------------  242 (350)
T d1koaa2         182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDW---------------  242 (350)
T ss_dssp             ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC---------------
T ss_pred             ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC---------------
Confidence               234679999999999999999999999999999999999999986433221 1111111100               


Q ss_pred             cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          578 SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       578 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..........+..+.+||.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01111112334568999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=363.83  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=184.0

Q ss_pred             CCCCCCccc----ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecC-Cee
Q 042486          353 DFNPSCWIK----GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNG-GNW  411 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~  411 (635)
                      +|.....||    |.||+|++       +++.||||+++..        +.+|..++.++ +|+||+++++++... +..
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence            344444454    89999986       2468999998643        34567777777 688999999998764 468


Q ss_pred             EEEeecccCCCcchhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCC
Q 042486          412 YLVYENAVNGSLSVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTD  477 (635)
Q Consensus       412 ~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~  477 (635)
                      ++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||+.+   |+||||||+||||+++
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCC
Confidence            99999999999999995431              234899999999999999999999954   9999999999999999


Q ss_pred             CcEEEeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCcchhhHHHH
Q 042486          478 FRAKIANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEA-PALYSEENMLLVD  556 (635)
Q Consensus       478 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p-~~~~~~~~~~l~~  556 (635)
                      +.+||+|||+++........ .......||+.|+|||.+.++.++.++|||||||++|||+||..| |....... .+..
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~~  248 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR  248 (299)
T ss_dssp             GCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHHH
T ss_pred             CcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence            99999999999865443221 233456799999999999999999999999999999999998654 43222111 1111


Q ss_pred             hhhcccccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          557 VLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       557 ~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .+.             .    ......+...+..+.+++.+||+.||++|||++||+++|++++++
T Consensus       249 ~~~-------------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         249 RLK-------------E----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHH-------------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHh-------------c----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            111             1    111123334455689999999999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=357.85  Aligned_cols=235  Identities=25%  Similarity=0.363  Sum_probs=185.3

Q ss_pred             ceEEEeeeC---C--cEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG---G--DFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~---~--~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |.||+|++.   +  ..||||+++.          ++.+|+++|++++||||++++|+|.+ +..++||||+++|+|.++
T Consensus        22 g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~  100 (273)
T d1u46a_          22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR  100 (273)
T ss_dssp             CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhh
Confidence            899999872   2  3789998853          35689999999999999999999965 467899999999999998


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccccc
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVG  506 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g  506 (635)
                      +.... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++................|
T Consensus       101 ~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~  176 (273)
T d1u46a_         101 LRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV  176 (273)
T ss_dssp             HHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred             hhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCcccc
Confidence            86543 2399999999999999999999994   4999999999999999999999999999977655444444455678


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      +..|+|||.+.+..++.++||||||+++|||+| |+.||...+...                  .+..+.........+.
T Consensus       177 ~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------------------~~~~i~~~~~~~~~~~  238 (273)
T d1u46a_         177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------------------ILHKIDKEGERLPRPE  238 (273)
T ss_dssp             CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------------------HHHHHHTSCCCCCCCT
T ss_pred             CcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------------------HHHHHHhCCCCCCCcc
Confidence            889999999999999999999999999999998 788875433221                  1111111122222334


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 042486          586 VTAILVIRLIESCLKKDPSGRPAMDKIAQSISRF  619 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  619 (635)
                      ..+..+.+|+.+||+.||++|||+.||++.|.+.
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            4456699999999999999999999999988764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=356.75  Aligned_cols=235  Identities=26%  Similarity=0.365  Sum_probs=179.2

Q ss_pred             ceEEEeeeC-----CcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKIG-----GDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~~-----~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |.||+|++.     +..||||+++.        .+.+|+++|++++||||++++|++. ++..++||||+++|+|.+++.
T Consensus        21 g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~   99 (273)
T d1mp8a_          21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ   99 (273)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhh
Confidence            899999872     34689998854        2568999999999999999999985 567899999999999999875


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ... ..+++..++.++.||+.||.|||+.+   ++||||||+||++++++.+||+|||+++.......  .......||+
T Consensus       100 ~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~--~~~~~~~gt~  173 (273)
T d1mp8a_         100 VRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPI  173 (273)
T ss_dssp             HTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------------------CCG
T ss_pred             ccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc--eeccceecCc
Confidence            443 34899999999999999999999954   99999999999999999999999999986543321  2234457899


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVT  587 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~  587 (635)
                      .|+|||.+.++.++.++|||||||++|||++ |..|+.......  +.                ..+... .....+...
T Consensus       174 ~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~----------------~~i~~~-~~~~~~~~~  234 (273)
T d1mp8a_         174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VI----------------GRIENG-ERLPMPPNC  234 (273)
T ss_dssp             GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH----------------HHHHTT-CCCCCCTTC
T ss_pred             ccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HH----------------HHHHcC-CCCCCCCCC
Confidence            9999999999999999999999999999998 777765433221  11                111111 111233445


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      +..+.+||.+||+.||++|||++||+++|++++++
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            56799999999999999999999999999998865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=364.34  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=189.5

Q ss_pred             CCCCCccc----ceEEEeee--CCc----EEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          354 FNPSCWIK----GSVYRGKI--GGD----FVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~--~~~----~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      |.....||    |+||+|++  +|+    .||+|+++.        ++.+|+++|++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            44444554    89999987  343    689998854        256899999999999999999999765 567888


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||+.+|+|.+++.... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        90 e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          90 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             ECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            9999999999886543 34999999999999999999999954   9999999999999999999999999998765433


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCchhhhhhh
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHL  574 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  574 (635)
                      .. .......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......  +...+                
T Consensus       166 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i----------------  226 (317)
T d1xkka_         166 KE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----------------  226 (317)
T ss_dssp             C---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHH----------------
T ss_pred             cc-ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----------------
Confidence            22 22334568999999999999999999999999999999999 666664332211  11111                


Q ss_pred             cCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          575 MDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       575 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                       ........|...+..+.+|+.+||+.||++|||+.||+++|.++....
T Consensus       227 -~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         227 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             -HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             -HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence             111112234445567899999999999999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-43  Score=362.45  Aligned_cols=235  Identities=25%  Similarity=0.342  Sum_probs=192.5

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      +|.....||    |.||+++.  +|+.||||+++.+          +.+|+.+|++++||||+++++++.+++..|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            444444554    89999997  7899999998532          4579999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      |+++|+|.+++.....  +++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        86 y~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-  159 (337)
T d1o6la_          86 YANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             CCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             ccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence            9999999999976543  899999999999999999999955   9999999999999999999999999998654322 


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  ..                .+..
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----------------~i~~  219 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----------------LILM  219 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----------------HHHH
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HH----------------HHhc
Confidence              123446899999999999999999999999999999999999999865433211  11                1111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      ..  ..+|...+..+.+||.+||+.||++||+     ++|+++|
T Consensus       220 ~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         220 EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11  1233444556899999999999999995     7888775

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-43  Score=354.90  Aligned_cols=239  Identities=20%  Similarity=0.276  Sum_probs=183.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHhhhccCCcccEEEEEecCC----eeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLNKINHSSLIRLLGICFNGG----NWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~  425 (635)
                      |.||+++.  +++.||||.++.+          +.+|+++|++++||||+++++++...+    ..|+||||+++|+|.+
T Consensus        21 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~  100 (277)
T d1o6ya_          21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  100 (277)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehh
Confidence            89999987  6899999998542          567999999999999999999998643    3799999999999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++...+  .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++..+++|||.+.................
T Consensus       101 ~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  175 (277)
T d1o6ya_         101 IVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI  175 (277)
T ss_dssp             HHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-------------
T ss_pred             hhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcccccccccccccc
Confidence            986554  3999999999999999999999854   99999999999999999999999999876544433333445568


Q ss_pred             cCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCCh
Q 042486          506 GTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPP  585 (635)
Q Consensus       506 gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~  585 (635)
                      ||+.|+|||++.+..+++++|||||||++|||+||+.||........ ....+...               +........
T Consensus       176 Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~---------------~~~~~~~~~  239 (277)
T d1o6ya_         176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED---------------PIPPSARHE  239 (277)
T ss_dssp             ---TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC---------------CCCGGGTSS
T ss_pred             CcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcC---------------CCCCchhcc
Confidence            99999999999999999999999999999999999999864333221 11111110               000001112


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHh
Q 042486          586 VTAILVIRLIESCLKKDPSGRP-AMDKIAQSISRFLN  621 (635)
Q Consensus       586 ~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~  621 (635)
                      ..+..+.+++.+||+.||++|| |++++++.|.++.+
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            2345689999999999999999 89999999998764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-43  Score=359.40  Aligned_cols=247  Identities=29%  Similarity=0.426  Sum_probs=194.4

Q ss_pred             CCCCCCccc----ceEEEeee--CCc--EEEEEEecc--------ChHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEe
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGD--FVAIKKVYG--------DASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~--~vavK~~~~--------~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      +|.....||    |.||+|++  ++.  .||||+++.        ++.+|+++|+++ +||||++++|+|.+++..++||
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~   90 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   90 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence            343344454    89999998  443  588888743        366899999999 7999999999999999999999


Q ss_pred             ecccCCCcchhhccc--------------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEE
Q 042486          416 ENAVNGSLSVWINDK--------------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAK  481 (635)
Q Consensus       416 E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  481 (635)
                      ||+++|+|.+++...              ....+++..+.+++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceE
Confidence            999999999999543              234599999999999999999999995   499999999999999999999


Q ss_pred             EeeecCcccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcc
Q 042486          482 IANFALARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPV  561 (635)
Q Consensus       482 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  561 (635)
                      |+|||+++.......    .....||..|+|||.+.++.++.++|||||||++|||++|..|+....... .+...+.  
T Consensus       168 l~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-~~~~~i~--  240 (309)
T d1fvra_         168 IADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLP--  240 (309)
T ss_dssp             ECCTTCEESSCEECC----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHGG--
T ss_pred             Ecccccccccccccc----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-HHHHHHH--
Confidence            999999976543321    233568999999999999999999999999999999999876543221111 1111111  


Q ss_pred             cccCCchhhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhcc
Q 042486          562 LHKEDGEESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNASL  624 (635)
Q Consensus       562 ~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s~  624 (635)
                                    . ......+...+..+.+||.+||+.||++||||+||+++|+++++...
T Consensus       241 --------------~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         241 --------------Q-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             --------------G-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             --------------h-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence                          1 11122334455679999999999999999999999999999986543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=357.63  Aligned_cols=229  Identities=25%  Similarity=0.335  Sum_probs=185.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |+||+|+.  +|+.||||+++.             .+.+|+++|++++|||||++++++.+++..|+||||+++|+|.++
T Consensus        24 g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~  103 (293)
T d1jksa_          24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF  103 (293)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccch
Confidence            89999997  689999998742             256899999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC----cEEEeeecCcccccccCCceeeec
Q 042486          427 INDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF----RAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       427 l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      +....  .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||+++......    ...
T Consensus       104 i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----~~~  174 (293)
T d1jksa_         104 LAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFK  174 (293)
T ss_dssp             HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC----BCS
T ss_pred             hcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc----ccc
Confidence            96654  3999999999999999999999955   99999999999998776    59999999998664332    123


Q ss_pred             ccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCC
Q 042486          503 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGN  582 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~  582 (635)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........ +........               .....
T Consensus       175 ~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~---------------~~~~~  238 (293)
T d1jksa_         175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNY---------------EFEDE  238 (293)
T ss_dssp             CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTCC---------------CCCHH
T ss_pred             ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCC---------------CCCch
Confidence            45789999999999999999999999999999999999999864332221 111111000               00000


Q ss_pred             CChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          583 YPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       583 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+...+..+.+||.+||+.||++|||++|+++|
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111234458899999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.5e-43  Score=364.91  Aligned_cols=230  Identities=24%  Similarity=0.277  Sum_probs=188.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC-------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD-------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~-------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |.||+++.  +|+.||||+++..       +.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++.... 
T Consensus        43 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-  121 (352)
T d1koba_          43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-  121 (352)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-
T ss_pred             eEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-
Confidence            89999987  7899999998643       4579999999999999999999999999999999999999998876543 


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC--CCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD--TDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ..+++.++..|+.||+.||+|||+.+   |+||||||+|||++  .++.+||+|||+++......    ......||+.|
T Consensus       122 ~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y  194 (352)
T d1koba_         122 YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEF  194 (352)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC----ceeeccCcccc
Confidence            33999999999999999999999855   99999999999997  67899999999998765432    22345799999


Q ss_pred             cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHH
Q 042486          511 MAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAIL  590 (635)
Q Consensus       511 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~  590 (635)
                      +|||++.+..++.++|||||||++|||+||+.||........ +......               +...........+..
T Consensus       195 ~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~---------------~~~~~~~~~~~~s~~  258 (352)
T d1koba_         195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRC---------------DWEFDEDAFSSVSPE  258 (352)
T ss_dssp             CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHC---------------CCCCCSSTTTTSCHH
T ss_pred             cCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC---------------CCCCCcccccCCCHH
Confidence            999999999999999999999999999999999864333211 1111110               111111222334556


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          591 VIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       591 l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +.+||.+||+.||++|||++|+++|
T Consensus       259 ~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         259 AKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            8999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-43  Score=359.33  Aligned_cols=241  Identities=24%  Similarity=0.409  Sum_probs=195.7

Q ss_pred             ceEEEeee-------CCcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI-------GGDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~-------~~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      |.||+|++       +++.||||+++.+        +.+|+.+++++ +|||||+++|+|.+++..++||||+++|+|.+
T Consensus        37 g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~  116 (311)
T d1t46a_          37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (311)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             eEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHH
Confidence            89999975       3468999999652        56799999999 79999999999999999999999999999999


Q ss_pred             hhcccC----------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          426 WINDKG----------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       426 ~l~~~~----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      ++....                ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.+|++|||+++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~  193 (311)
T d1t46a_         117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR  193 (311)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchhe
Confidence            985432                225899999999999999999999954   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchh
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEE  569 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  569 (635)
                      ....... ........||+.|+|||.+.++.++.++|||||||++|||+|++.|+.........+..             
T Consensus       194 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~-------------  259 (311)
T d1t46a_         194 DIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK-------------  259 (311)
T ss_dssp             CTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH-------------
T ss_pred             eccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH-------------
Confidence            7654432 23445578999999999999999999999999999999999966555432222111111             


Q ss_pred             hhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          570 SLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       570 ~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                          ++........+...+..+.+||.+||+.||++|||++||++.|++.+.++
T Consensus       260 ----~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         260 ----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             ----HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence                11112222333444566999999999999999999999999999988765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-42  Score=358.11  Aligned_cols=223  Identities=23%  Similarity=0.370  Sum_probs=186.5

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIND  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  429 (635)
                      |+||+++.  +|+.||||+++.          .+.+|+.+|++++||||+++++++.+++..|+||||++||+|..++..
T Consensus        18 g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~   97 (316)
T d1fota_          18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK   97 (316)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc
Confidence            79999987  689999999853          245799999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ...  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....      .....||+.
T Consensus        98 ~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~------~~~~~Gt~~  166 (316)
T d1fota_          98 SQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPD  166 (316)
T ss_dssp             TSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCCCCSCTT
T ss_pred             ccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc------cccccCccc
Confidence            543  78899999999999999999985   4999999999999999999999999999866432      234689999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAI  589 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~  589 (635)
                      |||||++.+..++.++|||||||++|||++|+.||...+...                  ....+....  ...|...+.
T Consensus       167 Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------------------~~~~i~~~~--~~~p~~~s~  226 (316)
T d1fota_         167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------------------TYEKILNAE--LRFPPFFNE  226 (316)
T ss_dssp             TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------------------HHHHHHHCC--CCCCTTSCH
T ss_pred             ccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------------------HHHHHHcCC--CCCCCCCCH
Confidence            999999999999999999999999999999999986432221                  111111111  122334455


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          590 LVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       590 ~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      .+.+++.+||+.||.+|+     |++|+++|
T Consensus       227 ~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            689999999999999996     89999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=356.02  Aligned_cols=239  Identities=25%  Similarity=0.383  Sum_probs=189.8

Q ss_pred             ceEEEeeeC---C--cEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEec-CCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKIG---G--DFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFN-GGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~~---~--~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |+||+|++.   +  ..||||+++.        ++.+|+++|++++||||++++|++.+ ++..++||||+++|+|.+++
T Consensus        41 g~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~  120 (311)
T d1r0pa_          41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  120 (311)
T ss_dssp             EEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhh
Confidence            899999972   1  2699999863        36789999999999999999999875 56889999999999999998


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeeeccccc
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALTSHIVG  506 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~g  506 (635)
                      ..... .+++..+++++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++........ ........|
T Consensus       121 ~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~g  196 (311)
T d1r0pa_         121 RNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL  196 (311)
T ss_dssp             HCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSC
T ss_pred             ccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccc
Confidence            65443 378899999999999999999984   4999999999999999999999999999876543221 112233578


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChH
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPV  586 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~  586 (635)
                      |..|+|||.+..+.++.++||||||+++|||+||+.||........ ....                +... .....|..
T Consensus       197 t~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~----------------i~~g-~~~~~p~~  258 (311)
T d1r0pa_         197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVY----------------LLQG-RRLLQPEY  258 (311)
T ss_dssp             CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----------------HHTT-CCCCCCTT
T ss_pred             cccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHH----------------HHcC-CCCCCccc
Confidence            9999999999999999999999999999999998888753222111 1111                0110 01122333


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          587 TAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       587 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .+..+.+|+.+||+.||++||++.||+++|+++++.
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            445689999999999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=352.63  Aligned_cols=238  Identities=27%  Similarity=0.424  Sum_probs=191.1

Q ss_pred             ceEEEeeeC---------CcEEEEEEeccC--------hHHHHHHHhhh-ccCCcccEEEEEecCCeeEEEeecccCCCc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYGD--------ASDQIKLLNKI-NHSSLIRLLGICFNGGNWYLVYENAVNGSL  423 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~~--------~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL  423 (635)
                      |.||+|+..         +..||||+++.+        +.+|...+.++ +||||++++++|.+++..++||||+++|+|
T Consensus        27 g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l  106 (299)
T d1fgka_          27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  106 (299)
T ss_dssp             -CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             cEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcH
Confidence            899999862         237999998654        34678888888 899999999999999999999999999999


Q ss_pred             chhhcccC--------------CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          424 SVWINDKG--------------GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       424 ~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .+++....              ...+++.+++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       107 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~  183 (299)
T d1fgka_         107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR  183 (299)
T ss_dssp             HHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred             HHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhc
Confidence            99995432              235899999999999999999999955   9999999999999999999999999998


Q ss_pred             cccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcchhhHHHHhhhcccccCCch
Q 042486          490 PAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLS-GKEAPALYSEENMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       490 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  568 (635)
                      ........ .......+|+.|+|||.+.++.++.++||||||+++|||++ |..||......  .....+.         
T Consensus       184 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~~~~i~---------  251 (299)
T d1fgka_         184 DIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELFKLLK---------  251 (299)
T ss_dssp             CGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHH---------
T ss_pred             cccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HHHHHHH---------
Confidence            76544322 23345678999999999999999999999999999999998 56665432221  1111111         


Q ss_pred             hhhhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          569 ESLRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       569 ~~l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                              .......+...+..+.+|+.+||+.||++|||+.||++.|++++.-
T Consensus       252 --------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         252 --------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             --------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                    1111223334455699999999999999999999999999999764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.9e-42  Score=347.32  Aligned_cols=229  Identities=22%  Similarity=0.282  Sum_probs=186.6

Q ss_pred             ceEEEeee--CCcEEEEEEecc----------------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG----------------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~----------------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gs  422 (635)
                      |+||+++.  +++.||||++..                .+.+|+.+|++++ ||||+++++++.+++..||||||+++|+
T Consensus        17 g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~   96 (277)
T d1phka_          17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE   96 (277)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCch
Confidence            89999987  789999999743                2557999999997 9999999999999999999999999999


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeec
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      |.+++....  .+++.++..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++......    ...
T Consensus        97 L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~  167 (277)
T d1phka_          97 LFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLR  167 (277)
T ss_dssp             HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----CBC
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCC----cee
Confidence            999997654  3999999999999999999999855   9999999999999999999999999998765432    123


Q ss_pred             ccccCCCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          503 HIVGTKGYMAPEYLEN------GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                      ...||+.|+|||.+.+      ..++.++||||+||++|||++|+.||........ ........               
T Consensus       168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~i~~~~---------------  231 (277)
T d1phka_         168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGN---------------  231 (277)
T ss_dssp             CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTC---------------
T ss_pred             eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-HHHHHhCC---------------
Confidence            4679999999998853      4568899999999999999999999865432221 11111100               


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...........+..+.+|+.+||+.||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            011111223445668999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.9e-42  Score=360.05  Aligned_cols=236  Identities=22%  Similarity=0.313  Sum_probs=187.0

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEeccC----------hHH---HHHHHhhhccCCcccEEEEEecCCeeEE
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYGD----------ASD---QIKLLNKINHSSLIRLLGICFNGGNWYL  413 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~~----------~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~l  413 (635)
                      +|.....||    |.||+|+.  +|+.||||++...          +.+   |+.+++.++||||+++++++.+++..|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            444444554    89999997  6899999998532          223   4667777789999999999999999999


Q ss_pred             EeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccc
Q 042486          414 VYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAER  493 (635)
Q Consensus       414 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  493 (635)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 vmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999996654  3899999999999999999999955   99999999999999999999999999986543


Q ss_pred             cCCceeeecccccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhh
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLR  572 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  572 (635)
                      ..     .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.........               ....
T Consensus       160 ~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---------------~~~~  219 (364)
T d1omwa3         160 KK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------------EIDR  219 (364)
T ss_dssp             SC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---------------HHHH
T ss_pred             Cc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHH
Confidence            32     234579999999999875 56899999999999999999999998643322211               0111


Q ss_pred             hhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          573 HLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       573 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .....  ....+...+..+.+||.+||+.||++|||     ++|+++|
T Consensus       220 ~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         220 MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             HSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             hcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            11111  11223334556899999999999999999     6888876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=356.25  Aligned_cols=240  Identities=25%  Similarity=0.417  Sum_probs=193.1

Q ss_pred             ceEEEeeeC-------CcEEEEEEeccC--------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchh
Q 042486          362 GSVYRGKIG-------GDFVAIKKVYGD--------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVW  426 (635)
Q Consensus       362 g~Vy~g~~~-------~~~vavK~~~~~--------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~  426 (635)
                      |+||+|++.       +..||||+++..        +.+|++++++++||||++++|+|..++..++||||+++|+|.++
T Consensus        34 G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~  113 (308)
T d1p4oa_          34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY  113 (308)
T ss_dssp             SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHH
Confidence            899999873       468999999652        56899999999999999999999999999999999999999998


Q ss_pred             hccc--------CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCce
Q 042486          427 INDK--------GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEF  498 (635)
Q Consensus       427 l~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +...        ....+++..+.+++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++....... .
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~-~  189 (308)
T d1p4oa_         114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-Y  189 (308)
T ss_dssp             HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-E
T ss_pred             HHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcc-e
Confidence            8432        123479999999999999999999995   499999999999999999999999999986654332 2


Q ss_pred             eeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCc
Q 042486          499 ALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPS  578 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  578 (635)
                      .......+|+.|+|||.+.++.++.++||||||+++|||+||+.++.......                 +.+..+.+..
T Consensus       190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-----------------~~~~~i~~~~  252 (308)
T d1p4oa_         190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----------------QVLRFVMEGG  252 (308)
T ss_dssp             EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----------------HHHHHHHTTC
T ss_pred             eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHhCC
Confidence            22344578999999999999999999999999999999999965443211111                 1122222221


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc
Q 042486          579 MQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS  623 (635)
Q Consensus       579 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s  623 (635)
                      . ...+...+..+.+++.+||+.||++|||++||+++|++.++..
T Consensus       253 ~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         253 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             C-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            1 1223444566999999999999999999999999998876643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=355.56  Aligned_cols=233  Identities=20%  Similarity=0.260  Sum_probs=185.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc--ChHHHHHHHhhh-ccCCcccEEEEEec----CCeeEEEeecccCCCcchhhcccCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--DASDQIKLLNKI-NHSSLIRLLGICFN----GGNWYLVYENAVNGSLSVWINDKGG  432 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  432 (635)
                      |+||+|+.  +++.||||+++.  .+.+|++++.++ +||||+++++++.+    +...|+||||++||+|.+++.....
T Consensus        26 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~  105 (335)
T d2ozaa1          26 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD  105 (335)
T ss_dssp             CEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC
T ss_pred             eEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC
Confidence            89999987  689999999965  466899987766 89999999999875    4568999999999999999976655


Q ss_pred             CCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC---CCcEEEeeecCcccccccCCceeeecccccCCC
Q 042486          433 KFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT---DFRAKIANFALARPAERQEGEFALTSHIVGTKG  509 (635)
Q Consensus       433 ~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  509 (635)
                      ..+++.++..|+.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++......    ......||+.
T Consensus       106 ~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~  178 (335)
T d2ozaa1         106 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPY  178 (335)
T ss_dssp             CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCS
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC----ccccccCCcc
Confidence            66999999999999999999999855   999999999999975   5679999999998654432    1234679999


Q ss_pred             ccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCC--CCCChHH
Q 042486          510 YMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQ--GNYPPVT  587 (635)
Q Consensus       510 y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~--~~~~~~~  587 (635)
                      |||||++.+..++.++|||||||++|||+||+.||........  ...+            ...+......  .......
T Consensus       179 y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~------------~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGM------------KTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             SCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------------CCCSCSSSCCTTHHHHS
T ss_pred             cCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHH------------HHHHhcCCCCCCCcccccC
Confidence            9999999999999999999999999999999999854322110  0000            0001111111  1111234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          588 AILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       588 ~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      +..+.+||.+||+.||++|||+.|+++|
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            5668999999999999999999999886

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-42  Score=356.85  Aligned_cols=232  Identities=21%  Similarity=0.299  Sum_probs=191.0

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc----------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEee
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYE  416 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E  416 (635)
                      +|.....||    |.||+++.  +|+.||||++..          .+.+|+++|++++||||+++++++.+.+..++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            455555555    89999987  689999999853          24589999999999999999999999999999999


Q ss_pred             cccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCC
Q 042486          417 NAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEG  496 (635)
Q Consensus       417 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  496 (635)
                      |+.+|+|.+++.....  +++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       122 ~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999966543  999999999999999999999955   999999999999999999999999999866432  


Q ss_pred             ceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC
Q 042486          497 EFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD  576 (635)
Q Consensus       497 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  576 (635)
                          .....||+.|||||++.+..++.++|||||||++|||+||+.||...+... .+.                 .+..
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~-----------------~i~~  252 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYE-----------------KIVS  252 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHH-----------------HHHH
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHH-----------------HHhc
Confidence                223679999999999999999999999999999999999999986432211 111                 1111


Q ss_pred             CcCCCCCChHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 042486          577 PSMQGNYPPVTAILVIRLIESCLKKDPSGRP-----AMDKIAQS  615 (635)
Q Consensus       577 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  615 (635)
                      ..  ...+...+..+.+|+.+||+.||.+|+     |++|+++|
T Consensus       253 ~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            11  112333455689999999999999994     89999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=348.30  Aligned_cols=244  Identities=25%  Similarity=0.302  Sum_probs=183.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc------------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG------------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~------------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  427 (635)
                      |+||+|+.  +|+.||||+++.            .+.+|+++|++++||||+++++++.+++..|+||||+.++++..+.
T Consensus        12 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~   91 (299)
T d1ua2a_          12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK   91 (299)
T ss_dssp             EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh
Confidence            89999987  689999998742            2558999999999999999999999999999999999988777666


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......   ......||
T Consensus        92 ~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~---~~~~~~gt  163 (299)
T d1ua2a_          92 DNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYTHQVVT  163 (299)
T ss_dssp             TCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---CCCCSCCC
T ss_pred             hcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc---cccceecC
Confidence            433  34899999999999999999999955   99999999999999999999999999986544321   22345799


Q ss_pred             CCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCc-----hhhhhhhcCCcCCC
Q 042486          508 KGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDG-----EESLRHLMDPSMQG  581 (635)
Q Consensus       508 ~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----~~~l~~~~d~~~~~  581 (635)
                      +.|+|||++.. ..++.++|||||||++|||++|+.||....+.+. +..... .......     .........-....
T Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-HHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             hhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHH-hcCCCChhhccchhccchhhhhccCC
Confidence            99999998865 4579999999999999999999988865443321 111111 1100000     00000000000000


Q ss_pred             CCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 NYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+     ...+..+.+|+.+||+.||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            011     1224568999999999999999999999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=350.76  Aligned_cols=230  Identities=21%  Similarity=0.252  Sum_probs=185.9

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |+||+|..  +++.||||.++.+      +.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++.... .
T Consensus        19 g~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~   97 (321)
T d1tkia_          19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-F   97 (321)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-C
T ss_pred             eEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-C
Confidence            89999987  6889999998653      5589999999999999999999999999999999999999999996543 2


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC--CCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT--DFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                      .+++.++..|+.||+.||+|||+.+   |+||||||+|||++.  ...+||+|||+++......    ......+|+.|+
T Consensus        98 ~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~~~~~~t~~y~  170 (321)
T d1tkia_          98 ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYY  170 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC----cccccccccccc
Confidence            3899999999999999999999855   999999999999975  4589999999998654332    223457899999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHHHHH
Q 042486          512 APEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTAILV  591 (635)
Q Consensus       512 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~~~l  591 (635)
                      |||.+.+..++.++|||||||++|||++|+.||....... .+.......+.               .........+..+
T Consensus       171 ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~---------------~~~~~~~~~s~~~  234 (321)
T d1tkia_         171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT---------------FDEEAFKEISIEA  234 (321)
T ss_dssp             CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC---------------CCHHHHTTSCHHH
T ss_pred             cchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---------------CChhhccCCCHHH
Confidence            9999999999999999999999999999999986543321 11111111000               0000001124458


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          592 IRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       592 ~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .+|+.+||..||++|||++|+++|
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-42  Score=352.49  Aligned_cols=226  Identities=28%  Similarity=0.386  Sum_probs=184.5

Q ss_pred             ceEEEeee--CCcEEEEEEeccC----------hHHHHHHHh-hhccCCcccEEEEEecCCeeEEEeecccCCCcchhhc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD----------ASDQIKLLN-KINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWIN  428 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~----------~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  428 (635)
                      |+||+|+.  +++.||||+++.+          +..|..++. .++||||+++++++.+++..|+||||+++|+|.+++.
T Consensus        16 g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~   95 (320)
T d1xjda_          16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ   95 (320)
T ss_dssp             SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh
Confidence            89999998  7899999998532          345666655 6899999999999999999999999999999999997


Q ss_pred             ccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCC
Q 042486          429 DKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       429 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      ....  +++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......   .......||+
T Consensus        96 ~~~~--~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~  167 (320)
T d1xjda_          96 SCHK--FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNTFCGTP  167 (320)
T ss_dssp             HHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBCCCCSCG
T ss_pred             ccCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc---ccccccCCCC
Confidence            6543  899999999999999999999955   9999999999999999999999999998654332   2234467999


Q ss_pred             CccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCCCCChHHH
Q 042486          509 GYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQGNYPPVTA  588 (635)
Q Consensus       509 ~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~~~~~  588 (635)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+...  +...                +...  ....|...+
T Consensus       168 ~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~----------------i~~~--~~~~p~~~s  227 (320)
T d1xjda_         168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHS----------------IRMD--NPFYPRWLE  227 (320)
T ss_dssp             GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----------------HHHC--CCCCCTTSC
T ss_pred             CcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHH----------------HHcC--CCCCCccCC
Confidence            9999999999999999999999999999999999986433221  1111                1000  012233445


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 042486          589 ILVIRLIESCLKKDPSGRPAMD-KIAQS  615 (635)
Q Consensus       589 ~~l~~li~~cl~~dP~~RPs~~-evl~~  615 (635)
                      ..+.+|+.+||+.||++||++. |+++|
T Consensus       228 ~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         228 KEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            5689999999999999999995 77653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-41  Score=343.66  Aligned_cols=246  Identities=26%  Similarity=0.344  Sum_probs=183.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||+|+.  +++.||||+++.         .+.+|+++|++++||||+++++++.+++..|+||||+.+ ++.+++...
T Consensus        16 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~   94 (298)
T d1gz8a_          16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS   94 (298)
T ss_dssp             SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhh
Confidence            89999987  689999999843         356899999999999999999999999999999999975 444555444


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+.|
T Consensus        95 ~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~~y  168 (298)
T d1gz8a_          95 ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWY  168 (298)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---BCTTCCBCCCTT
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc---ccceeeccccee
Confidence            4455999999999999999999999955   9999999999999999999999999997654322   223345799999


Q ss_pred             cCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc-CCchhhhhhhcC--CcCCC-CC--
Q 042486          511 MAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK-EDGEESLRHLMD--PSMQG-NY--  583 (635)
Q Consensus       511 ~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~l~~~~d--~~~~~-~~--  583 (635)
                      +|||.+.... ++.++|||||||++|+|++|+.||...+... .+.......... +..........+  ..... ..  
T Consensus       169 ~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T d1gz8a_         169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD  247 (298)
T ss_dssp             CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCC
T ss_pred             eehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccccccccccccccccc
Confidence            9999876654 5889999999999999999999987544332 111111111000 000000111000  00000 00  


Q ss_pred             ----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          584 ----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       584 ----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ....+..+.+|+.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                01223568899999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-41  Score=340.15  Aligned_cols=218  Identities=25%  Similarity=0.354  Sum_probs=178.0

Q ss_pred             ceEEEeee--CCcEEEEEEecc-------------ChHHHHHHHhhhc--cCCcccEEEEEecCCeeEEEeecccC-CCc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-------------DASDQIKLLNKIN--HSSLIRLLGICFNGGNWYLVYENAVN-GSL  423 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-------------~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~E~~~~-gsL  423 (635)
                      |+||+|+.  +|+.||||+++.             .+.+|+.+|++++  ||||+++++++.+++..++||||+.+ +++
T Consensus        18 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l   97 (273)
T d1xwsa_          18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL   97 (273)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchH
Confidence            89999997  689999998853             2468999999997  89999999999999999999999976 577


Q ss_pred             chhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-CCcEEEeeecCcccccccCCceeeec
Q 042486          424 SVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-DFRAKIANFALARPAERQEGEFALTS  502 (635)
Q Consensus       424 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~  502 (635)
                      .+++....  .+++.++..++.||+.||+|||+.   +|+||||||+|||++. ++.+||+|||+++......     ..
T Consensus        98 ~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~-----~~  167 (273)
T d1xwsa_          98 FDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YT  167 (273)
T ss_dssp             HHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC-----BC
T ss_pred             HHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceeccccc-----cc
Confidence            77775543  399999999999999999999985   4999999999999985 4799999999997654321     23


Q ss_pred             ccccCCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcCCcCCC
Q 042486          503 HIVGTKGYMAPEYLENGLV-STKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMDPSMQG  581 (635)
Q Consensus       503 ~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~~~~  581 (635)
                      ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+.       ....               ..    
T Consensus       168 ~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~~---------------~~----  221 (273)
T d1xwsa_         168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRG---------------QV----  221 (273)
T ss_dssp             CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHC---------------CC----
T ss_pred             ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------Hhhc---------------cc----
Confidence            4679999999999987654 6779999999999999999999853210       0000               00    


Q ss_pred             CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          582 NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       582 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ..+...+..+.+|+.+||+.||++|||++|++++
T Consensus       222 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1122234558999999999999999999999876

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-40  Score=337.07  Aligned_cols=255  Identities=24%  Similarity=0.331  Sum_probs=185.6

Q ss_pred             cCCCCCCccc----ceEEEeee---CCcEEEEEEecc---------ChHHHHHHHhhh---ccCCcccEEEEEec-----
Q 042486          352 DDFNPSCWIK----GSVYRGKI---GGDFVAIKKVYG---------DASDQIKLLNKI---NHSSLIRLLGICFN-----  407 (635)
Q Consensus       352 ~~f~~~~~ig----g~Vy~g~~---~~~~vavK~~~~---------~~~~E~~~l~~l---~h~nIv~l~~~~~~-----  407 (635)
                      ++|.....||    |+||+++.   +++.||||+++.         .+.+|+.+|+++   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            3444444554    89999986   366899998743         345788888776   79999999999863     


Q ss_pred             CCeeEEEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecC
Q 042486          408 GGNWYLVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFAL  487 (635)
Q Consensus       408 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  487 (635)
                      +...+++|||+.++.+...... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence            3467999999988776555433 3344899999999999999999999955   99999999999999999999999999


Q ss_pred             cccccccCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccc---cc
Q 042486          488 ARPAERQEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVL---HK  564 (635)
Q Consensus       488 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~  564 (635)
                      ++......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.... +........   ..
T Consensus       163 ~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~  237 (305)
T d1blxa_         163 ARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE  237 (305)
T ss_dssp             CCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred             hhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchh
Confidence            88654332    22346799999999999999999999999999999999999999875443321 111111000   00


Q ss_pred             CC-chhhh-hhhc---CCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          565 ED-GEESL-RHLM---DPSMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       565 ~~-~~~~l-~~~~---d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .. ..... ....   ............+..+.+|+.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00 00000 0000   0000111222344568899999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-40  Score=334.44  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=182.0

Q ss_pred             ceEEEeee-CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhcccC
Q 042486          362 GSVYRGKI-GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKG  431 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~  431 (635)
                      |+||+|+. +|+.||||+++.         .+.+|+.+|++++||||+++++++.+++..+++|||+.++.+..+.... 
T Consensus        16 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~-   94 (286)
T d1ob3a_          16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-   94 (286)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-
T ss_pred             cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc-
Confidence            89999998 689999999854         2568999999999999999999999999999999999887776666543 


Q ss_pred             CCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCcc
Q 042486          432 GKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGYM  511 (635)
Q Consensus       432 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  511 (635)
                       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||.+.......   .......+++.|+
T Consensus        95 -~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~~y~  167 (286)
T d1ob3a_          95 -GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYR  167 (286)
T ss_dssp             -TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTTC
T ss_pred             -CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc---cccceecccchhh
Confidence             34999999999999999999999855   9999999999999999999999999997654332   1223356899999


Q ss_pred             Ccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccc---cC-Cchhhhhhhc------CCcCC
Q 042486          512 APEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLH---KE-DGEESLRHLM------DPSMQ  580 (635)
Q Consensus       512 aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~-~~~~~l~~~~------d~~~~  580 (635)
                      |||.+.+ ..++.++|||||||++|||++|+.||......+. +.........   .. ..........      .+...
T Consensus       168 ~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (286)
T d1ob3a_         168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW  246 (286)
T ss_dssp             CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCG
T ss_pred             hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcccccccccCcch
Confidence            9999875 4569999999999999999999999865433221 1111110000   00 0000000000      00000


Q ss_pred             CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          581 GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       581 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .......+..+.+|+++||+.||++|||++|+++|
T Consensus       247 ~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122334568999999999999999999999865

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=340.16  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=180.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---hHHHHHHHhhhccCCcccEEEEEecC------CeeEEEeecccCCCcchhhc-c
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---ASDQIKLLNKINHSSLIRLLGICFNG------GNWYLVYENAVNGSLSVWIN-D  429 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~-~  429 (635)
                      |+||+|+.  +|+.||||+++.+   ..+|+++|++++|+||+++++++...      ...+|||||++++.+..+.. .
T Consensus        34 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~  113 (350)
T d1q5ka_          34 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS  113 (350)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhh
Confidence            89999998  6899999998653   56899999999999999999998642      34689999998764444332 1


Q ss_pred             cCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCceeeecccccCC
Q 042486          430 KGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEFALTSHIVGTK  508 (635)
Q Consensus       430 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~  508 (635)
                      .....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+++.......    .....||.
T Consensus       114 ~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~----~~~~~gt~  186 (350)
T d1q5ka_         114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSR  186 (350)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC----CCSCCSCT
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc----cccccccc
Confidence            23345999999999999999999999854   99999999999999775 899999999986544321    23357999


Q ss_pred             CccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhhhhhhcC----CcC----
Q 042486          509 GYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEESLRHLMD----PSM----  579 (635)
Q Consensus       509 ~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d----~~~----  579 (635)
                      .|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .+...... .... ..+.+.....    ...    
T Consensus       187 ~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~-~g~~-~~~~~~~~~~~~~~~~~~~~~  263 (350)
T d1q5ka_         187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKV-LGTP-TREQIREMNPNYTEFKFPQIK  263 (350)
T ss_dssp             TSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHH-HCCC-CHHHHHHHCC---CCCCCCCC
T ss_pred             cccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHH-hCCC-hHHhhhhhccchhhccccccc
Confidence            9999998764 568999999999999999999999986544332 11111111 1110 0111111110    000    


Q ss_pred             ----CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 ----QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                          ........+..+.+|+.+||+.||++|||+.|+++|
T Consensus       264 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         264 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                001122344568999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-38  Score=324.00  Aligned_cols=243  Identities=16%  Similarity=0.168  Sum_probs=189.8

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhcc-CCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINH-SSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|+.  +|+.||||.+..     .+.+|++.+++++| +|++.+++++..+...++||||+ +++|.+++.... .
T Consensus        19 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~-~   96 (293)
T d1csna_          19 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-R   96 (293)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-T
T ss_pred             eEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc-c
Confidence            89999987  689999998743     36789999999975 89999999999999999999998 689999886544 3


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECC-----CCcEEEeeecCcccccccCCc----eeeeccc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDT-----DFRAKIANFALARPAERQEGE----FALTSHI  504 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~  504 (635)
                      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+++........    .......
T Consensus        97 ~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~  173 (293)
T d1csna_          97 KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL  173 (293)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCce
Confidence            4899999999999999999999855   999999999999964     578999999999875433211    1123446


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH-HHHhhhcccccCCchhhhhhhcCCcCCCCC
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML-LVDVLNPVLHKEDGEESLRHLMDPSMQGNY  583 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~l~~~~d~~~~~~~  583 (635)
                      .||+.|||||.+.+..+++++||||||+++|||+||+.||......... ....+.......    ...+     +....
T Consensus       174 ~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~----~~~~-----l~~~~  244 (293)
T d1csna_         174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----PLRE-----LCAGF  244 (293)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS----CHHH-----HTTTS
T ss_pred             EEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC----ChHH-----hcCCC
Confidence            7999999999999999999999999999999999999999643332111 111110000000    0000     11223


Q ss_pred             ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          584 PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       584 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      |    ..+.+++..|+..+|++||+++.+.+.|++++..
T Consensus       245 p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         245 P----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             C----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             C----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            3    4588999999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-38  Score=328.90  Aligned_cols=246  Identities=23%  Similarity=0.299  Sum_probs=182.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------ChHHHHHHHhhhccCCcccEEEEEecCC----eeEEEeecccCCCcchhh
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------DASDQIKLLNKINHSSLIRLLGICFNGG----NWYLVYENAVNGSLSVWI  427 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l  427 (635)
                      |+||+|+.  +|+.||||+++.        .+.+|+++|++++||||+++++++....    ..+++++|+.+|+|.+++
T Consensus        22 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l  101 (345)
T d1pmea_          22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL  101 (345)
T ss_dssp             CCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhh
Confidence            89999987  699999999863        2457999999999999999999997543    234555667799999999


Q ss_pred             cccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccC
Q 042486          428 NDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGT  507 (635)
Q Consensus       428 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt  507 (635)
                      ...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++................||
T Consensus       102 ~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt  175 (345)
T d1pmea_         102 KTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT  175 (345)
T ss_dssp             HHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSC
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecccccc
Confidence            653   3999999999999999999999955   9999999999999999999999999998665443333334556799


Q ss_pred             CCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCch--------hhhhhhcCCc
Q 042486          508 KGYMAPEYLE-NGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGE--------ESLRHLMDPS  578 (635)
Q Consensus       508 ~~y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------~~l~~~~d~~  578 (635)
                      +.|+|||.+. ...++.++||||+||++|||++|+.||...+..+.....  ..........        ..........
T Consensus       176 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (345)
T d1pmea_         176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI--LGILGSPSQEDLNCIINLKARNYLLSLP  253 (345)
T ss_dssp             GGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCSCCHHHHHTCCCHHHHHHHHTSC
T ss_pred             ceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH--hhhccCCChhhhhhhhhhhhhcccccCC
Confidence            9999999985 456789999999999999999999998654332211110  0000000000        0000000000


Q ss_pred             CCCCCC-----hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          579 MQGNYP-----PVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       579 ~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .....+     ...+..+.+|+.+||+.||++|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         254 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000111     1123458899999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-38  Score=326.71  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=177.1

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEec--------CCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFN--------GGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~lV~E~~~~gs  422 (635)
                      |+||+|+.  +|+.||||++..         ++.+|+++|++++|+||+++++++..        ++..++||||+.++.
T Consensus        24 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~  103 (318)
T d3blha1          24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL  103 (318)
T ss_dssp             SEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEH
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCc
Confidence            89999997  689999998743         25689999999999999999999865        345799999998877


Q ss_pred             cchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCc-eeee
Q 042486          423 LSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGE-FALT  501 (635)
Q Consensus       423 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  501 (635)
                      +..+....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ ....
T Consensus       104 ~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~  178 (318)
T d3blha1         104 AGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY  178 (318)
T ss_dssp             HHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCC
T ss_pred             cchhhhcc--cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccc
Confidence            76555433  33899999999999999999999854   999999999999999999999999999765432211 1122


Q ss_pred             cccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhH--HHHhhhcccccCC---chhhhhhhc
Q 042486          502 SHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENML--LVDVLNPVLHKED---GEESLRHLM  575 (635)
Q Consensus       502 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~---~~~~l~~~~  575 (635)
                      ....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........  .............   .........
T Consensus       179 ~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T d3blha1         179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL  258 (318)
T ss_dssp             CSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC------
T ss_pred             cceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhh
Confidence            335799999999998754 6899999999999999999999998654332211  1111111100000   000000000


Q ss_pred             CCcCCCCCCh-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          576 DPSMQGNYPP-------VTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       576 d~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ........+.       .....+.+|+.+||+.||++|||++|+++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         259 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             -CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0000001111       012346789999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-38  Score=322.51  Aligned_cols=250  Identities=16%  Similarity=0.169  Sum_probs=185.3

Q ss_pred             ceEEEeee--CCcEEEEEEecc-----ChHHHHHHHhhhccCCcccE-EEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG-----DASDQIKLLNKINHSSLIRL-LGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~-----~~~~E~~~l~~l~h~nIv~l-~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      |.||+|+.  +|+.||||.+..     ++..|++++++++|+|++.. .+++.+++..++||||+ +++|.+.+.... .
T Consensus        21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~-~   98 (299)
T d1ckia_          21 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-R   98 (299)
T ss_dssp             SEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-T
T ss_pred             cEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhcc-C
Confidence            89999997  688999998643     56789999999987775555 55556778889999998 556666664333 3


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEEC---CCCcEEEeeecCcccccccCCc----eeeeccccc
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLD---TDFRAKIANFALARPAERQEGE----FALTSHIVG  506 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~g  506 (635)
                      .+++..+..++.|++.||+|||+.+   |+||||||+|||++   .+..+||+|||+++........    ........|
T Consensus        99 ~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~g  175 (299)
T d1ckia_          99 KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG  175 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCC
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCC
Confidence            4999999999999999999999955   99999999999985   4567999999999876543221    122344679


Q ss_pred             CCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHH--HHhhhcccccCCchhhhhhhcCCcCCCCCC
Q 042486          507 TKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLL--VDVLNPVLHKEDGEESLRHLMDPSMQGNYP  584 (635)
Q Consensus       507 t~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~~l~~~~d~~~~~~~~  584 (635)
                      |+.|||||.+.+..++.++|||||||++|||++|+.||..........  .........          ...+.+...  
T Consensus       176 t~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~--  243 (299)
T d1ckia_         176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----------TPIEVLCKG--  243 (299)
T ss_dssp             CSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH----------SCHHHHTTT--
T ss_pred             CccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC----------CChhHhccC--
Confidence            999999999999899999999999999999999999986543322111  000000000          000011112  


Q ss_pred             hHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhc-------ccccccc
Q 042486          585 PVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNAS-------LAWELSK  630 (635)
Q Consensus       585 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~s-------~~w~~~~  630 (635)
                        .+..+.+++..||+.||++||+++++.+.|+.++...       .||+..+
T Consensus       244 --~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~  294 (299)
T d1ckia_         244 --YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK  294 (299)
T ss_dssp             --SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred             --CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhc
Confidence              2345899999999999999999999999999886432       5676543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-38  Score=322.16  Aligned_cols=246  Identities=24%  Similarity=0.276  Sum_probs=186.4

Q ss_pred             ceEEEeee--CCcEEEEEEecc---------ChHHHHHHHhhhccCCcccEEEEEecCCeeEEEeecccCCCcchhhccc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG---------DASDQIKLLNKINHSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDK  430 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~  430 (635)
                      |+||+|+.  +++.||||+++.         .+.+|+.+|++++|+||+++++++.+.+..++|+|++.+++|..++...
T Consensus        16 g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~   95 (292)
T d1unla_          16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN   95 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccc
Confidence            89999997  788999999853         2458999999999999999999999999999999999999988887544


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccccCCCc
Q 042486          431 GGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIVGTKGY  510 (635)
Q Consensus       431 ~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  510 (635)
                      .  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.++.......   ......++..|
T Consensus        96 ~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~~~~  167 (292)
T d1unla_          96 G--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWY  167 (292)
T ss_dssp             T--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---CCCSCCSCGGG
T ss_pred             c--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc---cceeeccccch
Confidence            3  3899999999999999999999954   99999999999999999999999999986654321   22334677889


Q ss_pred             cCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC-CchhhhhhhcC---------CcC
Q 042486          511 MAPEYLENGL-VSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE-DGEESLRHLMD---------PSM  579 (635)
Q Consensus       511 ~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~~l~~~~d---------~~~  579 (635)
                      +|||.+.... ++.++|||||||++|||++|+.||....+................ ..........+         ...
T Consensus       168 ~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T d1unla_         168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS  247 (292)
T ss_dssp             CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC
T ss_pred             hhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccch
Confidence            9999887654 689999999999999999999997544333322221111110000 00000000000         000


Q ss_pred             CCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          580 QGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       580 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ........+..+.+|+.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111223345568899999999999999999999876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-37  Score=323.39  Aligned_cols=250  Identities=18%  Similarity=0.263  Sum_probs=185.2

Q ss_pred             CCCCCCccc----ceEEEeee--CCcEEEEEEecc----ChHHHHHHHhhhc-cCCcccEEEEEec--CCeeEEEeeccc
Q 042486          353 DFNPSCWIK----GSVYRGKI--GGDFVAIKKVYG----DASDQIKLLNKIN-HSSLIRLLGICFN--GGNWYLVYENAV  419 (635)
Q Consensus       353 ~f~~~~~ig----g~Vy~g~~--~~~~vavK~~~~----~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV~E~~~  419 (635)
                      +|.....||    |+||+|+.  +++.||||+++.    ++.+|+++|++++ ||||+++++++..  ....++||||+.
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~  115 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  115 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence            454444555    89999997  689999999865    3568999999995 9999999999974  356899999999


Q ss_pred             CCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC-cEEEeeecCcccccccCCce
Q 042486          420 NGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF-RAKIANFALARPAERQEGEF  498 (635)
Q Consensus       420 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~  498 (635)
                      +++|..+.+     .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+++.......  
T Consensus       116 ~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--  185 (328)
T d3bqca1         116 NTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--  185 (328)
T ss_dssp             SCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--
T ss_pred             CCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc--
Confidence            999987753     3899999999999999999999955   99999999999998654 699999999986554321  


Q ss_pred             eeecccccCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc-----------CC
Q 042486          499 ALTSHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK-----------ED  566 (635)
Q Consensus       499 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-----------~~  566 (635)
                        .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............... .+..           ..
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~-~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK-VLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH-HHCHHHHHHHHHHTTCC
T ss_pred             --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH-HHCCchhhhhhhhcccc
Confidence              2345789999999998764 4799999999999999999999998654433211111110 0000           00


Q ss_pred             chhhhhhhcCC--------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          567 GEESLRHLMDP--------SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       567 ~~~~l~~~~d~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ...........        ..........+..+.+||++||..||++|||++|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000000000        00111122344568999999999999999999999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-38  Score=329.39  Aligned_cols=240  Identities=25%  Similarity=0.350  Sum_probs=179.6

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecCC------eeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNGG------NWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~E~~~~gsL~  424 (635)
                      |+||+|+.  +|+.||||+++..         +.+|+++|++++|||||+++++|...+      +.|+||||+ +.+|.
T Consensus        32 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~  110 (346)
T d1cm8a_          32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG  110 (346)
T ss_dssp             -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHH
Confidence            89999987  6899999998642         457999999999999999999998654      469999999 56777


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      .+....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||+++......      ...
T Consensus       111 ~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~------~~~  178 (346)
T d1cm8a_         111 KLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGY  178 (346)
T ss_dssp             HHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC------CSS
T ss_pred             HHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc------ccc
Confidence            776543   3999999999999999999999955   9999999999999999999999999998654322      345


Q ss_pred             ccCCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc---------CCchhhhhhh
Q 042486          505 VGTKGYMAPEYLEN-GLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK---------EDGEESLRHL  574 (635)
Q Consensus       505 ~gt~~y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---------~~~~~~l~~~  574 (635)
                      .||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.... +..........         ..........
T Consensus       179 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (346)
T d1cm8a_         179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRLQSDEAKNYMKG  257 (346)
T ss_dssp             CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred             cccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhhhcchhhhhhhcc
Confidence            79999999999875 4578999999999999999999999865433221 11111000000         0000000000


Q ss_pred             cCCcCC---CCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          575 MDPSMQ---GNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       575 ~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      ......   .......+..+.+|+.+||..||++|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000   01112234557899999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-38  Score=325.39  Aligned_cols=239  Identities=24%  Similarity=0.347  Sum_probs=186.5

Q ss_pred             CCCCCccc----ceEEEeee-----CCcEEEEEEecc-----------ChHHHHHHHhhhcc-CCcccEEEEEecCCeeE
Q 042486          354 FNPSCWIK----GSVYRGKI-----GGDFVAIKKVYG-----------DASDQIKLLNKINH-SSLIRLLGICFNGGNWY  412 (635)
Q Consensus       354 f~~~~~ig----g~Vy~g~~-----~~~~vavK~~~~-----------~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~  412 (635)
                      |.....||    |+||+++.     +|+.||||.++.           .+.+|+++|++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            44444554    89999975     478999998743           25589999999977 79999999999999999


Q ss_pred             EEeecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCccccc
Q 042486          413 LVYENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAE  492 (635)
Q Consensus       413 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  492 (635)
                      ++|||+.+|+|.+++.....  +++.....++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999966543  788899999999999999999954   9999999999999999999999999998654


Q ss_pred             ccCCceeeecccccCCCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccCCchhh
Q 042486          493 RQEGEFALTSHIVGTKGYMAPEYLENG--LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKEDGEES  570 (635)
Q Consensus       493 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  570 (635)
                      ....  .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||..........              ..
T Consensus       181 ~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--------------~i  244 (322)
T d1vzoa_         181 ADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--------------EI  244 (322)
T ss_dssp             GGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--------------HH
T ss_pred             cccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--------------HH
Confidence            4322  123346799999999998754  46889999999999999999999986543221110              00


Q ss_pred             hhhhcCCcCCCCCChHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 042486          571 LRHLMDPSMQGNYPPVTAILVIRLIESCLKKDPSGRPA-----MDKIAQS  615 (635)
Q Consensus       571 l~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  615 (635)
                      .......  ....+...+..+.+|+.+||+.||++|||     ++|+++|
T Consensus       245 ~~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         245 SRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            1111111  11233445667999999999999999995     7888764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-37  Score=321.28  Aligned_cols=246  Identities=26%  Similarity=0.280  Sum_probs=176.2

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEec------CCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFN------GGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~lV~E~~~~gsL~  424 (635)
                      |+||+|+.  +|+.||||+++..         +.+|+.+|++++||||+++++++..      ....|+||||+.++.+.
T Consensus        31 g~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~  110 (355)
T d2b1pa1          31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ  110 (355)
T ss_dssp             CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH
Confidence            89999997  6899999998642         5589999999999999999999964      35789999999776554


Q ss_pred             hhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeeccc
Q 042486          425 VWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHI  504 (635)
Q Consensus       425 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  504 (635)
                      .+ ..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++......    .....
T Consensus       111 ~~-~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~----~~~~~  178 (355)
T d2b1pa1         111 VI-QM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPY  178 (355)
T ss_dssp             HH-TS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------
T ss_pred             hh-hc----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccccc----ccccc
Confidence            43 22    2899999999999999999999955   9999999999999999999999999987654432    22345


Q ss_pred             ccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhccccc-----CCchhhhhh------
Q 042486          505 VGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHK-----EDGEESLRH------  573 (635)
Q Consensus       505 ~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-----~~~~~~l~~------  573 (635)
                      .+|+.|+|||++.+..+++++||||+||+++||++|+.||...+.... ...........     .........      
T Consensus       179 ~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (355)
T d2b1pa1         179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVENRP  257 (355)
T ss_dssp             --CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSC
T ss_pred             cccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHHHhhhhHHHHhhcCc
Confidence            789999999999999999999999999999999999999865433221 11111000000     000000010      


Q ss_pred             ---------hcCCcCCC---CCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          574 ---------LMDPSMQG---NYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       574 ---------~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                               ........   ......+..+.+|+.+||+.||++|||++|+++|  .+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H--pw~~~  316 (355)
T d2b1pa1         258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH--PYINV  316 (355)
T ss_dssp             CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS--TTTGG
T ss_pred             cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCC
Confidence                     11101100   1123346678999999999999999999999988  45543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-37  Score=321.06  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=178.3

Q ss_pred             ceEEEeee--CCcEEEEEEeccC---------hHHHHHHHhhhccCCcccEEEEEecC-----CeeEEEeecccCCCcch
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD---------ASDQIKLLNKINHSSLIRLLGICFNG-----GNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~  425 (635)
                      |+||+|+.  +|+.||||+++..         +.+|+++|++++|+||+++++++...     ...+++++|+.+|+|.+
T Consensus        32 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~  111 (348)
T d2gfsa1          32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN  111 (348)
T ss_dssp             SSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhh
Confidence            89999986  7999999998642         45899999999999999999998633     34466777888999999


Q ss_pred             hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccCCceeeecccc
Q 042486          426 WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQEGEFALTSHIV  505 (635)
Q Consensus       426 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  505 (635)
                      ++...   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||++.......      ....
T Consensus       112 ~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~------~~~~  179 (348)
T d2gfsa1         112 IVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYV  179 (348)
T ss_dssp             HHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGGG------SSSC
T ss_pred             hcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCccc------cccc
Confidence            99543   3999999999999999999999955   9999999999999999999999999997654332      2357


Q ss_pred             cCCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcchhhHHHHhhhcccccC------CchhhhhhhcCCc
Q 042486          506 GTKGYMAPEYLENG-LVSTKLDVYAFGVLMLEMLSGKEAPALYSEENMLLVDVLNPVLHKE------DGEESLRHLMDPS  578 (635)
Q Consensus       506 gt~~y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------~~~~~l~~~~d~~  578 (635)
                      ||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..... ...........      .............
T Consensus       180 g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (348)
T d2gfsa1         180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSESARNYIQSL  258 (348)
T ss_dssp             HHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHHTTCCCHHHHHHHTTS
T ss_pred             ccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChHHhhhccchhhhhhhhhc
Confidence            89999999987654 5689999999999999999999998654332211 11110000000      0000011111100


Q ss_pred             CC-CCC-----ChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 042486          579 MQ-GNY-----PPVTAILVIRLIESCLKKDPSGRPAMDKIAQSISRFLNA  622 (635)
Q Consensus       579 ~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  622 (635)
                      .. ...     ....+..+.+||.+||+.||++|||++|+++|  .++..
T Consensus       259 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~~  306 (348)
T d2gfsa1         259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQ  306 (348)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred             ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhCC
Confidence            00 000     01123457899999999999999999999986  45543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.8e-32  Score=287.56  Aligned_cols=245  Identities=22%  Similarity=0.286  Sum_probs=174.1

Q ss_pred             ceEEEeee--CCcEEEEEEeccC------hHHHHHHHhhhc-----------cCCcccEEEEEecC--CeeEEEeecccC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYGD------ASDQIKLLNKIN-----------HSSLIRLLGICFNG--GNWYLVYENAVN  420 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~~------~~~E~~~l~~l~-----------h~nIv~l~~~~~~~--~~~~lV~E~~~~  420 (635)
                      |+||+|+.  +|+.||||+++.+      +.+|++++++++           |+||+++++++...  ...+++++++..
T Consensus        27 g~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~  106 (362)
T d1q8ya_          27 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  106 (362)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccc
Confidence            89999987  7899999999764      357899888875           57899999988643  455666666655


Q ss_pred             CCcch-hhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCC------cEEEeeecCcccccc
Q 042486          421 GSLSV-WINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDF------RAKIANFALARPAER  493 (635)
Q Consensus       421 gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~------~~kl~Dfg~a~~~~~  493 (635)
                      +.... .........+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++      .++++|||.+.....
T Consensus       107 ~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         107 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  184 (362)
T ss_dssp             CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             ccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEeeccccccccc
Confidence            44333 2333344558999999999999999999997  24599999999999997654      499999999875443


Q ss_pred             cCCceeeecccccCCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCcch-----hhHHHHhhhcccccCCch
Q 042486          494 QEGEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLMLEMLSGKEAPALYSEE-----NMLLVDVLNPVLHKEDGE  568 (635)
Q Consensus       494 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~-----~~~l~~~~~~~~~~~~~~  568 (635)
                      .      .....||+.|+|||++....++.++||||+||+++||++|+.||...+..     ...+...+. .+......
T Consensus       185 ~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~-~lg~~~~~  257 (362)
T d1q8ya_         185 H------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE-LLGELPSY  257 (362)
T ss_dssp             C------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH-HHCSCCHH
T ss_pred             c------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH-HhCCCCHH
Confidence            2      23457999999999999999999999999999999999999998643221     111111111 00000000


Q ss_pred             h-----hhhhhcCC-------------------cCCCCCChHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 042486          569 E-----SLRHLMDP-------------------SMQGNYPPVTAILVIRLIESCLKKDPSGRPAMDKIAQS  615 (635)
Q Consensus       569 ~-----~l~~~~d~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  615 (635)
                      .     ......+.                   ..........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0     00000000                   00122345677889999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.74  E-value=2.9e-19  Score=168.72  Aligned_cols=150  Identities=13%  Similarity=0.045  Sum_probs=105.6

Q ss_pred             ceEEEeee-CCcEEEEEEeccC-------------------------hHHHHHHHhhhccCCcccEEEEEecCCeeEEEe
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD-------------------------ASDQIKLLNKINHSSLIRLLGICFNGGNWYLVY  415 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~-------------------------~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~  415 (635)
                      |.||+|+. +|+.||||.++..                         ...|...+.++.|.+++..+++.    ..+++|
T Consensus        14 g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvm   89 (191)
T d1zara2          14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLM   89 (191)
T ss_dssp             EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEE
T ss_pred             eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEE
Confidence            89999987 7899999976421                         12477888999999999988653    237999


Q ss_pred             ecccCCCcchhhcccCCCCCCHHHHHHHHHHHHhhhcccccCCCCCeEeecccCCCEEECCCCcEEEeeecCcccccccC
Q 042486          416 ENAVNGSLSVWINDKGGKFLDWAQRIQIALDVATGLNYLHSFTNPPHVHKDIKCSNVLLDTDFRAKIANFALARPAERQE  495 (635)
Q Consensus       416 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  495 (635)
                      ||++++.+.+         +++.....++.|++.+|.|||+.+   |+||||||+|||++++ .++|+|||.+.......
T Consensus        90 e~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~  156 (191)
T d1zara2          90 ELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEG  156 (191)
T ss_dssp             ECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTT
T ss_pred             Eeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCC
Confidence            9998865543         333445678999999999999955   9999999999999865 58999999987554322


Q ss_pred             CceeeecccccCCCccCccccccCCCCcccchhhHHHHH
Q 042486          496 GEFALTSHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLM  534 (635)
Q Consensus       496 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvvl  534 (635)
                      ...........     -.|.+ ...++.++|+||..--+
T Consensus       157 ~~~~l~rd~~~-----~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         157 WREILERDVRN-----IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             HHHHHHHHHHH-----HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             cHHHHHHHHHH-----HHHHH-cCCCCCcccHHHHHHHH
Confidence            11000000000     00111 34577889999986444

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.40  E-value=3e-14  Score=100.20  Aligned_cols=46  Identities=28%  Similarity=0.442  Sum_probs=42.7

Q ss_pred             EEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCC
Q 042486          185 LSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPL  232 (635)
Q Consensus       185 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~  232 (635)
                      ++|+|++|||||+||++||+++++|+++|++.++  .|++||.|.||.
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~--~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQA--GLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCS--SCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCC--CCCCCCEEEeCC
Confidence            6899999999999999999999999999999753  599999999984

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.39  E-value=8.1e-14  Score=97.47  Aligned_cols=46  Identities=28%  Similarity=0.472  Sum_probs=42.5

Q ss_pred             EEEEeecCChHHhHHHHhCCChhHHHHhcCCCCCCCCcccceecccCCC
Q 042486          185 LSYLVKGGNTVYGISKRFGVDTDRTLEANGLSEGAPNIYPFTTLLVPLE  233 (635)
Q Consensus       185 ~~y~v~~gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~~~~l~iP~~  233 (635)
                      ++|+|++|||||.||++||+++++|+++|++.  + .|+|||.|.||++
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~--~-~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--A-NLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG--G-GCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc--c-cCcCCCEEEEEeC
Confidence            48999999999999999999999999999984  3 5999999999974

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.10  E-value=1.9e-11  Score=85.59  Aligned_cols=45  Identities=20%  Similarity=0.324  Sum_probs=42.1

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEe
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVP  106 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip  106 (635)
                      ++|+|++ |||||+||++||+++++|+++|++.++ .|.+||.|.||
T Consensus         2 i~y~V~~-GDTL~~IA~~y~v~~~~i~~~N~~~~~-~l~~Gq~L~IP   46 (48)
T d1y7ma2           2 LTYQVKQ-GDTLNSIAADFRISTAALLQANPSLQA-GLTAGQSIVIP   46 (48)
T ss_dssp             EEEECCT-TCCHHHHHHHTTSCCCCCCCTSCTTCS-SCCTTCEEEET
T ss_pred             EEEEECC-CCCHHHHHHHhCCCHHHHHHHcCCCCC-CCCCCCEEEeC
Confidence            6799999 999999999999999999999998654 69999999998

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.09  E-value=2.8e-11  Score=84.37  Aligned_cols=45  Identities=16%  Similarity=0.236  Sum_probs=41.8

Q ss_pred             eeeecCCCCCCHHHHHHHhCCChHhHhhhcCCCCCcccCCCcEEEEee
Q 042486           60 LIFRSKPPFNTVASISTLLASKPSQLSKINSVSETATFETNQMVIVPV  107 (635)
Q Consensus        60 ~~y~~~~~g~tl~~Ia~~~~~~~~~i~~~N~~~~~~~~~~gq~l~ip~  107 (635)
                      ++|+|++ ||||++||++||+++++|+++|++.  +.|.+||.|.||+
T Consensus         3 v~y~V~~-GDTl~~IA~~y~vs~~~i~~~N~l~--~~l~~Gq~L~i~v   47 (48)
T d1e0ga_           3 ITYRVRK-GDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECT-TCCHHHHHHHHTCCHHHHHHHCSCG--GGCCTTEEEECCC
T ss_pred             EEEEECC-CCCHHHHHHHHCCCHHHHHHHcCCc--ccCcCCCEEEEEe
Confidence            5799999 9999999999999999999999984  3699999999997

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.10  E-value=6.8e-06  Score=79.06  Aligned_cols=121  Identities=15%  Similarity=0.100  Sum_probs=84.1

Q ss_pred             ceEEEeeeCCcEEEEEEecc-------ChHHHHHHHhhhc-cCCcccEEEEEecCCeeEEEeecccCCCcchhhcccCCC
Q 042486          362 GSVYRGKIGGDFVAIKKVYG-------DASDQIKLLNKIN-HSSLIRLLGICFNGGNWYLVYENAVNGSLSVWINDKGGK  433 (635)
Q Consensus       362 g~Vy~g~~~~~~vavK~~~~-------~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  433 (635)
                      ..||+...++..+.||+...       ++.+|...+..+. +--+.+++.+..+++..++||++++|.++.+.....   
T Consensus        28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---  104 (263)
T d1j7la_          28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---  104 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred             CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence            47999888888888998754       3568888888774 334678888888888899999999998775543211   


Q ss_pred             CCCHHHHHHHHHHHHhhhcccccCC-------------------------------------------------------
Q 042486          434 FLDWAQRIQIALDVATGLNYLHSFT-------------------------------------------------------  458 (635)
Q Consensus       434 ~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------------  458 (635)
                       ..   ...++.+++..+..||+..                                                       
T Consensus       105 -~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  180 (263)
T d1j7la_         105 -QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPE  180 (263)
T ss_dssp             -SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCC
T ss_pred             -cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCc
Confidence             11   1122333334444444310                                                       


Q ss_pred             -CCCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          459 -NPPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       459 -~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                       ...++|+|+.|.||++++++..-|+||+.+.
T Consensus       181 ~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         181 EELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence             1237899999999999987667799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.59  E-value=0.00011  Score=69.75  Aligned_cols=64  Identities=14%  Similarity=0.194  Sum_probs=48.5

Q ss_pred             ceEEEeeeC-CcEEEEEEecc----ChHHHHHHHhhhccCC--cccEEEEEecCCeeEEEeecccCCCcch
Q 042486          362 GSVYRGKIG-GDFVAIKKVYG----DASDQIKLLNKINHSS--LIRLLGICFNGGNWYLVYENAVNGSLSV  425 (635)
Q Consensus       362 g~Vy~g~~~-~~~vavK~~~~----~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~  425 (635)
                      ..||+...+ +..+.+|....    ++..|...|+.+....  +.+++++..+++..++||++++|.++.+
T Consensus        25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            578988874 55678887654    4678999988885433  5678888888888899999998876643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.47  E-value=0.0062  Score=61.48  Aligned_cols=60  Identities=15%  Similarity=0.024  Sum_probs=38.7

Q ss_pred             ceEEEeee--CCcEEEEEEecc--------------ChHHHHHHHhhhc-c--CCcccEEEEEecCCeeEEEeecccCCC
Q 042486          362 GSVYRGKI--GGDFVAIKKVYG--------------DASDQIKLLNKIN-H--SSLIRLLGICFNGGNWYLVYENAVNGS  422 (635)
Q Consensus       362 g~Vy~g~~--~~~~vavK~~~~--------------~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lV~E~~~~gs  422 (635)
                      ..||+...  +++.++||.-..              ....|.+.|+.+. +  ..+.+++.+  +++..++|||++.+..
T Consensus        40 N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~~~~  117 (392)
T d2pula1          40 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             EEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTSE
T ss_pred             EeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccCCcc
Confidence            47998876  467899996432              1235888887763 2  346666655  4555689999997754


Q ss_pred             c
Q 042486          423 L  423 (635)
Q Consensus       423 L  423 (635)
                      +
T Consensus       118 ~  118 (392)
T d2pula1         118 I  118 (392)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.71  E-value=0.0092  Score=58.47  Aligned_cols=127  Identities=9%  Similarity=0.097  Sum_probs=72.1

Q ss_pred             ceEEEeee-CCcEEEEEEeccC------hHHHHHHHhhhccCCcc--cEE-----EEEecCCeeEEEeecccCCCcchh-
Q 042486          362 GSVYRGKI-GGDFVAIKKVYGD------ASDQIKLLNKINHSSLI--RLL-----GICFNGGNWYLVYENAVNGSLSVW-  426 (635)
Q Consensus       362 g~Vy~g~~-~~~~vavK~~~~~------~~~E~~~l~~l~h~nIv--~l~-----~~~~~~~~~~lV~E~~~~gsL~~~-  426 (635)
                      -.||+.+. +|+.+++|..+..      +..|...+..|....+.  ..+     ..+..++..+.++++++|..+... 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            37999998 7888999987643      56788888887533322  111     112245667889999877543210 


Q ss_pred             ----------h---cc----c---CCCCCCHH----------------------HHHHHHHHHHhhhccc-ccCCCCCeE
Q 042486          427 ----------I---ND----K---GGKFLDWA----------------------QRIQIALDVATGLNYL-HSFTNPPHV  463 (635)
Q Consensus       427 ----------l---~~----~---~~~~l~~~----------------------~~~~i~~~ia~aL~~L-H~~~~~~iv  463 (635)
                                +   +.    .   ....+++.                      .....+.++...+.-. ......+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                      0   00    0   00111111                      1122223333332221 122235689


Q ss_pred             eecccCCCEEECCCCcEEEeeecCccc
Q 042486          464 HKDIKCSNVLLDTDFRAKIANFALARP  490 (635)
Q Consensus       464 H~Dikp~NIll~~~~~~kl~Dfg~a~~  490 (635)
                      |+|+.+.|||++++  ..++||+.+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999754  45899998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.51  E-value=0.02  Score=55.52  Aligned_cols=30  Identities=23%  Similarity=0.264  Sum_probs=27.0

Q ss_pred             CCeEeecccCCCEEECCCCcEEEeeecCcc
Q 042486          460 PPHVHKDIKCSNVLLDTDFRAKIANFALAR  489 (635)
Q Consensus       460 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  489 (635)
                      .++||+|+.++||+++++...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            569999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.50  E-value=0.055  Score=54.14  Aligned_cols=59  Identities=14%  Similarity=0.187  Sum_probs=37.9

Q ss_pred             ceEEEeeeC---------CcEEEEEEecc-----ChHHHHHHHhhhccCCc-ccEEEEEecCCeeEEEeecccCCCcc
Q 042486          362 GSVYRGKIG---------GDFVAIKKVYG-----DASDQIKLLNKINHSSL-IRLLGICFNGGNWYLVYENAVNGSLS  424 (635)
Q Consensus       362 g~Vy~g~~~---------~~~vavK~~~~-----~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~E~~~~gsL~  424 (635)
                      -.+|+....         .+.|.++..-.     +..+|..+++.+.-.++ .++++++.+    .+|+||++|..|.
T Consensus        56 N~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l~  129 (395)
T d1nw1a_          56 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS  129 (395)
T ss_dssp             EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred             cceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccCC
Confidence            378887752         23455554321     24578889888854454 578887743    5899999886554